Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
FAM20C	"DKFZp547D065, DMP4, G-CK, IMAGE:4942737"	ENSG00000177706	"FAM20C, golgi associated secretory pathway kinase"	Q8IXL6	7	192969-260745	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	Biomineralization	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 80.6"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 52.4;Hepatocytes: 80.0;Hofbauer cells: 49.0;Peritubular cells: 53.0;Proximal tubular cells: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HSkMC: 50.3;hTERT-RPE1: 39.1;U-87 MG: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019823			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted in other tissues"	NA	NA		160000000	"Golgi apparatus"	Nucleoplasm	"HPA019823: AB_1848389"	"unprognostic (1.94e-1)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.47e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (9.40e-6)"	"unprognostic (1.97e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.83e-3)"	27.5	10.2	10.8	19.3	16.6	3.3	25.6	7.4	14.9	8.3	20.1	13.5	15.1	12.9	9.5	6.9	11.1	9.7	15.0	15.0	8.8	7.2	31.8	31.6	12.7	5.1	16.9	5.6	11.8	14.8	2.6	9.2	7.2	15.8	15.0	4.6	8.8	80.6	11.8	20.4	6.8	16.5	17.0	17.0	6.9	20.0	5.9	14.8	0.4	9.6	8.4	4.4	20.5	17.5	0.0	0.6	0.0	1.6	0.2	0.0	0.0	13.3	6.5	0.2	9.3	11.9	19.7	0.0	11.9	20.2	6.5	5.2	0.7	8.2	0.0	6.6	17.8	8.8	11.6	1.0	0.5	1.6	2.8	0.6	0.0	3.1	3.5	9.0	0.0	0.9	50.3	1.5	0.2	0.7	39.1	4.5	0.0	0.0	0.1	1.7	1.8	0.0	0.7	6.3	0.1	0.4	1.5	0.3	0.0	4.8	0.0	3.1	0.1	12.4	0.0	1.8	1.2	8.8	6.1	12.5	8.1	4.0	6.9	3.6	0.0	0.0	0.0	31.0	0.8	23.1	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.8	16.6	7.4	14.9	8.8	7.2	16.9	5.6	15.8	14.8	6.0	3.2	2.4	1.9	9.0	20.6	8.1	33.1	5.3	0.0	52.4	0.0	0.5	5.0	1.3	0.0	2.4	3.5	0.0	4.1	0.6	13.5	6.8	3.5	80.0	49.0	1.6	11.3	9.8	15.6	1.1	15.0	14.7	1.7	11.8	4.2	16.6	6.5	3.5	53.0	46.8	8.0	12.9	15.3	0.2	0.7	7.0	0.5	0.0	7.3	1.4
AC187653.1		ENSG00000248767			7	290170-294422	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	8	"testis: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.3			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.2		0.0	0.0	0.0	0.0	0.2	0.1		0.0	0.0	2.5			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDGFA	"PDGF-A, PDGF1"	ENSG00000197461	"Platelet derived growth factor subunit A"	P04085	7	497258-520296	"Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 63.1"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 83.4;Paneth cells: 77.2;Smooth muscle cells: 97.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"WM-115: 82.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005579, HPA065024"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		300000	"Golgi apparatus"		"CAB005579: AB_2161916, HPA065024: "	"unprognostic (2.22e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.75e-4)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (2.63e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.87e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (8.67e-4)"	9.5	6.1	13.1	6.6	20.4	2.1	16.5	9.0	16.6	11.1	14.8	33.4	5.8	16.3	15.5	11.2	8.5	12.1	10.0	14.0	14.9	14.2	10.4	5.4	16.5	8.1	29.8	12.5	6.6	54.7	5.7	6.1	21.5	21.1	14.4	12.7	7.4	16.6	10.2	63.1	10.6	20.3	10.7	26.4	11.8	20.9	4.5	22.7	1.6	6.0	8.6	2.7	11.0	12.7	3.0	3.3	11.6	4.6	5.3	3.6	2.9	5.8	4.0	0.4	5.7	1.1	0.2	13.6	1.3	0.7	1.7	1.2	6.2	6.7	0.1	2.3	1.1	0.7	14.9	0.4	18.1	0.9	3.3	0.6	0.1	3.3	2.2	7.4	0.6	0.7	0.8	7.2	0.8	5.7	2.3	3.3	0.3	0.5	0.8	4.1	7.3	0.8	1.3	10.7	2.3	0.8	2.9	0.4	0.6	2.3	1.4	0.6	0.5	20.1	1.1	3.4	13.4	2.8	0.7	9.7	3.7	10.3	2.1	7.9	0.2	0.3	0.2	3.3	1.8	82.4	11.6	2.6	3.5	2.7	2.9	3.6	3.0	2.7	2.5	2.3	3.0	3.3	3.3	7.6	5.3	4.6	3.3	2.8	2.9	13.1	20.4	9.0	14.5	14.9	14.2	29.8	12.5	21.1	22.7	83.4	11.0	0.0	18.2	24.8	15.7	25.0	5.1	6.7	17.0	14.0	7.9	7.8	5.0	14.2	0.3	19.6	51.1	0.0	46.6	3.8	15.1	23.5	10.4	0.6	1.9	30.2	12.5	22.1	1.5	0.0	2.0	1.6	13.5	1.8	28.3	0.5	52.4	77.2	6.0	8.0	1.9	38.8	97.6	0.2	1.1	8.5	2.4	0.0	20.3	14.5
PRKAR1B		ENSG00000188191	"Protein kinase cAMP-dependent type I regulatory subunit beta"	P31321	7	549197-727650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 83.6"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 48.9;Horizontal cells: 50.9;Late spermatids: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 41.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026719	Approved					NA	NA					"HPA026719: AB_1855419"	"unprognostic (4.90e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.02e-3)"	"unprognostic (3.28e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.38e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.64e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.00e-1)"	5.0	6.8	33.6	4.3	30.4	4.5	4.0	24.0	83.6	4.8	5.7	3.4	1.6	7.2	7.2	2.7	4.2	6.2	4.6	7.7	35.5	42.8	5.4	3.8	5.5	5.2	22.5	29.2	12.9	4.1	5.6	7.0	3.5	29.7	6.0	4.2	2.5	3.9	5.5	3.8	3.0	7.6	5.3	9.1	8.2	3.8	4.8	3.7	2.5	2.9	1.4	3.3	3.5	2.6	7.0	5.5	1.5	2.6	3.5	12.8	10.3	25.3	17.5	2.6	6.4	1.7	1.5	7.4	5.1	2.4	3.3	1.9	31.3	5.6	19.2	3.5	2.3	10.9	18.7	8.7	9.7	1.4	4.0	6.3	1.3	11.3	20.6	3.2	12.1	3.1	4.3	3.0	2.1	6.2	3.6	3.5	5.1	18.4	3.9	2.9	24.3	14.7	8.0	41.0	7.0	6.9	9.5	0.5	8.5	8.2	6.7	34.4	25.9	13.0	12.8	10.0	1.1	6.6	4.6	4.2	1.5	3.2	1.9	10.3	2.4	6.9	12.5	2.7	9.4	19.1	1.5	2.0	0.0	4.6	2.6	6.9	6.2	7.9	7.1	2.4	7.0	12.8	11.7	0.8	3.5	0.9	5.5	5.2	10.3	33.6	30.4	24.0	68.6	35.5	42.8	22.5	29.2	29.7	3.7	3.0	4.1	8.2	6.8	3.4	9.4	11.5	0.0	0.0	5.7	5.2	3.9	3.1	21.6	4.0	48.9	11.3	13.8	0.0	3.0	5.1	4.7	4.5	6.9	7.4	9.0	50.9	4.1	16.0	3.3	101.7	10.9	2.3	6.8	1.0	10.6	5.1	6.7	12.9	14.5	15.3	4.4	0.0	5.0	9.5	8.5	4.1	2.9	8.7	13.8	4.1
DNAAF5	"CILD18, FLJ20397, FLJ25564, FLJ31671, FLJ39381, HEATR2"	ENSG00000164818	"Dynein axonemal assembly factor 5"	Q86Y56	7	726701-786475	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020243	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA020243: AB_1848750"	"unprognostic (9.77e-2)"	"unprognostic (9.53e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.22e-3)"	"prognostic unfavorable (8.42e-4)"	"prognostic unfavorable (3.83e-4)"	"unprognostic (8.07e-3)"	"unprognostic (2.02e-1)"	"unprognostic (7.59e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.70e-3)"	11.5	13.0	9.3	13.5	11.4	10.7	12.3	17.4	14.2	15.5	16.3	14.7	10.3	12.0	18.4	13.9	16.7	23.4	15.4	18.8	11.6	8.6	15.0	18.2	9.9	11.8	9.5	7.6	20.6	22.5	14.4	21.1	12.1	10.4	16.1	9.9	14.0	17.6	14.3	33.9	12.0	13.6	13.9	9.2	12.5	13.0	14.8	9.4	20.7	15.9	11.2	14.2	15.6	12.4	3.3	4.6	1.4	2.8	3.0	4.7	1.9	30.7	24.4	7.3	16.9	4.8	5.3	18.4	6.4	6.2	8.0	7.6	24.3	16.4	18.9	9.3	6.7	19.1	18.7	13.4	16.1	6.2	3.2	22.8	4.6	14.5	17.5	6.6	14.0	8.4	6.4	6.9	10.0	7.4	5.3	10.8	9.6	29.3	3.9	5.8	30.3	8.3	12.6	26.8	10.2	19.4	15.4	2.3	13.0	9.3	13.0	15.3	25.4	10.5	25.9	7.4	8.7	22.8	11.8	9.0	4.5	16.0	15.3	14.3	7.7	9.2	10.9	9.8	14.8	23.3	0.0	1.9	1.4	2.2	2.8	3.3	1.6	3.5	4.7	2.7	3.3	3.3	2.5	0.0	3.0	2.0	4.6	0.8	1.9	9.3	11.4	17.4	14.2	11.6	8.6	9.5	7.6	10.4	9.4	17.9	7.8	0.0	5.2	0.0	5.8	12.5	5.1	14.7	7.9	8.7	25.5	6.8	13.3	6.0	0.5	5.6	3.8	0.0	3.6	11.2	5.1	3.9	0.0	8.2	5.0	9.5	3.5	5.5	8.2	1.3	6.6	2.7	0.0	0.0	10.5	9.1	8.6	0.0	8.1	8.6	16.1	0.0	3.9	6.7	20.0	0.0	3.8	2.2	11.2	3.5
SUN1	"FLJ12407, KIAA0810, UNC84A"	ENSG00000164828	"Sad1 and UNC84 domain containing 1"	O94901	7	816615-896435	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Meiosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 286.8;Late spermatids: 435.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008346, HPA008461"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA008346: AB_1080462, HPA008461: AB_1080461"	"unprognostic (2.70e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.57e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.33e-2)"	29.8	14.5	18.2	17.2	23.6	4.0	26.0	49.6	28.9	31.1	22.5	23.6	18.9	18.1	47.1	22.6	24.2	28.5	20.0	40.8	16.6	14.9	19.4	13.4	19.6	11.6	15.9	21.3	39.6	22.4	37.5	26.8	25.3	18.0	18.8	16.8	27.6	19.5	19.7	56.7	46.1	17.9	33.6	15.3	17.6	23.9	36.4	15.4	11.8	20.1	31.0	17.8	20.3	25.3	8.0	8.1	7.6	10.2	6.7	13.2	6.5	38.7	10.5	12.7	20.6	14.0	20.1	12.4	9.8	16.5	18.3	18.8	8.9	43.8	9.3	10.2	13.4	36.1	48.9	10.3	17.4	17.9	3.9	10.4	3.0	15.4	8.4	18.0	4.6	7.7	10.0	20.8	14.6	24.4	17.1	13.3	5.9	12.5	7.0	18.3	13.4	3.0	7.6	17.6	13.4	12.2	6.6	7.0	8.7	18.7	12.5	24.5	15.9	12.4	25.5	9.4	21.4	20.2	4.7	10.0	16.9	15.4	17.5	16.1	6.5	7.5	5.7	11.6	3.8	23.2	7.6	10.2	2.6	4.7	8.8	5.0	8.0	9.2	5.3	8.1	6.8	13.2	8.2	0.6	6.7	6.3	1.6	7.7	6.5	18.2	23.6	49.6	28.9	16.6	14.9	15.9	21.3	18.0	15.4	41.7	34.2	14.9	83.2	94.7	70.8	83.7	30.6	73.6	47.8	38.4	82.5	26.8	23.2	36.0	286.8	74.1	41.1	23.3	20.1	19.4	40.9	82.0	16.2	36.5	14.8	106.5	39.1	67.5	19.0	435.0	52.9	19.2	40.5	3.6	39.1	23.8	40.3	52.6	40.0	19.3	66.7	64.7	64.5	30.9	48.0	74.9	32.2	15.0	33.0	105.6
GET4	"C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35"	ENSG00000239857	"Golgi to ER traffic protein 4"	Q7L5D6	7	876552-896436	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	8	"Cone photoreceptor cells: 3.9;Horizontal cells: 7.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019765	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Mitotic chromosome,Cytosol"		Yes	No			"Nucleoplasm, Cytosol"	"Nucleoli, Mitotic chromosome"	"HPA019765: AB_1845750"	"unprognostic (2.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.66e-4)"	"unprognostic (9.86e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.93e-2)"	"unprognostic (9.47e-2)"	13.7	39.8	22.4	14.8	21.4	28.5	15.3	22.1	23.5	10.3	15.5	20.9	19.0	21.8	12.3	23.8	18.8	14.6	12.8	18.7	16.4	15.4	27.8	37.5	12.2	15.1	22.9	21.5	16.5	32.6	11.3	32.9	21.7	18.9	16.8	9.9	15.2	25.0	21.9	53.7	29.7	20.9	12.6	18.9	16.9	22.2	32.0	22.7	12.5	16.0	21.8	12.5	14.3	17.3	23.3	31.5	28.9	30.7	24.9	27.3	21.9	26.3	13.0	9.1	13.4	4.7	3.3	28.9	7.3	5.2	9.4	9.4	35.3	33.0	9.7	7.7	4.2	26.2	16.8	10.2	8.0	4.1	3.9	17.5	5.3	10.2	19.9	10.4	9.1	9.9	4.9	9.7	8.2	5.4	7.1	7.4	11.3	34.5	9.0	5.2	20.0	6.9	21.9	32.7	15.6	19.5	14.5	1.6	10.4	8.3	15.6	16.5	17.8	6.7	24.9	10.6	11.6	18.9	16.2	7.4	6.9	15.6	16.0	10.0	13.6	8.5	12.5	7.1	15.7	17.5	16.8	27.4	28.9	24.2	24.7	23.7	23.3	26.5	24.0	27.7	23.2	26.0	27.3	21.1	24.9	30.7	31.5	24.5	21.9	22.4	21.4	22.1	23.5	16.4	15.4	22.9	21.5	18.9	22.7	0.0	1.9	0.0	0.2	0.9	0.8	0.4	0.0	2.7	3.4	0.0	3.9	0.9	0.0	0.6	3.6	0.1	1.6	0.0	0.6	0.6	0.3	0.4	1.1	0.0	0.6	7.9	0.0	0.0	0.3	1.5	0.0	2.5	0.0	0.0	1.9	0.2	0.8	0.0	0.0	0.6	1.1	0.0	0.2	0.5	1.0	0.9	1.4	0.9	1.7	0.8
ADAP1	"CENTA1, GCS1L"	ENSG00000105963	"ArfGAP with dual PH domains 1"	O75689	7	897901-955407	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.8;intestine: 30.8"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 56.4;Mucus-secreting cells: 30.1;Paneth cells: 34.3;Undifferentiated cells: 26.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 31.2;CAPAN-2: 22.5;HMC-1: 21.6;OE19: 57.2;THP-1: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007033, HPA012049"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA007033: AB_1846529, HPA012049: AB_1846527"	"unprognostic (2.45e-1)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (9.13e-4)"	"unprognostic (3.06e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (4.13e-5)"	"unprognostic (5.88e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.79e-2)"	3.0	2.1	32.9	8.9	25.9	8.1	1.2	13.8	41.8	3.6	30.8	30.3	1.7	16.7	2.6	1.3	4.5	4.2	6.2	3.9	36.1	17.7	6.5	1.6	5.8	3.3	28.0	20.1	0.7	5.4	3.7	1.3	3.0	19.3	1.9	20.6	0.9	3.0	3.1	0.8	2.0	22.8	7.7	36.1	7.4	16.3	1.1	19.3	0.0	4.8	0.4	2.3	5.1	1.0	1.3	5.5	3.4	11.7	1.6	6.8	3.7	31.2	1.1	0.0	1.1	0.4	0.0	0.3	1.0	0.0	0.3	0.1	12.4	22.5	0.0	3.1	0.1	0.0	14.3	1.7	2.4	0.1	0.1	1.3	0.0	1.9	7.0	0.5	0.2	21.6	0.5	6.7	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	10.0	0.0	8.4	1.0	57.2	0.0	4.2	0.0	0.1	1.7	7.6	0.9	0.3	0.9	0.4	0.1	0.1	8.1	36.7	0.1	0.2	0.9	0.0	0.1	0.0	0.0	0.0	0.0	6.5	1.1	1.1	7.6	3.4	6.8	8.1	3.3	1.3	2.0	6.1	5.5	1.1	0.6	3.1	3.4	1.6	11.7	0.4	0.9	3.7	32.9	25.9	13.8	33.4	36.1	17.7	28.0	20.1	19.3	19.3	0.0	13.0	3.2	2.5	0.9	4.2	7.7	7.6	8.1	2.3	7.0	0.0	0.1	8.3	3.7	0.0	0.5	56.4	0.0	4.0	0.4	1.4	2.0	6.9	0.4	11.1	0.0	15.5	0.0	21.6	0.0	0.0	13.7	10.1	0.0	30.1	1.2	12.4	34.3	0.0	5.9	0.6	0.0	1.0	0.3	0.9	1.1	0.6	4.4	26.9	3.3
COX19	MGC104475	ENSG00000240230	"COX19, cytochrome c oxidase assembly factor"	Q49B96	7	898778-975599	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021226	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA021226: AB_1847176"	"unprognostic (1.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.76e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.96e-1)"	"unprognostic (5.60e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.14e-3)"	8.1	22.1	11.9	9.4	15.8	16.6	9.6	25.4	13.3	8.6	10.2	14.5	10.8	15.7	9.2	8.5	10.2	15.0	8.3	9.5	11.3	9.7	10.6	9.9	8.8	11.4	18.5	10.4	12.7	16.4	13.9	13.7	8.4	14.1	10.8	10.5	8.0	13.3	9.0	18.9	16.5	13.3	8.7	12.6	13.6	13.4	11.2	15.3	8.5	10.5	12.4	11.6	9.2	9.9	12.5	15.0	15.1	9.9	10.1	15.2	7.6	14.3	3.6	4.3	5.4	3.1	4.6	8.3	6.3	4.6	5.8	4.8	9.7	8.1	7.0	2.2	3.8	8.7	9.7	4.5	4.7	4.7	2.2	7.3	3.1	4.4	7.5	9.9	7.3	6.8	5.4	9.9	4.5	10.4	5.7	3.6	7.1	8.9	6.0	3.6	8.7	3.3	7.9	11.1	16.3	9.6	7.6	0.8	3.5	4.8	6.2	5.6	5.6	3.7	14.9	11.5	7.2	7.8	17.5	4.3	5.6	7.9	6.3	9.8	7.3	5.2	7.2	5.1	10.3	9.5	15.1	9.9	13.9	11.2	9.7	11.8	12.5	12.1	10.1	8.4	12.2	15.2	14.3	9.5	10.1	9.9	15.0	11.1	7.6	11.9	15.8	25.4	13.3	11.3	9.7	18.5	10.4	14.1	15.3	11.9	18.4	21.7	30.1	21.9	18.7	12.3	33.1	26.8	14.8	29.6	11.8	23.3	13.3	32.2	5.2	19.6	27.7	0.0	30.0	34.1	18.9	24.5	34.6	25.1	23.5	14.3	43.0	24.5	18.6	1.7	18.1	28.2	20.3	40.5	28.9	29.4	36.3	31.7	13.4	17.4	25.8	6.5	21.1	17.2	30.6	22.5	35.0	42.4	28.2	37.2
CYP2W1	"FLJ20359, MGC34287"	ENSG00000073067	"Cytochrome P450 family 2 subfamily W member 1"	Q8TAV3	7	983199-989640	"Predicted intracellular proteins"	"Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 18.0;intestine: 9.1;skin 1: 12.1"	"Cell type enriched"	"Detected in many"	8	"Intestinal endocrine cells: 94.6"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 25.3;stomach cancer: 15.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"CACO-2: 9.0;Hep G2: 32.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA012753	Uncertain				"Intracellular and membrane"	NA	NA					"HPA012753: AB_1847444"	"unprognostic (7.09e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.72e-5)"	"unprognostic (7.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (5.85e-4)"	0.8	18.0	0.0	1.3	0.0	0.0	0.1	0.0	0.3	0.8	1.4	0.0	0.0	9.1	0.0	0.0	3.6	0.2	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.0	2.4	0.3	0.0	0.3	6.1	0.3	1.9	0.7	1.7	0.3	2.2	0.0	12.1	5.0	0.0	0.7	0.4	0.9	2.4	0.0	0.0	0.0	2.3	0.7	1.1	3.2	0.4	0.1	1.5	0.2	0.1	0.5	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	32.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.4	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.4	2.8	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.5	0.1	0.2	0.5	0.2	0.3	0.1	0.2	0.2	0.1	0.4	0.2	0.3	1.5	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.3	0.0	3.0	0.0	0.0	1.8	3.5	0.0	0.3	0.0	2.7	2.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.8	0.4	1.4	0.7	0.0	0.0	1.0	0.0	94.6	0.0	0.0	0.0	1.7	0.0	0.0	0.0	5.7	12.1	0.1	2.9	0.0	0.0	0.6	0.0	0.0	0.1	0.0	3.9	1.6	0.0	4.2	3.1
C7orf50	"MGC11257, YCR016W"	ENSG00000146540	"Chromosome 7 open reading frame 50"	Q9BRJ6	7	996986-1138260	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 250.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052281	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA052281: AB_2681784"	"unprognostic (1.64e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.57e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (6.20e-6)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	22.5	14.2	37.7	14.9	29.4	9.7	14.9	16.4	32.8	17.0	17.5	15.5	19.4	12.8	20.1	18.8	14.8	21.0	20.3	28.7	28.1	21.4	21.7	14.2	16.1	21.2	22.4	23.0	21.6	79.5	12.3	39.3	13.9	17.3	21.7	7.9	25.9	25.1	28.8	68.4	8.2	13.8	34.5	19.1	19.5	25.1	19.5	9.8	6.0	20.8	18.0	16.6	17.2	10.9	32.3	41.5	76.3	27.0	8.1	20.6	22.7	41.6	26.7	8.9	27.2	4.8	6.9	18.9	18.7	9.3	16.7	14.2	18.8	17.9	12.5	12.4	12.0	21.2	26.5	10.7	22.6	3.3	11.9	21.6	11.4	18.9	25.5	19.7	14.5	7.9	9.8	18.1	15.5	14.3	7.3	11.4	10.6	20.3	12.0	7.4	60.2	6.7	38.9	21.9	18.8	39.7	19.8	3.3	20.7	7.8	11.6	20.6	29.5	15.4	18.3	25.2	6.2	43.9	26.8	13.1	9.7	43.2	28.9	24.5	10.3	13.8	11.4	19.5	24.2	30.6	3.2	27.0	76.3	20.6	26.2	14.6	23.6	16.9	17.4	41.5	32.3	13.2	15.3	3.0	8.1	25.0	12.0	19.7	22.7	37.7	29.4	16.4	32.8	28.1	21.4	22.4	23.0	17.3	9.8	32.8	64.7	92.5	33.2	20.6	74.8	64.4	40.8	56.2	30.7	62.8	17.7	65.3	250.4	73.5	7.0	40.5	17.6	23.3	74.9	70.2	42.1	41.1	54.3	32.5	140.0	54.0	87.1	33.7	63.1	3.4	34.2	61.3	67.4	120.8	45.0	82.9	55.6	17.3	41.8	101.0	58.5	25.8	67.4	18.1	41.5	21.3	38.9	48.4	57.1	30.7
GPR146	PGR8	ENSG00000164849	"G protein-coupled receptor 146"	Q96CH1	7	1044576-1059261	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	26	"Endothelial cells: 40.7;Extravillous trophoblasts: 225.4;Syncytiotrophoblasts: 68.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 36.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 36.2;T-cells: 11.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 22.8;NB-4: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.39e-2)"	"unprognostic (7.83e-2)"	"unprognostic (6.27e-4)"	"unprognostic (5.51e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.48e-3)"	"unprognostic (2.51e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.27e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.03e-2)"	37.2	4.2	7.4	3.0	7.2	10.3	35.1	10.8	10.3	6.9	8.5	6.2	4.0	4.2	8.2	4.3	6.0	9.2	9.8	10.2	6.9	5.6	5.0	17.8	16.8	5.7	8.7	3.4	8.5	8.1	2.6	2.1	13.7	11.1	7.3	2.0	6.4	12.0	8.2	9.9	7.0	4.7	5.1	7.9	4.2	9.6	4.9	10.5	0.4	6.0	5.0	2.2	8.5	8.5	0.0	5.6	36.2	0.1	0.4	11.4	2.1	1.2	1.2	0.4	1.1	1.2	0.3	22.8	0.1	0.8	0.2	1.1	0.9	1.0	0.4	0.9	0.1	3.3	0.7	0.0	0.2	0.1	0.8	1.2	1.6	0.7	1.8	1.5	0.1	0.2	0.5	0.0	0.7	0.0	2.3	1.6	0.5	1.1	1.2	0.2	0.9	0.0	6.4	1.6	1.1	0.7	5.2	0.0	1.6	0.3	0.2	1.2	1.7	1.7	0.2	1.8	0.9	1.1	2.0	0.5	0.9	1.3	1.6	0.8	2.0	2.0	0.1	6.0	2.0	2.0	0.0	0.0	36.2	0.3	0.0	0.5	0.0	3.9	0.3	0.7	0.0	11.4	2.2	0.0	0.4	0.1	5.6	6.1	2.1	7.4	7.2	10.8	10.3	6.9	5.6	8.7	3.4	11.1	10.5	0.0	3.2	0.5	0.8	1.5	2.4	0.3	0.0	0.0	3.4	1.8	0.0	6.0	1.7	0.8	0.0	40.7	0.0	0.0	0.5	225.4	1.8	0.6	2.3	16.8	9.2	3.2	4.1	7.4	0.3	0.4	2.8	0.7	3.3	0.0	0.0	22.9	1.0	0.0	3.2	2.5	4.7	0.0	0.6	0.5	1.1	1.9	68.9	0.0	1.0	0.3
GPER1	"CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER, GPR30, LERGU, LERGU2, LyGPR"	ENSG00000164850	"G protein-coupled estrogen receptor 1"	Q99527	7	1082208-1093815	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell cycle, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 22.2;Kupffer cells: 13.5;Paneth cells: 8.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 4.3;intermediate monocyte: 4.2;myeloid DC: 8.4"	"Group enriched"	"Detected in many"	18	"dendritic cells: 8.4;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.1;Daudi: 10.6;Hep G2: 19.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA016718, HPA027052"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA			Nucleoli	"Nucleoplasm, Vesicles, Cytosol"	"HPA016718: , HPA027052: AB_10612112"	"unprognostic (4.74e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (2.17e-1)"	"unprognostic (6.17e-2)"	"unprognostic (3.45e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.78e-2)"	14.2	10.9	12.1	3.6	13.2	1.2	11.5	5.1	11.1	6.4	7.1	5.6	3.5	2.0	5.4	1.8	5.5	4.8	3.2	6.0	8.3	6.2	7.4	19.5	25.6	6.4	8.6	8.7	3.3	4.0	1.8	4.7	13.3	6.1	6.8	3.7	5.2	4.2	11.8	8.6	2.8	2.6	5.5	4.1	6.5	23.9	2.2	8.6	1.3	16.5	2.3	2.8	6.4	7.2	0.3	8.4	0.0	4.3	0.0	0.0	1.6	0.9	0.4	0.2	10.1	2.5	2.4	1.0	5.8	3.9	1.8	3.3	0.2	0.2	10.6	1.0	7.3	0.1	0.5	0.1	0.0	0.2	2.2	1.8	0.0	1.3	19.4	0.3	0.1	0.7	1.3	0.0	1.1	0.0	1.4	0.5	0.2	0.1	0.1	0.4	0.7	0.0	0.3	1.9	2.0	6.9	0.9	0.0	0.0	0.2	0.0	0.1	4.0	0.0	0.4	2.1	0.8	0.2	0.1	1.4	0.4	2.6	6.1	1.8	0.0	0.0	3.6	3.4	0.2	0.2	0.0	4.3	0.0	0.0	4.2	0.0	0.3	0.0	0.0	8.4	0.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	1.6	12.1	13.2	5.1	11.1	8.3	6.2	8.6	8.7	6.1	8.6	0.0	0.0	0.0	0.0	0.5	0.0	2.5	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	2.2	1.3	0.0	2.8	0.5	1.4	0.7	0.0	22.2	0.5	0.0	1.2	0.6	13.5	0.6	2.6	1.7	0.0	0.0	2.5	4.3	0.8	8.2	1.1	3.0	0.4	0.0	4.1	0.3	3.1	0.3	0.0	0.0	1.5	0.0
ZFAND2A	AIRAP	ENSG00000178381	"Zinc finger AN1-type containing 2A"	Q8N6M9	7	1152071-1160759	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 410.8;Glandular cells: 278.1;Urothelial cells: 199.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 59.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019469	Approved					NA	NA					"HPA019469: AB_1859009"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.10e-3)"	"unprognostic (7.52e-2)"	"unprognostic (8.78e-2)"	"unprognostic (6.48e-2)"	"prognostic unfavorable (5.47e-7)"	"unprognostic (5.44e-3)"	"unprognostic (7.60e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.59e-2)"	10.8	9.4	22.8	7.0	22.7	44.7	20.2	15.1	29.0	5.9	11.5	13.1	9.2	11.6	8.6	10.8	10.0	7.9	12.3	6.8	20.6	21.0	9.8	49.3	10.0	10.2	20.1	15.1	9.9	17.1	5.0	8.6	14.0	17.1	8.8	12.6	7.4	13.5	10.4	5.4	7.3	10.4	10.2	18.9	8.0	10.5	13.9	11.1	6.1	18.5	8.4	7.8	8.1	58.0	22.2	24.0	35.5	17.8	20.5	26.1	21.1	14.3	17.0	4.4	10.1	9.7	7.2	7.0	13.0	11.0	13.9	10.6	11.7	11.8	4.8	5.5	11.2	21.8	19.5	3.5	3.6	14.1	3.9	7.0	3.2	7.8	59.2	18.7	9.2	6.7	6.8	11.8	11.1	20.0	9.5	4.8	10.6	17.7	11.1	10.1	22.6	2.7	10.9	17.5	34.0	23.0	7.9	0.8	7.4	5.5	6.3	6.3	6.6	4.8	13.5	15.8	9.6	13.2	18.9	6.1	10.3	8.1	11.9	17.7	13.9	16.4	9.0	9.9	10.8	21.5	35.5	17.8	22.3	23.1	16.5	20.9	22.2	21.1	24.1	13.0	20.7	20.4	17.7	21.6	20.5	15.8	24.0	26.1	21.1	22.8	22.7	15.1	29.0	20.6	21.0	20.1	15.1	17.1	11.1	29.8	18.8	32.5	410.8	20.0	14.1	11.2	20.4	12.0	9.1	7.0	15.7	16.8	19.9	18.8	7.4	33.7	81.5	0.0	34.6	26.1	39.5	278.1	118.4	47.4	34.9	11.1	121.4	19.6	31.6	9.9	12.4	26.8	30.4	38.7	26.7	15.1	49.8	38.6	17.0	16.3	20.2	0.0	35.4	40.0	40.5	24.2	55.2	34.1	15.5	199.3
UNCX	Uncx4.1	ENSG00000164853	"UNC homeobox"	A6NJT0	7	1232907-1237318	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 44.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	20	"cerebellum: 44.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	20	"NB-4: 47.2"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.6"	"Region enriched"	"Detected in many"	8	"cerebellum: 19.3"	HPA063294			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063294: AB_2684977"					"unprognostic (1.15e-1)"										"unprognostic (9.71e-2)"			0.1	0.1	0.0	0.2	0.0	0.1	0.1	44.8	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.1	3.5	0.1	0.1	0.1	0.9	0.0	0.1	0.1	0.1	0.3	0.1	2.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.8	0.0	0.0	1.1	0.9	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MICALL2	"FLJ23471, JRAB, MGC46023, MICAL-L2"	ENSG00000164877	"MICAL like 2"	Q8IY33	7	1428465-1459502	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 70.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 18.0;OE19: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA025695	Enhanced					NA	NA					"HPA025695: AB_10610140"	"unprognostic (2.46e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.01e-3)"	"unprognostic (2.23e-3)"	"unprognostic (3.51e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (6.53e-9)"	"unprognostic (1.95e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.84e-2)"	4.8	13.3	13.7	8.3	15.3	11.7	3.9	8.4	13.4	6.8	11.7	10.6	7.6	20.5	5.4	3.4	7.0	5.5	11.4	4.1	14.4	4.3	5.2	4.2	6.8	4.1	17.6	6.3	1.6	5.9	2.6	6.6	2.2	12.3	8.2	3.9	6.1	6.7	7.7	1.6	6.7	26.9	4.6	9.2	16.3	20.4	3.1	14.4	0.7	6.5	5.0	4.0	11.6	5.5	0.1	1.4	0.9	1.1	0.0	0.8	0.9	10.4	0.9	0.3	1.4	1.2	2.8	3.0	4.9	1.9	2.2	0.8	1.3	3.9	0.2	3.1	1.5	4.4	6.0	0.0	5.6	0.1	0.7	1.3	6.9	1.6	0.7	1.3	0.3	18.0	3.7	1.3	1.5	0.2	1.3	2.5	0.9	11.4	0.3	1.0	10.9	0.2	10.8	1.0	18.9	3.4	1.8	2.0	7.4	1.5	2.8	0.3	1.0	4.1	7.5	3.8	0.4	5.9	4.0	8.7	1.6	13.0	6.0	4.8	0.5	0.1	0.0	5.4	3.8	10.7	0.0	1.1	0.9	0.4	0.5	0.8	0.1	0.5	0.6	1.4	0.0	0.4	0.4	0.4	0.0	0.6	0.2	0.1	0.9	13.7	15.3	8.4	13.4	14.4	4.3	17.6	6.3	12.3	14.4	3.0	9.6	0.5	6.8	7.7	1.1	4.4	25.5	8.1	12.5	14.0	2.0	0.4	1.7	10.0	4.8	7.2	70.8	23.3	13.7	5.7	8.4	10.2	5.7	2.8	3.0	3.2	5.8	11.1	4.1	3.9	3.7	1.9	3.3	2.8	33.9	0.8	14.2	24.6	0.4	1.3	1.5	6.5	12.0	4.3	7.5	5.4	1.0	0.0	18.7	6.7
INTS1	"DKFZp586J0619, INT1, KIAA1440, NET28"	ENSG00000164880	"Integrator complex subunit 1"	Q8N201	7	1470277-1504367	"Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021658, HPA053009"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021658: AB_1852402, HPA053009: AB_2682016"	"unprognostic (3.20e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (7.72e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.90e-2)"	"prognostic favorable (4.83e-4)"	"unprognostic (4.30e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.81e-3)"	15.4	14.6	17.8	16.1	17.2	28.5	15.2	26.5	28.1	12.2	14.5	19.2	10.1	19.0	15.0	11.0	15.8	13.3	14.4	13.0	13.5	11.0	13.8	13.8	12.0	18.2	13.5	10.1	18.2	23.0	11.6	15.8	12.6	15.2	14.7	6.0	15.6	25.6	14.5	43.3	20.4	17.6	15.1	10.0	19.3	17.9	27.3	14.0	18.0	15.9	10.8	14.9	13.7	14.8	6.0	3.7	4.4	2.7	3.1	4.8	2.1	20.6	18.0	7.0	18.2	5.2	4.0	24.5	8.8	4.9	6.8	6.0	19.8	16.1	11.1	9.3	6.3	13.7	21.4	3.9	10.4	1.9	5.4	21.7	7.9	25.6	13.0	6.0	13.7	11.9	5.4	4.9	7.0	5.0	4.1	7.4	15.9	22.0	8.9	4.1	25.0	7.7	37.6	38.5	7.6	16.2	19.6	8.0	11.3	3.2	15.7	13.3	32.8	12.6	23.2	8.0	4.2	18.4	13.8	13.6	11.2	32.2	9.3	14.3	18.7	9.8	10.8	12.6	11.9	22.9	4.4	2.7	2.9	4.8	2.1	3.0	2.7	3.5	3.8	3.7	6.0	2.2	2.8	2.2	3.1	1.8	2.1	4.2	2.1	17.8	17.2	26.5	28.1	13.5	11.0	13.5	10.1	15.2	14.0	11.9	29.1	6.0	4.2	5.3	30.1	38.9	20.4	4.0	9.1	10.4	23.6	10.7	0.0	14.5	18.4	11.3	33.3	0.0	19.9	8.3	10.3	8.7	1.1	21.2	12.9	46.1	17.3	16.5	23.4	32.2	12.4	11.6	5.0	8.2	18.2	15.8	17.3	15.6	14.5	12.9	36.0	25.8	8.2	19.4	11.0	6.9	12.7	10.1	20.1	5.4
MAFK	"NFE2U, P18"	ENSG00000198517	"MAF bZIP transcription factor K"	O60675	7	1530714-1543043	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 62.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026820, HPA060841"	Enhanced		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"CAB026820: , HPA060841: AB_2684377"	"unprognostic (6.82e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.19e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.14e-1)"	15.7	14.3	12.6	12.4	20.1	16.3	13.0	4.2	12.5	9.3	18.0	13.5	6.7	18.2	14.7	5.0	10.1	10.2	12.7	30.9	13.2	11.8	10.5	10.9	18.7	8.7	19.7	11.0	7.2	34.9	6.0	8.7	62.4	14.5	16.1	5.1	6.7	11.0	12.0	26.8	12.8	16.8	26.1	12.1	11.3	13.2	4.1	13.1	22.8	9.1	9.7	7.5	13.7	19.0	1.9	5.1	3.6	1.7	1.5	2.6	1.4	20.0	14.4	0.5	2.1	1.6	2.0	11.0	13.3	7.6	3.2	2.3	10.3	5.5	4.7	4.9	3.3	21.9	15.6	1.2	3.8	1.4	7.2	10.5	2.7	18.4	7.5	3.7	6.4	8.7	2.0	5.0	5.4	4.1	4.0	2.9	14.8	7.0	2.6	1.5	13.2	7.2	23.1	4.6	4.9	14.6	10.9	0.5	7.9	3.0	8.3	6.2	2.3	8.0	23.8	5.8	3.3	9.2	8.6	6.9	5.0	34.8	25.0	7.2	5.0	1.5	7.8	6.6	8.9	7.0	1.7	1.6	3.6	2.1	0.8	2.3	1.4	1.2	2.5	0.7	1.9	2.6	2.0	2.2	1.5	1.7	5.1	2.2	1.4	12.6	20.1	4.2	12.5	13.2	11.8	19.7	11.0	14.5	13.1	38.7	21.2	5.1	38.8	56.7	1.8	2.4	12.7	9.4	15.9	29.6	2.0	7.9	1.7	12.6	2.8	17.5	32.5	0.0	12.9	7.1	20.6	51.3	9.2	11.6	9.5	11.1	22.2	10.4	16.3	3.8	4.4	14.9	18.6	5.4	21.7	7.5	30.7	26.8	2.8	2.1	0.6	12.9	22.7	0.5	4.7	50.4	65.2	8.6	13.4	64.3
TMEM184A	"MGC9712, SDMG1"	ENSG00000164855	"Transmembrane protein 184A"	Q6ZMB5	7	1542235-1560821	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.2;intestine: 39.3"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 57.2;Mucus-secreting cells: 31.0;Paneth cells: 31.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MCF7: 15.2;RT4: 17.3;SCLC-21H: 17.8;SK-BR-3: 27.6;T-47d: 24.4"					"Low region specificity"	"Detected in many"			"HPA053790, HPA071312"	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053790: AB_2682263, HPA071312: AB_2686387"	"unprognostic (3.67e-1)"	"unprognostic (4.83e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (2.38e-1)"	"unprognostic (4.41e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (5.47e-2)"	0.4	0.1	0.2	3.5	0.2	0.1	1.6	0.2	0.3	8.6	15.6	0.2	8.0	15.1	1.7	2.9	40.2	4.4	9.6	0.2	0.2	0.1	5.3	18.0	1.5	0.2	0.2	0.3	0.9	24.7	3.1	5.4	14.3	0.4	5.1	4.0	0.3	10.3	12.0	2.3	17.9	39.3	1.2	0.2	0.2	7.5	3.8	0.2	0.5	0.3	22.9	31.9	10.0	15.8	0.8	0.8	2.0	0.5	0.4	0.5	0.0	9.7	6.6	0.0	0.0	0.0	0.0	2.2	0.3	0.1	0.4	0.0	8.9	11.7	0.2	3.4	0.1	3.6	7.5	0.0	4.4	0.1	0.1	0.2	0.0	6.0	4.0	0.1	0.0	0.0	0.0	4.3	0.1	3.9	0.2	0.0	2.9	0.1	0.0	0.0	15.2	0.0	0.0	0.3	6.0	8.6	0.2	0.0	4.7	3.3	17.3	17.8	0.0	2.9	27.6	0.0	0.2	24.4	0.0	0.0	0.0	3.7	4.6	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.5	0.2	0.5	0.1	0.3	0.2	0.3	0.2	0.1	0.8	0.4	0.3	2.0	0.4	0.2	0.8	0.3	0.0	0.2	0.2	0.2	0.3	0.2	0.1	0.2	0.3	0.4	0.2	3.0	4.1	0.8	5.3	3.5	0.9	2.5	17.8	13.4	10.3	8.7	0.0	6.6	1.7	11.9	0.0	0.7	57.2	0.0	9.6	7.7	1.3	11.9	1.1	12.4	0.7	0.0	6.9	0.0	1.2	0.0	0.0	1.7	0.0	1.0	31.0	0.0	12.3	31.6	0.0	3.8	0.4	0.0	1.0	0.0	0.0	8.2	14.1	0.0	13.3	11.3
PSMG3	"C7orf48, MGC10911, PAC3"	ENSG00000157778	"Proteasome assembly chaperone 3"	Q9BT73	7	1567330-1571005	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023876	Approved					NA	NA					"HPA023876: AB_1844356"	"unprognostic (3.08e-1)"	"unprognostic (9.21e-2)"	"unprognostic (4.40e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (2.12e-1)"	"unprognostic (4.82e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.13e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	10.2	11.5	17.2	10.0	14.1	27.5	18.4	17.2	57.5	15.4	14.2	9.4	15.1	15.7	9.9	12.0	21.2	20.8	17.4	10.3	16.8	13.7	15.2	13.2	14.0	15.9	13.9	17.8	8.7	14.8	8.7	12.8	11.0	9.8	11.3	12.3	8.1	16.8	17.9	10.7	22.7	12.7	8.5	10.9	16.0	16.5	11.0	6.5	13.9	11.5	14.1	16.5	10.5	15.0	21.7	38.3	26.3	27.3	19.1	27.4	19.7	32.9	21.2	15.6	15.1	12.1	14.2	15.5	7.6	13.6	19.4	16.6	19.6	21.7	10.6	9.1	12.7	27.4	26.0	19.7	20.1	8.9	9.9	34.4	11.3	41.7	16.8	19.2	14.8	10.6	12.0	24.8	14.6	16.8	8.5	7.8	25.8	30.3	16.4	14.2	56.0	9.5	48.1	31.0	22.9	39.6	16.1	8.3	23.4	15.5	16.8	23.4	20.1	9.3	33.6	20.4	4.1	23.8	27.7	5.3	18.1	26.4	22.3	22.2	18.5	17.1	27.6	10.7	47.0	37.5	20.9	26.7	26.3	23.5	25.8	27.4	21.7	23.5	20.8	25.7	18.8	23.0	22.7	6.6	19.1	27.3	38.3	18.8	19.7	17.2	14.1	17.2	57.5	16.8	13.7	13.9	17.8	9.8	6.5	17.9	13.7	22.3	23.3	47.4	14.7	9.3	33.1	33.5	12.5	33.2	3.9	41.4	71.3	35.0	4.4	27.0	37.1	0.0	44.8	76.2	46.9	33.4	15.0	27.6	49.6	6.4	27.6	21.5	21.8	4.0	33.4	27.1	37.1	39.7	48.3	18.6	46.5	42.1	24.4	62.7	15.8	25.8	36.3	22.8	32.8	51.1	33.0	27.7	40.3	23.4
ELFN1	PPP1R28	ENSG00000225968	"Extracellular leucine rich repeat and fibronectin type III domain containing 1"	P0C7U0	7	1688119-1747954	"Predicted membrane proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 13.3"	"Cell type enhanced"	"Detected in some"	10	"Cone photoreceptor cells: 5.9;Hepatocytes: 7.8;Ito cells: 9.8;Rod photoreceptor cells: 6.7"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 19.5;U-138 MG: 12.3;U-2 OS: 18.0;U-2197: 20.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA066382			Approved	"Nucleoplasm,Cell Junctions"		NA	NA		11000	"Nucleoplasm, Cell Junctions"		"HPA066382: AB_2732744"	"unprognostic (8.45e-2)"	"unprognostic (3.39e-3)"	"unprognostic (6.54e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (9.68e-4)"	"unprognostic (4.60e-3)"	"unprognostic (1.63e-3)"	"unprognostic (6.60e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (7.47e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.07e-1)"	1.8	0.8	2.2	0.6	1.4	0.0	0.6	0.0	4.2	3.2	0.3			0.2	2.2	0.3	0.3	0.8	0.8	3.3	1.8	2.2	2.8	13.3	0.3	0.1	2.7		0.0	0.2	0.2	0.2	0.7		0.6	0.0		0.5	0.2	1.2	0.6	0.3	0.5	1.7	1.7	0.2	0.7			0.2		0.0	0.5	0.9	0.5	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	3.0	6.3	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.1	0.3	0.0	3.0	1.3	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	3.5	0.0	2.9	1.2	0.0	0.7	19.5	0.0	1.9	0.0	0.0	2.8	1.3	0.1	0.1	0.0	0.3	0.0	0.2	0.0	12.3	18.0	20.9	0.0	0.0	0.2	5.3	0.0	0.0	1.5	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.5	0.1	0.1	0.7	0.0	0.0	0.0	0.1	0.0											0.0	1.1	0.0	0.4	0.1	1.0	1.6	0.0	0.0	0.0	0.0	5.9	0.0	3.3	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	7.8	0.1	0.0	0.0	9.8	0.6	0.0	0.9	0.0	1.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	6.7	0.0	0.9	0.0	2.7	0.0	0.0	0.0	0.0	0.0
MAD1L1	"HsMAD1, MAD1, PIG9, TP53I9, TXBP181"	ENSG00000002822	"Mitotic arrest deficient 1 like 1"	Q9Y6D9	7	1815793-2233243	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"Early spermatids: 225.4;Late spermatids: 498.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003635, CAB015338"	Supported		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"CAB015338: AB_627901, HPA003635: AB_1853472"	"unprognostic (1.85e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.26e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.78e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.57e-1)"	11.8	7.6	11.4	17.3	29.7	19.1	9.0	15.7	15.0	10.0	9.3	12.1	6.1	8.8	10.4	8.5	12.3	9.2	10.9	11.4	12.3	10.0	7.9	17.6	13.3	23.2	14.8	13.3	10.3	10.7	7.8	10.7	9.3	10.5	9.4	6.8	12.0	10.3	8.3	16.8	17.4	9.8	10.3	11.9	21.2	9.8	15.4	11.0	25.9	10.5	7.2	19.1	11.3	11.3	25.4	21.9	25.8	21.6	6.7	46.8	18.2	17.0	6.8	8.5	12.9	6.0	5.2	11.2	12.6	7.9	13.6	11.0	13.4	10.3	10.6	4.8	7.5	19.8	13.6	7.9	9.2	7.8	5.4	8.0	11.8	10.4	20.8	7.9	8.1	23.3	6.6	7.6	14.8	7.6	3.0	6.7	6.1	13.5	8.2	7.2	17.1	3.4	32.0	14.0	2.8	8.1	18.3	9.1	7.9	7.5	9.8	5.9	16.2	10.0	10.2	28.9	6.5	7.8	28.0	8.3	9.8	27.6	27.8	12.6	12.9	12.0	13.0	8.6	25.7	33.4	25.8	12.1	8.6	27.9	21.6	26.0	19.7	27.2	27.1	21.9	25.4	37.7	26.2	3.4	6.7	19.6	8.1	46.8	18.2	11.4	29.7	15.7	15.0	12.3	10.0	14.8	13.3	10.5	11.0	3.0	7.2	29.6	12.2	15.7	6.9	7.5	0.0	6.7	9.1	7.0	9.8	13.5	13.3	10.9	225.4	10.8	7.0	0.0	9.9	13.5	13.2	7.9	40.5	28.0	35.1	22.3	31.2	4.3	18.6	498.1	11.5	30.9	35.4	29.7	7.7	17.4	12.6	6.0	9.9	8.6	11.6	19.4	9.8	28.6	33.1	18.7	20.5	41.5	6.5	9.5
MRM2	"FJH1, FTSJ2, RRMJ2"	ENSG00000122687	"Mitochondrial rRNA methyltransferase 2"	Q9UI43	7	2234231-2242198	"Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Transferase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 50.0;Extravillous trophoblasts: 29.7;Hofbauer cells: 31.2;Syncytiotrophoblasts: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019826, HPA049622"	Uncertain					NA	NA					"HPA019826: AB_2670282, HPA049622: AB_2680834"	"unprognostic (8.05e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.50e-3)"	"prognostic unfavorable (5.21e-6)"	"unprognostic (8.49e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.99e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.48e-1)"	10.6	18.1	14.9	11.9	13.0	5.9	18.8	14.8	17.4	9.9	11.5	12.5	11.0	11.5	11.3	10.5	15.5	12.1	7.7	18.5	12.4	10.2	13.2	18.2	11.1	17.2	12.0	10.6	13.4	18.9	13.3	10.1	15.3	14.7	14.3	11.7	12.6	12.6	14.9	24.3	13.8	11.4	10.8	10.5	17.7	11.9	21.3	11.8	15.4	15.2	10.7	18.2	12.3	11.3	25.4	33.8	15.5	26.4	20.5	18.7	17.5	25.2	16.0	12.9	9.5	8.0	9.0	10.5	14.8	15.2	18.6	17.7	21.7	11.9	23.8	7.0	11.2	15.7	20.6	20.7	19.4	19.5	9.1	17.5	15.9	14.6	12.3	10.5	20.8	14.1	7.9	13.5	14.7	14.3	7.9	8.0	13.7	24.5	13.6	14.1	28.4	6.2	23.6	38.3	15.1	16.2	14.4	18.6	18.0	12.2	18.2	12.5	19.6	11.0	31.6	12.7	18.0	28.5	29.6	6.4	10.8	27.5	21.7	22.9	12.5	19.0	24.2	12.6	21.1	32.3	5.6	23.7	15.5	14.2	26.4	17.0	25.4	14.8	15.8	33.8	22.3	18.7	16.3	1.7	20.5	20.7	17.5	16.5	17.5	14.9	13.0	14.8	17.4	12.4	10.2	12.0	10.6	14.7	11.8	20.8	13.7	0.0	0.0	0.0	0.0	0.0	0.0	17.4	14.8	10.4	0.0	50.0	26.6	20.1	0.0	0.0	0.0	0.0	17.3	29.7	0.0	0.0	10.5	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	20.8	0.0	0.0	19.2	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0
NUDT1	MTH1	ENSG00000106268	"Nudix hydrolase 1"	P36639	7	2242222-2251146	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 59.5"	"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 233.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012636	Approved		Supported	Cytosol		No	No			Cytosol		"HPA012636: AB_1854696"	"unprognostic (1.31e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (2.15e-2)"	"unprognostic (4.77e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.29e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.70e-1)"	8.8	3.9	7.4	12.6	13.4	37.1	10.8	5.0	10.8	5.9	9.0	8.7	2.2	9.1	8.2	9.2	13.1	6.0	8.1	11.3	8.7	4.7	4.1	2.9	7.2	18.9	8.2	7.0	4.8	4.0	0.7	1.8	5.8	7.2	7.2	6.3	4.0	5.5	4.2	12.0	18.8	9.3	10.5	11.9	11.1	5.5	26.7	5.3	30.7	4.1	14.4	17.2	6.8	8.1	18.3	59.5	11.9	21.3	10.1	20.4	13.0	21.7	35.1	19.3	25.5	7.1	9.8	14.2	9.6	8.4	13.2	15.4	18.9	16.5	23.0	7.8	10.5	26.9	26.6	14.6	14.6	7.7	10.2	25.0	17.9	29.6	16.0	1.7	13.9	18.1	6.4	3.8	19.0	6.8	4.3	7.1	33.5	14.2	25.7	14.7	55.5	25.9	54.2	41.4	10.8	21.7	36.3	28.6	19.2	7.2	12.3	19.4	26.9	9.9	29.2	4.4	14.6	19.2	37.0	6.5	12.7	48.5	29.3	22.8	19.9	15.0	23.8	12.8	34.7	45.6	9.0	17.5	11.9	12.9	21.3	10.2	18.3	15.1	13.6	26.6	18.0	15.1	13.1	4.6	10.1	17.4	59.5	20.4	13.0	7.4	13.4	5.0	10.8	8.7	4.7	8.2	7.0	7.2	5.3	6.0	6.9	41.2	21.9	35.6	10.2	15.1	12.7	8.1	7.9	10.4	3.9	30.9	16.6	20.1	42.6	10.8	14.4	233.6	32.2	67.3	28.8	13.6	61.0	5.3	76.9	0.0	7.5	4.3	37.3	78.4	20.4	69.4	43.9	36.9	26.8	18.6	17.6	17.3	17.7	11.7	6.1	32.3	28.5	80.4	63.8	32.4	19.8	39.2	33.8	16.0
SNX8	Mvp1	ENSG00000106266	"Sorting nexin 8"	Q9Y5X2	7	2251770-2354318	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 87.3;Late spermatids: 250.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 42.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057296, HPA060194"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA057296: AB_2683401, HPA060194: AB_2684219"	"unprognostic (2.22e-2)"	"unprognostic (3.38e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.32e-2)"	"prognostic unfavorable (8.47e-6)"	"unprognostic (5.23e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.06e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.35e-1)"	14.3	7.3	11.7	13.9	12.8	10.1	15.6	11.1	14.2	6.8	8.4	11.4	4.8	11.7	7.3	9.9	11.3	7.7	11.0	14.0	12.0	9.6	8.2	9.1	10.7	24.1	12.7	9.6	9.1	10.8	4.7	7.9	15.4	10.9	4.7	7.8	12.9	8.5	3.9	9.9	9.9	9.6	6.5	17.0	33.1	7.7	20.5	12.5	4.9	9.5	6.9	18.9	9.5	8.5	18.2	13.1	4.5	10.2	1.2	2.0	4.8	15.9	15.6	6.4	8.9	9.0	8.8	15.2	7.8	11.6	13.2	16.4	11.0	12.5	9.3	3.2	9.2	42.0	4.3	5.5	4.2	6.7	2.3	5.2	5.2	6.3	9.0	22.9	5.0	8.6	17.5	5.0	16.1	6.3	3.6	4.9	7.4	10.2	11.0	10.7	10.4	1.7	5.3	11.6	8.9	7.8	8.2	13.3	4.2	3.1	7.5	3.1	8.2	7.1	19.6	11.1	7.4	14.6	10.9	7.4	11.1	29.7	18.2	10.1	7.2	8.8	8.6	11.0	6.8	30.0	4.5	9.4	3.0	1.8	10.2	1.4	15.5	1.4	1.9	13.1	18.2	1.4	1.6	1.6	1.2	9.6	3.4	2.0	4.8	11.7	12.8	11.1	14.2	12.0	9.6	12.7	9.6	10.9	12.5	6.0	10.3	18.0	6.1	4.6	10.0	9.2	10.2	1.4	0.0	3.5	7.9	14.2	11.6	12.1	87.3	8.4	9.1	0.0	26.0	13.0	10.4	5.5	11.6	6.4	65.1	20.6	5.8	61.4	32.7	250.8	11.2	46.6	13.5	65.9	9.6	6.1	20.3	8.6	12.4	11.5	11.6	0.0	2.8	10.4	27.9	5.4	36.3	5.3	8.0	8.2
EIF3B	"eIF3b, EIF3S9, PRT1"	ENSG00000106263	"Eukaryotic translation initiation factor 3 subunit B"	P55884	7	2354086-2380745	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017562, HPA048983"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		22000	Cytosol	Nucleoplasm	"CAB017562: AB_2246341, HPA048983: AB_2680588"	"unprognostic (1.50e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.92e-2)"	"unprognostic (9.45e-3)"	"prognostic unfavorable (2.20e-4)"	"prognostic unfavorable (4.41e-9)"	"unprognostic (4.64e-3)"	"unprognostic (3.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (9.66e-6)"	"unprognostic (2.38e-1)"	"unprognostic (7.54e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.18e-3)"	27.5	27.3	16.5	28.9	21.8	38.7	28.8	20.0	26.2	23.5	33.3	22.4	25.7	20.3	29.6	24.1	38.8	28.6	26.2	32.1	15.8	16.5	24.3	51.4	21.7	29.6	22.2	19.4	31.2	66.6	24.2	20.3	34.6	21.1	26.0	24.0	18.0	34.1	24.2	72.3	39.8	23.9	33.0	16.5	31.6	29.7	45.2	19.0	44.9	23.1	34.3	35.9	32.9	29.7	6.5	8.0	3.7	7.3	16.5	9.5	4.4	85.9	44.0	18.2	49.4	20.6	18.7	45.1	30.3	22.7	34.5	32.4	57.4	33.7	50.2	25.0	32.1	48.8	46.9	50.1	39.8	38.1	15.0	58.8	38.2	42.7	38.7	29.1	46.5	28.4	23.2	26.3	37.3	39.3	18.2	27.7	23.4	97.1	23.4	31.5	61.0	22.4	52.3	56.8	30.1	39.6	27.7	36.9	51.7	22.1	39.4	41.6	31.1	32.0	71.3	17.3	33.2	47.4	51.6	29.2	26.7	58.9	40.9	54.5	25.9	34.7	50.9	30.3	52.2	65.1	1.8	7.3	3.7	7.6	6.8	9.5	6.3	7.4	8.4	7.8	6.5	8.8	8.9	0.6	16.5	5.8	8.0	8.7	4.4	16.5	21.8	20.0	26.2	15.8	16.5	22.2	19.4	21.1	19.0	23.8	61.0	27.4	38.7	57.1	36.2	30.7	28.1	24.1	48.9	26.2	60.9	54.0	3.3	33.5	9.1	45.4	29.7	0.0	52.8	53.4	38.1	43.4	16.2	53.9	42.2	49.3	45.8	70.6	38.4	13.9	40.6	33.2	15.1	16.2	54.8	41.2	58.1	20.1	35.0	25.4	44.8	25.8	40.6	29.9	34.0	68.4	69.1	28.9	53.9	38.6
CHST12	"C4S-2, C4ST2"	ENSG00000136213	"Carbohydrate sulfotransferase 12"	Q9NRB3	7	2403560-2448483	"Enzymes, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Ito cells: 159.0;T-cells: 128.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 26.2;NB-4: 27.1;U-266/70: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041680	Approved		Approved	"Golgi apparatus"		NA	NA		430000	"Golgi apparatus"		"HPA041680: AB_10959789"	"unprognostic (4.12e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.88e-2)"	"prognostic favorable (1.32e-5)"	"unprognostic (9.61e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	24.2	12.0	9.4	12.1	10.5	14.5	11.2	17.8	16.5	11.9	10.1	13.2	9.0	13.5	14.4	10.6	5.9	11.7	10.9	12.0	8.8	7.7	9.3	6.8	13.6	10.3	10.4	9.2	9.6	17.5	4.9	14.4	9.6	12.7	11.8	4.2	12.3	14.1	11.6	11.9	11.5	10.1	8.1	9.5	25.0	12.4	10.2	8.6	9.0	11.2	4.4	11.8	10.6	10.3	5.7	21.0	16.4	3.5	37.4	30.2	6.7	3.9	4.0	2.5	4.5	3.7	2.7	12.7	7.2	3.4	3.1	4.3	4.5	1.5	3.5	13.6	3.2	6.8	3.2	1.6	1.9	0.9	4.6	8.5	2.4	3.5	5.0	1.7	8.0	26.2	3.7	1.2	2.8	0.3	3.2	3.2	5.9	6.2	12.7	1.4	3.6	8.4	27.1	8.5	1.2	7.3	3.1	3.3	18.3	1.5	2.1	3.0	12.5	3.5	2.6	1.8	2.5	3.3	10.2	5.4	4.6	12.0	9.0	6.3	38.6	14.9	1.6	3.7	4.1	7.9	15.5	3.5	16.4	30.2	2.8	18.9	5.2	10.7	24.5	6.6	5.7	4.5	13.5	1.0	37.4	1.2	21.0	10.2	6.7	9.4	10.5	17.8	16.5	8.8	7.7	10.4	9.2	12.7	8.6	14.9	44.5	41.3	35.2	16.1	44.3	6.7	10.2	17.4	30.7	17.4	62.8	84.2	1.7	17.6	4.4	44.9	6.7	23.3	13.5	8.5	48.9	15.3	36.9	5.9	22.1	44.5	12.2	159.0	21.8	2.7	88.6	20.1	20.3	17.2	9.4	16.0	13.1	7.0	63.6	10.3	46.4	19.4	19.6	27.6	19.4	13.4	111.7	128.5	13.1	9.1
GRIFIN		ENSG00000275572	"Galectin-related inter-fiber protein"	A4D1Z8	7	2474844-2476894	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.6;skin 1: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HMC-1: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA										"unprognostic (1.18e-2)"			"unprognostic (2.98e-2)"		"unprognostic (1.36e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.68e-2)"	"unprognostic (4.31e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.73e-1)"			1.6	0.7		0.0		0.8	0.0		0.1	0.5	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.4			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.2	3.4	0.0	0.0		0.1	0.0	0.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LFNG	SCDO3	ENSG00000106003	"LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	Q8NES3	7	2512529-2529177	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 55.0"	"Cell type enhanced"	"Detected in many"	12	"Intestinal endocrine cells: 84.0;Kupffer cells: 31.7;Mucus-secreting cells: 36.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 18.5;OE19: 22.3;RH-30: 23.0;U-2 OS: 25.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069130	Approved				"Intracellular and membrane"	NA	NA		620000			"HPA069130: AB_2686091"	"unprognostic (4.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.52e-2)"	"prognostic favorable (6.36e-4)"	"unprognostic (1.85e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.15e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.16e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.28e-2)"	10.4	4.9	8.3	12.6	13.5	6.5	15.7	8.3	12.0	10.9	17.3	11.2	0.8	11.9	15.0	5.9	7.9	4.1	16.9	10.1	7.1	11.8	6.6	1.9	15.6	18.1	15.0	6.6	3.0	55.0	1.7	2.6	6.2	19.4	13.0	9.6	8.4	16.5	7.3	3.7	43.0	11.6	6.0	10.2	13.2	28.4	3.4	5.2	5.8	4.4	10.4	19.8	9.0	8.3	2.6	2.5	12.8	7.7	1.3	4.5	1.5	0.7	6.9	9.1	1.2	1.0	0.9	0.6	2.6	1.4	2.4	3.0	2.9	18.5	0.5	8.4	7.2	4.1	13.3	1.4	2.5	1.2	4.1	0.3	2.1	3.6	1.5	0.0	2.9	3.8	1.7	6.3	3.8	0.4	1.6	0.9	0.1	0.3	0.1	1.8	16.4	0.0	4.1	11.1	22.3	5.1	0.8	23.0	1.4	0.9	2.1	8.4	2.1	3.0	0.7	0.1	2.5	5.0	3.5	2.2	5.3	25.4	0.2	7.2	0.1	0.0	0.7	5.8	7.9	1.0	5.3	5.9	12.8	2.0	7.7	2.4	1.3	2.0	1.0	2.5	2.6	2.2	2.0	3.2	1.3	7.0	0.6	4.5	1.5	8.3	13.5	8.3	12.0	7.1	11.8	15.0	6.6	19.4	5.2	6.0	8.9	9.3	2.7	6.1	1.0	2.8	7.6	1.4	4.5	0.0	0.0	0.1	0.0	1.1	0.1	12.7	6.6	0.0	5.5	0.2	2.6	2.0	17.3	0.0	6.9	0.0	84.0	12.9	31.7	0.0	1.7	12.3	3.3	9.0	36.6	26.9	14.2	0.0	0.0	0.3	0.7	0.0	2.1	0.2	3.3	3.4	0.0	10.9	11.5	0.3
BRAT1	"BAAT1, C7orf27, MGC22916"	ENSG00000106009	"BRCA1 associated ATM activator 1"	Q6PJG6	7	2537877-2555727	"Disease related genes, Predicted intracellular proteins"	"DNA damage"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029455, HPA076508"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029455: AB_10600761, HPA076508: AB_2686803"	"unprognostic (2.53e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.04e-3)"	"unprognostic (6.07e-3)"	"unprognostic (8.95e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (2.03e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.10e-3)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (5.37e-2)"	"unprognostic (3.12e-2)"	"unprognostic (8.88e-2)"	"unprognostic (3.71e-2)"	16.1	19.2	12.2	13.0	14.3	12.1	10.1	20.4	12.9	11.4	9.6	14.3	9.4	16.5	12.2	11.7	10.3	11.4	15.8	8.1	13.4	9.1	9.1	13.7	15.9	11.6	14.7	9.8	13.8	17.0	9.9	12.5	11.0	8.9	14.0	3.1	12.9	20.0	13.7	12.0	19.0	13.8	8.8	11.3	14.6	14.5	17.0	10.6	19.2	14.5	5.8	12.3	10.2	10.8	14.2	23.1	18.7	22.2	10.2	17.1	14.6	15.0	13.8	3.2	12.0	3.1	2.8	11.0	5.2	2.9	4.5	3.9	9.8	9.3	11.4	8.3	3.4	8.6	15.3	3.9	5.9	0.7	4.4	20.1	5.2	10.1	6.2	4.0	7.0	8.1	4.9	4.2	4.6	1.3	2.6	5.2	8.9	16.7	4.1	3.1	21.5	4.9	33.2	15.8	3.7	21.2	12.2	9.9	10.9	2.8	4.8	8.8	13.5	7.8	13.0	5.3	1.5	11.7	14.5	5.1	6.1	19.7	12.7	9.9	9.2	7.1	8.1	6.9	14.2	14.5	3.6	22.2	12.3	16.8	20.2	14.7	14.2	15.2	17.1	23.1	12.6	12.8	13.7	18.7	10.2	17.4	16.4	13.0	14.6	12.2	14.3	20.4	12.9	13.4	9.1	14.7	9.8	8.9	10.6	11.9	5.4	8.2	16.1	6.9	10.7	5.7	15.3	5.3	12.5	8.7	11.8	18.4	13.3	9.5	15.3	10.5	12.9	0.0	11.8	11.3	10.3	7.4	13.9	12.9	27.9	3.2	10.9	18.4	13.2	6.1	21.0	12.4	6.8	18.0	12.9	11.2	11.0	13.3	20.8	13.6	10.8	6.5	9.5	27.0	39.0	5.9	12.2	13.4	13.4	7.6
IQCE	KIAA1023	ENSG00000106012	"IQ motif containing E"	Q6IPM2	7	2558972-2614734	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 360.6;Late spermatids: 290.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 8.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019515	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA019515: AB_1851855"	"unprognostic (2.29e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.78e-2)"	"prognostic favorable (5.91e-4)"	"unprognostic (7.96e-3)"	"unprognostic (3.75e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.31e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.56e-3)"	"unprognostic (3.13e-2)"	5.5	7.6	15.1	6.8	17.0	7.0	7.4	11.1	18.7	6.9	10.2	12.8	6.7	13.1	9.6	12.3	6.6	17.1	11.2	7.1	14.3	15.6	7.1	3.6	9.1	4.7	12.0	12.1	9.7	8.4	12.9	15.4	4.1	11.3	8.1	9.9	7.3	9.8	11.2	4.5	8.1	10.9	7.9	11.1	5.1	10.6	35.3	9.6	2.8	11.9	3.0	3.9	6.0	7.4	0.7	4.3	8.3	2.1	0.3	1.3	0.3	20.0	10.5	4.5	13.8	5.6	8.5	7.8	4.2	7.1	5.6	6.1	5.4	11.6	1.4	4.9	9.8	12.2	10.4	3.1	4.9	5.9	3.5	6.5	2.7	12.7	1.7	4.1	7.2	4.0	3.5	8.1	5.4	5.7	6.5	6.0	5.8	8.6	2.6	7.4	20.4	3.2	5.5	3.9	9.0	7.7	3.1	5.2	5.2	6.0	9.4	9.5	11.2	4.7	20.0	4.4	3.3	24.6	9.8	5.9	4.7	9.5	17.8	7.1	2.9	4.9	0.3	9.2	5.2	13.1	1.1	1.4	3.6	1.3	2.1	0.5	0.5	0.7	0.6	0.6	0.7	0.5	1.1	8.3	0.3	0.7	4.3	0.3	0.3	15.1	17.0	11.1	18.7	14.3	15.6	12.0	12.1	11.3	9.6	11.9	11.0	0.0	5.0	4.8	7.8	7.7	22.9	60.2	14.8	12.2	56.9	3.7	14.9	16.6	360.6	3.6	15.8	0.0	17.4	6.9	6.4	7.3	1.1	2.8	8.7	19.1	8.1	7.4	6.4	290.7	13.0	5.9	0.0	10.8	10.7	14.1	17.5	11.8	14.5	8.1	38.1	19.4	3.6	43.3	53.7	3.8	1.6	4.4	10.0	3.3
TTYH3	KIAA1691	ENSG00000136295	"Tweety family member 3"	Q9C0H2	7	2631951-2664802	"Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Hofbauer cells: 112.1;Kupffer cells: 64.9;Melanocytes: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 10.8;non-classical monocyte: 8.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 10.8"	"Cell line enhanced"	"Detected in many"		"U-2 OS: 54.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053520	Uncertain					NA	NA					"HPA053520: AB_2682176"	"unprognostic (2.53e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.35e-1)"	"unprognostic (5.25e-2)"	"unprognostic (7.42e-2)"	"prognostic unfavorable (2.53e-5)"	"unprognostic (5.53e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.59e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (2.58e-5)"	"unprognostic (7.90e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.85e-2)"	23.2	15.2	18.9	27.4	17.3	9.6	13.8	48.2	37.0	8.4	10.2	9.3	6.7	18.6	14.1	10.3	4.8	7.8	17.5	9.8	14.9	11.5	24.4	25.3	11.7	26.7	12.1	12.4	8.3	7.0	5.0	7.1	22.2	9.4	10.0	6.9	8.3	12.2	7.9	3.1	11.2	20.2	10.1	9.3	22.5	12.4	8.4	7.6	10.3	10.4	3.8	7.6	13.1	7.4	0.4	2.4	1.6	10.8	0.3	0.3	2.8	10.6	21.2	22.5	31.3	6.3	5.7	25.2	17.3	15.7	7.6	9.0	8.7	7.8	0.8	21.1	16.4	20.2	4.8	3.2	7.9	2.2	1.4	10.7	5.3	4.5	24.0	8.4	1.0	3.4	13.6	3.8	8.1	2.1	14.3	25.2	5.4	1.6	1.2	5.0	6.2	3.9	11.5	28.7	15.2	8.3	16.2	16.3	1.0	11.8	11.7	9.4	47.4	10.7	2.1	9.9	15.6	5.6	29.0	29.4	17.9	54.0	10.4	19.3	2.0	1.2	3.0	12.9	4.0	38.5	0.0	5.1	1.6	0.2	10.8	0.3	0.3	0.1	0.2	2.4	0.4	0.3	0.1	0.6	0.3	8.6	1.0	0.2	2.8	18.9	17.3	48.2	29.7	14.9	11.5	12.1	12.4	9.4	7.6	0.0	3.4	1.9	1.5	5.8	8.0	2.0	28.1	0.0	2.3	8.7	3.9	1.4	3.3	16.9	0.4	13.1	9.3	0.0	4.5	23.6	12.2	3.1	2.3	15.8	112.1	28.6	7.5	16.0	64.9	3.8	7.5	24.9	54.0	15.4	18.7	3.5	14.5	0.0	3.5	38.2	1.9	6.5	2.8	0.2	2.3	3.1	2.1	4.3	10.1	2.2
AMZ1	KIAA1950	ENSG00000174945	"Archaelysin family metallopeptidase 1"	Q400G9	7	2679522-2775500	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 10.0"	"Cell type enhanced"	"Detected in some"	20	"Cone photoreceptor cells: 3.9;Early spermatids: 18.8;Extravillous trophoblasts: 7.0;Late spermatids: 6.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 4.2;naive B-cell: 2.4;T-reg: 1.0"	"Group enriched"	"Detected in many"	6	"B-cells: 4.2;T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.2;MCF7: 6.4;SK-BR-3: 4.6;T-47d: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020233	Uncertain					NA	NA					"HPA020233: AB_1844818"	"unprognostic (9.08e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.81e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.64e-9)"	"unprognostic (1.60e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.13e-1)"	0.7	0.7	8.4	1.2	7.1	2.0	0.9	1.4	10.0	3.2	0.6	6.5	0.0	0.8	4.0	0.6	0.7	1.4	1.0	0.9	5.9	4.9	0.5	1.2	2.8	1.2	6.0	4.8	1.4	0.8	0.7	1.1	3.6	4.2	0.8	0.7	0.2	0.6	0.6	0.6	0.8	0.6	3.3	3.8	2.0	0.7	1.4	4.4	0.0	0.7	0.0	1.8	0.7	0.7	4.2	0.1	0.4	0.1	0.1	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	6.2	2.0	3.0	1.4	2.0	0.0	0.8	0.5	0.2	1.9	0.2	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	6.4	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	4.6	0.0	0.1	24.4	0.0	0.0	0.1	0.1	0.1	0.0	0.9	0.2	0.0	0.5	0.0	0.1	0.4	0.0	0.2	0.1	0.0	0.0	4.2	0.1	0.0	0.0	2.4	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.1	8.4	7.1	1.4	8.7	5.9	4.9	6.0	4.8	4.2	4.4	0.0	0.3	0.0	0.1	0.0	0.6	3.2	0.0	0.0	0.0	0.0	3.9	0.3	0.0	0.0	18.8	0.3	0.0	0.0	0.0	7.0	0.4	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	6.0	0.0	1.5	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.0
GNA12	gep	ENSG00000146535	"G protein subunit alpha 12"	Q03113	7	2728112-2844324	"Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 50.1;Syncytiotrophoblasts: 144.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010046	Approved		Supported	Cytosol		NA	NA			Cytosol		"CAB010046: AB_2263416"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (1.20e-6)"	"unprognostic (1.38e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.45e-3)"	"unprognostic (7.90e-2)"	"prognostic unfavorable (4.71e-5)"	"unprognostic (1.22e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.27e-4)"	19.4	15.0	26.5	12.3	22.8	10.5	11.9	12.9	22.5	13.7	11.9	19.4	5.2	5.9	13.8	5.9	9.2	12.1	11.0	17.6	22.9	19.3	7.6	7.3	10.4	14.2	25.2	11.4	21.9	13.4	9.5	13.8	27.2	22.1	11.4	7.4	7.4	8.8	14.2	5.4	4.4	8.5	16.8	24.4	11.7	9.1	11.5	18.2	4.6	7.7	3.9	11.4	13.3	12.8	4.7	4.3	2.5	3.1	0.2	1.8	0.9	15.1	8.4	8.7	13.0	14.0	11.2	24.1	12.8	15.0	14.0	16.1	8.0	10.8	3.2	8.8	15.1	29.4	6.9	5.9	13.2	9.5	38.7	6.0	6.6	4.5	8.4	16.4	1.0	5.9	10.8	7.2	16.3	11.1	14.4	14.8	4.7	7.3	10.2	12.5	7.2	1.7	6.0	12.2	3.9	14.6	11.5	10.0	6.5	5.1	10.4	6.9	10.0	7.2	10.9	5.4	13.0	6.0	9.1	17.4	15.3	18.3	14.9	21.0	7.3	8.5	2.9	16.4	9.8	14.9	2.5	1.3	0.2	0.6	3.1	0.9	2.7	1.5	0.8	1.1	4.7	1.4	0.2	0.3	0.2	0.8	4.3	1.8	0.9	26.5	22.8	12.9	19.7	22.9	19.3	25.2	11.4	22.1	18.2	6.0	13.2	10.9	3.2	6.3	5.3	11.6	7.6	5.3	6.8	1.8	11.8	50.1	3.3	6.5	11.9	12.1	4.0	23.3	8.8	13.6	14.6	7.1	0.0	12.7	23.5	7.9	7.5	21.5	21.9	9.8	15.8	10.8	20.3	23.4	5.3	11.2	10.7	4.2	17.7	7.7	10.8	0.0	15.5	8.6	7.8	3.1	144.9	5.3	4.7	2.4
CARD11	"BIMP3, CARMA1"	ENSG00000198286	"Caspase recruitment domain family member 11"	Q9BXL7	7	2906141-3043945	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.4;lymphoid tissue: 44.7"	"Cell type enhanced"	"Detected in some"	13	"B-cells: 19.1;Pancreatic endocrine cells: 15.2;T-cells: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 40.6;K-562: 16.2;RT4: 30.6;U-698: 36.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA052984	Approved					NA	NA					"HPA052984: AB_2682005"	"unprognostic (3.12e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.46e-3)"	"unprognostic (4.81e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.65e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (6.68e-8)"	"unprognostic (3.74e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (1.10e-4)"	1.2	1.7	1.4	44.7	1.0	9.0	0.9	0.7	1.4	1.7	1.4	1.2	0.6	1.9	0.8	0.5	2.7	1.2	11.4	0.8	1.4	2.3	1.9	1.4	3.8	25.0	2.1	0.5	0.9	1.4	0.1	1.0	0.5	1.1	2.8	1.2	1.2	6.7	1.0	0.3	0.5	14.2	1.4	2.9	27.4	3.9	1.4	1.5	22.8	1.3	1.7	28.6	9.4	5.2	4.6	21.4	0.3	0.0	3.3	5.5	1.8	5.4	0.8	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.2	0.0	10.7	12.0	40.6	10.1	0.0	0.0	9.1	0.0	0.1	0.1	13.8	0.4	0.0	1.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	7.8	4.5	16.2	0.0	0.0	0.1	1.5	0.0	15.3	6.8	0.0	1.9	0.0	10.1	3.9	30.6	0.1	0.5	0.0	0.0	0.0	6.4	0.0	0.8	5.1	0.0	4.1	0.0	0.0	4.2	0.0	36.2	0.0	0.0	0.0	0.3	0.0	0.0	5.5	0.0	5.2	3.8	3.2	3.6	0.6	4.6	2.1	3.8	0.1	3.3	0.0	21.4	2.2	1.8	1.4	1.0	0.7	1.4	1.4	2.3	2.1	0.5	1.1	1.5	0.0	0.0	19.1	0.3	0.0	0.4	1.7	0.0	0.0	0.0	1.8	0.0	0.0	0.0	4.6	0.1	0.0	0.0	0.0	4.7	0.0	0.5	0.3	5.7	0.0	1.5	0.0	0.0	0.0	1.5	0.0	0.3	2.2	3.3	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.3	0.0	24.5	0.0	3.1
SDK1	FLJ31425	ENSG00000146555	"Sidekick cell adhesion molecule 1"	Q7Z5N4	7	3301448-4269000	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 99.7;Late spermatids: 120.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	28	"neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"AF22: 7.9;BEWO: 9.8;RPTEC TERT1: 8.2;RT4: 10.2;SuSa: 9.9;U-2 OS: 12.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA011392	Approved		Approved	Cytosol		NA	NA		2700000	Cytosol		"HPA011392: AB_1856648"	"unprognostic (2.39e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-1)"	"prognostic favorable (4.08e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.37e-1)"	5.8	1.1	2.2	6.1	1.7	1.4	5.8	0.9	3.1	16.6	6.2	1.4	6.8	1.8	6.1	10.9	2.9	4.5	4.8	1.9	3.4	2.2	3.9	0.7	7.0	8.7	1.6	1.4	4.3	22.4	1.5	6.3	2.9	2.1	6.9	2.4	5.6	2.6	9.4	1.8	2.9	4.2	16.5	1.9	16.3	3.6	7.7	1.9	1.8	1.5	3.6	3.4	9.5	13.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.0	1.7	7.9	0.0	0.0	0.0	9.8	0.0	0.0	0.4	0.0	0.0	0.0	0.1	2.3	0.0	3.1	0.1	0.8	0.0	0.2	0.0	4.6	0.0	0.3	0.2	3.9	0.0	0.0	1.6	0.0	0.3	0.5	0.0	0.6	0.1	0.0	0.0	3.9	2.0	0.0	0.0	2.7	0.1	0.0	5.6	5.5	0.0	8.2	10.2	4.9	7.2	0.0	0.0	0.0	9.9	0.0	2.5	0.2	0.0	12.3	0.0	3.4	0.0	0.0	0.0	0.0	1.6	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	2.2	1.7	0.9	3.1	3.4	2.2	1.6	1.4	2.1	1.9	0.0	4.0	0.0	0.4	1.1	10.0	20.4	2.5	9.4	7.9	5.2	0.0	2.3	0.0	1.0	99.7	0.6	0.0	0.0	4.7	0.8	4.1	0.6	0.0	0.0	0.5	1.6	4.7	1.3	0.0	120.8	1.7	0.5	5.0	0.0	0.5	0.3	3.5	0.0	5.3	1.4	0.7	6.5	2.1	6.6	5.1	0.4	1.6	0.0	0.0	0.3
FOXK1	IMAGE:5164497	ENSG00000164916	"Forkhead box K1"	P85037	7	4682309-4771443	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017998, HPA018864"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA017998: AB_1849077, HPA018864: AB_1849079"	"unprognostic (3.05e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (2.34e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.66e-3)"	"unprognostic (4.96e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-1)"	13.0	16.7	15.5	12.7	16.0	24.7	10.3	18.1	23.8	14.1	15.4	18.4	9.5	10.1	16.9	8.3	12.4	14.4	11.7	13.6	14.4	13.7	10.7	8.4	14.3	11.9	19.3	13.9	15.5	17.6	10.6	22.2	9.9	14.2	11.7	9.3	13.8	12.6	14.0	27.4	21.0	11.3	15.5	12.1	15.6	11.9	14.7	19.9	12.5	9.2	9.5	11.0	14.9	19.0	3.2	2.8	1.9	4.0	3.7	6.5	2.9	8.7	11.3	7.3	14.5	7.2	5.5	9.1	4.0	3.6	2.9	3.3	11.2	10.0	15.0	4.8	6.5	9.4	14.5	7.9	9.9	3.0	4.3	4.9	7.0	11.7	6.3	7.1	8.7	8.1	10.4	5.6	7.0	9.7	4.7	5.6	5.8	15.1	3.3	3.5	10.1	3.3	15.6	11.0	3.6	5.7	12.5	7.3	9.5	4.2	13.1	6.6	8.3	6.1	13.4	4.8	6.0	7.4	11.6	17.1	5.1	16.1	7.8	8.6	9.3	7.6	9.9	6.8	10.2	8.0	1.9	2.4	1.0	4.6	4.0	6.5	3.2	4.5	4.3	2.8	3.2	5.1	4.7	1.4	3.7	3.7	2.3	2.2	2.9	15.5	16.0	18.1	21.4	14.4	13.7	19.3	13.9	14.2	19.9	29.8	13.7	14.4	10.4	29.8	16.7	11.1	10.2	10.7	9.1	14.0	21.6	11.0	5.0	8.8	33.5	14.3	7.8	0.0	13.2	3.8	16.7	21.0	7.0	10.6	9.5	22.3	12.6	11.6	19.4	86.3	17.8	8.8	15.1	10.8	9.2	9.8	16.4	8.6	26.9	14.7	14.2	19.4	34.0	14.0	15.7	43.7	3.3	14.4	15.6	18.8
AP5Z1	"KIAA0415, SPG48, zeta"	ENSG00000242802	"Adaptor related protein complex 5 zeta 1 subunit"	O43299	7	4775622-4794312	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035693	Supported		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA035693: AB_10960687"	"unprognostic (1.64e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.01e-3)"	"unprognostic (4.24e-2)"	"unprognostic (2.43e-3)"	"unprognostic (5.19e-1)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (1.50e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.32e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.22e-1)"	15.2	18.6	9.5	19.2	11.1	20.8	11.3	14.3	14.9	10.7	12.6	13.5	6.3	22.2	14.0	11.0	10.8	10.6	9.9	8.0	8.6	6.8	9.9	9.2	12.6	18.6	10.9	9.7	12.6	16.9	5.6	11.5	9.6	10.3	11.6	4.6	13.1	15.0	12.8	8.4	21.8	19.1	13.0	8.5	23.4	17.1	10.1	12.6	18.2	11.3	6.6	16.9	13.2	10.6	11.7	11.3	15.7	17.0	12.3	13.4	9.8	10.7	4.8	1.2	8.6	5.4	3.9	11.9	8.5	4.9	6.7	5.5	9.3	10.0	7.4	5.1	5.6	22.6	12.9	1.1	5.3	0.7	5.6	5.2	5.5	11.4	6.7	18.0	9.6	15.7	7.9	4.2	5.6	2.2	2.0	4.4	5.6	9.5	8.1	2.8	11.5	2.8	21.7	8.0	2.8	11.8	7.0	4.2	6.9	2.1	10.3	4.9	9.1	7.2	11.4	8.2	1.1	10.1	15.5	11.1	7.1	8.3	14.1	6.4	17.1	11.0	4.4	10.5	11.9	14.2	1.7	12.9	15.7	13.4	17.0	10.7	10.5	9.2	11.8	11.3	11.7	10.1	8.4	13.5	12.3	14.2	10.2	8.6	9.8	9.5	11.1	14.3	14.9	8.6	6.8	10.9	9.7	10.3	12.6	8.9	12.9	9.3	2.7	6.2	11.1	3.6	17.8	5.3	1.2	10.4	3.9	10.2	0.0	11.8	1.9	7.1	14.0	0.0	11.8	6.6	8.9	4.7	16.2	7.5	24.2	17.5	11.5	13.5	11.9	1.1	12.4	11.0	13.5	28.9	11.5	8.0	16.0	12.2	10.3	5.9	8.5	0.0	8.2	5.6	9.7	9.7	13.8	13.6	10.1	3.1
RADIL	"FLJ10324, KIAA1849, RASIP2"	ENSG00000157927	"Rap associating with DIL domain"	Q96JH8	7	4797055-4883719	"Predicted intracellular proteins"	"Cell adhesion"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.9;testis: 18.5"	"Cell type enhanced"	"Detected in many"	10	"Horizontal cells: 12.7;Spermatocytes: 18.2;Spermatogonia: 9.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.7;HEK 293: 6.0;NTERA-2: 6.8;SCLC-21H: 9.5;SH-SY5Y: 20.6;U-2197: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051776	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA051776: AB_2681605"	"unprognostic (6.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.74e-4)"	"unprognostic (4.63e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (7.89e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.49e-4)"	"unprognostic (5.10e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.33e-3)"	"unprognostic (4.28e-3)"	7.5	2.4	4.3	0.8	4.6	0.5	3.7	29.9	9.9	5.9	3.3	3.3	0.7	0.8	6.1	1.4	1.7	6.4	2.1	7.8	4.1	4.0	1.1	0.7	7.5	0.6	3.4	4.4	1.6	2.5	1.5	3.3	7.2	7.5	2.1	1.1	2.7	1.1	4.3	4.5	1.2	1.8	3.1	4.3	1.0	1.4	18.5	4.0	0.0	2.8	0.6	0.7	2.2	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.8	7.7	0.2	1.9	0.0	0.9	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.8	1.1	0.0	3.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	1.7	4.1	0.0	0.4	2.1	0.0	0.0	6.8	0.0	1.3	5.0	0.2	0.0	0.0	0.0	9.5	20.6	0.1	0.0	0.0	1.6	3.0	0.6	0.0	0.0	0.0	5.5	1.5	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	4.6	29.9	9.9	4.1	4.0	3.4	4.4	7.5	4.0	3.0	1.0	0.0	0.0	0.7	0.5	1.7	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.0	5.6	1.3	0.0	0.0	1.6	0.0	2.4	0.4	0.0	0.0	0.1	12.7	0.0	0.0	0.0	4.1	3.1	0.0	6.8	0.0	0.1	3.3	0.3	0.0	3.5	0.0	0.5	6.5	3.6	18.2	9.7	0.5	0.1	0.0	0.0	0.0
PAPOLB	PAPT	ENSG00000218823	"Poly(A) polymerase beta"	Q9NRJ5	7	4857733-4861994	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	63	"testis: 33.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 67.3;Late spermatids: 69.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"THP-1: 1.7"	"Not detected"	"Not detected"							HPA047285			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047285: "					"unprognostic (7.58e-2)"					"unprognostic (1.25e-1)"				"unprognostic (1.68e-2)"	"unprognostic (1.78e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	33.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.3	1.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.3	0.3	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.0	2.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.7	0.0	0.5	16.1	2.3	0.6	0.2	0.0	0.0	0.3
MMD2	PAQR10	ENSG00000136297	"Monocyte to macrophage differentiation associated 2"	Q8IY49	7	4905989-4959213	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	12	"brain: 38.5;testis: 10.1"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 2.0;Muller glia cells: 2.4;Rod photoreceptor cells: 2.3"	"Cancer enriched"	"Detected in single"	59	"glioma: 3.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.9;SH-SY5Y: 2.0;U-87 MG: 1.0"	"Low region specificity"	"Detected in all"													NA	NA										"unprognostic (2.32e-1)"							"unprognostic (1.53e-2)"		"unprognostic (5.03e-2)"	"unprognostic (2.03e-1)"			0.9	1.2	10.6	0.9	16.2	0.8	0.8	2.4	38.5	0.9	0.9	4.0	0.0	0.9	0.8	0.9	0.9	0.8	0.9	0.8	7.4	6.5	0.9	0.8	0.8	0.9	7.4	6.8	1.0	0.8	0.8	1.9	0.8	7.9	0.9	0.9	1.4	1.0	1.0	0.8	0.8	1.0	0.9	16.7	0.8	0.9	10.1	3.7	0.0	0.9	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.6	16.2	2.4	9.8	7.4	6.5	7.4	6.8	7.9	3.7	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0
RBAK-RBAKDN		ENSG00000272968	"RBAK-RBAKDN readthrough"		7	4983718-5073221	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in all"	10	"testis: 71.1"	"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 32.5;Spermatocytes: 34.9;Spermatogonia: 40.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MCF7: 5.6;U-266/70: 6.1"															NA	NA						"unprognostic (3.78e-2)"	"unprognostic (3.57e-1)"	"unprognostic (5.60e-2)"		"unprognostic (1.55e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.23e-1)"	"unprognostic (5.44e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.62e-7)"	"unprognostic (2.86e-1)"	"unprognostic (4.96e-2)"	"unprognostic (9.57e-2)"	"unprognostic (3.10e-2)"	3.1	2.0	2.3	4.8	3.4	2.0	2.7	6.4	3.1	2.5	2.2	1.1	3.6	1.9	2.6	2.7	4.6	1.8	1.8	1.6	2.6	2.2	2.3	2.2	2.6	5.4	2.5	3.4	2.7	1.9	1.7	3.4	1.7	2.3	2.3	1.7	1.3	3.2	4.5	1.9	2.7	2.2	2.4	2.3	3.0	2.4	71.1	3.2	6.8	2.9	4.8	2.6	3.2	2.8	0.4	0.3	0.2	0.9	0.8	2.1	0.2	1.4	0.4	0.6	2.7	0.5	1.3	0.5	1.1	0.7	0.7	0.5	2.0	0.6	1.1	3.8	0.9	0.8	1.1	0.0	0.6	1.5	0.1	1.9	0.9	1.1	1.3	1.5	3.7	3.8	0.0	1.0	0.9	2.1	0.9	0.6	1.6	2.3	0.0	0.1	5.6	0.4	0.7	1.3	0.1	3.5	0.4	0.4	2.2	0.2	0.2	1.4	2.2	0.0	1.7	1.5	1.6	1.4	3.1	0.0	0.9	1.8	1.2	1.0	6.1	2.0	1.2	1.1	1.0	1.0	0.0	0.1	0.2	0.8	0.9	0.2	0.3	2.1	0.2	0.0	0.4	2.0	1.6	0.0	0.8	0.0	0.3	0.0	0.2	2.3	3.4	6.4	3.1	2.6	2.2	2.5	3.4	2.3	3.2	0.0	0.6	0.0	5.3	6.6	27.3	0.0	5.1	1.4	2.3	1.8	11.8	2.3	5.0	5.6	4.9	6.7	0.4	0.0	4.6	5.8	7.3	8.2	1.1	4.3	6.0	25.4	2.4	3.1	3.3	2.1	14.7	7.4	5.0	5.4	2.3	17.2	6.5	4.0	7.1	4.0	32.5	6.5	7.2	34.9	40.7	6.4	1.8	9.6	2.8	4.4
RBAK	ZNF769	ENSG00000146587	"RB associated KRAB zinc finger"	Q9NYW8	7	5045821-5069488	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071231			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA071231: AB_2686370"	"unprognostic (2.82e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.04e-1)"	"unprognostic (4.32e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.91e-2)"	"unprognostic (6.84e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.66e-2)"	"unprognostic (6.12e-3)"	"unprognostic (5.75e-2)"	7.6	7.3	7.1	15.0	11.6	5.8	10.7	19.0	10.6	9.2	8.3	5.9	12.0	7.9	9.6	9.7	14.4	8.4	7.5	7.7	9.4	8.3	8.8	12.0	7.7	16.5	8.8	11.6	9.7	11.0	17.5	11.6	8.1	8.7	9.1	9.1	6.2	11.0	14.2	7.9	10.7	9.8	8.9	7.9	10.6	8.8	6.0	11.0	20.0	10.3	15.1	11.7	11.1	10.0	1.7	1.9	1.7	1.8	2.0	3.0	0.6	7.7	6.1	8.5	15.7	6.2	5.8	7.0	4.9	3.9	4.9	5.8	7.4	5.0	9.4	4.2	5.7	9.3	9.8	9.4	7.7	7.6	2.0	6.7	6.7	7.8	6.2	6.6	11.6	8.2	5.7	9.3	4.8	11.0	7.2	4.8	5.5	14.1	3.4	6.1	13.9	2.8	10.5	13.4	2.7	6.3	4.6	13.8	6.9	5.8	10.2	8.7	14.4	7.0	11.7	10.3	11.4	7.1	13.7	4.0	5.9	9.4	6.7	8.1	10.5	8.3	8.4	5.9	8.5	7.6	0.0	0.9	1.7	2.4	1.8	3.0	1.7	1.8	1.7	1.5	1.3	2.2	1.8	0.1	2.0	0.4	1.9	1.2	0.6	7.1	11.6	19.0	10.6	9.4	8.3	8.8	11.6	8.7	11.0	0.0	5.1	5.4	3.1	3.8	7.7	11.5	5.1	4.0	6.8	0.0	9.8	2.2	1.7	5.3	0.8	4.3	4.9	23.3	5.1	1.8	4.2	4.6	5.7	4.0	3.1	20.6	4.7	9.2	7.9	1.0	7.5	2.5	3.3	1.8	5.2	5.0	5.2	3.6	8.1	3.7	7.4	0.0	5.2	4.1	3.3	6.0	1.6	6.9	5.6	3.5
WIPI2	"ATG18B, ATG21, CGI-50, DKFZP434J154, DKFZp686P02188, FLJ12979, FLJ14217, FLJ42984"	ENSG00000157954	"WD repeat domain, phosphoinositide interacting 2"	Q9Y4P8	7	5190188-5233826	"Predicted intracellular proteins"	Autophagy		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019852, HPA021488"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA019852: AB_1846589, HPA021488: AB_1846591"	"unprognostic (5.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (7.69e-5)"	"unprognostic (1.96e-3)"	"unprognostic (9.27e-3)"	"unprognostic (4.60e-3)"	"unprognostic (4.96e-2)"	"unprognostic (6.60e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (9.78e-4)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.05e-6)"	"unprognostic (2.61e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.41e-2)"	"unprognostic (6.98e-2)"	24.5	23.6	33.9	17.8	34.7	32.7	21.9	30.6	47.4	20.6	21.7	27.8	17.4	20.3	24.4	23.1	25.4	25.3	20.5	30.5	27.9	27.2	23.5	27.5	21.9	22.3	26.0	31.2	25.0	30.8	28.7	23.2	27.0	26.1	25.0	17.2	25.0	34.7	25.5	28.3	31.8	18.2	22.9	25.6	22.0	23.0	49.3	26.0	26.6	24.1	15.9	23.4	22.9	20.5	6.1	6.9	13.0	6.3	2.6	9.2	2.2	27.2	17.4	17.1	29.1	26.3	27.6	26.3	24.3	28.0	26.0	27.5	16.9	25.4	19.5	18.7	30.4	32.4	20.0	17.2	19.8	20.3	10.0	26.7	13.3	17.6	18.6	26.0	20.8	14.6	29.0	23.9	29.5	16.4	26.0	36.1	26.8	37.6	17.7	23.5	28.3	15.8	36.1	35.5	14.6	25.6	26.1	24.4	32.0	17.1	13.3	21.3	32.1	17.8	30.7	21.1	29.9	18.8	39.8	28.6	16.6	35.0	27.7	18.1	31.8	29.6	22.2	27.1	24.2	24.5	0.3	4.9	13.0	5.1	6.3	3.1	5.6	6.7	9.1	4.5	6.1	8.5	5.4	9.9	2.6	4.2	6.9	9.2	2.2	33.9	34.7	30.6	47.4	27.9	27.2	26.0	31.2	26.1	26.0	35.7	26.9	47.2	36.3	48.8	67.7	25.4	25.5	21.4	17.0	17.4	58.9	79.1	61.3	36.3	146.8	28.9	32.1	46.7	36.2	84.9	33.8	70.9	31.1	55.0	59.9	44.5	37.9	47.9	51.5	127.3	39.4	39.2	42.2	65.9	47.0	87.1	45.2	38.5	52.6	60.3	50.4	51.8	32.0	181.0	130.5	62.0	126.1	42.4	42.2	42.4
SLC29A4	"ENT4, FLJ34923"	ENSG00000164638	"Solute carrier family 29 member 4"	Q7RTT9	7	5274369-5306870	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 35.7"	"Group enriched"	"Detected in many"	8	"Horizontal cells: 158.9;Intestinal endocrine cells: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 24.5;SH-SY5Y: 35.6;U-2 OS: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052829			Approved	"Microtubules,Cytokinetic bridge"		Yes	No			"Microtubules, Cytokinetic bridge"		"HPA052829: AB_2681967"	"unprognostic (6.04e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.49e-5)"	"unprognostic (2.53e-1)"	"unprognostic (1.47e-3)"	"unprognostic (4.24e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.73e-2)"	"prognostic favorable (4.52e-4)"	"unprognostic (2.06e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.60e-2)"	35.7	8.3	7.6	2.5	6.4	0.8	6.5	4.2	9.7	2.0	2.5	2.0	0.3	4.5	2.4	5.3	1.3	4.2	1.8	1.7	9.4	15.7	3.4	3.8	1.2	1.8	12.2	5.4	3.2	13.0	0.5	1.6	0.8	7.0	3.0	2.0	11.5	1.1	1.0	2.1	1.4	5.4	2.0	3.1	1.1	7.1	1.3	1.1	0.3	4.3	0.3	0.7	2.3	0.5	1.3	1.1	4.3	1.1	4.3	1.3	0.3	0.0	10.6	6.3	24.5	0.3	0.1	1.2	0.9	0.0	0.8	0.4	6.0	0.2	0.0	1.2	0.9	4.1	0.1	2.4	0.2	0.2	0.0	1.3	0.1	0.3	8.7	1.9	0.1	1.5	0.8	8.2	0.1	0.4	1.5	0.7	2.2	1.7	0.1	0.6	5.2	0.9	0.4	8.0	0.7	0.6	4.0	1.0	0.9	1.6	0.2	4.2	35.6	0.6	2.2	0.4	5.7	2.7	2.8	0.3	8.8	12.3	0.8	0.2	0.5	0.0	0.0	1.1	0.3	3.9	2.0	1.1	0.6	0.8	0.5	1.3	0.7	0.5	0.7	0.4	1.3	0.7	0.9	4.3	4.3	0.5	1.1	0.3	0.3	7.6	6.4	4.2	9.7	9.4	15.7	12.2	5.4	7.0	1.1	3.0	0.3	0.0	0.2	0.1	1.8	2.3	0.0	1.4	0.0	0.0	15.7	0.2	0.0	4.3	0.0	0.0	1.3	0.0	0.2	0.2	1.1	2.2	0.0	0.6	0.4	158.9	98.9	0.0	0.0	0.4	0.3	0.0	0.0	0.0	2.2	4.4	1.9	0.0	0.4	0.0	1.3	0.0	0.9	0.3	6.0	0.3	0.2	0.0	0.6	0.0
TNRC18	"CAGL79, KIAA1856, TNRC18A"	ENSG00000182095	"Trinucleotide repeat containing 18"	O15417	7	5306790-5425414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 17.6"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA020730, HPA024251"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Mitochondria,Cytosol"		NA	NA			"Nucleoplasm, Nuclear membrane, Mitochondria"	Cytosol	"HPA020730: AB_2670506, HPA024251: AB_2671498"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.67e-3)"	"unprognostic (4.44e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.29e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.34e-2)"	17.9	11.8	18.1	17.9	17.2	29.4	20.6	35.1	23.6	35.0	29.9	16.7	17.9	16.4	36.0	19.5	19.6	27.5	29.2	13.6	14.2	9.6	15.6	11.8	19.2	12.9	15.5	16.7	30.3	18.4	36.9	14.7	19.7	13.2	25.4	15.1	25.2	17.0	24.4	13.6	18.9	16.9	40.1	12.6	15.3	21.4	14.0	16.6	7.2	20.6	12.8	9.4	27.0	21.4	2.0	4.3	17.6	3.2	2.6	1.5	0.1	21.7	19.4	16.2	13.6	13.7	16.3	41.9	15.5	14.6	8.6	9.2	8.0	19.2	14.9	15.3	22.7	19.2	24.4	9.3	18.5	7.3	6.5	5.9	9.4	16.6	12.9	11.9	31.0	34.9	16.4	21.9	17.1	19.9	12.5	9.6	13.5	13.4	8.4	10.9	36.1	7.3	38.0	1.4	14.3	14.9	8.1	8.0	11.0	7.0	27.8	7.1	16.9	12.0	31.9	11.5	7.6	33.3	32.2	24.0	24.9	35.1	14.8	11.1	12.1	12.5	14.1	14.0	22.1	29.0	9.4	3.2	2.7	1.4	1.2	1.0	1.6	1.0	0.8	1.1	2.0	0.7	1.5	17.6	2.6	1.5	4.3	1.4	0.1	18.1	17.2	35.1	23.6	14.2	9.6	15.5	16.7	13.2	16.6	8.9	31.9	1.4	3.1	8.2	56.8	6.2	15.3	6.7	11.4	14.0	2.0	12.8	1.7	4.5	12.0	10.7	16.9	0.0	5.5	3.6	11.3	4.6	13.9	22.9	9.5	47.7	30.1	29.4	40.0	12.0	17.0	11.9	5.0	3.6	27.0	23.8	8.0	5.8	18.7	4.2	3.7	19.4	11.9	0.5	2.0	7.8	8.4	6.4	21.8	2.6
FBXL18	"Fbl18, FLJ11467"	ENSG00000155034	"F-box and leucine rich repeat protein 18"	Q96ME1	7	5431335-5513798	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036049			Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA036049: AB_2674918"	"unprognostic (2.86e-3)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (1.26e-2)"	"unprognostic (8.73e-3)"	"unprognostic (1.72e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.98e-4)"	"unprognostic (1.50e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.69e-1)"	"unprognostic (8.28e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.30e-4)"	"unprognostic (1.73e-3)"	6.4	6.2	11.0	7.2	15.0	8.5	3.7	10.8	17.7	3.0	4.6	8.1	4.3	5.6	5.1	3.4	6.1	4.4	3.3	5.0	10.2	8.0	4.3	3.6	4.4	5.7	6.6	12.3	4.3	8.0	6.2	4.8	4.2	7.6	5.0	3.2	5.6	5.3	3.8	10.8	10.2	5.0	4.3	5.4	5.4	4.6	5.7	7.7	4.3	4.8	2.8	5.6	4.8	3.2	3.4	2.5	8.9	4.0	3.9	2.7	1.8	9.3	12.3	3.5	7.5	3.2	3.4	6.1	5.6	2.9	3.5	3.7	9.3	6.0	4.3	6.8	2.7	6.6	14.8	4.1	9.8	2.6	3.3	5.1	2.2	9.3	3.0	2.4	4.8	3.6	2.8	5.3	5.4	2.6	2.6	4.1	2.7	6.8	3.8	2.4	9.8	2.5	3.0	11.3	3.3	10.2	6.3	6.8	2.3	2.2	4.9	7.6	10.6	8.7	14.8	2.9	4.5	14.5	2.9	9.5	11.5	16.5	8.4	8.5	5.1	6.3	3.3	5.9	5.9	13.6	7.9	3.5	1.3	2.7	3.2	2.7	2.1	1.7	2.5	2.5	3.4	1.9	2.4	8.9	3.9	4.0	2.5	2.0	1.8	11.0	15.0	10.8	17.7	10.2	8.0	6.6	12.3	7.6	7.7	6.0	4.5	0.8	1.7	2.3	8.8	3.9	2.5	2.7	7.9	0.0	3.9	3.2	0.0	1.8	1.1	1.6	2.6	0.0	2.1	2.5	2.3	1.3	2.3	1.7	1.3	1.6	4.6	1.8	3.2	0.0	1.4	2.2	0.0	2.8	1.9	4.8	1.7	2.6	0.7	1.0	6.4	0.0	1.4	2.6	5.1	2.9	1.8	2.9	3.8	1.6
ACTB		ENSG00000075624	"Actin beta"	P60709	7	5527147-5563784	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease mutation, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"monocytes: 32742.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB002621, HPA041264, HPA041271"	Supported					NA	NA					"CAB002621: , HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (1.66e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (9.80e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (3.78e-5)"	"unprognostic (2.68e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.88e-3)"	209.6	84.4	88.8	260.7	97.2	204.1	152.2	50.8	143.4	172.0	392.7	135.4	95.7	107.9	333.6	113.6	296.2	196.4	168.5	79.3	99.3	73.7	132.4	148.1	183.0	295.5	90.7	79.4	211.9	49.7	41.0	52.5	139.9	103.8	183.7	142.0	78.3	101.5	182.5	70.4	96.8	190.2	371.8	135.5	238.9	216.9	102.1	61.9	358.3	83.1	100.4	279.2	346.2	146.3	113.6	386.3	575.1	443.8	122.3	233.8	559.5	254.7	152.7	185.5	154.4	75.2	97.5	235.8	202.1	113.4	136.4	106.8	257.5	143.7	153.8	155.4	269.5	147.6	162.8	98.7	251.9	160.4	178.6	58.5	134.4	147.6	145.9	105.8	147.4	342.7	121.2	83.0	181.4	53.2	135.5	133.8	104.5	73.0	116.6	210.0	237.9	129.8	391.8	226.8	77.3	122.6	186.5	110.1	114.0	196.1	95.2	56.5	93.9	198.4	186.7	68.2	189.3	198.0	169.8	276.3	359.2	230.5	235.9	290.9	67.0	74.6	167.5	196.8	216.5	414.2	250.3	323.7	575.1	227.2	395.9	185.1	113.6	169.8	205.2	386.3	107.3	128.1	177.5	383.7	122.3	443.8	151.0	233.8	559.5	88.8	97.2	50.8	143.4	99.3	73.7	90.7	79.4	103.8	61.9	1069.0	822.3	2484.5	7353.8	5096.2	155.7	125.4	1202.6	477.8	624.4	2034.4	80.5	3302.0	1929.8	6734.3	80.2	1836.0	3281.7	1027.9	5552.5	10236.7	3325.6	3645.8	1466.1	2345.3	12685.3	254.3	1395.2	2304.3	7427.3	112.4	1635.9	7666.7	2841.0	32742.0	1861.9	1550.6	9573.5	2795.0	2519.6	1484.0	125.8	3233.8	4447.1	79.8	345.5	4127.8	2724.3	5423.3	1783.0	5007.2
FSCN1	"FLJ38511, p55, SNL"	ENSG00000075618	"Fascin actin-bundling protein 1"	Q16658	7	5592823-5606655	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.9"	"Cell type enriched"	"Detected in many"	9	"monocytes: 1791.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 82.1;K-562: 68.7;NB-4: 78.0;PC-3: 68.7;SH-SY5Y: 65.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000121, HPA005723, CAB035991, HPA050654"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	Yes		4500000	Cytosol	"Plasma membrane"	"CAB000121: AB_2278596, CAB035991: , HPA005723: AB_1849159, HPA050654: AB_2681203"	"unprognostic (1.91e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.12e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.76e-4)"	"unprognostic (2.16e-3)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (6.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.27e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (8.15e-7)"	"unprognostic (1.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.93e-3)"	26.3	13.3	23.7	29.6	30.1	6.3	8.1	5.5	56.9	9.9	5.5	35.1	0.0	5.4	11.7	2.3	22.3	5.9	8.9	10.6	27.7	16.8	5.5	7.1	11.3	15.2	26.9	23.6	21.8	5.1	2.3	7.0	29.4	20.1	4.1	3.0	8.1	11.0	3.9	7.8	17.3	6.6	7.0	29.6	39.3	7.6	15.9	28.3	9.3	8.5	15.9	11.4	14.7	12.3	0.2	5.4	1.0	1.9	0.0	0.1	1.4	8.0	18.6	12.4	44.5	4.8	9.2	82.1	19.3	8.6	3.3	3.6	12.9	2.0	0.1	23.6	8.5	3.2	30.5	7.1	31.0	0.2	9.1	3.8	0.5	19.8	60.8	2.5	0.0	1.6	5.7	9.2	6.2	5.1	5.5	16.2	0.0	68.7	0.1	4.2	0.8	0.2	78.0	32.5	0.5	68.7	18.1	2.9	0.3	4.8	0.7	9.9	65.9	16.1	0.2	0.6	8.4	0.4	4.9	32.8	22.9	40.3	13.3	19.8	0.1	0.1	0.0	14.8	0.0	43.0	0.0	1.9	0.1	0.0	0.5	0.0	0.2	0.1	0.0	5.4	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	1.4	23.7	30.1	5.5	41.3	27.7	16.8	26.9	23.6	20.1	28.3	3.0	5.5	2.4	19.0	161.1	7.2	6.9	2.5	1.4	0.0	1.8	0.0	4.4	0.0	6.8	13.1	49.6	1.3	0.0	4.2	90.3	72.6	6.3	16.1	0.8	207.2	0.0	40.2	97.6	22.0	7.9	23.6	10.6	49.0	1791.8	0.7	69.1	10.4	0.0	8.5	0.2	2.3	0.0	16.5	4.7	9.0	128.6	12.2	4.3	0.9	28.3
RNF216	"TRIAD3, UBCE7IP1, ZIN"	ENSG00000011275	"Ring finger protein 216"	Q9NWF9	7	5620047-5781739	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 118.7;Late spermatids: 171.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018955, HPA021123"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA018955: AB_1858500, HPA021123: AB_1858501"	"unprognostic (3.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (6.24e-5)"	"unprognostic (2.88e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.69e-3)"	16.9	14.9	22.0	18.8	24.8	22.2	18.4	33.5	27.8	17.8	26.9	22.0	13.4	11.5	26.9	13.3	18.7	19.6	14.2	29.1	20.5	17.4	12.7	11.8	14.9	23.8	23.8	14.8	25.6	21.3	23.2	24.9	14.6	20.4	17.7	11.8	18.9	16.2	21.5	22.5	15.1	20.1	25.0	18.7	23.3	18.3	34.3	26.3	18.5	19.8	9.6	24.1	17.7	30.7	8.8	6.7	24.5	8.4	10.0	9.7	6.5	14.3	15.4	12.7	21.6	15.2	13.1	8.7	15.3	16.1	15.9	14.8	11.1	8.2	12.5	7.9	17.1	27.6	10.3	13.1	10.8	13.0	7.8	11.4	9.7	9.3	11.2	18.1	15.8	16.6	13.5	13.8	12.2	14.9	13.2	12.6	12.2	19.3	8.8	17.6	22.0	5.9	25.2	17.4	8.1	12.9	15.1	17.9	7.0	9.5	12.1	9.7	15.4	9.7	24.3	8.7	14.9	9.6	16.2	13.6	16.1	29.1	16.4	13.8	7.2	5.3	10.2	12.1	14.7	25.6	1.3	7.7	24.5	9.0	8.4	9.0	7.3	7.9	6.7	6.7	8.8	9.7	9.1	13.1	10.0	7.7	5.4	7.0	6.5	22.0	24.8	33.5	27.8	20.5	17.4	23.8	14.8	20.4	26.3	6.0	19.2	11.0	16.6	14.7	36.2	25.7	5.1	13.4	14.8	12.2	49.1	11.9	21.6	15.1	118.7	24.8	10.2	0.0	12.0	11.1	20.5	16.4	18.5	13.4	19.2	27.0	5.8	23.9	19.0	171.4	34.5	23.8	11.8	33.3	12.5	35.8	13.1	3.5	28.3	10.6	49.0	25.8	22.7	96.9	99.0	14.2	12.7	23.0	10.8	13.1
OCM	OCM1	ENSG00000122543	Oncomodulin	P0CE72	7	5879827-5886362	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 5.7;brain: 9.5;lymphoid tissue: 5.5"	"Cell type enhanced"	"Detected in some"	13	"Early spermatids: 1.7;Late spermatids: 1.8;Spermatogonia: 1.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"T-reg: 5.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.1;PC-3: 1.9;THP-1: 1.5;U-937: 2.2"									"HPA046422, HPA052483"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA046422: AB_2679659, HPA052483: "	"unprognostic (1.79e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.92e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.90e-4)"	0.1	0.5	9.5	0.7	1.7	1.8	1.6	3.1	1.4	0.2	0.5			0.0	0.2	2.7	0.3	0.3	0.5	0.0	2.0	1.8	0.3	0.1	0.1	5.5	0.9		0.5	0.3	0.0	0.2	0.0		0.2	0.6		0.9	0.8	0.0	2.0	0.7	0.2	0.8	1.4	0.1	2.3			0.6		2.3	0.3	0.1	2.1	0.1	2.0	0.8	0.0	5.7	1.3	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.8	0.4	0.6	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.5	0.1	0.0	0.0	1.5	0.0	0.0	0.2	0.5	0.4	0.3	0.3	0.1	0.0	2.2	0.0	0.0	0.8	2.0	1.1	0.5	0.4	0.9	2.8	0.8	0.1	2.1	3.7	1.0	1.6	0.0	0.4	0.0	5.7	1.3											0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0
CCZ1	"C7orf28A, CCZ1A, CGI-43"	ENSG00000122674	"CCZ1 homolog, vacuolar protein trafficking and biogenesis associated"	P86791	7	5898725-5926550	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045114, HPA050006"	Uncertain		Enhanced	Vesicles		NA	NA			Vesicles		"HPA045114: AB_2679219, HPA050006: AB_2680989"	"unprognostic (1.91e-1)"	"unprognostic (2.97e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.10e-1)"	"unprognostic (9.25e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.67e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.41e-1)"	17.2	33.0	19.0	16.5	22.6	25.7	27.9	19.5	28.2	15.5	15.7	15.4	10.5	16.5	18.9	15.8	23.2	15.2	16.7	23.3	19.1	17.0	15.9	21.2	17.1	32.3	17.8	23.5	13.5	39.1	25.7	17.2	15.7	19.4	15.6	19.9	13.7	28.9	13.9	33.3	19.3	18.5	16.7	18.6	18.4	16.0	36.1	12.6	19.4	17.7	23.9	20.3	19.7	15.8	3.7	7.1	10.2	10.4	9.2	16.6	2.8	46.1	18.1	24.9	31.9	25.8	23.8	17.4	18.5	22.1	18.4	19.6	8.7	23.7	28.4	10.6	27.5	51.9	25.0	17.1	19.6	20.1	12.7	26.3	14.2	22.3	15.9	26.1	28.7	16.7	24.2	24.3	13.7	13.3	25.7	33.3	27.6	33.1	21.9	26.5	27.7	18.9	37.8	46.6	22.5	24.5	27.2	24.8	23.1	14.8	27.8	23.7	42.5	17.9	35.7	18.6	39.7	26.3	36.6	25.0	18.6	48.5	21.9	29.1	16.7	28.3	33.9	12.6	38.6	40.5	10.2	4.9	8.6	5.5	7.6	5.5	3.7	7.2	7.1	7.1	2.7	4.6	5.4	4.7	9.2	10.4	4.3	16.6	2.8	19.0	22.6	19.5	28.2	19.1	17.0	17.8	23.5	19.4	12.6	3.0	19.7	29.9	21.3	40.2	53.8	9.8	17.8	32.1	14.8	29.6	58.9	32.6	26.6	54.9	4.1	35.3	31.1	0.0	62.4	30.8	31.5	20.9	15.1	16.3	31.7	22.3	28.7	78.0	32.1	1.1	35.1	38.3	43.9	83.8	30.6	36.4	60.1	32.0	33.9	19.2	52.4	77.6	50.9	36.5	31.8	47.3	29.2	43.6	30.3	26.8
RSPH10B		ENSG00000155026	"Radial spoke head 10 homolog B"	P0C881	7	5925550-5970683	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"fallopian tube: 9.6;testis: 20.8"	"Group enriched"	"Detected in some"	16	"Ciliated cells: 69.6;Early spermatids: 44.5;Late spermatids: 98.8"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.4"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.9"									HPA049182	Supported					NA	NA					"HPA049182: AB_2680666"	"unprognostic (4.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.31e-2)"	"unprognostic (9.41e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.88e-3)"	"unprognostic (1.11e-3)"	"unprognostic (2.93e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.06e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.31e-3)"	0.0	0.1	1.1	0.0	1.3	0.0	0.0	0.2	0.2	0.8	0.0			0.0	0.3	0.2	0.0	9.6	0.0	0.0	1.5	1.6	0.0	0.2	1.4	0.0	0.1		0.0	0.0	2.2	0.8	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	20.8			0.1		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.7	0.1	0.2	1.0	0.0	0.4	0.2	0.0	0.0	0.2	0.1	0.1	0.4	0.2	0.4	0.8	0.3	0.2	0.0	0.1	0.6	1.1	0.4	0.2	1.9	0.6	0.0	0.5	0.4	2.9	0.1	0.5	0.0	0.1	0.1	1.0	0.7	1.0	0.2	0.5	0.4	1.6	0.0	0.7	0.4	0.4	0.1	0.0	0.0	0.0	0.6	0.1	0.7	0.1	1.2	0.0	1.2	0.0	0.0	1.3	0.0	0.0	0.9	1.3	0.1	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	69.6	4.5	0.0	0.0	0.0	0.0	0.0	44.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	98.8	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.9	0.3	0.0	0.0	0.0	0.0
PMS2	"H_DJ0042M02.9, HNPCC4, MLH4, PMSL2"	ENSG00000122512	"PMS1 homolog 2, mismatch repair system component"	P54278	7	5973239-6009125	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010235, HPA066490, HPA070310"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB010235: AB_2167281, HPA066490: AB_2685677, HPA070310: AB_2686250"	"unprognostic (5.13e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.38e-2)"	"prognostic favorable (1.23e-5)"	"unprognostic (5.31e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.81e-2)"	6.3	7.4	8.7	6.0	19.8	3.6	8.1	15.5	21.2	6.2	6.0	11.5	6.9	6.4	6.4	6.3	7.5	7.5	5.0	5.3	9.0	10.3	14.2	5.8	5.5	9.1	8.4	9.5	7.5	7.1	16.6	7.1	5.9	16.2	7.0	6.2	8.0	7.1	7.8	5.7	14.8	6.8	7.1	7.5	6.9	6.1	4.8	5.8	7.5	12.4	5.7	10.7	7.7	6.5	6.2	5.8	7.2	7.9	4.0	9.3	6.3	9.7	10.6	8.5	21.2	6.7	9.9	7.3	5.2	4.0	5.1	4.1	9.2	7.0	18.3	6.2	7.5	11.5	13.4	12.7	3.4	5.5	7.2	5.2	8.0	8.6	6.6	11.4	9.8	5.5	10.4	9.7	4.0	15.2	7.3	9.4	8.7	14.9	8.9	8.4	9.0	2.9	7.0	8.6	4.4	6.5	10.0	10.3	9.3	10.7	7.3	7.8	16.8	10.2	14.9	11.2	13.2	18.5	6.9	8.0	6.5	14.5	9.5	9.4	12.0	20.0	18.5	4.5	9.7	14.8	7.2	5.4	3.1	8.4	7.9	9.3	6.2	6.6	7.2	5.8	5.6	8.8	6.2	2.4	4.0	3.2	5.3	6.4	6.3	8.7	19.8	15.5	21.2	9.0	10.3	8.4	9.5	16.2	5.8	11.9	5.1	17.2	8.2	4.4	12.6	2.8	5.1	6.7	7.9	10.4	21.6	7.8	29.9	4.7	6.9	7.4	2.0	0.0	2.9	5.4	5.5	8.4	4.7	9.6	4.5	28.6	5.2	7.4	7.3	5.6	11.8	4.9	6.8	5.4	2.3	5.2	3.5	2.9	9.6	32.0	14.2	25.8	6.6	24.2	10.2	7.0	10.6	8.5	2.6	10.2
AIMP2	"JTV-1, JTV1, p38, PRO0992"	ENSG00000106305	"Aminoacyl tRNA synthetase complex interacting multifunctional protein 2"	Q13155	7	6009245-6023834	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Protein biosynthesis"	"Developmental protein"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 66.1"	"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019098, HPA020057"	Supported		Approved	Cytosol		NA	NA		8200	Cytosol		"HPA019098: AB_1852040, HPA020057: AB_1852042"	"unprognostic (1.24e-3)"	"unprognostic (1.66e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (9.29e-2)"	"unprognostic (3.41e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.96e-1)"	"prognostic favorable (1.38e-5)"	"unprognostic (7.44e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (3.09e-4)"	10.2	11.2	6.3	6.9	7.3	5.3	11.2	5.3	11.0	5.6	14.9	10.2	7.1	22.8	8.9	10.8	11.2	7.7	8.7	17.7	6.5	5.8	18.6	30.7	6.8	15.1	6.8	8.2	7.5	9.6	12.3	4.5	9.0	7.6	6.1	12.2	6.6	13.6	9.0	66.1	10.3	21.0	9.8	7.2	9.4	7.5	20.4	5.1	9.3	12.9	28.4	9.1	8.2	6.6	19.0	37.3	13.8	30.0	17.8	17.7	16.1	26.1	29.7	10.1	14.4	10.7	11.7	34.4	14.9	10.0	24.4	18.2	32.4	17.4	32.2	14.0	15.2	27.9	29.2	34.1	22.3	15.2	10.4	25.8	17.8	17.5	24.2	33.1	25.0	16.1	18.0	33.0	22.0	36.1	4.1	18.2	13.6	24.9	10.7	17.8	41.5	10.8	45.5	41.0	13.0	21.6	24.3	22.4	27.2	35.7	12.2	20.2	19.1	15.0	30.3	20.3	13.4	28.3	20.4	15.2	14.0	34.9	23.2	32.4	13.7	20.7	27.8	11.7	35.8	22.6	13.8	25.0	7.6	17.7	30.0	15.0	19.0	12.2	14.0	37.3	13.3	12.2	12.8	2.5	17.8	22.1	23.9	13.0	16.1	6.3	7.3	5.3	11.0	6.5	5.8	6.8	8.2	7.6	5.1	8.9	9.3	13.7	15.6	9.6	9.6	1.7	28.1	25.4	17.0	12.2	5.9	42.3	59.7	47.3	99.1	15.8	18.7	0.0	49.8	47.9	11.5	12.2	11.6	30.6	44.3	6.4	6.4	13.5	19.2	61.8	18.4	16.6	18.6	50.5	15.4	16.4	34.2	10.5	17.0	54.2	9.1	12.9	15.1	55.6	21.1	10.2	33.1	10.2	35.9	16.5
EIF2AK1	"HRI, KIAA1369"	ENSG00000086232	"Eukaryotic translation initiation factor 2 alpha kinase 1"	Q9BQI3	7	6022244-6059230	"Enzymes, Predicted intracellular proteins"		"Kinase, Protein synthesis inhibitor, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Cytotrophoblasts: 180.9;Syncytiotrophoblasts: 310.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016496, CAB022082, HPA061675"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB022082: , HPA016496: AB_1848057, HPA061675: AB_2684583"	"unprognostic (7.15e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.70e-2)"	"unprognostic (9.69e-3)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (2.36e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.06e-2)"	21.0	38.2	31.7	25.4	32.7	62.8	26.9	23.9	41.1	22.8	34.5	31.0	20.8	26.5	22.6	28.6	28.4	23.4	21.5	40.0	29.9	30.0	32.0	46.3	22.1	23.3	33.3	30.3	23.0	32.4	61.9	25.4	43.9	33.4	26.4	34.9	23.4	46.4	26.3	31.6	28.9	29.9	17.8	35.6	25.4	34.7	16.3	22.6	37.1	29.0	17.4	29.6	22.4	20.1	11.7	7.5	17.4	7.4	10.4	10.6	4.8	41.8	26.4	21.2	32.2	20.3	18.4	27.9	21.6	19.7	19.3	24.5	24.2	28.3	32.8	23.7	23.7	34.7	29.6	27.5	19.7	24.9	20.3	42.2	33.8	28.7	36.4	16.7	28.7	30.9	14.7	24.9	18.2	19.7	20.4	20.5	25.9	54.0	31.7	18.1	41.9	15.7	36.7	26.6	24.4	29.8	34.7	22.3	38.5	24.6	20.5	26.4	47.5	41.5	55.5	18.4	30.9	41.8	35.2	19.6	11.1	41.5	19.5	22.9	32.3	32.2	33.5	22.4	37.9	32.1	10.6	7.4	17.4	9.5	5.9	6.4	11.7	7.4	10.6	7.5	7.7	8.6	7.7	4.1	10.4	6.5	6.6	8.8	4.8	31.7	32.7	23.9	41.1	29.9	30.0	33.3	30.3	33.4	22.6	35.7	43.2	44.9	27.9	21.2	28.0	44.8	43.3	34.8	29.6	41.8	15.7	180.9	56.3	48.3	6.9	22.4	43.3	116.8	39.3	64.2	22.2	37.8	19.7	55.5	47.3	30.2	37.0	20.3	29.0	11.9	31.9	31.4	23.6	59.5	60.3	40.2	46.9	35.1	35.3	51.5	23.0	12.9	17.0	32.5	42.3	19.6	310.3	35.0	47.0	25.5
ANKRD61		ENSG00000157999	"Ankyrin repeat domain 61"	A6NGH8	7	6031376-6036386	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"bone marrow: 8.7;testis: 9.1"	"Group enriched"	"Detected in some"	19	"Early spermatids: 44.1;Late spermatids: 19.5"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 12.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029511, HPA050732"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029511: AB_10602430, HPA050732: "	"unprognostic (1.40e-1)"	"unprognostic (1.03e-3)"	"unprognostic (9.32e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.68e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.63e-1)"	0.5	0.5	0.0	0.7	0.2	8.7	0.7	0.5	0.9	0.4	0.3			0.6	0.6	0.0	0.4	0.5	0.2	0.6	0.1	0.1	0.3	0.5	0.5	1.1	0.0		0.8	1.0	0.1	0.5	0.4		0.4	0.0		0.9	0.0	0.6	2.1	0.8	0.0	0.2	0.9	0.9	9.1			0.9		0.0	0.5	0.5	0.6	1.5	0.9	1.1	0.0	0.8	0.3	2.2	6.0	1.8	2.8	0.3	0.3	2.6	1.4	0.4	0.6	0.6	3.0	5.6	1.1	0.6	0.2	2.6	2.2	1.0	0.0	0.7	0.3	0.8	1.5	12.7	0.4	0.2	1.7	2.6	0.4	1.2	0.5	1.1	1.3	0.5	1.7	2.0	1.8	0.7	3.8	0.3	1.8	0.9	0.4	0.7	1.6	0.5	0.3	0.5	2.9	1.4	2.5	1.4	1.6	0.2	2.9	3.0	1.1	1.2	2.4	4.9	2.9	1.8	1.6	1.8	0.9	0.7	1.4	1.5	0.9	1.1	0.0	0.1	1.1	0.0	0.0	0.0	0.8	1.5	0.6	0.1	0.5	0.0	0.0	0.5	0.0	0.0	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	44.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0
USP42	FLJ12697	ENSG00000106346	"Ubiquitin specific peptidase 42"	Q9H9J4	7	6104884-6161564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 70.7;Spermatocytes: 67.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064800			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA064800: AB_2685355"	"unprognostic (1.48e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.82e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.14e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.66e-1)"	6.7	5.6	5.7	5.7	9.5	19.8	7.2	14.1	10.6	8.5	7.4	10.4	5.5	8.1	14.1	7.0	6.9	8.1	6.5	5.4	5.8	6.0	7.4	7.1	7.3	6.5	6.7	4.9	10.6	11.7	10.5	10.9	8.2	6.2	7.4	6.5	8.9	6.6	6.3	7.4	9.2	9.2	8.7	9.9	7.8	6.7	25.2	8.1	14.3	7.7	6.2	8.3	7.6	6.9	1.9	2.2	3.3	2.4	1.9	4.3	0.8	8.4	6.3	11.4	11.1	6.6	5.0	7.8	4.6	5.9	5.4	5.4	4.4	4.5	10.1	3.0	5.7	8.0	7.9	9.5	5.0	5.9	2.4	7.4	4.6	5.4	4.5	5.6	10.8	5.3	5.9	6.0	5.8	7.5	5.0	6.6	8.5	17.8	6.8	3.6	7.5	6.5	12.1	12.9	4.4	4.8	12.4	8.9	6.9	5.1	4.5	8.8	15.5	5.8	12.2	3.6	10.9	5.6	5.6	5.5	4.9	18.1	6.1	5.4	6.1	5.1	8.8	4.1	6.6	9.5	2.3	1.1	3.3	2.1	2.4	3.0	1.9	2.6	1.3	1.1	1.1	1.7	4.3	1.4	1.9	1.2	2.2	1.8	0.8	5.7	9.5	14.1	10.6	5.8	6.0	6.7	4.9	6.2	8.1	11.9	6.5	11.5	16.3	35.9	18.1	6.9	0.0	10.7	6.8	1.8	21.6	7.3	0.0	9.4	70.7	12.2	12.5	0.0	8.9	6.5	8.5	16.7	9.2	7.8	7.2	20.6	10.3	14.7	7.0	32.5	13.3	11.5	10.1	6.4	14.6	11.3	10.2	7.0	12.0	4.2	17.9	12.9	11.3	67.4	32.6	36.3	22.4	12.1	11.3	13.5
CYTH3	"ARNO3, cytohesin-3, GRP1, PSCD3"	ENSG00000008256	"Cytohesin 3"	O43739	7	6161776-6272644	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 66.6"	"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 38.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 47.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 5.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.8;NK-cells: 3.3;T-cells: 5.9"	"Cell line enhanced"	"Detected in many"		"WM-115: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013979	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA013979: AB_1855799"	"unprognostic (6.58e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.63e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (2.63e-5)"	24.0	9.1	10.9	6.6	14.4	6.1	22.0	14.2	17.6	10.4	16.4	7.0	5.7	15.1	13.0	8.1	13.4	12.6	13.9	21.1	11.4	7.2	8.8	3.0	14.0	5.4	9.4	10.7	11.0	6.6	9.4	7.1	66.6	9.4	6.8	6.7	17.8	8.6	8.7	12.3	15.6	18.5	15.2	8.5	7.5	9.2	26.0	6.5	2.9	20.4	10.8	5.0	7.7	16.5	0.6	1.8	0.7	0.4	3.3	5.9	0.4	21.6	5.5	5.2	3.6	24.5	29.0	7.4	12.8	11.2	12.7	12.1	8.4	10.8	2.9	7.8	25.8	16.4	20.4	3.6	9.3	8.5	0.2	5.1	0.8	6.5	1.0	11.6	0.9	1.4	20.5	4.2	6.7	9.8	5.7	2.2	4.3	3.4	0.4	9.2	3.5	0.7	3.8	3.6	2.9	7.4	3.8	14.0	1.6	9.8	2.6	3.4	6.5	7.9	27.8	22.5	4.7	1.7	6.1	8.0	8.7	23.2	9.4	7.8	1.0	0.3	3.0	2.8	2.3	35.5	0.7	0.4	0.0	2.2	0.2	5.9	0.3	1.0	2.4	0.4	0.6	0.1	1.5	0.3	3.3	0.4	1.8	0.8	0.4	10.9	14.4	14.2	17.6	11.4	7.2	9.4	10.7	9.4	6.5	14.9	8.0	2.4	1.7	13.5	4.8	16.5	2.5	2.7	3.4	3.5	7.9	12.6	5.0	3.3	9.9	14.7	7.5	0.0	2.4	7.4	14.4	3.0	12.7	1.5	9.9	14.3	2.9	16.0	2.7	12.1	15.3	4.6	30.4	1.0	5.8	8.8	6.4	5.3	12.4	1.0	1.8	38.8	24.0	19.5	10.5	9.9	12.7	5.0	6.9	1.6
FAM220A	"ACPIN1, C7orf70, MGC12966, SIPAR"	ENSG00000178397	"Family with sequence similarity 220 member A"	Q7Z4H9	7	6329409-6348981	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.7;testis: 40.9"	"Group enriched"	"Detected in many"	14	"Early spermatids: 230.4;Late spermatids: 278.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA055050			Approved	Vesicles		NA	NA			Vesicles		"HPA055050: AB_2682684"	"unprognostic (3.49e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.69e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.26e-2)"	"unprognostic (4.02e-2)"	"prognostic unfavorable (5.17e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.84e-3)"	"unprognostic (1.14e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (3.71e-2)"	5.8	6.9	10.5	5.1	9.3	2.3	7.7	14.0	16.6	7.5	6.1	6.8	3.8	4.3	8.1	6.1	8.9	6.2	5.9	12.6	10.3	9.7	6.5	5.1	4.9	6.8	8.3	11.6	8.7	10.5	15.3	7.2	6.0	7.9	6.6	4.4	5.6	7.2	6.9	56.7	7.7	4.6	7.3	7.9	5.8	5.3	40.9	5.4	9.7	9.1	11.8	7.7	7.5	6.3	11.1	9.6	9.5	5.5	16.2	10.2	3.8	15.9	10.1	7.4	17.3	17.2	14.6	8.2	8.2	10.2	9.9	11.7	6.7	8.9	13.3	9.5	9.7	19.9	11.8	11.2	6.9	13.0	9.2	7.2	4.4	8.1	7.5	18.7	8.0	6.7	8.1	23.4	7.4	18.0	9.6	9.2	10.1	8.6	12.8	8.5	12.5	4.9	14.7	17.3	8.4	13.2	12.8	11.1	11.1	9.1	5.8	7.6	13.1	11.5	14.2	17.1	15.6	13.6	21.0	6.9	7.9	18.1	15.3	10.4	13.8	21.3	14.5	9.2	14.5	24.1	6.7	5.5	9.5	5.5	4.5	5.7	11.1	6.6	8.5	9.6	10.6	10.2	8.4	2.4	16.2	4.7	7.7	8.3	3.8	10.5	9.3	14.0	16.6	10.3	9.7	8.3	11.6	7.9	5.4	3.0	1.4	4.4	4.7	6.9	2.7	8.5	0.0	1.4	9.1	1.8	5.9	5.4	1.7	4.8	230.4	3.3	2.5	0.0	4.1	6.2	5.2	3.7	1.1	3.4	5.7	0.0	5.8	5.5	5.9	278.7	7.8	5.7	3.3	6.4	4.0	3.7	5.0	2.3	12.4	2.2	1.8	0.0	4.2	17.9	10.4	8.8	6.9	3.3	3.2	5.9
RAC1	"p21-Rac1, Rac-1, TC-25"	ENSG00000136238	"Rac family small GTPase 1"	P63000	7	6374523-6403977	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035994, HPA047820"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		44000000	"Nucleoplasm, Cytosol"	Nucleoli	"CAB035994: , HPA047820: AB_2680167"	"unprognostic (8.66e-3)"	"unprognostic (2.47e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.88e-3)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (1.74e-5)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.72e-3)"	45.2	35.0	71.0	28.4	64.0	24.4	46.5	42.1	93.0	48.7	58.9	75.5	22.5	51.6	48.7	49.5	93.4	47.2	40.0	48.4	73.8	59.8	47.8	42.9	45.6	38.3	76.7	60.9	45.1	29.2	51.0	25.2	55.8	54.9	40.5	64.0	37.2	43.3	48.9	57.4	58.6	49.8	57.3	88.2	35.0	49.7	28.1	47.1	41.3	40.9	42.8	50.7	52.2	54.0	11.0	32.0	49.1	31.9	7.3	11.8	10.7	75.1	34.1	35.3	38.3	41.9	53.5	21.1	42.4	52.1	56.6	57.7	33.5	71.1	21.2	27.5	59.1	58.6	53.6	37.6	51.4	72.5	9.9	31.2	21.3	27.6	24.1	50.4	19.2	17.4	35.6	46.0	40.7	45.7	43.1	49.8	21.0	38.0	16.8	60.9	54.8	10.5	45.2	63.2	38.3	40.9	18.7	35.9	31.1	72.7	47.7	26.8	45.1	29.9	109.6	34.0	42.1	61.8	57.8	52.2	37.2	56.0	45.5	48.9	12.8	14.0	20.0	34.3	36.7	70.4	7.6	31.9	16.4	7.2	22.2	4.5	11.0	8.1	9.2	32.0	11.0	9.8	6.5	49.1	7.3	22.1	18.2	11.8	10.7	71.0	64.0	42.1	93.0	73.8	59.8	76.7	60.9	54.9	47.1	137.0	112.5	192.8	745.4	829.8	84.3	183.1	481.6	92.3	104.6	338.5	23.6	691.3	454.3	121.1	58.5	522.9	706.2	303.7	149.3	914.8	466.9	1152.5	132.3	288.4	738.1	138.2	323.2	535.2	736.9	43.7	441.0	745.3	435.3	408.4	531.5	280.9	231.2	471.0	444.5	611.5	54.4	472.1	495.6	210.1	328.6	1004.1	707.0	194.1	436.1	1582.5
DAGLB	"DAGLBETA, KCCR13L"	ENSG00000164535	"Diacylglycerol lipase beta"	Q8NCG7	7	6409126-6484190	"Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069377			Supported	"Nucleoplasm,Plasma membrane"		No	No			"Plasma membrane"	Nucleoplasm	"HPA069377: AB_2686132"	"unprognostic (2.39e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (7.18e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-2)"	20.1	28.2	12.6	12.7	20.3	25.8	29.8	18.4	26.1	19.1	18.0	11.4	19.4	15.1	14.3	17.5	16.2	12.5	26.6	18.9	12.4	13.8	24.0	88.0	18.4	25.2	11.6	5.8	22.5	47.0	14.2	19.0	45.7	7.5	14.6	10.6	14.6	34.1	22.3	22.0	22.1	31.3	16.0	13.2	15.1	14.0	27.1	7.9	7.2	23.1	15.1	16.8	15.6	20.8	5.6	18.9	13.6	14.7	2.4	8.4	7.5	10.9	12.5	5.4	7.0	8.2	6.4	4.3	15.4	10.5	13.3	14.4	6.6	12.0	5.9	6.7	7.4	32.5	16.2	8.8	8.1	7.6	2.7	6.1	3.1	14.3	4.5	8.8	8.9	5.0	5.7	13.5	8.9	8.8	5.3	5.7	7.6	8.9	2.9	7.8	7.7	3.1	12.6	19.7	5.4	9.5	27.4	6.2	12.7	8.4	4.0	7.0	4.2	8.7	13.4	2.5	9.0	9.3	16.7	7.0	11.5	21.9	14.4	7.1	3.1	5.6	5.0	5.7	14.0	13.9	6.2	14.7	13.6	4.4	13.9	3.9	5.6	3.5	2.9	18.9	3.6	8.4	4.8	7.3	2.4	12.2	3.2	2.9	7.5	12.6	20.3	18.4	23.4	12.4	13.8	11.6	5.8	7.5	7.9	8.9	13.0	3.9	2.8	14.9	4.2	2.4	2.5	2.7	3.4	5.2	2.0	4.4	0.0	6.2	0.4	6.7	10.9	0.0	5.3	7.7	4.6	4.6	3.5	6.2	14.7	0.0	2.4	8.0	15.4	0.9	5.8	15.3	5.0	11.8	4.7	0.9	9.2	5.8	2.1	1.8	4.5	0.0	5.7	7.2	6.8	11.7	10.4	5.3	6.3	3.2
KDELR2	"ELP-1, ERD2.2"	ENSG00000136240	"KDEL endoplasmic reticulum protein retention receptor 2"	P33947	7	6445953-6484242	"Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Extravillous trophoblasts: 814.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016459	Approved					NA	NA					"HPA016459: AB_1852180"	"unprognostic (2.16e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.77e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (5.40e-5)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (1.85e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.33e-2)"	"unprognostic (5.42e-1)"	"prognostic unfavorable (6.79e-8)"	"unprognostic (7.72e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.71e-2)"	35.9	28.7	11.5	18.7	11.9	6.0	53.7	11.6	13.4	41.2	37.3	17.5	35.6	32.8	30.7	35.6	29.2	25.4	47.7	35.0	12.0	13.8	43.6	158.4	30.3	44.9	14.1	9.3	40.8	85.1	20.0	34.0	76.5	12.3	31.6	41.7	25.5	62.2	40.3	18.3	20.0	56.3	30.2	13.5	26.2	43.7	48.3	13.1	11.6	40.4	26.9	28.8	28.3	36.3	18.6	50.9	29.6	29.8	16.9	26.1	20.6	39.3	17.0	16.9	31.7	82.0	75.9	17.3	59.4	53.1	34.1	51.5	27.3	25.4	6.3	17.0	82.6	51.2	35.3	24.0	24.3	53.1	3.4	14.3	7.6	18.6	37.3	49.9	11.8	10.7	48.1	24.7	33.1	39.5	38.2	30.7	6.1	16.9	18.7	46.1	32.2	3.6	11.0	16.1	50.8	26.6	8.7	26.0	16.1	27.2	16.2	15.6	18.8	24.4	43.4	18.1	26.9	35.9	20.2	26.6	26.1	39.3	63.0	31.4	14.0	11.6	10.8	43.5	22.7	74.6	25.8	28.9	29.6	20.4	29.8	26.1	18.6	21.5	22.3	28.9	16.6	17.6	19.1	19.2	16.9	29.2	50.9	19.4	20.6	11.5	11.9	11.6	13.4	12.0	13.8	14.1	9.3	12.3	13.1	23.8	60.1	62.1	144.5	170.7	27.1	51.3	129.9	29.4	35.2	59.3	11.8	369.6	29.9	196.3	618.8	92.2	203.3	46.7	285.3	814.0	314.5	260.1	69.0	330.7	277.3	30.2	109.8	138.7	77.5	68.7	140.1	111.9	168.7	101.8	375.9	27.8	206.3	206.7	114.5	91.3	29.7	71.1	143.2	369.8	134.3	173.9	635.5	74.6	235.6	207.9
GRID2IP		ENSG00000215045	"Grid2 interacting protein"	A4D2P6	7	6497462-6551436	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 23.6"	"Cell type enhanced"	"Detected in single"	12	"Rod photoreceptor cells: 1.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 23.6"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"REH: 8.9"	"Group enriched"	"Detected in some"	5	"cerebellum: 25.2;thalamus: 7.9"	"Group enriched"	"Detected in all"	5	"cerebellum: 14.3;midbrain: 10.0;pons and medulla: 9.7;thalamus: 14.7"	HPA045381			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA045381: AB_10962495"	"unprognostic (1.77e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.39e-4)"	"unprognostic (1.19e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.06e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.54e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.17e-1)"	0.2	1.7	0.8	0.6	3.6	1.1	1.1	23.6	6.6	0.6	1.4	6.5	0.0	1.8	0.4	0.1	1.2	1.1	0.6	0.3	1.6	1.6	0.7	0.3	1.2	0.5	0.7	1.2	0.9	1.8	3.9	3.0	0.2	5.5	2.3	0.7	0.3	2.1	1.6	0.2	3.4	1.6	0.0	1.5	1.4	2.2	1.2	6.8	2.5	1.6	0.0	0.6	0.9	0.8	0.7	0.2	0.0	0.2	1.1	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.5	0.0	0.7	0.7	0.0	0.2	0.8	0.0	8.9	0.3	0.2	0.2	0.3	0.1	1.1	0.0	0.8	0.0	0.3	2.0	0.2	0.1	0.0	1.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.6	0.4	0.0	0.0	1.1	0.2	0.2	0.0	0.1	0.8	3.6	23.6	6.6	1.6	1.6	0.7	1.2	5.5	6.8	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.1
ZDHHC4	"FLJ10479, ZNF374"	ENSG00000136247	"Zinc finger DHHC-type containing 4"	Q9NPG8	7	6577434-6589374	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032124	Approved					NA	NA					"HPA032124: AB_10610699"	"unprognostic (1.07e-1)"	"prognostic unfavorable (9.35e-4)"	"unprognostic (6.82e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (3.95e-6)"	"unprognostic (9.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.18e-7)"	"unprognostic (8.75e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (8.94e-4)"	17.7	24.3	20.7	13.5	22.0	11.4	23.6	8.2	29.9	20.7	24.9	22.5	18.2	14.0	21.6	26.9	16.1	25.5	18.8	21.9	17.3	19.7	25.7	34.5	17.0	19.7	19.8	17.7	22.7	46.5	27.2	18.7	14.1	20.4	20.0	16.3	28.0	29.8	22.4	34.9	9.5	16.3	22.7	17.1	13.6	23.5	27.0	12.3	18.1	30.5	17.4	16.5	23.3	13.7	17.6	50.6	20.9	14.9	11.9	15.4	12.6	21.7	13.9	5.2	31.0	28.5	21.5	23.7	12.3	3.1	15.1	18.8	17.3	31.3	12.9	19.6	22.7	32.4	20.0	18.2	12.2	15.7	7.7	10.6	14.3	16.6	18.5	25.3	17.0	15.7	22.5	18.0	11.8	0.0	19.2	13.4	25.7	29.3	19.3	20.9	22.8	9.1	16.7	27.1	20.1	12.1	12.6	26.4	19.2	12.0	17.3	12.5	32.0	16.3	6.0	21.4	28.7	20.7	22.4	9.0	17.8	25.9	17.0	17.8	28.6	22.8	29.9	10.7	21.4	24.9	20.9	11.7	18.0	11.5	14.9	12.5	17.6	11.6	12.7	13.2	16.1	15.4	14.7	1.3	11.9	10.8	50.6	10.3	12.6	20.7	22.0	8.2	29.9	17.3	19.7	19.8	17.7	20.4	12.3	35.7	15.3	25.1	40.1	10.1	30.0	3.6	56.0	26.8	31.8	33.2	9.8	58.4	72.9	53.9	2.0	10.8	10.2	0.0	58.4	56.0	26.7	32.7	10.3	38.4	48.4	20.6	31.2	20.9	26.0	2.2	16.7	18.1	20.3	38.7	19.1	45.6	49.0	17.5	30.8	58.5	19.8	12.9	30.9	76.1	50.3	8.2	40.8	22.4	29.3	26.5
C7orf26	MGC2718	ENSG00000146576	"Chromosome 7 open reading frame 26"	Q96N11	7	6590017-6608726	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042899, HPA052175"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli, Intermediate filaments, Cytosol"	"HPA042899: AB_2678218, HPA052175: AB_2681750"	"unprognostic (4.85e-2)"	"unprognostic (6.87e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (6.95e-5)"	"unprognostic (4.72e-2)"	"unprognostic (2.26e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.55e-1)"	19.8	17.1	13.4	21.7	17.7	29.2	20.0	20.6	26.9	19.0	17.9	21.1	21.5	19.4	23.0	15.4	14.7	19.9	15.6	12.8	14.4	14.1	15.4	18.4	19.3	24.1	18.8	20.2	20.6	23.9	17.2	16.6	14.0	15.4	21.1	11.5	16.4	21.2	16.6	18.7	21.9	16.4	19.6	13.1	27.3	18.6	16.8	16.1	31.7	18.3	18.5	20.6	17.6	19.6	4.2	6.4	4.6	3.4	3.3	6.1	1.9	11.1	9.4	6.6	15.4	10.7	6.0	8.7	6.7	5.9	9.7	6.0	8.7	4.7	13.3	8.8	5.0	18.5	12.4	8.7	6.2	4.4	5.1	12.6	4.9	5.9	9.2	12.6	11.8	15.9	6.9	9.3	5.8	6.1	5.2	10.6	14.4	12.9	10.1	5.7	18.8	10.2	24.4	13.0	5.6	12.5	20.9	5.2	11.2	6.3	9.8	8.6	16.0	6.5	21.7	9.0	7.1	9.9	17.8	7.6	8.1	26.6	8.8	14.6	12.3	12.1	12.2	5.4	13.1	23.8	1.1	3.4	4.6	4.7	3.3	6.1	4.1	5.7	6.0	2.6	4.2	5.9	4.9	3.4	3.3	3.3	6.4	5.4	1.9	13.4	17.7	20.6	26.9	14.4	14.1	18.8	20.2	15.4	16.1	8.9	7.5	6.1	8.2	13.5	6.1	5.3	10.2	4.0	5.7	1.8	5.9	10.4	0.0	7.5	5.8	9.3	8.4	0.0	8.8	9.1	9.3	8.5	1.1	6.4	11.6	4.8	12.1	14.7	10.3	3.2	7.5	9.8	6.8	4.6	12.3	6.7	9.2	10.5	8.1	6.3	6.1	6.5	13.2	11.2	13.8	11.2	8.1	14.6	10.2	6.0
ZNF853	DKFZp434J1015	ENSG00000236609	"Zinc finger protein 853"	P0CG23	7	6615617-6624290	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 28.9"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 13.0;Muller glia cells: 10.9;Rod photoreceptor cells: 9.1;Sertoli cells: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 3.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.1;NK-cells: 1.1;T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.8;SH-SY5Y: 22.1;U-2 OS: 14.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067690	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA067690: AB_2685888"	"unprognostic (1.35e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.17e-2)"	"unprognostic (8.77e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.87e-3)"	"unprognostic (9.28e-2)"	"prognostic favorable (2.30e-6)"	"unprognostic (4.41e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.30e-3)"	"unprognostic (4.01e-2)"	3.7	3.9	16.6	2.9	14.4	1.0	4.6	4.5	13.5	7.8	7.7	10.4	2.8	1.8	9.4	5.9	5.6	11.8	5.8	12.3	16.1	15.5	3.3	0.9	4.5	4.3	14.8	9.1	15.6	10.6	7.3	4.5	3.7	11.9	7.6	2.5	6.0	6.7	11.5	28.9	2.4	2.7	8.5	10.1	4.3	3.6	3.0	9.9	2.6	9.9	2.7	2.7	6.5	11.7	0.3	0.4	3.1	0.0	1.1	1.5	0.3	0.0	1.2	3.5	14.8	0.1	0.0	0.1	0.3	0.0	1.6	0.3	2.6	0.6	0.0	5.8	0.0	0.5	0.0	5.3	0.1	1.5	0.0	1.9	0.4	0.0	2.7	2.1	0.0	0.1	0.5	0.5	0.2	0.0	1.5	0.0	1.2	2.2	0.0	0.9	0.1	0.3	1.9	5.5	0.0	0.0	1.6	5.8	0.1	1.1	5.5	4.7	22.1	0.0	0.2	0.9	3.0	0.8	3.1	0.0	1.1	14.8	0.0	1.3	0.3	0.1	0.0	0.0	0.0	5.7	0.0	0.0	3.1	1.2	0.0	1.5	0.3	0.8	1.4	0.0	0.3	0.2	1.4	0.0	1.1	0.0	0.4	0.0	0.3	16.6	14.4	4.5	12.4	16.1	15.5	14.8	9.1	11.9	9.9	0.0	0.0	0.0	1.5	0.5	13.0	8.5	0.0	4.0	1.2	7.0	5.9	0.0	0.0	0.5	1.5	1.5	0.0	0.0	0.6	0.0	2.3	1.1	0.0	0.0	0.1	4.8	1.7	1.8	0.0	1.7	4.9	0.0	3.3	0.0	0.0	10.9	0.4	0.0	8.1	0.2	9.1	12.9	1.4	0.5	0.7	0.3	0.2	0.8	0.0	0.7
ZNF316	"ENST00000305834, MZF-3"	ENSG00000205903	"Zinc finger protein 316"	A6NFI3	7	6637322-6656432	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.74e-1)"	"unprognostic (2.82e-3)"	"unprognostic (9.69e-3)"	"unprognostic (4.56e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.41e-1)"	"unprognostic (7.22e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.21e-3)"	"prognostic favorable (6.03e-5)"	"unprognostic (1.38e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.43e-3)"	7.4	7.1	5.0	8.1	8.7	8.9	8.2	6.0	10.2	7.5	6.4	7.7	7.9	6.0	8.2	10.5	5.3	5.3	7.8	3.4	7.3		4.2	3.3	6.1	7.1	9.4	6.1	7.9	10.0	16.9	5.8	5.0	7.2	5.7	3.7	6.5	5.6	6.9	11.7	8.8	5.6	10.4	5.1	10.6	6.6	8.1	7.9	5.6	8.6	6.3	5.9	5.0	9.3	1.2	2.9	1.4	1.4	2.3	1.4	0.5	12.4	11.1	14.0	13.3	7.5	3.9	8.5	9.9	4.7	4.4	4.6	10.3	9.0	16.7	6.8	7.2	17.6	12.8	6.8	6.7	4.2	5.0	9.3	11.5	16.7	5.8	8.2	14.3	13.2	5.5	7.1	6.8	8.3	9.0	3.8	7.7	21.2	8.4	5.0	20.9	5.3	18.2	7.9	8.6	8.4	9.9	10.7	7.2	4.5	28.4	16.3	26.7	7.2	27.0	8.0	12.5	15.5	15.7	7.0	8.9	17.7	12.6	13.2	18.5	17.0	13.5	7.0	12.0	17.7	0.0	1.2	0.8	0.9	1.4	1.3	1.1	0.9	1.4	0.9	1.2	0.6	0.9	1.4	2.3	0.6	2.9	1.0	0.5											6.0	9.4	1.4	2.7	0.0	12.1	8.5	12.7	2.7	6.8	14.0	9.8	2.9	3.3	4.0	0.6	6.3	5.6	0.0	5.2	1.7	3.7	6.9	1.1	11.4	6.3	17.5	16.0	9.8	11.2	0.4	6.1	4.2	0.0	2.8	10.2	5.6	5.2	5.8	6.7	2.9	7.5	0.0	2.5	2.6	3.1	0.0	1.8	4.4	8.1	4.6
ZNF12	"GIOT-3, KOX3, ZNF325"	ENSG00000164631	"Zinc finger protein 12"	P17014	7	6688433-6706923	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA063402			Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA063402: AB_2685005"	"unprognostic (2.68e-1)"	"unprognostic (6.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.41e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.89e-3)"	"unprognostic (5.52e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.36e-2)"	"unprognostic (8.46e-3)"	16.7	12.1	12.1	15.6	11.7	8.8	17.0	25.4	13.5	18.9	17.7	9.2	16.0	12.2	17.4	17.9	15.1	15.1	11.9	12.6	10.1	9.7	15.6	13.8	12.2	15.1	10.3	12.8	19.6	13.2	25.2	20.0	20.3	10.3	23.9	13.2	8.6	14.7	16.1	9.5	13.8	18.6	12.5	16.1	18.6	12.9	7.5	13.9	21.1	21.9	7.9	16.0	21.9	29.3	2.1	1.9	9.4	0.9	1.9	3.5	0.4	12.0	5.7	11.4	14.3	11.7	12.0	11.0	7.6	13.8	9.8	10.3	7.8	7.0	9.2	5.3	9.4	22.1	14.5	9.4	7.4	15.0	3.5	7.1	9.2	8.6	7.7	11.0	14.6	10.0	13.1	16.6	7.0	11.4	14.6	7.1	7.4	14.6	8.5	12.9	9.5	5.6	13.5	13.8	3.8	8.8	7.4	16.4	5.6	8.0	12.0	10.5	18.6	8.8	16.1	9.2	15.0	10.2	16.7	7.0	11.1	14.0	8.8	10.0	8.1	5.2	9.4	9.0	9.9	14.6	9.4	0.9	1.1	2.5	0.7	3.5	2.0	2.1	2.8	0.9	2.1	2.7	3.4	0.9	1.9	0.8	1.9	1.7	0.4	12.1	11.7	25.4	13.5	10.1	9.7	10.3	12.8	10.3	13.9	8.9	9.9	13.7	14.1	23.9	26.7	16.2	12.7	9.4	10.3	3.5	15.7	9.8	1.7	7.7	0.4	15.5	6.8	23.3	5.7	7.5	14.2	10.8	11.5	9.0	8.4	35.0	7.5	16.0	11.5	0.8	20.8	7.2	5.0	5.4	11.1	19.5	7.5	7.0	21.2	5.7	19.8	25.8	14.4	12.3	6.0	19.6	7.2	6.4	11.5	14.9
RSPH10B2		ENSG00000169402	"Radial spoke head 10 homolog B2"	B2RC85	7	6754109-6799365	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"fallopian tube: 10.7;testis: 19.3"	"Group enriched"	"Detected in some"	7	"Ciliated cells: 84.3;Early spermatids: 26.3;Late spermatids: 46.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;SH-SY5Y: 1.4;U-266/84: 3.3"									HPA049182	Supported					NA	NA					"HPA049182: AB_2680666"	"unprognostic (7.74e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.28e-2)"	"unprognostic (5.35e-3)"	"unprognostic (3.41e-1)"	"unprognostic (3.05e-3)"		"unprognostic (2.58e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.69e-5)"	"unprognostic (1.66e-1)"	"unprognostic (4.38e-2)"	"unprognostic (8.27e-3)"	"unprognostic (7.02e-2)"	0.0	0.0	0.4	0.0	0.9	0.2	0.0	0.1	0.0	0.3	0.0			0.0	0.1	0.3	0.0	10.7	0.0	0.0	0.9	1.0	0.0	0.0	1.3	0.0	0.0		0.0	0.0	2.4	0.5	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	19.3			0.0		0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.1	0.4	0.8	0.0	0.1	2.0	0.1	0.0	0.2	0.0	0.1	0.0	0.8	0.0	0.0	0.5	0.0	1.0	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.2	0.2	0.4	0.0	0.7	0.1	1.0	0.1	0.1	1.1	0.0	0.3	0.0	0.9	0.0	0.3	0.2	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.4	0.4	0.2	0.0	0.3	3.3	0.0	0.4	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	84.3	7.9	0.0	0.0	0.0	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	46.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0
CCZ1B	"C7orf28B, DKFZP586I1023, H_NH0577018.2, MGC19819"	ENSG00000146574	"CCZ1 homolog B, vacuolar protein trafficking and biogenesis associated"	P86790	7	6794134-6826770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045114, HPA050006"	Uncertain		Enhanced	Vesicles		NA	NA			Vesicles		"HPA045114: AB_2679219, HPA050006: AB_2680989"	"unprognostic (8.06e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.74e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.96e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.24e-1)"	2.5	4.5	3.6	2.1	4.4	3.2	4.2	3.8	8.4	2.7	3.5	10.7	2.1	2.6	3.5	7.0	5.7	5.3	3.5	2.6	4.0	3.6	3.0	2.4	3.4	3.7	2.9	2.1	3.0	3.3	11.8	2.6	2.7	9.1	3.0	2.5	5.2	6.6	7.0	10.6	3.4	2.7	2.1	2.7	3.0	3.2	5.4	2.1	3.0	2.5	2.1	3.5	4.3	2.6	4.3	5.6	10.5	9.5	6.1	6.6	1.8	13.0	4.7	9.4	23.4	8.4	8.3	10.4	8.1	12.3	9.9	10.9	5.4	8.6	5.5	9.7	11.7	18.1	8.9	17.7	10.2	11.3	3.3	6.3	3.8	5.7	13.4	8.7	27.5	19.5	5.5	5.5	9.4	4.9	4.8	8.5	17.5	7.3	6.4	9.9	22.3	13.1	12.3	26.2	12.4	8.8	8.2	20.3	6.8	7.3	9.7	14.7	23.5	9.1	17.9	12.1	8.4	14.6	31.6	9.3	2.8	8.8	11.5	17.4	6.5	13.3	4.0	9.1	28.9	16.8	10.5	3.8	6.5	3.8	4.6	4.5	4.3	4.5	5.6	4.8	3.9	3.2	4.2	4.8	6.1	9.5	5.6	6.6	1.8	3.6	4.4	3.8	8.4	4.0	3.6	2.9	2.1	9.1	2.1	6.0	10.1	18.1	7.8	7.4	8.6	6.7	5.1	30.8	11.4	3.5	13.7	8.6	13.3	16.3	2.7	9.2	10.2	0.0	24.7	9.4	10.3	7.4	2.3	6.8	9.4	15.9	17.9	16.0	13.2	2.3	6.6	16.3	13.5	25.2	16.4	11.0	20.1	14.4	9.9	9.0	11.1	19.4	10.0	11.4	8.8	10.9	6.6	13.8	12.5	10.8
C1GALT1	"C1GALT, T-synthase"	ENSG00000106392	"Core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1"	Q9NS00	7	7156934-7248651	"Enzymes, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Syncytiotrophoblasts: 171.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"LHCN-M2: 81.9"	"Low region specificity"	"Detected in all"							"HPA011294, HPA012819"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA		10000	"Nuclear bodies, Cytosol"		"HPA011294: AB_1845623, HPA012819: AB_1845624"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (7.38e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (2.03e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.33e-1)"	11.4	7.7	10.1	12.4	14.1	23.1	11.0	10.6	14.9	13.9	10.7	21.5	4.0	19.3	5.4	7.1	24.7	12.7	16.1	11.6	12.8	10.8	21.5	14.7	10.9	11.7	23.7	8.9	6.2	6.2	42.3	11.0	30.2	19.2	5.7	12.2	8.1	17.6	5.7	8.1	8.6	15.8	5.3	31.0	13.8	15.3	5.4	21.4	12.9	10.6	6.2	11.6	10.3	8.4	15.9	13.5	33.2	26.0	16.6	17.4	12.2	18.9	8.2	2.5	4.3	7.5	15.8	8.8	21.8	16.3	10.2	15.1	5.6	19.7	8.9	5.6	8.6	27.4	6.1	3.7	8.2	16.1	5.3	3.0	8.4	4.9	15.5	8.2	8.8	3.7	12.9	5.8	25.0	19.3	12.8	8.3	8.9	18.0	5.6	81.9	3.2	2.4	4.3	15.9	12.6	8.9	8.0	14.9	5.4	11.5	8.4	3.1	8.2	13.8	15.6	14.8	16.2	4.9	4.5	8.7	16.3	25.3	23.2	8.8	10.7	9.1	10.1	10.8	11.9	18.1	33.2	11.1	31.2	16.1	16.5	16.9	15.9	15.0	17.4	12.2	13.7	15.7	17.0	24.3	16.6	26.0	13.5	13.0	12.2	10.1	14.1	10.6	14.9	12.8	10.8	23.7	8.9	19.2	21.4	38.7	50.4	35.6	14.0	23.4	22.1	22.0	30.6	18.7	21.6	17.4	31.4	79.2	5.0	23.7	13.7	11.7	21.0	0.0	22.7	66.8	16.9	13.7	11.5	19.5	32.6	44.5	15.0	11.6	19.3	12.2	6.1	21.9	21.9	10.0	20.0	23.0	35.5	17.5	6.0	37.2	32.9	6.5	8.9	15.0	29.3	16.9	171.3	29.2	26.5	17.1
COL28A1		ENSG00000215018	"Collagen type XXVIII alpha 1 chain"	Q2UY09	7	7356203-7535853	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	12	"Ciliated cells: 16.0;Cone photoreceptor cells: 17.7"	"Cancer enhanced"	"Detected in many"		"glioma: 4.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 3.3;U-266/70: 14.2;U-266/84: 3.8;WM-115: 6.9"	"Region enriched"	"Detected in single"	8	"olfactory region: 4.5"	"Not detected"	"Not detected"			"HPA043844, HPA060468"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA			"Nucleoplasm, Cytosol"		"HPA043844: AB_2732508, HPA060468: AB_2684288"	"unprognostic (6.28e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.71e-3)"	"unprognostic (1.89e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.61e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.09e-2)"	2.7	3.7	1.0	7.0	1.1	0.3	3.1	2.4	1.6	10.2	11.8	0.6	11.5	1.3	2.9	16.2	14.7	5.5	5.7	7.0	1.3	2.2	2.8	1.9	1.3	1.0	9.8	0.2	2.9	5.8	0.1	12.2	0.5	6.1	5.8	4.7	12.8	19.3	6.2	5.6	2.1	6.6	16.0	7.9	0.3	5.7	3.2	0.2	0.2	1.4	10.2	0.9	8.4	14.2	0.6	0.3	1.6	0.2	2.1	1.0	0.0	2.0	0.0	0.0	0.0	0.2	1.1	0.3	0.1	0.6	0.0	0.0	1.6	0.6	0.3	0.1	0.1	1.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.3	0.1	0.2	0.0	0.3	2.0	0.2	0.3	0.0	0.9	1.2	0.5	0.0	0.1	0.0	3.3	0.1	0.2	0.0	0.1	1.0	0.0	0.5	0.1	0.9	1.0	0.0	0.7	1.8	0.0	14.2	3.8	0.0	0.2	0.8	6.9	0.5	0.1	0.3	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.6	0.4	1.0	1.6	2.1	0.1	0.3	0.0	0.0	1.0	1.1	2.4	1.3	1.3	2.2	9.8	0.2	6.1	0.2	0.0	2.6	0.0	0.1	0.2	4.6	0.8	0.0	16.0	5.7	3.5	17.7	0.3	0.0	0.1	0.8	0.0	0.0	0.0	0.2	0.0	0.5	0.1	1.1	0.0	0.1	4.8	0.0	3.1	0.0	0.8	0.9	0.0	0.0	0.0	0.3	2.4	0.5	2.8	0.7	0.3	4.5	0.0	0.0	0.7	0.0	0.1	0.2	0.0	0.3	0.1
MIOS	"FLJ20323, MIO, Sea4"	ENSG00000164654	"Meiosis regulator for oocyte development"	Q9NXC5	7	7566872-7608929	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 67.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042928, HPA052223"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042928: AB_10795610, HPA052223: AB_2681768"	"unprognostic (8.09e-3)"	"unprognostic (1.25e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (3.42e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.28e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.10e-2)"	"unprognostic (7.67e-3)"	"unprognostic (2.72e-1)"	9.9	7.8	6.7	14.4	9.5	10.3	9.6	11.7	10.3	9.9	7.0	7.3	10.3	5.5	8.8	8.7	17.1	8.1	6.4	8.0	7.3	5.6	12.0	11.2	7.4	13.9	5.7	7.2	9.0	16.2	24.6	14.9	11.0	16.8	14.7	8.7	10.9	12.3	14.3	67.7	15.3	8.9	8.0	8.8	15.2	10.6	11.9	7.8	14.0	6.8	14.6	19.0	9.3	12.2	10.5	8.3	8.9	11.0	6.4	7.5	4.2	18.9	8.5	10.3	12.3	8.1	17.5	8.6	14.9	11.9	9.5	9.6	10.5	7.5	16.8	4.7	8.8	25.6	17.2	10.4	10.9	12.7	6.8	9.1	4.1	10.2	7.0	11.4	18.0	4.7	14.5	13.7	8.5	21.4	9.4	8.5	5.7	20.9	13.8	40.2	13.2	4.0	8.2	20.8	9.6	9.1	12.5	15.7	16.1	8.6	9.7	10.8	17.5	7.9	22.7	8.8	19.8	12.3	16.2	7.4	14.9	16.0	8.2	12.6	12.3	13.5	15.0	13.0	10.5	17.3	0.0	5.9	8.9	5.1	11.0	4.3	10.5	5.5	4.7	8.3	9.5	7.5	5.8	0.6	6.4	5.3	5.0	5.4	4.2	6.7	9.5	11.7	10.3	7.3	5.6	5.7	7.2	16.8	7.8	8.9	11.0	15.3	12.4	10.8	7.9	16.5	10.2	12.0	9.1	7.0	11.8	14.7	14.9	11.0	29.5	6.4	6.3	0.0	15.2	7.3	5.7	25.8	9.2	15.1	13.8	11.1	4.1	6.7	20.9	40.8	5.5	13.5	6.8	5.4	8.1	7.8	11.3	9.0	7.1	8.4	15.6	12.9	6.6	24.4	28.0	16.6	17.7	12.5	9.3	16.5
RPA3	REPA3	ENSG00000106399	"Replication protein A3"	P35244	7	7636518-7718607	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Erythroid cells: 490.6;Proximal tubular cells: 304.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA005708	Approved					NA	NA					"HPA005708: AB_1856411"	"unprognostic (2.06e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.20e-3)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (5.16e-5)"	"unprognostic (5.31e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.24e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.83e-2)"	11.6	21.3	14.7	17.3	20.7	28.5	18.6	11.7	20.9	8.9	18.1	13.1	16.1	11.7	8.7	29.2	16.0	19.3	12.2	14.2	12.9	16.7	26.6	29.2	11.8	25.9	16.2	11.9	10.9	12.1	24.6	23.2	12.3	20.3	10.6	15.3	14.5	11.9	10.9	12.4	9.9	14.5	10.1	15.6	19.0	15.3	18.7	11.3	37.6	20.9	20.3	25.1	11.0	9.7	33.6	26.1	11.0	19.5	11.9	28.7	15.1	39.1	22.1	22.3	23.9	8.4	7.7	15.8	11.0	10.3	17.3	27.7	21.2	35.5	20.1	10.8	8.2	55.9	29.9	14.9	19.8	25.4	9.2	26.1	10.9	28.5	42.6	3.7	22.8	9.2	5.6	7.0	20.0	14.2	8.5	9.7	39.1	26.5	31.1	16.6	58.0	18.6	44.6	35.2	23.8	29.1	22.2	36.5	31.9	12.1	19.3	16.7	20.6	20.4	21.4	11.1	34.2	28.5	24.4	4.4	14.4	40.4	23.5	25.7	24.3	43.4	36.8	21.4	27.2	27.5	6.5	11.1	11.0	15.7	16.9	18.5	31.6	25.8	19.7	13.5	33.6	21.3	21.3	9.6	11.9	19.5	26.1	28.7	15.1	14.7	20.7	11.7	20.9	12.9	16.7	16.2	11.9	20.3	11.3	35.7	42.8	119.1	49.7	35.9	22.0	34.7	61.1	155.2	50.0	68.0	9.8	107.3	232.1	75.5	68.8	30.2	55.1	490.6	92.4	213.1	33.8	33.9	53.1	145.2	111.6	15.9	24.3	36.2	45.7	14.5	36.2	64.8	54.0	79.4	59.1	41.9	65.2	52.4	23.0	304.5	32.3	6.5	33.0	86.3	74.4	30.1	55.4	61.0	67.8	47.7
UMAD1	"RPA3-AS1, RPA3OS"	ENSG00000219545	"UBAP1-MVB12-associated (UMA) domain containing 1"		7	7640711-7968020	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA044806	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044806: AB_10961141"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.08e-3)"	"unprognostic (9.24e-2)"	"unprognostic (6.86e-3)"	"unprognostic (4.87e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.43e-1)"	"prognostic favorable (1.73e-8)"	"unprognostic (6.66e-3)"	"unprognostic (8.34e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.58e-1)"	4.1	8.7	7.0	6.5	8.5	3.8	6.7	6.8	8.8	4.2	6.1	5.3	9.6	7.6	6.2	7.8	4.2	5.0	5.1	6.6	5.5		8.7	7.0	6.6	6.9	7.5	8.3	7.2	18.7	12.5	17.0	4.2	8.1	10.0	5.8	6.1	11.4	11.9	3.5	2.6	8.1	6.3	7.3	5.1	11.6	2.4	6.3	8.6	12.9	3.5	6.3	7.1	8.4	17.0	9.7	27.4	13.0	10.1	22.0	10.9	14.1	10.5	5.4	6.2	7.8	9.2	6.2	8.8	10.1	6.9	10.6	4.4	10.6	7.7	9.3	5.4	28.0	9.2	6.1	8.8	8.7	5.8	4.7	4.2	8.0	5.1	8.7	7.7	9.9	8.7	11.1	10.0	7.7	8.1	4.2	10.2	8.6	23.9	9.1	11.5	7.0	4.2	9.7	9.5	8.8	7.8	12.7	12.3	12.6	6.5	2.2	8.9	12.3	15.9	12.4	16.7	12.4	9.5	4.6	7.1	16.7	13.9	8.8	17.2	18.8	8.9	16.0	11.1	21.8	22.8	9.7	24.6	12.1	12.4	15.0	17.0	17.3	15.1	8.1	16.2	20.5	15.3	27.4	10.1	13.0	9.7	22.0	10.9											23.8	11.0	5.3	24.5	0.0	6.5	10.1	12.7	17.4	18.2	14.0	13.7	14.4	33.2	7.4	6.3	6.0	11.2	0.0	12.8	17.6	9.6	27.0	14.0	8.9	14.4	14.3	5.8	4.9	9.8	2.8	12.4	9.3	0.0	7.2	14.3	11.3	9.3	11.0	7.4	26.2	9.4	25.8	7.4	3.0	4.6	0.0	17.7	10.2	9.9	19.2
GLCCI1	"FAM117C, GIG18, TSSN1"	ENSG00000106415	"Glucocorticoid induced 1"	Q86VQ1	7	7968794-8094272	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 55.7"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 77.4;Bipolar cells: 61.8;Early spermatids: 62.5;Spermatocytes: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 17.7;U-266/70: 41.2;U-698: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001674, HPA005987"	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA001674: AB_1078971, HPA005987: AB_1078970"	"unprognostic (6.12e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.02e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.68e-3)"	"unprognostic (3.57e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.17e-3)"	"unprognostic (3.35e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.09e-1)"	"unprognostic (9.20e-3)"	4.6	4.3	5.6	19.1	12.5	7.6	4.1	26.6	8.0	5.4	4.9	3.4	0.9	5.7	3.4	1.8	3.0	2.8	3.9	2.2	3.7	4.1	3.9	3.8	18.4	13.8	3.1	5.6	5.1	2.3	8.0	6.5	9.3	4.4	3.2	4.7	3.1	6.3	2.0	3.0	7.5	5.6	2.5	3.2	9.2	6.4	14.2	3.7	55.7	20.7	1.9	15.9	7.7	3.3	3.1	2.4	3.7	0.4	4.7	4.5	0.7	2.3	0.3	3.9	0.9	1.2	1.7	0.8	2.0	2.8	1.2	1.1	1.2	0.8	6.5	0.5	1.6	2.0	0.4	3.6	1.1	1.6	3.2	2.8	1.9	5.0	0.8	2.0	3.0	2.8	0.8	1.3	0.8	2.7	2.0	1.0	2.4	7.0	17.7	2.1	1.3	1.4	3.0	9.8	1.0	2.4	6.9	3.0	3.4	1.1	2.7	6.5	12.8	3.1	3.9	0.2	11.1	4.6	7.9	0.9	2.2	1.0	1.9	1.0	41.2	13.1	18.6	2.3	3.2	1.6	3.7	0.1	1.5	2.7	0.4	2.5	1.8	2.8	2.0	0.1	3.1	1.6	1.8	1.2	4.7	0.1	2.4	4.5	0.7	5.6	12.5	26.6	8.0	3.7	4.1	3.1	5.6	4.4	3.7	77.4	34.3	13.7	7.2	9.2	61.8	5.7	0.0	5.3	31.8	7.0	41.2	10.4	1.7	0.7	62.5	3.8	2.4	0.0	1.4	7.5	6.9	15.8	5.7	5.9	10.7	7.9	18.6	6.7	3.5	12.3	7.5	5.2	8.5	0.0	6.2	14.3	2.4	3.5	10.6	1.5	20.5	6.5	6.4	66.0	37.4	11.4	24.0	18.7	3.9	8.0
ICA1	"ICA69, ICAp69"	ENSG00000003147	"Islet cell autoantigen 1"	Q05084	7	8113184-8262687	"Predicted intracellular proteins, Predicted membrane proteins"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 58.6"	"Group enriched"	"Detected in many"	8	"Early spermatids: 546.5;Late spermatids: 690.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"T-reg: 20.8"	"Lineage enriched"	"Detected in many"	8	"T-cells: 20.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 16.3;MCF7: 15.3;OE19: 17.5;RT4: 17.9;SCLC-21H: 25.1;SH-SY5Y: 41.4;SK-BR-3: 19.6;T-47d: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017646, HPA061452"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA017646: AB_1851382, HPA061452: AB_2684525"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.83e-3)"	"unprognostic (9.49e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.54e-1)"	"unprognostic (7.61e-2)"	"unprognostic (3.42e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.62e-1)"	"prognostic favorable (4.23e-8)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.08e-2)"	8.9	6.1	12.6	4.2	15.3	11.7	13.0	19.4	24.2	10.7	13.2	2.5	8.7	7.7	5.5	8.5	5.8	8.1	10.4	25.7	7.7	7.8	9.1	5.3	9.2	6.9	4.8	12.4	1.6	58.6	13.2	13.5	4.6	10.5	13.7	14.3	2.5	21.2	8.3	2.8	7.0	10.4	3.7	2.8	7.6	17.9	16.0	3.2	0.8	8.1	4.1	5.5	9.6	4.1	0.3	1.7	2.4	1.6	0.7	20.8	1.1	0.0	0.3	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.3	16.3	0.1	1.6	0.0	0.3	0.0	0.3	0.7	0.0	0.0	2.5	3.4	0.3	0.0	0.1	2.8	0.5	0.0	1.1	0.0	0.0	0.1	11.9	3.2	9.6	0.0	0.0	15.3	0.1	0.0	3.7	17.5	0.1	0.0	0.0	7.1	7.0	17.9	25.1	41.4	0.0	19.6	0.2	4.4	15.9	5.2	7.0	0.0	0.3	0.0	0.3	5.2	2.4	0.0	0.0	2.2	3.4	0.5	1.6	0.1	0.2	0.5	0.4	0.2	3.9	0.3	1.7	0.3	0.2	0.1	2.4	0.7	0.2	0.4	20.8	1.1	12.6	15.3	19.4	24.2	7.7	7.8	4.8	12.4	10.5	3.2	26.8	16.6	0.8	11.9	18.2	10.0	32.3	20.4	14.7	17.0	21.0	5.9	2.2	36.5	31.7	546.5	36.1	22.9	0.0	65.8	0.7	3.3	58.9	8.1	0.8	19.0	0.0	74.0	36.2	8.3	690.2	6.9	5.8	13.5	9.0	64.9	0.8	53.9	47.2	2.8	7.3	1.6	6.5	4.7	7.5	6.4	7.9	1.8	8.9	33.8	34.2
NXPH1		ENSG00000122584	"Neurexophilin 1"	P58417	7	8433955-8752963	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"adrenal gland: 41.1;brain: 30.1"	"Cell type enhanced"	"Detected in some"	18	"Cardiomyocytes: 1.1;Early spermatids: 4.3;Late spermatids: 1.3;Rod photoreceptor cells: 3.4"	"Group enriched"	"Detected in some"	62	"breast cancer: 2.3;glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Karpas-707: 15.4;WM-115: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in brain"	NA	NA						"unprognostic (2.84e-2)"		"unprognostic (1.30e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.18e-1)"			"unprognostic (1.39e-2)"			"unprognostic (1.46e-4)"	"unprognostic (1.47e-1)"		"unprognostic (3.01e-2)"	"unprognostic (5.32e-1)"		"unprognostic (9.46e-2)"	0.8	41.1	9.6	0.7	9.8	0.7	1.1	3.6	30.1	0.7	0.7	3.0	0.0	0.7	0.7	0.7	0.7	0.7	0.8	0.7	6.5	13.9	0.7	0.7	0.7	0.7	6.2	7.1	0.7	0.7	0.7	1.9	0.7	6.8	0.7	0.7	0.0	1.0	0.7	0.7	0.7	0.7	0.7	3.3	0.7	0.7	0.9	1.9	0.0	0.7	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.4	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	1.3	0.0	0.0	1.6	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	9.8	3.6	11.5	6.5	13.9	6.2	7.1	6.8	1.9	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0
NDUFA4	"CI-9k, MLRQ"	ENSG00000189043	"NDUFA4, mitochondrial complex associated"	O00483	7	10931951-10940256	"Disease related genes, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 149.9;skeletal muscle: 151.6"	"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 3966.4;Distal tubular cells: 3355.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA055323, HPA078265"	Approved		Approved	Mitochondria		NA	NA		18000	Mitochondria		"HPA055323: , HPA078265: "	"unprognostic (1.83e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.85e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.90e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.74e-1)"	"prognostic favorable (4.61e-8)"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.08e-1)"	21.9	22.0	72.8	13.6	55.3	19.8	27.0	33.1	74.4	20.5	18.3	12.0	16.8	25.1	16.9	29.6	15.8	20.2	16.7	149.9	56.1	32.1	46.2	46.7	15.9	13.5	47.6	48.9	17.1	23.7	18.9	5.6	11.4	33.0	23.1	20.4	14.1	36.0	31.1	151.6	12.1	17.3	21.4	26.3	13.6	23.6	7.4	23.2	6.8	20.4	60.1	15.6	15.8	11.6	29.0	41.1	52.8	39.6	21.7	37.5	48.0	11.4	19.7	33.6	38.7	19.1	18.0	15.5	14.5	13.8	13.7	12.1	24.7	31.5	22.4	13.9	20.9	37.5	20.3	22.3	17.3	15.0	11.0	16.3	18.7	23.2	23.0	16.7	25.8	18.5	19.3	17.4	16.7	14.8	26.1	19.0	20.2	27.8	30.5	28.5	22.1	11.5	22.7	36.8	78.1	40.0	15.6	24.0	25.1	34.7	24.9	21.1	21.9	23.1	66.5	13.1	49.0	42.0	31.7	16.6	16.3	22.6	23.4	24.0	18.5	23.6	25.7	22.6	27.9	50.7	52.8	32.5	44.4	23.4	38.6	27.4	29.0	32.7	29.3	41.1	22.0	34.1	29.7	7.4	21.7	39.6	38.5	37.5	48.0	72.8	55.3	33.1	74.4	56.1	32.1	47.6	48.9	33.0	23.2	455.6	386.9	389.1	472.6	361.6	472.0	3966.4	996.2	704.0	533.5	903.7	251.3	756.7	3355.6	748.9	115.7	549.6	532.5	186.9	833.3	599.3	543.2	716.7	552.0	1498.2	844.7	149.4	201.3	748.3	552.8	81.7	457.0	587.9	868.9	625.8	610.1	384.0	636.5	584.4	737.2	2069.7	472.4	329.8	932.8	105.9	274.8	422.2	550.9	350.3	618.2	678.3
PHF14	KIAA0783	ENSG00000106443	"PHD finger protein 14"	O94880	7	10973336-11169630	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000538, HPA017376"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Cytosol"	"HPA000538: AB_1079604, HPA017376: AB_2732420"	"unprognostic (1.16e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.73e-3)"	"unprognostic (7.38e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.66e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.76e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.84e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.33e-1)"	12.5	10.9	25.0	12.4	20.4	6.4	18.4	21.4	23.8	14.0	12.7	10.7	7.2	10.3	17.9	11.0	10.6	12.4	12.6	7.7	24.7	22.1	12.2	14.8	11.3	12.0	18.5	15.5	20.2	9.8	18.4	21.4	11.0	20.0	13.9	14.3	7.1	10.0	11.5	9.3	11.3	10.1	14.9	16.2	12.9	13.3	12.0	14.9	31.5	12.7	7.6	12.9	11.9	10.6	3.9	5.8	1.6	2.0	3.4	4.6	0.8	6.7	14.1	20.7	21.4	7.3	7.1	9.9	5.3	4.5	6.5	7.1	12.5	12.2	26.4	9.8	5.0	14.3	9.5	18.4	6.3	7.1	9.5	7.0	13.0	12.5	16.3	6.7	28.8	12.4	6.4	6.8	7.5	13.8	9.0	9.3	10.4	17.2	9.4	7.7	8.7	11.4	12.8	17.3	28.2	10.1	19.3	13.3	8.3	6.7	13.2	18.5	26.0	8.2	28.0	8.9	15.4	14.9	21.2	8.5	9.0	12.0	5.7	10.3	12.1	20.9	18.5	6.3	24.5	21.1	1.6	2.0	1.2	2.9	1.8	2.3	3.9	3.2	3.7	1.2	3.4	4.6	3.8	0.1	3.4	1.6	5.8	4.1	0.8	25.0	20.4	21.4	23.8	24.7	22.1	18.5	15.5	20.0	14.9	38.7	34.5	48.8	62.8	51.1	77.9	19.4	30.6	36.1	53.4	31.4	55.0	57.8	23.2	78.4	17.7	69.7	43.4	0.0	73.0	66.3	61.3	43.8	56.4	39.4	36.4	74.7	88.5	58.9	35.9	9.5	95.3	36.0	35.4	30.7	59.7	49.5	75.4	42.1	110.0	27.0	64.0	51.8	48.4	133.9	124.4	45.8	33.3	30.5	59.7	46.9
THSD7A	KIAA0960	ENSG00000005108	"Thrombospondin type 1 domain containing 7A"	Q9UPZ6	7	11370357-11832198	"Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 22.5"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 104.8;Cone photoreceptor cells: 106.0;Horizontal cells: 197.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	76	"basophil: 7.5"	"Lineage enriched"	"Detected in single"	76	"granulocytes: 7.5"	"Cell line enhanced"	"Detected in some"		"A549: 9.7;HUVEC TERT2: 6.5;REH: 6.6;SH-SY5Y: 9.9;THP-1: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000923	Supported				"Secreted to blood"	NA	NA		3000000			"HPA000923: AB_1080271"	"unprognostic (3.01e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.88e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.75e-2)"	"prognostic favorable (2.24e-6)"	"unprognostic (2.13e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.33e-2)"	9.6	2.2	4.7	2.1	5.7	0.6	5.2	2.0	7.2	8.4	2.7	1.0	0.9	1.2	8.3	2.7	1.7	4.8	6.2	2.1	3.8	4.7	17.7	2.0	3.0	1.2	4.6	3.6	6.4	1.4	2.6	9.4	22.5	3.5	8.4	2.1	4.4	1.7	5.5	0.9	1.7	1.5	5.9	4.3	2.3	1.7	2.2	1.9	0.0	4.9	2.5	1.1	4.5	6.8	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	9.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	1.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	1.5	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	6.6	0.0	0.0	0.3	0.1	0.7	9.9	0.0	0.3	0.0	1.6	0.1	17.9	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	5.7	2.0	7.2	3.8	4.7	4.6	3.6	3.5	1.9	20.8	8.0	0.0	1.6	2.4	104.8	1.1	22.9	0.0	4.5	52.4	106.0	14.0	6.6	5.5	1.0	31.5	0.0	0.0	1.9	4.9	9.8	2.1	0.0	1.0	2.0	197.0	40.1	21.5	1.9	0.2	22.5	0.8	11.8	0.0	0.0	22.3	4.4	1.5	1.4	8.6	7.4	0.0	1.4	1.7	0.4	2.0	43.4	0.0	0.5	0.6
TMEM106B	"FLJ11273, MGC33727"	ENSG00000106460	"Transmembrane protein 106B"	Q9NUM4	7	12211241-12243367	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Amyotrophic lateral sclerosis, Disease mutation, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058342	Approved		Supported	Endosomes,Lysosomes		NA	NA			"Endosomes, Lysosomes"		"HPA058342: AB_2683684"	"unprognostic (5.29e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.50e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.52e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.70e-1)"	17.1	48.3	16.2	11.4	23.7	6.2	17.0	18.5	29.0	26.0	20.3	19.4	13.5	16.1	24.9	19.7	18.5	19.9	18.0	20.8	15.7	16.2	30.9	33.0	12.9	11.7	20.5	21.2	22.1	18.3	17.5	31.3	35.3	26.8	27.2	22.6	15.2	23.2	24.3	23.9	15.5	18.1	24.8	24.8	13.5	15.5	12.0	21.3	14.7	30.7	14.9	12.4	21.4	17.9	7.6	2.8	8.8	6.3	14.1	19.4	7.3	9.3	22.3	9.0	24.0	21.2	20.6	9.6	13.9	31.8	9.8	12.7	5.5	37.0	3.7	15.7	18.5	18.8	10.8	7.8	9.1	13.4	5.4	7.1	4.6	10.4	6.4	17.0	12.1	6.5	16.5	11.8	7.2	17.1	44.0	15.1	6.8	11.0	11.2	14.7	4.0	2.7	6.9	14.5	12.3	9.0	6.8	7.8	7.3	24.3	9.4	11.6	16.5	14.8	13.6	12.8	13.6	12.3	8.7	14.8	14.2	17.1	12.2	11.9	10.4	18.8	4.3	17.7	5.0	32.5	8.8	4.2	4.8	9.4	4.9	13.5	6.3	11.6	11.1	2.8	7.6	19.4	13.5	2.5	14.1	6.3	0.9	9.7	7.3	16.2	23.7	18.5	29.0	15.7	16.2	20.5	21.2	26.8	21.3	68.5	32.3	22.3	34.8	32.6	52.4	35.3	40.8	36.1	27.3	62.8	43.2	47.5	14.9	96.5	3.0	30.3	45.9	0.0	50.6	29.6	53.1	59.5	13.9	60.6	29.3	62.0	55.3	36.8	27.3	4.1	45.5	20.5	35.4	11.8	40.5	88.3	60.8	51.5	57.3	53.1	45.1	32.3	32.3	41.6	27.5	37.9	113.4	30.2	41.7	40.1
VWDE	FLJ14712	ENSG00000146530	"Von Willebrand factor D and EGF domains"	Q8N2E2	7	12330885-12403941	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pituitary gland: 29.5"	"Cell type enhanced"	"Detected in some"	14	"Basal glandular cells: 1.7;Cardiomyocytes: 4.7;Ciliated cells: 1.4;Glandular cells: 2.2;Urothelial cells: 1.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 10.8;NTERA-2: 5.4;SCLC-21H: 8.7"					"Low region specificity"	"Detected in many"			"HPA026619, HPA036044"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Cytosol	Nucleoplasm	"HPA026619: AB_2671920, HPA036044: AB_2674916"	"unprognostic (6.39e-2)"	"unprognostic (1.65e-3)"	"unprognostic (5.36e-3)"	"unprognostic (1.78e-4)"	"unprognostic (1.39e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.73e-1)"	0.4	0.5	1.6	0.3	2.7	2.3	2.3	0.4	2.3	0.8	0.9	0.0	0.9	0.2	0.7	4.9	0.8	1.5	0.7	4.1	0.8	0.5	0.7	0.5	0.7	0.2	0.4	0.5	0.5	0.9	0.0	29.5	0.3	0.5	1.5	0.3	0.1	5.7	5.5	0.4	0.6	0.6	0.2	0.4	0.5	2.0	0.6	0.0	0.1	6.2	0.0	1.3	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.6	0.0	0.5	0.0	0.3	1.8	0.0	2.1	0.7	0.8	0.4	3.0	0.2	0.0	0.0	0.7	0.4	2.1	2.0	0.6	4.0	2.2	3.5	4.8	0.0	0.0	1.1	2.4	0.1	0.3	0.0	1.2	2.7	0.8	1.2	10.8	0.0	0.0	1.2	0.0	0.0	5.4	0.0	0.6	0.0	0.0	1.6	0.0	1.3	8.7	1.4	0.0	1.7	0.0	1.4	0.0	1.1	0.1	0.0	1.0	0.0	0.9	3.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.9	0.1	1.6	2.7	0.4	2.3	0.8	0.5	0.4	0.5	0.5	0.0	0.0	1.0	0.0	1.7	0.2	0.0	4.7	0.0	1.4	1.2	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.4	0.2	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.0	0.4	1.6
AC013470.2		ENSG00000226690			7	12469621-12542222	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 7.7;epididymis: 6.3;fallopian tube: 10.6"	"Group enriched"	"Detected in some"	16	"Ciliated cells: 42.8;Club cells: 13.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.8;hTCEpi: 3.0;Karpas-707: 2.1;U-266/70: 2.4"															NA	NA						"unprognostic (3.89e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.53e-4)"		"unprognostic (1.14e-3)"	"unprognostic (3.62e-3)"	"unprognostic (7.82e-3)"	"unprognostic (3.61e-1)"	"unprognostic (8.04e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.88e-2)"		"unprognostic (2.67e-1)"	0.1	0.1	0.0	0.0	6.7	0.2	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.7	6.3	0.0	10.6	0.0	0.0	0.0		0.1	0.0	2.5	0.0	0.0	0.0	2.8	0.4	0.0	1.1	0.1	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	1.3	0.7	0.0	0.2	0.0	0.0	0.1	0.0	0.9	0.7	2.3	0.5	0.8	0.4	0.0	0.1	0.2	1.0	0.4	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.2	1.1	0.1	0.2	0.1	0.0	0.2	4.8	0.0	0.0	0.1	0.1	0.0	0.9	0.6	0.0	1.1	0.2	0.1	3.0	0.0	0.0	0.0	0.0	0.1	0.1	2.1	0.0	0.1	0.0	0.2	1.6	0.0	0.0	0.3	0.1	0.4	0.0	0.5	1.2	0.1	0.0	0.3	0.2	1.4	0.2	0.3	0.0	0.5	0.6	0.0	0.0	2.4	0.1	0.0	0.2	0.0	0.0	2.3	0.5	0.3	0.3	0.2	0.4	0.8	0.3	0.3	0.2	0.9	0.4	0.3	1.8	0.8	0.4	0.7	0.3	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.8	13.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SCIN	KIAA1905	ENSG00000006747	Scinderin	Q9Y6U3	7	12570577-12660179	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.3;intestine: 31.7;kidney: 30.3;placenta: 46.0"	"Cell type enhanced"	"Detected in many"	14	"Collecting duct cells: 317.6;Early spermatids: 90.6;Enterocytes: 121.7;Paneth cells: 111.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 38.6;SK-BR-3: 41.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA020518, HPA024264"	Enhanced		Enhanced	"Plasma membrane"		No	No			"Plasma membrane"		"HPA020518: AB_1856619, HPA024264: AB_1856621"	"unprognostic (3.68e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.64e-5)"	"unprognostic (1.31e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (4.26e-8)"	"unprognostic (3.87e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.18e-1)"	4.1	1.0	14.5	2.3	30.3	1.0	0.9	1.5	13.3	1.2	11.2	7.5	1.0	16.2	1.2	0.7	14.5	3.6	2.0	0.5	11.1	4.2	30.3	0.6	3.4	0.6	22.8	2.3	0.8	0.9	1.1	3.1	46.0	20.0	2.3	10.2	0.6	9.0	1.0	0.6	2.5	31.7	1.0	27.9	0.6	12.2	4.3	23.4	0.0	1.0	2.7	8.2	5.5	1.1	4.5	1.5	3.5	1.5	2.1	1.9	0.8	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.1	0.5	0.0	0.0	0.2	0.1	0.1	0.5	0.1	0.0	0.1	0.0	0.1	0.1	8.5	0.2	0.2	0.1	0.6	0.1	2.2	1.3	0.1	0.2	0.0	38.6	1.4	1.7	0.0	0.4	41.8	0.0	0.3	4.4	0.3	0.0	0.1	0.3	0.8	0.1	1.4	0.1	0.1	0.0	0.1	0.1	3.5	1.5	1.0	1.7	1.3	1.5	4.5	1.5	1.4	1.0	2.5	1.6	1.9	2.5	2.1	1.4	1.5	1.0	0.8	14.5	30.3	1.5	13.3	11.1	4.2	22.8	2.3	20.0	23.4	0.0	20.5	0.0	1.3	2.5	0.4	0.8	7.6	22.7	6.8	317.6	0.0	14.0	69.6	0.7	90.6	0.7	121.7	0.0	0.2	3.7	1.3	4.5	38.2	0.0	76.4	0.0	8.7	0.0	0.6	64.0	0.3	3.1	10.1	2.8	36.1	0.5	5.2	111.2	1.1	1.8	2.5	0.0	0.0	3.9	5.4	5.6	55.0	0.0	13.5	7.1
ARL4A	ARL4	ENSG00000122644	"ADP ribosylation factor like GTPase 4A"	P40617	7	12686856-12690934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 71.2"	"Group enriched"	"Detected in all"	6	"Early spermatids: 1213.7;Late spermatids: 2876.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 61.8;K-562: 73.5"	"Low region specificity"	"Detected in all"							HPA064513			Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA064513: AB_2685276"	"unprognostic (8.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.94e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.88e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.56e-2)"	"unprognostic (9.97e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.57e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (9.29e-2)"	"unprognostic (9.42e-3)"	"unprognostic (9.49e-3)"	22.6	3.6	12.3	6.7	6.7	30.8	21.5	3.0	15.8	16.9	19.4	3.2	7.4	11.3	13.6	9.9	23.5	11.0	7.5	7.0	6.0	4.6	5.2	6.6	8.6	9.5	10.3	11.0	5.2	3.5	1.8	5.6	19.2	8.5	12.0	13.7	4.0	39.0	6.8	4.2	34.9	44.6	12.8	6.5	9.5	10.3	71.2	6.7	3.7	8.8	9.2	6.5	10.5	25.0	22.8	7.4	3.3	15.4	6.5	17.6	7.3	10.1	10.9	29.0	61.8	4.7	7.8	0.0	4.1	3.8	6.8	4.1	9.6	7.7	0.0	1.8	5.8	17.5	2.9	6.4	5.3	6.9	2.2	4.8	2.1	14.2	8.9	9.7	8.9	3.8	3.5	21.1	4.0	17.9	4.3	16.3	4.1	73.5	10.0	6.9	4.4	0.4	12.6	10.5	29.7	12.5	0.0	10.1	4.7	9.0	4.9	5.3	5.0	6.9	7.3	1.4	7.8	3.6	7.3	5.6	2.7	9.7	10.3	16.7	4.6	6.0	2.3	7.1	3.7	10.9	3.3	7.8	0.3	6.3	13.0	17.6	21.4	15.0	9.7	7.4	22.8	7.4	6.1	1.1	6.5	15.4	6.6	8.9	7.3	12.3	6.7	3.0	15.8	6.0	4.6	10.3	11.0	8.5	6.7	20.8	20.7	36.3	179.9	301.7	21.4	12.9	40.8	100.4	60.3	19.2	80.5	129.5	23.2	34.7	1213.7	160.4	353.7	23.3	25.7	18.5	63.5	47.1	78.5	18.7	55.4	3.2	60.0	103.2	124.4	2876.1	63.9	134.7	114.7	54.1	63.0	9.4	39.9	112.2	25.1	13.0	114.7	12.9	42.2	236.6	53.4	205.1	371.3	38.3	56.5	52.6
ETV1	ER81	ENSG00000006468	"ETS variant 1"	P50549	7	13891228-13991425	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 90.0;salivary gland: 45.8"	"Cell type enhanced"	"Detected in many"	16	"Alveolar cells type 2: 112.4;Cardiomyocytes: 72.8;Intestinal endocrine cells: 190.4"	"Cancer enhanced"	"Detected in all"		"glioma: 22.5"	"Region enriched"	"Detected in all"	8	"cerebellum: 90.0"	"Cell type enriched"	"Detected in single"	5	"T-reg: 3.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.2;hTERT-RPE1: 25.6;SCLC-21H: 26.3;U-87 MG: 51.8;WM-115: 25.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 418.9"	"HPA068389, HPA077249"		Supported	Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA068389: , HPA077249: AB_2686829"	"unprognostic (2.45e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.64e-7)"	"unprognostic (7.08e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-2)"	2.5	12.4	8.1	1.1	11.7	0.2	4.4	90.0	35.2	1.4	2.4	3.1	0.1	1.2	2.4	1.3	1.5	1.1	9.2	18.0	7.0	4.5	2.1	2.0	14.9	0.7	4.5	6.9	1.0	1.6	11.4	7.4	1.9	8.3	3.1	2.4	0.9	45.8	7.1	0.9	1.5	1.9	2.0	3.5	4.5	1.7	4.5	2.9	0.3	6.5	0.9	4.7	1.8	1.3	0.0	0.0	0.0	0.6	0.0	3.1	0.2	0.0	1.6	11.6	22.2	4.1	12.2	0.0	1.0	3.9	0.6	2.6	0.0	5.3	0.0	1.2	1.8	3.2	0.1	0.4	1.2	1.4	0.3	0.5	0.6	1.0	0.0	2.4	3.8	1.5	3.6	0.0	7.6	0.6	25.6	5.0	0.3	3.4	0.1	4.7	0.0	0.0	0.0	17.5	0.6	11.8	0.0	7.1	0.9	7.9	0.1	26.3	5.1	0.0	0.4	6.3	4.2	0.4	0.1	2.7	2.3	0.7	4.5	4.3	4.0	1.2	0.0	51.8	0.2	25.6	0.0	0.2	0.0	0.1	0.6	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.2	8.1	11.7	90.0	10.9	7.0	4.5	4.5	6.9	8.3	2.9	17.9	112.4	0.0	2.5	0.9	4.2	72.8	38.2	1.4	1.2	3.5	0.0	0.4	5.0	2.7	18.7	5.2	0.0	0.0	0.8	0.3	4.2	0.2	2.3	11.0	2.6	4.8	190.4	1.8	6.0	6.6	1.4	0.8	11.8	0.0	0.7	12.2	0.9	0.0	32.5	2.7	0.4	19.4	8.2	0.5	1.0	1.1	0.2	0.7	1.1	0.3
DGKB	"DAGK2, DGK, DGK-BETA, KIAA0718"	ENSG00000136267	"Diacylglycerol kinase beta"	Q9Y6T7	7	14145049-14974777	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 37.7"	"Cell type enhanced"	"Detected in some"	21	"Bipolar cells: 16.8;Club cells: 3.4;Sertoli cells: 6.5"	"Cancer enriched"	"Detected in single"	11	"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 2.8;fHDF/TERT166: 5.7;hTEC/SVTERT24-B: 2.2;SCLC-21H: 2.9;SH-SY5Y: 2.1;U-266/70: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020321		Supported				NA	NA					"HPA020321: "	"unprognostic (9.89e-2)"	"unprognostic (9.72e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.34e-2)"	"unprognostic (5.91e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-4)"	1.1	5.2	11.5	1.1	37.7	0.8	0.8	1.3	34.0	4.9	1.6	1.4	0.0	0.9	6.1	0.9	1.6	2.7	1.3	1.4	10.5	4.3	2.6	1.1	0.8	0.8	2.2	11.3	0.8	0.9	0.8	1.8	0.7	4.8	1.1	1.7	0.0	0.9	0.9	1.2	0.9	1.2	3.1	3.5	0.8	0.8	0.9	7.9	0.0	0.9	0.0	0.8	1.5	0.6	0.7	0.6	1.3	0.3	0.6	0.5	0.1	0.1	0.0	2.8	0.1	0.0	0.2	0.1	0.0	1.2	0.0	0.3	0.2	0.0	0.1	0.0	5.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.3	0.1	0.0	0.1	0.1	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.4	0.0	0.0	2.9	2.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	1.0	0.0	0.0	7.6	0.0	0.0	0.1	0.1	0.1	0.7	0.3	0.3	0.5	0.2	0.4	0.3	0.5	0.2	0.1	0.7	0.5	0.4	1.3	0.6	0.2	0.6	0.2	0.1	11.5	37.7	1.3	19.1	10.5	4.3	2.2	11.3	4.8	7.9	0.0	0.0	0.0	0.2	0.1	16.8	1.2	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	1.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.2	6.5	1.4	0.2	0.2	0.4	0.0	0.0	0.0	0.3
AGMO	"FLJ16237, TMEM195"	ENSG00000187546	"Alkylglycerol monooxygenase"	Q6ZNB7	7	15200318-15562015	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 41.9;liver: 57.9"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 79.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 15.7"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basophil: 3.6;neutrophil: 3.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.6"	"Cell line enhanced"	"Detected in some"		"HSkMC: 4.1;Karpas-707: 8.7;NTERA-2: 3.9;SCLC-21H: 3.7;TIME: 4.4;WM-115: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA057900			Uncertain	Vesicles		NA	NA			Vesicles		"HPA057900: "	"unprognostic (2.82e-1)"	"unprognostic (9.28e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.44e-4)"	"unprognostic (7.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.61e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.35e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	6.8	0.2	0.8	1.0	1.2	0.1	3.7	0.3	0.5	0.3	16.5	1.1	0.1	4.6	0.3	7.3	0.3	0.3	4.7	0.9	0.7	0.6	5.3	57.9	0.4	0.5	1.1	0.8	0.3	0.3	0.0	0.7	0.4	0.7	0.4	0.3	0.0	0.4	0.1	0.5	0.5	41.9	0.1	1.1	0.3	0.3	1.8	2.0	0.0	0.7	0.1	0.1	1.0	0.4	0.2	0.1	3.6	0.1	0.6	0.1	0.0	0.0	2.5	0.1	2.2	0.2	3.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.1	3.9	0.0	0.0	0.0	0.0	1.3	0.0	0.7	3.7	0.0	0.0	0.0	0.0	2.9	0.0	0.0	4.4	1.5	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	17.2	3.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	3.1	0.6	0.0	0.1	0.0	0.0	0.8	1.2	0.3	0.4	0.7	0.6	1.1	0.8	0.7	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	15.3	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.7	0.1	2.6	0.0	0.0	0.1	0.7	0.0	0.0	79.7	0.1	0.0	1.7	1.3	1.3	0.9	0.0	0.1	3.3	0.0	0.1	0.0	0.6	0.0	0.0	15.2	0.0	6.5	0.2	0.4	2.5	0.0	0.1	0.0	0.6	0.0
MEOX2	"GAX, MOX2"	ENSG00000106511	"Mesenchyme homeobox 2"	P50222	7	15611212-15686812	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 45.3"	"Cell type enhanced"	"Detected in some"	13	"Leydig cells: 37.4;Peritubular cells: 23.7;Sertoli cells: 25.8;Smooth muscle cells: 32.1"	"Cancer enriched"	"Detected in many"	8	"glioma: 15.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AN3-CA: 72.3;U-138 MG: 18.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"pons and medulla: 4.4"	HPA053793	Enhanced					NA	NA					"HPA053793: AB_2682264"	"unprognostic (1.10e-1)"	"unprognostic (4.72e-2)"	"unprognostic (9.82e-3)"	"unprognostic (4.22e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.47e-3)"	"unprognostic (4.44e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.65e-5)"	"unprognostic (3.67e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.46e-4)"	45.3	0.9	0.7	6.0	0.6	0.0	22.7	0.4	0.6	6.9	5.4	0.0	3.9	0.3	8.1	13.3	9.8	3.2	4.4	10.5	0.5	0.8	0.6	1.4	12.0	6.1	0.7	0.0	4.5	1.5	0.9	1.2	33.8	1.5	7.5	1.5	0.6	6.7	3.1	16.5	5.5	2.1	6.3	3.2	0.6	2.3	7.6	0.0	1.1	7.4	19.4	7.0	14.2	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.3	0.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.4	0.6	0.5	0.8	0.7	0.0	1.5	0.0	0.0	0.3	0.0	0.0	7.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	8.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	37.4	0.3	3.3	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	25.8	32.1	0.0	0.2	6.0	0.1	0.0	0.0	0.0
ISPD	"hCG_1745121, IspD, Nip"	ENSG00000214960	"Isoprenoid synthase domain containing"	A4D126	7	16087527-16421322	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	17	"basophil: 10.7"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 10.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 8.5;HEL: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043810, HPA053554"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA043810: AB_10964489, HPA053554: AB_2682185"	"unprognostic (4.65e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.07e-1)"	"prognostic favorable (1.38e-11)"	"unprognostic (4.01e-2)"	"unprognostic (1.78e-4)"	"unprognostic (6.26e-2)"	"unprognostic (2.79e-1)"	3.0	3.8	4.2	1.9	4.5	2.6	3.0	7.7	7.7	3.7	2.9	3.9	3.4	1.8	4.7	2.4	2.0	2.8	3.2	7.1	4.4	4.5	7.0	10.0	2.9	1.5	4.7	3.9	2.7	3.9	3.6	5.7	8.0	4.6	3.5	3.0	5.7	5.5	10.1	4.5	2.6	1.8	3.7	4.9	1.4	10.2	3.9	2.4	1.1	2.6	2.4	1.4	3.2	3.7	0.3	0.4	10.7	0.1	0.4	0.3	0.0	0.3	2.4	1.3	1.9	1.1	1.5	8.5	1.9	1.3	1.6	1.4	2.7	2.2	0.0	4.1	2.7	0.8	3.1	1.4	0.0	2.9	1.0	1.5	11.7	1.5	0.6	1.4	0.9	1.5	2.7	1.2	1.3	0.2	0.8	1.2	1.0	2.8	0.3	4.2	0.5	1.1	1.1	2.2	1.0	0.3	0.0	1.9	0.1	2.8	0.8	2.0	1.3	1.4	2.5	2.5	2.7	1.7	2.6	1.3	2.3	2.1	0.3	2.2	0.2	0.0	0.0	1.9	2.7	2.8	10.7	0.1	0.4	0.3	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.3	0.2	0.6	0.4	0.0	0.4	0.0	0.0	4.2	4.5	7.7	7.7	4.4	4.5	4.7	3.9	4.6	2.4	0.0	2.9	0.0	1.6	0.3	6.0	7.3	0.0	2.7	4.5	3.5	7.9	2.1	1.7	1.0	7.5	2.2	0.4	0.0	0.6	7.9	2.2	2.2	1.1	4.7	0.7	4.8	1.2	4.9	0.3	1.2	1.4	0.0	1.7	0.0	2.0	4.1	2.6	0.0	3.2	5.8	5.8	0.0	0.7	6.6	6.1	0.9	2.4	0.5	1.2	1.7
SOSTDC1	"DAND7, DKFZp564D206, USAG1"	ENSG00000171243	"Sclerostin domain containing 1"	Q6X4U4	7	16461481-16530580	"Predicted secreted proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.1;retina: 74.8;stomach 1: 32.3"	"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 24.9;Horizontal cells: 28.6;Melanocytes: 30.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 25.9"	"Region enriched"	"Detected in many"	9	"pons and medulla: 51.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.5;EFO-21: 11.2;HEL: 4.2;NTERA-2: 4.4;RPTEC TERT1: 20.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 9.4;hippocampal formation: 20.4;pons and medulla: 15.8;thalamus: 12.8"	"Low region specificity"	"Detected in many"			HPA042856			Uncertain	"Nucleoli,Nucleoli rim,Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA			"Golgi apparatus"	"Nucleoli, Nucleoli rim, Vesicles"	"HPA042856: "	"unprognostic (2.08e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.17e-3)"	"unprognostic (5.59e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.41e-2)"	"prognostic favorable (8.69e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.62e-1)"	"prognostic favorable (3.22e-5)"	"unprognostic (7.01e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (8.72e-4)"	0.4	0.4	2.0	1.4	1.9	0.0	9.5	0.5	5.8	2.6	5.9	7.0	0.2	6.1	2.5	2.4	2.7	2.7	0.4	3.7	3.5	1.6	12.8	0.2	22.0	0.1	0.7	5.3	0.6	1.1	0.0	2.9	0.0	51.1	1.1	8.4	74.8	12.5	6.4	0.3	13.7	4.8	0.5	1.0	0.2	32.3	1.9	0.0	0.0	4.7	3.1	4.9	1.0	3.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	11.2	0.0	0.0	0.2	0.4	0.0	0.0	0.1	2.2	4.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.3	0.1	0.0	0.0	0.7	0.8	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.0	1.9	0.5	5.8	3.5	1.6	0.7	5.3	51.1	0.0	0.0	0.0	0.0	4.5	4.9	0.4	1.0	0.0	0.0	3.4	14.0	0.0	0.0	24.9	0.0	14.4	0.2	0.0	0.0	0.0	0.0	2.1	0.8	0.0	0.0	0.0	28.6	2.4	0.6	0.0	9.4	6.6	0.0	30.4	0.0	0.0	15.0	0.2	0.0	2.5	14.4	0.4	0.0	0.4	2.7	0.9	6.4	0.0	0.0	2.1	0.3
LRRC72		ENSG00000205858	"Leucine rich repeat containing 72"	A6NJI9	7	16526880-16581568	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 15.6"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 117.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA020554	Uncertain					NA	NA					"HPA020554: AB_1859508"															"unprognostic (1.58e-2)"			0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0
ANKMY2	"DKFZP564O043, ZMYND20"	ENSG00000106524	"Ankyrin repeat and MYND domain containing 2"	Q8IV38	7	16599776-16645817	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067100			Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA067100: AB_2685777"	"unprognostic (3.07e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.00e-2)"	"prognostic favorable (1.05e-7)"	"unprognostic (5.75e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.85e-2)"	9.6	10.3	14.5	6.6	30.1	10.0	11.8	14.6	28.7	12.4	13.6	9.0	13.3	12.2	10.8	10.4	9.4	13.1	11.1	30.2	18.5	12.7	13.3	8.9	9.4	6.7	12.7	21.2	21.5	9.6	13.2	14.9	7.3	20.4	11.3	14.1	11.8	11.4	16.3	17.3	8.5	13.5	14.4	11.9	8.8	19.1	8.0	7.8	8.9	17.7	7.5	7.1	14.6	11.6	6.7	4.9	18.5	8.9	10.6	10.2	5.2	10.5	9.0	12.3	12.2	11.7	12.3	6.6	12.9	15.8	10.0	15.4	15.0	16.2	2.1	15.1	13.5	20.9	11.1	8.3	4.9	15.0	4.7	5.7	19.1	10.8	6.7	7.6	14.2	7.4	10.6	2.6	10.0	10.1	13.9	9.0	13.0	19.6	3.5	14.1	2.8	6.0	9.9	8.2	32.7	10.7	9.9	11.1	5.1	15.5	9.2	7.8	4.7	8.7	6.4	5.2	12.0	7.6	12.8	5.5	7.7	6.9	17.2	8.8	12.9	9.4	3.3	11.9	11.7	12.3	18.5	3.2	14.3	10.0	4.3	9.6	6.7	8.2	10.2	4.9	6.7	6.9	8.2	2.7	10.6	8.9	4.7	8.3	5.2	14.5	30.1	14.6	28.7	18.5	12.7	12.7	21.2	20.4	7.8	3.0	10.8	3.7	9.1	4.1	13.2	33.4	12.7	40.2	19.4	10.4	5.9	11.7	18.3	5.8	18.4	5.8	14.9	0.0	8.0	9.4	11.8	5.1	5.8	5.0	8.0	7.9	18.5	3.7	4.8	26.3	11.8	5.0	13.5	7.2	14.1	16.0	4.9	10.5	12.7	9.7	18.2	25.8	14.6	3.7	4.1	3.6	14.2	6.2	15.0	5.4
BZW2	"HSPC028, MST017, MSTP017"	ENSG00000136261	"Basic leucine zipper and W2 domains 2"	Q9Y6E2	7	16646131-16706523	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 104.4;skeletal muscle: 89.7"	"Cell type enhanced"	"Detected in many"	12	"Extravillous trophoblasts: 786.3;Syncytiotrophoblasts: 638.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022813, HPA026709"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane, Actin filaments, Cytosol"		"HPA022813: AB_1845511, HPA026709: AB_10600752"	"unprognostic (2.27e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.91e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.08e-3)"	"prognostic unfavorable (7.86e-8)"	"unprognostic (9.13e-3)"	"unprognostic (8.49e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.25e-1)"	10.6	7.2	4.2	7.8	8.5	10.1	13.5	3.4	8.9	7.9	13.6	3.4	22.0	7.7	7.6	7.6	17.9	7.1	6.1	70.8	4.4	2.8	8.4	10.2	8.1	11.4	3.5	5.8	6.4	12.3	1.8	5.7	104.4	2.5	9.8	16.2	13.2	10.1	25.3	89.7	16.8	8.0	16.6	2.8	8.4	15.6	3.5	3.4	14.5	13.6	41.1	11.1	16.8	10.3	17.2	37.3	1.7	20.3	20.1	23.6	16.3	17.0	16.5	28.1	40.6	13.8	24.4	25.2	24.3	32.0	24.1	25.6	40.0	25.9	39.7	29.0	18.8	17.6	35.5	33.1	27.8	31.9	5.3	19.1	24.8	18.7	22.5	14.3	33.8	15.6	18.7	15.1	21.0	38.8	18.7	34.3	29.2	47.3	8.6	19.5	20.0	17.1	39.2	28.7	50.3	34.2	20.6	18.4	41.8	22.8	31.1	36.0	21.2	9.6	85.9	12.8	33.8	37.8	29.4	19.5	19.1	24.1	28.0	26.8	16.5	17.2	56.0	9.3	42.6	68.2	0.9	17.4	1.7	11.0	20.3	17.9	17.2	16.1	14.9	37.3	15.8	23.6	19.5	0.7	20.1	14.5	14.4	11.9	16.3	4.2	8.5	3.4	8.9	4.4	2.8	3.5	5.8	2.5	3.4	20.8	55.0	24.4	57.3	51.2	48.9	247.1	10.2	32.1	46.6	45.4	60.9	187.5	49.7	33.5	5.3	35.0	23.9	0.0	56.6	786.3	42.5	23.4	20.7	12.2	59.0	6.4	29.3	9.8	28.9	4.8	11.2	28.7	23.6	49.5	35.3	13.3	39.9	31.7	9.2	14.7	83.3	6.5	31.1	4.7	3.8	45.0	638.0	16.2	80.3	79.3
TSPAN13	"NET-6, TM4SF13"	ENSG00000106537	"Tetraspanin 13"	O95857	7	16753535-16784536	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 461.6;Mucus-secreting cells: 362.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 24.7;plasmacytoid DC: 51.3"	"Group enriched"	"Detected in many"	41	"B-cells: 24.7;dendritic cells: 51.3"	"Cell line enhanced"	"Detected in many"		"OE19: 74.3;SCLC-21H: 34.3;SK-BR-3: 49.6;T-47d: 92.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007426	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA007426: AB_10603137"	"unprognostic (3.22e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (3.56e-5)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (5.69e-2)"	"unprognostic (6.63e-2)"	"prognostic favorable (2.20e-4)"	"unprognostic (1.50e-1)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-1)"	20.8	24.2	17.7	7.6	24.9	6.2	25.6	10.7	33.0	18.6	23.6	3.0	21.0	25.2	5.9	12.3	8.8	5.7	16.0	6.8	14.5	21.7	3.3	22.2	53.4	14.8	12.0	15.9	2.1	55.2	4.6	48.0	19.0	14.0	15.1	29.1	8.5	49.1	19.2	4.1	4.7	27.8	5.9	3.6	12.9	31.3	3.1	3.4	3.6	13.0	7.1	18.5	12.1	10.6	24.7	51.3	0.9	0.0	0.8	0.0	1.2	7.1	5.9	7.6	8.0	0.9	0.0	2.1	15.4	2.5	0.4	0.7	20.8	11.1	0.2	3.9	5.5	1.9	11.1	8.7	12.9	3.4	0.2	9.4	3.0	2.4	2.2	2.1	0.2	0.6	0.9	5.6	0.8	0.9	4.4	4.7	3.2	10.0	0.0	0.4	20.4	0.4	0.4	5.3	74.3	7.2	8.2	0.0	7.4	24.0	13.6	34.3	5.2	2.8	49.6	0.7	11.3	92.8	0.8	0.4	0.2	2.7	0.2	5.0	4.5	0.1	0.1	7.1	0.1	10.8	0.1	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.2	24.7	0.0	0.0	0.9	0.8	0.0	51.3	0.0	1.2	17.7	24.9	10.7	33.0	14.5	21.7	12.0	15.9	14.0	3.4	461.6	65.1	58.0	67.1	37.8	65.4	15.8	38.2	25.4	58.0	27.9	7.9	258.0	6.6	62.2	1.0	52.8	83.8	46.7	178.4	88.6	42.3	128.5	9.2	25.9	34.7	14.3	103.4	9.8	15.8	1.8	0.6	4.3	30.4	105.6	362.8	2.3	99.4	94.7	0.7	0.7	7.4	32.3	10.8	0.7	16.8	34.6	168.2	8.7	117.0	107.7
AGR2	"AG2, HAG-2, PDIA17, XAG-2"	ENSG00000106541	"Anterior gradient 2, protein disulphide isomerase family member"	O95994	7	16791811-16833433	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 160.2;gallbladder: 147.0;seminal vesicle: 159.4"	"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 1045.3;Mucus-secreting cells: 2788.2;Paneth cells: 1013.4;Undifferentiated cells: 1404.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"OE19: 672.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA007912	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		22000	"Endoplasmic reticulum"		"HPA007912: AB_1844879"	"unprognostic (6.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (8.79e-5)"	"unprognostic (6.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.22e-3)"	0.9	0.9	0.9	23.0	0.9	0.0	5.3	0.9	0.9	52.8	58.8	1.3	160.2	36.5	4.8	51.9	4.0	23.7	147.0	0.9	0.9	0.9	3.3	0.9	19.0	0.0	0.8	0.0	4.0	59.2	0.0	11.3	1.6	0.1	18.8	97.7	0.0	70.0	159.4	0.9	1.1	62.2	3.3	0.8	0.9	107.6	0.9	0.0	0.1	1.1	20.0	97.7	13.2	3.7	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.3	0.0	0.0	0.0	0.2	0.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	672.3	5.3	0.0	0.0	0.1	21.3	12.6	0.0	0.0	0.0	3.4	0.0	0.0	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.9	0.9	0.9	0.9	0.9	0.8	0.0	0.1	0.0	47.6	221.9	2.2	104.9	2.5	0.0	0.0	351.6	1045.3	577.8	76.8	0.0	4.6	0.0	37.7	2.8	0.1	824.5	0.0	764.4	3.5	4.2	606.7	44.8	0.6	180.1	0.0	501.7	0.0	0.6	0.0	0.3	2.7	3.3	1.8	2788.2	0.0	180.9	1013.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	2.7	0.7	1404.9	754.7
AGR3	"BCMP11, hAG-3, HAG3, PDIA18"	ENSG00000173467	"Anterior gradient 3, protein disulphide isomerase family member"	Q8TD06	7	16859405-16881987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 40.5;intestine: 99.1"	"Cell type enhanced"	"Detected in many"	14	"Ciliated cells: 1287.5;Club cells: 422.0;Enterocytes: 526.8;Mucus-secreting cells: 499.0;Paneth cells: 524.0"	"Cancer enhanced"	"Detected in many"		"breast cancer: 104.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"OE19: 27.2;T-47d: 86.4"	"Region enriched"	"Detected in single"	5	"olfactory region: 5.6"					HPA053942	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA		31000	"Endoplasmic reticulum"	Vesicles	"HPA053942: AB_2682317"	"unprognostic (2.18e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.59e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.08e-2)"		"unprognostic (1.49e-1)"		"unprognostic (1.46e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.96e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.57e-1)"	0.6	0.0	0.6	7.5	0.7	0.0	13.1	0.7	0.6	4.4	45.8	0.6	0.6	29.2	1.2	5.4	0.9	40.5	11.8	0.6	0.6	0.3	1.5	0.6	26.3	0.6	0.6	0.6	5.1	1.9	0.0	12.9	2.8	1.9	1.1	38.9	0.6	9.4	0.6	0.6	0.3	99.1	1.2	0.8	0.6	17.1	1.0	0.6	0.6	1.4	1.9	3.9	4.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	27.2	0.0	0.0	0.0	0.5	2.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	86.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.7	0.6	0.6	0.3	0.6	0.6	1.9	0.6	309.7	310.7	0.0	9.4	2.4	0.0	0.0	35.7	1287.5	422.0	27.9	0.0	1.4	1.7	20.8	0.0	0.0	526.8	0.0	65.4	1.2	0.2	4.4	19.7	0.0	0.5	0.0	108.2	0.0	0.0	0.0	0.3	0.7	0.0	1.0	499.0	0.0	10.6	524.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.5	1.8	0.0	345.5	94.0
AHR	bHLHe76	ENSG00000106546	"Aryl hydrocarbon receptor"	P35869	7	16916359-17346152	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Cancer-related genes, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 69.6"	"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 140.0;granulocytes: 130.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 28.0;hTERT-HME1: 29.2;RT4: 24.0"									"CAB005072, HPA029722, HPA029723"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB005072: AB_633731, HPA029722: AB_10599189, HPA029723: AB_10599025"	"unprognostic (1.29e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.32e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.53e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.25e-2)"	"unprognostic (9.45e-2)"	23.1	12.2	2.5	13.2	3.5	19.8	19.1	1.6	3.5	14.6	14.0	5.7	8.7	8.5	11.9	10.1	14.2	11.2	22.2	14.8	3.2	2.2	7.3	23.9	26.4	20.0	6.5	2.5	21.3	6.8	4.5	3.8	69.6	3.7	21.4	8.9	10.9	11.1	8.5	5.2	16.6	13.7	12.1	4.8	15.6	13.3	6.8	4.0	7.1	12.4	7.9	12.3	26.7	26.6	1.1	9.3	5.6	7.6	3.1	2.9	2.0	3.0	2.5	1.0	0.0	7.7	5.3	0.4	6.3	9.1	2.9	4.3	3.0	6.8	0.0	1.9	9.2	11.6	8.4	0.6	5.7	7.7	0.1	1.4	1.8	3.2	2.7	14.3	3.0	4.5	7.2	28.0	11.1	29.2	13.3	9.7	0.0	0.2	0.0	13.2	1.5	0.0	4.8	0.8	23.0	4.0	0.0	0.0	0.1	9.3	24.0	0.9	0.0	4.7	5.1	4.6	7.7	3.6	1.0	1.6	1.2	0.0	15.9	0.0	1.3	0.0	0.0	20.4	11.7	20.0	0.7	7.6	5.6	0.7	3.6	1.1	0.8	2.6	1.4	9.3	1.1	1.5	1.1	0.8	3.1	1.3	2.2	2.9	2.0	2.5	3.5	1.6	3.5	3.2	2.2	6.5	2.5	3.7	4.0	140.0	72.8	9.4	40.0	66.9	34.6	12.9	43.3	42.8	75.1	7.0	7.9	3.1	0.0	15.8	4.8	55.4	13.6	0.0	13.4	1.2	31.0	42.7	130.4	40.0	24.3	41.3	5.2	44.2	75.1	2.4	3.4	73.2	67.4	36.9	10.6	0.5	24.6	16.9	2.5	5.6	5.7	6.5	41.1	2.4	2.3	78.0	18.0	7.5	12.6	90.1
AC019117.3		ENSG00000283321			7	17299295-17467234	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"cervix, uterine: 9.9;urinary bladder: 21.3"	"Group enriched"	"Detected in some"	7	"Ciliated cells: 5.3;Club cells: 13.6"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 35.1"									HPA029722	Uncertain					NA	NA					"HPA029722: AB_10599189"																		2.8	0.1	0.0	1.5	0.0	0.6	1.3	0.0	2.2	9.9	0.9	0.0	0.5	0.3	1.7	0.8	1.3	2.2	1.6	0.7	0.0		1.0	1.8	2.5	4.8	0.0	0.0	1.1	4.1	0.0	0.0	3.3	0.4	1.6	0.3	0.7	0.8	3.9	0.0	0.5	0.1	4.8	1.3	1.8	1.1	0.4	0.3	0.3	0.6	2.4	1.3	21.3	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	35.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	7.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	5.3	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SNX13	"KIAA0713, RGS-PX1"	ENSG00000071189	"Sorting nexin 13"	Q9Y5W8	7	17790761-17940501	"Predicted membrane proteins"	"Protein transport, Transport"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 264.8;Late spermatids: 161.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (7.26e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.02e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.58e-2)"	"prognostic favorable (5.98e-6)"	"unprognostic (8.12e-2)"	"unprognostic (6.96e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.46e-1)"	22.4	22.8	20.4	18.0	22.7	7.7	22.5	23.4	29.1	22.0	22.2	19.1	20.3	17.0	24.2	23.6	16.2	18.0	16.5	21.3	20.1	19.0	24.4	15.5	19.8	17.7	19.4	18.3	25.5	20.6	36.2	31.2	26.4	25.1	23.9	24.4	15.1	22.4	18.6	28.2	17.7	18.3	20.7	24.9	17.7	19.5	16.2	21.1	21.8	30.2	15.2	12.6	20.0	22.8	2.6	2.5	5.9	4.5	2.5	3.6	1.5	6.8	3.2	6.3	8.2	16.9	16.4	7.4	6.9	11.0	5.6	6.7	2.8	7.1	7.6	4.7	7.8	12.0	7.5	4.8	6.4	9.2	1.4	5.6	2.7	6.5	3.7	10.6	6.5	5.1	11.7	12.2	5.3	9.0	11.3	8.0	5.4	5.8	6.4	10.0	3.2	4.7	8.4	5.9	8.9	5.8	3.5	6.5	4.0	12.1	10.7	5.4	5.7	6.4	14.9	6.1	13.0	7.9	11.4	7.3	8.7	4.2	11.5	8.1	12.9	4.8	6.0	12.3	4.5	12.4	2.6	2.8	3.5	2.2	4.5	3.6	2.6	2.0	1.6	2.5	1.9	2.8	2.3	5.9	2.5	3.4	1.6	1.3	1.5	20.4	22.7	23.4	29.1	20.1	19.0	19.4	18.3	25.1	21.1	20.8	30.9	14.9	12.0	9.4	18.7	37.1	10.2	28.1	33.0	12.2	41.2	27.2	11.6	10.3	264.8	19.1	21.2	23.3	11.2	12.1	17.3	18.7	18.5	13.0	20.1	15.9	19.0	37.4	22.0	161.7	21.9	22.6	5.0	13.6	14.0	18.4	10.7	25.9	16.6	16.5	23.1	25.8	18.6	31.3	19.6	10.5	42.9	10.0	13.5	14.6
PRPS1L1	"PRPS3, PRPSL"	ENSG00000229937	"Phosphoribosyl pyrophosphate synthetase 1-like 1"	P21108	7	18026774-18027863	"Enzymes, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"testis: 38.4"	"Group enriched"	"Detected in some"	8	"Early spermatids: 39.0;Spermatocytes: 72.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.3;K-562: 2.1"									HPA051269			Uncertain	Vesicles		NA	NA			Vesicles		"HPA051269: "					"unprognostic (2.39e-2)"									"unprognostic (3.18e-2)"	"unprognostic (1.11e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.7	0.3	0.6	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.4	0.3	0.6	0.8	0.9	0.5	0.1	0.4	1.1	0.7	0.1	0.6	0.1	0.4	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	6.5	0.0	72.2	1.3	0.0	0.0	0.0	0.0	0.0
HDAC9	"HD7, HDAC, HDAC7B, KIAA0744, MITR"	ENSG00000048052	"Histone deacetylase 9"	Q9UKV0	7	18086949-19002416	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 197.2;Late spermatids: 49.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 29.5"	"Group enriched"	"Detected in many"	9	"B-cells: 21.8;dendritic cells: 29.5;monocytes: 9.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 55.1;hTERT-HME1: 26.4;SH-SY5Y: 22.0;U-698: 21.8;WM-115: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028926	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028926: AB_10602327"	"unprognostic (2.06e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.01e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	10.7	13.5	12.6	10.7	16.2	5.9	8.4	19.1	16.9	11.6	7.4	11.3	7.5	3.8	17.8	6.7	4.7	10.5	7.5	14.9	13.1	12.0	3.9	3.1	5.7	18.9	13.9	14.9	3.0	2.7	3.0	17.7	6.8	11.2	12.5	6.2	9.7	6.9	16.5	15.5	3.8	8.4	14.4	17.6	17.4	9.1	8.7	18.2	2.9	5.5	5.4	19.3	7.1	9.6	21.8	29.5	0.5	9.7	2.0	2.1	4.5	12.5	0.0	2.1	0.0	0.3	2.8	0.0	0.7	7.4	3.1	5.3	0.1	4.1	5.4	13.9	8.3	17.1	1.9	55.1	1.0	8.1	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	1.0	1.0	9.8	26.4	2.7	0.1	0.8	0.0	8.4	4.3	0.0	0.5	1.1	6.7	0.0	1.2	1.5	0.8	3.1	1.7	3.3	3.9	22.0	0.1	0.1	4.0	3.3	0.2	4.9	0.5	11.4	3.6	0.6	7.1	9.7	4.1	21.8	3.0	0.5	22.5	0.1	9.7	0.0	1.7	6.7	1.7	21.8	0.6	0.8	29.5	16.3	0.0	0.9	0.5	2.0	3.8	6.4	2.1	4.5	12.6	16.2	19.1	16.9	13.1	12.0	13.9	14.9	11.2	18.2	6.0	3.2	26.4	0.4	2.2	32.0	12.1	0.0	1.4	4.5	0.0	15.7	0.1	3.3	6.6	197.2	11.1	0.0	0.0	0.6	0.1	5.7	1.4	1.1	0.8	10.5	19.1	6.9	13.5	45.7	49.8	1.4	31.1	15.1	0.0	0.4	5.0	7.0	0.2	0.7	0.0	27.3	6.5	6.9	10.3	8.8	1.8	0.1	8.7	0.0	2.0
TWIST1	"ACS3, bHLHa38, BPES2, BPES3, CRS, CRS1, H-twist, SCS, TWIST"	ENSG00000122691	"Twist family bHLH transcription factor 1"	Q15672	7	19020991-19117672	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 50.0;placenta: 45.6"	"Group enriched"	"Detected in some"	6	"Basal keratinocytes: 11.1;Fibroblasts: 17.6;Melanocytes: 11.8;Smooth muscle cells: 9.8;Suprabasal keratinocytes: 7.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	6	"SH-SY5Y: 75.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"									NA	NA						"unprognostic (4.58e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.29e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.51e-3)"	"unprognostic (5.91e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.69e-1)"	"unprognostic (1.29e-9)"	"unprognostic (8.55e-3)"	"unprognostic (1.54e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.97e-2)"	19.9	5.1	0.6	2.6	0.6	0.1	50.0	0.4	1.2	4.6	3.3	0.5	1.4	0.2	19.6	4.0	7.0	2.2	7.5	3.3	0.6	0.4	0.7	0.3	0.4	2.8	0.7	1.1	6.2	0.4	0.2	5.3	45.6	1.6	7.6	0.6	2.2	6.4	1.0	3.5	12.0	0.4	11.3	1.0	0.1	4.5	3.6	0.5	0.0	2.8	8.6	5.3	12.6	11.4	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.4	0.5	2.5	0.0	13.1	5.4	0.0	10.7	5.0	8.2	10.9	0.0	0.0	0.0	1.1	8.8	2.0	0.0	1.0	0.8	5.5	2.3	2.8	0.0	1.1	0.0	7.8	2.7	0.0	13.0	2.8	1.7	4.5	2.5	0.0	0.1	0.0	0.0	8.7	0.0	0.0	0.1	1.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	4.5	75.7	1.7	0.0	2.1	1.7	0.2	3.4	0.0	10.2	0.0	8.0	1.8	0.0	0.0	0.0	5.6	0.0	12.8	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.6	0.4	1.2	0.6	0.4	0.7	1.1	1.6	0.5	0.0	0.0	0.0	0.2	11.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.1	0.8	0.0	0.0	0.0	0.1	17.6	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.0	1.2	11.8	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.3	0.0	9.8	0.5	0.9	7.4	1.1	0.0	0.0	0.3
FERD3L	"bHLHa31, N-TWIST, NATO3"	ENSG00000146618	"Fer3 like bHLH transcription factor"	Q96RJ6	7	19144782-19145421	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 2.7;pituitary gland: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	160	"SCLC-21H: 15.9"	"Region enhanced"	"Detected in some"		"thalamus: 1.0"	"Region enriched"	"Detected in many"	18	"midbrain: 34.7"	HPA043494	Uncertain					NA	NA					"HPA043494: AB_10964193"																		0.3	0.4	1.4	0.0	0.1	0.0	0.5	0.0	2.7	0.2	0.0	2.2	0.0	0.0	0.5	0.0	0.4	0.2	0.0	0.9	1.1	1.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.4	1.3	1.4	0.1	0.2	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	1.8	1.1	1.5	1.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TWISTNB		ENSG00000105849	"TWIST neighbor"	Q3B726	7	19695462-19709087	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019071, HPA022416"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA019071: AB_1858465, HPA022416: AB_1858466"	"unprognostic (5.66e-3)"	"unprognostic (3.43e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (1.16e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.02e-2)"	"unprognostic (4.93e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.96e-1)"	16.4	13.9	11.5	13.6	17.6	21.5	15.8	13.2	20.8	16.1	14.0	9.9	12.3	8.5	20.4	9.4	14.8	14.3	9.7	14.6	13.5	12.5	13.3	15.9	9.9	16.6	13.1	11.7	17.5	12.6	15.4	12.0	16.4	13.5	15.3	11.0	6.4	11.4	14.5	25.5	13.8	11.4	22.7	13.4	17.7	12.4	10.8	11.3	20.8	13.6	14.1	18.8	20.2	14.4	10.8	7.7	3.5	5.0	14.6	11.6	5.0	11.7	9.0	6.6	9.9	7.8	9.6	5.2	6.8	5.1	8.0	9.3	7.3	10.4	13.2	19.9	8.4	10.1	10.7	13.5	12.7	14.9	4.1	10.4	12.2	7.2	5.6	11.9	24.9	8.9	8.7	9.0	8.7	10.5	5.4	13.0	9.3	18.8	11.9	11.4	4.3	13.7	23.3	17.3	12.3	10.2	11.2	11.5	13.9	13.1	6.1	4.8	7.3	6.2	16.9	8.4	11.4	6.8	22.4	10.8	16.6	8.9	15.3	16.4	15.3	9.4	33.6	11.2	37.5	24.2	3.5	3.9	1.1	7.2	5.0	10.8	10.8	8.6	9.5	6.0	10.4	10.0	11.6	0.3	14.6	4.7	7.7	7.8	5.0	11.5	17.6	13.2	20.8	13.5	12.5	13.1	11.7	13.5	11.3	14.9	23.5	21.4	59.8	110.2	25.7	20.1	10.2	24.1	37.5	8.7	11.8	32.6	36.5	21.9	4.1	30.8	6.3	23.3	23.7	26.9	40.3	29.1	118.6	27.1	30.4	31.8	23.4	29.4	15.2	2.5	29.7	41.4	59.1	25.2	16.5	19.0	19.5	14.0	32.9	24.5	12.1	19.4	57.7	25.0	44.7	125.0	13.8	37.3	21.5	43.6
TMEM196	MGC42090	ENSG00000173452	"Transmembrane protein 196"	Q5HYL7	7	19719310-19773598	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 15.0;pituitary gland: 12.6"	"Cell type enriched"	"Detected in some"	10	"Bipolar cells: 51.1"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"ASC diff: 8.8;ASC TERT1: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043163	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA043163: AB_10794772"					"unprognostic (6.08e-3)"					"unprognostic (1.88e-2)"	"unprognostic (2.14e-2)"		"unprognostic (9.30e-2)"	"unprognostic (5.63e-2)"				0.7	3.7	8.0	0.6	8.6	0.4	0.4	0.3	15.0	1.2	0.6	0.3	0.0	0.4	3.8	1.5	0.5	1.2	0.4	0.4	3.6	10.1	0.6	0.4	0.4	0.4	2.9	7.4	0.4	3.0	0.7	12.6	0.4	5.0	0.5	0.5	0.5	0.4	0.4	0.4	0.4	0.4	1.0	1.4	0.4	2.6	0.5	2.8	0.0	0.4	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	8.8	8.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	8.6	0.3	7.3	3.6	10.1	2.9	7.4	5.0	2.8	0.0	0.0	0.0	0.0	0.0	51.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.8	0.4	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MACC1	"7A5, SH3BP4L"	ENSG00000183742	"MACC1, MET transcriptional regulator"	Q6ZN28	7	20134655-20217404	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 29.5;kidney: 23.9"	"Cell type enhanced"	"Detected in many"	11	"Club cells: 103.5;Pancreatic endocrine cells: 96.6;Urothelial cells: 233.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 41.3;CAPAN-2: 9.7;HaCaT: 29.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA020081, HPA020103, HPA029476, CAB068194"	Supported		Approved	Mitochondria		NA	NA			Mitochondria		"CAB068194: AB_2665682, HPA020081: AB_1844386, HPA020103: AB_1844387, HPA029476: AB_10610136"	"unprognostic (1.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (2.26e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (5.71e-9)"	"unprognostic (4.49e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.93e-3)"	4.8	2.6	0.5	5.6	0.4	0.7	4.5	0.4	0.5	8.3	13.7	0.0	4.4	10.1	0.7	6.1	14.1	0.9	9.6	0.5	0.5	0.5	23.9	1.0	13.3	1.1	0.4	0.0	1.3	11.3	0.1	4.0	1.6	0.1	3.9	3.3	0.1	11.4	6.0	0.5	4.5	29.5	0.1	0.8	6.0	5.0	0.8	0.0	1.7	1.5	16.0	13.6	4.0	5.1	2.3	1.0	1.4	1.0	0.8	0.6	0.5	41.3	0.1	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	9.2	9.7	5.8	0.4	0.0	0.0	29.1	0.1	0.4	0.0	0.0	0.1	5.5	0.1	0.0	0.0	2.3	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	5.9	2.8	0.0	3.4	0.0	0.5	0.4	8.1	0.0	0.0	0.3	4.4	7.3	2.8	0.1	0.2	0.0	3.3	0.0	0.2	1.7	0.1	0.1	0.1	0.0	0.0	0.1	8.9	0.4	2.2	0.0	0.3	0.0	1.0	0.6	0.3	0.3	0.7	0.6	2.3	0.2	0.5	0.3	2.0	0.3	0.3	1.4	0.8	1.0	1.0	0.2	0.5	0.5	0.4	0.4	0.5	0.5	0.5	0.4	0.0	0.1	0.0	65.5	63.4	1.4	71.9	2.5	2.1	0.6	22.9	58.9	103.5	38.4	2.0	0.5	6.6	49.2	2.2	0.7	25.7	0.0	55.2	0.1	2.3	64.3	11.6	1.0	4.6	1.6	37.1	3.7	2.4	0.8	2.0	4.4	1.7	13.6	15.0	0.5	96.6	14.0	2.5	12.9	1.0	0.0	0.4	0.2	0.4	3.4	0.2	3.9	13.3	233.0
ITGB8		ENSG00000105855	"Integrin subunit beta 8"	P26012	7	20330702-20415754	"Cancer-related genes, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 99.3;Ciliated cells: 78.9;Glandular cells: 109.9;Urothelial cells: 146.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	105	"basophil: 13.8"	"Lineage enriched"	"Detected in single"	105	"granulocytes: 13.8"	"Cell line enhanced"	"Detected in many"		"AF22: 16.6;EFO-21: 21.4;RPTEC TERT1: 33.2;WM-115: 47.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027796, HPA027797"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA027796: AB_10600299, HPA027797: AB_10600879"	"unprognostic (8.32e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.37e-3)"	"unprognostic (5.63e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.49e-3)"	"unprognostic (8.47e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.92e-3)"	4.7	4.1	18.0	5.8	20.0	1.2	12.7	7.8	24.3	22.1	4.6	19.4	9.0	4.6	10.5	19.0	8.8	10.4	11.7	3.9	19.4	12.5	28.1	1.7	3.7	1.3	29.3	14.5	7.1	17.5	8.1	7.7	10.7	22.8	9.6	4.4	37.5	16.6	13.1	0.9	8.5	6.0	7.0	23.1	0.8	6.2	8.7	24.0	0.0	3.4	1.3	9.0	6.8	9.9	0.0	0.0	13.8	0.1	0.0	0.1	0.0	10.2	0.4	16.6	2.1	1.4	5.9	0.0	0.0	0.1	0.1	0.6	0.1	2.6	0.0	21.4	0.7	0.6	11.4	0.7	1.6	0.2	0.0	0.2	0.0	8.0	0.0	0.7	0.0	0.0	0.7	4.7	0.2	0.9	10.2	0.8	0.0	0.0	3.1	0.3	0.0	0.0	0.0	1.2	0.1	1.8	0.0	1.4	0.0	33.2	0.9	0.2	0.7	3.2	0.0	8.3	0.3	0.2	0.0	1.1	4.3	2.8	1.2	2.1	3.9	0.0	0.0	1.0	0.0	47.5	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	18.0	20.0	7.8	14.2	19.4	12.5	29.3	14.5	22.8	24.0	11.9	3.7	0.8	99.3	29.5	5.2	3.1	43.3	78.9	30.7	36.6	0.0	12.5	6.6	22.1	2.3	1.9	4.6	0.0	15.3	0.9	3.2	109.9	1.1	0.0	3.1	1.6	32.6	1.3	1.5	3.5	40.9	12.4	3.3	55.1	6.8	26.0	24.5	6.2	42.1	44.6	1.2	0.0	1.4	0.5	0.7	10.8	4.1	0.5	7.3	146.8
ABCB5	"ABCB5alpha, ABCB5beta, EST422562"	ENSG00000004846	"ATP binding cassette subfamily B member 5"	Q2M3G0	7	20615207-20777038	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 33.4;retina: 43.3"	"Cell type enhanced"	"Detected in some"	17	"Basal glandular cells: 2.6;Early spermatids: 6.1;Melanocytes: 1.7"	"Cancer enriched"	"Detected in some"	9	"melanoma: 5.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	6	"SK-MEL-30: 32.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.82e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.26e-3)"	"unprognostic (3.56e-3)"	"unprognostic (9.30e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.70e-2)"	10.6	0.1	0.0	0.4	0.0	0.3	8.6	0.0	0.1	4.4	3.8	0.0	5.3	0.1	1.8	33.4	0.3	0.4	2.8	0.9	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.4	0.1	2.9	0.6	43.3	0.3	0.4	1.0	2.1	0.9	1.5	0.3	0.1	0.7	2.6	0.0	0.0	0.1	0.2	0.1	1.8	1.6	0.7	0.5	2.3	0.5	0.5	0.3	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	4.4	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.6	0.0	0.0	0.1	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.5	0.4	0.2	0.2	0.1	0.4	0.3	0.2	0.1	0.7	0.2	0.3	0.8	0.5	0.2	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	2.6	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.9	0.7	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.3	0.5	0.2	0.5	0.0	0.0	0.0	0.7
SP8		ENSG00000164651	"Sp8 transcription factor"	Q8IXZ3	7	20782283-20786886	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"prostate: 14.3"	"Cell type enhanced"	"Detected in some"	16	"Basal glandular cells: 2.9;Glandular cells: 2.4;Spermatocytes: 1.2;Spermatogonia: 1.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.3;HUVEC TERT2: 5.9;NTERA-2: 12.2;PC-3: 20.6"	"Group enriched"	"Detected in some"	13	"basal ganglia: 15.7;olfactory region: 66.8"	"Region enriched"	"Detected in some"	11	"olfactory region: 72.4"	HPA054006	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA054006: AB_2682340"		"unprognostic (1.56e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.90e-4)"		"unprognostic (3.46e-1)"	"unprognostic (5.49e-1)"	"unprognostic (1.73e-2)"		"unprognostic (2.42e-2)"		"unprognostic (3.38e-1)"	"unprognostic (7.44e-2)"			0.1	0.1	2.3	0.1	2.8	0.1	0.2	0.1	3.2	0.3	0.3	1.9	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.4	0.5	0.3	0.1	0.2	0.1	0.1	1.7	0.1	0.1	0.1	0.1	0.2	0.7	14.3	0.1	0.0	0.1	0.1	0.1	2.4	0.8	0.1	0.2	0.2	0.3	0.5	0.7	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.2	0.0	1.1	0.0	0.0	0.0	4.3	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.8	12.2	0.1	20.6	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.4	0.8	0.0	0.0	0.0	0.0	2.6	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.8	0.1	3.2	2.4	0.5	0.1	1.7	0.7	0.7	0.0	0.0	0.0	2.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.6	0.0	0.0	0.0	0.0	0.7
SP4	"HF1B, MGC130008, MGC130009, SPR-1"	ENSG00000105866	"Sp4 transcription factor"	Q02446	7	21428034-21514822	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010246, HPA040395"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB010246: AB_2194481, HPA040395: AB_2676959"	"unprognostic (1.57e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.28e-2)"	"unprognostic (9.14e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.18e-2)"	"unprognostic (7.80e-3)"	5.8	4.7	7.9	8.9	11.0	10.2	6.3	25.9	9.5	8.6	4.4	6.4	3.8	3.1	9.2	5.8	4.1	7.8	4.6	6.5	8.3	6.1	5.4	3.4	6.0	11.7	8.6	6.9	19.8	5.2	17.1	11.8	3.7	6.7	7.3	4.3	6.0	5.0	5.7	10.5	5.0	5.6	5.3	6.8	9.1	4.9	6.0	10.0	27.0	13.1	4.8	11.2	6.8	6.3	5.4	1.5	7.2	1.8	3.5	8.3	3.1	2.2	1.7	5.1	8.1	1.5	1.0	1.5	2.3	1.7	2.7	3.7	3.5	2.7	9.2	1.4	1.5	7.2	2.8	7.5	2.2	5.3	2.7	2.8	4.8	3.3	1.5	1.1	4.0	5.7	1.1	1.9	2.9	3.3	1.4	5.4	6.7	6.0	7.0	2.2	1.0	9.3	2.9	12.3	4.3	2.1	20.9	8.7	3.3	0.9	1.6	6.6	8.2	5.3	2.4	1.8	5.1	2.6	2.9	2.3	4.4	5.5	2.7	4.2	9.3	7.3	14.4	2.5	6.4	6.1	4.3	0.8	7.2	6.8	0.9	8.3	3.7	6.4	6.6	0.9	5.4	7.6	7.1	1.9	3.5	1.8	1.5	7.6	3.1	7.9	11.0	25.9	9.5	8.3	6.1	8.6	6.9	6.7	10.0	3.0	7.0	5.0	11.4	11.2	15.9	7.6	10.2	1.4	7.9	0.0	7.9	1.0	0.0	1.7	5.5	5.8	1.1	0.0	1.8	1.0	6.1	7.1	4.7	4.0	1.5	17.5	10.3	11.6	6.5	4.1	5.2	5.9	6.8	2.8	1.8	9.8	1.4	8.6	6.3	1.4	18.8	0.0	4.1	7.9	8.3	9.7	1.3	14.6	2.8	4.3
DNAH11	"CILD7, DNAHBL, Dnahc11, DNHBL, DPL11"	ENSG00000105877	"Dynein axonemal heavy chain 11"	Q96DT5	7	21543215-21901839	"Disease related genes, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 22.2;parathyroid gland: 62.2"	"Cell type enriched"	"Detected in some"	9	"Ciliated cells: 111.1"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"basal ganglia: 5.5;pons and medulla: 15.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 7.6;HUVEC TERT2: 2.4;U-2 OS: 2.7;U-2197: 3.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA045880, HPA056474"	Approved					NA	NA					"HPA045880: AB_10962003, HPA056474: AB_2683145"	"unprognostic (2.24e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.10e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (9.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.86e-3)"	"unprognostic (4.79e-3)"	3.2	4.6	0.8	0.5	5.5	0.4	0.4	0.2	1.0	1.6	0.9	6.7	3.0	0.4	0.8	22.2	2.5	9.3	0.5	1.1	2.5	1.2	0.5	0.8	7.7	0.4	0.2	0.6	7.2	0.5	62.2	0.8	2.9	15.5	1.1	0.5	0.0	0.4	1.0	1.5	0.9	0.6	0.4	0.3	0.4	0.5	0.9	2.1	0.7	5.2	0.3	0.5	0.4	3.4	0.6	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.7	0.0	0.6	0.9	0.0	0.1	0.1	0.0	0.4	0.0	0.1	7.6	0.1	0.0	0.7	1.5	0.0	1.7	0.0	0.5	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.4	0.7	0.2	0.3	0.0	0.0	0.6	0.0	0.1	0.7	0.0	1.4	0.0	0.0	1.7	0.7	2.7	3.4	0.4	0.2	0.1	0.3	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.8	5.5	0.2	1.0	2.5	1.2	0.2	0.6	15.5	2.1	6.0	3.8	0.0	3.5	2.2	0.0	3.3	0.0	111.1	12.5	0.0	0.0	0.0	0.0	0.1	2.5	0.3	0.0	0.0	0.0	1.3	0.2	2.3	0.0	0.2	0.1	6.4	0.0	0.0	0.0	1.5	0.3	0.0	1.7	1.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.7	0.4	0.3	1.4	0.0	0.0	0.7
CDCA7L	"JPO2, R1, RAM2"	ENSG00000164649	"Cell division cycle associated 7 like"	Q96GN5	7	21900900-21946084	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 47.9"	"Cell type enhanced"	"Detected in many"	7	"Spermatogonia: 61.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 11.8;memory B-cell: 28.6;naive B-cell: 38.5;naive CD4 T-cell: 9.7;plasmacytoid DC: 21.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in some"	5	"olfactory region: 22.0"	"HPA027169, HPA074623"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoplasm, Nucleoli"	Cytosol	"HPA027169: AB_1856058, HPA074623: "	"unprognostic (5.13e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (4.36e-6)"	"unprognostic (4.09e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.83e-3)"	6.2	1.2	3.7	19.9	9.6	24.2	8.0	6.5	4.2	8.4	9.0	7.8	3.9	5.2	11.1	3.6	6.0	7.0	5.4	12.5	3.9	2.5	2.7	4.5	7.3	18.7	6.2	4.0	13.9	17.4	1.0	1.6	2.2	3.7	7.6	10.2	5.8	10.5	8.0	2.7	13.6	8.7	6.6	3.0	9.3	12.7	12.6	5.3	47.9	20.0	5.1	16.5	6.0	9.4	38.5	21.8	11.8	1.3	0.8	9.7	3.3	19.7	6.8	6.4	0.1	3.5	4.5	0.0	16.2	13.9	12.6	17.9	2.5	18.0	41.3	5.3	13.9	25.1	12.2	10.1	16.6	25.5	0.0	6.7	9.9	20.1	1.6	4.5	25.9	0.1	8.3	3.0	9.7	28.5	13.0	24.8	32.3	13.6	0.0	9.7	7.4	32.7	9.3	36.5	3.9	8.4	32.9	22.9	27.5	3.5	3.7	23.5	19.2	7.3	4.5	7.4	8.5	11.0	11.7	10.5	13.8	17.0	23.9	19.5	21.3	14.6	53.4	13.2	35.0	13.5	0.3	0.6	11.8	0.6	0.9	0.1	28.6	1.9	0.9	4.3	38.5	9.7	3.9	1.1	0.8	1.3	21.8	2.7	3.3	3.7	9.6	6.5	4.2	3.9	2.5	6.2	4.0	3.7	5.3	17.9	20.3	28.9	22.5	24.2	0.2	26.3	2.5	6.7	31.8	0.0	2.0	0.5	3.3	6.7	2.6	3.7	1.5	0.0	5.3	0.2	4.3	7.7	8.1	3.4	9.6	12.7	10.3	2.5	10.2	3.6	3.7	3.5	8.5	0.0	26.4	2.4	4.9	3.5	2.5	0.0	2.1	12.9	12.3	2.7	61.1	6.8	0.2	2.5	24.4	3.9
RAPGEF5	"GFR, KIAA0277, MR-GEF"	ENSG00000136237	"Rap guanine nucleotide exchange factor 5"	Q92565	7	22118238-22357144	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 67.0;parathyroid gland: 258.2"	"Cell type enhanced"	"Detected in many"	8	"Ito cells: 81.0;Late spermatids: 45.4;Sertoli cells: 84.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 11.8;HUVEC TERT2: 25.2;SCLC-21H: 19.5;TIME: 14.3;U-698: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057821, HPA076772"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA057821: AB_2683538, HPA076772: AB_2686814"	"unprognostic (1.00e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (9.44e-4)"	"unprognostic (5.22e-2)"	"prognostic favorable (3.52e-5)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.76e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.26e-3)"	10.8	5.8	12.6	3.6	22.6	1.8	6.2	5.2	25.1	4.5	4.6	47.6	0.6	3.9	4.4	3.1	6.1	4.2	7.0	6.7	21.3	10.1	7.3	8.5	14.1	5.7	41.8	13.3	3.7	7.9	258.2	3.3	23.2	31.5	2.8	5.2	0.9	3.4	3.4	2.7	4.4	4.1	5.6	67.0	17.1	3.7	3.5	29.5	3.9	5.4	1.8	4.9	3.9	4.9	0.7	0.0	0.0	0.0	0.0	0.2	0.4	1.5	0.0	2.6	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	3.0	0.8	11.8	0.6	0.1	0.4	7.4	1.5	1.1	0.0	0.0	2.3	0.1	0.0	2.9	0.0	0.0	0.0	0.3	1.3	0.7	0.4	0.4	25.2	3.3	2.6	0.1	0.0	0.6	1.6	0.0	2.0	2.9	2.3	2.9	0.0	4.0	2.4	1.0	19.5	5.2	0.3	3.4	0.0	0.4	1.7	0.0	14.3	0.0	0.6	0.2	0.6	6.6	1.3	21.2	0.3	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	12.6	22.6	5.2	25.1	21.3	10.1	41.8	13.3	31.5	29.5	8.9	13.9	2.2	4.3	9.7	14.8	7.3	10.2	0.0	5.7	0.0	0.0	0.1	1.7	4.3	41.5	38.5	14.3	0.0	5.9	0.1	2.1	2.2	8.1	5.8	0.2	22.3	6.9	81.0	5.1	45.4	1.7	1.5	6.8	0.0	16.0	0.5	6.0	17.5	4.6	0.2	1.1	84.1	10.3	0.9	1.1	9.8	0.2	2.1	8.8	3.7
STEAP1B		ENSG00000105889	"STEAP family member 1B"	Q6NZ63	7	22419444-22632925	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 15.6"	"Cell type enhanced"	"Detected in some"	16	"Horizontal cells: 11.1;monocytes: 20.8;Spermatocytes: 7.2;Spermatogonia: 13.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	88	"memory B-cell: 9.9;naive B-cell: 8.6"	"Lineage enriched"	"Detected in single"	94	"B-cells: 9.9"	"Group enriched"	"Detected in many"	4	"hTEC/SVTERT24-B: 29.7;HUVEC TERT2: 33.4;K-562: 19.4;WM-115: 36.7"															NA	NA						"unprognostic (7.35e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.34e-3)"	"unprognostic (3.96e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.31e-5)"	"unprognostic (2.29e-3)"	"unprognostic (4.96e-2)"	"unprognostic (7.37e-3)"	"unprognostic (7.38e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.85e-10)"	"unprognostic (1.06e-4)"	"unprognostic (3.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.21e-3)"	3.5	1.8	5.3	3.9	14.5	0.6	1.8	0.6	9.3	2.3	1.6	13.5	0.8	0.5	0.7	1.4	1.7	1.0	2.2	1.4	5.2	2.9	0.4	0.7	1.4	5.9	14.9	2.7	0.5	1.1	0.8	1.0	3.6	9.0	1.5	1.5	1.0	1.4	2.1	3.2	1.1	1.0	1.9	8.6	6.4	1.1	7.5	15.6	0.6	0.8	0.3	5.5	2.1	3.6	9.9	0.0	0.0	0.0	0.0	0.1	0.4	4.1	0.0	2.9	0.0	1.8	1.9	0.0	2.9	0.4	0.0	0.1	0.0	0.1	0.4	0.9	5.7	1.0	0.0	4.2	0.0	0.2	0.3	0.4	0.0	0.1	0.0	0.2	0.0	0.0	3.5	0.0	29.7	0.0	3.5	33.4	0.1	19.4	1.6	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.6	0.0	1.7	0.0	0.0	0.0	0.1	0.1	0.0	2.4	0.4	0.0	0.0	3.4	0.4	0.1	4.5	0.0	0.4	3.8	3.9	7.0	0.0	36.7	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.1	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.3	14.5	0.6	9.3	5.2	2.9	14.9	2.7	9.0	15.6	0.0	0.0	4.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	11.1	0.0	0.6	0.3	1.3	0.0	0.1	3.3	20.8	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	7.2	13.0	0.1	0.1	0.0	0.0	0.1
IL6	"BSF2, HGF, HSF, IFNB2, IL-6"	ENSG00000136244	"Interleukin 6"	P05231	7	22725884-22732002	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Cytokine, Growth factor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.1;lymphoid tissue: 48.0"	"Cell type enriched"	"Detected in many"	9	"Smooth muscle cells: 589.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 10.0;cerebral cortex: 4.4;hippocampal formation: 3.9;pons and medulla: 12.8"	"Group enriched"	"Detected in some"	70	"memory B-cell: 6.1;naive B-cell: 7.7"	"Lineage enriched"	"Detected in single"	77	"B-cells: 7.7"	"Group enriched"	"Detected in some"	4	"BJ hTERT+: 208.4;GAMG: 141.1"					"Low region specificity"	"Detected in single"			"CAB023406, CAB072821"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	5700		Vesicles		"CAB023406: AB_617317, CAB072821: "	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (1.10e-11)"	"unprognostic (2.45e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.31e-2)"	"unprognostic (7.80e-2)"	60.1	5.6	1.4	48.0	10.0	15.3	11.5	0.7	4.4	2.9	8.1	1.2	0.4	0.7	2.1	4.6	14.3	7.8	16.1	21.6	3.9	1.5	1.3	5.2	34.9	3.0	1.8	0.2	5.3	8.3	5.7	14.2	4.5	12.8	6.5	7.5	3.3	3.1	0.8	6.9	2.8	4.5	8.2	7.0	3.5	6.5	3.2	1.2	0.1	4.5	12.7	3.5	34.9	8.4	7.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.8	208.4	3.9	13.4	0.0	0.0	0.0	6.8	1.3	141.1	0.1	0.0	0.0	5.3	8.2	0.0	0.0	0.3	0.0	4.4	0.0	0.0	0.5	0.0	39.8	5.7	3.8	1.4	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	13.5	0.0	0.0	0.7	0.0	0.0	1.2	1.3	0.1	2.4	0.4	0.0	2.3	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	10.0	0.7	4.4	3.9	1.5	1.8	0.2	12.8	1.2	6.0	27.2	7.2	1.9	39.6	0.0	0.9	0.0	13.4	20.5	3.5	0.0	0.5	0.0	5.8	0.3	40.7	0.0	0.0	2.4	3.1	63.9	7.3	5.8	0.0	4.2	0.0	0.0	3.1	6.1	0.0	0.0	46.2	38.8	7.2	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	589.1	0.0	0.0	29.2	1.1	0.0	0.0	9.0
TOMM7	Tom7	ENSG00000196683	"Translocase of outer mitochondrial membrane 7"	Q9P0U1	7	22812628-22822852	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 253.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (6.69e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (6.30e-4)"	"unprognostic (2.25e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.69e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.01e-2)"	63.5	76.7	66.0	36.7	63.2	48.5	70.1	41.3	58.1	42.7	46.2	19.8	41.4	51.3	41.8	36.0	41.1	40.1	39.1	61.6	50.2	42.6	42.1	43.7	37.0	70.0	58.4	42.5	106.7	96.4	23.0	43.4	22.7	44.0	41.7	30.1	39.5	62.4	42.1	253.0	37.5	41.7	71.5	52.0	45.4	43.6	24.4	47.4	21.1	36.6	81.9	44.2	49.1	70.8	117.8	81.0	47.7	51.3	49.5	151.7	130.5	57.3	17.4	19.4	40.9	48.4	51.6	23.4	49.3	37.1	18.7	15.1	12.2	33.7	35.2	51.8	37.7	101.8	40.0	31.9	27.0	17.3	23.4	36.5	19.3	45.2	17.1	45.2	54.3	27.0	74.7	54.0	31.5	45.6	121.1	26.8	37.3	53.4	38.1	30.7	24.3	25.6	59.0	74.7	88.1	44.1	23.6	23.5	55.6	15.8	18.1	16.8	34.7	32.6	73.2	107.1	68.6	52.6	88.5	37.0	21.3	42.5	43.5	46.5	98.2	83.0	64.1	32.1	49.1	80.4	20.4	51.3	47.7	65.5	44.0	81.2	117.8	112.6	79.2	51.8	102.3	151.7	106.3	17.8	49.5	44.2	81.0	84.2	130.5	66.0	63.2	41.3	58.1	50.2	42.6	58.4	42.5	44.0	47.4	241.2	277.9	735.1	671.2	787.2	247.2	1080.5	685.3	305.1	280.9	331.5	62.8	408.1	1125.7	384.0	287.0	426.3	659.7	420.4	808.5	601.1	500.9	701.8	487.8	1059.1	606.1	143.0	510.4	635.3	808.8	297.8	919.7	682.5	747.3	555.5	881.1	452.3	538.0	770.5	714.2	838.1	229.6	478.6	571.8	454.7	180.7	810.0	339.6	682.9	815.4	663.4
FAM126A	"DRCTNNB1A, HCC, HYCC1, hyccin"	ENSG00000122591	"Family with sequence similarity 126 member A"	Q9BYI3	7	22889371-23014130	"Disease related genes, Predicted intracellular proteins"			"Cataract, Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042873	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA042873: AB_2678207"	"unprognostic (7.94e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.54e-4)"	"unprognostic (1.35e-1)"	"unprognostic (9.76e-3)"	"unprognostic (1.30e-2)"	"unprognostic (7.23e-2)"	"unprognostic (6.19e-2)"	"prognostic unfavorable (6.04e-7)"	"prognostic unfavorable (5.99e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (9.03e-4)"	15.6	6.1	12.4	13.6	16.9	4.6	14.3	1.7	10.2	10.5	10.5	9.3	1.5	9.6	10.9	4.7	16.1	7.3	12.3	12.2	11.9	6.4	6.1	8.6	15.0	16.8	12.0	5.2	8.6	7.9	1.5	13.2	16.6	10.0	9.7	5.2	11.3	8.4	6.0	28.4	6.0	10.7	13.1	8.6	14.7	6.0	22.3	11.4	12.8	8.1	10.3	14.3	10.6	15.0	9.5	5.9	16.3	12.1	3.6	5.3	3.3	9.6	4.0	19.6	7.9	18.7	29.7	3.0	29.0	29.4	12.8	19.3	6.3	3.6	8.8	5.2	23.6	28.4	3.7	19.8	6.5	21.1	4.2	7.0	7.5	6.7	4.4	16.1	12.9	8.8	12.9	4.8	26.3	25.9	25.0	14.9	5.8	16.1	26.4	23.1	2.7	7.9	10.2	19.3	0.0	8.5	8.6	19.5	4.5	3.7	3.4	6.5	0.0	11.8	0.3	12.0	17.3	5.7	9.3	14.7	44.1	5.9	22.7	15.6	36.2	14.0	30.4	28.5	6.9	38.5	3.9	4.6	16.3	2.3	9.5	1.8	7.6	3.3	2.1	5.9	9.5	1.8	2.4	0.9	3.6	12.1	2.2	5.3	3.3	12.4	16.9	1.7	9.4	11.9	6.4	12.0	5.2	10.0	11.4	3.0	13.7	13.1	5.2	22.7	39.4	18.9	2.5	1.4	4.5	3.5	2.0	9.7	0.0	6.4	27.6	31.7	1.3	0.0	4.2	11.0	31.5	4.2	8.1	17.4	12.5	15.9	7.5	24.5	27.1	16.2	18.7	26.2	33.7	12.6	1.3	7.0	3.5	0.3	18.4	4.8	4.0	19.4	33.0	40.9	9.1	21.0	5.0	13.8	1.3	6.0
KLHL7	"KLHL6, RP42, SBBI26"	ENSG00000122550	"Kelch like family member 7"	Q8IXQ5	7	23105758-23177914	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 452.0;Late spermatids: 236.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029491, HPA029492"	Uncertain		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029491: AB_10599605, HPA029492: AB_10600881"	"unprognostic (1.24e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (3.78e-1)"	"unprognostic (6.10e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (8.98e-5)"	"unprognostic (2.46e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.27e-2)"	7.5	14.6	9.2	5.6	13.0	8.2	10.3	12.6	15.1	8.8	5.7	7.9	4.7	5.9	9.1	9.9	7.7	7.4	7.6	37.1	8.1	8.7	9.2	7.7	6.4	5.8	8.3	9.7	9.6	5.9	7.1	6.1	6.5	15.9	8.1	6.3	8.6	7.2	6.8	7.4	8.6	5.8	8.1	10.6	5.8	5.2	40.7	6.2	9.6	7.2	5.1	6.7	6.9	7.1	5.5	5.5	32.0	8.7	4.2	8.0	6.0	10.9	9.4	25.9	30.6	12.7	11.1	9.5	9.7	14.4	14.3	16.7	11.4	8.0	10.8	7.9	11.8	23.7	11.9	9.9	6.8	12.1	2.8	7.1	7.1	8.1	14.6	9.5	14.3	5.6	9.8	8.9	16.4	13.5	11.4	18.2	13.4	12.4	11.8	23.3	12.6	11.9	22.8	35.7	7.5	11.2	10.6	14.5	9.8	13.4	9.5	15.6	15.3	21.1	10.5	9.9	16.6	8.7	7.5	7.7	12.1	12.6	26.5	11.5	18.6	15.2	25.7	8.0	15.2	14.4	18.7	7.8	32.0	6.8	8.7	7.1	4.5	7.3	6.4	5.5	5.5	5.5	5.4	7.4	4.2	7.5	4.0	8.0	6.0	9.2	13.0	12.6	15.1	8.1	8.7	8.3	9.7	15.9	6.2	20.8	5.6	13.3	15.2	20.9	19.9	85.8	5.1	16.0	9.1	8.7	27.5	18.6	10.0	15.7	452.0	14.1	4.9	0.0	15.3	24.1	17.0	11.5	20.8	5.9	16.7	35.0	10.4	14.1	15.3	236.4	15.5	14.1	11.8	12.6	7.6	23.5	14.7	0.0	19.4	9.8	15.0	6.5	19.1	94.0	10.6	29.5	19.8	15.2	6.4	22.7
NUPL2	"CG1, H_RG271G13.9, hCG1, NLP_1"	ENSG00000136243	"Nucleoporin like 2"	O15504	7	23181827-23201011	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Early spermatids: 230.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049036, HPA057251"			Supported	Nucleoplasm		No	No			Nucleoplasm		"HPA049036: , HPA057251: "	"unprognostic (3.81e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.87e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.59e-1)"	"unprognostic (1.32e-2)"	13.3	21.1	19.4	27.0	17.1	23.3	14.4	25.9	30.4	15.4	16.4	12.3	26.8	15.4	19.5	26.5	17.9	17.7	18.7	24.3	16.1	16.1	17.8	16.2	14.7	23.2	14.9	19.9	16.7	14.6	22.3	19.7	10.8	15.2	16.5	16.9	12.5	20.3	20.8	16.9	21.6	14.9	19.1	14.6	20.1	15.2	32.2	16.9	19.7	20.8	16.8	19.6	17.7	16.7	16.4	13.8	22.9	8.7	13.9	12.3	9.8	12.1	7.0	9.0	17.0	8.9	11.4	6.6	10.1	7.6	10.8	11.4	9.0	13.6	20.4	9.0	7.0	24.3	14.7	15.5	8.8	13.5	5.9	16.4	14.1	14.9	8.9	11.1	28.7	17.2	5.5	10.7	10.3	6.6	8.3	11.3	11.5	23.7	14.4	10.7	3.5	13.7	16.7	17.1	14.9	10.0	12.6	8.1	15.3	11.9	9.3	11.9	11.4	10.6	5.6	15.6	15.1	7.1	31.4	11.5	7.8	9.8	13.4	16.2	19.0	28.6	22.5	7.3	21.5	17.8	22.9	8.7	7.6	11.4	8.4	10.2	16.4	12.2	11.3	11.5	14.0	11.5	12.3	8.5	13.9	7.1	13.8	12.3	9.8	19.4	17.1	25.9	30.4	16.1	16.1	14.9	19.9	15.2	16.9	14.9	8.6	15.3	14.1	11.9	20.9	15.4	5.1	17.4	12.5	22.7	19.6	14.9	33.2	19.5	230.4	12.2	7.4	0.0	11.6	11.0	12.2	10.0	13.9	5.0	23.6	22.3	15.0	14.1	16.5	25.9	23.3	16.2	8.5	24.4	10.9	16.0	15.1	14.4	19.4	22.3	23.0	12.9	19.8	24.4	11.8	11.8	5.5	20.2	16.8	11.9
GPNMB	"HGFIN, NMB"	ENSG00000136235	"Glycoprotein nmb"	Q14956	7	23235967-23275108	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 137.7"	"Cell type enhanced"	"Detected in many"	13	"Basal keratinocytes: 290.6;Hofbauer cells: 788.7;Melanocytes: 566.8;Suprabasal keratinocytes: 314.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 354.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.8;intermediate monocyte: 7.1"	"Lineage enriched"	"Detected in many"	6	"monocytes: 7.1"	"Cell line enriched"	"Detected in many"	5	"ASC diff: 329.4"	"Region enhanced"	"Detected in some"		"olfactory region: 12.1"	"Low region specificity"	"Detected in single"								"Intracellular and membrane"	NA	NA		41000000				"unprognostic (3.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.89e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.40e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.82e-1)"	"unprognostic (6.95e-2)"	137.7	4.3	7.7	9.5	5.9	0.7	33.8	1.0	5.5	56.0	20.7	7.9	9.2	3.5	56.5	34.6	32.6	17.3	45.8	50.0	5.5	2.8	10.8	8.9	58.7	24.1	4.4	5.0	39.7	4.0	0.3	3.7	52.7	18.2	24.8	15.7	115.7	18.1	9.8	11.3	97.2	12.1	26.2	15.7	8.4	11.2	19.8	1.5	20.6	14.0	31.7	26.7	33.4	41.9	0.4	0.8	1.2	7.1	0.3	0.2	0.8	1.1	0.0	0.0	0.0	329.4	60.0	0.0	2.1	35.7	1.7	7.6	0.0	0.0	0.0	0.0	6.8	3.2	7.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	41.3	8.6	2.9	0.3	47.8	0.0	0.0	0.0	0.0	9.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.5	27.8	0.1	0.0	0.0	11.1	51.4	0.0	0.1	0.1	0.0	10.5	1.2	19.1	0.3	0.3	0.5	0.0	3.6	0.1	10.5	0.9	3.8	0.1	0.2	7.1	0.1	0.2	0.0	0.0	0.8	0.4	0.2	0.1	1.2	0.3	0.3	0.8	0.1	0.8	7.7	5.9	1.0	5.5	5.5	2.8	4.4	5.0	18.2	1.5	17.9	28.2	2.7	6.4	290.6	0.4	176.6	2.5	2.7	14.8	71.5	0.0	5.9	3.3	0.4	2.4	9.6	0.0	0.0	0.7	2.7	76.6	1.8	20.9	3.8	788.7	1.6	0.0	6.2	136.5	2.1	120.3	119.7	566.8	4.6	0.0	0.2	0.7	0.0	101.5	0.7	0.5	0.0	64.0	3.8	1.2	314.4	24.1	0.0	0.0	10.9
MALSU1	"C7orf30, mtRsfA"	ENSG00000156928	"Mitochondrial assembly of ribosomal large subunit 1"	Q96EH3	7	23298739-23311729	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AN3-CA: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020487, HPA052210"	Approved		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA020487: AB_1845757, HPA052210: AB_2681762"	"unprognostic (3.62e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.66e-3)"	"unprognostic (5.24e-3)"	"prognostic unfavorable (9.71e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.15e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.68e-1)"	7.9	11.3	9.5	6.9	9.4	7.6	11.0	8.6	11.1	7.9	8.4	8.3	5.8	5.1	9.2	10.2	12.3	10.1	7.6	29.8	8.8	9.1	12.5	21.2	8.2	10.2	8.9	7.2	10.3	10.1	8.0	7.8	12.6	12.7	7.9	7.8	17.2	10.6	10.3	20.1	6.7	7.0	8.9	8.1	6.9	7.5	13.7	5.6	8.5	14.8	14.9	8.0	9.2	7.5	6.1	4.8	3.5	5.4	4.2	7.3	5.1	4.8	6.1	4.5	26.3	4.4	3.1	4.5	3.7	2.7	3.5	3.2	10.2	4.1	4.9	4.1	2.4	14.3	5.0	4.4	2.3	4.3	2.4	7.9	2.9	8.3	15.7	2.9	6.4	1.8	2.6	3.6	2.9	3.2	20.9	3.1	4.5	8.7	1.3	4.4	3.4	4.4	20.0	8.2	9.1	16.4	3.8	3.7	6.5	3.4	4.4	4.1	4.9	3.1	5.0	7.7	9.1	2.5	3.8	5.5	2.8	2.5	5.3	6.6	2.0	4.8	8.5	10.6	7.9	8.7	3.4	5.4	3.5	4.4	4.0	5.0	6.1	6.1	4.9	4.7	5.7	7.3	4.9	3.4	4.2	3.3	4.8	5.7	5.1	9.5	9.4	8.6	11.1	8.8	9.1	8.9	7.2	12.7	5.6	35.7	32.4	26.7	44.7	38.8	30.2	85.9	30.6	44.2	29.6	41.8	15.7	68.8	97.8	85.3	113.0	32.3	23.8	23.3	83.4	55.2	42.4	35.4	13.9	91.2	47.7	17.5	18.5	37.4	30.7	19.1	45.8	21.4	33.7	38.7	30.2	34.9	64.5	28.1	46.3	93.2	28.6	32.3	41.9	55.6	72.8	38.6	41.6	20.8	44.3	42.7
IGF2BP3	"CT98, IMP-3, IMP3"	ENSG00000136231	"Insulin like growth factor 2 mRNA binding protein 3"	O00425	7	23310209-23470467	"Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"placenta: 74.0"	"Cell type enhanced"	"Detected in many"	12	"Cytotrophoblasts: 68.4;Extravillous trophoblasts: 72.8;Hofbauer cells: 30.1;Syncytiotrophoblasts: 65.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 49.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA002037, HPA076951"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA002037: AB_1851483, HPA076951: "	"unprognostic (5.72e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.25e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.60e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.02e-5)"	"unprognostic (8.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.43e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.87e-4)"	"unprognostic (7.51e-3)"	0.4	0.2	0.3	0.9	0.2	0.3	0.2	0.2	0.3	0.4	0.3	0.4	0.1	0.0	0.2	1.3	4.8	0.7	0.1	0.5	0.3	0.2	0.2	0.3	1.2	3.4	0.2	0.0	0.2	1.5	0.0	0.2	74.0	0.7	0.2	0.0	0.3	0.7	0.1	0.2	0.2	0.3	0.0	1.2	1.0	0.2	6.5	0.0	11.4	0.6	0.2	6.0	0.2	0.6	1.2	0.4	1.5	1.5	0.0	0.2	3.0	13.8	4.1	31.1	9.2	4.9	13.2	19.0	2.3	10.5	5.8	7.3	13.1	11.0	10.4	12.6	6.1	26.0	9.1	13.4	10.2	10.3	1.6	5.3	5.5	11.1	10.9	15.3	10.0	3.9	13.4	7.2	4.4	1.9	34.8	49.8	5.9	25.2	0.0	14.1	0.0	6.1	6.7	24.8	10.6	12.8	9.5	10.4	13.4	11.5	1.2	8.2	17.9	1.4	0.0	11.6	37.1	0.0	1.9	20.0	5.6	0.3	12.1	6.0	0.0	4.4	16.5	22.4	11.2	21.5	0.0	1.5	0.0	0.1	0.8	0.0	1.2	0.0	0.0	0.4	0.9	0.2	0.0	1.5	0.0	0.0	0.0	0.0	3.0	0.3	0.2	0.2	0.3	0.3	0.2	0.2	0.0	0.7	0.0	0.0	0.0	1.7	0.6	0.2	0.5	0.3	0.0	4.0	0.0	0.0	0.0	68.4	0.0	1.1	21.3	0.1	0.0	0.0	0.2	72.8	0.5	0.2	3.5	0.0	30.1	1.6	0.0	1.3	0.0	16.9	2.0	1.3	3.3	0.0	0.0	0.3	0.8	0.0	0.0	0.0	1.7	0.0	0.4	1.9	1.5	0.4	65.7	0.0	0.0	0.5
TRA2A	"AWMS1, htra-2-alpha, tra2a"	ENSG00000164548	"Transformer 2 alpha homolog"	Q13595	7	23504780-23532041	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054018	Uncertain		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			Nucleoli	"Nucleoplasm, Vesicles"	"HPA054018: AB_2682344"	"unprognostic (2.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.77e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.28e-2)"	"unprognostic (2.50e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.87e-3)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (1.79e-6)"	"unprognostic (1.46e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.36e-3)"	23.4	29.4	27.8	29.5	34.1	70.6	27.4	38.1	27.5	30.3	22.9	29.0	31.6	19.8	32.7	34.5	29.4	25.9	17.6	18.7	28.6	29.3	21.3	21.8	28.6	32.2	35.8	18.5	36.8	27.4	14.9	46.6	24.4	28.2	26.4	30.1	23.7	21.9	26.7	15.7	31.6	22.6	35.2	30.4	33.8	21.1	25.9	37.3	35.6	24.7	20.5	38.0	25.0	31.8	15.5	23.9	20.4	23.0	14.7	21.7	8.2	19.3	21.4	33.3	52.1	17.9	11.3	21.5	24.7	11.7	24.8	20.5	17.6	26.6	36.6	14.3	18.3	29.6	32.2	39.9	23.0	31.3	22.0	23.3	22.4	23.7	27.8	18.7	26.1	21.1	13.3	15.9	18.7	23.5	22.5	28.2	16.3	43.5	18.0	28.1	18.9	31.5	43.8	29.9	24.0	22.2	36.1	26.3	21.9	28.7	28.0	28.9	23.5	23.1	26.7	16.5	25.7	21.0	29.4	25.4	19.8	28.3	18.1	28.6	20.1	25.1	30.0	17.0	35.6	26.3	11.5	14.9	18.5	21.7	23.0	18.7	15.5	20.3	19.8	16.8	14.4	17.7	20.9	20.4	14.7	20.4	23.9	20.0	8.2	27.8	34.1	38.1	27.5	28.6	29.3	35.8	18.5	28.2	37.3	56.6	68.2	70.3	85.9	92.7	49.7	37.0	48.4	77.6	60.3	83.7	49.1	76.6	21.6	48.0	48.5	63.2	67.9	70.0	38.1	71.1	87.2	68.2	83.3	62.7	48.6	35.0	113.5	70.0	86.5	17.7	60.1	73.9	54.0	60.5	57.4	42.4	49.0	80.7	63.6	32.1	101.0	71.1	79.3	92.3	54.5	98.9	98.6	97.5	61.7	73.5
CCDC126	FLJ23031	ENSG00000169193	"Coiled-coil domain containing 126"	Q96EE4	7	23597379-23644708	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 75.4"	"Group enriched"	"Detected in many"	18	"Early spermatids: 588.1;Late spermatids: 350.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"basophil: 75.4"	"Lineage enriched"	"Detected in all"	18	"granulocytes: 75.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010969, HPA026883"	Uncertain		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		31000000	"Golgi apparatus"		"HPA010969: , HPA026883: AB_1846131"	"unprognostic (2.02e-1)"	"unprognostic (2.76e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.90e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.29e-2)"	"unprognostic (7.35e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.28e-1)"	6.7	8.1	8.7	4.4	9.2	6.9	19.5	11.6	13.2	7.4	6.5	5.6	5.8	8.7	8.0	5.3	6.6	6.7	6.2	5.7	13.8	8.9	7.6	11.7	6.5	9.3	10.5	3.9	7.4	9.8	12.2	12.6	4.6	11.1	6.0	6.5	5.8	7.5	6.5	10.0	6.6	9.4	6.7	12.9	6.1	6.8	41.3	8.1	5.4	9.9	5.0	8.6	7.0	7.7	3.8	3.0	75.4	3.6	2.9	4.1	2.9	4.8	3.4	7.5	9.5	12.6	7.1	17.3	6.1	6.0	5.3	7.7	3.6	1.6	10.4	9.7	5.1	10.1	2.8	3.2	2.9	6.9	2.2	4.3	1.8	1.4	4.6	5.1	4.7	9.3	7.5	8.5	1.7	1.6	4.4	7.0	4.4	4.1	3.0	6.3	2.2	3.2	5.7	3.5	6.4	4.3	2.2	11.9	3.1	5.5	2.2	4.6	8.6	6.3	6.1	4.5	12.2	5.1	4.4	8.4	3.1	5.6	7.1	4.8	8.4	8.3	7.4	3.5	6.9	16.9	75.4	3.6	16.4	3.0	3.3	3.7	3.8	3.3	3.5	3.0	3.2	4.1	3.2	6.9	2.9	3.1	0.6	3.6	2.9	8.7	9.2	11.6	13.2	13.8	8.9	10.5	3.9	11.1	8.1	6.0	7.2	7.1	7.0	16.9	12.6	8.3	7.6	9.4	3.4	12.2	7.9	9.0	6.6	10.1	588.1	10.5	5.8	0.0	8.0	5.6	10.4	7.1	6.9	12.7	6.2	7.9	14.5	10.4	5.1	350.6	10.6	7.9	13.5	6.4	8.6	7.2	8.1	6.2	13.4	7.2	12.6	12.9	12.2	26.8	23.8	20.7	16.9	7.5	5.6	5.9
FAM221A	"C7orf46, DKFZp686F0810, FLJ45875, MGC72075"	ENSG00000188732	"Family with sequence similarity 221 member A"	A4D161	7	23680130-23703249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 46.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 11.6;GAMG: 15.8;MOLT-4: 15.0;SCLC-21H: 14.1;SH-SY5Y: 24.0"	"Low region specificity"	"Detected in many"							"HPA019719, HPA026748, HPA026752"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA019719: AB_1853910, HPA026748: AB_1853911, HPA026752: AB_1853912"	"unprognostic (1.28e-1)"	"unprognostic (7.28e-3)"	"unprognostic (6.03e-3)"	"unprognostic (2.54e-1)"	"unprognostic (3.33e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.51e-3)"	"unprognostic (2.18e-3)"	"unprognostic (3.10e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.42e-2)"	"unprognostic (9.30e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.81e-2)"	3.9	4.8	12.8	3.8	19.7	2.1	5.7	12.9	12.3	5.0	8.2	25.1	2.9	12.0	3.5	5.1	8.7	12.1	6.8	4.0	15.9	13.4	8.4	10.0	5.5	4.3	30.0	10.3	4.5	25.2	3.8	4.5	2.3	17.2	4.7	11.0	27.8	8.7	9.2	2.1	4.7	8.9	3.2	24.6	2.3	14.6	22.9	24.3	2.1	7.7	1.4	6.2	4.2	3.1	6.9	5.3	3.8	5.2	6.8	11.4	3.7	0.0	0.3	6.7	5.5	0.2	0.0	3.1	0.2	0.5	0.8	1.0	6.8	3.0	0.7	11.6	0.1	15.8	1.3	0.0	0.0	1.3	0.0	9.0	1.8	0.6	0.0	1.8	0.0	10.0	0.4	0.4	0.1	0.0	1.4	2.1	6.8	0.0	0.0	0.2	3.1	15.0	0.0	0.0	0.0	3.3	6.2	0.6	0.0	3.7	3.0	14.1	24.0	1.0	0.0	0.0	1.6	3.0	4.3	0.3	0.0	2.4	1.3	0.6	0.0	0.0	0.0	0.6	0.0	1.1	0.0	3.0	3.8	5.4	1.9	11.0	6.9	9.0	6.5	5.3	6.0	10.6	5.7	0.1	6.8	5.2	4.3	11.4	3.7	12.8	19.7	12.9	12.3	15.9	13.4	30.0	10.3	17.2	24.3	14.9	7.4	3.9	8.6	14.3	7.0	4.4	12.7	46.8	20.5	7.0	2.0	3.0	8.3	11.6	6.8	7.1	7.7	0.0	9.3	0.2	5.0	10.3	4.7	13.1	5.7	6.4	14.3	3.7	3.7	8.2	4.4	7.7	8.5	0.0	21.7	7.3	11.7	18.7	3.5	10.3	8.0	19.4	6.1	26.5	25.7	16.6	0.7	4.4	17.1	9.5
STK31	"SgK396, TDRD8"	ENSG00000196335	"Serine/threonine kinase 31"	Q9BXU1	7	23710167-23832513	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	63	"testis: 56.0"	"Cell type enriched"	"Detected in some"	5	"Spermatocytes: 163.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"CACO-2: 20.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA023194	Enhanced					NA	NA					"HPA023194: AB_1857590"	"unprognostic (4.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.98e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.29e-6)"	"unprognostic (7.83e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.65e-1)"	0.1	0.0	0.1	0.1	0.7	0.0	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	56.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	20.1	2.5	0.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.8	0.1	0.2	0.0	0.1	0.1	0.1	0.1	3.0	1.4	0.0	0.2	0.1	1.7	0.4	2.5	6.7	4.5	0.0	0.0	0.5	0.0	0.2	16.5	0.0	0.3	0.0	0.6	0.1	0.0	0.3	0.0	0.8	0.2	0.0	1.2	0.0	0.0	12.3	3.1	0.0	0.0	0.0	0.2	1.3	0.4	0.8	2.8	0.0	1.2	0.0	0.0	163.1	32.6	0.1	0.5	0.0	0.4	0.4
NPY	PYY4	ENSG00000122585	"Neuropeptide Y"	P01303	7	24284163-24291865	"Plasma proteins, Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 50.5;brain: 63.6;prostate: 131.2"	"Cell type enriched"	"Detected in some"	5	"Glandular cells: 55.9"	"Cancer enriched"	"Detected in many"	187	"prostate cancer: 1214.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	36	"SH-SY5Y: 124.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB016733, CAB034368, HPA036636, HPA044572, HPA056798"	Supported	Supported	Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	30700000		"Golgi apparatus"		"CAB016733: , CAB034368: AB_2298657, HPA036636: , HPA044572: AB_2678996, HPA056798: AB_2630371"			"unprognostic (2.00e-1)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (4.15e-1)"					"unprognostic (3.76e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.52e-1)"		1.6	50.5	27.2	5.5	63.6	2.8	1.0	0.1	55.9	1.0	1.8	2.8	1.4	4.7	1.1	1.1	2.5	1.0	1.4	1.0	11.9	20.6	1.1	1.0	1.1	1.0	2.6	18.3	1.0	4.0	1.0	0.5	1.0	1.9	131.2	1.7	0.0	1.0	14.7	1.0	1.0	5.0	1.4	1.4	1.0	1.7	1.3	13.9	0.0	1.1	0.0	1.0	3.9	4.5	0.5	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	3.4	0.0	0.1	0.0	0.0	0.1	124.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	27.2	63.6	0.1	31.2	11.9	20.6	2.6	18.3	1.9	13.9	0.0	0.0	0.0	1.3	0.1	1.0	0.2	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.2	0.2	55.9	0.0	0.0	2.2	0.0	0.0	0.0	0.0	8.5	0.3	0.0	1.7	0.0	0.0	0.4	0.5	0.0	0.4	0.0	0.5	0.0	0.0	2.3	2.1	0.0	4.2	0.0	0.0	0.7
MPP6	"p55T, PALS2, VAM-1"	ENSG00000105926	"Membrane palmitoylated protein 6"	Q9NZW5	7	24573268-24694193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.3"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 41.2;Spermatocytes: 58.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 9.4"	"Group enriched"	"Detected in many"	4	"B-cells: 9.4;dendritic cells: 4.0;T-cells: 3.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019085, HPA020456"	Enhanced					NA	NA					"HPA019085: AB_1858713, HPA020456: AB_1858714"	"unprognostic (2.79e-1)"	"unprognostic (3.49e-1)"	"unprognostic (7.84e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (8.85e-5)"	"unprognostic (2.18e-3)"	"unprognostic (3.80e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.05e-5)"	"unprognostic (1.94e-1)"	"unprognostic (8.51e-2)"	"prognostic unfavorable (5.28e-4)"	"unprognostic (1.88e-3)"	4.5	3.7	12.2	4.1	17.9	3.5	4.7	10.2	11.4	2.2	1.9	3.1	0.5	4.4	2.8	1.8	3.8	3.6	22.5	2.4	13.2	5.8	10.5	11.1	2.5	5.6	4.9	11.0	11.7	9.3	0.6	1.9	1.4	5.9	3.5	2.1	1.3	3.3	2.0	10.3	2.8	5.4	4.0	6.8	2.5	3.1	27.3	7.8	2.6	7.5	2.1	5.8	2.6	3.2	9.4	4.0	0.3	1.2	1.4	3.4	0.8	9.8	5.7	6.5	9.6	7.3	5.2	4.7	7.5	4.2	5.3	6.7	17.5	7.6	17.3	6.1	4.6	13.8	6.2	11.3	9.1	10.6	6.9	8.7	2.9	9.8	4.3	5.7	11.4	2.1	5.3	3.9	6.3	11.4	3.9	8.3	10.7	18.6	7.0	6.1	4.0	7.6	3.0	35.7	4.7	9.3	9.3	11.0	9.4	7.4	13.6	5.0	20.6	8.6	8.6	2.5	13.7	4.4	1.7	7.7	3.4	14.6	10.6	14.3	26.2	2.7	35.0	6.1	4.4	12.7	0.2	0.1	0.1	2.9	1.2	1.8	6.3	1.3	2.9	0.2	9.4	3.4	2.9	0.3	1.4	0.1	4.0	1.0	0.8	12.2	17.9	10.2	11.4	13.2	5.8	4.9	11.0	5.9	7.8	6.0	2.7	12.0	9.5	9.8	2.1	3.6	28.1	0.0	6.8	5.2	41.2	1.8	3.3	27.1	22.4	2.2	1.3	0.0	15.7	1.7	14.6	12.0	0.0	15.6	1.3	3.2	2.9	3.1	2.2	24.7	4.9	1.1	1.7	1.0	7.6	1.4	14.5	14.1	6.7	25.8	5.5	0.0	5.0	58.5	23.7	7.8	0.5	6.9	4.9	8.9
GSDME	"DFNA5, ICERE-1"	ENSG00000105928	"Gasdermin E"	O60443	7	24698351-24758113	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Necrosis		"Deafness, Non-syndromic deafness, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	21	"Cytotrophoblasts: 151.1;Distal tubular cells: 34.9;Hofbauer cells: 35.4;Syncytiotrophoblasts: 87.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 8.7;myeloid DC: 6.9;naive B-cell: 8.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011326, CAB019306"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"CAB019306: , HPA011326: AB_1847629"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.29e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (2.49e-5)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.48e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.90e-2)"	8.1	6.5	7.7	2.2	10.3	0.5	6.1	5.9	12.1	12.0	14.5	7.8	0.5	6.1	18.4	12.8	4.2	9.9	6.7	7.4	7.5	8.8	10.7	3.6	4.0	4.0	9.3	4.5	14.1	2.3	2.2	4.5	27.1	10.1	5.9	2.1	9.0	2.0	17.7	5.1	1.8	31.3	12.2	25.4	1.5	2.7	9.9	5.0	0.8	11.7	4.0	2.9	9.5	7.0	8.7	6.9	0.0	2.1	0.0	0.1	0.7	9.7	7.2	3.1	13.3	17.0	9.6	5.3	7.6	20.4	8.0	11.3	7.4	0.3	0.1	6.8	21.0	26.7	6.6	1.8	33.5	14.0	0.0	0.7	0.2	12.6	15.0	14.3	0.0	0.5	10.5	24.5	14.1	33.8	23.9	13.5	4.4	0.9	1.6	17.8	0.1	0.6	0.2	3.3	0.0	5.1	0.0	10.9	0.0	24.1	6.9	0.1	19.6	12.0	0.2	13.3	8.3	0.7	0.8	9.1	7.6	13.3	10.2	9.1	0.8	0.2	4.7	22.9	0.0	1.9	0.0	2.1	0.0	0.0	0.2	0.0	8.7	0.1	0.0	6.9	8.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	7.7	10.3	5.9	9.5	7.5	8.8	9.3	4.5	10.1	5.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.2	5.2	0.0	151.1	34.9	1.5	0.0	0.0	0.0	0.0	0.8	19.3	0.0	0.0	0.0	0.0	35.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	14.4	0.0	0.0	1.3	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	87.5	0.0	0.0	0.0
OSBPL3	"KIAA0704, ORP-3, ORP3, OSBP3"	ENSG00000070882	"Oxysterol binding protein like 3"	Q9H4L5	7	24796539-24981634	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 75.0;Club cells: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 44.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000691, HPA048401"	Enhanced		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA000691: AB_1854814, HPA048401: AB_2680386"	"unprognostic (3.57e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.11e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (2.34e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-2)"	3.7	2.2	3.9	18.2	9.5	3.8	6.6	1.2	16.0	12.1	6.1	6.2	0.7	9.8	3.8	3.7	10.2	6.2	10.4	5.3	4.3	4.3	14.4	1.9	9.0	10.9	4.2	7.4	8.4	3.9	23.1	4.2	6.3	3.1	4.3	6.7	3.7	6.9	2.9	6.7	12.8	10.4	4.0	6.7	10.2	8.7	3.5	4.1	13.9	16.8	7.2	14.7	12.4	9.6	3.7	3.5	6.3	2.1	8.1	9.8	2.4	14.7	4.0	3.0	5.5	6.8	13.7	6.7	16.7	18.7	7.9	12.5	10.0	19.7	8.2	2.4	17.9	10.4	13.0	9.0	12.6	12.2	4.9	3.7	1.9	5.9	7.5	9.7	5.6	44.0	6.7	10.5	10.2	12.4	10.1	11.7	7.2	10.3	11.5	13.3	0.0	3.4	6.8	5.8	14.1	5.2	2.7	8.3	3.3	7.9	10.5	0.6	6.2	11.4	8.2	2.5	9.3	4.2	0.5	13.9	3.5	7.0	18.9	12.5	8.0	11.5	20.7	7.6	9.2	38.7	6.3	2.1	1.5	9.8	1.8	8.4	3.7	6.2	6.3	3.5	1.7	2.1	4.2	0.4	8.1	1.2	2.5	9.8	2.4	3.9	9.5	1.2	16.0	4.3	4.3	4.2	7.4	3.1	4.1	0.0	25.0	4.5	6.6	10.8	0.0	4.7	0.0	75.0	30.7	24.4	0.0	7.1	3.3	3.3	0.3	2.9	2.9	0.0	3.4	1.3	2.6	2.1	0.0	0.2	9.4	0.0	1.7	4.3	12.0	0.0	0.6	9.2	15.1	7.2	0.5	5.8	14.9	3.5	0.0	0.5	0.1	0.0	2.2	0.5	4.1	6.9	3.3	13.1	3.4	12.9
CYCS	"CYC, HCS"	ENSG00000172115	"Cytochrome c, somatic"	P99999	7	25120091-25125361	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Electron transport, Respiratory chain, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 109.6;skeletal muscle: 103.7"	"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 1409.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004222, CAB005126, CAB018597"	Enhanced		Supported	Mitochondria		NA	NA		190000000	Mitochondria		"CAB004222: AB_627385, CAB005126: AB_2090472, CAB018597: AB_627383"	"unprognostic (3.06e-2)"	"unprognostic (3.39e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.81e-4)"	"unprognostic (4.44e-2)"	"unprognostic (7.04e-3)"	"unprognostic (5.67e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.30e-5)"	"unprognostic (1.18e-1)"	"unprognostic (4.94e-2)"	"unprognostic (8.75e-3)"	"unprognostic (7.04e-2)"	20.3	29.3	29.8	20.0	44.8	17.1	14.7	25.1	41.1	12.1	62.1	13.3	9.6	35.4	11.4	10.7	26.6	11.0	13.1	109.6	30.2	26.4	39.8	37.0	13.4	13.8	30.7	34.7	12.2	9.3	24.8	18.6	10.3	29.9	13.7	58.5	13.5	14.9	15.7	103.7	11.3	30.2	21.8	28.0	15.6	24.3	23.5	18.1	17.3	18.3	41.2	20.0	15.9	14.3	35.5	38.0	17.1	38.3	25.2	31.0	25.2	41.7	23.4	25.3	35.2	14.6	11.2	26.1	40.3	16.6	30.2	35.1	38.7	28.6	48.1	19.8	17.6	89.2	49.7	51.4	37.9	53.3	14.2	23.0	40.0	27.8	27.4	22.9	91.5	35.7	14.9	34.0	30.1	65.4	13.1	27.0	29.5	73.3	51.0	32.0	19.3	49.9	35.6	47.4	94.1	44.3	35.2	30.4	46.0	47.0	41.0	51.4	24.4	21.0	89.6	32.4	46.5	46.4	54.8	19.4	27.8	50.5	42.8	74.3	52.8	61.1	107.5	37.0	66.7	76.8	17.1	20.0	14.0	25.3	38.3	31.0	35.5	23.4	26.8	38.0	26.0	22.4	26.8	3.0	25.2	33.6	27.8	29.5	25.2	29.8	44.8	25.1	41.1	30.2	26.4	30.7	34.7	29.9	18.1	77.4	123.3	298.1	610.6	612.7	158.0	675.3	165.6	120.5	170.6	174.5	72.6	180.3	1409.2	260.2	374.4	142.6	539.3	116.8	187.6	286.9	225.4	312.0	210.9	174.2	320.2	125.5	369.3	82.3	121.9	99.1	83.4	292.4	560.1	339.0	300.1	181.9	228.9	349.1	88.1	469.8	154.2	135.8	467.2	297.7	184.8	625.2	292.1	228.4	388.1	691.0
C7orf31		ENSG00000153790	"Chromosome 7 open reading frame 31"	Q8N865	7	25134697-25180356	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 60.9"	"Group enriched"	"Detected in many"	17	"Early spermatids: 399.0;Late spermatids: 665.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 18.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA020346			Uncertain	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria"	Cytosol	"HPA020346: AB_1845758"	"unprognostic (3.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.90e-3)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.12e-3)"	"unprognostic (8.26e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.15e-2)"	2.4	6.2	1.5	4.8	3.1	1.3	2.3	4.0	1.6	3.3	5.1	2.9	2.0	3.3	3.3	2.9	2.4	2.6	3.7	3.1	1.9	1.5	2.6	1.2	2.8	7.0	2.0	2.2	4.6	1.8	4.3	2.1	1.1	2.3	3.2	3.6	4.1	6.0	2.3	0.9	1.8	3.9	2.4	2.9	3.7	3.4	60.9	2.4	5.9	4.6	0.9	3.3	3.5	5.1	3.0	5.9	2.3	1.3	2.8	2.8	0.9	2.8	2.0	4.5	5.2	1.8	1.0	2.5	1.2	4.9	3.7	5.6	3.9	2.7	7.2	1.9	2.2	14.6	1.1	5.0	1.4	4.0	3.4	4.9	3.4	0.2	5.2	4.3	5.5	8.3	3.1	3.9	3.0	0.7	2.6	0.7	6.2	5.1	4.0	0.9	0.0	5.6	7.0	1.8	6.6	1.8	7.0	5.2	1.1	2.5	3.6	1.3	3.8	1.2	4.9	4.6	6.6	0.8	9.2	1.0	2.3	6.2	0.0	1.8	18.0	5.7	10.3	0.7	5.3	10.6	1.4	1.3	2.3	1.7	0.6	2.3	3.0	1.1	1.5	1.7	2.1	2.8	2.2	0.1	2.8	0.8	5.9	2.8	0.9	1.5	3.1	4.0	1.6	1.9	1.5	2.0	2.2	2.3	2.4	0.0	5.3	2.9	2.3	1.0	0.9	1.0	2.5	5.3	0.0	0.0	0.0	2.8	3.3	1.0	399.0	2.2	2.5	0.0	3.4	2.1	2.5	0.9	0.0	1.0	2.4	0.0	4.1	1.8	5.0	665.4	6.6	2.9	3.3	4.6	2.8	7.7	3.2	6.5	4.9	0.6	0.5	0.0	2.1	31.4	12.4	0.5	1.9	4.3	6.0	0.9
NPVF	"C7orf9, RFRP"	ENSG00000105954	"Neuropeptide VF precursor"	Q9HCQ7	7	25224570-25228486	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"brain: 9.5;lymphoid tissue: 2.9;retina: 7.0"	"Cell type enriched"	"Detected in some"	44	"Muller glia cells: 336.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	95	"hypothalamus: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	17	"hypothalamus: 7.2"	"Region enriched"	"Detected in some"	4	"hypothalamus: 3.8"	HPA041733	Enhanced				"Secreted in other tissues"	NA	NA					"HPA041733: AB_10794524"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	336.5	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NFE2L3	Nrf3	ENSG00000050344	"Nuclear factor, erythroid 2 like 3"	Q9Y4A8	7	26152240-26187125	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 54.9"	"Group enriched"	"Detected in many"	14	"Cytotrophoblasts: 226.3;Syncytiotrophoblasts: 584.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 44.0;NTERA-2: 36.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055889	Enhanced		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Vesicles"		"HPA055889: AB_2682958"	"unprognostic (4.99e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.36e-3)"	"unprognostic (5.37e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.00e-3)"	"unprognostic (7.29e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.88e-2)"	"prognostic unfavorable (6.62e-5)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (7.58e-12)"	"prognostic favorable (2.14e-4)"	"unprognostic (2.40e-1)"	"unprognostic (8.25e-2)"	"unprognostic (4.13e-3)"	3.5	2.5	0.8	7.8	1.2	1.6	4.1	6.2	1.6	1.8	6.7	4.0	2.4	6.2	1.9	1.7	3.1	2.4	7.1	3.6	1.3	1.1	4.2	2.3	5.8	6.9	2.5	0.8	1.7	7.5	0.0	2.1	54.9	2.1	3.7	4.0	2.1	7.7	0.4	3.4	8.2	7.1	0.8	3.7	10.4	5.6	2.5	1.5	11.2	1.6	1.5	8.9	3.1	2.1	1.4	2.8	0.8	1.1	1.1	2.6	0.4	12.7	1.1	0.5	1.3	0.0	0.0	44.0	2.5	5.0	4.9	9.1	8.4	22.3	0.9	16.8	0.2	18.6	2.7	1.9	4.3	11.3	8.7	2.7	1.7	1.8	6.1	3.4	1.5	17.0	0.4	0.5	2.0	0.7	7.3	11.4	3.6	2.6	22.6	1.0	1.7	1.0	2.7	36.9	3.5	4.5	1.5	0.1	6.3	6.7	12.6	4.0	4.7	0.0	1.0	0.4	12.8	0.6	0.9	23.9	0.4	0.7	0.2	10.2	13.8	21.9	1.0	0.0	5.5	17.0	0.0	1.1	0.0	0.5	1.1	1.6	1.0	2.1	1.0	2.8	1.4	1.2	0.7	0.8	1.1	0.3	0.9	2.6	0.4	0.8	1.2	6.2	1.6	1.3	1.1	2.5	0.8	2.1	1.5	6.0	3.2	0.8	2.8	1.5	1.2	1.4	17.8	1.4	5.7	10.4	0.0	226.3	0.0	9.8	0.7	3.8	3.3	0.0	4.7	28.3	2.3	3.6	27.6	0.0	21.3	0.0	1.2	3.1	12.9	0.0	0.0	11.1	1.7	5.4	6.5	0.9	11.2	4.3	0.0	0.3	1.3	0.0	1.0	0.3	5.7	1.4	584.2	4.9	8.3	5.4
HNRNPA2B1	HNRPA2B1	ENSG00000122566	"Heterogeneous nuclear ribonucleoprotein A2/B1"	P22626	7	26189927-26201529	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Ribonucleoprotein, RNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001666, HPA005812, CAB012403, HPA065537"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		11000000	Nucleoplasm		"CAB012403: , HPA001666: AB_1850836, HPA005812: AB_2667441, HPA065537: AB_2685507"	"unprognostic (1.19e-1)"	"unprognostic (4.45e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.39e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.04e-3)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.25e-2)"	"unprognostic (9.12e-3)"	"unprognostic (4.35e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (5.12e-4)"	"prognostic unfavorable (8.01e-5)"	"unprognostic (6.74e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.56e-2)"	82.2	97.4	85.1	105.3	106.3	90.9	74.4	123.3	87.4	77.1	85.7	89.4	68.7	87.5	92.6	71.9	90.4	75.1	51.7	87.9	82.4	71.8	113.4	103.7	76.2	127.7	118.6	57.0	121.0	75.7	107.2	121.2	100.7	96.3	75.5	98.6	64.4	71.4	66.5	167.2	58.7	94.8	73.7	139.7	116.5	74.1	73.1	135.4	180.3	81.9	104.4	140.7	74.2	128.8	33.7	46.5	35.1	52.4	32.1	42.5	36.0	124.0	105.9	154.2	115.6	39.7	36.3	71.4	79.6	62.1	88.0	79.7	97.8	90.4	226.9	76.1	73.8	105.0	86.6	164.9	104.0	124.0	70.5	100.5	137.5	127.8	116.9	33.3	148.0	94.2	34.3	54.5	83.7	76.4	46.4	90.8	104.9	161.7	74.2	88.8	100.4	158.3	173.1	136.6	95.1	81.7	147.2	125.3	95.0	101.6	108.6	90.1	110.5	95.7	94.3	58.1	98.3	105.7	128.9	78.4	49.5	102.5	67.0	135.8	98.6	195.4	215.9	63.8	168.7	93.2	17.4	38.7	35.1	42.5	52.4	38.6	33.7	35.5	36.6	46.5	29.2	35.6	35.6	13.0	32.1	48.4	43.6	36.1	36.0	85.1	106.3	123.3	87.4	82.4	71.8	118.6	57.0	96.3	135.4	452.6	512.0	456.4	620.8	656.0	459.5	635.5	267.5	721.4	702.9	326.2	280.8	790.3	391.3	484.7	96.5	561.1	396.4	280.4	392.8	789.3	528.7	417.7	617.9	353.4	530.6	295.6	471.8	332.7	355.7	124.0	380.5	569.8	372.8	501.4	392.2	570.4	369.1	357.7	366.7	366.6	518.1	433.4	564.3	596.8	448.9	524.9	905.5	489.7	465.4	566.2
CBX3	HP1Hs-gamma	ENSG00000122565	"Chromobox 3"	Q13185	7	26201162-26213356	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB001973, HPA004902"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes		40000	Nucleoplasm	"Nuclear bodies"	"CAB001973: , HPA004902: AB_1850635"	"prognostic unfavorable (7.92e-4)"	"unprognostic (1.43e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.85e-2)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (2.20e-8)"	"unprognostic (2.13e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.71e-3)"	"prognostic unfavorable (4.00e-4)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.56e-7)"	"unprognostic (7.79e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.78e-2)"	40.7	49.4	41.2	54.3	38.8	65.8	69.4	37.4	45.9	33.9	38.4	20.3	39.0	49.8	39.5	42.1	36.4	33.9	28.6	43.3	39.0	40.8	51.1	45.8	37.0	68.6	44.9	37.2	45.3	31.8	22.4	27.5	45.4	51.1	30.7	43.7	23.7	35.0	45.6	60.4	27.1	56.4	46.7	66.9	54.0	29.3	45.1	33.7	92.3	32.1	38.2	65.0	39.8	38.1	38.8	37.4	55.2	48.4	39.5	60.7	35.1	50.3	22.3	47.7	47.1	17.2	31.3	37.6	39.6	30.2	30.2	30.7	26.3	42.6	76.6	32.0	26.1	64.7	40.3	39.8	33.0	49.4	21.1	29.7	43.7	29.4	29.3	18.9	69.0	42.5	22.9	29.0	23.8	34.2	37.5	40.7	48.9	69.9	37.9	51.1	28.8	66.5	83.3	60.7	43.8	32.3	43.6	44.3	63.2	44.0	28.3	58.4	64.8	32.8	69.8	36.3	52.9	59.3	62.7	30.2	27.5	49.9	32.0	52.5	56.3	81.1	130.3	23.9	59.5	123.9	47.8	38.4	55.2	34.6	47.6	42.8	38.8	51.7	42.7	37.4	35.8	55.0	54.0	39.3	39.5	48.4	30.5	60.7	35.1	41.2	38.8	37.4	45.9	39.0	40.8	44.9	37.2	51.1	33.7	101.3	77.8	131.1	75.5	127.6	104.6	114.5	129.9	139.2	130.8	61.1	72.6	154.4	119.3	152.3	115.5	136.8	88.3	303.7	123.2	293.9	107.2	64.5	211.9	239.9	127.2	47.7	105.7	149.1	266.0	31.0	126.2	175.5	99.5	110.0	127.3	132.2	139.2	87.7	92.3	112.3	126.4	77.6	91.0	234.4	415.8	94.4	226.4	163.9	186.9	86.2
SNX10		ENSG00000086300	"Sorting nexin 10"	Q9Y5X0	7	26291895-26374329	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"		"Disease mutation, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 67.6;brain: 39.0;liver: 37.4"	"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 242.1;Hofbauer cells: 146.8;Kupffer cells: 156.1;Macrophages: 186.4;Muller glia cells: 262.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 67.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 27.2;U-937: 22.3;WM-115: 77.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015605, HPA064782"	Approved		Supported	Nucleoplasm,Nucleoli,Microtubules		NA	NA			"Nucleoplasm, Microtubules"	Nucleoli	"HPA015605: AB_1857342, HPA064782: AB_2685349"	"unprognostic (6.42e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (6.92e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.51e-2)"	"unprognostic (4.87e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (8.06e-5)"	"unprognostic (1.12e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.50e-1)"	17.7	8.7	20.2	18.6	17.9	20.9	6.7	13.2	39.0	2.9	3.3	2.1	0.1	2.5	5.4	0.8	1.8	1.9	5.2	1.3	22.2	32.7	21.3	37.4	22.4	18.0	27.8	20.8	1.0	5.0	0.6	3.0	8.9	36.2	2.2	3.9	1.8	1.4	1.5	0.9	1.0	3.6	5.4	15.4	22.1	2.3	3.0	2.1	3.8	1.9	0.1	13.6	6.3	1.8	16.3	20.1	67.6	30.9	9.0	5.6	11.6	13.9	1.3	0.0	2.6	0.0	0.0	15.2	0.0	1.0	0.0	0.0	0.1	4.7	6.1	11.0	0.0	9.6	0.4	3.5	0.9	0.0	8.4	3.3	0.6	0.1	9.2	0.0	13.0	2.3	0.1	1.4	0.0	1.1	0.0	0.2	7.9	0.3	0.0	0.0	2.4	5.4	13.7	4.0	0.1	1.3	0.0	0.0	0.3	27.2	3.0	6.0	1.8	3.0	2.2	15.8	5.0	4.0	18.6	0.0	0.0	3.3	0.0	3.4	4.7	3.7	4.1	0.1	22.3	77.5	8.2	29.2	0.7	4.0	30.9	3.8	16.3	2.8	3.4	20.1	14.5	1.5	2.6	67.6	9.0	30.1	7.4	5.6	11.6	20.2	17.9	13.2	39.0	22.2	32.7	27.8	20.8	36.2	2.1	3.0	17.1	49.9	1.0	4.7	17.7	1.6	20.4	1.4	7.9	22.7	2.0	11.6	242.1	51.3	0.9	5.6	2.6	23.3	23.5	64.7	3.6	2.8	31.1	90.6	146.8	33.4	9.1	2.5	156.1	0.7	1.1	186.4	8.5	49.5	2.5	262.3	22.1	0.0	0.0	123.2	20.4	0.0	3.3	1.6	28.0	2.6	24.0	38.8	9.7	0.9
SKAP2	"RA70, SAPS, SCAP2, SKAP-HOM, SKAP55R"	ENSG00000005020	"Src kinase associated phosphoprotein 2"	O75563	7	26667062-26995239	"Predicted intracellular proteins"	"B-cell activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 255.1;Kupffer cells: 178.5;Late spermatids: 271.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 47.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005560, HPA024045"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		3200000	Nucleoplasm	Cytosol	"HPA005560: AB_2667360, HPA024045: AB_2671416"	"unprognostic (8.52e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.62e-2)"	"unprognostic (7.91e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.51e-2)"	20.8	22.5	11.5	29.4	12.9	12.8	28.5	6.0	12.8	7.7	15.3	7.6	11.0	10.5	5.2	15.4	14.0	9.4	9.6	12.6	9.5	12.1	20.4	7.8	31.6	36.4	12.0	8.9	13.3	6.1	25.1	10.9	5.3	15.5	10.2	15.0	2.5	5.8	9.8	8.3	8.6	16.5	21.1	42.6	31.8	11.7	10.1	11.5	6.4	6.1	1.9	19.3	19.3	28.1	9.9	12.3	37.3	18.0	8.3	5.1	6.7	11.7	6.2	0.6	15.5	2.9	2.4	3.8	4.8	7.2	2.4	6.0	4.9	47.4	9.1	21.1	9.0	17.5	6.3	8.5	4.9	5.0	5.1	13.7	10.0	1.8	6.5	3.9	18.4	35.4	10.6	4.6	6.9	9.5	0.4	14.4	0.0	5.3	4.7	9.4	2.2	0.0	9.3	0.5	10.5	6.1	11.9	1.5	0.7	29.3	9.2	7.7	0.2	8.7	4.7	6.3	3.7	6.5	9.7	21.0	4.0	0.1	13.3	4.9	7.5	9.5	15.9	9.5	23.9	15.2	8.2	12.6	19.4	3.7	15.0	5.1	9.9	2.1	3.0	9.6	8.0	0.5	2.9	37.3	8.3	18.0	12.3	3.5	6.7	11.5	12.9	6.0	12.8	9.5	12.1	12.0	8.9	15.5	11.5	17.9	29.9	77.3	32.3	23.6	12.3	4.7	5.1	14.7	9.1	22.7	11.8	11.1	54.7	7.9	255.1	35.8	46.2	23.3	20.3	18.4	9.5	16.9	50.9	8.3	82.6	4.8	41.3	90.9	178.5	271.4	8.3	120.8	18.6	28.9	64.6	13.0	15.8	31.6	10.3	65.3	12.7	0.0	12.0	19.9	34.3	37.9	15.6	34.8	45.4	27.2
HOXA1	"HOX1, HOX1F"	ENSG00000105991	"Homeobox A1"	P49639	7	27092993-27095996	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 12.9"	"Cell type enhanced"	"Detected in some"	7	"Basal keratinocytes: 2.1;granulocytes: 2.3;Intestinal endocrine cells: 2.9;Ito cells: 3.1;Kupffer cells: 1.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"pons and medulla: 5.0"	"Group enriched"	"Detected in many"	5	"intermediate monocyte: 6.0;NK-cell: 6.8;non-classical monocyte: 8.7"	"Group enriched"	"Detected in many"	6	"monocytes: 8.7;NK-cells: 6.8"	"Cell line enhanced"	"Detected in many"		"HMC-1: 12.8"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.0"	"Group enriched"	"Detected in some"	5	"midbrain: 1.3;pons and medulla: 1.9"							NA	NA						"unprognostic (7.39e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.17e-4)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (6.73e-5)"	"unprognostic (4.70e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.06e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.77e-3)"	"unprognostic (1.17e-1)"	1.5	1.2	0.2	3.7	0.4	0.4	2.9	0.2	0.3	1.1	1.9	0.4	0.0	0.4	1.2	3.6	8.2	2.2	2.9	0.9	0.2	0.2	2.9	0.5	0.8	2.1	0.4	0.0	3.8	0.4	3.2	0.3	0.9	5.0	3.7	1.9	0.3	0.3	5.3	0.7	4.1	3.0	2.6	4.9	8.0	1.2	0.8	0.0	3.1	0.4	1.3	5.2	12.9	10.6	0.4	1.2	1.0	8.7	6.8	1.3	0.6	5.4	2.4	0.2	3.1	0.0	0.0	5.0	0.7	3.2	2.1	2.5	12.2	3.5	3.8	7.3	1.9	7.8	11.9	4.3	3.5	1.5	0.3	12.6	4.9	0.2	0.1	0.6	4.1	12.8	2.3	3.5	2.5	5.1	0.0	3.1	3.9	5.3	0.0	4.2	0.1	0.0	6.7	0.0	2.2	0.5	4.7	1.4	0.0	7.0	5.3	0.4	0.0	2.7	0.0	3.3	4.3	0.0	1.9	2.3	0.5	5.0	3.7	0.9	0.0	0.0	1.7	1.9	7.3	5.2	1.0	0.3	0.6	1.2	6.0	1.2	0.4	1.3	1.2	1.2	0.0	0.6	1.2	0.3	6.8	8.7	0.0	1.2	0.6	0.2	0.4	0.2	0.3	0.2	0.2	0.4	0.0	5.0	0.0	0.0	0.0	0.0	1.2	2.1	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.2	0.2	2.3	0.0	0.1	0.0	2.9	3.1	1.9	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.1	1.0	0.0	1.0	0.9	1.1
HOXA2	HOX1K	ENSG00000105996	"Homeobox A2"	O43364	7	27100354-27102811	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 18.1"	"Cell type enhanced"	"Detected in some"	17	"Intestinal endocrine cells: 4.6;Ito cells: 6.2;Melanocytes: 1.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	44	"pons and medulla: 15.7"	"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 16.8;HaCaT: 6.9;RPTEC TERT1: 5.5"	"Region enriched"	"Detected in single"	35	"pons and medulla: 6.1"	"Region enriched"	"Detected in single"	27	"pons and medulla: 7.7"	HPA078220			Approved	Nucleoplasm,Vesicles		Yes	NA			"Nucleoplasm, Vesicles"		"HPA078220: AB_2686880"	"unprognostic (7.30e-2)"	"unprognostic (4.90e-4)"	"unprognostic (2.81e-1)"	"unprognostic (7.43e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.58e-2)"	"unprognostic (4.98e-9)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.28e-2)"	2.7	1.6	0.3	1.9	0.1	0.0	2.6	0.1	0.2	1.4	4.5	0.2	8.7	1.5	3.4	9.7	8.3	6.3	4.9	1.8	0.1	0.0	4.2	0.7	4.7	1.9	0.3	0.1	3.8	0.4	9.6	0.1	0.1	15.7	2.8	3.5	0.1	0.1	4.1	1.2	2.7	4.3	2.4	18.1	2.9	3.7	0.8	0.1	3.8	2.2	2.9	3.3	3.2	3.5	0.0	0.0	1.8	0.3	0.0	0.1	0.0	1.2	0.8	4.2	16.8	0.0	0.0	0.0	0.2	0.1	0.0	0.1	2.2	4.1	0.2	1.9	0.2	2.3	6.9	0.2	0.0	0.0	0.0	2.4	0.0	0.1	0.4	1.9	0.1	0.3	1.0	0.0	3.6	3.4	0.0	2.8	0.4	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	1.1	1.0	0.7	0.0	5.5	0.7	1.2	0.0	0.2	0.0	1.1	0.3	0.0	0.0	2.8	0.0	0.2	1.2	0.6	0.0	0.0	0.1	0.1	0.7	3.0	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.1	0.2	0.1	0.0	0.3	0.1	15.7	0.1	0.0	0.0	0.0	0.3	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	4.6	6.2	0.0	0.0	0.0	0.0	1.7	0.0	1.3	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.4	0.3
HOXA3	"HOX1, HOX1E"	ENSG00000105997	"Homeobox A3"	O43365	7	27106184-27152581	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ito cells: 9.2;Mucus-secreting cells: 14.6;Proximal tubular cells: 11.0;Undifferentiated cells: 13.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"pons and medulla: 6.6"	"Cell type enhanced"	"Detected in some"		"neutrophil: 3.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 19.1;CACO-2: 12.3;CAPAN-2: 32.9;HEK 293: 14.7;WM-115: 17.6"	"Region enriched"	"Detected in single"	31	"pons and medulla: 2.9"	"Region enriched"	"Detected in single"	34	"pons and medulla: 5.0"	HPA029157	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029157: AB_10601020"	"unprognostic (1.32e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.85e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.05e-2)"	"unprognostic (8.61e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.82e-2)"	5.3	2.6	0.5	11.0	0.5	0.0	8.9	0.5	0.5	3.9	13.7	0.7	9.8	3.9	7.5	7.2	6.9	16.0	4.7	4.7	0.5	0.0	9.9	1.5	5.2	3.5	1.3	0.5	5.5	0.6	5.4	0.5	0.5	6.6	5.6	4.9	0.5	0.5	4.2	7.2	3.8	7.8	3.6	4.7	2.5	6.3	2.7	0.5	6.7	2.5	9.8	2.7	9.4	6.0	0.5	1.3	3.8	1.1	1.3	0.5	0.3	5.7	6.8	0.0	19.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	12.3	32.9	0.9	9.5	0.5	2.6	7.7	0.3	0.8	0.0	0.2	14.7	0.2	0.1	9.9	0.6	0.3	0.3	1.2	0.0	1.5	1.8	0.0	1.8	0.8	0.6	0.1	0.7	0.3	0.0	0.5	0.0	1.6	4.2	6.8	2.2	0.0	5.6	2.6	2.8	0.0	1.0	0.0	2.7	0.3	0.5	0.4	8.1	0.0	1.0	2.0	1.5	0.0	0.0	0.3	0.6	1.2	17.6	1.7	0.2	0.7	0.5	0.2	0.0	0.5	0.3	0.5	1.3	0.1	0.0	0.3	3.8	1.3	1.1	0.1	0.5	0.3	0.5	0.5	0.5	0.5	0.5	0.0	1.3	0.5	6.6	0.5	0.0	0.0	0.0	3.0	1.0	0.0	0.6	0.0	0.0	0.0	3.5	0.0	0.0	5.0	0.0	6.5	1.4	5.0	0.0	0.0	0.0	1.1	2.2	1.1	0.0	0.1	0.0	4.1	9.2	0.3	7.3	0.6	0.0	3.3	0.0	14.6	0.0	0.0	7.0	0.0	11.0	0.0	0.0	4.2	1.2	0.4	1.1	0.0	0.0	13.6	2.6
HOXA4	"HOX1, HOX1D"	ENSG00000197576	"Homeobox A4"	Q00056	7	27128507-27130799	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Distal tubular cells: 13.3;Ito cells: 12.3;Proximal tubular cells: 10.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	18	"pons and medulla: 26.7"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 19.1;HEK 293: 14.5;REH: 13.4;WM-115: 19.0"	"Region enriched"	"Detected in single"	47	"pons and medulla: 11.9"	"Region enriched"	"Detected in single"	60	"pons and medulla: 24.6"	HPA060088	Approved		Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA060088: AB_2684200"	"unprognostic (3.37e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.59e-4)"	"unprognostic (3.93e-2)"	8.9	6.2	0.4	2.2	0.3	0.2	11.6	0.3	1.2	2.7	7.5	0.4	8.2	3.5	3.9	10.3	27.5	18.1	5.7	4.8	0.3	0.0	9.6	2.0	10.5	3.0	1.4	0.3	8.8	1.1	17.6	0.3	0.5	26.7	4.1	1.7	0.3	0.7	5.6	29.8	3.5	5.2	4.9	25.8	5.5	9.3	1.6	0.4	0.3	2.3	3.4	1.2	5.5	10.9	0.9	1.4	0.1	0.5	0.1	0.3	0.2	6.0	2.0	0.0	19.1	0.0	0.0	1.2	0.5	0.6	2.0	2.0	3.8	1.2	1.6	0.1	1.8	1.8	2.6	0.7	0.3	1.6	0.0	14.5	0.0	0.6	8.7	2.2	2.0	3.6	2.1	1.6	6.8	0.5	0.0	6.7	0.5	0.0	0.0	6.5	1.6	0.0	7.1	0.0	2.1	4.7	13.4	2.9	0.1	9.6	1.4	0.9	0.0	1.9	0.0	7.0	0.7	0.4	1.0	8.8	0.0	3.1	5.0	0.1	0.0	0.0	0.7	4.1	3.3	19.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.2	0.2	0.2	0.0	0.3	0.0	0.0	0.1	0.5	1.4	0.0	0.2	0.4	0.3	0.3	1.2	0.3	0.0	1.4	0.3	26.7	0.4	0.0	0.0	0.0	2.9	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.4	1.9	0.7	0.0	0.0	0.5	0.3	0.6	0.0	0.0	0.2	0.0	2.9	12.3	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	10.1	0.0	0.0	2.1	0.2	2.7	1.1	0.1	0.0	2.0	2.4
HOXA5	"HOX1, HOX1C"	ENSG00000106004	"Homeobox A5"	P20719	7	27141052-27143668	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 42.0"	"Cell type enhanced"	"Detected in many"	7	"Ito cells: 16.0;Paneth cells: 15.9;Proximal tubular cells: 21.3;Undifferentiated cells: 18.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	46	"pons and medulla: 16.3"	"Group enriched"	"Detected in some"	4	"basophil: 3.0;neutrophil: 1.6;NK-cell: 2.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.0;NK-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 33.1;HEK 293: 56.5;RPTEC TERT1: 12.8"	"Region enriched"	"Detected in single"	88	"pons and medulla: 23.0"	"Region enriched"	"Detected in single"	22	"pons and medulla: 5.5"							NA	NA						"unprognostic (2.43e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.87e-1)"	"unprognostic (7.80e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.02e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.00e-2)"	"unprognostic (4.37e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.00e-1)"	6.8	42.0	0.2	2.1	0.2	1.2	10.9	0.2	0.3	1.9	6.6	1.0	16.0	1.1	6.0	25.0	12.3	22.1	2.5	1.4	0.2	0.0	16.8	1.8	23.9	1.5	0.2	0.2	9.3	1.3	2.0	0.5	0.3	16.3	3.9	3.3	0.2	0.2	7.1	5.6	3.4	6.8	3.0	19.4	4.4	5.6	2.6	0.2	0.2	1.3	0.2	0.2	6.6	3.3	0.2	0.4	3.0	0.5	2.5	0.2	0.1	1.9	1.0	0.0	33.1	0.0	0.0	0.1	0.5	0.4	0.6	0.5	0.6	3.4	1.0	4.9	1.0	0.7	2.6	1.8	0.1	0.6	0.4	56.5	0.7	0.4	1.9	0.3	1.2	0.8	3.7	0.2	1.1	1.9	0.0	7.3	1.9	0.1	0.0	1.1	0.6	0.0	0.3	0.0	0.7	1.0	4.5	0.1	0.0	12.8	2.6	3.9	0.0	2.5	0.0	1.1	0.1	0.4	0.4	2.9	0.1	0.4	2.0	1.3	0.0	0.0	1.1	0.2	3.6	3.6	3.0	0.4	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.4	0.2	0.2	0.1	1.6	2.5	0.5	0.4	0.1	0.1	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	16.3	0.2	0.0	0.6	0.0	3.8	3.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	5.1	9.3	0.0	0.0	0.0	1.3	2.2	0.0	0.0	0.6	0.0	8.6	16.0	4.1	0.0	0.3	0.9	1.7	1.0	8.4	0.0	0.0	15.9	0.0	21.3	0.0	0.0	3.3	0.2	0.7	2.5	0.1	0.0	18.1	5.0
HOXA6	"HOX1, HOX1B"	ENSG00000106006	"Homeobox A6"	P31267	7	27145396-27150603	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 10.4"	"Cell type enhanced"	"Detected in some"	12	"Distal tubular cells: 5.0;Enterocytes: 3.5;Intestinal endocrine cells: 8.6;Paneth cells: 4.8;Undifferentiated cells: 4.4"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	8	"basophil: 5.9;NK-cell: 2.0"	"Group enriched"	"Detected in many"	8	"granulocytes: 5.9;NK-cells: 2.0"	"Group enriched"	"Detected in some"	9	"AN3-CA: 29.3;HEK 293: 39.9"	"Region enriched"	"Detected in single"	34	"pons and medulla: 3.5"					"HPA004203, HPA077900"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"HPA004203: AB_1079079, HPA077900: "	"unprognostic (1.70e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.06e-2)"		"unprognostic (9.73e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.94e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (2.03e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.81e-2)"		"unprognostic (3.93e-1)"	3.2	2.9	0.0	1.2	0.0	0.0	2.3	0.0	0.0	1.6	5.4			0.0	6.7	4.6	0.1	10.4	0.0	0.0	0.0	0.0	5.9	0.0	2.3	0.8	0.0		0.0	0.0	0.5	0.0	0.0		2.5	1.5		0.0	2.2	1.0	3.2	4.2	1.4	1.0	0.0	1.2	0.0			0.0		0.0	4.3	1.3	0.1	0.5	5.9	0.1	2.0	0.2	0.0	0.5	0.9	0.0	29.3	0.0	0.0	0.1	0.2	0.3	0.2	0.3	0.7	3.4	0.7	1.1	0.2	0.1	1.3	0.7	0.0	0.0	0.8	39.9	0.4	0.5	0.4	0.0	0.6	1.0	2.4	0.0	0.0	0.3	0.0	1.3	0.9	0.2	0.0	0.3	0.3	0.0	0.1	0.0	0.1	1.0	3.8	0.0	0.0	2.8	1.8	3.1	0.0	1.3	0.1	0.6	0.0	0.3	0.3	0.0	0.0	0.4	1.6	1.0	0.0	0.0	0.6	0.0	2.8	2.9	5.9	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	2.0	0.0	0.5	0.2	0.0											0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	5.0	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.1	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	4.8	0.0	1.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	4.4	1.0
HOXA7	"HOX1, HOX1A"	ENSG00000122592	"Homeobox A7"	P31268	7	27153716-27157936	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 27.8"	"Group enriched"	"Detected in many"	5	"Distal tubular cells: 111.0;Proximal tubular cells: 39.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	14	"pons and medulla: 9.2"	"Cell type enriched"	"Detected in some"	5	"NK-cell: 7.7"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 7.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 19.7;RPTEC TERT1: 24.4;SCLC-21H: 19.7"	"Region enriched"	"Detected in single"	12	"pons and medulla: 1.4"	"Region enriched"	"Detected in single"	10	"pons and medulla: 2.9"	HPA074048			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA074048: AB_2686655"	"unprognostic (5.40e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (3.30e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.15e-5)"	"unprognostic (9.08e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-1)"	6.5	14.5	0.2	4.8	0.2	0.0	11.2	0.3	0.6	7.3	10.0	0.2	7.9	0.0	5.0	15.4	3.0	12.2	0.5	0.2	0.2	0.0	25.4	0.4	2.6	3.5	0.2	0.2	6.2	0.2	0.3	0.2	1.3	9.2	8.2	7.2	0.2	0.2	8.9	27.8	8.2	6.1	8.1	14.3	3.7	3.2	2.7	0.2	1.6	0.9	0.2	1.1	11.4	6.7	0.2	0.9	0.0	0.0	7.7	1.6	0.2	6.9	2.4	0.0	7.5	0.0	0.0	0.4	2.5	4.3	5.2	6.0	3.6	2.7	4.8	7.0	1.9	0.2	4.8	19.7	0.0	3.1	0.0	12.4	0.3	2.8	0.1	0.5	0.4	0.2	4.1	0.2	0.6	7.0	0.0	9.8	8.4	0.0	0.0	1.9	1.2	0.0	1.1	0.3	5.0	0.7	2.5	4.6	0.0	24.4	4.8	19.7	0.0	13.6	0.0	0.0	1.4	0.2	1.9	0.8	0.0	4.7	14.0	2.4	0.0	0.1	0.1	0.0	9.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.2	0.9	0.0	0.0	0.1	0.0	7.7	0.0	0.6	0.4	0.2	0.2	0.2	0.3	0.6	0.2	0.0	0.2	0.2	9.2	0.2	0.0	0.0	0.0	7.5	8.0	0.0	0.3	0.0	0.0	0.0	12.2	0.0	0.4	111.0	0.0	15.9	2.2	3.0	0.0	0.0	4.6	2.7	4.0	0.0	0.0	0.2	0.0	15.5	0.0	0.0	2.1	0.6	0.5	3.3	0.0	11.2	0.0	0.1	10.4	0.0	39.0	0.0	0.0	7.3	0.4	0.2	10.8	0.2	0.9	15.7	2.6
HOXA9	"HOX1, HOX1G"	ENSG00000078399	"Homeobox A9"	P31269	7	27162435-27175180	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 35.1"	"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 46.4;Intestinal endocrine cells: 37.7;Proximal tubular cells: 60.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basophil: 5.4;myeloid DC: 6.0;NK-cell: 11.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.0;granulocytes: 5.4;NK-cells: 11.7"	"Cell line enhanced"	"Detected in some"		"HEK 293: 43.6;PC-3: 15.2;RPTEC TERT1: 15.0;SCLC-21H: 40.5;U-937: 14.5"									"HPA061982, HPA076200"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA061982: AB_2684651, HPA076200: "	"unprognostic (4.72e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.35e-2)"	"unprognostic (8.44e-3)"	"unprognostic (5.50e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.87e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.80e-3)"	"unprognostic (6.45e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.35e-1)"	3.2	3.4	0.2	8.8	0.1	2.4	8.7	0.1	0.2	15.5	12.8	0.2	4.1	0.0	10.4	16.8	1.4	12.2	0.3	0.1	0.1	0.0	35.1	0.1	0.8	0.7	0.1	0.1	2.0	0.1	0.0	0.1	1.4	0.4	16.6	4.5	0.2	0.5	5.6	21.0	13.3	8.2	13.1	0.7	1.0	0.0	2.4	0.1	2.6	0.3	0.3	0.3	16.2	11.4	0.5	6.0	5.4	1.0	11.7	1.5	0.5	12.7	0.0	0.0	6.4	2.1	1.6	0.0	5.1	4.1	0.4	0.4	0.8	0.5	0.1	0.5	2.7	0.0	11.9	8.2	0.0	0.4	0.0	43.6	0.1	0.3	0.0	0.2	0.0	0.1	2.2	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	15.2	2.7	0.0	0.0	15.0	0.2	40.5	0.0	5.4	0.0	0.1	0.2	0.0	10.7	0.4	0.0	4.0	4.9	0.0	0.0	0.0	0.0	0.0	14.5	0.0	5.4	1.0	0.0	1.5	0.2	0.2	0.2	0.0	0.1	6.0	0.5	0.3	0.1	0.9	11.7	0.4	1.9	0.2	0.5	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.8	10.6	22.2	0.0	0.6	0.0	0.0	0.0	17.4	0.0	0.3	46.4	0.0	0.0	0.2	7.9	0.0	0.0	0.3	10.8	14.2	0.0	0.0	0.3	0.0	37.7	0.0	4.8	0.0	0.0	1.6	5.0	0.0	19.1	0.0	0.0	18.4	0.0	60.8	0.0	0.0	3.6	0.0	0.6	24.1	0.2	4.4	19.4	11.5
AC004080.3		ENSG00000257184			7	27163535-27180013	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"cervix, uterine: 24.9;endometrium 1: 20.7;prostate: 12.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.8;BJ: 4.4;BJ hTERT+ SV40 Large T+: 1.5;HEK 293: 2.9;RPTEC TERT1: 2.2;U-937: 2.2"															NA	NA								"unprognostic (4.27e-1)"									"unprognostic (4.63e-1)"		"unprognostic (4.49e-1)"				1.6	0.2	0.3	1.8	0.3	0.0	0.2	0.3	0.3	24.9	6.9	0.0	1.0	0.0	20.7	2.1	0.2	0.2	0.0	0.3	0.2	0.3	4.7	0.3	0.2	0.0	0.3	0.0	0.3	0.3	0.0	0.3	4.6	0.0	12.9	1.1	0.0	0.2	1.2	6.9	0.3	0.5	6.7	0.2	0.2	0.2	1.0	0.0	0.0	0.3	0.0	0.0	7.8	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	1.2	0.2	4.4	0.8	1.5	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HOXA10	"HOX1, HOX1H"	ENSG00000253293	"Homeobox A10"	P31260	7	27170591-27180261	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 48.2;endometrium 1: 45.6"	"Cell type enhanced"	"Detected in many"	11	"Fibroblasts: 28.2;Intestinal endocrine cells: 65.4;Mucus-secreting cells: 25.9;Paneth cells: 38.6;Undifferentiated cells: 27.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 7.8;NK-cell: 12.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 7.8;NK-cells: 12.7"	"Cell line enhanced"	"Detected in many"		"HEK 293: 56.0;THP-1: 29.4;U-937: 30.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB019384, HPA071918"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB019384: , HPA071918: "	"unprognostic (4.98e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.13e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-2)"	5.9	2.7	0.3	4.6	0.4	1.2	2.5	0.3	0.3	48.2	15.9	0.3	4.0	0.0	45.6	5.4	0.3	3.4	0.5	0.3	0.3	0.0	7.9	0.3	0.3	0.5	0.3	0.3	1.3	0.3	0.0	0.3	7.7	0.3	22.2	5.3	0.3	0.6	6.6	28.0	2.4	3.1	19.2	0.4	0.3	0.0	3.4	0.3	2.2	0.3	0.3	0.3	19.0	7.6	0.2	1.2	7.8	0.1	12.7	2.3	0.3	6.2	1.3	0.0	18.7	9.4	9.1	0.0	12.4	8.5	5.7	5.3	1.8	5.5	0.0	3.5	9.7	0.0	7.0	4.8	0.0	4.2	2.8	56.0	6.5	4.8	0.1	0.2	2.8	9.9	5.7	0.3	0.4	0.0	0.0	8.6	1.9	0.2	0.0	4.1	0.0	0.0	19.0	0.0	5.0	5.9	0.6	1.2	0.0	10.9	2.9	14.8	0.0	4.3	0.0	0.0	2.1	0.0	29.4	0.0	0.0	5.2	6.6	0.0	0.1	0.0	0.0	0.0	30.5	0.1	7.8	0.1	0.3	2.3	0.0	0.0	0.1	0.0	0.2	1.2	0.2	0.0	0.0	0.0	12.7	0.0	0.4	0.0	0.3	0.3	0.4	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.0	5.8	3.3	0.0	1.0	0.0	0.0	0.0	7.0	0.0	0.4	16.6	0.0	0.0	0.2	18.7	0.0	0.0	0.4	28.2	11.3	0.0	0.0	0.7	0.0	65.4	0.0	4.6	0.0	0.0	2.3	5.0	0.0	25.9	0.0	0.0	38.6	0.4	20.7	0.0	0.0	12.7	1.4	2.3	3.6	0.5	4.4	27.1	7.4
HOXA11	"HOX1, HOX1I"	ENSG00000005073	"Homeobox A11"	P31270	7	27181510-27185223	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 35.7;endometrium 1: 60.9;smooth muscle: 27.3"	"Cell type enhanced"	"Detected in some"	10	"Distal tubular cells: 5.0;Fibroblasts: 4.3;Intestinal endocrine cells: 5.1;Smooth muscle cells: 2.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 14.7;BJ hTERT+: 17.8;HEK 293: 25.0;THP-1: 17.9;U-937: 23.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006770, HPA035623"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006770: AB_2667672, HPA035623: AB_10601576"	"unprognostic (5.95e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.29e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.82e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (2.57e-5)"	"unprognostic (2.17e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.56e-1)"	1.5	0.4	0.0	1.7	0.0	0.0	2.0	0.0	0.0	35.7	9.3	0.0	5.7	0.0	60.9	8.8	0.0	0.7	0.0	0.2	0.0	0.0	3.6	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	9.0	0.0	16.5	2.4	0.0	0.1	6.3	4.9	0.7	0.2	27.3	0.0	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	20.1	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.1	0.0	6.8	8.4	5.9	0.0	14.7	17.8	10.5	7.5	0.1	0.8	0.0	3.4	12.5	0.0	1.6	8.7	0.0	7.7	0.8	25.0	3.1	6.1	0.3	0.5	6.2	0.9	3.7	0.3	0.0	0.0	0.0	7.6	0.6	0.2	0.0	1.1	0.1	0.0	4.8	0.0	2.1	7.4	0.4	0.0	0.1	5.0	4.3	3.2	0.0	3.6	0.0	1.0	2.1	0.6	17.9	0.0	0.1	7.2	1.6	0.7	0.0	0.0	0.0	0.1	23.4	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	5.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	4.3	2.0	0.0	0.0	0.3	0.0	5.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.6	0.7
HOXA13	"HOX1, HOX1J"	ENSG00000106031	"Homeobox A13"	P31271	7	27193503-27200106	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 48.5;prostate: 25.1"	"Group enriched"	"Detected in some"	15	"Basal glandular cells: 2.9;Enterocytes: 7.7;Fibroblasts: 3.5;Glandular cells: 4.8;Intestinal endocrine cells: 8.1;Mucus-secreting cells: 9.8;Paneth cells: 5.8;Undifferentiated cells: 9.7;Urothelial cells: 2.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 15.5;HEK 293: 21.6;PC-3: 10.7;RT4: 23.9;THP-1: 10.2;U-937: 11.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046098, HPA069061"			Supported	"Nucleoplasm,Mitotic chromosome,Intermediate filaments"		NA	NA			Nucleoplasm	"Mitotic chromosome, Intermediate filaments"	"HPA046098: AB_2679536, HPA069061: "	"unprognostic (7.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.04e-4)"	"unprognostic (1.06e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.22e-3)"	"unprognostic (7.30e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.42e-11)"	"unprognostic (2.58e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.36e-2)"	0.6	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	48.5	6.9	0.0	7.1	0.0	5.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	16.5	0.0	25.1	8.6	0.0	0.1	17.9	1.2	0.4	0.1	15.7	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	12.1	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.0	1.4	0.1	0.0	0.0	7.6	8.3	3.0	1.9	1.5	0.1	0.0	0.9	3.5	0.4	0.0	15.5	0.0	2.5	0.0	21.6	1.0	4.1	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	4.9	0.0	6.6	10.7	1.5	0.4	0.0	0.0	23.9	0.4	0.0	1.9	0.0	0.1	1.2	0.0	10.2	0.0	0.3	2.7	0.1	0.1	0.0	0.0	0.0	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	7.7	0.0	0.0	0.1	3.5	4.8	0.0	0.0	0.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	9.7	2.8
EVX1		ENSG00000106038	"Even-skipped homeobox 1"	P49640	7	27242700-27250493	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 6.5;prostate: 6.4;seminal vesicle: 6.7;urinary bladder: 8.9"	"Group enriched"	"Detected in some"	29	"Early spermatids: 49.8;Late spermatids: 47.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	26	"pons and medulla: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"OE19: 21.4;RT4: 13.3"	"Group enriched"	"Detected in some"	15	"midbrain: 1.0;pons and medulla: 1.0"	"Not detected"	"Not detected"			HPA055132			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055132: AB_2682707"	"unprognostic (2.73e-2)"	"unprognostic (3.59e-1)"	"unprognostic (4.31e-1)"		"unprognostic (5.16e-2)"		"unprognostic (1.76e-3)"	"unprognostic (2.08e-2)"			"unprognostic (8.48e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.26e-8)"	"unprognostic (2.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.83e-2)"	0.1	6.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	4.2	0.6	0.1	0.1	0.0	0.9	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.5	3.0	6.4	0.7	0.1	0.1	6.7	0.1	0.0	0.1	1.9	0.1	0.1	0.0	1.7	0.1	0.1	0.1	0.1	0.1	8.9	5.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.2	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	3.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	47.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7
HIBADH	NS5ATP1	ENSG00000106049	"3-hydroxyisobutyrate dehydrogenase"	P31937	7	27525442-27662995	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"Distal tubular cells: 460.9;Proximal tubular cells: 261.0;Syncytiotrophoblasts: 227.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019522, HPA021002"	Enhanced					NA	NA		780000			"HPA019522: AB_1850690, HPA021002: AB_1850692"	"unprognostic (6.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.50e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-3)"	"unprognostic (7.22e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (5.56e-11)"	"unprognostic (2.49e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.39e-2)"	17.7	40.3	8.4	9.4	10.0	2.1	23.8	9.3	9.2	13.7	16.5	8.7	8.3	10.0	15.3	12.0	8.8	14.0	11.9	36.2	6.7	7.4	45.8	56.5	8.3	8.3	9.8	7.0	12.6	20.2	24.8	12.5	27.7	10.6	15.8	10.3	19.6	15.5	14.8	31.4	7.5	17.2	19.6	7.5	6.6	11.6	14.5	7.2	8.1	26.3	17.7	5.6	15.2	10.8	12.5	12.9	5.4	14.7	14.0	17.2	11.1	19.2	12.4	7.7	13.1	21.1	31.0	8.8	13.2	22.4	12.9	14.4	6.8	20.7	7.9	10.8	21.5	23.3	17.1	9.2	17.6	17.1	5.5	11.1	4.5	17.7	25.7	19.3	5.4	4.4	29.2	14.4	9.5	29.3	28.1	18.5	10.1	16.0	7.7	30.5	7.6	5.6	8.0	8.3	28.5	17.8	5.8	8.6	8.1	26.4	12.5	8.6	8.7	25.4	41.0	17.9	19.9	19.9	10.8	11.1	7.6	15.7	12.6	7.7	15.1	10.4	4.8	11.6	17.0	21.8	2.3	11.7	5.4	12.0	14.7	16.1	12.5	13.4	13.7	12.9	11.4	17.2	13.9	2.1	14.0	13.4	5.9	8.4	11.1	8.4	10.0	9.3	9.2	6.7	7.4	9.8	7.0	10.6	7.2	8.9	5.4	12.3	31.3	18.9	14.6	93.6	38.2	32.1	12.5	45.4	3.9	134.5	460.9	26.7	46.7	20.2	28.4	23.3	25.6	107.8	49.5	40.5	2.3	140.3	46.4	22.3	15.0	21.5	26.9	46.3	41.4	16.6	62.4	10.8	26.7	29.8	25.8	24.6	34.6	261.0	9.4	45.3	37.6	28.1	48.2	13.6	227.8	11.7	39.7	43.5
TAX1BP1	"CALCOCO3, TXBP151"	ENSG00000106052	"Tax1 binding protein 1"	Q86VP1	7	27739331-27844564	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024432	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA024432: AB_1857783"	"unprognostic (1.38e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.83e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.59e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (3.69e-1)"	"prognostic favorable (2.80e-6)"	"unprognostic (1.76e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.03e-1)"	28.5	63.0	31.1	19.5	49.8	34.9	30.7	33.5	48.4	33.8	33.4	16.1	26.7	23.7	27.4	35.5	46.6	30.7	28.2	47.4	30.8	31.9	51.0	35.3	28.7	23.0	41.0	34.8	32.0	29.7	46.3	69.4	65.8	54.1	36.4	31.1	18.7	32.3	32.6	50.3	23.5	41.0	48.8	41.7	34.5	30.3	30.3	35.2	34.2	44.5	27.0	24.6	51.3	29.0	21.1	17.5	59.7	31.3	17.3	33.0	22.5	39.8	22.1	22.6	21.4	35.9	26.2	15.4	29.8	36.7	22.4	28.1	17.9	32.5	8.5	28.2	43.5	38.7	28.4	21.2	19.5	35.1	15.9	11.0	23.0	23.7	35.5	34.0	33.5	27.4	22.1	40.6	26.0	29.9	27.0	24.1	14.8	25.5	26.2	45.2	14.7	14.7	33.1	25.5	52.3	20.8	12.3	24.3	17.4	31.7	45.2	15.0	24.5	41.8	54.7	62.2	45.5	25.5	50.6	25.9	21.2	33.2	26.3	19.6	48.2	33.4	15.9	24.8	63.7	48.4	37.4	24.2	59.7	21.8	29.3	26.3	21.1	25.9	25.3	17.5	17.9	24.0	24.0	48.9	17.3	31.3	16.2	33.0	22.5	31.1	49.8	33.5	48.4	30.8	31.9	41.0	34.8	54.1	35.2	199.5	169.7	106.1	180.8	162.8	267.0	498.7	129.9	654.5	232.0	122.1	90.3	129.6	349.8	187.1	99.7	143.3	138.9	70.0	229.8	91.8	123.1	243.4	143.4	96.2	109.6	151.0	134.4	76.7	127.2	72.2	108.1	171.8	108.0	226.4	131.6	177.5	242.3	125.6	139.7	231.8	140.4	103.5	117.9	217.7	133.4	167.7	519.6	133.7	103.0	398.4
JAZF1	"DKFZp761K2222, TIP27, ZNF802"	ENSG00000153814	"JAZF zinc finger 1"	Q86VZ6	7	27830573-28180743	"Disease related genes, Predicted intracellular proteins"	"Lipid metabolism, Transcription, Transcription regulation"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 85.4;Late spermatids: 64.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019271, HPA066967"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"CAB019271: , HPA066967: AB_2685758"	"unprognostic (1.19e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.18e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.74e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.27e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.18e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-2)"	11.9	65.2	18.7	13.4	13.1	16.7	17.7	26.9	19.2	50.1	23.0	8.5	12.8	3.4	34.1	18.4	8.4	11.9	9.9	17.0	14.0	14.8	4.8	12.2	9.9	10.8	8.9	16.9	11.6	5.7	5.6	19.0	12.3	11.1	23.6	7.3	4.8	4.2	28.1	5.6	5.9	6.7	29.7	12.2	11.0	7.4	14.3	10.0	6.3	12.1	5.5	11.9	18.7	24.3	4.6	12.5	17.6	3.7	4.3	4.6	2.4	0.7	0.6	2.4	0.6	18.6	22.7	0.0	5.8	14.7	9.7	11.8	0.0	3.8	16.8	11.8	11.7	6.5	0.3	3.2	4.2	7.7	2.5	5.1	6.0	4.2	0.0	12.7	2.5	1.7	10.2	5.2	7.2	4.8	7.3	5.9	1.3	0.1	27.5	5.2	0.7	0.7	8.7	5.2	0.1	3.9	1.8	1.1	5.1	3.4	0.1	1.5	2.6	4.6	0.1	6.0	7.7	1.7	3.0	5.8	15.3	6.0	4.1	6.4	5.0	1.4	6.5	4.9	6.2	8.4	17.6	3.7	5.5	4.6	3.0	1.3	2.9	1.4	3.1	3.3	4.6	0.6	3.1	3.2	4.3	3.2	12.5	2.9	2.4	18.7	13.1	26.9	18.7	14.0	14.8	8.9	16.9	11.1	10.0	3.0	6.5	8.0	2.6	13.1	7.4	23.4	10.2	14.7	3.4	1.8	5.9	0.5	6.6	12.7	85.4	8.0	0.0	23.3	2.1	1.0	21.1	2.5	24.2	4.2	9.1	15.9	5.2	2.5	22.5	64.7	50.9	27.7	21.9	17.2	0.7	3.9	4.3	0.0	32.5	1.4	3.9	12.9	15.5	8.4	15.8	9.8	1.1	13.4	0.2	1.4
CREB5	"CRE-BPA, H_GS165L15.1"	ENSG00000146592	"CAMP responsive element binding protein 5"	Q02930	7	28299321-28825894	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 53.3;brain: 38.0"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 116.6;Macrophages: 74.2;monocytes: 74.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 53.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 53.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 32.2;Karpas-707: 13.5;U-2 OS: 14.2;U-2197: 15.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA050020, HPA061622"			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	Yes			Nucleoplasm	"Vesicles, Plasma membrane"	"HPA050020: AB_2680993, HPA061622: AB_2684569"	"unprognostic (3.59e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.90e-3)"	"unprognostic (2.01e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.91e-3)"	"unprognostic (6.61e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.52e-3)"	20.0	3.6	12.1	15.4	19.5	11.5	9.0	10.4	17.8	4.6	5.6	38.0	0.9	2.8	16.3	6.9	7.7	4.7	23.1	10.4	16.7	8.7	6.6	4.6	9.5	6.1	17.9	12.1	2.4	7.0	1.5	2.8	19.5	18.3	3.1	4.3	1.1	6.5	3.0	6.2	5.5	4.2	9.8	14.6	12.6	3.2	2.3	22.7	0.0	3.8	7.0	2.5	5.5	5.0	0.3	4.8	53.3	7.8	0.0	0.0	1.5	0.0	0.3	3.9	0.2	0.2	5.7	0.1	0.3	0.8	2.4	3.6	2.2	1.4	9.9	0.7	0.9	2.4	0.4	0.1	3.4	7.6	0.0	2.7	10.7	2.1	0.2	0.2	32.2	0.4	0.7	0.7	10.2	11.0	0.5	1.6	0.0	1.2	13.5	0.8	0.0	0.0	0.0	4.9	0.0	3.9	0.2	3.7	0.2	4.9	1.0	0.4	2.8	0.1	0.2	1.1	5.7	0.1	0.7	0.4	4.7	14.2	15.5	4.5	0.8	2.2	0.1	5.2	0.2	8.0	0.0	7.8	0.0	0.0	2.7	0.0	0.3	0.0	0.0	4.8	0.0	0.0	0.0	53.3	0.0	0.8	0.0	0.0	1.5	12.1	19.5	10.4	15.6	16.7	8.7	17.9	12.1	18.3	22.7	6.0	11.1	4.5	116.6	19.5	0.0	14.1	22.9	5.3	6.8	12.2	0.0	2.5	1.7	61.9	0.4	14.9	0.0	0.0	23.7	9.2	31.3	32.4	13.9	0.5	8.1	4.8	0.0	7.4	46.4	1.1	5.5	74.2	28.7	74.9	0.0	16.6	30.3	0.0	0.4	18.3	0.6	19.4	10.7	12.5	3.3	11.5	20.7	1.3	0.0	28.7
TRIL	KIAA0644	ENSG00000255690	"TLR4 interactor with leucine rich repeats"	Q7L0X0	7	28953358-28958292	"Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.7"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 11.9;Horizontal cells: 6.4;Muller glia cells: 13.7;Sertoli cells: 12.9"	"Cancer enhanced"	"Detected in many"		"glioma: 20.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 14.0;SH-SY5Y: 25.3;SK-BR-3: 22.4;T-47d: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.26e-3)"	"unprognostic (3.29e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (2.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-2)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (8.52e-4)"	"unprognostic (4.27e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.07e-2)"	3.5	2.9	14.7	0.6	13.2	0.0	5.1	11.2	19.2	2.6	2.2	19.5	0.0	2.4	2.5	2.2	1.9	2.3	1.2	3.0	18.2		6.6	0.7	3.1	0.4	9.1	11.5	1.8	0.4	0.6	0.0	1.3	20.7	2.4	2.3	0.3	9.6	1.8	3.3	0.5	2.7	4.1	17.0	2.9	2.8	0.3	14.4	0.0	2.8	0.2	0.3	2.0	0.0	0.0	0.1	0.1	0.1	0.0	0.7	0.0	0.0	0.0	14.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.5	25.3	0.0	22.4	0.0	2.1	9.9	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0											11.9	4.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	1.2	1.8	0.0	0.1	3.3	0.0	0.0	2.1	0.0	0.0	0.0	1.8	0.8	0.0	0.0	0.2	0.1	6.4	0.0	2.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	1.6	0.7	12.9	0.2	0.2	0.7	0.0	0.1	0.0	0.6	0.1
CPVL		ENSG00000106066	"Carboxypeptidase, vitellogenic like"	Q9H3G5	7	28995231-29195451	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 111.9;lymphoid tissue: 84.0"	"Cell type enhanced"	"Detected in many"	9	"Hofbauer cells: 263.6;Kupffer cells: 230.2;Macrophages: 292.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 95.8;intermediate monocyte: 81.6;myeloid DC: 111.9"	"Group enriched"	"Detected in many"	52	"dendritic cells: 111.9;monocytes: 95.8"	"Cell line enriched"	"Detected in many"	4	"RPTEC TERT1: 131.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB003697, HPA045715, HPA056466"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		510000	"Endoplasmic reticulum"		"CAB003697: AB_425990, HPA045715: AB_2679429, HPA056466: AB_2683140"	"unprognostic (4.72e-2)"	"unprognostic (7.08e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.49e-2)"	"unprognostic (6.85e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.07e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.46e-3)"	"prognostic unfavorable (4.99e-4)"	19.0	6.2	4.0	15.0	9.1	11.9	7.7	11.6	3.4	9.1	10.0	7.7	4.2	7.6	6.9	20.4	6.4	7.2	10.2	30.2	6.1	4.4	39.1	12.3	13.5	30.5	6.6	2.3	10.1	8.5	0.2	6.1	31.3	20.1	8.4	6.0	15.8	3.5	5.2	7.9	5.1	13.3	8.1	9.7	84.0	4.7	10.6	4.2	29.7	51.9	5.0	8.1	11.0	15.7	0.1	111.9	1.9	95.8	0.5	0.3	74.4	0.2	0.0	3.3	0.0	0.0	0.0	31.5	0.0	0.0	0.3	0.0	9.5	0.0	0.0	15.0	0.1	15.6	0.5	8.4	0.6	0.1	0.0	7.8	10.6	0.1	22.8	0.0	0.0	0.0	0.0	0.9	0.1	0.2	0.0	0.1	4.4	7.1	0.0	0.2	0.0	9.8	0.0	5.2	0.0	2.6	0.0	0.0	0.0	131.9	3.6	1.9	1.5	8.6	20.6	15.9	16.8	2.4	7.9	0.0	0.0	0.1	0.0	1.9	2.9	31.7	0.1	0.0	3.9	3.3	1.0	95.8	0.4	0.2	81.6	0.3	0.1	0.1	0.1	111.9	0.1	0.1	0.1	1.9	0.5	26.0	2.9	0.1	74.4	4.0	9.1	11.6	3.4	6.1	4.4	6.6	2.3	20.1	4.2	6.0	20.2	17.9	1.1	11.1	0.0	63.1	7.6	2.7	4.5	68.0	0.0	103.1	29.9	0.5	15.2	12.6	0.0	0.0	14.2	103.4	14.2	0.2	4.7	0.5	263.6	0.0	1.7	6.7	230.2	6.4	8.6	292.5	10.1	4.6	0.8	0.2	1.2	0.0	2.8	23.9	0.3	0.0	5.7	15.2	103.9	7.8	99.1	0.9	0.9	0.9
AC004593.3		ENSG00000285162	"Beta-chimaerin isoform 3 "		7	29122340-29514667	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 6.3;brain: 16.3"	"Group enriched"	"Detected in some"	11	"Collecting duct cells: 1.8;Early spermatids: 1.0;granulocytes: 1.1;Hepatocytes: 2.4;Late spermatids: 1.1"									"Group enriched"	"Detected in some"	34	"classical monocyte: 6.2;intermediate monocyte: 5.1;myeloid DC: 6.3;non-classical monocyte: 2.5"	"Group enriched"	"Detected in many"	59	"dendritic cells: 6.3;monocytes: 6.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.7;GAMG: 3.3;HaCaT: 3.5;HEL: 2.5;U-266/84: 4.1"									HPA019026			Uncertain	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA019026: "																		0.1	0.3	0.1	0.2	0.1	0.2	0.1	16.3	0.1	0.1	0.2	0.1	0.1	2.6	0.4	0.1	0.1	0.0	0.4	1.2	0.1		0.5	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.5	0.7	0.1	0.0	0.1	0.1	0.1	0.1	0.0	2.0	0.1	0.1	0.5	1.9	2.9	0.1	0.1	1.7	0.1	0.1	0.1	0.1	0.0	6.3	0.1	6.2	0.0	0.0	2.2	0.0	0.2	0.7	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.3	1.5	0.0	2.7	0.0	3.3	3.5	0.1	0.0	0.0	0.1	1.2	2.5	0.8	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	1.2	0.0	1.6	1.3	0.7	0.0	0.2	0.0	0.3	0.6	0.2	0.1	0.8	1.2	0.9	1.6	0.4	0.1	0.7	0.6	0.0	0.0	0.1	0.3	4.1	0.0	0.0	0.0	1.7	0.0	6.2	0.0	0.0	5.1	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.1	0.0	2.5	0.1	0.0	2.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHN2	"ARHGAP3, RhoGAP3"	ENSG00000106069	"Chimerin 2"	P52757	7	29146569-29514328	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 89.2;intestine: 44.3"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 299.6;Early spermatids: 94.3;Hepatocytes: 85.0;Late spermatids: 83.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 18.6;HMC-1: 36.3"									"HPA018989, HPA019026"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA018989: AB_1846681, HPA019026: "	"unprognostic (3.88e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.71e-2)"	"unprognostic (7.54e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.58e-3)"	2.7	4.4	7.9	3.3	21.8	1.4	2.1	89.2	14.7	6.6	14.1	19.2	0.3	44.3	2.7	2.1	1.9	5.0	4.8	6.9	10.5	7.0	8.2	22.0	3.7	2.0	34.7	6.9	13.4	13.9	0.5	1.9	6.4	16.5	5.3	5.9	4.6	1.6	2.9	2.7	1.5	36.3	3.0	16.5	5.1	4.2	2.3	29.2	0.8	4.7	0.0	1.7	3.5	4.0	0.3	8.5	3.9	11.2	9.3	2.5	2.6	0.1	0.4	1.6	0.0	0.0	0.0	9.7	0.0	0.0	0.4	0.0	5.1	1.5	0.5	3.1	0.1	0.6	2.7	5.1	0.0	0.0	9.1	1.7	18.6	0.8	9.9	0.1	0.0	36.3	0.0	3.4	0.0	0.7	0.0	1.9	3.0	0.7	0.2	0.1	0.2	5.0	0.2	0.6	3.4	1.8	0.4	0.0	1.0	9.4	6.3	9.7	0.7	2.2	3.3	5.9	5.5	0.3	1.0	0.2	0.5	0.1	0.0	0.2	1.8	7.1	0.0	0.1	1.1	0.7	3.9	10.5	0.1	2.5	11.2	1.8	0.3	0.4	2.2	8.5	0.2	0.5	1.0	0.6	9.3	6.4	1.0	0.0	2.6	7.9	21.8	89.2	14.7	10.5	7.0	34.7	6.9	16.5	29.2	6.0	5.1	1.4	0.6	2.4	299.6	10.6	2.5	10.7	3.4	3.5	41.2	22.2	0.0	0.2	94.3	5.5	13.6	0.0	1.8	28.5	3.4	1.2	23.1	85.0	15.9	6.4	37.7	1.8	19.1	83.5	4.6	19.6	16.9	0.0	18.9	8.5	0.3	12.9	4.6	1.6	15.0	0.0	1.1	2.3	5.9	0.5	13.7	15.2	8.6	0.6
PRR15		ENSG00000176532	"Proline rich 15"	Q8IV56	7	29563811-29567295	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 66.1"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 66.9;Enterocytes: 108.9;Paneth cells: 46.5;Undifferentiated cells: 48.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.6"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 15.5;HaCaT: 17.9;OE19: 38.3;RT4: 13.7;SK-BR-3: 30.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA040996, HPA048121"	Enhanced		Uncertain	"Vesicles,Cell Junctions"		NA	NA			Vesicles	"Cell Junctions"	"HPA040996: AB_2677241, HPA048121: AB_2680271"	"unprognostic (5.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.97e-2)"	"prognostic favorable (6.37e-4)"	"unprognostic (7.49e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-3)"	"unprognostic (1.25e-1)"	"prognostic favorable (1.83e-6)"	"unprognostic (1.30e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.58e-2)"	3.8	0.5	0.7	14.4	0.4	0.0	3.1	0.4	0.8	22.8	58.9	0.8	2.6	24.8	6.8	13.3	0.7	2.9	12.1	1.0	0.6	0.5	12.7	0.5	3.7	0.6	0.4	0.4	4.0	2.0	0.0	2.7	19.0	0.5	2.7	18.5	0.3	4.6	0.9	0.5	0.3	66.1	1.1	1.1	0.4	16.6	1.4	0.4	0.3	1.0	1.0	1.9	7.0	1.9	1.6	0.0	0.0	0.5	0.0	0.0	0.6	6.5	9.3	0.0	0.0	3.6	4.5	11.9	0.3	0.4	0.1	0.1	8.1	15.5	0.0	1.7	2.2	0.2	17.9	1.9	0.0	0.0	0.0	1.3	0.5	1.7	8.8	1.2	0.0	0.0	0.0	3.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	1.5	0.2	1.2	1.4	38.3	7.4	0.0	0.0	8.2	10.7	13.7	0.2	0.1	0.9	30.2	0.0	5.5	2.2	0.0	7.9	0.2	0.0	0.0	0.3	0.7	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.4	0.4	0.8	0.6	0.5	0.4	0.4	0.5	0.4	0.0	0.3	0.0	1.1	0.1	0.0	0.3	10.2	66.9	6.8	36.6	0.0	12.5	24.9	6.1	0.6	0.3	108.9	0.0	19.6	8.7	0.3	2.1	0.0	0.0	2.5	0.0	8.1	0.0	0.0	0.0	1.4	2.7	0.0	1.0	37.6	0.0	10.9	46.5	2.1	9.2	0.0	0.0	0.4	0.0	0.4	0.0	5.3	0.0	48.1	19.0
WIPF3	"CR16, FLJ36931"	ENSG00000122574	"WAS/WASL interacting protein family member 3"	A6NGB9	7	29806486-29917066	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6;ovary: 44.7"	"Group enriched"	"Detected in many"	8	"Leydig cells: 46.9;Peritubular cells: 94.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 18.5;HEK 293: 4.1;K-562: 6.3;NTERA-2: 5.2;RPMI-8226: 11.1;SK-MEL-30: 4.5"	"Region enhanced"	"Detected in many"		"hippocampal formation: 234.6"					"HPA041145, HPA041211"	Uncertain		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA041145: AB_10795001, HPA041211: AB_10795003"	"prognostic favorable (7.93e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.12e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.53e-1)"	"unprognostic (8.95e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.41e-1)"	1.8	6.6	13.4	1.6	40.6	1.1	1.9	5.5	15.1	1.2	1.4	3.8	1.0	3.6	4.2	21.8	2.1	9.9	3.5	4.6	30.0	5.1	3.3	1.3	1.3	1.4	4.0	12.1	44.7	2.4	1.6	5.6	1.0	1.5	5.5	1.3	0.8	4.5	5.9	23.0	1.7	3.5	5.2	1.7	1.7	6.3	27.6	7.8	0.0	2.8	2.9	2.3	3.2	0.8	0.8	2.1	2.6	1.2	0.9	1.3	0.2	0.3	1.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.2	0.0	18.5	0.0	0.0	0.0	4.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.1	0.0	0.1	0.0	0.1	5.2	0.0	3.6	0.0	0.0	11.1	0.0	0.0	1.8	1.6	0.1	0.1	4.5	2.6	0.4	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.6	0.5	0.9	0.3	0.7	0.6	0.7	0.9	0.3	0.3	0.8	1.3	0.8	1.2	0.9	1.2	2.1	0.5	0.2	13.4	40.6	5.5	15.1	30.0	5.1	4.0	12.1	1.5	7.8	0.0	0.0	0.0	1.3	1.9	4.9	8.9	0.0	8.1	2.3	3.5	2.0	0.0	3.3	3.7	1.3	1.1	1.3	0.0	3.1	0.1	0.9	1.1	0.0	0.4	4.7	4.8	1.7	0.6	0.0	3.0	46.9	0.0	5.0	0.0	0.5	5.4	2.3	0.8	94.4	3.5	2.7	6.5	2.1	0.5	3.0	0.4	0.0	0.0	1.9	0.3
SCRN1	KIAA0193	ENSG00000136193	"Secernin 1"	Q12765	7	29920103-29990289	"Enzymes, Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 62.8"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 65.2;Muller glia cells: 76.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 69.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024517	Enhanced		Approved	Cytosol		No	No		110000	Cytosol		"HPA024517: AB_2184811"	"prognostic unfavorable (8.32e-4)"	"prognostic unfavorable (8.46e-4)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.00e-5)"	"unprognostic (1.87e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.15e-5)"	"unprognostic (2.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (2.60e-4)"	6.8	14.8	32.0	6.3	31.5	3.6	7.6	62.8	55.4	12.4	8.1	23.2	4.5	3.4	13.3	8.8	10.0	13.9	8.5	9.8	26.6	30.7	12.8	1.5	8.3	6.7	42.7	26.6	17.5	18.5	42.9	12.1	8.0	26.3	15.0	5.6	7.8	8.4	20.2	1.0	5.7	5.0	17.7	42.9	5.2	7.1	11.4	23.3	8.2	7.1	1.5	10.6	9.4	5.8	10.4	7.8	6.9	16.7	4.8	8.1	2.2	21.8	15.8	25.8	10.4	18.3	28.2	0.1	20.4	27.4	22.2	24.0	18.2	17.4	2.7	18.2	26.1	49.4	9.9	29.3	8.7	32.5	0.1	6.1	9.0	10.6	11.7	23.4	0.0	0.1	23.5	12.6	20.1	10.8	30.3	20.4	5.9	0.1	7.1	31.2	12.3	3.1	0.0	23.5	0.0	17.0	0.0	27.5	0.2	15.5	10.8	9.4	22.4	21.1	13.7	23.6	33.9	18.5	1.4	22.5	28.9	24.9	0.3	25.8	2.3	35.4	0.2	13.6	0.1	69.6	2.2	2.3	6.9	0.6	10.2	8.1	10.4	0.1	0.8	7.7	5.0	0.6	1.0	0.4	4.8	16.7	7.8	0.0	2.2	32.0	31.5	62.8	43.1	26.6	30.7	42.7	26.6	26.3	23.3	26.8	13.1	8.2	9.7	2.7	63.5	12.6	20.4	21.4	22.7	31.4	43.2	0.3	13.3	18.8	49.3	5.8	0.0	0.0	21.5	1.6	7.7	14.1	8.1	0.5	4.8	65.2	11.6	2.5	10.0	48.7	12.7	10.6	6.8	4.6	0.9	76.1	21.8	17.3	19.8	1.8	39.0	6.5	8.5	2.3	12.3	1.5	0.8	4.3	1.0	17.0
FKBP14	"FKBP22, FLJ20731"	ENSG00000106080	"FK506 binding protein 14"	Q9NWM8	7	30010587-30026684	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Isomerase, Rotamase"	"Deafness, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013329, HPA026829"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			Cytosol	"Nucleoplasm, Golgi apparatus"	"HPA013329: AB_1848613, HPA026829: AB_10601651"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.12e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.41e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (6.06e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.93e-3)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-3)"	"prognostic unfavorable (4.25e-4)"	8.8	7.4	8.7	9.2	7.3	5.1	8.8	17.6	7.7	14.9	7.8	4.1	6.9	4.2	12.1	14.2	8.0	8.1	8.5	9.8	7.1	5.2	5.4	9.2	7.6	8.1	9.2	5.2	13.0	9.8	8.6	27.8	10.7	7.1	9.8	6.9	8.4	7.6	10.9	3.3	6.4	5.3	18.8	8.1	6.7	7.2	4.2	7.1	2.6	5.6	5.9	7.7	13.4	8.7	1.6	3.3	2.7	1.2	1.0	1.6	0.6	3.4	2.6	7.4	17.2	19.3	24.8	3.4	17.7	16.6	6.2	12.1	2.2	2.2	1.2	8.4	15.5	7.6	7.6	4.1	6.4	12.4	0.6	5.9	2.8	5.0	6.5	9.8	2.0	4.9	15.5	6.7	10.8	12.8	14.6	13.7	1.8	4.5	2.6	11.1	1.4	1.0	2.4	3.9	3.8	4.8	0.0	5.0	4.0	6.1	3.1	1.9	6.5	6.2	14.2	4.3	9.2	3.2	2.6	11.0	6.6	7.7	11.3	7.0	3.9	4.0	2.1	9.4	1.9	20.6	1.9	1.2	1.2	1.3	0.8	1.0	1.1	1.6	1.1	2.2	1.6	1.5	1.3	2.7	1.0	0.5	3.3	1.4	0.6	8.7	7.3	17.6	7.7	7.1	5.2	9.2	5.2	7.1	7.1	17.9	16.5	3.7	19.2	24.4	15.5	13.5	7.6	2.7	10.3	17.4	25.5	9.5	1.7	6.7	0.3	7.4	3.3	0.0	3.2	24.1	26.4	15.0	2.3	6.6	5.3	14.3	1.2	8.6	2.8	0.0	12.0	5.8	10.1	2.8	7.9	31.5	5.3	14.4	19.4	2.9	19.8	6.5	10.5	0.7	3.3	15.9	13.2	4.3	4.8	24.8
PLEKHA8	"FAPP2, MGC3358"	ENSG00000106086	"Pleckstrin homology domain containing A8"	Q96JA3	7	30027404-30130483	"Predicted intracellular proteins"	"Lipid transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072314			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA072314: AB_2686511"	"unprognostic (5.49e-3)"	"unprognostic (8.62e-3)"	"unprognostic (2.39e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.70e-4)"	"unprognostic (5.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.07e-2)"	7.3	5.6	9.7	7.2	11.6	3.2	7.5	16.3	13.0	8.5	7.8	8.3	4.8	8.3	8.6	10.0	9.2	5.4	7.7	6.0	8.2	7.5	14.0	6.1	7.1	8.7	9.9	5.8	9.3	9.0	10.5	8.8	21.0	9.9	7.6	8.4	9.1	8.5	9.0	4.8	7.9	9.0	8.7	7.8	5.2	6.9	8.1	9.6	6.9	6.6	1.7	10.2	8.7	8.6	1.2	0.5	2.8	0.9	1.0	1.7	0.3	6.5	4.5	20.6	21.8	5.9	4.7	14.3	4.7	3.8	3.8	5.0	8.5	2.8	15.3	6.5	4.8	9.9	4.8	10.7	5.7	5.4	2.9	7.2	8.8	7.6	7.8	5.1	3.8	3.1	2.3	4.4	5.2	7.4	4.7	8.2	7.5	8.0	5.6	5.4	4.3	7.7	2.7	13.7	3.2	5.1	0.0	5.8	10.3	4.3	5.2	2.7	15.7	5.3	17.2	6.8	19.4	6.0	4.0	6.9	3.4	14.4	3.5	5.5	11.5	20.0	8.9	6.6	2.5	8.0	2.8	0.6	2.5	1.7	0.6	0.9	1.2	1.0	1.1	0.5	0.8	1.2	1.6	0.1	1.0	0.9	0.1	1.0	0.3	9.7	11.6	16.3	13.0	8.2	7.5	9.9	5.8	9.9	9.6	3.0	1.6	4.2	5.3	10.0	14.2	4.1	2.5	0.0	1.2	12.2	23.6	16.1	3.3	9.5	1.5	4.9	6.2	0.0	6.2	15.8	6.2	8.6	4.6	4.0	5.9	9.5	2.4	3.7	2.2	1.1	3.1	4.2	10.1	5.4	4.4	5.8	9.4	23.0	4.6	8.7	19.1	6.5	5.6	8.1	12.2	11.0	16.9	3.3	3.4	8.4
MTURN	"C7orf41, Ells1, FLJ25903"	ENSG00000180354	"Maturin, neural progenitor differentiation regulator homolog"	Q8N3F0	7	30134810-30162762	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 189.2"	"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 132.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 9.9"	"Group enriched"	"Detected in many"	4	"granulocytes: 9.9;NK-cells: 3.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 23.1;HEL: 40.2;SCLC-21H: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029507	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA029507: AB_10601149"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.70e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-3)"	"unprognostic (9.80e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.11e-3)"	"unprognostic (8.11e-3)"	"prognostic favorable (7.64e-13)"	"unprognostic (9.50e-2)"	"unprognostic (7.64e-2)"	"unprognostic (4.64e-1)"	"unprognostic (3.26e-1)"	35.9	5.7	113.5	4.8	86.7	9.3	14.2	21.7	100.8	12.9	5.2	97.0	3.3	3.0	7.9	45.6	9.6	8.2	5.3	11.2	122.8	79.5	24.7	2.3	10.1	2.8	162.4	26.2	16.5	6.2	9.7	2.7	4.0	54.2	9.2	5.3	2.9	14.9	12.0	14.3	7.8	3.4	8.5	189.2	4.1	10.0	4.5	49.4	0.0	6.7	2.4	3.0	6.0	6.5	0.7	1.4	9.9	0.4	3.0	0.8	2.4	5.1	0.9	3.0	3.2	23.1	15.8	2.7	2.5	2.9	0.8	1.2	0.4	2.1	0.3	2.1	5.5	4.8	1.0	6.8	9.8	2.8	2.2	5.5	40.2	6.4	2.8	1.8	2.0	13.3	7.8	4.6	2.6	4.7	3.7	1.3	5.5	2.5	2.1	5.8	1.9	2.3	0.9	2.1	4.8	3.2	0.2	7.1	8.6	10.3	2.1	29.7	7.9	1.6	8.1	8.1	3.0	5.7	3.0	6.5	3.4	3.7	7.1	3.5	3.6	5.1	0.4	4.5	4.3	1.7	9.9	0.4	4.8	0.5	0.2	0.1	0.7	0.3	0.2	0.6	0.5	0.2	0.5	3.1	3.0	0.0	1.4	0.8	2.4	113.5	86.7	21.7	51.7	122.8	79.5	162.4	26.2	54.2	49.4	14.9	18.3	2.9	13.7	33.3	0.0	22.0	17.8	22.7	9.1	41.8	0.0	1.8	132.6	7.5	10.1	17.9	0.4	0.0	7.6	5.5	12.8	24.6	5.8	4.4	4.8	0.0	52.0	18.4	18.2	26.7	15.8	6.5	52.3	10.8	9.2	0.0	8.6	5.7	11.7	9.1	0.0	6.5	31.2	1.4	3.4	32.1	1.8	6.9	3.0	16.5
ZNRF2	RNF202	ENSG00000180233	"Zinc and ring finger 2"	Q8NHG8	7	30284307-30367692	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 5.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072244	Approved		Uncertain	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			"Nucleoplasm, Vesicles"	"Nucleoli fibrillar center"	"HPA072244: AB_2732197"	"unprognostic (9.44e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.64e-2)"	"prognostic unfavorable (7.68e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.93e-2)"	"prognostic favorable (2.29e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (8.71e-4)"	"unprognostic (8.67e-2)"	7.8	8.0	10.0	9.3	10.6	9.7	16.2	12.8	10.0	5.8	16.1	10.5	7.6	11.3	7.7	9.7	14.2	5.2	8.7	8.4	9.6	6.1	19.3	24.0	7.9	12.0	10.0	7.4	5.8	14.0	8.0	9.9	9.6	11.0	7.0	14.3	5.8	10.5	13.7	17.5	11.5	12.7	8.3	10.5	9.2	12.4	20.6	9.1	7.9	13.3	9.8	10.9	9.4	11.8	1.3	5.8	1.4	1.1	0.7	2.4	0.5	6.7	2.5	2.0	1.8	2.3	1.6	10.7	2.6	2.7	2.9	3.9	1.2	11.3	7.1	6.8	2.1	7.5	6.6	6.7	4.4	3.1	6.9	6.1	4.4	5.2	3.3	1.2	3.4	8.4	2.5	7.5	2.0	4.9	3.0	2.4	5.5	5.4	14.2	3.1	2.6	6.9	9.0	4.7	6.7	3.1	6.0	4.4	12.1	8.7	14.6	7.0	6.6	5.2	22.0	4.3	12.4	5.9	13.8	2.7	2.8	4.8	2.7	5.4	24.3	20.8	9.3	3.1	7.4	4.1	0.5	0.9	1.1	1.0	0.9	1.5	1.3	1.2	1.4	0.8	0.8	0.7	1.1	1.4	0.7	1.1	5.8	2.4	0.5	10.0	10.6	12.8	10.0	9.6	6.1	10.0	7.4	11.0	9.1	8.9	6.7	5.2	5.8	14.2	11.0	3.2	17.8	2.7	4.5	15.7	39.3	7.5	6.6	4.9	4.3	4.5	42.5	0.0	8.9	8.0	4.4	5.5	3.5	33.4	9.4	1.6	30.1	9.2	18.9	7.6	2.6	11.2	11.8	9.0	14.5	4.3	6.7	14.4	2.1	26.0	5.7	6.5	7.2	20.9	7.9	16.6	9.6	8.7	19.6	10.8
NOD1	"CARD4, CLR7.1, NLRC1"	ENSG00000106100	"Nucleotide binding oligomerization domain containing 1"	Q9Y239	7	30424527-30478784	"Predicted intracellular proteins"	"Apoptosis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 10.8;Ito cells: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074367			Approved	Mitochondria		NA	NA			Mitochondria		"HPA074367: AB_2686683"	"unprognostic (2.58e-1)"	"unprognostic (1.56e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.09e-3)"	"unprognostic (2.07e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.01e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.74e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.68e-4)"	"unprognostic (6.62e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.95e-4)"	"unprognostic (2.64e-1)"	15.2	3.2	3.9	11.1	3.7	6.6	18.3	2.0	2.4	6.5	6.2	4.3	5.0	2.2	8.7	8.9	6.1	7.3	10.1	10.9	2.9	2.1	5.0	2.9	13.8	6.0	3.2	2.2	13.6	4.6	3.8	4.6	13.3	4.7	5.5	4.7	6.4	7.7	7.6	7.2	7.1	6.2	16.3	4.7	12.4	6.9	3.2	3.5	5.1	27.2	6.4	11.1	7.6	6.1	10.9	8.2	13.3	6.2	8.7	9.8	2.4	4.3	2.3	3.2	9.6	2.1	9.9	5.0	3.0	2.1	5.1	6.5	2.0	5.2	6.1	3.6	3.8	5.7	10.1	3.2	5.2	3.5	3.2	2.7	8.6	7.1	2.0	2.6	3.8	6.5	9.1	2.3	3.2	2.8	4.6	16.7	9.3	4.5	2.2	4.6	2.5	5.4	6.8	3.8	4.7	4.1	6.5	3.7	5.5	1.7	3.4	0.6	11.7	3.8	9.9	3.3	4.7	3.3	8.6	7.0	4.5	7.4	5.5	4.1	2.0	6.8	0.2	3.3	13.5	4.6	12.7	3.9	13.3	8.8	5.2	9.8	7.6	6.1	5.7	3.4	10.9	5.6	4.5	3.0	8.7	6.2	8.2	4.6	2.4	3.9	3.7	2.0	2.4	2.9	2.1	3.2	2.2	4.7	3.5	3.0	10.8	0.0	0.4	0.7	0.6	4.0	0.0	4.0	7.9	5.2	0.0	4.5	0.0	1.3	0.0	6.0	2.0	0.0	1.8	2.0	3.4	0.2	2.3	0.8	3.8	0.0	0.0	10.4	4.3	0.0	0.6	4.4	5.0	3.6	5.7	0.9	1.1	0.0	1.8	0.5	0.0	0.0	4.7	0.0	0.5	1.6	1.3	2.9	5.2	0.9
GGCT	"C7orf24, CRF21, GCTG, Ggc, MGC3077"	ENSG00000006625	Gamma-glutamylcyclotransferase	O75223	7	30496621-30504844	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 343.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020735, HPA029914"	Approved					NA	NA		2400000			"HPA020735: AB_1845754, HPA029914: AB_10602321"	"prognostic unfavorable (7.68e-4)"	"unprognostic (2.66e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.54e-3)"	"unprognostic (5.80e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (1.33e-3)"	"unprognostic (2.19e-2)"	"unprognostic (6.42e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.12e-3)"	"unprognostic (2.00e-3)"	"unprognostic (9.92e-2)"	30.8	18.6	15.5	14.5	15.9	10.2	26.4	10.8	25.6	12.6	20.2	7.3	19.3	16.7	10.4	59.6	33.4	13.5	22.5	12.2	14.6	12.4	22.0	18.7	14.6	13.6	11.6	14.4	15.2	17.2	14.9	11.4	18.5	15.0	14.3	21.9	8.0	23.9	19.2	12.6	29.8	16.8	14.2	9.9	13.2	13.3	8.1	5.8	11.0	28.7	32.1	18.9	17.4	19.1	14.8	21.7	5.6	12.8	15.3	16.4	10.1	40.4	10.6	17.3	23.3	7.3	13.3	20.2	13.8	5.4	13.3	16.2	14.1	14.2	26.2	9.2	5.2	15.1	51.6	18.2	14.5	17.5	5.0	20.1	18.5	21.5	18.5	9.6	31.0	14.3	12.9	11.7	13.9	18.0	4.6	13.4	12.6	26.2	15.1	10.5	22.4	18.7	42.0	25.1	41.6	17.2	18.9	20.1	26.0	12.8	37.0	22.0	22.2	12.4	77.7	14.8	23.5	49.8	29.5	8.0	8.8	16.5	16.6	27.0	11.1	26.2	20.2	6.8	42.2	16.3	5.6	12.8	4.2	9.6	12.5	13.3	14.8	12.7	12.3	21.7	11.7	12.3	11.9	0.7	15.3	7.3	19.1	16.4	10.1	15.5	15.9	10.8	25.6	14.6	12.4	11.6	14.4	15.0	5.8	14.9	29.6	26.1	44.9	68.5	23.0	43.7	20.4	81.7	51.2	41.8	3.9	343.3	104.5	74.5	21.3	42.7	45.1	0.0	69.7	113.6	40.1	51.8	26.5	45.3	113.3	31.8	27.2	28.8	40.5	6.6	23.0	53.5	59.1	21.6	78.5	20.5	50.0	49.1	36.7	159.0	11.6	25.8	43.2	13.5	16.0	65.4	113.4	30.2	117.6	52.0
AC005154.6		ENSG00000281039			7	30497077-30550761	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	19	"Cardiomyocytes: 6.7;granulocytes: 4.6;Intestinal endocrine cells: 6.8"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 19.2"									HPA020735	Uncertain					NA	NA					"HPA020735: AB_1845754"	"unprognostic (1.15e-2)"	"unprognostic (5.67e-3)"			"unprognostic (1.07e-2)"			"unprognostic (8.33e-2)"	"unprognostic (3.92e-2)"		"unprognostic (6.95e-3)"	"unprognostic (1.57e-1)"	"unprognostic (6.37e-4)"		"unprognostic (2.55e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.50e-4)"	2.8	2.0	3.3	1.0	1.0	7.3	2.2	1.0	3.9	1.0	1.4	1.6	4.5	2.4	1.5	7.8	1.0	0.9	2.8	1.0	2.0		1.0	1.0	3.1	3.1	1.0	1.0	2.0	1.0	0.7	8.8	1.8	4.1	1.6	1.8	1.6	4.4	1.7	2.1	3.9	1.0	1.0	3.1	2.7	1.8	1.0	1.9	1.0	1.6	3.0	2.6	1.0	1.0	1.5	2.1	1.8	1.2	0.8	2.3	0.2	1.7	0.0	6.6	6.7	4.8	10.9	2.5	4.5	4.8	2.5	1.8	1.0	0.7	2.3	1.3	3.6	3.2	4.8	0.9	2.0	2.6	2.9	1.2	2.3	4.6	2.1	4.4	5.1	10.6	7.4	6.3	1.9	3.8	5.3	2.5	5.0	1.9	10.8	3.9	0.4	2.0	6.7	1.4	1.0	0.6	1.9	0.5	3.9	4.0	2.9	1.5	2.5	2.3	1.4	3.0	8.3	3.6	7.3	2.4	1.9	1.3	1.8	1.0	19.2	4.2	2.2	3.2	6.3	5.6	0.0	1.0	1.8	2.3	0.8	0.9	0.0	0.6	1.8	2.1	1.5	1.7	0.1	0.8	0.8	1.2	0.7	0.5	0.2											0.0	0.3	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.1	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GARS	"CMT2D, DSMAV, GlyRS, SMAD1"	ENSG00000106105	"Glycyl-tRNA synthetase"	P41250	7	30594681-30634033	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Hydrolase, Ligase, Transferase"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017896, HPA019097"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	NA	NA		660000	Cytosol		"HPA017896: AB_1849478, HPA019097: AB_1849480"	"prognostic unfavorable (1.02e-4)"	"unprognostic (2.46e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-3)"	"prognostic unfavorable (8.95e-5)"	"unprognostic (7.31e-3)"	"unprognostic (4.76e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.45e-2)"	"prognostic unfavorable (1.70e-5)"	"unprognostic (3.92e-1)"	"unprognostic (3.40e-2)"	"unprognostic (6.32e-2)"	"prognostic unfavorable (3.04e-5)"	25.8	27.3	24.5	26.2	28.5	24.6	32.4	31.1	44.7	21.5	23.7	17.0	11.5	17.2	24.1	23.3	43.7	18.6	18.4	25.7	21.1	26.8	27.6	57.2	27.9	28.0	22.9	28.4	35.4	49.4	44.4	33.3	24.3	37.6	17.2	30.2	14.1	28.7	21.6	35.6	33.2	18.1	30.1	17.6	23.5	30.5	29.7	14.9	28.6	31.4	33.9	38.4	22.8	25.7	22.5	26.4	21.2	27.2	15.3	27.6	21.2	33.5	16.6	14.8	52.3	27.6	41.5	28.0	50.2	45.5	25.9	52.5	22.1	16.8	56.5	15.2	61.1	40.7	26.6	36.8	31.9	45.6	13.5	17.2	26.1	13.6	18.6	87.7	38.4	23.1	39.5	56.0	37.1	44.1	18.4	33.2	52.5	51.7	65.9	41.1	20.7	33.4	26.6	39.8	31.0	31.8	16.9	13.0	43.9	29.7	15.2	17.8	29.9	13.4	37.6	71.4	27.6	33.5	58.9	30.4	12.3	41.3	24.7	31.7	65.2	54.6	66.5	43.0	58.2	57.8	21.2	19.0	17.7	23.2	25.8	23.7	22.5	23.7	25.1	26.4	19.3	25.5	27.6	5.6	15.3	27.2	18.0	25.9	21.2	24.5	28.5	31.1	44.7	21.1	26.8	22.9	28.4	37.6	14.9	38.7	27.4	35.6	34.3	29.9	23.3	30.7	25.5	14.7	27.3	19.2	21.6	41.1	28.2	79.9	48.1	24.6	13.9	0.0	131.2	61.8	33.2	32.2	40.3	27.0	39.9	17.5	25.2	31.9	25.5	44.0	21.6	32.4	32.1	57.7	36.9	20.2	111.3	7.0	21.5	31.8	15.7	12.9	30.0	71.9	80.1	24.1	33.3	25.4	22.3	44.7
CRHR2	"CRF-RB, CRF2, HM-CRF"	ENSG00000106113	"Corticotropin releasing hormone receptor 2"	Q13324	7	30651943-30700129	"G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 11.7"	"Cell type enriched"	"Detected in single"	13	"Horizontal cells: 12.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.3;HeLa: 1.8;NTERA-2: 3.0;SCLC-21H: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA						"unprognostic (7.14e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.24e-3)"	"unprognostic (5.69e-2)"	"unprognostic (8.58e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.86e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.90e-4)"	"unprognostic (4.02e-2)"	"unprognostic (8.29e-4)"	"unprognostic (3.73e-3)"	"unprognostic (2.84e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.84e-1)"	1.4	0.7	0.9	0.5	4.1	0.4	1.6	0.5	11.7	0.8	0.6	0.0	3.6	2.1	1.1	0.5	1.7	2.1	1.0	3.2	4.3	3.2	0.8	0.4	0.6	0.6	0.9	3.2	1.0	3.9	0.9	8.0	0.4	3.1	0.9	0.9	1.7	0.7	6.2	5.5	0.8	1.2	1.1	0.8	0.3	1.0	1.8	1.0	0.0	1.7	3.2	0.6	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	1.3	0.0	1.8	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.3	0.0	0.0	0.2	0.2	3.0	0.0	0.4	0.0	0.0	0.6	0.0	0.9	1.7	0.1	0.2	0.0	0.2	0.6	0.1	0.0	0.5	0.4	1.0	0.3	0.2	0.8	0.3	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.1	0.5	11.7	4.3	3.2	0.9	3.2	3.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
INMT		ENSG00000241644	"Indolethylamine N-methyltransferase"	O95050	7	30697985-30757602	"Enzymes, Predicted intracellular proteins"	Detoxification	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 73.5"	"Group enriched"	"Detected in many"	10	"Ito cells: 257.8;Leydig cells: 264.1;Peritubular cells: 428.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 22.2"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"CACO-2: 18.7;HHSteC: 8.0"									HPA061343			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA061343: AB_2684483"	"unprognostic (1.70e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.39e-4)"	"prognostic favorable (5.72e-4)"	"unprognostic (3.08e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.51e-2)"	"unprognostic (9.07e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.43e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.58e-2)"	19.7	18.0	0.3	3.0	0.7	0.0	5.9	0.3	0.6	4.9	3.7	1.3	14.0	0.8	9.8	18.9	12.4	16.3	14.7	24.6	0.6	0.4	11.8	24.3	73.5	12.1	1.1	0.8	20.2	4.0	0.7	3.2	12.9	2.5	10.1	1.6	13.0	6.1	19.9	4.7	1.5	3.9	11.3	1.3	6.5	5.0	28.2	0.2	0.5	9.4	3.8	2.8	9.6	6.4	1.7	1.1	4.2	1.0	2.2	1.0	0.6	0.0	0.1	0.1	0.1	1.8	2.6	0.4	0.2	2.4	0.0	0.0	18.7	0.1	0.0	0.1	0.6	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	8.0	0.1	0.3	0.9	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.3	0.3	0.1	0.0	0.4	0.9	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.2	0.6	0.1	0.8	0.0	0.8	0.2	0.1	1.1	0.1	0.8	0.3	0.1	0.8	0.3	0.1	0.2	0.1	0.3	4.2	1.0	0.8	0.7	0.4	0.7	1.2	0.7	0.6	0.4	1.7	1.0	0.8	3.0	2.2	0.4	1.1	0.6	0.6	0.3	0.7	0.3	0.6	0.6	0.4	1.1	0.8	2.5	0.2	0.0	5.1	0.0	0.2	1.9	0.0	7.8	2.5	1.4	4.5	0.0	0.0	0.5	0.0	0.0	1.3	9.7	0.0	0.0	0.0	0.2	21.8	0.2	0.0	3.0	0.7	0.0	1.2	257.8	19.4	8.5	264.1	0.5	3.3	0.0	0.0	0.0	0.0	0.0	428.2	0.0	0.0	32.3	16.0	1.4	1.4	1.9	1.5	0.0	0.0	0.3
MINDY4	"C7orf67, FAM188B, FLJ22374"	ENSG00000106125	"MINDY lysine 48 deubiquitinase 4"	Q4G0A6	7	30771417-30892387	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 8.9;Ciliated cells: 33.5;Collecting duct cells: 12.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.1;T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"K-562: 16.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA019475, HPA030129, HPA030130"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA019475: AB_1848806, HPA030129: AB_10599621, HPA030130: AB_10601565"	"unprognostic (2.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.07e-1)"	"unprognostic (6.01e-3)"	"unprognostic (3.81e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	9.3	6.7	9.3	2.6	15.2	4.1	7.0	3.4	15.1	10.8	6.6	5.4	16.6	2.9	15.6	16.2	5.7	20.7	10.0	7.5	8.4	5.1	9.4	3.8	14.2	2.4	4.3	9.5	14.8	5.6	9.6	16.1	6.2	9.0	9.4	4.3	7.8	5.3	15.9	3.7	5.1	3.7	10.8	3.6	2.3	5.8	20.1	5.0	1.5	12.5	3.6	2.2	6.4	6.3	0.0	1.1	0.0	0.3	0.0	2.7	0.7	2.1	5.3	2.8	8.5	2.5	9.6	4.1	3.1	5.4	2.4	2.0	0.0	4.0	0.0	3.6	2.0	3.3	2.3	1.9	1.7	2.3	0.0	3.1	1.7	2.8	0.0	3.1	2.3	1.2	4.9	2.8	7.0	1.4	0.2	3.4	1.6	16.4	1.0	2.0	0.0	1.3	0.7	8.0	7.4	1.2	0.4	0.0	0.5	6.4	1.0	5.2	7.1	2.1	11.3	1.2	3.4	5.7	1.7	2.0	0.1	1.3	2.4	1.3	2.3	3.0	0.0	4.5	0.1	10.0	0.0	0.1	0.0	0.6	0.0	2.7	0.0	0.8	0.2	1.1	0.0	0.3	0.5	0.0	0.0	0.3	0.0	0.5	0.7	9.3	15.2	3.4	15.1	8.4	5.1	4.3	9.5	9.0	5.0	8.9	3.8	0.0	0.0	0.0	0.0	0.0	0.0	33.5	3.4	12.2	0.0	2.1	3.3	2.3	0.0	0.0	0.0	0.0	1.2	3.5	0.0	0.0	2.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
AC004691.2		ENSG00000250424			7	30852273-30923812	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.3;ASC diff: 1.1;SH-SY5Y: 1.9;SK-BR-3: 1.3"									"HPA019206, HPA030130"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA019206: AB_1844965, HPA030130: AB_10601565"	"unprognostic (2.15e-1)"	"unprognostic (3.12e-1)"			"unprognostic (1.83e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.72e-4)"		"unprognostic (5.13e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.76e-1)"		"unprognostic (2.49e-1)"	"unprognostic (3.71e-2)"	0.8	0.2	0.0	0.0	0.4	0.2	0.6	0.0	0.3	1.1	1.3			1.4	1.4	1.5	0.7	2.4	3.1	0.8	0.0	0.1	0.5	0.0	1.1	0.0	0.0		0.6	2.2	0.0	0.3	0.0		0.7	0.2		0.7	1.2	0.4	0.3	0.4	2.3	0.0	0.0	0.9	0.1			0.7		0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.3	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.6	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AQP1	"CHIP28, CO"	ENSG00000240583	"Aquaporin 1 (Colton blood group)"	P29972	7	30911694-30925516	"Blood group antigen proteins, Predicted membrane proteins, Transporters"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 156.5"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 218.3;Cholangiocytes: 377.0;Endothelial cells: 221.7;Proximal tubular cells: 281.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 20.9;HeLa: 7.0;SH-SY5Y: 7.8;U-2 OS: 9.8;WM-115: 37.8"									"CAB001707, HPA019206"	Enhanced		Supported	"Plasma membrane"		NA	NA		250000	"Plasma membrane"		"CAB001707: , HPA019206: AB_1844965"	"unprognostic (4.18e-2)"	"unprognostic (7.82e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (6.52e-4)"	"unprognostic (1.95e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.80e-2)"	"unprognostic (4.16e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (1.32e-8)"	"unprognostic (3.43e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.21e-2)"	68.2	8.0	9.9	8.7	17.1	9.4	51.9	10.7	13.0	46.5	18.1	62.1	7.7	10.8	28.0	20.8	58.8	29.0	36.3	46.7	18.1	15.4	156.5	4.2	103.2	9.1	36.9	17.8	16.4	49.9	12.9	4.0	9.1	63.2	32.4	10.6	8.3	19.8	22.7	35.2	24.8	18.2	41.2	56.4	2.9	18.2	15.0	17.8	1.9	21.3	33.5	12.5	36.0	76.7	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.1	0.6	0.4	1.8	0.4	1.2	0.4	0.0	0.0	0.2	0.3	0.0	20.9	1.1	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.2	7.0	0.0	0.4	0.1	0.0	3.3	0.0	0.1	0.0	0.0	2.9	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.0	0.0	5.2	0.1	0.7	0.0	0.2	7.8	1.2	0.6	0.0	3.9	0.1	0.1	0.0	0.0	9.8	0.8	0.3	0.5	0.3	0.0	0.1	0.0	37.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	9.9	17.1	10.7	13.0	18.1	15.4	36.9	17.8	63.2	17.8	166.7	218.3	2.9	1.1	81.4	1.1	57.7	377.0	6.7	6.8	29.6	7.9	1.9	24.9	35.6	1.9	221.7	4.2	0.0	2.1	3.0	91.5	1.0	1.1	1.3	3.3	0.0	7.0	154.1	1.8	1.6	1.1	9.8	84.4	2.8	18.2	0.3	2.8	19.2	3.2	281.0	0.2	12.9	92.0	0.3	1.3	68.8	6.1	0.0	71.0	1.0
GHRHR		ENSG00000106128	"Growth hormone releasing hormone receptor"	Q02643	7	30938669-30993254	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	36	"pituitary gland: 108.9"	"Cell type enhanced"	"Detected in single"	31	"Spermatogonia: 2.4"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (8.32e-2)"		"unprognostic (1.45e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.39e-1)"		"unprognostic (7.23e-2)"	"unprognostic (4.15e-1)"		"unprognostic (2.28e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.87e-3)"		0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	108.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	2.4	0.0	0.0	0.0	0.0	0.0
ADCYAP1R1	"PAC1, PAC1R, PACAPR"	ENSG00000078549	"ADCYAP receptor type I"	P41586	7	31052461-31111479	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.2;fallopian tube: 25.1"	"Group enriched"	"Detected in some"	5	"Leydig cells: 10.6;Peritubular cells: 5.3"	"Cancer enriched"	"Detected in some"	11	"glioma: 45.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.6;NTERA-2: 7.3;SCLC-21H: 6.2;SH-SY5Y: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030739, HPA049877"	Enhanced		Enhanced	Vesicles		NA	NA			Vesicles		"HPA030739: AB_2732461, HPA049877: AB_2680928"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.16e-2)"	"prognostic favorable (5.78e-4)"	"unprognostic (2.17e-1)"	"unprognostic (8.36e-2)"	"unprognostic (4.93e-2)"	"unprognostic (5.75e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.67e-3)"	"unprognostic (6.43e-4)"	"unprognostic (1.09e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-4)"	5.4	10.6	23.6	2.7	24.2	0.9	2.9	13.7	71.2	12.8	2.7	13.4	0.0	1.6	5.4	2.3	3.3	25.1	2.0	2.8	22.1	21.6	1.0	1.1	1.6	1.0	19.0	20.2	1.9	2.2	2.9	4.4	1.0	18.7	2.1	2.0	0.0	2.6	3.7	1.9	1.8	2.0	3.9	6.5	1.3	1.6	2.2	13.3	0.0	2.3	0.9	1.6	1.4	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	11.1	0.0	0.0	0.0	2.2	0.0	0.0	0.3	0.9	1.3	0.2	0.1	0.0	0.0	0.0	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	23.6	24.2	13.7	17.3	22.1	21.6	19.0	20.2	18.7	13.3	0.0	0.0	0.0	0.0	0.5	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	10.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.2	0.0	1.4	0.0	1.5	0.3	0.0	0.0	0.0	0.0
NEUROD6	"Atoh2, bHLHa2, Math-2, Nex1, NEX1M"	ENSG00000164600	"Neuronal differentiation 6"	Q96NK8	7	31337461-31340894	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"brain: 30.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 8.3;basal ganglia: 10.7;cerebral cortex: 25.5;hippocampal formation: 30.6;olfactory region: 17.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	119	"SCLC-21H: 11.8"	"Group enriched"	"Detected in many"	5	"cerebral cortex: 99.2;hippocampal formation: 246.6"	"Group enriched"	"Detected in many"	9	"cerebral cortex: 26.0;hippocampal formation: 108.7"	HPA074530	Enhanced					NA	NA					"HPA074530: AB_2732257"					"unprognostic (3.68e-2)"													0.5	0.5	8.3	0.5	10.7	0.5	0.5	3.9	25.5	0.5	0.5	0.7	0.0	0.5	0.5	0.5	0.5	0.5	0.5	0.5	30.6	0.5	0.5	0.5	0.5	0.5	1.3	17.4	0.5	0.5	0.5	0.1	0.5	0.4	0.5	0.5	0.0	0.5	0.5	0.5	0.5	0.5	0.5	0.4	0.5	0.5	0.5	0.0	0.0	0.5	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	10.7	3.9	25.5	30.6	0.5	1.3	17.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC129	FLJ38344	ENSG00000180347	"Coiled-coil domain containing 129"	Q6ZRS4	7	31514071-31658720	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 17.2;salivary gland: 10.9"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 8.2;Intestinal endocrine cells: 1.7;Late spermatids: 5.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"cerebellum: 7.9;midbrain: 5.0;pons and medulla: 17.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 1.6;CACO-2: 1.3;RH-30: 2.1;T-47d: 2.7;U-2 OS: 5.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA024103	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024103: AB_1846132"	"unprognostic (1.11e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.78e-5)"	"unprognostic (9.72e-3)"	"unprognostic (1.78e-1)"		"unprognostic (3.89e-2)"	"unprognostic (6.42e-3)"		"unprognostic (1.01e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.53e-1)"		0.1	0.0	0.1	0.6	2.0	0.1	3.3	7.9	0.3	3.7	0.9	1.2	0.0	2.1	1.1	0.2	0.1	0.1	0.1	0.0	0.4	1.4	0.1	0.0	0.4	0.0	5.0	0.0	0.0	0.2	0.0	0.4	0.9	17.2	0.1	0.2	0.0	10.9	0.0	0.0	4.5	0.9	1.1	0.2	0.0	0.8	2.7	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.8	0.8	1.1	0.0	0.1	1.0	0.1	0.0	0.0	1.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.5	0.8	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.2	0.2	0.1	2.1	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.2	2.7	0.0	0.0	0.0	5.6	0.2	0.3	0.2	0.1	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.2	0.0	0.1	0.7	0.2	0.1	0.1	0.8	1.0	0.4	1.1	0.1	0.0	0.8	0.0	0.1	0.1	2.0	7.9	0.3	0.4	1.4	5.0	0.0	17.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	5.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0
PPP1R17	"C7orf16, GSBS"	ENSG00000106341	"Protein phosphatase 1 regulatory subunit 17"	O96001	7	31686715-31708455	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 10.5;blood: 24.5;brain: 29.7"	"Group enriched"	"Detected in some"	126	"Early spermatids: 30.6;Late spermatids: 68.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in many"	6	"cerebellum: 29.7;hypothalamus: 8.5"	"Cell type enriched"	"Detected in some"	4	"non-classical monocyte: 24.5"	"Lineage enriched"	"Detected in many"	19	"monocytes: 24.5"	"Group enriched"	"Detected in some"	197	"NTERA-2: 15.7;SCLC-21H: 47.7"	"Region enriched"	"Detected in some"	32	"cerebellum: 483.2"	"Region enriched"	"Detected in many"	4	"cerebellum: 339.5"	"HPA047819, HPA073123"	Enhanced					NA	NA					"HPA047819: AB_2680166, HPA073123: AB_2732219"					"unprognostic (1.50e-1)"			"unprognostic (1.33e-1)"					"unprognostic (6.56e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.33e-1)"			0.6	10.5	0.9	0.6	1.3	0.8	0.1	29.7	4.6	0.1	0.1	1.7	0.0	0.1	0.8	0.3	0.1	0.1	0.1	0.4	0.6	8.5	0.1	0.2	1.1	0.1	1.1	0.9	0.1	0.1	0.1	2.9	0.1	2.6	0.3	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0.4	1.0	0.3	0.3	1.7	3.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	1.2	0.0	24.5	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.8	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	24.5	0.0	0.0	0.4	0.9	1.3	29.7	3.3	0.6	8.5	1.1	0.9	2.6	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	68.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0
PDE1C	Hcam3	ENSG00000154678	"Phosphodiesterase 1C"	Q14123	7	31751179-32299329	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.6;heart muscle: 56.2"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 55.0;Cardiomyocytes: 112.6;Cone photoreceptor cells: 49.1;Early spermatids: 40.4;Late spermatids: 38.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 15.2;fHDF/TERT166: 49.0;hTERT-RPE1: 15.0;U-251 MG: 26.5;WM-115: 35.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052375			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052375: AB_2681802"	"unprognostic (1.29e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.68e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.65e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.75e-1)"	"unprognostic (6.79e-3)"	"unprognostic (6.49e-2)"	"unprognostic (3.88e-5)"	"unprognostic (7.03e-2)"	"unprognostic (3.09e-3)"	"unprognostic (5.76e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.06e-3)"	2.9	2.7	10.6	3.2	27.7	0.9	5.1	2.4	17.1	1.2	2.7	30.1	0.0	2.3	3.1	6.8	7.4	8.4	2.4	56.2	14.8	7.5	4.0	1.0	5.0	1.4	31.1	12.0	4.9	2.7	1.3	1.3	4.0	16.3	2.9	2.7	7.9	2.6	4.2	1.4	0.9	2.8	10.4	17.1	1.4	3.8	4.2	33.6	0.0	3.9	0.2	1.0	7.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	5.2	0.0	0.2	0.1	0.0	15.2	6.2	7.2	5.9	0.0	0.0	0.0	0.0	49.0	0.0	0.4	0.0	0.0	9.3	0.0	0.0	0.4	0.4	0.0	0.0	0.0	10.9	0.6	0.0	1.5	0.1	15.0	2.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	7.4	0.0	2.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	8.1	3.0	0.1	26.5	0.0	0.0	0.0	0.7	0.1	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	27.7	2.4	17.1	14.8	7.5	31.1	12.0	16.3	33.6	0.0	0.0	0.0	0.8	0.0	55.0	112.6	0.0	4.0	1.2	1.8	49.1	0.0	0.0	5.6	40.4	2.9	0.0	0.0	0.4	0.0	0.0	0.2	8.1	0.0	0.1	3.2	0.0	0.0	0.0	38.3	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.4	0.0	4.4	0.0	2.1	1.1	0.7	0.0	0.0	0.0	0.0	0.0
LSM5	YER146W	ENSG00000106355	"LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated"	Q9Y4Y9	7	32485332-32495283	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA019054	Uncertain					NA	NA					"HPA019054: AB_10960217"	"unprognostic (1.92e-1)"	"unprognostic (5.36e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.92e-2)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (7.53e-5)"	"unprognostic (2.22e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (1.84e-4)"	"unprognostic (3.08e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.18e-1)"	19.2	25.5	22.7	20.3	39.6	34.1	33.8	24.0	30.5	18.8	30.0	15.8	16.1	22.2	20.2	21.6	27.8	19.0	23.5	26.2	21.7	21.1	24.6	38.9	19.9	29.5	21.7	19.4	20.7	36.7	10.7	26.3	15.0	23.5	19.9	32.8	17.1	25.5	20.3	28.2	18.4	21.1	27.5	23.4	24.7	26.4	17.6	22.8	34.1	23.9	31.8	36.5	21.8	19.8	26.8	37.6	12.3	20.9	16.2	37.6	17.0	34.2	21.0	28.6	40.0	10.0	11.2	14.2	16.3	13.8	20.9	22.2	28.9	29.4	20.2	8.7	11.5	51.2	20.5	21.0	20.3	28.6	14.2	23.1	20.9	33.2	39.4	8.9	44.6	21.7	9.3	15.0	20.4	24.2	14.0	22.8	35.1	43.2	15.8	29.2	41.6	23.2	100.5	46.9	50.3	24.5	20.5	22.7	34.0	18.6	16.8	24.8	36.5	14.6	41.3	18.6	44.9	25.9	56.4	10.9	18.2	44.6	16.8	41.5	26.3	54.4	58.7	17.2	53.3	51.3	5.5	13.9	12.3	15.8	20.9	23.3	26.8	25.8	20.5	19.1	23.8	37.6	27.8	2.3	16.2	17.5	37.6	21.5	17.0	22.7	39.6	24.0	30.5	21.7	21.1	21.7	19.4	23.5	22.8	29.8	45.3	144.5	124.4	130.2	50.2	94.4	99.3	87.0	46.6	108.2	21.6	176.7	235.4	106.0	12.5	78.8	78.3	116.8	187.4	255.4	112.4	120.9	69.4	274.5	168.0	41.3	48.6	73.1	110.4	15.7	70.2	137.1	116.4	174.9	144.3	57.3	134.3	112.2	77.4	236.6	52.4	64.7	118.5	73.9	149.1	155.2	84.1	117.7	210.9	105.6
AVL9	KIAA0241	ENSG00000105778	"AVL9 cell migration associated"	Q8NBF6	7	32495426-32588721	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050957	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA050957: AB_2681289"	"unprognostic (2.33e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.72e-3)"	"unprognostic (5.14e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.21e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.68e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.05e-1)"	12.0	15.8	17.4	16.7	22.9	12.2	15.6	24.1	25.7	14.2	22.5	12.9	14.0	18.8	13.1	18.6	12.4	12.9	11.6	8.8	16.6	20.0	15.6	11.9	12.0	14.1	14.5	15.1	13.8	15.9	12.7	15.9	16.3	17.3	14.4	26.2	15.4	15.2	12.8	12.6	11.6	19.9	12.2	11.5	14.3	17.4	10.0	10.3	21.3	19.3	6.6	15.8	12.9	11.0	12.5	9.9	27.4	10.7	5.1	10.9	9.4	9.4	8.3	8.7	11.7	5.3	7.6	6.1	8.5	11.3	8.4	11.3	6.5	12.7	11.9	0.1	7.4	32.5	7.8	8.3	8.4	14.3	5.1	5.1	8.9	5.7	7.0	19.4	15.1	11.7	8.2	8.3	10.7	12.3	9.3	12.4	9.6	21.7	11.0	26.3	9.7	6.1	12.7	9.8	13.1	7.4	5.9	9.7	9.0	8.9	16.0	18.8	12.0	7.1	17.7	7.6	12.2	12.6	13.9	9.4	8.8	10.4	6.9	7.4	25.5	22.1	19.0	17.3	14.4	19.1	12.8	10.7	15.5	10.6	8.4	9.1	9.9	8.8	9.9	8.2	12.5	10.9	9.5	27.4	5.1	7.9	9.9	8.0	9.4	17.4	22.9	24.1	25.7	16.6	20.0	14.5	15.1	17.3	10.3	6.0	9.4	15.9	9.1	10.2	32.8	6.1	12.7	14.7	11.4	12.2	58.9	13.5	3.3	11.2	4.6	9.5	26.2	0.0	15.0	11.6	9.3	16.4	17.3	11.1	13.1	30.2	21.5	11.6	28.6	1.8	9.5	14.6	11.8	5.4	28.5	13.8	20.1	28.1	8.9	13.1	38.6	6.5	10.0	8.1	7.5	9.3	14.6	16.2	24.7	20.1
KBTBD2	"BKLHD1, DKFZP566C134"	ENSG00000170852	"Kelch repeat and BTB domain containing 2"	Q8IY47	7	32868172-32894131	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021133	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Nucleoplasm, Nucleoli fibrillar center"		"HPA021133: AB_1852093"	"unprognostic (1.01e-1)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (3.17e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (3.96e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.80e-3)"	"unprognostic (5.05e-1)"	"unprognostic (6.79e-3)"	"unprognostic (3.81e-3)"	"unprognostic (1.42e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.96e-1)"	20.9	12.3	13.9	15.0	15.7	34.4	16.4	18.3	18.0	13.6	12.2	12.9	10.2	11.3	17.3	8.1	12.8	12.0	18.5	17.0	13.8	14.3	11.2	15.3	17.5	24.9	18.2	13.4	13.9	9.6	16.2	13.8	18.4	17.5	12.5	14.6	12.1	11.7	11.6	36.5	12.2	13.4	18.3	21.1	21.1	10.9	12.5	13.8	26.3	15.2	18.2	16.8	13.6	20.4	6.9	3.5	25.1	8.6	6.8	7.4	2.3	18.3	9.2	23.9	11.8	14.4	14.6	8.6	16.5	16.8	15.7	19.1	9.1	14.3	15.5	11.5	17.0	26.5	13.6	12.1	12.9	19.9	6.1	8.7	13.1	15.2	11.7	14.9	14.0	17.3	15.4	13.6	17.1	16.7	14.6	17.3	14.2	23.7	23.1	23.1	15.1	11.7	23.0	19.3	12.8	8.8	11.3	20.9	13.0	13.9	11.1	12.5	23.5	10.6	14.5	18.2	20.9	10.3	24.0	14.9	15.3	19.8	14.2	22.5	19.2	18.9	28.4	15.0	17.0	38.1	9.2	4.2	13.0	7.4	7.7	6.2	4.5	3.6	6.5	3.5	6.9	2.8	4.7	25.1	6.8	8.6	1.8	4.7	2.3	13.9	15.7	18.3	18.0	13.8	14.3	18.2	13.4	17.5	13.8	26.8	19.2	12.7	14.0	35.8	14.2	16.5	15.3	4.0	31.8	1.8	9.8	5.5	0.0	10.3	3.9	43.6	14.7	0.0	10.5	7.5	19.3	14.5	42.7	13.2	11.6	7.9	14.3	32.5	21.6	4.3	12.0	20.7	23.6	4.6	11.9	9.0	12.8	13.1	5.6	3.6	7.9	19.4	18.1	15.8	7.0	31.6	6.3	13.8	10.5	13.9
FKBP9	"FKBP60, FKBP63"	ENSG00000122642	"FK506 binding protein 9"	O95302	7	32957404-33006931	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 7.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 58.4;fHDF/TERT166: 71.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012595, HPA055256"	Approved		Approved	"Golgi apparatus,Vesicles,Mitochondria"	"Intracellular and membrane"	No	No			"Golgi apparatus, Mitochondria"	Vesicles	"HPA012595: AB_1848629, HPA055256: AB_2682761"	"unprognostic (1.23e-2)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (6.94e-2)"	"unprognostic (6.25e-3)"	"prognostic unfavorable (5.80e-4)"	"prognostic unfavorable (2.02e-4)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (3.40e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.90e-3)"	"prognostic unfavorable (7.02e-6)"	35.4	21.1	9.7	12.5	13.6	0.9	43.7	4.5	16.3	33.6	18.3	9.3	16.8	8.8	31.3	30.9	23.7	24.1	28.8	44.4	9.7	11.9	18.2	10.1	30.6	17.5	10.8	9.7	25.9	26.0	12.9	16.0	35.2	13.2	23.7	21.2	30.4	16.0	25.6	17.1	28.0	13.4	37.0	12.8	10.7	17.4	16.3	6.4	2.9	18.9	19.4	11.1	23.7	23.6	0.4	1.4	7.4	4.1	0.3	0.1	0.9	7.1	13.6	5.3	21.9	50.4	58.4	7.1	38.7	40.3	12.8	20.4	5.9	17.0	0.0	15.8	71.8	20.5	14.0	7.8	18.9	14.7	0.0	2.3	1.2	14.6	5.8	21.0	0.0	2.1	37.9	11.5	11.4	11.1	30.5	16.1	0.0	2.7	1.4	26.0	6.9	0.0	3.6	1.1	14.3	7.2	0.0	14.3	0.0	14.3	2.4	5.0	12.1	22.1	11.3	13.7	14.1	7.9	3.5	21.5	21.0	20.2	13.0	8.8	4.6	8.9	0.0	20.5	0.0	41.7	1.5	4.1	0.9	0.1	2.6	0.1	0.4	0.1	0.0	1.4	0.3	0.1	0.1	7.4	0.3	0.7	0.3	0.0	0.9	9.7	13.6	4.5	16.3	9.7	11.9	10.8	9.7	13.2	6.4	11.9	20.0	0.0	12.5	30.5	7.7	38.3	15.3	6.7	7.9	17.4	9.8	17.1	5.0	16.3	0.5	65.3	16.9	0.0	36.7	25.2	46.6	8.5	5.7	10.5	6.7	11.1	11.7	58.9	6.2	0.7	33.9	4.5	57.3	3.6	27.2	34.3	30.2	17.5	51.9	7.4	4.5	45.3	51.9	0.9	0.9	25.0	11.0	1.3	21.4	8.6
NT5C3A	"cN-III, hUMP1, NT5C3, p36, P5'N-1, PN-I, POMP, PSN1, UMPH, UMPH1"	ENSG00000122643	"5'-nucleotidase, cytosolic IIIA"	Q9H0P0	7	33014113-33062797	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA010630, HPA029058"	Uncertain				"Intracellular and membrane"	NA	NA					"HPA010630: AB_2668319, HPA029058: AB_10601380"	"unprognostic (7.50e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (9.37e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.12e-3)"	"unprognostic (3.43e-3)"	12.3	12.1	9.9	17.0	9.9	15.4	11.4	16.2	12.2	12.0	27.5	7.4	8.1	20.9	14.7	11.6	12.0	9.0	12.9	11.6	9.8	10.3	11.7	10.5	11.6	15.0	10.3	9.8	10.3	19.1	5.5	10.9	10.6	8.4	9.6	27.2	8.5	9.0	8.9	53.3	15.0	19.7	7.5	9.9	18.4	14.5	6.3	8.9	15.4	9.8	28.8	22.8	12.0	11.6	21.4	6.8	36.6	11.4	8.6	18.9	13.3	14.3	10.5	9.8	8.7	7.4	6.5	7.9	15.7	10.3	10.7	14.6	6.5	40.6	36.1	9.1	9.2	18.7	21.9	10.5	10.4	15.9	5.6	13.5	16.4	12.4	9.4	7.9	19.5	13.6	7.2	9.3	11.7	23.5	6.5	7.0	12.4	14.1	9.6	13.2	9.8	7.2	30.6	10.0	17.3	9.2	9.6	8.9	21.3	34.1	15.1	10.5	13.1	10.3	19.4	24.6	8.6	12.9	10.9	6.1	9.1	8.2	15.5	20.5	19.3	22.0	17.7	7.5	12.1	14.2	26.9	8.0	29.8	9.0	10.2	10.2	21.4	12.1	11.0	6.8	20.5	12.4	10.6	36.6	8.6	11.4	6.4	18.9	13.3	9.9	9.9	16.2	12.2	9.8	10.3	10.3	9.8	8.4	8.9	20.8	10.7	82.5	30.5	41.6	22.0	14.0	30.6	37.5	27.3	15.7	39.3	30.8	24.9	25.8	3.2	34.9	102.1	46.7	70.0	25.2	31.9	27.6	17.3	16.3	22.9	1.6	114.8	20.3	26.5	3.6	31.4	25.2	25.3	17.2	74.0	23.6	44.1	98.2	20.8	48.5	23.5	12.9	27.8	30.9	17.2	34.0	23.7	34.5	50.5	60.6
RP9	PAP-1	ENSG00000164610	"RP9, pre-mRNA splicing factor"	Q8TA86	7	33094797-33109401	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031523, HPA050778"	Uncertain		Enhanced	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA031523: AB_10603235, HPA050778: AB_2681233"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (6.71e-2)"	"unprognostic (6.22e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.65e-5)"	"unprognostic (4.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.61e-1)"	10.1	13.8	11.7	9.4	16.0	20.7	14.9	17.1	16.0	10.9	12.2	13.0	7.0	10.3	14.6	18.8	8.1	10.0	10.7	19.2	11.1	10.1	11.4	11.5	9.7	19.4	17.4	8.6	14.2	16.9	10.4	14.2	11.7	11.0	14.0	11.8	12.8	15.0	14.4	34.7	10.7	12.5	15.7	11.8	17.2	10.5	15.2	12.6	13.6	15.6	9.0	18.2	13.4	16.0	34.1	11.7	8.1	5.0	5.9	8.4	3.3	9.9	14.3	15.1	17.2	9.6	9.0	7.2	12.7	10.9	14.7	11.8	12.7	7.3	12.6	8.4	10.5	18.1	10.0	18.3	10.9	19.0	5.7	11.4	9.2	11.3	11.8	16.9	12.3	6.5	9.0	10.3	16.7	33.1	12.0	12.0	13.5	16.5	11.6	14.7	20.6	13.2	33.8	12.7	13.3	10.3	13.3	13.1	8.4	10.6	9.6	14.6	20.0	8.9	20.0	21.7	18.7	10.5	17.1	9.6	14.6	20.5	12.9	20.6	18.9	17.1	25.1	10.3	17.6	28.2	6.4	5.0	8.1	6.6	3.6	6.1	22.0	7.0	7.4	5.3	34.1	8.4	7.8	0.9	5.9	4.6	11.7	5.9	3.3	11.7	16.0	17.1	16.0	11.1	10.1	17.4	8.6	11.0	12.6	11.9	8.5	17.4	13.8	18.7	16.3	32.5	12.7	10.7	11.4	14.0	13.7	16.9	18.3	14.1	3.5	21.7	10.5	0.0	13.7	16.3	19.4	11.5	3.5	15.1	16.0	7.9	9.8	14.7	7.6	2.7	16.7	9.9	21.9	9.0	16.4	15.8	13.4	5.8	15.2	13.5	12.9	25.8	20.2	33.0	48.0	15.7	8.7	11.8	18.0	10.7
BBS9	"B1, PTHB1"	ENSG00000122507	"Bardet-Biedl syndrome 9"	Q3SYG4	7	33129244-33606068	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision"		"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 27.5;Rod photoreceptor cells: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021289	Uncertain					NA	NA					"HPA021289: AB_1845286"	"unprognostic (1.18e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.68e-2)"	"unprognostic (4.13e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.86e-4)"	"unprognostic (2.75e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.20e-1)"	"unprognostic (6.90e-3)"	8.2	11.5	8.2	6.2	11.5	3.0	10.6	21.1	12.5	15.8	7.6	12.8	9.8	2.0	16.0	11.7	7.4	15.3	9.7	7.3	9.3	9.2	11.7	8.7	10.3	6.2	9.6	7.9	13.4	5.5	22.5	27.8	11.5	11.0	10.0	7.9	15.6	8.5	13.1	4.5	7.4	5.3	11.7	11.8	7.0	7.1	19.8	10.7	11.9	16.7	4.1	8.2	8.7	13.3	5.5	3.7	5.5	6.0	8.7	7.5	4.5	2.5	3.6	7.0	6.5	16.9	16.7	2.9	4.2	11.0	4.5	8.4	3.0	5.0	4.7	3.9	9.9	8.3	3.5	2.8	9.5	8.4	2.4	5.2	1.3	5.3	3.1	7.1	1.1	2.3	13.3	6.8	6.7	2.9	9.2	9.4	9.1	2.3	7.4	7.4	3.1	3.1	2.4	3.9	3.6	3.6	3.9	2.5	1.7	5.5	1.8	2.8	4.7	7.0	3.0	6.8	12.3	7.6	2.7	3.4	5.0	4.0	6.5	2.2	6.4	7.5	6.2	7.8	2.0	6.9	3.7	4.0	5.5	5.8	6.0	7.5	5.5	5.8	6.4	3.7	5.3	5.9	6.0	1.5	8.7	5.7	1.6	6.9	4.5	8.2	11.5	21.1	12.5	9.3	9.2	9.6	7.9	11.0	10.7	3.0	3.0	2.2	5.9	3.3	6.2	9.2	2.5	13.4	6.8	5.2	27.5	3.1	3.3	2.4	14.3	5.2	1.0	0.0	1.4	3.9	4.3	2.5	0.0	2.0	3.2	4.8	3.5	6.7	0.6	3.9	3.7	2.2	1.7	1.0	2.3	7.2	1.5	0.0	5.3	3.4	50.4	0.0	3.6	19.7	13.0	2.9	2.1	4.3	2.3	4.3
BMPER	"CRIM3, Cv2"	ENSG00000164619	"BMP binding endothelial regulator"	Q8N8U9	7	33904911-34155872	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	17	"Ito cells: 97.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 11.8;BJ: 11.2;fHDF/TERT166: 14.5;HBF TERT88: 15.9;HSkMC: 11.9;hTEC/SVTERT24-B: 10.6;U-138 MG: 16.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (4.50e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.96e-4)"	"unprognostic (5.34e-3)"	"unprognostic (3.10e-1)"	"unprognostic (9.98e-3)"	"unprognostic (3.50e-3)"	"unprognostic (8.01e-4)"	"unprognostic (1.96e-1)"	"unprognostic (5.67e-5)"	"unprognostic (2.54e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.47e-3)"	7.0	1.1	2.2	8.5	6.3	0.3	2.2	9.5	9.7	5.0	2.4	0.6	0.0	1.3	3.4	6.7	1.6	1.6	2.0	2.7	2.4	1.9	1.1	12.9	5.7	7.8	1.6	4.7	3.3	1.0	0.4	5.3	11.3	6.0	9.5	2.0	1.8	1.9	0.9	3.7	1.0	3.8	2.0	1.7	1.0	4.2	1.4	0.0	0.0	1.1	2.0	0.3	1.6	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	11.8	6.3	0.0	11.2	2.8	7.1	6.2	0.0	0.0	0.1	0.0	14.5	3.9	5.3	0.0	0.0	15.9	0.0	0.5	0.0	0.5	0.0	1.2	0.0	0.0	11.9	0.0	10.6	0.0	0.6	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	2.1	0.9	0.0	0.0	16.6	1.4	8.2	0.0	1.4	0.0	0.0	6.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	6.3	9.5	9.7	2.4	1.9	1.6	4.7	6.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	4.2	0.0	0.0	0.0	0.0	5.9	0.4	0.0	0.1	1.5	0.6	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	4.1	97.6	4.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.3	0.0	0.8	0.0	3.9	0.1	0.1	0.0	0.0	0.2
NPSR1	"GPR154, GPRA, PGR14"	ENSG00000187258	"Neuropeptide S receptor 1"	Q6W5P4	7	34658239-34878332	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	Asthma	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 3.5;retina: 9.1;stomach 1: 3.7"	"Cell type enriched"	"Detected in single"	6	"Early spermatids: 3.7"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HAP1: 4.7;SCLC-21H: 2.6"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 9.6"							NA	NA							"unprognostic (3.56e-1)"	"unprognostic (9.34e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.00e-2)"		"unprognostic (9.35e-2)"			"unprognostic (6.34e-3)"			"unprognostic (2.85e-1)"	"unprognostic (1.36e-2)"		"unprognostic (2.08e-2)"	0.0	0.2	0.5	1.0	0.1	0.0	0.0	3.5	1.0	0.1	0.9	1.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.6	3.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	1.1	0.0	0.6	9.1	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	3.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	4.7	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	3.5	1.0	0.6	3.2	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
DPY19L1	KIAA0877	ENSG00000173852	"Dpy-19 like C-mannosyltransferase 1"	Q2PZI1	7	34928876-35038271	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 183.8;Late spermatids: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059139	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA059139: AB_2683921"	"unprognostic (4.66e-2)"	"unprognostic (1.11e-3)"	"unprognostic (8.53e-3)"	"unprognostic (2.47e-3)"	"unprognostic (2.50e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.02e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (3.21e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.12e-2)"	9.7	12.2	11.0	10.2	13.0	9.0	13.7	16.9	27.0	15.6	9.3	13.5	4.5	4.8	17.7	4.3	7.1	10.3	13.8	18.1	11.8	13.4	7.2	25.2	13.0	9.9	16.3	12.0	8.6	6.7	5.0	11.2	19.0	23.6	8.6	11.3	10.3	6.4	8.4	4.0	4.5	6.8	17.5	38.1	14.1	9.0	31.7	5.8	2.3	10.4	3.6	8.4	11.5	11.3	1.6	1.6	2.8	2.3	1.6	4.1	1.0	5.3	21.0	12.0	15.2	23.7	18.9	2.5	11.9	10.8	7.4	10.6	5.0	14.0	7.7	17.5	12.3	30.8	9.5	9.1	6.5	16.8	4.0	7.3	11.3	13.3	8.2	8.6	10.5	10.5	9.7	5.4	10.1	6.7	21.3	30.6	3.8	8.4	31.6	26.0	3.0	0.1	10.5	7.7	12.5	9.5	7.8	15.8	11.0	28.2	18.5	5.5	14.5	10.6	1.5	6.1	19.7	10.7	12.7	35.3	14.9	18.0	10.2	16.0	14.3	30.8	8.7	18.4	9.8	41.3	2.8	1.7	0.1	3.9	2.3	4.1	1.3	1.7	3.1	1.5	1.6	0.6	1.8	0.3	1.6	0.8	1.6	1.0	1.0	11.0	13.0	16.9	27.0	11.8	13.4	16.3	12.0	23.6	5.8	26.8	16.0	1.9	5.0	6.4	7.2	12.0	5.1	10.7	14.8	7.0	17.7	10.8	0.0	6.4	183.8	10.5	4.5	0.0	14.0	3.5	8.7	7.7	26.5	13.9	7.4	11.1	14.3	21.5	8.2	52.5	8.6	4.0	5.0	0.0	5.0	7.2	16.9	5.8	9.6	1.5	13.3	0.0	6.6	8.3	3.4	4.3	17.7	5.3	6.3	9.5
TBX20		ENSG00000164532	"T-box 20"	Q9UMR3	7	35202430-35254147	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Atrial septal defect, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 26.5;heart muscle: 46.4;prostate: 24.2;smooth muscle: 47.0;urinary bladder: 32.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.3;HHSteC: 4.8;HMC-1: 5.4;RH-30: 5.3;SH-SY5Y: 10.1;WM-115: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.20e-1)"		"unprognostic (1.25e-2)"	"unprognostic (1.87e-2)"				"unprognostic (8.47e-2)"		"unprognostic (3.95e-2)"				"unprognostic (2.75e-1)"	"unprognostic (1.74e-1)"		"unprognostic (9.75e-2)"	0.2	4.3	0.2	0.1	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.1	0.2	0.1	0.2	0.2	26.5	46.4	0.2	0.2	0.2	0.6	0.2	0.1	0.2	0.0	0.2	0.2	0.1	1.8	15.1	0.0	24.2	0.1	2.7	0.2	0.1	0.2	0.2	0.2	47.0	0.2	0.2	0.2	0.4	0.0	0.0	0.2	0.0	0.1	32.3	14.4	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	3.4	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	2.3	3.1	0.0	0.6	0.0	0.2	0.3	4.3	0.0	0.1	2.2	3.5	4.3	1.4	0.0	4.8	0.0	5.4	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	5.3	0.0	0.1	0.0	0.3	10.1	0.5	0.0	0.0	2.7	0.0	3.8	0.0	0.0	0.2	3.7	0.0	0.4	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0
HERPUD2	FLJ22313	ENSG00000122557	"HERPUD family member 2"	Q9BSE4	7	35632659-35695571	"Predicted intracellular proteins, Predicted membrane proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 290.9;Late spermatids: 471.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015630, HPA076087"	Approved		Approved	"Nucleoli,Nucleoli rim"		No	No			"Nucleoli, Nucleoli rim"		"HPA015630: AB_1850609, HPA076087: AB_2686774"	"unprognostic (1.85e-2)"	"unprognostic (5.31e-3)"	"unprognostic (2.76e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.30e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.42e-2)"	"unprognostic (6.54e-2)"	22.7	13.7	19.2	25.6	21.7	34.3	21.9	25.0	21.7	24.2	20.3	18.6	18.8	16.1	24.3	17.1	21.2	19.9	26.4	16.6	17.5	14.0	17.6	25.3	22.7	33.7	16.7	18.3	37.0	31.4	18.0	22.5	21.6	15.4	21.6	19.3	19.5	19.6	23.8	17.9	20.9	20.5	23.9	18.5	24.1	18.0	39.5	18.3	34.3	22.5	15.4	23.2	25.0	22.0	5.7	5.9	19.2	9.2	12.1	12.2	4.8	18.0	6.9	13.0	12.7	19.5	14.9	10.5	12.9	18.1	8.4	9.5	8.2	21.6	13.0	20.5	16.3	28.8	22.8	7.2	9.3	13.1	8.6	9.3	9.0	8.4	5.5	16.8	9.1	11.5	18.6	16.8	10.6	17.2	17.3	13.9	16.1	14.1	17.4	14.5	7.6	10.3	14.9	10.9	11.2	9.5	12.5	15.7	10.4	10.9	8.1	10.8	17.9	16.3	15.5	11.1	20.7	15.6	11.0	16.2	13.2	15.2	12.8	10.2	24.3	27.6	13.7	12.7	14.1	24.1	5.8	6.8	19.2	10.6	7.6	12.2	4.4	9.5	11.3	5.9	5.7	5.9	8.0	11.7	12.1	9.2	3.6	8.6	4.8	19.2	21.7	25.0	21.7	17.5	14.0	16.7	18.3	15.4	18.3	23.8	17.9	41.2	14.4	14.9	13.6	11.8	15.3	10.7	11.4	5.2	7.9	14.5	14.9	21.2	290.9	17.4	20.8	0.0	25.4	21.7	16.6	16.1	35.8	17.9	15.8	11.1	13.7	20.9	26.3	471.7	25.3	19.2	21.9	22.6	12.2	22.4	26.9	14.0	23.7	11.2	13.0	12.9	15.0	27.7	18.3	13.8	26.0	62.3	13.4	18.2
SEPT7	"CDC10, CDC3, SEPT7A"	ENSG00000122545	"Septin 7"	Q16181	7	35800932-35907105	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 1164.8;Sertoli cells: 802.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023309, HPA029524"	Enhanced		Enhanced	"Nucleoli,Actin filaments,Midbody,Cytosol"		Yes	No		16000000	"Actin filaments"	"Nucleoli, Midbody, Cytosol"	"HPA023309: AB_10600093, HPA029524: AB_10601573"	"unprognostic (7.91e-3)"	"unprognostic (6.89e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (2.37e-4)"	"unprognostic (2.00e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.43e-3)"	35.5	28.5	89.0	26.8	77.8	31.9	29.5	41.9	81.5	35.1	28.7	54.3	11.5	15.7	37.8	36.2	31.7	25.4	34.2	47.5	86.4	58.1	24.3	21.5	28.3	38.8	79.6	66.2	42.8	11.2	22.9	31.9	41.0	72.0	28.4	28.2	9.6	14.9	29.9	21.7	29.1	20.1	42.6	76.8	29.5	18.1	19.3	98.2	33.0	22.6	17.3	41.4	36.9	24.0	40.4	24.0	47.3	24.8	69.1	56.8	48.6	36.1	17.4	44.5	29.2	50.2	51.9	22.8	46.7	43.1	39.9	34.4	27.0	28.1	34.3	31.7	47.5	53.6	27.5	31.4	31.1	57.0	23.4	16.5	27.6	24.4	14.6	29.3	33.2	30.5	33.6	24.4	31.3	30.9	41.8	41.5	27.1	21.6	27.1	64.7	16.9	33.5	55.8	47.7	33.9	24.7	34.6	42.4	19.7	38.6	27.0	23.9	42.0	32.6	42.0	27.9	76.2	31.0	36.8	35.0	40.3	47.8	24.7	51.4	32.0	29.1	86.5	25.7	55.6	85.0	47.3	20.7	34.9	55.4	24.0	56.8	40.4	39.6	50.5	24.0	37.4	35.6	44.9	39.3	69.1	24.8	17.2	34.2	48.6	89.0	77.8	41.9	81.5	86.4	58.1	79.6	66.2	72.0	98.2	142.9	97.9	186.4	0.0	141.0	199.4	207.8	40.8	222.1	184.2	129.1	43.2	148.6	127.6	0.0	342.3	214.2	64.6	23.3	0.0	161.3	239.6	0.0	368.3	69.5	168.4	1164.8	58.6	187.2	128.6	256.8	324.7	171.1	178.8	0.0	61.0	328.2	0.0	106.6	426.0	108.1	113.7	802.0	509.2	101.6	233.2	140.9	103.9	294.1	77.5	0.0
EEPD1	KIAA1706	ENSG00000122547	"Endonuclease/exonuclease/phosphatase family domain containing 1"	Q7L9B9	7	36153149-36301543	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cholangiocytes: 28.1;Hofbauer cells: 25.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 23.2;neutrophil: 21.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 23.2;T-cells: 11.5"	"Cell line enhanced"	"Detected in many"		"GAMG: 13.4;HDLM-2: 13.9;PC-3: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053668			Approved	"Nuclear speckles,Vesicles"		NA	NA			"Nuclear speckles"	Vesicles	"HPA053668: AB_2682223"	"unprognostic (1.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.54e-3)"	"unprognostic (5.21e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.76e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.75e-2)"	"unprognostic (7.89e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.59e-2)"	20.3	5.1	4.9	6.4	8.6	8.1	22.5	3.3	19.3	9.6	15.2	11.8	6.5	11.0	12.5	5.6	6.5	5.4	18.4	6.2	6.4	5.4	3.7	15.2	8.7	4.6	13.3	3.5	6.9	8.1	2.4	3.3	4.6	5.6	8.2	4.5	5.7	3.8	4.3	39.7	10.2	23.6	9.1	10.2	7.5	10.5	3.4	7.7	11.5	2.2	4.4	3.6	6.1	10.9	0.1	1.5	23.2	2.8	1.7	11.5	2.0	1.6	4.6	1.4	4.4	13.1	2.8	0.1	1.1	5.6	0.9	1.6	0.9	3.5	4.5	1.4	1.7	13.4	1.9	1.9	2.2	0.8	13.9	3.1	0.6	0.4	8.4	1.2	0.7	4.4	5.9	1.4	0.5	0.3	3.6	0.1	3.4	5.4	0.5	1.0	1.8	4.5	11.1	6.4	5.7	17.6	1.2	1.6	0.9	2.8	3.6	3.5	2.4	0.4	0.6	1.7	2.7	1.4	5.4	0.4	1.7	5.2	1.2	1.3	3.5	3.7	0.0	4.3	2.9	1.1	10.0	2.8	23.2	1.5	1.7	2.6	0.1	11.5	3.3	1.5	0.0	2.6	0.7	21.9	1.7	0.7	1.3	5.1	2.0	4.9	8.6	3.3	7.5	6.4	5.4	13.3	3.5	5.6	7.7	0.0	0.3	0.5	11.6	2.4	2.1	3.4	28.1	2.7	0.0	0.0	19.6	0.1	5.0	17.7	15.1	12.6	10.1	0.0	6.5	0.2	2.3	7.2	9.2	16.0	25.1	6.4	9.2	0.6	5.2	3.6	4.6	6.2	3.3	1.8	5.8	1.9	11.6	6.8	15.6	1.9	0.8	6.5	5.9	0.5	4.1	3.4	0.5	1.5	5.9	8.1
KIAA0895		ENSG00000164542	KIAA0895	Q8NCT3	7	36324221-36390125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 69.3;Late spermatids: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021036, HPA061066"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cell Junctions, Cytosol"	"HPA021036: AB_2670571, HPA061066: AB_2684423"	"unprognostic (4.94e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.79e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.49e-1)"	"unprognostic (4.51e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.24e-2)"	1.5	9.9	8.1	1.3	11.0	2.8	5.2	28.9	13.5	3.7	3.0	5.8	6.0	3.0	4.6	9.1	3.6	8.6	4.6	2.6	6.2	8.1	13.1	10.4	4.2	0.7	4.2	8.2	12.7	12.4	18.6	14.7	2.0	8.0	4.6	2.1	6.6	4.1	4.7	2.1	7.8	1.7	4.4	4.7	1.2	14.3	27.1	4.9	2.1	5.5	1.5	0.9	2.3	2.7	0.6	0.5	1.3	0.1	0.5	1.5	0.4	7.3	4.5	9.3	9.1	0.2	0.2	2.1	2.0	2.3	4.4	5.4	1.9	3.8	0.0	2.0	0.4	7.7	4.2	12.0	3.9	3.9	0.6	7.6	0.1	7.0	1.7	1.6	1.2	0.2	1.0	7.1	3.9	5.0	5.4	0.1	4.0	2.9	0.1	0.5	2.4	3.6	2.6	0.4	1.9	1.1	1.4	0.4	0.0	10.1	0.8	28.4	9.9	3.6	8.6	2.6	6.6	8.6	1.3	0.0	0.6	2.2	1.3	2.9	4.2	9.4	0.0	1.8	0.3	2.1	0.8	0.1	0.3	0.1	0.1	1.3	0.3	0.9	0.2	0.1	0.6	1.4	0.6	1.3	0.5	0.1	0.5	1.5	0.4	8.1	11.0	28.9	13.5	6.2	8.1	4.2	8.2	8.0	4.9	6.0	2.4	0.0	4.2	8.7	17.4	2.6	5.1	16.0	3.4	3.5	25.5	1.9	5.0	4.7	69.3	1.1	0.4	0.0	2.5	1.3	0.9	3.6	1.1	5.0	0.4	11.1	8.1	0.0	0.0	54.0	2.6	0.2	3.3	0.0	1.0	5.0	3.7	1.4	0.4	9.4	15.7	6.5	1.0	21.6	12.4	7.5	0.6	0.0	1.0	1.4
ANLN	"ANILLIN, scra, Scraps"	ENSG00000011426	"Anillin actin binding protein"	Q9NQW6	7	36389806-36453791	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.4;lymphoid tissue: 32.7"	"Cell type enhanced"	"Detected in many"	21	"Early spermatids: 106.8;Late spermatids: 41.2;Spermatocytes: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HBF TERT88: 100.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005680, CAB033902, HPA050556, CAB062547, CAB068175"	Enhanced		Enhanced	Nucleoplasm,Midbody		Yes	Yes			Nucleoplasm	Midbody	"CAB033902: AB_2058302, CAB062547: AB_2665622, CAB068175: AB_2665623, HPA005680: AB_2667388, HPA050556: AB_2681175"	"unprognostic (4.23e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (5.97e-7)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (2.69e-2)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (2.00e-6)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.04e-3)"	1.7	0.6	13.9	7.2	10.5	20.9	1.3	1.8	36.7	1.9	3.9	1.6	0.0	2.9	1.3	2.4	12.8	0.6	1.4	0.6	24.0	12.1	0.7	0.8	3.3	4.2	30.5	2.5	0.9	0.4	0.3	0.3	12.9	9.7	0.7	5.5	0.0	0.9	0.3	0.4	8.9	3.4	9.4	63.4	1.6	3.3	9.2	12.5	32.7	0.6	17.7	6.7	2.6	1.3	0.0	0.3	0.6	0.9	0.0	1.7	2.0	68.4	14.4	12.0	9.1	1.6	4.2	12.9	43.2	25.3	52.2	39.2	9.8	21.2	3.4	12.5	21.8	27.8	35.3	9.4	25.2	100.3	2.3	6.8	4.7	16.2	8.1	0.2	6.7	5.5	0.9	1.1	34.0	22.4	6.2	16.2	4.6	9.8	7.3	42.5	10.3	5.7	7.8	13.3	10.5	15.2	4.2	36.0	2.3	11.5	11.2	5.1	6.0	22.7	26.4	3.9	17.4	17.8	7.7	15.3	32.7	36.8	19.2	50.4	3.0	4.8	6.4	11.1	10.9	68.6	0.0	0.9	0.1	0.0	0.2	0.0	0.0	0.9	0.5	0.3	0.0	0.6	0.0	0.6	0.0	0.3	0.2	1.7	2.0	13.9	10.5	1.8	7.7	24.0	12.1	30.5	2.5	9.7	12.5	0.0	0.6	0.0	1.0	12.6	0.0	0.6	0.0	2.7	1.2	0.0	0.0	2.5	0.0	0.5	106.8	0.1	0.9	0.0	0.2	20.2	3.5	1.3	0.0	0.0	8.0	0.0	0.0	1.8	1.5	41.2	1.1	2.6	0.0	0.0	2.2	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.4	20.9	14.9	8.2	2.4	1.5	1.6	1.4
AOAH		ENSG00000136250	"Acyloxyacyl hydrolase"	P28039	7	36512949-36724549	"Enzymes, Predicted secreted proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.6;lymphoid tissue: 57.4"	"Cell type enhanced"	"Detected in many"	17	"Hofbauer cells: 31.1;Kupffer cells: 110.3;Macrophages: 54.2;T-cells: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 54.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.1;NB-4: 21.3;THP-1: 16.3;U-937: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA021666, HPA026716"	Approved		Uncertain	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA021666: AB_2670799, HPA026716: AB_2671960"	"unprognostic (3.55e-2)"	"unprognostic (4.03e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.58e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.14e-3)"	"unprognostic (5.42e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.35e-1)"	8.4	3.4	5.2	17.2	4.9	19.3	2.8	1.9	3.6	3.1	5.3	7.4	0.2	4.9	3.9	7.2	2.5	3.1	8.4	3.4	4.8	3.8	3.1	6.8	9.4	23.2	6.9	2.0	2.1	2.3	0.6	2.4	5.7	5.8	3.8	7.3	3.8	4.5	1.4	1.5	1.6	7.6	4.7	12.6	57.4	3.3	1.4	6.8	14.0	2.9	0.4	10.9	7.2	2.8	0.3	34.8	18.7	54.6	19.2	8.8	31.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.5	0.0	0.0	0.0	2.9	0.0	0.3	0.1	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.5	21.3	0.1	0.0	0.0	0.4	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	7.1	0.0	0.3	54.6	17.6	8.8	47.9	1.8	0.3	0.4	6.1	34.8	0.0	1.0	7.8	18.7	19.2	20.2	0.5	0.1	31.0	5.2	4.9	1.9	3.6	4.8	3.8	6.9	2.0	5.8	6.8	0.0	14.0	8.8	0.0	0.7	0.0	0.4	0.0	1.4	4.5	0.0	0.0	0.2	1.7	0.2	0.4	0.5	5.8	0.0	0.0	0.2	0.5	0.1	4.7	0.6	31.1	0.0	14.9	3.1	110.3	0.4	0.0	54.2	0.0	19.0	0.4	3.2	0.0	1.5	0.4	0.3	0.2	0.0	0.9	0.0	0.0	0.3	0.1	51.7	0.5	0.1
ELMO1	"CED-12, CED12, ELMO-1, KIAA0281"	ENSG00000155849	"Engulfment and cell motility 1"	Q92556	7	36854361-37449249	"Predicted intracellular proteins"	"Apoptosis, Phagocytosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 58.3"	"Cell type enhanced"	"Detected in many"	5	"Endothelial cells: 37.9;Ito cells: 37.4;Kupffer cells: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 28.8;JURKAT: 31.3;Karpas-707: 27.9;U-266/70: 24.0;U-698: 34.5;U-937: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.77e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.71e-1)"	"prognostic favorable (4.62e-4)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (3.27e-5)"	"unprognostic (1.65e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.16e-3)"	13.5	9.5	33.7	16.8	39.9	28.5	7.7	39.7	58.3	7.7	7.0	34.9	1.4	4.3	5.0	3.6	6.8	5.4	11.7	7.5	33.6	21.1	3.4	15.8	14.6	24.0	30.5	17.2	8.5	8.4	2.9	5.6	21.8	37.0	4.5	7.9	4.0	4.3	6.7	3.1	4.5	6.6	8.9	36.4	28.4	5.3	4.5	29.7	9.3	47.4	2.1	26.0	11.3	6.5	14.3	20.4	41.4	13.7	10.8	15.3	13.4	0.0	1.1	1.9	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.5	0.0	0.3	0.1	0.0	0.0	0.0	15.9	1.0	20.4	0.1	0.0	0.0	13.2	8.9	0.4	0.0	0.0	0.0	0.0	10.9	31.3	0.3	27.9	0.0	0.2	16.6	20.1	4.5	0.0	0.0	17.8	2.1	16.1	0.0	0.0	2.5	10.2	0.0	5.7	0.1	7.5	0.0	9.5	2.8	0.0	0.3	0.0	0.1	24.0	22.5	34.5	5.6	27.8	1.2	10.9	13.7	41.4	9.0	11.7	9.8	14.3	15.3	10.5	20.4	12.8	14.4	10.6	32.4	10.8	9.9	11.6	14.7	13.4	33.7	39.9	39.7	52.8	33.6	21.1	30.5	17.2	37.0	29.7	0.0	7.4	19.0	3.6	4.4	16.7	2.2	10.2	0.0	1.2	0.0	0.0	1.2	0.0	0.2	0.9	37.9	0.0	0.0	1.0	20.6	12.0	1.7	34.6	10.6	17.5	0.0	3.5	37.4	44.8	0.9	5.8	32.7	6.8	24.4	0.7	1.2	0.8	0.0	23.3	1.6	1.6	12.9	3.1	1.4	3.2	3.8	16.5	28.0	0.1	1.3
GPR141	PGR13	ENSG00000187037	"G protein-coupled receptor 141"	Q7Z602	7	37683796-37833788	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 27.6;brain: 18.1"	"Cell type enhanced"	"Detected in some"	23	"Alveolar cells type 2: 4.8;granulocytes: 22.0;Kupffer cells: 8.5;Macrophages: 4.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 11.4;eosinophil: 8.1;gdT-cell: 4.8;memory CD8 T-cell: 4.5;myeloid DC: 5.8;naive CD8 T-cell: 3.3;neutrophil: 10.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 7.8;HMC-1: 30.8;NTERA-2: 16.6;THP-1: 4.9;U-937: 13.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.91e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.26e-4)"	"unprognostic (4.70e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.51e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.39e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.60e-1)"	1.7	0.9	2.5	4.4	3.3	27.6	0.9	1.0	3.2	1.9	1.4	0.6	0.0	1.0	1.9	2.0	1.8	1.5	3.7	1.7	3.2	1.4	1.2	1.3	4.3	10.0	5.3	0.7	0.6	1.5	0.3	1.0	2.8	5.8	2.0	2.0	2.7	1.7	0.5	0.6	1.2	1.8	1.8	18.1	10.0	1.2	1.5	5.1	2.9	1.1	1.0	2.1	4.8	2.3	0.0	5.8	10.7	11.4	0.6	4.8	3.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	7.8	0.6	0.0	0.0	0.1	30.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	4.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	13.0	0.0	0.0	11.4	8.1	4.8	0.9	0.0	0.0	1.2	4.5	5.8	0.0	0.5	3.3	10.7	0.6	0.1	0.2	0.0	3.4	2.5	3.3	1.0	3.2	3.2	1.4	5.3	0.7	5.8	5.1	3.0	4.8	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.8	0.0	0.0	0.0	8.5	0.6	0.0	4.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.2	0.5	0.0	0.0
EPDR1	"EPDR, MERP-1, MERP1, UCC1"	ENSG00000086289	"Ependymin related 1"	Q9UM22	7	37683843-37951941	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 57.6;skeletal muscle: 55.8"	"Cell type enhanced"	"Detected in many"	10	"Peritubular cells: 93.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 5.4"	"Group enriched"	"Detected in many"	9	"dendritic cells: 5.4;NK-cells: 1.9;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"U-937: 36.5;WM-115: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026298, HPA072321"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB026298: AB_425991, HPA072321: "	"unprognostic (1.99e-2)"	"unprognostic (9.30e-2)"	"unprognostic (4.44e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (2.53e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.88e-2)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (4.13e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.00e-4)"	11.2	23.3	21.9	2.2	16.0	2.1	4.8	30.5	30.5	21.5	4.9	7.5	1.6	7.0	22.4	7.4	4.6	15.5	5.3	13.9	20.3	34.3	8.6	6.0	13.8	2.9	25.3	18.8	18.6	5.7	5.8	4.6	2.8	57.6	18.5	4.7	8.0	7.3	22.6	55.8	1.5	6.8	16.4	13.9	8.3	3.4	6.7	5.2	5.2	16.1	7.7	1.7	4.7	8.5	0.0	5.4	0.2	0.3	1.9	1.9	0.4	0.0	23.8	2.0	0.0	18.8	6.8	0.0	1.8	0.0	0.9	2.9	2.3	1.5	0.0	27.0	26.5	28.2	0.0	0.5	0.2	0.0	0.0	3.0	10.4	3.2	14.5	0.1	8.6	0.0	11.4	0.0	6.7	0.1	6.4	0.0	10.6	0.0	7.9	15.9	1.5	3.3	7.3	7.4	0.0	3.5	10.6	6.9	9.1	14.7	5.8	2.6	9.2	0.0	1.2	8.3	5.1	0.0	6.1	0.0	5.2	8.9	14.4	11.0	10.6	4.5	0.1	24.1	36.5	35.6	0.0	0.3	0.2	1.7	0.3	0.0	0.0	0.0	1.9	1.0	0.0	0.1	1.1	0.2	1.9	0.0	5.4	0.0	0.4	21.9	16.0	30.5	30.5	20.3	34.3	25.3	18.8	57.6	5.2	29.8	37.4	1.3	9.3	1.1	5.1	16.9	7.6	5.3	20.5	1.8	0.0	0.5	14.9	8.1	0.2	1.4	6.8	0.0	7.1	0.1	8.4	9.6	2.3	11.9	3.1	11.1	3.5	6.7	1.3	0.9	26.2	2.2	27.0	24.4	4.7	10.5	13.6	5.3	93.0	11.3	5.3	6.5	12.8	0.0	0.6	0.3	0.1	0.5	4.7	2.0
NME8	"CILD6, NM23-H8, SPTRX2, TXNDC3"	ENSG00000086288	"NME/NM23 family member 8"	Q8N427	7	37848597-37900401	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 7.9;bone marrow: 13.4;testis: 11.3"	"Group enriched"	"Detected in some"	5	"Early spermatids: 33.4;Late spermatids: 14.1"	"Low cancer specificity"	"Detected in single"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 1.7;HMC-1: 2.5;NB-4: 3.7;NTERA-2: 3.5;THP-1: 3.2;U-937: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016416, HPA019259, HPA029572"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA			Cytosol	"Nuclear speckles"	"CAB016416: , HPA019259: AB_1858475, HPA029572: "	"unprognostic (7.44e-3)"	"unprognostic (2.32e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.97e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.20e-2)"	"unprognostic (6.56e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.13e-8)"	"unprognostic (5.90e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-1)"	0.1	0.0	0.1	0.5	0.1	13.4	0.0	0.0	0.0	0.1	0.1			0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.2	0.2	0.1	0.1	0.5	0.4	0.4		0.0	0.0	0.0	0.0	0.1		0.1	0.0		0.0	0.0	0.0	0.3	0.1	0.0	0.8	1.9	0.1	11.3			0.0		0.2	0.0	0.0	0.0	7.9	3.8	1.9	0.2	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.4	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	3.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	10.0	0.0	0.0	1.9	1.5	0.7	0.4	0.0	0.0	0.1	1.3	1.5	0.0	0.0	0.7	3.8	0.2	0.0	7.9	0.0	0.8											0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.8	0.0	0.0	0.0	3.0	14.1	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.9	0.0	0.0	3.8	0.0	0.0
SFRP4	"FRP-4, frpHE, FRZB-2"	ENSG00000106483	"Secreted frizzled related protein 4"	Q6FHJ7	7	37905932-38025695	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 144.9;endometrium 1: 100.7;retina: 123.0"	"Cell type enriched"	"Detected in some"	5	"Peritubular cells: 177.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 14.1;HSkMC: 5.5;U-937: 5.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA009712, HPA050585"	Enhanced				"Secreted in female reproductive system"	NA	NA		1500000			"HPA009712: AB_1856778, HPA050585: AB_2681183"	"unprognostic (5.93e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.36e-5)"	"unprognostic (7.37e-3)"	"unprognostic (1.61e-1)"	"unprognostic (4.35e-3)"	"unprognostic (1.89e-3)"	4.6	2.3	0.5	0.9	0.9	0.0	12.5	0.3	0.4	144.9	0.8	1.7	5.4	0.0	100.7	11.5	3.2	35.1	2.5	5.5	0.4	0.4	1.2	0.2	3.9	0.8	0.8	0.7	42.7	1.4	0.1	4.0	0.4	1.3	4.9	0.2	123.0	2.3	7.1	1.4	0.3	0.5	14.5	3.3	4.1	0.5	5.8	0.3	0.4	3.3	2.5	0.5	8.8	14.8	0.4	0.8	0.4	0.6	0.1	0.1	0.0	0.0	2.6	2.9	0.0	14.1	0.6	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	3.0	0.4	0.1	0.0	0.3	0.3	0.0	0.0	0.2	0.2	2.0	0.1	0.4	0.0	5.5	0.7	0.6	0.0	1.0	0.2	0.2	0.0	0.3	0.2	0.4	0.0	1.7	0.1	0.0	0.0	0.2	1.7	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.3	0.6	0.0	0.0	0.9	0.0	1.2	1.7	0.2	0.5	0.1	0.2	0.3	5.3	0.9	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.1	0.0	0.8	0.0	0.0	0.5	0.9	0.3	0.4	0.4	0.4	0.8	0.7	1.3	0.3	0.0	2.6	0.0	1.7	0.9	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.4	0.1	8.6	1.6	0.0	0.0	0.2	0.0	0.0	4.3	0.0	0.9	38.6	0.8	0.0	0.0	0.0	2.7	0.1	0.0	177.1	2.1	0.1	0.0	3.1	0.2	0.5	1.4	0.2	0.0	0.0	0.0
STARD3NL	"MENTHO, MGC3251"	ENSG00000010270	"STARD3 N-terminal like"	O95772	7	38178222-38230671	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019204	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA019204: AB_2197800"	"unprognostic (1.55e-3)"	"unprognostic (2.80e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.37e-2)"	"prognostic unfavorable (2.20e-4)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (9.64e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.37e-2)"	"prognostic favorable (8.48e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.09e-3)"	"unprognostic (2.65e-1)"	"unprognostic (8.71e-2)"	18.3	15.6	28.9	15.3	26.5	23.4	20.3	16.1	37.7	23.2	14.6	22.5	11.8	12.7	23.3	19.8	9.6	19.4	15.5	18.2	27.9	36.7	23.8	11.8	22.4	15.8	34.6	19.4	17.8	11.1	9.5	19.7	33.7	29.8	29.3	16.7	16.4	10.0	16.1	10.6	4.5	13.7	22.9	33.1	17.6	11.8	21.7	15.3	13.4	23.2	5.9	10.2	17.3	16.0	14.4	21.0	27.0	23.4	34.2	27.8	20.8	11.5	12.4	27.5	17.8	19.0	19.0	9.6	19.0	19.7	18.8	24.8	9.8	18.4	9.1	19.2	17.3	57.6	12.6	15.1	14.4	28.6	8.2	13.1	18.5	6.9	13.4	16.8	20.3	21.7	17.8	7.1	19.9	15.9	21.6	34.1	25.2	21.0	16.0	28.8	7.1	11.4	32.7	19.4	9.7	9.9	14.1	25.6	4.2	26.3	10.9	11.1	25.9	6.5	17.3	17.9	39.7	12.1	26.9	23.2	12.9	18.5	20.1	26.7	17.1	17.2	3.4	26.2	36.2	41.9	14.4	23.4	27.0	27.8	20.0	12.7	14.4	11.7	20.5	21.0	14.1	9.9	19.4	26.3	34.2	21.5	14.9	11.6	20.8	28.9	26.5	16.1	37.7	27.9	36.7	34.6	19.4	29.8	15.3	17.9	38.9	35.0	46.4	18.4	8.0	15.9	12.7	17.4	15.9	29.6	11.8	43.7	26.6	28.6	97.7	36.8	10.2	0.0	30.1	76.6	25.5	61.8	23.1	10.5	57.9	4.8	20.6	48.5	50.4	71.1	17.0	44.7	25.3	13.6	20.3	25.1	30.1	22.9	24.4	41.1	11.2	12.9	41.8	40.2	33.6	14.2	35.4	46.8	21.1	42.2
AMPH		ENSG00000078053	Amphiphysin	P49418	7	38383704-38631567	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 57.2"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 53.7;Cone photoreceptor cells: 82.5;Rod photoreceptor cells: 54.5"	"Cancer enhanced"	"Detected in many"		"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 31.2;ASC TERT1: 18.5;BJ hTERT+ SV40 Large T+: 12.1;BJ hTERT+ SV40 Large T+ RasG12V: 14.4;GAMG: 21.3;HBF TERT88: 11.1;U-138 MG: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008559, HPA019828, HPA019829"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"CAB008559: AB_1611845, HPA019828: AB_1844801, HPA019829: AB_1844802"	"unprognostic (1.76e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.37e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (9.96e-4)"	"unprognostic (5.06e-2)"	"unprognostic (5.81e-5)"	"unprognostic (1.23e-2)"	"unprognostic (5.63e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-3)"	3.8	2.4	17.4	2.5	17.7	1.0	2.8	29.7	57.2	7.7	2.2	1.8	0.0	1.4	5.1	4.7	4.5	5.7	4.2	6.5	13.5	16.0	3.7	1.4	1.6	1.3	10.4	20.4	1.7	2.9	1.2	12.6	1.0	26.5	2.4	2.5	4.8	1.5	4.2	2.9	1.3	1.9	5.0	4.9	1.9	2.0	3.5	1.5	0.0	1.2	0.2	1.1	2.9	1.7	0.2	1.6	0.0	0.8	0.7	2.9	0.2	0.0	0.0	7.9	0.0	31.2	18.5	0.0	1.1	0.0	12.1	14.4	0.0	0.0	0.0	0.0	2.2	21.3	0.0	0.0	0.0	11.1	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	10.8	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.2	0.0	0.1	0.0	0.1	4.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	11.8	8.4	4.1	4.5	0.0	0.1	0.0	8.0	0.1	10.6	0.0	0.8	0.0	2.9	0.2	1.7	0.0	1.0	1.5	0.2	0.2	0.4	2.0	0.0	0.7	0.2	1.6	0.2	0.2	17.4	17.7	29.7	32.9	13.5	16.0	10.4	20.4	26.5	1.5	0.0	0.0	0.5	0.1	0.2	53.7	6.3	0.0	0.0	0.0	0.0	82.5	0.0	1.7	0.1	7.7	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	1.6	0.0	5.5	14.2	10.2	2.6	0.0	0.0	0.0	0.0	4.7	0.1	0.0	4.6	0.0	54.5	6.5	3.0	0.4	3.0	0.3	0.0	0.0	0.0	0.0
VPS41	HVSP41	ENSG00000006715	"VPS41, HOPS complex subunit"	P49754	7	38722963-38932394	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020080, HPA020299"	Approved					NA	NA					"HPA020080: AB_1858768, HPA020299: AB_1858769"	"unprognostic (9.20e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.66e-1)"	"unprognostic (6.63e-2)"	"prognostic favorable (3.40e-8)"	"unprognostic (1.62e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.28e-1)"	18.7	16.6	26.0	13.3	34.4	7.6	15.7	13.9	42.4	20.0	17.1	18.0	11.3	11.8	21.2	13.0	17.2	17.0	25.4	17.0	23.2	26.0	22.0	18.0	17.1	15.7	27.8	27.4	23.1	16.0	25.8	34.6	15.8	32.0	16.9	14.1	18.8	12.3	18.8	8.4	13.1	12.8	17.7	33.0	15.2	14.4	10.6	19.2	14.2	21.8	7.3	17.1	16.4	13.3	18.6	19.6	22.6	21.5	18.7	13.5	10.8	11.3	15.2	15.6	16.7	23.2	21.9	7.9	11.9	22.0	10.0	16.3	9.2	17.0	11.4	35.6	16.0	42.0	14.5	22.7	15.2	17.2	15.2	11.0	11.0	9.4	7.3	18.5	13.4	22.1	16.0	12.7	13.7	13.5	17.6	18.0	14.4	16.4	24.1	18.2	10.3	13.6	7.6	16.9	15.8	10.2	14.7	14.3	11.8	18.7	28.4	13.4	23.7	11.8	18.8	11.1	29.1	21.1	17.0	19.0	11.3	11.5	15.2	12.3	24.6	44.2	21.4	24.4	11.8	38.3	16.8	16.2	22.6	13.5	16.2	11.3	14.2	10.3	12.3	19.6	18.6	10.9	11.9	19.3	18.7	21.5	11.8	11.1	10.8	26.0	34.4	13.9	40.5	23.2	26.0	27.8	27.4	32.0	19.2	20.8	28.8	14.7	9.3	13.5	32.0	24.2	45.9	21.4	12.5	31.4	17.7	15.1	18.3	24.6	2.1	15.7	11.1	0.0	12.0	10.7	15.0	12.8	40.5	20.2	25.2	28.6	23.1	17.8	25.6	2.2	14.1	23.4	28.7	43.3	14.6	37.7	16.9	14.0	24.8	19.3	19.3	0.0	13.9	9.1	10.9	14.9	21.6	12.1	13.2	11.2
POU6F2	RPF-1	ENSG00000106536	"POU class 6 homeobox 2"	P78424	7	38977998-39493095	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 13.2;pancreas: 12.3"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 4.3;Cholangiocytes: 12.7;Cone photoreceptor cells: 7.9;Early spermatids: 3.5;Smooth muscle cells: 3.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 4.5;Karpas-707: 3.3;NTERA-2: 4.3;SK-BR-3: 3.5;SuSa: 3.7;T-47d: 7.7;U-266/70: 8.5;U-266/84: 10.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.89e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.80e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.68e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.00e-3)"	"unprognostic (4.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	0.9	0.3	2.9	0.4	6.2	0.8	1.0	0.4	13.2	1.2	0.4	0.6	0.0	0.6	0.3	0.3	0.7	0.3	2.4	1.9	3.1	2.1	0.5	2.9	0.5	0.3	2.0	11.2	1.0	12.3	0.3	0.9	3.6	2.3	0.4	0.4	1.5	0.5	0.5	0.3	0.5	0.4	0.3	0.8	0.4	0.4	2.0	1.0	0.0	0.4	0.0	0.4	3.0	0.8	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	3.3	0.0	0.0	0.0	0.0	4.3	0.9	0.0	0.0	0.0	0.1	0.0	0.3	2.7	0.0	0.0	3.5	0.0	3.7	7.7	0.0	0.0	0.0	0.8	0.0	0.0	8.5	10.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	6.2	0.4	13.2	3.1	2.1	2.0	11.2	2.3	1.0	0.0	1.7	0.0	0.1	0.0	4.3	1.6	12.7	0.0	0.0	0.0	7.9	0.2	0.0	0.9	3.5	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	3.9	0.3	1.0	0.0	0.1	0.0	0.0	0.0
YAE1D1	"C7orf36, GK003"	ENSG00000241127	"Yae1 domain containing 1"	Q9NRH1	7	39566376-39610320	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019226, HPA031249"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA019226: AB_1845759, HPA031249: AB_2673807"	"unprognostic (1.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.73e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.75e-2)"	"unprognostic (4.30e-1)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.94e-1)"	"unprognostic (8.02e-3)"	11.9	17.3	24.1	14.2	26.0	2.7	20.2	28.6	23.6	16.5	20.3	15.9	16.3	15.7	19.5	26.2	15.9	18.4	12.6	17.8	19.1	17.4	17.3	13.0	12.2	10.1	20.1	20.3	25.2	13.2	16.9	27.6	12.5	18.1	15.6	22.8	10.9	15.2	14.5	14.1	12.1	22.2	17.8	21.1	11.2	15.2	20.9	23.4	9.9	16.7	8.6	10.2	15.2	13.6	12.2	8.0	12.0	5.2	7.5	19.2	6.6	11.6	7.8	16.7	18.3	13.2	13.5	9.9	17.2	15.2	15.9	18.1	6.6	7.0	6.6	8.5	14.4	27.5	12.3	15.7	12.0	15.6	6.5	13.0	6.1	9.7	12.9	12.0	6.2	4.6	12.3	10.0	16.6	18.7	9.6	13.8	5.9	19.2	3.0	13.8	8.2	5.1	12.6	36.8	14.8	9.3	7.0	9.8	7.6	15.1	10.9	21.2	24.0	14.1	19.7	18.1	19.3	17.7	12.1	9.2	8.4	15.6	10.2	14.8	9.8	20.7	14.3	10.0	14.3	24.4	12.0	5.0	6.3	8.3	5.2	9.0	12.2	10.7	12.0	5.7	11.4	19.2	13.5	0.5	7.5	3.8	8.0	11.5	6.6	24.1	26.0	28.6	23.6	19.1	17.4	20.1	20.3	18.1	23.4	6.0	5.6	3.4	6.2	4.2	12.8	14.9	5.1	28.1	23.9	15.7	2.0	13.0	28.2	12.3	33.7	10.5	17.3	0.0	10.7	11.2	12.2	4.5	9.2	7.8	8.6	3.2	8.6	4.3	4.0	12.1	20.8	3.4	5.0	4.6	21.5	18.3	12.6	11.4	20.1	21.4	11.2	6.5	11.3	33.4	26.0	5.0	4.2	6.9	13.6	3.1
RALA	RAL	ENSG00000006451	"RAS like proto-oncogene A"	P11233	7	39623483-39708124	"Predicted intracellular proteins, RAS pathway related proteins"	"Cell cycle, Cell division, Exocytosis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Pancreatic endocrine cells: 277.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 78.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047037, HPA065232"	Approved		Supported	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane"	"Focal adhesion sites"	"HPA047037: , HPA065232: AB_2685440"	"unprognostic (1.20e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.14e-2)"	"prognostic unfavorable (5.32e-5)"	"unprognostic (7.71e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (7.46e-4)"	"prognostic unfavorable (6.30e-4)"	"unprognostic (3.32e-1)"	"unprognostic (4.95e-3)"	"unprognostic (5.38e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.95e-2)"	19.2	25.2	24.7	14.3	24.6	4.8	24.4	16.1	22.0	18.4	22.3	17.2	8.0	23.5	15.7	15.5	44.9	15.0	20.0	13.8	24.7	20.2	15.9	15.4	30.3	14.8	27.6	18.9	17.4	11.6	12.8	14.2	23.7	20.3	12.9	23.6	9.1	18.5	12.7	16.8	19.5	25.5	15.7	36.0	16.0	24.4	12.2	21.9	19.9	13.8	31.0	28.9	15.2	20.8	13.3	16.3	21.5	11.2	15.7	20.4	11.5	20.1	4.6	11.4	9.9	21.8	18.2	7.9	17.7	25.6	16.1	17.9	11.5	9.9	10.4	6.7	13.7	15.1	21.0	16.1	11.5	27.9	9.9	7.6	8.1	7.6	8.4	35.4	14.0	11.5	14.3	14.1	28.7	40.9	20.2	78.1	10.2	16.2	6.9	16.3	6.5	9.8	16.7	32.1	22.1	9.2	12.3	10.3	9.0	16.4	9.4	20.5	19.9	10.9	17.5	12.0	21.5	16.4	15.4	25.0	9.5	8.5	12.0	12.6	12.3	9.5	12.7	10.7	14.6	17.3	21.5	9.8	11.0	9.7	11.2	12.0	11.5	15.7	12.4	16.3	13.3	20.4	17.9	4.5	15.7	8.6	10.6	19.7	11.5	24.7	24.6	16.1	20.8	24.7	20.2	27.6	18.9	20.3	21.9	77.4	36.8	45.3	32.8	80.0	10.9	33.0	45.9	29.4	21.6	22.7	5.9	45.4	18.3	162.0	51.6	66.4	59.6	23.3	107.3	77.4	54.6	33.5	31.1	26.2	97.6	11.1	45.8	69.3	24.5	12.3	44.3	67.7	28.7	146.1	46.5	37.7	277.8	66.0	65.4	28.4	15.8	32.3	24.7	52.6	55.6	95.7	51.8	25.5	51.1	47.7
CDK13	"CDC2L, CDC2L5, CHED, KIAA1791"	ENSG00000065883	"Cyclin dependent kinase 13"	Q14004	7	39949646-40099580	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059241	Uncertain		Supported	"Nuclear speckles,Golgi apparatus,Cytosol"		NA	NA			"Nuclear speckles"	"Golgi apparatus, Cytosol"	"HPA059241: AB_2683956"	"unprognostic (1.99e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.42e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.53e-2)"	16.9	15.3	16.0	29.0	14.5	26.7	20.4	23.3	18.2	16.6	18.3	16.4	14.2	11.3	20.3	17.7	20.9	18.1	20.2	13.6	14.3	11.3	14.7	17.5	19.6	21.9	16.5	15.1	24.2	15.3	26.3	15.3	14.8	12.0	15.5	15.5	14.9	17.6	14.5	19.4	16.7	16.3	16.4	11.5	17.4	14.5	20.2	15.7	31.2	23.1	14.6	21.5	18.5	23.6	14.0	3.9	7.9	3.4	5.0	5.0	1.4	15.7	9.4	16.4	15.6	14.8	14.5	11.3	12.6	13.7	11.6	14.6	9.8	10.9	28.6	7.4	13.2	20.4	19.2	13.4	11.1	17.1	14.0	9.9	12.7	11.5	8.8	14.2	19.3	13.9	8.5	14.9	13.2	17.7	13.3	13.6	13.3	21.4	19.8	12.0	8.1	15.3	13.7	23.7	11.1	11.0	17.0	10.9	11.5	10.9	16.0	11.7	17.0	16.0	34.7	11.4	22.2	14.2	24.1	16.1	16.0	15.3	10.3	17.1	16.4	13.8	23.6	11.7	17.5	20.4	7.9	2.7	4.4	5.0	2.2	3.4	7.6	4.8	3.7	1.5	14.0	4.9	4.9	7.6	5.0	3.4	3.9	4.3	1.4	16.0	14.5	23.3	18.2	14.3	11.3	16.5	15.1	12.0	15.7	41.7	63.7	28.9	17.1	19.1	42.3	25.6	30.6	34.8	47.8	29.6	66.8	11.5	6.6	19.1	10.7	22.5	15.9	0.0	13.4	7.5	19.4	16.3	16.2	20.7	11.6	35.0	18.0	20.3	23.2	7.0	24.2	18.3	13.5	15.4	17.7	26.6	24.2	10.5	16.6	11.1	68.4	6.5	15.6	31.4	31.5	22.8	10.2	22.5	18.8	21.7
MPLKIP	"C7orf11, ORF20, TTDN1"	ENSG00000168303	"M-phase specific PLK1 interacting protein"	Q8TAP9	7	40126023-40134652	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA058457, HPA065463"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA058457: AB_2683724, HPA065463: AB_2685493"	"unprognostic (5.59e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.34e-3)"	"unprognostic (2.73e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.61e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.08e-2)"	13.7	15.2	11.6	9.3	12.7	8.7	14.8	13.9	12.1	12.7	14.5	12.6	9.5	11.9	11.0	13.6	12.9	10.0	9.3	9.3	11.8	11.4	20.5	52.1	8.7	13.3	15.0	8.8	12.0	17.3	10.1	16.1	13.8	10.4	11.5	11.6	11.1	14.4	10.5	10.1	11.3	13.4	9.2	11.9	12.7	10.8	11.0	12.0	25.5	19.2	7.9	12.8	11.3	12.6	53.8	41.9	52.9	38.0	30.7	45.0	40.9	24.1	7.1	13.3	16.7	13.4	15.8	14.7	8.7	10.3	13.9	14.1	9.7	11.8	19.7	12.9	9.0	26.5	29.7	8.0	16.3	17.4	15.1	29.0	15.0	10.5	20.4	16.1	17.8	14.4	14.8	22.6	9.9	12.9	13.9	16.7	21.6	39.3	15.1	14.1	12.4	18.0	60.4	18.4	20.2	24.2	26.4	9.2	25.9	15.4	5.7	19.4	24.1	14.3	13.6	20.9	19.5	17.5	26.7	15.1	7.5	22.7	9.1	13.5	24.6	29.1	33.4	12.8	30.6	22.1	43.4	38.0	52.9	28.0	34.3	31.3	53.8	35.9	32.8	39.4	47.0	40.0	35.1	20.4	30.7	31.5	41.9	45.0	40.9	11.6	12.7	13.9	12.1	11.8	11.4	15.0	8.8	10.4	12.0	47.6	34.6	54.8	74.2	97.8	44.2	15.9	53.5	53.5	39.8	55.8	23.6	94.3	99.5	60.1	107.2	61.3	51.0	0.0	47.7	63.7	58.5	51.4	49.7	109.9	60.4	50.9	46.7	45.4	55.0	29.2	70.2	56.9	55.6	52.3	57.8	42.0	52.6	70.6	51.9	148.0	42.4	51.8	48.1	54.9	49.5	117.2	80.0	48.0	77.3	91.3
SUGCT	"C7orf10, DERP13, FLJ11808, ORF19"	ENSG00000175600	"Succinyl-CoA:glutarate-CoA transferase"	Q9HAC7	7	40134977-40860763	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.1;liver: 27.6"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 24.1;Proximal tubular cells: 61.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 28.0;LHCN-M2: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026698, HPA026704, HPA026705"	Enhanced					NA	NA					"HPA026698: AB_10600191, HPA026704: AB_10600230, HPA026705: AB_10601003"	"unprognostic (4.66e-3)"	"unprognostic (3.45e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.32e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.27e-3)"	"unprognostic (7.65e-2)"	"prognostic favorable (3.93e-7)"	"unprognostic (2.62e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.41e-3)"	"prognostic unfavorable (2.53e-4)"	2.7	13.5	3.2	5.1	4.6	0.7	4.0	1.1	3.1	4.4	5.0	1.1	0.7	1.4	9.6	2.9	3.2	2.7	4.5	6.9	4.3	2.4	42.1	27.6	1.2	3.9	2.8	2.4	5.7	3.8	3.8	3.5	1.2	4.8	3.4	2.9	5.4	2.4	4.3	11.3	1.6	5.6	13.9	5.0	1.3	1.8	4.1	4.1	0.0	2.4	6.3	1.5	2.9	3.5	1.4	0.2	1.1	0.2	0.0	4.6	0.7	0.5	0.0	3.1	2.3	3.3	7.7	1.2	1.6	2.9	2.2	2.5	1.3	0.6	2.1	0.8	2.2	2.3	0.1	1.0	28.0	3.5	0.0	1.4	1.8	0.2	4.5	4.2	0.2	0.2	9.8	6.4	2.4	1.4	4.5	0.6	0.9	2.4	0.3	16.9	0.0	0.1	0.3	5.3	0.0	2.4	1.9	0.3	0.0	4.8	0.0	0.2	1.8	2.5	1.1	3.5	5.5	0.1	0.4	2.3	9.6	2.7	0.1	0.6	0.2	0.0	0.1	1.8	0.8	2.2	0.0	0.1	0.3	0.7	0.0	1.2	1.4	2.0	1.0	0.1	1.2	4.6	2.7	1.1	0.0	0.2	0.2	0.0	0.7	3.2	4.6	1.1	3.1	4.3	2.4	2.8	2.4	4.8	4.1	3.0	0.3	2.2	1.8	1.8	0.8	4.3	0.0	0.0	5.7	1.8	7.9	1.4	14.9	1.5	24.1	0.6	7.9	0.0	0.7	2.1	2.0	0.7	0.0	15.3	0.3	0.0	3.5	0.0	1.5	12.2	5.8	0.4	3.3	0.0	1.3	5.2	0.6	3.2	2.8	61.7	4.3	6.5	5.6	2.1	2.5	0.5	0.7	0.0	5.2	0.6
INHBA		ENSG00000122641	"Inhibin beta A subunit"	P08476	7	41667168-41705834	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Growth factor, Hormone"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"placenta: 148.2"	"Cell type enhanced"	"Detected in many"	17	"Leydig cells: 127.4;Smooth muscle cells: 270.9;Syncytiotrophoblasts: 149.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.8;non-classical monocyte: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 19.2;hTEC/SVTERT24-B: 58.9;hTERT-HME1: 24.3;hTERT-RPE1: 36.3;TIME: 30.4;U-138 MG: 45.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"								"Secreted to blood"	NA	NA		290000				"unprognostic (4.11e-3)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (4.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.18e-2)"	"prognostic unfavorable (4.34e-4)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (7.72e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (7.91e-8)"	"unprognostic (6.22e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.18e-3)"	1.7	1.0	1.2	3.6	3.7	6.6	1.3	0.7	3.5	1.7	1.5	0.8	1.3	0.3	13.6	4.2	3.8	1.6	17.3	9.3	1.9	1.6	2.0	7.9	26.4	0.6	1.2	0.7	5.2	1.2	0.0	0.8	148.2	4.8	2.4	0.2	1.4	4.3	3.8	1.2	2.9	0.8	3.8	8.7	0.4	1.5	3.9	1.3	0.4	1.5	2.6	0.7	4.8	1.8	0.2	0.7	1.8	1.3	0.0	0.0	0.3	1.0	0.0	0.1	0.0	0.8	1.9	0.0	4.6	0.5	2.5	0.8	0.0	0.1	0.0	0.3	1.7	3.0	3.8	0.0	19.2	2.5	1.2	0.0	0.0	0.0	0.0	3.7	0.0	0.0	1.8	1.1	58.9	24.3	36.3	2.0	0.0	0.1	0.0	5.9	0.0	0.0	0.1	0.4	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.8	0.1	0.0	1.7	0.0	0.0	30.4	45.9	13.3	4.9	4.8	0.0	0.0	0.0	1.8	0.0	0.1	0.1	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	1.8	0.0	1.3	0.0	0.0	0.3	1.2	3.7	0.7	1.3	1.9	1.6	1.2	0.7	4.8	1.3	3.0	17.8	0.5	7.8	15.3	0.0	4.8	0.0	4.0	5.7	0.0	0.0	0.4	0.0	4.5	0.5	3.1	0.0	0.0	1.6	2.6	14.6	5.6	7.0	11.4	1.4	0.0	0.0	1.3	2.7	1.9	127.4	45.7	13.5	46.9	0.0	12.6	10.6	0.0	21.9	0.0	0.9	0.0	270.9	0.5	0.1	7.9	149.2	0.0	0.0	2.3
GLI3	"ACLS, GCPS, PAP-A, PAPA, PAPA1, PAPB, PHS, PPDIV"	ENSG00000106571	"GLI family zinc finger 3"	P10071	7	41960950-42237870	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 31.6"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 20.8;Syncytiotrophoblasts: 28.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 26.6;WM-115: 19.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005534	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			Nucleoplasm	"Nucleoli, Vesicles"	"HPA005534: AB_1078973"	"unprognostic (2.53e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.24e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.48e-5)"	"unprognostic (9.13e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.21e-3)"	"unprognostic (7.00e-2)"	7.3	2.6	4.6	6.8	5.4	0.3	9.4	0.8	6.4	21.1	13.1	2.9	10.9	1.4	31.6	10.0	7.3	10.8	7.0	2.0	4.2	1.7	2.3	0.7	5.8	2.4	1.8	2.1	17.6	1.5	0.8	1.9	13.4	1.8	10.6	3.8	5.1	3.7	14.3	2.2	9.7	4.2	13.8	0.9	1.8	3.8	2.3	3.0	1.7	6.1	8.7	4.0	6.4	9.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	26.6	0.2	6.9	12.6	1.7	1.6	5.6	4.8	5.6	0.1	0.0	0.0	1.0	11.1	6.2	5.5	3.6	4.3	4.1	0.0	3.3	0.0	3.3	0.0	4.4	0.0	0.1	10.4	6.3	5.0	4.0	2.8	4.4	2.9	0.0	0.1	2.2	2.4	0.3	0.0	12.0	0.0	10.1	6.3	0.1	0.7	0.0	4.4	0.7	0.0	2.6	3.3	2.0	11.4	4.4	0.0	4.6	5.9	8.5	8.2	2.8	0.0	0.0	0.0	4.4	0.1	19.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.6	5.4	0.8	6.4	4.2	1.7	1.8	2.1	1.8	3.0	0.0	4.8	0.0	6.8	20.8	1.8	1.4	0.0	1.4	1.2	1.8	0.0	17.7	0.0	0.0	11.6	2.8	0.0	0.0	0.0	12.0	18.1	3.2	1.1	0.0	2.8	0.0	0.0	2.5	0.3	4.3	17.8	0.0	8.5	0.0	0.0	11.8	0.1	0.0	3.2	3.4	0.8	12.9	14.6	0.4	0.9	13.6	28.6	0.0	0.0	3.7
C7orf25	MGC2821	ENSG00000136197	"Chromosome 7 open reading frame 25"	Q9BPX7	7	42908726-42912305	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	7	"Collecting duct cells: 3.5;Cone photoreceptor cells: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 20.9;eosinophil: 12.3;neutrophil: 6.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 20.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020120, HPA049635"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA020120: AB_1845755, HPA049635: AB_2680837"	"unprognostic (6.29e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.56e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.23e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.05e-3)"	4.8	6.5	7.6	3.8	7.6	2.4	6.1	7.1	11.0	5.0	5.2	6.3	2.6	2.1	5.3	11.0	5.2	6.5	5.9	5.8	9.2	8.6	7.7	5.9	4.8	5.2	10.0	9.1	7.2	5.1	12.6	6.5	5.8	12.2	8.2	3.4	4.0	5.0	9.2	5.7	3.9	5.3	5.8	9.6	5.2	5.3	11.0	5.3	5.8	7.7	4.5	3.8	5.3	4.4	2.1	1.4	20.9	1.9	1.6	2.2	1.1	3.5	9.1	3.3	4.9	4.6	2.5	3.6	7.0	2.6	4.6	4.2	5.9	4.6	9.2	5.4	6.7	6.7	6.0	3.5	6.2	5.3	4.4	8.7	4.8	9.3	3.6	8.4	3.6	3.1	5.1	4.2	4.6	4.7	2.3	3.5	5.9	6.1	2.1	3.8	6.6	1.9	3.5	4.0	3.2	11.8	2.2	3.5	3.8	2.6	8.7	4.1	4.6	10.3	3.1	3.6	4.8	4.1	3.5	9.4	4.6	5.3	5.0	4.4	4.9	10.9	2.8	4.3	4.6	9.9	20.9	1.9	12.3	1.5	1.8	2.2	2.1	1.1	1.4	1.4	1.7	1.6	1.6	6.4	1.6	1.7	0.6	0.8	1.1	7.6	7.6	7.1	11.0	9.2	8.6	10.0	9.1	12.2	5.3	0.0	0.6	0.8	0.4	0.2	1.0	0.5	0.0	1.4	0.0	3.5	3.9	0.6	1.7	0.8	0.0	0.1	0.0	0.0	1.0	0.2	0.3	0.5	0.0	0.6	0.2	0.0	0.0	1.8	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.3	0.9	0.0	0.7	1.0	0.5	0.0	0.4	1.2	1.2	0.4	0.7	0.0	0.0	0.1
PSMA2	"HC3, MU, PMSA2"	ENSG00000106588	"Proteasome subunit alpha 2"	P25787	7	42916857-42932223	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 569.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA008188	Uncertain					NA	NA		80000000			"HPA008188: AB_1855819"	"unprognostic (9.40e-3)"	"unprognostic (2.08e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.01e-2)"	"unprognostic (9.25e-2)"	"prognostic favorable (6.73e-5)"	"unprognostic (1.77e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.38e-2)"	"unprognostic (4.24e-2)"	24.7	32.2	25.3	24.6	29.5	29.7	29.4	19.6	22.0	19.2	25.6	13.4	26.0	29.8	22.6	26.2	31.1	19.4	20.5	35.8	22.3	16.6	33.3	90.9	23.2	27.4	27.2	17.6	20.8	28.8	12.0	18.8	33.7	29.2	24.5	26.0	10.1	21.7	19.6	57.2	22.4	33.1	22.0	21.4	26.6	27.8	18.6	23.5	42.2	29.9	44.6	29.9	22.8	20.2	46.2	54.1	81.7	47.4	36.7	56.7	75.0	32.1	34.6	40.6	49.1	21.7	24.4	30.3	28.5	33.4	46.1	49.4	51.5	53.0	59.9	50.9	25.2	72.2	45.1	41.9	39.5	53.2	43.2	33.3	30.5	46.9	54.3	23.2	51.7	33.1	22.4	28.9	35.5	21.2	33.0	43.3	36.9	61.4	36.8	36.8	37.8	46.1	101.8	80.4	53.2	43.0	45.1	39.5	58.8	44.3	44.5	33.0	33.6	31.0	71.3	31.1	57.6	51.8	60.6	30.9	27.4	49.9	29.2	56.1	48.0	72.7	98.0	46.5	65.8	77.2	59.0	45.7	81.7	35.2	45.2	40.4	46.2	43.4	40.5	48.5	40.7	39.0	41.3	23.3	36.7	47.4	54.1	56.7	75.0	25.3	29.5	19.6	22.0	22.3	16.6	27.2	17.6	29.2	23.5	83.4	79.1	145.3	58.9	0.1	28.0	0.0	124.9	107.1	122.8	90.7	21.6	258.4	144.2	278.9	15.8	73.3	147.1	70.0	330.5	246.8	63.2	74.2	161.7	195.1	170.9	27.0	148.7	112.3	163.6	12.0	73.4	114.0	0.0	569.9	160.7	54.7	284.0	133.3	79.5	175.7	38.7	129.4	0.0	98.4	110.0	0.0	233.4	138.4	230.0	89.8
MRPL32	"bMRP-59b, HSPC283, L32mt, MRP-L32"	ENSG00000106591	"Mitochondrial ribosomal protein L32"	Q9BYC8	7	42932200-42948958	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA048965	Uncertain				"Intracellular and membrane"	NA	NA					"HPA048965: AB_2680576"	"unprognostic (1.15e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.90e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.64e-2)"	"unprognostic (8.22e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.05e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.21e-2)"	22.4	36.7	18.7	13.8	24.6	9.8	21.8	13.7	18.7	18.1	22.5	8.0	20.6	21.3	17.7	26.2	23.0	18.1	18.4	38.4	15.1	18.2	41.5	52.7	17.3	15.2	15.5	19.2	22.8	31.4	13.7	23.5	18.2	17.4	26.7	20.7	14.6	20.5	16.8	26.3	11.2	21.0	19.9	12.7	22.3	23.0	12.9	15.5	15.3	30.1	21.2	18.3	23.3	23.1	43.4	28.0	41.9	29.0	27.4	44.7	32.3	15.8	22.3	14.9	24.2	23.9	19.7	17.6	24.4	17.4	20.3	23.1	26.9	17.0	33.7	23.6	13.7	34.7	36.4	23.4	26.0	23.8	22.0	27.9	16.6	18.3	29.4	35.4	28.1	16.4	22.0	19.8	15.0	26.5	17.8	25.1	23.5	30.2	18.0	25.6	23.9	19.2	47.7	39.2	37.9	33.3	19.1	17.9	35.4	45.0	31.8	18.9	16.5	19.7	54.9	20.6	22.6	30.8	21.4	22.3	17.8	29.2	18.9	33.8	29.8	48.4	35.5	13.0	36.2	37.8	41.9	27.2	41.1	24.2	29.0	32.0	43.4	35.9	31.6	28.0	35.1	38.5	36.2	5.4	27.4	24.5	27.6	44.7	32.3	18.7	24.6	13.7	18.7	15.1	18.2	15.5	19.2	17.4	15.5	50.6	38.6	39.4	77.1	116.9	20.4	82.0	63.7	46.8	37.5	55.8	7.9	93.0	152.5	96.4	7.1	68.1	55.1	46.7	87.4	79.4	70.2	77.0	62.4	89.4	55.7	15.9	45.0	44.2	32.7	7.8	48.9	38.8	60.8	60.5	55.3	14.7	96.5	45.6	47.7	177.0	22.7	51.8	143.6	28.4	65.1	95.7	74.9	48.4	83.9	89.4
HECW1	"KIAA0322, NEDL1"	ENSG00000002746	"HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1"	Q76N89	7	43112599-43566001	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.0;kidney: 15.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 118.3;Horizontal cells: 42.9;Late spermatids: 44.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 5.5;GAMG: 4.9;U-266/70: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007203, HPA007593, HPA007609"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA007203: AB_2667776, HPA007593: AB_1852305, HPA007609: AB_2117518"	"unprognostic (1.40e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.57e-1)"	"unprognostic (4.39e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.65e-4)"	"unprognostic (6.93e-2)"	"unprognostic (7.30e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.23e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.42e-2)"	0.7	0.5	10.3	0.8	12.1	1.4	0.8	13.6	24.0	0.6	0.8	1.1	0.0	0.4	0.8	1.7	2.6	0.5	4.0	0.4	3.9	4.1	15.4	0.6	0.6	1.3	3.8	15.5	1.0	0.4	1.7	0.4	0.6	10.2	3.2	0.5	0.6	1.0	0.8	1.8	2.1	0.6	0.7	1.4	0.6	1.0	3.7	1.6	0.0	1.5	0.0	0.8	1.2	0.6	2.4	1.6	7.0	1.7	1.6	0.7	0.1	0.1	5.5	0.6	0.8	0.0	0.0	0.0	1.6	2.8	0.1	0.7	0.0	0.0	0.2	3.1	2.7	4.9	0.4	0.0	0.0	0.2	0.2	0.9	0.0	0.4	0.2	0.2	1.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	3.0	0.0	0.0	0.0	0.0	2.4	0.1	0.9	0.5	0.0	0.0	0.0	0.1	0.2	0.7	0.5	0.1	0.0	0.3	0.4	0.0	0.0	0.8	1.1	1.3	0.4	15.7	0.5	0.0	3.5	0.4	0.0	6.4	1.7	1.1	0.7	1.0	0.5	1.0	0.7	0.3	0.2	2.4	0.6	0.7	7.0	1.6	0.9	1.6	0.2	0.1	10.3	12.1	13.6	24.0	3.9	4.1	3.8	15.5	10.2	1.6	0.0	0.0	0.0	0.3	0.3	13.6	1.2	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	118.3	0.3	2.0	0.0	0.0	0.1	0.8	0.5	0.0	0.0	0.0	42.9	0.0	0.6	0.0	44.2	0.3	0.4	0.0	0.0	0.0	0.5	0.0	0.6	0.4	15.9	1.8	0.0	0.8	2.1	2.5	0.3	0.0	0.5	0.4	0.3
STK17A	DRAK1	ENSG00000164543	"Serine/threonine kinase 17a"	Q9UEE5	7	43582758-43626786	"Enzymes, Plasma proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 43.3"	"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 549.3;Urothelial cells: 279.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA018138, HPA037979"	Uncertain		Supported	"Nuclear speckles,Plasma membrane"		Yes	No			"Nuclear speckles"	"Plasma membrane"	"HPA018138: AB_2669784, HPA037979: AB_10795247"	"unprognostic (1.81e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.76e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.97e-3)"	"unprognostic (3.66e-1)"	7.1	10.1	6.1	43.3	8.2	20.2	8.4	7.9	7.2	4.8	9.3	3.7	2.0	6.1	5.3	4.2	10.1	4.7	8.6	17.7	5.7	5.6	6.7	8.1	15.2	36.6	6.6	2.6	7.3	14.3	1.5	6.3	37.2	5.7	6.2	5.3	3.6	8.6	3.4	10.7	4.8	12.3	5.8	5.3	27.8	11.0	9.0	2.8	30.1	7.3	6.8	37.7	10.3	8.1	10.8	1.4	11.5	0.9	12.7	11.4	2.9	4.4	5.5	5.0	3.4	6.3	8.3	2.1	15.9	17.3	8.7	8.9	4.8	3.2	7.1	25.1	13.3	17.8	9.1	3.8	21.2	12.2	17.5	4.3	6.3	4.1	5.9	4.7	10.8	4.2	6.8	25.0	11.5	10.6	34.5	16.3	7.7	7.4	24.4	10.0	2.0	17.6	5.0	7.7	2.6	18.1	6.1	3.2	14.0	15.2	3.3	2.7	6.1	7.2	3.3	4.6	10.7	3.8	5.5	16.3	19.0	7.2	11.2	17.8	14.8	7.3	10.2	19.3	9.6	30.2	0.7	0.4	11.5	5.8	0.2	5.8	10.8	6.1	9.7	0.3	10.1	11.4	10.2	6.4	12.7	0.9	1.4	3.2	2.9	6.1	8.2	7.9	5.9	5.7	5.6	6.6	2.6	5.7	2.8	113.2	27.8	121.1	549.3	161.6	3.0	25.4	5.1	52.2	81.9	19.2	9.8	44.4	28.2	110.3	36.3	19.4	29.1	0.0	82.8	19.7	31.9	134.1	39.1	7.7	15.8	0.0	6.9	16.5	16.2	8.8	5.5	19.9	33.7	55.1	27.8	8.1	75.9	56.1	2.5	9.7	25.2	6.5	55.6	45.1	29.6	118.9	55.8	186.8	10.0	279.4
COA1	"C7orf44, FLJ10803, MITRAC15"	ENSG00000106603	"Cytochrome c oxidase assembly factor 1 homolog"	Q9GZY4	7	43608456-43729717	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA011944	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA011944: AB_1848671"	"unprognostic (1.16e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.85e-3)"	"prognostic unfavorable (7.84e-5)"	"unprognostic (2.21e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.39e-2)"	13.8	16.2	22.4	14.4	21.7	17.6	14.5	13.8	24.0	11.8	10.9	14.4	17.4	11.4	14.8	14.3	15.1	9.6	10.9	47.8	19.7	18.5	23.4	14.4	11.9	24.2	23.0	13.2	11.1	23.9	9.4	22.1	11.3	17.4	10.9	14.7	17.9	17.5	17.7	55.5	7.0	12.6	9.7	19.9	16.2	14.5	11.8	14.3	16.2	15.8	22.4	28.3	14.8	8.8	21.0	17.9	24.2	17.2	18.6	21.0	14.4	10.5	28.5	23.6	23.2	6.9	7.8	15.8	14.8	25.4	20.2	21.0	21.7	24.2	20.1	25.1	9.0	42.6	15.4	27.2	22.8	25.6	18.0	25.0	25.0	16.8	19.9	11.4	19.4	11.1	6.4	14.6	14.6	21.8	21.7	18.3	24.4	42.3	17.5	16.4	14.4	28.5	48.8	14.8	22.1	20.6	17.3	21.6	37.1	24.6	11.9	14.5	26.0	14.9	27.7	9.6	35.6	20.7	13.1	13.6	10.0	21.9	9.8	20.9	42.2	34.1	36.1	28.5	25.0	26.6	1.3	15.3	16.0	12.9	17.2	9.5	19.7	12.0	13.2	17.9	21.0	16.9	21.0	24.2	18.6	14.6	16.0	11.5	14.4	22.4	21.7	13.8	24.0	19.7	18.5	23.0	13.2	17.4	14.3	26.8	35.0	59.1	58.9	11.6	42.6	55.7	17.8	29.4	23.9	33.2	43.2	28.3	99.5	49.1	4.8	25.8	16.9	46.7	37.1	43.0	26.0	44.0	25.4	19.2	50.1	31.8	26.6	18.4	33.8	6.6	27.3	34.8	35.4	48.7	20.9	22.3	38.8	10.5	18.4	100.4	53.4	12.9	22.7	54.2	85.2	14.6	15.0	52.2	24.9	37.6
BLVRA	BLVR	ENSG00000106605	"Biliverdin reductase A"	P53004	7	43758680-43807342	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 210.4;monocytes: 171.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019709, HPA042865, HPA054322"	Approved		Supported	Cytosol		NA	NA		1600000	Cytosol		"HPA019709: AB_2670239, HPA042865: AB_10797024, HPA054322: AB_2682450"	"unprognostic (2.47e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.79e-2)"	"unprognostic (2.16e-3)"	"unprognostic (6.45e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.63e-2)"	"prognostic favorable (8.65e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.93e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.63e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.56e-2)"	31.7	13.1	14.5	16.2	14.7	23.8	22.5	13.3	21.9	22.7	25.9	9.1	12.6	5.2	19.3	58.7	35.8	18.7	17.5	21.7	11.9	16.2	26.8	6.0	27.7	25.1	15.8	15.4	26.4	14.8	19.3	13.1	12.2	20.5	21.8	8.8	17.2	17.9	21.1	23.0	15.1	12.2	26.4	10.6	40.9	17.7	9.3	6.7	12.1	19.0	21.3	21.5	28.5	18.9	4.9	23.2	27.5	61.6	3.4	14.0	30.7	11.3	22.0	6.4	26.7	13.7	18.3	0.3	7.7	23.9	13.2	16.2	5.2	6.8	0.0	14.9	12.2	46.9	14.9	19.6	19.5	11.3	53.1	13.7	24.4	20.3	32.2	35.0	2.7	9.2	12.4	33.1	13.9	9.3	26.7	22.4	12.3	16.1	13.5	10.0	12.2	8.4	1.4	8.7	2.5	25.4	18.8	11.1	61.4	29.3	6.3	8.3	25.6	15.8	15.8	12.8	11.8	35.5	18.3	13.6	12.2	13.5	5.3	13.1	18.3	14.4	0.0	19.9	11.0	18.9	7.8	50.5	27.5	7.0	61.6	6.6	4.9	14.0	11.7	23.2	2.4	7.5	5.8	4.5	3.4	57.7	3.4	13.6	30.7	14.5	14.7	13.3	21.9	11.9	16.2	15.8	15.4	20.5	6.7	56.6	76.2	9.0	49.2	25.8	17.0	52.9	12.7	76.3	62.6	33.2	2.0	8.3	48.0	45.9	0.6	26.4	1.3	46.7	30.3	8.7	33.7	33.1	108.6	0.9	210.4	7.9	0.0	24.5	107.5	1.3	34.2	72.6	43.9	171.3	0.0	19.3	29.9	0.0	27.3	86.5	11.5	45.3	49.2	2.6	3.8	30.1	4.3	25.0	0.4	35.9
MRPS24	"HSPC335, MRP-S24"	ENSG00000062582	"Mitochondrial ribosomal protein S24"	Q96EL2	7	43866558-43869893	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 136.5"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 38.8;Club cells: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073947	Approved					NA	NA					"HPA073947: "	"unprognostic (1.35e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.32e-2)"	"unprognostic (8.63e-3)"	"unprognostic (9.42e-2)"	"prognostic unfavorable (1.91e-4)"	"unprognostic (2.03e-1)"	"unprognostic (6.86e-3)"	"unprognostic (9.58e-3)"	"unprognostic (1.71e-2)"	"prognostic favorable (9.89e-4)"	"unprognostic (2.87e-1)"	"unprognostic (9.08e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.95e-1)"	17.9	31.6	23.0	15.1	21.1	26.8	42.8	17.4	34.9	16.6	21.7	8.5	19.3	24.5	16.5	15.5	27.9	19.3	21.3	63.4	18.8	17.1	26.6	38.7	16.6	29.3	19.7	19.1	22.7	50.1	12.7	13.9	17.3	13.0	19.1	16.4	13.3	33.3	18.6	136.5	17.3	21.3	22.9	12.3	15.3	23.1	25.0	11.7	16.9	25.3	54.7	17.4	20.4	19.5	50.2	55.7	20.6	41.9	26.4	47.7	36.8	28.3	46.0	14.3	29.6	15.0	25.8	23.8	27.5	67.5	36.7	36.4	41.0	27.0	24.3	33.2	27.6	50.2	36.3	20.3	24.8	28.8	22.7	51.0	14.8	51.6	48.7	22.4	23.9	19.4	24.3	25.2	28.6	34.4	23.5	21.1	24.2	47.7	18.4	22.9	44.9	29.0	53.9	36.0	31.9	46.3	23.8	20.5	92.8	26.4	24.1	28.6	32.7	27.8	69.1	27.6	19.3	46.7	44.0	17.0	34.8	48.5	20.9	39.2	56.4	42.6	30.6	42.2	32.2	54.4	8.4	41.9	20.6	28.2	40.0	30.6	50.2	41.3	33.6	55.7	44.8	41.6	35.6	3.4	26.4	38.6	37.5	47.7	36.8	23.0	21.1	17.4	34.9	18.8	17.1	19.7	19.1	13.0	11.7	6.0	11.8	2.2	2.3	3.9	4.8	0.4	7.6	38.8	22.7	5.2	5.9	1.2	3.3	4.9	1.5	1.6	1.3	0.0	0.6	2.8	3.3	1.2	3.5	18.1	1.1	0.0	4.1	12.9	11.8	0.9	0.3	5.1	3.3	3.6	1.3	0.8	4.3	0.0	0.7	1.4	7.1	0.0	4.7	1.0	1.4	5.1	1.6	7.5	2.0	2.6
URGCP-MRPS24		ENSG00000270617	"URGCP-MRPS24 readthrough"		7	43866558-43906589	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Ciliated cells: 16.0;Club cells: 10.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 6.6;HBEC3-KT: 5.4;SCLC-21H: 6.6"															NA	NA						"unprognostic (2.69e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.14e-2)"		"unprognostic (5.06e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.92e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.57e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.20e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.40e-1)"	"unprognostic (5.46e-2)"	3.7	3.8	6.5	2.1	6.1	1.6	2.4	8.3	7.7	8.9	5.8	4.5	2.8	1.6	5.3	5.6	3.0	5.1	2.6	5.0	6.5	5.1	5.0	5.7	2.8	3.1	5.3	5.6	4.1	7.7	1.6	3.6	4.0	4.0	4.7	3.2	4.8	4.0	2.3	9.0	1.8	7.4	5.0	3.2	2.5	4.8	3.0	3.2	0.8	2.4	1.7	3.2	2.6	2.4	1.1	1.3	0.4	1.6	1.3	3.9	1.1	0.5	1.0	1.3	1.1	0.0	2.0	0.4	0.0	1.8	0.7	0.8	3.4	0.0	0.3	0.6	1.7	6.6	1.4	1.0	5.4	0.0	2.9	2.1	3.2	0.7	0.9	1.0	3.2	0.0	1.6	2.5	0.0	1.8	2.5	0.7	1.2	1.2	0.0	2.1	3.1	0.7	0.6	0.0	1.9	0.7	0.4	0.9	0.0	0.0	0.0	6.6	1.1	0.0	0.0	0.7	0.7	1.3	0.0	0.0	2.1	0.1	1.7	0.6	0.3	0.7	0.0	0.0	1.7	0.7	0.0	0.6	0.0	1.1	1.3	0.6	1.1	1.3	3.9	1.3	0.3	0.7	2.4	0.4	1.3	1.6	0.9	0.0	1.1	6.5	6.1	8.3	7.7	6.5	5.1	5.3	5.6	4.0	3.2	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	16.0	10.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
URGCP	"DKFZp666G166, DKFZp686O0457, FLJ20654, KIAA1507, URG4"	ENSG00000106608	"Upregulator of cell proliferation"	Q8TCY9	7	43875894-43926411	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019879, HPA020134, HPA029468"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA019879: AB_1858651, HPA020134: AB_1858652, HPA029468: AB_10601831"	"unprognostic (5.66e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.42e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.23e-3)"	"unprognostic (3.71e-1)"	"prognostic favorable (1.90e-4)"	"unprognostic (1.56e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.69e-3)"	13.7	27.1	18.5	13.4	21.4	8.6	13.4	28.3	29.5	15.8	18.2	18.6	14.8	22.2	18.3	15.1	13.8	15.6	11.6	19.3	18.3	15.9	20.4	21.3	12.1	9.5	13.8	19.5	21.6	18.4	22.5	22.1	14.4	17.9	17.7	19.6	19.8	18.4	17.1	26.8	17.4	21.0	19.1	10.9	13.8	12.8	7.0	17.2	8.3	14.6	7.9	12.5	15.0	12.3	6.1	9.8	5.8	7.5	2.6	11.9	6.1	13.7	12.8	5.1	16.6	14.1	13.1	5.0	15.2	30.2	18.5	18.9	10.7	11.3	8.2	8.6	16.3	28.2	22.2	14.6	12.2	18.3	15.4	8.4	5.5	12.7	9.2	15.0	8.6	10.7	9.9	15.1	14.6	14.2	12.1	9.2	9.6	13.9	6.4	12.4	10.5	8.9	7.3	9.8	16.5	12.2	12.5	7.1	11.3	17.7	14.0	13.6	23.0	17.2	25.7	8.0	9.1	13.0	10.3	8.5	10.5	4.6	11.6	12.6	17.6	25.6	10.2	12.2	13.6	19.8	2.6	4.5	5.8	9.0	7.3	9.9	6.1	9.6	11.9	9.8	5.6	10.6	9.3	0.5	2.6	7.5	1.5	9.6	6.1	18.5	21.4	28.3	29.5	18.3	15.9	13.8	19.5	17.9	17.2	3.0	8.6	8.3	10.9	9.8	24.6	17.1	10.2	9.4	5.7	12.2	7.9	5.1	14.9	11.7	1.1	9.0	34.1	0.0	11.4	10.5	13.0	11.7	6.9	22.7	5.5	15.9	8.1	12.3	3.3	3.1	17.0	7.0	11.8	4.6	11.9	11.1	13.4	15.0	17.7	20.9	19.9	6.5	12.5	5.4	5.5	12.9	2.9	6.9	12.2	12.7
UBE2D4	HBUCE1	ENSG00000078967	"Ubiquitin conjugating enzyme E2 D4 (putative)"	Q9Y2X8	7	43926438-43956136	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 48.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 25.3"					"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (9.95e-3)"	"unprognostic (6.76e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.24e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.58e-3)"	"unprognostic (4.74e-2)"	"unprognostic (5.04e-2)"	"prognostic favorable (4.86e-4)"	"prognostic favorable (5.77e-4)"	"prognostic favorable (6.51e-4)"	"unprognostic (1.11e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.34e-1)"	10.1	13.1	14.7	5.0	13.3	4.5	9.1	13.8	17.4	8.8	7.6	11.4	7.9	5.3	7.5	11.2	8.0	9.0	7.2	23.8	14.2	10.0	12.7	15.3	8.4	5.3	12.1	9.4	7.9	17.4	8.7	6.9	5.9	11.9	8.7	6.2	8.1	10.6	9.1	48.6	9.4	5.3	10.3	12.8	7.3	6.5	5.1	6.1	2.7	9.6	16.1	5.7	7.7	6.5	10.7	11.8	12.9	20.5	7.7	14.0	6.7	3.8	3.2	2.0	9.1	9.4	3.8	1.5	1.9	4.7	2.4	3.2	1.7	4.6	3.7	5.3	5.0	6.8	4.4	2.5	2.1	3.7	8.3	4.2	4.0	5.0	4.4	3.5	8.7	8.2	2.9	4.4	2.7	4.2	3.5	3.0	4.6	4.4	7.8	3.3	2.5	5.1	5.0	4.4	4.7	4.2	3.2	2.8	5.8	5.1	4.7	7.4	25.3	4.0	8.1	3.0	3.8	4.0	2.6	2.6	1.6	5.1	3.4	5.5	11.2	8.4	1.8	4.8	11.4	8.9	6.3	11.7	12.9	9.3	18.4	9.5	10.3	11.6	10.5	11.8	10.7	14.0	11.5	1.1	7.7	20.5	10.2	9.4	6.7	14.7	13.3	13.8	17.4	14.2	10.0	12.1	9.4	11.9	6.1	0.0	6.2	8.8	8.1	5.6	8.3	21.8	5.1	2.7	6.8	15.7	2.0	9.7	46.4	15.9	5.0	11.9	8.4	0.0	24.7	17.3	10.8	9.8	4.6	22.2	24.7	11.1	18.0	9.2	7.3	8.0	11.2	12.9	15.1	24.4	7.1	9.1	14.6	5.8	20.5	38.0	10.4	6.5	12.0	15.1	8.3	9.8	6.4	6.9	7.9	9.3
SPDYE1	"Ringo1, SPDYE, WBSCR19"	ENSG00000136206	"Speedy/RINGO cell cycle regulator family member E1"	Q8NFV5	7	44000889-44010122	"Disease related genes, Predicted intracellular proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"testis: 10.2"	"Group enriched"	"Detected in some"	21	"Early spermatids: 56.7;Late spermatids: 38.3"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 5.0"									HPA051750	Supported					NA	NA					"HPA051750: AB_2681590"	"unprognostic (2.16e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.98e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.95e-6)"	"unprognostic (2.68e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.19e-2)"	0.1	0.2	0.1	1.1	0.2	1.7	0.2	0.5	0.5	0.3	0.2			0.8	0.3	0.0	0.4	0.1	0.1	0.2	0.1	0.1	0.2	0.3	0.3	1.0	0.1		0.5	0.5	0.0	0.3	0.2		0.4	0.0		0.6	0.0	1.5	2.2	0.9	0.0	0.1	0.8	0.5	10.2			0.5		0.0	0.3	0.3	2.9	2.3	3.0	1.6	1.0	1.5	0.6	1.6	1.0	1.4	2.5	0.0	0.0	1.7	1.9	0.0	0.0	0.0	0.8	1.8	1.7	0.9	0.0	0.8	2.5	0.0	0.0	0.0	1.4	1.3	0.8	3.0	0.7	0.0	1.5	2.1	0.0	0.0	0.0	0.0	0.3	0.0	1.0	1.9	5.0	0.0	1.3	1.3	1.7	2.0	1.1	0.6	2.6	0.8	1.7	0.0	2.2	1.6	1.0	1.6	1.0	0.1	1.6	1.6	0.7	1.5	2.3	2.0	1.0	2.3	2.7	1.8	1.7	0.7	2.1	3.0	3.0	1.6	1.9	1.5	1.6	1.5	1.5	1.3	0.4	0.6	2.9	1.0	1.5	2.8	1.0	1.0	2.3	0.3	0.6											0.0	0.6	0.0	0.0	0.3	1.0	0.8	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	56.7	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.1	0.0	0.1	1.6	0.0	0.0	0.3	38.3	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	2.2	0.0	0.0	0.5	0.2	0.3	0.1	0.0	0.0	0.0
DBNL	"ABP1, HIP-55, SH3P7"	ENSG00000136279	"Drebrin like"	Q9UJU6	7	44044640-44069456	"Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Endocytosis, Immunity, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"monocytes: 471.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020265, HPA027735"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		15000000	Cytosol	Nucleoplasm	"HPA020265: AB_1850723, HPA027735: AB_10603790"	"unprognostic (9.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.12e-5)"	"unprognostic (2.25e-1)"	"unprognostic (6.18e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.88e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.76e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.51e-2)"	23.9	19.6	21.2	45.4	17.4	34.1	20.5	11.4	24.0	23.9	21.0	19.6	23.5	17.9	22.0	21.8	65.6	19.1	32.7	18.0	18.3	18.8	18.9	18.4	23.6	49.8	19.1	23.8	15.2	19.2	16.7	18.5	25.8	16.1	21.0	15.2	17.2	23.4	22.3	15.9	26.2	23.2	25.2	19.8	46.8	24.7	13.0	15.8	31.0	18.2	32.0	52.3	23.6	31.6	46.7	66.0	64.1	73.7	31.6	35.4	80.5	19.6	28.6	17.9	19.4	22.3	14.4	16.6	32.3	27.0	32.2	27.1	28.7	27.4	44.0	23.5	35.2	40.3	34.9	10.4	37.8	12.1	23.5	12.1	14.9	21.4	16.3	22.7	22.3	27.8	13.6	15.1	30.6	10.7	21.0	22.1	27.5	18.7	15.3	30.5	28.5	39.9	25.1	14.6	20.2	24.2	22.2	14.6	21.8	20.8	27.4	21.8	28.9	22.0	43.3	6.9	13.4	31.9	31.1	35.3	26.5	24.0	15.3	37.4	35.9	15.4	24.6	24.9	25.3	62.6	39.2	66.3	50.2	35.4	73.7	28.0	46.7	26.7	28.8	63.9	45.8	27.0	28.2	64.1	31.6	71.0	66.0	31.3	80.5	21.2	17.4	11.4	24.0	18.3	18.8	19.1	23.8	16.1	15.8	41.7	39.3	122.1	30.1	15.7	32.3	28.5	25.5	16.0	19.4	29.6	33.4	67.1	38.1	80.6	8.5	35.4	50.3	46.7	64.8	122.0	37.7	30.1	63.6	19.2	155.2	38.1	36.4	29.4	130.7	6.2	34.2	90.1	52.3	471.5	44.3	39.0	78.0	73.7	31.8	24.0	36.5	6.5	39.1	19.9	13.0	23.3	73.0	66.0	34.9	51.4
PGAM2	PGAM-M	ENSG00000164708	"Phosphoglycerate mutase 2"	P15259	7	44062727-44065587	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 111.6;skeletal muscle: 379.1;tongue: 119.0"	"Group enriched"	"Detected in many"	13	"Early spermatids: 421.0;Late spermatids: 1332.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.2;neutrophil: 1.1;plasmacytoid DC: 1.3;T-reg: 1.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.3;granulocytes: 1.2;T-cells: 1.7"	"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 39.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA043801, HPA050314, HPA060173"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		60000000	Nucleoplasm	"Nucleoli, Cytosol"	"HPA043801: , HPA050314: AB_2732558, HPA060173: AB_2684215"																		1.4	0.8	2.0	0.4	2.2	0.4	0.5	6.9	2.1	0.5	0.5	3.6	0.0	0.6	0.5	9.1	6.1	0.6	0.7	111.6	2.1	3.2	0.8	0.4	0.4	0.4	4.2	1.6	0.5	0.6	0.6	1.3	0.4	2.0	1.9	0.4	2.3	7.6	0.5	379.1	0.4	0.4	0.4	3.2	0.5	0.5	16.7	1.1	4.8	1.5	119.0	4.8	0.4	0.0	0.3	1.3	1.2	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.0	4.3	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	1.3	1.7	0.2	2.0	2.2	6.9	2.1	2.1	3.2	4.2	1.6	2.0	1.1	0.0	0.0	0.5	0.2	1.0	4.3	0.0	0.0	0.0	0.0	0.0	9.8	0.0	68.0	0.0	421.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	22.0	0.0	0.3	1332.7	7.2	0.4	1.7	0.0	0.0	3.8	0.2	0.2	5.6	1.9	4.2	25.8	3.1	30.5	5.6	0.5	0.0	0.0	0.2	0.4
POLM	Tdt-N	ENSG00000122678	"DNA polymerase mu"	Q9NP87	7	44072247-44082540	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 31.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 31.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 38.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058900, HPA066007"			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA058900: AB_2683848, HPA066007: AB_2685595"	"unprognostic (2.44e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.91e-1)"	"unprognostic (9.36e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.87e-3)"	10.7	8.7	7.0	18.0	7.1	7.6	12.2	11.9	8.8	13.8	11.2	11.1	11.7	12.2	10.1	12.0	11.7	11.8	11.8	10.8	6.8	4.4	13.0	12.5	10.1	20.9	9.9	7.0	13.8	12.3	10.0	9.0	8.1	8.2	11.8	7.1	12.4	13.5	14.3	11.2	12.0	12.6	8.9	9.0	18.7	12.0	6.8	8.1	30.1	15.4	8.3	17.6	12.4	10.7	5.9	4.8	31.6	2.1	3.5	4.2	1.3	1.1	1.5	1.5	3.5	2.2	2.6	5.0	3.5	4.0	2.7	1.6	1.9	2.6	11.3	3.6	3.0	3.4	3.4	1.6	38.3	1.6	3.9	3.6	1.3	1.6	0.7	3.1	3.5	5.1	4.0	3.7	2.3	2.8	5.6	4.9	11.3	1.6	5.5	2.3	2.6	7.1	3.1	3.3	3.4	8.2	5.7	0.9	4.4	3.0	1.8	1.6	3.0	1.7	7.3	3.7	2.7	4.6	6.0	3.4	1.9	2.8	1.9	5.1	9.0	4.5	8.8	3.5	3.2	4.6	8.6	1.8	5.1	3.3	2.1	3.3	4.0	2.9	3.0	1.6	5.9	4.2	3.4	31.6	3.5	1.6	4.8	2.7	1.3	7.0	7.1	11.9	8.8	6.8	4.4	9.9	7.0	8.2	8.1	3.0	8.5	24.9	9.9	3.9	18.3	5.5	15.3	4.0	9.1	12.2	27.5	10.7	1.7	6.4	0.4	6.4	12.3	0.0	8.2	8.5	5.0	11.9	24.2	8.9	9.0	17.5	5.2	12.9	10.8	0.4	13.0	9.1	10.1	10.0	7.3	7.2	6.9	15.6	9.6	3.8	38.8	0.0	13.0	10.8	11.5	4.4	8.1	14.4	10.1	10.7
AEBP1	ACLP	ENSG00000106624	"AE binding protein 1"	Q8IUX7	7	44104361-44114562	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, DNA-binding, Repressor"	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 177.1"	"Cell type enhanced"	"Detected in many"	19	"Fibroblasts: 159.0;Leydig cells: 140.4;Peritubular cells: 478.4;Smooth muscle cells: 174.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 10.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 10.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 34.9;BJ: 45.9;BJ hTERT+: 30.3;fHDF/TERT166: 49.3;JURKAT: 34.8;WM-115: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009966, HPA047724, HPA063595, HPA064970"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA		2300000	Vesicles	"Nucleoplasm, Cytosol"	"CAB009966: AB_2225690, HPA047724: AB_2680132, HPA063595: AB_2685052, HPA064970: AB_2685394"	"unprognostic (1.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.13e-1)"	"unprognostic (7.00e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (9.31e-9)"	"unprognostic (2.88e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.28e-3)"	46.5	19.0	8.9	23.9	9.5	3.1	90.9	1.7	5.4	78.1	20.5	17.9	15.8	5.8	73.7	39.4	20.7	43.7	47.9	35.4	12.7	6.4	19.6	6.3	35.5	13.0	12.5	10.8	84.8	8.8	2.7	10.9	26.7	17.2	46.1	7.9	33.3	11.9	70.2	11.4	19.7	16.9	42.6	43.7	16.6	17.6	30.6	9.6	48.0	19.6	12.3	7.5	58.2	177.1	2.3	10.5	0.0	0.0	0.2	1.4	0.4	0.1	0.0	10.8	0.0	34.9	12.4	0.2	45.9	30.3	5.2	1.1	0.0	0.0	1.2	5.1	49.3	0.0	0.0	0.5	0.8	2.2	0.1	0.0	3.1	0.0	0.0	9.8	0.0	0.0	18.8	0.0	17.7	0.0	0.2	2.3	34.8	1.9	0.0	0.0	0.0	19.9	3.7	4.6	0.0	0.0	16.5	0.4	0.3	1.2	0.0	1.1	6.1	0.0	0.0	20.1	10.6	0.1	3.3	8.0	0.0	21.3	0.1	0.0	0.2	0.2	24.2	0.1	0.0	28.2	0.0	0.0	0.0	0.4	0.0	0.3	2.1	0.4	0.0	0.0	2.3	1.4	0.8	0.0	0.2	0.0	10.5	0.0	0.4	8.9	9.5	1.7	5.4	12.7	6.4	12.5	10.8	17.2	9.6	0.0	4.5	6.7	5.4	30.7	0.2	15.5	0.0	4.0	2.3	7.0	0.0	1.7	0.0	0.8	2.0	14.4	0.0	0.0	0.0	2.6	159.0	2.4	2.3	0.0	3.1	0.0	0.0	38.6	1.9	9.5	140.4	3.8	81.0	1.0	0.0	0.1	0.7	0.0	478.4	0.6	0.6	38.8	174.1	2.4	4.5	24.0	2.9	0.7	0.0	2.0
POLD2		ENSG00000106628	"DNA polymerase delta 2, accessory subunit"	P49005	7	44114681-44124358	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 217.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026745	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA026745: AB_1855520"	"unprognostic (9.09e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.50e-3)"	"unprognostic (4.94e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.01e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.44e-3)"	17.2	19.1	17.5	14.3	16.7	16.3	33.9	14.3	25.9	15.8	15.4	17.1	12.6	13.9	16.1	9.7	27.5	34.5	14.5	35.9	16.3	13.8	15.9	43.6	15.3	16.2	15.2	14.7	24.4	49.0	18.9	17.9	12.9	15.0	15.9	12.9	17.4	19.9	14.3	42.6	19.3	11.5	15.7	13.7	11.9	16.0	14.4	14.8	27.7	20.3	25.1	15.8	13.4	16.7	28.1	37.0	3.2	13.7	13.3	29.3	21.3	26.5	35.1	19.6	41.0	17.4	18.7	19.4	16.4	16.5	22.5	16.9	29.6	25.6	61.5	21.0	23.5	45.1	36.8	32.0	44.7	14.7	17.4	37.6	13.5	37.7	25.0	19.9	41.3	16.6	17.0	27.4	34.8	33.9	23.7	18.8	41.6	49.5	29.6	24.8	43.3	50.3	78.1	30.8	38.3	34.5	33.9	26.3	87.2	19.5	17.2	38.9	30.4	20.4	73.7	14.0	13.2	42.6	53.3	14.7	29.9	37.7	36.6	51.2	46.5	68.7	58.9	26.8	41.9	42.2	0.5	13.7	3.2	17.9	12.4	26.8	28.1	21.6	18.2	23.2	27.3	29.3	21.4	1.1	13.3	11.8	37.0	17.0	21.3	17.5	16.7	14.3	25.9	16.3	13.8	15.2	14.7	15.0	14.8	6.0	35.1	22.3	62.4	43.8	38.9	57.0	38.2	60.2	37.5	27.9	29.5	61.7	87.9	57.0	88.9	29.0	11.8	0.0	52.0	69.9	44.0	51.0	25.5	84.6	40.8	50.9	40.3	20.3	12.3	217.8	38.6	15.8	47.2	10.0	53.1	37.9	39.5	14.0	50.2	78.7	48.2	19.4	68.0	59.4	64.6	52.9	29.6	23.3	71.7	63.1
MYL7	"MYL2A, MYLC2A"	ENSG00000106631	"Myosin light chain 7"	Q01449	7	44138864-44141332	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	822	"heart muscle: 639.9"	"Cell type enriched"	"Detected in single"	8987	"Cardiomyocytes: 8328.0"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"BEWO: 14.8;CACO-2: 50.4;SuSa: 20.8"	"Not detected"	"Not detected"							"HPA013331, CAB033884, HPA039262"	Enhanced					NA	NA					"CAB033884: AB_2266773, HPA013331: AB_1854245, HPA039262: AB_2676418"	"unprognostic (1.00e-2)"	"unprognostic (7.99e-2)"		"unprognostic (4.36e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.51e-1)"				"unprognostic (1.28e-1)"	"unprognostic (7.85e-2)"				"unprognostic (1.67e-1)"		"unprognostic (7.28e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	639.9	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.1	0.0	50.4	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.4	0.1	0.0	20.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8328.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GCK	"HK4, MODY2"	ENSG00000106633	Glucokinase	P35557	7	44144271-44198170	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pituitary gland: 46.8"	"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 5.5;Cardiomyocytes: 3.1;Fibroblasts: 3.9;Horizontal cells: 4.8;Muller glia cells: 3.0;Smooth muscle cells: 4.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 4.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.4;naive CD4 T-cell: 4.8"	"Group enriched"	"Detected in many"	17	"B-cells: 4.4;T-cells: 4.8"	"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 12.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA007034, HPA007093"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA007034: AB_1079050, HPA007093: AB_1079051"	"unprognostic (3.09e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.64e-7)"	"unprognostic (8.00e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.11e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.53e-1)"	1.1	0.5	3.2	0.7	2.8	0.0	0.7	9.5	3.7	1.4	1.4	1.3	0.7	0.3	1.5	1.5	0.7	2.3	0.9	7.1	2.1	7.5	0.7	8.7	0.7	0.7	2.9	1.2	2.2	2.9	0.0	46.8	3.3	1.6	0.8	0.5	0.8	0.7	1.6	0.7	1.2	0.7	0.7	1.7	0.7	0.9	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.9	4.4	0.2	0.0	0.0	0.0	4.8	0.7	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.2	0.6	0.4	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.6	0.9	0.0	1.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.3	2.2	1.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.1	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.6	4.4	1.6	0.4	0.2	0.7	4.8	0.9	0.0	0.0	0.0	0.0	0.0	0.7	3.2	2.8	9.5	2.4	2.1	7.5	2.9	1.2	1.6	0.7	0.0	0.0	0.0	0.7	1.0	5.5	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	3.9	0.3	0.0	0.6	0.6	4.8	2.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.0	0.1	0.0	2.1	0.0	0.8	0.0	4.3	0.2	0.9	0.1	0.7	0.0	0.0	0.1
YKT6		ENSG00000106636	"YKT6 v-SNARE homolog"	O15498	7	44200968-44214294	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA030817, HPA030818"	Approved		Approved	Mitochondria,Cytosol		No	No			Cytosol	Mitochondria	"HPA030817: AB_10599828, HPA030818: AB_10602102"	"unprognostic (1.25e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.30e-3)"	"unprognostic (7.80e-3)"	"unprognostic (7.45e-3)"	"prognostic unfavorable (4.64e-4)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.77e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.66e-3)"	26.5	21.9	35.1	21.4	30.6	31.1	23.1	19.0	32.2	21.8	27.6	26.5	27.9	21.1	21.0	32.6	31.1	16.0	16.8	22.3	34.9	33.5	24.4	17.3	19.6	25.7	36.1	24.0	14.3	51.2	29.7	21.6	25.7	26.8	21.3	26.7	18.3	39.1	24.6	29.1	21.8	21.7	27.1	31.4	20.5	24.9	27.3	25.1	22.2	21.0	23.4	26.3	17.5	15.5	7.7	11.1	15.7	12.8	7.2	12.4	6.3	22.6	23.9	20.1	28.1	25.3	22.2	16.6	45.7	35.1	25.6	26.0	25.1	18.8	21.6	20.6	44.8	49.3	28.0	24.6	30.2	32.7	26.0	23.5	12.6	17.7	15.7	31.7	26.7	23.1	20.7	29.6	31.2	33.4	22.7	30.8	19.9	29.2	16.0	33.9	23.4	19.9	29.7	49.2	30.4	40.0	21.9	18.2	18.6	21.1	19.1	23.6	46.4	21.7	34.7	24.7	29.8	27.3	27.6	35.2	27.5	34.1	27.2	50.2	42.7	47.1	32.1	37.4	23.7	53.8	5.9	11.2	15.7	7.8	12.8	11.0	6.9	9.2	12.4	10.3	7.7	8.8	8.6	9.5	7.2	12.1	11.1	9.4	6.3	35.1	30.6	19.0	32.2	34.9	33.5	36.1	24.0	26.8	25.1	11.9	10.3	13.7	14.7	23.1	6.4	17.3	7.6	1.4	6.8	19.2	9.8	21.7	21.6	42.1	21.1	14.0	30.8	0.0	71.4	49.0	21.6	29.1	1.1	14.3	36.6	12.7	13.3	11.1	19.6	5.9	9.2	17.2	25.3	55.1	24.1	9.8	58.9	17.5	12.7	18.2	7.7	0.0	18.4	15.6	18.8	22.6	41.2	8.5	18.3	28.6
CAMK2B	"CAM2, CAMK2, CAMKB"	ENSG00000058404	"Calcium/calmodulin dependent protein kinase II beta"	Q13554	7	44217150-44334577	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.9;heart muscle: 39.2;skeletal muscle: 70.7"	"Cell type enriched"	"Detected in many"	11	"Bipolar cells: 838.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 42.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006849, HPA026307, HPA051783, HPA051785, HPA053973"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		680000	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (1.88e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.23e-7)"	"unprognostic (7.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.95e-2)"	1.4	8.1	20.6	1.4	46.7	1.2	2.0	60.1	81.9	1.2	1.4	4.0	0.7	1.7	1.3	18.8	2.0	1.8	1.2	39.2	36.5	18.0	1.7	3.5	1.2	1.8	10.3	21.3	1.1	3.3	5.6	9.9	1.1	13.4	3.0	1.4	2.7	1.8	2.2	70.7	1.8	1.6	1.2	4.1	1.3	2.4	2.3	4.8	0.0	7.7	2.4	2.0	1.1	0.0	1.3	1.0	3.2	1.2	3.2	1.2	0.8	0.0	0.3	0.2	0.3	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.9	0.2	0.1	0.1	0.2	0.8	0.0	1.1	2.4	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	5.3	0.0	0.2	0.1	0.0	2.4	0.1	0.9	0.1	0.0	0.0	42.0	2.2	0.2	0.0	0.0	0.1	1.9	0.2	0.2	0.2	0.4	0.2	0.0	0.5	0.4	0.1	0.2	0.0	0.2	3.2	0.7	1.0	0.8	0.9	1.2	1.1	1.0	0.5	0.5	1.3	1.2	1.1	2.0	3.2	1.2	1.0	0.9	0.8	20.6	46.7	60.1	42.4	36.5	18.0	10.3	21.3	13.4	4.8	0.0	0.0	0.0	27.8	1.0	838.1	74.9	2.5	0.0	0.0	0.0	43.2	0.0	8.3	0.0	0.8	0.6	0.0	0.0	0.0	0.1	0.4	2.6	4.6	4.4	0.2	57.2	39.0	0.0	1.2	2.1	1.7	0.0	1.7	0.0	0.0	14.1	0.1	0.0	0.0	0.8	46.7	0.0	0.9	0.0	1.7	0.4	0.2	0.0	0.0	0.7
NUDCD3	"KIAA1068, NudCL"	ENSG00000015676	"NudC domain containing 3"	Q8IVD9	7	44379121-44490880	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019136, HPA019528, HPA019529"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA019136: AB_1852370, HPA019528: AB_1852372, HPA019529: AB_1852374"	"unprognostic (3.72e-2)"	"unprognostic (9.28e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.05e-3)"	"unprognostic (2.18e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.62e-2)"	"prognostic favorable (9.16e-4)"	"unprognostic (3.51e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.50e-2)"	8.3	6.3	15.3	5.4	20.8	7.3	7.2	10.9	26.0	7.8	5.8	7.7	6.4	4.0	6.9	7.3	8.0	10.3	6.7	19.5	15.2	13.0	6.0	5.8	7.2	6.2	12.5	16.8	9.3	6.8	12.8	4.7	5.3	10.1	8.4	5.7	6.1	7.1	9.9	18.3	7.0	5.0	8.8	10.1	5.8	5.9	9.9	7.1	4.1	8.1	4.8	6.6	6.3	5.3	4.7	2.8	3.2	3.1	2.5	4.7	3.5	3.1	5.9	4.3	7.8	5.4	4.5	1.7	5.2	5.0	6.0	6.3	4.0	2.2	10.1	3.9	6.7	8.4	3.7	5.9	6.8	3.5	5.8	6.3	2.9	3.6	2.9	5.0	4.8	1.8	4.0	4.6	4.5	5.2	3.6	7.3	3.4	7.2	3.3	4.4	2.8	2.1	4.5	5.5	3.1	7.9	3.3	4.7	3.7	3.4	4.9	4.7	13.5	3.0	5.6	2.3	4.5	4.3	6.9	7.1	4.3	4.4	2.7	4.1	9.2	9.6	5.1	4.5	5.8	7.4	2.0	2.8	3.2	4.6	2.7	4.7	3.5	4.4	3.8	2.6	4.7	4.6	4.0	1.8	2.5	3.1	2.8	4.4	3.5	15.3	20.8	10.9	26.0	15.2	13.0	12.5	16.8	10.1	7.1	11.9	19.2	17.2	11.6	10.1	37.9	38.9	12.7	21.4	13.6	36.6	51.1	17.0	19.9	27.0	56.9	21.1	21.5	0.0	18.7	15.8	15.0	14.2	9.2	28.8	15.6	46.1	16.7	21.5	19.8	67.6	28.1	11.6	15.1	19.8	21.4	25.5	23.6	21.2	26.5	21.3	40.2	32.3	15.5	52.1	13.7	14.2	12.0	15.8	25.0	10.8
NPC1L1	SLC65A2	ENSG00000015520	"NPC1 like intracellular cholesterol transporter 1"	Q9UHC9	7	44512535-44541315	"FDA approved drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 77.0;liver: 29.8"	"Group enriched"	"Detected in some"	9	"Cholangiocytes: 10.2;Early spermatids: 13.1;Hepatocytes: 27.0"	"Group enriched"	"Detected in many"	5	"liver cancer: 8.5;pancreatic cancer: 7.8;stomach cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 6.9;Hep G2: 17.2;SCLC-21H: 14.8"	"Region enhanced"	"Detected in single"		"cerebral cortex: 0.7"	"Low region specificity"	"Detected in all"			"CAB070127, CAB070128"	Enhanced					NA	NA					"CAB070127: AB_10002744, CAB070128: AB_10000815"	"unprognostic (2.96e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.57e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.59e-2)"	"unprognostic (8.08e-10)"	"unprognostic (1.64e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.83e-2)"	0.5	0.1	0.1	0.0	0.2	0.0	0.4	0.5	0.2	0.3	42.0	0.0	0.0	30.5	0.4	0.3	0.3	0.3	11.4	0.1	0.1	0.1	0.7	29.8	0.2	0.0	0.1	0.0	0.5	1.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.2	77.0	0.0	0.1	0.1	0.8	0.7	0.0	0.0	0.1	0.0	0.0	0.3	0.5	0.2	0.0	0.6	0.2	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	14.8	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.5	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	10.2	0.0	0.0	1.8	0.0	0.0	0.0	0.2	13.1	0.0	0.0	0.0	0.4	0.0	0.3	0.2	0.0	27.0	0.0	0.0	1.7	1.8	1.0	1.9	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
DDX56	NOH61	ENSG00000136271	"DEAD-box helicase 56"	Q9NY93	7	44565417-44575051	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019749, CAB037320"	Uncertain		Supported	"Nucleoli,Mitotic chromosome"		NA	NA			Nucleoli	"Mitotic chromosome"	"CAB037320: , HPA019749: AB_1847579"	"unprognostic (3.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.08e-3)"	"unprognostic (2.12e-3)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (5.17e-2)"	"unprognostic (2.76e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.01e-3)"	"prognostic unfavorable (8.41e-7)"	"unprognostic (2.60e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.90e-2)"	12.8	12.0	10.3	12.4	11.9	12.4	9.2	13.6	18.9	11.9	10.0	12.2	8.6	11.9	12.8	10.3	13.1	12.6	12.5	9.3	10.6	9.9	17.7	29.2	8.9	13.2	10.4	9.3	15.0	22.5	13.1	11.9	12.3	12.2	14.1	9.0	11.0	16.9	11.5	16.9	16.3	11.4	8.4	8.8	12.1	10.6	14.6	10.9	14.5	13.8	16.7	15.1	9.2	10.3	12.8	16.0	6.9	16.5	15.7	12.3	12.7	7.6	20.5	1.6	4.4	2.0	2.0	6.8	7.3	3.7	8.3	7.3	13.2	7.6	13.5	9.5	2.7	11.4	13.1	3.3	7.3	1.5	5.0	20.8	8.9	13.0	10.1	3.6	9.3	5.0	2.9	5.3	7.4	4.6	1.5	4.2	5.0	18.3	3.8	5.3	10.1	4.7	8.6	11.1	6.6	19.3	3.8	7.2	5.3	4.7	8.2	5.2	8.4	9.6	15.0	5.5	1.3	10.9	9.6	8.9	6.8	9.9	4.6	18.3	12.4	19.0	19.4	7.5	11.4	9.5	6.9	11.8	4.3	9.9	15.3	12.3	11.5	10.7	11.1	16.0	12.8	12.3	10.3	0.4	15.7	16.5	7.7	10.1	12.7	10.3	11.9	13.6	18.9	10.6	9.9	10.4	9.3	12.2	10.9	14.9	25.3	16.0	20.1	15.1	25.2	10.8	12.7	24.1	34.2	21.0	13.7	48.6	23.2	34.9	39.1	23.8	26.9	0.0	28.4	38.8	18.4	15.9	27.7	27.7	31.4	6.4	17.7	18.4	10.1	30.0	19.5	17.4	13.5	32.5	19.6	20.6	31.1	20.1	18.7	40.8	23.2	12.9	20.6	30.2	29.0	17.3	39.5	18.7	27.0	18.1
TMED4	"HNLF, p24a3, p24alpha3"	ENSG00000158604	"Transmembrane p24 trafficking protein 4"	Q7Z7H5	7	44577894-44582287	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014650	Approved				"Intracellular and membrane"	NA	NA					"HPA014650: AB_1858066"	"unprognostic (7.34e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.46e-3)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (2.09e-3)"	"unprognostic (4.50e-3)"	"unprognostic (2.54e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.65e-2)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.21e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.11e-1)"	"unprognostic (6.61e-2)"	19.5	28.1	19.8	15.5	23.4	20.0	20.7	28.1	32.6	23.2	44.2	34.7	58.3	40.8	26.2	39.3	19.6	26.5	27.4	30.4	20.7	22.6	42.0	25.8	21.8	15.9	23.8	19.2	39.2	52.7	59.3	37.8	55.4	23.9	28.3	23.3	38.3	39.3	45.2	29.2	19.8	55.2	25.7	28.3	20.8	25.4	17.6	19.9	21.9	55.1	14.7	24.8	23.0	21.2	30.3	50.7	35.2	27.7	33.2	46.4	21.3	15.0	18.5	26.7	30.2	24.0	14.4	22.8	18.2	22.6	18.8	23.6	20.1	37.5	14.3	30.5	19.5	40.6	24.7	14.0	15.2	22.9	18.9	22.9	12.7	33.1	19.0	21.7	20.3	24.5	18.6	23.2	19.9	16.2	34.9	16.7	22.6	19.7	31.9	22.2	13.5	19.5	27.4	17.1	23.5	19.1	16.8	12.9	27.7	27.0	24.8	21.4	30.6	19.6	43.9	20.2	31.7	34.4	20.7	15.7	13.9	20.8	15.9	28.4	48.0	43.5	17.4	28.7	22.0	49.0	32.2	26.6	35.2	38.6	26.3	46.4	30.3	38.9	36.9	23.3	25.5	32.5	35.9	24.9	33.2	27.7	50.7	32.3	21.3	19.8	23.4	28.1	32.6	20.7	22.6	23.8	19.2	23.9	19.9	110.2	61.2	54.4	46.3	49.9	140.9	64.4	66.2	71.0	64.8	146.5	70.7	151.4	34.9	65.9	44.0	36.7	130.5	70.0	53.0	45.9	63.2	73.3	39.4	50.8	62.8	106.5	60.4	41.1	36.4	77.5	72.5	48.0	38.8	64.1	67.2	109.0	68.5	72.9	76.4	112.3	117.3	58.2	45.7	46.5	58.3	49.7	133.8	70.8	73.2	57.0
OGDH	E1k	ENSG00000105953	"Oxoglutarate dehydrogenase"	Q02218	7	44606572-44709066	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 99.3"	"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 100.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019514, HPA020347"	Supported		Enhanced	Mitochondria		No	No		53000	Mitochondria		"HPA019514: AB_1854772, HPA020347: AB_1854773"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (2.22e-14)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.88e-3)"	18.9	20.8	12.3	14.5	18.5	8.7	11.0	14.3	23.7	10.1	19.4	15.9	13.5	29.0	16.2	11.1	19.5	11.1	11.8	73.9	11.3	12.8	28.8	14.8	13.0	11.1	14.2	11.7	9.8	13.0	25.5	11.0	14.5	22.2	12.3	13.3	22.3	23.7	15.9	99.3	15.6	35.5	16.4	10.1	12.1	14.9	11.3	11.0	11.3	17.8	39.8	15.8	13.0	10.8	7.2	13.4	7.5	20.4	11.2	25.7	11.6	10.8	22.8	13.7	20.8	21.2	23.3	13.3	17.0	16.6	19.3	16.9	20.7	22.5	47.8	20.2	24.7	39.0	33.8	27.0	25.4	18.9	27.9	7.1	14.5	46.1	10.2	10.8	17.9	16.3	21.6	19.3	27.4	19.7	14.2	26.2	16.0	16.7	14.3	20.4	15.3	17.7	10.3	12.6	30.2	25.7	17.0	9.6	53.6	22.2	32.4	23.4	11.2	24.5	34.1	10.6	25.9	20.2	18.0	20.6	13.9	12.6	24.2	19.6	13.0	24.9	26.4	25.3	20.3	25.3	4.8	12.1	7.3	11.7	17.7	12.8	7.2	13.5	11.7	13.4	5.9	5.8	7.0	7.5	11.2	20.4	6.6	25.7	11.6	12.3	18.5	14.3	23.7	11.3	12.8	14.2	11.7	22.2	11.0	6.0	22.7	20.4	11.1	17.3	20.1	100.7	15.3	12.0	9.1	45.4	17.7	19.4	26.6	13.2	43.1	14.2	61.4	0.0	14.8	14.3	16.4	14.4	20.8	17.5	29.3	58.8	22.4	14.1	22.4	20.0	10.9	21.9	20.3	21.6	29.2	15.4	16.7	21.0	16.3	38.9	22.2	19.4	18.2	9.1	20.0	23.1	30.7	13.8	27.6	14.2
ZMIZ2	"DKFZp761I2123, hZIMP7, KIAA1886, NET27, ZIMP7"	ENSG00000122515	"Zinc finger MIZ-type containing 2"	Q8NF64	7	44748581-44769881	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA040716	Supported		Supported	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA040716: AB_10805826"	"unprognostic (2.28e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.21e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (6.82e-5)"	"unprognostic (2.47e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.89e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.15e-3)"	14.3	16.0	31.7	24.5	31.5	19.8	13.3	24.0	43.2	12.7	15.2	22.9	17.5	23.8	16.4	16.8	16.8	17.3	17.3	15.9	28.2	15.4	19.0	10.1	18.3	24.0	17.0	27.2	17.9	32.3	19.8	23.0	11.0	17.0	16.4	12.5	16.5	32.5	23.0	18.7	31.1	22.2	17.9	16.5	28.8	21.3	20.8	17.5	16.7	25.1	14.0	19.1	15.5	13.2	4.9	4.1	1.0	2.4	3.4	2.5	0.9	14.4	16.6	7.8	15.0	5.3	3.5	8.2	7.4	7.1	6.4	7.7	9.4	22.7	9.9	11.7	7.7	15.9	19.8	4.8	8.4	3.8	23.5	9.2	4.0	15.6	7.4	10.9	5.7	8.9	5.4	5.2	10.0	6.6	5.7	11.8	10.8	11.7	22.6	9.3	13.8	12.7	15.9	14.7	11.0	16.2	15.9	4.3	12.9	7.5	11.1	27.7	18.3	10.0	19.6	4.5	7.7	18.6	8.9	17.5	6.1	13.4	16.4	17.0	33.3	10.5	7.7	11.8	10.2	24.9	1.0	1.6	0.7	2.5	2.4	1.6	2.7	1.2	1.8	1.6	4.9	0.8	0.9	0.7	3.4	1.2	4.1	1.1	0.9	31.7	31.5	24.0	43.2	28.2	15.4	17.0	27.2	17.0	17.5	11.9	19.2	10.7	3.8	9.0	10.7	14.5	2.5	8.1	11.4	22.7	13.7	6.7	1.7	15.0	24.7	12.3	15.8	0.0	13.5	2.1	9.7	8.2	13.9	14.5	9.7	11.1	19.1	15.4	17.9	62.4	12.4	14.8	13.5	32.5	17.7	4.9	20.5	14.0	17.0	6.9	6.9	6.5	9.8	4.5	5.3	16.2	6.1	9.6	20.0	8.4
PPIA	CYPA	ENSG00000196262	"Peptidylprolyl isomerase A"	P62937	7	44796680-44824564	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004655, HPA058345"	Uncertain				"Secreted to blood"	NA	NA		420000000			"CAB004655: AB_425607, HPA058345: AB_2683685"	"unprognostic (3.10e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.86e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (2.27e-6)"	"unprognostic (1.12e-3)"	"unprognostic (3.30e-2)"	"unprognostic (3.92e-2)"	"unprognostic (8.68e-3)"	"unprognostic (2.52e-1)"	"unprognostic (6.35e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.16e-1)"	92.0	90.3	147.0	80.4	124.3	105.9	169.0	88.9	148.0	111.3	143.5	81.6	52.9	73.9	74.8	125.1	176.5	76.3	80.4	60.2	132.0	121.9	149.2	214.3	95.4	137.1	123.2	88.3	74.2	103.2	93.1	58.3	96.2	142.5	83.0	149.1	68.1	84.7	102.3	68.4	114.7	105.1	113.9	120.8	137.0	73.1	62.4	59.8	228.2	130.2	123.4	191.2	94.3	93.1	129.8	158.5	35.0	83.1	76.0	117.7	180.3	85.4	114.8	145.8	105.8	122.2	185.9	48.1	125.3	196.9	240.8	236.3	127.3	131.1	193.3	64.6	159.6	265.6	116.9	187.4	240.0	222.2	110.5	136.7	78.1	132.3	121.2	99.2	158.2	81.5	136.0	164.8	170.6	187.5	123.7	244.4	134.0	160.4	156.3	247.6	121.7	173.3	280.1	166.4	289.1	158.3	124.5	88.3	245.9	326.5	120.9	109.2	90.5	105.6	303.0	82.3	181.0	162.4	216.0	108.6	124.1	119.7	83.0	164.2	114.1	225.3	326.2	108.2	180.1	187.2	23.4	74.5	35.0	94.9	83.1	102.0	129.8	97.0	97.1	134.8	103.9	80.3	88.2	9.2	76.0	77.7	158.5	117.7	180.3	147.0	124.3	88.9	148.0	132.0	121.9	123.2	88.3	142.5	59.8	738.4	649.6	630.7	788.0	769.8	81.7	43.6	573.3	655.8	728.0	572.3	17.7	772.4	1198.7	1053.9	61.2	614.7	668.4	210.2	1054.9	1359.4	612.8	450.0	590.8	641.5	1374.9	104.9	508.7	685.7	1073.8	53.8	539.0	844.5	656.3	1506.8	976.8	169.9	1130.2	533.1	576.3	1183.4	66.5	388.1	545.9	364.4	288.3	865.6	509.5	657.9	1124.8	784.3
H2AFV	"H2AV, MGC10170, MGC10831, MGC1947"	ENSG00000105968	"H2A histone family member V"	Q71UI9	7	44826791-44848083	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057236	Supported					NA	NA					"HPA057236: AB_2683377"	"unprognostic (2.16e-2)"	"prognostic favorable (4.66e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.51e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.68e-1)"	"prognostic favorable (8.04e-4)"	"unprognostic (4.86e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.25e-1)"	27.1	34.1	41.0	36.5	40.8	96.0	26.5	49.8	35.3	27.8	39.3	37.5	30.5	29.3	36.0	25.9	34.4	28.1	34.0	73.8	34.3	32.4	37.7	34.3	30.4	50.0	38.2	36.0	28.1	30.4	35.0	24.9	25.7	29.0	30.3	41.1	36.8	29.1	29.9	64.2	23.8	34.7	42.1	35.0	37.1	34.1	33.7	35.3	87.8	39.6	32.8	61.4	33.7	35.3	19.1	39.1	57.9	16.8	18.9	41.9	12.2	37.8	49.3	56.2	50.8	24.3	19.6	22.3	28.1	33.7	34.0	41.0	38.8	52.8	57.1	29.6	37.9	57.5	43.8	46.3	38.3	53.5	52.1	27.2	34.7	68.5	42.7	16.7	84.6	44.8	15.8	16.8	39.2	34.2	25.7	40.1	56.4	64.1	59.6	49.9	83.9	78.4	124.3	42.4	48.8	41.3	63.6	66.1	50.1	33.8	37.0	39.2	51.3	53.8	58.3	20.3	55.7	51.3	77.7	37.4	30.9	76.1	27.5	66.6	51.8	58.1	90.2	30.4	66.8	93.1	24.5	16.8	57.9	17.9	13.6	22.8	19.1	24.8	23.6	25.4	17.1	18.5	17.9	20.5	18.9	12.1	39.1	41.9	12.2	41.0	40.8	49.8	35.3	34.3	32.4	38.2	36.0	29.0	35.3	68.5	53.6	117.8	86.3	170.0	101.0	222.1	84.1	66.9	46.6	108.2	90.3	116.8	89.5	110.3	414.9	92.4	128.9	93.5	88.4	368.6	116.4	115.1	84.1	99.1	210.4	82.6	155.9	82.3	101.3	90.0	51.2	149.2	114.7	458.9	161.3	104.0	102.4	129.8	77.8	119.6	108.3	90.5	113.6	214.4	198.3	152.9	89.4	135.1	182.2	105.0
PURB	PURBETA	ENSG00000146676	"Purine rich element binding protein B"	Q96QR8	7	44876293-44885361	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048766			Supported	Nucleoplasm		NA	NA		13000	Nucleoplasm		"HPA048766: "	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.21e-2)"	"unprognostic (9.49e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.12e-1)"	"unprognostic (5.66e-2)"	"unprognostic (4.29e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.22e-2)"	12.1	9.6	19.1	12.0	20.3	13.5	14.2	30.8	22.0	13.7	14.2	11.1	6.6	8.7	13.1	9.4	13.9	11.6	11.6	9.1	18.5	9.2	11.3	10.0	12.4	11.1	15.6	13.4	12.5	10.1	17.4	10.4	15.4	12.9	12.8	9.0	11.0	11.3	11.6	14.3	16.7	10.7	18.5	12.4	10.8	10.8	7.8	15.0	12.3	13.9	7.8	11.9	11.7	11.8	1.5	1.6	3.3	1.2	1.5	2.0	0.6	8.9	5.0	9.0	16.9	8.4	13.5	6.0	12.4	9.8	9.3	9.1	7.5	7.0	13.4	10.9	14.3	22.1	16.6	8.4	11.0	18.5	10.8	6.9	6.7	12.4	4.2	8.4	10.5	10.7	11.0	14.1	17.8	13.1	10.0	9.8	11.1	11.7	12.6	19.5	12.4	8.7	13.2	14.1	6.0	8.8	7.2	27.4	8.7	7.7	15.4	9.0	12.7	12.3	25.8	7.6	11.4	17.2	12.1	16.5	16.4	18.0	10.6	20.7	22.2	19.3	4.3	12.2	12.3	21.7	1.6	1.2	1.7	1.9	1.1	2.0	0.9	1.6	1.5	0.6	1.5	1.5	1.7	3.3	1.5	0.9	1.6	1.2	0.6	19.1	20.3	30.8	22.0	18.5	9.2	15.6	13.4	12.9	15.0	35.7	36.3	18.8	30.6	62.0	57.4	16.5	20.4	30.8	31.8	17.4	31.4	16.0	8.3	16.9	16.5	32.7	14.2	0.0	19.4	11.1	24.9	35.8	35.8	11.6	15.0	50.9	19.5	36.8	19.7	14.0	19.2	30.9	16.9	10.0	18.0	38.9	23.0	7.0	18.7	9.2	51.0	45.3	32.7	16.8	12.2	75.3	15.8	20.0	21.5	37.3
MYO1G	HA-2	ENSG00000136286	"Myosin IG"	B0I1T2	7	44962662-44979098	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 37.9;bone marrow: 27.4;lymphoid tissue: 46.8"	"Cell type enriched"	"Detected in many"	7	"monocytes: 573.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.2;HEL: 24.5;HL-60: 14.0;JURKAT: 30.5;MOLT-4: 31.0;NB-4: 13.1;THP-1: 27.5;U-937: 20.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021252	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		120000	"Plasma membrane"	Nucleoplasm	"HPA021252: AB_1854254"	"unprognostic (2.74e-2)"	"prognostic favorable (8.26e-4)"	"unprognostic (5.20e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.54e-3)"	"unprognostic (6.47e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (8.71e-8)"	"unprognostic (3.20e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.92e-2)"	2.5	1.2	1.6	11.0	3.0	27.4	1.5	0.4	2.0	1.0	1.9	0.7	0.0	1.8	1.2	2.1	2.4	1.9	3.6	3.2	1.0	0.9	1.9	1.9	13.0	18.6	4.5	0.0	0.9	0.8	0.0	0.9	1.5	2.7	1.5	1.1	1.5	5.8	0.5	0.6	1.2	8.3	1.9	2.6	22.3	2.1	0.9	1.8	46.8	2.1	2.2	26.6	4.7	1.3	9.9	14.0	9.4	37.9	6.7	24.4	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	24.5	0.8	0.0	0.0	14.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	30.5	0.0	0.0	0.0	0.0	31.0	13.1	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	20.2	0.0	9.4	17.0	5.2	19.9	29.6	12.6	9.9	12.7	17.4	14.0	6.6	4.6	9.0	1.7	6.7	37.9	1.2	24.4	19.3	1.6	3.0	0.4	2.0	1.0	0.9	4.5	0.0	2.7	1.8	3.0	11.4	56.6	0.3	2.5	0.0	1.1	0.0	1.4	2.3	0.0	0.0	0.1	0.0	0.1	0.3	0.6	0.0	0.0	0.9	0.2	1.7	0.4	30.0	0.9	10.8	3.2	0.0	2.5	71.9	1.2	0.0	51.5	3.3	573.5	0.0	0.2	0.2	0.0	0.4	0.3	0.0	6.5	1.6	0.4	0.2	1.5	0.1	86.3	0.0	0.1
CCM2	"C7orf22, MGC4607, OSM"	ENSG00000136280	"CCM2 scaffolding protein"	Q9BSQ5	7	44999475-45076469	"Disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"monocytes: 208.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020273, HPA021669, HPA065815"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA020273: AB_1846185, HPA021669: AB_1846186, HPA065815: AB_2685562"	"unprognostic (4.30e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (4.85e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.37e-3)"	"unprognostic (3.92e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (5.06e-7)"	"unprognostic (2.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.48e-1)"	16.7	18.3	31.6	20.7	52.0	11.2	8.6	21.3	36.1	9.7	12.5	13.9	8.6	10.5	7.2	7.0	10.6	8.4	9.1	13.7	29.8	23.1	7.9	31.6	12.4	30.7	29.0	14.2	8.2	17.9	16.5	11.2	11.5	17.8	7.7	8.8	6.9	13.6	12.6	27.0	13.4	10.6	13.3	14.7	20.8	11.2	10.5	11.5	37.5	7.4	8.2	23.4	15.4	12.6	14.8	7.3	32.4	13.8	17.6	50.6	11.1	13.6	15.1	9.1	18.0	17.2	15.1	6.7	16.6	13.7	11.9	16.1	10.9	14.2	19.3	12.8	21.0	37.8	17.9	5.6	21.4	7.9	21.5	10.8	8.5	12.1	7.7	15.2	3.5	23.1	17.0	14.1	20.9	9.0	11.1	21.6	28.3	9.8	15.7	23.8	20.6	16.9	46.8	10.5	11.4	16.8	9.0	5.2	15.6	12.1	13.2	17.5	13.6	13.6	10.7	7.3	12.3	12.3	16.1	16.3	16.2	13.8	16.2	15.8	28.1	22.0	38.9	15.9	12.7	19.5	27.1	10.5	31.2	17.3	12.1	11.6	13.6	20.5	18.7	7.2	14.8	19.9	14.7	32.4	17.6	13.8	7.3	50.6	11.1	31.6	52.0	21.3	36.1	29.8	23.1	29.0	14.2	17.8	11.5	17.9	20.8	51.3	20.1	41.6	18.3	12.5	17.8	6.7	21.6	14.0	3.9	22.8	21.6	27.6	5.8	25.3	21.7	0.0	33.3	31.3	26.3	15.3	34.7	50.4	43.3	77.9	15.0	27.0	34.3	8.0	19.5	45.2	32.1	208.2	13.4	21.4	35.1	11.5	19.1	17.0	11.9	19.4	27.8	16.2	36.4	20.1	8.7	56.6	13.5	16.1
NACAD	KIAA0363	ENSG00000136274	"NAC alpha domain containing"	O15069	7	45080438-45088914	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.0"	"Cell type enhanced"	"Detected in many"	16	"Horizontal cells: 30.2;Peritubular cells: 11.3"	"Group enriched"	"Detected in many"	7	"glioma: 12.1;testis cancer: 16.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.4;non-classical monocyte: 1.8"	"Group enriched"	"Detected in many"	12	"monocytes: 1.8;T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"GAMG: 24.1;SCLC-21H: 18.5;SH-SY5Y: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020981, HPA079208"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA020981: AB_2670549, HPA079208: "	"unprognostic (5.54e-6)"	"unprognostic (1.89e-1)"	"unprognostic (8.55e-4)"	"unprognostic (7.06e-3)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.61e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.17e-2)"	"unprognostic (8.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (7.72e-3)"	"unprognostic (2.72e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.87e-2)"	4.7	8.9	11.5	2.7	19.4	1.1	2.1	16.7	45.0	4.8	3.5	43.1	0.1	2.1	6.9	2.3	3.9	4.8	3.7	5.1	16.7	15.9	2.2	1.2	3.0	1.9	30.2	12.9	10.4	2.4	3.2	11.7	3.8	26.7	4.7	2.3	1.1	3.2	5.7	2.0	2.1	2.7	7.4	30.8	2.7	2.5	4.5	21.5	0.0	1.4	0.0	1.5	3.2	2.3	0.1	0.0	0.0	1.8	0.0	1.4	0.1	0.0	0.0	1.8	0.0	1.1	0.5	0.0	2.0	2.5	5.6	3.5	0.1	0.1	0.0	1.6	3.6	24.1	0.1	1.6	1.3	2.0	0.0	0.5	0.0	1.2	0.0	1.3	0.0	0.0	1.2	0.0	2.4	0.2	2.9	1.7	0.0	0.0	2.5	1.4	0.0	0.0	0.0	1.6	0.0	1.5	0.0	0.7	0.0	0.2	0.0	18.5	12.8	0.0	0.0	0.1	5.0	0.0	0.0	0.6	0.0	0.0	0.1	0.3	1.3	0.7	0.0	1.1	0.0	3.7	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.1	11.5	19.4	16.7	24.1	16.7	15.9	30.2	12.9	26.7	21.5	0.0	0.0	0.0	2.7	0.6	5.1	4.2	0.0	1.4	0.0	1.8	0.0	0.0	0.0	0.4	2.0	1.0	0.0	0.0	0.2	0.0	3.8	1.7	1.1	0.0	0.1	30.2	1.2	0.6	0.0	3.6	6.4	0.0	1.7	1.8	0.0	1.9	0.1	0.0	11.3	0.0	1.4	6.5	2.2	1.5	0.6	0.1	0.1	0.0	0.0	0.6
TBRG4	"Cpr2, FASTKD4, H_TD2522F11.8, KIAA0948"	ENSG00000136270	"Transforming growth factor beta regulator 4"	Q969Z0	7	45100100-45112047	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020582, HPA050430"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA020582: AB_1857804, HPA050430: AB_2681125"	"unprognostic (2.22e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.29e-3)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.53e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.66e-3)"	"unprognostic (3.91e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.52e-1)"	13.7	16.8	10.8	16.0	15.6	14.9	13.0	12.9	22.1	10.5	20.8	15.6	14.1	21.8	14.2	8.2	20.1	12.8	12.4	26.2	9.8	10.0	20.9	27.7	10.5	17.0	10.6	8.9	15.6	16.9	11.3	10.1	16.2	14.7	13.6	14.1	10.8	14.2	12.4	42.6	16.9	17.8	13.9	9.9	16.2	14.0	22.5	9.5	15.0	13.8	23.7	20.3	14.5	13.3	15.8	20.1	10.9	24.2	9.7	21.0	17.5	13.0	30.4	9.7	21.3	8.8	8.2	19.6	10.6	9.8	20.6	17.1	32.9	18.4	25.0	16.4	10.8	28.5	34.2	22.6	24.2	10.5	12.9	21.1	17.1	19.9	22.4	14.7	19.5	17.7	10.8	22.5	19.6	14.1	7.3	12.6	21.5	47.4	12.6	12.6	22.0	19.8	44.7	30.8	29.3	24.3	17.6	12.5	36.4	12.1	13.4	19.3	18.3	10.8	60.2	20.9	13.2	26.8	32.5	9.8	15.3	18.5	9.3	17.2	22.7	22.6	36.5	14.1	28.1	34.4	7.4	13.3	10.9	18.4	24.2	17.6	15.8	15.4	17.8	20.1	12.3	21.0	19.9	1.0	9.7	20.4	7.5	14.6	17.5	10.8	15.6	12.9	22.1	9.8	10.0	10.6	8.9	14.7	9.5	3.0	18.9	26.9	23.8	31.1	14.5	24.1	15.3	5.3	9.1	19.2	0.0	53.3	36.5	29.7	12.3	11.7	28.7	0.0	16.1	61.7	16.9	15.1	13.9	27.7	30.7	11.1	21.4	10.4	12.6	14.5	15.3	17.8	16.9	45.9	30.0	14.0	25.4	21.0	11.0	36.6	12.9	12.9	19.4	46.1	32.2	25.6	40.0	17.0	44.5	25.9
RAMP3		ENSG00000122679	"Receptor activity modifying protein 3"	O60896	7	45157791-45186302	"FDA approved drug targets, Predicted membrane proteins"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"Endothelial cells: 183.2;Ito cells: 555.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.7"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.7"	"Cell line enriched"	"Detected in some"	7	"Karpas-707: 7.6"	"Group enriched"	"Detected in many"	5	"cerebellum: 69.9;cerebral cortex: 50.2;thalamus: 191.1"	"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.62e-3)"	"prognostic favorable (2.89e-4)"	"unprognostic (4.85e-2)"	"unprognostic (6.88e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.44e-3)"	"prognostic favorable (2.50e-6)"	"unprognostic (1.14e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.79e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.21e-2)"	34.7	10.4	5.4	11.0	3.8	0.1	23.7	1.7	5.9	17.0	8.3	10.0	5.0	5.3	14.2	7.2	12.1	7.4	18.3	34.6	5.5	7.5	23.9	12.6	53.7	24.5	11.4	2.3	6.6	6.5	10.6	8.4	6.2	16.6	11.0	4.7	26.5	7.8	8.3	13.9	7.5	9.1	13.1	37.3	4.1	8.3	6.3	6.4	1.0	24.3	14.5	15.6	18.6	17.9	0.0	0.1	2.7	0.0	0.0	0.7	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.6	0.0	0.0	0.2	0.6	1.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.7	0.3	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	1.7	5.4	3.8	1.7	5.9	5.5	7.5	11.4	2.3	16.6	6.4	0.0	3.4	4.5	0.4	14.4	0.6	7.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	183.2	0.0	0.0	0.6	0.0	5.1	0.4	0.0	5.9	0.4	0.0	0.0	555.5	44.3	4.7	1.1	1.7	25.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	6.2	0.3	0.9	12.7	0.0	1.9	0.0	0.4
ADCY1	"AC1, DFNB44"	ENSG00000164742	"Adenylate cyclase 1"	Q08828	7	45574140-45723116	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, cAMP biosynthesis"	"Calmodulin-binding, Lyase"	"Cancer-related genes, Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.0"	"Group enriched"	"Detected in many"	8	"Cone photoreceptor cells: 490.9;Rod photoreceptor cells: 145.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 15.3;SH-SY5Y: 17.6;SK-MEL-30: 20.3;WM-115: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018364, HPA068274"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"CAB018364: AB_2223098, HPA068274: "	"unprognostic (9.41e-3)"	"unprognostic (7.30e-4)"	"unprognostic (9.31e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.74e-6)"	"unprognostic (2.49e-1)"	"unprognostic (7.65e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.23e-1)"	2.8	2.8	11.5	0.7	11.7	0.4	6.8	22.7	29.0	7.8	0.9	2.0	0.0	0.7	2.7	1.1	1.2	2.4	1.2	4.0	11.6	4.0	1.8	9.6	1.0	0.8	5.8	13.4	1.2	3.6	1.0	1.5	0.9	6.2	4.1	1.0	5.0	0.8	2.1	9.2	0.6	0.7	1.6	2.2	1.0	1.8	3.9	1.2	0.0	3.0	0.2	0.8	1.0	1.5	0.5	0.4	0.6	0.1	0.0	0.2	0.0	0.5	3.9	1.5	2.2	2.9	0.0	2.7	0.1	0.0	0.5	0.2	0.4	0.0	0.0	0.2	0.1	4.0	1.2	2.5	0.2	0.0	7.0	1.8	0.0	0.0	0.3	0.0	0.1	0.0	3.4	1.9	0.3	15.3	0.0	0.1	5.8	0.2	4.7	0.2	4.6	0.0	0.0	5.7	3.3	0.0	0.0	0.0	7.6	0.0	3.8	9.2	17.6	1.4	0.0	20.3	2.2	1.3	2.3	0.0	0.4	2.9	0.3	2.3	0.0	0.0	0.0	0.0	0.0	11.6	0.4	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.2	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	11.5	11.7	22.7	29.0	11.6	4.0	5.8	13.4	6.2	1.2	0.0	0.0	0.0	0.4	0.2	35.8	9.0	0.0	0.0	0.0	0.0	490.9	0.1	1.7	0.0	2.3	1.0	0.0	0.0	0.8	0.1	1.9	2.6	0.0	34.7	0.3	39.7	30.0	18.4	3.2	0.4	1.7	0.0	3.3	0.0	0.2	11.9	0.9	0.0	7.1	0.2	145.7	0.0	5.0	0.7	6.8	0.1	0.0	0.0	0.5	0.3
AC096582.3		ENSG00000283247			7	45859994-45873082	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	4	"breast: 2.8;epididymis: 1.2;placenta: 3.3"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 2.2"															NA	NA																							0.1	0.0	0.1	0.1	0.1	0.0	2.8	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	0.1	0.1	0.1	0.1		0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	3.3	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.3	0.3	0.1	0.3	0.6	0.0	0.1	0.1	0.1	0.7	0.8	0.1	0.8	0.4	0.4	0.5	0.0	0.3	0.4	0.4	0.4	0.1	0.3	0.5	0.0	0.1	0.5	0.1	0.1	0.3	1.2	0.6	0.0	0.3	0.2	0.0	0.5	0.2	0.5	0.2	0.0	0.2	0.4	0.3	0.4	0.1	0.8	1.0	0.4	0.2	1.0	0.4	0.2	0.7	0.6	0.0	2.2	0.4	0.2	0.5	0.1	0.7	0.1	0.2	0.3	0.1	1.4	1.3	0.2	0.7	1.3	0.2	1.2	0.2	0.3	0.0	0.1	0.2	0.3	0.0	0.3	0.5	0.3	0.6	0.0	0.4	0.3	0.4	0.3	0.3	0.0	0.3	0.2	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGFBP1	"AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12"	ENSG00000146678	"Insulin like growth factor binding protein 1"	P08833	7	45888357-45893668	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"liver: 157.6;placenta: 292.3"	"Cell type enriched"	"Detected in some"	23	"Hepatocytes: 863.0"	"Cancer enriched"	"Detected in many"	29	"liver cancer: 385.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"Hep G2: 18.0;U-2197: 29.5;U-87 MG: 51.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004445, HPA046972, HPA050640"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	28100000	22000000	"Golgi apparatus"		"CAB004445: AB_627782, HPA046972: AB_2679884, HPA050640: AB_2681197"	"unprognostic (8.66e-3)"	"unprognostic (1.45e-1)"	"unprognostic (9.41e-2)"	"unprognostic (7.80e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.09e-3)"	"unprognostic (8.95e-2)"		"prognostic unfavorable (6.90e-11)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (7.20e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.43e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	10.7	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.2	157.6	0.1	0.0	0.1	0.0	9.3	0.0	0.0	0.2	292.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.5	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	18.0	0.1	0.3	0.0	0.0	0.2	3.9	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	29.5	0.0	0.0	0.0	0.0	51.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.8	38.2	0.0	1.2	0.0	0.0	0.7	0.0	6.7	0.1	0.0	0.0	23.3	0.0	2.0	1.0	0.0	0.0	863.0	1.6	0.0	3.4	9.2	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.9	0.0	0.0	0.0
IGFBP3	"BP-53, IBP3"	ENSG00000146674	"Insulin like growth factor binding protein 3"	P17936	7	45912245-45921874	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 320.7"	"Cell type enhanced"	"Detected in many"	19	"Basal keratinocytes: 406.6;Extravillous trophoblasts: 1874.7;Urothelial cells: 581.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 28.9"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 28.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 422.0;U-2197: 175.0;U-87 MG: 90.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB010360			Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA	3250000000	5600000000	Vesicles	"Nucleoplasm, Cytosol"	"CAB010360: AB_2233528"	"unprognostic (4.46e-3)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (8.14e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (5.07e-7)"	"unprognostic (2.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.63e-1)"	47.4	1.6	4.4	10.6	2.7	0.0	52.1	2.7	4.1	44.3	21.3	1.7	3.2	6.9	58.4	8.1	11.7	14.9	5.4	41.6	4.4	2.6	11.1	80.4	11.7	12.7	3.7	1.9	49.2	2.2	0.6	19.2	320.7	4.1	22.5	6.1	9.1	6.4	9.3	13.9	23.9	10.2	22.9	3.8	18.7	8.3	12.1	3.1	2.2	5.6	8.6	8.3	32.0	26.3	0.0	28.9	0.0	0.0	0.0	6.0	1.7	9.6	2.9	5.7	0.0	4.3	1.8	0.0	42.1	7.6	3.6	1.9	0.0	7.8	0.0	13.4	422.0	1.8	23.2	0.0	0.1	1.5	0.0	0.0	0.0	1.0	0.0	1.1	0.0	0.0	14.8	0.6	0.7	2.7	5.7	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	3.9	2.6	20.8	0.6	1.6	14.6	0.5	0.7	13.3	0.0	0.0	0.0	41.7	0.0	175.0	2.3	0.6	0.0	0.0	90.6	0.0	14.0	0.0	0.0	0.0	5.2	0.0	4.3	0.0	6.0	5.6	0.0	0.0	2.8	4.7	0.0	0.0	0.0	28.9	0.3	1.7	4.4	2.7	2.7	4.1	4.4	2.6	3.7	1.9	4.1	3.1	3.0	4.6	0.0	95.2	406.6	0.6	9.7	7.6	33.5	117.2	216.3	0.0	45.9	10.0	71.8	0.8	62.6	0.4	0.0	1.7	1874.7	137.7	80.4	1.1	1.7	72.5	0.0	263.4	181.7	8.2	1.9	266.9	3.0	15.1	12.6	1.6	0.4	19.7	2.9	6.3	0.7	0.6	0.0	28.8	0.4	0.4	213.8	129.0	8.2	0.6	581.2
TNS3	"FLJ13732, H_NH0549I23.2, TEM6, TENS1"	ENSG00000136205	"Tensin 3"	Q68CZ2	7	47275154-47582558	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 66.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 5.8;intermediate monocyte: 4.7;memory B-cell: 3.7;myeloid DC: 4.0;naive B-cell: 2.9;non-classical monocyte: 4.4;plasmacytoid DC: 5.6"	"Group enriched"	"Detected in many"	6	"B-cells: 3.7;dendritic cells: 5.6;monocytes: 5.8"	"Cell line enhanced"	"Detected in many"		"A549: 65.8;LHCN-M2: 42.4"	"Low region specificity"	"Detected in all"							"HPA055338, HPA056015"	Approved		Enhanced	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA055338: AB_2682789, HPA056015: AB_2683010"	"unprognostic (1.46e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.00e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.70e-1)"	"unprognostic (6.60e-2)"	"prognostic favorable (5.21e-4)"	"unprognostic (3.13e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.20e-2)"	"unprognostic (9.09e-3)"	46.9	18.5	16.4	19.3	12.7	2.8	29.8	8.1	11.7	18.2	15.7	11.4	9.1	9.9	27.4	13.9	7.7	12.3	29.6	13.5	12.1	13.2	27.3	24.9	25.1	37.7	16.0	3.6	22.4	35.5	16.4	5.5	44.9	9.6	15.0	9.3	40.3	36.4	11.7	14.9	6.7	20.7	14.7	11.6	42.7	13.9	9.6	7.8	3.8	23.8	9.6	19.9	12.5	19.3	3.7	5.6	0.8	5.8	0.1	0.2	1.8	6.3	65.8	4.0	6.9	9.2	7.5	12.8	5.8	33.4	5.7	8.8	14.7	8.6	3.2	10.4	21.2	21.5	12.2	6.4	9.5	5.2	0.0	0.4	9.0	9.5	7.8	9.5	0.0	0.1	7.4	4.1	3.3	5.2	37.5	4.5	0.0	0.0	20.3	42.4	3.9	0.0	0.2	3.8	9.2	7.9	2.9	9.8	10.7	19.8	13.1	0.4	8.2	11.5	2.3	6.4	21.1	8.8	6.7	17.9	8.9	7.1	0.1	8.9	13.1	16.9	7.6	2.2	6.3	32.2	0.2	5.8	0.0	0.1	4.7	0.2	3.7	0.0	0.0	4.0	2.9	0.0	0.0	0.8	0.1	4.4	5.6	0.0	1.8	16.4	12.7	8.1	11.7	12.1	13.2	16.0	3.6	9.6	7.8	62.5	12.0	3.7	7.3	4.2	1.4	17.3	33.1	16.0	25.0	29.6	0.0	21.4	1.7	14.4	9.5	6.9	28.0	0.0	15.8	47.3	17.5	2.8	0.0	35.1	66.7	0.0	14.5	40.5	35.8	11.8	5.8	13.7	15.1	11.8	15.6	34.2	21.0	8.6	14.5	11.5	1.4	25.8	8.2	1.7	3.4	2.9	25.1	1.9	15.3	2.1
HUS1		ENSG00000136273	"HUS1 checkpoint clamp component"	O60921	7	47695730-47979581	"Predicted intracellular proteins"	"DNA damage"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026787	Approved					NA	NA					"HPA026787: AB_10601431"	"unprognostic (1.87e-1)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (2.65e-1)"	"unprognostic (1.73e-3)"	"unprognostic (6.93e-3)"	"unprognostic (8.83e-3)"	"prognostic unfavorable (9.54e-5)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.89e-2)"	13.8	18.4	13.3	14.7	16.2	15.4	17.6	16.3	14.8	12.1	13.8	13.9	15.2	12.7	13.0	13.4	18.5	8.8	9.0	13.6	11.5	11.9	15.3	23.8	14.1	14.4	11.8	12.0	13.3	19.5	18.4	16.5	15.8	13.2	12.1	19.2	14.2	13.7	13.1	21.1	9.7	11.7	15.7	12.9	12.1	9.7	10.9	9.9	18.9	13.8	11.0	15.9	14.1	13.9	8.8	14.0	12.0	14.1	13.6	13.4	8.9	5.2	8.8	6.2	10.2	5.6	5.9	4.7	10.9	4.1	5.6	5.5	5.5	5.8	5.0	5.7	7.5	30.0	6.9	6.0	7.9	15.1	5.5	3.9	2.7	10.0	5.5	5.1	5.0	6.4	2.9	10.5	6.8	3.5	5.0	9.4	4.1	5.4	6.0	15.2	6.1	6.8	14.0	6.4	8.8	8.6	4.4	4.5	8.2	8.4	13.9	8.4	10.4	7.0	11.2	5.7	12.9	8.7	12.2	4.2	12.0	9.0	18.2	12.9	4.8	10.3	9.7	9.8	8.9	20.5	12.0	14.1	8.0	12.6	12.6	13.1	8.7	12.1	13.4	12.4	8.8	11.8	13.2	3.3	13.6	8.7	14.0	13.0	8.9	13.3	16.2	16.3	14.8	11.5	11.9	11.8	12.0	13.2	9.9	3.0	3.8	25.1	14.4	8.7	11.8	14.6	0.0	6.7	11.4	10.4	9.8	15.8	18.3	15.6	21.2	15.0	14.6	0.0	12.8	25.6	10.8	9.3	23.1	14.3	21.4	12.7	6.4	11.6	19.5	36.6	8.6	20.9	16.9	21.6	10.7	7.3	15.0	28.1	11.0	11.9	14.6	0.0	7.9	12.6	5.5	6.4	26.7	16.0	8.6	13.6
PKD1L1	PRO19563	ENSG00000158683	"Polycystin 1 like 1, transient receptor potential channel interacting"	Q8TDX9	7	47774652-47948491	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	Heterotaxy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lung: 13.4;tongue: 16.7"	"Cell type enhanced"	"Detected in some"	21	"Bipolar cells: 3.1;Early spermatids: 11.4;Ito cells: 2.5;Late spermatids: 2.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"T-47d: 6.5;U-266/70: 17.1;U-266/84: 6.1"	"Not detected"	"Not detected"							"HPA020422, HPA022424"	Uncertain					NA	NA					"HPA020422: AB_1855434, HPA022424: AB_1855435"	"unprognostic (5.47e-2)"	"unprognostic (5.33e-3)"	"unprognostic (1.49e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.63e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.88e-4)"	"unprognostic (1.88e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.90e-1)"	5.4	0.2	1.0	2.3	1.8	0.2	1.6	1.3	1.1	1.2	0.8	0.7	0.1	2.0	2.5	1.6	0.9	0.6	1.0	7.4	0.8	1.5	0.5	1.1	13.4	1.2	0.9	0.1	0.6	0.3	0.1	1.2	2.0	1.0	0.3	0.9	10.0	2.6	0.1	6.4	0.7	0.7	1.7	1.0	0.8	0.4	3.8	0.1	0.9	1.2	16.7	1.4	2.2	1.4	0.0	0.2	0.0	0.8	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.4	0.2	0.0	0.1	0.3	0.1	6.5	0.0	0.0	0.0	0.9	0.0	0.0	17.1	6.1	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	1.8	1.3	1.1	0.8	1.5	0.9	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.1	3.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	1.0	1.6	0.0	2.5	0.0	2.5	0.3	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0
SUN3	"MGC33329, SUNC1"	ENSG00000164744	"Sad1 and UNC84 domain containing 3"	Q8TAQ9	7	47987148-48029119	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"testis: 30.9"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 435.2"	"Cancer enhanced"	"Detected in single"		"testis cancer: 2.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"GAMG: 7.2;U-2 OS: 21.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA008344, HPA076890"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA008344: AB_1857656, HPA076890: "	"unprognostic (5.11e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-4)"	"unprognostic (2.31e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.59e-5)"	"unprognostic (4.88e-1)"	"unprognostic (1.47e-1)"		"unprognostic (2.65e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.58e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	1.5	0.1	0.7	1.2	0.3	0.2	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	3.2	0.1	0.0	0.0	7.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.3	0.0	1.3	21.5	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.4	1.2	0.1	0.1	0.7	0.4	0.4	0.0	0.8	0.5	0.2	1.5	0.7	0.1	0.2	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	435.2	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	54.9	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.2	0.0	6.5	0.1	6.7	7.4	0.0	0.7	0.0	0.0	0.0
C7orf57		ENSG00000164746	"Chromosome 7 open reading frame 57"	Q8NEG2	7	48035511-48061304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.0;fallopian tube: 20.9;testis: 11.4"	"Cell type enriched"	"Detected in some"	6	"Ciliated cells: 143.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 20.0"	"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.3"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"GAMG: 6.2;hTERT-HME1: 9.8;U-266/70: 5.8;U-698: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021286	Enhanced					NA	NA					"HPA021286: AB_1845760"	"unprognostic (1.74e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.77e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.93e-5)"	"unprognostic (5.17e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.20e-1)"	0.2	0.2	2.3	0.2	5.0	0.5	0.3	0.1	1.0	0.8	0.2	3.5	0.0	0.3	0.9	7.1	1.4	20.9	0.2	0.3	3.7	4.0	0.3	0.2	4.3	0.3	0.1	0.4	1.6	0.1	0.7	0.4	0.2	20.0	0.2	0.2	0.0	0.2	0.2	0.2	0.3	0.2	0.2	0.7	0.2	0.2	11.4	2.1	0.0	0.5	1.8	0.4	0.2	0.5	0.0	0.1	0.0	0.0	0.6	2.3	0.1	0.7	0.2	0.1	0.1	0.0	0.0	0.2	0.1	0.5	0.3	0.4	0.0	2.4	0.0	0.2	0.1	6.2	0.3	0.0	1.0	0.7	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.8	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.1	0.1	0.9	0.1	0.1	0.0	0.3	0.8	0.0	0.0	0.1	0.6	0.9	0.4	0.6	5.8	0.8	3.3	1.4	0.0	0.9	0.0	0.0	0.0	0.6	0.0	2.3	0.0	0.6	0.6	0.1	0.0	0.4	0.2	0.0	0.6	0.0	0.0	0.0	0.1	2.3	5.0	0.1	1.0	3.7	4.0	0.1	0.4	20.0	2.1	0.0	4.8	0.0	0.0	0.0	0.0	0.8	0.0	143.2	22.7	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.1	0.2	0.1	2.3	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	9.4	0.4	0.0	0.0	0.0	0.0	0.0
UPP1	"UDRPASE, UP, UPASE, UPP"	ENSG00000183696	"Uridine phosphorylase 1"	Q16831	7	48088628-48108733	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 206.2;Macrophages: 205.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 26.4;hTERT-HME1: 103.9;SK-MEL-30: 24.1;WM-115: 23.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA054040, HPA055394"	Enhanced		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA054040: AB_2682352, HPA055394: AB_2682805"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.21e-3)"	"unprognostic (6.36e-2)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.81e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.39e-1)"	16.7	8.4	2.8	12.6	4.2	17.6	7.1	5.7	3.8	10.3	8.0	1.7	2.1	7.5	2.8	4.2	37.7	3.3	8.5	7.0	2.3	3.3	12.4	9.1	18.3	17.4	5.8	1.4	2.9	5.8	2.4	5.0	28.9	5.5	3.0	7.6	2.9	7.5	2.1	5.1	2.0	9.7	5.2	3.9	13.9	2.5	1.8	4.8	1.2	6.2	34.0	19.4	7.9	19.6	0.6	8.2	15.7	22.0	5.7	19.7	16.0	6.5	7.9	0.8	1.6	2.7	1.2	8.1	3.2	4.5	4.1	5.1	3.3	3.2	0.0	1.2	2.6	26.4	4.6	1.5	13.1	2.7	1.3	1.4	0.2	1.9	1.3	2.4	0.2	0.5	1.6	6.4	1.9	103.9	1.9	2.7	0.2	0.4	3.9	2.2	0.7	0.0	1.1	3.1	1.1	6.9	0.0	1.7	1.7	9.5	3.4	0.7	0.7	3.3	0.9	24.1	8.9	0.8	0.2	3.8	9.7	8.3	2.6	8.2	7.5	10.0	1.1	9.8	1.0	23.6	15.7	22.0	15.1	19.7	16.7	12.5	0.2	12.6	13.5	8.2	0.6	13.0	12.0	9.1	5.7	15.9	0.7	11.2	16.0	2.8	4.2	5.7	3.8	2.3	3.3	5.8	1.4	5.5	4.8	17.9	64.1	14.6	17.3	41.6	27.8	10.4	22.9	8.1	13.6	10.4	31.4	6.0	59.7	36.9	0.6	58.5	53.1	0.0	35.8	206.2	39.5	10.1	24.4	15.1	111.9	15.9	12.5	78.5	137.0	1.5	4.9	205.8	82.7	43.3	11.6	13.5	73.7	52.6	2.1	15.4	28.8	6.5	33.0	0.0	3.0	26.1	65.8	46.7	13.3	29.6
ABCA13	"FLJ33876, FLJ33951"	ENSG00000179869	"ATP binding cassette subfamily A member 13"		7	48171458-48647496	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"bone marrow: 35.4;lung: 15.7;lymphoid tissue: 14.4"	"Cell type enriched"	"Detected in some"	7	"Ciliated cells: 64.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"basophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 8.7;LHCN-M2: 3.7;U-2 OS: 10.4;U-266/84: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063601			Approved	Vesicles,Centrosome,Cytosol		NA	NA			Vesicles	"Centrosome, Cytosol"	"HPA063601: AB_2685057"	"unprognostic (8.97e-2)"	"unprognostic (5.82e-2)"	"unprognostic (3.18e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-3)"	"unprognostic (6.03e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.62e-2)"	0.3	0.2	0.1	0.3	1.0	35.4	0.7	0.0	1.1	1.2	0.3	0.4	0.0	0.3	0.3	1.1	10.3	1.8	0.5	3.5	1.8	0.2	1.1	0.7	15.7	0.2	0.1	0.0	0.4	1.2	0.1	8.7	1.2	0.4	0.2	0.4	0.0	1.7	0.4	0.8	1.3	0.3	0.2	0.9	1.3	0.2	4.2	0.0	4.6	7.1	5.4	14.4	0.5	0.3	0.6	0.6	3.2	0.7	1.0	0.4	0.2	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.3	1.0	0.0	0.3	0.0	0.0	0.0	2.2	0.0	1.9	0.6	1.2	2.1	0.0	8.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	1.0	0.8	0.0	0.3	0.0	0.1	3.7	0.0	0.0	0.1	0.1	0.0	2.1	0.3	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.7	0.0	0.1	0.1	0.1	0.0	0.6	10.4	0.4	1.5	3.1	4.2	0.0	1.3	0.4	0.4	3.2	0.7	0.6	0.3	0.4	0.3	0.4	0.2	0.2	0.1	0.6	0.4	0.4	1.6	1.0	0.3	0.6	0.1	0.2	0.1	1.0	0.0	1.1	1.8	0.2	0.1	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.0	0.0	64.3	9.1	1.8	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.2	0.0	0.0	0.0	0.3	0.1
VWC2	"PSST739, UNQ739"	ENSG00000188730	"Von Willebrand factor C domain containing 2"	Q2TAL6	7	49773661-49921950	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 17.0;heart muscle: 12.8;ovary: 12.5"	"Cell type enhanced"	"Detected in some"	23	"Bipolar cells: 26.4;Cardiomyocytes: 44.9;Paneth cells: 9.7;Rod photoreceptor cells: 12.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.4;U-266/70: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055243	Approved				"Secreted to extracellular matrix"	NA	NA					"HPA055243: AB_2682755"	"unprognostic (3.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.90e-4)"	"unprognostic (8.97e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.56e-3)"		"unprognostic (3.41e-2)"		"unprognostic (4.11e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.69e-4)"	"unprognostic (1.60e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.70e-3)"	0.5	0.3	3.6	0.4	3.9	0.4	0.5	17.0	6.9	0.6	0.5	1.4	0.0	0.5	1.9	0.4	0.5	0.8	0.5	12.8	1.7	2.8	0.4	0.3	0.6	0.4	2.1	1.8	12.5	0.3	0.3	0.2	0.3	3.8	0.4	0.5	0.6	0.4	0.5	0.4	1.2	0.7	1.5	0.8	0.6	0.4	0.5	0.8	0.0	0.4	0.0	0.3	0.4	0.2	0.1	0.0	0.9	0.4	1.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.4	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.2	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.9	1.0	0.2	0.0	0.0	0.0	3.6	3.9	17.0	6.9	1.7	2.8	2.1	1.8	3.8	0.8	0.0	0.0	0.0	0.0	0.5	26.4	44.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	9.7	0.0	0.0	12.3	0.0	0.3	0.0	0.4	1.8	0.0	0.0	0.2	0.1
ZPBP	"SP38, ZPBP1"	ENSG00000042813	"Zona pellucida binding protein"	Q9BS86	7	49850421-50121329	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	95	"testis: 90.4"	"Group enriched"	"Detected in some"	16	"Early spermatids: 705.4;Spermatocytes: 420.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 1.4;NTERA-2: 1.2;SCLC-21H: 1.7;U-698: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058673	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA058673: AB_2683794"	"unprognostic (1.16e-1)"							"unprognostic (6.46e-2)"		"unprognostic (7.80e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.15e-7)"		"unprognostic (9.49e-2)"	"unprognostic (2.34e-4)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.4	0.1	0.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	9.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	705.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	35.4	10.3	0.0	0.0	0.0	0.0	2.0	0.2	0.0	7.4	0.3	19.4	6.5	0.0	420.4	8.1	0.3	0.0	0.0	0.0	0.1
SPATA48	C7orf72	ENSG00000164500	"Spermatogenesis associated 48"	A4D263	7	50096036-50159830	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 13.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.0"	"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.1"	"Cell line enriched"	"Detected in some"	12	"U-698: 15.3"					"Low region specificity"	"Detected in some"			HPA026094	Uncertain					NA	NA					"HPA026094: AB_1859516"																		0.0	0.0	0.4	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IKZF1	"hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1"	ENSG00000185811	"IKAROS family zinc finger 1"	Q13422	7	50304068-50405101	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.7;bone marrow: 55.2;lymphoid tissue: 86.7"	"Cell type enhanced"	"Detected in many"	11	"B-cells: 46.7;Kupffer cells: 47.2;Macrophages: 43.8;monocytes: 70.3;T-cells: 103.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 26.9;HDLM-2: 45.8;HMC-1: 42.9;JURKAT: 26.3;MOLT-4: 33.5;REH: 36.3;U-698: 68.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009247, HPA035221, HPA035222"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB009247: AB_2124699, HPA035221: AB_2674524, HPA035222: AB_2674525"	"prognostic favorable (4.28e-4)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.49e-3)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-1)"	"prognostic favorable (8.63e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.67e-2)"	3.5	1.5	2.9	25.5	3.8	55.2	2.3	0.7	1.8	1.6	3.6	2.8	0.8	2.4	1.6	2.1	2.2	2.4	2.9	1.6	3.4	1.8	2.5	2.3	8.3	44.4	5.9	1.1	1.1	1.3	0.2	1.2	1.2	3.4	2.2	2.5	1.5	5.2	0.7	0.9	1.9	14.5	1.4	5.1	31.0	3.7	1.1	4.1	86.7	2.4	1.2	26.3	4.5	2.9	24.0	12.6	12.8	23.6	12.8	28.7	12.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.8	0.0	9.2	0.0	0.0	0.0	16.3	42.9	0.0	0.0	0.0	0.0	0.0	0.0	26.3	11.9	3.2	0.0	0.0	33.5	16.2	0.4	0.0	0.0	36.3	0.0	7.6	0.0	0.0	0.3	0.3	0.1	0.2	0.1	0.0	0.0	22.5	0.0	0.0	0.3	0.0	0.0	14.6	7.5	68.8	0.1	17.7	0.1	10.2	7.7	12.8	20.4	23.6	17.0	24.0	21.2	19.9	8.2	21.3	28.7	20.7	11.2	12.8	22.3	12.6	17.1	12.7	2.9	3.8	0.7	1.8	3.4	1.8	5.9	1.1	3.4	4.1	3.0	16.4	46.7	0.1	2.5	0.0	1.1	5.1	2.7	3.4	1.8	0.0	0.3	0.0	0.1	3.0	2.9	0.0	23.3	0.0	0.2	3.4	0.1	22.0	1.0	27.1	0.0	0.0	4.3	47.2	4.5	0.0	43.8	18.6	70.3	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	2.1	0.0	0.7	2.4	0.6	103.3	0.0	0.1
FIGNL1		ENSG00000132436	"Fidgetin like 1"	Q6PIW4	7	50444128-50542535	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA055542	Approved					NA	NA					"HPA055542: AB_2682841"	"unprognostic (4.62e-2)"	"unprognostic (8.76e-2)"	"unprognostic (3.99e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.73e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (3.62e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.79e-2)"	"prognostic unfavorable (9.54e-7)"	"unprognostic (1.86e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.68e-2)"	6.4	6.9	7.7	10.0	12.6	9.6	11.2	17.5	13.1	10.9	7.8	9.4	4.5	8.7	11.5	6.5	15.4	6.9	5.8	5.0	9.9	7.7	5.7	6.5	5.1	12.0	10.7	12.6	15.3	5.5	3.3	8.3	8.4	10.7	8.0	8.5	5.6	7.1	6.1	7.6	10.9	8.3	13.1	9.8	9.8	5.3	8.9	12.8	19.2	5.8	6.0	16.3	6.4	9.0	6.2	1.9	1.3	8.1	5.2	6.0	2.2	5.2	10.7	14.0	15.2	3.2	5.8	9.0	18.3	9.3	19.6	21.9	16.7	12.0	20.1	9.8	5.4	16.4	18.2	14.8	9.1	31.4	17.0	11.1	8.9	21.5	5.7	1.9	21.1	14.2	2.6	4.6	12.9	6.7	3.1	20.4	9.2	20.6	12.7	14.8	7.7	12.8	15.7	12.8	19.9	12.8	12.1	12.1	7.3	6.1	13.6	16.0	12.5	6.7	15.0	6.9	6.9	14.6	7.1	7.9	0.0	8.2	23.7	14.9	21.5	22.1	15.5	6.3	19.5	30.8	0.0	1.7	1.3	2.8	3.1	5.1	5.4	3.4	5.4	1.9	6.2	5.0	4.6	1.0	5.2	8.1	1.8	6.0	2.2	7.7	12.6	17.5	13.1	9.9	7.7	10.7	12.6	10.7	12.8	0.0	0.3	4.5	1.9	3.7	11.2	12.1	0.0	0.0	2.3	1.8	5.9	4.1	3.3	2.7	0.9	3.7	0.9	46.7	1.0	7.9	3.4	0.9	2.3	1.8	3.8	9.5	0.0	4.9	3.1	1.1	10.6	2.5	3.3	4.6	0.3	6.1	2.0	1.7	8.9	1.8	14.5	0.0	3.9	14.7	19.8	2.6	1.1	4.3	4.1	0.3
DDC	AADC	ENSG00000132437	"Dopa decarboxylase"	P20711	7	50458436-50565457	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 90.1;kidney: 68.1"	"Group enriched"	"Detected in many"	5	"Intestinal endocrine cells: 394.4;Proximal tubular cells: 366.2;Rod photoreceptor cells: 456.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"midbrain: 7.9;pons and medulla: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"CACO-2: 17.2;Hep G2: 15.1;OE19: 26.4;SCLC-21H: 43.6;SH-SY5Y: 45.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"midbrain: 90.4;pons and medulla: 40.7"	HPA017742	Enhanced		Approved	"Actin filaments"		NA	NA		380000	"Actin filaments"		"HPA017742: AB_1847832"	"unprognostic (1.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.49e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.36e-3)"	"unprognostic (5.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.16e-1)"	0.3	10.9	0.3	3.0	0.7	0.0	0.3	0.3	0.4	0.3	36.7	0.4	0.3	33.5	0.3	1.8	0.3	0.0	0.7	0.3	0.3	1.3	68.1	11.7	0.7	0.3	7.9	0.3	0.4	9.8	0.0	0.3	0.3	3.4	0.4	8.1	0.4	0.3	0.3	0.3	0.1	90.1	0.3	0.3	0.3	4.3	0.6	0.5	0.3	0.3	0.4	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	26.4	0.0	0.0	0.0	0.2	0.4	0.0	43.6	45.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.7	0.3	0.4	0.3	1.3	7.9	0.3	3.4	0.5	0.0	9.8	0.8	0.0	0.0	81.1	0.4	5.1	0.0	1.2	3.5	39.3	0.0	21.6	0.0	3.6	0.0	72.8	0.0	0.7	0.1	0.0	0.4	0.0	58.7	0.1	3.2	394.4	1.3	1.3	4.3	0.0	0.0	0.0	0.0	30.4	24.1	0.2	26.6	0.0	366.2	456.4	0.0	0.0	3.6	0.4	0.0	0.1	0.0	46.0	0.0
GRB10		ENSG00000106070	"Growth factor receptor bound protein 10"	Q13322	7	50590063-50793462	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 65.8"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 82.5;Early spermatids: 134.4;Late spermatids: 152.5;Rod photoreceptor cells: 83.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"basophil: 11.4;eosinophil: 3.5"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 11.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019423, HPA027502, HPA031818"	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"CAB019423: AB_2112883, HPA027502: AB_10602325, HPA031818: AB_2674057"	"unprognostic (2.82e-2)"	"unprognostic (1.69e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.31e-3)"	"unprognostic (4.44e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.73e-3)"	"unprognostic (8.16e-3)"	"unprognostic (2.63e-2)"	"unprognostic (8.50e-2)"	14.3	14.6	14.7	4.9	26.7	6.5	18.8	22.0	20.9	9.7	10.5	14.6	2.0	12.3	8.9	8.0	7.3	9.0	15.6	19.1	13.8	14.8	19.8	15.6	8.3	4.3	19.8	10.7	6.5	65.8	6.0	21.5	10.6	20.9	10.6	5.1	16.5	7.0	11.7	35.7	3.7	8.4	13.0	9.9	15.9	7.2	11.4	16.9	0.4	18.3	4.2	3.2	12.7	17.3	0.0	0.1	11.4	0.2	0.0	0.4	0.1	0.1	10.6	17.6	7.1	8.2	6.3	9.3	4.3	3.7	8.4	10.1	6.4	0.1	0.2	7.7	5.4	24.3	1.0	18.1	4.6	4.1	0.1	7.3	18.4	10.9	4.6	17.5	11.5	28.6	16.5	7.2	12.9	12.8	8.3	21.4	1.3	34.8	0.2	6.3	1.2	2.0	15.5	19.1	8.9	18.6	5.4	0.0	0.1	5.6	4.2	7.7	0.0	0.5	2.7	22.9	11.9	9.3	23.4	26.1	7.4	10.2	15.2	16.4	0.7	0.2	0.1	23.6	10.5	25.1	11.4	0.1	3.5	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.1	0.0	0.1	14.7	26.7	22.0	20.9	13.8	14.8	19.8	10.7	20.9	16.9	6.0	8.8	0.9	5.6	6.6	11.0	12.2	58.6	1.4	3.4	5.2	82.5	3.7	1.7	16.5	134.4	28.6	8.6	23.3	21.0	11.9	11.5	17.1	0.0	22.5	1.4	4.8	0.0	52.2	11.4	152.5	1.7	2.3	6.8	1.0	2.2	18.0	30.3	2.9	0.4	14.7	83.0	0.0	12.7	1.4	19.2	3.8	2.2	0.9	3.3	5.6
COBL	KIAA0633	ENSG00000106078	"Cordon-bleu WH2 repeat protein"	O75128	7	51016212-51316818	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 68.7"	"Cell type enhanced"	"Detected in many"	7	"Muller glia cells: 114.1;Rod photoreceptor cells: 71.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	46	"plasmacytoid DC: 4.6"	"Lineage enriched"	"Detected in single"	46	"dendritic cells: 4.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 15.1;HeLa: 27.0;OE19: 23.9;RPMI-8226: 20.7;SuSa: 16.0;U-266/84: 15.3"	"Low region specificity"	"Detected in many"							"HPA019033, HPA019167"	Enhanced		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"HPA019033: AB_2083648, HPA019167: AB_1847070"	"unprognostic (8.09e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-3)"	"unprognostic (3.13e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.92e-2)"	"prognostic favorable (5.21e-12)"	"unprognostic (7.64e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.41e-3)"	1.8	1.3	27.5	1.8	26.1	0.7	9.5	12.5	23.8	3.9	11.6	27.9	2.2	11.6	2.0	4.4	9.5	12.7	5.8	32.8	27.7	14.5	8.3	12.3	8.8	0.7	23.8	13.8	2.6	11.4	24.7	5.2	3.4	10.8	9.4	7.3	2.8	26.9	3.7	68.7	10.7	20.7	2.2	25.0	0.8	7.4	2.5	16.8	0.0	5.5	12.2	3.1	1.0	2.3	0.0	4.6	0.0	0.0	0.0	0.0	0.0	5.5	4.1	0.0	0.1	0.0	0.0	15.1	0.0	0.0	0.0	0.0	9.9	8.9	0.0	0.4	0.0	0.6	10.4	5.7	0.0	0.0	0.0	4.4	0.0	27.0	2.1	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.0	0.8	2.8	0.1	0.0	3.5	0.0	0.0	4.0	23.9	3.4	0.0	0.2	20.7	8.1	0.0	5.4	0.1	1.9	12.1	1.7	16.0	8.7	0.0	0.0	0.0	4.9	0.1	0.4	0.0	15.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	27.5	26.1	12.5	19.0	27.7	14.5	23.8	13.8	10.8	16.8	35.7	15.8	2.2	2.5	15.9	1.6	66.3	17.8	37.5	19.4	8.7	55.0	16.7	0.0	19.8	2.6	1.4	61.6	0.0	8.3	8.0	1.8	28.8	9.3	24.7	1.8	0.0	17.9	0.6	0.6	2.7	0.6	1.8	15.1	1.8	27.0	114.1	19.3	28.1	0.4	14.7	71.8	0.0	1.0	0.5	5.5	31.1	33.6	1.3	11.7	6.4
POM121L12	DKFZp564N2472	ENSG00000221900	"POM121 transmembrane nucleoporin like 12"	Q8N7R1	7	53035642-53036924	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	175	"testis: 36.1"	"Cell type enriched"	"Detected in single"	7	"Spermatocytes: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA027836	Enhanced					NA	NA					"HPA027836: AB_10669592"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0
VSTM2A	"MGC33530, VSTM2"	ENSG00000170419	"V-set and transmembrane domain containing 2A"	Q8TAG5	7	54542325-54571080	"Plasma proteins, Predicted secreted proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 13.7;brain: 51.7;prostate: 13.7"	"Cell type enriched"	"Detected in some"	5	"Bipolar cells: 38.3"	"Cancer enhanced"	"Detected in some"		"breast cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Karpas-707: 3.4;SCLC-21H: 10.5;SH-SY5Y: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA						"unprognostic (1.15e-1)"		"unprognostic (1.02e-1)"		"unprognostic (1.89e-1)"						"unprognostic (1.14e-2)"	"unprognostic (4.66e-1)"	"prognostic favorable (5.34e-4)"	"unprognostic (4.34e-2)"	"unprognostic (6.79e-2)"		"unprognostic (7.15e-2)"	0.7	13.7	18.4	0.7	22.7	0.7	1.1	0.5	51.7	0.7	6.0	1.4	0.0	2.4	0.7	0.7	0.7	0.7	0.9	0.7	9.4	15.5	0.8	0.7	0.8	0.7	4.4	13.6	0.7	1.8	0.7	0.4	0.7	6.7	13.7	5.8	1.1	0.7	0.7	0.8	0.7	1.1	0.8	3.2	0.7	7.2	1.2	3.0	0.0	0.7	0.0	0.7	0.9	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.5	7.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.4	22.7	0.5	51.7	9.4	15.5	4.4	13.6	6.7	3.0	0.0	0.0	0.0	0.0	0.0	38.3	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
SEC61G	SSS1	ENSG00000132432	"Sec61 translocon gamma subunit"	P60059	7	54752250-54759974	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"glioma: 333.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053196	Uncertain					NA	NA					"HPA053196: AB_2682077"	"unprognostic (1.39e-2)"	"unprognostic (4.51e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.82e-2)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (4.64e-7)"	"prognostic unfavorable (3.85e-6)"	"unprognostic (2.09e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (6.60e-8)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.95e-3)"	"unprognostic (8.43e-2)"	32.5	38.0	31.5	33.4	27.2	35.3	44.2	21.6	27.1	48.0	45.9	18.7	52.6	28.2	35.0	90.5	41.3	29.3	34.4	49.7	26.4	29.0	48.9	99.1	33.3	33.6	27.5	22.4	33.3	114.9	15.9	65.6	45.8	24.5	33.2	45.1	24.0	70.6	55.9	35.1	25.0	42.2	37.3	25.0	40.9	33.8	33.5	23.4	37.9	54.8	56.0	39.1	48.4	30.9	24.2	108.6	37.1	24.1	18.9	34.4	20.7	50.7	29.2	40.8	42.6	41.5	52.3	25.6	80.0	51.0	43.0	77.1	41.0	32.5	43.5	43.0	61.1	89.8	37.6	34.4	57.3	89.9	39.4	30.4	28.5	58.9	46.5	59.2	50.4	28.9	39.3	49.8	43.6	75.1	57.6	56.2	29.1	42.1	105.4	90.8	25.6	25.8	88.8	56.6	64.0	52.3	19.9	24.7	71.4	52.3	30.5	37.5	47.5	33.8	75.9	34.7	73.2	38.8	51.5	46.3	36.3	49.9	148.7	60.9	45.0	41.6	81.6	76.0	30.3	70.5	37.1	23.3	19.4	25.7	22.2	34.4	24.2	29.4	27.2	25.5	17.6	21.0	24.8	7.6	18.9	24.1	108.6	26.8	20.7	31.5	27.2	21.6	27.1	26.4	29.0	27.5	22.4	24.5	23.4	92.3	137.4	198.0	222.1	336.5	44.8	213.4	323.6	111.1	86.4	239.0	7.9	237.6	510.6	588.3	29.8	265.2	458.5	163.5	870.7	578.0	399.6	460.8	145.3	669.9	422.5	22.3	294.3	277.5	340.3	28.5	232.4	327.4	472.3	600.5	452.6	85.0	779.0	403.3	209.3	500.1	30.7	109.9	292.0	299.4	247.4	405.5	424.3	249.0	332.7	285.3
EGFR	"ERBB, ERBB1"	ENSG00000146648	"Epidermal growth factor receptor"	P00533	7	55019021-55211628	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Host-virus interaction"	"Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 102.3"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 207.2;Syncytiotrophoblasts: 315.1"	"Cancer enhanced"	"Detected in all"		"glioma: 136.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	12	"A-431: 345.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000035, HPA001200, HPA018530, CAB068186, CAB073534"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA	4740000	93000000	"Plasma membrane, Cell Junctions"		"CAB000035: , CAB068186: AB_2665679, CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044"	"unprognostic (2.62e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.62e-2)"	"prognostic unfavorable (2.04e-5)"	16.2	8.4	4.9	7.5	6.8	0.1	39.8	5.1	8.5	13.8	7.8	3.3	10.7	3.6	8.2	11.7	15.6	8.8	8.5	4.8	6.8	2.7	7.6	23.5	14.2	2.3	4.1	3.9	10.4	10.1	1.8	2.1	102.3	5.6	10.9	6.7	9.2	15.4	12.9	10.7	32.5	6.3	15.5	3.5	3.3	7.8	5.5	5.9	3.2	12.8	15.5	8.0	10.2	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	345.9	4.4	1.1	1.5	7.1	4.4	1.2	3.4	4.6	2.1	1.6	0.8	3.7	0.2	0.8	2.9	9.0	13.9	0.0	15.3	2.5	0.1	0.2	0.0	1.9	0.2	1.8	0.0	0.0	2.1	14.0	5.3	28.6	3.1	0.2	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.3	1.3	2.2	0.0	0.6	0.0	2.6	3.7	0.0	1.3	2.9	3.5	0.7	1.2	0.3	0.8	1.0	1.9	0.5	14.9	3.2	0.0	0.3	0.2	2.6	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	6.8	5.1	6.6	6.8	2.7	4.1	3.9	5.6	5.9	89.3	37.5	4.2	67.7	76.2	1.5	7.3	53.5	16.0	59.1	21.0	5.9	207.2	0.0	30.6	4.6	10.9	15.9	23.3	21.0	36.6	45.3	37.8	0.0	77.4	24.2	0.0	4.1	6.7	7.0	2.2	118.8	1.3	16.9	2.8	25.3	106.1	41.7	17.3	125.5	14.0	2.3	77.6	23.1	1.6	2.7	78.5	315.1	0.0	20.0	46.4
LANCL2	"GPR69B, TASP"	ENSG00000132434	"LanC like 2"	Q9NS86	7	55365448-55433742	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 38.4;Late spermatids: 42.1"	"Cancer enhanced"	"Detected in all"		"glioma: 52.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	7	"A-431: 58.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019711, HPA029535"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA019711: AB_1852699, HPA029535: AB_10602342"	"unprognostic (1.11e-1)"	"unprognostic (6.89e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.89e-4)"	"unprognostic (1.35e-3)"	"unprognostic (5.58e-2)"	"prognostic favorable (1.03e-6)"	"unprognostic (4.58e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.45e-1)"	3.1	4.9	20.4	2.3	17.0	3.1	5.9	9.9	28.5	6.1	4.6	19.8	1.8	5.0	9.6	5.3	3.5	5.6	3.8	3.9	17.2	11.3	6.0	4.8	3.0	4.0	12.9	21.1	9.6	3.4	10.4	4.2	3.9	10.1	5.9	4.7	2.4	3.3	6.9	5.7	5.3	4.2	7.0	10.8	2.8	3.5	5.7	13.1	3.3	6.6	0.3	2.7	2.8	2.7	2.7	4.7	0.7	4.5	3.6	6.0	2.6	58.4	2.0	4.1	2.7	1.2	2.2	2.3	2.7	3.2	4.1	3.5	2.0	1.7	4.1	2.5	3.8	4.1	2.6	2.2	1.5	2.5	1.8	4.3	1.4	1.6	2.0	2.2	4.5	2.7	3.9	1.6	3.1	1.0	2.1	2.0	1.9	2.5	2.7	3.8	1.7	1.1	2.1	7.9	1.6	2.5	1.7	1.9	2.0	2.7	4.7	7.2	6.8	3.8	5.7	1.5	1.6	2.3	4.8	3.3	2.6	3.5	4.9	5.1	2.6	3.1	4.4	2.0	1.0	4.9	0.4	3.6	0.7	2.6	4.5	4.5	2.7	3.4	3.9	4.7	2.6	3.1	2.7	0.5	3.6	3.0	3.7	6.0	2.6	20.4	17.0	9.9	28.5	17.2	11.3	12.9	21.1	10.1	13.1	3.0	6.2	7.6	5.5	3.5	8.0	7.5	7.6	8.1	4.5	10.4	5.9	10.6	5.0	6.7	38.4	4.8	6.6	23.3	10.4	11.1	9.3	4.3	11.5	7.3	6.6	14.3	12.1	9.2	6.3	42.1	8.3	5.0	0.0	9.0	8.6	10.6	6.7	7.0	7.1	19.5	8.2	0.0	3.1	12.0	10.9	3.3	15.9	4.4	10.3	4.7
VOPP1	"DKFZp564K0822, ECop, FLJ20532, GASP, WBP1L2"	ENSG00000154978	"VOPP1, WBP1/VOPP1 family member"	Q96AW1	7	55436056-55572988	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cone photoreceptor cells: 200.3;monocytes: 192.0;Rod photoreceptor cells: 193.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 79.8;HDLM-2: 69.6;Karpas-707: 89.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.59e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.60e-2)"	"unprognostic (9.13e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.69e-2)"	"prognostic unfavorable (4.35e-5)"	"unprognostic (8.65e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.91e-3)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (6.99e-8)"	"unprognostic (3.32e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.60e-2)"	13.3	7.9	24.0	27.8	19.1	14.3	19.5	15.0	26.2	16.8	17.8	11.6	10.0	15.4	14.7	13.7	9.1	17.7	14.5	12.7	17.1	21.1	15.5	13.4	15.3	38.5	20.5	14.4	13.7	10.2	11.4	27.6	9.0	12.1	10.5	19.2	20.4	16.3	10.0	18.6	6.3	20.8	12.8	24.3	36.4	17.1	7.9	11.6	40.5	10.2	8.3	33.7	19.0	14.1	37.0	13.3	16.0	9.0	13.5	18.7	10.9	79.8	15.5	8.2	7.9	18.3	10.4	3.6	20.3	18.6	17.8	17.8	7.2	20.1	17.8	14.1	18.3	29.3	12.9	8.6	17.1	19.1	69.6	4.9	0.0	9.5	10.0	4.2	6.4	8.0	8.9	9.0	16.0	6.2	12.0	23.4	6.0	4.5	89.9	29.9	5.9	2.5	4.4	18.1	10.1	9.3	4.2	8.4	42.6	19.6	7.7	16.7	6.3	11.7	8.4	4.2	14.6	9.4	7.9	19.9	18.3	27.3	24.2	21.3	43.1	30.3	19.1	7.8	5.9	27.8	7.3	4.6	16.0	12.6	5.4	9.8	37.0	16.0	16.6	12.1	16.2	12.7	13.8	11.8	13.5	9.0	13.3	18.7	10.9	24.0	19.1	15.0	26.2	17.1	21.1	20.5	14.4	12.1	11.6	3.0	12.7	87.0	21.7	11.2	50.8	6.6	35.7	5.3	13.6	47.1	200.3	1.0	8.3	33.8	10.9	31.2	31.5	23.3	28.3	5.1	14.2	24.1	5.8	19.8	35.4	39.7	51.2	40.5	74.3	7.3	17.8	89.3	37.1	192.0	45.8	64.4	43.8	37.4	21.2	9.2	193.8	32.3	12.7	1.5	28.8	7.3	1.0	41.5	32.2	22.0
SEPT14	FLJ44060	ENSG00000154997	"Septin 14"	Q6ZU15	7	55793544-55862789	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"pituitary gland: 6.5;testis: 25.5"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 1.7;Extravillous trophoblasts: 1.1;Late spermatids: 4.5;Spermatogonia: 3.8"	"Cancer enriched"	"Detected in some"	10	"glioma: 6.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 10.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA073255	Enhanced					NA	NA					"HPA073255: AB_2686590"					"unprognostic (1.29e-1)"					"unprognostic (3.50e-1)"				"unprognostic (1.98e-2)"	"unprognostic (1.57e-1)"			0.3	0.2	0.3	0.7	0.3	1.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.4	0.4	0.3	0.2	0.3	0.3	0.3	0.3	0.4	1.4	0.3	0.3	0.3	0.3	0.5	0.3	1.0	6.5	0.4	0.3	0.5	0.2	0.3	0.3	0.3	0.3	0.7	0.3	0.3	0.3	0.5	0.2	25.5	0.3	0.3	0.5	0.3	0.3	0.3	0.3	1.2	0.7	2.5	0.6	2.0	0.6	0.3	1.9	0.6	2.1	4.8	2.1	1.8	10.2	1.4	1.2	1.1	1.5	0.5	1.3	1.6	0.4	0.8	2.3	1.8	2.3	1.6	2.9	2.5	1.2	1.0	3.2	3.6	4.7	2.1	2.4	1.8	2.9	1.4	2.5	2.0	1.1	3.7	3.6	2.2	1.7	1.0	2.8	2.8	1.8	3.2	0.4	1.1	2.0	2.2	1.7	1.5	1.7	2.2	0.6	1.3	1.9	2.4	1.4	2.9	0.9	1.5	1.5	1.4	1.0	2.8	8.8	2.2	1.1	7.3	2.2	2.5	0.6	0.5	0.6	0.4	0.5	0.6	0.5	0.5	0.3	1.2	0.6	0.6	1.8	2.0	0.6	0.7	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	3.8	0.0	0.0	0.0	0.0	0.0
AC092647.5		ENSG00000249773			7	55887277-55955239	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	23	"Ciliated cells: 4.0;granulocytes: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA047159	Uncertain					NA	NA					"HPA047159: AB_2679961"	"unprognostic (1.54e-1)"	"unprognostic (5.85e-2)"	"unprognostic (5.72e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.02e-2)"		"unprognostic (3.98e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.83e-3)"	"unprognostic (3.99e-4)"	"unprognostic (1.87e-1)"	"unprognostic (4.67e-3)"	"unprognostic (7.51e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-2)"	"unprognostic (7.06e-2)"	2.1	1.4	5.5	1.8	7.8	3.6	4.6	4.3	7.5	2.5	1.7	8.6	2.0	1.8	4.6	1.7	1.5	4.2	1.8	2.6	6.2	3.6	3.3	1.8	2.1	0.8	10.9	3.7	2.8	2.9	4.1	6.4	2.2	5.8	2.4	2.1	1.8	1.8	2.9	2.0	1.7	2.4	2.8	6.4	1.4	3.4	8.8	8.6	5.5	2.6	0.0	2.0	1.9	1.8	0.4	1.1	1.2	1.3	0.4	1.1	0.8	7.9	0.3	5.4	5.9	0.6	0.3	1.9	1.2	0.2	0.8	0.3	0.4	3.0	3.5	2.5	0.4	4.1	0.9	2.7	1.8	0.6	2.0	2.8	1.2	2.7	0.8	0.8	2.6	1.4	0.5	1.4	0.5	1.7	1.3	1.2	2.2	2.2	1.1	0.7	0.7	3.2	1.0	4.7	1.6	1.2	2.9	1.3	0.5	3.0	0.5	4.3	5.1	4.8	1.5	0.3	2.6	4.8	1.5	0.9	0.2	7.6	0.5	2.6	1.8	2.0	3.2	1.3	1.4	4.7	1.2	0.2	0.5	0.4	0.2	0.0	0.4	0.4	1.1	1.1	0.1	0.2	0.4	0.0	0.4	1.3	0.3	0.2	0.8	5.5	7.8	4.3	7.5	6.2	3.6	10.9	3.7	5.8	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ZNF713	FLJ39963	ENSG00000178665	"Zinc finger protein 713"	Q8N859	7	55887475-55942225	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 13.4;Early spermatids: 14.3;Late spermatids: 12.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 10.2"					"Low region specificity"	"Detected in all"			"HPA059425, HPA062887"	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA059425: AB_2684013, HPA062887: AB_2684894"	"unprognostic (5.27e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.07e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.77e-3)"	"unprognostic (7.78e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.63e-3)"	2.0	2.7	7.0	2.6	9.7	4.1	4.0	5.6	9.3	3.8	2.2	10.6	2.7	2.7	5.5	3.5	1.7	7.1	2.9	2.4	7.8	6.1	3.9	1.7	2.6	1.7	13.4	4.8	5.6	3.2	4.2	8.1	2.2	7.3	4.1	1.9	2.6	2.4	2.9	4.7	3.1	1.9	3.7	9.8	2.5	4.0	9.4	10.6	6.9	4.9	0.4	1.8	2.1	2.0	2.2	1.7	6.9	1.3	1.4	1.0	0.4	1.8	1.2	7.4	6.7	0.9	1.0	2.6	0.8	0.5	1.0	1.4	0.7	2.4	3.1	2.7	0.6	2.1	0.7	1.8	0.6	1.4	1.7	2.9	0.7	2.5	1.9	1.2	3.7	2.0	1.7	1.5	0.5	1.4	1.7	1.8	3.4	2.0	1.4	1.2	1.6	3.7	2.2	5.0	1.9	1.4	3.1	1.8	0.4	3.6	3.3	8.6	10.2	4.3	1.2	1.2	4.1	2.8	3.3	1.9	0.9	3.6	0.7	1.2	1.6	2.2	1.4	0.6	2.1	6.3	3.7	1.3	3.3	0.9	1.0	0.6	1.3	0.7	0.6	0.4	2.2	0.9	1.0	6.9	1.4	1.0	1.7	0.4	0.4	7.0	9.7	5.6	9.3	7.8	6.1	13.4	4.8	7.3	10.6	0.0	3.0	0.0	2.8	1.1	2.8	1.5	5.1	13.4	4.5	0.0	9.8	1.0	0.0	1.0	14.3	1.4	0.3	0.0	1.2	1.0	1.4	1.6	1.1	0.0	0.4	7.9	0.0	1.3	2.1	12.1	0.6	1.8	0.0	0.0	1.0	5.8	1.3	0.0	2.5	0.5	2.7	6.5	1.4	6.0	6.1	1.6	1.7	1.3	0.9	2.2
NIPSNAP2	GBAS	ENSG00000146729	"Nipsnap homolog 2"	O75323	7	55951793-56000181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 97.3;skeletal muscle: 144.4"	"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 161.9;Distal tubular cells: 192.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 80.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063084	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA063084: AB_2684938"	"unprognostic (6.88e-2)"	"unprognostic (6.53e-3)"	"unprognostic (8.20e-3)"	"unprognostic (4.95e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.02e-8)"	"unprognostic (1.79e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.65e-3)"	"unprognostic (3.59e-1)"	14.5	19.3	18.4	8.4	22.9	8.6	16.6	11.8	24.5	12.6	14.6	8.9	11.8	8.1	11.0	11.1	12.9	13.4	8.0	97.3	18.7	15.9	16.6	5.2	13.2	16.6	17.0	16.7	9.5	13.5	11.8	8.6	8.0	17.2	14.3	14.2	6.8	18.9	15.5	144.4	6.3	8.3	21.6	19.3	6.5	11.6	5.8	12.1	7.4	22.6	39.8	7.2	12.4	7.8	14.3	34.1	14.1	33.1	15.2	14.1	24.7	80.6	14.3	18.9	31.4	10.9	19.1	9.3	6.8	16.1	19.7	15.2	9.9	17.9	11.8	11.4	12.7	19.1	10.8	14.2	14.4	19.6	7.5	20.9	8.4	8.5	12.6	15.7	18.1	8.5	17.3	22.1	6.7	18.3	22.4	20.7	17.2	14.9	11.7	15.2	3.5	18.0	18.8	18.5	18.0	14.5	18.3	8.8	24.3	26.5	12.7	20.2	22.8	15.5	18.7	21.0	15.6	36.2	19.6	12.0	9.0	13.6	3.1	14.0	9.6	8.1	21.9	9.9	11.4	26.5	13.4	33.1	14.1	8.7	31.8	10.6	14.3	11.7	9.3	34.1	12.3	14.1	10.1	5.8	15.2	23.9	14.1	13.6	24.7	18.4	22.9	11.8	24.5	18.7	15.9	17.0	16.7	17.2	12.1	47.6	42.3	0.0	0.0	0.0	0.0	0.0	0.0	161.9	79.6	59.3	0.0	65.3	192.3	62.3	0.0	0.0	0.0	0.0	50.1	44.3	0.0	0.0	15.1	0.0	79.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	69.5	0.0	0.0	39.8	0.0	0.0	65.2	0.0	0.0	0.0	0.0	0.0	0.0	43.0	0.0	0.0	0.0
MRPS17	"HSPC011, MRP-S17, RPMS17"	ENSG00000239789	"Mitochondrial ribosomal protein S17"	Q9Y2R5	7	55951819-55956501	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 64.1"									HPA047159	Approved					NA	NA					"HPA047159: AB_2679961"	"unprognostic (3.38e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.61e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.94e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.20e-3)"	"unprognostic (7.17e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.63e-1)"	10.5	13.3	14.3	9.0	14.8	10.3	13.6	13.6	18.1	8.3	12.3	7.8	9.9	10.8	12.3	11.6	13.0	12.6	9.2	19.2	15.2	13.0	13.8	20.4	7.3	9.9	10.1	18.5	12.1	18.5	5.6	8.5	7.8	11.8	11.0	12.0	5.9	10.6	13.4	36.4	9.0	8.7	18.8	10.8	10.2	11.0	10.2	9.5	8.4	12.0	18.5	10.7	10.4	8.9	13.6	11.1	2.6	8.5	9.4	14.6	6.5	64.1	8.4	5.8	12.5	6.0	5.9	7.6	7.0	6.7	8.4	9.7	10.2	8.8	16.3	10.3	5.5	20.0	14.7	13.1	13.2	10.2	6.8	10.1	4.8	11.6	10.6	8.5	12.1	5.0	6.7	10.7	8.5	14.0	6.2	8.7	9.3	18.7	6.5	7.4	7.1	9.6	16.9	12.8	15.8	14.5	7.8	5.6	12.8	13.5	7.8	8.8	7.6	8.0	26.2	8.9	10.6	17.2	9.5	6.1	2.8	14.2	20.8	15.9	5.7	10.9	27.6	2.9	6.1	12.9	2.6	7.5	2.2	9.5	8.5	11.1	13.6	12.7	13.4	11.1	11.8	14.6	12.8	2.2	9.4	8.4	10.9	12.5	6.5	14.3	14.8	13.6	18.1	15.2	13.0	10.1	18.5	11.8	9.5	20.8	9.4	2.2	11.8	0.0	6.4	0.0	10.2	25.4	26.1	5.2	0.0	26.3	24.9	44.9	15.6	6.7	8.5	0.0	47.0	19.3	6.7	6.6	4.7	31.1	16.8	17.5	4.7	17.8	10.3	2.4	8.6	11.5	0.0	24.4	17.8	7.8	43.0	14.0	10.3	28.8	5.9	6.5	0.0	23.2	10.9	0.0	17.8	11.4	29.2	8.6
PSPH	PSP	ENSG00000146733	"Phosphoserine phosphatase"	P78330	7	56011051-56051604	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 91.2;Early spermatids: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020376, HPA029515"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA020376: AB_1855867, HPA029515: AB_10601492"	"prognostic unfavorable (2.30e-4)"	"unprognostic (7.80e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavorable (2.75e-5)"	"unprognostic (1.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.45e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (3.78e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.90e-3)"	"unprognostic (9.05e-3)"	7.5	13.4	14.1	5.9	16.6	5.1	11.0	10.1	14.6	5.4	8.0	13.2	11.4	6.9	7.0	9.0	11.0	26.3	10.6	12.8	13.2	12.5	14.7	9.8	5.4	7.4	14.8	10.0	13.9	15.9	7.8	17.1	6.4	11.1	10.6	6.9	6.9	6.8	11.5	6.8	6.4	6.2	8.5	15.2	5.7	8.5	9.1	13.3	10.2	12.2	6.9	8.5	7.1	16.0	7.8	11.9	6.8	8.5	5.3	6.2	5.8	46.9	14.4	8.8	32.9	7.4	10.0	6.1	11.9	7.0	6.6	11.8	12.9	8.2	23.2	8.0	11.0	16.7	9.8	19.5	10.1	6.9	17.6	10.9	6.5	3.9	21.7	15.9	6.5	10.0	12.5	19.0	10.5	12.2	9.4	6.5	22.0	15.5	15.0	10.0	6.3	9.9	15.5	14.1	16.8	20.2	13.0	5.3	13.3	6.3	2.4	16.1	18.6	8.6	5.3	23.8	7.5	15.9	13.7	5.5	5.8	9.2	17.9	10.8	10.4	18.0	26.3	8.3	14.3	18.2	2.2	7.7	6.8	4.2	5.3	3.0	7.2	4.0	5.1	11.9	7.8	6.2	5.5	3.6	5.3	8.5	11.3	5.1	5.8	14.1	16.6	10.1	14.6	13.2	12.5	14.8	10.0	11.1	13.3	3.0	1.0	9.7	8.3	6.1	4.4	9.4	17.8	34.8	9.1	5.2	2.0	11.9	91.2	7.9	131.4	3.6	1.3	0.0	6.8	6.3	5.3	5.3	1.1	7.3	7.9	1.6	4.6	6.7	6.5	38.2	7.8	4.8	6.8	4.6	3.9	41.4	7.8	3.5	5.6	39.1	2.8	12.9	5.7	23.6	26.0	7.4	3.9	5.0	7.5	4.7
CCT6A	"CCT6, Cctz, HTR3, TCP20, TCPZ, TTCP20"	ENSG00000146731	"Chaperonin containing TCP1 subunit 6A"	P40227	7	56051630-56063989	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 179.4"									"HPA042996, HPA045576, HPA049949"	Supported		Approved	Cytosol		NA	NA		7400000	Cytosol		"HPA042996: AB_2678261, HPA045576: AB_2679372, HPA049949: AB_2680968"	"prognostic unfavorable (4.04e-4)"	"unprognostic (5.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (8.45e-4)"	"prognostic unfavorable (9.00e-10)"	"unprognostic (1.19e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.24e-2)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.78e-1)"	"unprognostic (9.44e-3)"	32.9	36.5	35.3	35.8	36.1	32.0	62.4	43.7	40.4	26.2	29.1	19.6	28.4	29.8	31.7	23.7	39.5	29.7	22.9	49.3	34.7	39.8	43.2	45.7	22.6	42.0	36.8	26.8	33.4	42.9	48.3	33.7	33.9	34.9	30.2	35.4	16.4	27.3	32.2	72.3	32.6	28.6	35.3	35.8	36.7	32.3	27.0	26.5	41.1	38.2	41.4	44.0	37.1	83.7	24.0	35.3	11.8	34.2	26.6	29.9	25.8	179.4	41.1	24.7	37.3	17.4	21.9	28.5	33.9	19.2	33.4	27.0	46.2	22.6	55.6	26.3	21.8	60.2	38.2	50.6	38.9	46.3	31.2	38.4	34.8	39.9	40.6	18.9	49.8	28.3	18.7	22.4	33.7	33.6	26.5	32.8	25.4	76.0	14.0	37.7	22.2	38.3	43.5	52.3	40.3	54.8	35.3	25.3	32.0	37.6	34.4	33.1	33.2	30.0	51.2	29.9	39.5	37.6	38.4	27.5	23.0	44.1	76.2	69.7	17.2	35.4	68.7	23.0	44.3	76.0	6.9	25.0	11.8	22.4	31.6	29.9	24.0	23.5	24.4	35.3	17.8	24.0	25.4	3.1	26.6	34.2	19.6	24.2	25.8	35.3	36.1	43.7	40.4	34.7	39.8	36.8	26.8	34.9	26.5	83.4	81.3	76.7	149.2	96.7	57.8	100.5	58.6	236.9	216.1	45.4	25.5	172.0	74.6	212.7	12.0	112.8	57.1	0.0	237.7	208.2	81.7	105.7	127.1	61.8	133.8	36.5	97.8	66.9	79.5	15.6	65.3	122.3	55.6	225.4	84.4	73.1	209.1	73.7	85.2	112.3	50.9	58.2	92.9	81.2	184.0	95.9	167.2	86.7	111.5	124.2
SUMF2	DKFZp566I1024	ENSG00000129103	"Sulfatase modifying factor 2"	Q8NBJ7	7	56064002-56080670	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024040, CAB025743, HPA074892"	Enhanced		Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	Yes	No		730000	"Vesicles, Plasma membrane"		"CAB025743: , HPA024040: AB_1857651, HPA074892: "	"unprognostic (2.93e-1)"	"prognostic unfavorable (6.58e-6)"	"unprognostic (2.42e-2)"	"prognostic favorable (3.96e-4)"	"unprognostic (3.87e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (7.71e-4)"	26.8	38.3	13.0	17.7	17.0	15.4	26.2	10.9	28.2	35.0	31.9	24.8	35.4	31.1	32.2	32.3	23.8	37.8	51.2	16.8	12.8	11.6	36.0	40.4	30.2	25.9	19.8	18.0	28.6	91.0	34.7	18.3	37.5	20.7	29.5	25.0	25.0	39.7	37.1	14.0	23.6	35.1	27.2	19.6	27.0	32.9	16.2	17.6	29.8	33.3	15.1	25.1	29.1	23.1	21.0	43.1	17.1	28.5	15.7	33.4	28.5	64.4	19.5	8.5	39.3	42.0	29.1	13.2	21.1	29.6	17.8	22.2	10.6	52.4	10.1	18.3	30.2	17.3	32.8	5.1	24.4	11.9	16.5	8.2	6.5	12.8	9.9	27.2	15.9	20.8	23.0	24.0	16.0	27.9	36.2	26.2	18.7	20.6	45.4	28.6	14.2	13.5	18.7	11.6	50.2	9.9	10.9	8.7	65.0	24.3	7.1	10.0	12.2	26.5	56.1	25.9	19.9	56.3	26.5	21.6	16.5	23.6	40.4	18.1	30.9	23.5	15.1	27.1	30.1	52.6	17.1	21.0	7.5	26.2	27.4	33.4	21.0	25.6	26.2	24.8	18.7	28.5	27.7	1.3	15.7	28.5	43.1	26.8	28.5	13.0	17.0	10.9	28.2	12.8	11.6	19.8	18.0	20.7	17.6	53.6	29.1	34.1	31.9	30.0	26.4	8.5	76.5	34.8	25.0	85.5	13.7	39.0	16.6	71.5	2.7	41.8	53.0	23.3	48.6	78.8	43.6	38.3	53.1	70.4	61.1	41.3	57.0	43.0	64.9	5.8	64.5	46.7	50.6	84.8	54.5	25.7	53.3	63.1	44.6	36.9	12.1	51.8	39.4	16.8	23.6	36.6	39.0	50.0	78.0	31.5
PHKG1	PHKG	ENSG00000164776	"Phosphorylase kinase catalytic subunit gamma 1"	Q16816	7	56080283-56092996	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 105.6;tongue: 32.9"	"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 50.9"	"Cancer enriched"	"Detected in many"	18	"glioma: 23.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012057	Enhanced					NA	NA					"HPA012057: AB_1855305"	"unprognostic (2.00e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.09e-3)"	"unprognostic (5.87e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.69e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.14e-4)"	"unprognostic (1.92e-1)"	"unprognostic (7.97e-9)"	"unprognostic (6.61e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.85e-2)"	2.0	1.5	4.9	0.8	6.1	1.1	1.5	6.0	5.8	0.7	2.6	6.5	0.0	1.0	0.9	1.5	3.2	0.9	1.1	11.8	4.1	2.9	0.6	0.7	0.9	0.8	3.5	3.9	1.0	0.8	1.2	0.6	0.6	6.8	1.4	0.8	0.0	1.6	0.8	105.6	1.6	0.9	1.1	3.6	0.8	0.8	0.7	4.8	0.0	0.6	32.9	1.2	1.8	0.3	1.3	0.6	3.3	0.7	0.3	1.9	0.2	2.9	2.1	0.5	1.8	3.2	5.4	1.4	0.4	0.6	1.0	0.8	0.7	1.3	0.8	0.5	1.0	1.2	1.6	1.2	0.2	0.8	0.8	2.1	0.8	3.0	0.7	0.8	1.5	3.3	3.4	2.3	1.6	0.7	0.8	0.3	2.1	2.2	4.0	0.1	1.3	2.2	5.6	1.0	0.9	1.3	1.2	0.3	1.0	0.6	1.9	1.5	1.6	0.3	2.2	0.1	0.5	1.2	1.9	0.8	0.5	1.7	4.5	1.1	1.8	0.7	2.2	1.2	1.4	1.0	0.4	0.5	0.0	0.8	0.2	1.9	0.3	1.2	0.3	0.2	1.3	0.6	0.6	3.3	0.3	0.7	0.6	0.5	0.2	4.9	6.1	6.0	5.8	4.1	2.9	3.5	3.9	6.8	4.8	11.9	3.4	25.1	6.4	1.1	4.0	1.4	50.9	4.0	6.8	26.2	0.0	6.6	1.7	13.2	2.2	1.4	11.4	23.3	10.9	11.6	6.1	9.6	8.1	41.4	11.0	11.1	16.0	20.9	30.5	5.6	16.7	6.0	1.7	8.2	10.9	4.8	12.7	10.5	15.2	9.0	4.3	12.9	1.0	7.6	9.4	0.9	6.1	8.7	14.4	7.0
CHCHD2	C7orf17	ENSG00000106153	"Coiled-coil-helix-coiled-coil-helix domain containing 2"	Q9Y6H1	7	56101569-56106576	"Disease related genes, Predicted intracellular proteins"	Transcription	Activator	"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 224.0"	"Low region specificity"	"Detected in all"							"HPA027407, HPA052510"	Uncertain		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA027407: AB_10959659, HPA052510: AB_2681856"	"unprognostic (8.68e-3)"	"unprognostic (2.79e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (1.90e-5)"	"prognostic unfavorable (9.41e-5)"	"unprognostic (4.38e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.60e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.40e-2)"	41.5	112.8	57.2	33.0	59.5	73.0	46.0	39.3	56.9	38.0	46.6	33.2	45.5	51.9	34.2	53.8	50.1	39.2	44.3	75.3	46.8	50.2	56.2	66.9	34.2	62.6	58.3	49.0	43.8	77.8	28.4	42.8	38.4	42.3	41.3	40.1	45.3	56.5	70.0	147.2	33.0	49.3	45.7	42.6	34.1	44.2	27.1	28.1	48.9	62.1	65.9	38.8	38.5	30.9	63.2	107.7	52.6	69.1	51.5	72.8	121.3	224.0	39.2	25.9	53.4	20.5	28.3	19.2	33.0	31.3	42.5	41.2	35.9	37.5	65.7	43.7	20.2	55.1	38.2	32.7	36.1	34.3	42.7	59.6	38.8	33.1	51.1	38.1	52.2	62.7	25.2	41.4	31.9	39.1	23.1	31.7	58.1	81.3	40.0	34.6	31.1	70.3	161.7	56.0	61.6	62.6	47.4	25.2	107.9	38.1	29.3	49.4	61.5	26.0	64.1	41.4	18.5	73.2	74.7	25.3	26.3	61.6	108.7	48.5	37.0	52.6	117.2	41.4	56.4	32.5	40.5	69.1	52.6	53.1	61.0	54.8	63.2	57.2	56.3	79.5	57.8	51.6	52.8	37.0	51.5	59.5	107.7	72.8	121.3	57.2	59.5	39.3	56.9	46.8	50.2	58.3	49.0	42.3	28.1	238.2	265.3	489.1	766.8	637.3	337.7	148.9	461.1	385.4	275.3	392.6	58.9	829.8	1576.7	867.5	105.9	435.3	847.1	303.7	1153.3	1054.3	581.8	939.9	386.6	693.4	849.1	465.6	519.8	355.4	420.9	153.5	568.7	575.0	723.7	764.7	720.0	545.6	1044.9	757.6	475.6	1300.4	258.3	420.4	656.7	417.0	565.7	628.8	1027.6	495.9	809.6	1069.0
NUPR2	NUPR1L	ENSG00000185290	"Nuclear protein 2, transcriptional regulator"	A6NF83	7	56114681-56116400	"Predicted intracellular proteins"	"Cell cycle, Growth arrest, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 93.5"	"Group enriched"	"Detected in many"	21	"Early spermatids: 3268.4;Late spermatids: 11633.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 9.3"	"Lineage enriched"	"Detected in many"	4	"T-cells: 9.3"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 14.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"									NA	NA						"unprognostic (5.81e-2)"	"unprognostic (2.01e-1)"		"unprognostic (1.10e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.25e-2)"		"unprognostic (2.46e-1)"		"unprognostic (1.34e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (9.53e-5)"	"unprognostic (1.66e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.44e-2)"	1.1	2.1	2.0	0.4	2.7	0.3	1.6	2.0	1.5	1.0	0.3	0.1	7.8	0.5	0.2	6.5	0.3	0.9	1.1	0.6	0.8	1.5	4.1	1.3	0.8	0.2	0.8	0.7	0.7	3.2	1.1	3.7	0.3	1.2	1.8	0.3	0.2	5.2	11.8	0.7	0.4	0.2	0.2	0.4	0.2	1.9	93.5	0.1	0.0	4.8	0.0	0.4	0.3	0.3	0.9	1.4	2.1	0.7	0.6	9.3	1.6	1.2	3.9	1.8	5.0	4.7	2.0	0.6	0.2	1.8	0.9	0.6	0.5	2.7	0.4	6.0	0.2	1.9	0.4	2.4	0.6	1.1	0.9	7.6	2.9	1.7	3.4	2.5	0.9	0.5	3.6	2.6	1.3	5.6	2.2	1.7	3.9	3.6	3.2	1.8	4.1	1.6	3.7	1.6	1.5	4.2	1.4	2.0	14.4	2.8	0.7	5.0	4.6	2.4	0.6	6.7	6.2	1.5	0.9	1.3	0.8	2.1	1.2	0.9	4.8	5.6	5.5	3.1	3.7	1.4	2.1	0.6	1.0	0.6	0.1	0.9	0.8	3.2	1.0	0.7	0.9	9.3	2.6	0.1	0.6	0.7	1.4	0.8	1.6	2.0	2.7	2.0	1.5	0.8	1.5	0.8	0.7	1.2	0.1	0.0	1.0	0.0	18.3	0.0	0.8	0.0	0.0	5.3	3.4	85.5	0.0	9.2	358.1	3.1	3268.4	0.0	0.0	0.0	1.7	0.9	0.0	39.9	1.1	0.0	0.5	15.9	14.0	0.0	0.0	11633.4	87.2	0.4	0.0	0.0	2.5	0.2	0.9	0.0	64.3	1.9	0.4	84.1	0.0	86.6	50.7	0.0	2.4	0.0	1.0	16.6
ZNF479	KR19	ENSG00000185177	"Zinc finger protein 479"	Q96JC4	7	57119614-57139864	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"testis: 7.4"	"Group enriched"	"Detected in some"	7	"Early spermatids: 62.7;Late spermatids: 25.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"																	NA	NA																				"unprognostic (1.54e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.7	0.2	1.2	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.5	0.2	0.3	0.4	0.3	0.3	0.2	0.5	0.8	0.8	0.2	1.2	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	6.0	0.0	0.0	0.0	0.0	0.1
ZNF716	FLJ46189	ENSG00000182111	"Zinc finger protein 716"	A6NP11	7	57450177-57473546	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 2.9;testis: 6.9"	"Group enriched"	"Detected in some"	7	"Early spermatids: 3.2;Late spermatids: 2.5;Spermatocytes: 1.5;Spermatogonia: 4.3"	"Cancer enriched"	"Detected in single"	23	"testis cancer: 2.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 4.8;SuSa: 1.2;T-47d: 3.1"															NA	NA															"unprognostic (1.57e-1)"				"unprognostic (1.95e-2)"	"unprognostic (1.21e-1)"			0.1	0.2	0.1	0.1	0.1	1.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.3	0.1	0.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0.4	0.1	0.1	0.1	0.1	0.1	0.2	0.7	0.2	0.1	0.1	0.1	0.1	6.9	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.9	0.6	2.9	0.6	1.1	0.9	0.2	0.1	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.4	0.0	0.1	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.3	1.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.1	0.1	4.8	0.0	0.2	0.2	0.1	0.1	0.1	0.0	1.2	3.1	0.0	0.0	0.2	0.8	0.2	0.1	0.2	0.0	0.0	0.0	0.2	0.0	2.4	0.6	0.7	0.6	0.4	0.3	0.6	0.6	0.4	0.2	0.9	0.9	0.8	2.9	1.1	0.3	0.6	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.5	4.3	0.0	0.0	0.0	0.0	0.3
AC115220.1		ENSG00000241149			7	63998874-64016130	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	17	"testis: 10.9"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	19	"testis cancer: 1.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 4.4;T-47d: 1.4;U-266/70: 1.4"															NA	NA																				"unprognostic (6.95e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZNF727	ZNF727P	ENSG00000214652	"Zinc finger protein 727"	A8MUV8	7	64045443-64078549	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"pituitary gland: 13.7"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 1.9;Distal tubular cells: 3.3;Early spermatids: 1.8;Horizontal cells: 1.6;Late spermatids: 1.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.4"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"T-47d: 13.1"									"HPA051027, HPA061215"	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051027: , HPA061215: AB_2684452"	"unprognostic (5.87e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.73e-4)"	"unprognostic (8.70e-2)"	"unprognostic (6.36e-2)"	"unprognostic (8.61e-2)"	2.6	1.6	2.7	0.9	10.6	0.3	5.4	3.9	7.4	5.2	1.7	5.8	0.0	0.6	5.9	3.1	2.0	4.7	1.6	2.2	4.7		3.1	0.5	1.9	1.2	5.3	2.5	9.1	2.0	1.1	13.7	0.3	7.2	4.9	2.0	3.1	2.2	3.3	1.2	2.0	1.0	3.7	4.2	1.6	2.0	5.5	6.1	0.0	8.7	0.0	0.9	2.6	3.9	1.1	0.4	0.0	0.4	0.4	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.0	13.1	0.0	0.0	0.0	1.6	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.4	1.1	1.0	0.7	0.0	0.4	0.4	0.0	0.0	0.5											0.0	0.0	0.0	0.4	0.0	1.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.4	0.1	0.2	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0
ZNF735	ZNF735P	ENSG00000223614	"Zinc finger protein 735"	P0CB33	7	64207090-64220508	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in single"		"testis: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																				"unprognostic (2.01e-1)"			0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	1.3			0.0		0.0	0.0		0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
ZNF679	MGC42415	ENSG00000197123	"Zinc finger protein 679"	Q8IYX0	7	64228474-64266931	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	14	"testis: 4.6"	"Group enriched"	"Detected in some"	14	"Early spermatids: 4.5;Late spermatids: 3.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SH-SY5Y: 2.2;T-47d: 1.5"															NA	NA															"unprognostic (1.27e-1)"					"unprognostic (8.09e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6			0.1		0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	2.2	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.3	0.0	0.0	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0
ZNF736		ENSG00000234444	"Zinc finger protein 736"	B4DX44	7	64307459-64354860	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 36.3;Late spermatids: 47.2;Rod photoreceptor cells: 44.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA051027, HPA061215"	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051027: , HPA061215: AB_2684452"	"unprognostic (2.41e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.17e-3)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (4.14e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.20e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (2.26e-1)"	"unprognostic (9.63e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.22e-3)"	"prognostic favorable (8.65e-4)"	7.1	5.4	8.5	8.2	17.4	17.0	12.9	8.3	19.8	7.7	5.5	7.8	4.7	3.9	8.4	9.8	5.4	7.7	6.3	5.3	7.5	6.0	8.2	3.7	7.4	14.0	5.5	8.2	13.1	7.5	6.2	7.6	5.4	13.8	8.6	6.1	11.5	7.7	5.7	4.2	13.1	8.5	6.3	5.8	10.1	6.2	16.8	7.0	17.1	10.6	2.0	11.4	6.1	7.4	4.7	3.5	2.8	2.1	0.3	2.4	1.0	0.5	0.2	4.6	15.9	1.7	3.1	4.7	2.5	0.1	3.3	5.4	1.2	2.6	11.9	3.8	2.1	4.5	2.0	3.5	1.0	5.3	0.2	3.3	4.8	1.4	0.1	1.7	2.1	6.9	2.5	1.0	3.8	0.1	1.6	0.4	7.0	5.7	2.6	4.6	3.0	7.2	11.3	8.9	0.1	0.9	6.2	7.2	5.8	4.1	7.0	5.0	7.3	5.7	4.1	1.5	9.1	11.3	8.8	0.3	5.2	3.7	1.3	3.0	3.1	4.3	14.5	0.1	2.6	0.1	0.0	1.9	2.8	1.5	1.8	1.1	4.7	2.3	1.3	2.1	4.5	2.4	1.9	0.4	0.3	2.1	3.5	1.0	1.0	8.5	17.4	8.3	19.8	7.5	6.0	5.5	8.2	13.8	7.0	6.0	4.8	7.7	2.1	3.4	14.4	2.8	10.2	1.4	4.5	5.2	11.8	3.0	5.0	3.3	36.3	4.3	1.3	0.0	1.9	2.6	3.1	2.5	0.0	2.9	3.1	7.9	1.2	6.2	5.3	47.2	2.3	6.4	3.3	1.8	4.7	6.8	1.9	2.9	2.8	3.4	44.8	0.0	2.0	6.3	6.5	3.4	2.3	4.4	2.8	1.7
ZNF680	FLJ90430	ENSG00000173041	"Zinc finger protein 680"	Q8NEM1	7	64519884-64563106	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003173			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003173: AB_1080744"	"unprognostic (1.65e-1)"	"unprognostic (3.21e-2)"	"unprognostic (6.88e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.52e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.46e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.05e-3)"	6.4	15.8	18.7	4.2	24.4	2.6	15.4	37.0	23.7	7.7	4.4	7.1	3.3	3.4	5.9	7.0	4.4	6.2	6.2	12.1	20.0	10.8	9.8	21.6	5.7	6.9	23.4	14.6	13.1	5.8	4.0	10.0	5.3	19.9	12.0	6.2	3.9	5.4	6.8	11.6	6.6	3.9	7.1	25.9	7.3	7.0	4.7	24.4	5.4	28.5	6.6	6.0	6.8	5.2	4.3	1.7	4.2	1.3	8.3	4.4	1.7	3.7	2.2	8.8	10.6	4.4	5.0	5.6	3.1	2.5	5.6	7.0	3.0	7.3	7.1	7.6	2.9	6.3	2.6	7.2	3.3	9.1	1.3	5.1	5.4	4.3	2.7	1.9	7.1	4.9	3.3	4.0	4.9	5.5	7.0	5.2	10.1	9.7	0.0	7.6	2.9	11.0	11.5	10.4	3.3	2.7	8.7	9.0	21.4	7.7	12.2	7.2	9.7	9.2	8.7	3.2	17.4	8.8	3.1	2.8	6.8	3.4	3.2	5.2	6.3	8.1	20.2	0.3	6.6	5.9	4.2	1.0	1.1	3.0	1.3	2.5	4.3	4.1	3.5	1.7	3.4	4.4	4.0	0.5	8.3	1.1	1.4	1.2	1.7	18.7	24.4	37.0	23.7	20.0	10.8	23.4	14.6	19.9	24.4	11.9	3.2	9.9	9.2	3.8	11.2	11.6	20.4	2.7	12.5	24.4	3.9	10.0	8.3	7.5	0.8	8.7	2.2	0.0	8.0	8.8	9.1	11.1	6.9	17.4	4.4	1.6	0.0	26.4	12.4	1.3	25.6	5.6	6.8	8.2	4.3	22.8	5.2	3.5	20.8	5.6	9.0	19.4	6.9	11.1	15.1	4.5	5.9	10.2	4.5	8.1
ZNF107	"smap-7, ZFD25, ZNF588"	ENSG00000196247	"Zinc finger protein 107"	Q9UII5	7	64666083-64711582	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 37.4"	"Cell type enhanced"	"Detected in many"	5	"B-cells: 18.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 23.3;REH: 24.8;U-698: 26.2"															NA	NA						"unprognostic (1.25e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.34e-1)"	"unprognostic (6.78e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (3.32e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.49e-2)"	"unprognostic (7.15e-3)"	5.6	8.6	3.7	16.2	6.6	9.6	19.3	8.6	5.0	9.5	3.6	5.8	2.7	3.5	4.1	3.4	5.9	4.2	3.9	3.2	4.2	3.2	4.0	3.0	4.7	19.7	7.8	3.2	6.3	4.0	2.9	9.3	4.5	5.8	6.0	4.8	2.4	10.3	6.1	2.2	9.6	14.6	3.3	8.2	17.8	4.8	4.2	7.7	37.4	7.0	4.2	18.9	8.4	7.2	10.1	2.7	13.5	1.6	2.5	6.2	1.6	3.4	2.0	6.0	10.3	1.4	1.5	4.4	2.6	1.7	3.9	5.2	3.2	3.3	20.1	4.8	1.7	5.3	2.7	6.6	2.6	5.9	4.8	4.5	3.9	3.1	1.8	0.7	7.3	7.0	2.5	1.8	3.3	1.9	2.0	1.9	18.6	6.8	10.5	3.5	2.8	23.3	8.0	11.5	2.1	2.3	24.8	5.0	4.4	2.1	6.8	6.7	5.4	4.0	4.2	2.6	8.7	6.6	5.1	1.6	6.6	2.6	2.6	3.7	5.0	4.4	26.2	1.5	5.1	4.3	8.6	0.7	1.4	3.5	1.6	3.7	8.4	4.7	4.7	1.0	10.1	6.2	5.7	13.5	2.5	1.1	2.7	3.9	1.6	3.7	6.6	8.6	5.0	4.2	3.2	7.8	3.2	5.8	7.7	11.9	6.2	18.2	2.8	1.9	5.7	2.8	5.1	2.7	5.7	7.0	2.0	2.5	1.7	2.4	5.8	3.8	1.2	0.0	2.7	2.0	2.7	3.9	0.0	0.5	1.5	3.2	6.3	2.5	2.5	5.7	4.0	3.4	0.0	1.0	3.3	3.5	3.2	2.9	3.2	1.7	5.7	6.5	1.7	2.9	5.1	3.6	2.1	7.5	3.3	2.7
ZNF138	pHZ-32	ENSG00000197008	"Zinc finger protein 138"	P52744	7	64794388-64833681	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"brain: 41.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA						"unprognostic (1.12e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.12e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.23e-3)"	"unprognostic (5.04e-2)"	6.2	10.3	15.3	6.5	24.7	5.7	15.0	41.5	18.7	7.6	6.0	5.9	1.5	5.5	4.5	8.2	7.7	4.3	5.5	5.7	14.2	9.7	8.3	8.9	5.0	11.0	16.2	12.6	5.9	4.3	3.1	10.5	5.1	16.3	7.2	8.0	3.5	7.8	5.4	7.0	15.2	5.5	5.4	16.6	6.2	7.9	9.5	17.1	10.0	7.4	5.6	11.2	5.5	6.4	9.6	6.9	11.2	3.9	4.0	8.9	3.3	3.9	2.9	5.8	11.0	4.0	4.8	6.1	2.5	2.5	3.5	5.9	5.2	6.4	15.7	6.2	1.6	8.3	2.5	9.2	2.7	6.4	6.1	5.9	4.7	4.1	3.6	1.9	9.4	4.7	2.7	2.8	6.0	4.9	4.6	3.1	11.1	12.1	5.9	4.1	7.0	9.1	5.9	13.2	4.3	6.2	7.0	6.5	5.4	4.7	8.8	9.6	9.8	4.3	7.3	5.8	16.3	11.4	8.9	1.7	4.0	4.5	3.5	6.2	8.9	10.4	19.0	2.6	6.3	3.0	11.2	2.2	4.0	5.3	3.9	5.9	9.5	8.3	8.4	2.7	9.6	8.9	8.3	3.4	4.0	3.6	6.9	7.6	3.3	15.3	24.7	41.5	18.7	14.2	9.7	16.2	12.6	16.3	17.1	0.0	3.2	4.2	6.2	8.1	20.2	12.1	0.0	0.0	4.5	5.2	5.9	8.8	6.6	6.3	8.5	8.0	3.8	0.0	12.2	8.3	6.6	3.6	13.9	5.9	6.5	22.3	4.1	4.3	7.0	8.0	6.4	9.3	1.7	7.2	7.0	10.3	7.6	7.0	4.6	5.4	12.4	0.0	4.7	17.6	13.9	9.3	4.7	10.8	7.6	5.9
ZNF273	HZF9	ENSG00000198039	"Zinc finger protein 273"	Q14593	7	64870172-64930966	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Ciliated cells: 95.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA077549			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA077549: AB_2732352"	"unprognostic (7.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.87e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.02e-5)"	"unprognostic (2.54e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.85e-2)"	2.8	1.5	1.9	1.7	4.1	5.5	4.8	8.6	3.7	3.5	1.5	2.1	1.0	1.4	2.6	0.7	2.9	3.4	0.9	1.7	2.7	1.6	1.7	1.8	1.8	5.0	4.4	2.6	3.7	1.7	0.9	2.8	2.1	5.2	1.9	1.9	0.0	1.8	1.7	1.9	12.1	1.6	1.4	2.6	3.8	1.7	9.2	5.1	11.5	5.8	4.2	3.5	2.2	1.8	3.2	1.8	5.0	0.7	0.7	2.5	1.0	2.2	1.6	3.6	5.2	0.5	1.2	3.0	1.0	0.7	1.5	2.8	2.5	2.0	5.9	3.2	0.4	2.8	0.7	7.2	1.4	1.2	2.9	2.6	3.1	0.9	0.8	0.2	3.1	2.1	0.8	0.9	2.5	2.4	1.1	1.4	8.8	8.3	2.2	1.8	2.0	6.5	3.1	7.1	1.2	2.5	6.9	5.6	3.5	0.8	1.3	3.3	3.4	2.8	1.4	1.6	7.3	2.6	4.2	0.7	1.8	1.9	1.3	2.1	2.2	2.9	8.7	0.5	3.0	1.3	5.0	0.6	3.1	1.0	0.7	1.9	3.2	2.1	1.4	1.7	2.4	1.7	2.5	1.0	0.7	0.5	1.8	2.2	1.0	1.9	4.1	8.6	3.7	2.7	1.6	4.4	2.6	5.2	5.1	3.0	2.9	8.7	5.1	22.1	5.3	3.7	2.5	95.0	13.6	1.8	0.0	5.2	6.6	2.6	20.2	8.0	0.3	23.3	2.5	10.4	7.5	3.1	3.5	0.8	3.1	4.8	0.0	6.7	4.3	8.2	5.8	3.7	5.0	3.6	1.7	2.9	2.6	5.8	3.2	1.1	2.6	0.0	3.3	16.7	7.9	16.6	2.4	7.2	3.3	2.5
ZNF117	"H-plk, HPF9"	ENSG00000152926	"Zinc finger protein 117"	Q03924	7	64971776-65006684	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 2: 34.7"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"neutrophil: 6.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.2;SuSa: 16.7;THP-1: 15.4"									HPA031148			Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center, Cytosol"		"HPA031148: AB_2673759"	"unprognostic (1.04e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.35e-1)"	"unprognostic (7.10e-2)"	"prognostic unfavorable (2.17e-11)"	"unprognostic (1.08e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.21e-1)"	11.1	13.2	1.3	3.4	1.5	2.1	7.1	2.1	3.7	3.1	2.1			0.5	4.2	6.5	5.2	2.8	5.6	2.7	1.1	1.3	2.3	0.9	3.9	2.6	1.0		5.0	2.1	2.4	4.0	5.3		2.8	2.2		3.6	2.4	0.6	4.2	1.6	2.8	1.3	3.4	1.8	5.3			3.4		2.6	2.5	4.5	1.0	0.7	6.2	1.9	0.9	0.6	0.2	1.2	0.1	14.5	15.2	5.5	2.5	8.2	3.1	0.7	0.8	1.5	0.6	6.2	5.3	2.6	1.6	2.4	0.9	1.7	0.4	1.8	1.6	1.4	2.4	0.4	2.9	0.5	0.0	1.5	3.2	0.6	0.6	0.6	5.9	2.4	6.3	9.8	3.6	3.6	2.7	5.4	5.5	6.1	1.7	0.2	7.2	1.0	1.0	2.0	2.3	2.3	12.4	1.5	0.6	0.7	16.7	2.7	15.4	7.2	4.4	0.5	2.6	1.9	2.5	4.5	2.8	1.6	6.9	2.7	0.4	0.6	1.0	0.6	1.9	0.6	1.0	0.4	0.4	0.7	1.0	0.4	0.4	6.2	0.9	0.5	0.7	0.5	0.2											3.0	34.7	0.0	4.9	3.0	14.3	6.1	15.3	22.7	25.0	5.2	0.0	4.1	10.0	9.4	1.7	7.0	1.7	0.0	24.3	2.3	5.0	6.1	10.4	3.0	5.5	27.0	5.1	19.0	9.8	2.5	8.1	7.0	5.0	1.8	3.6	10.0	17.7	0.0	4.9	2.1	7.4	6.5	4.1	6.5	7.9	4.1	9.3	4.9	2.8	10.4
ERV3-1	"envR, ERV-R, ERV3, H-PLK, HERV-R"	ENSG00000213462	"Endogenous retrovirus group 3 member 1, envelope"	Q14264	7	64990809-65006743	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 10.1;monocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 19.5"									"HPA017209, HPA046508"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA017209: AB_2732419, HPA046508: AB_2732525"	"unprognostic (2.74e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.48e-1)"	"unprognostic (2.03e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.88e-2)"	27.2	41.3	9.9	9.0	11.7	8.6	18.3	13.8	11.6	9.4	7.1	8.7	5.6	3.9	11.2	31.9	18.9	9.0	17.9	8.4	10.1	7.2	7.3	4.0	10.7	5.6	11.2	9.2	10.6	7.6	9.6	19.3	21.2	11.7	8.1	6.5	9.3	14.9	13.1	5.1	14.2	5.8	8.5	13.2	7.0	6.9	9.4	12.7	12.6	10.2	6.2	10.2	10.5	13.8	0.9	1.2	10.1	2.5	1.4	1.5	1.1	2.1	0.7	12.7	19.5	8.0	3.3	8.6	4.0	4.5	1.4	3.3	0.7	14.2	3.5	3.7	1.5	2.7	2.5	1.7	0.9	2.2	2.6	0.9	1.9	0.6	6.8	0.6	5.2	2.5	3.9	1.1	1.3	0.3	7.5	8.1	4.1	8.4	7.0	5.3	5.3	3.3	3.2	3.6	6.8	0.8	7.7	0.5	2.5	2.2	4.4	2.4	12.3	4.3	1.2	0.4	14.1	3.2	11.5	6.6	4.9	0.6	3.6	2.0	2.2	5.1	1.1	3.9	15.1	2.9	0.1	1.5	3.4	0.9	2.5	0.8	0.7	0.2	0.7	1.2	0.9	0.6	0.6	10.1	1.4	0.8	0.7	1.5	1.1	9.9	11.7	13.8	11.6	10.1	7.2	11.2	9.2	11.7	12.7	3.0	9.6	34.1	15.5	3.8	26.4	1.8	15.3	10.7	11.4	15.7	27.5	14.5	8.3	12.4	5.5	11.3	6.7	23.3	15.3	9.4	6.9	10.3	8.1	2.1	8.2	17.5	13.3	15.4	15.4	4.1	10.6	15.5	10.1	13.6	7.2	14.0	14.3	7.0	9.2	2.2	18.2	6.5	7.1	9.8	9.5	5.0	33.6	25.8	6.0	22.2
ZNF92	"HPF12, TF12"	ENSG00000146757	"Zinc finger protein 92"	Q03936	7	65373799-65401135	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 34.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003173			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003173: AB_1080744"	"unprognostic (1.07e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (5.48e-3)"	"unprognostic (1.30e-2)"	"unprognostic (3.86e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.50e-3)"	6.7	9.3	9.6	13.7	13.0	20.8	16.3	24.4	11.9	8.3	6.2	5.0	6.1	6.1	5.7	7.2	11.2	5.4	6.3	4.6	9.6	8.9	7.9	5.6	5.7	14.8	12.1	8.6	8.8	6.9	7.7	13.4	5.7	12.6	6.6	7.0	2.5	6.9	6.6	4.7	4.9	10.1	3.9	18.5	14.8	7.6	7.6	15.7	26.0	9.4	5.1	14.0	8.3	5.7	10.7	2.3	5.6	2.7	9.4	6.0	2.2	4.5	3.1	13.7	13.5	3.5	4.2	6.5	3.8	2.8	4.2	6.1	5.7	6.8	17.7	7.4	2.1	6.3	4.5	10.6	2.6	6.9	6.6	7.1	7.9	1.7	5.6	1.2	9.5	7.6	3.6	2.3	3.8	2.9	5.7	5.1	9.4	10.3	7.3	6.0	1.3	14.0	10.8	18.5	4.8	4.2	12.8	8.0	6.0	4.6	9.2	11.7	8.9	5.8	9.1	4.3	13.9	6.5	13.0	3.7	4.9	4.4	2.9	5.4	4.6	4.1	25.7	3.2	7.7	4.3	5.6	1.6	4.0	2.7	2.1	5.7	10.7	4.2	4.1	2.3	9.2	5.1	5.2	1.3	9.4	2.7	2.2	6.0	2.2	9.6	13.0	24.4	11.9	9.6	8.9	12.1	8.6	12.6	15.7	8.9	0.6	34.0	6.2	4.9	7.6	3.4	5.1	1.4	7.9	5.2	0.0	5.3	10.0	6.3	1.0	5.8	2.6	0.0	4.2	4.4	5.1	6.3	11.5	2.1	3.7	4.8	6.9	6.2	5.4	1.7	6.6	6.8	5.0	9.0	7.2	7.7	6.3	7.0	6.0	3.5	4.8	0.0	5.7	19.6	24.5	3.3	4.1	7.9	4.7	7.0
VKORC1L1		ENSG00000196715	"Vitamin K epoxide reductase complex subunit 1 like 1"	Q8N0U8	7	65873267-65959563	"Enzymes, FDA approved drug targets, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA053954	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA053954: AB_2682319"	"unprognostic (3.01e-1)"	"unprognostic (1.76e-3)"	"unprognostic (4.64e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.00e-3)"	"unprognostic (7.15e-3)"	"unprognostic (1.30e-3)"	"unprognostic (8.84e-3)"	"unprognostic (5.12e-2)"	"unprognostic (5.59e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.30e-1)"	"unprognostic (5.06e-2)"	38.2	9.2	10.5	8.3	16.7	3.0	23.7	9.0	19.7	10.4	11.1	14.2	9.2	8.6	10.1	8.8	10.0	8.8	8.0	9.3	10.3	11.4	8.2	17.8	14.3	6.2	12.0	12.1	14.4	11.7	28.5	8.0	9.7	14.1	9.9	10.0	8.0	9.0	10.5	14.9	11.4	9.7	9.3	13.2	5.7	9.9	9.4	7.6	9.1	11.1	4.5	6.6	9.7	9.3	2.8	7.5	5.6	4.2	6.5	3.4	1.8	22.4	14.5	11.7	14.7	37.4	14.9	21.3	24.4	15.8	14.6	14.8	14.0	22.2	19.6	19.8	17.5	22.2	15.5	16.7	9.9	24.5	12.2	16.5	13.3	13.3	11.9	18.3	18.4	10.3	11.9	12.8	14.8	20.7	11.4	14.5	11.2	28.0	15.0	17.4	8.8	15.1	21.5	28.1	21.3	10.9	16.6	17.1	24.4	14.1	9.0	14.1	20.2	18.9	34.3	10.7	17.4	17.2	14.3	16.4	23.7	16.2	14.8	24.7	13.6	22.1	22.5	14.5	21.0	20.6	3.8	2.7	5.6	2.9	2.5	2.4	2.8	3.4	3.2	2.8	2.5	2.3	2.3	3.1	6.5	4.2	7.5	3.1	1.8	10.5	16.7	9.0	19.7	10.3	11.4	12.0	12.1	14.1	7.6	68.5	29.5	0.8	14.6	22.0	20.5	21.3	30.6	8.1	26.1	15.7	11.8	10.0	5.0	15.9	28.9	15.9	16.9	23.3	21.7	18.4	16.7	23.4	4.7	44.5	14.4	28.6	13.3	8.6	7.0	5.5	16.4	9.0	6.8	4.6	23.5	8.5	24.2	2.9	17.3	10.2	17.4	6.5	13.4	17.9	6.6	28.0	7.3	5.2	18.7	16.9
GUSB		ENSG00000169919	"Glucuronidase beta"	P08236	7	65960684-65982314	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Cancer-related genes, Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 56.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036322, HPA036323"	Approved		Supported	Vesicles	"Intracellular and membrane"	NA	NA		48000	Vesicles		"HPA036322: AB_10670796, HPA036323: AB_2675059"	"unprognostic (1.54e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.98e-1)"	"unprognostic (5.06e-1)"	"unprognostic (1.45e-1)"	23.5	12.0	3.7	7.9	5.5	20.7	25.4	5.7	4.4	10.4	14.6	7.7	22.0	10.0	10.4	12.2	9.3	7.6	11.1	8.0	3.7	2.9	11.8	50.4	15.3	12.3	6.3	3.1	8.6	17.1	9.0	7.3	30.0	4.5	12.1	11.4	9.9	17.2	11.8	5.9	10.0	16.1	8.3	3.9	17.5	11.0	7.9	5.8	14.7	17.7	5.9	13.0	9.2	7.4	9.7	27.7	22.1	36.0	15.2	11.5	15.8	17.0	6.6	6.5	14.5	22.1	13.2	9.4	5.4	15.1	11.9	11.0	9.5	17.6	7.8	8.5	6.9	6.2	6.9	4.2	6.5	7.1	7.3	8.5	10.6	10.0	6.4	10.8	22.7	17.7	9.1	7.0	6.9	9.0	14.2	10.4	4.5	16.1	56.5	7.7	12.4	8.3	24.4	4.3	26.0	5.5	8.6	15.0	44.2	7.5	10.3	9.5	8.4	14.5	33.9	18.9	7.6	18.9	22.6	7.3	14.6	13.2	5.5	13.5	32.1	38.5	13.1	10.9	30.2	17.7	7.4	28.1	22.1	11.5	36.0	10.3	9.7	9.0	10.2	27.7	7.8	6.2	7.3	4.5	15.2	30.0	11.3	11.3	15.8	3.7	5.5	5.7	4.4	3.7	2.9	6.3	3.1	4.5	5.8	47.6	56.2	18.6	26.4	16.0	13.7	8.3	25.5	48.2	37.5	27.9	7.9	72.3	5.0	32.4	47.6	31.3	41.1	23.3	26.7	48.8	48.3	25.5	35.8	64.7	114.3	15.9	41.2	39.9	74.2	36.8	40.0	72.1	37.1	43.3	42.3	27.3	25.9	48.9	26.9	19.2	17.7	25.8	22.6	41.3	28.8	12.9	56.0	34.6	40.6	25.3
ASL		ENSG00000126522	"Argininosuccinate lyase"	P04424	7	66075798-66093558	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 99.5"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 226.8;Hepatocytes: 477.5;Paneth cells: 217.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB003696, HPA016646"	Enhanced		Approved	Cytosol		NA	NA		10000000	Cytosol		"CAB003696: AB_425316, HPA016646: AB_1845096"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.05e-6)"	"unprognostic (4.83e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.25e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.40e-3)"	5.6	4.8	4.0	8.0	4.3	7.3	5.9	7.2	7.4	5.5	17.2	3.7	7.8	20.8	5.0	7.1	7.7	4.9	19.5	4.3	3.7	4.3	16.0	99.5	8.1	4.5	4.4	6.2	5.9	10.4	3.3	5.8	3.3	7.2	5.4	12.4	5.8	7.1	5.7	2.4	4.1	16.6	3.4	3.2	8.6	12.6	2.1	3.5	1.2	7.1	7.9	5.9	5.2	5.9	8.6	19.3	20.7	18.4	30.4	9.2	10.7	18.2	7.5	4.1	14.8	9.5	7.3	9.0	12.8	11.2	18.3	16.7	16.9	22.6	5.6	20.5	16.8	13.3	5.0	2.6	21.7	5.3	4.6	3.4	7.4	7.3	26.1	17.7	8.4	21.7	13.7	7.9	12.8	20.5	4.6	18.0	4.0	13.1	10.7	10.1	13.0	1.7	11.6	6.2	22.8	9.7	4.5	4.3	19.3	13.3	11.0	7.1	9.7	11.7	40.8	4.4	4.4	17.8	7.6	20.4	23.2	12.0	9.2	16.5	11.7	6.1	7.3	21.9	16.0	18.7	12.1	18.1	20.7	7.7	18.4	6.5	8.6	5.2	6.1	19.3	5.6	3.7	4.0	4.0	30.4	13.8	1.2	9.2	10.7	4.0	4.3	7.2	7.4	3.7	4.3	4.4	6.2	7.2	3.5	17.9	52.0	20.8	16.7	4.8	12.5	7.1	132.5	38.8	15.9	29.6	21.6	19.3	44.7	51.9	3.5	25.6	226.8	0.0	192.3	35.3	14.5	13.1	44.9	477.5	40.4	14.3	51.9	35.6	39.6	4.9	8.6	16.1	8.5	61.3	87.3	6.5	99.6	217.5	7.8	174.9	12.2	12.9	13.9	3.0	5.8	3.8	18.7	27.5	126.5	20.6
AC068533.4		ENSG00000249319			7	66087761-66152277	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"liver: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"																	NA	NA						"unprognostic (7.24e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.79e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.50e-3)"	"unprognostic (9.62e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.13e-1)"		"unprognostic (1.19e-1)"	"unprognostic (1.34e-1)"	1.2	1.3	1.9	1.7	2.0	1.6	2.1	3.2	2.4	2.8	4.4			2.7	1.1	1.4	1.1	1.2	0.8	0.8	1.7	2.6	3.6	10.0	1.5	0.2	1.9		2.1	1.6	5.4	1.6	0.6		1.7	3.9		1.0	1.6	0.6	0.8	1.4	1.8	2.2	1.0	2.2	0.2			1.2		1.2	0.9	1.1	6.5	2.9	6.5	7.9	4.8	6.4	2.3	2.9	0.0	3.0	2.3	5.1	6.9	0.7	3.6	4.2	1.6	2.3	1.4	3.8	2.6	3.5	8.7	7.8	4.2	0.8	2.1	6.1	0.8	2.1	0.9	2.0	1.6	3.0	1.8	3.7	4.6	4.4	7.1	11.7	7.2	2.2	1.2	2.4	1.5	2.0	1.3	2.3	2.5	2.4	12.2	2.2	1.1	1.8	4.1	5.0	1.6	2.8	5.1	2.6	14.3	0.9	7.8	5.0	0.8	5.3	2.1	2.1	3.7	4.3	2.6	3.3	1.3	10.2	5.4	2.0	5.9	3.7	4.8	6.4	4.3	6.4	6.5	2.8	4.9	2.9	5.0	4.4	5.4	6.5	4.8	7.9	2.2	4.7	2.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRCP	"CGRP-RCP, RCP, RCP9"	ENSG00000241258	"CGRP receptor component"	O75575	7	66114604-66154568	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007216	Approved		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA007216: AB_1856160"	"unprognostic (2.36e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.42e-3)"	"unprognostic (3.38e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.67e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.59e-3)"	"unprognostic (8.49e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.87e-2)"	"unprognostic (4.81e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.06e-1)"	19.0	19.8	18.5	13.1	21.5	32.5	18.7	26.1	23.3	18.2	18.8	17.0	19.6	16.5	20.9	16.1	21.4	19.4	15.8	18.1	15.4	18.9	17.7	22.3	17.0	15.5	16.0	19.5	19.8	33.9	23.7	22.3	14.2	16.7	18.9	21.3	17.6	31.6	17.9	19.5	20.5	14.6	21.8	18.8	16.5	17.8	19.1	15.6	15.0	21.3	13.3	17.1	22.2	20.0	14.5	11.3	20.2	14.6	9.2	17.7	10.5	17.7	11.7	7.9	10.8	11.8	15.0	8.0	12.0	14.0	19.2	14.9	17.6	14.7	15.6	15.2	11.4	15.8	13.1	11.0	15.2	20.0	10.7	10.8	8.9	7.6	7.5	7.7	18.8	13.5	11.8	13.7	16.5	31.5	12.0	10.3	9.3	20.0	12.2	12.8	13.5	14.0	13.3	16.2	24.2	14.1	14.9	12.8	15.6	11.1	16.4	19.6	26.0	14.2	39.5	12.0	9.9	31.8	9.1	11.5	26.7	14.2	14.9	22.6	15.1	27.8	22.1	15.3	14.7	21.4	18.9	11.7	18.5	17.7	10.1	17.3	14.2	15.3	14.4	8.5	14.5	14.7	17.1	20.2	9.2	14.6	11.3	14.7	10.5	18.5	21.5	26.1	23.3	15.4	18.9	16.0	19.5	16.7	15.6	26.8	23.8	16.4	18.7	11.8	29.5	21.6	10.2	50.9	29.6	15.7	21.6	10.9	29.9	17.3	3.3	12.4	9.8	0.0	21.5	10.0	11.6	21.9	32.4	22.5	10.8	28.6	15.4	10.4	9.9	3.0	17.3	13.5	15.1	20.8	13.3	19.3	22.0	12.7	20.8	13.7	22.8	6.5	11.3	21.6	16.8	12.9	9.6	25.5	12.0	27.4
TPST1	TANGO13A	ENSG00000169902	"Tyrosylprotein sulfotransferase 1"	O60507	7	66205199-66420543	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Fibroblasts: 72.5;Spermatocytes: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 21.3;neutrophil: 17.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047415, HPA061837"	Approved		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA047415: AB_10964056, HPA061837: AB_2732672"	"unprognostic (7.46e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.78e-3)"	"unprognostic (5.71e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.59e-1)"	"unprognostic (9.25e-3)"	"unprognostic (4.12e-2)"	"unprognostic (4.98e-1)"	"prognostic unfavorable (8.16e-6)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (3.73e-5)"	15.4	12.8	16.7	9.8	28.2	5.6	11.2	12.2	19.2	34.0	7.7	8.8	3.4	3.4	20.2	13.8	10.8	10.9	34.2	6.6	26.1	22.2	13.4	38.9	9.0	5.9	15.3	12.2	11.5	7.1	8.1	19.6	23.2	28.1	15.5	7.9	9.7	5.4	15.8	2.9	6.2	5.9	35.7	27.5	9.0	10.0	19.6	11.4	0.3	10.7	3.2	5.2	27.2	19.9	6.3	0.1	21.3	1.1	3.9	2.0	0.8	4.3	2.6	6.8	8.6	20.7	16.6	2.1	8.2	19.0	10.2	14.4	8.3	2.5	0.5	6.6	16.8	16.2	3.4	6.3	9.3	13.5	1.2	3.6	0.9	6.4	6.3	24.5	0.7	0.7	23.5	7.4	19.4	8.6	11.3	12.3	1.1	0.4	3.9	15.5	2.3	0.0	1.1	6.1	0.1	3.5	3.0	5.5	4.4	10.5	4.6	3.9	16.8	10.4	0.8	22.1	14.1	3.3	1.7	23.4	13.0	8.3	9.3	14.9	3.5	4.8	1.7	11.5	2.6	18.3	21.3	1.1	10.7	0.4	0.0	0.3	2.4	0.2	0.3	0.1	6.3	1.1	2.0	17.3	3.9	0.0	0.0	0.0	0.8	16.7	28.2	12.2	19.2	26.1	22.2	15.3	12.2	28.1	11.4	0.0	6.2	6.2	7.4	9.6	9.4	1.2	2.5	18.7	5.7	29.6	2.0	1.7	8.3	19.8	7.2	17.9	0.0	0.0	42.8	3.7	72.5	4.4	4.6	28.0	14.3	6.4	7.5	12.9	5.1	9.1	44.5	5.6	13.5	27.1	0.7	4.9	20.9	0.0	35.0	3.1	3.7	6.5	26.4	81.4	24.5	6.6	3.2	0.0	0.4	7.0
KCTD7	"CLN14, EPM3, FLJ32069"	ENSG00000243335	"Potassium channel tetramerization domain containing 7"	Q96MP8	7	66628767-66649067	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Epilepsy, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.53e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (1.30e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.49e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.97e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.45e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.19e-2)"	7.1	12.2	14.5	9.2	17.6	5.6	8.0	16.4	18.3	11.6	11.9	27.6	6.0	6.1	16.7	16.3	5.7	11.4	9.4	11.0	14.4	13.9	7.1	4.0	8.5	13.5	27.3	15.4	20.6	4.1	14.1	10.5	9.6	21.7	12.9	8.4	16.8	6.3	13.8	6.1	7.2	9.6	15.4	26.7	11.1	8.6	18.6	20.7	3.9	9.9	3.0	13.8	10.8	8.9	4.7	2.0	10.2	2.1	3.9	6.3	2.0	3.1	6.2	13.9	9.9	6.2	8.3	1.0	5.3	6.6	9.2	8.3	9.2	4.3	10.2	1.4	7.1	22.6	1.8	12.1	1.5	7.9	10.5	5.1	1.1	15.5	5.5	3.6	2.7	8.7	4.8	5.4	7.4	4.2	10.7	4.3	5.7	9.9	9.6	6.1	1.3	3.1	3.9	8.1	1.2	5.4	3.6	5.1	4.7	5.0	1.4	7.1	12.3	4.0	2.7	10.5	13.0	4.6	3.1	4.8	10.0	7.3	3.8	4.2	4.5	3.0	8.0	12.9	3.8	7.6	3.9	1.9	10.2	5.8	1.5	6.3	3.7	5.0	4.4	2.0	4.7	3.3	4.6	1.7	3.9	2.1	2.0	5.0	2.0	14.5	17.6	16.4	17.7	14.4	13.9	27.3	15.4	21.7	20.7	3.0	7.0	6.9	1.3	1.0	15.0	9.8	0.0	2.7	3.4	0.0	35.3	3.9	1.7	1.0	6.5	3.8	2.0	0.0	1.1	1.8	2.5	1.9	4.7	1.6	4.8	17.5	8.1	6.7	3.4	12.3	6.1	3.2	1.7	3.6	2.1	19.3	0.8	3.5	11.7	1.3	54.7	6.5	3.1	12.2	8.2	1.0	2.3	8.5	2.0	0.3
RABGEF1	"rabex-5, RABEX5"	ENSG00000154710	"RAB guanine nucleotide exchange factor 1"	Q9UJ41	7	66682164-66811464	"Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA001407			Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA001407: AB_1856024"	"unprognostic (6.65e-2)"	"unprognostic (6.44e-4)"	"unprognostic (7.32e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (4.06e-5)"	"unprognostic (3.77e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.64e-4)"	"unprognostic (6.45e-2)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.43e-1)"	"unprognostic (5.55e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.39e-1)"	18.4	15.2	13.0	14.7	14.4	59.2	12.0	22.4	16.8	16.9	14.1	12.6	9.4	9.1	16.4	9.5	20.6	12.0	13.5	10.8	13.5	15.6	14.9	17.2	10.5	10.6	12.8	12.1	14.7	13.2	13.3	10.2	18.8	13.5	13.1	11.0	13.8	10.6	16.1	12.1	21.9	15.5	15.3	11.9	15.3	11.9	21.5	9.8	13.1	22.3	20.7	18.2	19.1	16.3	15.7	10.4	18.1	13.5	15.4	10.9	7.6	20.6	6.2	5.4	9.1	14.7	20.6	5.4	18.2	23.3	19.2	18.3	5.8	13.4	10.1	7.1	26.3	14.1	8.7	7.4	9.8	26.8	6.9	5.9	5.4	7.3	5.7	11.7	9.2	7.7	10.2	12.7	24.7	27.4	15.9	5.0	6.9	9.9	7.4	19.0	10.4	6.2	12.9	7.1	9.6	9.0	5.5	9.4	7.6	16.8	9.5	6.2	9.7	8.4	18.6	9.8	9.4	10.7	5.8	6.5	31.2	6.5	19.1	14.2	9.6	12.5	12.0	14.4	10.3	9.9	18.1	7.8	9.4	8.6	6.9	9.3	11.2	8.1	10.9	7.3	15.7	8.8	8.2	15.1	15.4	13.5	10.4	6.7	7.6	13.0	14.4	22.4	16.8	13.5	15.6	12.8	12.1	13.5	9.8	11.9	13.8	5.2	6.5	3.7	9.7	4.2	0.0	20.1	18.2	5.2	15.7	3.2	10.0	4.5	4.1	5.8	5.9	0.0	4.8	3.0	5.1	10.1	13.9	5.9	4.2	7.9	17.2	4.9	12.3	1.8	5.5	9.3	1.7	5.4	5.1	4.8	12.5	14.0	8.9	4.0	16.7	0.0	7.3	6.6	6.4	5.8	11.3	2.5	4.7	11.1
TMEM248	"C7orf42, FLJ10099, FLJ13090"	ENSG00000106609	"Transmembrane protein 248"	Q9NWD8	7	66921225-66958551	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016495	Uncertain		Approved	Vesicles		NA	NA		1200000	Vesicles		"HPA016495: AB_1848643"	"unprognostic (6.74e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.86e-2)"	"unprognostic (4.64e-2)"	"unprognostic (6.67e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.57e-2)"	32.2	33.0	23.8	30.2	30.6	11.9	44.6	28.0	28.4	38.7	32.8	23.8	39.0	32.1	40.6	32.9	26.0	36.1	40.7	28.2	24.6	30.4	30.9	46.3	31.6	38.3	20.9	21.3	40.8	58.4	47.2	28.9	35.6	21.0	34.7	32.4	39.4	36.9	36.8	19.1	23.7	44.8	34.7	23.8	32.6	33.7	33.3	20.6	40.1	37.7	24.0	35.9	33.2	40.7	10.7	10.1	8.6	5.2	9.0	9.3	2.3	18.2	21.5	18.2	25.9	41.5	32.0	16.0	22.5	38.8	21.5	23.3	15.5	24.0	18.6	27.5	30.3	29.4	16.6	15.6	18.6	26.8	17.0	11.5	13.6	15.4	17.9	26.9	22.5	18.9	28.7	21.6	18.0	15.0	31.4	27.9	14.6	25.9	12.5	34.0	11.1	21.1	27.8	27.0	18.9	14.7	15.5	21.2	31.4	29.1	14.1	12.7	27.2	19.8	36.5	19.9	28.4	18.3	20.8	25.7	30.3	14.9	19.7	24.6	15.4	17.3	20.9	25.3	25.2	28.7	2.3	5.0	8.6	7.9	5.2	9.3	9.6	8.5	8.1	3.9	10.7	8.4	8.8	7.4	9.0	3.1	10.1	5.6	2.3	23.8	30.6	28.0	28.4	24.6	30.4	20.9	21.3	21.0	20.6	47.6	36.0	52.8	43.6	57.4	17.6	20.0	56.0	26.8	22.7	50.6	5.9	43.1	10.0	31.7	90.3	43.5	63.0	23.3	40.8	69.9	58.2	82.8	27.7	96.6	46.4	17.5	26.6	55.9	54.2	141.2	59.0	47.5	47.2	24.4	75.1	91.8	47.7	67.4	61.9	30.6	12.3	32.3	48.4	79.2	60.9	64.5	73.7	59.8	53.0	69.4
SBDS	"CGI-97, FLJ10917, SDS, SWDS"	ENSG00000126524	"SBDS, ribosome maturation factor"	Q9Y3A5	7	66987677-66995601	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 1381.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028891	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		55000	"Nucleoplasm, Cytosol"		"HPA028891: AB_10601500"	"prognostic unfavorable (1.49e-4)"	"unprognostic (1.87e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.71e-3)"	"unprognostic (8.06e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.99e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-3)"	40.9	34.5	37.7	18.7	44.0	41.7	44.5	23.6	43.2	30.7	37.5	35.3	20.2	39.1	35.6	27.3	40.8	27.7	34.0	70.0	39.2	40.9	36.9	38.4	32.1	16.7	50.6	36.6	31.9	27.5	50.4	26.9	38.6	44.6	35.1	35.7	20.1	23.5	40.5	130.7	26.1	34.4	52.0	63.2	16.7	32.8	15.9	48.2	7.2	33.9	38.7	15.6	54.0	38.0	21.6	15.5	20.8	12.6	16.6	39.1	19.4	31.4	13.3	11.8	10.7	43.2	32.3	13.2	53.5	44.1	41.0	31.5	27.4	16.2	11.7	40.6	48.9	27.1	15.3	19.9	31.8	44.1	11.1	26.3	5.7	24.9	16.4	38.5	14.6	8.0	29.1	42.8	31.1	54.2	21.2	25.2	7.7	42.2	12.8	63.6	18.8	7.7	21.2	13.1	43.4	31.7	5.9	25.5	24.4	43.2	14.1	18.2	12.5	26.8	46.4	35.5	27.3	34.6	12.4	33.5	55.4	18.9	28.0	39.0	7.9	9.3	26.7	19.0	24.0	30.6	20.8	11.1	20.2	23.4	12.6	29.6	21.6	30.6	27.2	11.3	18.7	39.1	31.5	4.7	16.6	11.2	15.5	25.9	19.4	37.7	44.0	23.6	43.2	39.2	40.9	50.6	36.6	44.6	48.2	282.9	101.3	66.6	339.3	412.4	74.2	273.7	79.0	58.9	128.5	87.2	11.8	116.1	222.2	161.5	544.8	139.6	267.8	46.7	145.1	193.1	210.9	212.5	144.6	97.2	95.0	55.6	97.9	127.7	39.0	1381.2	117.6	84.1	243.0	99.2	183.0	124.0	212.7	199.9	158.4	222.6	46.7	161.7	333.7	75.3	45.3	375.9	333.3	96.2	134.2	299.8
TYW1	"FLJ10900, MGC23001, MGC60291, RSAFD1, TYW1A, YPL207W"	ENSG00000198874	"TRNA-yW synthesizing protein 1 homolog"	Q9NV66	7	66995173-67239519	"Enzymes, Predicted membrane proteins"	"tRNA processing"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA013568, HPA014118, HPA015535, HPA043136, HPA047029, HPA047052, HPA052097"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA013568: AB_2668852, HPA014118: AB_2668941, HPA015535: AB_1856487, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723"	"unprognostic (1.53e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (4.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.79e-2)"	15.4	19.1	10.2	12.3	15.4	11.9	15.1	14.9	15.3	18.8	12.9	21.2	18.2	14.1	22.7	15.3	12.0	15.5	10.8	12.9	10.8	9.8	15.2	17.7	11.1	15.5	14.1	10.8	19.4	23.9	22.9	28.0	13.2	14.5	14.9	16.5	17.8	15.3	14.7	26.2	14.4	12.8	14.0	13.9	15.1	12.6	13.7	13.4	19.7	19.0	13.6	23.3	15.3	15.2	9.6	8.3	3.6	9.1	11.2	11.8	5.3	10.6	13.6	8.3	17.2	12.5	8.7	9.7	11.4	8.7	9.0	8.5	15.5	13.9	18.5	17.5	10.5	12.7	12.6	17.2	14.0	13.1	14.5	13.2	8.0	11.3	10.5	12.4	18.4	10.6	8.9	14.2	12.2	18.8	7.1	8.2	13.5	21.0	11.2	10.3	10.5	11.6	15.5	14.6	18.0	12.2	13.2	11.6	23.3	12.2	10.8	12.8	12.7	13.7	26.6	11.4	16.6	18.1	13.1	9.6	10.4	7.4	8.2	15.5	11.3	15.9	22.3	8.5	17.4	14.3	2.0	7.0	3.6	8.6	7.8	11.7	8.5	9.4	9.8	8.3	9.6	11.5	11.8	2.0	11.2	9.1	6.6	6.8	5.3	10.2	15.4	14.9	15.3	10.8	9.8	14.1	10.8	14.5	13.4	6.0	15.4	4.5	4.9	9.3	9.0	8.1	10.2	9.4	4.5	10.4	3.9	16.5	0.0	6.6	5.5	6.7	4.7	0.0	6.0	10.7	7.7	4.9	33.5	12.5	6.9	3.2	4.6	6.7	4.3	3.1	7.8	8.9	8.5	10.0	12.1	7.7	6.1	3.5	7.8	2.1	11.7	19.4	7.1	17.0	22.7	14.8	12.7	8.5	9.7	2.8
AUTS2	"FBRSL2, KIAA0442"	ENSG00000158321	"AUTS2, activator of transcription and developmental regulator"	Q8WXX7	7	69598296-70793495	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Autism, Autism spectrum disorder, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 8.6;naive B-cell: 11.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 28.1;REH: 27.4;SCLC-21H: 38.5;SH-SY5Y: 20.9;T-47d: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000390	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA000390: AB_1845218"	"unprognostic (8.73e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.62e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (7.33e-2)"	10.3	7.3	29.3	11.6	30.3	9.3	20.3	14.3	19.1	10.5	14.0	17.3	4.1	8.9	10.5	12.4	13.7	8.0	16.6	5.6	22.2	12.9	14.6	19.7	14.7	6.1	14.8	12.3	17.2	6.0	9.9	17.4	5.7	18.9	14.6	13.1	9.9	52.1	8.3	14.9	23.3	18.8	13.6	10.2	8.2	11.3	10.0	20.6	10.5	6.7	7.9	8.9	13.0	10.8	11.6	3.2	0.8	0.2	1.5	2.2	0.7	0.1	2.5	28.1	1.5	1.8	1.1	0.3	1.7	0.0	0.1	0.1	9.5	0.1	4.1	0.6	1.7	0.1	9.1	3.4	3.8	0.8	18.6	7.5	2.0	2.6	0.1	0.8	0.0	0.1	2.9	5.2	4.2	1.0	1.0	0.0	4.5	0.1	2.2	2.4	1.6	0.4	0.8	20.0	6.2	0.0	27.4	13.7	11.6	0.0	4.1	38.5	20.9	1.8	3.1	0.0	12.7	26.3	0.0	0.0	0.1	9.4	3.0	17.2	0.0	0.0	14.2	0.0	0.0	0.0	0.8	0.2	0.2	1.6	0.1	2.2	8.6	1.1	1.5	0.7	11.6	0.2	0.9	0.5	1.5	0.1	3.2	0.2	0.7	29.3	30.3	14.3	19.1	22.2	12.9	14.8	12.3	18.9	20.6	17.9	31.0	10.7	17.8	25.3	35.0	19.0	10.2	12.0	19.4	8.7	15.7	1.0	5.0	9.8	26.8	8.3	16.3	0.0	1.1	0.1	11.3	21.3	0.0	24.5	0.7	60.4	27.7	16.0	3.1	14.8	14.7	4.3	16.9	1.0	20.8	14.3	2.6	14.0	13.8	9.8	22.5	25.8	7.4	11.3	15.4	14.1	1.1	19.2	22.7	20.3
GALNT17	"GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17"	ENSG00000185274	"Polypeptide N-acetylgalactosaminyltransferase 17"	Q6IS24	7	71132169-71713600	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.9"	"Cell type enhanced"	"Detected in single"	28	"Collecting duct cells: 1.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.6;NTERA-2: 7.2;RPMI-8226: 8.0;SK-BR-3: 30.5;SuSa: 10.0"	"Low region specificity"	"Detected in all"							"HPA013624, HPA047986"	Approved		Uncertain	"Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"	"Nucleoli, Nuclear bodies"	"HPA013624: AB_1858787, HPA047986: "	"unprognostic (2.79e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.41e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (4.60e-4)"	"unprognostic (2.00e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.96e-2)"	"unprognostic (9.63e-3)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.92e-1)"	"unprognostic (7.94e-3)"	1.8	7.8	8.2	2.1	13.9	0.5	1.2	25.7	42.9	2.3	4.9	1.7	1.9	0.8	7.9	4.6	8.9	4.4	2.7	19.4	13.2	4.6	2.3	0.6	3.5	0.5	2.1	12.0	22.3	9.4	0.6	4.1	0.7	4.5	9.1	1.4	1.2	1.7	8.3	1.9	0.8	1.5	12.3	1.2	3.3	1.1	3.8	0.8	0.3	9.4	0.0	1.8	10.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.5	0.0	0.0	30.5	0.0	10.0	0.0	0.0	0.0	0.0	2.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	13.9	25.7	22.5	13.2	4.6	2.1	12.0	4.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CALN1	CABP8	ENSG00000183166	"Calneuron 1"	Q9BXU9	7	71779491-72447151	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 16.0;brain: 48.5;lymphoid tissue: 20.0"	"Cell type enhanced"	"Detected in some"	11	"Cardiomyocytes: 4.8;Early spermatids: 5.1;Spermatocytes: 6.9;Spermatogonia: 11.4;Suprabasal keratinocytes: 8.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	6	"Karpas-707: 31.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036278, HPA036708"	Approved		Uncertain	"Vesicles,Plasma membrane"		No	No			Vesicles	"Plasma membrane"	"HPA036278: AB_10673125, HPA036708: "	"unprognostic (6.38e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.67e-4)"	"unprognostic (3.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.72e-4)"	"unprognostic (2.99e-1)"	0.8	16.0	10.8	0.8	17.7	1.5	1.0	48.5	39.1	2.3	0.9	5.1	0.0	0.9	1.4	0.8	0.8	1.0	1.3	0.8	9.5	4.4	0.8	1.0	0.9	0.8	6.8	7.3	1.0	1.9	0.8	0.3	0.8	18.6	1.0	0.9	0.0	0.8	2.4	0.9	4.2	0.8	0.9	8.4	0.8	0.8	11.3	3.3	20.0	0.9	0.0	0.8	0.9	1.9	0.3	1.3	0.6	0.4	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	31.4	0.0	0.0	0.0	0.0	4.2	0.0	0.0	4.8	0.0	0.5	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	0.0	0.0	5.0	4.8	0.0	0.2	0.0	0.0	0.6	0.4	0.3	0.2	0.1	0.1	0.2	0.2	0.2	1.3	0.3	0.2	0.2	0.5	0.3	0.1	0.4	0.1	0.1	10.8	17.7	48.5	11.6	9.5	4.4	6.8	7.3	18.6	3.3	0.0	0.0	0.0	0.2	2.1	0.1	4.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	1.8	0.3	3.2	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.7	0.0	0.6	0.0	0.0	6.9	11.4	8.5	0.1	0.0	0.0	0.1
TYW1B	"LINC00069, MGC87315, NCRNA00069, RSAFD2"	ENSG00000277149	"TRNA-yW synthesizing protein 1 homolog B"		7	72558744-72828198	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 9.8;Rod photoreceptor cells: 8.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA013568, HPA014118, HPA043136, HPA047029, HPA047052, HPA052097"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA013568: AB_2668852, HPA014118: AB_2668941, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723"	"unprognostic (2.61e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.91e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.19e-2)"	"unprognostic (8.96e-3)"	"unprognostic (5.78e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.33e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.90e-2)"	2.7	1.6	1.8	4.5	3.8	4.4	4.2	6.0	3.3	5.6	2.9	5.8	7.4	1.5	6.0	5.2	3.4	4.1	1.5	2.3	1.9		3.1	7.9	2.9	2.4	3.9	1.7	10.1	5.7	2.0	11.6	3.0	3.4	4.1	4.4	4.7	4.1	5.9	4.4	2.5	2.9	3.6	4.7	3.0	3.1	7.2	3.8	6.0	5.9	1.8	6.0	3.1	1.1	7.5	5.4	5.7	3.5	2.4	3.0	0.9	2.3	2.5	1.0	2.0	1.6	0.5	1.1	1.2	0.5	1.1	1.1	8.0	4.2	7.3	0.7	0.8	1.0	1.1	1.9	0.8	1.3	7.9	2.3	0.7	1.2	4.7	0.8	7.4	2.1	3.8	0.6	1.3	0.9	0.7	0.7	1.6	10.0	7.7	1.1	1.0	2.4	3.8	1.8	3.1	4.6	1.4	5.5	2.6	1.1	0.8	1.8	0.9	1.5	8.4	4.3	3.3	2.1	2.6	3.2	1.8	4.3	9.7	1.4	6.7	8.1	8.3	0.5	2.1	9.7	4.0	3.5	5.7	3.0	1.8	2.8	7.5	2.0	1.8	1.4	5.2	2.3	2.7	4.3	2.4	1.7	5.4	2.0	0.9											0.0	1.3	4.7	1.8	0.0	3.4	4.8	2.5	2.7	1.2	0.0	9.8	3.5	0.0	2.0	3.3	1.4	1.2	0.0	0.6	1.5	2.1	1.6	1.1	1.5	2.9	1.6	0.0	1.3	1.5	0.4	0.9	0.7	0.0	2.8	2.3	1.6	1.0	0.3	0.7	0.5	8.1	0.0	1.7	5.5	5.1	0.0	1.6	2.2	1.1	0.9
POM121	"DKFZP586G1822, DKFZP586P2220, KIAA0618, POM121A"	ENSG00000196313	"POM121 transmembrane nucleoporin"	Q96HA1	7	72879365-72951440	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cone photoreceptor cells: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB003710, HPA043809, HPA049817"	Approved		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"CAB003710: , HPA043809: AB_2678680, HPA049817: AB_2680896"	"unprognostic (2.33e-1)"	"unprognostic (3.05e-2)"	"unprognostic (9.71e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.38e-2)"	"unprognostic (7.07e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.40e-1)"	19.4	15.2	14.5	16.0	17.7	35.0	14.4	25.9	22.0	13.1	16.6	16.0	14.2	19.5	17.9	14.8	15.8	15.8	14.9	11.8	11.7	10.0	14.0	16.6	13.3	18.7	10.8	12.7	18.6	23.3	14.9	20.6	15.4	13.4	18.6	11.4	20.2	17.4	11.7	18.4	17.0	19.1	12.1	12.7	19.0	16.3	17.3	13.5	24.5	19.5	15.2	22.3	15.8	14.5	3.7	4.3	3.7	3.6	4.5	5.2	2.6	17.1	12.6	15.7	35.3	8.5	7.0	13.1	12.3	10.5	12.3	10.7	22.2	10.9	23.7	4.0	10.6	13.7	13.2	15.6	11.9	13.8	20.5	31.1	17.7	12.6	14.7	8.7	36.6	22.6	9.2	8.5	16.3	15.0	8.0	9.1	13.8	48.4	17.8	12.0	13.2	21.8	23.3	16.5	9.6	15.3	20.0	12.3	20.0	6.2	15.1	22.5	19.8	10.8	20.8	11.0	11.0	17.3	19.3	12.8	22.1	13.6	17.4	24.6	21.4	19.8	34.4	12.9	23.5	21.8	0.1	2.3	3.7	5.2	1.4	3.0	3.0	3.3	3.8	2.6	3.7	3.0	4.3	2.6	4.5	3.6	4.3	1.7	2.6	14.5	17.7	25.9	22.0	11.7	10.0	10.8	12.7	13.4	13.5	35.7	28.2	12.7	8.8	22.3	31.1	4.4	25.5	17.4	20.5	17.4	92.3	14.5	5.0	10.8	6.8	14.2	16.9	23.3	14.7	10.9	16.5	15.7	16.1	20.3	13.8	38.1	17.2	17.8	15.8	4.2	13.8	18.3	18.6	7.2	19.6	18.3	17.2	10.5	16.6	5.4	23.8	12.9	15.9	14.2	11.8	27.0	16.2	18.1	19.0	18.4
TRIM74	"MGC45440, TRIM50C"	ENSG00000155428	"Tripartite motif containing 74"	Q86UV6	7	72959485-72969466	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"stomach 1: 10.9"	"Cell type enhanced"	"Detected in single"	22	"Ciliated cells: 1.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 7.7;Hep G2: 5.4"									HPA047843			Approved	Cytosol		NA	NA			Cytosol		"HPA047843: AB_2680176"	"unprognostic (8.78e-3)"	"unprognostic (3.78e-4)"	"unprognostic (5.84e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.68e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.78e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.12e-3)"	1.1	1.6	0.6	1.0	1.4	1.7	1.0	4.8	0.7	1.1	0.5			2.4	1.3	2.5	0.4	2.3	0.8	0.5	0.6	0.8	1.3	2.3	0.6	1.9	0.4		1.7	5.0	0.2	1.6	0.1		1.6	0.5		1.2	1.0	0.8	1.5	1.2	0.8	0.7	1.6	10.9	6.0			1.5		0.5	0.4	1.0	2.2	0.2	0.7	0.1	0.0	1.1	0.0	0.0	0.3	1.4	1.5	0.5	0.0	0.0	0.8	0.0	0.2	0.5	2.0	1.5	1.0	0.2	0.0	0.5	0.7	0.1	0.1	0.1	0.8	7.7	1.2	0.0	5.4	0.2	2.4	3.3	0.8	0.3	0.0	0.4	1.1	0.0	1.9	1.0	4.6	0.1	2.2	0.9	3.8	0.1	0.0	1.7	1.7	0.6	0.8	2.2	0.8	0.6	0.7	0.8	0.0	1.7	0.2	0.1	1.1	2.7	0.3	1.0	0.5	0.0	3.5	2.7	0.6	1.2	1.4	0.7	0.7	0.0	0.7	1.0	0.0	1.1	2.2	0.7	0.2	0.0	0.1	0.8	0.2	0.0	0.0	0.1	0.2	0.5	0.0											0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.1	0.0	0.0	0.0	0.0
NSUN5	"FLJ10267, NOL1R, NSUN5A, p120(NOL1), WBSCR20, WBSCR20A, Ynl022cL"	ENSG00000130305	"NOP2/Sun RNA methyltransferase family member 5"	Q96P11	7	73302517-73308867	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, RNA-binding, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020536, HPA045590, HPA046867"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA020536: AB_1858789, HPA045590: AB_2679376, HPA046867: AB_2679847"	"unprognostic (3.94e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (3.96e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-2)"	9.0	7.7	11.2	13.1	12.8	40.9	8.7	12.9	14.4	8.5	10.3	15.0	4.8	12.6	12.3	6.9	10.8	12.0	8.1	9.4	10.8	9.3	9.4	9.8	8.0	16.1	19.4	11.9	10.6	19.6	9.5	8.3	8.3	13.6	9.7	6.2	7.7	13.6	9.7	27.1	11.8	12.1	10.9	11.6	15.8	9.6	14.6	13.6	23.5	10.6	11.2	12.1	10.6	8.9	33.5	21.2	18.7	14.4	16.8	22.3	15.3	12.2	17.0	4.8	10.5	2.0	2.5	18.2	5.9	3.4	9.1	9.8	22.9	9.1	20.2	4.0	2.9	13.4	10.6	9.0	5.9	3.0	13.3	20.9	7.6	12.4	13.1	7.8	16.8	10.4	3.4	9.9	7.8	6.6	2.1	1.2	15.2	24.9	4.8	4.3	29.5	14.2	34.6	19.3	9.0	13.1	17.4	3.6	28.9	3.9	6.1	12.4	20.7	10.3	27.6	13.3	5.4	17.7	13.4	1.9	0.1	13.3	13.2	3.9	19.3	24.9	28.8	0.2	23.6	0.9	14.2	14.4	15.0	14.0	12.5	11.0	21.5	15.9	14.3	16.5	33.5	22.3	18.8	18.7	16.8	9.3	21.2	17.3	15.3	11.2	12.8	12.9	14.4	10.8	9.3	19.4	11.9	13.6	13.6	6.0	6.1	51.6	17.1	15.0	25.1	17.1	25.5	10.7	12.5	34.9	11.8	33.4	31.5	36.0	12.8	7.3	18.6	0.0	28.6	37.8	16.9	12.9	26.5	20.3	30.9	30.2	3.5	6.7	17.4	16.3	27.0	19.4	20.3	46.9	16.4	13.8	24.0	17.5	19.4	19.5	21.4	6.5	14.1	60.6	58.5	18.6	18.2	25.4	19.9	15.5
TRIM50	"FLJ32804, TRIM50A"	ENSG00000146755	"Tripartite motif containing 50"	Q86XT4	7	73312539-73328082	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"pancreas: 17.2;stomach 1: 22.8"	"Cell type enhanced"	"Detected in some"	14	"Distal tubular cells: 1.7;Early spermatids: 1.9;Spermatocytes: 4.4;Spermatogonia: 4.5"	"Group enriched"	"Detected in some"	8	"liver cancer: 2.9;renal cancer: 6.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	33	"Hep G2: 12.3"									"HPA019862, HPA047843"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA019862: AB_1858305, HPA047843: AB_2680176"	"unprognostic (1.93e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (9.36e-7)"	"unprognostic (3.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.25e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0		0.0	17.2	0.2	0.0	0.3		0.0	0.0		0.0	0.0	1.8	0.0	1.0	0.0	0.0	0.1	22.8	4.4			0.0		0.0	0.0	0.0	0.9	0.3	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	12.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.4	1.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	4.4	4.5	0.0	0.1	0.0	0.0	0.0
FKBP6	"FKBP36, PPIase"	ENSG00000077800	"FK506 binding protein 6"	O75344	7	73328164-73358637	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	63	"testis: 33.0"	"Cell type enhanced"	"Detected in some"	18	"Early spermatids: 62.1;Late spermatids: 61.4;Spermatocytes: 105.5;Spermatogonia: 35.0"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.3;Karpas-707: 1.5;SiHa: 2.1;U-266/84: 1.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA061109	Enhanced					NA	NA					"HPA061109: AB_2684430"	"unprognostic (5.07e-2)"	"unprognostic (3.34e-2)"		"unprognostic (1.56e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.98e-2)"	"unprognostic (8.72e-3)"	"unprognostic (4.34e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.60e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.20e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.47e-1)"	"unprognostic (6.86e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.3	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.5	0.0	0.5	0.6	0.8	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.3	0.3	2.1	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.8	0.2	0.7	1.3	0.0	0.4	0.3	0.3	0.5	0.3	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.8	0.4	0.0	20.1	2.3	0.0	0.0	0.0	0.0	0.3	62.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	61.4	2.8	0.0	0.0	0.0	0.0	0.5	0.2	0.0	1.1	0.0	0.3	0.0	0.0	105.5	35.0	0.0	0.1	0.0	0.0	0.1
FZD9	"CD349, FZD3"	ENSG00000188763	"Frizzled class receptor 9"	O00144	7	73433783-73436120	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 14.4"	"Group enriched"	"Detected in some"	5	"Early spermatids: 7.3;Late spermatids: 10.0;Muller glia cells: 4.8;Sertoli cells: 6.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 6.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 8.4;MCF7: 3.6;NTERA-2: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (9.60e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.90e-5)"	"unprognostic (8.99e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.21e-2)"	4.4	1.2	6.8	0.7	4.7	2.4	1.1	3.3	7.0	1.1	1.3	4.5	0.0	1.9	0.9	0.9	1.3	0.9	0.7	0.8	7.1	6.3	0.9	0.8	0.9	0.9	7.0	4.5	0.9	3.8	1.6	4.3	1.9	5.0	3.0	0.8	1.4	4.4	1.4	14.4	1.7	2.9	0.9	3.6	1.0	1.0	5.4	6.7	0.3	0.9	1.7	0.8	0.7	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.6	2.7	2.8	3.1	0.0	0.1	0.0	1.9	0.0	0.4	0.1	0.7	0.0	0.0	0.9	0.1	1.2	0.2	1.4	0.0	0.0	0.0	8.4	0.0	0.6	0.9	1.2	0.0	0.3	0.3	0.0	0.1	0.0	0.1	0.2	0.0	2.8	0.0	0.2	3.6	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.7	2.4	1.7	1.8	0.4	1.7	0.9	0.1	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	6.8	4.7	3.3	7.0	7.1	6.3	7.0	4.5	5.0	6.7	0.0	0.0	0.0	0.7	0.6	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.3	0.6	0.0	0.0	0.3	0.2	0.3	1.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	1.0	0.0	4.8	0.2	0.0	0.4	0.0	0.7	6.5	0.5	0.4	0.3	1.0	0.0	0.0	0.0	0.3
BAZ1B	"WBSCR10, WBSCR9, WSTF"	ENSG00000009954	"Bromodomain adjacent to zinc finger domain 1B"	Q9UIG0	7	73440398-73522278	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037081, CAB037158, HPA067010"	Supported		Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"CAB037081: AB_477637, CAB037158: AB_477636, HPA067010: AB_2685763"	"unprognostic (1.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.16e-1)"	23.3	22.3	21.4	26.4	23.9	20.7	24.6	32.4	23.4	24.6	24.2	21.1	34.1	15.3	26.3	19.8	18.1	20.6	16.5	19.8	22.4	21.4	17.1	23.4	19.4	24.7	29.3	19.4	31.8	20.2	34.9	27.0	23.1	22.3	23.1	20.5	16.4	18.0	30.8	28.9	14.6	19.2	28.7	22.9	22.2	18.8	16.2	27.3	46.5	23.5	17.9	27.7	24.7	24.4	5.3	6.2	6.1	3.1	5.6	6.3	1.7	21.0	21.7	29.9	33.4	15.5	16.6	10.0	20.5	15.7	19.7	20.8	17.6	16.0	39.8	4.8	18.2	30.1	14.8	36.3	13.6	29.8	22.4	18.4	23.7	25.8	15.2	17.3	35.7	20.1	11.8	13.3	24.3	30.0	14.8	15.7	21.8	41.2	25.1	22.1	20.0	36.5	16.4	19.4	16.2	16.2	37.2	26.2	26.5	11.2	16.5	30.0	25.6	29.2	32.6	17.0	26.7	20.0	17.9	18.3	34.3	19.8	20.5	34.8	14.5	23.1	68.2	19.4	33.8	31.0	6.1	3.1	1.9	6.3	2.2	5.5	2.5	4.8	4.6	2.1	5.3	3.8	4.1	2.2	5.6	1.7	6.2	4.7	1.7	21.4	23.9	32.4	23.4	22.4	21.4	29.3	19.4	22.3	27.3	71.5	120.0	59.6	29.7	26.6	70.4	68.2	28.1	69.6	93.3	19.2	41.2	44.5	6.6	33.2	6.4	50.4	22.5	0.0	19.8	50.2	34.4	24.5	48.7	47.1	29.2	57.2	33.4	30.7	35.9	5.9	56.7	29.8	11.8	39.7	25.8	48.9	24.9	5.8	71.8	11.3	51.0	32.3	46.7	59.6	105.4	22.1	28.9	43.6	35.7	33.8
BCL7B		ENSG00000106635	"BCL tumor suppressor 7B"	Q9BQE9	7	73536356-73558002	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Differentiation, Wnt signaling pathway"		"Allergen, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049943, HPA058069"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049943: AB_2680963, HPA058069: AB_2683594"	"unprognostic (2.79e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.37e-2)"	"unprognostic (9.43e-2)"	"prognostic favorable (4.38e-4)"	"unprognostic (4.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.32e-1)"	24.3	13.6	19.2	10.3	21.7	44.1	21.2	10.2	24.2	10.8	21.4	10.3	12.5	11.2	12.1	12.2	13.1	9.7	12.2	28.7	17.6	14.0	15.2	16.6	15.9	11.5	12.8	13.7	7.9	9.9	13.9	16.1	15.3	13.1	11.7	10.7	14.9	10.4	14.9	43.2	7.7	16.5	20.8	9.3	14.2	15.2	15.8	10.6	11.9	13.7	9.3	11.6	16.4	12.5	13.2	14.6	14.4	15.4	17.1	12.8	5.7	18.5	9.4	5.4	11.0	4.4	6.0	9.6	20.6	14.7	14.7	11.7	10.4	16.4	19.3	4.3	13.1	17.3	7.7	4.9	9.4	12.3	19.2	9.4	10.0	5.8	5.5	11.1	14.3	25.7	4.5	8.1	13.2	13.2	5.5	9.1	6.9	14.9	13.7	8.2	15.4	26.1	15.8	12.8	10.5	23.9	13.5	7.1	17.4	9.8	12.9	15.4	16.1	16.2	15.9	13.0	3.3	11.1	15.0	12.6	17.6	14.6	10.3	21.2	12.8	10.7	28.9	16.2	19.7	18.4	10.3	12.0	14.4	10.1	13.6	12.0	10.2	11.5	12.8	11.8	13.2	12.0	10.6	7.0	17.1	15.4	14.6	9.1	5.7	19.2	21.7	10.2	24.2	17.6	14.0	12.8	13.7	13.1	10.6	29.8	16.5	31.6	71.7	57.5	27.0	27.7	17.8	12.0	15.9	15.7	5.9	59.7	46.4	37.9	5.2	31.9	47.7	0.0	40.1	35.9	32.0	54.5	32.3	17.1	45.7	39.7	33.1	25.8	22.4	5.9	23.9	39.6	30.4	45.1	29.3	22.9	49.1	49.1	28.7	33.5	15.3	45.3	46.7	60.8	68.5	50.4	85.1	55.4	35.3	58.1
TBL2	"DKFZP43N024, WBSCR13, WS-betaTRP"	ENSG00000106638	"Transducin beta like 2"	Q9Y4P3	7	73568932-73578791	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 70.5"	"Group enriched"	"Detected in many"	7	"Early spermatids: 291.7;Late spermatids: 375.4;Spermatocytes: 284.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007477, HPA051533"			Supported	Cytosol	"Secreted in male reproductive system"	NA	NA			Cytosol		"HPA007477: AB_1080214, HPA051533: AB_2681523"	"unprognostic (9.04e-2)"	"unprognostic (6.61e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (2.24e-3)"	"unprognostic (7.50e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.88e-5)"	"unprognostic (1.59e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.31e-1)"	8.9	12.1	3.7	5.4	3.3	1.8	5.9	2.7	5.3	8.7	6.6	3.4	11.6	6.1	6.5	10.9	7.3	5.5	6.3	5.4	2.5	2.5	6.1	14.2	6.5	4.7	3.5	2.1	10.7	27.0	8.5	7.0	13.0	3.4	6.5	6.9	5.1	16.3	8.0	4.9	6.9	6.3	5.4	3.0	5.4	8.2	70.5	3.7	6.2	11.8	4.2	5.2	8.5	6.2	4.2	14.4	13.2	11.4	8.3	6.7	7.6	12.2	14.0	4.8	7.1	13.2	12.8	6.0	14.7	11.0	5.6	10.1	21.4	13.2	10.0	3.3	12.9	11.9	9.4	10.2	5.9	11.1	3.9	6.9	3.6	7.4	14.0	19.0	7.3	13.3	7.9	10.2	17.1	13.7	10.9	6.4	1.9	14.7	7.9	8.5	11.9	7.1	7.2	5.0	15.0	11.5	4.6	8.7	22.1	7.2	8.6	5.1	8.2	14.6	40.0	9.2	6.6	10.5	5.6	10.8	10.6	5.2	9.8	14.8	15.9	9.9	11.3	13.6	9.0	12.3	13.2	11.4	5.2	6.6	7.9	6.5	3.4	5.6	6.0	14.4	4.2	6.7	4.2	1.0	8.3	7.0	10.8	6.5	7.6	3.7	3.3	2.7	5.3	2.5	2.5	3.5	2.1	3.4	3.7	23.8	9.4	12.3	11.1	4.0	10.0	4.5	12.7	6.7	7.9	5.2	7.9	39.4	1.7	21.8	291.7	9.8	10.9	0.0	26.3	45.4	11.5	14.0	13.9	15.3	26.0	3.2	9.1	12.9	7.5	375.4	21.9	7.9	6.8	23.4	15.7	7.8	21.3	14.4	25.1	5.0	12.9	6.5	8.0	284.6	22.2	3.1	36.3	3.3	14.3	7.5
MLXIPL	"bHLHd14, CHREBP, MIO, MONDOB, WBSCR14, WS-bHLH"	ENSG00000009950	"MLX interacting protein like"	Q9NP71	7	73593194-73624543	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 103.6"	"Group enriched"	"Detected in many"	6	"Cholangiocytes: 71.4;Hepatocytes: 220.3;Intestinal endocrine cells: 86.4"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 60.9"	"Region enhanced"	"Detected in many"		"cerebellum: 20.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 30.1;K-562: 9.0;SCLC-21H: 16.2;T-47d: 7.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064640			Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA064640: AB_2685309"	"unprognostic (1.11e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.18e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.04e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.46e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.13e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.72e-3)"	30.0	18.0	4.2	0.8	3.9	0.5	10.9	20.4	6.8	1.1	16.5	0.4	2.6	33.2	0.4	22.1	1.0	3.5	5.5	1.8	3.2	1.7	11.6	103.6	0.9	0.4	1.2	4.0	2.0	6.5	4.0	3.9	0.4	5.0	0.9	1.3	1.1	2.7	0.9	24.7	1.2	27.1	0.7	1.2	0.4	3.5	5.7	0.0	0.0	2.0	7.7	0.4	0.8	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.6	0.0	3.7	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.3	0.0	0.1	0.0	0.3	0.7	0.0	0.0	0.0	0.1	4.6	0.0	2.5	30.1	0.8	0.1	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	3.5	0.0	0.0	0.4	4.8	0.7	0.0	0.0	0.7	0.0	0.0	16.2	0.4	0.5	2.5	0.0	0.0	7.3	3.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.2	3.9	20.4	6.8	3.2	1.7	1.2	4.0	5.0	0.0	0.0	14.4	0.0	4.4	1.0	3.5	2.1	71.4	5.3	7.9	3.5	19.6	0.1	1.7	1.8	1.7	1.5	5.2	0.0	0.9	0.1	2.5	2.1	0.0	220.3	0.4	1.6	86.4	12.3	11.6	0.2	2.6	1.7	6.8	0.0	7.7	2.8	2.2	4.2	1.1	9.9	7.4	0.0	1.9	3.6	0.9	0.6	0.5	2.9	10.3	2.5
VPS37D	"MGC35352, WBSCR24"	ENSG00000176428	"VPS37D, ESCRT-I subunit"	Q86XT2	7	73667825-73672112	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 10.7;Collecting duct cells: 10.4;Distal tubular cells: 8.3;Muller glia cells: 7.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040978	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA040978: AB_10805833"	"unprognostic (2.98e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (2.07e-5)"	"unprognostic (4.19e-2)"	"prognostic favorable (5.80e-9)"	"unprognostic (9.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.43e-1)"	2.6	1.7	7.2	0.8	8.3	0.6	2.9	7.5	9.2	4.7	1.9	3.8	1.7	4.1	3.9	6.9	0.9	6.4	3.2	3.9	6.0	7.6	8.8	6.2	1.8	0.7	5.1	2.6	6.0	5.3	3.8	2.4	1.0	5.3	4.5	0.7	2.2	7.2	5.0	2.8	2.3	2.4	1.9	3.8	1.2	1.9	5.5	3.3	0.8	7.4	0.2	0.5	3.6	5.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.7	2.9	2.3	4.8	1.6	3.2	1.4	1.2	2.0	1.0	1.2	0.3	0.8	1.0	1.1	1.6	2.7	0.3	2.5	1.1	0.3	0.4	2.5	0.0	0.2	3.2	4.2	0.0	1.4	2.5	0.7	1.4	0.5	4.6	1.1	4.1	1.3	0.2	1.4	3.5	0.7	0.1	1.6	0.8	4.2	0.1	0.1	0.2	3.9	0.3	4.7	15.0	0.0	2.0	2.7	0.4	4.8	0.2	1.7	2.9	4.0	1.7	1.0	1.9	0.2	1.3	6.5	0.0	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	7.2	8.3	7.5	7.2	6.0	7.6	5.1	2.6	5.3	3.3	0.0	0.0	0.0	0.5	0.9	10.7	1.6	0.0	0.0	0.0	10.4	0.0	0.1	8.3	3.3	0.7	0.5	0.0	0.0	0.7	0.3	0.9	1.4	0.0	5.1	0.1	0.0	4.7	1.8	0.0	0.7	1.7	0.0	5.0	1.0	0.0	7.7	1.8	0.6	2.5	6.3	4.9	0.0	1.4	0.5	5.7	1.0	0.2	0.0	0.2	0.3
DNAJC30	WBSCR18	ENSG00000176410	"DnaJ heat shock protein family (Hsp40) member C30"	Q96LL9	7	73680969-73683453	"Predicted membrane proteins"	"ATP synthesis"	Chaperone	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Late spermatids: 179.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017318		Supported				NA	NA					"HPA017318: AB_1858788"	"unprognostic (1.86e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.85e-3)"	"unprognostic (4.60e-2)"	"prognostic favorable (4.91e-8)"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.20e-2)"	13.3	20.6	14.7	8.3	15.8	6.4	8.9	8.5	23.4	10.2	8.9	11.1	11.7	9.2	10.2	15.3	7.4	12.0	14.8	18.6	13.4	14.2	14.7	22.1	8.2	9.5	11.8	14.1	14.9	12.2	11.1	14.5	10.3	15.0	12.6	8.2	10.6	14.3	12.3	12.9	7.2	9.2	7.5	7.9	10.0	10.3	24.4	7.3	12.7	16.5	9.7	8.1	9.4	6.0	12.5	7.5	4.6	7.3	6.7	11.9	5.7	6.2	6.2	4.5	9.1	7.2	5.1	4.8	9.8	7.3	7.6	7.5	5.9	6.5	5.5	2.5	7.7	11.2	8.8	4.1	5.5	4.3	6.4	8.3	3.2	5.7	6.2	7.5	5.4	4.5	5.7	4.5	7.0	6.0	5.4	6.6	7.1	6.4	5.0	7.5	12.5	8.6	10.8	3.9	5.7	10.6	5.9	3.5	13.3	9.8	7.3	12.4	6.6	10.0	17.6	7.1	4.8	16.0	3.5	6.4	8.1	5.8	8.4	6.9	5.3	3.6	5.2	6.5	3.7	9.9	4.6	7.3	4.6	8.1	6.7	10.0	9.0	9.8	9.7	7.3	12.5	11.9	9.9	1.0	6.7	5.1	7.5	6.7	5.7	14.7	15.8	8.5	23.4	13.4	14.2	11.8	14.1	15.0	7.3	17.9	3.8	14.7	14.1	5.3	34.8	15.1	15.3	6.7	13.6	17.4	13.7	34.8	48.0	26.0	87.9	5.7	9.5	0.0	24.5	14.7	11.1	12.4	12.7	22.1	19.6	19.1	16.7	12.9	9.4	179.1	22.7	9.2	13.5	36.1	11.8	22.1	17.9	7.0	17.3	60.7	28.3	19.4	8.0	32.1	14.1	7.2	30.1	11.8	15.7	10.5
BUD23	"MERM1, MGC19709, MGC2022, MGC5140, PP3381, WBMT, WBSCR22"	ENSG00000071462	"BUD23, rRNA methyltransferase and ribosome maturation factor"	O43709	7	73683025-73705161	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 144.6;Exocrine glandular cells: 122.2;Pancreatic endocrine cells: 97.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 113.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052185	Approved		Supported	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA052185: AB_2681753"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.62e-3)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (9.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.20e-2)"	"unprognostic (6.71e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-3)"	16.6	23.4	16.3	15.0	18.8	19.6	18.3	12.3	20.6	17.5	19.3	17.9	19.5	18.3	19.1	30.6	17.5	24.1	23.1	34.2	16.0	17.5	28.1	36.3	16.1	18.3	25.3	17.5	19.3	27.9	14.3	21.8	22.1	16.4	16.5	19.8	20.3	25.1	25.6	52.2	19.3	21.6	21.2	18.7	18.7	18.9	97.0	16.5	22.1	25.8	22.6	22.7	18.7	14.8	43.9	49.0	14.4	18.3	30.1	37.6	31.4	22.2	24.6	9.0	71.4	12.4	11.1	15.0	15.4	13.9	19.9	16.3	34.0	30.1	26.0	8.1	16.5	34.3	16.0	20.7	14.9	18.4	18.2	24.0	11.3	28.7	13.7	15.7	31.7	16.6	10.0	17.2	17.5	15.9	10.1	12.8	21.5	44.7	48.2	17.2	35.1	19.9	43.6	21.5	51.7	28.3	17.8	17.6	113.3	22.0	16.1	27.3	20.5	20.6	55.0	22.8	9.3	34.6	25.4	13.7	17.2	21.9	21.7	32.9	16.7	29.2	43.7	39.4	24.2	35.9	11.5	17.1	14.4	30.7	18.3	34.3	43.9	35.5	33.6	31.5	38.0	37.6	34.4	3.2	30.1	16.2	49.0	37.3	31.4	16.3	18.8	12.3	20.6	16.0	17.5	25.3	17.5	16.4	16.5	41.7	53.9	0.0	0.0	0.0	0.0	0.0	0.0	144.6	78.5	43.6	0.0	64.0	82.9	81.2	0.0	0.0	0.0	0.0	122.2	66.3	0.0	0.0	43.0	0.0	62.2	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.0	36.9	0.0	0.0	97.5	0.0	0.0	82.3	0.0	0.0	0.0	0.0	0.0	0.0	89.2	0.0	0.0	0.0
STX1A	"HPC-1, p35-1, STX1"	ENSG00000106089	"Syntaxin 1A"	Q16623	7	73699206-73719672	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Exocytosis, Neurotransmitter transport, Transport"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 73.7;pituitary gland: 26.9"	"Cell type enhanced"	"Detected in many"	13	"Intestinal endocrine cells: 50.6;Pancreatic endocrine cells: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.5;T-reg: 2.4"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 50.8;U-87 MG: 33.8"	"Group enriched"	"Detected in many"	5	"amygdala: 253.0;basal ganglia: 94.3;cerebral cortex: 362.2;hippocampal formation: 251.5"	"Group enriched"	"Detected in all"	8	"amygdala: 69.4;cerebral cortex: 158.6;hippocampal formation: 149.3"	"CAB008372, HPA069176"	Enhanced		Approved	"Nuclear membrane,Vesicles"	"Intracellular and membrane"	NA	NA			Vesicles	"Nuclear membrane"	"CAB008372: AB_592786, HPA069176: AB_2686098"	"unprognostic (5.12e-3)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (3.12e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.02e-8)"	"unprognostic (1.11e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.52e-2)"	"unprognostic (6.34e-2)"	"unprognostic (7.70e-3)"	"unprognostic (4.18e-6)"	"unprognostic (2.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-3)"	"unprognostic (6.20e-2)"	1.4	5.6	27.4	2.4	20.9	7.6	1.4	33.7	73.7	1.7	2.6	1.3	0.8	3.7	2.8	1.8	1.7	2.3	5.5	1.2	22.0	8.3	1.1	1.2	1.8	1.4	4.0	28.0	2.2	5.7	1.5	26.9	2.2	2.6	1.9	2.1	0.1	1.9	1.8	1.1	1.9	3.5	2.6	1.3	1.3	6.2	2.0	0.7	0.0	1.6	0.0	1.1	2.8	1.1	0.4	0.0	0.1	0.2	0.0	2.5	2.7	1.6	7.5	1.2	3.6	1.6	4.2	0.8	5.1	3.4	2.1	1.4	2.6	4.3	1.9	0.7	3.6	11.8	1.3	1.8	3.2	1.6	3.5	1.4	0.6	2.6	1.5	1.8	0.8	1.8	2.5	1.4	14.8	5.2	9.6	3.7	0.3	1.6	2.3	4.0	3.7	0.6	7.3	0.9	2.8	17.0	0.0	0.8	1.9	1.7	1.3	50.8	8.0	1.5	4.2	1.0	1.5	1.4	0.6	13.8	10.5	3.5	8.1	13.5	1.3	0.8	0.9	33.8	0.7	12.3	0.0	0.2	0.0	2.5	0.0	0.9	0.4	0.4	0.6	0.0	0.1	0.8	0.3	0.1	0.0	0.0	0.0	2.4	2.7	27.4	20.9	33.7	49.9	22.0	8.3	4.0	28.0	2.6	0.7	0.0	3.2	0.0	11.2	3.8	4.5	2.2	5.1	2.7	3.4	1.8	3.9	0.4	0.0	3.1	0.0	0.5	1.8	0.0	3.2	1.6	2.4	9.7	15.0	0.2	0.6	7.9	50.6	1.3	0.8	0.0	1.7	1.7	3.3	0.0	2.4	0.8	18.8	0.3	1.4	0.4	1.8	0.0	2.3	1.7	3.3	2.4	0.6	2.2	1.5	12.9
ABHD11	"PP1226, WBSCR21"	ENSG00000106077	"Abhydrolase domain containing 11"	Q8NFV4	7	73736094-73738867	"Disease related genes, Predicted intracellular proteins"		Hydrolase	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 161.7;Urothelial cells: 241.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 34.7;SK-BR-3: 44.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024042, HPA049641"	Approved		Supported	Mitochondria		NA	NA		450000	Mitochondria		"HPA024042: AB_1844445, HPA049641: AB_2680838"	"unprognostic (4.74e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.91e-2)"	"unprognostic (9.32e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.66e-7)"	"unprognostic (3.61e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.29e-2)"	5.6	8.9	7.7	11.5	8.7	4.2	12.2	8.8	9.2	8.1	28.5	8.3	14.8	15.7	6.0	12.7	8.3	14.0	17.0	20.1	7.1	8.1	21.6	6.6	8.4	6.9	8.6	5.6	5.0	18.9	7.3	10.8	40.2	10.0	14.7	17.5	7.8	23.9	22.2	9.8	7.9	28.1	5.6	5.9	5.2	8.3	6.1	5.6	6.9	20.1	8.4	12.6	5.8	5.4	8.3	12.9	12.2	21.0	9.7	6.7	8.0	17.5	4.1	2.8	6.4	1.4	2.0	15.6	8.1	3.4	5.0	5.9	5.0	19.8	8.3	2.4	3.4	6.8	7.8	1.2	4.6	3.4	3.1	6.0	4.1	2.7	3.1	2.6	4.4	4.5	1.8	1.9	6.4	3.0	1.8	3.5	2.9	5.5	4.8	4.7	34.7	3.3	5.6	3.2	11.1	15.1	1.9	4.5	15.4	11.5	8.3	7.2	3.0	6.6	44.2	2.7	2.1	14.3	2.9	3.4	4.3	4.0	18.2	8.4	2.9	1.5	5.6	6.8	4.2	7.9	6.1	13.1	12.2	6.0	21.0	4.8	6.3	6.7	6.2	12.9	8.3	6.3	4.4	10.5	9.7	20.7	6.3	4.4	8.0	7.7	8.7	8.8	9.2	7.1	8.1	8.6	5.6	10.0	5.6	41.7	11.2	11.1	58.4	4.8	14.7	15.3	40.8	83.0	36.4	54.1	3.9	68.1	61.3	45.0	1.0	8.4	161.7	0.0	35.7	109.7	8.7	56.7	15.0	7.8	24.5	4.8	60.0	6.2	8.9	2.1	8.3	14.8	13.5	9.0	63.5	26.4	35.6	108.7	3.2	34.8	14.2	0.0	12.0	5.4	8.0	5.5	106.8	13.1	94.5	241.0
CLDN3	"C7orf1, CPE-R2, CPETR2, HRVP1, RVP1"	ENSG00000165215	"Claudin 3"	O15551	7	73768997-73770270	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 100.4;thyroid gland: 91.6"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 2133.6;Mucus-secreting cells: 1109.4;Paneth cells: 1932.3;Undifferentiated cells: 955.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"cerebellum: 3.1;pons and medulla: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.6;MCF7: 66.5;PC-3: 14.2;RPMI-8226: 11.4;SCLC-21H: 17.6;T-47d: 31.6"	"Not detected"	"Not detected"							HPA014361	Enhanced		Supported	"Cell Junctions"		NA	NA		15000	"Cell Junctions"		"HPA014361: AB_2668982"	"unprognostic (1.84e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.42e-1)"	"prognostic favorable (3.39e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.18e-2)"	"unprognostic (6.72e-2)"	0.3	0.1	0.1	11.5	0.1	0.2	7.1	3.1	0.2	3.8	77.9	1.6	21.8	24.3	2.8	8.8	0.3	9.4	11.3	0.1	0.2	0.4	20.7	16.0	6.0	0.2	0.0	0.0	4.3	38.0	0.2	7.4	3.1	3.0	14.6	8.0	1.9	31.1	32.1	0.1	2.1	100.4	0.5	0.0	0.1	0.7	1.2	0.0	2.2	91.6	0.9	3.6	0.8	0.4	0.2	0.0	0.1	0.0	0.0	0.1	0.5	0.7	1.0	0.0	0.1	0.0	0.0	5.3	0.0	0.0	0.0	0.0	1.2	10.6	0.0	3.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.5	0.1	0.3	0.6	2.6	14.2	0.0	0.0	11.4	0.6	0.0	17.6	0.2	0.0	10.1	0.0	0.0	31.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	3.1	0.2	0.2	0.4	0.0	0.0	3.0	0.0	35.7	34.4	4.2	34.2	0.1	0.7	0.5	206.4	104.4	48.9	120.4	3.9	47.1	8.3	212.5	0.0	0.0	2133.6	23.3	15.9	8.6	0.5	498.9	28.7	32.7	4.3	0.0	581.8	0.0	0.0	0.0	2.3	0.9	10.1	3.6	1109.4	10.8	59.3	1932.3	0.0	42.3	8.5	0.0	0.4	0.0	0.0	0.0	60.5	2.9	955.0	455.4
CLDN4	"CPE-R, CPETR, CPETR1, hCPE-R, WBSCR8"	ENSG00000189143	"Claudin 4"	O14493	7	73799542-73832693	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 141.0"	"Cell type enhanced"	"Detected in many"	17	"Basal glandular cells: 2545.0;Glandular cells: 2415.4;Urothelial cells: 7943.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 43.3;BEWO: 51.0;CAPAN-2: 95.4;MCF7: 48.6;OE19: 49.3;PC-3: 62.1;RT4: 42.0;SK-BR-3: 80.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB002610	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB002610: "	"unprognostic (1.14e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (2.16e-3)"	"unprognostic (5.11e-1)"	"prognostic favorable (3.46e-10)"	"unprognostic (5.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.38e-2)"	"unprognostic (4.63e-2)"	0.7	0.2	0.4	17.1	0.4	0.0	17.1	0.4	0.5	17.5	53.7	0.7	23.2	25.0	5.1	15.9	62.3	15.4	15.4	0.5	0.4	0.3	30.2	2.0	28.8	0.4	0.4	0.4	5.5	32.4	2.7	3.5	78.1	1.3	31.8	24.7	0.7	52.0	25.7	0.6	35.3	93.3	2.7	0.4	0.4	2.7	2.5	0.4	3.8	141.0	60.9	55.7	38.5	21.0	0.1	0.1	0.2	0.1	0.1	0.6	0.0	43.3	0.5	0.0	0.2	0.0	0.0	51.0	0.4	0.0	0.0	0.0	22.7	95.4	0.0	3.5	0.0	0.3	24.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	15.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	48.6	0.0	0.2	0.0	49.3	62.1	0.0	0.8	1.0	11.6	42.0	10.1	0.2	0.0	80.9	0.1	2.9	31.6	0.1	0.0	0.1	1.8	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.6	0.2	0.1	0.0	0.1	0.0	0.0	0.4	0.4	0.4	0.5	0.4	0.3	0.4	0.4	1.3	0.4	256.1	182.2	2.2	2545.0	14.3	0.2	0.6	242.0	323.9	224.1	207.6	0.0	586.9	11.6	821.2	0.0	2.9	1686.2	0.0	388.8	629.5	21.8	2415.4	27.6	0.8	67.0	0.0	648.6	0.0	0.3	0.0	2.3	10.6	13.5	27.1	955.9	0.9	781.5	1557.1	0.0	10.2	0.0	0.0	2.1	0.0	0.2	47.2	799.6	1.7	627.6	7943.2
METTL27	WBSCR27	ENSG00000165171	"Methyltransferase like 27"	Q8N6F8	7	73834590-73842535	"Disease related genes, Predicted intracellular proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	15	"Ciliated cells: 56.2;Collecting duct cells: 19.2;Distal tubular cells: 24.9;Proximal tubular cells: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 9.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 9.6;RPMI-8226: 40.8;T-47d: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA022420, HPA074662"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA022420: AB_2304370, HPA074662: "	"unprognostic (6.70e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.38e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (1.10e-6)"	"unprognostic (1.86e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.24e-2)"	5.7	2.7	1.5	1.4	2.6	0.3	5.2	4.2	3.9	10.2	3.6	3.8	14.5	3.3	5.3	4.4	5.8	9.3	12.4	0.9	1.4	1.3	9.2	2.7	4.7	6.0	1.2	6.0	5.2	11.1	10.0	4.0	8.7	2.8	8.0	1.3	2.4	20.3	12.4	2.3	2.0	4.5	1.3	1.3	5.1	1.7	10.6	0.8	3.0	6.6	0.9	3.1	4.3	3.6	2.4	1.4	2.0	3.4	0.0	9.2	0.3	6.4	7.9	0.0	0.6	1.2	3.5	1.3	0.0	0.1	0.2	0.2	0.4	9.6	1.5	1.5	1.3	5.6	0.6	0.0	2.5	0.1	1.0	0.1	0.0	2.3	2.4	1.4	0.0	0.0	1.4	0.6	4.1	2.0	0.4	1.5	0.5	0.1	1.3	0.9	1.8	0.0	0.0	0.1	5.1	2.0	0.4	1.8	40.8	2.1	1.2	0.7	0.2	0.9	0.7	0.7	1.9	11.9	0.4	1.7	2.5	0.6	4.9	2.5	1.8	0.6	0.0	0.5	0.0	0.8	0.0	1.0	2.0	0.1	3.4	0.0	2.4	0.6	0.0	1.4	1.0	1.2	0.8	1.0	0.0	0.8	1.0	9.2	0.3	1.5	2.6	4.2	3.9	1.4	1.3	1.2	6.0	2.8	0.8	6.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	56.2	4.5	19.2	0.0	3.4	24.9	12.8	0.0	0.0	0.0	0.0	1.9	1.5	0.0	0.0	2.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	7.4	0.0	0.0	40.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
TMEM270	"MGC26719, WBSCR28"	ENSG00000175877	"Transmembrane protein 270"	Q6UE05	7	73861159-73865893	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"testis: 35.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"T-reg: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.1;GAMG: 1.5;MCF7: 5.3;PC-3: 1.8;RPMI-8226: 1.4;U-2197: 1.4;U-87 MG: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA077196			Approved	Vesicles		NA	NA			Vesicles		"HPA077196: AB_2732334"	"unprognostic (3.84e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.87e-5)"	"unprognostic (1.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.31e-3)"		"unprognostic (2.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.23e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	2.1	0.2	0.0	0.4	1.5	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.4	0.0	0.3	1.8	0.0	0.0	1.4	0.3	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	1.4	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ELN	"SVAS, WBS, WS"	ENSG00000049540	Elastin	P15502	7	74027789-74069907	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Fibroblasts: 53.4;Ito cells: 49.1;Leydig cells: 102.4;Peritubular cells: 139.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.9;BJ: 23.4;fHDF/TERT166: 33.6;U-2197: 133.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"CAB010750, HPA018111, HPA056941"	Supported		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		2900000	"Plasma membrane"		"CAB010750: AB_476930, HPA018111: AB_1848109, HPA056941: AB_2683280"	"unprognostic (1.51e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.79e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (1.62e-3)"	35.0	8.8	4.3	14.9	3.6	0.0	24.8	27.8	5.8	23.3	12.1	12.9	9.1	3.2	22.3	26.0	30.1	17.1	30.8	41.5	5.4	3.0	8.3	3.7	49.7	7.5	4.4	9.2	10.6	35.3	0.7	6.1	22.5	13.7	25.1	4.6	34.3	16.8	14.5	6.0	23.6	9.2	34.7	9.9	10.7	16.0	8.1	6.4	0.9	11.9	10.3	4.4	34.0	21.7	0.4	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.3	0.1	0.0	16.9	0.1	0.1	23.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	1.3	0.1	0.1	0.0	9.0	0.1	0.0	0.0	4.6	11.0	0.0	0.2	0.0	1.7	0.1	0.0	0.0	0.0	0.0	133.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	4.3	3.6	27.8	5.8	5.4	3.0	4.4	9.2	13.7	6.4	0.0	8.3	0.0	13.2	9.7	0.9	8.9	2.5	4.0	5.7	7.0	2.0	0.1	0.0	0.2	2.5	26.4	0.0	0.0	3.5	0.2	53.4	1.2	0.0	2.1	0.4	6.4	1.7	49.1	0.3	4.2	102.4	1.0	13.5	0.0	1.3	17.8	1.5	0.0	139.3	0.0	0.7	0.0	31.5	0.9	1.1	9.5	0.1	0.0	0.0	0.8
LIMK1	LIMK	ENSG00000106683	"LIM domain kinase 1"	P53667	7	74082933-74122525	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.2"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 22.9;Hofbauer cells: 25.0;Horizontal cells: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028516, HPA073571"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"		"HPA028516: AB_10601751, HPA073571: "	"unprognostic (1.45e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (4.95e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (7.79e-6)"	"unprognostic (1.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (6.63e-8)"	"unprognostic (4.14e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.79e-2)"	8.8	8.6	31.6	18.2	18.6	6.3	7.4	14.3	44.1	11.5	6.6	7.1	6.6	6.9	7.3	5.3	6.4	6.0	10.8	6.3	26.8	32.9	5.2	2.6	12.5	22.0	33.4	22.2	12.1	8.1	4.0	7.2	8.0	45.2	6.1	4.7	4.8	18.1	9.6	10.9	6.8	7.2	7.6	10.8	18.4	7.8	10.4	6.5	4.3	7.5	3.7	18.1	14.1	7.2	4.6	8.6	3.8	7.7	6.9	2.4	3.1	17.0	13.3	10.2	16.9	13.5	18.3	7.4	10.6	10.2	8.6	9.6	7.7	16.9	10.6	4.8	13.0	28.9	10.3	3.8	6.5	3.3	18.3	6.7	7.8	4.5	8.8	15.5	5.9	28.7	18.1	5.9	6.9	3.6	26.0	12.8	7.7	5.2	3.4	10.7	14.9	5.1	10.7	19.3	6.0	8.4	7.4	15.8	6.6	9.6	3.7	4.0	9.3	6.8	16.4	8.5	11.7	5.2	5.4	15.2	13.7	12.8	35.4	17.0	3.8	4.3	19.4	50.9	4.3	9.3	0.1	6.5	3.8	2.4	7.7	1.8	4.6	0.6	1.5	8.6	2.4	0.2	0.7	0.7	6.9	4.7	0.8	0.4	3.1	31.6	18.6	14.3	44.1	26.8	32.9	33.4	22.2	45.2	6.5	3.0	2.4	22.9	4.6	2.6	5.6	2.7	7.6	2.7	3.4	1.8	2.0	2.2	0.0	6.6	0.6	3.0	0.9	0.0	5.6	5.4	7.5	5.1	5.7	1.1	25.0	33.4	2.4	2.5	10.7	1.5	6.6	14.1	3.3	10.0	2.1	3.1	10.2	2.9	5.6	1.5	3.1	0.0	2.1	1.9	12.4	2.8	3.1	10.1	2.5	6.2
EIF4H	"KIAA0038, WBSCR1, WSCR1"	ENSG00000106682	"Eukaryotic translation initiation factor 4H"	Q15056	7	74174245-74197101	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 1039.9;Late spermatids: 2062.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030542	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		520000	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA030542: AB_10601368"	"unprognostic (2.83e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (3.89e-4)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.27e-2)"	46.8	42.7	47.6	37.6	52.8	82.3	42.8	56.0	89.5	39.8	44.5	46.6	36.2	43.1	48.1	37.9	58.6	44.4	40.7	47.4	45.6	41.4	34.5	50.7	37.4	42.8	45.4	54.6	54.2	74.3	54.3	30.1	72.2	47.6	44.8	35.1	35.6	60.3	45.4	89.6	53.0	41.5	43.4	59.9	34.6	45.4	52.5	32.1	46.8	43.5	57.9	44.2	43.4	41.4	38.4	57.6	60.2	64.2	46.7	52.0	80.6	87.4	58.3	44.5	53.9	39.7	42.3	50.6	62.6	47.6	51.9	51.1	71.4	67.5	75.2	17.1	57.8	75.1	46.5	49.0	83.2	49.1	50.5	57.4	41.9	54.8	57.3	45.5	70.6	42.3	49.5	52.9	57.6	82.0	61.0	56.8	45.0	73.6	32.7	53.1	74.7	55.7	83.8	59.4	72.7	57.8	65.4	59.7	67.9	43.1	56.0	45.3	57.2	58.4	73.8	49.6	61.4	83.4	45.8	59.0	74.4	50.6	62.2	78.7	38.9	46.4	128.4	58.1	74.2	76.3	45.7	58.4	60.2	43.5	64.2	44.9	38.4	44.7	43.0	57.6	35.3	52.0	42.4	39.0	46.7	63.6	24.4	47.6	80.6	47.6	52.8	56.0	89.5	45.6	41.4	45.4	54.6	47.6	32.1	77.4	68.6	90.9	132.2	105.9	91.7	38.9	66.2	53.5	59.1	41.8	23.6	170.5	91.2	122.8	1039.9	93.3	74.9	46.7	138.2	310.9	112.7	87.9	121.1	74.9	110.6	92.2	86.8	73.6	90.7	2062.3	96.1	91.0	69.2	181.3	80.6	92.2	119.2	69.1	104.0	54.1	63.7	84.1	131.0	55.4	62.9	101.5	330.6	89.7	87.9	119.5
LAT2	"HSPC046, LAB, NTAL, WBSCR15, WBSCR5, WSCR5"	ENSG00000086730	"Linker for activation of T cells family member 2"	Q9GZY6	7	74199652-74229834	"Disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Mast cell degranulation"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 98.4;lymphoid tissue: 36.7"	"Cell type enhanced"	"Detected in many"	12	"B-cells: 89.1;granulocytes: 165.4;Hofbauer cells: 75.1;Kupffer cells: 75.9;Macrophages: 83.0;monocytes: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 98.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"NB-4: 46.6;REH: 53.0;RPMI-8226: 19.0;THP-1: 48.0;U-937: 46.8"					"Low region specificity"	"Detected in all"			HPA003462	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"HPA003462: AB_1079238"	"unprognostic (1.24e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.30e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.34e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (4.10e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (7.44e-2)"	"unprognostic (2.03e-1)"	4.6	3.7	10.3	21.4	19.3	32.8	2.5	2.7	9.6	2.8	3.9	11.6	0.5	3.3	2.5	2.4	2.5	3.8	5.9	2.4	8.8	6.5	3.0	3.8	11.6	29.3	21.9	2.5	1.4	2.8	1.0	2.8	4.4	15.7	4.5	4.7	2.3	3.6	2.2	2.7	1.8	9.9	5.0	19.3	36.7	3.6	1.6	17.6	3.2	2.4	1.0	32.7	5.8	4.6	26.8	32.5	98.4	39.5	10.0	1.3	24.7	0.4	0.2	0.2	0.8	0.0	0.0	0.3	0.3	0.3	0.2	0.2	0.5	8.1	5.3	0.1	0.1	1.6	0.2	0.0	0.3	0.1	8.5	0.3	2.1	0.3	0.3	0.0	15.5	15.6	0.1	0.2	0.5	0.1	0.3	0.0	0.2	0.3	2.4	0.2	0.3	0.3	46.6	0.2	1.3	0.5	53.0	0.2	19.0	0.0	0.4	0.2	0.2	0.1	0.3	0.2	0.2	0.2	48.0	0.6	0.6	5.6	0.2	0.4	0.2	1.5	8.3	2.7	46.8	0.3	98.4	39.5	5.9	1.3	22.3	0.1	24.4	0.3	0.1	32.5	26.8	0.1	0.4	69.1	10.0	12.4	1.2	0.6	24.7	10.3	19.3	2.7	9.6	8.8	6.5	21.9	2.5	15.7	17.6	3.0	23.9	89.1	0.6	3.1	0.0	0.8	7.6	10.7	5.7	3.5	0.0	0.5	0.0	0.0	2.3	1.0	0.0	0.0	0.2	0.9	1.4	1.0	165.4	3.2	75.1	0.0	7.5	4.9	75.9	1.9	0.0	83.0	1.7	54.1	0.2	0.3	0.6	0.0	0.7	0.0	1.3	0.0	0.7	0.4	1.1	2.3	1.0	51.6	0.4	0.5
RFC2	"A1, RFC40"	ENSG00000049541	"Replication factor C subunit 2"	P35250	7	74231499-74254458	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA replication"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029493	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	Yes			Nucleoplasm	"Golgi apparatus"	"HPA029493: AB_10603991"	"unprognostic (1.25e-1)"	"prognostic favorable (9.91e-4)"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.09e-7)"	"unprognostic (2.22e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.59e-1)"	11.0	9.5	16.1	15.8	15.4	23.0	15.3	13.9	16.6	10.1	12.8	10.0	5.0	8.6	10.0	9.4	17.9	10.1	9.0	9.1	12.1	9.1	10.1	23.0	10.6	20.4	12.3	14.0	11.7	15.1	10.9	8.6	17.5	15.1	11.0	15.0	8.9	12.2	8.1	16.5	18.8	10.0	12.7	14.8	14.2	12.2	13.5	14.0	22.1	10.4	14.7	28.5	9.9	11.6	22.4	18.7	27.5	24.2	24.8	13.6	15.8	22.9	17.9	20.9	20.7	4.3	5.1	9.6	13.5	14.9	27.5	33.2	19.8	21.4	21.7	3.8	9.5	26.1	15.8	17.0	22.6	28.6	15.5	29.5	13.2	24.9	14.7	3.4	19.8	8.2	5.1	5.1	25.9	17.9	6.0	14.7	20.9	27.4	13.4	21.1	27.1	19.7	38.6	23.8	36.5	15.1	29.5	23.2	27.1	14.7	18.6	17.0	21.6	16.0	30.3	11.0	26.9	21.9	18.3	5.7	27.3	18.1	21.0	30.1	8.2	10.6	37.7	13.8	30.7	28.3	19.5	22.0	15.6	11.4	24.2	11.7	19.0	9.9	10.4	18.7	22.4	12.6	9.5	27.5	24.8	22.4	10.0	13.6	15.8	16.1	15.4	13.9	16.6	12.1	9.1	12.3	14.0	15.1	14.0	11.9	12.0	15.3	19.1	21.2	14.1	5.0	10.2	9.4	15.9	5.2	2.0	51.5	5.0	14.8	2.2	11.7	9.9	0.0	16.7	50.3	12.7	9.4	22.0	13.1	32.8	3.2	4.6	11.6	12.7	1.8	8.1	24.0	20.3	34.3	7.8	12.8	12.3	5.8	10.3	7.8	8.7	6.5	15.1	23.6	52.6	14.9	38.6	23.6	15.6	12.4
CLIP2	"CLIP, CLIP-115, CYLN2, KIAA0291, WBSCR3, WBSCR4, WSCR3, WSCR4"	ENSG00000106665	"CAP-Gly domain containing linker protein 2"	Q9UDT6	7	74289475-74405943	"Plasma proteins, Predicted intracellular proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 44.0"	"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 26.9;Enterocytes: 28.7"	"Cancer enhanced"	"Detected in all"		"glioma: 43.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 31.4"	"Low region specificity"	"Detected in all"							"HPA020430, CAB020767"	Enhanced					NA	NA		960000			"CAB020767: , HPA020430: AB_1846958"	"unprognostic (7.46e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.38e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.96e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.38e-1)"	6.3	7.1	27.8	9.3	24.1	3.7	2.9	16.0	44.0	8.6	15.3	28.2	3.3	10.5	8.9	2.6	6.3	4.8	10.3	4.7	28.3	24.9	4.9	2.3	6.0	4.8	30.9	17.9	16.7	11.9	6.3	5.6	8.3	19.3	5.4	9.5	4.0	3.7	9.5	2.2	9.0	12.7	8.0	34.7	6.0	11.1	3.0	18.3	2.0	1.9	1.0	6.8	7.4	10.5	2.8	0.7	2.9	2.1	0.1	0.6	0.9	3.1	11.0	8.6	9.3	10.2	11.5	0.1	8.1	16.1	4.7	5.1	2.4	14.4	0.5	1.6	14.3	31.4	11.8	1.6	8.8	2.0	21.3	0.8	2.5	1.5	6.1	9.9	0.5	3.0	12.8	4.0	14.2	11.8	12.3	6.8	0.3	0.6	0.1	8.9	1.0	0.3	16.4	3.9	14.3	10.8	16.8	3.3	0.7	6.1	11.1	1.8	9.8	4.5	1.3	15.9	6.9	1.0	1.9	8.1	12.7	7.8	17.4	4.9	0.4	0.1	0.0	14.7	4.6	10.7	2.9	1.2	0.0	0.1	2.1	0.6	2.8	0.0	0.0	0.7	0.9	0.0	0.4	0.8	0.1	0.9	0.0	0.0	0.9	27.8	24.1	16.0	27.6	28.3	24.9	30.9	17.9	19.3	18.3	0.0	0.0	1.3	4.6	26.9	8.9	1.6	10.2	1.4	1.2	3.5	0.0	0.2	0.0	8.8	0.2	7.1	28.7	0.0	5.4	0.3	8.4	1.9	1.1	1.1	4.8	17.5	9.9	4.9	3.3	0.0	2.6	7.0	11.8	7.2	12.0	4.0	8.7	16.9	7.4	0.3	3.3	12.9	11.5	0.0	1.7	5.9	0.8	4.3	8.7	1.0
GTF2IRD1	"BEN, Cream1, GTF3, MusTRD1, RBAP2, WBSCR11, WBSCR12"	ENSG00000006704	"GTF2I repeat domain containing 1"	Q9UHL9	7	74453790-74602604	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 62.8"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 29.7;Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044254	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA044254: AB_10964747"	"unprognostic (8.92e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.71e-5)"	"unprognostic (2.24e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.89e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.25e-3)"	4.6	7.6	4.3	5.1	6.8	0.6	6.3	4.4	7.8	9.4	8.2	8.2	9.2	7.0	7.4	8.7	16.4	7.0	8.6	7.7	3.9	5.5	9.3	3.6	7.2	2.6	8.5	5.3	8.6	10.0	21.1	25.3	5.3	6.6	8.2	5.5	21.6	11.3	8.3	62.8	15.6	5.2	12.1	5.6	1.6	8.8	4.5	5.7	1.3	16.4	12.9	7.3	10.5	13.2	0.6	1.8	2.7	0.5	0.6	0.7	0.1	9.3	5.9	12.9	14.1	10.4	5.1	0.1	4.0	10.6	7.8	8.2	10.2	13.4	2.4	3.0	8.0	19.2	5.4	10.2	4.7	5.8	0.1	6.1	0.4	19.9	11.4	33.4	0.1	0.3	7.1	19.2	5.4	22.6	18.3	4.0	4.7	6.8	0.0	8.7	11.8	1.2	8.2	10.3	11.3	6.1	12.6	7.5	8.7	14.8	6.5	10.6	14.5	9.8	17.8	8.7	6.8	10.6	9.3	2.2	8.1	8.3	5.2	9.0	0.5	1.4	3.9	3.3	0.1	6.5	1.2	0.5	0.5	0.3	0.2	0.3	0.4	0.7	0.2	1.8	0.6	0.3	0.4	2.7	0.6	0.1	0.6	0.2	0.1	4.3	6.8	4.4	7.8	3.9	5.5	8.5	5.3	6.6	5.7	8.9	8.0	0.0	9.4	7.0	29.7	7.2	7.6	10.7	4.5	8.7	31.4	0.9	10.0	6.4	0.5	2.7	3.3	0.0	8.1	1.4	4.6	16.3	2.3	2.6	2.2	20.6	4.1	1.8	2.4	0.0	3.7	4.0	6.8	1.0	4.0	5.6	8.5	2.9	5.3	12.4	38.9	0.0	4.6	0.0	5.1	5.8	2.4	0.0	6.8	14.2
GTF2I	"BAP-135, BTKAP1, DIWS, IB291, SPIN, TFII-I, WBSCR6"	ENSG00000263001	"General transcription factor IIi"	P78347	7	74657667-74760692	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004595, HPA026638"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004595: AB_628345, HPA026638: AB_1857959"	"unprognostic (3.47e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.28e-1)"	"prognostic favorable (6.35e-6)"	"unprognostic (7.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.88e-2)"	10.2	14.3	12.6	10.2	14.3	4.0	11.5	13.1	15.2	11.3	8.6	15.4	6.0	9.1	10.5	9.6	9.9	12.5	10.8	8.6	12.8		13.5	10.2	10.2	8.8	18.1	9.7	12.1	8.5	29.0	12.4	9.8	12.9	12.1	6.9	12.1	11.7	10.3	13.4	10.9	7.9	11.1	8.8	7.5	12.0	4.3	16.0	21.2	22.3	6.3	11.6	10.3	7.1	16.8	14.8	10.9	6.9	14.2	13.2	5.8	29.6	24.5	50.8	49.8	28.1	25.0	10.6	18.8	17.3	20.8	20.7	17.0	36.2	35.8	7.6	23.0	27.7	26.1	49.7	22.6	26.9	26.9	26.3	18.2	29.1	23.6	16.9	34.5	27.3	23.1	19.5	15.7	16.2	30.5	27.8	12.1	35.5	17.1	25.0	27.6	28.7	30.9	54.4	63.3	15.3	31.6	17.6	29.3	27.3	51.7	42.6	54.4	34.2	51.5	17.2	44.6	26.3	22.9	24.8	28.6	15.4	14.3	23.9	20.2	17.8	56.9	16.3	20.9	28.5	5.1	6.9	10.9	8.3	5.1	13.2	14.6	11.3	12.9	10.5	16.8	13.1	12.9	2.8	14.2	4.2	14.8	5.7	5.8											74.5	52.9	73.0	73.2	53.3	262.6	25.7	193.6	52.2	54.6	113.4	267.0	84.7	48.0	123.3	33.9	79.4	49.7	0.0	72.6	51.4	66.4	111.8	12.7	84.7	68.3	236.8	108.4	117.2	104.4	29.3	141.5	49.6	52.3	67.7	67.6	192.8	108.5	76.4	181.4	83.8	173.7	84.1	49.5	22.3	38.3	80.4	60.4	45.7	63.2	92.7
NCF1	"NCF1A, NOXO2, p47phox, SH3PXD1A"	ENSG00000158517	"Neutrophil cytosolic factor 1"	P14598	7	74773962-74789315	"Disease related genes, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 166.6;lymphoid tissue: 42.1"	"Cell type enhanced"	"Detected in many"	14	"B-cells: 168.1;Kupffer cells: 142.9;Macrophages: 51.2;monocytes: 81.2"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in many"	5	"basophil: 75.1;classical monocyte: 49.6;eosinophil: 106.8;neutrophil: 166.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 166.6;monocytes: 49.6"	"Group enriched"	"Detected in some"	6	"Daudi: 36.1;HMC-1: 51.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004524, HPA047836, HPA052095"	Enhanced					NA	NA					"CAB004524: AB_627987, HPA047836: AB_2680173, HPA052095: AB_2681721"	"unprognostic (4.93e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.55e-3)"	"unprognostic (7.60e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.23e-3)"	"unprognostic (9.99e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-3)"	"unprognostic (3.16e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.09e-1)"	2.4	0.9	0.7	11.9	0.5	25.9	0.7	0.0	0.2	0.4	2.0			1.9	0.3	0.0	1.2	1.2	1.2	0.7	0.7	0.8	1.3	1.4	6.6	17.1	1.3		0.2	0.3	0.0	0.4	1.0		0.7	0.9		1.3	0.0	0.1	0.1	10.0	0.7	2.5	42.1	1.4	0.0			0.9		11.8	3.2	0.6	21.2	21.2	166.6	49.6	0.7	1.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	1.1	0.3	0.3	0.0	0.3	51.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.5	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.1	0.0	0.0	0.2	0.1	6.2	0.1	3.0	0.0	75.1	49.6	106.8	0.3	18.6	0.7	18.2	0.7	0.4	5.9	21.2	1.0	0.6	166.6	0.7	4.1	21.2	0.7	29.3											0.0	3.2	168.1	1.0	2.7	0.0	0.5	7.6	0.0	1.2	3.5	0.0	0.5	0.0	0.9	6.5	1.0	0.0	23.3	0.6	9.6	1.1	0.9	13.9	0.8	34.7	3.2	0.0	4.3	142.9	4.8	0.0	51.2	10.1	81.2	0.2	0.3	0.9	1.1	0.4	1.4	0.3	0.0	0.3	0.0	0.2	1.5	3.8	25.9	0.2	1.6
GTF2IRD2	"FLJ37938, GTF2IRD2A"	ENSG00000196275	"GTF2I repeat domain containing 2"	Q86UP8	7	74796144-74851551	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 35.0"									"HPA056679, HPA056680"			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056679: AB_2683205, HPA056680: AB_2683206"	"unprognostic (7.91e-5)"	"unprognostic (3.90e-3)"	"unprognostic (1.43e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.47e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.22e-1)"	"unprognostic (6.11e-2)"	"unprognostic (4.43e-5)"	"unprognostic (3.18e-2)"	"unprognostic (8.97e-3)"	"unprognostic (2.58e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.59e-4)"	3.9	4.3	3.1	2.1	2.0	4.0	5.6	2.1	2.1	6.0	5.6			3.2	5.6	3.1	3.1	6.0	2.5	4.6	2.8	2.7	4.6	6.4	4.3	2.8	2.8		9.3	6.6	4.3	5.6	1.9		6.5	3.8		4.9	4.3	21.6	3.2	3.8	4.5	2.7	3.4	5.3	2.6			6.0		2.9	4.5	4.2	14.9	12.4	10.4	6.8	5.0	9.8	6.6	9.7	3.4	4.4	6.6	6.4	4.2	4.0	3.3	3.4	4.0	4.4	0.7	8.1	2.6	0.9	5.4	6.7	2.0	0.1	2.1	3.3	1.2	0.8	2.5	5.0	4.6	6.0	3.4	0.4	3.9	3.2	1.1	3.1	4.8	3.9	1.9	6.0	5.3	3.6	9.0	1.3	9.7	7.3	10.4	2.3	2.5	1.5	9.1	9.2	8.5	3.3	10.3	13.6	35.0	7.5	3.9	7.4	6.5	3.7	5.9	1.5	1.0	5.3	4.1	1.7	2.6	5.1	2.4	12.6	10.4	6.8	7.2	3.4	3.9	5.0	14.9	7.6	9.8	7.0	10.0	9.2	5.9	1.1	5.0	3.3	12.4	6.5	6.6											17.9	20.6	19.7	9.7	2.9	23.8	10.1	22.9	25.4	21.6	12.2	53.0	5.5	3.3	17.6	17.8	5.8	12.5	0.0	24.7	5.1	9.3	11.3	13.9	8.1	3.9	35.0	25.9	16.5	5.1	3.8	40.6	6.9	10.1	8.2	20.3	16.6	22.6	21.0	24.4	4.2	42.7	12.9	8.6	2.7	2.0	3.8	5.4	12.9	24.0	6.8
CASTOR2	"GATSL1, GATSL2"	ENSG00000274070	"Cytosolic arginine sensor for mTORC1 subunit 2"	A6NHX0	7	74964818-75024798	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 7.5;skeletal muscle: 28.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in all"		"testis cancer: 11.6"					"Cell type enriched"	"Detected in single"	6	"neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"A549: 22.3"									HPA057229	Uncertain					NA	NA					"HPA057229: AB_2683374"	"unprognostic (1.07e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.78e-5)"	"unprognostic (1.28e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.27e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.20e-3)"	1.3	1.2	4.1	0.4	4.8	4.4	0.7	2.6	7.5	1.1	1.9	5.0	0.0	1.8	1.7	1.2	2.1	1.4	1.7	2.7	5.6		0.8	0.1	0.8	0.1	3.3	4.5	3.7	3.6	1.4	1.3	2.2	4.2	1.7	0.4	1.1	2.1	2.1	28.1	0.9	1.1	1.7	2.8	0.3	0.7	2.1	4.0	2.1	0.4	1.4	0.8	0.9	0.5	0.0	0.0	2.2	0.0	0.0	0.3	0.0	2.5	22.3	3.4	10.6	4.6	2.3	7.6	2.7	2.1	1.8	1.9	7.9	1.0	0.4	1.8	5.8	3.3	1.3	6.7	1.8	1.3	2.0	3.4	1.8	9.1	8.2	1.9	0.4	3.1	5.4	0.8	4.4	0.6	0.8	3.6	4.7	3.2	1.1	1.2	4.4	3.6	1.3	5.9	3.2	2.6	8.5	2.5	2.4	4.5	5.1	10.5	5.8	3.0	5.6	0.6	4.6	3.4	0.7	4.9	3.0	5.2	5.3	0.9	1.2	3.5	2.7	1.9	2.0	1.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.2	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
RCC1L	WBSCR16	ENSG00000274523	"RCC1 like"	Q96I51	7	75027122-75074228	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor, RNA-binding, rRNA-binding"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 33.4"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 50.0;Distal tubular cells: 41.4;Extravillous trophoblasts: 33.6;monocytes: 29.7;Syncytiotrophoblasts: 45.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052184, HPA060643"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA052184: AB_2681752, HPA060643: AB_2684335"	"unprognostic (9.73e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.87e-2)"	"prognostic unfavorable (4.88e-4)"	"unprognostic (8.91e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.28e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-1)"	7.4	8.5	4.4	7.0	5.1	4.2	3.3	4.3	5.6	5.8	6.4	7.0	7.2	6.4	5.0	4.8	7.4	4.8	7.7	11.5	3.7		7.9	12.0	3.9	5.5	5.6	4.0	7.1	9.1	4.9	3.3	6.5	3.8	7.2	3.2	7.3	7.8	6.4	33.4	4.3	6.0	9.5	2.3	6.8	4.8	5.4	5.7	3.6	8.7	8.4	6.8	5.8	7.7	6.8	5.5	4.8	4.9	6.7	9.2	2.6	15.3	23.5	12.4	21.1	8.9	7.3	17.2	15.0	10.8	12.9	10.6	23.7	18.9	16.3	6.9	12.1	16.9	18.2	10.5	10.0	5.4	17.9	16.7	12.0	15.7	22.1	12.6	19.2	19.5	9.0	8.3	11.2	9.1	8.7	11.4	3.5	38.4	10.6	9.9	32.6	0.9	29.1	29.0	18.6	18.5	9.3	10.1	34.0	11.2	14.0	13.5	20.2	20.1	42.6	18.3	9.1	30.0	20.1	12.8	17.1	14.3	15.2	19.5	11.9	9.4	25.6	13.1	20.4	22.5	4.8	3.8	2.2	7.3	4.9	5.7	5.7	7.8	6.4	5.3	6.8	7.5	9.2	1.4	6.7	3.5	5.5	5.9	2.6											0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	5.3	4.5	21.0	0.0	50.0	41.4	21.1	0.0	0.0	0.0	0.0	17.7	33.6	0.0	0.0	4.7	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	29.7	0.0	0.0	16.6	0.0	0.0	24.8	0.0	0.0	0.0	0.0	0.0	0.0	45.5	0.0	0.0	0.0
GTF2IRD2B		ENSG00000174428	"GTF2I repeat domain containing 2B"	Q6EKJ0	7	75092573-75149817	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 12.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA056679, HPA056680"			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056679: AB_2683205, HPA056680: AB_2683206"	"prognostic favorable (3.27e-4)"	"unprognostic (1.32e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.19e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.90e-4)"	"unprognostic (1.54e-2)"	"unprognostic (7.21e-3)"	"unprognostic (2.31e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.65e-5)"	7.3	6.7	6.3	9.2	13.4	7.5	9.9	5.9	9.4	11.2	11.0	11.4	4.6	2.7	13.4	4.4	5.4	12.7	9.2	12.3	7.9	4.5	8.7	9.5	8.2	7.3	11.0	6.7	21.7	10.4	10.5	7.5	4.2	10.8	12.9	5.7	9.8	7.2	8.4	18.8	4.7	5.6	11.3	5.8	4.4	8.7	3.5	14.1	6.3	7.8	4.0	7.1	13.0	6.7	12.8	1.5	5.1	1.9	1.6	3.3	0.5	12.1	5.6	8.7	9.8	7.0	9.8	6.6	6.7	10.1	3.2	8.2	2.5	9.8	8.1	6.6	6.9	12.3	4.4	4.1	4.3	3.9	9.8	3.8	6.0	7.2	5.1	13.6	8.8	8.6	9.0	9.0	2.6	11.6	11.2	4.6	3.0	7.6	17.1	10.4	8.7	6.2	20.5	8.7	11.1	8.2	12.0	2.8	11.3	9.0	9.3	8.5	14.9	13.4	14.8	14.3	2.5	14.4	8.9	7.2	8.1	5.4	7.6	8.5	6.7	4.0	20.7	4.2	9.0	17.8	0.5	1.3	5.1	1.2	1.9	2.0	12.8	2.1	2.6	1.2	5.7	3.3	1.3	1.7	1.6	1.1	1.5	2.7	0.5	6.3	13.4	5.9	9.4	7.9	4.5	11.0	6.7	10.8	14.1	0.0	9.6	11.3	4.4	3.9	8.5	20.6	12.7	9.4	2.3	7.0	11.8	1.7	0.0	10.5	11.1	6.6	8.1	0.0	11.3	1.6	8.2	4.5	3.5	11.1	2.2	12.7	18.5	8.0	8.9	3.6	25.3	3.5	20.3	4.6	13.8	4.8	12.0	14.0	15.9	2.9	12.7	12.9	10.3	2.3	1.3	3.8	2.5	5.7	13.8	3.4
TRIM73	TRIM50B	ENSG00000178809	"Tripartite motif containing 73"	Q86UV7	7	75395063-75410996	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"stomach 1: 11.5"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 20.3;Cone photoreceptor cells: 17.7;Horizontal cells: 30.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 7.9;Hep G2: 13.3"									"HPA047843, HPA051845"	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA047843: AB_2680176, HPA051845: AB_2681635"	"unprognostic (1.01e-2)"	"unprognostic (9.85e-5)"	"unprognostic (4.72e-3)"	"unprognostic (9.44e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.25e-3)"	"unprognostic (9.17e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.46e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-3)"	1.9	1.6	0.3	1.2	0.9	2.4	1.6	4.0	0.6	2.4	0.6			4.2	1.7	0.3	0.3	3.8	1.0	0.9	0.4	0.5	1.7	2.3	1.1	2.3	0.2		2.3	7.2	1.3	1.7	0.1		2.1	0.0		1.9	1.9	2.6	2.4	2.2	0.0	0.5	1.8	11.5	5.4			2.4		0.2	0.7	1.3	1.3	1.4	2.0	0.8	1.7	2.2	1.3	1.3	4.1	1.7	2.5	0.0	0.9	0.6	0.5	0.1	0.1	1.0	0.0	2.0	2.3	0.4	0.2	0.3	1.4	0.3	0.0	0.2	5.1	7.9	1.5	3.1	13.3	0.9	0.8	5.6	2.3	0.0	0.3	0.4	1.2	0.1	3.3	0.7	6.5	0.0	0.9	2.1	2.7	0.2	0.3	1.4	3.6	0.2	1.2	0.4	0.0	2.1	1.6	2.6	0.9	2.1	0.7	0.6	2.4	1.6	1.1	1.9	1.7	1.1	3.1	1.8	2.4	1.7	3.3	1.5	1.1	0.8	0.7	2.2	0.6	1.2	1.1	1.3	0.4	0.4	1.3	2.1	1.6	2.0	1.7	0.2	1.4	2.0	1.3											0.0	0.3	1.9	2.2	0.8	20.3	2.0	2.5	5.3	3.4	5.2	17.7	1.9	5.0	1.6	5.0	2.2	2.0	0.0	4.0	0.6	1.3	2.7	0.0	1.8	2.5	30.2	4.7	3.1	1.0	8.5	6.1	1.7	1.7	1.0	4.0	9.5	3.1	4.0	3.5	2.9	12.6	0.0	1.1	9.4	2.7	1.8	0.9	4.5	3.3	2.4
POM121C		ENSG00000272391	"POM121 transmembrane nucleoporin C"		7	75416787-75486271	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 64.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043809, HPA049817"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA043809: AB_2678680, HPA049817: AB_2680896"	"unprognostic (9.11e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.84e-3)"	"unprognostic (2.03e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.00e-2)"	5.5	5.5	6.5	9.9	8.4	11.0	4.5	11.2	7.4	5.9	5.1	5.8	6.5	4.5	7.0	7.5	6.6	5.9	6.0	5.3	6.8		6.9	6.3	5.0	10.3	4.3	4.4	8.4	7.5	7.7	10.1	6.6	5.4	5.4	5.2	9.3	6.5	5.3	5.7	5.5	6.2	6.2	4.6	6.7	5.3	4.6	6.3	13.1	7.0	7.3	12.0	6.6	5.0	3.5	3.4	3.9	1.6	2.7	3.8	1.7	15.8	13.3	18.4	35.2	6.9	7.8	12.1	11.6	10.7	9.5	9.2	15.9	10.3	28.1	4.8	12.6	14.9	14.4	15.6	14.3	15.7	18.9	21.6	13.9	15.3	10.6	9.2	36.8	19.8	6.6	9.1	14.4	10.8	14.0	9.6	11.7	38.9	15.8	15.3	16.0	22.4	18.7	14.6	12.3	15.1	20.2	12.3	14.4	5.2	21.7	20.6	27.0	13.4	21.4	9.4	17.4	18.6	13.1	10.6	23.1	12.5	16.8	23.9	16.9	19.8	34.8	15.0	18.9	21.2	0.6	1.2	1.3	3.8	1.6	3.3	2.6	2.9	1.1	0.9	3.5	1.5	1.9	3.9	2.7	1.0	3.4	0.5	1.7											32.8	22.1	15.2	8.3	16.0	29.4	10.1	30.6	21.4	28.4	12.2	64.8	11.5	5.0	11.7	1.5	15.8	11.4	0.0	14.9	8.4	12.0	18.1	7.0	12.3	10.2	23.8	27.5	12.9	17.3	2.9	16.7	15.5	6.8	7.2	13.8	20.6	15.0	3.5	14.5	8.6	28.6	12.9	12.1	14.0	12.3	16.2	14.2	20.1	16.9	19.0
SPDYE5		ENSG00000170092	"Speedy/RINGO cell cycle regulator family member E5"		7	75493625-75504304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"blood: 4.1;skin 1: 3.8;testis: 5.0"	"Group enriched"	"Detected in some"	6	"Early spermatids: 6.1;Horizontal cells: 4.8;Late spermatids: 5.1;Rod photoreceptor cells: 2.0"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 6.0;RT4: 5.1"									HPA051750	Approved					NA	NA					"HPA051750: AB_2681590"	"unprognostic (2.22e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.28e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.77e-2)"	"unprognostic (7.25e-3)"	"unprognostic (2.27e-2)"	"unprognostic (6.34e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.43e-2)"	"unprognostic (9.10e-4)"	"unprognostic (1.51e-10)"	"unprognostic (4.21e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.08e-4)"	0.0	0.5		0.8		1.6	0.0		0.6	0.0	0.0			0.2	0.0	0.0	0.1	0.0	0.8	0.0			0.0	0.0	0.0	1.2			0.3	0.5	0.0		0.1		0.0	0.0		0.4	0.0	0.4	3.8	0.6	0.0		0.8	0.3	5.0			0.6		0.0	0.6		3.8	2.6	4.1	2.2	1.0	3.6	0.7	1.4	1.4	1.5	2.5	0.1	0.0	1.5	1.1	0.0	0.0	0.0	1.4	1.4	2.0	0.6	0.0	0.9	1.6	0.0	0.0	0.0	1.0	0.9	0.8	6.0	1.0	0.0	3.7	0.9	0.0	0.0	0.0	0.0	0.6	0.0	1.2	1.9	2.3	0.0	2.2	0.9	2.7	1.2	0.5	1.0	1.0	0.3	0.0	0.0	5.1	1.8	1.2	1.2	1.4	0.3	1.2	2.0	0.5	2.4	2.7	1.1	1.6	1.5	1.7	0.7	2.8	0.4	1.7	1.8	4.1	2.2	1.1	3.6	1.2	1.9	2.0	1.9	1.8	0.9	3.8	1.7	2.1	3.5	1.0	2.1	2.6	0.5	0.7											0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	4.8	0.0	0.0	0.6	5.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0
HIP1	ILWEQ	ENSG00000127946	"Huntingtin interacting protein 1"	O00291	7	75533300-75738962	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Apoptosis, Differentiation, Endocytosis, Transcription, Transcription regulation"	"Actin-binding, Activator"	"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 1171.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 27.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013606, CAB015334, CAB016402, HPA017964"	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"CAB015334: AB_2117565, CAB016402: AB_627725, HPA013606: AB_1850717, HPA017964: AB_1850719"	"unprognostic (8.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.73e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.73e-3)"	"unprognostic (9.67e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.09e-1)"	16.5	8.7	14.6	7.2	25.9	5.1	13.5	13.2	20.8	13.2	5.3	34.4	4.9	2.9	13.4	10.1	5.7	13.8	8.7	9.2	17.5	11.9	14.6	9.6	17.7	4.6	27.2	11.8	8.1	4.0	4.9	3.6	20.0	16.1	6.8	4.5	9.9	4.0	12.4	3.9	10.8	4.6	12.6	24.8	10.8	4.6	18.5	29.7	1.6	15.8	5.7	4.6	9.7	8.8	0.5	4.0	8.8	1.1	3.3	1.5	0.3	2.5	27.3	18.6	17.5	7.9	10.7	5.6	4.8	3.1	3.1	2.3	1.5	2.4	1.8	5.6	11.8	10.9	3.1	18.8	3.9	4.2	1.5	3.5	1.4	3.2	2.5	7.8	0.4	7.4	8.2	2.4	10.2	2.1	5.8	13.0	2.0	1.9	1.8	5.0	10.4	1.2	10.6	20.2	0.2	3.3	2.1	7.8	0.1	2.4	9.7	0.9	8.2	4.4	2.8	6.3	17.3	17.2	6.7	4.6	9.2	7.1	3.1	6.6	2.0	0.2	4.4	9.2	3.9	6.2	8.8	1.1	7.6	1.1	1.1	1.0	0.4	0.2	0.9	1.6	0.5	0.1	0.7	7.7	3.3	0.8	4.0	1.5	0.3	14.6	25.9	13.2	16.9	17.5	11.9	27.2	11.8	16.1	29.7	56.6	35.7	6.0	6.3	15.7	7.1	12.5	5.1	0.0	17.0	26.2	11.8	1.3	11.6	10.2	240.8	40.7	0.7	0.0	5.3	7.5	15.4	4.0	13.9	20.2	11.7	22.3	4.6	30.1	15.1	1171.7	20.8	22.9	10.1	1.0	1.4	18.6	2.6	8.5	23.3	2.2	8.2	84.1	37.2	9.3	4.1	8.0	0.7	17.0	2.6	3.1
CCL26	"eotaxin-3, IMAC, MIP-4a, MIP-4alpha, SCYA26, TSC-1"	ENSG00000006606	"C-C motif chemokine ligand 26"	Q9Y258	7	75769533-75789896	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ovary: 16.6;retina: 50.2"	"Cell type enhanced"	"Detected in some"	12	"Leydig cells: 15.5;Sertoli cells: 12.9;Smooth muscle cells: 17.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 14.0"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	27	"intermediate monocyte: 2.7"	"Lineage enriched"	"Detected in single"	27	"monocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 10.6;PC-3: 30.2;U-2 OS: 8.6"					"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	117000					"unprognostic (1.14e-1)"	"unprognostic (4.17e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.02e-1)"	"unprognostic (8.71e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.05e-11)"	"unprognostic (2.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.73e-1)"	"unprognostic (6.29e-3)"	1.7	2.9	0.4	0.5	0.6	0.0	1.4	0.4	0.9	2.8	0.8	0.9	1.0	0.4	0.8	2.3	1.1	1.9	1.3	3.3	0.6	0.0	1.5	0.4	1.2	4.1	1.2	0.4	16.6	0.4	5.9	13.6	0.4	3.3	1.3	8.7	50.2	1.0	0.4	0.4	1.4	0.7	1.6	0.8	0.4	0.6	1.5	0.6	0.8	0.8	0.8	0.9	1.0	3.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	6.9	0.0	0.0	0.7	0.9	0.0	0.4	3.1	2.8	5.9	0.3	2.0	0.0	4.7	2.6	0.2	1.3	0.1	0.0	3.9	0.0	0.6	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.4	10.6	0.1	1.6	0.0	0.0	5.2	0.0	2.0	0.7	0.0	0.0	6.6	0.4	30.2	0.0	0.7	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	2.3	0.0	0.0	0.2	5.1	8.6	2.7	1.7	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.4	0.9	0.6	0.0	1.2	0.4	3.3	0.6	0.0	0.0	0.0	1.0	1.0	0.4	0.3	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.4	0.4	1.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	1.9	0.4	15.5	0.0	0.0	0.0	3.3	0.3	0.3	0.0	4.6	0.0	1.6	12.9	17.5	0.0	0.0	1.6	0.0	0.0	0.5	0.4
CCL24	"Ckb-6, eotaxin-2, MPIF-2, MPIF2, SCYA24"	ENSG00000106178	"C-C motif chemokine ligand 24"	O00175	7	75811665-75823356	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 33.1;lung: 23.3;lymphoid tissue: 63.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"colorectal cancer: 67.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"intermediate monocyte: 3.3"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.8;EFO-21: 2.7;HMC-1: 2.7;OE19: 4.1;RH-30: 3.4;U-2 OS: 9.4"	"Low region specificity"	"Detected in many"												"Secreted to blood"	NA	NA	276000					"unprognostic (4.55e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.41e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-2)"	8.2	0.5	0.3	5.7	0.3	0.0	0.8	0.3	0.3	0.6	12.2	0.3	0.2	9.4	0.4	0.6	1.0	0.4	1.1	0.5	0.3	0.3	0.6	3.8	23.3	21.2	0.3	0.2	0.6	0.4	0.0	0.4	0.3	0.3	0.5	33.1	0.6	0.6	0.5	0.4	0.7	26.8	0.5	0.3	63.3	1.0	1.0	0.2	1.2	0.5	0.9	2.8	13.4	0.7	0.0	0.6	0.0	3.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.0	8.8	0.2	2.7	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.4	0.7	0.2	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.8	0.0	4.1	0.0	0.1	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	9.4	0.0	0.5	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.5	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RHBDD2	"NPD007, RHBDL7"	ENSG00000005486	"Rhomboid domain containing 2"	Q6NTF9	7	75842602-75888926	"Enzymes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 233.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045074, HPA051960"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA045074: AB_10965705, HPA051960: AB_2681673"	"unprognostic (2.75e-1)"	"unprognostic (3.89e-2)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (9.79e-2)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.75e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.87e-2)"	"prognostic favorable (8.68e-6)"	"unprognostic (3.73e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.03e-1)"	12.3	50.9	44.3	9.2	64.6	12.1	12.1	14.4	68.3	17.9	11.9	18.5	43.8	18.2	8.5	31.8	14.2	22.6	12.5	14.1	48.5	69.1	18.5	21.7	22.1	8.9	33.6	29.9	12.3	23.6	81.3	56.5	10.6	37.1	15.8	9.1	23.0	22.8	57.3	6.0	14.4	12.5	7.0	16.2	9.5	15.3	15.5	10.7	9.5	34.3	4.2	7.6	10.0	9.6	11.1	13.5	76.4	14.0	13.2	27.4	12.2	7.5	25.0	11.2	22.7	6.6	4.3	4.7	4.6	18.1	10.5	8.9	13.5	20.9	2.9	4.1	8.7	22.9	12.3	7.4	5.4	3.2	8.6	14.7	2.5	15.8	12.9	18.2	4.3	23.6	9.4	13.3	11.7	5.3	16.2	6.7	19.4	5.8	18.6	8.9	50.4	8.1	24.1	11.0	14.9	14.3	6.0	7.8	21.7	17.2	13.6	14.9	29.7	17.1	36.3	17.4	9.0	23.7	8.2	6.2	16.4	13.7	10.8	9.4	15.4	5.3	4.5	16.4	6.8	20.0	76.4	14.0	17.6	18.9	13.9	16.6	11.1	21.3	16.7	13.5	10.8	18.0	15.3	24.0	13.2	7.9	11.1	27.4	12.2	44.3	64.6	14.4	68.3	48.5	69.1	33.6	29.9	37.1	10.7	38.7	29.3	20.0	41.3	20.6	34.2	7.7	53.5	46.8	39.8	82.0	31.4	45.1	16.6	79.5	128.0	23.5	40.6	0.0	89.9	35.2	36.2	52.9	189.3	34.5	39.0	17.5	86.2	65.7	29.1	233.4	39.4	32.1	57.3	21.6	32.4	62.9	61.3	31.6	49.5	44.0	27.9	6.5	24.7	38.5	29.7	20.7	43.5	43.7	23.9	42.0
POR	"CYPOR, FLJ26468"	ENSG00000127948	"Cytochrome p450 oxidoreductase"	P16435	7	75899200-75986855	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Congenital adrenal hyperplasia, Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 78.4"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 443.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 74.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004372, HPA010136"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"CAB004372: AB_627391, HPA010136: AB_1079657"	"unprognostic (1.89e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.94e-2)"	"unprognostic (9.89e-2)"	12.8	48.2	7.4	7.5	10.8	3.6	15.0	5.3	16.4	11.0	20.8	9.6	32.1	24.9	9.0	8.2	13.4	12.8	9.9	8.4	7.1	7.2	12.0	78.4	13.7	9.9	5.2	10.1	14.4	12.8	12.1	18.5	18.6	7.1	9.3	5.3	10.8	7.8	58.7	13.1	10.0	24.3	7.0	5.2	11.7	9.8	22.4	5.0	8.2	33.3	9.9	8.6	9.8	10.2	5.7	20.6	26.7	18.4	11.2	9.9	13.9	12.8	28.2	12.9	24.0	48.9	18.6	21.6	5.4	17.7	10.2	14.3	21.1	57.3	12.3	5.0	11.7	34.8	6.3	16.9	8.5	4.4	10.5	12.5	5.7	8.3	39.0	34.0	5.7	10.2	38.1	10.7	13.4	9.8	8.2	9.4	6.1	17.0	5.3	9.1	18.9	6.1	10.2	16.1	20.2	16.0	8.8	8.5	13.2	11.5	15.6	13.5	12.9	14.5	74.1	19.5	7.6	21.2	9.6	8.5	9.6	10.6	14.4	10.6	5.2	8.0	8.4	13.6	8.7	12.3	26.7	18.4	25.3	9.9	17.7	8.3	5.4	8.4	9.2	20.6	5.7	8.4	7.1	24.3	11.2	13.0	5.8	8.7	13.9	7.4	10.8	5.3	16.4	7.1	7.2	5.2	10.1	7.1	5.0	35.7	31.2	12.6	24.7	15.1	30.1	9.3	56.0	78.9	37.5	69.8	11.8	88.1	1.7	55.5	13.2	25.3	144.8	0.0	25.7	71.6	24.8	20.8	24.3	443.8	58.9	14.3	19.0	27.6	38.6	6.1	70.2	40.5	11.8	16.2	29.0	33.2	24.3	119.3	105.7	27.5	21.8	64.7	30.9	14.7	32.6	12.8	161.6	20.0	36.8	40.7
TMEM120A	"NET29, TMPIT"	ENSG00000189077	"Transmembrane protein 120A"	Q9BXJ8	7	75986837-75994659	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 64.3"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 217.5;Late spermatids: 771.6"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in all"		"neutrophil: 64.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.78e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.75e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.58e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.15e-2)"	8.7	14.0	6.3	2.4	6.2	3.0	11.8	3.5	5.2	5.2	15.2	3.1	11.1	15.5	3.4	5.6	6.4	5.3	7.4	25.0	5.6		8.2	14.9	3.9	5.1	6.0	3.9	12.6	8.9	3.1	1.9	3.8	15.4	5.5	3.7	4.3	7.3	12.7	11.0	2.4	24.0	4.5	3.8	3.9	5.0	10.8	5.0	0.5	4.7	12.5	3.0	4.2	5.0	5.4	8.0	64.3	16.5	7.7	13.6	11.1	4.8	7.7	3.2	27.0	24.7	16.1	8.5	4.6	12.5	6.1	8.4	12.5	6.2	2.6	3.5	13.1	19.4	5.4	3.3	4.8	2.0	4.1	4.1	2.5	5.2	17.3	23.9	0.9	16.3	17.5	4.0	4.7	6.1	6.4	10.3	5.5	4.4	3.4	10.8	8.1	1.4	15.5	1.5	10.7	8.0	1.5	3.9	11.4	12.6	4.4	1.7	9.1	5.0	14.1	8.0	8.2	10.5	5.8	5.3	17.4	6.0	10.3	3.9	4.5	3.2	0.9	10.2	2.5	3.9	24.5	16.5	29.4	7.7	14.6	5.8	4.4	6.4	6.0	8.0	5.4	4.5	4.4	64.3	7.7	14.6	3.0	13.6	11.1											20.8	10.5	14.7	17.4	0.0	5.0	99.7	45.9	8.1	15.9	26.2	5.9	18.4	21.6	38.0	217.5	23.9	179.6	23.3	34.0	12.7	22.1	21.2	23.2	102.6	31.8	11.1	8.1	18.4	36.2	771.6	37.4	28.9	0.0	14.4	31.0	12.6	35.2	112.2	29.0	101.8	5.9	38.8	23.0	80.7	14.5	0.0	9.2	20.8	35.2	23.1
STYXL1	"DUSP24, MK-STYX"	ENSG00000127952	"Serine/threonine/tyrosine interacting like 1"	Q9Y6J8	7	75996338-76048004	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA050261	Uncertain					NA	No					"HPA050261: AB_2681066"	"unprognostic (6.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.88e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.50e-3)"	"unprognostic (4.77e-2)"	"unprognostic (8.01e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.28e-1)"	"prognostic favorable (8.22e-4)"	9.4	19.2	16.0	10.2	23.1	12.7	17.5	12.8	19.8	15.7	15.1	19.6	13.9	10.5	10.3	21.0	21.1	28.2	9.4	13.2	16.6	12.1	14.8	20.1	11.3	13.7	20.9	13.5	15.4	30.0	15.9	19.9	24.6	16.8	16.6	20.1	12.2	16.0	13.9	12.4	19.3	10.3	14.0	17.0	17.4	14.0	25.0	19.7	20.8	19.9	12.1	19.5	14.8	14.6	19.7	23.0	30.8	29.3	24.7	22.1	17.4	19.8	10.6	8.4	11.2	13.3	14.5	8.7	9.0	12.8	14.6	14.5	12.3	18.1	4.6	4.5	11.8	23.1	8.8	13.5	17.9	21.2	14.8	6.0	5.6	5.0	11.0	18.9	7.8	10.3	14.0	21.1	17.4	43.9	18.8	14.1	7.0	18.1	14.0	13.0	16.0	3.1	33.5	7.1	19.2	25.7	11.9	7.0	12.2	18.5	13.0	11.0	11.4	8.4	19.2	22.4	21.9	21.1	15.1	7.0	12.6	5.3	13.8	12.7	15.2	9.6	15.7	11.1	15.0	19.5	30.8	29.3	25.8	13.7	25.3	15.2	19.7	13.2	15.2	23.0	15.6	11.7	13.2	24.6	24.7	23.7	15.1	22.1	17.4	16.0	23.1	12.8	19.8	16.6	12.1	20.9	13.5	16.8	19.7	20.8	10.4	12.3	13.2	6.5	5.6	15.4	10.2	54.9	30.7	10.4	0.0	25.9	33.2	13.9	68.8	7.8	14.4	0.0	22.7	20.3	7.6	16.5	10.4	15.5	26.7	3.2	19.4	12.9	23.8	50.5	10.6	18.9	3.3	32.5	24.6	18.8	19.6	40.3	9.6	16.3	8.9	6.5	6.1	22.2	12.6	8.7	37.6	9.6	17.7	15.9
MDH2		ENSG00000146701	"Malate dehydrogenase 2"	P40926	7	76048051-76067508	"Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 175.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019714, HPA019716, HPA019848, HPA026720"	Enhanced		Enhanced	Mitochondria		No	No		47000000	Mitochondria		"HPA019714: AB_1853678, HPA019716: AB_1853680, HPA019848: AB_1853683, HPA026720: AB_1853685"	"unprognostic (3.20e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.55e-3)"	"unprognostic (8.94e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.70e-2)"	"prognostic favorable (1.49e-5)"	"unprognostic (8.57e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.66e-1)"	18.1	39.1	17.4	15.4	20.6	18.3	22.2	15.3	34.4	14.9	27.0	13.5	16.9	32.5	16.6	13.5	31.8	19.4	17.6	103.1	17.1	18.8	29.1	101.9	13.8	26.6	17.4	21.9	17.3	35.5	16.8	16.9	17.5	20.5	17.9	24.3	15.0	26.8	21.5	175.8	24.6	26.7	21.9	12.8	21.1	22.3	17.6	9.5	22.4	20.1	76.2	23.8	19.9	17.8	37.1	52.8	22.1	45.3	30.1	45.6	44.7	29.0	47.7	17.3	43.2	19.7	21.7	29.7	19.5	25.2	28.0	25.4	41.9	35.0	44.0	8.8	25.7	30.3	29.7	44.3	29.2	20.0	31.3	64.1	24.4	25.6	38.6	24.3	38.0	25.3	27.4	26.1	27.2	40.6	22.0	26.0	27.4	76.9	25.7	25.9	65.8	32.9	67.0	38.5	51.5	60.2	26.9	21.3	63.2	26.2	38.4	43.3	39.4	19.6	98.1	40.3	23.0	55.7	42.9	20.1	28.1	26.6	30.5	38.8	28.9	23.8	48.7	24.4	48.7	42.7	22.1	38.9	18.2	32.7	43.5	34.2	37.1	36.9	35.3	52.8	32.1	36.0	33.1	10.2	30.1	45.3	47.1	45.6	44.7	17.4	20.6	15.3	34.4	17.1	18.8	17.4	21.9	20.5	9.5	47.6	54.0	113.9	144.7	120.7	61.8	448.3	122.3	80.3	48.9	109.9	17.7	283.1	379.7	210.0	208.8	86.2	316.5	0.0	291.5	257.6	93.5	138.9	53.1	240.8	220.1	68.3	162.9	73.1	117.9	127.9	92.0	117.1	172.1	171.3	226.5	63.6	223.7	228.0	93.3	301.0	48.8	84.1	129.5	71.9	69.5	145.2	246.6	109.1	306.4	194.4
SRRM3	FLJ37078	ENSG00000177679	"Serine/arginine repetitive matrix 3"		7	76201900-76287288	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	7	"brain: 43.2"	"Group enriched"	"Detected in many"	13	"Bipolar cells: 127.8;Cone photoreceptor cells: 451.6;Horizontal cells: 162.1;Rod photoreceptor cells: 475.2"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"SCLC-21H: 14.4;SH-SY5Y: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019337			Approved	"Plasma membrane,Intermediate filaments,Microtubules"		NA	NA			"Plasma membrane"	"Intermediate filaments, Microtubules"	"HPA019337: AB_1848909"	"unprognostic (1.65e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.37e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.53e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.07e-3)"	"unprognostic (6.37e-2)"	"unprognostic (3.73e-3)"	"unprognostic (5.05e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.15e-2)"	0.6	6.2	8.1	0.7	18.1	0.4	0.4	43.2	14.6	0.4	0.6	0.0	0.0	0.9	0.7	1.1	0.5	0.5	0.5	0.5	5.1		0.5	0.4	0.5	0.4	0.0	10.9	0.6	0.5	0.5	4.4	0.4	10.0	0.5	0.7	1.8	0.6	0.5	0.6	0.5	0.6	0.5	0.6	0.4	1.6	2.9	2.9	0.0	0.4	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.3	0.2	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	10.6	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0											0.0	0.0	0.0	5.1	1.8	127.8	6.9	0.0	0.0	0.0	0.0	451.6	0.3	0.0	1.4	18.9	0.0	0.0	0.0	2.1	7.0	2.7	1.2	0.0	0.0	0.4	162.1	11.6	0.6	0.0	23.9	2.0	0.0	3.3	0.0	0.0	14.5	1.2	0.0	2.1	0.3	475.2	0.0	1.4	5.4	2.6	1.0	1.8	0.0	0.0	4.7
HSPB1	"CMT2F, Hs.76067, Hsp25, HSP27, HSP28"	ENSG00000106211	"Heat shock protein family B (small) member 1"	P04792	7	76302544-76304295	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	Chaperone	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 565.5"	"Group enriched"	"Detected in many"	4	"Basal glandular cells: 13325.7;Exocrine glandular cells: 5786.9;Urothelial cells: 14386.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 165.4;MCF7: 232.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000497, CAB004439, CAB047330, CAB047331, CAB047332"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		57000000	"Plasma membrane, Cytosol"		"CAB004439: AB_627755, CAB047330: , CAB047331: , CAB047332: , HPA000497: AB_1851172"	"unprognostic (2.55e-1)"	"unprognostic (7.25e-3)"	"prognostic unfavorable (9.94e-5)"	"unprognostic (7.07e-3)"	"unprognostic (3.47e-3)"	"unprognostic (6.61e-3)"	"unprognostic (4.08e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.78e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.72e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.63e-1)"	67.6	41.7	23.0	42.9	22.8	7.3	186.2	10.1	21.3	127.6	84.9	10.8	89.2	27.1	126.5	65.9	410.5	57.7	52.2	164.8	21.4	22.5	85.4	26.3	43.3	25.1	25.7	14.3	63.4	34.7	16.6	15.5	106.9	32.8	99.6	12.0	31.1	50.5	101.3	439.2	164.4	24.6	139.7	27.3	17.8	37.6	22.0	23.4	31.9	72.9	207.3	126.8	146.2	565.5	27.8	17.8	4.1	27.9	23.2	36.8	14.4	74.1	55.2	6.0	44.0	35.9	31.7	0.3	31.5	16.7	17.1	21.5	4.9	43.5	0.6	24.4	40.9	35.3	68.1	25.8	18.4	5.6	41.4	8.7	3.4	42.6	23.3	19.2	5.0	31.1	39.4	165.4	25.8	3.8	32.5	56.6	12.7	27.0	75.8	19.6	232.3	8.4	34.3	30.2	15.0	48.3	26.2	12.1	60.3	25.5	28.3	0.4	33.8	22.2	90.4	28.2	17.6	106.6	35.5	30.5	51.5	76.9	16.0	79.5	5.3	8.7	0.7	37.7	15.5	37.5	4.1	4.5	2.8	18.6	21.1	9.6	27.5	30.6	20.2	11.1	27.8	36.8	31.5	1.7	23.2	27.9	17.8	19.7	14.4	23.0	22.8	10.1	21.3	21.4	22.5	25.7	14.3	32.8	23.4	253.1	212.2	115.1	13325.7	1643.2	181.1	724.5	257.4	163.3	246.9	1085.2	304.3	116.8	1271.6	1614.7	8.7	728.0	540.2	0.0	5786.9	328.3	1183.3	2785.1	218.6	220.1	1062.0	66.7	404.2	589.9	103.8	18.4	277.3	433.3	1950.2	307.4	101.7	223.5	2381.8	1422.3	502.4	1699.1	24.3	601.5	2360.7	6.2	90.5	1959.6	2034.5	83.1	148.1	14386.7
YWHAG	PPP1R170	ENSG00000170027	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma"	P61981	7	76326794-76359031	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 117.8;skeletal muscle: 91.8"	"Cell type enhanced"	"Detected in all"	5	"Basal keratinocytes: 363.1;Suprabasal keratinocytes: 371.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB013274, CAB018389, HPA026918, HPA061603"	Approved	Approved	Supported	"Nucleoplasm,Nucleoli rim,Cytosol"		NA	NA		160000000	Cytosol	"Nucleoplasm, Nucleoli rim"	"CAB013274: , CAB018389: AB_2217962, HPA026918: AB_10610566, HPA061603: "	"unprognostic (3.71e-2)"	"prognostic unfavorable (4.53e-4)"	"unprognostic (3.88e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.40e-3)"	"unprognostic (8.98e-3)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (7.44e-4)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (9.31e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.70e-1)"	52.4	31.2	46.3	17.7	54.6	7.3	17.2	36.2	117.8	13.4	14.2	13.3	4.6	14.4	15.0	7.0	18.6	9.0	17.0	33.1	50.2	56.2	15.9	22.0	12.9	12.1	45.9	49.8	13.3	18.0	14.8	7.8	16.6	74.6	14.7	14.0	8.6	10.0	13.3	91.8	11.7	12.5	20.2	22.8	12.7	11.2	8.9	13.5	6.8	8.8	13.8	14.3	14.7	13.2	3.1	5.9	3.2	5.0	1.1	3.3	1.7	37.4	47.2	41.7	53.0	42.8	24.7	18.9	43.6	21.6	27.1	29.4	29.6	40.4	52.9	15.0	38.7	45.1	35.1	52.3	48.1	38.1	35.8	22.8	50.1	32.3	32.8	39.1	61.1	49.0	27.1	46.2	31.6	65.5	28.8	42.9	28.8	68.7	59.9	40.3	35.3	43.6	45.2	46.3	30.3	33.1	51.1	42.3	58.4	42.4	25.6	22.4	62.3	48.3	62.0	30.8	56.2	43.1	37.0	45.3	52.9	30.7	46.9	58.2	19.9	37.2	81.5	47.5	57.8	56.3	3.2	5.0	1.1	2.1	4.6	3.3	3.1	2.4	2.6	5.2	1.8	1.8	2.0	1.1	1.1	3.8	5.9	2.0	1.7	46.3	54.6	36.2	88.9	50.2	56.2	45.9	49.8	74.6	13.5	29.8	23.7	44.7	105.7	363.1	100.2	200.1	43.3	22.7	45.5	36.6	11.8	29.7	31.5	43.8	87.4	64.2	34.1	46.7	32.8	61.5	84.6	106.7	66.8	81.5	75.7	117.6	81.9	48.5	90.6	18.9	42.8	83.5	89.4	41.5	31.5	23.8	60.8	28.8	40.7	41.0	26.9	32.3	122.6	10.3	16.7	371.9	56.2	18.7	33.8	146.6
SSC4D	"S4D-SRCRB, SRCRB-S4D, SRCRB4D"	ENSG00000146700	"Scavenger receptor cysteine rich family member with 4 domains"	Q8WTU2	7	76389334-76409695	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"salivary gland: 9.3;seminal vesicle: 9.5;thyroid gland: 8.6"	"Cell type enhanced"	"Detected in some"	14	"Collecting duct cells: 10.4;Distal tubular cells: 3.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.6"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.6"	"Group enriched"	"Detected in some"	12	"EFO-21: 5.9;Hep G2: 8.1;SuSa: 9.9;U-2 OS: 23.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA062611	Uncertain				"Secreted - unknown location"	NA	NA					"HPA062611: AB_2684807"	"unprognostic (3.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (2.83e-6)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (3.52e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.49e-3)"	"unprognostic (3.18e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.73e-2)"	1.1	0.5	0.1	0.1	0.1	0.0	0.4	0.0	0.2	1.0	0.2	0.3	3.0	0.2	0.3	0.8	0.0	0.4	0.1	0.0	0.2	0.2	7.7	0.7	0.2	0.1	0.2	0.8	2.3	4.4	7.8	7.2	0.7	0.4	0.1	0.0	0.8	9.3	9.5	0.4	0.0	0.0	0.2	0.7	0.3	0.1	0.3	0.0	0.0	8.6	0.0	0.2	0.0	0.0	0.3	0.1	0.0	1.6	0.0	0.2	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.9	0.1	0.0	0.4	0.0	0.0	0.8	0.0	0.2	0.0	0.7	0.1	0.0	0.0	0.1	0.9	0.4	0.0	0.0	9.9	0.1	0.0	0.0	0.0	23.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.6	0.1	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.2	0.2	0.8	0.4	0.0	0.0	0.3	0.0	0.4	0.0	0.2	1.5	0.0	0.0	0.0	10.4	0.0	0.2	3.3	1.7	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.3	0.0	2.1	2.7	1.6	0.0	1.3	1.2	0.0	0.9	0.8	0.0	0.0	0.0	2.0	0.4	0.0	0.4	1.0	0.1	0.0	0.0	0.5	3.0	0.0	0.2	0.0	0.0	0.3
ZP3	"ZP3-372, ZP3-424, ZP3A, ZP3B, ZPC"	ENSG00000188372	"Zona pellucida glycoprotein 3"	P21754	7	76397518-76442071	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Fertilization	Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 36.5;Late spermatids: 52.3;Spermatocytes: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 16.5;hTCEpi: 17.6;Karpas-707: 24.4;MCF7: 32.5"									HPA054061	Supported				"Secreted in female reproductive system"	NA	NA					"HPA054061: AB_2682363"	"unprognostic (6.48e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.29e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (1.02e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.13e-1)"	2.4	5.6	3.3	1.9	13.9	4.3	6.7	1.7	4.4	3.1	5.1	3.2	1.8	4.2	2.6	5.3	7.4	8.7	1.5	1.4	2.1	2.4	2.0	2.0	1.2	6.9	2.6	2.2	5.8	11.9	1.4	3.1	1.4	4.6	3.3	5.7	5.6	3.7	3.4	2.7	8.7	2.6	2.5	2.8	3.6	2.5	2.3	4.0	0.8	2.0	4.4	4.7	1.7	4.1	2.8	10.3	0.9	9.9	0.3	5.2	3.4	7.9	16.5	0.1	8.5	0.4	0.5	0.4	0.5	1.3	0.1	1.5	0.6	7.1	0.0	0.3	2.0	0.2	2.0	1.7	0.5	0.1	4.3	4.1	1.3	4.6	0.1	3.7	0.3	2.4	0.7	17.6	1.7	0.5	0.0	0.3	4.3	1.8	24.4	0.0	32.5	0.7	4.1	1.8	13.4	4.7	0.0	0.7	1.7	0.7	0.1	3.6	0.0	2.2	11.1	0.2	0.2	7.3	1.3	1.0	0.1	0.9	0.1	0.1	7.4	6.0	0.1	0.7	9.2	1.4	0.5	9.9	0.1	0.2	3.9	0.5	2.8	1.3	0.6	10.3	1.5	5.2	3.7	0.9	0.3	4.2	2.2	0.2	3.4	3.3	13.9	1.7	4.4	2.1	2.4	2.6	2.2	4.6	4.0	3.0	2.2	2.2	3.6	7.6	1.4	0.8	5.1	5.3	1.2	1.8	0.0	5.5	0.0	2.7	36.5	1.6	2.0	0.0	3.6	3.3	2.8	1.8	0.0	1.0	6.3	1.6	4.1	2.5	6.5	52.3	4.0	4.8	3.3	1.8	3.8	4.6	3.0	8.4	5.3	1.6	1.6	6.5	1.2	26.6	14.0	8.7	7.8	2.2	7.4	12.0
DTX2	"KIAA1528, RNF58"	ENSG00000091073	"Deltex E3 ubiquitin ligase 2"	Q86UW9	7	76461676-76505995	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 19.1;esophagus: 19.2"	"Cell type enhanced"	"Detected in many"	4	"Urothelial cells: 51.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 28.3;CAPAN-2: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042931	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes			"Nucleoplasm, Nuclear membrane"		"HPA042931: AB_2678227"	"unprognostic (1.72e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (2.85e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (1.13e-8)"	"unprognostic (2.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.19e-2)"	2.9	1.3	0.4	4.8	0.5	1.5	3.2	0.4	0.2	4.8	5.7			4.1	3.0	0.0	19.2	3.2	3.8	1.8	0.5	0.5	1.6	2.8	3.2	3.9	0.7		2.7	4.3	3.8	2.1	1.8		4.6	3.2		10.5	1.3	2.8	11.6	5.5	1.3	1.1	4.9	6.1	8.3			2.7		4.0	4.6	8.8	7.0	14.7	19.1	14.1	3.3	9.0	6.4	12.9	28.3	4.2	6.2	2.4	2.3	9.1	2.8	2.4	3.1	4.3	7.9	46.8	4.0	2.0	2.8	16.4	9.7	2.2	13.4	1.9	9.0	4.8	2.3	5.8	6.9	3.2	3.3	5.8	4.2	8.2	8.0	4.3	2.4	2.3	7.2	7.0	6.1	3.7	6.3	5.1	11.6	6.1	9.8	4.3	5.6	3.9	7.2	1.4	10.1	1.7	3.5	4.5	7.8	3.8	3.9	7.8	8.9	2.4	17.5	8.4	5.9	11.2	4.6	5.4	4.6	3.8	3.6	9.0	12.4	9.2	13.3	7.6	10.9	5.5	6.0	6.4	7.5	8.4	7.0	6.6	6.9	19.1	3.3	14.1	14.7	9.0	6.4											6.0	5.3	7.3	17.3	30.1	2.6	1.7	5.1	29.4	18.2	7.0	7.9	16.0	3.3	16.6	13.7	4.7	27.5	0.0	9.5	11.1	6.0	16.5	3.5	3.2	18.8	3.2	8.7	9.2	11.1	6.7	5.2	11.6	6.8	9.0	26.8	5.0	19.5	35.3	4.6	2.9	8.7	6.5	4.1	9.2	10.1	30.9	31.5	8.3	21.7	51.5
UPK3B	"FLJ32198, MGC10902, p35, UPIIIb"	ENSG00000243566	"Uroplakin 3B"	Q9BT76	7	76510428-76516521	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 28.5;esophagus: 40.2;lung: 34.1;lymphoid tissue: 25.0"	"Cell type enriched"	"Detected in some"	10	"Alveolar cells type 1: 113.2"	"Group enriched"	"Detected in many"	12	"ovarian cancer: 64.6;urothelial cancer: 78.4"	"Region enriched"	"Detected in single"	58	"pons and medulla: 5.8"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"A549: 7.8;CAPAN-2: 28.5;HaCaT: 5.8;RT4: 19.5;T-47d: 16.2"									HPA010506	Approved					NA	NA					"HPA010506: AB_1080479"	"unprognostic (8.33e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-3)"	"unprognostic (2.26e-3)"	"unprognostic (7.87e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.03e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.37e-9)"	"unprognostic (3.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.34e-2)"	28.5	0.3	0.0	7.1	0.0	0.4	0.3	0.0	0.3	1.5	6.9	0.1	0.0	0.3	0.8	7.9	40.2	2.8	3.0	9.4	0.0	0.0	0.3	0.4	34.1	0.4	0.0	0.0	13.2	0.3	0.3	0.1	0.3	5.8	1.4	0.3	0.8	1.4	0.3	0.4	1.1	0.5	1.5	0.2	0.4	0.6	6.1	0.0	0.2	0.3	6.1	25.0	20.5	2.1	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.6	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.5	0.0	0.2	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.2	2.3	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	113.2	3.5	0.0	0.2	1.4	0.0	0.3	2.5	4.0	9.1	3.5	3.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.2	1.1	0.0	0.1	1.6	0.0	0.6	0.0	0.0	11.2	0.9	3.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	2.5	0.1	0.0	0.1	2.5
SPDYE16		ENSG00000185040	"Speedy/RINGO cell cycle regulator family member E16"	A6NNV3	7	76531319-76541459	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"blood: 3.8"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 11.8;Early spermatids: 19.4;Late spermatids: 20.9;Rod photoreceptor cells: 7.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 7.0;Karpas-707: 5.4"									HPA051750	Supported					NA	NA					"HPA051750: AB_2681590"		"unprognostic (3.22e-1)"						"unprognostic (2.79e-1)"		"unprognostic (6.99e-3)"				"unprognostic (1.70e-1)"			"unprognostic (4.54e-2)"	0.0	0.0		0.9		1.1	0.0		0.6	0.0	0.3			1.0	0.4	0.0	0.2	0.0	0.0	0.2			0.0	0.0	0.2	1.5			0.0	0.0	0.0		0.1		0.0	0.0		0.2	0.0	1.0	1.7	1.3	0.0		1.3	0.7	1.0			0.2		0.0	0.3		1.7	2.6	3.8	1.3	0.8	1.2	0.5	2.0	1.7	0.4	1.2	0.0	0.1	1.8	1.5	0.0	0.0	0.0	0.5	1.1	1.2	0.6	0.0	0.6	1.1	0.0	0.0	0.0	0.6	0.5	0.5	7.0	0.2	0.0	2.1	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.2	5.4	0.0	0.8	0.5	1.0	1.0	0.2	0.2	0.9	0.4	1.9	0.0	0.7	0.7	0.3	1.5	0.6	0.5	1.3	0.4	0.9	1.4	2.1	1.1	1.6	0.7	1.0	0.8	2.3	0.9	1.8	0.7	1.0	0.4	1.4	0.8	1.3	0.7	1.7	0.8	0.9	0.2	0.9	1.1	1.2	3.8	0.8	0.5	2.6	0.7	0.5											0.0	3.5	0.0	0.1	0.0	3.3	0.4	0.0	1.4	1.2	1.8	11.8	0.1	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	1.0	0.4	3.2	0.0	0.0	0.6	20.9	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	7.1	0.0	0.0	0.4	0.4	0.0	0.6	0.0	0.1	0.1
POMZP3	"POM-ZP3, POM121"	ENSG00000146707	"POM121 and ZP3 fusion"	Q6PJE2	7	76609986-76627261	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 38.3;Late spermatids: 28.3"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA049817	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA049817: AB_2680896"	"unprognostic (2.23e-1)"	"prognostic favorable (4.34e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (4.31e-1)"	"unprognostic (7.49e-2)"	"prognostic favorable (9.31e-4)"	"unprognostic (4.94e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.99e-2)"	4.0	3.0	4.7	3.4	5.6	6.6	4.5	6.0	5.3	4.7	4.6			2.4	5.8	5.2	3.8	2.8	2.1	3.8	4.7	3.5	4.4	2.2	3.6	3.1	3.5		5.8	4.7	2.0	3.1	1.7		4.5	3.7		4.3	5.1	14.2	5.3	3.0	7.0	4.0	2.5	3.9	9.5			3.9		3.6	4.0	3.9	4.2	3.5	5.7	3.3	3.0	4.8	1.1	1.9	8.1	13.0	16.7	8.6	3.4	1.9	2.9	4.5	2.1	2.7	4.7	3.6	1.2	0.8	2.6	4.6	1.1	3.0	1.3	2.0	4.9	4.6	5.4	4.4	2.7	2.0	2.4	3.6	2.9	5.4	7.2	2.5	1.0	1.3	2.1	2.9	9.4	9.2	2.5	4.2	10.0	5.7	3.0	4.0	1.8	9.5	2.0	1.5	3.0	6.8	12.3	2.5	11.8	4.2	14.4	4.5	3.1	5.0	6.6	0.9	16.4	6.7	2.4	2.1	8.7	1.3	9.7	9.2	1.4	3.3	5.7	2.4	1.5	3.5	2.5	3.9	4.0	3.3	4.2	4.8	2.7	3.8	3.0	1.6	3.5	3.4	1.1											3.0	2.6	3.0	6.4	6.3	4.1	6.0	2.5	4.0	0.0	5.2	11.8	5.7	0.0	1.1	38.3	3.0	4.5	0.0	1.9	3.1	6.0	4.2	5.7	1.7	2.6	3.2	12.5	1.8	4.1	28.3	5.8	3.0	10.1	0.0	2.7	4.6	1.6	4.0	7.4	3.5	5.2	12.9	3.2	22.1	4.1	6.0	8.7	2.2	5.6	8.4
CCDC146	KIAA1505	ENSG00000135205	"Coiled-coil domain containing 146"	Q8IYE0	7	77122434-77329533	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.7;fallopian tube: 27.9"	"Cell type enhanced"	"Detected in many"	22	"Ciliated cells: 570.2;Early spermatids: 154.6;Spermatocytes: 113.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"pons and medulla: 32.7"	"Cell type enhanced"	"Detected in many"		"eosinophil: 12.5;neutrophil: 14.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 14.0;NK-cells: 5.0;T-cells: 4.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA020082, HPA020105"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA020082: AB_1852410, HPA020105: AB_2072056"	"unprognostic (3.07e-3)"	"unprognostic (9.94e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (7.37e-4)"	"unprognostic (1.95e-3)"	"unprognostic (8.02e-3)"	"unprognostic (4.05e-4)"	"unprognostic (1.73e-1)"	"unprognostic (4.63e-1)"	"unprognostic (4.09e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.70e-3)"	"unprognostic (5.58e-3)"	1.8	0.8	6.5	1.9	7.2	1.3	1.9	1.8	8.3	4.3	3.2	4.5	2.7	1.9	3.7	9.1	3.5	27.9	2.6	1.4	7.4	3.4	4.2	1.3	4.9	2.2	1.6	4.2	6.4	1.8	2.9	10.9	1.5	32.7	3.4	2.2	4.4	3.9	1.8	1.6	7.4	2.2	2.4	2.8	2.8	2.5	22.2	2.9	0.5	6.3	0.9	2.0	3.1	3.4	1.0	1.8	14.0	0.7	5.0	4.4	0.6	1.0	1.5	4.5	2.4	2.9	3.0	0.5	1.1	1.1	1.1	1.9	0.0	7.6	2.5	0.2	0.3	4.6	1.6	0.6	1.4	1.9	3.0	0.5	2.9	2.0	1.3	0.9	3.3	2.4	1.8	2.2	2.0	0.3	3.7	1.0	2.5	0.0	2.8	0.3	0.3	2.6	4.7	0.5	1.0	1.1	7.0	0.8	0.3	4.6	0.8	3.4	2.3	1.7	1.5	0.9	1.4	1.4	1.1	1.4	1.7	0.7	2.4	0.7	4.5	6.9	2.1	4.0	4.9	4.0	0.6	0.5	12.5	4.4	0.7	3.1	1.0	1.9	3.0	0.8	0.2	1.2	1.9	14.0	5.0	0.3	1.8	1.4	0.6	6.5	7.2	1.8	8.3	7.4	3.4	1.6	4.2	32.7	2.9	3.0	8.9	2.4	2.2	6.4	7.3	28.3	2.5	570.2	84.2	5.2	58.9	0.9	18.3	2.3	154.6	4.9	2.7	0.0	1.4	0.4	13.1	3.6	5.8	0.8	1.4	4.8	1.7	35.6	5.6	25.2	11.2	6.0	5.0	0.0	1.0	10.6	1.5	5.1	6.0	14.1	53.5	6.5	15.8	113.3	10.8	3.0	2.1	5.1	3.0	4.2
FGL2	"pT49, T49"	ENSG00000127951	"Fibrinogen like 2"	Q14314	7	77193371-77199848	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 82.0"	"Group enriched"	"Detected in many"	5	"Kupffer cells: 431.4;Macrophages: 384.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	50	"classical monocyte: 59.3;eosinophil: 52.6;intermediate monocyte: 82.0;myeloid DC: 38.1;neutrophil: 68.4;non-classical monocyte: 73.5"	"Group enriched"	"Detected in many"	56	"dendritic cells: 38.1;granulocytes: 68.4;monocytes: 82.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.1;Karpas-707: 3.8;LHCN-M2: 4.2;NB-4: 4.6;RPTEC TERT1: 8.0;U-937: 8.4;WM-115: 9.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021011, HPA026682"	Enhanced				"Secreted to blood"	NA	NA	38800000	6400000			"HPA021011: AB_1848532, HPA026682: AB_1848533"	"unprognostic (9.80e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.01e-2)"	30.0	8.7	6.0	28.7	10.7	1.5	18.0	5.7	4.7	8.0	29.5	5.0	7.7	14.2	7.6	18.4	41.4	13.8	16.2	17.8	5.1	5.5	23.3	14.3	17.0	28.1	10.3	4.1	6.4	3.0	1.8	8.0	7.0	11.4	17.9	20.3	6.8	11.7	4.4	6.2	8.6	40.9	73.7	18.4	63.4	16.9	3.4	8.6	12.0	19.2	18.3	9.1	55.8	7.7	1.0	38.1	68.4	82.0	0.7	1.1	34.6	0.0	0.0	0.0	0.0	4.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	3.8	4.2	0.1	0.0	4.6	0.3	0.0	0.2	0.2	0.5	0.4	8.0	1.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	3.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.3	8.4	9.0	0.6	59.3	52.6	1.1	82.0	0.5	1.0	0.7	1.0	38.1	0.5	0.4	0.8	68.4	0.7	73.5	1.2	1.1	34.6	6.0	10.7	5.7	4.7	5.1	5.5	10.3	4.1	11.4	8.6	6.0	18.4	34.2	1.0	33.9	1.1	3.2	0.0	4.0	9.1	83.7	9.8	1.1	5.0	0.2	7.0	45.8	11.9	0.0	0.0	1.0	69.5	0.8	9.3	4.2	36.4	1.6	0.0	56.4	431.4	7.1	25.6	384.4	47.2	1.0	0.3	11.3	0.1	2.8	18.4	5.4	7.7	0.0	9.5	0.5	0.3	27.4	3.1	19.2	0.3	1.4
GSAP	"LOC54103, PION"	ENSG00000186088	"Gamma-secretase activating protein"	A4D1B5	7	77310751-77416400	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"lung: 33.1"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 71.5;Alveolar cells type 2: 50.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 11.2;U-937: 14.7"	"Low region specificity"	"Detected in many"							HPA023994			Approved	Vesicles		NA	NA			Vesicles		"HPA023994: AB_1855386"	"prognostic favorable (3.36e-4)"	"unprognostic (3.70e-1)"	"unprognostic (8.55e-3)"	"unprognostic (4.53e-3)"	"unprognostic (6.80e-3)"	"unprognostic (3.52e-3)"	"unprognostic (4.36e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.98e-3)"	"unprognostic (2.07e-3)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (3.61e-1)"	"unprognostic (1.82e-2)"	"unprognostic (9.49e-2)"	"prognostic favorable (4.15e-5)"	5.7	6.3	3.8	19.9	3.9	7.0	5.7	1.7	6.6	3.5	6.4	4.4	2.8	2.0	3.9	6.7	5.0	5.7	8.0	7.3	4.2	5.4	6.2	13.9	33.1	24.0	4.5	2.2	4.0	5.4	9.4	14.0	3.6	4.2	5.8	4.1	5.6	5.6	5.3	2.5	3.7	10.1	8.0	5.5	21.5	6.9	1.9	3.3	3.8	9.4	3.4	14.8	5.5	3.4	13.7	11.7	1.3	9.7	11.2	6.6	5.7	3.2	1.7	0.0	0.0	0.5	2.2	0.3	2.0	6.8	1.1	2.9	0.5	4.7	0.7	0.2	0.0	3.9	1.6	0.1	1.6	3.0	2.1	1.4	3.5	0.2	9.0	3.0	0.3	0.0	0.8	6.2	5.5	11.2	8.2	0.5	0.0	0.0	0.3	9.2	1.8	0.0	7.0	0.5	5.1	2.4	0.0	0.1	0.1	6.2	2.7	0.2	5.2	2.2	1.1	5.3	0.4	2.0	2.9	0.0	1.7	1.2	0.2	6.1	1.3	0.0	1.2	7.9	14.7	1.4	0.0	9.7	0.9	6.6	8.9	3.9	13.7	2.2	4.5	11.7	12.3	2.9	4.8	1.3	11.2	6.4	0.3	0.1	5.7	3.8	3.9	1.7	6.6	4.2	5.4	4.5	2.2	4.2	3.3	71.5	50.8	31.3	9.0	4.6	16.8	7.3	5.1	12.0	29.6	3.5	15.7	2.4	21.6	6.2	0.0	9.9	0.9	0.0	5.3	0.7	2.6	10.5	12.7	13.2	9.6	19.1	5.2	3.7	33.4	0.0	4.9	31.0	8.5	13.6	5.3	37.9	6.0	5.7	3.5	6.8	21.3	6.5	3.1	1.1	0.4	4.0	1.4	15.9	4.3	15.9
PTPN12	"PTP-PEST, PTPG1"	ENSG00000127947	"Protein tyrosine phosphatase, non-receptor type 12"	Q05209	7	77537275-77640071	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007097	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		1100000	"Plasma membrane, Cytosol"		"HPA007097: AB_1079689"	"unprognostic (2.28e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.48e-3)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.27e-6)"	"unprognostic (4.99e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.21e-1)"	29.6	15.1	14.3	20.5	19.6	29.7	25.1	15.7	22.7	20.0	28.9	8.1	13.8	8.8	20.7	9.6	22.0	18.1	19.8	45.6	17.3	12.6	16.9	14.8	34.7	17.4	15.3	13.4	19.0	10.7	12.4	19.8	36.0	18.6	14.1	13.8	9.9	12.8	17.1	17.6	17.6	14.6	23.0	24.0	25.0	14.4	13.9	17.7	9.7	16.7	11.9	12.9	23.2	61.2	2.5	3.9	9.9	4.9	12.8	3.8	2.8	17.2	10.6	25.2	12.8	17.7	18.5	13.5	18.0	23.0	14.2	20.3	5.2	27.0	2.0	5.8	21.0	31.1	12.3	8.4	18.0	28.7	5.0	4.7	10.8	10.7	21.2	17.4	6.1	7.2	15.1	20.1	30.9	39.9	25.5	30.0	0.5	12.9	3.0	45.2	11.8	0.8	17.1	20.3	23.5	12.2	3.6	20.2	1.0	24.4	9.3	3.1	16.7	22.1	20.3	17.5	45.3	9.8	22.5	21.8	30.8	18.6	11.2	33.9	3.1	1.7	5.3	18.1	15.9	53.3	3.7	4.2	6.6	3.6	2.9	1.4	2.5	1.2	2.7	3.9	1.1	0.6	3.8	9.9	12.8	4.9	0.3	1.5	2.8	14.3	19.6	15.7	22.7	17.3	12.6	15.3	13.4	18.6	17.7	65.5	54.6	13.7	41.5	61.1	15.5	35.1	22.9	16.0	46.6	19.2	7.9	34.1	3.3	38.7	2.6	99.1	17.1	0.0	34.2	48.2	53.7	44.4	13.9	19.2	45.4	33.4	11.6	98.8	74.4	5.4	43.1	86.9	33.7	25.2	19.9	63.0	55.1	20.1	44.2	15.8	14.3	64.7	55.6	14.7	57.8	88.7	60.3	26.2	18.0	78.6
RSBN1L	"FLJ42526, FLJ45813, MGC71764"	ENSG00000187257	"Round spermatid basic protein 1 like"	Q6PCB5	7	77696443-77783022	"Cancer-related genes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 337.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 31.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 31.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020406, HPA020413"	Approved		Supported	"Nuclear speckles,Plasma membrane"		NA	NA			"Nuclear speckles"	"Plasma membrane"	"HPA020406: AB_1856488, HPA020413: AB_2253910"	"unprognostic (2.02e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (3.74e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.53e-3)"	12.9	10.6	15.0	22.1	14.6	9.5	15.5	28.7	17.0	22.8	23.5	8.9	12.1	11.1	17.2	13.6	15.0	14.2	13.4	10.6	12.4	10.3	12.0	14.9	15.7	18.2	11.1	11.0	19.2	14.9	19.5	16.2	12.2	11.8	18.8	15.1	13.9	14.0	15.4	13.6	11.7	14.9	18.0	11.0	20.7	14.3	29.8	13.8	34.5	21.1	6.7	18.0	23.6	28.2	7.2	7.0	31.5	4.0	3.0	5.2	1.2	9.0	7.0	11.7	20.5	8.2	10.5	5.7	6.7	7.3	9.6	11.0	8.6	16.2	18.6	2.6	6.9	12.1	7.9	15.8	8.7	13.8	10.1	8.5	14.8	11.0	8.4	6.9	18.1	14.0	7.5	6.4	8.8	9.7	7.3	7.9	12.4	20.1	19.6	9.9	10.4	15.5	18.3	8.3	11.7	6.3	16.2	11.7	19.5	6.0	11.9	13.8	14.4	10.2	18.6	7.3	12.4	11.3	9.7	7.5	14.4	13.3	8.6	10.2	8.8	9.3	29.9	6.8	16.9	9.4	9.1	4.0	6.4	5.2	2.9	3.9	5.4	4.5	3.8	2.2	7.2	4.3	4.7	31.5	3.0	3.2	7.0	4.5	1.2	15.0	14.6	28.7	17.0	12.4	10.3	11.1	11.0	11.8	13.8	53.6	44.7	77.1	91.4	69.9	234.2	15.9	38.2	69.6	80.8	52.4	221.9	45.1	33.2	32.4	254.3	67.5	45.0	0.0	43.8	30.0	64.1	42.7	68.2	48.3	38.0	149.4	74.4	43.0	41.9	50.1	94.0	54.7	60.8	45.1	68.1	88.8	31.9	58.5	112.4	18.0	337.1	71.1	85.6	98.9	156.4	65.7	32.4	99.1	57.8	72.2
TMEM60	"C7orf35, DC32"	ENSG00000135211	"Transmembrane protein 60"	Q9H2L4	7	77793728-77798580	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062625	Approved					NA	NA					"HPA062625: AB_2684811"	"prognostic favorable (3.09e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.02e-3)"	"unprognostic (3.91e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.73e-3)"	"unprognostic (3.46e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.72e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.43e-3)"	16.4	19.7	14.6	16.2	14.8	6.9	22.8	8.6	21.3	17.4	18.0	10.0	17.1	13.3	16.4	23.1	15.0	14.5	13.6	15.1	14.6	17.8	25.5	25.8	19.3	18.8	15.7	12.2	18.6	24.1	33.9	30.6	20.1	19.7	17.9	18.4	16.0	27.5	21.3	19.2	15.1	19.6	14.7	15.3	22.7	14.2	20.3	9.8	18.8	30.9	17.2	20.5	14.0	14.1	25.9	15.6	48.3	17.2	8.8	23.1	12.2	15.1	10.2	16.2	18.7	21.6	19.2	7.4	14.3	27.0	15.2	24.3	9.4	19.5	11.8	3.5	13.1	52.9	16.1	15.0	8.2	17.2	9.1	14.2	6.3	9.6	13.0	15.3	8.9	11.9	14.0	12.0	11.3	13.8	15.0	10.7	11.0	14.8	23.7	23.7	16.1	6.7	22.8	11.3	18.6	13.3	8.1	12.7	16.8	17.9	11.3	8.1	13.1	10.7	15.1	21.4	17.8	18.3	16.5	7.2	19.7	13.8	17.1	10.5	9.7	14.8	16.8	14.9	18.6	17.3	48.3	16.0	28.6	9.4	17.2	10.1	25.9	16.5	11.6	11.9	20.9	14.0	11.8	15.6	8.8	15.7	15.6	23.1	12.2	14.6	14.8	8.6	21.3	14.6	17.8	15.7	12.2	19.7	9.8	8.9	11.5	29.7	29.5	26.7	6.9	5.6	12.7	21.4	7.9	41.8	7.9	49.2	44.7	24.1	6.5	19.7	20.7	0.0	25.8	34.9	31.9	26.7	24.3	23.5	59.9	12.7	8.7	25.8	36.2	8.4	42.3	34.9	27.0	33.3	30.3	16.2	24.9	24.6	33.2	41.8	9.3	51.8	17.0	43.3	39.5	29.2	36.7	16.6	26.4	33.5
PHTF2	DKFZp434D166	ENSG00000006576	"Putative homeodomain transcription factor 2"	Q8N3S3	7	77798792-77957503	"Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 67.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"non-classical monocyte: 18.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012312	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA012312: AB_2668649"	"unprognostic (1.96e-1)"	"unprognostic (2.60e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.99e-3)"	"unprognostic (5.36e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (3.09e-7)"	"unprognostic (8.28e-3)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (5.53e-2)"	7.5	4.5	5.6	15.1	8.6	7.7	5.9	8.7	10.3	7.0	5.9	8.9	5.3	3.2	7.3	4.6	6.4	5.7	7.8	9.1	7.0	5.2	5.4	4.7	6.8	13.7	7.0	6.3	7.4	4.7	27.7	8.2	11.4	9.3	5.9	5.1	4.7	5.7	6.9	67.0	5.5	7.8	8.5	8.2	12.1	4.7	9.1	5.8	9.2	5.7	18.2	15.5	7.9	6.3	6.7	2.1	9.2	18.2	3.8	6.2	2.0	15.2	7.0	9.6	19.5	8.4	9.3	8.0	27.0	24.7	16.2	18.4	11.9	12.4	13.7	2.2	20.9	17.6	12.7	13.7	7.0	23.1	9.2	10.9	5.6	7.7	3.5	9.2	7.4	15.5	5.5	6.7	9.4	14.2	10.4	5.7	7.7	9.1	24.4	17.2	9.6	6.0	4.8	8.7	4.3	8.3	6.1	19.5	11.2	4.4	20.6	9.3	13.0	15.1	17.2	9.8	14.8	18.2	5.8	5.7	27.9	15.0	15.6	15.8	11.5	13.4	17.1	8.8	12.0	24.0	9.2	2.1	3.4	1.5	9.2	3.0	6.7	4.7	1.4	2.1	4.2	1.4	1.5	1.2	3.8	18.2	1.0	6.2	2.0	5.6	8.6	8.7	10.3	7.0	5.2	7.0	6.3	9.3	5.8	6.0	17.5	23.8	17.3	14.2	7.8	21.5	15.3	9.4	9.1	7.0	11.8	11.2	0.0	4.0	10.8	9.0	5.3	0.0	5.8	7.0	14.7	6.5	37.1	4.3	10.4	3.2	5.2	23.4	33.1	4.4	11.2	29.4	10.1	1.8	6.0	4.0	6.0	5.8	12.7	1.8	9.3	12.9	12.8	22.9	32.2	15.6	12.4	35.5	4.5	20.4
MAGI2	"ACVRIP1, AIP1, ARIP1, KIAA0705, MAGI-2"	ENSG00000187391	"Membrane associated guanylate kinase, WW and PDZ domain containing 2"	Q86UL8	7	78017057-79453574	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.7;parathyroid gland: 31.8"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 30.1;Horizontal cells: 44.5;Muller glia cells: 24.9"	"Cancer enhanced"	"Detected in many"		"glioma: 7.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"Karpas-707: 43.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013650	Approved					NA	NA					"HPA013650: AB_1853501"	"unprognostic (4.32e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.70e-4)"	"unprognostic (5.04e-2)"	"unprognostic (3.33e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.06e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (4.34e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.01e-2)"	5.4	8.3	21.0	2.2	20.5	1.8	3.9	43.7	36.8	5.5	3.2	17.7	2.5	3.1	5.6	5.6	3.6	4.8	4.6	3.9	21.8	12.7	7.6	2.5	4.4	1.6	13.6	19.5	11.5	5.1	31.8	7.7	2.3	16.5	11.9	3.0	3.5	2.8	11.6	2.9	2.3	3.2	4.1	15.1	3.1	2.9	5.1	24.4	0.0	9.0	0.0	1.4	4.1	2.9	2.0	1.4	3.8	0.9	1.0	0.9	0.2	0.0	0.3	10.3	0.2	2.1	3.4	0.1	1.8	3.4	0.4	0.5	0.0	0.1	0.0	0.0	1.1	1.4	0.1	0.6	0.0	0.5	0.5	0.4	0.1	0.2	0.6	3.2	0.2	0.5	2.5	0.1	0.2	0.1	1.9	0.4	0.3	0.3	43.1	0.9	0.4	0.1	0.2	2.3	0.3	0.1	0.1	0.1	0.7	0.1	0.1	1.6	2.6	0.4	0.1	1.0	1.6	0.2	0.3	0.6	1.5	0.5	4.2	0.2	0.2	0.0	0.1	0.9	0.1	0.6	2.7	0.7	0.8	0.9	0.6	0.6	1.1	0.6	0.5	0.4	2.0	0.6	0.8	3.8	1.0	0.9	1.4	0.6	0.2	21.0	20.5	43.7	34.5	21.8	12.7	13.6	19.5	16.5	24.4	8.9	8.4	0.0	1.1	0.9	30.1	5.2	5.1	2.7	5.7	1.8	19.6	0.3	5.0	0.4	21.7	2.0	0.9	0.0	0.8	0.1	4.4	3.0	0.0	1.6	0.2	44.5	2.4	3.1	0.0	22.8	6.1	0.1	1.7	0.0	1.1	24.9	0.3	1.1	18.7	1.4	21.2	12.9	4.7	2.4	1.2	0.9	0.3	0.0	1.2	0.7
GNAI1		ENSG00000127955	"G protein subunit alpha i1"	P63096	7	80133955-80219402	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 195.4;Suprabasal keratinocytes: 187.2;Syncytiotrophoblasts: 153.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"NK-cell: 20.0"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 20.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022449, HPA042141"	Approved		Supported	Nucleoplasm,Nucleoli,Centrosome		NA	NA		9000000	Centrosome	"Nucleoplasm, Nucleoli"	"CAB022449: , HPA042141: AB_2677870"	"unprognostic (2.29e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (5.09e-4)"	"unprognostic (9.78e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.48e-1)"	"unprognostic (9.41e-3)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.53e-1)"	33.2	23.4	17.2	5.4	26.2	1.5	14.4	14.4	33.7	9.4	10.5	36.9	3.0	6.9	10.0	3.0	16.6	9.0	8.6	5.7	23.8	18.3	25.9	13.1	10.3	3.4	40.3	21.9	14.3	5.4	2.5	7.3	30.4	26.2	10.1	9.0	2.8	4.9	9.5	4.2	32.4	5.3	12.2	49.7	5.7	8.3	11.1	32.0	0.9	11.1	3.2	4.6	15.5	9.0	0.1	3.7	2.1	1.5	20.0	2.3	0.7	2.9	20.8	19.0	0.1	23.7	15.2	8.7	12.6	15.2	11.2	13.9	0.0	3.2	0.1	4.1	13.5	9.6	3.0	10.6	12.9	14.9	0.1	9.7	17.8	18.3	1.3	24.0	2.3	3.8	16.3	32.8	6.0	17.3	9.1	7.5	0.0	1.4	0.0	21.0	0.5	0.1	0.1	5.5	0.1	7.5	8.3	7.3	8.9	33.5	10.0	13.9	9.6	13.5	0.2	10.8	16.3	2.6	0.4	13.3	25.1	17.7	5.8	4.7	0.1	0.0	0.1	6.6	1.3	11.1	2.1	0.7	0.7	0.1	0.7	0.0	0.0	0.3	0.2	3.7	0.1	2.3	0.9	0.3	20.0	1.5	0.3	0.2	0.7	17.2	26.2	14.4	25.5	23.8	18.3	40.3	21.9	26.2	32.0	17.9	14.4	0.8	17.7	195.4	3.7	6.1	15.3	36.1	13.6	27.9	0.0	72.1	74.6	6.5	0.9	24.0	2.9	0.0	3.3	66.5	57.4	6.1	27.9	16.8	8.7	25.4	19.1	18.4	1.0	3.5	31.1	5.8	97.8	4.6	7.3	46.1	6.8	7.0	70.0	9.8	5.0	109.9	38.2	6.2	40.1	187.2	153.4	0.0	8.5	14.5
CD36	"FAT, GP3B, GP4, GPIV, SCARB3"	ENSG00000135218	"CD36 molecule"	P16671	7	80369575-80679277	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Transport"	Receptor	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 464.3;breast: 156.1"	"Cell type enhanced"	"Detected in many"	16	"Cardiomyocytes: 491.8;Hofbauer cells: 1111.0;Ito cells: 465.9;Sertoli cells: 685.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 104.4;intermediate monocyte: 30.4;myeloid DC: 56.9"	"Group enriched"	"Detected in many"	45	"dendritic cells: 56.9;monocytes: 104.4"	"Group enriched"	"Detected in some"	5	"ASC diff: 82.7;HEL: 39.3"	"Low region specificity"	"Detected in many"							"HPA002018, CAB025866, HPA071026"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		92000000	"Golgi apparatus"		"CAB025866: , HPA002018: AB_1078464, HPA071026: AB_2732170"	"unprognostic (7.16e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (4.47e-4)"	"unprognostic (7.05e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.73e-3)"	464.3	3.6	1.2	8.9	1.3	10.9	156.1	0.5	0.5	1.8	31.8	0.6	3.3	9.8	1.8	7.5	7.5	3.3	7.2	76.8	1.8	1.9	2.2	13.3	11.5	4.8	0.6	0.3	2.5	3.9	3.1	0.8	37.9	2.9	9.2	3.5	0.8	4.6	2.3	23.6	5.4	23.4	4.7	0.8	42.8	5.0	6.0	0.5	2.7	13.6	15.3	1.4	9.4	19.2	0.3	56.9	1.8	104.4	0.7	0.2	60.2	0.0	0.0	0.2	0.1	82.7	0.8	0.1	0.2	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.0	0.1	0.0	0.1	0.1	39.3	0.1	6.3	0.0	0.0	0.0	8.0	3.1	0.0	0.0	1.9	0.2	0.0	1.4	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.2	0.1	0.0	0.7	2.7	4.5	0.0	0.1	0.5	0.1	0.0	0.0	0.1	0.1	0.0	13.5	10.4	0.9	104.4	0.3	0.2	30.4	0.2	0.3	0.0	0.0	56.9	0.0	0.1	0.0	1.8	0.7	7.5	14.3	0.1	60.2	1.2	1.3	0.5	0.5	1.8	1.9	0.6	0.3	2.9	0.5	6.0	69.8	5.2	0.1	6.5	0.0	491.8	7.6	0.0	5.7	7.0	0.0	8.5	0.0	0.0	9.2	46.6	0.0	163.5	0.0	9.4	14.4	0.7	14.0	12.1	1111.0	0.0	0.0	465.9	196.7	2.3	0.6	68.0	15.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.3	685.6	31.5	4.7	0.7	4.1	15.3	1.3	0.0	0.1
GNAT3	"GDCA, gustducin"	ENSG00000214415	"G protein subunit alpha transducin 3"	A8MTJ3	7	80458671-80512020	"Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"intestine: 14.5"	"Cell type enriched"	"Detected in single"	22	"Early spermatids: 2.2"	"Group enriched"	"Detected in some"	6	"breast cancer: 0.8;urothelial cancer: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 8.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	17	"olfactory region: 1.8"							NA	NA																"unprognostic (2.01e-1)"							1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	6.8	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.1	1.1	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.1	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SEMA3C	"SEMAE, SemE"	ENSG00000075223	"Semaphorin 3C"	Q99985	7	80742538-80922359	"Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 109.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"basophil: 25.8"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 25.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 49.5;hTERT-RPE1: 43.2;RT4: 45.2;T-47d: 51.2;U-2197: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042418			Approved	"Golgi apparatus,Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA			"Golgi apparatus, Cytosol"	"Plasma membrane"	"HPA042418: AB_10797389"	"unprognostic (1.93e-2)"	"unprognostic (2.54e-3)"	"unprognostic (4.94e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.74e-2)"	"prognostic unfavorable (5.72e-5)"	"unprognostic (9.28e-3)"	"unprognostic (1.91e-3)"	"unprognostic (1.39e-2)"	"unprognostic (9.01e-2)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (2.07e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.92e-2)"	27.1	4.1	3.7	11.9	5.6	0.2	25.1	1.2	6.8	37.0	31.7	7.6	21.6	4.3	26.9	25.1	20.0	7.1	16.4	12.4	5.2	6.1	5.8	1.1	12.3	0.3	13.1	3.0	23.5	1.5	0.0	4.1	5.9	25.5	29.6	14.1	27.4	13.6	19.7	7.3	9.7	10.6	48.8	8.5	8.9	13.3	11.6	6.0	0.2	2.5	15.2	1.5	35.5	14.5	0.0	2.0	25.8	3.2	0.0	0.0	0.8	1.1	14.6	30.4	0.1	6.8	16.5	0.0	9.9	11.4	5.0	6.4	2.3	27.6	0.0	0.4	3.3	49.5	5.9	0.1	8.9	8.2	0.0	3.0	1.8	13.1	0.1	8.2	0.1	0.0	7.2	5.9	12.4	12.2	43.2	0.0	0.0	0.1	0.0	8.4	21.1	0.0	0.0	0.2	4.1	2.3	0.0	14.7	0.2	26.3	45.2	0.1	15.7	27.8	7.2	1.7	13.5	51.2	0.0	23.8	27.5	12.6	66.4	17.4	0.2	0.0	0.0	10.4	0.0	27.2	25.8	3.2	0.5	0.0	1.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.5	0.0	1.0	1.8	0.0	0.8	3.7	5.6	1.2	6.8	5.2	6.1	13.1	3.0	25.5	6.0	8.9	12.8	0.0	33.4	23.5	0.0	35.1	0.0	109.7	19.4	7.0	5.9	0.3	1.7	3.6	0.4	3.5	25.9	0.0	5.8	0.5	25.3	36.0	4.7	0.0	9.3	0.0	5.8	1.3	2.6	1.7	7.2	8.6	52.3	4.6	16.2	1.3	40.1	15.8	49.1	0.1	0.3	0.0	16.2	0.3	0.2	16.6	0.2	0.0	23.4	52.9
HGF	"DFNB39, F-TCF, HGFB, HPTA, SF"	ENSG00000019991	"Hepatocyte growth factor"	P14210	7	81699008-81770438	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Serine protease homolog"	"Cancer-related genes, Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 116.9"	"Cell type enhanced"	"Detected in many"	9	"Fibroblasts: 19.8;Ito cells: 40.5;Muller glia cells: 30.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"basophil: 33.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 33.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 45.8;HHSteC: 35.8;HL-60: 20.1;hTEC/SVTERT24-B: 22.5;Karpas-707: 62.0;U-87 MG: 16.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010333, HPA040360, HPA044088"	Approved				"Secreted to blood"	NA	NA	4110000				"CAB010333: AB_647965, HPA040360: AB_2676939, HPA044088: AB_2678804"	"unprognostic (5.24e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.45e-5)"	"unprognostic (1.66e-1)"	"unprognostic (9.28e-3)"	"unprognostic (3.28e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (5.59e-4)"	"unprognostic (7.90e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.06e-2)"	6.2	10.6	1.4	2.9	1.2	4.6	4.8	0.5	4.5	5.1	4.0	0.4	2.9	1.5	5.2	3.1	2.9	4.0	7.1	9.3	3.6	1.3	7.3	27.5	15.8	2.0	1.3	1.4	3.2	1.4	1.6	4.3	116.9	1.9	10.8	1.9	2.0	2.2	3.2	1.4	0.9	1.8	15.1	6.0	6.6	2.3	2.0	0.9	0.5	5.3	1.4	1.4	10.5	21.5	0.0	2.0	33.5	7.6	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.7	45.8	0.0	0.1	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	35.8	20.1	0.1	10.8	0.0	22.5	0.0	0.0	0.5	0.0	0.0	62.0	0.1	0.0	0.0	13.9	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	16.4	4.2	0.0	33.5	6.6	1.6	0.0	7.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.3	0.0	6.7	0.4	0.0	1.5	1.4	1.2	0.5	4.5	3.6	1.3	1.3	1.4	1.9	0.9	0.0	5.5	0.0	0.3	0.9	0.1	0.8	2.5	0.0	1.2	0.0	0.0	4.6	0.0	0.0	11.8	6.3	0.0	0.0	0.0	3.2	19.8	0.2	1.1	0.5	17.6	0.0	0.0	40.5	14.3	1.7	17.0	5.5	1.7	3.6	0.0	30.6	0.0	0.0	10.3	0.0	0.3	12.9	13.8	0.0	0.1	0.1	10.1	0.0	0.0	0.1
CACNA2D1	"CACNA2, CACNL2A, LINC01112, lncRNA-N3, MHS3"	ENSG00000153956	"Calcium voltage-gated channel auxiliary subunit alpha2delta 1"	P54289	7	81946444-82443798	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 59.0"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 89.3;Early spermatids: 53.8;Intestinal endocrine cells: 37.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 49.0;HUVEC TERT2: 20.6;SH-SY5Y: 23.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008213, HPA008621"	Enhanced				"Intracellular and membrane"	NA	NA		310000000			"HPA008213: AB_1233654, HPA008621: AB_1845863"	"unprognostic (5.07e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.24e-3)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (4.28e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.03e-4)"	9.9	13.4	15.7	4.2	18.1	0.7	4.3	8.8	20.8	5.7	11.3	7.3	1.0	5.0	7.1	2.9	5.4	4.1	6.3	25.8	12.7	14.9	8.0	1.8	3.6	2.2	6.3	15.6	7.8	2.0	1.9	8.3	4.2	8.6	12.8	5.3	1.9	3.3	6.6	59.0	4.7	3.5	13.0	5.6	4.3	5.5	3.7	8.0	0.0	16.9	14.6	3.3	6.8	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	4.0	0.0	7.1	9.0	0.0	8.7	5.6	4.3	4.3	0.0	1.3	0.0	0.0	7.5	5.4	0.0	4.2	0.0	5.7	0.0	5.6	0.2	5.6	0.0	4.6	1.9	0.0	5.3	0.0	15.1	0.0	49.0	20.6	0.0	0.0	0.0	9.7	0.0	0.0	0.0	4.7	0.0	1.8	0.8	0.8	0.0	0.3	0.3	8.0	23.9	1.7	0.0	0.0	4.4	0.0	0.0	14.7	7.7	5.8	7.6	0.0	0.0	0.0	0.0	6.5	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	18.1	8.8	20.8	12.7	14.9	6.3	15.6	8.6	8.0	0.0	1.7	0.0	4.0	5.0	30.7	89.3	0.0	1.4	2.3	7.0	17.7	0.0	0.0	0.0	53.8	9.0	0.0	0.0	0.0	0.0	11.0	11.4	24.3	0.0	0.2	23.8	37.2	1.3	0.0	25.0	9.5	0.4	1.7	1.0	0.2	5.8	0.6	0.0	5.6	9.9	6.0	6.5	17.6	1.0	2.3	5.6	0.1	0.0	0.0	1.4
PCLO	"ACZ, DKFZp779G1236, KIAA0559"	ENSG00000186472	"Piccolo presynaptic cytomatrix protein"	Q9Y6V0	7	82754013-83162930	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.3"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 95.6;Cone photoreceptor cells: 123.7;Horizontal cells: 81.0;Intestinal endocrine cells: 57.6;Rod photoreceptor cells: 84.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	28	"REH: 62.4;U-2 OS: 71.7"	"Low region specificity"	"Detected in all"							"HPA015858, HPA029579, CAB079012"	Approved	Supported	Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Nuclear speckles, Plasma membrane"		"CAB079012: , HPA015858: AB_1855071, HPA029579: AB_10602044"	"unprognostic (1.32e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.49e-3)"	"unprognostic (6.14e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.79e-6)"	"unprognostic (5.15e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-5)"	"unprognostic (6.62e-5)"	3.1	7.9	8.8	0.8	26.3	0.4	4.7	50.3	19.4	3.2	3.9	1.6	0.4	2.9	1.0	7.3	2.3	2.0	1.9	2.2	9.8	5.7	8.2	0.6	1.8	0.6	4.6	12.6	1.9	4.0	11.4	19.2	1.0	9.1	4.9	3.5	3.6	2.5	5.0	0.6	2.6	2.4	0.7	5.3	1.1	2.9	4.5	4.4	0.0	8.4	0.0	0.8	1.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.4	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	1.9	0.1	1.4	0.5	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.4	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.2	1.1	62.4	1.0	0.0	0.4	0.2	1.2	0.8	0.0	0.6	0.1	0.3	0.8	0.1	0.0	0.0	71.7	0.3	0.1	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.8	26.3	50.3	19.4	9.8	5.7	4.6	12.6	9.1	4.4	8.9	14.1	0.0	8.3	2.3	95.6	24.6	20.4	9.4	18.2	1.8	123.7	0.9	6.6	4.6	9.0	4.1	14.6	0.0	4.4	0.3	0.4	5.3	0.0	0.0	1.3	81.0	57.6	0.0	0.0	5.6	2.6	0.0	0.0	0.0	12.3	17.5	2.5	14.4	6.0	16.7	84.6	0.0	0.3	3.9	13.8	3.0	0.6	0.0	7.7	4.8
SEMA3E	"coll-5, KIAA0331, M-SemaK, SEMAH"	ENSG00000170381	"Semaphorin 3E"	O15041	7	83363238-83649113	"Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 163.8;Alveolar cells type 2: 146.0;Ciliated cells: 62.9;Club cells: 75.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.0;SK-BR-3: 20.6;U-2 OS: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029419, HPA063804"	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			Vesicles	Nucleoplasm	"HPA029419: AB_10602090, HPA063804: AB_2685127"	"unprognostic (4.42e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.82e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.27e-2)"	"unprognostic (9.36e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.46e-6)"	"unprognostic (1.32e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.62e-1)"	4.0	1.1	2.4	1.0	12.2	0.6	7.8	2.0	12.2	5.5	6.4	1.9	0.5	2.2	5.4	1.4	4.7	2.3	6.5	0.9	4.0	4.7	1.0	1.0	6.1	0.6	5.9	6.4	0.9	9.6	0.7	1.4	1.1	5.1	15.0	4.9	2.4	6.2	9.1	1.0	2.2	3.6	10.3	6.6	0.7	3.8	0.9	3.1	0.9	2.2	0.5	0.8	9.8	3.3	0.5	0.3	1.4	0.6	0.7	0.5	0.2	0.2	1.1	0.2	0.0	0.5	3.3	0.0	0.0	0.2	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.6	0.0	3.5	0.0	1.4	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.9	0.0	0.0	0.5	0.5	1.2	0.0	2.1	0.0	0.0	0.8	0.1	0.0	0.0	20.6	0.0	3.6	1.6	0.0	0.0	0.8	7.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.8	1.4	0.3	0.5	0.3	0.3	0.5	0.3	0.4	0.3	0.3	0.5	0.5	0.5	0.8	0.7	0.6	0.3	0.3	0.2	2.4	12.2	2.0	8.7	4.0	4.7	5.9	6.4	5.1	3.1	163.8	146.0	0.0	1.0	1.0	41.8	1.2	17.8	62.9	75.1	1.8	0.0	0.7	0.0	4.2	0.9	0.5	0.0	0.0	1.0	0.2	2.1	3.6	22.1	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.9	1.1	1.7	1.8	0.0	39.8	4.4	0.0	0.0	0.1	2.7	0.0	1.0	0.3	0.4	0.4	0.2	0.0	0.0	1.1
SEMA3A	"coll-1, Hsema-I, SEMA1, SEMAD, SemD"	ENSG00000075213	"Semaphorin 3A"	Q14563	7	83955777-84492724	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 24.5"	"Cell type enhanced"	"Detected in many"	16	"Ciliated cells: 18.7;Club cells: 20.5;Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 65.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"non-classical monocyte: 4.7"	"Lineage enriched"	"Detected in single"	15	"monocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"AF22: 42.8;BJ: 33.3;fHDF/TERT166: 36.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA029447, HPA052235"	Approved		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA		1200000	Vesicles	Nucleoplasm	"HPA029447: AB_10602302, HPA052235: AB_2681770"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (1.51e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.92e-3)"	"unprognostic (6.05e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.44e-2)"	"unprognostic (6.18e-12)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.47e-4)"	9.6	1.1	2.9	5.2	14.6	0.3	3.7	1.0	6.0	7.4	17.8	1.4	0.7	2.3	1.5	3.3	8.6	3.5	8.6	3.7	2.0	2.1	1.3	1.1	4.9	12.9	1.6	6.5	1.4	1.0	1.3	12.0	14.7	11.1	5.0	8.7	8.2	1.5	0.8	1.0	2.7	5.3	24.5	3.3	17.9	5.4	1.8	1.8	0.0	4.2	1.4	2.4	11.9	2.1	0.0	0.2	0.0	4.7	0.3	0.3	0.0	3.7	10.2	42.8	0.0	1.3	1.0	2.8	33.3	19.6	2.8	1.7	3.6	10.0	0.0	1.6	36.2	0.3	18.5	0.1	7.9	3.9	0.0	1.4	0.0	1.9	0.0	1.1	0.8	0.0	1.3	0.0	6.0	1.4	8.7	10.4	0.0	0.0	0.0	1.1	0.2	0.0	0.0	16.0	0.1	3.7	0.7	18.2	1.0	6.2	0.2	3.3	1.7	0.2	0.0	0.3	7.1	0.2	0.3	5.8	3.7	3.9	10.7	4.8	2.5	1.7	0.0	3.8	1.4	7.3	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.3	4.7	0.0	0.0	0.0	2.9	14.6	1.0	6.0	2.0	2.1	1.6	6.5	11.1	1.8	3.0	1.7	0.0	0.0	0.8	10.3	4.1	0.0	18.7	20.5	0.0	43.2	0.3	0.0	0.0	0.1	2.7	0.0	0.0	1.8	0.1	4.7	0.3	1.1	0.0	1.0	3.2	0.0	0.6	0.3	0.0	2.3	0.0	1.7	0.0	0.0	16.0	3.2	0.0	0.0	0.0	65.3	0.0	1.0	1.6	1.7	1.1	0.2	0.0	0.0	0.3
SEMA3D	"coll-2, Sema-Z2"	ENSG00000153993	"Semaphorin 3D"	O95025	7	84995553-85186855	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.8;thyroid gland: 33.0"	"Cell type enhanced"	"Detected in many"	20	"Early spermatids: 137.5;Leydig cells: 48.6;Peritubular cells: 58.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"amygdala: 17.1"	"Cell type enriched"	"Detected in single"	5	"naive B-cell: 2.0"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 17.0;HaCaT: 17.3;TIME: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037522	Uncertain		Approved	"Golgi apparatus,Plasma membrane"	"Secreted in other tissues"	NA	NA		77000	"Golgi apparatus"	"Plasma membrane"	"HPA037522: AB_10672494"	"unprognostic (7.05e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.58e-3)"	"unprognostic (4.02e-3)"	"unprognostic (9.94e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-3)"	"unprognostic (5.25e-3)"	4.1	2.2	17.1	1.9	2.3	0.1	4.3	0.8	2.8	4.6	2.9	1.8	2.5	1.4	1.9	7.4	1.3	3.9	1.4	2.0	3.6	2.7	3.0	1.0	3.6	6.1	2.4	3.1	4.1	0.8	0.4	1.5	0.6	5.4	6.2	2.6	2.6	5.6	2.9	0.7	2.1	2.7	3.2	4.8	33.8	2.4	4.3	2.5	0.0	33.0	0.6	1.1	4.7	3.9	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.3	4.6	5.0	5.4	2.6	0.0	0.0	0.0	1.4	17.0	0.1	17.3	1.9	0.0	3.6	0.0	3.5	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	4.4	6.3	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	4.5	1.2	5.5	4.0	1.7	0.0	0.1	0.6	0.0	0.0	0.2	8.9	0.2	0.0	26.5	0.0	1.7	0.2	0.0	3.3	1.9	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	17.1	2.3	0.8	2.2	3.6	2.7	2.4	3.1	5.4	2.5	0.0	3.5	0.8	2.3	3.2	1.5	0.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	137.5	5.2	0.0	0.0	0.2	0.0	6.7	7.1	2.3	0.0	0.9	1.6	25.4	1.8	0.0	14.9	48.6	0.8	11.8	0.0	0.0	0.9	0.0	0.0	58.7	4.5	4.1	0.0	2.1	0.7	0.7	2.0	0.0	0.0	0.1	0.4
GRM3	"GPRC1C, mGlu3, MGLUR3"	ENSG00000198822	"Glutamate metabotropic receptor 3"	Q14832	7	86643914-86864884	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	24	"brain: 53.3"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 5.4;Cone photoreceptor cells: 3.9;Early spermatids: 16.8;Horizontal cells: 12.7"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"AF22: 28.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (2.05e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.70e-3)"	"unprognostic (3.16e-1)"	"unprognostic (1.07e-3)"	"unprognostic (6.99e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.91e-3)"	"unprognostic (4.00e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.12e-2)"	1.2	2.2	10.6	1.2	22.5	1.2	1.2	4.6	53.3	1.3	1.3	23.9	0.0	1.3	1.3	1.2	1.2	1.2	1.3	1.3	12.6	5.6	1.4	1.2	1.3	1.2	18.9	13.0	1.2	1.2	1.2	0.2	1.2	11.5	1.7	1.2	0.0	1.3	1.3	2.1	1.2	1.2	1.2	12.0	1.8	1.3	2.2	22.1	0.0	1.2	0.0	1.2	1.4	0.1	0.5	0.1	0.5	0.0	0.1	0.3	0.1	0.0	0.0	28.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	10.6	22.5	4.6	20.2	12.6	5.6	18.9	13.0	11.5	22.1	0.0	0.0	0.0	0.7	0.1	5.4	1.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	16.8	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.5	0.3	0.0	1.7	0.0	0.0	0.3	0.1	0.0	0.4	0.0	1.8	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.2
KIAA1324L	"EIG121L, FLJ31340"	ENSG00000164659	"KIAA1324 like"	A8MWY0	7	86876906-87059699	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 28.9"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 73.9;Early spermatids: 53.7;Horizontal cells: 31.8;Late spermatids: 70.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 5.8"	"Group enriched"	"Detected in many"	5	"B-cells: 2.7;NK-cells: 4.8;T-cells: 5.8"	"Cell line enhanced"	"Detected in many"		"AF22: 15.4;hTERT-HME1: 17.9;HUVEC TERT2: 15.0;K-562: 23.0;SCLC-21H: 19.1;SuSa: 17.5;TIME: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044527, HPA076093"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044527: AB_10963793, HPA076093: AB_2686776"	"unprognostic (2.78e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.15e-4)"	"unprognostic (3.79e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.82e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.37e-1)"	11.1	4.5	7.7	2.3	17.3	1.0	6.5	15.6	15.8	4.0	5.0	28.9	1.2	1.8	4.3	1.0	4.5	3.9	5.0	5.5	10.8	8.7	2.9	1.5	24.4	3.8	22.4	10.4	2.7	5.5	11.7	13.5	9.0	22.7	7.6	6.5	2.4	3.6	6.3	3.5	3.4	2.7	6.4	23.5	6.4	4.1	3.6	21.7	0.0	6.1	1.0	4.0	5.9	2.8	2.7	0.9	0.4	0.0	4.8	5.8	0.7	0.9	0.0	15.4	0.0	0.2	0.0	4.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	3.8	0.3	0.1	0.0	1.6	0.0	0.0	3.7	0.3	11.8	4.1	1.3	0.1	0.1	1.5	1.2	0.0	0.0	17.9	0.1	15.0	5.8	23.0	0.4	1.7	4.7	0.3	0.0	8.4	0.0	3.8	0.0	1.0	2.4	1.6	6.8	19.1	14.3	4.1	5.4	1.7	17.5	1.6	0.3	17.6	0.2	6.0	0.1	0.0	8.5	5.0	0.1	4.5	0.0	0.2	0.0	0.0	0.4	0.7	0.0	5.8	0.9	2.1	1.3	0.4	2.7	2.2	1.2	0.0	4.8	0.0	0.9	0.7	0.7	7.7	17.3	15.6	15.8	10.8	8.7	22.4	10.4	22.7	21.7	11.9	73.9	0.0	1.4	1.0	11.6	2.0	0.0	6.7	3.4	3.5	9.8	0.4	3.3	1.3	53.7	10.0	1.7	0.0	1.0	0.4	3.1	3.6	2.3	0.0	0.3	31.8	8.1	0.6	0.8	70.4	2.3	1.6	0.0	0.0	2.7	1.1	1.0	1.9	2.1	0.7	3.2	6.5	6.2	0.7	2.1	1.4	0.1	0.7	2.6	1.4
DMTF1	"DMP1, DMTF, hDMP1, MRUL"	ENSG00000135164	"Cyclin D binding myb like transcription factor 1"	Q9Y222	7	87152361-87196337	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA023846	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA023846: AB_1847779"	"unprognostic (3.86e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.82e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.26e-3)"	"unprognostic (9.77e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.89e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (6.39e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-3)"	16.8	14.2	22.5	17.8	27.2	24.3	19.1	35.2	24.2	19.2	17.8	19.2	22.3	15.0	23.7	35.0	12.3	19.6	14.0	14.1	23.0	15.1	14.5	10.6	18.4	17.2	28.9	20.0	27.1	14.8	24.9	41.6	16.4	23.1	17.0	18.3	14.3	13.4	16.9	10.0	17.9	17.7	19.9	23.6	17.5	13.5	42.0	32.4	29.4	25.0	7.0	16.6	18.2	17.0	10.3	5.9	13.6	5.1	6.6	10.0	3.5	12.2	6.3	27.6	22.8	7.9	13.7	11.5	15.3	6.0	9.1	14.6	5.5	11.4	15.4	11.1	9.7	10.7	6.9	19.5	10.7	17.7	8.1	9.9	11.2	17.2	8.3	7.8	10.4	12.2	12.8	8.5	17.8	17.5	14.9	11.6	16.9	19.2	18.0	14.6	11.4	18.5	12.9	21.6	8.0	11.4	16.1	14.9	10.0	8.2	10.8	18.9	23.5	19.7	7.5	12.0	35.9	11.2	6.5	14.8	16.8	8.3	21.4	13.7	14.2	19.9	28.2	9.4	8.3	14.6	13.6	4.4	8.8	10.0	4.8	9.2	10.3	7.7	7.0	3.6	9.3	9.2	8.2	6.8	6.6	5.1	5.9	9.1	3.5	22.5	27.2	35.2	24.2	23.0	15.1	28.9	20.0	23.1	32.4	20.8	24.8	18.9	14.2	11.6	25.0	9.4	12.7	25.4	20.5	3.5	35.3	12.2	3.3	8.7	19.4	19.5	16.6	0.0	7.0	7.4	11.3	19.7	34.8	8.6	9.4	17.5	18.9	20.9	19.6	9.9	21.6	16.0	0.0	10.8	12.8	11.9	8.1	17.5	21.2	3.0	25.8	32.3	12.0	53.4	18.6	11.0	6.4	27.7	10.3	18.4
TMEM243	"C7orf23, MGC4175, MM-TRAG"	ENSG00000135185	"Transmembrane protein 243"	Q9BU79	7	87196160-87220587	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014918	Uncertain					NA	Yes					"HPA014918: AB_2067447"	"unprognostic (5.14e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.39e-2)"	"prognostic favorable (5.45e-4)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (4.58e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.32e-2)"	"prognostic favorable (9.13e-4)"	14.3	8.6	7.9	26.0	7.9	11.3	15.9	6.2	9.0	15.1	13.4	5.5	18.8	11.5	15.6	19.3	12.0	13.0	10.7	8.3	7.1	7.1	23.6	3.8	26.6	29.5	7.2	6.9	19.5	33.8	11.2	12.3	15.2	8.4	14.0	8.4	10.3	27.5	18.3	4.4	10.8	19.3	9.8	10.1	26.8	12.5	6.7	6.1	23.8	42.5	6.4	36.6	11.7	22.3	45.4	32.8	10.3	9.4	16.1	37.8	9.9	11.8	7.2	7.2	9.0	17.3	19.5	17.4	9.7	14.8	7.3	13.5	10.0	14.5	25.6	21.5	9.7	13.3	11.4	6.8	9.8	9.8	10.8	18.2	0.4	12.5	21.1	13.6	9.2	2.0	12.8	9.9	5.6	11.3	14.1	10.9	13.5	1.2	13.8	9.9	19.5	11.4	1.5	8.1	1.3	10.0	22.7	21.7	35.0	21.1	9.3	7.9	7.2	7.2	15.1	10.7	13.1	5.6	1.6	5.8	12.4	10.9	31.5	8.4	19.7	16.9	49.6	11.4	8.5	7.2	10.3	9.2	5.8	12.4	9.4	17.8	45.4	22.3	15.5	15.6	44.1	37.8	26.2	4.0	16.1	6.2	32.8	19.7	9.9	7.9	7.9	6.2	9.0	7.1	7.1	7.2	6.9	8.4	6.1	23.8	79.5	136.8	39.7	37.9	5.5	0.8	33.1	33.5	27.3	21.0	37.3	97.6	44.7	21.0	31.6	29.3	9.2	23.3	37.3	35.0	55.2	32.9	2.3	2.9	44.2	11.1	7.0	24.5	49.1	9.8	76.8	45.9	49.0	19.8	23.5	7.7	23.2	28.1	55.5	54.9	11.9	45.3	24.9	16.1	37.2	33.2	28.0	61.8	35.9	37.9
CROT	COT	ENSG00000005469	"Carnitine O-octanoyltransferase"	Q9UKG9	7	87345681-87399795	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 116.1;Rod photoreceptor cells: 76.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 35.3;RT4: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA019052, HPA019364, HPA019365"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA019052: AB_1847172, HPA019364: AB_1847173, HPA019365: AB_1847174"	"unprognostic (2.80e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.93e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (2.55e-6)"	"unprognostic (3.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.60e-3)"	"prognostic favorable (4.02e-4)"	4.6	10.1	9.3	5.1	9.6	1.6	10.5	7.4	8.4	9.0	9.4	5.5	24.1	19.6	10.0	12.6	17.0	6.8	8.7	5.9	5.2	5.4	12.3	21.5	4.2	3.4	5.4	6.6	7.2	4.6	15.5	9.1	13.7	5.8	14.8	7.0	9.8	8.3	32.3	7.2	15.0	19.1	8.8	6.8	4.8	4.9	3.8	4.7	7.4	27.1	8.4	8.0	22.4	15.3	2.2	2.3	3.4	5.5	13.0	9.5	3.0	7.2	5.4	6.6	2.3	6.3	5.8	4.9	7.7	7.2	4.7	5.1	2.8	3.8	3.0	6.8	6.5	9.4	9.1	1.1	10.2	6.7	4.3	4.6	6.6	3.8	3.6	4.1	4.1	4.1	4.7	35.3	3.8	3.0	6.0	6.6	5.0	0.3	4.4	12.3	7.1	5.1	4.1	1.4	2.6	8.0	2.3	9.1	0.5	6.0	34.6	1.1	5.2	9.4	10.9	4.9	4.7	6.9	1.5	3.5	10.9	4.7	14.7	7.2	6.7	9.6	4.2	7.3	0.0	6.4	2.0	1.4	3.4	7.4	1.7	9.5	2.2	7.5	6.0	2.0	2.2	6.1	6.6	0.9	13.0	5.5	2.3	6.3	3.0	9.3	9.6	7.4	8.4	5.2	5.4	5.4	6.6	5.8	4.7	20.8	7.7	4.4	49.0	14.9	16.1	13.2	7.6	32.1	36.4	50.6	43.2	116.1	8.3	6.6	18.7	6.5	24.7	0.0	7.6	5.2	7.3	20.4	7.0	28.8	12.0	14.3	7.0	5.5	7.5	33.1	14.7	7.4	18.6	6.4	13.1	24.1	8.0	7.4	13.1	15.3	76.5	6.5	8.3	2.5	3.6	13.4	41.0	7.0	10.9	43.1
ABCB4	"GBD1, MDR2, MDR3, PFIC-3, PGY3"	ENSG00000005471	"ATP binding cassette subfamily B member 4"	P21439	7	87401697-87480435	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 93.2"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 235.3"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 16.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"memory B-cell: 4.9;naive B-cell: 11.4"	"Lineage enriched"	"Detected in many"	8	"B-cells: 11.4"	"Group enriched"	"Detected in some"	5	"SH-SY5Y: 12.0;WM-115: 22.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA049395, HPA053288"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Nucleoplasm, Plasma membrane, Actin filaments"	"Focal adhesion sites"	"HPA049395: AB_2680745, HPA053288: AB_2682102"	"unprognostic (7.92e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.47e-1)"	0.5	4.1	0.2	4.3	0.2	0.2	0.3	0.1	1.1	0.2	0.6	0.4	0.0	0.0	0.1	0.2	0.6	0.1	0.3	4.0	0.3	0.2	0.4	93.2	0.1	4.1	0.3	0.2	0.3	0.1	0.0	0.5	0.0	0.3	0.3	0.4	0.8	0.4	0.1	2.9	0.6	1.2	1.6	0.5	5.2	0.2	0.5	0.4	0.1	0.4	4.2	3.2	0.6	0.5	11.4	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	12.0	0.0	0.6	2.2	0.5	0.2	0.5	0.0	0.2	1.6	0.1	0.0	0.0	0.0	2.8	0.2	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.1	1.4	11.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.2	0.1	1.1	0.3	0.2	0.3	0.2	0.3	0.4	0.0	0.3	23.1	0.0	0.9	0.0	9.3	0.0	0.0	0.0	1.8	0.0	0.9	0.0	0.1	0.6	0.8	0.1	0.0	0.0	0.2	1.5	0.0	0.0	235.3	0.5	36.5	0.0	5.5	5.4	0.2	0.0	0.0	10.1	0.0	0.0	0.0	0.1	0.0	0.4	0.5	0.0	0.0	0.9	0.5	0.1	0.4	0.1	0.0	0.0	0.0
ABCB1	"ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1"	ENSG00000085563	"ATP binding cassette subfamily B member 1"	P08183	7	87503633-87713323	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 57.8;intestine: 49.6"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 104.4;Enterocytes: 174.5;Paneth cells: 77.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 14.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 19.2"	"Group enriched"	"Detected in many"	8	"NK-cells: 11.4;T-cells: 19.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 30.1;HEK 293: 9.3;HEL: 16.7;Hep G2: 8.2;RPTEC TERT1: 11.5;SH-SY5Y: 36.8"									"CAB001716, HPA002199, HPA074614"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA			"Nucleoplasm, Plasma membrane"	"Focal adhesion sites"	"CAB001716: , HPA002199: AB_1844428, HPA074614: "	"unprognostic (5.38e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.99e-5)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.17e-2)"	"prognostic favorable (3.33e-4)"	"unprognostic (5.19e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.12e-2)"	2.6	57.8	9.4	3.2	11.5	1.2	3.4	5.1	10.5	5.5	22.7	3.8	2.0	14.4	9.4	3.5	2.0	3.2	9.0	1.8	9.2	6.6	19.1	15.6	3.8	2.2	9.4	5.7	2.2	1.5	1.7	1.3	3.1	11.1	2.7	10.7	7.6	1.5	2.1	1.1	1.3	49.6	5.7	9.0	2.4	1.7	1.3	8.6	0.1	2.4	1.4	2.2	2.6	5.9	1.9	0.0	0.1	0.0	11.4	19.2	1.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	9.3	16.7	1.9	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	11.5	0.1	0.4	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.4	3.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	7.8	0.0	19.2	0.4	2.0	4.7	0.0	1.9	1.2	4.8	0.1	11.4	0.0	0.0	0.0	1.5	9.4	11.5	5.1	10.5	9.2	6.6	9.4	5.7	11.1	8.6	0.0	4.8	5.9	0.1	0.7	0.6	2.8	104.4	1.4	1.2	47.1	0.0	5.0	5.0	10.2	21.6	23.1	174.5	23.3	1.6	0.1	0.5	0.1	3.5	32.6	0.4	0.0	0.0	3.7	1.2	2.5	0.9	0.8	0.0	0.0	8.9	0.0	11.4	77.2	0.0	44.0	0.9	0.0	0.8	0.5	0.4	0.5	8.2	27.3	1.7	0.1
RUNDC3B	"RPIB9, RPIP9"	ENSG00000105784	"RUN domain containing 3B"	Q96NL0	7	87627548-87832296	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 13.2;brain: 16.4"	"Cell type enhanced"	"Detected in many"	6	"Endothelial cells: 13.7;Hepatocytes: 16.6;Spermatocytes: 20.2;Spermatogonia: 21.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1;memory CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.0;HEK 293: 2.5;SCLC-21H: 6.7;SH-SY5Y: 3.0;U-138 MG: 2.5;U-266/70: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056968, HPA057155, HPA075760"	Uncertain		Uncertain	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA056968: AB_2683292, HPA057155: AB_2683353, HPA075760: "	"unprognostic (2.49e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.19e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.42e-5)"	"unprognostic (4.44e-1)"	"prognostic favorable (2.62e-6)"	"unprognostic (1.97e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.55e-2)"	1.1	13.2	3.6	0.8	9.4	0.1	1.4	16.4	7.9	2.7	3.7	1.0	1.0	4.7	3.4	1.2	1.0	2.0	1.7	1.4	2.8	5.1	3.3	9.7	0.8	0.4	2.8	4.8	2.3	0.5	0.5	2.0	0.2	7.9	1.1	2.7	0.7	0.9	0.8	1.1	0.9	5.2	3.8	2.2	0.4	0.6	3.1	1.0	0.0	0.6	0.1	0.5	1.6	1.1	0.1	0.0	0.4	0.0	0.0	2.1	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	3.0	0.4	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	2.5	0.1	1.5	1.0	0.1	1.2	0.4	0.0	0.7	0.0	0.4	0.0	1.2	0.0	1.2	0.0	0.0	1.3	0.0	0.0	0.4	0.0	2.0	0.0	0.0	0.0	0.0	0.2	6.7	3.0	0.0	0.2	0.1	0.1	0.1	0.0	0.4	2.5	0.0	0.2	0.0	3.9	0.0	0.0	0.8	0.0	1.0	0.0	0.0	0.4	2.1	0.0	0.8	0.1	0.0	1.7	0.0	0.1	0.3	1.2	0.3	0.0	0.0	0.0	0.0	0.1	3.6	9.4	16.4	6.5	2.8	5.1	2.8	4.8	7.9	1.0	0.0	0.0	0.0	0.1	4.2	8.0	2.2	5.1	0.0	0.0	0.0	5.9	0.5	1.7	0.9	2.0	13.7	9.7	0.0	0.2	0.3	0.1	0.1	0.0	16.6	0.1	11.1	0.0	1.8	0.0	1.0	3.7	0.0	3.3	0.0	2.9	0.7	0.8	5.8	1.4	8.7	7.6	0.0	1.2	20.2	21.5	2.6	1.0	0.0	3.8	0.0
SLC25A40	MCFP	ENSG00000075303	"Solute carrier family 25 member 40"	Q8TBP6	7	87833568-87876357	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055197	Uncertain					NA	NA					"HPA055197: AB_2682735"	"unprognostic (4.19e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.80e-2)"	"unprognostic (4.03e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (3.73e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.78e-2)"	"prognostic favorable (1.52e-5)"	"unprognostic (8.42e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.85e-2)"	8.2	12.1	13.8	12.5	20.5	10.8	13.1	19.8	26.3	10.0	12.3	12.4	5.9	10.2	11.1	10.2	10.4	10.2	8.7	14.7	13.3	17.0	13.4	10.4	12.6	15.3	17.1	15.4	14.4	9.3	13.0	15.9	5.8	28.2	14.4	15.7	10.0	11.1	8.9	9.0	12.7	11.1	8.5	13.5	14.8	11.0	9.2	11.3	20.0	11.4	6.6	15.1	9.8	9.7	2.6	5.9	9.3	5.8	6.3	3.0	2.4	11.4	3.0	9.6	3.7	3.9	6.3	2.8	8.3	7.3	6.0	8.8	2.6	16.4	13.5	5.4	4.1	9.6	5.0	4.6	4.7	8.7	8.5	2.3	7.1	6.9	3.2	3.8	17.2	9.6	3.8	3.4	5.4	4.3	5.0	6.4	10.9	7.7	20.0	10.2	4.9	19.9	14.5	4.4	9.5	3.5	9.9	12.2	11.8	8.7	6.2	4.7	11.3	10.6	10.5	7.9	8.1	5.1	13.6	4.4	10.3	7.7	16.0	7.8	11.0	12.0	17.5	7.2	21.2	21.0	9.3	5.4	7.1	1.9	5.8	3.0	2.6	2.7	2.6	5.9	2.6	3.0	2.7	3.0	6.3	5.8	1.5	3.0	2.4	13.8	20.5	19.8	26.3	13.3	17.0	17.1	15.4	28.2	11.3	3.0	4.0	12.3	4.7	6.6	4.5	12.6	17.8	2.7	7.9	7.0	9.8	7.0	13.3	3.2	8.4	4.5	5.1	0.0	3.5	6.6	4.7	5.3	4.7	6.0	10.2	3.2	2.9	7.4	32.8	2.9	7.2	14.5	20.3	1.8	10.0	3.3	5.6	10.8	10.3	6.8	4.2	12.9	2.6	6.5	4.9	6.9	3.1	6.9	9.0	4.2
DBF4	"ASK, chif, DBF4A, ZDBF1"	ENSG00000006634	"DBF4 zinc finger"	Q9UBU7	7	87876216-87909541	"Predicted intracellular proteins"	"Cell cycle, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 11.8;testis: 34.2"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 250.0;Spermatocytes: 291.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA042923			Supported	"Nucleoplasm,Nuclear bodies"		Yes	Yes			"Nucleoplasm, Nuclear bodies"		"HPA042923: AB_2678222"	"unprognostic (2.48e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.86e-3)"	"unprognostic (2.81e-2)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (4.45e-6)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.05e-3)"	"unprognostic (2.78e-3)"	"prognostic unfavorable (6.42e-7)"	"unprognostic (1.98e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.30e-1)"	1.1	1.2	1.4	5.9	2.0	1.8	3.0	1.9	1.9	1.4	2.1	0.0	0.6	1.2	1.2	1.4	1.7	1.1	1.5	1.0	1.5	1.4	1.2	1.1	2.4	5.0	1.3	1.0	3.4	1.3	1.2	1.8	1.4	0.8	1.2	1.2	0.0	1.2	1.1	1.9	1.3	1.5	0.9	1.2	4.6	1.1	34.2	0.7	11.8	1.4	1.9	2.7	1.6	1.1	1.3	0.9	4.0	0.4	0.9	1.6	0.5	1.3	1.4	3.0	3.8	0.7	0.6	0.9	1.4	0.3	1.5	3.0	2.3	0.9	3.1	1.1	0.9	2.6	1.3	3.1	0.8	1.6	2.3	2.1	2.0	1.7	0.5	0.2	2.4	1.6	0.7	0.8	1.7	1.6	0.5	1.3	2.9	1.7	6.5	2.0	2.4	4.2	3.0	3.0	3.1	2.9	1.1	4.7	3.7	1.2	0.2	4.4	2.8	1.9	3.3	1.5	2.5	1.4	2.5	0.6	1.8	2.2	4.7	3.0	3.7	7.7	3.1	1.3	4.4	3.9	4.0	0.4	0.4	1.2	0.3	0.3	0.8	1.1	0.6	0.2	1.3	1.1	1.3	1.1	0.9	0.4	0.9	1.6	0.5	1.4	2.0	1.9	1.9	1.5	1.4	1.3	1.0	0.8	0.7	3.0	13.0	34.9	16.3	13.9	5.8	3.6	0.0	14.7	5.7	8.7	11.8	12.2	3.3	5.4	250.0	8.5	4.5	46.7	12.9	31.0	7.6	10.6	30.1	5.4	13.9	3.2	14.3	7.4	8.8	57.4	14.4	14.2	11.8	9.0	18.6	1.9	10.7	7.0	8.9	4.4	15.5	12.9	8.2	291.4	77.1	11.0	8.0	21.5	15.8	11.4
ADAM22	MDC2	ENSG00000008277	"ADAM metallopeptidase domain 22"	Q9P0K1	7	87934143-88202889	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.9"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 30.7;Cone photoreceptor cells: 21.6;Horizontal cells: 14.3;Rod photoreceptor cells: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 36.3;SH-SY5Y: 34.6;U-266/84: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050325, CAB079064"		Supported	Approved	"Cell Junctions"	"Intracellular and membrane"	NA	NA		78000	"Cell Junctions"		"CAB079064: , HPA050325: AB_2681087"	"unprognostic (1.20e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.09e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.61e-4)"	"unprognostic (4.70e-2)"	2.9	11.7	10.9	1.5	15.7	1.5	2.1	46.9	36.4	8.6	2.3	6.2	1.6	1.3	6.3	11.2	1.6	3.7	3.7	3.0	14.0	10.6	5.5	0.8	2.0	2.9	8.8	14.4	5.6	1.8	4.5	3.7	0.9	17.0	14.5	2.3	2.9	1.5	7.1	3.3	1.8	1.9	5.0	8.2	2.9	1.4	2.7	5.7	2.8	4.5	0.0	1.9	2.1	2.9	0.4	1.2	1.9	0.0	0.5	1.6	0.1	1.1	0.3	2.1	2.6	0.6	0.1	1.6	0.0	0.2	0.1	0.2	2.2	3.6	3.2	0.9	0.0	1.5	0.0	3.0	0.0	0.0	8.7	4.0	2.4	2.3	0.6	0.0	2.9	0.0	0.3	0.0	0.0	0.1	2.8	0.2	3.5	0.1	36.3	0.1	2.8	3.7	0.6	5.1	0.2	1.1	2.2	8.4	4.6	0.0	1.7	11.6	34.6	1.8	0.0	0.3	1.7	1.5	0.3	0.0	2.2	1.5	0.4	1.5	8.4	13.9	2.5	1.8	6.1	3.1	1.9	0.0	0.0	1.0	0.0	0.1	0.4	0.3	1.0	0.0	0.3	1.6	1.2	0.2	0.5	0.0	1.2	0.0	0.1	10.9	15.7	46.9	21.8	14.0	10.6	8.8	14.4	17.0	5.7	0.0	1.3	0.0	1.8	0.5	30.7	2.9	0.0	1.4	1.2	1.8	21.6	0.3	1.7	0.0	5.9	0.7	0.0	0.0	0.0	0.1	1.0	0.3	0.0	0.0	0.1	14.3	1.2	0.0	0.0	1.1	2.3	0.0	1.7	0.0	0.8	1.4	0.0	1.5	2.5	0.8	10.6	0.0	0.9	0.5	1.1	0.4	0.0	0.5	1.0	0.1
SRI		ENSG00000075142	Sorcin	P30626	7	88205118-88226993	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 140.7"	"Cell type enhanced"	"Detected in all"	7	"Enterocytes: 1052.9;Paneth cells: 1613.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019004, HPA073666"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		1400000	"Nucleoplasm, Cytosol"		"HPA019004: AB_2670006, HPA073666: AB_2686623"	"unprognostic (1.86e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.24e-3)"	"prognostic favorable (3.08e-4)"	"unprognostic (9.87e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.87e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.14e-3)"	20.6	22.0	47.7	24.6	53.5	18.7	22.4	18.9	43.6	24.1	140.7	32.5	7.0	45.3	18.1	33.1	15.6	39.4	14.2	19.4	35.9	40.2	21.7	14.6	21.9	16.6	45.0	44.8	23.3	18.4	12.1	18.3	21.2	36.9	19.5	115.0	11.1	17.7	18.4	8.7	11.1	62.8	25.2	41.9	14.6	16.2	10.0	28.0	9.2	19.7	9.4	19.4	27.0	18.7	29.7	34.5	95.4	42.1	36.3	36.4	32.7	34.4	13.2	35.8	36.8	58.0	49.0	18.0	20.7	33.5	23.4	27.8	12.3	78.2	38.3	21.9	31.4	57.4	34.9	44.9	46.8	30.6	30.8	20.2	19.8	36.4	0.0	35.1	26.4	21.3	50.1	42.9	24.7	36.0	42.0	70.0	24.5	17.5	33.2	32.0	21.7	38.5	18.2	31.4	48.9	26.7	16.0	50.7	21.2	43.5	34.5	25.9	30.7	63.1	36.3	28.8	35.7	17.1	11.8	43.7	43.9	36.8	40.2	36.8	31.1	14.4	41.0	43.1	25.3	74.2	86.5	26.1	95.4	31.0	36.5	36.4	29.7	34.5	35.2	34.5	24.9	25.8	29.8	16.3	36.3	42.1	27.5	34.7	32.7	47.7	53.5	18.9	43.6	35.9	40.2	45.0	44.8	36.9	28.0	80.4	103.8	93.1	338.4	84.4	36.4	95.1	30.6	495.2	193.3	148.3	11.8	123.5	374.7	201.2	45.8	112.5	1052.9	210.2	371.4	826.3	181.0	282.1	132.7	33.9	132.6	44.5	90.6	92.1	77.3	23.0	159.3	104.1	99.5	215.6	393.6	112.7	336.5	1613.2	133.0	124.1	19.7	109.9	144.4	65.6	106.7	94.6	165.0	117.6	448.6	382.7
STEAP4	"FLJ23153, SchLAH, STAMP2, TIARP, TNFAIP9"	ENSG00000127954	"STEAP4 metalloreductase"	Q687X5	7	88270892-88306891	"Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 122.8"	"Cell type enhanced"	"Detected in many"	15	"Alveolar cells type 2: 320.5;Club cells: 178.6;Sertoli cells: 452.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 45.9"	"Group enriched"	"Detected in some"	5	"midbrain: 1.7;pons and medulla: 6.4"	"Cell type enriched"	"Detected in some"	13	"neutrophil: 48.9"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 48.9"	"Group enriched"	"Detected in some"	6	"HSkMC: 39.3;SiHa: 36.9;U-2197: 52.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065201			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA065201: "	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.96e-2)"	"prognostic favorable (2.97e-4)"	"unprognostic (7.40e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.66e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.51e-3)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.53e-2)"	122.8	29.3	0.3	12.7	0.8	2.4	55.6	0.6	0.7	15.9	14.0	1.1	5.3	1.4	10.7	22.3	23.7	17.1	9.3	18.7	0.5	0.3	10.8	71.7	27.5	49.4	1.7	0.2	17.8	13.3	12.0	35.1	45.0	6.4	25.8	3.9	4.9	14.6	4.6	22.1	10.5	5.2	13.9	1.8	5.3	5.7	27.3	0.4	0.4	40.9	8.4	5.2	28.4	26.3	0.0	0.3	48.9	3.8	0.0	0.0	0.7	1.4	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.1	5.8	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	39.3	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	36.9	3.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	52.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.8	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	48.9	0.0	0.0	0.0	0.0	0.7	0.3	0.8	0.6	0.7	0.5	0.3	1.7	0.2	6.4	0.4	50.6	320.5	0.0	6.3	8.4	1.1	4.0	0.0	97.7	178.6	0.0	2.0	0.3	0.0	11.7	12.9	8.9	0.0	0.0	8.2	9.0	11.1	62.8	15.1	0.4	2.1	0.0	0.0	19.0	5.1	1.9	106.4	7.7	5.0	0.0	0.0	2.4	16.5	0.0	8.5	0.0	0.2	452.7	115.4	0.9	0.2	16.4	9.2	0.0	0.0	12.2
ZNF804B	FLJ32110	ENSG00000182348	"Zinc finger protein 804B"	A4D1E1	7	88759368-89337057	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	9	"thyroid gland: 31.4"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 11.9;Proximal tubular cells: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"AF22: 2.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA026702	Uncertain					NA	NA					"HPA026702: AB_1859459"					"unprognostic (1.10e-1)"							"unprognostic (5.00e-2)"			"unprognostic (1.29e-1)"	"unprognostic (1.99e-1)"		0.2	0.2	0.6	0.7	1.3	0.1	0.4	0.2	2.0	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.6	0.2	0.4	2.5	0.2	0.2	3.3	0.2	0.5	0.5	1.3	0.1	0.4	0.6	1.6	0.6	0.1	1.3	1.2	0.1	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.3	0.0	0.0	31.4	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.3	0.2	2.0	0.2	0.4	0.2	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0
TEX47	"C7orf62, MGC26647"	ENSG00000164645	"Testis expressed 47"	Q8TBZ9	7	88794106-88795721	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	158	"testis: 26.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA023817, HPA024163"			Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA023817: AB_1853868, HPA024163: AB_1853869"					"unprognostic (1.43e-1)"													0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STEAP1	"PRSS24, STEAP"	ENSG00000164647	"STEAP family member 1"	Q9UHE8	7	90154375-90164829	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 44.7"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 43.1;Exocrine glandular cells: 33.5;Glandular cells: 64.3;Urothelial cells: 39.0"	"Cancer enriched"	"Detected in all"	6	"prostate cancer: 94.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 29.6;CAPAN-2: 35.5;U-138 MG: 45.1"									HPA030985	Uncertain					NA	NA					"HPA030985: AB_2673686"	"unprognostic (2.88e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.21e-3)"	"unprognostic (9.20e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.74e-3)"	"unprognostic (6.36e-2)"	"unprognostic (6.45e-3)"	"unprognostic (8.31e-3)"	"unprognostic (3.79e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.38e-1)"	19.8	1.5	2.9	16.5	1.4	0.0	26.0	0.9	6.3	5.5	10.0	0.1	0.7	2.7	3.0	4.4	10.0	7.3	8.4	7.1	1.4	0.5	5.3	21.2	9.3	2.9	0.5	2.7	12.4	6.5	0.2	5.8	0.5	1.4	44.7	7.3	1.2	9.8	5.3	3.9	3.3	7.4	13.7	1.4	2.8	7.4	2.1	0.7	0.0	4.6	6.5	3.7	12.5	16.1	0.8	1.7	0.0	0.0	0.0	0.0	0.2	6.8	13.9	0.8	2.5	29.6	24.6	0.2	4.7	5.8	0.6	0.8	10.3	35.5	0.0	0.2	7.7	12.6	1.4	6.0	6.6	1.3	0.0	2.2	0.0	0.1	3.4	1.1	0.0	0.0	17.3	1.0	19.6	10.4	4.6	25.4	2.1	0.3	19.8	8.1	0.1	0.0	0.1	4.2	0.3	6.7	0.0	0.0	0.0	5.6	1.4	0.0	0.3	1.8	0.0	3.1	0.5	7.8	0.1	13.0	45.1	2.3	22.7	5.7	3.7	0.1	0.0	22.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.9	1.4	0.9	6.3	1.4	0.5	0.5	2.7	1.4	0.7	0.0	0.3	0.0	43.1	3.8	0.0	0.8	0.0	6.7	2.3	1.8	0.0	0.0	0.0	2.1	0.3	2.2	3.5	0.0	33.5	0.1	15.0	64.3	0.0	30.1	0.5	0.0	6.9	1.8	1.0	1.0	0.9	1.8	6.8	0.0	4.1	9.4	29.2	10.5	1.4	13.9	0.2	6.5	5.6	12.6	30.9	1.9	0.2	0.0	13.5	39.0
STEAP2	"IPCA-1, PCANAP1, STAMP1, STMP"	ENSG00000157214	"STEAP2 metalloreductase"	Q8NFT2	7	90167590-90238137	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"prostate: 100.2"	"Cell type enriched"	"Detected in many"	4	"Glandular cells: 110.4"	"Cancer enriched"	"Detected in many"	12	"prostate cancer: 88.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 13.4;CAPAN-2: 28.9;U-138 MG: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029115, HPA055603"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA029115: AB_10603894, HPA055603: "	"unprognostic (6.26e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.20e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.67e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.71e-2)"	"unprognostic (9.73e-2)"	"unprognostic (6.11e-2)"	"unprognostic (9.86e-5)"	"unprognostic (3.69e-2)"	10.7	4.1	6.2	9.7	14.5	1.3	13.6	8.7	18.2	7.0	8.3	2.3	2.2	5.7	5.4	3.6	9.1	7.5	8.8	9.4	5.1	5.2	6.5	3.6	10.8	1.6	3.2	11.1	19.5	6.4	10.3	17.6	1.4	6.0	100.2	7.0	3.8	6.8	6.7	2.3	3.5	5.9	9.0	2.9	3.0	9.2	2.3	1.6	1.6	5.8	1.2	2.5	10.4	19.9	1.1	0.4	1.3	0.4	0.3	0.2	0.0	1.8	13.4	0.3	3.8	7.2	7.0	0.2	1.6	3.5	0.2	0.5	2.5	28.9	0.0	0.2	4.4	5.4	1.1	2.9	2.1	0.5	0.0	2.9	0.0	0.0	0.7	0.6	0.0	0.0	5.1	0.4	7.0	1.4	5.8	3.6	0.0	0.0	0.2	4.0	0.0	0.0	0.4	5.5	0.0	1.5	0.0	0.0	0.1	6.3	3.9	0.3	1.3	2.1	0.0	0.1	0.6	10.2	0.0	3.0	16.8	3.8	2.3	1.4	0.0	0.0	0.0	7.3	0.0	0.7	1.3	0.4	0.5	0.2	0.2	0.1	1.1	0.1	0.1	0.0	0.4	0.2	0.2	1.2	0.3	0.2	0.4	0.0	0.0	6.2	14.5	8.7	18.2	5.1	5.2	3.2	11.1	6.0	1.6	0.0	0.6	0.0	20.8	4.2	5.1	11.6	17.8	16.0	13.6	12.2	2.0	0.0	0.0	0.6	0.4	1.8	11.8	0.0	6.6	0.0	17.5	110.4	0.0	4.9	0.0	1.6	15.1	2.5	0.0	0.4	14.4	1.7	0.0	0.0	12.5	26.2	8.6	25.8	14.5	8.6	1.2	0.0	6.2	1.0	3.4	4.6	0.0	0.0	12.7	19.6
CFAP69	"C7orf63, FAP69, FLJ21062"	ENSG00000105792	"Cilia and flagella associated protein 69"	A5D8W1	7	90245174-90311063	"Predicted intracellular proteins"	"Differentiation, Olfaction, Sensory transduction, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Ciliated cells: 95.0;Spermatocytes: 24.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062883	Uncertain					NA	NA					"HPA062883: AB_2684893"	"unprognostic (7.69e-4)"	"unprognostic (9.93e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.13e-3)"	"unprognostic (3.12e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.80e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.46e-3)"	"unprognostic (2.44e-3)"	6.7	2.5	3.4	4.1	9.4	0.5	10.5	2.8	6.3	7.4	5.2	3.5	6.7	3.0	11.1	18.6	3.3	16.3	7.2	4.3	4.0	4.9	7.6	5.1	6.4	1.0	1.7	6.3	7.5	4.0	11.0	17.5	1.4	10.3	23.1	3.5	7.4	4.6	8.1	2.8	4.5	3.2	7.3	3.3	3.4	3.9	11.1	2.8	0.0	9.2	4.1	1.5	5.7	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	2.3	0.3	4.3	4.9	5.0	0.9	0.2	3.4	1.4	2.1	7.9	3.2	0.4	0.2	3.9	5.5	1.3	1.5	1.8	2.4	0.0	1.5	0.0	1.0	2.3	2.8	0.5	0.1	5.7	2.3	5.7	2.1	7.7	1.4	0.4	1.8	0.0	2.4	2.1	0.0	3.3	2.1	0.1	1.1	0.0	0.5	0.0	7.9	1.0	0.8	1.8	3.5	0.4	0.8	0.9	1.3	0.1	0.2	4.4	0.9	4.2	1.4	0.9	0.2	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	9.4	2.8	6.3	4.0	4.9	1.7	6.3	10.3	2.8	3.0	7.5	0.0	1.2	0.0	4.1	2.4	2.5	95.0	12.5	5.2	17.7	0.2	1.7	1.6	13.3	0.0	0.0	0.0	1.4	0.1	0.3	5.1	0.0	1.7	0.1	7.9	0.0	0.6	0.3	3.6	1.1	0.0	0.0	0.0	0.9	5.6	0.4	0.0	2.1	3.3	17.9	0.0	0.5	24.9	1.6	0.0	0.1	0.0	0.9	1.2
FAM237B		ENSG00000283267	"Family with sequence similarity 237 member B"		7	90316503-90321308	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"prostate: 1.1;testis: 1.7"	"Cell type enriched"	"Detected in single"	20	"Ciliated cells: 2.7"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 1.0;U-266/70: 1.0"	"Group enriched"	"Detected in some"	6	"hypothalamus: 1.9;thalamus: 5.4"	"Low region specificity"	"Detected in all"									NA	NA																							0.0	0.2		0.3		0.1	0.0		0.1	0.0	0.0			0.2	0.2	0.0	0.0	0.1	0.1	0.0			0.5	0.0	0.8	0.0			0.0	0.0	0.0		0.0		1.1	0.0		0.2	0.0	0.0	0.2	0.0	0.0		0.1	0.0	1.7			0.3		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.7	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GTPBP10	"DKFZP686A10121, FLJ38242, OBGH2"	ENSG00000105793	"GTP binding protein 10"	A4D1E9	7	90335223-90391455	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA021076	Approved					NA	NA					"HPA021076: AB_1850411"	"unprognostic (2.74e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.44e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (6.76e-5)"	"unprognostic (8.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.72e-3)"	12.8	16.3	10.7	13.3	15.3	9.4	16.6	18.8	18.5	12.1	13.4	11.0	14.1	13.6	15.9	15.1	15.6	11.3	9.0	15.2	10.5	11.2	19.8	28.4	10.4	15.9	16.8	15.1	14.0	13.4	7.3	25.7	9.5	19.8	12.3	15.4	9.6	14.0	13.8	24.6	14.0	16.8	11.8	16.9	13.6	16.0	16.6	14.9	23.2	15.2	12.3	14.9	14.3	12.3	11.8	6.5	16.4	7.2	7.1	13.1	6.2	15.6	9.9	6.8	10.2	8.0	7.3	11.3	10.1	6.6	9.3	7.4	14.5	12.0	19.6	16.9	6.6	20.3	10.1	15.3	13.3	11.9	12.2	7.8	8.1	6.6	7.6	7.8	23.2	7.2	9.0	5.7	15.6	31.4	7.4	5.4	16.6	29.5	14.5	8.1	16.2	16.3	6.7	8.4	14.2	12.0	10.5	20.0	16.4	7.0	8.7	8.4	7.9	12.8	19.9	18.9	10.0	9.5	10.2	10.0	13.4	15.7	23.6	19.2	10.9	13.9	27.7	10.0	16.6	14.1	16.4	5.4	8.9	6.9	7.2	11.6	11.8	11.1	8.2	6.5	9.4	11.9	11.1	5.0	7.1	4.3	5.6	13.1	6.2	10.7	15.3	18.8	18.5	10.5	11.2	16.8	15.1	19.8	14.9	11.9	13.1	9.7	7.7	5.3	10.4	11.5	10.2	17.4	18.2	15.7	13.7	6.5	11.6	7.2	15.7	5.8	6.3	0.0	13.5	6.1	5.4	8.7	11.5	10.6	5.6	4.8	9.2	7.4	7.3	2.1	8.6	6.4	6.8	3.6	6.1	11.0	8.8	5.8	8.9	17.0	11.2	6.5	5.8	23.0	17.6	5.4	5.6	13.8	8.7	6.8
CLDN12		ENSG00000157224	"Claudin 12"	P56749	7	90383721-90513402	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 274.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026945	Approved					NA	NA					"HPA026945: AB_10603786"	"unprognostic (1.45e-2)"	"prognostic unfavorable (6.36e-4)"	"unprognostic (3.84e-2)"	"unprognostic (4.87e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.47e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.67e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.30e-1)"	7.3	18.2	10.4	5.5	22.5	2.3	17.1	20.5	21.5	11.9	17.2	7.3	9.8	14.9	15.0	16.5	11.6	13.0	15.2	17.2	9.5	13.7	19.7	40.4	9.7	1.5	9.2	12.4	18.4	16.7	16.2	42.4	8.2	14.5	20.1	19.5	19.1	19.3	11.2	15.7	6.7	22.6	11.6	12.3	4.3	16.9	10.4	8.0	3.3	14.0	9.4	7.0	12.1	10.1	1.1	3.6	0.0	0.9	0.0	2.4	0.9	10.9	9.8	11.8	8.0	13.3	10.9	6.5	14.0	15.2	9.5	15.9	9.8	28.8	1.8	11.2	8.3	20.9	9.7	10.9	12.7	18.9	2.5	9.8	1.1	8.6	10.2	12.4	2.2	1.2	13.0	13.6	15.9	26.0	17.0	4.7	2.2	6.6	6.6	14.0	5.3	2.9	5.1	19.9	14.0	6.8	1.4	17.1	2.7	13.9	7.3	9.7	17.7	7.7	6.9	22.2	20.4	8.1	7.0	12.4	22.7	13.6	16.6	14.5	3.5	3.3	0.2	15.6	1.6	10.6	0.0	0.7	0.0	1.4	0.9	1.4	1.1	2.4	0.5	3.6	0.6	1.0	1.2	0.0	0.0	0.1	1.1	1.7	0.9	10.4	22.5	20.5	21.5	9.5	13.7	9.2	12.4	14.5	8.0	29.8	6.4	1.5	13.4	8.8	34.0	12.1	28.1	14.7	9.1	17.4	19.6	6.9	6.6	16.9	274.0	3.8	15.1	0.0	35.2	7.5	12.4	40.7	0.0	44.8	6.0	19.1	16.0	9.8	1.0	13.0	9.8	3.4	18.6	4.6	12.7	52.7	27.4	10.7	9.9	23.8	19.9	12.9	11.4	16.8	5.5	9.5	4.2	0.0	14.0	22.9
CDK14	"PFTAIRE1, PFTK1"	ENSG00000058091	"Cyclin dependent kinase 14"	O94921	7	90466424-91210590	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 44.0;Horizontal cells: 163.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 7.5;memory B-cell: 9.8;naive B-cell: 5.3;neutrophil: 5.6"	"Group enriched"	"Detected in many"	9	"B-cells: 9.8;granulocytes: 7.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015267	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA015267: AB_1855249"	"prognostic favorable (5.86e-4)"	"unprognostic (3.96e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (7.79e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.39e-3)"	8.2	4.7	19.8	7.1	19.4	6.1	8.3	28.6	34.9	10.6	5.2	3.7	0.6	2.7	8.6	3.2	3.1	12.0	11.9	11.5	25.8	15.5	19.8	12.7	9.2	10.9	17.3	17.4	14.9	14.2	3.8	14.2	5.9	22.8	11.3	3.4	4.3	7.7	7.0	5.4	2.7	3.8	7.4	7.0	7.5	7.4	7.2	4.5	0.9	13.1	1.6	11.9	6.9	6.7	9.8	0.9	7.5	0.7	0.1	0.2	0.6	7.1	0.0	14.3	1.8	13.4	13.7	3.3	6.0	5.7	3.7	4.0	0.1	3.5	25.4	0.7	5.9	5.4	2.1	0.7	8.4	7.1	0.0	3.4	0.0	4.7	0.1	6.2	7.2	0.1	9.7	2.1	10.9	3.9	6.1	4.7	0.1	0.1	31.3	7.4	0.0	0.0	2.8	9.0	0.0	3.9	19.5	19.7	19.3	1.9	1.9	3.2	9.2	15.2	0.0	0.3	6.7	1.9	3.6	11.5	15.9	20.4	13.3	9.2	17.7	13.5	18.1	6.0	9.5	15.5	7.5	0.3	0.5	0.0	0.7	0.0	9.8	0.0	0.0	0.9	5.3	0.0	0.0	5.6	0.1	0.5	0.1	0.2	0.6	19.8	19.4	28.6	34.9	25.8	15.5	17.3	17.4	22.8	4.5	17.9	3.2	27.7	7.4	0.7	5.1	11.1	10.2	4.0	13.6	10.4	0.0	0.2	6.6	9.4	44.0	2.1	0.0	0.0	5.8	0.1	12.5	8.3	0.0	9.6	4.0	163.7	1.7	1.3	5.1	27.0	14.4	4.6	5.0	1.0	0.1	8.8	9.4	0.2	14.9	18.1	9.5	0.0	6.6	3.8	6.5	1.1	0.0	0.5	0.0	2.3
FZD1	DKFZp564G072	ENSG00000157240	"Frizzled class receptor 1"	Q9UP38	7	91264364-91271326	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 61.2"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 61.1;Horizontal cells: 133.5;Peritubular cells: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 4.2;non-classical monocyte: 5.4"	"Lineage enriched"	"Detected in many"	4	"monocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"AF22: 16.6;HSkMC: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013008	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB013008: "	"unprognostic (1.46e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.29e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.39e-3)"	"prognostic favorable (8.87e-7)"	"unprognostic (1.05e-2)"	"unprognostic (4.16e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.13e-2)"	5.8	4.6	2.6	4.9	3.5	0.9	10.7	8.2	2.8	17.6	8.5	4.1	9.3	4.9	10.1	9.9	7.8	6.1	11.0	12.3	6.1	1.8	15.3	3.9	10.5	1.4	2.0	3.2	15.0	7.9	2.5	4.6	10.0	5.7	12.3	3.7	11.1	9.2	17.5	3.1	10.7	8.3	7.2	4.6	3.4	4.5	4.4	3.5	1.4	61.2	6.5	2.9	10.4	13.9	0.1	1.3	0.2	5.4	0.0	0.0	0.4	0.5	1.6	16.6	1.7	13.5	11.7	3.0	6.0	3.8	2.2	1.6	0.7	2.8	0.0	1.5	3.8	2.8	3.0	2.5	1.3	1.5	0.0	3.2	0.1	3.2	0.8	1.0	2.7	0.7	22.1	2.4	5.1	1.6	8.5	0.5	1.8	0.9	2.4	6.4	3.9	0.5	0.7	4.2	0.8	2.8	3.3	10.2	0.3	3.5	7.7	2.3	4.3	4.5	3.7	0.9	4.0	1.9	2.4	2.5	9.4	7.1	10.0	2.4	2.2	1.5	0.2	10.1	2.3	10.9	0.0	1.4	0.0	0.0	4.2	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	5.4	0.1	0.0	0.4	2.6	3.5	8.2	2.8	6.1	1.8	2.0	3.2	5.7	3.5	3.0	1.0	1.3	30.9	3.8	0.8	12.1	61.1	0.0	4.5	12.2	2.0	3.0	0.0	4.5	0.2	3.6	4.6	0.0	1.8	1.6	12.0	11.7	12.7	0.5	3.6	133.5	3.4	10.4	14.3	0.4	30.8	11.2	16.9	0.0	3.2	3.7	2.1	3.4	42.5	10.8	3.1	0.0	9.4	0.4	2.0	4.4	1.7	0.5	3.5	5.9
MTERF1	MTERF	ENSG00000127989	"Mitochondrial transcription termination factor 1"	Q99551	7	91692008-91880720	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA044894, HPA069560"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA044894: AB_10966284, HPA069560: AB_2686154"	"unprognostic (5.57e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.46e-3)"	"unprognostic (7.62e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.22e-3)"	8.9	11.5	16.1	10.9	18.1	13.9	14.4	23.2	18.9	10.4	11.8	12.1	10.0	11.5	11.6	11.0	13.4	9.8	8.3	8.7	15.2	10.5	13.2	17.6	8.3	19.4	20.3	13.1	14.7	11.4	10.0	18.0	10.6	18.8	11.6	12.1	8.5	12.5	9.2	9.3	9.9	13.6	9.7	22.7	17.6	12.5	10.0	18.5	11.9	12.2	10.3	19.0	12.0	11.4	15.0	9.4	24.8	8.8	9.8	19.0	10.0	10.4	9.1	8.8	5.9	8.5	9.0	7.7	8.9	9.0	9.6	11.9	11.0	10.0	21.5	7.4	7.0	14.1	9.2	13.1	7.9	13.7	1.2	9.5	9.7	9.8	8.5	7.6	17.1	10.8	10.7	10.5	10.5	11.2	7.6	8.3	5.4	17.7	8.9	11.1	13.3	17.9	19.6	13.2	12.9	10.2	5.1	11.7	14.7	9.9	11.4	8.1	15.6	9.0	19.0	17.9	16.8	6.6	12.3	5.3	11.4	14.0	15.4	9.0	12.8	12.9	29.1	8.2	5.6	15.9	24.8	8.8	11.9	10.6	7.5	12.7	14.6	13.8	15.2	9.4	15.0	19.0	15.1	4.2	9.8	8.2	7.4	13.2	10.0	16.1	18.1	23.2	18.9	15.2	10.5	20.3	13.1	18.8	18.5	8.9	11.7	3.4	3.4	0.0	0.0	4.5	5.1	2.7	4.5	3.5	0.0	8.2	5.0	5.1	0.9	2.9	3.8	0.0	4.5	6.1	1.9	2.9	4.7	8.9	4.5	0.0	1.2	6.7	7.6	1.1	6.4	5.3	0.0	7.2	3.2	0.0	3.2	3.5	6.7	6.2	0.0	12.9	1.4	11.2	9.8	0.0	3.8	8.6	4.6	1.8
AKAP9	"AKAP350, AKAP450, CG-NAP, HYPERION, KIAA0803, LQT11, MU-RMS-40.16A, PPP1R45, PRKA9, YOTIAO"	ENSG00000127914	"A-kinase anchoring protein 9"	Q99996	7	91940867-92110673	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease mutation, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	10	"Cone photoreceptor cells: 2100.9;Rod photoreceptor cells: 1161.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008548, CAB012909, HPA026109"	Supported		Enhanced	"Golgi apparatus,Vesicles,Centrosome"		NA	NA			"Golgi apparatus"	"Vesicles, Centrosome"	"CAB012909: AB_2533235, HPA008548: AB_1078121, HPA026109: AB_1844688"	"unprognostic (9.57e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.59e-2)"	"unprognostic (7.59e-2)"	"unprognostic (6.32e-2)"	"prognostic favorable (2.10e-6)"	"unprognostic (8.89e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.96e-2)"	13.7	15.9	18.0	22.6	17.1	14.9	15.6	35.8	17.5	14.4	24.5	4.7	17.2	25.5	13.0	17.1	15.3	12.4	15.0	14.8	13.3	7.0	19.5	25.1	19.9	13.2	12.4	12.3	22.3	21.3	22.1	40.5	12.9	14.0	11.9	25.3	11.1	20.1	25.9	29.6	16.1	29.1	12.0	11.1	10.4	15.0	6.9	14.4	10.3	14.9	15.7	8.6	14.0	14.2	34.4	39.5	31.9	16.6	10.6	20.3	3.4	11.4	7.1	10.6	6.7	15.2	11.2	7.5	8.5	5.9	4.4	5.6	12.1	10.0	10.4	12.5	7.5	9.3	10.6	10.2	5.6	8.2	9.4	8.7	11.4	12.5	7.9	6.2	18.9	12.2	7.0	8.9	9.1	10.4	9.3	9.5	12.0	16.9	17.1	7.5	16.6	12.8	7.5	8.1	9.4	8.9	7.8	17.7	8.4	6.1	12.6	17.3	12.1	18.2	20.4	8.8	13.1	5.3	9.2	17.4	8.9	11.5	15.5	11.6	12.2	13.5	14.0	7.9	9.6	10.0	31.9	16.6	21.4	18.4	9.3	15.4	31.4	18.7	16.7	7.2	34.4	20.3	19.3	23.2	10.6	16.3	39.5	14.9	3.4	18.0	17.1	35.8	17.5	13.3	7.0	12.4	12.3	14.0	14.4	488.4	309.8	122.9	114.8	91.9	252.0	215.2	267.5	697.3	270.7	167.5	2100.9	111.3	86.2	108.2	8.6	85.9	257.2	163.5	80.8	65.2	74.7	91.4	129.8	127.1	50.9	340.1	177.6	92.7	65.9	8.5	160.5	90.0	55.6	92.8	259.7	147.7	95.5	204.4	127.6	36.7	1161.3	135.8	61.8	76.2	133.4	97.7	279.2	105.4	127.3	84.0
CYP51A1	"CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1"	ENSG00000001630	"Cytochrome P450 family 51 subfamily A member 1"	Q16850	7	92112151-92142952	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.9"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 62.5;Alveolar cells type 2: 133.7;Club cells: 77.3;Early spermatids: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 96.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041325, HPA043508"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA041325: AB_2677411, HPA043508: AB_2678520"	"unprognostic (6.68e-2)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (3.48e-2)"	"unprognostic (1.18e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.59e-9)"	"unprognostic (1.82e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.09e-3)"	10.3	27.0	16.7	8.1	22.1	10.5	15.5	13.3	32.0	11.8	21.1	32.9	6.3	33.1	9.1	15.3	23.4	7.1	10.3	9.9	18.6	20.8	18.6	80.9	22.2	5.0	17.2	13.7	21.0	20.2	32.4	11.9	8.8	47.1	18.2	16.9	17.1	11.0	7.7	4.3	12.8	28.8	8.3	43.7	7.3	18.1	35.7	19.5	2.3	14.1	18.7	10.0	9.0	13.2	14.2	14.1	3.5	13.9	6.7	10.7	7.1	21.4	10.5	26.6	17.0	18.7	30.7	3.8	7.3	22.1	9.5	26.0	25.3	39.3	18.7	11.6	12.6	96.2	18.8	23.1	46.1	11.1	7.8	16.4	5.4	11.2	19.0	25.6	11.0	8.1	22.2	21.0	37.1	39.0	8.4	9.7	3.8	20.2	43.2	11.1	22.0	2.3	10.2	19.8	8.8	10.5	7.6	5.5	42.2	43.0	36.4	18.7	12.5	15.5	30.9	22.6	12.6	11.2	13.2	11.5	13.0	14.6	18.8	9.5	14.7	13.1	17.1	10.0	14.6	16.6	1.8	9.7	3.5	10.7	13.9	7.1	14.2	7.6	8.4	14.1	10.7	7.2	9.2	1.5	6.7	8.3	12.4	5.8	7.1	16.7	22.1	13.3	32.0	18.6	20.8	17.2	13.7	47.1	19.5	62.5	133.7	7.5	1.0	2.3	2.1	1.2	7.6	28.1	77.3	1.8	2.0	1.3	1.7	9.2	70.7	2.1	14.4	23.3	17.0	0.8	1.8	1.3	27.7	4.2	1.3	0.0	10.4	8.6	6.6	27.7	3.4	2.1	0.0	1.0	12.0	1.9	12.3	10.4	1.4	1.7	1.8	0.0	2.8	3.2	1.5	4.6	3.7	1.0	11.5	2.1
LRRD1	IMAGE:4798971	ENSG00000240720	"Leucine rich repeats and death domain containing 1"	A4D1F6	7	92112159-92179531	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 19.1"	"Group enriched"	"Detected in some"	82	"Early spermatids: 257.1;Late spermatids: 670.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA055670, HPA079440"	Enhanced		Approved	Vesicles,Mitochondria		NA	NA			Mitochondria	Vesicles	"HPA055670: , HPA079440: "	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.72e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.12e-1)"		"unprognostic (5.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.13e-3)"	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	19.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.7	3.8	0.6	0.7	0.8	0.1	0.9	0.2	0.9	0.9	0.4	1.7	0.6	0.8	0.0	0.5	0.4	0.3	1.3	0.9	0.2	0.0	0.5	0.7	0.1	0.0	0.7	0.9	0.9	0.6	1.0	0.3	0.4	3.3	1.1	0.2	0.4	0.7	0.3	0.9	0.5	1.3	1.2	2.4	0.9	2.0	0.8	2.5	0.4	0.1	0.7	0.5	0.9	0.5	0.1	0.7	0.7	0.6	0.1	0.3	0.1	0.7	0.5	0.4	1.3	1.0	1.2	1.0	0.7	1.2	0.3	1.3	0.4	0.9	0.4	3.8	0.6	0.4	0.5	0.3	0.4	0.5	0.5	0.4	0.1	1.0	0.4	0.5	1.9	0.7	0.4	0.7	0.8	0.1	0.1	0.1	0.5	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	1.1	0.0	0.3	0.2	0.7	0.2	0.0	2.7	1.2	0.0	0.0	0.1	0.0	0.0	257.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.1	0.0	0.1	1.6	0.0	0.0	0.0	670.8	4.4	0.3	0.0	0.0	0.0	0.5	0.0	0.0	2.8	0.0	0.4	0.0	0.1	5.6	2.7	0.3	0.0	0.0	0.0	0.3
KRIT1	"CAM, CCM1"	ENSG00000001631	"KRIT1, ankyrin repeat containing"	O00522	7	92198969-92246166	"Disease related genes, Predicted intracellular proteins"	Angiogenesis		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 177.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049606	Supported		Uncertain	Vesicles		NA	NA			Vesicles		"HPA049606: AB_2680832"	"unprognostic (8.12e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.93e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.18e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.04e-1)"	16.7	16.2	18.0	15.6	22.4	7.1	15.8	32.7	32.0	18.7	16.3	11.7	16.8	14.8	19.3	16.1	15.4	16.2	17.1	19.5	14.7	13.5	17.5	14.0	13.5	14.4	22.1	15.9	23.1	16.6	26.2	46.0	16.3	17.2	17.5	13.5	12.8	17.2	19.6	23.0	13.3	14.6	16.7	20.3	14.7	16.2	23.7	19.9	19.1	25.0	12.6	17.2	19.4	19.8	11.8	8.2	11.7	5.8	12.7	11.4	3.6	19.0	13.1	16.4	17.6	14.7	14.5	15.4	17.9	13.1	12.0	11.6	11.1	20.0	17.1	17.8	10.4	16.6	15.9	16.0	10.6	16.6	18.1	19.1	17.4	16.8	7.6	11.5	22.3	21.3	13.6	14.2	11.7	13.5	13.3	12.1	14.4	34.2	24.0	13.8	17.7	24.3	13.2	17.1	14.2	13.6	16.6	24.0	21.6	7.8	17.2	17.9	22.0	21.6	23.0	14.3	21.2	13.7	12.1	17.0	23.3	20.7	32.0	13.1	18.8	21.4	32.1	13.2	18.3	21.9	11.7	5.8	5.9	7.8	4.3	8.1	11.8	8.8	10.5	6.0	10.0	11.4	9.9	2.4	12.7	3.2	8.2	8.2	3.6	18.0	22.4	32.7	32.0	14.7	13.5	22.1	15.9	17.2	19.9	14.9	30.1	23.0	24.1	17.6	42.8	24.6	20.4	44.2	27.3	40.1	31.4	30.9	39.7	19.8	19.6	33.8	18.6	0.0	21.0	25.7	28.6	21.5	34.8	24.5	16.6	27.0	19.5	43.6	20.6	12.2	47.5	20.7	6.8	19.0	19.9	38.9	19.6	28.1	50.9	24.8	49.3	38.8	20.2	177.4	82.6	22.0	23.5	29.4	22.9	16.3
ANKIB1	"DKFZP434A0225, KIAA1386"	ENSG00000001629	"Ankyrin repeat and IBR domain containing 1"	Q9P2G1	7	92246234-92401384	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019358, HPA021780"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA019358: AB_1844831, HPA021780: AB_2670819"	"unprognostic (1.77e-1)"	"unprognostic (5.96e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.97e-3)"	"unprognostic (2.75e-1)"	"unprognostic (7.67e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.52e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.06e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.20e-1)"	11.9	11.8	21.4	9.2	29.2	5.8	12.3	15.0	25.5	13.6	12.1	34.9	16.0	10.7	12.6	16.4	11.8	10.0	14.7	9.7	22.7	20.0	25.3	10.1	10.6	11.5	31.1	18.4	13.1	12.7	28.5	10.9	12.2	23.4	10.2	12.6	8.4	12.7	18.4	8.6	14.0	11.3	13.4	23.8	11.4	10.9	19.4	35.0	11.5	17.1	4.5	11.1	13.1	13.3	4.8	4.5	3.1	2.0	3.2	4.9	1.1	16.8	10.3	9.1	13.8	16.9	18.0	9.7	13.2	15.1	12.8	16.8	7.5	26.1	9.7	11.6	19.5	33.1	8.1	8.4	13.8	19.6	16.4	6.9	6.1	11.9	6.0	11.5	8.7	13.6	12.2	11.7	15.1	20.0	18.0	14.5	8.8	7.8	21.0	15.1	13.6	18.5	8.2	9.9	11.8	11.6	7.0	11.2	10.4	13.6	14.6	12.7	14.9	18.9	21.3	11.1	18.9	8.8	5.0	12.9	24.8	20.1	28.0	13.4	13.2	23.5	12.2	14.4	10.6	28.3	2.8	1.3	3.1	2.7	2.0	2.2	3.9	2.6	3.8	1.1	4.8	2.2	2.8	0.8	3.2	1.6	4.5	4.9	1.1	21.4	29.2	15.0	25.5	22.7	20.0	31.1	18.4	23.4	35.0	23.8	25.4	15.9	15.3	16.6	20.1	32.3	17.8	14.7	23.9	26.2	17.7	11.3	1.7	18.0	40.4	15.7	15.3	0.0	16.6	22.9	19.1	16.9	26.5	12.9	11.8	28.6	40.3	28.3	21.1	45.0	30.8	16.4	16.9	6.4	23.5	26.9	26.0	7.0	38.2	30.1	15.7	19.4	18.1	58.5	57.5	19.8	11.7	17.5	19.2	21.8
GATAD1	"FLJ22489, ODAG, RG083M05.2"	ENSG00000157259	"GATA zinc finger domain containing 1"	Q8WUU5	7	92447448-92459432	"Disease related genes, Predicted intracellular proteins, Transcription factors"			"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 125.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006105, HPA072785"			Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		"HPA006105: AB_1078956, HPA072785: AB_2686556"	"unprognostic (8.37e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.31e-3)"	"unprognostic (6.24e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.65e-3)"	"unprognostic (6.43e-2)"	"unprognostic (5.16e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.98e-3)"	20.1	20.9	14.7	13.7	32.1	8.7	21.1	19.5	23.5	23.1	18.2	32.9	20.8	17.6	23.2	29.8	13.7	21.7	20.0	14.9	18.3	13.4	21.5	17.5	22.5	12.4	37.7	21.4	32.9	27.3	19.7	22.5	19.3	22.1	21.7	18.3	19.5	17.0	21.2	10.4	15.3	16.9	22.2	28.9	18.9	21.1	11.5	31.8	6.5	28.1	8.0	11.3	21.4	18.7	4.5	3.8	7.3	3.8	3.1	3.0	1.1	8.6	5.5	11.3	11.8	14.7	17.0	9.1	8.7	13.0	9.2	12.7	6.0	13.5	6.5	12.1	6.4	21.6	10.4	7.7	5.9	9.8	11.3	8.4	8.3	5.5	8.3	20.5	9.9	22.5	12.8	14.2	7.0	20.6	16.6	10.3	4.8	16.8	14.0	10.0	12.5	3.8	14.1	15.2	14.0	10.6	5.1	13.4	8.5	9.9	9.8	10.1	16.0	11.4	12.1	16.3	14.7	6.8	13.4	9.4	14.8	11.3	22.3	11.1	11.3	3.9	7.2	12.4	6.5	20.2	7.3	3.8	3.4	2.6	2.3	2.5	2.8	2.0	1.6	2.0	4.5	2.1	3.0	3.9	3.1	2.5	3.8	2.0	1.1	14.7	32.1	19.5	23.5	18.3	13.4	37.7	21.4	22.1	31.8	44.7	54.7	23.8	32.5	11.7	77.4	13.2	20.4	45.5	33.0	45.4	66.8	21.8	3.3	18.5	3.3	25.3	24.9	0.0	19.1	19.7	20.3	33.0	50.9	19.5	21.7	58.8	16.1	30.1	26.3	3.4	42.0	29.9	20.3	10.8	35.4	86.9	22.4	33.6	32.9	13.5	125.5	19.4	26.7	10.7	7.0	15.6	17.3	18.5	29.9	26.0
ERVW-1	"envW, ERVWE1, HERV-7q, HERV-W, HERV-W-ENV, HERVW"	ENSG00000242950	"Endogenous retrovirus group W member 1, envelope"	Q9UQF0	7	92468380-92477986	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"placenta: 83.4"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 179.3;Syncytiotrophoblasts: 714.1"	"Cancer enriched"	"Detected in single"	143	"testis cancer: 31.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	34	"BEWO: 43.6;SuSa: 13.9"															NA	NA						"unprognostic (2.85e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.48e-4)"	"unprognostic (4.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.96e-2)"	"unprognostic (8.02e-2)"	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	2.0	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	83.4	0.2	0.2	0.1	0.2	0.4	0.2	0.4	0.4	0.2	0.2	0.3	0.3	0.5	10.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.0	2.2	0.8	0.1	0.2	0.0	0.1	0.2	0.3	0.2	0.0	0.3	43.6	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.6	0.3	0.2	0.1	0.1	0.1	0.2	0.2	0.5	0.1	0.0	0.2	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.7	0.0	0.2	0.2	0.3	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.3	0.0	0.6	0.0	13.9	0.1	0.2	0.1	0.0	0.8	0.2	0.1	0.7	0.3	0.1	0.1	0.2	0.0	0.0	0.4	2.2	0.2	0.8	0.1	0.5	0.1	0.0	0.0	0.3	0.0	0.1	0.4	0.1	0.6	0.0	0.1	0.0	0.2	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.2	0.2	3.0	1.9	0.0	0.5	0.7	2.2	0.2	0.0	9.4	2.3	0.0	0.0	179.3	0.0	0.0	28.9	0.1	0.0	0.0	0.0	79.7	2.8	0.2	2.3	0.0	23.6	0.0	0.0	0.0	1.0	5.3	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	1.4	0.0	0.0	0.5	0.4	1.8	714.1	0.0	0.0	0.5
PEX1	"ZWS, ZWS1"	ENSG00000127980	"Peroxisomal biogenesis factor 1"	O43933	7	92487020-92528531	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis, Protein transport, Transport"		"Amelogenesis imperfecta, Deafness, Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020235	Approved		Supported	Peroxisomes		NA	NA			Peroxisomes		"HPA020235: AB_1855224"	"unprognostic (4.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.81e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.17e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.35e-3)"	"unprognostic (4.90e-2)"	11.3	13.8	8.9	13.1	19.1	5.8	14.0	14.3	14.7	12.7	13.2	15.8	19.0	10.2	12.2	18.7	13.0	9.5	10.6	13.4	9.5	9.3	22.4	20.3	8.4	9.9	15.4	9.3	14.3	17.5	23.3	22.5	8.0	18.5	12.9	15.4	13.7	13.6	20.6	16.1	15.0	12.7	12.2	15.0	10.2	12.9	10.2	13.6	15.2	13.8	14.6	11.1	11.5	11.6	5.5	2.1	3.1	3.6	7.9	6.2	1.9	5.7	6.3	10.4	17.6	6.6	5.6	9.4	3.8	5.0	4.6	6.6	3.8	6.1	8.5	8.7	4.4	7.0	5.9	7.9	6.9	7.3	8.8	7.0	4.1	6.8	4.8	4.6	7.3	4.6	6.1	6.3	6.8	9.3	5.7	7.1	8.9	15.0	12.2	7.1	10.8	14.5	7.1	7.2	8.4	5.9	10.3	11.6	10.6	6.4	8.5	7.7	12.4	8.8	24.6	7.5	15.1	5.0	3.1	5.8	4.4	6.0	16.6	4.0	13.7	10.8	11.8	4.1	4.3	7.0	1.1	2.0	3.1	4.7	3.2	4.6	5.5	4.9	5.1	2.1	4.7	5.7	6.2	1.6	7.9	3.6	1.3	4.6	1.9	8.9	19.1	14.3	14.7	9.5	9.3	15.4	9.3	18.5	13.6	26.8	13.6	5.7	7.2	5.3	42.4	25.0	2.5	41.5	12.5	5.2	33.4	7.5	8.3	5.6	4.8	8.7	15.1	23.3	6.5	3.1	5.2	8.0	8.1	11.6	4.7	38.1	13.4	8.6	9.4	3.8	13.3	5.6	6.8	13.6	12.9	16.6	5.7	13.6	14.2	15.3	45.7	6.5	6.1	28.4	10.4	6.8	7.0	8.7	13.3	7.0
RBM48	"C7orf64, DKFZp564O0523, HSPC304"	ENSG00000127993	"RNA binding motif protein 48"	Q5RL73	7	92528773-92538005	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021777, HPA025306"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021777: AB_1845763, HPA025306: AB_1845764"	"unprognostic (2.79e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.59e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.43e-2)"	"unprognostic (8.04e-2)"	11.1	13.0	23.9	10.8	36.0	24.6	14.1	28.3	34.2	11.7	9.0	18.4	7.1	10.3	12.0	12.4	9.9	10.9	8.9	12.1	22.8	15.2	12.4	10.5	9.9	17.1	42.4	15.1	17.0	10.6	11.1	18.3	10.6	20.7	11.5	11.0	9.0	13.0	8.9	16.5	10.8	10.7	9.7	28.0	14.5	9.8	12.5	36.9	13.6	14.5	6.6	13.9	10.2	10.1	20.1	10.6	37.5	12.1	18.1	25.8	14.0	7.5	5.6	9.7	15.2	11.9	12.4	7.6	9.1	9.4	12.1	11.5	6.5	10.4	10.8	16.5	7.7	15.2	7.8	9.9	7.3	13.5	12.2	12.2	8.5	12.2	7.4	10.1	14.9	10.2	9.5	14.4	11.9	12.7	13.9	12.1	14.1	16.8	19.2	11.2	8.9	19.2	15.2	8.6	10.8	9.4	8.9	8.5	14.6	9.6	7.3	11.5	16.2	9.1	17.6	12.7	13.3	5.5	14.7	6.2	17.1	9.3	13.5	13.0	11.4	15.1	18.5	8.1	13.1	15.6	37.5	10.1	21.0	18.5	12.1	20.2	20.1	20.3	18.9	9.7	18.5	25.8	22.1	13.4	18.1	9.9	10.6	18.3	14.0	23.9	36.0	28.3	34.2	22.8	15.2	42.4	15.1	20.7	36.9	11.9	6.9	15.6	11.1	7.6	12.2	14.6	5.1	9.4	11.4	3.5	0.0	8.8	6.6	6.9	6.1	9.3	5.8	23.3	5.2	4.8	8.7	8.9	29.0	3.8	5.4	11.1	0.0	4.9	6.5	5.7	5.5	8.9	5.0	8.2	3.8	12.5	4.1	6.6	6.0	7.4	12.5	12.9	8.3	21.2	15.6	9.9	12.8	14.1	5.2	10.3
FAM133B	MGC40405	ENSG00000234545	"Family with sequence similarity 133 member B"	Q5BKY9	7	92560793-92590394	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA066175, HPA069513"			Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA066175: AB_2685629, HPA069513: AB_2686143"	"unprognostic (5.54e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.87e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.73e-3)"	"unprognostic (9.01e-3)"	"unprognostic (3.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-2)"	10.5	11.7	18.5	11.1	23.6	32.1	15.1	25.7	23.3	13.6	10.4	8.2	12.0	11.9	13.0	22.5	11.4	10.4	9.2	9.2	13.8	9.1	11.2	14.3	11.2	14.1	15.3	13.2	15.1	13.6	13.4	21.3	12.9	18.0	12.0	11.7	7.5	11.4	10.5	17.1	12.8	10.8	15.7	18.5	12.1	10.6	7.3	17.3	15.9	12.5	7.5	12.8	10.6	12.0	22.5	23.2	9.8	11.7	10.7	17.0	5.9	13.1	6.8	19.2	29.4	11.3	12.0	11.5	14.9	16.1	14.6	17.8	10.9	14.6	21.5	14.5	10.1	12.7	10.6	15.1	9.4	22.4	12.1	19.7	17.4	10.0	21.8	11.8	19.1	15.1	8.0	9.9	11.2	14.0	11.5	8.6	16.8	22.9	27.3	15.6	16.0	30.0	29.9	26.2	12.0	8.8	21.8	19.3	17.8	14.5	14.1	18.6	18.0	12.8	16.3	17.3	18.8	15.1	14.1	9.9	16.8	26.7	19.5	16.7	7.1	7.5	38.5	10.1	25.2	21.6	9.5	11.7	9.8	10.7	10.5	13.9	22.5	13.6	13.2	9.6	18.8	17.0	14.4	4.9	10.7	7.8	23.2	14.3	5.9	18.5	23.6	25.7	23.3	13.8	9.1	15.3	13.2	18.0	17.3	53.6	65.5	102.1	185.5	101.5	81.2	25.7	180.9	38.8	62.6	83.7	70.7	55.8	84.6	78.1	31.4	87.5	92.6	163.5	75.9	52.0	92.4	103.6	86.4	97.3	62.9	52.4	131.6	108.1	107.2	13.2	95.0	114.5	72.6	69.5	83.4	83.5	72.6	112.3	83.4	48.4	75.1	51.8	103.0	97.0	117.4	91.7	59.0	97.2	97.8	127.1
CDK6	PLSTIRE	ENSG00000105810	"Cyclin dependent kinase 6"	Q00534	7	92604921-92836594	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 74.6"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 219.8;Late spermatids: 186.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 93.5;REH: 45.7"					"Low region specificity"	"Detected in all"			"HPA002637, CAB004363"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004363: AB_627242, HPA002637: AB_1846432"	"unprognostic (1.29e-1)"	"unprognostic (5.98e-3)"	"unprognostic (9.07e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.19e-2)"	"unprognostic (7.78e-3)"	"prognostic unfavorable (3.86e-6)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (2.33e-5)"	6.6	11.3	6.0	9.1	7.5	22.5	5.9	2.4	6.0	7.8	10.0	9.6	5.7	7.5	6.0	5.9	8.5	4.6	7.8	6.6	6.9	4.2	6.5	7.5	7.3	7.4	7.0	5.2	5.0	10.0	25.7	4.2	20.5	7.5	6.1	9.2	4.4	10.9	6.1	2.0	11.6	9.4	9.8	7.5	6.3	10.8	5.4	8.0	74.6	4.3	9.2	10.3	6.7	9.0	3.6	5.6	6.5	4.8	3.9	7.1	2.3	6.2	2.9	8.0	5.1	2.3	2.6	1.7	6.4	4.0	3.2	3.0	7.8	4.8	4.8	3.7	4.3	2.0	3.8	4.4	9.2	7.6	10.5	3.1	12.0	5.5	7.5	1.4	7.4	0.6	2.6	5.0	4.3	20.4	3.0	1.2	19.6	11.5	13.3	5.7	1.2	93.5	0.8	2.5	7.9	2.6	45.7	28.1	8.1	4.4	0.1	4.2	27.3	0.7	2.2	3.7	6.1	0.1	12.3	4.7	10.5	16.5	4.1	12.9	7.1	0.1	6.4	1.5	25.5	13.9	4.9	1.9	6.5	5.2	3.9	5.9	2.0	5.5	5.6	4.0	3.6	7.1	4.0	1.1	3.9	4.8	5.6	2.8	2.3	6.0	7.5	2.4	6.0	6.9	4.2	7.0	5.2	7.5	8.0	23.8	3.0	11.9	19.5	53.5	0.2	14.8	25.5	4.0	27.3	21.0	0.0	42.7	8.3	31.7	219.8	24.1	11.0	0.0	20.1	3.4	21.6	18.1	24.3	18.4	15.0	0.0	16.1	7.4	23.4	186.0	4.6	21.9	18.6	20.8	46.7	0.5	63.1	14.0	3.2	5.1	0.0	6.5	22.1	2.6	46.4	44.2	14.8	20.3	68.3	23.3
SAMD9	"C7orf5, FLJ20073, KIAA2004"	ENSG00000205413	"Sterile alpha motif domain containing 9"	Q5K651	7	93099513-93118023	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 34.6;lymphoid tissue: 35.4"	"Cell type enhanced"	"Detected in many"	5	"Paneth cells: 59.6;T-cells: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 29.4;GAMG: 28.8"					"Low region specificity"	"Detected in all"			"HPA021318, HPA021319"	Approved		Supported	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA021318: AB_2183383, HPA021319: AB_1856554"	"unprognostic (3.66e-2)"	"unprognostic (5.35e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (8.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.48e-2)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (8.31e-5)"	"unprognostic (6.00e-2)"	"prognostic unfavorable (8.40e-7)"	"unprognostic (5.91e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.64e-1)"	9.6	4.0	2.3	9.2	2.4	5.2	2.6	1.0	1.6	9.3	6.8	0.6	0.9	4.3	2.8	3.0	34.6	2.7	4.3	2.5	1.3	1.5	6.3	3.5	7.8	10.8	2.5	1.1	6.3	2.3	0.1	6.4	11.3	3.1	5.3	7.0	0.7	5.7	1.6	2.4	1.5	12.7	2.2	2.5	21.7	6.3	2.5	1.7	35.4	3.3	9.9	9.5	4.8	9.7	5.5	3.0	15.6	9.8	7.4	7.6	2.6	11.7	1.5	0.4	0.1	5.3	6.8	0.1	4.6	19.3	22.2	29.4	0.0	13.1	4.9	7.3	11.4	28.8	13.9	0.0	4.2	7.5	16.8	0.5	7.2	7.9	0.0	2.4	8.0	10.0	3.0	6.1	7.3	2.0	1.2	3.3	5.5	0.5	12.3	4.6	0.0	11.9	6.6	0.0	0.0	3.3	3.9	3.9	5.6	0.1	1.5	1.9	0.2	3.6	1.4	3.8	0.0	0.4	3.9	14.2	5.2	1.9	15.5	2.5	7.4	1.4	4.6	5.4	4.7	5.1	15.6	3.6	12.7	7.6	7.0	7.3	5.0	5.9	6.5	3.0	5.5	6.3	5.7	15.5	7.4	9.8	2.1	7.2	2.6	2.3	2.4	1.0	1.6	1.3	1.5	2.5	1.1	3.1	1.7	8.9	3.0	23.2	7.5	2.1	1.6	0.9	2.5	20.1	9.1	14.0	0.0	1.5	0.0	20.9	0.0	24.8	12.1	0.0	10.8	4.6	8.3	6.6	41.7	1.0	10.7	6.4	2.9	8.0	24.0	0.2	14.1	26.3	3.3	13.6	20.9	2.0	32.1	59.6	11.7	2.1	0.0	12.9	9.2	0.2	0.0	1.6	0.3	50.7	3.3	25.5
SAMD9L	"C7orf6, FLJ39885, KIAA2005"	ENSG00000177409	"Sterile alpha motif domain containing 9 like"	Q8IVG5	7	93130055-93148369	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"monocytes: 71.3;Paneth cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 21.0;GAMG: 17.0;HDLM-2: 18.6;Karpas-707: 50.1"	"Low region specificity"	"Detected in all"							"HPA019461, HPA019465, HPA019488"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA019461: AB_1856555, HPA019465: AB_2183384, HPA019488: AB_1856557"	"unprognostic (6.93e-3)"	"unprognostic (6.12e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.03e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.18e-3)"	"unprognostic (1.05e-3)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (6.63e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.22e-1)"	25.1	6.8	6.0	16.5	7.9	5.9	7.1	5.1	5.7	10.0	6.7	3.3	3.2	7.4	5.9	11.4	8.8	7.0	9.4	5.5	5.7	3.3	9.1	3.7	14.8	17.3	4.5	5.9	11.1	3.9	1.2	6.4	11.3	7.4	8.8	7.7	4.2	8.1	4.5	3.6	2.6	13.2	5.8	6.5	28.4	9.3	3.9	6.0	26.7	11.7	5.5	10.3	9.1	7.8	11.2	4.5	21.7	9.7	5.9	10.1	2.4	2.6	0.1	0.0	0.1	3.6	7.4	0.0	2.3	9.7	13.2	21.0	0.0	6.0	1.7	2.9	6.2	17.0	1.1	0.0	0.8	2.1	18.6	0.0	1.6	0.6	0.0	2.9	3.4	2.6	2.8	0.3	2.6	0.4	2.4	5.7	2.6	0.0	50.1	5.5	0.0	5.5	3.1	0.2	0.0	0.6	2.3	0.8	4.0	0.7	0.2	0.0	0.1	0.4	0.0	3.6	0.0	0.1	1.8	13.2	3.9	0.8	11.3	1.4	13.9	4.6	0.5	4.1	3.1	3.8	14.3	4.9	11.4	10.1	9.7	8.9	11.2	5.8	7.4	4.5	7.9	3.3	5.7	21.7	5.9	8.9	3.3	8.2	2.4	6.0	7.9	5.1	5.7	5.7	3.3	4.5	5.9	7.4	6.0	32.8	9.1	23.1	2.1	2.1	0.0	1.2	5.1	17.4	7.9	10.4	0.0	0.3	8.3	10.9	0.0	20.7	2.6	0.0	5.3	0.7	7.6	2.8	33.5	0.0	23.8	0.0	1.2	23.9	18.6	0.7	8.9	22.7	6.8	71.3	8.4	16.3	9.9	51.8	11.0	3.3	0.0	6.5	5.6	0.2	0.0	1.9	0.1	28.7	2.4	7.3
HEPACAM2	FLJ38683	ENSG00000188175	"HEPACAM family member 2"	A8MVW5	7	93188586-93226524	"Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 43.4;kidney: 24.5;pituitary gland: 16.1"	"Group enriched"	"Detected in some"	23	"Intestinal endocrine cells: 209.3;Mucus-secreting cells: 364.1;Paneth cells: 298.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	37	"SCLC-21H: 63.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA012381			Supported	"Nucleoplasm,Vesicles,Mitotic spindle"		Yes	NA		89000	"Vesicles, Mitotic spindle"	Nucleoplasm	"HPA012381: AB_1853037"	"unprognostic (2.01e-3)"	"unprognostic (6.05e-2)"	"prognostic favorable (9.73e-5)"	"unprognostic (1.33e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.48e-2)"	"unprognostic (8.40e-3)"	"unprognostic (7.61e-2)"	"unprognostic (8.68e-2)"	"unprognostic (5.37e-3)"	"unprognostic (4.93e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.34e-2)"	0.1	0.2	0.2	8.5	0.2	0.6	3.4	0.1	0.1	0.1	29.4	0.1	5.3	11.8	0.1	0.4	0.2	0.1	0.8	0.3	0.2	0.2	24.5	0.2	0.4	0.1	0.2	0.1	0.1	5.5	0.0	16.1	0.4	0.2	0.7	38.9	0.1	4.1	1.2	0.1	0.1	43.4	0.4	0.2	0.2	4.0	1.4	0.1	0.3	0.1	0.1	2.1	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.2	0.1	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	8.3	0.0	2.1	0.0	6.7	0.0	0.0	0.0	0.0	1.2	4.6	0.0	0.0	0.0	209.3	0.0	0.0	1.9	0.0	0.0	6.8	0.0	364.1	0.0	0.0	298.7	0.0	0.0	0.0	0.0	0.0	4.5	0.7	0.1	0.1	0.0	12.4	0.0
VPS50	"CCDC132, DKFZp313I2429, FLJ20097, KIAA1861, VPS54L"	ENSG00000004766	"VPS50, EARP/GARPII complex subunit"	Q96JG6	7	93232340-93361121	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026679	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA026679: AB_1846135"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.12e-2)"	"unprognostic (7.43e-2)"	"unprognostic (4.97e-2)"	"prognostic unfavorable (7.21e-5)"	"unprognostic (1.05e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.69e-1)"	"unprognostic (5.17e-2)"	"prognostic favorable (1.35e-6)"	"unprognostic (2.08e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"	15.9	16.3	16.4	15.3	24.2	6.9	21.6	26.1	28.3	13.0	16.0	9.9	13.3	11.5	17.7	17.5	15.7	11.9	10.4	12.6	19.8	16.0	20.0	12.1	13.2	15.3	16.4	22.2	15.4	13.5	23.9	30.8	12.8	26.7	14.3	18.5	7.5	15.0	14.2	18.7	16.8	12.8	14.8	15.9	15.5	14.1	13.8	19.2	15.8	15.8	14.0	15.3	14.2	12.9	5.5	10.4	4.2	8.1	5.2	11.2	4.3	11.1	6.7	8.7	13.4	16.2	11.6	8.7	10.5	9.0	10.9	12.0	9.4	13.0	9.9	11.9	9.1	20.1	9.6	12.9	10.0	15.2	11.5	9.0	18.4	13.0	5.9	9.9	9.4	10.1	9.8	11.6	13.2	13.3	10.7	14.1	9.7	14.5	12.8	14.5	11.1	8.8	8.4	6.0	15.2	9.5	7.0	11.5	13.4	10.2	8.9	6.3	13.4	12.2	26.8	10.8	13.7	9.2	7.1	12.7	15.9	9.4	29.0	10.7	7.0	15.5	11.9	11.7	9.3	12.6	4.2	7.0	3.4	6.2	8.1	11.2	5.5	6.9	7.6	10.4	5.5	5.5	7.4	1.7	5.2	4.8	5.1	8.1	4.3	16.4	24.2	26.1	28.3	19.8	16.0	16.4	22.2	26.7	19.2	11.9	9.9	3.4	3.8	0.0	11.8	0.0	2.5	10.7	9.1	5.2	15.7	5.9	3.3	6.3	12.3	5.3	1.1	23.3	4.7	9.2	1.9	2.7	7.0	6.4	9.4	9.5	2.4	9.8	10.4	11.0	8.3	6.4	0.0	6.4	9.9	8.5	6.3	7.0	6.7	6.9	13.7	6.5	0.0	17.2	12.5	0.0	7.9	6.9	5.9	2.0
CALCR	CTR	ENSG00000004948	"Calcitonin receptor"		7	93424487-93574730	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"brain: 10.8;kidney: 7.5"	"Group enriched"	"Detected in some"	14	"Early spermatids: 13.2;Late spermatids: 4.4"	"Cancer enriched"	"Detected in single"	5	"renal cancer: 1.1"	"Region enhanced"	"Detected in many"		"hypothalamus: 10.8"	"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.1"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.1"	"Group enriched"	"Detected in some"	7	"MCF7: 2.4;RPTEC TERT1: 4.0;SuSa: 7.7;T-47d: 7.7"	"Group enriched"	"Detected in some"	5	"basal ganglia: 6.7;hypothalamus: 28.7"	"Low region specificity"	"Detected in all"			"HPA028962, HPA061428"	Enhanced	Supported				NA	NA					"HPA028962: AB_10602339, HPA061428: AB_2732661"	"unprognostic (1.95e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.73e-5)"	"unprognostic (1.64e-1)"	"unprognostic (9.24e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.49e-4)"	"unprognostic (1.05e-2)"	0.3	0.7	1.4	0.0	2.1	0.0	1.3	0.1	1.5	0.5	0.2	0.0	0.0	0.1	0.1	0.5	0.3	0.1	0.4	0.4	2.1	10.8	7.5	0.1	0.9	0.0	0.8	0.0	0.7	0.1	0.3	3.2	2.1	5.9	0.1	0.2	0.2	1.4	0.0	3.7	0.1	0.2	0.3	2.5	0.1	0.1	2.3	0.7	0.0	0.1	2.5	0.7	0.1	0.1	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.2	0.0	7.7	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	2.1	0.1	1.5	2.1	10.8	0.8	0.0	5.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	4.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0
GNGT1	GNG1	ENSG00000127928	"G protein subunit gamma transducin 1"	P63211	7	93591573-93911265	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"retina: 107.2"	"Cell type enriched"	"Detected in some"	5	"Rod photoreceptor cells: 1939.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 12.5;HeLa: 4.2;SK-BR-3: 4.0;SuSa: 6.1;T-47d: 6.8;U-266/70: 3.9;U-266/84: 5.2"	"Not detected"	"Not detected"							HPA042721	Enhanced					NA	NA					"HPA042721: AB_10806370"		"unprognostic (1.30e-1)"	"unprognostic (2.55e-4)"	"unprognostic (3.32e-4)"		"unprognostic (5.01e-2)"		"unprognostic (2.54e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.55e-1)"		"unprognostic (2.23e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.69e-1)"		"unprognostic (1.35e-1)"	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.5	0.3	0.1	1.9	0.0	0.0	0.0	0.4	0.0	2.6	0.1	0.1	0.1	7.9	0.3	0.0	0.0	107.2	1.0	0.0	0.0	0.4	0.0	0.1	0.3	0.1	0.4	0.7	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.5	0.5	1.6	0.2	0.1	1.2	0.6	1.4	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.1	12.5	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.4	0.0	4.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.6	0.1	1.9	0.1	0.0	2.0	0.2	0.1	0.0	0.0	0.6	0.3	1.5	3.6	1.3	0.2	4.0	0.1	6.1	6.8	0.2	0.2	0.0	3.7	0.2	0.0	3.9	5.2	0.0	0.2	0.0	0.0	1.6	0.0	0.1	0.7	0.1	0.9	0.5	1.0	0.9	0.3	0.4	0.8	0.8	1.3	0.1	0.2	0.5	1.2	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	300.7	0.0	0.0	1.4	1.2	0.0	363.2	0.4	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	187.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	352.7	0.0	0.0	0.0	3.7	1939.7	0.0	0.0	0.0	0.2	0.0	5.9	0.0	0.0	0.0
TFPI2	"PP5, REF1, TFPI-2"	ENSG00000105825	"Tissue factor pathway inhibitor 2"	P48307	7	93885397-93890991	"Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"placenta: 1024.1"	"Group enriched"	"Detected in many"	4	"Ductal cells: 708.9;Syncytiotrophoblasts: 1826.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 65.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 182.0;hTEC/SVTERT24-B: 90.4;U-138 MG: 87.8;U-2197: 78.3;U-87 MG: 148.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010142, HPA049158"	Enhanced				"Secreted to extracellular matrix"	NA	NA					"CAB010142: AB_628166, HPA049158: AB_2680659"	"prognostic favorable (8.33e-7)"	"unprognostic (2.20e-2)"	"unprognostic (2.10e-2)"	"prognostic favorable (5.42e-4)"	"unprognostic (5.19e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.86e-2)"	"unprognostic (7.54e-3)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (3.38e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.91e-2)"	21.5	14.6	0.6	5.1	0.7	0.0	4.8	0.6	0.6	1.0	1.0	0.6	0.9	0.0	4.8	1.3	0.7	5.4	2.2	3.3	0.6	1.5	4.7	3.1	3.5	0.6	0.6	0.6	14.9	10.0	0.0	4.4	1024.1	0.9	2.2	0.1	58.2	0.7	0.8	1.0	0.0	0.6	1.2	0.6	0.7	1.5	0.8	0.6	1.5	0.6	0.7	0.6	1.9	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	9.9	3.1	0.0	7.1	1.2	0.0	13.0	2.3	1.3	1.0	0.0	0.0	0.0	182.0	3.0	3.0	1.0	0.0	13.9	2.0	0.1	0.0	0.0	0.8	0.0	37.0	0.0	0.0	0.6	0.7	90.4	6.5	15.2	31.1	0.0	0.0	0.1	16.4	0.0	0.0	0.0	0.8	0.0	2.3	0.0	0.0	0.0	3.5	0.3	0.0	8.1	0.0	1.0	0.0	2.4	0.0	0.1	44.9	87.8	0.7	78.3	0.1	0.0	0.1	0.3	148.8	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.7	0.6	0.6	0.6	1.5	0.6	0.6	0.9	0.6	3.0	3.8	0.8	195.2	0.6	15.8	0.4	5.1	5.3	43.3	301.8	37.3	13.6	0.0	708.9	0.0	24.6	0.0	0.0	35.5	197.3	81.4	72.9	0.0	0.8	15.1	3.2	0.0	115.4	5.6	0.0	1.4	1.0	3.3	29.7	0.0	14.5	39.4	0.0	0.0	1.0	104.5	0.0	40.6	0.1	0.2	1.3	1826.6	0.0	0.0	22.3
GNG11	GNGT11	ENSG00000127920	"G protein subunit gamma 11"	P61952	7	93921699-93928610	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Endothelial cells: 1335.6;Ito cells: 1014.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 6.6;neutrophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 45.8;HUVEC TERT2: 71.4;SK-MEL-30: 42.1;TIME: 40.6;U-87 MG: 39.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045255	Uncertain					NA	NA		970000			"HPA045255: AB_10794781"	"unprognostic (1.30e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.89e-3)"	"unprognostic (4.94e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.94e-1)"	"unprognostic (4.71e-3)"	41.0	11.0	5.9	7.9	8.4	2.0	57.7	2.4	5.2	16.8	11.0	3.5	17.9	5.1	24.7	19.4	13.7	15.9	19.4	25.7	6.7	5.5	12.6	8.6	22.0	11.6	8.2	4.3	31.7	8.0	1.8	5.3	69.4	7.4	15.7	5.1	51.3	4.6	17.3	14.1	5.8	7.5	23.1	6.7	22.0	8.3	6.6	4.1	9.9	15.1	16.9	3.6	17.3	21.4	1.3	1.9	6.6	0.4	0.0	0.1	26.3	0.0	6.9	13.9	6.3	10.8	8.5	0.0	7.0	13.8	3.9	5.6	0.0	0.6	0.0	45.8	3.5	16.6	0.1	0.1	0.6	5.0	0.0	0.4	2.2	7.7	0.0	17.3	0.0	0.0	2.8	0.0	12.6	1.2	16.4	71.4	0.0	0.0	0.0	17.5	0.0	0.0	0.0	1.2	0.0	2.1	6.4	1.5	0.0	8.4	0.0	0.0	14.0	0.0	0.0	42.1	1.8	29.6	0.4	40.6	19.5	2.1	14.1	0.7	0.0	0.0	0.1	39.1	0.0	16.6	6.6	0.4	0.1	0.0	0.0	0.1	1.3	0.0	0.0	0.5	1.0	0.1	0.0	5.7	0.0	0.0	1.9	0.0	26.3	5.9	8.4	2.4	5.2	6.7	5.5	8.2	4.3	7.4	4.1	11.9	36.7	28.2	10.4	74.2	0.4	59.7	17.8	2.7	4.5	177.9	0.0	2.3	63.0	96.9	5.4	1335.6	0.0	0.0	4.9	10.9	148.3	10.1	2.3	5.5	13.3	0.0	0.0	1014.7	68.5	13.1	76.2	21.4	178.8	24.4	0.0	3.9	4.9	0.0	81.7	4.3	3.5	148.8	207.0	1.4	4.5	57.5	19.9	13.8	0.0	2.6
BET1	hbet1	ENSG00000105829	"Bet1 golgi vesicular membrane trafficking protein"	O15155	7	93962762-94004382	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (6.85e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.60e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (2.10e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.24e-3)"	16.0	26.2	14.3	11.6	15.4	3.1	25.9	13.0	11.7	18.8	15.3	10.5	34.7	16.3	17.0	27.6	13.0	14.2	11.3	12.4	13.6	16.6	18.4	27.5	10.6	16.2	13.0	9.2	19.5	30.8	10.9	36.3	55.0	11.1	16.6	13.2	12.5	27.4	30.6	6.5	10.3	22.7	15.3	13.7	14.5	14.6	11.4	12.1	15.8	16.8	9.3	15.1	17.5	16.0	22.3	21.9	27.8	11.5	12.1	15.7	10.1	9.0	7.8	12.6	11.8	22.5	25.9	8.7	15.5	20.4	13.4	17.8	4.3	10.7	15.4	30.4	8.3	26.0	4.9	6.9	11.3	23.4	8.5	8.9	5.9	8.2	11.0	23.5	10.7	6.2	10.5	20.8	12.1	33.8	19.9	18.8	10.8	12.7	21.6	18.0	7.5	14.4	15.7	12.6	13.3	11.6	9.4	8.3	20.7	27.5	5.7	5.8	10.6	11.5	16.9	30.2	18.3	10.6	11.1	12.1	18.0	9.0	36.2	9.9	14.2	16.2	20.8	25.8	14.7	12.9	27.8	10.2	10.8	11.7	10.3	14.7	22.3	13.2	11.7	9.3	20.2	15.7	12.9	3.3	12.1	11.5	21.9	10.8	10.1	14.3	15.4	13.0	11.7	13.6	16.6	13.0	9.2	11.1	12.1	11.9	18.4	50.2	23.0	17.3	10.1	9.3	25.5	26.8	9.1	40.1	3.9	57.8	86.2	42.6	6.7	29.4	17.4	0.0	30.4	123.5	32.9	48.9	11.5	48.7	31.8	9.5	15.0	27.6	22.5	5.1	33.6	23.4	25.3	74.9	25.9	13.7	34.3	23.2	20.8	74.2	7.7	25.8	14.4	63.2	44.1	22.2	107.3	21.8	18.4	22.0
COL1A2	OI4	ENSG00000164692	"Collagen type I alpha 2 chain"	P08123	7	94394561-94431232	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Dwarfism, Ehlers-Danlos syndrome, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 244.6"	"Cell type enhanced"	"Detected in many"	15	"Fibroblasts: 1445.8;Ito cells: 427.2;Leydig cells: 918.4;Peritubular cells: 470.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 154.3;ASC TERT1: 185.1;BJ: 151.4;BJ hTERT+: 111.2;fHDF/TERT166: 512.4;HSkMC: 160.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB032650, HPA059738"	Approved		Supported	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		21000000	"Endoplasmic reticulum"		"CAB032650: AB_2082039, HPA059738: AB_2684116"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.38e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.51e-9)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.31e-3)"	44.7	9.8	1.2	34.9	4.3	0.0	33.4	1.7	2.4	244.6	26.5	2.1	54.1	3.8	166.9	139.1	28.2	36.6	101.4	45.1	1.3	0.8	10.2	4.1	37.1	20.4	1.8	2.8	68.3	10.9	1.8	6.0	70.6	3.8	40.3	10.1	23.0	17.5	28.0	12.1	35.6	15.2	100.7	3.2	16.4	16.1	49.7	1.1	5.6	14.7	42.7	12.6	62.4	55.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	57.1	154.3	185.1	0.0	151.4	111.2	24.9	33.3	0.0	0.1	0.0	0.1	512.4	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	40.4	0.0	0.0	160.7	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.5	63.6	0.0	39.4	4.2	0.0	0.0	0.0	15.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.3	1.7	2.4	1.3	0.8	1.8	2.8	3.8	1.1	3.0	17.5	0.0	0.5	198.1	0.1	13.3	0.0	1.4	5.7	1.8	0.0	23.0	0.0	2.8	7.1	30.1	0.0	0.0	0.2	19.3	1445.8	1.2	9.3	1.1	95.1	0.0	0.0	427.2	1.0	22.0	918.4	12.0	226.0	4.6	0.0	3.0	8.5	0.0	470.9	0.3	0.3	297.5	291.6	5.1	3.2	163.7	59.2	0.0	0.0	0.7
CASD1	"C7orf12, FLJ21213, FLJ21879"	ENSG00000127995	"CAS1 domain containing 1"	Q96PB1	7	94509219-94557019	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 54.4;Horizontal cells: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044404	Uncertain		Approved	Nucleoplasm		Yes	No			Nucleoplasm		"HPA044404: AB_10964353"	"unprognostic (4.02e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.04e-2)"	"unprognostic (7.90e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.83e-2)"	"unprognostic (4.74e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.16e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.93e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.59e-3)"	8.6	21.6	16.6	7.1	24.2	4.1	13.2	20.5	24.8	10.0	13.2	10.9	7.5	5.0	11.7	12.5	5.1	9.2	8.1	13.6	25.9	22.2	10.2	7.1	9.0	9.2	13.1	16.6	14.1	7.8	12.7	22.8	9.8	20.0	11.8	15.9	8.4	22.6	8.2	11.3	3.7	6.3	9.7	13.7	8.0	6.0	10.1	11.5	7.3	13.2	2.9	8.3	9.0	6.3	1.8	1.1	0.2	0.7	1.8	4.7	0.7	3.0	5.9	20.3	7.5	6.2	7.5	3.4	4.2	7.4	4.6	6.1	3.7	7.6	7.8	11.0	5.6	8.3	1.7	5.1	1.4	9.2	12.4	4.1	6.9	5.0	6.7	5.3	11.4	0.0	6.8	5.4	4.2	6.1	9.1	7.3	9.2	3.7	17.2	11.4	4.5	15.8	6.5	10.4	4.3	4.7	10.9	16.5	6.0	9.4	8.5	7.7	26.3	6.5	12.1	4.1	15.4	3.1	7.2	3.8	11.6	9.2	9.5	6.0	16.5	15.4	16.3	6.3	2.7	7.5	0.0	0.6	0.2	1.9	0.7	4.7	1.8	2.8	2.3	1.1	1.7	2.9	2.2	0.0	1.8	0.6	1.0	1.7	0.7	16.6	24.2	20.5	24.8	25.9	22.2	13.1	16.6	20.0	11.5	26.8	22.9	6.9	5.2	4.0	54.4	17.1	17.8	18.7	17.0	19.2	17.7	9.7	3.3	4.5	2.7	13.3	12.0	0.0	4.8	4.6	9.3	11.8	10.3	10.9	7.4	63.5	6.9	17.2	11.5	4.7	10.6	5.6	23.6	2.8	27.6	25.0	6.1	8.6	9.2	8.8	28.9	19.4	7.1	6.3	11.9	4.0	14.1	7.2	14.1	3.7
SGCE	DYT11	ENSG00000127990	"Sarcoglycan epsilon"	O43556	7	94524204-94656572	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 84.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 2.9;memory B-cell: 6.4;naive B-cell: 9.2"	"Group enriched"	"Detected in many"	4	"B-cells: 9.2;T-cells: 2.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074790			Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Plasma membrane"		Yes	No		50000	"Vesicles, Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA074790: AB_2686713"	"unprognostic (3.16e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (1.19e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.80e-3)"	"unprognostic (9.69e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.44e-2)"	22.4	35.7	16.9	7.5	19.0	0.6	23.2	23.6	18.5	22.5	20.5	16.8	14.0	5.3	23.6	16.8	11.1	17.1	19.0	19.3	17.7	14.3	12.9	8.9	17.3	9.0	21.5	12.9	59.3	12.9	8.7	23.1	31.9	15.0	15.6	9.7	11.2	11.9	22.7	6.1	3.5	8.0	28.1	20.9	15.8	11.2	13.2	17.5	2.9	15.4	6.9	4.4	22.7	16.1	9.2	0.3	0.6	0.1	1.4	2.9	0.5	3.7	11.9	12.0	19.4	19.2	36.0	2.1	14.3	29.0	12.2	18.6	7.4	22.5	3.5	20.4	25.3	25.5	2.5	18.1	6.4	16.7	0.6	9.8	0.3	11.7	8.0	15.0	1.1	0.0	29.1	8.9	18.0	23.5	33.3	8.6	0.0	0.0	28.4	14.2	11.8	0.0	0.0	9.2	2.2	9.4	5.4	14.9	7.5	23.8	3.7	7.6	6.1	0.0	15.9	18.2	14.6	5.5	0.1	0.0	38.8	13.0	3.6	22.1	14.7	18.3	4.3	14.4	0.0	21.8	0.6	0.1	0.1	2.9	0.1	1.2	6.4	0.9	1.4	0.1	9.2	0.3	1.0	0.5	1.4	0.1	0.3	0.2	0.5	16.9	19.0	23.6	18.5	17.7	14.3	21.5	12.9	15.0	17.5	65.5	26.6	5.2	18.8	4.4	16.7	15.1	17.8	22.7	43.3	19.2	3.9	75.6	5.0	31.9	1.1	15.0	0.0	0.0	3.9	20.1	52.5	6.3	2.3	7.2	5.5	19.1	1.2	44.8	4.8	1.9	69.9	2.3	49.0	0.0	0.0	27.8	2.8	0.0	54.8	14.7	28.3	84.1	46.2	9.1	3.4	3.4	69.2	0.9	0.0	2.0
PEG10	"HB-1, KIAA1051, Mar2, Mart2, MEF3L, RGAG3, RTL2, SIRH1"	ENSG00000242265	"Paternally expressed 10"	Q86TG7	7	94656325-94669695	"Predicted intracellular proteins"	"Apoptosis, Differentiation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 67.5;brain: 143.8;pituitary gland: 102.6;placenta: 171.4"	"Group enriched"	"Detected in many"	13	"Cytotrophoblasts: 1669.7;Syncytiotrophoblasts: 2388.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 143.8"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.1;naive B-cell: 2.6;NK-cell: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 95.0;HAP1: 123.3;Hep G2: 95.0;SCLC-21H: 60.4"	"Region enhanced"	"Detected in many"		"hypothalamus: 130.3"	"Low region specificity"	"Detected in all"			"HPA021324, HPA029915, HPA051038"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA021324: AB_1855181, HPA029915: AB_2673250, HPA051038: AB_2630372"	"unprognostic (1.03e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-3)"	"unprognostic (9.70e-3)"	"unprognostic (2.61e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.48e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.40e-2)"	2.3	67.5	32.0	2.1	143.8	1.4	10.6	25.6	16.8	4.2	2.1	7.4	0.0	1.5	3.3	1.9	2.0	5.1	2.4	1.8	21.0	47.0	4.0	2.0	7.3	2.9	13.1	21.3	27.0	5.4	2.3	102.6	171.4	27.4	2.2	1.9	1.8	4.3	2.2	1.9	1.4	1.6	2.6	14.4	1.8	2.1	19.8	11.1	1.5	5.4	0.0	2.3	1.8	1.0	2.6	0.0	0.0	0.0	2.7	0.7	0.2	2.6	13.4	95.0	40.1	2.0	3.6	5.5	7.3	4.3	5.2	7.1	22.3	4.4	0.2	0.2	8.4	10.8	0.8	123.3	5.2	7.3	0.3	13.0	0.0	15.3	95.0	1.5	15.1	0.0	8.0	1.7	13.0	9.0	4.6	3.1	0.0	0.0	29.8	10.2	0.6	0.0	0.0	43.5	2.2	8.5	5.7	30.4	7.9	23.9	9.9	60.4	3.4	0.0	2.0	7.2	24.9	12.9	0.0	0.0	4.2	0.2	0.5	5.5	8.0	5.3	11.8	9.4	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.7	0.0	2.6	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.2	32.0	143.8	25.6	14.4	21.0	47.0	13.1	21.3	27.4	11.1	142.9	64.2	2.4	7.4	0.7	70.4	25.2	7.6	16.0	126.3	15.7	7.9	1669.7	54.7	10.7	2.8	2.4	0.0	0.0	4.3	85.1	27.1	7.0	2.3	2.9	150.9	35.0	58.0	2.5	0.0	11.4	8.3	1.4	13.5	0.0	0.7	118.3	4.2	0.0	3.9	10.0	25.7	6.5	12.5	16.4	5.1	0.6	2388.4	0.5	0.1	0.6
PPP1R9A	"FLJ20068, KIAA1222, Neurabin-I"	ENSG00000158528	"Protein phosphatase 1 regulatory subunit 9A"	Q9ULJ8	7	94907202-95296415	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 109.7;Rod photoreceptor cells: 85.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 5.8;NK-cell: 10.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 5.8;NK-cells: 10.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 10.5;RH-30: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027726, HPA075591"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA027726: AB_1855653, HPA075591: AB_2732296"	"unprognostic (1.05e-1)"	"unprognostic (6.59e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (7.17e-4)"	"unprognostic (2.26e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (8.63e-6)"	"unprognostic (2.74e-1)"	"unprognostic (4.85e-2)"	"unprognostic (8.47e-2)"	"unprognostic (8.79e-3)"	2.9	11.7	11.0	1.9	23.5	0.8	8.1	10.9	19.7	5.2	8.7	7.4	7.7	3.0	5.4	9.2	3.2	9.6	4.4	8.2	11.5	9.7	8.2	1.1	6.4	0.9	8.1	13.7	5.0	14.3	16.5	15.5	4.5	12.7	4.2	6.8	5.7	14.2	5.3	6.7	1.1	3.0	5.1	9.1	3.2	6.2	10.0	11.2	0.0	10.9	1.3	1.0	4.2	1.4	1.3	0.3	5.8	0.1	10.9	0.2	0.2	0.0	9.4	6.0	6.7	0.0	0.0	4.8	0.4	0.1	0.9	0.7	5.2	3.1	0.0	8.0	0.4	0.6	0.0	10.5	0.0	1.2	0.0	4.0	9.6	3.8	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.7	4.0	0.1	0.0	4.9	4.3	1.7	0.0	10.5	0.0	9.8	7.8	6.4	6.6	0.0	0.8	1.3	3.9	2.0	0.0	0.0	0.1	3.9	0.1	3.4	6.4	9.2	0.0	0.1	0.0	0.7	5.8	0.0	0.5	0.0	0.0	0.2	0.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	10.9	0.1	0.3	0.0	0.2	11.0	23.5	10.9	18.3	11.5	9.7	8.1	13.7	12.7	11.2	38.7	49.4	0.0	0.8	0.3	51.3	109.7	7.6	33.5	26.1	45.4	53.0	16.9	3.3	20.0	13.6	2.2	8.8	0.0	6.1	2.0	1.4	8.0	5.7	1.3	1.5	1.6	37.3	8.0	0.0	12.2	2.3	0.4	6.8	0.0	13.4	56.5	7.0	10.5	0.7	6.2	85.0	0.0	3.1	18.2	10.2	0.6	27.7	0.0	16.4	1.0
PON1	"ESA, PON"	ENSG00000005421	"Paraoxonase 1"	P27169	7	95297676-95324707	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"liver: 144.1"	"Cell type enriched"	"Detected in some"	47	"Hepatocytes: 399.2"	"Cancer enriched"	"Detected in some"	78	"liver cancer: 97.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 1.5;HeLa: 1.0;RH-30: 1.0;U-266/70: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA001610	Approved				"Secreted to blood"	NA	NA	96000000000	24000000000			"HPA001610: AB_1079656"	"unprognostic (2.02e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.70e-1)"		"prognostic favorable (7.24e-7)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.97e-2)"	"unprognostic (6.74e-9)"	"unprognostic (1.09e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.54e-3)"	0.0	1.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	144.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.0	1.0	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.4	0.0	0.2	0.0	1.0	0.0	0.0	0.3	0.6	0.1	0.0	0.3	0.0	0.2	0.4	0.0	0.5	0.0	0.1	0.0	0.2	1.0	0.3	0.0	0.0	0.2	0.3	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.0	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.0	399.2	0.0	0.0	2.9	8.0	8.6	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0
PON3		ENSG00000105852	"Paraoxonase 3"	Q15166	7	95359944-95396368	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 148.0"	"Cell type enriched"	"Detected in many"	14	"Hepatocytes: 460.4"	"Group enriched"	"Detected in many"	9	"liver cancer: 30.8;lung cancer: 7.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"NK-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"A549: 20.2;CACO-2: 6.5;CAPAN-2: 4.9;Hep G2: 22.4;T-47d: 12.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA014848, CAB025250"	Enhanced				"Secreted to blood"	NA	NA	1760000000	350000000			"CAB025250: , HPA014848: AB_1855540"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.28e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.44e-3)"	"unprognostic (9.14e-2)"	"unprognostic (7.18e-3)"	"unprognostic (8.30e-9)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (5.12e-2)"	0.4	0.7	0.3	0.1	0.6	0.0	6.9	0.2	0.5	0.9	1.0	0.3	2.3	1.5	0.2	1.2	0.2	0.4	0.7	0.4	0.7	0.3	0.7	148.0	4.0	0.0	0.4	0.2	2.4	7.1	0.0	15.5	0.2	0.5	0.2	0.4	0.8	21.4	5.5	0.1	1.8	1.7	0.1	0.3	0.2	0.5	3.6	0.4	0.4	1.5	0.0	1.1	0.5	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.2	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	4.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	12.6	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.5	0.7	0.3	0.4	0.2	0.5	0.4	6.0	32.1	1.4	0.7	0.8	0.0	0.3	25.5	8.1	14.8	3.5	0.0	1.5	1.7	0.2	9.0	0.5	4.0	0.0	1.8	1.9	2.6	2.2	0.0	460.4	0.2	0.0	0.0	8.6	7.0	3.6	7.5	0.0	13.5	0.0	2.3	3.0	1.5	0.0	2.8	5.2	0.0	0.0	0.1	17.7	13.6	1.1	1.1	0.5	2.3	0.3
PON2		ENSG00000105854	"Paraoxonase 2"	Q15165	7	95404863-95435329	"Candidate cardiovascular disease genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 81.0"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 257.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"myeloid DC: 22.1"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 22.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025430, HPA029193"	Enhanced				"Secreted to blood"	NA	NA		350000000			"CAB025430: , HPA029193: AB_10602148"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.43e-5)"	"unprognostic (3.80e-1)"	"unprognostic (4.14e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.19e-3)"	"unprognostic (9.87e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (4.30e-8)"	"unprognostic (1.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.99e-3)"	"unprognostic (2.56e-1)"	17.0	42.2	54.1	7.5	59.1	3.3	23.1	25.4	52.2	16.5	24.0	29.7	7.4	28.2	16.6	22.7	10.2	15.0	18.9	13.1	57.2	31.4	23.9	81.0	33.1	4.5	41.4	31.0	10.6	7.2	10.9	15.0	34.3	34.8	14.7	31.1	9.9	8.5	17.2	4.3	19.4	19.1	18.4	44.2	7.3	8.8	9.6	40.1	1.8	13.6	5.1	11.2	13.7	8.1	0.9	22.1	0.5	5.2	5.0	3.5	3.0	9.6	60.7	49.4	26.7	6.9	15.3	13.9	19.8	23.2	15.4	16.8	13.7	22.2	0.0	27.8	19.5	29.6	6.5	9.0	15.2	17.6	0.1	11.8	4.9	36.5	45.2	11.0	0.0	6.8	22.1	17.6	8.3	11.3	31.6	31.9	0.0	3.2	0.2	45.4	8.8	0.0	5.4	9.7	25.9	14.1	0.0	23.3	2.3	47.7	7.6	3.4	10.6	28.2	31.5	19.0	29.8	9.3	3.2	34.7	23.2	16.9	7.8	19.0	5.2	6.0	0.0	21.7	4.5	30.2	0.0	5.2	0.5	3.5	2.6	3.1	0.9	1.3	3.2	22.1	0.4	1.9	2.4	0.0	5.0	1.2	5.3	0.6	3.0	54.1	59.1	25.4	34.3	57.2	31.4	41.4	31.0	34.8	40.1	119.1	85.8	10.2	37.2	14.9	3.9	25.4	71.4	37.5	67.1	80.3	0.0	66.3	8.3	132.9	1.4	51.7	71.3	70.0	44.3	257.9	23.1	23.4	13.9	127.1	35.6	36.5	12.1	36.8	21.8	2.0	15.0	30.4	106.3	20.8	37.6	174.2	71.8	87.7	20.5	39.6	7.9	19.4	40.1	1.9	5.5	14.1	42.1	9.2	65.6	18.4
ASB4	ASB-4	ENSG00000005981	"Ankyrin repeat and SOCS box containing 4"	Q9Y574	7	95478444-95540232	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"adrenal gland: 28.6;pituitary gland: 40.1;skeletal muscle: 20.7"	"Cell type enhanced"	"Detected in some"	11	"Cardiomyocytes: 2.4;Ciliated cells: 2.7;Early spermatids: 1.9;Late spermatids: 1.6"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.2"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 7.0;Hep G2: 11.4;SCLC-21H: 7.2"	"Group enriched"	"Detected in some"	4	"basal ganglia: 10.0;hypothalamus: 37.1"	"Region enriched"	"Detected in single"	7	"midbrain: 3.7"	HPA055240	Uncertain					NA	NA					"HPA055240: AB_2682753"	"unprognostic (1.41e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.24e-1)"	"unprognostic (9.13e-7)"	"unprognostic (1.71e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.23e-2)"	0.3	28.6	0.7	0.1	1.1	0.3	0.2	0.1	1.3	0.1	0.1	1.3	0.1	0.2	0.1	0.3	0.1	0.2	0.4	2.6	0.7	0.6	0.1	1.0	0.4	0.1	1.7	0.5	0.1	0.4	0.0	40.1	1.3	0.2	0.2	0.0	0.1	0.3	0.1	20.7	0.2	0.2	0.1	1.6	0.1	0.4	0.2	0.1	0.2	0.2	2.5	0.4	0.1	0.1	1.0	0.6	1.3	0.3	0.9	0.7	0.0	0.3	7.0	0.3	2.5	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.8	1.3	0.2	0.1	0.2	0.2	0.3	0.0	0.0	0.0	0.2	0.2	0.1	0.5	11.4	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.1	0.3	0.1	0.6	0.0	0.2	0.2	0.3	0.2	0.2	1.6	0.2	0.2	0.0	0.2	0.2	7.2	0.0	0.1	0.4	0.7	0.3	0.1	0.3	0.3	0.4	0.4	0.1	0.2	0.8	0.2	0.4	0.2	0.4	0.2	0.3	0.3	0.5	0.6	0.1	0.7	1.0	0.6	0.5	0.2	1.0	0.7	0.7	1.3	0.9	0.3	0.6	0.3	0.0	0.7	1.1	0.1	1.3	0.7	0.6	1.7	0.5	0.2	0.1	0.0	0.3	0.0	0.1	0.1	0.0	2.4	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.0	0.0
PDK4		ENSG00000004799	"Pyruvate dehydrogenase kinase 4"	Q16654	7	95583499-95596491	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 351.0;skeletal muscle: 497.0"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 766.1;Collecting duct cells: 359.4;Kupffer cells: 351.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 107.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"classical monocyte: 14.2;eosinophil: 15.6;intermediate monocyte: 26.1;myeloid DC: 7.1;non-classical monocyte: 15.6"	"Group enriched"	"Detected in many"	11	"dendritic cells: 7.1;granulocytes: 15.6;monocytes: 26.1"	"Cell line enriched"	"Detected in some"	7	"ASC diff: 107.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056731	Approved					NA	NA					"HPA056731: AB_2683218"	"unprognostic (3.18e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.47e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.87e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (9.15e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.12e-1)"	90.7	41.9	6.9	5.9	14.6	0.4	49.1	2.5	9.1	12.3	30.9	9.0	150.6	13.6	10.7	13.7	29.0	14.7	15.6	351.0	9.2	3.7	27.7	39.5	14.1	6.1	18.2	2.4	46.6	102.9	0.8	8.1	19.4	26.1	29.3	8.4	4.4	8.4	150.6	497.0	10.2	46.2	20.7	13.9	19.0	21.2	10.8	17.4	1.0	13.4	12.3	2.5	23.8	46.4	0.7	7.1	15.6	26.1	1.4	0.0	4.7	0.0	8.0	0.3	2.0	107.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.7	0.0	1.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.1	0.5	0.1	0.6	0.0	0.6	1.6	0.5	0.2	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	14.2	15.6	0.0	26.1	0.0	0.1	0.0	0.0	7.1	0.7	0.0	0.0	1.0	1.4	15.6	0.2	0.0	4.7	6.9	14.6	2.5	9.1	9.2	3.7	18.2	2.4	26.1	17.4	29.8	13.6	12.6	245.0	9.3	0.0	766.1	28.1	96.4	52.4	359.4	0.0	2.7	11.6	4.3	10.2	89.9	112.9	0.0	4.7	0.7	44.7	113.9	4.7	93.7	42.3	0.0	53.1	160.8	351.0	2.5	124.3	29.1	86.0	1.8	47.0	11.6	8.2	42.1	42.1	35.5	0.3	161.7	181.3	0.2	0.5	8.2	9.2	5.7	27.3	131.1
DYNC1I1	"DNCI1, DNCIC1"	ENSG00000158560	"Dynein cytoplasmic 1 intermediate chain 1"	O14576	7	95772506-96110322	"Predicted intracellular proteins"	Transport	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.0"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 40.0;Cardiomyocytes: 28.5;Cone photoreceptor cells: 47.1;Muller glia cells: 109.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 14.2;SH-SY5Y: 10.5;SuSa: 8.1;U-266/84: 8.9;WM-115: 9.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061689	Enhanced	Supported				NA	NA					"HPA061689: AB_2684586"	"unprognostic (2.61e-1)"	"unprognostic (4.58e-2)"	"unprognostic (3.83e-2)"	"prognostic favorable (3.79e-4)"	"unprognostic (6.27e-2)"	"unprognostic (2.11e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.24e-4)"	"unprognostic (2.25e-4)"	"unprognostic (1.63e-1)"	"unprognostic (7.81e-4)"	"unprognostic (1.10e-2)"	3.1	16.5	15.6	2.9	20.3	2.3	3.6	34.3	62.0	3.1	7.9	5.2	1.2	2.8	3.8	7.3	5.3	2.6	3.5	21.6	29.2	23.1	3.6	1.6	2.3	2.1	25.8	26.5	10.7	3.6	2.0	17.2	2.2	27.3	10.3	4.9	9.5	2.7	11.3	4.2	4.0	2.5	17.1	18.8	2.8	3.3	3.9	7.4	0.0	3.6	0.0	1.9	10.5	3.6	0.8	2.7	4.7	1.1	2.1	1.0	0.6	0.4	0.3	0.2	1.3	0.2	0.1	0.5	0.2	0.0	0.7	0.2	1.7	1.1	0.5	14.2	1.9	1.1	0.6	4.9	0.3	0.3	0.1	1.1	3.4	0.5	0.0	0.2	0.4	4.6	0.2	0.3	0.3	0.6	0.6	0.3	2.0	0.6	0.5	2.2	3.1	0.4	0.6	0.9	0.3	2.9	0.8	0.4	1.9	1.8	1.6	1.9	10.5	0.1	0.2	2.2	8.1	1.0	0.8	0.4	4.1	2.9	2.2	2.2	7.3	8.9	0.4	4.7	0.5	9.1	1.5	1.1	0.6	1.0	0.6	0.5	0.7	0.5	0.4	0.2	0.8	0.7	0.6	4.7	2.1	0.3	2.7	0.6	0.6	15.6	20.3	34.3	30.4	29.2	23.1	25.8	26.5	27.3	7.4	0.0	0.0	0.0	1.0	0.7	40.0	28.5	0.0	0.0	0.0	0.0	47.1	1.2	0.0	0.3	4.6	2.9	0.0	0.0	0.9	0.1	1.0	0.6	0.0	0.6	0.5	1.6	1.7	9.2	0.3	3.6	17.5	0.2	20.3	0.0	0.0	109.5	0.6	0.0	11.0	0.0	22.8	6.5	10.8	0.5	3.1	1.0	0.1	0.0	0.0	0.5
SLC25A13	"ARALAR2, CITRIN, CTLN2"	ENSG00000004864	"Solute carrier family 25 member 13"	Q9UJS0	7	96120220-96322147	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 79.1"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 124.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018997	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA018997: AB_1857023"	"unprognostic (3.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (9.14e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.32e-1)"	"unprognostic (7.09e-2)"	7.7	10.3	4.2	4.9	11.8	4.1	6.7	3.0	7.5	5.4	12.5	21.1	15.6	8.9	5.1	8.0	6.9	5.9	6.7	4.5	5.6	5.3	17.7	79.1	5.5	4.9	14.5	4.8	5.9	7.3	8.2	8.8	8.9	12.4	5.9	10.2	12.6	5.7	17.3	4.6	8.2	9.7	5.0	13.1	7.2	7.9	4.3	12.6	1.8	7.9	3.0	4.8	5.0	5.3	3.7	8.9	3.1	6.7	2.8	2.4	2.1	16.1	14.3	16.5	5.7	2.8	2.3	23.2	4.1	3.1	10.0	10.1	25.6	15.2	7.3	19.6	2.6	21.8	9.7	18.5	5.9	11.8	2.8	12.2	8.3	13.5	19.9	6.7	10.5	6.5	6.1	6.3	8.5	7.7	3.8	11.4	1.1	23.3	2.8	4.8	17.8	0.0	9.8	29.1	17.3	8.9	4.1	9.8	16.8	23.8	15.3	7.9	26.0	14.2	30.2	24.3	28.7	9.0	8.1	6.6	7.4	16.6	17.5	12.4	5.7	14.3	4.6	9.1	10.1	12.2	0.6	4.6	3.1	2.2	6.3	2.4	3.7	1.8	2.0	8.9	2.0	1.2	1.5	0.8	2.8	6.7	4.7	1.8	2.1	4.2	11.8	3.0	7.5	5.6	5.3	14.5	4.8	12.4	12.6	8.9	9.3	10.5	6.9	6.5	34.3	7.1	38.2	14.7	6.8	17.4	51.1	25.9	23.2	17.3	9.5	16.9	23.5	0.0	16.5	20.5	14.8	9.8	13.9	124.1	20.1	9.5	36.2	12.3	22.7	6.7	12.0	19.6	20.3	2.8	19.4	22.1	18.9	24.6	14.9	50.8	47.6	12.9	8.3	5.4	9.1	6.9	16.7	5.7	23.3	12.2
SEM1	"C7orf76, DSS1, ECD, FLJ42280, SHFD1, Shfdg1, SHFM1, SHSF1"	ENSG00000127922	"SEM1, 26S proteasome complex subunit"	"P60896, Q6ZVN7"	7	96481626-96709891	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 543.9;Exocrine glandular cells: 464.8;Extravillous trophoblasts: 599.1;Syncytiotrophoblasts: 729.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020429, HPA072648"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA020429: AB_1859527, HPA072648: AB_2686543"	"unprognostic (5.41e-3)"	"unprognostic (6.25e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.24e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (2.52e-4)"	"unprognostic (4.55e-1)"	"unprognostic (6.92e-2)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (8.00e-5)"	44.1	58.5	33.3	38.6	48.7	23.1	29.0	25.0	36.3	29.6	48.4	16.8	44.0	41.5	33.5	44.1	45.4	24.0	29.5	69.9	34.8	27.9	34.7	91.6	24.3	28.2	31.7	31.8	45.7	43.6	14.8	51.2	63.5	32.2	32.2	27.8	22.0	43.4	34.5	109.5	34.2	39.0	42.1	43.8	25.0	40.0	52.5	28.8	28.8	28.7	61.8	28.0	31.5	34.0	50.6	94.9	36.7	65.7	42.0	79.0	48.9	63.4	37.5	52.3	54.3	22.4	19.5	28.2	51.9	25.5	21.9	27.4	33.9	52.8	41.9	129.0	25.2	67.7	32.9	43.7	35.0	31.1	48.7	33.0	50.2	55.2	52.6	20.5	74.2	37.6	24.8	27.5	32.7	33.5	34.3	29.2	50.4	65.0	51.8	22.2	80.4	83.8	105.3	70.7	64.4	34.3	32.6	67.4	49.5	31.0	63.2	43.1	54.5	96.9	81.4	52.8	83.8	23.2	56.6	60.0	43.2	75.2	79.8	64.7	32.6	87.4	121.2	47.2	65.6	59.4	36.7	61.3	15.8	45.5	65.7	43.2	50.6	59.3	53.1	86.3	45.3	46.9	47.2	4.1	42.0	55.4	94.9	79.0	48.9	33.3	48.7	25.0	36.3	34.8	27.9	31.7	31.8	32.2	28.8	160.8	197.7	0.0	0.0	0.0	0.0	0.0	0.0	274.4	190.0	232.1	0.0	543.9	349.8	309.5	0.0	0.0	0.0	0.0	464.8	599.1	0.0	0.0	94.2	0.0	339.5	0.0	0.0	0.0	0.0	0.0	0.0	130.5	0.0	421.2	0.0	0.0	446.5	0.0	0.0	414.8	0.0	0.0	0.0	0.0	0.0	0.0	729.5	0.0	0.0	0.0
DLX6		ENSG00000006377	"Distal-less homeobox 6"	P56179	7	97005548-97011039	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 23.2;placenta: 11.3;testis: 10.4"	"Cell type enhanced"	"Detected in some"	20	"Cytotrophoblasts: 24.7;Extravillous trophoblasts: 48.9;Sertoli cells: 12.9;Syncytiotrophoblasts: 14.5"	"Cancer enriched"	"Detected in many"	8	"endometrial cancer: 12.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 23.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.3;BEWO: 24.3;HAP1: 10.9;SH-SY5Y: 8.0;SuSa: 14.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"olfactory region: 44.2"	"HPA030608, HPA061460"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA030608: AB_10600867, HPA061460: AB_2684529"	"unprognostic (7.50e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.06e-2)"	"unprognostic (8.16e-2)"	"unprognostic (3.05e-1)"		"unprognostic (4.32e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.86e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.12e-7)"	"unprognostic (5.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.58e-2)"	"unprognostic (8.12e-2)"	0.9	0.4	1.8	0.3	23.2	0.9	0.4	0.3	6.1	5.7	0.6	0.5	0.0	0.4	7.0	2.4	0.3	1.5	0.3	0.5	3.9	2.6	0.4	0.3	0.3	1.0	0.5	2.8	0.9	0.3	0.4	0.4	11.3	0.0	0.7	0.3	0.0	1.7	2.5	0.5	1.6	0.3	0.9	0.3	0.5	0.4	10.4	4.2	0.1	0.7	0.0	0.8	0.9	0.6	0.4	0.6	1.5	0.7	0.5	0.7	0.3	0.0	0.0	0.0	7.3	0.0	0.0	24.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.4	0.0	0.0	1.3	10.9	0.0	0.0	0.0	2.8	0.0	4.1	4.9	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.8	1.1	0.0	0.0	0.0	0.0	1.5	5.3	8.0	0.7	0.0	0.2	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.7	0.8	0.6	1.1	0.5	0.6	0.2	0.3	0.5	0.4	0.4	0.3	0.3	0.4	0.7	0.6	1.5	0.5	0.7	0.6	0.5	0.3	1.8	23.2	0.3	6.1	3.9	2.6	0.5	2.8	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.0	9.5	0.0	0.0	0.0	0.0	48.9	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	12.9	0.0	1.7	7.1	0.0	14.5	0.0	0.0	0.1
DLX5		ENSG00000105880	"Distal-less homeobox 5"	P56178	7	97020392-97024950	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Osteogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 17.7;placenta: 44.5;skin 1: 20.6"	"Cell type enhanced"	"Detected in some"	19	"Cytotrophoblasts: 128.5;Extravillous trophoblasts: 203.8;Sertoli cells: 58.2;Syncytiotrophoblasts: 263.3"	"Cancer enriched"	"Detected in many"	11	"endometrial cancer: 81.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 32.9;HAP1: 16.5;SuSa: 8.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 13.5;olfactory region: 36.5"	"Region enhanced"	"Detected in many"		"olfactory region: 24.3"	HPA005670	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA005670: AB_1078681"	"unprognostic (3.99e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.43e-8)"	"unprognostic (1.39e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.55e-1)"	1.5	0.6	2.7	0.5	11.5	0.3	1.5	0.1	3.9	10.0	0.6	0.3	1.4	0.7	17.7	1.7	5.8	2.0	0.8	1.2	2.2	4.5	0.4	0.2	0.4	1.9	0.5	2.5	2.1	0.2	0.4	1.9	44.5	0.0	1.8	0.3	0.1	3.6	3.9	0.6	20.6	0.3	1.4	0.2	0.3	0.3	1.2	3.1	2.5	1.6	6.5	2.7	1.5	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	32.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	3.7	16.5	0.0	0.0	0.0	2.8	0.0	0.3	0.2	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	2.1	0.9	1.3	0.1	0.0	0.0	8.6	0.0	0.0	0.0	1.0	0.2	0.2	0.0	0.0	0.0	0.0	2.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	11.5	0.1	3.9	2.2	4.5	0.5	2.5	0.0	3.1	0.0	0.0	0.0	0.7	8.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	128.5	0.0	0.0	0.1	0.5	0.0	0.0	0.0	203.8	2.2	1.1	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	58.2	7.1	1.8	6.0	18.1	263.3	0.0	0.0	1.4
SDHAF3	"ACN9, DC11, LYRM10, Sdh7"	ENSG00000196636	"Succinate dehydrogenase complex assembly factor 3"	Q9NRP4	7	97116590-97181763	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 126.0;Proximal tubular cells: 122.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 32.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020515, HPA020523"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA020515: , HPA020523: AB_2670464"	"unprognostic (3.94e-2)"	"unprognostic (9.11e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.61e-2)"	"unprognostic (9.60e-3)"	"unprognostic (3.21e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.07e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.34e-1)"	"unprognostic (8.45e-2)"	8.2	16.0	11.8	11.6	12.0	11.4	9.6	5.4	15.5	6.7	12.3	7.9	11.1	15.2	8.3	11.8	12.0	8.8	12.5	22.0	11.3	12.8	17.6	20.1	10.2	14.6	12.9	11.5	7.4	16.2	5.8	13.7	5.8	16.6	8.4	12.8	9.4	16.8	12.4	18.3	9.7	13.2	9.8	15.7	11.5	12.1	14.9	9.6	15.6	14.6	11.2	8.7	9.6	7.9	12.0	25.9	11.3	8.7	6.4	15.0	12.2	7.4	6.1	3.2	20.7	2.0	1.7	3.2	2.3	1.5	2.4	4.1	1.1	6.0	12.1	7.6	2.1	3.6	2.7	7.9	6.6	5.3	8.7	11.1	8.3	6.2	11.2	3.7	17.3	3.3	3.6	4.1	4.3	5.8	1.7	2.2	10.0	21.5	0.3	4.9	0.0	20.3	24.4	7.0	11.2	6.7	4.2	2.9	17.5	3.1	5.5	15.5	8.1	8.9	11.7	10.4	5.8	0.1	4.7	3.6	0.9	11.6	19.0	2.3	7.1	17.0	32.3	3.4	30.6	11.8	5.4	6.9	2.7	9.1	8.7	12.1	12.0	11.6	14.3	9.5	9.8	15.0	14.9	11.3	6.4	8.2	25.9	10.2	12.2	11.8	12.0	5.4	15.5	11.3	12.8	12.9	11.5	16.6	9.6	17.9	8.4	34.0	19.4	0.0	13.1	32.7	25.5	29.4	12.5	24.4	3.9	33.2	126.0	25.1	89.5	10.1	4.6	0.0	33.8	22.6	9.5	17.7	4.7	49.5	26.9	9.5	12.9	17.8	19.4	10.2	21.0	16.4	0.0	4.6	30.6	28.6	20.6	35.1	23.3	122.5	16.9	32.3	12.2	18.4	51.7	0.0	8.0	25.9	48.7	19.2
TAC1	"NKNA, NPK, TAC2"	ENSG00000006128	"Tachykinin precursor 1"	P20366	7	97731908-97740472	"Predicted secreted proteins"		"Neuropeptide, Neurotransmitter"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 61.3;lymphoid tissue: 62.9"	"Group enriched"	"Detected in some"	7	"Cholangiocytes: 7.6;Glandular cells: 3.3;Proximal tubular cells: 8.4;Smooth muscle cells: 2.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 61.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"U-266/70: 22.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 557.4"	"Region enriched"	"Detected in many"	9	"basal ganglia: 312.7"	HPA014429	Enhanced				"Secreted to blood"	NA	NA					"HPA014429: AB_1857722"	"unprognostic (9.24e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"					"unprognostic (2.08e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.86e-2)"	1.8	6.5	4.1	7.7	61.3	0.3	1.7	0.3	39.8	0.7	3.7	0.1	0.0	6.0	0.9	1.6	0.3	0.7	4.9	0.5	9.3	21.5	1.6	0.6	0.3	0.3	8.0	4.5	0.3	0.7	0.3	0.3	0.3	24.5	1.0	2.9	0.3	4.5	2.0	0.4	1.2	7.6	5.3	6.7	62.9	0.9	0.6	9.4	0.0	1.6	0.0	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	61.3	0.3	9.2	9.3	21.5	8.0	4.5	24.5	9.4	0.0	0.0	0.0	0.0	0.3	0.0	0.2	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	8.4	0.0	0.0	2.1	0.1	0.4	0.1	0.0	0.0	0.5	0.1
ASNS		ENSG00000070669	"Asparagine synthetase (glutamine-hydrolyzing)"	P08243	7	97852118-97872542	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Asparagine biosynthesis"	Ligase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 68.0"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 197.3;Erythroid cells: 93.5;Late spermatids: 147.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 8.6;T-cells: 13.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004924, HPA029318, HPA064737"	Approved		Enhanced	Cytosol		No	No			Cytosol		"HPA004924: AB_2667295, HPA029318: AB_10602389, HPA064737: AB_2685341"	"unprognostic (3.93e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.70e-2)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (8.79e-5)"	"prognostic unfavorable (9.42e-6)"	"unprognostic (2.28e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (6.21e-7)"	"unprognostic (5.33e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.33e-1)"	6.5	7.5	15.9	10.9	21.4	7.6	9.9	31.7	32.3	5.7	10.1	9.4	5.6	6.5	10.0	19.9	10.2	6.9	6.8	9.2	24.5	20.4	6.5	5.9	9.6	16.0	16.3	13.4	19.2	68.0	16.7	16.7	3.2	35.9	9.2	12.7	4.4	49.9	9.3	3.5	13.6	7.8	11.3	20.6	11.0	20.8	16.9	9.2	3.6	16.7	8.2	15.0	9.6	6.6	8.6	1.4	1.5	1.2	2.2	13.2	3.2	19.0	7.3	7.4	60.1	5.9	8.3	18.1	14.1	9.0	6.7	20.2	9.4	7.6	15.0	7.1	28.7	14.0	8.7	19.1	22.3	16.1	18.7	14.1	4.8	3.7	7.0	54.3	30.6	13.5	16.3	75.0	8.8	54.5	3.6	5.5	14.1	26.8	53.3	10.6	40.3	0.9	8.1	10.1	45.6	20.0	2.3	1.4	39.3	4.3	3.7	32.3	24.3	3.6	19.6	76.0	9.9	8.3	21.5	1.4	3.3	22.1	8.8	6.6	63.1	31.5	57.1	41.8	13.9	32.1	1.5	0.3	0.5	3.8	1.2	4.9	8.6	7.4	3.4	1.4	6.2	10.2	5.5	1.5	2.2	0.8	0.1	13.2	3.2	15.9	21.4	31.7	32.3	24.5	20.4	16.3	13.4	35.9	9.2	8.9	4.5	3.7	18.8	11.0	20.1	5.9	12.7	1.4	3.4	8.7	23.6	2.0	6.6	34.4	197.3	3.1	1.7	93.5	52.9	7.7	6.6	17.6	8.1	1.6	1.0	23.8	23.4	2.5	0.6	147.0	8.9	1.8	8.5	11.8	12.9	8.5	38.4	11.9	8.9	3.1	25.4	6.5	12.3	2.3	7.0	9.5	4.7	13.3	7.9	15.2
OCM2		ENSG00000135175	"Oncomodulin 2"	P0CE71	7	97984684-97991169	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in single"		"testis: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"WM-115: 1.7"									"HPA046422, HPA052483"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA046422: AB_2679659, HPA052483: "																		0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.6		0.0	0.0		0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	1.4			0.0		0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LMTK2	"AATYK2, BREK, cprk, KIAA1079, KPI-2, KPI2, LMR2, PPP1R100"	ENSG00000164715	"Lemur tyrosine kinase 2"	Q8IWU2	7	98106885-98209633	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010657, HPA041836"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Nuclear speckles, Centriolar satellite"	"Plasma membrane, Cytosol"	"HPA010657: AB_1079259, HPA041836: AB_2677698"	"unprognostic (7.36e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.96e-1)"	"prognostic unfavorable (8.03e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.65e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (1.88e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.16e-2)"	"unprognostic (6.38e-3)"	5.1	10.3	13.7	5.6	21.3	17.3	5.6	16.6	34.3	7.3	13.8	6.1	5.6	12.6	6.1	6.3	12.7	6.4	7.9	16.9	11.0	10.1	10.1	8.5	10.0	5.1	7.5	18.9	8.0	21.0	22.2	10.0	4.8	13.2	7.9	11.8	5.4	10.5	6.5	17.5	11.5	13.8	5.7	5.5	6.8	9.4	8.0	6.9	7.2	8.7	5.7	7.4	8.3	8.1	0.6	0.7	4.8	0.9	0.3	1.6	0.5	9.8	11.6	9.0	9.2	4.8	3.9	8.4	4.1	4.5	4.0	4.9	9.1	9.0	5.2	11.8	5.2	15.3	10.8	10.4	6.3	6.3	7.4	7.3	3.5	10.4	9.1	5.9	6.2	6.3	2.6	8.7	8.3	11.3	4.1	6.0	6.0	9.1	10.9	3.6	13.3	6.6	3.7	11.0	13.5	5.7	7.2	6.1	10.2	6.7	17.3	6.5	12.9	8.2	15.0	6.0	9.5	4.1	2.5	7.3	8.4	13.8	16.8	9.3	4.9	8.5	10.3	5.7	4.9	10.0	1.2	0.6	0.5	0.8	0.3	0.5	0.6	0.9	0.9	0.3	0.6	1.1	1.6	4.8	0.3	0.9	0.7	0.8	0.5	13.7	21.3	16.6	34.3	11.0	10.1	7.5	18.9	13.2	6.9	26.8	10.5	0.0	4.2	8.7	14.0	18.7	17.8	10.7	9.1	1.8	13.7	2.3	1.7	5.0	0.8	3.1	26.2	0.0	7.9	1.6	3.5	6.2	2.3	6.8	1.8	6.4	11.5	3.1	2.6	2.1	1.7	2.3	1.7	0.0	13.5	5.8	8.6	13.1	4.2	2.4	9.9	0.0	3.8	6.3	4.7	9.5	2.5	2.9	12.6	13.2
BHLHA15	"bHLHa15, BHLHB8, MIST1"	ENSG00000180535	"Basic helix-loop-helix family member a15"	Q7RTS1	7	98211427-98212979	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"pancreas: 145.8;salivary gland: 95.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"prostate cancer: 16.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"memory B-cell: 1.7"	"Lineage enriched"	"Detected in single"	7	"B-cells: 1.7"	"Group enriched"	"Detected in some"	8	"Karpas-707: 17.1;RPMI-8226: 31.7;U-266/70: 37.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB034083, HPA047834"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"CAB034083: AB_2065216, HPA047834: AB_2680172"	"unprognostic (2.80e-2)"	"unprognostic (9.45e-3)"	"unprognostic (8.10e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.10e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.60e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.70e-4)"	"unprognostic (3.36e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.95e-1)"	"unprognostic (8.25e-3)"	0.1	0.1	0.2	0.8	0.2	0.0	0.1	0.1	0.2	0.3	1.2	0.0	3.5	0.9	0.1	0.1	0.4	0.1	0.8	0.1	0.3	0.2	0.3	4.7	0.5	1.8	0.1	0.0	0.0	145.8	0.0	0.4	0.0	0.0	1.6	0.1	0.0	95.2	6.8	0.4	0.2	0.8	0.0	0.1	1.9	6.2	0.1	0.0	0.0	0.2	1.2	2.7	0.4	0.1	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	1.7	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	17.1	0.0	0.3	0.0	0.0	0.5	1.2	0.5	0.2	0.0	31.7	0.0	0.0	1.9	0.7	0.0	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	37.9	2.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TECPR1	"DKFZP434B0335, FLJ23419, FLJ90593, KIAA1358"	ENSG00000205356	"Tectonin beta-propeller repeat containing 1"	Q7Z6L1	7	98214624-98252251	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 63.9"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 100.1;Rod photoreceptor cells: 66.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021061	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA021061: AB_1847687"	"unprognostic (8.10e-3)"	"unprognostic (7.89e-2)"	"unprognostic (9.05e-3)"	"unprognostic (5.00e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (8.12e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.24e-1)"	"unprognostic (9.46e-2)"	"unprognostic (6.12e-2)"	6.5	4.7	11.5	8.9	10.6	5.2	6.3	9.0	15.8	4.1	5.9	6.2	5.1	8.4	4.5	5.5	5.8	4.8	7.6	5.9	10.4	9.0	4.6	5.4	9.0	11.0	6.8	12.8	4.0	63.9	4.2	10.2	7.7	9.8	6.9	4.9	8.0	29.5	5.0	6.9	5.4	8.1	4.6	8.5	11.2	9.3	3.3	7.0	6.4	5.9	5.9	6.4	5.1	5.4	3.4	4.1	6.1	7.4	1.6	8.7	3.1	3.0	4.2	5.9	12.8	5.1	3.1	4.4	6.3	3.5	5.0	6.2	4.0	3.8	2.5	10.2	7.2	6.2	1.9	4.0	2.9	2.1	5.9	5.7	3.6	5.9	4.2	6.1	4.3	7.0	5.4	2.4	4.8	3.8	4.7	17.5	10.5	2.3	14.1	3.8	4.9	6.2	4.5	2.3	6.0	4.1	5.2	6.0	17.6	3.8	3.3	10.7	11.9	3.7	11.2	5.9	4.5	3.4	6.2	17.9	4.8	8.2	12.2	5.2	18.0	6.4	1.2	9.9	3.8	8.9	2.6	4.7	1.4	3.9	5.2	2.4	3.4	5.1	3.1	2.9	3.2	8.7	7.2	6.1	1.6	7.4	4.1	5.1	3.1	11.5	10.6	9.0	15.8	10.4	9.0	6.8	12.8	9.8	7.0	8.9	17.3	10.5	1.9	2.1	33.6	8.2	7.6	5.3	6.8	5.2	100.1	4.4	1.7	5.7	2.0	17.9	11.8	0.0	11.4	7.4	4.1	5.1	8.1	6.7	11.2	30.2	28.2	18.4	21.9	1.6	6.6	7.6	1.7	10.8	20.9	10.0	9.0	11.4	3.2	2.9	66.4	0.0	4.4	4.2	3.8	1.6	2.9	10.2	6.0	2.5
BRI3		ENSG00000164713	"Brain protein I3"	O95415	7	98252379-98310441	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 23.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042215	Uncertain					NA	NA					"HPA042215: AB_10794790"	"unprognostic (1.51e-2)"	"unprognostic (5.03e-2)"	"unprognostic (7.08e-3)"	"unprognostic (3.48e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (2.04e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.93e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.71e-1)"	41.4	40.9	15.2	17.2	18.2	40.4	97.1	6.9	16.6	22.2	41.1	12.9	16.7	32.5	21.5	22.6	29.6	17.5	25.7	57.2	14.1	13.6	38.5	56.4	56.6	51.1	14.6	11.3	27.5	56.7	6.4	26.7	59.8	14.0	33.4	18.0	38.3	45.9	15.9	86.0	20.5	53.3	28.7	14.8	52.8	41.6	29.3	12.9	11.7	35.9	21.5	13.3	29.2	38.5	0.6	5.5	23.5	12.9	0.1	1.4	1.4	26.3	4.2	7.8	10.0	50.1	22.8	18.7	22.1	25.6	18.5	25.0	3.4	12.5	2.7	46.4	39.4	59.3	9.2	9.8	14.0	12.5	9.2	11.3	1.8	3.2	5.8	49.3	2.0	9.0	17.9	19.7	15.7	28.3	25.6	22.3	3.3	5.3	17.8	34.6	1.8	5.9	6.6	9.6	18.1	11.7	5.9	4.3	8.9	17.7	2.0	6.5	13.4	5.8	23.2	54.3	14.0	2.5	13.4	22.1	36.3	21.3	47.7	17.1	19.0	25.0	7.0	42.1	9.2	19.1	1.2	8.1	11.9	0.5	12.9	0.7	0.5	0.5	0.6	3.9	0.6	0.8	0.7	23.5	0.1	11.8	5.5	1.4	1.4	15.2	18.2	6.9	16.6	14.1	13.6	14.6	11.3	14.0	12.9	77.4	99.5	48.3	226.1	130.0	81.0	100.5	140.1	21.4	33.0	127.4	31.4	104.6	482.4	36.9	537.3	139.8	186.1	46.7	101.1	380.4	110.9	370.7	22.0	237.2	602.5	122.3	75.3	167.0	284.1	88.1	92.9	261.8	158.6	20.8	159.0	187.7	78.8	188.1	114.2	526.3	66.9	109.9	138.1	49.1	54.1	149.8	141.7	34.1	116.0	410.5
BAIAP2L1	IRTKS	ENSG00000006453	"BAI1 associated protein 2 like 1"	Q9UHR4	7	98291651-98401068	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 91.6;Urothelial cells: 132.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 27.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA019484, HPA021257, HPA023874, HPA029503"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA019484: AB_1845265, HPA021257: AB_1845266, HPA023874: AB_1845267, HPA029503: AB_10602330"	"unprognostic (1.75e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.31e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.44e-1)"	4.7	11.2	1.3	16.9	1.1	0.0	10.3	0.3	0.9	6.1	27.3	1.1	10.8	16.2	3.6	4.7	17.9	6.8	29.6	2.1	0.7	0.6	8.9	31.0	15.4	0.9	0.8	0.2	2.6	47.4	4.7	16.9	17.0	1.2	15.2	12.5	6.5	14.7	12.3	3.3	11.3	34.0	3.4	0.7	1.4	33.0	11.6	0.4	2.1	18.0	11.2	14.1	18.9	12.9	1.3	2.7	0.1	0.2	0.0	0.9	0.1	15.8	12.6	0.3	0.3	0.0	0.5	21.2	4.1	2.7	2.1	1.6	17.5	23.8	0.6	6.2	1.5	18.3	14.1	5.9	17.4	1.9	0.0	7.6	0.0	5.4	9.9	2.6	0.0	5.7	0.6	23.5	1.2	17.3	4.8	0.0	0.0	9.4	0.0	1.8	13.3	0.0	0.0	10.0	22.9	6.8	0.0	0.2	2.5	13.5	14.0	9.1	1.8	9.5	27.7	4.8	14.3	7.7	0.3	0.5	3.2	15.4	0.6	1.8	0.3	4.7	8.0	0.3	2.0	4.9	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.3	0.0	1.3	0.9	0.2	0.1	0.0	0.2	2.7	0.1	0.1	1.3	1.1	0.3	0.9	0.7	0.6	0.8	0.2	1.2	0.4	11.9	19.3	0.0	43.5	14.8	0.6	1.9	28.1	37.5	28.4	21.0	3.9	10.1	8.3	49.7	27.7	7.5	49.7	0.0	67.4	67.3	2.9	91.6	0.0	13.0	2.2	1.6	30.9	0.0	0.8	35.9	0.9	1.5	8.5	4.6	43.9	1.3	82.9	31.7	0.7	0.8	0.8	0.0	4.3	29.0	49.5	16.9	10.2	0.0	28.5	132.5
NPTX2		ENSG00000106236	"Neuronal pentraxin 2"	P47972	7	98617297-98629868	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 24.0;brain: 45.6;pancreas: 19.5;pituitary gland: 71.6;testis: 20.7"	"Group enriched"	"Detected in many"	6	"Peritubular cells: 306.6;Sertoli cells: 148.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 1.5"	"Cell line enriched"	"Detected in some"	12	"LHCN-M2: 128.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB020801, HPA049799, HPA058320"	Enhanced		Approved	"Golgi apparatus,Actin filaments,Centrosome"	"Secreted to blood"	NA	NA	2490000	320000	"Golgi apparatus, Actin filaments"	Centrosome	"CAB020801: , HPA049799: AB_2680889, HPA058320: AB_2732621"	"unprognostic (1.18e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (1.91e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.42e-2)"	"unprognostic (6.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (5.46e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.69e-2)"	4.3	24.0	7.1	2.3	8.4	1.0	1.4	0.2	45.6	8.2	3.8	3.2	0.1	1.1	1.8	3.9	2.2	1.5	1.6	3.2	9.2	11.0	0.9	0.9	0.8	0.7	9.4	2.2	1.5	19.5	0.8	71.6	0.8	7.0	2.1	1.4	1.3	1.5	2.2	2.9	4.0	1.3	2.9	2.9	6.1	1.9	20.7	5.0	0.0	1.6	0.1	0.9	1.4	2.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.4	0.2	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.7	0.0	0.9	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	6.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	7.1	8.4	0.2	24.6	9.2	11.0	9.4	2.2	7.0	5.0	0.0	1.1	0.0	0.4	3.4	17.7	2.8	5.1	0.0	2.3	0.0	3.9	0.0	0.0	5.8	9.7	2.9	2.4	0.0	11.0	0.2	6.2	3.2	0.0	0.2	0.4	0.0	15.3	6.2	0.0	19.9	13.0	0.0	11.8	0.0	0.0	0.8	4.7	0.0	306.6	0.0	2.4	148.8	3.8	14.0	40.1	2.6	0.1	0.0	0.4	0.5
TMEM130	"DKFZp761L1417, FLJ42643"	ENSG00000166448	"Transmembrane protein 130"	Q8N3G9	7	98846488-98870771	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 28.2;brain: 82.2;pituitary gland: 24.0;testis: 26.4"	"Cell type enriched"	"Detected in some"	8	"Bipolar cells: 49.7"	"Cancer enhanced"	"Detected in many"		"renal cancer: 9.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 4.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 7.6;EFO-21: 7.4;GAMG: 8.0;hTERT-RPE1: 12.8;NTERA-2: 4.4;SH-SY5Y: 9.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012928	Uncertain		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA012928: AB_1858085"	"unprognostic (1.36e-2)"	"unprognostic (1.33e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.97e-1)"	"prognostic favorable (7.84e-4)"	"unprognostic (1.07e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.86e-3)"	"unprognostic (7.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.73e-1)"	1.3	28.2	27.3	2.0	53.8	1.4	1.8	14.1	82.2	3.5	1.8	2.8	0.0	1.6	1.8	8.0	2.2	1.7	2.2	1.4	29.3	47.0	2.8	1.1	5.4	2.4	13.4	35.1	1.7	1.6	1.5	24.0	1.3	25.8	2.7	1.9	1.0	1.3	6.2	2.1	1.3	2.1	1.6	9.2	1.4	1.4	26.4	3.9	0.1	1.4	0.0	1.2	1.7	1.2	1.0	0.6	4.8	0.9	1.0	0.7	0.3	0.0	0.6	0.0	0.0	0.2	0.0	0.2	3.4	7.6	0.6	0.5	0.1	0.1	0.1	7.4	1.9	8.0	0.1	0.0	0.0	0.1	0.2	0.4	0.1	0.2	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	12.8	0.3	0.1	0.1	0.6	0.4	0.6	0.1	0.1	4.4	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.5	9.1	0.1	0.1	0.0	3.0	0.0	0.0	0.0	0.1	0.6	0.0	0.2	0.4	0.2	0.1	0.3	0.4	0.1	2.2	0.9	0.6	0.5	0.4	0.4	0.7	0.5	0.4	0.2	1.0	0.7	0.6	4.8	1.0	0.6	0.6	0.4	0.3	27.3	53.8	14.1	44.2	29.3	47.0	13.4	35.1	25.8	3.9	0.0	0.0	0.0	0.3	0.3	49.7	0.8	2.5	0.0	3.4	1.8	2.0	0.1	0.0	0.0	1.3	0.3	0.0	0.0	0.2	0.1	1.1	0.3	0.0	0.0	0.1	0.0	0.0	0.6	0.0	1.9	0.9	0.2	0.0	0.0	0.0	1.3	0.0	0.0	6.3	0.0	3.7	0.0	0.3	0.4	0.7	0.3	0.2	0.0	0.0	0.1
TRRAP	"PAF400, TR-AP, Tra1"	ENSG00000196367	"Transformation/transcription domain associated protein"	Q9Y4A5	7	98877933-99050831	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054376			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA054376: AB_2682467"	"unprognostic (2.10e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (1.40e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.96e-1)"	9.6	14.2	10.7	18.4	13.4	18.8	14.9	22.8	14.4	14.1	11.3	15.4	10.0	10.6	15.1	10.1	11.3	17.1	11.4	11.4	10.7	9.5	10.8	11.0	13.1	17.1	12.4	9.4	22.4	16.2	26.7	29.9	12.2	9.6	11.8	10.2	13.7	11.8	16.7	11.7	16.9	13.3	16.9	14.2	14.5	11.5	19.3	12.1	37.1	16.6	7.7	19.3	12.8	11.5	2.7	3.1	5.7	0.9	1.3	2.7	0.3	12.3	14.4	15.0	12.7	7.4	7.6	7.5	5.4	7.3	8.6	8.3	11.2	5.5	17.2	8.7	10.1	16.6	6.4	15.5	7.5	9.5	9.9	15.2	10.5	10.5	6.5	5.5	18.8	7.8	7.1	4.4	14.0	12.0	6.0	11.0	15.6	17.9	32.7	8.0	23.8	23.0	7.5	11.4	7.5	8.9	17.0	8.6	13.1	4.5	13.8	11.9	14.8	13.8	9.1	4.6	12.8	4.6	8.5	11.5	11.6	16.9	15.3	12.7	13.5	15.3	25.5	8.2	9.7	11.4	5.7	0.9	0.6	1.5	0.6	2.7	2.0	2.7	1.3	0.9	2.7	1.9	1.8	2.9	1.3	0.9	3.1	2.0	0.3	10.7	13.4	22.8	14.4	10.7	9.5	12.4	9.4	9.6	12.1	14.9	13.9	4.5	3.7	14.1	13.1	9.2	5.1	4.0	10.3	14.0	25.5	7.7	0.0	6.7	3.0	9.0	6.1	0.0	5.7	4.3	8.0	6.5	5.7	10.9	7.0	20.6	12.1	9.2	8.7	4.0	8.1	8.4	8.5	5.4	10.6	5.8	7.9	3.5	8.1	4.3	8.5	0.0	6.1	14.4	8.0	18.6	9.2	9.2	9.5	6.0
SMURF1	KIAA1625	ENSG00000198742	"SMAD specific E3 ubiquitin protein ligase 1"	Q9HCE7	7	99027438-99144100	"Enzymes, Predicted intracellular proteins"	"Differentiation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019671, HPA055245"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA019671: , HPA055245: AB_2682757"	"unprognostic (2.21e-1)"	"unprognostic (6.15e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.62e-2)"	15.0	11.1	8.7	10.5	15.0	23.8	12.4	12.1	16.5	11.8	10.9	20.9	6.9	9.5	11.6	5.7	19.3	10.2	12.5	7.9	9.3	8.4	10.3	10.1	16.0	8.1	15.4	9.4	19.6	22.5	9.0	15.1	15.4	14.9	11.7	10.6	14.3	13.4	9.6	10.7	17.3	10.3	9.8	10.6	9.1	19.5	26.0	11.8	6.6	7.8	6.6	12.7	11.5	13.3	1.2	1.2	2.4	1.9	1.0	2.1	0.6	13.7	7.9	6.4	4.5	5.1	5.4	9.6	7.7	7.4	6.3	5.9	3.9	11.4	4.3	8.4	7.2	13.9	7.5	3.5	10.0	6.5	3.2	3.0	2.3	4.6	3.8	4.8	2.6	5.7	4.8	6.9	9.9	11.5	9.6	5.9	4.2	6.9	7.6	5.8	11.2	4.5	5.4	7.5	7.6	8.5	4.3	6.0	2.6	6.9	11.4	2.8	6.4	7.4	9.8	6.8	11.8	3.1	5.0	8.7	10.0	10.3	17.8	15.4	6.8	4.6	4.5	5.0	5.2	15.4	2.0	1.4	2.3	1.3	1.5	1.6	0.9	2.1	1.3	1.1	1.2	1.2	1.0	2.4	1.0	1.9	1.2	2.0	0.6	8.7	15.0	12.1	16.5	9.3	8.4	15.4	9.4	14.9	11.8	17.9	28.0	5.2	20.4	23.0	25.8	3.9	20.4	20.1	20.5	12.2	7.9	6.1	1.7	13.9	3.7	10.8	7.8	0.0	13.9	8.0	10.1	31.9	2.3	6.7	5.7	25.4	10.9	7.4	3.1	5.3	5.8	8.5	8.5	4.6	8.7	3.7	25.0	10.5	13.1	4.4	6.9	6.5	15.5	41.5	1.0	19.3	17.6	2.5	7.8	65.2
KPNA7	IPOA8	ENSG00000185467	"Karyopherin subunit alpha 7"	A9QM74	7	99173574-99207506	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"stomach 1: 9.0"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 1: 3.0;Ciliated cells: 4.0;Ductal cells: 4.8;Exocrine glandular cells: 2.8;Pancreatic endocrine cells: 7.3;Urothelial cells: 8.5"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 4.7;CAPAN-2: 3.6;HaCaT: 2.0;OE19: 4.4;SK-BR-3: 5.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA031395	Uncertain					NA	NA					"HPA031395: AB_10601584"	"unprognostic (7.38e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.44e-2)"	"unprognostic (8.37e-2)"	"unprognostic (9.35e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.23e-1)"	"unprognostic (7.94e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.28e-13)"	"unprognostic (2.21e-2)"	"unprognostic (1.23e-1)"		"unprognostic (3.54e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.4			0.2	0.0	0.0	2.4	1.6	0.6	0.0	0.0	0.0	0.0	1.2	0.9	0.0	0.0		1.1	0.2	0.0	0.0	0.0		0.1	0.1		0.7	0.0	0.0	0.1	0.2	0.0	0.0	0.0	9.0	0.0			0.0		0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	4.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.2	0.0	0.0	0.3	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.4	0.5	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0											3.0	0.3	0.0	0.8	0.5	0.0	0.3	0.0	4.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.4	0.0	2.8	0.1	0.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	8.5
AC004922.1		ENSG00000284292			7	99325879-99394653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	25	"Club cells: 4.5;Exocrine glandular cells: 1.3;granulocytes: 1.1"									"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA004334	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cell Junctions"	Cytosol	"HPA004334: AB_1078215"																		6.0	5.2	4.2	9.4	6.2	6.9	7.8	3.2	9.1	5.3	6.6	4.6	5.6	13.8	5.8	3.8	5.3	5.0	4.5	4.9	7.1		4.1	6.3	4.6	8.1	3.2	6.0	3.9	6.4	3.0	4.1	5.2	6.2	5.0	3.1	4.9	3.3	5.4	4.6	2.4	9.6	4.2	3.0	6.5	7.0	3.9	3.2	2.9	6.0	6.4	4.4	4.6	4.1	7.9	13.0	18.1	16.3	5.1	11.9	18.0	4.2	4.0	0.4	1.0	0.6	2.8	5.1	3.3	1.8	3.0	3.2	7.2	5.9	4.4	10.9	3.5	3.8	2.8	1.2	3.8	0.6	2.2	7.5	2.5	2.9	1.9	0.9	2.7	3.1	2.7	1.1	3.1	1.2	0.7	4.4	2.3	3.9	4.0	2.1	7.9	4.9	1.2	2.6	1.7	11.9	2.1	1.1	1.5	0.6	2.0	1.1	1.0	2.8	4.6	8.4	0.7	2.2	1.7	2.9	4.9	2.6	7.2	4.3	0.0	2.3	4.7	3.0	4.2	5.7	9.2	15.5	18.1	7.1	16.3	5.1	7.3	7.0	6.9	13.0	7.9	6.1	6.1	13.9	5.1	15.0	8.9	11.9	18.0											0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ARPC1A	"Arc40, SOP2Hs, SOP2L"	ENSG00000241685	"Actin related protein 2/3 complex subunit 1A"	Q92747	7	99325910-99366262	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA004334	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA		2400000	"Cell Junctions"	Cytosol	"HPA004334: AB_1078215"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (2.52e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.88e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.83e-1)"	36.6	39.8	40.2	25.2	41.0	18.7	49.1	32.3	55.9	40.0	43.6	32.3	37.9	50.1	30.4	45.9	58.3	43.3	32.1	65.3	45.9	43.5	30.6	41.2	29.6	32.2	38.6	39.7	47.2	41.9	30.9	31.4	31.8	40.6	28.2	44.2	33.9	31.7	36.7	20.9	46.1	55.0	31.9	27.9	26.8	53.1	28.6	25.1	23.7	44.4	41.8	31.6	31.5	33.9	11.1	16.1	33.2	29.1	10.9	12.6	9.9	45.5	24.8	28.2	12.9	26.3	44.9	24.0	32.8	38.5	33.4	33.4	27.8	52.6	16.0	48.5	39.7	49.5	19.4	37.0	47.5	40.5	7.9	31.1	8.5	18.5	22.4	29.0	10.0	11.2	41.7	26.6	43.1	46.0	39.7	54.7	13.2	21.3	18.5	51.3	66.6	16.8	13.4	26.5	51.0	56.2	9.9	19.5	19.5	24.8	27.7	29.2	24.9	32.1	46.1	43.6	49.9	23.0	14.8	42.4	42.9	38.4	75.5	52.2	7.2	13.3	22.7	37.0	22.6	56.2	33.2	18.9	31.9	9.8	28.6	7.6	11.0	9.3	12.6	16.1	11.1	12.1	9.1	23.8	10.9	29.1	11.7	12.1	9.9	40.2	41.0	32.3	55.9	45.9	43.5	38.6	39.7	40.6	25.1	47.6	40.3	44.7	107.8	36.9	36.8	41.2	86.6	64.3	34.2	55.8	17.7	167.1	114.4	166.9	15.6	83.7	206.9	116.8	242.7	281.6	45.8	130.5	12.7	70.0	73.9	31.8	71.2	92.1	68.9	20.6	61.9	41.2	75.9	60.5	155.3	53.9	324.8	150.8	63.3	116.3	29.0	181.1	159.3	117.8	120.8	41.9	108.5	26.7	144.4	216.4
ARPC1B	"ARC41, p40-ARC, p41-ARC"	ENSG00000130429	"Actin related protein 2/3 complex subunit 1B"	O15143	7	99374249-99394814	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 213.6"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 816.2;Hofbauer cells: 990.8;Kupffer cells: 840.4;monocytes: 924.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 112.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004832	Enhanced		Supported	Vesicles,Cytosol		NA	NA		53000000	"Vesicles, Cytosol"		"HPA004832: AB_1845044"	"unprognostic (5.94e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (2.57e-4)"	"unprognostic (4.37e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.86e-1)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.27e-2)"	31.8	17.8	8.7	50.7	14.4	56.4	35.4	1.9	7.7	17.9	30.7	8.4	18.1	32.6	17.4	21.8	16.0	18.3	23.4	24.4	5.7	7.0	27.9	34.8	40.0	92.8	10.7	3.7	11.6	13.0	3.8	13.1	36.2	9.4	15.6	10.5	20.6	18.3	15.1	10.6	10.0	42.3	12.1	10.2	81.8	16.3	10.8	9.3	31.0	23.0	13.7	37.2	19.0	21.1	53.5	133.7	127.2	154.4	38.9	83.4	213.6	16.0	29.2	2.2	6.4	8.5	30.7	22.4	22.3	22.5	9.0	8.0	19.0	62.6	27.9	41.8	24.3	19.7	12.1	2.8	19.7	3.7	22.7	10.5	20.3	8.5	13.1	24.5	20.3	69.1	17.1	10.2	12.7	12.6	18.1	23.7	14.9	22.5	67.3	13.1	74.1	22.4	44.5	8.0	19.0	63.6	18.1	2.0	68.3	18.6	7.9	1.8	5.9	15.2	67.1	112.2	7.6	15.8	41.4	34.6	25.7	21.3	45.3	28.1	12.5	24.9	34.1	25.6	53.0	46.0	53.7	153.2	121.6	53.8	154.4	50.2	53.5	62.8	59.6	133.7	42.8	37.0	49.3	127.2	38.9	142.0	77.9	83.4	213.6	8.7	14.4	1.9	7.7	5.7	7.0	10.7	3.7	9.4	9.3	38.7	80.0	287.6	95.5	53.8	9.2	5.6	119.8	56.2	54.6	123.9	7.9	492.8	21.6	353.0	2.6	242.9	360.5	0.0	368.7	816.2	113.0	95.0	189.2	37.0	990.8	1.6	108.2	201.3	840.4	4.0	34.5	558.1	170.4	924.3	71.7	20.6	324.8	290.8	17.0	73.6	15.8	90.5	96.8	2.1	14.7	32.4	253.6	319.0	152.9	154.0
PDAP1	"HASPP28, PAP, PAP1"	ENSG00000106244	"PDGFA associated protein 1"	Q13442	7	99392048-99408829	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021103, HPA050294, HPA060836"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA		40000	Cytosol	"Plasma membrane"	"CAB021103: AB_10057973, HPA050294: AB_2681077, HPA060836: AB_2684374"	"unprognostic (2.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.97e-2)"	26.7	25.7	25.5	25.0	23.9	23.0	22.4	23.4	28.5	22.8	25.9	18.3	21.6	21.1	25.8	21.6	32.2	20.5	23.4	30.2	23.4	20.4	25.2	31.8	20.5	20.2	23.2	23.5	23.4	28.2	23.3	18.0	28.8	24.2	23.0	22.0	19.0	27.8	26.4	103.5	24.8	19.6	26.9	22.2	20.5	22.6	19.7	24.3	20.1	22.4	37.2	25.2	24.1	28.2	11.3	15.8	24.2	11.9	20.4	14.2	4.6	31.3	27.4	18.6	23.6	14.4	15.0	12.0	26.0	15.1	21.1	17.9	27.7	15.7	13.8	23.1	24.5	26.8	17.0	22.3	26.1	20.6	19.7	24.8	14.0	26.5	24.1	21.1	26.2	13.9	15.7	19.7	23.1	38.0	19.1	21.0	22.9	33.0	25.3	20.6	65.4	36.3	35.8	23.7	32.0	29.8	16.8	18.6	23.9	21.3	24.2	19.0	38.2	19.5	31.1	13.2	21.8	13.7	13.8	19.0	28.4	31.5	33.7	40.7	24.3	27.8	30.7	22.8	23.5	29.6	7.6	9.4	8.6	12.4	11.9	11.1	11.3	11.5	8.9	7.4	11.1	8.3	10.3	24.2	20.4	10.6	15.8	14.2	4.6	25.5	23.9	23.4	28.5	23.4	20.4	23.2	23.5	24.2	24.3	80.4	78.5	58.8	93.4	55.3	99.3	58.0	66.2	127.2	88.7	40.1	31.4	195.3	142.6	147.5	43.9	96.1	85.9	0.0	148.5	178.1	80.5	110.4	69.4	70.3	101.3	73.1	113.2	60.8	32.4	62.9	77.3	76.3	97.8	137.1	82.1	110.3	138.1	86.8	86.7	87.8	76.8	51.8	85.5	104.4	108.0	57.3	154.2	80.4	92.4	105.8
BUD31	"Cwc14, EDG-2, EDG2, fSAP17, G10, YCR063W"	ENSG00000106245	"BUD31 homolog"	P41223	7	99408641-99419616	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028943	Approved		Approved	Nucleoplasm,Microtubules,Centrosome		NA	NA			Nucleoplasm	"Microtubules, Centrosome"	"HPA028943: AB_10602396"	"unprognostic (1.68e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.63e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.16e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (9.66e-4)"	"unprognostic (1.42e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.71e-1)"	26.4	31.9	43.6	26.1	44.8	66.6	29.5	28.3	36.4	25.6	31.3	25.6	31.6	27.0	25.1	32.2	35.2	35.7	28.1	30.8	39.2	36.3	37.9	33.2	26.2	34.5	39.5	27.4	28.8	31.4	21.0	35.2	33.7	32.3	27.3	22.7	22.0	31.5	28.9	20.7	23.5	31.2	25.4	34.5	29.1	26.7	51.2	27.0	24.1	40.1	29.0	31.6	35.3	26.5	39.1	32.2	91.2	42.7	34.1	37.6	56.6	25.2	29.8	16.7	37.4	16.8	18.9	16.2	24.3	23.4	27.9	30.7	34.8	25.2	19.4	29.7	23.4	30.4	15.1	18.4	22.2	23.5	23.4	24.9	14.1	21.2	22.8	35.0	24.0	18.7	18.4	27.5	25.4	48.1	16.3	21.7	20.4	34.6	44.5	25.6	66.3	31.5	65.1	36.7	27.0	37.4	16.5	16.9	33.5	24.4	20.2	29.4	35.4	24.0	27.7	50.5	11.3	17.4	30.3	17.7	26.6	33.9	52.7	37.9	28.0	46.9	51.7	23.5	35.9	48.1	59.1	39.3	91.2	34.1	40.5	31.9	39.1	32.8	33.0	32.2	36.6	27.9	29.2	83.0	34.1	42.7	31.1	37.6	56.6	43.6	44.8	28.3	36.4	39.2	36.3	39.5	27.4	32.3	27.0	77.4	75.2	90.6	127.0	171.3	30.4	11.1	68.8	149.9	61.4	87.2	9.8	144.5	202.2	156.4	106.4	90.4	143.8	23.3	162.5	137.0	129.0	115.9	89.0	77.4	132.0	15.9	140.8	71.8	86.2	82.8	75.9	103.3	129.9	174.1	105.3	65.9	188.4	119.3	69.6	168.4	26.3	58.2	153.3	197.9	133.6	160.7	152.5	126.4	87.3	146.8
PTCD1	KIAA0632	ENSG00000106246	"Pentatricopeptide repeat domain 1"	O75127	7	99416739-99466163	"Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 22.3"									"HPA020106, HPA047679"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA020106: AB_2176551, HPA047679: AB_2680119"	"unprognostic (4.70e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.19e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (4.39e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.14e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.71e-2)"	"unprognostic (7.10e-3)"	10.3	11.4	9.9	12.0	11.9	21.9	10.6	13.9	16.3	9.4	15.7	5.3	12.0	13.2	12.4	10.6	17.7	12.7	13.2	22.9	10.5	9.1	18.3	29.5	11.5	14.8	9.2	13.1	13.5	19.9	9.3	9.7	9.8	10.7	13.4	7.4	9.1	17.4	13.6	43.8	19.7	18.9	6.4	8.6	15.8	11.6	18.0	7.5	16.0	12.2	30.8	11.3	12.4	10.5	6.2	4.7	4.5	5.0	4.1	8.0	3.2	3.6	7.5	2.6	7.2	2.4	2.0	7.3	5.0	1.9	3.7	2.6	22.3	4.4	7.3	5.9	1.4	6.1	3.9	3.1	4.6	1.3	5.7	8.7	3.7	6.0	5.4	3.8	3.6	7.1	1.6	2.9	3.0	3.0	2.5	1.1	4.7	7.4	5.0	1.8	10.2	6.7	9.6	4.8	3.6	6.3	4.1	3.4	9.0	1.9	3.9	4.8	5.2	5.6	18.8	4.8	3.9	4.0	4.0	2.0	5.6	6.5	10.8	5.4	7.6	6.5	7.8	5.7	5.1	7.6	3.5	4.5	1.8	8.0	5.0	5.2	4.2	5.0	5.2	3.2	6.2	5.9	7.1	4.5	4.1	3.5	4.7	3.3	3.2	9.9	11.9	13.9	16.3	10.5	9.1	9.2	13.1	10.7	7.5	0.0	4.3	11.3	3.5	5.6	7.8	5.5	2.5	8.1	3.4	5.2	9.8	8.1	1.7	4.4	1.0	4.3	3.0	0.0	5.9	4.6	5.0	3.0	12.7	5.9	5.8	7.9	7.0	3.7	1.6	1.5	3.4	4.8	3.3	3.6	5.8	4.6	3.6	3.4	2.8	2.4	8.3	0.0	5.4	6.5	7.1	3.6	4.7	5.7	5.6	2.4
ATP5MF-PTCD1	ATP5J2-PTCD1	ENSG00000248919	"ATP5MF-PTCD1 readthrough"		7	99419749-99466197	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"Ciliated cells: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020106, HPA047679"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA020106: AB_2176551, HPA047679: AB_2680119"	"unprognostic (1.15e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.84e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.50e-2)"	9.3	10.3	7.5	8.6	9.2	1.2	8.1	8.2	13.0	9.6	12.4	3.6	9.2	8.7	10.4	8.1	14.8	11.0	8.3	18.6	8.3	6.7	14.5	23.6	7.0	7.8	6.2	10.2	9.0	15.6	11.5	7.1	8.3	8.3	12.3	7.2	6.8	13.9	12.1	35.7	8.7	15.0	8.4	6.7	8.3	8.9	14.2	5.4	12.7	8.7	24.8	8.6	14.1	10.4	4.2	8.7	1.8	8.3	6.2	6.1	6.8	5.5	6.1	5.1	14.4	6.3	3.7	10.9	3.8	4.6	9.7	8.8	23.3	9.2	7.3	9.5	3.6	9.0	5.5	8.7	7.9	4.1	8.1	8.2	4.2	4.1	4.8	6.7	5.7	4.5	6.3	7.1	8.7	7.1	3.6	4.0	8.6	13.9	11.1	6.2	11.6	13.1	7.5	9.0	9.6	7.9	7.1	4.8	19.3	5.2	1.9	6.7	6.7	8.2	14.0	8.3	3.6	6.9	9.1	2.4	6.8	6.1	14.2	10.0	8.9	7.6	11.5	5.0	6.5	12.1	1.8	6.3	1.7	5.5	8.3	5.8	3.6	4.6	4.6	8.7	4.2	4.9	6.1	0.5	6.2	4.8	4.3	3.5	6.8	7.5	9.2	8.2	13.0	8.3	6.7	6.2	10.2	8.3	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CPSF4	"CPSF30, NAR"	ENSG00000160917	"Cleavage and polyadenylation specific factor 4"	O95639	7	99438922-99457371	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049094, HPA066470"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA049094: AB_2680626, HPA066470: AB_2685672"	"unprognostic (4.03e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.87e-4)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.73e-3)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.23e-2)"	15.2	11.6	19.3	11.8	19.0	15.7	11.8	20.9	25.6	9.3	9.8	19.8	13.1	12.4	11.1	11.4	13.6	11.2	10.3	10.0	21.5	16.0	10.0	11.7	9.3	20.3	16.8	17.4	13.4	25.4	7.3	12.7	15.1	21.9	11.6	10.2	9.9	17.3	12.2	21.2	18.4	9.6	10.5	20.3	13.9	11.5	38.4	14.6	8.7	11.0	10.7	17.8	10.5	10.4	10.2	6.4	3.1	4.1	5.0	9.7	3.9	14.8	13.1	22.3	17.7	9.1	10.5	26.4	9.8	12.4	15.4	20.3	21.4	20.1	21.5	13.4	9.7	19.5	13.0	15.4	15.5	14.8	15.6	16.4	10.2	15.0	20.7	47.9	18.4	13.1	19.0	13.4	16.2	24.8	11.6	14.1	15.7	26.4	25.5	14.5	36.8	37.8	33.8	20.3	20.2	18.5	15.3	15.0	25.4	9.6	14.1	17.7	20.5	11.4	23.7	23.3	24.8	9.9	19.7	7.7	14.5	20.1	24.8	18.8	23.8	25.1	31.2	11.1	18.3	17.1	1.4	4.1	3.1	4.4	3.3	5.8	10.2	6.7	7.9	5.2	8.5	8.5	7.6	1.6	5.0	2.6	6.4	9.7	3.9	19.3	19.0	20.9	25.6	21.5	16.0	16.8	17.4	21.9	14.6	6.0	9.9	6.7	14.2	7.8	3.8	8.6	7.6	1.4	6.8	1.8	9.8	47.0	13.3	12.3	2.7	9.2	7.0	0.0	14.8	28.0	9.5	12.1	12.7	7.6	18.7	6.4	7.5	4.9	8.1	4.2	25.3	10.5	8.5	21.6	10.0	6.9	12.9	3.5	16.3	14.0	6.0	19.4	19.5	14.7	22.0	8.2	38.0	10.1	11.9	12.7
ATP5MF	"ATP5J2, ATP5JL"	ENSG00000241468	"ATP synthase membrane subunit f"	P56134	7	99448475-99466331	"Predicted intracellular proteins, Predicted membrane proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 700.3;Distal tubular cells: 1212.0;Hofbauer cells: 681.7;monocytes: 591.5;Proximal tubular cells: 993.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA067267, HPA070412"	Approved		Supported	"Nuclear membrane,Mitochondria"		NA	NA		1400000	Mitochondria	"Nuclear membrane"	"HPA067267: AB_2685815, HPA070412: AB_2686266"	"unprognostic (2.43e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.55e-3)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.31e-3)"	"unprognostic (2.58e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.88e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.78e-2)"	42.4	49.0	68.0	36.6	52.0	46.4	42.8	37.3	58.8	30.7	62.7	19.0	39.9	62.9	21.2	41.2	57.4	24.8	36.6	94.5	53.9	49.8	59.6	93.5	30.0	35.5	54.6	43.6	20.7	63.6	16.3	36.7	33.4	36.3	35.0	47.3	30.9	57.1	45.2	178.8	27.8	61.5	24.6	33.0	35.6	43.4	58.3	25.5	52.9	37.9	98.0	37.6	27.8	30.2	68.3	129.7	117.2	104.1	58.3	84.0	140.0	86.7	76.6	64.6	104.3	50.9	51.7	40.9	57.6	44.9	61.9	67.1	81.3	80.2	81.4	60.8	35.7	105.4	53.5	71.4	66.0	66.2	58.6	91.7	55.1	122.5	104.8	38.4	93.9	63.1	58.9	63.7	53.8	57.0	54.2	58.9	70.6	111.7	89.7	64.8	203.9	140.4	163.0	91.9	174.2	90.2	62.9	53.9	139.1	130.5	96.5	62.1	68.5	75.4	186.6	54.5	100.7	47.0	121.9	49.9	54.5	87.2	90.0	84.0	51.4	118.1	169.8	63.1	91.9	83.7	90.0	104.0	117.2	54.2	104.1	51.7	68.3	63.5	61.0	129.7	56.9	55.8	59.5	49.7	58.3	79.2	102.7	84.0	140.0	68.0	52.0	37.3	58.8	53.9	49.8	54.6	43.6	36.3	25.5	20.8	44.7	0.0	0.0	0.0	0.0	0.0	0.0	93.7	67.1	366.4	0.0	700.3	1212.0	418.8	0.0	0.0	0.0	0.0	501.7	525.7	0.0	0.0	59.3	0.0	681.7	0.0	0.0	0.0	0.0	0.0	0.0	46.9	0.0	591.5	0.0	0.0	502.5	0.0	0.0	993.9	0.0	0.0	0.0	0.0	0.0	0.0	364.9	0.0	0.0	0.0
ZNF789		ENSG00000198556	"Zinc finger protein 789"	Q5FWF6	7	99472841-99503650	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA029500, HPA050793"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029500: AB_10603009, HPA050793: AB_2681240"	"unprognostic (6.84e-3)"	"unprognostic (5.75e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.25e-3)"	"unprognostic (4.38e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (7.14e-4)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (6.63e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.33e-2)"	"prognostic favorable (5.31e-6)"	6.1	5.5	11.0	15.9	10.0	11.6	9.2	31.9	14.4	6.1	9.2	9.2	11.0	15.1	10.9	12.8	5.0	7.8	6.6	4.0	10.0	8.5	9.0	8.1	6.5	10.5	6.8	9.8	8.9	7.8	6.3	13.3	4.6	7.6	16.4	12.5	14.8	10.3	13.8	8.9	13.3	12.6	8.5	8.6	11.2	8.4	17.6	8.1	8.4	9.3	4.8	10.1	4.1	5.6	3.9	14.2	2.0	1.6	4.1	7.0	2.1	11.2	3.8	6.2	11.2	1.8	2.1	8.6	5.8	2.2	3.5	7.7	6.4	7.7	8.6	4.9	2.6	4.1	5.7	3.5	3.3	4.9	3.9	6.0	6.5	10.6	10.8	3.1	4.4	14.9	2.3	3.0	7.5	3.3	2.3	3.7	11.1	9.7	8.4	3.2	10.7	5.3	11.9	6.3	5.3	6.0	7.0	5.9	9.0	4.6	3.5	6.2	6.8	4.1	11.2	6.5	3.7	3.0	7.0	6.9	6.7	8.2	10.0	5.6	5.1	7.0	10.8	10.6	8.0	7.2	2.0	1.6	1.5	2.7	1.1	2.9	2.7	3.4	2.9	5.6	3.9	7.0	4.2	0.4	4.1	1.4	14.2	5.3	2.1	11.0	10.0	31.9	14.4	10.0	8.5	6.8	9.8	7.6	8.1	0.0	4.6	4.2	3.8	4.8	17.5	1.7	2.5	6.7	4.5	1.8	13.7	4.0	1.7	3.6	21.1	5.6	4.7	23.3	4.8	3.0	3.4	2.5	3.5	2.9	5.6	6.4	5.2	0.6	4.4	6.4	3.1	6.6	6.8	2.8	5.1	10.9	3.5	4.5	4.2	3.4	13.5	0.0	4.2	10.6	3.8	4.5	1.8	4.8	5.6	3.0
ZNF394	"FLJ12298, ZKSCAN14, ZSCAN46"	ENSG00000160908	"Zinc finger protein 394"	Q53GI3	7	99486519-99500324	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051421, HPA054639"	Uncertain		Enhanced	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA051421: AB_2681479, HPA054639: AB_2682553"	"prognostic favorable (3.56e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (2.11e-4)"	"unprognostic (3.62e-2)"	"unprognostic (4.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.70e-2)"	"unprognostic (7.47e-2)"	"unprognostic (3.42e-1)"	"prognostic favorable (1.09e-4)"	11.3	8.3	10.0	11.5	11.8	77.5	12.2	16.4	13.2	10.8	10.9	11.7	8.8	10.7	11.0	7.7	12.2	11.2	9.3	10.4	7.9	6.2	9.4	9.5	12.6	12.2	11.2	6.6	14.3	12.0	7.9	16.2	8.4	9.7	13.0	9.1	10.1	10.1	9.0	14.8	13.6	13.5	9.1	9.1	19.1	10.9	9.5	11.0	15.6	11.4	8.8	17.5	11.9	11.6	17.6	22.3	31.6	17.0	24.3	29.3	17.0	7.8	7.8	5.3	11.1	8.2	5.6	10.5	6.7	8.9	7.8	7.6	8.2	8.7	9.4	9.7	6.9	11.0	7.6	7.1	8.5	7.7	6.8	9.4	9.2	9.3	9.0	6.6	13.1	16.1	7.4	7.4	7.6	8.1	5.8	8.9	8.4	13.2	18.7	7.1	14.7	13.5	21.5	11.8	9.8	9.4	7.7	5.8	16.3	8.4	11.2	6.3	13.1	7.8	19.0	12.6	13.5	4.9	16.3	9.3	9.5	9.5	13.6	8.3	15.4	16.1	15.2	6.7	13.3	9.9	31.6	14.3	24.1	23.1	17.0	24.2	17.6	23.6	25.0	15.6	17.2	29.3	23.1	26.3	24.3	16.7	22.3	25.2	17.0	10.0	11.8	16.4	13.2	7.9	6.2	11.2	6.6	9.7	11.0	14.9	22.4	32.0	29.5	31.6	8.1	7.0	2.5	20.1	11.4	10.4	11.8	13.3	14.9	13.3	5.6	16.9	25.5	0.0	12.4	14.8	17.4	23.7	57.7	10.5	16.3	14.3	20.0	12.9	22.1	1.1	14.4	20.8	27.0	15.4	14.7	12.4	14.1	18.6	12.7	9.5	10.6	12.9	17.0	42.5	30.3	31.0	24.8	44.5	15.8	52.9
ZKSCAN5	"ZFP95, ZNF914, ZSCAN37"	ENSG00000196652	"Zinc finger with KRAB and SCAN domains 5"	Q9Y2L8	7	99504651-99534700	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003201	Uncertain		Approved	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA003201: AB_10610701"	"unprognostic (2.47e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (7.59e-6)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.35e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (3.42e-1)"	6.3	7.2	8.4	5.9	11.8	5.4	8.1	16.5	12.6	7.2	6.1	12.9	3.8	3.7	7.7	8.4	5.4	7.6	5.9	7.4	9.8	8.2	7.4	6.6	6.8	6.7	9.9	8.2	8.9	7.6	10.5	9.0	7.7	9.8	7.6	6.4	6.8	4.7	8.8	9.5	5.2	5.3	9.9	7.2	6.9	5.5	17.8	10.2	12.5	8.7	4.6	8.6	7.3	5.8	1.7	4.0	4.7	2.8	3.8	4.7	2.4	5.6	9.5	11.4	15.1	8.5	6.3	4.6	9.8	10.0	12.1	11.9	6.5	5.3	9.7	9.3	7.6	14.8	4.1	10.5	6.9	12.3	5.8	5.0	6.1	6.4	6.1	8.6	9.1	10.3	5.6	9.6	10.5	16.2	7.7	8.6	8.9	12.9	13.6	13.0	7.2	13.0	10.0	9.8	5.2	7.7	8.0	10.1	8.2	7.6	5.7	8.0	13.0	9.3	8.1	7.1	9.7	5.0	7.0	7.7	15.3	11.1	12.2	8.3	9.1	12.9	15.2	6.8	6.2	13.6	1.3	1.5	4.7	4.7	2.8	4.1	1.7	1.7	2.3	4.0	0.9	3.5	3.7	0.3	3.8	1.7	1.6	2.9	2.4	8.4	11.8	16.5	12.6	9.8	8.2	9.9	8.2	9.8	10.2	6.0	2.7	7.1	1.6	2.4	5.4	5.0	0.0	1.4	6.8	3.5	13.7	2.9	0.0	2.6	3.9	3.5	3.8	0.0	2.9	2.8	3.4	2.0	5.7	3.0	2.8	9.5	5.8	5.5	3.5	1.6	3.7	3.9	0.0	2.8	2.7	8.1	3.8	0.0	5.3	2.1	6.3	6.5	3.1	10.9	5.9	2.5	2.2	3.5	2.3	0.9
FAM200A	"C7orf38, DKFZp727G131, FLJ36794"	ENSG00000221909	"Family with sequence similarity 200 member A"	Q8TCP9	7	99546308-99558536	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA017855	Uncertain					NA	NA					"HPA017855: AB_1847703"	"unprognostic (3.98e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.63e-2)"	"prognostic unfavorable (9.24e-4)"	"unprognostic (2.38e-3)"	"unprognostic (4.12e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.42e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.17e-7)"	"unprognostic (8.38e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.41e-2)"	5.5	13.1	10.2	7.2	14.2	2.6	10.4	23.2	13.1	11.4	6.0	7.1	10.9	5.9	9.1	11.5	7.1	8.8	6.2	8.9	11.0	12.4	11.1	6.0	6.6	9.2	15.1	8.8	18.2	8.4	11.7	21.3	8.5	10.0	12.1	5.5	6.1	10.4	9.5	9.2	8.9	6.0	5.6	10.7	7.7	7.8	16.1	13.9	12.3	12.6	5.9	8.5	8.1	10.6	6.7	3.5	6.6	3.1	3.3	10.3	3.3	7.7	4.7	11.1	13.1	9.9	9.6	7.2	7.1	7.5	6.3	7.8	4.5	6.6	4.7	7.5	4.6	10.1	6.2	8.8	6.7	10.4	6.8	7.8	5.3	6.4	5.5	8.0	6.1	6.2	6.7	12.0	5.9	11.6	8.4	6.4	8.0	11.4	4.2	11.3	5.7	11.3	12.1	10.0	2.1	7.7	5.7	9.4	4.8	5.8	5.3	8.6	16.5	4.2	6.9	11.8	13.9	5.4	6.8	5.0	9.5	11.4	13.5	6.2	5.6	4.9	5.7	7.5	5.2	14.8	6.6	3.1	4.0	5.8	2.2	8.4	4.8	5.7	7.0	3.4	6.7	10.3	8.4	2.0	3.3	1.9	3.5	7.5	3.3	10.2	14.2	23.2	13.1	11.0	12.4	15.1	8.8	10.0	13.9	8.9	4.0	2.7	3.7	1.6	14.2	5.8	2.5	6.7	5.7	7.0	0.0	6.3	6.6	3.9	67.1	4.9	2.0	0.0	3.0	4.4	3.1	3.0	0.0	1.7	3.7	12.7	0.0	1.8	1.8	9.6	8.3	2.1	1.7	5.4	2.7	12.3	3.7	4.3	5.6	4.1	9.4	0.0	2.1	17.4	7.6	2.9	6.8	4.9	2.9	1.1
ZNF655	"VIK, VIK-1"	ENSG00000197343	"Zinc finger protein 655"	Q8N720	7	99558406-99576453	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029534, HPA050750"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA029534: AB_10603008, HPA050750: AB_2681225"	"prognostic favorable (7.12e-4)"	"unprognostic (3.03e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.00e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.93e-3)"	"prognostic unfavorable (7.24e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.12e-1)"	14.6	19.0	17.4	24.1	20.7	10.3	16.9	31.1	20.3	18.8	20.2	19.7	18.0	22.2	15.3	19.0	39.2	15.6	15.1	11.3	14.7	14.4	19.1	21.2	19.9	23.8	21.3	16.1	19.4	30.8	13.9	25.0	21.1	20.4	16.9	16.8	14.1	25.5	19.0	18.2	25.5	19.7	19.8	21.3	22.2	24.1	11.1	19.4	27.8	16.0	14.3	23.1	21.4	20.7	15.0	17.5	44.7	22.2	14.7	25.7	21.4	16.2	15.8	5.8	8.6	6.6	9.9	5.0	9.8	18.5	17.0	16.3	8.7	16.0	11.4	0.1	13.7	22.6	10.3	6.8	11.9	17.2	13.7	9.9	7.9	6.7	11.0	10.1	14.4	15.3	8.5	14.5	15.7	22.2	8.2	7.4	9.7	21.0	15.8	10.6	0.0	20.1	13.2	6.8	0.0	0.0	7.2	5.4	22.4	11.2	17.9	6.7	12.4	9.3	0.3	9.8	9.6	5.3	8.6	5.2	9.5	25.1	15.6	17.6	18.6	27.1	24.8	9.7	7.3	15.3	44.7	18.8	31.2	22.3	19.9	20.5	15.0	20.5	25.6	17.5	13.3	16.5	20.7	21.9	14.7	22.2	10.1	25.7	21.4	17.4	20.7	31.1	20.3	14.7	14.4	21.3	16.1	20.4	19.4	89.3	73.3	45.4	33.6	39.8	46.9	31.5	33.1	26.8	48.9	22.7	39.3	24.8	28.2	24.8	7.8	13.4	38.0	0.0	31.4	35.4	23.7	39.5	17.4	20.8	32.5	47.7	39.9	19.0	58.3	7.1	23.6	52.1	21.9	33.3	34.0	23.0	36.8	49.1	23.7	33.4	45.2	12.9	24.1	30.2	25.1	42.8	61.6	48.4	25.9	52.5
TMEM225B		ENSG00000244219	"Transmembrane protein 225B"	P0DP42	7	99598066-99610813	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 86.7"	"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 2: 4.0;Club cells: 1.2;Exocrine glandular cells: 2.2;granulocytes: 1.1;Proximal tubular cells: 1.4;Syncytiotrophoblasts: 1.4"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 14.6;U-266/70: 8.2"					"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.91e-3)"	"unprognostic (5.04e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.95e-1)"	"unprognostic (6.27e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.00e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.50e-1)"	0.1	0.2	0.1	0.1	0.1	0.0	0.7	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	1.1	0.1	0.6	0.1	0.1	0.1		0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.7	0.1	0.1	0.1	0.1	0.0	86.7	0.1	0.1	0.4	0.1	0.1	0.1	0.1	4.5	3.6	2.9	0.3	3.0	3.6	1.8	1.2	1.8	0.9	0.2	4.9	1.3	0.0	0.6	3.1	1.7	2.1	0.2	1.1	1.3	0.0	0.1	0.6	0.1	0.5	0.1	3.6	4.6	0.8	0.2	0.0	0.3	1.4	1.0	1.0	0.4	0.6	0.1	2.8	5.9	0.0	2.3	0.8	14.6	0.7	0.0	2.5	5.4	0.1	0.0	0.0	0.8	1.3	1.9	0.5	0.0	0.6	1.4	0.3	0.0	0.5	0.7	0.0	0.7	0.1	0.7	2.3	4.3	0.2	8.2	1.8	2.8	0.8	1.7	1.4	0.0	0.1	2.9	1.7	0.3	3.0	2.9	2.2	1.1	1.2	4.5	2.1	3.6	0.7	3.0	0.3	3.6	1.4	1.8											0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0
ZSCAN25	"FLJ32468, ZNF498"	ENSG00000197037	"Zinc finger and SCAN domain containing 25"	Q6NSZ9	7	99616946-99632407	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055127, HPA057173"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA055127: AB_2682706, HPA057173: AB_2683360"	"unprognostic (2.21e-3)"	"unprognostic (3.96e-2)"	"unprognostic (4.45e-1)"	"unprognostic (3.92e-2)"	"unprognostic (5.89e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.97e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.82e-3)"	"unprognostic (9.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.19e-3)"	10.8	10.0	11.4	12.2	12.5	12.3	14.5	18.5	14.6	11.3	11.0	13.1	16.9	7.4	14.5	11.7	12.7	12.4	9.6	7.7	9.4	6.9	9.4	9.1	10.0	16.4	10.3	12.2	18.5	12.3	15.0	12.3	9.4	9.2	12.7	8.6	10.3	15.4	13.9	9.7	15.6	10.8	12.6	8.7	13.6	10.3	15.7	11.0	14.9	11.2	8.7	11.8	11.7	11.4	3.3	3.0	5.5	4.2	4.2	9.0	4.7	5.7	2.7	8.0	9.1	3.6	2.7	7.8	6.4	5.4	7.4	7.7	7.2	4.8	8.2	7.5	5.3	6.8	7.5	8.6	7.3	9.3	4.5	7.3	5.4	4.6	6.1	6.1	12.5	4.9	4.3	9.3	5.9	6.2	3.0	4.6	9.2	15.2	6.6	5.2	6.3	18.0	17.4	14.6	3.3	6.3	7.6	8.2	8.7	3.2	7.9	5.4	13.5	8.4	12.8	9.1	9.9	3.5	8.6	3.3	11.6	9.3	6.6	10.7	5.9	9.4	14.0	6.2	7.9	16.9	5.5	3.8	4.8	7.4	4.2	9.0	3.3	5.1	6.9	3.0	2.9	8.7	8.4	4.6	4.2	3.7	2.4	7.2	4.7	11.4	12.5	18.5	14.6	9.4	6.9	10.3	12.2	9.2	11.0	0.0	3.8	0.0	1.8	3.1	4.6	3.2	0.0	1.4	0.0	1.8	7.9	3.7	1.7	2.5	3.9	3.6	2.6	0.0	2.5	3.1	2.3	2.4	4.7	3.4	3.1	4.8	2.4	5.5	3.5	3.0	3.4	1.0	1.7	3.6	5.3	2.6	1.7	3.5	5.6	2.1	4.3	6.5	2.1	6.5	5.1	1.9	1.6	5.3	3.7	1.4
CYP3A5	"CP35, P450PCN3, PCN3"	ENSG00000106258	"Cytochrome P450 family 3 subfamily A member 5"	P20815	7	99648194-99680026	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 72.9;liver: 73.4;stomach 1: 21.3"	"Cell type enhanced"	"Detected in many"	11	"Cholangiocytes: 346.5;Enterocytes: 640.5;Hepatocytes: 330.1;Urothelial cells: 352.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 38.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 8.3;CAPAN-2: 5.6;Hep G2: 5.7;OE19: 23.6"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA072245: , HPA075539: "	"unprognostic (2.13e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.73e-1)"	"prognostic favorable (3.72e-5)"	"unprognostic (1.37e-3)"	"unprognostic (1.21e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.85e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-4)"	"unprognostic (6.58e-3)"	1.0	3.3	0.4	2.0	0.5	0.0	1.3	0.6	0.6	1.9	32.6	0.6	1.0	30.3	0.7	0.5	5.2	0.5	8.2	0.4	0.4	0.0	6.8	73.4	2.4	0.8	0.4	0.4	0.6	12.1	0.0	1.8	0.6	0.8	4.9	5.1	0.4	0.6	1.3	0.4	4.3	72.9	0.6	0.5	0.4	21.3	0.7	0.4	0.5	0.4	2.2	4.0	3.0	2.7	0.0	0.2	0.1	0.6	0.0	0.7	0.2	0.0	2.1	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	8.3	5.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.1	0.0	0.3	0.2	23.6	0.0	0.1	0.0	0.6	0.5	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.4	0.5	0.6	0.6	0.4	0.0	0.4	0.4	0.8	0.4	11.9	11.3	11.2	107.3	41.0	13.1	1.0	346.5	14.7	12.5	3.5	11.8	1.3	0.0	58.0	1.7	2.5	640.5	46.7	44.6	1.0	3.8	166.5	9.3	330.1	0.6	7.9	52.5	9.8	8.3	0.0	2.3	4.6	3.3	7.2	117.1	6.0	69.5	210.5	2.5	4.2	20.2	0.0	3.5	6.8	4.2	51.6	1.3	12.9	85.2	352.8
CYP3A7	"CP37, P450-HFLA"	ENSG00000160870	"Cytochrome P450 family 3 subfamily A member 7"	P24462	7	99684957-99735196	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 82.6"	"Cell type enriched"	"Detected in some"	7	"Cholangiocytes: 135.0"	"Cancer enriched"	"Detected in some"	43	"liver cancer: 38.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 1.9;BJ hTERT+: 3.3;Hep G2: 6.4;HHSteC: 3.7;RT4: 1.9"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA072245: , HPA075539: "	"unprognostic (8.10e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.28e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-11)"	"unprognostic (2.02e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.34e-3)"	0.1	0.4	0.1	0.1	0.0	0.0	2.6	0.1	0.1	0.0	0.7	0.0	0.0	0.1	0.3	0.1	0.2	0.0	3.9	0.0	0.1	0.0	2.8	82.6	0.6	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.4	1.9	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.4	3.7	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	135.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	18.4	0.1	0.0	0.0	4.9	3.7	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1
CYP3A7-CYP3A51P		ENSG00000282301	"CYP3A7-CYP3A51P readthrough"	P24462	7	99685226-99735093	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 73.9"	"Cell type enriched"	"Detected in some"	7	"Cholangiocytes: 7.6"									"Cell type enhanced"	"Detected in single"		"eosinophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.3;U-87 MG: 2.6"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA072245: , HPA075539: "																		0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.1	0.0	3.5	0.0	0.0		1.1	73.9	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	1.1	0.0	0.0	0.5	0.0	0.3	0.5	1.6	0.5	0.2	4.3	0.0	0.6	0.2	0.0	0.0	0.0	1.3	0.1	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.9	1.4	1.9	0.0	0.0	0.5	0.3	0.4	0.4	0.0	0.4	0.5	0.0	0.8	0.5	1.1	0.1	0.2	1.2	0.5	0.2	0.5	0.2	0.1	0.4	1.5	0.0	0.0	0.4	0.2	0.0	0.5	0.6	0.6	0.0	0.1	0.4	0.3	0.5	0.5	0.6	0.9	0.7	0.1	2.6	0.7	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0											0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP3A4	CYP3A3	ENSG00000160868	"Cytochrome P450 family 3 subfamily A member 4"	P08684	7	99756960-99784265	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	45	"intestine: 145.3;liver: 464.6"	"Cell type enriched"	"Detected in some"	45	"Hepatocytes: 2276.5"	"Cancer enriched"	"Detected in some"	240	"liver cancer: 351.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.2;NB-4: 4.5;RPMI-8226: 6.7;SCLC-21H: 2.6;SH-SY5Y: 5.0"									"CAB033671, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"CAB033671: AB_782375, HPA072245: , HPA075539: "	"unprognostic (4.55e-2)"	"unprognostic (8.95e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.07e-3)"	"unprognostic (9.09e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.89e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.82e-2)"	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	145.3	0.1	0.1	56.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	464.6	0.1	0.1	0.1	0.1	0.1	6.8	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	126.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.2	0.6	0.2	0.6	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.2	0.0	1.9	0.4	0.0	1.2	0.0	0.4	0.0	0.0	0.1	0.5	0.0	0.5	0.0	0.1	4.5	0.3	0.0	0.0	0.0	2.2	6.7	0.0	0.5	2.6	5.0	0.5	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.4	0.0	0.7	0.1	0.7	0.1	0.7	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.6	0.6	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	4.3	1.0	0.3	0.0	0.3	40.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	2.6	46.7	0.8	0.0	0.0	0.5	0.0	2276.5	0.0	0.0	0.0	39.3	50.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.4	0.9
CYP3A43		ENSG00000021461	"Cytochrome P450 family 3 subfamily A member 43"	Q9HB55	7	99828013-99866102	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"liver: 32.5"	"Cell type enhanced"	"Detected in some"	15	"Early spermatids: 6.3;granulocytes: 2.3;Hepatocytes: 6.8;Late spermatids: 2.5"	"Cancer enriched"	"Detected in single"	18	"liver cancer: 1.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"											"HPA066463, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA066463: AB_2685670, HPA072245: , HPA075539: "	"unprognostic (1.20e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.64e-3)"		"unprognostic (7.24e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.46e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.37e-4)"	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.2	0.9	0.1	0.0	0.1	0.1	0.1	0.0	0.2	32.5	0.1	0.1	0.1	0.1	0.1	8.0	0.0	2.2	0.1	0.1	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.5	1.6	0.6	0.3	0.6	0.2	0.1	0.0	0.9	0.3	1.1	0.2	0.2	0.0	0.2	0.2	0.2	1.2	0.7	1.5	0.3	0.3	0.1	1.3	0.2	0.0	0.7	0.2	0.5	0.9	1.5	1.3	0.3	0.9	1.3	0.0	0.7	0.0	0.0	0.6	0.5	0.1	1.0	1.0	0.0	0.0	0.0	0.6	0.4	0.3	0.0	0.9	0.0	0.2	0.8	1.6	0.5	0.4	0.6	1.7	0.0	0.7	0.5	0.0	1.6	0.5	0.2	1.1	0.7	1.1	1.2	0.1	0.8	0.4	0.2	1.5	0.6	0.4	0.6	0.2	0.3	0.3	0.3	0.2	0.1	0.6	0.5	0.5	1.6	0.3	0.2	0.5	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.3	0.2	0.0	0.0	0.0	0.0	0.0	0.5	2.3	6.8	0.1	1.6	0.0	0.0	0.0	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.9	0.2	0.3	0.0	0.0	0.0	0.0
OR2AE1	OR2AE2	ENSG00000244623	"Olfactory receptor family 2 subfamily AE member 1"	Q8NHA4	7	99875987-99877057	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.5"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"HBF TERT88: 1.0;hTEC/SVTERT24-B: 1.2;U-2197: 2.3;U-266/70: 1.0;U-266/84: 1.2"									HPA042957	Uncertain					NA	NA					"HPA042957: AB_10794539"	"unprognostic (6.75e-2)"				"unprognostic (6.22e-2)"				"unprognostic (5.21e-2)"				"unprognostic (1.58e-1)"	"unprognostic (3.16e-2)"				0.4	0.4	0.0	0.0	0.2	0.1	1.2	0.3	0.2	0.4	0.1			1.1	0.7	1.4	0.3	0.4	0.0	0.3	0.0	0.1	0.3	0.1	0.4	0.6	0.0		0.2	0.3	1.2	0.8	0.2		0.5	0.5		1.3	0.2	1.2	0.8	0.2	0.4	0.1	0.3	0.1	0.1			0.3		0.4	0.3	0.1	1.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.6	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.8	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.3	0.1	1.0	1.2	0.1	0.2	0.5	0.5	0.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM4	RNF87	ENSG00000146833	"Tripartite motif containing 4"	Q9C037	7	99876958-99919600	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA019356, HPA029461"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA019356: AB_1856376, HPA029461: AB_10600834"	"unprognostic (1.88e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.36e-6)"	"unprognostic (1.00e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.46e-2)"	"unprognostic (5.65e-2)"	19.1	22.6	13.5	22.1	15.9	6.7	22.1	20.1	15.5	19.5	17.3	12.4	22.5	13.9	21.9	18.8	16.4	19.0	19.8	11.1	13.3	9.3	16.6	17.9	21.1	22.4	15.3	8.8	35.0	23.2	18.9	27.4	16.1	12.2	21.9	15.7	18.4	19.4	33.8	9.4	20.7	18.3	18.1	11.9	18.2	17.4	16.2	14.5	18.4	20.5	11.9	18.8	20.0	28.9	18.6	17.0	20.0	19.2	13.9	30.3	17.4	9.7	11.7	7.0	5.8	18.4	17.3	3.1	16.4	20.0	13.7	16.0	6.2	9.6	14.2	0.1	13.9	12.1	11.6	9.2	10.1	14.0	14.4	0.7	11.6	6.2	9.7	26.0	16.7	16.6	18.4	21.5	10.6	27.0	18.7	11.9	7.2	16.9	22.0	11.4	12.1	12.3	15.0	5.3	14.7	10.1	7.0	10.0	16.2	15.2	12.6	8.2	5.8	12.5	19.2	19.5	10.7	8.8	9.6	14.5	15.2	13.6	29.1	15.7	18.5	20.2	11.5	10.0	18.8	20.1	20.0	19.2	15.3	20.6	19.2	23.8	18.6	21.6	23.5	17.0	18.6	30.3	22.2	8.2	13.9	16.6	12.7	21.5	17.4	13.5	15.9	20.1	15.5	13.3	9.3	15.3	8.8	12.2	14.5	23.8	15.3	18.2	24.1	22.2	20.2	4.8	12.7	16.0	10.3	21.0	17.7	13.3	8.3	12.8	5.2	16.1	9.7	23.3	11.3	5.9	15.1	19.8	27.6	17.5	12.8	6.4	8.6	17.8	20.0	8.4	28.7	15.4	21.9	18.0	10.3	34.3	12.7	11.8	25.8	13.4	20.0	0.0	23.1	19.3	8.2	20.1	13.6	18.7	12.1	22.0
GJC3	"CX30.2, GJE1"	ENSG00000176402	"Gap junction protein gamma 3"	Q8NFK1	7	99923269-99929620	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 9.1;pancreas: 12.1;salivary gland: 9.0"	"Cell type enhanced"	"Detected in many"	11	"Exocrine glandular cells: 20.9;Glandular cells: 18.1;Pancreatic endocrine cells: 8.3;Proximal tubular cells: 8.2;Urothelial cells: 9.7"	"Group enriched"	"Detected in many"	5	"breast cancer: 3.8;melanoma: 3.0;prostate cancer: 3.6"					"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.5;T-reg: 2.1"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"OE19: 3.3;SK-MEL-30: 5.7;U-2197: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA015024	Uncertain					NA	NA					"HPA015024: AB_1847132"	"unprognostic (9.31e-2)"	"unprognostic (6.43e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.68e-2)"	"unprognostic (9.14e-2)"	"unprognostic (6.71e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.81e-3)"	1.0	0.5	0.1	0.0	0.3	0.0	9.1	0.0	0.5	0.0	0.1			0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	1.1	2.8	0.1	0.1	0.6		0.3	12.1	0.0	0.1	1.2		4.3	0.0		9.0	0.0	0.0	2.0	0.0	0.1	0.7	0.0	0.8	1.6			0.2		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.4	0.6	0.8	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.4	1.2	2.6	0.0	0.0	1.0	0.5	0.5	0.0	0.0	0.2	0.3	0.9	0.2	2.3	0.0	0.4	0.3	0.4	0.0	0.1	0.6	0.2	1.1	1.8	1.4	1.7	0.3	1.3	0.5	1.2	3.0	3.3	0.2	0.0	1.2	0.8	0.0	1.1	0.5	0.6	0.3	1.0	5.7	1.5	1.8	0.2	0.8	0.2	1.0	4.8	0.3	0.4	1.4	0.1	0.6	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.0	2.1	0.4											3.0	3.0	0.0	4.8	0.2	0.0	0.0	2.5	0.0	1.2	1.8	0.0	0.0	1.7	0.3	0.2	0.6	0.0	0.0	20.9	0.0	0.0	18.1	4.6	3.9	0.1	0.0	1.2	0.0	0.0	0.5	0.3	0.0	0.0	1.0	0.0	3.7	8.3	0.0	0.0	8.2	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	9.7
AZGP1	"ZA2G, ZAG"	ENSG00000160862	"Alpha-2-glycoprotein 1, zinc-binding"	P25311	7	99966720-99976157	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 158.8;salivary gland: 270.5"	"Group enriched"	"Detected in many"	6	"Glandular cells: 2272.6;Hepatocytes: 3981.0"	"Group enriched"	"Detected in many"	12	"breast cancer: 412.6;liver cancer: 273.6;prostate cancer: 469.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 16.8;Karpas-707: 9.6;OE19: 49.6;RPMI-8226: 38.9;T-47d: 13.0"	"Region enriched"	"Detected in single"	4	"olfactory region: 0.9"					"HPA012582, HPA012876, CAB016087, CAB032276"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	55200000000	160000000000	Vesicles	Nucleoplasm	"CAB016087: AB_667849, CAB032276: AB_2062580, HPA012582: AB_1845226, HPA012876: "	"unprognostic (8.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.41e-1)"	"unprognostic (5.42e-3)"	"unprognostic (4.98e-2)"	"unprognostic (5.74e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-3)"	6.4	0.0	1.1	1.3	1.7	0.0	64.1	1.1	1.4	1.1	1.4	1.5	0.9	1.4	0.9	1.2	1.3	0.0	2.2	9.0	1.2	0.4	18.0	158.8	3.0	0.9	2.7	1.2	1.0	55.3	0.0	0.9	1.0	1.3	62.4	0.0	1.6	270.5	2.5	1.0	11.5	1.5	0.9	1.1	0.9	14.4	1.2	1.7	0.9	1.0	3.0	3.2	1.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.2	4.3	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	1.6	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	1.4	0.0	49.6	0.0	0.0	0.5	38.9	0.0	0.0	0.0	0.6	0.2	7.9	3.8	0.0	13.0	0.0	0.0	0.1	0.0	0.6	0.3	0.6	0.2	0.1	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	1.7	1.1	1.4	1.2	0.4	2.7	1.2	1.3	1.7	20.8	187.7	32.0	321.8	3.8	0.0	94.8	420.4	5.3	50.0	5.2	2.0	0.0	39.7	11.0	1.3	0.4	8.5	46.7	221.1	0.0	0.2	2272.6	3.5	3981.0	0.0	0.0	11.9	58.3	79.1	3.1	0.9	0.3	59.1	3.6	5.4	22.6	173.5	5.8	0.0	512.3	0.2	0.0	1.1	4.3	0.4	8.4	0.0	15.2	6.3	497.4
ZKSCAN1	"KOX18, PHZ-37, ZNF139, ZNF36, ZSCAN33"	ENSG00000106261	"Zinc finger with KRAB and SCAN domains 1"	P17029	7	100015572-100041689	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Intestinal endocrine cells: 212.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006672	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		Yes	No			"Nuclear bodies"	"Nucleoplasm, Mitochondria"	"HPA006672: AB_1080707"	"unprognostic (2.58e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.76e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.34e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.27e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.09e-3)"	11.7	19.5	16.1	12.1	23.9	8.1	23.6	15.0	23.9	16.8	21.2	38.9	16.3	18.1	16.2	18.3	19.8	23.0	25.1	10.8	18.8	15.2	14.2	47.6	11.7	12.2	26.1	27.3	20.6	26.7	18.3	14.3	11.1	27.6	24.3	24.3	14.7	25.0	19.4	11.9	32.5	16.5	14.3	23.6	13.5	33.0	16.4	23.1	17.3	12.5	11.4	12.1	14.4	17.5	6.1	7.3	13.3	10.0	11.7	7.5	4.5	9.2	6.8	18.1	19.8	18.7	22.8	6.8	10.4	12.7	6.2	6.3	4.1	8.8	10.5	13.3	11.6	11.0	7.7	10.4	9.0	12.0	10.1	6.4	8.5	8.3	10.6	10.6	16.1	10.2	15.3	14.4	8.4	28.3	17.0	13.7	12.5	19.5	9.2	12.3	12.3	15.3	9.6	7.3	17.4	8.6	9.1	9.2	9.4	10.5	14.6	21.1	25.2	16.2	21.3	18.3	10.8	10.8	10.8	20.6	13.7	13.4	15.9	10.5	10.7	18.5	10.9	9.3	11.6	17.9	13.3	4.7	5.0	6.8	4.0	6.7	5.1	5.4	6.7	7.3	6.1	7.5	5.3	5.3	11.7	10.0	5.2	4.3	4.5	16.1	23.9	15.0	23.9	18.8	15.2	26.1	27.3	27.6	23.1	23.8	39.4	30.6	38.6	13.4	91.6	37.3	142.7	161.9	56.9	43.6	141.4	32.1	13.3	46.0	35.7	43.9	59.0	0.0	38.3	12.7	32.9	84.1	33.6	124.6	17.1	84.2	212.3	35.6	28.8	14.6	47.5	27.1	38.8	27.9	82.8	74.9	41.8	84.2	50.2	23.0	68.3	19.4	22.2	28.9	14.6	18.7	55.2	18.7	98.9	47.9
ZSCAN21	"DKFZp434L134, NY-REN-21, Zipro1, ZNF38"	ENSG00000166529	"Zinc finger and SCAN domain containing 21"	Q9Y5A6	7	100049774-100065038	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA016948, HPA023591"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA016948: , HPA023591: AB_1859037"	"unprognostic (2.44e-3)"	"unprognostic (3.77e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.42e-3)"	"unprognostic (8.59e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (6.09e-2)"	10.6	12.2	10.9	10.8	11.1	8.1	12.5	15.2	14.8	13.6	12.3	16.3	10.7	7.3	15.9	14.9	10.9	13.9	12.7	8.3	10.8	9.9	14.9	14.8	9.4	8.5	12.0	15.5	13.7	20.3	12.1	10.7	12.0	11.1	13.1	8.4	14.9	16.3	11.9	16.1	9.7	9.6	12.2	11.5	9.1	10.6	26.0	13.3	10.5	12.6	5.7	7.3	11.2	9.7	7.7	6.5	13.5	6.4	10.2	12.0	5.1	4.5	7.6	12.6	14.5	11.8	7.7	10.3	5.2	7.9	10.2	10.3	6.0	5.1	4.8	6.5	6.1	17.4	4.1	11.1	7.4	10.2	6.4	9.2	4.4	6.1	5.5	12.8	6.1	1.8	9.0	13.1	9.9	16.7	8.5	8.1	10.0	10.3	4.3	7.5	11.3	10.4	10.3	15.5	6.2	5.7	7.2	10.1	5.8	8.5	7.0	6.5	16.4	7.0	15.3	9.9	18.6	6.1	5.4	3.8	9.3	11.5	8.1	7.1	8.4	7.8	10.8	4.4	4.0	12.4	13.5	6.4	12.7	11.1	6.3	12.0	7.7	6.9	10.2	6.5	7.1	7.6	8.6	0.8	10.2	3.9	6.2	7.5	5.1	10.9	11.1	15.2	14.8	10.8	9.9	12.0	15.5	11.1	13.3	3.0	3.2	3.7	2.9	1.3	5.2	1.2	5.1	2.7	5.7	3.5	2.0	14.7	6.6	6.1	1.7	4.2	2.6	0.0	3.5	5.4	4.3	3.4	2.3	4.7	4.4	9.5	1.7	1.8	2.6	0.0	5.5	2.2	3.3	3.6	2.5	15.4	4.2	3.4	9.2	8.4	5.3	0.0	4.1	10.4	17.7	3.3	14.8	1.8	2.9	1.4
ZNF3	"A8-51, FLJ20216, HF.12, KOX25, PP838, Zfp113"	ENSG00000166526	"Zinc finger protein 3"	P17036	7	100064033-100082548	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003719	Supported	Supported	Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA003719: AB_1080701"	"unprognostic (5.92e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (5.73e-4)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.65e-1)"	"unprognostic (2.50e-3)"	"unprognostic (7.54e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.41e-2)"	"prognostic favorable (2.20e-4)"	16.1	12.8	12.8	9.8	16.8	20.7	19.2	18.3	22.6	18.6	16.4	39.5	16.6	19.3	23.9	20.5	15.2	33.9	11.6	11.5	14.8	11.2	15.0	19.3	11.7	11.1	20.8	11.1	22.5	18.9	17.9	17.8	13.3	21.1	15.6	17.8	19.7	16.4	16.3	18.9	15.4	22.1	14.6	18.0	15.6	16.0	11.8	21.9	21.4	17.6	11.1	16.6	16.7	15.5	16.2	11.2	17.9	12.2	17.3	17.2	9.4	6.2	7.0	19.3	27.6	9.8	7.7	11.3	8.0	9.1	12.2	10.4	8.7	9.4	9.0	14.6	7.6	9.9	8.5	14.2	8.7	10.0	9.9	12.0	7.3	9.1	11.9	11.6	13.0	6.9	9.5	10.9	8.1	19.1	13.5	10.8	13.4	20.3	14.3	11.0	16.8	30.5	13.1	26.6	11.3	12.8	13.1	15.6	22.3	10.9	12.4	21.7	30.2	9.3	27.9	12.4	19.1	8.2	13.2	8.3	15.2	10.9	10.8	10.3	19.2	21.7	17.9	7.7	11.7	14.2	12.3	9.8	17.9	14.2	9.6	17.2	13.3	12.5	14.9	9.9	16.2	14.2	15.5	4.1	17.3	12.2	11.2	11.5	9.4	12.8	16.8	18.3	22.6	14.8	11.2	20.8	11.1	21.1	21.9	11.9	35.9	12.2	8.4	6.8	16.1	9.8	25.5	38.8	14.8	3.5	15.7	10.4	6.6	16.8	1.1	14.6	19.7	0.0	9.6	5.9	8.5	10.1	15.0	12.4	5.7	17.5	25.2	10.4	12.0	1.1	14.1	6.0	3.3	11.8	17.4	20.5	13.3	17.5	14.2	10.6	18.3	6.5	7.3	10.3	17.4	7.9	8.7	11.8	15.8	7.4
COPS6	"CSN6, MOV34-34KD"	ENSG00000168090	"COP9 signalosome subunit 6"	Q7L5N1	7	100088954-100092200	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044315	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		58000	Nucleoplasm		"HPA044315: AB_10959750"	"unprognostic (1.48e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.45e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (6.72e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-2)"	"unprognostic (8.57e-2)"	"unprognostic (8.77e-2)"	25.4	30.0	37.7	20.2	50.6	19.7	25.6	31.5	43.3	32.5	30.4	26.5	15.1	19.3	31.0	39.8	33.4	33.7	32.4	47.2	31.5	32.1	31.7	41.2	20.1	30.4	33.3	32.6	30.8	42.8	38.1	28.2	29.1	34.1	27.4	26.6	25.0	28.3	35.7	53.1	23.4	19.2	45.2	30.1	22.7	26.9	25.5	30.8	29.4	27.6	21.6	25.8	26.7	24.8	53.4	67.6	58.9	64.0	48.2	69.4	45.3	32.3	46.2	27.7	32.9	24.4	29.2	17.6	29.4	45.3	49.3	36.3	37.7	30.7	22.4	38.1	48.2	55.1	24.8	31.3	49.8	50.0	22.3	49.1	19.1	45.8	29.0	51.1	21.6	19.9	28.8	33.1	53.1	56.8	33.0	67.4	34.8	27.4	32.4	58.0	80.6	47.8	32.2	25.0	47.7	55.5	22.9	46.1	53.4	39.2	30.5	43.5	32.3	30.4	60.2	22.3	38.0	24.8	21.4	35.3	47.6	43.4	56.9	51.7	24.0	26.6	45.9	36.0	29.5	70.2	58.9	61.9	51.7	61.1	64.0	61.2	53.4	61.3	57.8	67.6	49.8	48.3	53.9	24.1	48.2	57.4	50.2	69.4	45.3	37.7	50.6	31.5	43.3	31.5	32.1	33.3	32.6	34.1	30.8	47.6	36.9	81.5	102.7	98.2	102.2	140.2	79.0	83.0	60.3	82.0	49.1	166.8	179.1	109.3	59.3	92.0	58.6	46.7	99.3	110.5	106.3	89.3	89.9	52.9	111.6	90.6	72.3	79.8	61.4	119.0	118.2	67.5	148.5	112.8	58.6	129.0	94.7	59.6	117.8	164.9	114.4	97.0	134.0	70.6	115.8	87.7	115.3	82.8	79.4	85.2
MCM7	"CDC47, MCM2, PPP1R104"	ENSG00000166508	"Minichromosome maintenance complex component 7"	P33993	7	100092728-100101940	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002163, HPA003898, CAB016312"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB002163: AB_564113, CAB016312: AB_627235, HPA003898: AB_1853632"	"unprognostic (1.87e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (1.36e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (2.18e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.79e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.34e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.38e-1)"	8.6	5.2	17.5	13.6	21.7	37.3	11.2	20.0	20.6	8.2	14.2	19.2	15.0	10.4	16.0	6.3	10.7	8.6	9.9	5.1	18.1	12.4	5.5	8.5	7.4	22.4	23.7	9.5	12.6	13.1	7.5	10.3	10.7	15.5	10.0	15.7	7.2	9.2	9.2	11.5	10.1	10.3	11.7	23.5	10.7	7.8	14.9	22.3	7.5	9.4	4.1	28.2	10.3	10.0	7.3	5.7	1.9	5.7	7.6	9.0	6.0	24.9	28.8	31.8	24.0	3.1	4.1	16.3	15.2	18.4	42.5	45.3	22.0	26.4	42.3	14.5	10.8	27.1	19.8	46.7	22.1	35.9	21.6	39.9	26.9	16.2	15.2	1.7	45.7	17.5	2.8	4.2	31.1	18.7	5.4	16.1	24.4	51.5	34.7	21.5	53.3	77.6	18.7	27.9	23.2	20.9	41.8	46.7	51.6	8.2	15.1	20.8	31.7	24.0	22.3	7.5	18.6	10.2	19.2	6.8	16.0	29.1	31.4	30.1	14.5	24.8	76.1	11.1	36.7	28.6	1.8	2.5	1.9	8.1	4.1	6.2	5.3	5.7	7.9	5.5	7.3	5.9	5.7	1.6	7.6	5.7	5.7	9.0	6.0	17.5	21.7	20.0	20.6	18.1	12.4	23.7	9.5	15.5	22.3	8.9	17.0	23.7	20.7	41.4	8.7	7.9	15.3	24.1	9.1	3.5	13.7	90.8	8.3	17.6	40.0	14.5	15.8	70.0	22.4	78.1	17.3	11.3	24.2	10.4	34.4	6.4	16.7	8.0	10.8	22.7	19.5	16.5	18.6	17.2	34.7	10.1	16.0	20.1	14.5	9.1	11.9	12.9	22.7	83.2	67.3	30.9	60.2	28.7	60.9	12.3
AP4M1	"MU-4, MU-ARP2, SPG50"	ENSG00000221838	"Adaptor related protein complex 4 mu 1 subunit"	O00189	7	100101549-100110345	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 71.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066774	Approved					NA	NA					"HPA066774: AB_2685718"	"unprognostic (6.40e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.22e-2)"	"unprognostic (2.24e-3)"	"prognostic unfavorable (7.63e-5)"	"unprognostic (1.58e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.05e-2)"	"unprognostic (7.18e-2)"	"prognostic unfavorable (8.29e-4)"	"unprognostic (6.59e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.46e-1)"	7.3	7.8	10.4	6.3	10.4	4.7	13.3	9.5	11.1	9.9	12.4	11.1	12.4	13.9	15.4	12.3	12.4	13.9	17.6	12.0	10.3	8.9	9.7	4.3	12.1	7.2	13.4	8.3	9.2	22.0	9.4	14.6	9.5	8.9	11.9	7.3	10.0	13.7	14.4	10.3	12.8	13.7	21.5	9.9	6.7	11.3	26.3	7.4	8.0	10.2	9.5	5.6	11.0	9.3	7.2	11.2	13.3	13.6	3.0	7.3	5.8	4.8	7.4	8.6	20.0	5.2	11.6	10.2	3.2	6.3	4.7	5.8	6.7	15.4	6.5	17.0	7.8	8.0	4.7	3.6	6.8	2.3	6.1	4.6	3.3	5.7	7.1	10.9	3.9	4.7	9.3	11.6	12.9	7.2	10.0	15.0	10.1	6.9	4.2	15.1	17.5	14.6	8.0	6.7	5.7	9.2	12.5	4.1	7.8	10.6	5.9	15.0	12.3	9.5	23.1	6.8	5.0	10.2	7.6	14.3	12.9	10.6	10.2	4.8	3.0	3.7	9.4	9.9	4.5	11.4	6.4	9.0	13.3	6.8	10.0	5.6	7.2	6.3	7.3	11.2	4.4	3.4	4.6	2.4	3.0	13.6	6.3	6.0	5.8	10.4	10.4	9.5	11.1	10.3	8.9	13.4	8.3	8.9	7.4	14.9	2.9	9.3	15.3	8.4	16.4	3.3	20.4	26.8	9.1	15.7	49.1	12.4	6.6	20.3	53.3	12.8	15.8	0.0	16.7	14.1	10.6	11.6	3.5	2.9	8.8	6.4	11.6	11.6	6.3	71.6	13.6	7.0	13.5	18.0	13.3	26.6	17.2	17.3	12.0	8.1	62.4	12.9	9.0	67.4	36.5	7.3	11.7	8.4	13.3	9.6
TAF6	"MGC:8964, TAF2E, TAFII70, TAFII80, TAFII85"	ENSG00000106290	"TATA-box binding protein associated factor 6"	P49848	7	100107070-100119841	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006566			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006566: AB_1080194"	"unprognostic (5.60e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (6.06e-5)"	"unprognostic (2.02e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.38e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.37e-1)"	14.1	19.8	21.5	15.4	23.6	13.9	12.0	23.5	35.8	19.4	17.5	12.7	12.6	12.1	24.1	17.6	16.8	23.6	16.8	17.2	20.5	16.3	16.1	10.2	12.9	14.3	13.1	15.9	26.2	16.6	22.6	21.7	19.5	19.3	15.8	13.7	15.6	17.9	23.3	23.1	17.9	13.2	23.7	13.1	14.6	14.0	27.3	14.7	21.7	21.3	11.5	17.0	19.6	14.9	15.3	14.3	13.2	25.7	14.0	18.7	13.1	17.1	32.2	20.9	34.2	27.5	14.6	29.3	18.9	21.2	24.4	22.6	23.9	21.0	15.7	21.6	28.9	41.9	14.6	28.6	22.5	26.3	25.6	18.6	15.1	31.3	15.8	27.4	14.6	14.3	14.9	14.1	35.7	39.5	19.7	19.7	27.9	26.1	29.1	22.0	61.0	31.0	23.7	30.8	15.5	26.0	22.9	25.7	23.3	17.4	14.0	19.0	27.6	23.9	37.1	15.8	31.5	13.5	14.5	19.5	37.0	38.1	47.8	24.4	18.0	31.1	26.4	25.1	20.5	31.8	12.7	11.0	13.2	15.6	11.4	18.7	10.2	15.0	15.7	14.3	15.3	15.3	14.3	6.4	14.0	25.7	8.5	13.9	13.1	21.5	23.6	23.5	35.8	20.5	16.3	13.1	15.9	19.3	14.7	8.9	10.2	11.1	17.3	10.1	12.5	0.9	15.3	16.0	6.8	24.4	0.0	61.4	14.9	20.7	21.7	10.8	11.9	0.0	14.6	30.0	16.7	12.7	0.0	6.4	18.1	12.7	15.0	10.4	7.8	34.8	20.1	9.7	11.8	24.4	11.8	16.7	14.1	14.2	29.4	17.8	11.6	25.8	18.9	24.5	61.1	10.3	28.8	17.5	14.3	12.2
CNPY4	"MGC40499, PRAT4B"	ENSG00000166997	"Canopy FGF signaling regulator 4"	Q8N129	7	100119613-100125511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Leydig cells: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014166, HPA025240"	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA014166: AB_1853895, HPA025240: AB_2082630"	"unprognostic (9.64e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.09e-3)"	"unprognostic (8.44e-2)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.59e-5)"	"unprognostic (6.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.35e-2)"	12.9	18.3	10.9	13.4	9.9	5.5	11.6	16.5	13.1	22.8	13.0	14.8	8.8	6.1	23.5	15.8	6.3	16.2	20.3	13.6	9.9	9.1	11.0	6.7	9.2	15.5	9.5	9.9	26.1	7.2	17.6	17.8	20.8	10.4	14.0	10.3	18.0	6.5	17.0	4.7	8.3	9.5	21.7	11.4	14.0	8.4	9.1	13.7	16.4	11.1	9.6	9.5	13.0	16.2	2.8	5.2	8.8	9.3	8.3	15.2	4.7	3.3	5.8	14.6	26.1	34.4	16.6	7.3	12.6	13.6	6.6	12.4	3.1	3.0	7.3	14.6	22.5	4.8	3.4	5.7	6.1	6.9	6.8	5.8	3.0	9.6	4.4	9.8	5.1	5.7	15.1	1.7	6.0	2.7	14.5	22.8	3.6	2.5	4.9	9.4	9.6	10.7	6.7	7.5	2.1	8.4	3.1	11.0	3.9	6.7	0.8	3.6	7.4	12.0	9.7	6.4	9.9	4.9	2.8	18.4	21.2	12.8	8.8	5.6	4.2	6.7	6.6	12.4	7.9	8.6	8.8	3.7	5.7	11.8	8.0	15.2	2.8	12.1	14.7	5.2	2.4	9.9	14.9	1.7	8.3	9.3	3.3	9.6	4.7	10.9	9.9	16.5	13.1	9.9	9.1	9.5	9.9	10.4	13.7	6.0	1.6	0.0	2.0	3.2	6.6	3.2	5.1	4.0	4.5	12.2	2.0	29.6	1.7	5.4	0.4	11.7	2.3	23.3	2.2	8.4	26.6	0.6	9.2	0.9	11.9	7.9	2.4	19.6	1.6	0.9	32.5	3.6	15.1	5.4	1.8	25.5	2.7	2.9	29.7	2.3	13.7	12.9	12.3	1.0	3.8	3.3	15.3	6.5	1.9	0.7
MBLAC1	MGC49416	ENSG00000214309	"Metallo-beta-lactamase domain containing 1"	A4D2B0	7	100126694-100128498	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA071574	Uncertain					NA	NA					"HPA071574: AB_2686419"	"unprognostic (8.28e-3)"	"unprognostic (4.83e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.84e-3)"	"unprognostic (2.38e-4)"	"unprognostic (1.18e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (1.21e-1)"	"prognostic favorable (7.90e-5)"	"unprognostic (7.83e-2)"	"unprognostic (5.30e-2)"	"unprognostic (4.07e-1)"	"unprognostic (5.88e-2)"	3.7	5.2	5.4	2.6	7.9	3.1	2.1	12.3	13.8	2.9	3.1	3.2	10.5	6.6	3.6	2.2	2.8	3.7	5.0	4.4	5.3	4.2	4.2	3.3	4.0	2.4	3.6	6.2	5.2	3.5	2.5	6.0	3.1	3.2	4.6	1.9	2.6	8.0	5.1	5.7	3.0	4.0	2.5	3.1	2.9	3.7	3.6	2.6	0.7	2.6	2.9	1.7	3.0	2.8	3.7	0.7	3.2	1.6	1.1	2.6	0.3	2.9	2.8	1.6	1.8	2.0	0.6	2.5	3.1	1.4	1.8	1.3	4.1	2.1	1.7	2.9	1.6	4.8	1.5	0.6	0.0	0.4	5.8	3.7	1.0	2.5	2.8	1.8	2.9	2.8	1.2	0.3	1.1	0.7	1.8	1.3	2.5	2.2	7.5	1.2	3.3	5.4	2.4	2.0	0.4	6.1	3.8	2.4	3.3	0.5	3.4	2.4	4.8	5.1	7.5	2.7	0.5	0.8	1.4	1.9	3.9	7.5	2.9	4.5	5.1	3.4	7.1	1.5	2.4	4.5	0.3	0.7	2.2	1.2	0.8	0.9	0.4	1.6	1.8	0.6	3.7	2.6	2.4	3.2	1.1	1.6	0.7	0.0	0.3	5.4	7.9	12.3	13.8	5.3	4.2	3.6	6.2	3.2	2.6	0.0	1.4	0.5	4.0	0.5	4.2	3.1	2.5	0.0	1.2	3.5	3.9	1.3	10.0	3.4	0.3	1.0	2.9	0.0	4.4	1.1	2.1	3.7	0.0	2.0	2.5	4.8	2.9	1.8	0.8	0.9	6.9	2.0	0.0	4.6	2.3	6.0	2.4	0.9	3.9	5.9	4.5	6.5	1.4	2.3	2.1	1.0	1.7	1.3	2.1	1.0
LAMTOR4	C7orf59	ENSG00000188186	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 4"	Q0VGL1	7	100148907-100155944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 206.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 206.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020998	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA020998: AB_1845762"	"prognostic favorable (2.48e-4)"	"prognostic favorable (6.08e-4)"	"unprognostic (1.29e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.21e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.42e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.68e-2)"	31.0	30.7	43.8	36.0	40.2	54.7	43.2	20.9	70.6	28.5	41.8	27.9	26.5	28.6	25.0	35.3	32.9	35.9	36.0	42.2	39.5	35.1	36.3	24.9	32.0	44.7	49.5	30.7	30.0	36.9	19.3	28.5	26.8	38.7	30.8	34.5	31.2	35.4	27.5	44.4	84.7	27.2	31.3	47.8	41.5	29.7	21.3	35.2	15.7	37.3	33.1	26.6	31.3	39.6	31.4	35.1	206.0	53.2	17.6	26.5	46.2	19.2	46.9	24.8	31.3	26.4	30.5	20.2	11.6	28.6	21.6	26.8	21.6	31.1	31.1	39.3	17.5	39.5	20.4	23.5	29.9	9.3	31.4	66.4	24.8	44.4	37.2	24.9	19.2	35.9	36.5	29.6	22.6	28.0	24.2	33.0	29.2	23.3	50.2	29.4	91.9	18.6	77.5	26.3	53.5	37.7	19.6	20.4	55.4	24.5	23.6	17.5	32.4	21.4	50.4	38.4	19.8	20.2	38.2	22.0	20.7	30.8	42.6	18.6	30.5	40.6	57.6	33.0	54.0	29.3	52.0	53.2	183.0	19.6	46.9	16.3	31.4	24.8	20.2	35.1	27.7	25.5	20.5	206.0	17.6	43.4	29.7	26.5	46.2	43.8	40.2	20.9	70.6	39.5	35.1	49.5	30.7	38.7	35.2	86.4	157.1	194.3	153.1	244.3	54.7	157.4	145.2	139.2	85.3	207.6	11.8	217.7	452.6	149.0	26.3	183.1	559.6	0.0	283.4	159.4	191.6	159.9	180.0	212.1	461.4	55.6	287.5	220.4	484.9	36.2	135.4	342.4	411.7	182.1	346.6	148.8	173.2	634.8	113.1	406.9	51.3	142.3	219.3	71.5	128.6	579.4	168.4	176.8	418.7	161.9
C7orf43	FLJ10925	ENSG00000146826	"Chromosome 7 open reading frame 43"	Q8WVR3	7	100154420-100158715	"Predicted intracellular proteins"			"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019359, HPA029463, HPA029464"	Approved		Enhanced	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA			Vesicles	"Plasma membrane, Centriolar satellite"	"HPA019359: AB_1848677, HPA029463: AB_10600001, HPA029464: AB_10600205"	"unprognostic (1.57e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.59e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.36e-3)"	"unprognostic (5.68e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.25e-1)"	"prognostic favorable (6.19e-5)"	"unprognostic (2.42e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.26e-1)"	"unprognostic (6.54e-3)"	7.0	10.4	10.6	23.0	11.3	12.2	12.2	24.8	23.2	6.7	14.0	9.4	13.6	16.2	9.6	10.8	12.1	8.4	10.5	6.4	12.8	13.9	12.3	12.9	19.0	21.4	10.8	10.6	5.7	11.6	18.7	14.5	21.6	14.6	10.2	13.5	8.8	13.5	10.8	10.1	28.1	16.4	6.9	6.0	25.8	14.9	26.8	6.9	17.6	12.2	7.4	14.0	8.5	7.8	2.1	0.7	5.2	1.7	0.5	2.6	1.0	4.8	6.3	7.5	12.6	4.7	2.5	8.4	9.1	7.2	6.4	4.6	4.9	5.8	6.2	8.4	6.9	9.9	9.5	3.5	7.3	2.5	11.6	6.8	4.6	7.9	4.3	5.6	5.8	21.8	5.1	5.0	6.2	4.8	4.6	5.5	6.4	10.1	11.3	8.3	15.2	13.1	12.4	8.3	9.1	9.2	7.9	3.4	6.9	5.5	5.6	9.5	10.1	8.2	24.0	4.8	5.2	4.8	7.0	7.6	12.7	10.8	16.8	7.0	16.9	15.9	6.3	7.1	8.0	13.4	1.7	1.0	3.5	2.0	1.6	1.4	0.9	2.6	1.8	0.7	2.1	1.5	2.2	5.2	0.5	1.7	0.6	0.2	1.0	10.6	11.3	24.8	23.2	12.8	13.9	10.8	10.6	14.6	6.9	0.0	3.2	2.9	4.0	4.9	7.5	1.4	0.0	4.0	1.2	7.0	0.0	4.8	0.0	4.6	3.5	3.1	8.8	0.0	7.3	5.9	2.3	5.6	0.0	1.5	7.0	11.1	4.1	5.5	5.6	2.5	2.0	5.4	0.0	9.0	5.1	5.0	9.1	10.1	1.1	2.1	5.1	6.5	2.3	14.0	5.9	9.5	16.2	4.4	5.3	4.8
GAL3ST4	FLJ12116	ENSG00000197093	"Galactose-3-O-sulfotransferase 4"	Q96RP7	7	100159244-100168750	"Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 37.8"	"Cell type enriched"	"Detected in some"	6	"Hofbauer cells: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 4.4;naive CD4 T-cell: 15.0;naive CD8 T-cell: 4.5;plasmacytoid DC: 4.3"	"Group enriched"	"Detected in many"	26	"dendritic cells: 4.3;T-cells: 15.0"	"Cell line enhanced"	"Detected in many"		"WM-115: 29.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038137, HPA038138"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038137: AB_10697239, HPA038138: AB_2675854"	"unprognostic (4.22e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (5.44e-4)"	"unprognostic (8.64e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.57e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (3.98e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.36e-2)"	3.9	5.4	8.4	4.2	9.4	1.0	4.1	1.5	10.9	7.8	6.5	18.6	0.4	4.1	9.0	3.7	8.4	6.3	5.9	4.9	8.0	3.8	1.8	1.0	5.3	2.9	11.9	4.7	7.6	1.5	1.6	4.6	9.8	8.1	6.5	7.0	4.2	24.9	4.3	1.9	27.8	8.9	10.6	14.9	2.7	2.8	4.4	10.2	37.8	2.0	2.4	3.9	7.3	10.6	0.1	4.3	0.3	0.1	0.2	15.0	2.2	0.0	0.6	4.0	1.8	3.6	7.1	7.6	2.2	2.2	1.3	1.8	0.4	0.2	0.7	0.5	7.4	2.3	8.6	0.2	1.3	0.4	0.0	0.4	0.2	0.1	0.2	2.4	0.4	2.4	8.7	3.4	3.9	0.4	2.8	2.5	3.1	1.1	0.1	2.4	0.3	2.7	0.1	1.3	8.2	0.9	2.2	1.8	0.1	0.0	0.3	0.2	1.7	0.6	0.0	4.6	0.7	0.0	0.2	2.2	0.2	1.2	0.3	0.1	0.1	0.1	1.7	1.4	0.4	29.6	0.0	0.1	0.0	0.5	0.0	0.0	0.0	4.4	0.3	0.0	0.1	15.0	4.5	0.3	0.2	0.1	4.3	1.1	2.2	8.4	9.4	1.5	10.9	8.0	3.8	11.9	4.7	8.1	10.2	0.0	0.3	0.0	2.0	3.8	0.0	0.8	2.5	0.0	1.2	0.0	0.0	0.3	0.0	0.5	0.1	0.5	0.0	0.0	0.0	0.2	6.0	0.3	0.0	0.0	38.9	0.0	0.0	1.8	0.3	0.0	4.4	0.7	5.0	1.0	0.6	0.5	0.5	2.9	4.9	0.0	0.0	0.0	2.2	0.4	0.2	7.0	0.7	0.0	6.0	0.9
GPC2	"cerebroglycan, DKFZp547M109, FLJ38962"	ENSG00000213420	"Glypican 2"	Q8N158	7	100169606-100177372	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 34.3;skin 1: 9.4;testis: 16.7"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 30.9;Intestinal endocrine cells: 10.3;Spermatocytes: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 24.2;AN3-CA: 9.7;BEWO: 8.6;SH-SY5Y: 26.7"					"Low region specificity"	"Detected in all"			CAB025423	Uncertain				"Intracellular and membrane"	NA	NA					"CAB025423: "	"unprognostic (4.33e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.59e-4)"	"unprognostic (3.42e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.87e-4)"	"unprognostic (7.25e-4)"	"unprognostic (1.67e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (9.94e-4)"	0.5	0.5	3.2	3.5	1.9	1.9	0.6	2.2	4.3	0.8	0.9	2.1	0.0	0.5	2.6	0.3	0.2	0.4	0.4	0.3	2.9	1.6	0.2	0.1	0.5	2.2	2.0	0.9	0.8	0.3	0.5	0.7	0.3	1.5	0.5	0.8	0.5	1.7	0.4	0.8	9.4	0.7	0.8	3.3	1.4	0.3	16.7	2.0	34.3	0.3	0.7	2.0	0.6	1.1	0.0	0.1	0.0	0.0	0.0	0.9	0.3	0.0	0.1	24.2	9.7	0.0	0.0	8.6	0.8	0.0	0.1	0.2	0.0	0.3	2.0	0.5	0.2	1.4	0.8	0.8	0.3	0.0	0.0	0.7	0.2	0.3	0.0	0.4	0.5	3.7	0.8	0.4	0.5	0.0	0.4	1.1	5.4	0.9	0.0	0.6	0.3	5.5	0.7	4.2	0.4	1.4	6.3	1.7	0.0	0.1	0.4	6.4	26.7	0.5	0.6	0.8	3.5	0.4	0.4	0.9	0.2	3.9	0.5	0.1	0.8	0.3	2.8	0.2	1.2	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.3	3.2	1.9	2.2	1.7	2.9	1.6	2.0	0.9	1.5	2.0	0.0	0.0	0.0	0.9	1.5	0.1	1.4	0.0	0.0	0.0	1.8	3.9	0.3	0.0	1.1	30.9	0.6	0.0	0.0	0.8	0.6	0.6	0.7	0.0	0.0	0.3	0.0	10.3	0.0	0.3	4.1	0.9	0.6	0.0	0.0	0.8	1.7	1.2	0.0	1.1	0.0	1.8	0.0	0.9	12.5	5.5	3.3	0.3	0.0	1.2	0.6
STAG3		ENSG00000066923	"Stromal antigen 3"	Q9UJ98	7	100177563-100221488	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Chromosome partition, Meiosis"		"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 85.4"	"Cell type enhanced"	"Detected in many"	10	"B-cells: 79.6;Spermatocytes: 87.4;Spermatogonia: 38.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	8	"memory B-cell: 4.8;naive B-cell: 7.6"	"Lineage enriched"	"Detected in single"	10	"B-cells: 7.6"	"Group enriched"	"Detected in some"	6	"BEWO: 27.0;HMC-1: 34.2;U-698: 9.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA049106, HPA058330"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA049106: AB_2680634, HPA058330: AB_2683681"	"unprognostic (6.56e-4)"	"prognostic favorable (8.45e-4)"	"unprognostic (1.25e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.31e-4)"	"unprognostic (4.26e-4)"	"unprognostic (7.48e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.07e-4)"	0.4	0.7	0.4	0.9	1.0	0.3	0.2	0.6	3.8	0.3	0.3	1.1	0.5	0.1	0.5	0.4	0.3	7.8	0.4	0.5	0.6	0.2	0.2	3.9	0.3	1.2	0.5	0.6	0.4	1.4	0.0	0.2	0.4	0.5	0.3	0.2	0.5	0.2	0.5	4.1	0.5	2.2	0.4	0.7	5.1	0.1	85.4	0.8	0.7	0.3	0.2	1.6	0.3	0.2	7.6	0.5	0.2	0.7	0.2	0.5	0.3	0.0	2.0	0.8	0.1	0.1	0.0	27.0	1.4	0.0	0.1	0.1	0.0	0.0	0.9	0.2	0.3	0.0	0.0	0.0	0.1	0.0	3.8	0.4	0.0	0.0	0.6	0.0	0.0	34.2	0.0	0.0	0.6	0.1	0.0	0.1	0.8	0.4	0.0	0.0	0.5	1.6	0.1	0.8	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.5	1.5	0.6	0.4	0.0	0.4	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	9.8	0.5	0.2	0.4	0.0	0.0	0.0	0.0	0.7	0.1	4.8	0.2	0.5	0.5	7.6	0.4	0.3	0.2	0.2	0.3	0.1	0.0	0.3	0.4	1.0	0.6	0.7	0.6	0.2	0.5	0.6	0.5	0.8	0.0	2.4	79.6	8.0	6.1	7.0	1.8	2.5	14.7	1.2	7.0	2.0	1.7	11.6	0.1	19.3	2.9	1.1	0.0	0.2	2.7	3.3	7.0	1.1	22.9	2.1	19.1	1.2	3.7	2.1	18.4	4.4	4.8	5.0	4.6	4.1	3.2	0.2	0.0	1.8	3.4	7.3	0.0	7.5	87.4	38.7	7.4	2.4	10.4	1.6	9.6
CASTOR3	"DKFZp686B07267, GATS, STAG3OS"	ENSG00000239521	"CASTOR family member 3"	Q8NAP1	7	100200653-100272218	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 14.8;skeletal muscle: 20.4"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 1: 6.0;Ciliated cells: 14.7;Club cells: 7.9;Ductal cells: 5.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 4.3;HMC-1: 3.5"									HPA043176	Uncertain					NA	NA					"HPA043176: AB_10794883"	"unprognostic (8.29e-2)"	"prognostic favorable (7.56e-7)"	"unprognostic (7.67e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.66e-3)"	"unprognostic (9.42e-2)"	"unprognostic (3.90e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.56e-3)"	"unprognostic (5.14e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.86e-2)"	1.8	1.6	3.8	1.3	8.2	4.4	1.5	10.0	10.2	1.8	1.4	14.8	0.0	1.2	2.1	1.2	1.5	1.7	2.1	1.7	4.5		1.4	1.2	1.5	1.8	6.5	5.6	2.6	1.7	1.2	2.6	1.3	10.4	1.6	1.3	0.6	1.9	2.1	20.4	1.4	2.1	1.5	5.3	1.4	1.2	1.5	7.4	2.6	1.5	2.5	1.4	1.2	0.0	0.8	0.0	1.8	0.3	0.6	1.6	0.1	0.5	4.3	1.6	0.0	0.3	0.0	2.6	0.0	0.3	0.3	0.4	1.6	0.3	0.2	2.0	0.3	0.7	0.5	0.1	0.7	0.0	2.8	0.5	0.1	0.4	1.1	0.2	0.0	3.5	0.0	0.9	0.3	0.0	0.3	0.9	2.4	0.1	0.5	0.0	0.3	2.5	0.2	0.3	0.4	1.3	0.9	0.3	0.0	0.7	0.0	2.6	3.0	0.6	0.0	0.0	1.4	0.0	0.0	1.2	0.1	0.6	0.0	0.0	1.8	2.0	0.9	0.1	0.1	0.3	0.0	0.0	1.6	1.6	0.3	0.5	0.8	0.3	0.1	0.0	0.0	0.9	0.6	1.8	0.6	0.1	0.0	0.0	0.1											6.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	7.9	3.5	0.0	3.8	0.0	5.8	0.0	0.0	0.0	0.0	4.3	1.0	0.0	0.0	1.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	4.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
PVRIG	"C7orf15, CD112R, MGC2463"	ENSG00000213413	"PVR related immunoglobulin domain containing"	Q6DKI7	7	100218241-100221490	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 51.7;lymphoid tissue: 21.0"	"Group enriched"	"Detected in some"	7	"Alveolar cells type 2: 1.1;granulocytes: 2.3;Horizontal cells: 3.2;T-cells: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	32	"gdT-cell: 43.5;MAIT T-cell: 51.7;memory B-cell: 24.8;memory CD4 T-cell: 28.9;memory CD8 T-cell: 42.9;naive B-cell: 19.3;naive CD4 T-cell: 32.6;naive CD8 T-cell: 32.2;NK-cell: 42.9;T-reg: 22.8"	"Group enriched"	"Detected in many"	37	"B-cells: 24.8;NK-cells: 42.9;T-cells: 51.7"	"Group enriched"	"Detected in some"	26	"Daudi: 36.9;JURKAT: 21.8;MOLT-4: 40.2;U-698: 11.9"					"Low region specificity"	"Detected in all"			HPA047497	Uncertain		Approved	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Nucleoli, Endoplasmic reticulum"		"HPA047497: AB_2680069"	"unprognostic (1.63e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.21e-3)"	"unprognostic (5.13e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.55e-2)"	"unprognostic (9.29e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.71e-3)"	0.5	0.1	0.4	5.6	0.7	1.2	0.4	0.4	1.1	0.4	0.5	0.7	0.4	0.5	0.4	0.4	0.4	0.3	0.4	0.4	0.4	0.0	0.5	0.9	0.9	15.9	0.4	0.4	0.6	0.5	0.0	0.4	0.4	0.8	0.4	0.0	0.4	0.7	0.4	2.0	0.0	8.9	0.4	0.4	21.0	1.4	0.6	0.4	18.0	0.5	0.4	4.2	1.0	0.4	24.8	0.2	1.0	0.1	42.9	51.7	17.5	0.1	0.8	0.4	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	21.8	0.0	0.1	0.0	0.1	40.2	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.1	0.1	0.0	43.5	0.1	51.7	24.8	28.9	42.9	0.1	19.3	32.6	32.2	1.0	42.9	0.1	0.2	22.8	17.5	0.4	0.7	0.4	0.4	0.4	0.0	0.4	0.4	0.8	0.4	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0
SPDYE3		ENSG00000214300	"Speedy/RINGO cell cycle regulator family member E3"	A6NKU9	7	100307702-100322196	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 1.3;testis: 5.2"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 174.4"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.4"									HPA051750	Supported					NA	NA					"HPA051750: AB_2681590"	"prognostic favorable (8.73e-4)"	"unprognostic (6.27e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (2.00e-6)"	"unprognostic (1.06e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.90e-1)"	"unprognostic (6.91e-2)"	"unprognostic (3.99e-2)"	"unprognostic (7.32e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.08e-2)"	"unprognostic (5.06e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.58e-1)"	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0		0.0	0.2	0.0	0.2	0.0		0.1	0.0		0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.1	5.2			0.1		0.0	0.0	0.0	1.3	0.7	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.2	1.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.4	0.5	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.3	0.0	1.2	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	2.4	0.0	0.1	0.2	0.8	0.5	0.1	0.1	0.3	0.3	0.1	0.0	0.4	0.0	0.4	0.5	0.1	0.0	0.5	0.4	0.0	0.0	0.5	0.5	0.5	0.3	0.6	0.6	1.1	0.1	0.6	0.3	0.0	0.1	0.0	0.2	0.1	0.2	1.3	0.2	0.1	0.0	0.8	0.2	0.2	0.0	0.0	0.0	0.7	0.0	0.0											0.0	0.3	0.0	0.6	1.4	5.3	1.8	0.0	1.4	1.2	0.0	9.8	0.1	0.0	0.0	174.4	0.6	0.0	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.3	36.7	2.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	1.8	0.0	3.5	0.0	1.9	3.3	0.9	1.5	0.1	1.3	0.0	0.7
PILRB	"FDFACT1, FDFACT2"	ENSG00000121716	"Paired immunoglobin-like type 2 receptor beta"	Q9UKJ0	7	100352176-100367733	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"testis: 80.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 51.1;neutrophil: 34.8"	"Group enriched"	"Detected in many"	8	"granulocytes: 51.1;monocytes: 16.8"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 81.3"									HPA026750	Approved		Approved	Mitochondria	"Intracellular and membrane"	NA	Yes			Mitochondria		"HPA026750: AB_10670828"	"unprognostic (8.33e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.32e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.54e-2)"	"unprognostic (6.27e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (4.85e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.35e-3)"	10.6	11.3	8.2	11.2	8.2	11.2	10.2	25.2	10.3	9.9	8.2	8.2	8.2	11.4	10.3	12.6	8.2	10.0	8.8	8.2	8.2	5.0	18.6	17.6	8.2	13.2	8.2	8.2	12.1	12.9	19.0	27.6	9.8	8.2	13.6	10.2	8.2	12.0	10.7	12.3	15.8	10.1	8.2	10.5	16.7	9.2	80.1	8.2	8.2	18.3	8.2	11.0	9.9	8.2	0.3	4.3	51.1	16.8	4.0	2.9	4.7	14.0	11.9	13.7	23.7	15.2	3.5	13.3	8.5	3.8	6.1	6.0	8.4	16.4	11.5	16.3	4.4	10.9	15.1	7.5	9.0	4.2	9.4	11.1	10.6	39.9	7.2	3.4	10.6	27.6	4.4	10.6	8.2	16.8	7.6	5.1	17.2	11.3	28.0	4.2	19.0	16.7	55.3	5.9	11.8	6.3	9.8	4.0	11.7	27.5	23.1	12.8	9.2	7.2	81.3	10.1	15.3	14.2	16.5	12.2	21.8	13.9	13.9	11.0	16.9	21.5	13.9	6.1	15.9	12.8	4.1	8.5	51.1	2.9	14.0	1.7	0.1	0.3	1.8	4.3	0.3	0.3	0.7	34.8	4.0	16.8	0.1	0.1	4.7	8.2	8.2	25.2	10.3	8.2	5.0	8.2	8.2	8.2	8.2	35.7	41.6	25.1	19.4	14.0	37.1	1.1	63.7	37.5	42.1	14.0	64.8	10.8	1.7	5.8	13.5	16.4	15.8	0.0	4.9	9.6	8.9	14.5	23.3	62.2	8.5	71.5	28.3	17.8	14.3	9.1	68.4	12.3	18.6	10.0	23.8	26.5	6.4	17.3	48.1	3.4	60.9	25.8	12.0	43.6	9.8	11.8	13.2	66.0	24.8	10.8
PILRA	FDF03	ENSG00000085514	"Paired immunoglobin like type 2 receptor alpha"	Q9UKJ1	7	100367530-100400099	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"blood: 138.4"	"Cell type enhanced"	"Detected in many"	12	"Hofbauer cells: 82.8;Kupffer cells: 85.3;Leydig cells: 48.6;Macrophages: 111.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 138.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 138.4;monocytes: 87.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 21.0;HMC-1: 18.8;NB-4: 14.2"									HPA056132	Approved				"Secreted to blood"	NA	NA					"HPA056132: AB_2683048"	"unprognostic (5.53e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (7.61e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.01e-3)"	"unprognostic (9.95e-2)"	"unprognostic (8.57e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (3.47e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.80e-2)"	18.6	5.4	7.2	32.3	7.2	19.4	8.2	15.6	6.2	6.1	4.5	10.6	2.3	3.8	4.8	10.0	2.6	7.5	8.4	6.5	7.7	4.4	8.5	8.0	31.9	30.1	11.0	2.6	5.7	5.1	4.3	9.2	13.2	11.9	6.6	4.9	7.1	3.1	4.1	2.5	2.6	3.9	8.6	18.4	29.5	3.1	6.4	10.7	3.3	5.3	1.1	3.3	9.8	5.4	0.1	24.0	138.4	87.3	0.5	0.2	22.9	0.2	0.3	0.4	0.5	21.0	1.4	0.1	0.1	1.0	0.1	0.3	0.0	0.3	0.4	1.2	0.3	0.2	0.6	0.1	0.1	0.0	1.0	0.7	0.4	0.8	0.1	0.2	0.8	18.8	1.5	0.3	0.1	0.4	0.0	0.2	1.7	0.2	1.2	0.1	0.6	1.4	14.2	0.4	0.3	0.2	0.4	0.0	0.3	0.8	0.4	0.5	0.2	0.0	5.2	0.4	0.1	0.1	4.3	0.4	0.9	0.9	0.6	0.2	1.8	1.4	0.4	0.2	1.6	0.3	21.3	48.4	1.4	0.2	70.2	0.1	0.1	0.0	0.0	24.0	0.0	0.0	0.1	138.4	0.5	87.3	0.4	0.1	22.9	7.2	7.2	15.6	6.2	7.7	4.4	11.0	2.6	11.9	10.7	3.0	14.3	5.9	0.2	1.5	3.3	0.4	5.1	4.0	5.7	1.8	3.9	0.4	23.2	0.1	0.4	1.4	0.0	0.0	0.3	0.6	1.3	0.5	9.3	1.5	82.8	1.6	0.0	3.1	85.3	1.5	48.6	111.8	1.7	19.8	1.1	1.9	0.3	0.0	20.1	0.6	2.4	0.0	0.3	0.5	1.3	0.6	0.7	0.8	0.9	0.2
ZCWPW1	"DKFZp434N0510, FLJ10057, ZCW1"	ENSG00000078487	"Zinc finger CW-type and PWWP domain containing 1"	Q9H0M4	7	100400826-100428992	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 42.2"	"Group enriched"	"Detected in many"	6	"Spermatocytes: 370.4;Spermatogonia: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 14.8;hTERT-HME1: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020911			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA020911: AB_1858990"	"unprognostic (1.86e-2)"	"prognostic favorable (1.99e-4)"	"unprognostic (1.92e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.58e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (4.84e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.93e-4)"	"unprognostic (2.43e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (5.26e-4)"	3.5	2.7	3.8	2.5	8.2	2.4	4.1	3.5	4.8	2.5	3.0	7.9	2.5	1.1	3.7	4.3	2.3	4.7	2.7	3.5	3.8	3.1	3.3	5.3	2.6	3.3	8.9	3.1	5.9	2.3	4.9	2.3	1.7	5.7	3.0	1.8	2.1	1.9	3.7	3.3	4.0	2.5	3.3	6.6	3.5	2.2	42.2	6.8	1.8	4.8	1.5	3.3	3.7	3.2	11.4	3.2	13.5	7.4	2.7	4.5	1.8	5.5	2.5	1.2	2.1	7.2	5.8	0.8	2.8	3.3	2.4	3.1	0.9	1.8	14.8	11.4	2.1	5.5	1.5	1.3	0.9	3.8	1.1	1.1	4.5	0.6	0.7	2.3	1.8	2.8	3.2	6.0	1.9	13.8	1.1	0.2	3.0	3.2	4.5	2.2	5.1	1.5	4.1	0.5	2.8	0.7	3.4	1.0	0.9	2.0	1.2	4.2	1.8	7.2	2.0	4.4	1.2	3.0	3.0	0.3	6.3	2.5	5.4	1.0	1.6	1.9	6.7	2.4	5.0	5.4	3.2	1.4	13.5	2.1	2.9	3.3	11.4	2.6	2.8	1.6	11.4	4.5	3.1	5.0	2.7	7.4	3.2	1.5	1.8	3.8	8.2	3.5	4.8	3.8	3.1	8.9	3.1	5.7	6.8	0.0	9.0	5.1	8.8	7.1	11.2	4.8	0.0	28.1	11.4	5.2	2.0	1.0	10.0	4.7	24.3	5.3	3.0	0.0	3.1	0.5	6.9	5.5	20.7	9.6	3.1	4.8	2.4	4.3	7.3	43.2	15.3	5.5	1.7	2.8	2.3	11.3	4.0	2.9	7.4	7.2	4.9	45.3	3.4	370.4	163.3	4.0	1.1	7.0	3.5	6.0
MEPCE	"BCDIN3, FLJ20257, MePCE"	ENSG00000146834	"Methylphosphate capping enzyme"	Q7L2J0	7	100428790-100434126	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026384, HPA051587"	Supported		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"CAB026384: , HPA051587: AB_2681544"	"unprognostic (8.59e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (6.01e-6)"	"unprognostic (1.09e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.09e-1)"	"prognostic favorable (1.01e-10)"	"unprognostic (9.66e-2)"	"unprognostic (9.31e-2)"	"unprognostic (4.57e-1)"	"unprognostic (9.50e-3)"	17.5	24.1	17.7	13.9	22.8	18.5	15.0	24.1	24.1	15.7	14.0	16.7	26.9	14.1	18.8	22.5	16.1	18.6	22.9	12.4	20.1	13.7	18.7	20.8	13.5	19.7	19.7	16.4	29.2	18.3	32.5	15.0	19.0	19.3	15.8	10.2	17.2	18.5	24.2	21.4	26.1	15.8	15.7	17.7	34.9	14.4	63.1	20.4	21.7	25.7	17.1	17.9	16.3	20.4	8.4	8.7	9.3	3.6	7.3	9.1	10.6	13.5	17.6	13.1	14.0	12.7	12.8	9.7	15.2	22.3	16.5	12.8	14.3	20.0	28.0	25.4	9.5	13.0	12.6	14.2	11.5	10.9	12.5	16.2	14.4	13.6	10.8	10.7	18.4	17.9	13.2	13.8	18.8	23.9	9.0	13.7	9.0	28.5	20.8	15.7	50.5	21.0	42.0	24.1	11.4	19.6	17.0	10.5	25.4	11.0	8.4	19.7	17.0	23.8	46.7	15.9	6.8	11.9	16.9	11.7	27.8	21.6	18.7	20.0	13.8	13.1	31.2	15.6	23.1	24.3	2.5	3.6	4.8	5.6	3.2	6.5	8.0	6.4	6.0	4.4	8.4	9.1	8.0	9.3	7.3	2.6	8.7	5.7	10.6	17.7	22.8	24.1	24.1	20.1	13.7	19.7	16.4	19.3	20.4	8.9	20.5	18.0	14.7	26.9	8.9	19.8	17.8	9.4	7.9	21.0	7.9	13.3	13.3	9.0	21.7	18.0	26.9	0.0	10.4	7.0	12.5	12.5	17.4	17.9	10.9	11.1	10.3	33.2	27.3	44.1	16.1	14.2	8.5	18.0	18.8	16.7	8.8	24.6	14.5	11.7	9.1	6.5	12.8	34.9	13.7	22.0	17.7	15.8	15.5	8.6
PPP1R35	"C7orf47, MGC22793"	ENSG00000160813	"Protein phosphatase 1 regulatory subunit 35"	Q8TAP8	7	100435282-100436565	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 129.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021604, HPA051607"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021604: AB_2670774, HPA051607: AB_2681548"	"unprognostic (2.17e-3)"	"unprognostic (2.17e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.77e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.40e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.97e-4)"	5.3	12.0	4.4	12.5	5.6	8.8	5.9	9.7	8.7	9.9	9.6	3.6	7.2	12.8	7.1	6.1	7.4	6.3	7.2	5.4	4.2	4.1	7.4	11.1	5.6	14.4	3.9	7.1	10.6	12.4	7.4	7.9	7.9	4.8	7.7	2.8	7.4	10.6	6.8	7.0	7.7	11.2	6.8	3.6	20.8	8.8	32.2	2.6	20.3	8.6	4.5	10.7	7.6	6.1	4.6	6.8	12.1	2.0	2.7	6.8	2.5	16.0	6.9	4.9	8.6	1.6	1.6	6.3	4.4	4.8	3.7	4.3	2.6	16.5	5.2	7.9	2.6	18.8	5.2	2.5	4.3	0.7	11.4	6.4	5.2	4.9	6.2	6.8	4.5	6.9	3.1	7.7	3.3	5.0	6.0	7.6	18.4	7.4	10.7	4.7	15.3	13.3	21.9	9.6	7.4	9.3	3.6	1.8	15.7	4.8	4.4	4.6	11.5	4.0	28.0	12.7	3.0	8.4	12.9	5.9	5.5	6.5	6.3	11.2	12.4	6.9	6.9	6.1	7.9	11.0	12.1	2.0	4.5	5.2	0.8	5.6	3.5	5.3	6.0	1.7	4.6	3.1	3.0	9.3	2.7	0.5	6.8	6.8	2.5	4.4	5.6	9.7	8.7	4.2	4.1	3.9	7.1	4.8	2.6	14.9	8.1	24.8	32.5	18.7	33.7	1.6	20.4	10.7	2.3	45.4	7.9	56.3	44.7	6.8	7.0	20.0	21.1	0.0	8.7	34.2	11.4	31.9	8.1	13.9	14.4	46.1	17.9	8.0	6.5	4.7	16.7	17.8	16.9	13.6	25.2	25.5	9.8	26.8	8.9	33.9	36.2	12.9	13.3	129.2	24.3	29.2	28.4	28.7	24.7	37.5
C7orf61	IMAGE:4839025	ENSG00000185955	"Chromosome 7 open reading frame 61"	Q8IZ16	7	100456615-100464271	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"testis: 80.4"	"Group enriched"	"Detected in many"	48	"Early spermatids: 438.3;Late spermatids: 271.6"	"Cancer enhanced"	"Detected in some"		"glioma: 3.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"HUVEC TERT2: 22.2;NB-4: 8.1;TIME: 13.0"									HPA060395	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA060395: AB_2684274"	"unprognostic (1.88e-1)"	"unprognostic (5.02e-1)"	"unprognostic (1.26e-2)"	"unprognostic (7.70e-5)"	"unprognostic (1.65e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.26e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.39e-13)"	"unprognostic (9.54e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.24e-2)"	0.5	0.3	2.8	0.6	3.1	1.2	0.5	1.4	3.4	0.5	0.5	0.5	0.5	0.1	0.8	0.8	0.5	0.7	0.6	0.5	3.0	2.3	0.5	0.5	0.5	0.8	3.2	0.5	1.0	0.5	0.4	0.9	0.6	0.6	0.5	0.2	0.5	0.5	0.7	0.5	0.7	0.5	0.5	3.1	1.0	0.1	80.4	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.1	0.6	1.3	1.2	0.8	2.9	0.2	0.8	0.2	0.7	0.8	0.9	2.0	0.3	0.3	1.3	0.2	0.7	0.9	0.4	0.6	1.5	0.8	1.2	0.6	0.3	0.0	0.5	0.8	1.5	1.2	1.7	0.0	1.1	0.4	0.3	0.3	0.4	0.8	1.2	2.1	22.2	2.1	0.6	1.1	1.3	2.1	0.4	8.1	0.5	0.3	1.0	2.1	0.0	0.4	0.3	0.3	0.0	0.0	0.5	0.7	1.3	0.4	0.4	2.2	13.0	1.2	2.0	2.5	0.4	0.3	0.2	0.8	0.2	1.9	0.1	0.0	1.2	0.0	0.8	0.7	0.3	0.0	1.1	0.6	0.6	0.1	0.1	1.6	1.3	0.8	0.4	0.0	2.9	0.2	2.8	3.1	1.4	1.5	3.0	2.3	3.2	0.5	0.6	0.5	0.0	0.0	0.0	0.4	7.3	1.5	0.9	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.4	438.3	1.5	0.3	0.0	0.0	0.3	1.3	0.6	0.0	0.0	0.8	3.2	0.0	0.0	0.3	271.6	7.2	1.7	5.0	1.0	0.2	6.3	0.3	0.0	3.5	0.0	0.0	6.5	0.8	3.6	2.5	5.4	0.1	0.0	0.4	0.4
TSC22D4	"THG-1, TILZ2"	ENSG00000166925	"TSC22 domain family member 4"	Q9Y3Q8	7	100463359-100479279	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 97.2"	"Cell type enriched"	"Detected in many"	4	"Muller glia cells: 493.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006757	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA006757: AB_1080403"	"unprognostic (2.34e-2)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (5.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (9.45e-4)"	"unprognostic (9.96e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.84e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.81e-3)"	11.2	11.9	77.8	16.4	83.5	32.4	7.7	17.8	92.4	9.7	9.9	96.1	3.4	12.4	9.1	6.2	10.3	9.9	8.0	10.2	69.5	53.8	8.9	5.1	10.2	18.7	97.2	40.6	11.7	9.7	8.8	7.1	12.2	60.5	11.5	6.2	11.8	49.2	13.0	7.8	17.2	12.5	8.0	89.8	24.0	11.7	8.0	62.3	6.7	5.8	1.7	12.2	8.6	5.7	6.9	7.5	32.2	11.4	10.2	13.8	8.8	12.3	9.3	3.2	10.6	11.3	13.5	6.0	9.4	15.9	9.1	8.4	4.9	7.6	11.2	11.2	7.6	20.8	9.6	3.8	8.5	3.2	19.2	7.7	10.0	9.8	4.2	18.1	13.2	26.8	15.2	7.7	10.5	10.5	10.8	18.7	9.0	22.1	20.7	7.3	22.5	16.5	60.8	4.3	10.9	13.3	27.3	2.5	15.5	7.5	6.8	2.7	7.5	13.0	25.0	19.6	5.5	7.0	19.6	15.5	12.4	12.6	30.2	6.9	13.0	12.3	7.9	11.4	20.4	14.9	5.0	10.9	15.6	11.7	11.4	9.1	6.9	10.0	10.8	7.2	6.6	9.6	10.0	32.2	10.2	10.8	7.5	13.8	8.8	77.8	83.5	17.8	65.4	69.5	53.8	97.2	40.6	60.5	62.3	11.9	6.2	54.1	32.3	29.1	13.9	11.6	45.9	4.0	4.5	38.4	5.9	27.8	116.0	50.9	1.4	25.1	57.3	0.0	29.7	30.6	33.2	48.6	16.1	9.5	68.0	17.5	32.2	43.6	53.1	3.1	42.3	43.7	52.3	86.6	28.4	493.0	47.4	43.5	37.4	15.9	11.6	45.3	36.0	0.9	3.6	29.5	66.1	90.8	30.2	50.5
NYAP1	"C7orf51, FLJ37538, KIAA1486L"	ENSG00000166924	"Neuronal tyrosine phosphorylated phosphoinositide-3-kinase adaptor 1"	Q6ZVC0	7	100483927-100494799	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.8"	"Cell type enhanced"	"Detected in some"	19	"Bipolar cells: 4.3;Horizontal cells: 12.7;Muller glia cells: 3.8;Peritubular cells: 4.2"	"Cancer enhanced"	"Detected in some"		"glioma: 4.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 10.5;HUVEC TERT2: 5.2;SH-SY5Y: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022251	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA022251: AB_1848915"	"unprognostic (6.59e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.51e-4)"	"unprognostic (2.89e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.06e-2)"	"unprognostic (4.31e-1)"	"unprognostic (8.65e-2)"	3.1	6.3	11.8	1.6	15.2	1.3	1.4	15.4	32.8	1.8	1.6	3.8	0.0	1.6	2.8	1.3	1.5	1.9	1.6	1.2	13.2	12.8	1.9	1.1	1.3	1.4	7.4	13.4	5.7	2.1	1.1	10.2	1.7	11.4	2.9	1.4	1.0	2.3	3.2	1.2	1.9	1.8	2.1	3.9	1.6	2.3	9.0	4.4	0.0	1.2	0.0	1.2	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	4.1	1.8	2.7	1.7	0.3	0.1	1.3	0.2	0.6	0.5	0.2	0.0	1.4	0.4	10.5	0.1	0.8	0.2	0.0	1.8	0.2	0.2	0.4	0.2	2.0	0.0	1.1	1.8	0.0	0.6	0.7	0.4	5.2	0.3	0.7	0.1	0.0	0.4	0.0	0.0	0.8	0.4	0.1	0.1	0.0	0.0	0.1	0.0	1.2	12.7	0.4	0.3	1.2	1.6	0.2	0.0	1.9	0.0	2.6	0.7	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	15.2	15.4	20.6	13.2	12.8	7.4	13.4	11.4	4.4	0.0	0.0	0.0	0.1	0.1	4.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	12.7	0.0	0.0	0.0	0.4	2.3	0.0	0.0	0.0	0.0	3.8	0.0	0.0	4.2	0.0	0.7	0.0	0.0	0.9	2.4	0.1	0.0	0.0	0.0	0.0
AGFG2	"HRBL, RABR"	ENSG00000106351	"ArfGAP with FG repeats 2"	O95081	7	100539211-100568219	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"salivary gland: 154.3"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 35.8;Ito cells: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019689, HPA073562"	Enhanced					NA	NA					"HPA019689: AB_1855074, HPA073562: "	"unprognostic (7.67e-2)"	"unprognostic (1.04e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.99e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.64e-4)"	"unprognostic (3.00e-1)"	"prognostic favorable (1.03e-6)"	"unprognostic (7.83e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.90e-3)"	"unprognostic (9.31e-2)"	4.8	13.6	9.2	5.5	12.5	3.8	3.7	8.8	9.6	6.6	8.7	6.6	8.5	7.0	7.1	4.5	14.3	7.7	7.9	5.1	9.1	5.1	7.1	21.4	4.7	5.6	7.2	8.6	11.3	9.7	3.4	8.4	2.7	7.7	5.9	6.9	4.0	154.3	9.5	3.8	11.7	6.5	5.7	10.0	11.7	5.5	6.8	7.5	4.0	6.5	3.7	10.9	5.2	4.7	1.4	1.0	4.5	0.4	1.1	4.5	1.1	6.3	10.3	1.3	3.1	9.5	5.0	1.8	3.0	8.3	4.9	5.1	9.0	5.8	4.1	10.2	3.6	21.5	5.3	1.5	3.1	2.2	14.1	4.1	1.2	4.7	19.4	3.8	1.3	7.2	8.2	2.4	3.9	4.4	3.0	13.2	2.7	3.7	5.6	3.9	5.6	5.1	4.7	0.9	17.8	4.3	2.5	1.5	3.6	2.8	3.3	1.9	2.3	5.9	8.6	2.7	2.2	2.4	1.8	3.3	6.1	4.1	15.1	3.2	3.5	17.7	1.5	4.6	3.8	3.4	3.6	0.1	4.5	3.8	0.4	3.3	0.7	3.8	4.5	0.2	1.4	1.3	1.7	0.9	1.1	0.1	1.0	3.0	1.1	9.2	12.5	8.8	9.6	9.1	5.1	7.2	8.6	7.7	7.5	0.0	3.8	7.0	5.7	1.8	1.3	8.4	30.6	0.0	2.3	24.4	2.0	1.3	10.0	10.5	1.3	11.4	14.7	0.0	10.1	1.4	3.3	4.4	2.3	35.8	1.3	3.2	25.4	65.7	5.7	1.8	5.2	1.7	3.3	10.8	11.2	2.7	6.4	8.6	8.5	1.9	1.4	12.9	3.3	5.7	8.5	4.6	0.7	10.1	12.0	6.4
SAP25	FLJ00248	ENSG00000205307	"Sin3A associated protein 25"	Q8TEE9	7	100572228-100573820	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 50.2"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 19.4;Cone photoreceptor cells: 66.8;Horizontal cells: 20.6;Rod photoreceptor cells: 58.2;Spermatocytes: 18.4;Spermatogonia: 71.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 12.8;NB-4: 28.2;OE19: 47.3;U-937: 11.0"									HPA062610			Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA062610: AB_2684806"	"unprognostic (1.70e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.09e-5)"	"unprognostic (6.89e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.26e-3)"	"unprognostic (9.96e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.04e-2)"	"unprognostic (6.57e-3)"	"unprognostic (1.71e-2)"	"unprognostic (7.52e-6)"	"unprognostic (7.36e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.18e-3)"	2.4	2.5	2.0	9.5	2.5	15.2	2.0	5.0	2.6	3.1	2.3	2.3	2.0	3.5	2.2	2.7	2.0	2.5	2.6	2.0	2.4	1.2	5.1	2.0	4.7	15.2	2.0	2.0	7.9	2.0	0.5	4.8	2.8	2.3	3.2	0.6	2.0	5.2	3.6	2.0	3.3	6.7	2.0	3.0	19.6	2.6	50.2	2.0	2.0	5.7	2.0	4.5	2.0	2.2	0.2	1.2	3.8	1.9	0.0	0.9	0.2	1.5	0.5	1.1	0.6	0.1	0.1	2.7	1.3	0.2	0.8	0.3	1.3	1.6	0.8	0.7	0.0	0.1	1.7	0.2	0.4	0.1	1.5	1.0	1.5	1.1	0.4	0.2	1.7	12.8	0.3	0.8	0.4	0.1	0.6	0.2	3.3	1.8	3.2	0.1	3.6	3.1	28.2	1.8	47.3	0.6	6.7	0.4	1.2	0.1	0.5	0.7	2.1	0.1	1.5	1.7	1.3	2.3	6.4	1.4	1.2	2.5	1.1	1.1	5.4	1.3	0.6	0.3	11.0	1.2	2.2	0.8	0.0	0.9	1.9	0.2	0.2	0.5	0.1	0.2	0.2	0.6	0.8	3.8	0.0	0.7	1.2	0.0	0.2	2.0	2.5	5.0	2.6	2.4	1.2	2.0	2.0	2.3	2.0	0.0	5.5	1.9	1.3	0.0	19.4	0.0	2.5	0.0	2.3	0.0	66.8	2.1	0.0	1.6	1.4	0.0	1.3	0.0	0.6	0.5	0.8	2.2	1.1	1.1	2.9	20.6	0.0	1.8	9.4	3.4	3.1	4.5	0.0	3.6	2.6	9.2	1.5	1.9	1.1	0.2	58.2	6.5	0.0	18.4	71.9	0.0	3.0	4.9	1.5	1.4
LRCH4	"LRN, LRRN1"	ENSG00000077454	"Leucine rich repeats and calponin homology domain containing 4"	O75427	7	100574011-100586153	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 153.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 45.7;NB-4: 70.7"					"Low region specificity"	"Detected in all"			"HPA037667, HPA037668"	Enhanced		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			"Nucleoplasm, Focal adhesion sites, Cytosol"		"HPA037667: AB_10671882, HPA037668: AB_10672910"	"unprognostic (2.41e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (8.32e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.96e-3)"	"unprognostic (8.98e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.63e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.26e-2)"	11.4	15.2	14.5	32.0	25.7	52.7	13.8	19.7	22.2	12.0	14.0	16.4	11.8	22.0	12.3	9.6	14.4	14.0	15.9	10.2	16.2	9.1	16.1	12.2	20.8	39.1	25.8	13.1	23.7	17.3	8.9	22.8	26.4	19.2	14.6	7.2	18.3	23.5	13.0	15.8	15.0	27.8	8.1	25.7	54.5	14.9	43.3	23.1	31.1	20.0	6.8	25.2	9.9	12.0	5.9	6.2	24.2	8.4	1.4	7.3	2.9	7.9	4.5	4.5	4.0	2.7	2.1	8.6	7.7	3.5	4.5	3.7	7.5	11.7	5.8	8.7	2.3	4.8	6.9	2.2	3.2	1.3	5.7	6.0	6.6	5.3	3.5	8.6	11.4	45.7	3.5	3.5	3.8	2.1	2.9	4.6	15.2	8.2	11.9	3.2	15.0	13.1	70.7	4.7	7.4	5.3	14.6	3.7	7.1	3.5	2.8	5.9	8.8	3.7	11.8	9.0	6.1	7.9	24.9	7.2	6.2	11.3	8.6	4.6	12.1	5.7	5.2	4.8	28.3	10.6	12.6	8.4	11.9	5.2	6.8	4.7	4.7	5.1	5.9	6.2	5.9	7.3	5.9	24.2	1.4	4.7	5.9	5.2	2.9	14.5	25.7	19.7	22.2	16.2	9.1	25.8	13.1	19.2	23.1	8.9	16.7	24.7	13.8	10.6	13.6	0.7	25.5	6.7	6.8	21.0	39.3	33.4	13.3	27.1	153.1	9.5	22.2	0.0	21.3	11.2	9.5	12.1	18.5	11.3	30.3	12.7	5.8	15.4	53.4	19.7	23.0	33.3	13.5	52.3	12.9	15.5	23.1	14.0	9.6	6.2	29.9	19.4	12.2	42.6	28.7	10.0	86.4	42.9	11.0	14.2
FBXO24	FBX24	ENSG00000106336	"F-box protein 24"	O75426	7	100583982-100601117	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"testis: 43.3"	"Group enriched"	"Detected in some"	40	"Early spermatids: 485.7;Late spermatids: 455.7"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 5.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA050951	Enhanced					NA	NA					"HPA050951: AB_2681286"	"unprognostic (3.73e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.76e-4)"	"unprognostic (3.52e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.86e-4)"	"unprognostic (2.31e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.44e-1)"	"unprognostic (9.20e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.48e-2)"	0.2	0.2	0.2	0.3	0.6	0.2	0.2	0.2	0.5	0.4	0.2	0.3	0.2	0.0	0.6	0.4	0.3	0.4	0.5	0.3	0.2	0.1	0.3	0.2	0.6	0.6	0.5	0.2	1.0	0.2	0.0	0.7	0.3	0.3	0.4	0.0	0.3	1.6	0.2	0.2	0.8	0.3	0.2	1.1	0.4	0.2	43.3	0.3	0.3	0.2	0.2	0.2	0.2	0.4	1.7	2.1	1.7	0.7	0.1	1.8	1.2	1.1	1.0	1.4	1.9	3.9	0.2	0.9	0.9	0.6	0.5	0.4	1.9	3.3	1.7	0.6	0.1	0.5	0.9	0.2	0.4	0.0	0.7	2.3	0.2	0.6	0.1	0.8	0.0	2.9	1.9	1.9	0.0	0.0	0.1	0.6	2.3	0.5	2.5	0.0	2.9	0.5	3.7	2.1	2.6	0.9	0.1	0.1	0.5	0.1	1.2	0.2	2.3	1.7	2.3	1.2	3.2	1.9	0.8	0.0	1.5	5.9	4.6	0.3	1.3	0.6	0.6	0.6	2.0	2.4	0.0	0.5	0.0	0.2	0.7	0.6	1.7	0.5	0.3	1.1	0.6	0.7	1.0	1.7	0.1	0.0	2.1	1.8	1.2	0.2	0.6	0.2	0.5	0.2	0.1	0.5	0.2	0.3	0.3	0.0	0.0	0.0	0.6	0.2	0.4	1.4	0.0	0.0	0.0	0.0	7.9	0.2	0.0	0.4	485.7	0.1	0.0	0.0	0.5	0.4	0.7	0.3	0.0	0.0	0.3	0.0	0.0	0.6	0.0	455.7	3.4	0.0	0.0	1.0	0.0	0.8	0.3	0.0	3.5	0.0	1.2	0.0	0.0	11.8	4.2	0.3	0.1	0.0	0.3	0.3
PCOLCE	"PCPE, PCPE1"	ENSG00000106333	"Procollagen C-endopeptidase enhancer"	Q15113	7	100602177-100608175	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	16	"Fibroblasts: 347.3;Leydig cells: 130.0;Smooth muscle cells: 134.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 85.2;BJ hTERT+: 63.5;HSkMC: 97.7;SH-SY5Y: 68.1;U-138 MG: 39.4;U-2197: 120.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017623, HPA042927"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		1300000000	"Golgi apparatus, Vesicles"		"CAB017623: AB_2251882, HPA042927: AB_2678224"	"unprognostic (4.14e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (1.68e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.43e-2)"	29.5	16.7	0.6	18.1	1.3	0.0	29.3	1.0	2.0	90.4	11.2	1.6	22.8	2.0	42.1	89.9	23.1	29.6	34.3	47.3	0.7	0.7	14.6	73.0	24.5	51.1	3.7	1.9	38.8	7.9	1.2	11.4	23.8	2.9	49.4	4.5	54.6	16.0	19.8	10.0	16.0	7.4	26.1	6.9	10.5	9.1	20.8	0.5	2.4	17.8	20.1	18.4	28.2	34.0	0.8	1.0	1.6	1.0	1.1	1.1	0.1	0.0	0.0	0.1	0.2	30.1	85.2	0.2	34.9	63.5	15.8	13.9	1.3	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.0	1.3	0.2	0.2	0.0	0.5	1.7	8.4	0.0	0.2	97.7	0.0	8.3	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.1	0.0	0.2	7.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	68.1	0.0	0.1	0.1	0.7	0.1	0.0	0.2	39.4	10.9	120.2	0.0	0.0	0.0	0.0	13.7	0.0	6.6	0.0	0.3	1.6	0.5	1.0	1.1	0.8	0.9	0.6	1.0	0.2	0.6	0.3	0.4	1.1	0.8	0.0	0.4	0.1	0.6	1.3	1.0	2.0	0.7	0.7	3.7	1.9	2.9	0.5	8.9	3.2	0.8	2.9	35.5	3.0	15.7	2.5	4.0	5.7	5.2	0.0	13.9	23.2	5.0	10.4	10.5	0.0	0.0	4.5	10.7	347.3	1.6	1.1	16.1	18.8	15.9	1.7	53.4	1.3	18.5	130.0	4.4	30.4	0.0	0.7	10.8	4.7	0.2	47.4	1.9	1.6	32.3	134.4	21.6	14.0	29.0	21.1	7.2	0.4	2.6
MOSPD3	"CDS3, NET30"	ENSG00000106330	"Motile sperm domain containing 3"	O75425	7	100612102-100615384	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1149.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 33.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041137, HPA048240"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA041137: AB_10803996, HPA048240: AB_2680325"	"unprognostic (1.24e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.20e-2)"	13.8	22.3	13.0	7.7	12.8	17.4	9.8	9.0	16.9	14.7	9.1	14.5	13.9	9.9	12.0	12.9	22.5	12.0	14.9	10.2	11.2	10.8	19.3	29.8	11.1	18.5	10.6	11.6	13.1	17.1	6.7	9.8	7.8	12.0	12.9	4.8	14.9	19.1	11.3	11.3	24.4	10.6	10.3	9.5	11.8	14.7	37.0	9.9	16.6	12.2	13.6	16.8	12.4	13.4	11.6	17.9	22.2	16.7	20.9	29.7	8.0	6.0	8.2	6.6	11.4	3.5	2.6	4.7	4.6	5.5	4.8	4.9	7.6	8.1	3.8	10.2	4.2	6.8	4.7	3.8	6.6	0.9	9.8	5.1	3.9	6.1	11.4	4.5	3.0	15.1	7.4	5.7	4.1	2.4	4.2	8.2	6.4	9.1	7.8	4.9	17.9	8.4	23.0	6.0	7.9	12.4	7.9	6.9	9.1	7.6	9.1	3.6	21.7	8.6	13.4	4.6	2.8	8.1	8.9	9.2	9.3	14.7	19.3	4.4	6.2	5.8	2.6	9.3	33.7	11.4	18.5	16.7	22.2	18.8	12.4	22.2	11.6	21.8	21.8	17.9	11.3	13.0	13.5	12.3	20.9	8.5	12.0	29.7	8.0	13.0	12.8	9.0	16.9	11.2	10.8	10.6	11.6	12.0	9.9	8.9	6.5	11.9	14.9	10.8	6.6	3.2	17.8	9.4	4.5	19.2	5.9	6.0	36.5	33.9	271.2	15.7	8.7	0.0	37.6	23.2	22.0	20.1	3.5	26.2	25.2	6.4	20.7	19.0	23.0	1149.7	25.6	15.1	25.3	14.4	14.9	11.4	39.0	17.5	20.5	35.7	3.4	12.9	20.0	17.7	21.5	17.1	5.1	29.3	16.9	17.8
TFR2	"HFE3, TFRC2"	ENSG00000106327	"Transferrin receptor 2"	Q9UP52	7	100620416-100642779	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 112.6"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 379.7"	"Cancer enriched"	"Detected in many"	70	"liver cancer: 136.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	46	"basophil: 5.5;eosinophil: 3.9"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 5.5"	"Group enriched"	"Detected in some"	11	"HEL: 28.5;HMC-1: 39.6;K-562: 26.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB016255, HPA017171, HPA073125"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB016255: AB_628395, HPA017171: , HPA073125: "	"unprognostic (4.18e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.13e-2)"	"prognostic favorable (2.48e-4)"	"unprognostic (2.29e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.18e-9)"	"unprognostic (6.51e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.18e-2)"	0.1	0.0	0.1	0.1	0.1	5.3	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.3	0.1	0.0	0.1	112.6	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	0.0	2.9	0.0	0.6	39.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	7.8	0.9	0.2	5.3	0.9	12.7	0.0	1.2	0.0	7.9	0.1	0.0	0.4	4.0	0.0	0.0	93.5	0.2	1.1	0.4	0.5	0.0	379.7	0.3	20.6	0.0	7.4	6.9	5.7	0.0	0.5	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	1.8	0.0	0.7	0.7	2.0	0.5	0.1	2.5	0.5	0.6
ACTL6B	"ACTL6, BAF53B"	ENSG00000077080	"Actin like 6B"	O94805	7	100643097-100656461	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 43.6"	"Cell type enhanced"	"Detected in some"	16	"Bipolar cells: 7.7;Cone photoreceptor cells: 2.0;Horizontal cells: 6.4;Rod photoreceptor cells: 2.1"	"Group enriched"	"Detected in some"	11	"glioma: 3.9;pancreatic cancer: 1.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	75	"SCLC-21H: 21.5;SH-SY5Y: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045126	Uncertain		Approved	"Nucleoli rim,Mitotic chromosome"		Yes	NA			"Nucleoli rim, Mitotic chromosome"		"HPA045126: AB_10961265"	"unprognostic (3.31e-2)"	"unprognostic (6.89e-2)"		"unprognostic (4.59e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.27e-3)"	"unprognostic (4.81e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.01e-4)"	"unprognostic (1.64e-1)"	"unprognostic (6.84e-2)"		"unprognostic (2.01e-2)"	1.1	3.8	9.4	1.1	17.4	1.1	1.0	25.9	43.6	1.0	1.2	0.8	0.0	1.3	1.0	1.0	1.0	1.0	1.0	1.0	9.7	9.9	1.1	1.0	1.1	1.0	5.3	12.2	1.0	2.2	1.0	7.0	1.0	9.4	1.0	1.1	0.3	1.0	1.0	1.0	1.1	1.2	1.1	1.6	1.0	2.0	1.7	1.9	0.0	1.1	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	17.4	25.9	26.8	9.7	9.9	5.3	12.2	9.4	1.9	0.0	0.0	0.0	0.0	0.0	7.7	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	2.1	0.0	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0
GNB2		ENSG00000172354	"G protein subunit beta 2"	P62879	7	100673531-100679174	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 42.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010032, HPA040736"	Approved		Supported	"Plasma membrane"		NA	NA		36000000	"Plasma membrane"		"CAB010032: AB_2263466, HPA040736: AB_2677106"	"unprognostic (1.55e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.68e-3)"	"unprognostic (3.52e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.98e-1)"	49.9	45.9	43.8	41.6	58.4	60.9	88.8	31.7	40.9	40.5	43.1	22.3	39.4	34.8	41.1	39.7	74.6	49.6	44.0	54.0	38.9	36.1	39.1	72.9	49.1	94.9	32.5	42.3	47.5	45.6	33.5	45.9	38.0	35.6	47.7	29.0	28.8	77.8	42.5	39.2	59.9	38.3	39.1	23.6	50.7	42.2	31.9	33.9	43.7	40.9	45.8	35.1	37.8	50.1	6.3	9.9	42.7	14.8	5.2	7.9	4.0	51.8	40.0	33.7	40.9	26.4	31.4	29.2	31.3	43.6	44.9	37.3	30.4	50.1	23.3	34.2	46.2	50.8	36.3	26.6	46.5	15.9	32.4	22.8	17.5	30.7	24.9	44.1	22.8	38.2	40.4	44.4	46.3	37.7	36.5	51.5	19.7	32.6	45.9	40.7	140.1	36.1	64.8	26.2	32.9	43.5	34.1	20.6	37.1	35.8	43.2	35.8	58.0	41.3	68.0	28.8	19.9	29.1	28.3	48.5	48.2	53.4	93.6	39.0	13.3	15.9	34.4	36.5	51.0	66.5	7.8	10.6	23.6	6.5	14.8	6.1	4.8	6.8	5.7	9.9	6.3	4.5	4.7	42.7	5.2	12.2	8.5	7.9	4.0	43.8	58.4	31.7	40.9	38.9	36.1	32.5	42.3	35.6	33.9	53.6	112.8	83.5	121.5	134.9	6.7	29.5	107.0	37.5	28.4	80.3	3.9	158.6	137.6	144.7	22.9	125.4	215.4	46.7	189.3	250.9	125.4	201.1	43.8	58.7	231.1	68.3	173.2	118.4	164.4	15.3	134.0	187.0	133.3	161.5	167.9	119.9	203.3	197.2	122.4	84.0	7.1	64.7	122.6	36.1	47.7	170.3	245.8	92.2	152.9	221.4
GIGYF1	"GYF1, PERQ1"	ENSG00000146830	"GRB10 interacting GYF protein 1"	O75420	7	100679507-100694037	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 43.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020999, HPA023995"	Enhanced		Approved	Vesicles,Microtubules		NA	NA			Vesicles	Microtubules	"HPA020999: AB_2111744, HPA023995: AB_1855221"	"unprognostic (3.82e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.46e-2)"	"prognostic favorable (7.42e-4)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (1.43e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.65e-2)"	"prognostic favorable (1.35e-5)"	"unprognostic (3.66e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.67e-3)"	15.5	17.3	22.1	15.9	23.0	28.2	16.3	66.8	32.4	20.6	14.0	18.9	27.3	17.1	25.1	20.2	11.5	18.3	16.4	13.2	20.3	9.4	14.4	13.3	13.5	18.5	14.1	16.3	29.8	23.8	17.8	26.3	16.2	15.7	17.1	9.3	19.6	26.5	25.7	25.5	31.7	17.6	12.9	9.3	24.0	17.0	18.9	20.4	11.8	20.5	10.4	14.2	14.3	14.0	4.1	3.9	8.8	2.6	2.5	5.1	0.9	7.1	7.3	11.8	17.3	5.7	4.4	21.1	6.7	5.5	4.2	4.9	4.2	12.3	10.0	8.8	4.9	8.6	8.6	5.8	6.8	2.6	10.6	11.8	6.9	18.1	6.1	5.6	7.8	11.9	7.0	5.5	5.4	7.7	7.0	4.2	11.9	19.1	9.9	3.8	16.1	13.9	43.5	14.4	2.8	9.0	22.3	6.2	9.9	3.1	6.5	10.6	16.8	8.7	14.2	7.7	8.4	6.4	13.2	6.5	12.3	15.3	20.1	6.2	8.1	3.5	5.4	7.1	15.8	7.2	3.3	2.6	2.2	5.1	2.3	3.8	2.7	3.4	3.2	1.0	4.1	3.1	3.2	8.8	2.5	2.5	3.9	1.8	0.9	22.1	23.0	66.8	32.4	20.3	9.4	14.1	16.3	15.7	20.4	3.0	5.6	23.1	9.7	28.2	22.4	6.0	30.6	2.7	4.5	17.4	17.7	11.2	13.3	9.7	0.8	16.3	15.7	23.3	8.1	8.8	16.6	8.6	5.7	17.4	9.9	49.3	17.9	20.3	23.8	2.4	22.7	10.7	16.9	4.6	21.7	11.8	10.5	16.9	17.0	7.6	25.7	32.3	17.2	14.0	36.4	19.6	13.6	24.1	15.1	9.2
POP7	"RPP2, RPP20"	ENSG00000172336	"POP7 homolog, ribonuclease P/MRP subunit"	O75817	7	100706053-100707495	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021007	Uncertain		Supported	Nucleoli,Vesicles		NA	NA			"Nucleoli, Vesicles"		"HPA021007: AB_10963575"	"unprognostic (3.19e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (2.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.50e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.21e-2)"	"unprognostic (6.73e-2)"	12.3	16.6	20.5	15.1	21.0	25.3	16.1	25.1	33.2	11.3	14.7	8.7	14.0	17.5	13.9	12.5	20.4	13.4	13.9	19.6	18.3	18.1	13.1	31.4	11.7	18.2	16.8	22.0	13.2	21.2	6.6	11.5	18.1	13.3	16.0	8.1	10.0	24.2	15.8	46.4	22.6	17.6	12.3	12.9	12.3	15.5	7.0	9.4	11.0	11.6	20.5	11.8	11.5	12.5	32.1	30.4	46.4	35.6	42.1	37.0	32.0	24.6	24.6	9.9	17.5	5.3	5.1	19.5	14.0	6.6	15.6	15.5	35.9	16.0	20.0	23.6	6.1	17.2	15.7	14.5	16.5	7.7	18.2	43.9	9.0	16.0	34.4	9.0	13.8	11.1	5.9	6.2	15.9	15.7	4.4	8.6	14.3	31.9	17.9	8.1	70.0	34.6	47.3	30.5	15.7	34.0	26.2	10.5	34.0	9.3	13.6	20.0	20.3	11.3	34.9	16.6	9.3	11.5	14.0	8.4	21.6	26.0	42.4	27.5	7.6	20.6	35.9	13.6	23.9	23.4	46.4	35.6	38.2	32.4	34.1	29.4	32.1	32.5	31.6	30.4	26.4	29.9	31.1	21.9	42.1	35.3	27.9	37.0	32.0	20.5	21.0	25.1	33.2	18.3	18.1	16.8	22.0	13.3	9.4	17.9	14.2	18.6	25.5	93.3	23.7	23.0	33.1	25.4	10.3	33.2	5.9	127.6	79.6	64.3	1.9	39.5	51.5	70.0	76.1	144.7	43.7	49.5	17.3	88.3	57.5	30.2	38.6	28.8	23.7	5.6	38.9	27.4	54.0	41.5	44.2	33.8	71.6	45.0	35.0	66.2	18.4	45.3	39.1	7.5	43.1	104.3	116.5	27.4	49.7	41.7
EPO	EP	ENSG00000130427	Erythropoietin	P01588	7	100720800-100723700	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Predicted secreted proteins"	"Erythrocyte maturation"	Hormone	"Cancer-related genes, Congenital erythrocytosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 10.9;endometrium 1: 8.7;liver: 29.3"	"Cell type enhanced"	"Detected in some"	16	"Exocrine glandular cells: 3.6;Extravillous trophoblasts: 12.2;Hepatocytes: 8.5;Pancreatic endocrine cells: 6.1"	"Group enriched"	"Detected in many"	5	"liver cancer: 2.7;renal cancer: 5.4"	"Region enriched"	"Detected in single"	9	"cerebral cortex: 4.4"	"Cell type enriched"	"Detected in single"	13	"non-classical monocyte: 1.2"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.2"	"Group enriched"	"Detected in some"	7	"BEWO: 3.6;Hep G2: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010336	Supported				"Secreted to blood"	NA	NA	12300				"CAB010336: AB_2098408"	"unprognostic (2.93e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (3.52e-2)"	"unprognostic (5.16e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.44e-3)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (2.18e-6)"	"unprognostic (4.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.34e-1)"	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	4.4	10.9	0.0	0.0	0.0	0.0	8.7	0.6	0.4	0.0	0.0	0.1	0.0	0.0	2.8	29.3	0.0	0.0	0.0	0.0	0.1	7.8	0.0	0.0	0.7	0.0	1.6	0.0	0.7	0.9	1.6	0.0	0.7	0.0	0.6	0.0	0.0	0.0	2.4	0.4	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	1.1	0.2	0.0	0.0	13.4	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.6	0.4	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.6	0.3	0.4	0.0	0.1	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.5	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	12.2	0.0	0.1	0.0	8.5	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.1	2.4	0.0	0.0	0.0
ZAN		ENSG00000146839	"Zonadhesin (gene/pseudogene)"		7	100733626-100797797	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	9	"testis: 14.3"	"Group enriched"	"Detected in some"	8	"Early spermatids: 8.0;Late spermatids: 9.6"	"Cancer enriched"	"Detected in single"	8	"testis cancer: 1.3"					"Cell type enriched"	"Detected in single"	16	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 1.6"	"Group enriched"	"Detected in some"	6	"REH: 1.1;SK-BR-3: 1.4"					"Not detected"	"Not detected"									NA	NA						"unprognostic (1.10e-1)"	"unprognostic (1.40e-1)"		"unprognostic (3.69e-1)"	"unprognostic (4.60e-2)"	"unprognostic (5.83e-6)"	"unprognostic (9.44e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.70e-2)"	"unprognostic (4.10e-9)"	"unprognostic (5.70e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.43e-2)"	"unprognostic (3.06e-2)"	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.0
EPHB4	"HTK, Tyro11"	ENSG00000196411	"EPH receptor B4"	P54760	7	100802565-100827521	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 50.1;Endothelial cells: 43.5;Ito cells: 106.8;Syncytiotrophoblasts: 172.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 3.6;neutrophil: 7.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013537	Uncertain					NA	NA		1000000			"CAB013537: "	"prognostic unfavorable (8.56e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.33e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.51e-3)"	"unprognostic (6.63e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (8.84e-4)"	14.0	20.7	1.8	4.2	2.9	2.2	17.1	1.9	3.0	29.1	9.5	2.9	14.6	4.1	28.8	10.3	11.0	13.1	35.0	19.0	3.4	1.1	16.8	29.8	16.5	12.0	2.2	0.9	24.6	11.6	5.6	3.1	35.5	3.2	13.7	5.4	11.6	10.8	14.7	5.1	14.2	7.0	12.4	2.2	50.5	8.6	12.2	2.1	2.3	10.2	13.1	7.0	7.7	21.5	0.0	1.6	7.4	3.6	0.0	0.0	1.2	12.6	11.2	11.2	32.6	7.2	4.6	33.3	5.0	10.8	7.8	10.2	9.2	9.7	1.6	22.7	5.1	10.9	13.2	4.9	13.1	4.1	2.1	9.1	0.4	6.5	14.3	4.2	0.2	0.3	5.4	19.7	4.9	11.6	8.6	29.1	0.5	23.9	0.6	6.3	22.1	0.2	4.9	19.2	18.7	16.9	17.2	5.5	2.9	9.9	6.7	0.0	9.7	7.6	3.6	7.4	16.3	9.0	2.2	24.4	9.7	15.4	17.9	7.3	0.1	0.2	0.5	1.4	4.1	17.6	0.0	3.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	7.4	0.0	0.2	0.3	0.0	1.2	1.8	2.9	1.9	3.0	3.4	1.1	2.2	0.9	3.2	2.1	8.9	13.0	6.4	8.7	18.2	0.0	3.6	10.2	1.4	5.7	5.2	0.0	50.1	0.0	9.9	20.9	43.5	2.4	0.0	5.7	7.3	7.4	8.7	1.1	18.1	8.1	0.0	2.9	106.8	5.6	8.1	7.5	1.1	3.3	1.0	14.8	1.5	17.1	7.0	3.9	3.7	0.0	6.5	5.0	1.0	12.4	15.6	172.7	1.7	17.9	7.1
SLC12A9	CIP1	ENSG00000146828	"Solute carrier family 12 member 9"	Q9BXP2	7	100826820-100867009	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 72.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067536	Approved					NA	NA					"HPA067536: AB_2732768"	"unprognostic (6.53e-2)"	"unprognostic (3.65e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.11e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.38e-3)"	"prognostic favorable (5.97e-4)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.00e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (1.52e-2)"	"unprognostic (6.00e-2)"	"unprognostic (6.74e-3)"	"unprognostic (6.38e-2)"	11.3	12.1	10.6	13.4	12.7	10.5	9.0	7.3	14.2	11.0	12.8	26.8	12.7	12.4	11.9	7.5	11.8	10.2	18.2	6.3	11.7	9.8	12.0	9.2	12.7	16.3	18.3	9.6	10.2	16.7	12.5	6.2	21.8	13.8	11.1	9.2	7.6	11.8	11.5	3.7	11.9	13.2	10.3	19.8	19.5	10.8	4.8	13.9	8.8	9.5	6.5	14.5	13.6	8.5	1.3	5.1	2.9	4.0	0.3	0.8	1.6	8.1	6.4	2.1	17.6	6.5	4.0	22.5	4.2	7.8	6.2	8.7	9.0	13.8	5.7	13.5	7.6	9.9	8.7	3.7	8.9	1.6	6.2	6.2	2.1	5.9	6.4	8.1	2.6	9.2	9.6	5.2	4.9	4.9	4.9	11.9	4.6	5.1	3.1	8.6	25.5	2.8	12.6	4.2	16.7	12.9	6.6	2.2	9.0	6.1	7.2	3.6	8.4	4.5	32.2	8.5	3.7	4.0	9.8	7.2	7.6	7.6	12.5	7.3	1.6	6.6	1.9	5.3	8.9	9.1	0.0	2.9	0.0	0.5	3.8	0.8	1.3	0.2	0.3	5.1	1.3	0.5	0.3	2.9	0.3	4.0	2.5	0.6	1.6	10.6	12.7	7.3	14.2	11.7	9.8	18.3	9.6	13.8	13.9	3.0	17.3	13.7	10.7	9.7	4.9	2.0	5.1	2.7	11.4	17.4	2.0	72.5	0.0	11.9	0.4	10.5	12.3	0.0	11.6	19.9	8.9	8.6	1.1	5.5	27.7	6.4	10.9	11.6	16.2	0.6	8.3	23.4	8.5	10.0	11.1	20.0	11.7	23.0	6.0	11.2	6.0	12.9	7.5	1.4	8.2	9.9	42.0	11.5	16.2	10.2
TRIP6	"MGC10556, MGC10558, MGC29959, MGC3837, MGC4423, OIP1, ZRP-1"	ENSG00000087077	"Thyroid hormone receptor interactor 6"	Q15654	7	100867138-100873454	"Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046454, CAB046460, HPA052813"	Approved		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA		12000	"Plasma membrane, Focal adhesion sites, Cytosol"		"CAB046454: AB_10604048, CAB046460: AB_2303907, HPA052813: AB_2681961"	"unprognostic (7.94e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.84e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.61e-3)"	"unprognostic (8.48e-2)"	"unprognostic (4.18e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-1)"	15.5	14.7	10.9	16.2	11.2	6.0	18.1	4.2	7.3	36.7	14.6	9.4	22.5	4.4	28.2	30.8	27.2	18.5	43.5	14.5	8.7	7.7	21.6	24.1	18.4	5.8	11.7	9.4	22.0	19.2	28.0	6.5	13.6	9.7	22.1	3.9	22.7	23.0	38.2	8.3	23.9	6.5	25.5	9.7	7.9	9.9	17.5	7.8	7.3	26.6	30.6	12.6	25.0	23.6	3.1	7.7	0.2	4.7	0.0	1.7	0.5	27.0	11.2	5.8	27.7	8.8	10.2	29.1	16.9	18.1	23.2	21.8	10.5	31.2	1.1	17.8	19.0	28.9	20.2	8.5	32.5	5.9	3.9	11.5	0.1	18.6	0.1	23.2	13.0	1.6	18.5	21.4	15.4	24.2	13.7	11.9	4.1	17.0	0.2	20.0	47.5	0.2	20.5	20.0	11.1	10.0	10.2	5.8	2.7	14.3	6.7	2.1	0.3	14.1	42.7	16.8	9.0	4.5	16.6	18.2	34.1	32.1	36.9	39.4	0.2	0.4	0.1	21.2	1.6	51.3	0.0	1.9	0.2	0.2	3.0	0.6	3.1	1.5	1.3	3.1	2.5	1.7	0.7	0.2	0.0	4.7	7.7	1.3	0.5	10.9	11.2	4.2	7.3	8.7	7.7	11.7	9.4	9.7	7.8	44.7	35.0	7.5	130.2	117.2	0.0	14.4	38.2	10.7	37.5	57.6	0.0	99.2	68.0	79.4	0.8	30.6	3.6	0.0	73.3	72.2	63.2	50.1	8.1	26.8	40.2	1.6	4.7	19.6	7.0	2.2	60.9	26.5	35.4	31.5	10.3	87.6	78.1	10.5	68.2	104.6	3.3	71.1	72.2	0.9	2.5	85.9	111.1	6.1	17.5	140.8
SRRT	"ARS2, Asr2, serrate"	ENSG00000087087	"Serrate, RNA effector molecule"	Q9BXP5	7	100875111-100888664	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 199.7;Late spermatids: 241.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042858, HPA058379"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042858: AB_2678201, HPA058379: AB_2683697"	"unprognostic (5.83e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (1.90e-5)"	"unprognostic (4.36e-2)"	"unprognostic (4.99e-3)"	"unprognostic (2.35e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (1.01e-6)"	"unprognostic (6.30e-3)"	"unprognostic (2.77e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.10e-3)"	18.8	25.2	23.0	32.4	26.7	62.8	22.0	43.4	28.2	25.5	20.7	27.6	37.6	24.3	25.9	27.9	26.5	23.0	22.3	19.3	26.0	15.5	24.2	29.6	20.2	36.5	26.7	20.0	31.6	25.7	26.4	32.6	25.2	24.1	30.8	17.2	23.5	32.4	39.1	23.8	44.2	24.3	18.8	17.4	31.8	22.4	67.6	28.9	39.9	27.9	24.3	32.6	18.9	26.2	10.4	9.9	13.2	14.9	6.1	26.1	12.3	24.9	30.0	31.3	30.2	13.4	9.6	28.9	27.8	14.2	28.8	24.8	39.1	28.4	41.7	19.2	20.3	21.4	23.8	37.6	25.0	14.5	36.8	30.8	39.6	34.6	32.1	12.1	51.1	67.9	14.3	9.8	25.6	7.2	13.1	15.6	25.6	34.6	34.0	19.8	43.4	47.1	56.3	32.0	21.6	26.4	44.2	23.9	25.1	18.4	27.7	24.7	23.9	27.4	34.3	18.0	16.7	21.5	31.4	23.5	32.6	31.3	27.4	37.5	21.5	30.6	44.3	18.1	34.2	30.5	4.6	9.2	13.2	19.7	14.9	12.3	8.4	12.9	26.1	9.9	10.4	11.3	15.9	6.8	6.1	10.4	9.0	6.2	12.3	23.0	26.7	43.4	28.2	26.0	15.5	26.7	20.0	24.1	28.9	23.8	51.7	19.3	25.8	34.2	21.3	19.7	15.3	38.8	48.9	15.7	13.7	32.7	6.6	21.3	199.7	19.9	14.2	23.3	27.6	41.8	23.3	18.3	25.5	11.4	23.3	25.4	31.6	9.8	10.5	241.6	31.4	23.9	15.1	29.7	17.9	26.9	21.0	14.4	26.2	9.9	45.7	19.4	29.9	83.4	63.9	38.0	45.3	29.9	26.2	17.0
UFSP1	UFSP	ENSG00000176125	"UFM1 specific peptidase 1 (inactive)"	Q6NVU6	7	100888723-100889718	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 6.6;Proximal tubular cells: 5.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA027099	Uncertain					NA	NA					"HPA027099: AB_2214069"	"unprognostic (8.56e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.71e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.09e-2)"	7.4	6.3	2.8	3.9	5.4	2.6	4.0	3.1	4.1	3.1	4.5	6.1	2.8	4.3	5.6	6.1	4.1	4.6	2.5	3.6	4.8	4.6	5.3	6.5	2.8	5.9	8.9	4.1	5.8	8.6	3.4	6.8	5.7	3.9	4.8	2.8	3.0	6.4	5.0	10.6	3.4	5.8	4.0	3.5	4.3	5.1	2.0	7.8	6.5	4.2	2.8	5.0	4.8	4.7	5.9	7.2	2.4	3.9	4.4	6.4	3.1	3.7	4.7	1.1	4.9	4.9	2.9	3.1	2.8	0.9	1.2	0.8	1.9	2.6	0.8	2.2	2.3	1.8	7.1	1.5	1.7	0.7	3.2	10.7	3.1	3.9	2.2	4.8	1.3	1.5	3.2	2.2	1.6	6.1	1.3	0.3	1.9	4.6	2.3	1.8	9.1	3.0	7.5	3.7	3.8	6.6	1.5	1.5	7.0	2.1	1.5	3.5	5.6	5.6	7.3	3.1	1.4	1.8	1.1	1.2	3.3	3.2	3.5	2.2	2.3	2.7	0.2	1.1	2.4	3.6	0.0	3.9	2.4	5.4	3.4	6.1	1.8	4.7	2.9	4.8	5.9	5.3	6.4	0.8	4.4	3.3	7.2	2.0	3.1	2.8	5.4	3.1	4.1	4.8	4.6	8.9	4.1	3.9	7.8	0.0	0.0	0.0	1.9	0.6	0.2	0.6	0.0	0.0	0.0	1.8	0.0	2.0	6.6	2.0	0.3	0.6	1.7	0.0	1.8	1.1	1.2	1.1	0.0	2.9	1.6	0.0	2.9	1.8	1.2	0.0	1.7	0.3	0.0	0.0	1.4	2.0	1.8	1.7	1.8	5.3	0.5	6.5	1.2	0.2	0.2	0.9	1.4	0.0	2.0	1.8
ACHE	YT	ENSG00000087085	"Acetylcholinesterase (Cartwright blood group)"	P22303	7	100889994-100896974	"Blood group antigen proteins, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Neurotransmitter degradation"	"Blood group antigen, Hydrolase, Serine esterase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 43.8;skeletal muscle: 98.2"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 45.5;Erythroid cells: 46.7;Exocrine glandular cells: 34.7;Horizontal cells: 52.4;Paneth cells: 52.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.2;CACO-2: 12.9;K-562: 15.2;Karpas-707: 25.2;U-2 OS: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027098			Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		650000	"Golgi apparatus"	Vesicles	"HPA027098: AB_2672111"	"unprognostic (2.23e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.71e-2)"	"unprognostic (5.80e-3)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (2.49e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (3.88e-5)"	"unprognostic (2.95e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.28e-2)"	"unprognostic (8.38e-2)"	1.4	4.8	5.8	3.5	16.1	10.3	1.4	22.8	11.8	1.4	4.2	2.7	1.4	5.7	1.9	2.6	2.8	1.8	3.1	4.5	5.5	43.8	1.4	1.8	1.8	5.9	22.2	4.8	1.7	1.6	7.0	3.2	2.0	37.9	3.3	3.4	4.6	6.5	3.3	98.2	1.4	7.9	1.9	8.7	2.3	2.1	1.9	2.6	3.5	1.6	15.9	3.2	2.1	1.2	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.3	0.2	0.5	0.0	8.2	0.3	0.0	0.1	0.2	12.9	0.3	0.0	0.5	0.0	1.2	0.4	2.2	0.1	0.0	4.4	0.5	0.2	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.1	15.2	25.2	0.1	3.6	0.0	0.1	1.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.0	1.0	0.0	3.7	0.0	0.0	0.1	0.7	6.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	16.1	22.8	11.8	5.5	43.8	22.2	4.8	37.9	2.6	0.0	0.0	0.0	21.7	0.7	7.2	4.5	0.0	0.0	0.0	0.0	0.0	5.4	0.0	6.2	0.0	2.3	45.5	46.7	34.7	1.9	4.2	17.2	0.0	0.0	0.7	52.4	3.4	1.3	0.0	0.0	0.6	0.0	1.7	8.2	7.6	11.9	30.0	52.6	0.7	1.0	4.3	0.0	3.3	3.9	4.5	0.9	5.9	0.0	3.3	11.2
MUC3A	MUC3	ENSG00000169894	"Mucin 3A, cell surface associated"	Q02505	7	100949555-100968346	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"gallbladder: 84.4;intestine: 138.0"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 181.0;Mucus-secreting cells: 104.0;Paneth cells: 136.8;Undifferentiated cells: 104.3"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 29.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 11.8;CAPAN-2: 3.9;MCF7: 2.6;OE19: 5.9"									HPA010871	Uncertain				"Intracellular and membrane"	NA	NA					"HPA010871: AB_1854201"	"unprognostic (1.12e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.91e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.29e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.50e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.51e-2)"	0.1	0.0	0.0	1.6	0.0	0.0	0.4	0.0	0.0	0.0	31.4	0.0	0.0	23.3	0.0	0.0	0.0	0.0	84.4	0.8	0.0		0.0	2.8	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.5	6.7	0.0	0.0	0.0	2.4	0.0	138.0	0.1	0.0	0.0	1.4	0.0	0.0	19.3	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	11.8	3.9	0.0	0.1	0.0	0.1	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	2.6	0.0	0.0	1.7	5.9	0.0	0.0	0.0	0.3	0.6	0.0	0.9	0.0	0.0	1.2	0.0	1.3	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	21.4	0.0	0.0	1.2	33.1	0.0	0.0	1.8	0.0	0.3	0.0	12.0	0.4	0.0	181.0	0.0	25.0	0.6	0.0	42.1	0.0	5.1	0.2	0.0	9.9	0.6	1.5	0.0	0.3	0.0	0.0	1.8	104.0	0.0	34.7	136.8	0.0	0.1	0.0	0.0	1.3	0.5	3.4	0.1	0.2	0.0	104.3	12.8
MUC12	MUC11	ENSG00000205277	"Mucin 12, cell surface associated"	Q9UKN1	7	100969623-101018949	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 35.6"	"Group enriched"	"Detected in many"	5	"Enterocytes: 444.8;Mucus-secreting cells: 128.0;Paneth cells: 173.4;Undifferentiated cells: 234.4"	"Cancer enriched"	"Detected in some"	7	"colorectal cancer: 13.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.8"									HPA023835	Enhanced					NA	NA					"HPA023835: AB_1854199"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.84e-4)"	"unprognostic (4.40e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.33e-7)"	"unprognostic (8.42e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.54e-2)"	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	25.2			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		5.0	35.6		0.0	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	2.7	10.9	3.4	0.0	2.0	0.0	6.7	2.3	1.8	0.0	0.2	0.0	4.6	2.9	1.3	444.8	0.0	2.3	1.2	14.1	7.1	9.2	0.0	2.0	0.0	45.6	1.3	0.6	4.0	0.9	4.8	3.3	0.0	128.0	0.0	7.9	173.4	3.2	0.0	0.0	0.0	5.9	2.4	1.3	2.6	0.5	1.0	234.4	4.3
MUC17		ENSG00000169876	"Mucin 17, cell surface associated"	Q685J3	7	101020072-101058745	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	299	"intestine: 125.2"	"Cell type enriched"	"Detected in some"	5	"Enterocytes: 59.0"	"Group enriched"	"Detected in some"	29	"colorectal cancer: 6.1;pancreatic cancer: 4.9;stomach cancer: 22.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;OE19: 1.0"									HPA031634	Enhanced				"Intracellular and membrane"	NA	NA					"HPA031634: AB_10603021"			"unprognostic (2.37e-2)"	"unprognostic (2.41e-1)"		"unprognostic (8.17e-3)"					"unprognostic (5.57e-3)"	"unprognostic (6.07e-2)"	"unprognostic (8.79e-8)"	"unprognostic (1.28e-1)"	"unprognostic (2.47e-2)"			0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	64.7	0.0	0.0	15.8	0.0	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	2.5	0.0	0.1	0.0	0.1	0.1	125.2	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	3.5	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0
TRIM56	RNF109	ENSG00000169871	"Tripartite motif containing 56"	Q9BRZ2	7	101085439-101097967	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024358	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA024358: AB_1858308"	"unprognostic (6.47e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.44e-3)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (2.63e-1)"	"unprognostic (4.11e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-3)"	"unprognostic (8.13e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (2.13e-4)"	14.3	12.0	6.2	15.7	9.3	4.7	24.5	3.2	11.1	14.9	15.0	6.8	22.3	9.7	14.3	13.1	12.9	12.8	13.7	8.7	7.5	5.2	10.8	10.4	23.7	11.7	15.8	5.2	17.3	10.8	10.7	15.2	14.0	8.8	12.5	8.3	7.5	12.2	22.1	8.7	13.2	12.8	15.2	8.5	17.2	10.3	5.6	12.0	9.7	14.0	9.1	12.0	13.6	22.0	3.3	2.1	7.4	2.4	7.7	3.6	1.0	9.9	12.5	5.4	6.9	12.5	13.0	6.5	8.3	7.4	13.5	12.6	5.9	14.5	11.8	9.0	6.9	18.8	11.5	2.2	7.6	9.1	11.8	3.5	7.4	15.7	4.4	11.2	13.1	16.9	8.2	11.1	8.8	14.4	13.2	7.1	7.6	12.9	15.0	9.3	13.6	11.0	14.6	5.4	5.3	10.4	10.2	8.8	7.7	7.1	10.4	0.3	0.2	9.2	25.8	7.0	7.2	5.9	8.6	13.4	19.0	16.9	14.2	8.9	7.4	7.4	9.3	9.4	10.7	14.8	2.5	2.4	2.1	3.6	1.5	2.6	2.0	2.7	2.3	0.8	3.3	2.6	3.4	7.4	7.7	2.1	2.1	1.1	1.0	6.2	9.3	3.2	11.1	7.5	5.2	15.8	5.2	8.8	12.0	68.5	72.4	41.5	67.9	4.6	3.2	19.1	89.2	77.6	52.4	48.8	2.0	33.7	3.3	51.6	1.8	75.8	45.5	23.3	41.2	22.2	26.5	58.9	14.0	41.9	17.0	9.5	28.1	86.5	38.1	0.8	122.6	36.3	1.7	21.6	43.9	23.6	46.8	49.1	88.8	6.7	2.8	64.7	27.4	4.7	6.6	2.9	24.9	62.3	41.9	50.8
SERPINE1	"PAI, PAI1, PLANH1"	ENSG00000106366	"Serpin family E member 1"	P05121	7	101127089-101139266	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 253.6"	"Cell type enhanced"	"Detected in many"	22	"Pancreatic endocrine cells: 138.9;Syncytiotrophoblasts: 545.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	20	"NK-cell: 10.8"	"Lineage enriched"	"Detected in single"	20	"NK-cells: 10.8"	"Cell line enhanced"	"Detected in many"		"BJ: 142.8;HUVEC TERT2: 165.7;LHCN-M2: 160.0;TIME: 409.8;U-138 MG: 195.1;U-251 MG: 171.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA050039, CAB068501"	Uncertain		Approved	Cytosol	"Secreted to blood"	No	No	142000000	14000000	Cytosol		"CAB068501: AB_1642775, HPA050039: AB_2680997"	"unprognostic (5.02e-2)"	"prognostic unfavorable (5.01e-4)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (2.10e-2)"	"unprognostic (9.04e-3)"	"prognostic unfavorable (2.84e-5)"	"unprognostic (6.80e-3)"	"prognostic unfavorable (4.41e-6)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (5.88e-8)"	"prognostic unfavorable (3.27e-6)"	"unprognostic (1.05e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (5.51e-4)"	45.5	14.0	1.1	16.7	1.8	0.1	11.4	0.5	1.5	13.3	7.0	3.4	3.3	1.2	6.6	14.4	6.8	9.3	69.6	29.2	1.5	0.6	7.8	65.3	56.3	3.3	4.1	1.8	19.7	24.7	1.4	2.6	253.6	5.9	7.6	0.9	2.3	2.4	6.2	12.4	4.1	2.3	13.5	4.1	5.8	6.6	8.6	2.2	0.6	11.3	3.7	2.8	71.7	18.1	0.2	0.4	0.5	0.2	10.8	0.3	1.0	3.0	2.6	0.0	0.2	32.7	65.2	3.7	142.8	27.0	72.1	63.0	0.3	0.2	0.1	34.2	45.4	99.7	0.7	0.0	11.0	74.4	0.1	0.0	0.0	0.2	2.4	65.8	0.0	0.1	25.5	4.4	110.5	58.1	39.1	165.7	0.0	0.2	0.1	160.0	0.0	0.0	0.0	0.7	0.0	1.7	0.0	0.2	0.1	0.2	1.2	0.0	0.0	11.7	3.2	0.3	18.0	0.1	0.4	409.8	195.1	8.5	66.4	171.5	0.0	0.1	0.1	48.7	0.0	1.8	0.5	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.3	0.2	0.0	0.1	0.2	10.8	0.0	0.4	0.0	1.0	1.1	1.8	0.5	1.5	1.5	0.6	4.1	1.8	5.9	2.2	0.0	11.4	0.0	30.0	35.5	0.4	1.9	7.6	8.1	7.9	5.2	0.0	34.4	0.0	22.9	0.0	53.9	0.0	0.0	3.8	35.1	24.7	5.4	10.3	90.0	15.2	0.0	5.1	60.2	4.7	0.4	16.4	7.5	6.8	1.8	0.0	0.3	138.9	0.0	11.3	0.0	0.2	38.8	16.5	0.0	0.0	21.7	545.0	0.7	0.0	5.9
AP1S1	"AP19, CLAPS1, EKV3, SIGMA1A, WUGSC:H_DJ0747G18.2"	ENSG00000106367	"Adaptor related protein complex 1 sigma 1 subunit"	P61966	7	101154400-101161596	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Ichthyosis, Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.8"	"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 291.8;Proximal tubular cells: 208.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060945	Supported		Supported	"Golgi apparatus,Vesicles"		NA	Yes			"Golgi apparatus, Vesicles"		"HPA060945: AB_2684393"	"unprognostic (1.98e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.98e-3)"	"unprognostic (8.70e-3)"	"unprognostic (7.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-1)"	7.6	9.7	30.6	7.9	41.1	3.0	10.8	7.9	45.8	6.8	16.5	6.4	4.6	23.3	6.6	10.6	10.9	8.9	9.3	4.2	22.9	14.6	16.6	15.5	6.7	6.9	12.3	25.3	7.9	8.0	6.3	10.5	10.2	10.1	10.9	14.2	4.6	10.4	6.1	3.5	12.3	18.0	7.9	8.7	7.7	13.2	6.9	9.3	4.7	9.3	7.4	8.5	8.7	6.1	4.4	8.2	2.1	5.5	1.9	5.9	4.2	26.4	21.5	14.5	27.4	10.7	17.6	31.4	17.8	12.1	12.1	12.9	11.5	33.8	5.9	31.1	19.4	23.5	13.2	8.3	27.3	10.8	13.4	13.4	4.0	13.5	14.3	13.2	10.8	20.1	19.7	20.9	11.9	5.2	18.1	17.9	13.4	12.9	24.0	29.9	66.0	9.0	23.4	23.1	39.2	43.4	5.7	6.6	12.4	29.1	22.6	11.4	37.3	10.1	26.8	32.4	24.9	11.8	10.1	18.5	17.5	30.5	6.6	12.2	5.4	11.3	11.4	44.4	12.0	35.1	0.8	5.5	0.5	4.2	4.9	3.7	4.4	5.9	4.7	7.4	3.8	3.5	3.2	2.1	1.9	2.8	8.2	5.5	4.2	30.6	41.1	7.9	35.1	22.9	14.6	12.3	25.3	10.1	9.3	6.0	0.0	18.5	25.1	34.5	26.2	1.1	50.9	0.0	2.3	52.4	7.9	145.9	291.8	115.8	1.0	22.5	124.9	0.0	97.6	75.8	26.7	26.8	5.7	37.6	83.8	28.6	86.6	25.2	24.7	2.0	32.5	23.2	50.6	83.0	83.1	23.6	132.7	74.8	20.5	208.8	16.4	19.4	13.3	10.1	80.0	39.6	50.6	15.2	96.8	26.8
VGF	"SCG7, SgVII"	ENSG00000128564	"VGF nerve growth factor inducible"	O15240	7	101162509-101165593	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 59.4;pituitary gland: 30.4"	"Group enriched"	"Detected in many"	7	"Horizontal cells: 212.9;Intestinal endocrine cells: 123.0"	"Cancer enriched"	"Detected in many"	6	"melanoma: 236.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 36.7;SK-MEL-30: 99.1;U-2 OS: 18.0;WM-115: 29.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055177, HPA072505"	Enhanced		Enhanced	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1270000	2800000	"Golgi apparatus, Vesicles"		"HPA055177: AB_2682728, HPA072505: AB_2686528"	"unprognostic (3.04e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.19e-3)"	"prognostic unfavorable (4.25e-4)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (1.51e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.25e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.84e-3)"	"unprognostic (3.70e-3)"	"unprognostic (9.82e-3)"	"unprognostic (3.79e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.21e-1)"	3.8	3.1	10.9	2.3	25.2	1.3	1.1	1.3	59.4	1.1	1.5	1.3	0.0	1.3	2.2	1.1	1.1	1.1	1.2	1.2	12.2	51.0	1.4	1.1	1.1	1.1	3.9	22.8	1.1	6.2	1.1	30.4	1.2	41.2	1.2	1.2	0.5	1.1	1.1	1.1	1.4	1.3	1.5	6.6	1.2	3.6	1.4	0.5	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	2.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.6	0.0	0.3	0.2	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.4	0.0	4.7	0.0	0.4	3.7	0.2	0.4	0.1	0.0	0.0	0.0	0.0	3.0	36.7	0.0	0.1	99.1	0.2	0.1	0.0	0.0	0.0	18.0	0.0	0.4	0.0	0.1	0.9	2.9	0.0	29.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	25.2	1.3	59.4	12.2	51.0	3.9	22.8	41.2	0.5	0.0	0.0	0.0	1.0	1.3	8.5	2.4	0.0	0.0	0.0	0.0	0.0	1.3	24.9	0.3	0.0	0.3	1.3	0.0	0.0	6.3	0.2	2.8	0.0	0.0	0.5	212.9	123.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	1.4	9.5	2.9	0.0	1.0	4.5	0.0	0.2	0.2	4.2	1.9	1.1	0.0	0.9	0.5
NAT16	"C7orf52, FLJ39237"	ENSG00000167011	"N-acetyltransferase 16 (putative)"	Q8N8M0	7	101170493-101180276	"Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.1;pancreas: 6.0;pituitary gland: 5.8;thyroid gland: 4.6"	"Cell type enriched"	"Detected in some"	45	"Horizontal cells: 276.5"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.1"	"Group enriched"	"Detected in many"	4	"amygdala: 3.1;basal ganglia: 9.1;cerebral cortex: 2.9;hypothalamus: 4.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 4.6;SH-SY5Y: 6.9;SK-MEL-30: 5.2;U-2 OS: 6.1;U-87 MG: 3.4"									HPA021918	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021918: AB_1848922"	"unprognostic (4.32e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.69e-3)"	"unprognostic (4.58e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.35e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.62e-2)"	"unprognostic (5.53e-5)"	"unprognostic (7.65e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.02e-5)"	"unprognostic (1.59e-1)"	0.2	0.4	3.1	0.2	9.1	0.7	0.1	0.4	8.2	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.1	0.2	0.1	0.1	0.9	4.8	0.1	0.5	0.1	0.2	0.7	0.6	0.1	6.0	0.2	5.8	0.1	0.8	0.2	0.3	0.5	0.3	0.1	0.3	0.4	0.2	0.2	0.4	0.3	1.2	0.4	1.2	0.0	4.6	0.0	0.0	0.1	0.0	1.2	0.7	2.2	0.6	1.3	0.8	0.0	0.5	0.0	0.1	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.2	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.1	0.2	0.0	0.1	0.0	1.3	0.5	0.5	0.1	0.1	0.8	0.0	0.6	0.2	0.1	4.6	0.1	0.5	0.1	6.9	0.0	0.3	5.2	0.5	0.3	0.0	0.0	0.4	6.1	0.5	0.1	0.1	0.0	0.1	3.4	0.0	1.6	0.4	0.6	0.3	0.3	0.4	0.3	0.2	0.2	0.1	0.2	1.2	0.8	0.4	2.2	1.3	0.3	0.7	0.3	0.0	3.1	9.1	0.4	2.9	0.9	4.8	0.7	0.6	0.8	1.2	0.0	0.0	0.0	0.0	0.0	1.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	276.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
MOGAT3	"DC7, DGAT2L2, MGAT3"	ENSG00000106384	"Monoacylglycerol O-acyltransferase 3"	Q86VF5	7	101195007-101201021	"Enzymes, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 61.6;liver: 16.0"	"Cell type enhanced"	"Detected in some"	22	"Enterocytes: 76.6;Paneth cells: 56.1;Undifferentiated cells: 21.5"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.0;liver cancer: 11.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"CACO-2: 4.8;Hep G2: 16.2"									HPA011940	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA011940: AB_1854057"		"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.14e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.20e-1)"	"unprognostic (9.54e-3)"		"unprognostic (9.36e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.65e-1)"		"unprognostic (2.59e-2)"	0.2	0.1	0.2	2.6	0.2	0.4	0.2	0.2	0.2	0.2	17.3	0.2	0.2	19.7	0.2	0.5	0.2	0.1	0.2	0.2	0.2	0.1	0.9	16.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	7.1	0.2	0.2	0.2	0.2	0.1	61.6	0.4	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.7	1.2	5.3	0.9	1.9	1.2	0.3	0.6	0.2	0.2	0.5	0.0	0.2	0.4	0.6	0.0	0.0	0.0	4.8	1.1	0.4	0.6	0.1	0.6	0.4	0.2	0.1	0.1	0.1	0.2	0.6	0.6	16.2	0.2	0.5	0.6	0.1	0.1	0.0	0.1	0.4	0.1	0.3	0.2	0.7	0.1	0.3	0.3	0.5	0.2	0.5	0.6	0.3	0.1	0.4	0.7	0.6	0.3	0.3	0.3	0.6	0.1	0.8	0.3	0.3	0.8	0.9	0.2	1.0	0.5	0.4	0.2	0.1	1.7	0.6	1.4	2.2	0.9	1.1	1.0	0.7	0.7	1.0	0.8	0.7	0.5	1.7	0.9	1.2	5.3	1.9	0.6	1.2	0.5	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	76.6	0.0	0.0	0.0	0.2	0.2	0.0	5.5	0.0	0.0	1.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.1	56.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	21.5	0.4
PLOD3	LH3	ENSG00000106397	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3"	O60568	7	101205977-101218420	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Dioxygenase, Glycosyltransferase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 13.4;monocytes: 14.3;T-cells: 9.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 105.8;WM-115: 102.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001236	Uncertain				"Secreted - unknown location"	NA	NA		370000			"HPA001236: AB_1855474"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.91e-5)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.11e-3)"	"unprognostic (8.00e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.87e-2)"	23.9	16.1	11.9	19.5	24.0	14.6	35.4	7.2	19.2	17.8	20.0	31.2	16.6	22.7	22.9	15.1	11.0	17.4	16.7	22.1	14.8	11.6	20.2	54.1	21.0	18.2	36.3	8.9	16.1	23.2	18.5	16.5	33.1	22.4	14.4	14.2	11.1	11.3	19.6	8.8	14.0	23.2	23.2	29.0	20.4	16.7	10.1	30.6	5.1	16.8	6.0	6.9	17.3	42.6	2.6	13.4	2.8	14.3	2.5	9.2	5.3	10.1	9.2	3.8	25.8	18.4	13.3	7.9	18.7	21.0	19.2	13.9	14.8	13.2	0.8	21.1	32.3	14.8	12.4	7.7	11.0	4.9	5.5	3.5	1.0	11.1	14.4	25.4	4.6	8.7	14.3	10.5	11.2	8.9	18.2	17.0	0.7	9.8	105.8	12.9	29.0	0.4	10.9	8.1	17.5	14.0	3.2	5.2	15.7	6.5	3.0	2.9	17.5	11.6	17.0	41.7	10.7	3.2	15.9	14.8	29.1	14.2	35.2	22.9	5.9	10.8	0.6	17.2	11.1	102.0	0.0	10.8	2.8	9.2	14.3	8.1	2.6	6.8	6.1	10.4	1.8	3.2	3.4	1.0	2.5	14.3	13.4	4.3	5.3	11.9	24.0	7.2	19.2	14.8	11.6	36.3	8.9	22.4	30.6	20.8	8.3	9.0	8.8	7.9	5.1	12.3	17.8	12.0	7.9	24.4	13.7	16.7	1.7	35.7	0.4	23.6	35.9	0.0	27.6	62.3	31.0	7.5	19.6	16.6	45.4	7.9	15.5	27.0	21.6	1.5	24.2	16.4	59.1	20.8	16.2	10.8	29.4	28.1	13.8	10.5	5.9	19.4	17.6	7.2	12.6	4.3	15.8	8.6	21.1	4.2
ZNHIT1	"CG1I, H_DJ0747G18.14, ZNFN4A1"	ENSG00000106400	"Zinc finger HIT-type containing 1"	O43257	7	101217668-101224190	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Hepatocytes: 796.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019043	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA019043: AB_1859481"	"unprognostic (1.16e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.52e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.26e-2)"	"unprognostic (6.61e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.39e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.36e-1)"	"unprognostic (7.24e-3)"	24.6	21.0	29.4	18.7	26.9	18.3	23.6	11.7	20.8	21.1	24.5	16.6	29.4	24.5	15.0	29.4	21.1	23.2	29.8	26.9	24.7	19.4	27.7	77.2	14.1	18.5	27.9	17.2	13.2	34.7	17.2	17.3	19.9	18.7	17.4	16.2	12.0	29.3	29.9	32.7	16.2	23.4	15.0	28.0	18.4	22.7	13.1	17.6	21.0	27.3	24.0	14.1	14.7	20.9	27.9	42.8	45.5	47.1	22.4	39.7	45.9	14.1	14.6	9.6	18.4	17.8	23.0	9.4	17.5	17.3	17.2	17.1	14.5	16.5	10.1	23.4	19.1	14.9	12.0	8.7	24.3	7.4	10.5	33.7	5.5	12.8	17.3	22.7	11.2	11.9	21.5	29.5	15.2	7.4	14.6	25.1	15.2	17.4	16.8	14.6	42.1	18.4	60.9	18.4	22.9	36.8	9.8	7.5	31.1	23.0	6.7	11.9	26.9	13.2	23.9	28.9	11.3	6.2	13.8	19.1	16.2	14.2	27.9	12.4	13.6	17.2	12.2	15.6	19.8	21.6	42.0	47.1	45.5	27.4	42.5	28.9	27.4	30.5	27.5	40.6	27.9	24.7	26.5	39.1	22.4	40.8	42.8	39.7	45.9	29.4	26.9	11.7	20.8	24.7	19.4	27.9	17.2	18.7	17.6	86.4	76.3	87.8	100.5	89.4	29.5	69.6	216.6	103.1	83.0	181.5	15.7	165.9	306.7	174.5	18.7	143.6	325.7	93.5	222.5	162.7	150.6	101.7	77.3	796.2	180.7	11.1	231.8	154.1	203.1	46.0	125.1	115.6	123.2	212.8	211.4	63.3	222.4	336.6	117.4	541.3	29.9	148.8	103.2	50.5	36.9	101.9	136.7	113.6	219.4	110.3
CLDN15		ENSG00000106404	"Claudin 15"	P56746	7	101232092-101238820	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	13	"intestine: 194.8"	"Cell type enhanced"	"Detected in many"	6	"Undifferentiated cells: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (8.85e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (5.31e-5)"	"unprognostic (9.98e-2)"	"unprognostic (2.89e-2)"	"unprognostic (9.64e-2)"	"prognostic favorable (3.30e-4)"	15.4	0.7	1.0	5.2	1.0	3.9	12.5	1.3	1.1	2.5	172.9	1.1	1.2	76.6	2.4	4.4	1.8	3.2	7.2	2.1	1.7	0.8	3.7	7.0	2.2	2.9	1.7	0.8	4.4	1.3	1.1	1.3	2.0	1.7	2.2	2.4	0.8	1.4	1.2	1.1	2.1	194.8	1.6	2.3	5.7	1.7	2.4	1.4	1.0	1.8	1.3	2.3	2.7	3.0	1.0	1.8	1.7	1.2	0.8	1.9	1.4	2.2	6.9	3.7	5.8	5.8	4.7	2.5	2.2	2.8	2.7	4.0	4.6	2.6	7.4	3.9	1.4	4.5	4.2	6.1	1.3	2.7	9.2	12.9	3.4	3.9	5.9	5.1	3.8	7.5	4.5	6.1	3.6	4.7	5.9	2.2	7.5	16.0	12.1	2.1	7.7	6.0	21.9	2.9	3.3	4.8	8.2	3.2	6.1	1.6	2.8	3.6	12.7	2.0	3.8	10.6	5.3	3.5	7.7	3.2	9.0	7.8	13.6	2.6	12.8	16.0	7.9	2.5	10.0	5.2	0.2	1.2	0.1	1.9	0.7	0.6	0.4	1.9	0.2	0.8	1.0	1.3	1.4	1.7	0.8	0.9	1.8	0.8	1.4	1.0	1.0	1.3	1.0	1.7	0.8	1.7	0.8	1.7	1.4	3.0	1.4	5.2	5.3	6.1	17.9	0.8	12.7	5.3	7.9	21.0	29.5	4.1	11.6	4.4	13.8	6.7	24.5	0.0	5.8	3.2	6.0	5.3	0.0	8.1	2.4	14.3	11.6	4.9	1.9	3.0	14.1	2.9	6.8	3.6	27.6	4.1	4.8	25.4	2.1	2.2	21.1	6.5	2.5	6.0	6.3	4.5	4.2	8.2	51.4	2.7
FIS1	"CGI-135, Fis1, H_NH0132A01.6, TTC11"	ENSG00000214253	"Fission, mitochondrial 1"	Q9Y3D6	7	101239458-101252316	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA017430	Approved		Supported	Mitochondria		NA	NA		590000	Mitochondria		"HPA017430: AB_1848608"	"unprognostic (1.45e-2)"	"unprognostic (8.20e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.73e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.47e-2)"	"prognostic favorable (1.08e-7)"	"unprognostic (1.29e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	35.1	46.8	53.4	22.3	49.9	32.7	35.8	26.0	60.0	30.3	34.4	57.9	38.0	30.0	31.1	42.7	35.6	47.0	39.4	78.6	52.6	44.8	39.6	58.3	27.8	23.6	65.3	37.8	41.2	56.6	39.5	37.1	34.0	45.1	29.3	26.3	28.8	45.2	43.8	120.5	29.7	29.2	32.4	87.9	28.1	31.1	30.4	44.1	21.3	47.1	48.8	22.6	30.5	29.3	73.0	73.4	63.6	67.4	55.6	72.8	87.9	25.0	29.5	22.1	31.7	25.6	34.2	15.1	27.2	33.1	24.9	21.5	20.3	41.2	24.5	36.3	37.3	22.8	14.8	15.4	43.9	13.9	19.0	22.4	11.1	42.9	26.9	30.5	20.7	17.3	32.6	41.4	17.3	26.7	28.0	44.9	13.6	23.3	33.7	37.4	115.0	32.2	37.4	24.5	50.6	28.7	15.8	12.4	53.8	37.6	29.0	28.7	33.6	13.0	62.5	18.4	20.3	20.8	23.5	36.8	29.2	18.8	30.2	28.9	28.6	21.8	14.1	27.1	23.6	38.1	58.9	67.4	63.6	63.2	65.5	65.1	72.2	61.0	59.7	73.4	73.0	60.7	63.5	51.4	55.6	59.0	61.4	72.8	87.9	53.4	49.9	26.0	60.0	52.6	44.8	65.3	37.8	45.1	44.1	95.3	100.9	113.2	110.6	93.2	42.7	311.2	216.6	109.7	67.1	218.1	15.7	209.3	475.9	225.3	158.1	164.5	399.5	537.3	254.1	253.9	149.0	192.6	133.9	365.3	254.4	33.4	210.7	152.2	158.6	575.1	179.5	136.4	207.5	212.0	223.3	159.0	210.6	475.1	168.3	613.6	43.3	97.0	162.7	157.3	182.7	118.6	271.1	129.8	226.8	173.1
IFT22	"DKFZp761N0823, FLJ13225, FLJ14117, RABL5"	ENSG00000128581	"Intraflagellar transport 22"	Q9H7X7	7	101313367-101321823	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 59.5"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 478.2;Late spermatids: 1059.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 47.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042930	Approved		Approved	Microtubules,Cytosol		NA	NA			"Microtubules, Cytosol"		"HPA042930: AB_10794537"	"unprognostic (1.55e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.33e-1)"	6.6	12.3	18.1	4.4	19.9	2.9	9.3	4.8	17.1	11.2	9.9	10.1	9.5	3.1	13.0	28.8	7.6	39.9	12.0	15.9	14.6	15.8	25.5	6.1	7.9	5.7	12.9	13.9	15.3	13.2	15.6	16.2	3.9	13.5	11.2	4.6	15.5	10.6	12.7	14.7	6.5	3.5	13.8	8.6	2.9	7.7	59.5	6.4	9.2	26.2	6.7	4.6	9.3	5.8	9.9	6.7	1.5	5.1	8.3	7.9	3.0	15.1	19.0	15.4	29.6	9.8	12.5	3.9	8.0	7.1	10.7	8.3	7.3	13.7	2.2	14.8	12.5	24.8	8.1	7.8	9.3	7.5	3.5	7.6	0.7	9.7	6.3	9.2	5.4	3.1	10.0	8.3	16.2	4.4	19.9	8.6	10.8	6.3	1.4	8.9	47.3	11.5	6.2	11.4	9.3	10.0	9.5	9.0	2.4	17.8	8.2	12.9	22.8	18.2	11.4	7.5	16.6	12.1	2.9	7.6	18.5	15.9	42.3	11.1	1.3	7.1	4.7	14.7	1.2	10.7	1.0	1.2	1.5	6.5	2.0	6.7	9.9	7.9	5.9	2.3	9.3	7.0	6.8	1.1	8.3	5.1	6.7	3.1	3.0	18.1	19.9	4.8	17.1	14.6	15.8	12.9	13.9	13.5	6.4	23.8	11.0	19.2	21.0	0.0	26.4	37.5	48.4	188.7	35.2	47.1	51.1	16.8	117.7	62.7	478.2	9.5	2.0	0.0	32.2	14.6	27.1	19.5	9.2	8.9	15.3	30.2	17.7	14.1	2.6	1059.8	35.1	9.9	0.0	4.6	11.8	43.3	28.1	9.3	38.9	121.8	87.3	12.9	21.1	208.9	81.0	0.0	5.5	5.7	8.5	12.1
COL26A1	"EMI6, EMID2, Emu2"	ENSG00000160963	"Collagen type XXVI alpha 1 chain"	Q96A83	7	101362820-101559024	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 11.4;brain: 18.3"	"Cell type enhanced"	"Detected in some"	15	"Collecting duct cells: 5.2;Hepatocytes: 2.6;Late spermatids: 2.2;Spermatogonia: 2.2"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 12.6;ovarian cancer: 5.7;prostate cancer: 4.6;testis cancer: 14.7"					"Cell type enriched"	"Detected in single"	63	"plasmacytoid DC: 11.4"	"Lineage enriched"	"Detected in single"	63	"dendritic cells: 11.4"	"Cell line enhanced"	"Detected in some"		"AF22: 20.3;BEWO: 16.3;HAP1: 7.2;NTERA-2: 17.1;SuSa: 13.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA027059	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA027059: AB_1848142"	"unprognostic (5.94e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.35e-1)"	"prognostic favorable (2.32e-5)"	"unprognostic (1.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.24e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.48e-4)"	"unprognostic (2.83e-3)"	0.0	4.1	2.5	0.3	7.0	0.3	0.2	0.4	18.3	0.1	0.0	0.2	0.0	0.1	0.5	0.3	0.0	0.2	0.3	0.1	3.3		3.1	4.8	0.6	0.9	0.0	8.1	0.2	3.1	6.7	0.0	0.5	0.6	3.7	0.0	0.0	0.2	1.1	0.0	0.1	0.1	0.1	0.3	0.4	0.2	0.8	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.5	20.3	1.2	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	3.2	0.0	0.0	0.0	7.2	0.0	0.0	0.7	0.8	0.0	0.0	5.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	17.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.1	13.7	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0											0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	5.2	0.0	0.1	0.0	0.1	1.1	0.0	0.0	0.0	0.5	0.2	0.0	0.5	0.0	2.6	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.3	0.0	0.0	0.5
MYL10	"MGC3479, MYLC2PL, PLRLC"	ENSG00000106436	"Myosin light chain 10"	Q9BUA6	7	101613325-101629296	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 4.5;skeletal muscle: 9.1"	"Cell type enhanced"	"Detected in some"	26	"Cardiomyocytes: 1.4;Peritubular cells: 2.5"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"PC-3: 12.3;RH-30: 7.1;SuSa: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019763	Uncertain		Uncertain	Microtubules		NA	NA			Microtubules		"HPA019763: AB_1854243"		"unprognostic (2.32e-2)"		"unprognostic (3.09e-1)"					"unprognostic (1.11e-1)"		"unprognostic (1.74e-2)"	"unprognostic (2.78e-3)"		"unprognostic (5.04e-3)"	"unprognostic (8.93e-2)"		"unprognostic (1.10e-2)"	0.2	0.1	0.2	0.2	0.2	1.5	0.2	0.2	0.3	1.9	0.2	0.2	0.2	0.1	0.9	0.4	0.2	0.4	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	2.7	2.0	0.2	2.9	0.9	0.2	0.3	0.2	9.1	1.1	0.2	0.2	0.2	0.2	0.1	0.9	0.2	0.2	0.2	2.9	0.6	1.0	0.2	1.4	1.0	4.5	0.9	1.4	1.3	0.2	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.9	0.0	0.3	0.1	0.5	0.2	0.1	0.2	0.0	0.2	0.2	0.1	0.2	0.1	0.0	0.1	0.2	0.2	0.8	0.1	0.1	0.5	0.2	0.2	0.1	0.1	0.1	0.1	0.5	0.0	0.2	0.3	0.0	12.3	0.0	7.1	0.0	0.1	0.5	0.2	0.0	0.1	0.1	1.2	3.7	0.2	0.1	0.3	0.6	1.3	0.0	0.2	0.4	0.2	1.2	0.1	0.3	0.0	4.5	0.9	0.8	0.4	0.5	0.4	0.9	0.6	0.8	0.3	1.4	0.9	0.7	3.4	1.4	0.5	1.0	1.3	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CUX1	"CASP, CDP, CDP/Cut, CDP/Cux, CDP1, Clox, CUT, CUTL1, CUX, Cux/CDP, GOLIM6"	ENSG00000257923	"Cut like homeobox 1"	"P39880, Q13948"	7	101815904-102283958	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Transport"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"non-classical monocyte: 21.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003277, HPA003317"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA003277: AB_10601804, HPA003317: AB_2666891"	"unprognostic (5.86e-2)"	"unprognostic (5.39e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (5.72e-7)"	"unprognostic (1.12e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.97e-1)"	19.3	12.7	22.9	19.2	24.4	19.5	12.3	48.6	29.9	31.6	26.4	23.1	17.3	22.2	52.1	17.4	23.9	24.5	23.2	53.8	18.8	18.3	27.4	16.0	22.0	11.8	20.4	11.7	33.0	41.4	34.4	30.2	24.4	16.9	22.8	17.2	26.8	26.3	16.9	31.0	15.9	25.3	27.5	31.6	15.0	23.4	8.3	17.1	44.0	33.5	23.2	24.1	31.8	21.9	2.0	12.1	4.7	21.0	3.0	2.2	4.5	14.5	15.6	11.0	13.7	9.0	18.6	6.9	14.7	15.6	6.2	4.1	9.3	9.4	18.9	23.6	14.5	11.5	12.0	7.0	11.8	3.7	9.0	7.8	6.6	11.6	7.7	23.9	8.5	3.6	12.9	24.1	4.8	10.9	17.9	8.0	12.2	15.3	16.0	5.8	30.0	27.8	10.5	4.5	22.5	16.4	18.4	9.2	22.3	10.2	16.7	10.2	30.3	12.8	32.2	12.5	9.6	6.3	10.3	11.9	26.3	17.8	19.8	8.3	10.5	4.9	40.8	24.3	7.9	18.3	2.1	8.6	1.5	2.1	8.8	2.2	2.0	1.6	2.2	7.0	1.7	1.6	2.2	4.7	3.0	21.0	12.1	1.5	4.5	22.9	24.4	48.6	29.9	18.8	18.3	20.4	11.7	16.9	17.1	92.3	45.5	28.3	27.6	23.4	53.5	101.2	28.1	46.8	45.5	38.4	64.8	44.1	8.3	29.7	7.2	31.1	49.5	0.0	20.8	48.4	40.9	44.0	11.5	30.9	29.9	50.9	40.8	32.5	70.3	7.4	38.3	36.4	16.9	25.2	44.2	49.6	28.5	54.3	57.3	53.1	57.1	25.8	24.5	12.0	13.8	37.9	73.6	20.8	37.2	42.8
SH2B2	APS	ENSG00000160999	"SH2B adaptor protein 2"		7	102285091-102321711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"skeletal muscle: 37.8"	"Cell type enhanced"	"Detected in many"	13	"B-cells: 20.7;Extravillous trophoblasts: 58.6;Syncytiotrophoblasts: 48.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 5.2;neutrophil: 3.9"	"Group enriched"	"Detected in many"	5	"B-cells: 5.2;granulocytes: 3.9;monocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.5;Karpas-707: 22.9;RPMI-8226: 16.8;U-266/70: 21.3;U-266/84: 37.3;U-698: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051131	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA051131: AB_2681354"	"unprognostic (2.01e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.32e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.42e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (6.99e-7)"	"unprognostic (1.25e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.02e-3)"	"unprognostic (3.42e-2)"	5.5	1.3	4.2	11.8	5.1	3.9	2.4	6.5	4.3	2.9	2.0	1.3	0.0	3.1	3.3	1.1	2.3	2.9	2.2	1.7	2.7	5.0	3.2	1.1	9.2	12.6	3.6	1.5	2.2	2.6	1.9	1.9	5.7	4.3	2.9	1.1	0.9	2.0	1.5	37.8	2.4	3.5	1.9	5.0	16.7	2.9	2.2	4.1	0.6	2.8	2.6	10.4	3.1	3.9	5.2	0.7	3.9	3.3	0.0	0.2	0.1	1.3	1.0	1.1	2.4	0.2	0.1	10.4	0.4	0.1	0.3	0.2	0.3	0.2	23.5	2.4	0.1	1.0	1.3	0.2	0.3	0.1	2.9	1.0	0.0	0.6	0.2	0.2	0.1	0.8	0.2	0.3	0.2	0.0	0.4	0.0	0.6	0.1	22.9	0.4	2.5	0.1	4.1	2.6	0.8	4.3	2.9	1.2	16.8	0.8	0.3	1.2	4.3	0.8	2.1	0.5	0.9	0.3	3.0	0.0	0.4	2.4	4.1	0.4	21.3	37.3	31.7	1.5	0.8	0.5	0.0	0.6	0.0	0.2	3.3	0.0	1.4	0.0	0.0	0.7	5.2	0.0	0.0	3.9	0.0	1.3	0.0	0.0	0.1	4.2	5.1	6.5	2.9	2.7	5.0	3.6	1.5	4.3	4.1	0.0	0.0	20.7	2.1	2.3	5.9	1.1	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.1	0.3	3.5	0.0	0.0	0.0	58.6	1.8	2.8	0.0	0.8	7.1	4.8	1.7	1.3	7.1	0.7	0.6	6.4	6.8	0.0	0.6	8.5	0.1	0.0	0.4	10.3	1.4	0.0	2.5	0.9	12.6	1.4	48.6	0.0	1.2	1.8
SPDYE6		ENSG00000260097	"Speedy/RINGO cell cycle regulator family member E6"		7	102347206-102356444	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"skeletal muscle: 4.5;skin 1: 3.9;testis: 4.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 12.1"									HPA051750	Approved					NA	NA					"HPA051750: AB_2681590"	"unprognostic (5.47e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.89e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.84e-3)"	"unprognostic (9.81e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.09e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.49e-2)"	"unprognostic (7.81e-6)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.12e-1)"	0.0	0.2		2.0		3.2	0.0		0.0	0.0	0.3			0.7	0.3	0.0	0.8	0.0	0.1	0.2			0.1	0.0	0.0	3.3			0.0	1.1	0.0		0.3		0.0	0.0		1.1	0.0	4.5	3.9	0.8	0.0		1.5	0.9	4.2			1.1		0.0	0.4		3.0	1.1	1.3	1.9	0.4	2.2	1.1	2.9	1.4	1.6	3.1	0.0	0.0	5.3	4.5	0.0	0.0	0.0	1.2	2.5	4.9	1.6	0.0	0.6	1.4	0.0	0.0	0.0	1.0	4.2	2.6	7.9	0.8	0.0	2.2	2.4	0.0	0.0	0.0	0.0	0.2	0.0	1.9	3.4	12.1	0.0	4.5	1.1	2.7	1.6	0.8	0.0	3.6	0.5	2.9	0.0	5.6	3.1	1.8	5.9	2.4	1.2	3.6	1.2	2.0	1.4	5.3	1.7	3.2	2.5	3.0	2.2	2.8	1.0	4.3	2.3	0.1	0.9	1.3	2.2	1.6	2.1	0.6	1.4	0.9	0.5	3.0	1.4	2.0	0.9	0.4	1.9	1.1	1.7	1.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRKRIP1	"C114, FLJ13902, KRBOX3"	ENSG00000128563	"PRKR interacting protein 1"	Q9H875	7	102363872-102426676	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051146	Uncertain		Supported	"Actin filaments,Cytosol"		NA	NA			"Actin filaments"	Cytosol	"HPA051146: AB_2681361"	"unprognostic (4.78e-3)"	"unprognostic (7.23e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (8.25e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.99e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.61e-3)"	"unprognostic (9.79e-3)"	"prognostic unfavorable (4.39e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.88e-1)"	"prognostic favorable (1.94e-4)"	14.9	19.3	20.1	21.1	22.6	31.0	15.2	28.0	23.0	15.9	14.0	19.2	24.2	14.9	17.6	20.4	15.0	16.2	13.9	16.5	19.0	21.2	16.7	12.3	14.6	22.4	19.1	20.3	18.9	17.0	26.6	18.9	18.1	17.9	17.7	11.6	17.1	21.5	17.8	20.7	27.0	14.5	16.6	20.1	19.1	14.6	43.7	19.0	15.8	16.8	12.4	19.6	14.1	14.4	15.3	18.5	21.7	15.7	14.7	15.1	10.7	12.8	8.9	11.0	13.9	6.5	5.7	10.6	9.8	8.3	14.7	13.9	12.2	12.6	11.9	16.8	7.8	11.8	11.3	7.0	8.6	9.3	13.7	13.0	5.9	9.8	9.0	10.0	9.0	8.1	5.4	9.0	11.9	8.7	9.2	8.3	12.2	14.1	27.3	11.3	26.7	23.0	27.9	11.0	10.9	9.1	15.3	9.1	19.2	8.0	8.8	9.0	17.8	15.5	21.5	13.1	10.0	10.3	11.4	9.3	16.9	16.4	19.0	12.7	23.8	19.5	22.9	12.5	14.3	20.4	5.3	12.7	20.1	13.8	12.4	13.0	15.3	13.1	14.2	8.1	15.1	15.1	14.1	21.7	14.7	15.7	18.5	13.4	10.7	20.1	22.6	28.0	20.8	19.0	21.2	19.1	20.3	17.9	19.0	29.8	17.9	24.4	16.5	11.8	21.4	19.9	20.4	34.8	27.3	15.7	29.5	23.5	26.6	20.9	55.7	18.0	11.8	23.3	21.7	24.1	15.5	18.3	22.0	12.3	24.0	22.3	15.6	11.6	8.5	62.4	15.8	16.9	11.8	25.2	11.4	21.7	24.2	10.5	15.6	22.1	19.4	32.3	17.0	45.4	43.5	15.4	35.0	21.3	9.8	15.3
ORAI2	"C7orf19, CBCIP2, FLJ12474, FLJ14733, H_NH0514P08.8, TMEM142B"	ENSG00000160991	"ORAI calcium release-activated calcium modulator 2"	Q96SN7	7	102433106-102456821	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"B-cells: 169.1;Cone photoreceptor cells: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 30.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 46.5;RPMI-8226: 45.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055137, HPA065937"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055137: AB_2682712, HPA065937: AB_2685581"	"unprognostic (5.09e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.07e-3)"	"unprognostic (8.56e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.07e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (8.49e-5)"	"unprognostic (7.16e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.97e-2)"	"unprognostic (1.88e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (2.46e-1)"	6.3	7.2	13.8	28.1	15.8	24.3	8.0	18.6	15.9	4.7	5.7	5.0	5.6	5.6	7.7	6.2	2.7	7.7	6.6	4.1	11.9	17.1	6.9	1.5	6.2	25.9	9.3	4.8	5.0	4.8	13.9	24.8	4.1	10.3	4.3	2.8	4.3	5.1	7.6	1.8	1.6	10.3	4.6	7.0	21.9	7.7	1.8	5.1	9.9	10.9	1.3	20.3	10.0	4.4	14.4	2.5	30.9	2.7	7.4	2.3	2.5	6.4	14.7	5.7	10.9	5.2	5.9	0.4	6.3	7.0	7.0	6.1	8.4	6.8	46.5	17.6	10.7	14.0	2.5	2.2	1.6	2.4	5.0	4.1	6.6	6.9	2.5	7.9	15.8	8.9	5.5	1.1	11.4	1.9	7.3	12.5	6.3	8.2	37.3	5.4	13.5	23.4	7.3	7.1	2.2	6.9	9.6	5.1	45.7	4.1	4.8	9.7	24.2	6.2	2.6	3.4	3.1	3.8	6.2	11.9	16.5	18.4	11.3	8.3	36.4	25.5	34.0	12.3	9.6	8.4	4.9	2.7	30.9	2.0	2.4	2.3	13.3	1.8	1.6	1.6	14.4	1.2	1.4	25.6	7.4	1.4	2.5	0.8	2.5	13.8	15.8	18.6	11.2	11.9	17.1	9.3	4.8	10.3	5.1	3.0	11.1	169.1	8.0	3.5	25.3	2.6	12.7	20.1	15.9	15.7	62.8	1.0	5.0	18.0	2.6	20.1	0.3	0.0	10.3	1.5	12.6	8.4	25.4	0.8	14.7	41.3	16.6	23.4	19.4	4.9	7.5	17.5	10.1	29.7	2.0	11.8	9.9	0.0	9.6	7.9	21.1	0.0	5.9	3.2	9.4	2.8	2.5	25.5	1.3	5.8
ALKBH4	FLJ20013	ENSG00000160993	"AlkB homolog 4, lysine demethylase"	Q9NXW9	7	102456238-102464876	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Actin-binding, Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051422	Approved					NA	NA					"HPA051422: AB_2681480"	"unprognostic (1.18e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.75e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.83e-2)"	"unprognostic (2.71e-3)"	"unprognostic (6.04e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-3)"	"unprognostic (3.20e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (3.09e-4)"	"unprognostic (1.44e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.44e-2)"	5.4	8.8	11.5	6.2	11.6	10.1	11.3	19.8	14.6	9.3	6.5	9.3	6.1	8.7	7.7	8.7	6.5	9.3	6.1	9.0	11.3	11.1	9.0	8.0	6.4	12.9	9.8	12.9	9.0	14.1	11.0	8.5	6.6	8.8	7.0	6.2	8.1	11.8	8.5	9.0	9.4	7.4	6.8	8.1	11.2	7.5	7.5	10.7	10.2	11.4	4.6	7.4	6.3	6.2	7.3	9.0	4.2	11.3	11.4	11.2	4.8	4.7	6.6	5.5	12.6	3.8	4.2	6.0	3.7	6.3	7.7	7.3	7.4	6.4	5.8	6.2	5.1	6.8	3.9	6.9	4.9	5.7	5.6	14.4	5.7	3.4	5.1	5.8	4.9	5.5	6.4	6.9	5.9	2.7	6.7	5.0	9.1	9.7	6.9	4.7	17.3	13.5	15.3	8.1	9.0	10.0	8.2	5.7	9.9	6.4	5.2	6.7	10.1	4.5	13.7	4.8	7.1	5.7	5.7	1.7	8.1	9.6	12.6	7.7	10.2	7.7	10.6	4.9	6.8	8.5	4.2	7.2	3.7	8.6	6.4	8.8	7.3	6.7	11.2	7.0	6.9	7.0	8.6	2.1	11.4	11.3	9.0	6.5	4.8	11.5	11.6	19.8	14.6	11.3	11.1	9.8	12.9	8.8	10.7	6.0	4.3	4.5	3.2	7.3	15.5	2.1	12.7	5.3	3.4	8.7	3.9	22.4	21.6	13.9	0.7	9.0	7.7	0.0	13.2	12.1	7.3	3.9	3.5	6.8	13.3	27.0	5.8	11.6	11.0	1.3	13.0	5.6	3.3	13.6	8.4	11.8	9.9	12.2	20.1	14.0	9.1	0.0	6.2	10.7	17.4	6.5	9.3	9.2	9.6	1.5
LRWD1	"CENP-33, DKFZp434K1815, ORCA"	ENSG00000161036	"Leucine rich repeats and WD repeat domain containing 1"	Q9UFC0	7	102464929-102473168	"Predicted intracellular proteins"	"DNA replication"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"testis: 129.9"	"Group enriched"	"Detected in many"	8	"Early spermatids: 733.2;Spermatocytes: 397.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021320	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Vesicles"	"HPA021320: AB_1853372"	"unprognostic (1.50e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.60e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.72e-3)"	"unprognostic (4.97e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.04e-2)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.46e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.82e-2)"	"unprognostic (9.20e-2)"	2.7	4.6	3.6	3.8	5.0	7.6	1.9	7.9	5.8	2.5	2.5	3.4	3.4	2.9	2.8	2.8	2.1	7.1	2.5	2.6	4.3	4.0	4.0	5.1	2.6	4.4	3.4	3.7	3.1	3.4	3.4	4.9	2.0	4.2	2.2	1.6	1.7	3.3	4.0	3.6	2.2	4.3	2.7	2.4	6.6	3.3	129.9	3.8	3.9	2.7	1.6	4.2	2.3	1.8	12.6	9.8	9.2	4.0	9.9	10.4	5.8	7.4	10.3	5.6	15.7	4.3	3.2	8.7	7.9	5.2	13.6	9.4	9.9	4.3	18.4	11.4	6.0	16.0	7.9	8.2	7.1	4.0	6.4	15.9	3.8	4.7	6.1	5.7	7.1	7.4	3.0	4.3	15.7	3.3	4.6	7.1	14.4	17.8	5.7	7.3	22.4	21.3	16.9	11.9	9.4	15.0	11.3	5.2	19.8	4.0	4.7	7.4	21.1	8.7	8.4	7.7	6.8	4.8	5.9	4.1	7.5	16.1	23.2	12.6	20.9	36.0	17.6	8.3	6.6	13.0	9.1	2.5	9.2	10.4	4.0	9.9	11.1	9.1	9.1	2.8	12.6	5.8	7.4	5.9	9.9	3.5	9.8	9.0	5.8	3.6	5.0	7.9	5.8	4.3	4.0	3.4	3.7	4.2	3.8	0.0	0.6	5.2	5.8	9.3	11.7	0.7	2.5	16.0	6.8	12.2	2.0	7.7	6.6	12.2	733.2	5.8	7.9	0.0	9.2	9.8	5.7	3.5	0.0	6.8	7.8	4.8	7.5	5.5	5.7	71.5	17.5	3.9	5.0	10.0	6.3	8.6	9.9	6.0	14.9	11.5	8.1	0.0	5.1	397.6	39.9	8.5	5.1	7.0	6.3	3.3
POLR2J	"hRPB14, POLR2J1, RPB11, RPB11A, RPB11m"	ENSG00000005075	"RNA polymerase II subunit J"	P52435	7	102473118-102478907	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046970			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046970: AB_2679882"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.80e-2)"	"unprognostic (6.47e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.53e-3)"	"unprognostic (4.46e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.45e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-2)"	19.0	28.1	30.9	16.5	28.9	37.0	52.2	17.9	27.6	20.0	20.6	15.1	22.7	22.2	16.3	27.9	20.0	19.6	27.9	65.7	26.1	25.1	21.0	40.9	21.2	31.9	28.5	17.8	21.7	50.2	16.0	23.4	15.6	22.3	18.4	16.7	19.4	28.2	23.9	75.9	19.1	24.3	28.1	35.9	18.6	20.7	18.1	23.1	20.8	24.9	38.8	18.6	19.9	18.3	42.8	42.3	63.4	40.1	25.5	44.8	38.1	31.5	32.3	22.2	29.2	21.1	16.3	16.3	17.5	18.8	25.8	22.0	29.3	24.7	14.6	33.9	24.4	37.2	17.0	20.5	21.6	15.9	27.2	36.6	14.6	23.2	28.3	25.8	28.2	21.9	21.2	27.1	23.1	13.0	16.9	23.0	31.4	34.1	43.7	21.1	97.3	46.3	50.4	20.5	31.5	41.7	22.1	21.8	43.0	20.6	21.0	18.9	31.5	21.1	40.4	24.9	23.6	18.1	34.6	18.5	29.2	37.2	45.7	34.2	27.0	39.2	37.8	26.0	35.2	33.9	48.3	40.1	63.4	32.1	39.1	30.4	42.8	34.5	35.6	31.3	37.6	29.8	30.0	58.5	25.5	35.5	42.3	44.8	38.1	30.9	28.9	17.9	27.6	26.1	25.1	28.5	17.8	22.3	23.1	32.8	37.7	101.2	100.0	84.3	36.9	165.4	71.4	69.6	36.4	118.7	11.8	175.6	232.1	122.3	40.3	90.9	189.8	140.2	173.5	165.1	101.3	117.4	42.7	165.1	176.1	33.4	98.9	85.3	97.5	33.8	117.6	117.2	135.0	153.3	115.9	97.7	155.7	164.9	104.0	180.9	34.8	51.8	107.2	95.4	243.8	101.5	152.3	76.2	104.4	130.5
RASA4B		ENSG00000170667	"RAS p21 protein activator 4B"	C9J798	7	102482445-102517781	"Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 47.4"	"Cell type enhanced"	"Detected in some"	10	"Bipolar cells: 2.3;Cardiomyocytes: 4.0;Distal tubular cells: 1.7;Intestinal endocrine cells: 2.4"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	7	"classical monocyte: 3.7;intermediate monocyte: 3.7;myeloid DC: 6.2;plasmacytoid DC: 3.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 6.2;monocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 9.1;SH-SY5Y: 11.8;U-138 MG: 16.5;U-2 OS: 14.2"									HPA043010	Uncertain		Approved	"Vesicles,Cell Junctions"		NA	NA			Vesicles	"Cell Junctions"	"HPA043010: AB_2678267"	"unprognostic (1.05e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.44e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.10e-1)"	2.9	1.1	2.3	1.4	1.2	0.0	2.1	0.5	4.4	3.2	2.4			2.5	4.1	0.0	0.6	1.5	1.3	0.5	1.8	2.0	0.9	0.1	0.8	1.3	1.1		2.2	0.9	0.0	1.1	1.7		1.5	0.0		0.7	3.7	47.4	1.8	3.0	0.5	0.5	1.9	0.8	0.2			0.3		0.2	1.4	2.3	0.1	6.2	0.0	3.7	0.0	0.2	1.8	0.2	0.9	3.2	0.2	0.5	1.9	0.1	5.7	3.1	1.2	2.9	0.2	0.4	2.2	6.4	6.6	0.5	7.7	0.0	0.0	0.0	0.2	0.7	0.3	1.7	0.5	0.0	0.0	0.2	2.1	0.3	0.0	0.0	9.1	0.8	0.1	0.6	8.1	0.7	2.2	0.0	1.1	0.0	0.3	0.9	2.3	1.1	3.6	0.0	0.8	2.2	11.8	0.9	0.2	0.2	2.2	0.2	1.6	1.0	16.5	14.2	1.3	0.5	2.7	1.9	0.2	1.9	0.4	2.6	0.0	3.7	0.0	0.2	3.7	0.1	0.1	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.6	3.9	0.0	1.8											0.0	1.1	0.5	0.2	0.3	2.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.0	2.4	0.0	0.3	0.0	0.3	0.7	0.0	0.0	1.2	0.3	0.1	0.0	0.0	0.1	0.4	0.0	0.9	0.2	0.0	1.0	0.1	0.5	0.0	0.1
POLR2J3		ENSG00000168255	"RNA polymerase II subunit J3"		7	102537918-102572653	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"blood: 12.3"	"Group enriched"	"Detected in some"	635	"Cytotrophoblasts: 71.6;Extravillous trophoblasts: 52.6;Hofbauer cells: 37.9;Syncytiotrophoblasts: 92.0"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 21.5"									"HPA011403, HPA046970"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA011403: AB_2668503, HPA046970: AB_2679882"	"unprognostic (3.55e-2)"	"unprognostic (2.04e-4)"	"unprognostic (4.55e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.90e-4)"	"unprognostic (3.04e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-2)"	2.8	3.0	0.9	1.7	1.4	2.3	1.9	4.0	4.7	3.1	2.4			3.6	4.5	0.1	2.3	4.9	0.3	1.3	1.1	1.1	2.2	2.8	2.2	1.0	1.5		4.5	1.7	2.9	2.3	1.7		2.5	2.1		4.1	0.2	1.0	5.0	3.5	1.8	1.6	3.9	2.2	0.8			4.0		3.5	4.1	2.2	4.9	5.9	12.3	5.6	4.4	4.4	3.4	8.5	4.1	1.7	0.1	0.2	0.7	0.7	5.1	1.5	3.3	3.8	3.2	2.4	1.2	0.3	0.0	4.8	4.1	2.7	2.1	3.6	21.5	4.7	2.4	3.2	1.0	0.9	3.0	2.2	0.3	1.8	1.7	1.7	6.5	5.2	2.1	2.7	1.5	0.5	6.9	7.5	0.4	0.0	3.0	5.2	0.3	2.9	2.0	0.8	1.1	1.7	0.3	9.4	0.9	5.0	2.1	0.0	1.4	4.2	3.1	8.3	0.0	1.3	0.2	0.6	3.6	5.2	2.4	3.4	9.0	5.6	7.8	3.3	2.0	1.7	4.7	3.1	4.4	5.9	4.9	3.8	3.6	12.3	4.4	3.5	4.3	4.2	3.4											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.6	0.0	0.0	0.0	0.0	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.0	0.0	0.0	0.0
UPK3BL2		ENSG00000284981	"Uroplakin 3B like 2"	E5RIL1	7	102538417-102543849	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 12.2;lymphoid tissue: 12.8"	"Cell type enriched"	"Detected in single"	14	"Ciliated cells: 1.4"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA011403	Approved					NA	NA					"HPA011403: AB_2668503"																		0.8	0.0		1.5		6.5	1.0		0.3	0.0	0.6			1.0	0.7	0.4	12.2	0.9	0.6	0.0			0.0	0.1	0.8	3.4			0.4	0.7	0.2		0.3		1.2	0.8		1.5	3.6	2.7	2.8	0.9	0.1		3.2	0.4	0.0			4.5		12.8	2.5		5.0	8.4	6.1	3.7	1.0	7.9	1.3	5.8	9.0	3.9	6.8	1.9	0.6	13.4	10.7	13.4	13.5	16.7	3.1	9.8	6.6	5.3	4.0	1.4	18.9	0.4	5.0	3.7	7.3	11.0	2.3	14.8	5.3	7.8	5.7	7.3	6.5	7.4	3.9	3.6	3.1	6.1	8.6	6.1	15.3	4.9	23.9	6.4	9.6	1.5	2.8	1.8	5.0	2.1	9.6	7.6	22.9	5.0	5.5	6.0	2.9	5.4	7.0	3.1	5.4	2.7	7.2	3.2	4.6	4.3	15.3	4.8	4.1	2.0	10.3	5.2	0.2	3.7	2.6	7.9	1.9	2.9	4.7	3.1	2.5	1.5	5.0	5.6	2.8	6.1	1.0	2.0	8.4	3.0	1.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC093668.1		ENSG00000270249			7	102541501-102592444	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"parathyroid gland: 6.9"	"Cell type enriched"	"Detected in single"	12	"Club cells: 1.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 3.7;hTERT-RPE1: 3.4;Karpas-707: 4.0"									HPA046970			Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046970: AB_2679882"																		0.4	0.7	0.6	0.8	0.6	0.7	0.4	3.1	1.1	1.0	1.0			2.5	0.9	2.5	0.4	0.6	0.0	0.3	0.6	0.5	1.4	0.1	0.7	0.5	0.3		0.7	1.2	6.9	2.9	0.4		0.5	0.6		1.1	0.2	5.4	1.7	1.4	0.0	0.3	1.3	1.1	0.2			0.3		0.1	0.4	0.7	4.0	3.5	1.3	1.0	0.7	5.3	1.2	0.1	0.0	1.0	0.2	0.2	3.7	0.5	1.1	0.7	0.6	0.0	0.0	2.1	2.3	0.7	1.6	0.4	0.8	0.0	0.0	0.0	0.7	0.0	1.3	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.4	0.0	1.2	0.0	4.0	0.0	0.4	2.6	1.3	0.5	2.3	1.0	1.4	0.0	0.5	0.3	0.8	1.5	1.2	0.0	0.0	0.2	1.7	0.5	0.0	0.0	0.0	0.1	0.3	0.0	1.8	1.5	0.4	0.4	1.0	0.0	0.0	0.7	0.4	2.9	0.9	4.1	4.0	3.8	2.9	1.7	3.1	5.3	3.0	1.3	0.7	1.0	3.5	5.1	1.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPDYE2	MGC119295	ENSG00000205238	"Speedy/RINGO cell cycle regulator family member E2"	Q495Y8	7	102551232-102562308	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"testis: 10.7"	"Cell type enhanced"	"Detected in single"	25	"Suprabasal keratinocytes: 1.3"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 11.4;Karpas-707: 12.3"									HPA051750	Approved					NA	NA					"HPA051750: AB_2681590"	"unprognostic (2.04e-2)"	"unprognostic (8.58e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.49e-3)"	"unprognostic (7.94e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.04e-1)"	0.5	0.6	0.2	3.1	0.5	5.4	0.6	1.4	2.3	0.8	0.6			1.8	1.3	0.0	1.1	0.9	0.7	0.9	0.3	0.4	1.0	0.6	1.2	2.9	0.2		1.4	1.4	0.0	1.1	0.5		1.2	0.0		1.2	0.0	6.4	4.6	1.5	0.0	0.3	2.5	1.3	10.7			1.8		0.0	1.2	1.0	4.8	4.4	5.4	3.9	0.8	3.7	0.7	2.9	5.0	2.3	1.8	0.0	0.0	4.0	2.0	0.0	0.0	0.0	3.0	1.7	4.0	2.0	0.0	0.4	4.0	0.0	0.0	0.0	2.5	1.2	1.4	11.4	1.4	0.0	4.5	1.3	0.0	0.0	0.0	0.0	0.7	0.0	1.8	4.9	12.3	0.0	6.2	2.7	2.9	1.9	1.3	0.6	3.7	0.4	4.1	0.0	4.4	2.8	1.7	7.8	1.4	0.8	4.1	2.0	1.0	2.2	7.3	2.3	3.5	3.3	2.3	1.9	2.5	1.9	4.3	2.7	4.9	3.9	0.8	3.7	1.6	2.3	2.8	2.7	2.0	1.2	4.8	2.5	2.2	5.4	0.8	1.8	4.4	1.3	0.7											0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0
POLR2J3		ENSG00000285437	"RNA polymerase II subunit J3"		7	102562133-102572583	"Predicted intracellular proteins, RNA polymerase related proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"blood: 29.2;skeletal muscle: 14.6"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 246.4;Cone photoreceptor cells: 333.8;Rod photoreceptor cells: 291.4"									"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA046970			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046970: AB_2679882"																		0.5	2.3		1.9		5.5	1.3		5.7	0.0	3.9			2.0	2.7	3.7	1.7	0.0	0.5	0.0			2.9	2.7	0.5	1.9			1.3	0.3	0.0		0.5		0.5	2.0		0.0	0.6	14.6	2.0	1.6	0.0		2.1	1.6	1.2			0.5		1.1	0.5		22.4	26.8	29.2	25.2	16.5	23.5	14.4	14.4	1.8	20.7	18.4	1.1	4.3	7.8	20.3	0.7	4.4	1.3	6.8	11.5	6.7	10.1	3.5	10.7	8.9	2.7	4.8	13.4	0.9	3.1	15.4	26.1	20.2	2.9	25.7	15.2	4.7	6.0	2.4	1.8	12.0	5.9	12.3	13.3	39.1	1.9	7.3	36.5	11.4	6.2	18.4	0.5	17.1	18.6	19.3	5.8	18.4	9.9	14.8	16.1	16.2	14.2	24.5	6.2	14.8	6.5	27.6	12.5	24.2	16.3	17.6	25.9	40.6	15.4	18.1	16.6	26.8	19.9	29.2	17.7	18.0	16.1	22.4	23.5	20.0	17.9	20.2	20.4	19.5	21.1	16.5	25.2	26.8	21.8	14.4											6.0	1.6	68.9	89.5	10.9	246.4	14.3	89.2	9.4	5.7	7.0	333.8	0.0	1.7	0.3	6.1	20.5	47.8	23.3	0.3	0.0	14.6	61.1	13.8	37.1	0.0	168.5	56.1	102.5	57.8	5.0	84.0	10.8	23.6	1.8	38.2	55.9	0.9	59.6	48.4	2.2	291.4	25.8	24.7	93.1	107.3	12.9	0.0	90.0	43.8	82.1
RASA4	"CAPRI, GAPL, KIAA0538"	ENSG00000105808	"RAS p21 protein activator 4"	O43374	7	102573807-102616757	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 58.0"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 65.5;Intestinal endocrine cells: 69.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 27.6"									HPA043010	Uncertain		Approved	"Vesicles,Cell Junctions"		NA	NA			Vesicles	"Cell Junctions"	"HPA043010: AB_2678267"	"unprognostic (6.44e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.62e-3)"	"unprognostic (4.19e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.18e-2)"	5.5	2.3	4.2	2.5	2.6	1.6	4.4	2.7	4.7	4.9	4.0			3.6	6.3	1.8	1.9	3.6	1.9	1.5	3.6	3.0	3.3	0.2	2.7	3.6	1.9		4.1	2.1	6.8	3.7	4.0		3.3	1.6		2.0	5.6	58.0	5.4	4.3	3.2	1.2	4.1	2.2	0.6			2.2		2.4	3.9	4.7	3.6	11.3	2.2	9.4	1.5	3.7	3.1	0.7	1.2	9.2	1.9	1.7	4.7	0.3	9.4	4.8	3.2	3.3	3.8	2.7	7.2	7.0	14.3	0.3	9.2	0.4	0.1	2.4	1.3	2.4	2.0	3.7	0.9	1.8	1.3	2.7	4.4	1.1	0.8	0.4	12.3	1.6	4.9	3.2	10.6	0.7	3.7	7.2	5.0	0.7	5.0	4.8	9.9	2.0	10.3	0.3	3.5	9.0	18.8	1.7	2.2	1.2	6.1	1.9	3.6	2.3	27.6	13.4	3.1	2.4	16.8	10.3	6.2	3.4	3.0	3.4	0.4	8.4	0.3	1.9	9.4	3.7	2.8	3.2	2.2	11.3	3.6	3.4	2.4	2.2	1.5	1.2	9.8	3.5	3.1											11.9	10.4	6.0	4.5	3.4	65.5	0.6	2.5	6.7	7.9	3.5	15.7	0.2	11.6	1.1	0.4	10.8	6.2	0.0	0.6	0.1	2.3	0.9	1.1	0.8	5.8	27.0	69.0	3.7	8.0	0.0	7.8	16.2	1.7	2.8	12.1	5.8	1.4	2.9	7.4	7.5	11.0	12.9	7.2	2.1	2.3	3.0	0.3	5.0	1.9	2.7
UPK3BL1	"UPK3BL, UPLP"	ENSG00000267368	"Uroplakin 3B like 1"	"B0FP48, E5RIL1"	7	102637025-102642791	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 45.1;lymphoid tissue: 34.6"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 8.9;Alveolar cells type 2: 10.7;Ciliated cells: 9.4;Club cells: 5.7;granulocytes: 7.0;monocytes: 3.6;Pancreatic endocrine cells: 2.9"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 48.8"									HPA011403	Supported					NA	NA					"HPA011403: AB_2668503"	"unprognostic (4.63e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.39e-3)"	"unprognostic (4.00e-1)"	"unprognostic (8.11e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.15e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.93e-2)"	3.0	2.2	2.1	3.3	2.7	7.9	3.0	4.5	2.1	6.5	2.9			3.6	3.4	1.7	45.1	3.7	1.0	2.2	3.0	1.9	4.6	4.0	3.4	7.1	2.1		3.7	3.8	3.4	4.3	1.7		5.9	1.5		7.7	23.7	6.5	5.1	4.6	0.9	2.0	8.8	3.0	1.3			13.1		34.6	11.8	15.1	5.3	6.8	13.6	5.9	7.1	9.6	4.7	7.4	5.9	3.8	1.6	1.6	0.2	5.2	0.0	0.8	0.9	2.2	0.9	4.0	1.1	1.4	0.9	1.2	48.8	1.1	5.4	0.6	6.6	8.6	1.1	2.4	1.7	0.5	1.9	2.0	3.2	7.1	0.0	1.3	6.7	6.9	0.2	2.8	4.1	2.5	16.9	3.0	16.2	1.7	6.4	1.8	3.0	2.1	6.1	7.0	5.9	2.6	6.0	10.1	2.6	2.4	3.2	0.8	3.0	2.3	14.5	6.2	5.1	2.8	4.3	2.0	0.7	3.1	4.5	2.4	13.6	5.9	8.5	9.6	5.2	4.4	5.3	5.0	4.7	6.8	4.9	6.3	4.8	7.1	7.1	1.7	6.8	7.9	4.7											8.9	10.7	0.0	0.0	0.0	0.0	0.0	0.0	9.4	5.7	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	7.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.6	0.0	0.0	2.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SPDYE2B		ENSG00000173678	"Speedy/RINGO cell cycle regulator family member E2B"	A6NHP3	7	102650325-102661398	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"testis: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 6.8;Karpas-707: 10.1"									HPA051750	Supported					NA	NA					"HPA051750: AB_2681590"	"unprognostic (2.67e-1)"				"unprognostic (4.29e-1)"			"unprognostic (2.29e-1)"		"unprognostic (2.09e-3)"			"unprognostic (2.68e-3)"	"unprognostic (1.48e-1)"				0.3	0.6	0.3	1.8	0.3	2.0	0.3	0.5	2.0	0.3	0.7			0.7	0.4	0.0	0.6	0.3	0.4	0.5	0.3	0.3	0.5	0.5	0.5	1.5	0.2		0.5	1.8	0.0	0.5	0.3		0.4	0.0		0.6	0.0	4.3	2.0	2.2	0.0	0.2	2.9	0.5	6.7			0.7		0.0	0.5	0.4	1.3	1.0	3.0	0.5	0.4	0.9	0.4	1.8	2.2	0.7	1.7	0.0	0.0	2.3	2.1	0.0	0.0	0.0	1.2	1.8	2.0	0.9	0.0	0.4	2.4	0.0	0.0	0.0	1.5	1.5	0.7	6.8	0.6	0.0	3.1	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.4	1.9	10.1	0.0	1.5	1.0	3.0	1.6	0.2	1.0	1.4	1.1	3.3	0.0	1.6	1.2	1.0	3.4	2.1	0.8	1.6	0.8	0.5	0.0	3.1	3.5	1.7	1.4	1.2	1.1	2.0	1.5	1.7	1.2	3.0	0.5	0.7	0.8	0.2	0.7	0.2	0.3	0.4	1.0	1.3	0.6	0.7	2.0	0.4	0.3	0.5	0.9	0.4											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
POLR2J2	RPB11b1	ENSG00000228049	"RNA polymerase II subunit J2"	Q9GZM3	7	102665368-102671629	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"brain: 32.6"	"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 23.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 18.1;RT4: 13.0;U-2 OS: 12.8"									HPA046970			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046970: AB_2679882"																		3.8	3.9	12.0	9.5	10.0	5.4	6.6	10.6	32.6	7.2	4.6	6.5	3.4	7.9	6.9	6.5	4.8	4.6	7.4	4.3	12.5	5.5	5.8	6.1	6.1	7.8	10.1	7.7	9.0	3.7	3.2	6.1	5.7	7.8	4.6	5.2	4.5	11.2	3.4	11.9	9.9	10.3	9.8	9.3	7.5	6.6	3.5	6.2	4.2	5.8	1.3	11.0	4.7	5.1	7.9	6.0	11.3	4.0	2.9	6.5	1.3	2.5	2.2	1.5	1.9	3.4	4.8	3.0	2.8	0.6	1.7	1.8	1.6	5.1	2.6	0.5	1.9	1.0	2.4	1.1	0.7	4.3	1.8	3.0	1.4	3.1	1.0	1.5	6.1	2.8	0.9	0.5	1.3	2.4	0.8	0.6	1.6	2.6	6.6	1.3	1.0	18.1	1.8	1.1	0.9	0.6	2.3	0.4	2.4	1.0	13.0	1.4	1.7	2.4	1.3	1.1	2.4	0.8	1.0	1.0	3.9	12.8	0.6	2.1	2.9	2.1	2.3	1.6	2.7	1.3	11.3	4.0	2.9	5.9	2.3	3.9	5.5	6.0	4.2	1.9	7.9	6.5	5.0	3.2	2.9	3.6	6.0	3.5	1.3	12.0	10.0	10.6	32.6	12.5	5.5	10.1	7.7	7.8	6.2	6.0	1.6	10.0	3.2	1.4	6.1	0.0	2.5	4.0	1.2	8.7	9.8	6.1	5.0	2.9	0.0	3.1	2.9	23.3	0.7	3.5	2.4	2.0	1.1	1.7	3.2	4.8	3.5	5.5	3.2	0.0	8.3	3.8	0.0	8.2	1.9	1.3	1.5	0.0	3.2	2.9	4.1	0.0	2.2	8.6	10.7	1.1	6.5	4.3	2.3	2.7
FAM185A	MGC35361	ENSG00000222011	"Family with sequence similarity 185 member A"	Q8N0U4	7	102748971-102809225	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020470, HPA029883"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA020470: AB_1853890, HPA029883: AB_10601903"	"unprognostic (8.28e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.97e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.03e-1)"	"prognostic favorable (9.36e-5)"	"unprognostic (3.64e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.13e-3)"	"unprognostic (5.25e-2)"	3.7	4.6	6.6	3.0	4.9	3.6	3.8	9.3	6.3	5.6	4.3	4.4	4.1	2.3	3.8	3.1	4.4	3.1	3.4	4.2	4.2	2.3	4.0	9.4	4.8	2.3	5.1	6.0	4.7	3.7	8.7	4.8	2.8	4.0	5.2	4.3	6.1	5.1	8.4	9.5	4.6	3.1	3.7	4.5	3.0	5.9	2.2	5.1	3.0	3.8	2.4	2.7	4.4	4.0	3.3	2.6	7.5	3.0	1.2	2.2	0.9	1.4	3.5	1.6	4.1	0.6	1.7	4.2	0.9	1.7	1.6	0.5	3.4	2.9	0.0	2.2	1.2	4.3	3.6	2.3	2.4	1.6	1.8	2.0	0.2	0.4	4.2	1.0	2.9	0.4	0.0	2.7	1.0	1.2	3.3	2.0	1.1	2.1	1.5	1.7	2.7	1.4	0.3	1.8	2.7	0.0	0.3	0.1	10.2	0.8	2.5	1.4	3.0	3.4	5.4	0.4	0.9	3.3	0.0	3.6	0.4	1.7	2.5	0.5	4.9	1.6	0.6	0.7	0.9	0.0	0.0	3.0	3.3	2.1	2.2	0.9	3.3	1.4	2.2	2.6	1.9	1.3	1.5	7.5	1.2	1.0	2.4	1.6	0.9	6.6	4.9	9.3	6.3	4.2	2.3	5.1	6.0	4.0	5.1	3.0	1.0	2.4	5.9	3.8	7.7	4.4	10.2	2.7	6.8	0.0	9.8	11.6	16.6	3.7	3.1	4.5	2.3	0.0	2.0	4.9	3.3	3.1	0.0	5.9	4.0	4.8	1.2	4.3	1.3	1.9	6.6	1.9	6.8	1.8	2.2	3.5	2.2	0.0	4.9	9.1	21.2	12.9	2.8	5.2	3.6	4.0	6.8	4.9	3.5	5.1
FBXL13	"DRC6, Fbl13, MGC21636"	ENSG00000161040	"F-box and leucine rich repeat protein 13"	Q8NEE6	7	102813230-103074843	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 23.2;testis: 24.8"	"Group enriched"	"Detected in many"	6	"Early spermatids: 149.2;Late spermatids: 321.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	46	"eosinophil: 6.2;neutrophil: 23.2"	"Lineage enriched"	"Detected in single"	73	"granulocytes: 23.2"	"Cell line enhanced"	"Detected in some"		"HEL: 6.7;HUVEC TERT2: 12.7;U-266/84: 15.5;U-87 MG: 8.9;U-937: 11.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA057232	Uncertain					NA	NA					"HPA057232: AB_2683375"	"unprognostic (1.46e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.73e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.69e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.64e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.54e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.47e-1)"	0.7	1.7	1.9	0.6	2.6	0.6	0.6	0.5	2.1	1.0	0.5	3.4	2.8	0.4	2.2	5.2	0.5	6.7	0.6	0.6	1.6	1.1	1.3	0.4	1.3	0.5	1.5	0.8	4.6	0.9	0.5	6.0	0.4	7.3	0.8	0.6	4.0	0.5	0.7	0.4	0.7	0.5	0.7	1.8	0.7	6.2	24.8	1.5	0.0	1.5	0.0	0.3	0.6	0.6	0.3	0.0	23.2	0.0	0.0	0.1	0.0	0.5	0.1	0.2	1.1	0.0	0.2	0.1	0.4	0.4	0.2	0.2	0.5	0.4	0.9	0.4	0.3	0.8	0.3	0.0	0.0	0.4	0.5	0.2	6.7	1.1	0.2	2.3	6.1	0.3	0.0	0.1	3.6	0.1	1.1	12.7	0.7	2.0	0.3	0.9	0.4	0.5	5.6	0.9	0.1	0.4	0.2	0.0	0.5	1.6	0.3	0.5	0.5	0.2	0.0	0.1	0.3	0.0	0.2	0.3	1.9	3.6	1.5	0.1	0.8	15.5	1.6	8.9	11.0	5.4	0.0	0.0	6.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.1	23.2	0.0	0.0	0.0	0.0	0.0	1.9	2.6	0.5	2.1	1.6	1.1	1.5	0.8	7.3	1.5	0.0	0.6	0.0	0.8	1.5	0.8	0.6	0.0	38.8	2.3	0.0	11.8	0.1	3.3	1.1	149.2	1.0	0.0	0.0	1.0	0.1	0.7	0.6	0.0	0.0	0.1	0.0	1.7	0.6	0.0	321.2	0.6	0.8	0.0	0.0	0.0	1.8	1.1	0.0	3.2	1.1	8.5	12.9	21.7	12.2	6.3	0.6	0.1	0.0	0.0	0.7
LRRC17	"H_RG318M05.3, P37NB"	ENSG00000128606	"Leucine rich repeat containing 17"	Q8N6Y2	7	102912991-102944949	"Predicted secreted proteins"	Osteogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 39.0"	"Group enriched"	"Detected in some"	4	"Leydig cells: 94.3;Peritubular cells: 29.7;Sertoli cells: 64.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	17	"eosinophil: 12.0"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 12.0"	"Cell line enriched"	"Detected in some"	5	"LHCN-M2: 172.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073458			Approved	"Vesicles,Cytokinetic bridge"	"Secreted in other tissues"	NA	NA			Vesicles	"Cytokinetic bridge"	"HPA073458: "	"unprognostic (1.77e-1)"	"unprognostic (7.73e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.76e-4)"	"unprognostic (6.09e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (4.12e-6)"	"unprognostic (8.57e-3)"	"unprognostic (4.48e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (6.30e-4)"	5.1	1.3	1.1	0.5	1.2	0.0	6.2	1.4	2.0	15.0	1.4	1.5	5.6	0.5	8.3	17.1	5.2	8.9	13.5	6.4	1.2	1.3	1.5	1.4	1.6	1.6	1.1	2.1	39.0	2.6	1.2	1.7	1.8	2.5	7.8	1.4	2.7	2.8	2.5	5.3	2.0	2.6	5.1	1.2	1.2	3.5	5.1	0.2	2.2	2.6	6.7	1.3	6.7	4.2	0.1	0.1	12.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.8	4.3	0.0	0.2	2.5	0.0	0.4	0.0	0.0	0.0	0.4	0.2	1.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	4.0	0.1	3.0	0.0	20.0	19.6	0.0	0.0	0.0	172.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	33.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.2	2.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	1.2	1.4	2.0	1.2	1.3	1.1	2.1	2.5	0.2	0.0	0.6	0.0	0.1	0.8	3.7	0.8	0.0	0.0	0.0	1.8	2.0	0.2	0.0	1.5	2.4	3.6	0.0	0.0	0.3	0.1	11.8	0.2	1.1	0.6	0.3	0.0	0.0	9.2	0.0	0.7	94.3	0.0	5.0	1.0	0.0	0.2	0.2	0.0	29.7	0.0	1.9	64.7	14.3	0.6	0.3	0.5	0.0	0.0	0.1	0.1
NFE4	NF-E4	ENSG00000230257	"Nuclear factor, erythroid 4"		7	102973437-102988856	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	6	"blood: 20.8;placenta: 15.7"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 2: 1.1;Cone photoreceptor cells: 2.0"	"Low cancer specificity"	"Detected in some"							"Group enriched"	"Detected in some"	48	"eosinophil: 9.1;neutrophil: 20.8"	"Lineage enriched"	"Detected in single"	66	"granulocytes: 20.8"	"Group enriched"	"Detected in some"	4	"BEWO: 23.5;HUVEC TERT2: 28.9"															NA	NA						"unprognostic (6.56e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.40e-2)"	"unprognostic (9.31e-3)"	"unprognostic (7.47e-2)"		"unprognostic (4.97e-2)"		"unprognostic (2.19e-2)"	"unprognostic (7.68e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.36e-9)"	"unprognostic (1.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.84e-2)"	"unprognostic (8.71e-3)"	0.2	1.9	0.2	0.4	0.2	2.6	0.2	0.2	2.2	0.2	0.2	0.2	0.2	0.3	0.2	2.2	0.5	0.0	0.4	0.6	0.2		0.2	0.2	1.2	0.6	0.2	0.2	1.1	0.6	0.0	0.2	15.7	0.2	0.2	0.0	0.2	0.2	0.2	0.2	1.7	0.2	0.2	0.2	2.5	0.1	1.5	0.2	0.2	1.5	2.9	0.2	0.2	0.2	0.1	0.1	20.8	0.1	0.0	0.3	0.0	0.2	0.2	0.8	0.2	0.0	0.0	23.5	0.2	0.0	0.0	0.0	1.1	0.6	0.6	0.3	0.0	0.2	0.3	0.0	0.0	0.1	0.1	1.5	5.7	4.2	0.1	0.3	2.1	0.3	0.2	0.0	0.8	0.0	0.6	28.9	0.7	2.6	0.4	0.6	0.3	1.0	1.8	0.3	0.2	0.3	0.9	0.5	0.2	0.0	0.5	0.9	0.3	0.3	0.4	0.0	3.4	0.5	0.6	0.3	1.0	2.9	1.5	0.2	0.8	5.9	0.3	1.8	6.1	0.6	0.0	0.1	9.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.2	20.8	0.0	0.1	0.1	0.0	0.0											0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.0
ARMC10	"MGC3195, SVH"	ENSG00000170632	"Armadillo repeat containing 10"	Q8N2F6	7	103074881-103099764	"Predicted intracellular proteins, Predicted membrane proteins"	"Growth regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011036, HPA011057"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA011036: AB_1080139, HPA011057: AB_1080137"	"unprognostic (7.03e-3)"	"unprognostic (2.44e-1)"	"unprognostic (8.18e-2)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (8.90e-6)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (5.57e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.90e-2)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (1.02e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.67e-2)"	21.6	21.7	28.0	12.6	25.0	9.1	24.5	11.4	28.0	24.4	18.6	24.7	20.8	14.0	20.4	24.2	22.2	23.2	20.0	16.7	26.2	26.2	27.4	30.2	15.0	15.7	26.3	24.2	26.5	28.7	26.0	12.0	15.4	19.7	22.2	18.8	17.6	15.7	23.4	15.8	21.6	12.8	20.3	25.5	14.4	19.8	14.1	19.6	21.5	30.7	15.6	15.7	22.3	20.5	5.1	6.8	6.6	5.4	3.9	4.7	2.2	12.6	10.8	6.4	12.4	13.4	12.8	6.4	8.9	9.7	6.4	7.8	5.8	15.0	22.8	19.3	7.8	18.4	11.4	9.0	9.9	9.2	8.5	10.3	8.0	4.6	2.8	13.5	22.0	9.6	8.3	17.5	8.1	13.3	19.6	14.6	12.9	19.6	14.1	11.4	23.4	16.1	17.1	14.3	21.7	11.7	9.8	6.7	29.6	16.3	8.9	7.2	9.9	12.1	18.3	13.4	11.6	7.4	11.0	9.7	10.0	9.5	23.4	13.3	21.7	33.9	18.3	11.3	20.5	12.4	0.0	4.4	6.6	2.6	5.4	4.5	4.0	4.1	4.4	6.8	5.1	4.6	4.7	0.9	3.9	2.8	5.3	4.2	2.2	28.0	25.0	11.4	28.0	26.2	26.2	26.3	24.2	19.7	19.6	23.8	17.0	26.1	49.5	69.9	22.6	15.4	22.9	6.7	15.9	26.2	13.7	38.2	56.3	15.6	10.1	27.0	15.3	0.0	13.3	39.5	28.9	60.5	17.3	34.7	41.8	7.9	14.5	25.2	32.4	6.3	31.4	31.1	43.9	2.8	33.1	24.5	20.4	10.5	32.2	71.6	26.5	32.3	47.6	11.6	30.8	91.1	37.6	30.5	39.3	65.2
NAPEPLD	"C7orf18, FMP30, NAPE-PLD"	ENSG00000161048	"N-acyl phosphatidylethanolamine phospholipase D"	Q6IQ20	7	103099776-103149560	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 74.1;Early spermatids: 112.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019832, HPA024338"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA019832: AB_1844422, HPA024338: AB_2671533"	"unprognostic (3.62e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.39e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (7.32e-6)"	"unprognostic (8.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.41e-2)"	3.8	5.3	8.6	3.8	14.0	3.1	3.9	13.9	18.5	5.1	8.8	17.2	3.7	15.9	4.9	3.5	2.6	6.5	6.1	4.2	6.4	5.5	15.1	7.4	4.3	3.8	15.0	11.6	9.7	4.1	8.5	6.2	2.9	10.3	5.4	10.1	5.0	4.2	4.1	5.0	5.7	10.8	4.5	9.7	6.6	11.2	11.1	16.7	5.3	8.8	0.9	3.8	6.9	4.6	7.9	3.7	5.7	4.6	2.9	7.6	2.5	4.6	6.2	4.0	3.6	3.6	3.9	0.6	3.0	2.8	2.1	3.4	2.7	6.2	4.2	5.1	2.3	4.7	4.3	2.8	1.0	2.5	6.5	3.9	1.7	3.7	1.2	0.9	3.7	1.8	2.2	1.2	1.9	0.0	7.8	3.4	3.0	2.0	4.5	4.0	1.7	4.4	2.0	3.7	7.3	7.3	2.8	1.8	2.2	7.6	2.1	2.9	3.9	8.2	2.6	1.8	2.2	1.7	2.1	3.0	5.9	4.2	12.0	3.7	5.6	6.1	3.6	4.2	2.7	11.3	0.2	3.1	5.7	4.9	4.6	4.4	7.4	5.3	5.8	3.7	7.9	7.6	5.6	0.3	2.9	3.0	2.7	4.7	2.5	8.6	14.0	13.9	18.5	6.4	5.5	15.0	11.6	10.3	16.7	17.9	7.7	9.8	4.8	6.0	74.1	10.2	20.4	1.4	6.8	50.6	49.1	7.3	8.3	4.4	112.3	2.9	30.7	0.0	2.3	3.1	4.6	8.5	4.6	18.4	3.5	47.7	13.3	4.9	3.5	31.4	29.4	2.7	13.5	4.6	26.3	21.0	3.7	28.6	31.5	26.7	34.0	6.5	2.3	14.6	10.9	2.5	2.4	4.3	23.0	5.5
PMPCB	"MPPB, MPPP52"	ENSG00000105819	"Peptidase, mitochondrial processing beta subunit"	O75439	7	103297422-103329511	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040674, HPA074168"	Approved		Enhanced	Mitochondria		No	No		57000	Mitochondria		"HPA040674: AB_10961998, HPA074168: AB_2686671"	"prognostic favorable (2.79e-4)"	"unprognostic (3.11e-1)"	"unprognostic (7.18e-3)"	"unprognostic (3.03e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.67e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.42e-3)"	"prognostic favorable (2.95e-8)"	"unprognostic (2.59e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.39e-2)"	29.1	41.8	31.8	23.0	34.3	41.5	31.6	41.1	38.4	29.0	26.9	21.6	28.2	35.1	32.0	25.9	27.9	26.9	23.5	41.4	27.7	20.1	45.9	47.2	21.9	31.3	32.6	35.0	36.8	40.6	41.1	33.9	24.8	34.2	31.6	31.5	20.8	30.6	31.0	31.5	31.6	31.0	25.7	27.8	27.9	33.6	31.3	35.9	37.2	33.2	24.2	30.0	30.7	27.9	19.5	18.4	9.7	16.1	12.9	21.9	15.7	12.4	18.0	21.2	28.6	12.9	26.2	16.0	11.6	20.0	23.5	28.0	19.2	14.3	32.0	18.6	19.7	25.1	16.2	25.5	18.7	22.4	11.2	30.4	11.1	30.9	25.6	15.7	15.2	13.1	23.9	17.4	18.3	17.7	22.5	12.4	24.1	21.4	32.6	21.4	28.9	25.1	35.8	26.0	24.8	22.6	17.6	14.9	32.5	22.0	22.3	26.7	32.6	15.6	46.2	22.8	22.4	18.9	20.4	10.2	20.7	24.9	36.9	21.5	25.0	31.9	24.6	15.4	24.5	16.3	9.7	14.1	9.3	14.7	16.1	16.1	19.5	17.1	14.7	18.4	14.3	21.5	17.4	4.4	12.9	13.6	9.4	21.9	15.7	31.8	34.3	41.1	38.4	27.7	20.1	32.6	35.0	34.2	35.9	29.8	31.7	53.2	52.9	32.5	29.3	64.2	28.1	49.5	40.9	26.2	21.6	104.2	61.3	64.5	72.7	34.3	36.7	0.0	64.0	49.3	41.1	31.6	58.9	46.5	48.7	22.3	26.0	24.5	42.2	18.6	48.1	38.4	25.3	93.8	43.0	33.6	54.8	42.1	46.7	96.5	33.4	64.7	42.9	84.6	53.0	32.9	104.5	57.5	55.1	47.7
DNAJC2	"MPHOSPH11, MPP11, ZRF1, ZUO1, zuotin"	ENSG00000105821	"DnaJ heat shock protein family (Hsp40) member C2"	Q99543	7	103312474-103344873	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chaperone, Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 178.0;Spermatocytes: 193.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020454	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA020454: AB_1859492"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.13e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.28e-1)"	12.8	12.5	12.8	21.5	14.2	37.0	13.6	12.9	16.8	13.3	15.0	5.1	10.7	14.3	13.4	12.5	13.6	11.8	11.5	13.6	11.4	11.0	16.2	25.2	10.7	15.5	13.3	12.7	16.4	13.2	12.2	28.5	13.8	16.1	12.0	13.0	5.6	12.6	9.1	29.4	12.7	18.6	13.1	12.2	19.7	12.8	30.6	15.7	17.6	13.0	12.0	13.6	16.6	16.5	9.1	7.1	28.6	9.1	10.0	8.8	3.7	17.6	12.7	7.3	14.0	5.9	8.2	15.0	12.2	8.8	13.6	10.1	19.0	13.0	24.9	19.5	8.3	19.5	12.0	19.8	8.8	20.8	13.3	16.3	18.5	12.1	16.1	10.6	32.5	14.7	7.1	7.7	15.8	14.2	5.6	8.8	9.4	42.7	16.3	11.0	29.5	30.9	33.6	26.2	19.3	19.8	19.9	15.1	23.2	8.0	8.4	14.4	13.4	16.4	22.9	12.6	14.6	9.7	16.5	10.5	13.5	21.6	29.1	23.7	17.4	22.8	50.0	9.6	33.8	16.8	28.6	6.0	5.5	7.6	6.5	8.4	7.8	7.6	7.9	5.9	9.1	8.8	8.8	2.4	10.0	9.1	7.1	8.1	3.7	12.8	14.2	12.9	16.8	11.4	11.0	13.3	12.7	16.1	15.7	23.8	46.0	38.8	57.0	57.5	25.3	25.8	25.5	49.5	63.7	21.0	39.3	37.3	29.9	31.3	178.0	30.7	27.2	0.0	40.1	63.7	36.8	49.2	51.0	26.6	35.1	20.6	33.9	14.7	21.3	21.3	36.5	37.8	18.6	32.5	34.3	18.6	41.4	28.1	29.4	26.7	27.3	38.8	35.8	193.5	136.9	54.3	46.3	33.1	42.7	70.8
PSMC2	"MSS1, Nbla10058, S7"	ENSG00000161057	"Proteasome 26S subunit, ATPase 2"	P35998	7	103344254-103369395	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019238, HPA049621"	Supported		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA		39000	"Cytosol, Cytoplasmic bodies"		"HPA019238: AB_1855834, HPA049621: AB_2680833"	"unprognostic (4.00e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.08e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.71e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.41e-1)"	29.3	35.8	29.4	27.2	35.3	41.6	24.4	25.9	39.7	23.2	23.4	26.2	22.0	22.8	28.2	26.6	29.9	22.5	19.5	38.5	30.1	24.7	36.9	58.8	24.4	26.2	32.0	29.9	23.7	18.5	27.8	33.6	31.1	37.0	23.1	24.8	23.2	24.1	24.8	83.5	31.2	23.2	29.2	31.5	28.4	24.9	23.4	34.3	27.5	25.5	35.2	31.8	26.5	22.2	25.7	40.7	65.7	52.3	29.6	50.2	35.1	51.8	36.4	31.2	45.8	33.6	25.1	28.7	38.7	35.9	45.2	45.3	44.2	46.2	35.0	83.0	34.0	67.0	32.0	39.3	27.5	47.5	55.7	26.5	31.3	30.1	32.1	29.5	51.0	39.1	22.3	22.5	45.0	15.1	24.0	33.7	26.9	72.4	47.7	38.6	74.2	50.4	33.8	38.8	43.9	38.4	28.4	39.0	40.9	30.6	32.5	28.4	25.4	36.3	53.9	33.8	38.2	24.8	26.1	35.9	39.7	48.2	74.8	61.1	42.9	99.6	68.5	44.0	53.8	60.9	65.7	30.5	28.1	26.5	44.2	30.1	25.7	31.0	28.2	40.7	20.1	27.5	27.6	4.6	29.6	52.3	23.8	50.2	35.1	29.4	35.3	25.9	39.7	30.1	24.7	32.0	29.9	37.0	34.3	44.7	22.7	24.6	35.9	35.3	36.2	50.6	38.2	34.8	33.0	26.2	13.7	151.6	56.3	91.2	87.1	38.3	24.9	116.8	84.4	92.2	48.9	32.9	55.4	45.1	116.9	25.4	8.1	33.2	43.1	22.7	54.1	47.1	30.4	71.3	25.6	66.8	71.7	26.9	60.5	70.1	44.5	58.2	44.5	67.6	45.8	37.5	193.8	45.8	28.1	36.7
SLC26A5	"DFNB61, PRES"	ENSG00000170615	"Solute carrier family 26 member 5"	P58743	7	103352730-103446177	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell shape, Hearing"	"Motor protein"	"Deafness, Non-syndromic deafness"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 20.4"	"Cell type enhanced"	"Detected in some"	14	"Alveolar cells type 1: 6.0;Ciliated cells: 4.0;Ito cells: 3.7"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	8	"cerebellum: 20.4"	"Cell type enriched"	"Detected in single"	8	"basophil: 2.7"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.9;PC-3: 2.6;U-2197: 1.8"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in some"	8	"basal ganglia: 9.5"							NA	NA						"unprognostic (3.86e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.38e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.56e-4)"	"unprognostic (4.21e-3)"	"unprognostic (8.92e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.67e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.69e-3)"	1.3	1.0	0.6	0.3	0.7	2.3	3.1	20.4	0.8	0.6	0.3	0.5	0.0	0.9	0.5	0.0	0.2	0.4	0.2	0.4	0.8	0.4	0.7	0.9	2.2	1.2	1.3	0.4	0.4	0.7	2.5	4.6	0.1	2.6	3.1	0.1	0.9	1.4	1.0	0.6	2.2	0.5	1.2	2.9	0.9	3.2	0.9	0.2	0.0	1.8	0.0	0.2	3.2	0.4	0.2	0.0	2.7	0.1	0.3	0.1	0.0	0.2	0.0	0.3	0.7	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	1.1	0.7	0.4	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.2	0.9	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.4	2.9	0.0	1.2	0.8	0.3	0.1	0.5	2.6	0.3	0.1	0.4	0.0	0.8	0.9	1.5	0.3	0.3	0.0	0.6	0.7	0.0	0.0	0.6	0.6	1.8	0.4	0.8	0.4	0.4	0.2	0.2	0.3	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.7	20.4	0.8	0.8	0.4	1.3	0.4	2.6	0.2	6.0	1.6	0.0	0.0	0.2	0.1	0.8	0.0	4.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	3.7	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.6
RELN	"PRO1598, RL"	ENSG00000189056	Reelin	P78509	7	103471784-103989516	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Developmental protein, Hydrolase, Protease, Serine protease"	"Disease mutation, Epilepsy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 73.4;liver: 35.8"	"Cell type enriched"	"Detected in some"	15	"Ito cells: 182.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.7"	"Region enriched"	"Detected in many"	11	"cerebellum: 73.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 34.4;PC-3: 7.0;SCLC-21H: 8.4;SH-SY5Y: 9.1;TIME: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077891			Approved	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		59000000	"Golgi apparatus"	Vesicles	"HPA077891: "	"unprognostic (1.42e-1)"	"unprognostic (2.93e-3)"	"unprognostic (4.31e-2)"	"unprognostic (1.29e-4)"	"unprognostic (1.30e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.06e-2)"	2.7	5.9	5.7	1.2	5.3	0.5	6.3	73.4	6.7	2.9	2.1	0.8	0.0	1.1	1.0	3.0	1.7	4.4	1.9	3.2	5.7	5.3	1.2	35.8	1.6	7.9	1.8	2.5	1.3	1.0	0.3	0.8	0.4	5.1	1.2	2.1	10.6	1.1	2.1	0.4	1.1	1.9	2.4	3.2	1.1	0.8	1.5	0.0	0.0	2.6	1.7	0.9	1.7	2.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	1.3	0.0	0.1	0.0	0.0	2.4	0.0	34.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.0	0.0	1.4	0.0	0.0	0.0	8.4	9.1	0.0	0.0	0.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	5.3	73.4	6.7	5.7	5.3	1.8	2.5	5.1	0.0	0.0	0.0	0.0	0.0	0.6	11.3	3.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.3	2.6	0.0	0.0	1.0	0.1	2.4	0.3	0.0	2.4	0.2	0.0	0.0	182.3	9.4	4.8	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.2	0.0	0.4	0.0	0.1	0.5	0.2	0.0	0.0	0.0
ORC5	"ORC5L, Orc5p, ORC5T, PPP1R117"	ENSG00000164815	"Origin recognition complex subunit 5"	O43913	7	104126341-104208047	"Predicted intracellular proteins"	"DNA replication, Photosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019730	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA019730: AB_10696205"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.72e-2)"	"unprognostic (4.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.47e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (6.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.73e-2)"	12.4	13.7	10.6	9.3	17.9	6.2	16.3	18.7	21.6	12.9	14.2	12.1	9.0	10.1	14.4	17.5	14.1	11.3	8.5	8.2	13.0	12.9	12.6	20.3	10.2	13.7	10.1	11.8	13.8	17.4	10.8	15.9	11.4	17.6	21.5	16.0	14.0	11.8	13.8	10.9	14.8	11.0	14.2	8.6	12.0	12.3	27.3	10.0	20.5	12.6	7.9	15.8	13.4	12.7	14.0	7.2	6.8	7.4	12.5	18.6	8.2	16.3	17.2	10.0	18.0	10.6	10.6	8.9	14.5	13.9	16.4	13.7	11.2	10.7	24.2	12.2	9.0	18.1	15.6	20.0	13.9	19.7	13.1	12.9	8.9	9.8	11.3	14.8	16.8	7.9	10.0	13.3	18.8	17.5	6.9	15.4	13.5	29.0	14.0	13.9	23.2	23.5	17.0	10.7	22.2	18.0	9.8	18.1	24.0	12.6	12.2	13.4	11.3	13.6	27.8	18.6	8.2	9.3	13.0	8.9	14.9	17.5	24.3	18.2	15.5	33.4	31.9	10.7	22.9	18.7	6.8	6.3	4.5	13.1	7.4	17.1	14.0	13.6	15.0	7.2	11.9	17.2	18.6	0.8	12.5	6.0	7.0	11.3	8.2	10.6	17.9	18.7	21.6	13.0	12.9	10.1	11.8	17.6	10.0	3.0	7.4	9.1	2.8	3.9	5.9	4.8	10.2	16.0	7.9	3.5	0.0	18.8	1.7	8.0	4.0	8.0	4.7	0.0	7.7	11.6	5.8	4.1	4.7	8.3	7.7	3.2	5.2	4.9	4.5	4.5	5.8	5.3	1.7	8.2	8.3	2.9	6.4	3.5	7.4	5.7	11.5	0.0	12.3	30.5	22.8	7.4	8.8	9.6	9.1	1.4
LHFPL3	LHFPL4	ENSG00000187416	"LHFPL tetraspan subfamily member 3"	Q86UP9	7	104328656-104907232	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"brain: 36.5"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 7.0"	"Cancer enriched"	"Detected in some"	12	"glioma: 27.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;K-562: 2.2;SCLC-21H: 4.1;SH-SY5Y: 5.5;SK-BR-3: 4.6;SK-MEL-30: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069691			Approved	Vesicles		No	NA			Vesicles		"HPA069691: AB_2686171"		"unprognostic (1.20e-2)"	"unprognostic (6.91e-2)"	"unprognostic (4.59e-3)"	"unprognostic (5.03e-2)"			"unprognostic (2.27e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.96e-2)"	"unprognostic (5.81e-2)"	"unprognostic (5.99e-3)"	"unprognostic (8.50e-3)"	"unprognostic (3.07e-1)"		"unprognostic (1.33e-1)"	0.5	0.6	6.4	0.6	7.7	0.5	0.5	2.3	36.5	4.3	0.8	6.1	0.0	2.0	0.7	0.5	0.5	0.9	0.5	0.5	4.9	5.6	1.4	0.5	2.2	0.5	4.8	4.2	0.7	1.5	0.5	0.1	0.5	5.6	0.7	0.6	3.8	0.5	0.5	0.5	0.7	1.4	0.5	6.0	0.9	0.8	0.7	6.7	0.0	0.5	0.0	0.6	0.5	0.2	0.5	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.2	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	4.1	5.5	0.0	4.6	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.4	0.0	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	7.7	2.3	7.1	4.9	5.6	4.8	4.2	5.6	6.7	0.0	0.3	0.0	0.0	0.0	0.7	0.2	0.0	1.4	0.0	0.0	7.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
KMT2E	"HDCMC04P, MLL5"	ENSG00000005483	"Lysine methyltransferase 2E"	Q8IZD2	7	105014179-105114361	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Growth arrest, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042866, HPA056125"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA042866: , HPA056125: AB_2683044"	"unprognostic (1.05e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.03e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.53e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (3.80e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.06e-1)"	22.7	11.8	18.6	24.5	23.5	44.8	20.9	41.6	22.4	26.4	20.9	18.6	21.7	14.7	25.3	15.8	16.5	18.6	18.2	16.8	20.6	15.1	14.2	11.6	22.8	20.1	22.7	17.4	33.5	15.6	20.5	20.1	18.7	18.6	21.2	20.5	17.6	19.6	19.2	21.3	25.7	18.5	26.2	23.1	21.6	17.9	12.9	27.2	24.6	21.7	15.1	22.7	26.6	21.4	38.2	24.7	72.9	20.8	20.3	30.6	14.7	15.1	10.7	22.7	19.5	14.1	16.9	5.8	11.6	17.4	9.8	12.1	8.7	13.9	12.6	11.6	13.6	13.2	11.8	12.5	11.5	16.3	20.3	7.2	12.7	14.0	7.4	13.3	17.0	16.0	11.8	10.8	13.6	14.6	17.9	17.7	14.1	17.3	36.1	13.8	11.9	27.1	14.6	7.9	8.3	8.6	23.4	14.0	14.6	9.7	15.4	13.0	15.7	16.1	13.9	8.8	15.9	6.0	10.2	21.8	23.2	16.2	26.5	11.5	27.6	21.8	29.1	15.2	13.0	15.9	48.5	18.0	39.4	30.6	13.6	30.3	35.6	28.4	26.1	12.8	38.2	28.0	26.0	72.9	20.3	20.8	24.7	23.6	14.7	18.6	23.5	41.6	22.4	20.6	15.1	22.7	17.4	18.6	27.2	131.0	136.3	133.9	100.8	130.3	219.2	86.5	76.5	84.3	142.1	109.9	237.6	33.5	29.9	70.0	19.2	197.7	91.8	93.5	59.6	38.6	151.9	115.7	236.2	33.7	53.7	174.8	96.0	86.5	76.0	18.6	130.6	138.7	133.3	110.0	88.5	114.4	63.9	84.2	123.8	28.6	269.1	122.9	222.6	98.9	71.7	117.7	54.6	186.4	107.4	119.5
SRPK2	SFRSK2	ENSG00000135250	"SRSF protein kinase 2"	P78362	7	105110704-105399308	"Enzymes, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 69.3"	"Group enriched"	"Detected in many"	6	"Early spermatids: 1076.1;Late spermatids: 1865.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 58.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 58.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015522, HPA020876"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA015522: AB_1857479, HPA020876: AB_1857480"	"unprognostic (9.75e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.38e-2)"	"unprognostic (7.95e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.44e-1)"	9.9	12.1	24.8	10.1	27.6	7.1	13.3	28.4	47.1	12.7	9.4	21.0	7.8	8.2	13.2	11.9	11.9	10.9	11.6	10.4	26.4	28.6	10.3	10.1	9.2	11.5	27.2	30.2	13.0	10.5	11.9	15.3	12.0	27.3	14.0	10.9	7.9	10.1	11.1	7.9	16.9	8.2	13.3	23.1	12.0	11.3	69.3	32.3	22.1	11.3	4.7	14.0	13.6	9.7	12.2	7.3	58.2	8.1	10.0	11.9	6.0	13.3	8.9	14.2	28.1	15.2	17.2	7.9	13.1	15.3	13.1	15.3	6.9	11.4	8.5	16.7	16.9	14.7	8.0	14.3	13.8	16.8	14.7	12.7	12.0	8.4	6.0	17.6	11.4	18.0	11.9	25.7	11.1	20.9	12.7	22.5	20.3	11.8	34.8	14.5	25.2	42.2	8.7	11.7	7.6	9.7	13.7	15.6	18.4	18.9	20.7	20.8	14.4	14.8	22.3	13.8	19.6	8.3	8.0	14.7	24.2	17.6	23.0	12.2	38.2	37.6	20.9	9.5	11.8	18.0	11.2	8.1	26.0	11.9	5.5	7.1	12.2	9.0	8.9	7.3	11.6	8.5	9.7	58.2	10.0	6.2	6.4	10.1	6.0	24.8	27.6	28.4	38.7	26.4	28.6	27.2	30.2	27.3	32.3	26.8	28.5	33.3	51.2	189.1	70.3	20.1	33.1	48.2	27.3	22.7	47.1	40.1	23.2	44.1	1076.1	52.5	12.9	0.0	40.5	30.6	44.1	65.7	40.4	25.1	41.0	117.6	27.6	43.0	45.7	1865.0	71.1	31.8	55.6	40.5	32.1	65.3	32.7	21.0	90.2	21.7	65.2	45.3	45.3	237.2	50.3	90.3	53.9	56.8	23.6	46.7
PUS7	FLJ20485	ENSG00000091127	"Pseudouridylate synthase 7 (putative)"	Q96PZ0	7	105439661-105522267	"Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024116	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024116: AB_1848754"	"unprognostic (3.07e-1)"	"unprognostic (1.52e-3)"	"unprognostic (9.03e-2)"	"unprognostic (4.94e-2)"	"unprognostic (8.91e-2)"	"unprognostic (7.95e-2)"	"prognostic unfavorable (4.89e-6)"	"unprognostic (2.86e-2)"	"prognostic unfavorable (7.58e-5)"	"unprognostic (1.87e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (1.03e-8)"	"unprognostic (2.76e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (6.28e-4)"	"unprognostic (4.90e-2)"	12.7	6.9	7.7	13.0	12.5	5.8	14.1	12.2	12.9	10.2	9.6	8.5	4.6	7.0	11.4	5.6	14.7	9.8	6.0	9.4	8.3	7.0	7.5	11.8	8.8	8.3	12.3	8.0	10.0	11.9	17.0	8.1	9.8	11.4	8.6	11.6	5.3	9.3	11.0	19.5	13.3	6.3	13.2	9.0	5.4	8.0	8.5	13.8	4.3	14.6	13.5	10.0	8.0	11.0	5.9	3.3	0.4	5.0	2.7	5.4	2.0	15.4	10.4	9.2	14.2	6.6	7.8	10.0	7.7	6.7	13.8	11.8	13.7	5.9	9.0	12.9	7.9	11.7	12.0	17.4	9.2	21.4	6.4	13.3	13.7	8.8	12.4	8.2	21.1	4.9	7.7	10.1	11.6	14.7	4.8	13.7	8.0	30.7	7.3	8.7	20.5	23.2	16.5	22.3	18.3	12.2	14.5	14.9	38.5	14.2	11.7	15.0	14.8	15.3	24.9	9.5	11.1	9.0	4.3	8.4	19.3	13.3	24.2	16.1	5.7	10.9	25.7	6.5	17.7	16.0	0.0	2.1	0.4	2.6	5.0	5.4	5.9	3.5	2.8	3.3	3.6	2.9	3.8	0.2	2.7	4.2	0.1	2.2	2.0	7.7	12.5	12.2	12.9	8.3	7.0	12.3	8.0	11.4	13.8	6.0	7.0	1.5	6.8	11.8	4.1	3.1	0.0	5.3	7.9	1.8	2.0	4.0	1.7	6.5	0.9	6.0	0.9	0.0	6.2	7.8	5.1	7.2	11.5	3.9	3.7	0.0	6.9	3.7	1.3	1.2	3.7	3.5	0.0	5.4	3.4	1.5	6.0	2.9	1.8	4.4	2.9	0.0	10.8	1.4	10.9	8.5	2.9	0.7	6.0	6.4
RINT1	"FLJ11785, RINT-1"	ENSG00000135249	"RAD50 interactor 1"	Q6NUQ1	7	105532085-105567677	"Predicted intracellular proteins"	"Cell cycle, ER-Golgi transport, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019875, HPA031646"	Approved		Approved	"Golgi apparatus"		Yes	No			"Golgi apparatus"		"HPA019875: AB_1856283, HPA031646: AB_2673975"	"unprognostic (1.58e-2)"	"unprognostic (3.94e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.33e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.41e-1)"	"unprognostic (8.72e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.75e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.39e-5)"	"unprognostic (1.76e-1)"	12.2	13.6	9.0	13.0	12.4	13.8	12.8	17.8	15.0	12.7	10.5	8.9	11.9	13.6	13.4	8.4	17.7	11.9	9.1	11.8	16.2	8.1	12.9	14.5	11.3	15.5	10.2	12.0	15.0	24.7	14.7	17.9	11.9	13.3	10.7	11.3	9.9	14.7	11.8	35.1	14.5	11.6	9.7	12.3	12.0	12.7	15.1	10.1	15.5	13.3	10.5	17.8	13.1	13.6	9.9	5.5	4.2	5.5	8.0	12.0	6.4	12.8	11.1	5.4	11.5	8.4	11.5	7.0	12.5	8.4	12.5	14.3	12.2	7.0	14.4	14.4	10.7	13.1	9.0	10.5	9.3	16.3	7.5	11.9	8.0	12.4	8.1	6.1	17.4	8.4	6.8	6.4	13.2	7.1	8.0	13.4	7.2	17.5	9.3	13.3	21.0	12.7	9.1	11.6	8.8	10.8	7.2	9.7	20.6	4.8	10.8	9.8	10.4	13.4	20.5	7.1	8.5	9.1	5.7	9.5	14.3	10.6	39.2	14.1	19.4	26.0	28.0	9.6	14.3	16.1	4.2	3.8	4.0	6.9	5.5	12.0	9.9	10.1	9.2	5.5	7.4	9.7	9.0	0.4	8.0	4.3	4.1	9.6	6.4	9.0	12.4	17.8	15.0	16.2	8.1	10.2	12.0	13.3	10.1	3.0	9.8	8.8	8.4	6.0	5.2	8.7	2.5	21.4	7.9	3.5	7.9	9.6	8.3	6.8	5.3	5.1	5.1	0.0	5.5	8.8	7.2	5.1	9.3	4.2	6.5	6.4	5.2	3.7	4.9	4.5	8.1	3.8	5.0	4.6	5.6	6.6	6.0	3.5	9.2	5.3	8.9	6.5	5.7	23.3	12.4	6.8	10.1	7.0	6.9	7.4
EFCAB10		ENSG00000185055	"EF-hand calcium binding domain 10"	A6NFE3	7	105565120-105600875	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 29.0;testis: 34.9"	"Cell type enhanced"	"Detected in some"	24	"Ciliated cells: 275.7;Early spermatids: 163.2;Late spermatids: 68.5;Spermatocytes: 62.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA019751	Uncertain					NA	NA					"HPA019751: AB_1848011"	"unprognostic (1.20e-1)"	"unprognostic (2.24e-3)"	"unprognostic (8.96e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.11e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.58e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-3)"	"unprognostic (6.87e-2)"	"unprognostic (3.07e-9)"	"unprognostic (2.13e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.67e-2)"	0.4	0.8	2.0	0.9	9.6	2.2	0.3	0.7	3.7	1.5	0.7	4.2	0.0	0.7	1.3	6.2	0.9	29.0	0.5	0.5	2.9	3.5	0.7	0.7	6.4	1.0	0.7	3.5	6.9	1.6	0.2	2.0	0.4	11.8	0.7	0.5	0.0	1.0	0.2	1.3	1.4	0.8	0.2	1.1	0.9	0.8	34.9	2.3	0.0	0.7	0.0	0.3	0.8	0.4	2.9	1.7	3.7	1.2	1.4	3.0	0.6	2.1	6.0	3.2	2.1	0.6	0.3	1.4	2.9	0.0	0.0	0.1	1.1	1.4	2.9	2.6	0.1	0.6	0.8	0.1	0.0	0.0	1.1	5.4	1.5	4.1	3.3	0.4	1.9	1.9	0.2	0.0	0.2	0.0	2.0	0.0	1.4	4.4	2.4	0.1	4.5	2.1	4.1	5.3	1.4	2.2	1.4	3.3	6.3	0.3	1.3	3.1	4.2	1.7	6.2	1.0	4.4	1.2	2.2	1.6	3.1	2.1	6.4	1.9	3.4	4.0	2.7	1.8	3.0	1.5	3.7	1.2	1.0	1.9	0.9	1.7	1.6	1.9	1.6	0.7	2.9	3.0	2.2	1.4	1.4	0.9	1.7	1.2	0.6	2.0	9.6	0.7	3.7	2.9	3.5	0.7	3.5	11.8	2.3	0.0	4.1	0.0	0.1	0.0	0.7	0.3	0.0	275.7	12.5	0.0	0.0	0.0	0.0	0.0	163.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	68.5	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.3	0.1	0.0	0.0	62.1	1.9	0.0	0.1	0.0	0.0	0.0
ATXN7L1	"ATXN7L4, KIAA1218, MGC33190"	ENSG00000146776	"Ataxin 7 like 1"	Q9ULK2	7	105605067-105876604	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 68.4;Late spermatids: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021448	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021448: AB_1845213"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.84e-1)"	"unprognostic (8.20e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.65e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.01e-1)"	10.8	10.7	10.3	12.1	16.6	7.7	10.6	24.7	13.4	13.3	11.7	9.7	12.3	7.9	9.2	9.1	9.6	11.7	8.4	6.4	8.5	6.2	14.1	12.3	7.8	15.6	7.1	7.3	13.3	7.2	11.2	17.8	10.8	6.9	10.1	11.6	8.3	11.4	12.1	5.2	12.2	10.9	9.7	6.9	10.4	9.8	20.8	9.9	12.4	11.8	4.6	17.9	11.3	11.7	3.9	3.1	4.3	4.8	4.2	14.5	3.4	2.9	3.9	8.4	3.9	5.2	6.1	2.6	5.2	5.2	4.7	4.4	3.8	5.6	1.2	4.1	5.4	4.1	2.7	4.7	5.3	3.4	16.1	3.1	3.9	2.9	3.6	3.1	6.3	13.0	4.2	4.4	3.1	3.1	3.4	4.2	2.8	4.6	2.6	3.8	6.9	3.4	3.5	15.5	8.0	3.9	3.4	2.8	0.8	3.5	2.9	5.2	3.5	3.7	7.3	7.3	8.6	3.8	6.4	10.5	7.3	3.4	6.0	2.0	0.6	0.0	0.1	4.6	9.8	7.3	2.3	4.2	4.3	2.9	4.8	2.1	3.9	7.5	6.4	3.1	3.6	8.2	4.7	1.4	4.2	2.8	2.1	14.5	3.4	10.3	16.6	24.7	13.4	8.5	6.2	7.1	7.3	6.9	9.9	0.0	4.6	3.6	4.7	4.5	8.2	2.4	2.5	16.0	2.3	5.2	2.0	5.6	5.0	3.3	68.4	3.6	10.8	0.0	2.3	3.1	4.9	5.1	4.7	13.4	6.5	7.9	5.2	6.7	10.3	39.7	6.1	6.3	8.5	7.2	8.2	2.0	3.7	10.5	4.2	29.8	0.6	6.5	4.2	7.9	1.7	3.4	4.5	8.7	8.1	3.3
CDHR3	"CDH28, FLJ23834, FLJ44366"	ENSG00000128536	"Cadherin related family member 3"	Q6ZTQ4	7	105876796-106033773	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 51.9;lung: 28.9;ovary: 22.3"	"Cell type enriched"	"Detected in many"	6	"Ciliated cells: 341.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 15.9"	"Group enriched"	"Detected in some"	5	"memory B-cell: 2.9;naive B-cell: 6.9;neutrophil: 1.8"	"Group enriched"	"Detected in many"	6	"B-cells: 6.9;granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"AF22: 7.9;Daudi: 10.1;WM-115: 6.8"	"Low region specificity"	"Detected in many"							HPA011218	Supported		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA011218: AB_1078886"	"unprognostic (4.38e-4)"	"unprognostic (9.18e-2)"	"unprognostic (8.16e-3)"	"unprognostic (8.08e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.70e-3)"	"unprognostic (3.51e-3)"	0.4	0.6	2.2	0.6	3.3	0.5	2.5	4.4	1.4	2.4	7.6	4.9	1.1	1.1	2.4	14.9	5.9	51.9	0.2	3.3	3.1	2.1	0.7	0.6	28.9	0.4	1.1	0.3	22.3	0.3	0.1	1.4	0.1	15.9	0.3	0.9	0.1	0.3	0.6	0.5	0.4	12.0	1.7	0.6	0.2	4.6	2.2	1.2	0.1	1.4	0.4	0.7	0.3	0.1	6.9	0.2	1.8	0.2	0.3	0.7	0.1	0.1	0.4	7.9	1.4	2.8	2.7	0.2	0.7	0.6	0.3	0.2	0.0	0.1	10.1	0.0	0.5	1.1	0.1	1.9	0.0	0.3	0.9	1.2	0.0	0.2	0.7	0.0	0.2	0.4	1.0	0.3	0.5	0.0	0.2	0.0	0.0	0.1	0.3	0.3	0.0	0.2	0.1	1.8	2.8	0.6	0.0	0.0	0.4	0.1	0.1	0.6	2.9	0.0	0.8	0.5	1.4	0.0	0.0	0.4	1.4	0.5	1.5	0.0	0.0	0.0	3.3	0.2	0.3	6.8	0.1	0.1	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	6.9	0.3	0.1	1.8	0.3	0.2	0.2	0.7	0.1	2.2	3.3	4.4	1.4	3.1	2.1	1.1	0.3	15.9	1.2	3.0	7.2	0.0	1.6	2.4	4.5	1.2	2.5	341.3	55.7	0.0	0.0	0.5	5.0	0.5	5.4	1.0	2.8	0.0	0.5	0.2	1.5	0.5	3.5	1.7	0.1	0.0	28.7	0.0	0.0	2.5	2.6	0.6	8.5	0.0	3.6	9.5	0.2	2.9	1.4	4.4	1.0	6.5	1.7	1.4	3.1	1.8	0.2	0.7	2.9	0.4
SYPL1	SYPL	ENSG00000008282	"Synaptophysin like 1"	Q16563	7	106090503-106112576	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 478.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA014141	Approved					NA	NA					"HPA014141: AB_1857716"	"unprognostic (8.88e-2)"	"unprognostic (8.10e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.61e-2)"	"unprognostic (8.74e-2)"	"unprognostic (9.15e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.32e-1)"	"prognostic favorable (1.25e-9)"	"unprognostic (2.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.17e-1)"	38.7	27.1	13.5	23.2	20.3	13.0	30.9	8.1	18.9	42.4	31.8	45.3	32.7	17.6	47.7	28.3	60.0	32.3	27.3	28.2	18.3	14.6	46.3	31.4	23.7	40.1	39.9	11.7	32.8	26.0	34.7	13.3	34.1	32.8	38.1	23.6	23.5	54.1	39.0	47.0	31.7	32.6	37.7	87.6	32.0	29.5	41.3	26.4	30.5	50.3	46.4	49.0	43.5	38.6	42.9	10.2	17.9	12.6	21.5	18.6	11.9	36.7	17.1	9.2	15.2	39.8	30.4	13.4	23.2	26.1	21.9	26.8	11.6	65.7	37.1	31.3	28.9	37.2	31.4	14.7	37.5	36.4	10.1	17.4	16.3	11.2	11.3	31.2	27.5	13.5	22.6	48.8	22.9	29.7	29.3	30.0	14.1	16.6	0.0	43.3	31.8	28.9	32.8	10.2	42.6	22.9	3.6	15.5	19.2	46.1	60.2	4.5	10.3	22.4	54.5	22.5	23.1	16.6	22.0	26.8	43.8	22.5	46.5	26.3	17.0	19.6	39.1	19.2	47.8	24.6	17.9	12.6	13.5	4.6	11.7	9.4	42.9	12.3	9.1	10.2	39.8	18.6	11.5	4.9	21.5	9.2	9.9	10.4	11.9	13.5	20.3	8.1	18.9	18.3	14.6	39.9	11.7	32.8	26.4	50.6	56.2	102.7	250.1	152.5	9.0	62.7	150.3	76.3	63.7	177.9	15.7	173.1	96.2	141.4	478.9	138.4	44.1	46.7	94.2	119.4	109.4	180.2	91.0	87.0	81.3	19.1	36.4	132.0	71.7	110.9	88.1	80.2	138.3	11.8	72.6	92.7	105.2	77.6	88.4	191.9	12.0	155.2	131.8	418.1	119.7	151.2	153.9	46.8	82.8	226.9
NAMPT	"PBEF, PBEF1"	ENSG00000105835	"Nicotinamide phosphoribosyltransferase"	P43490	7	106248285-106286326	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Biological rhythms, Pyridine nucleotide biosynthesis"	"Cytokine, Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 597.4;Macrophages: 479.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	18	"neutrophil: 143.5"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 143.5"	"Cell line enhanced"	"Detected in all"		"U-87 MG: 110.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034349, HPA047776, HPA057722"	Approved		Approved	"Nuclear speckles,Cell Junctions"	"Secreted to blood"	NA	NA	2140000	410000	"Nuclear speckles"	"Cell Junctions"	"CAB034349: AB_2251220, HPA047776: AB_2680151, HPA057722: "	"unprognostic (2.87e-1)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (8.81e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (6.83e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.44e-3)"	67.3	22.2	8.1	113.6	18.1	110.4	52.6	7.8	12.9	11.6	18.2	2.9	9.5	9.3	9.9	13.5	53.4	27.8	28.1	84.4	13.4	6.3	13.5	92.9	48.9	117.5	10.3	5.2	27.3	18.3	5.5	10.0	23.9	29.2	17.4	10.5	8.2	32.9	14.3	41.0	12.9	14.1	44.9	59.1	41.1	26.4	11.9	7.1	6.2	13.5	40.7	13.2	48.8	26.4	0.8	2.0	143.5	7.3	1.0	1.5	1.3	19.2	12.9	4.6	7.8	19.7	23.0	7.6	6.1	34.6	12.4	21.9	7.6	11.7	16.1	14.7	6.8	37.2	15.2	8.6	18.4	27.2	9.5	9.2	6.5	5.5	5.9	73.7	12.6	12.1	21.9	21.1	22.2	26.0	18.6	39.5	8.0	13.6	62.0	14.8	10.1	12.6	5.3	9.0	12.2	10.4	6.0	6.6	35.5	11.8	18.2	9.5	5.2	8.6	18.8	21.8	13.4	6.0	3.6	33.6	18.5	14.3	26.5	11.2	42.7	24.2	23.3	110.0	14.3	27.4	8.1	2.3	3.5	0.4	5.6	0.7	0.8	0.5	0.6	2.0	0.7	0.8	0.4	143.5	1.0	7.3	0.8	1.5	1.3	8.1	18.1	7.8	12.9	13.4	6.3	10.3	5.2	29.2	7.1	122.1	246.8	48.1	258.1	184.4	22.1	87.9	163.1	104.4	177.5	40.1	11.8	23.8	39.7	250.8	6.3	173.0	92.2	0.0	120.5	44.2	117.9	276.9	178.5	597.4	98.8	38.1	24.1	141.8	340.8	4.5	37.4	479.6	153.5	65.9	46.4	19.5	161.8	35.1	29.4	36.0	28.4	25.8	234.9	14.9	57.9	181.7	21.2	41.5	63.9	273.8
CCDC71L	"C7orf74, FLJ36031"	ENSG00000253276	"Coiled-coil domain containing 71 like"	Q8N9Z2	7	106656765-106660996	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 42.9"	"Cell type enhanced"	"Detected in many"	5	"Smooth muscle cells: 44.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067925	Approved		Approved	"Golgi apparatus,Actin filaments,Cytosol"		NA	NA			"Golgi apparatus, Actin filaments"	Cytosol	"HPA067925: AB_2685925"	"unprognostic (1.51e-1)"	"prognostic unfavorable (9.08e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.95e-3)"	"unprognostic (9.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.38e-3)"	"unprognostic (6.03e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (2.53e-6)"	"unprognostic (3.34e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.35e-2)"	19.5	5.2	2.4	13.2	2.2	8.8	10.6	0.6	3.8	7.8	8.4	2.5	5.8	4.3	10.3	6.5	6.3	19.7	9.2	6.3	3.5	2.3	9.0	42.9	11.2	10.8	1.8	2.7	13.4	6.3	3.2	3.7	4.0	2.3	9.3	4.0	8.1	16.5	4.9	6.7	3.2	8.3	7.0	2.4	17.0	9.0	12.7	2.2	35.3	9.1	2.9	6.8	12.5	10.8	2.3	2.4	7.3	1.2	1.6	2.9	0.8	10.4	2.2	3.2	3.8	7.3	7.0	0.0	16.2	20.7	6.3	6.8	0.3	6.6	7.1	5.6	27.1	12.0	1.1	1.5	4.6	5.2	16.5	3.8	0.8	0.4	0.0	11.5	3.5	8.5	5.9	2.8	2.8	1.6	13.2	21.7	4.0	23.5	17.4	7.4	3.0	4.7	5.5	7.0	0.8	7.7	6.5	0.9	1.4	3.2	0.6	1.4	9.7	10.3	3.7	22.4	7.1	1.7	4.3	9.6	14.0	1.3	1.6	6.2	17.0	1.5	5.7	10.8	4.6	15.3	7.2	1.0	3.0	2.0	0.8	1.5	2.3	1.6	1.5	0.7	1.7	0.8	1.2	7.3	1.6	1.2	2.4	2.9	0.8	2.4	2.2	0.6	3.8	3.5	2.3	1.8	2.7	2.3	2.2	3.0	12.3	4.9	31.2	7.2	4.0	5.3	5.1	8.1	0.0	5.2	2.0	2.4	10.0	6.8	0.9	15.0	9.7	0.0	9.3	5.7	23.0	9.8	11.5	26.7	7.5	6.4	6.3	32.5	11.1	1.6	20.1	12.8	11.8	6.4	6.2	4.5	10.3	11.5	16.6	3.9	4.8	0.0	44.3	5.6	3.6	4.4	2.7	7.9	9.0	13.3
PIK3CG		ENSG00000105851	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma"	P48736	7	106865278-106907145	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Angiogenesis, Chemotaxis, Endocytosis, Immunity, Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 24.5;bone marrow: 27.8;lymphoid tissue: 40.8"	"Cell type enhanced"	"Detected in some"	8	"B-cells: 17.3;Early spermatids: 26.6;granulocytes: 19.7;monocytes: 24.4;T-cells: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 12.4;HL-60: 12.1;HMC-1: 15.5;Karpas-707: 12.9;MOLT-4: 23.5;U-266/70: 31.5;U-937: 22.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069976	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA069976: AB_2686224"	"unprognostic (8.34e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.82e-3)"	"unprognostic (3.02e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.38e-1)"	"unprognostic (5.24e-2)"	5.0	1.8	2.2	16.0	3.1	27.8	2.3	0.8	1.7	1.7	4.1	2.7	0.0	2.8	1.7	2.0	2.0	1.8	3.5	1.7	1.7	1.5	1.9	1.5	4.3	13.1	3.0	1.0	1.7	1.5	0.6	1.4	2.0	2.5	2.2	2.6	1.9	3.1	0.5	1.1	1.3	6.1	1.9	6.4	17.4	2.5	7.6	3.0	40.8	2.3	0.9	21.2	4.1	1.5	6.2	5.6	14.2	24.5	5.3	5.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.6	0.0	0.0	0.0	12.1	15.5	0.0	0.0	0.0	0.0	0.0	4.8	7.4	8.6	12.9	0.0	0.0	23.5	4.6	0.0	0.0	0.0	6.2	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	1.2	0.0	0.1	0.0	0.0	31.5	0.0	11.7	0.0	22.2	2.9	4.6	3.4	14.2	5.6	10.6	5.1	4.7	2.6	4.2	5.6	6.2	2.8	3.8	13.9	5.3	24.5	4.9	2.6	3.6	2.2	3.1	0.8	1.7	1.7	1.5	3.0	1.0	2.5	3.0	0.0	2.6	17.3	0.0	0.7	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	26.6	0.9	0.0	0.0	0.0	0.0	0.1	0.0	19.7	0.5	5.9	0.0	0.0	1.8	11.0	12.8	0.6	13.3	6.8	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	3.1	0.3	0.1	17.5	0.0	0.0
PRKAR2B	PRKAR2	ENSG00000005249	"Protein kinase cAMP-dependent type II regulatory subunit beta"	P31323	7	107044649-107161811	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"adipose tissue: 80.2;breast: 114.1"	"Cell type enhanced"	"Detected in many"	7	"Peritubular cells: 49.8;Smooth muscle cells: 35.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.1;Daudi: 27.6;K-562: 16.6;U-698: 71.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008421, HPA063879"	Enhanced		Uncertain	Mitochondria		NA	NA		1600000	Mitochondria		"HPA008421: AB_1855421, HPA063879: "	"unprognostic (3.18e-1)"	"unprognostic (2.48e-2)"	"prognostic favorable (6.38e-4)"	"unprognostic (1.63e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.43e-3)"	"unprognostic (2.76e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.97e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (1.50e-1)"	"unprognostic (5.12e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (7.15e-2)"	80.2	21.5	9.4	6.0	17.2	8.4	114.1	4.5	17.0	3.9	9.1	1.9	2.4	3.1	5.1	3.9	8.4	3.4	4.7	9.0	8.8	8.6	4.5	2.4	3.2	3.0	8.4	12.1	19.5	6.5	5.6	8.1	10.7	3.0	6.4	5.5	2.6	6.8	3.9	2.2	1.6	4.7	7.4	3.4	11.1	4.1	14.5	4.6	0.8	1.6	2.8	3.3	8.4	11.8	0.2	3.1	1.3	1.5	0.5	0.1	2.5	0.0	0.4	2.6	20.1	10.8	0.0	0.0	1.0	3.2	0.8	0.8	0.0	0.0	27.6	0.2	0.6	2.5	0.0	2.0	0.0	1.6	0.7	2.2	9.2	0.0	0.0	3.0	0.1	1.3	0.1	0.0	0.0	0.0	0.9	12.1	1.5	16.6	0.8	0.0	2.0	3.7	0.1	4.9	0.0	0.8	1.1	0.0	0.0	0.0	0.0	3.3	4.8	1.5	0.3	1.0	6.9	0.6	1.9	6.8	1.0	2.6	0.0	1.9	0.6	0.0	71.0	0.7	4.8	9.6	1.3	1.5	0.0	0.0	1.4	0.1	0.2	0.0	0.0	3.1	0.0	0.1	0.1	0.7	0.5	0.7	1.1	0.0	2.5	9.4	17.2	4.5	17.0	8.8	8.6	8.4	12.1	3.0	4.6	3.0	1.0	0.8	1.4	2.2	29.0	26.0	10.2	6.7	1.2	7.0	9.8	0.0	0.0	1.7	6.2	15.5	0.0	0.0	0.0	0.4	5.1	5.9	4.6	0.0	1.5	4.8	0.0	14.1	14.0	4.7	27.6	10.4	16.9	13.6	0.5	5.5	0.2	2.6	49.8	0.6	9.1	19.4	35.8	1.6	4.5	2.0	0.0	2.9	1.9	3.9
HBP1		ENSG00000105856	"HMG-box transcription factor 1"	O60381	7	107168961-107202529	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 228.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020225, CAB032824"	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB032824: AB_2114615, HPA020225: "	"unprognostic (9.00e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.43e-1)"	"unprognostic (4.79e-2)"	"unprognostic (7.49e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.50e-1)"	"prognostic favorable (7.70e-5)"	"unprognostic (7.39e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.69e-2)"	"unprognostic (5.26e-2)"	28.7	26.2	17.5	14.2	19.2	33.7	27.9	33.6	20.7	27.0	21.1	17.3	23.9	13.1	36.5	16.9	28.8	18.8	16.7	23.8	16.3	8.9	21.0	27.4	25.8	13.8	29.4	12.3	27.8	18.0	18.5	14.4	37.1	19.8	26.4	14.6	14.5	23.7	19.4	40.8	34.3	17.6	21.5	23.5	17.9	18.5	25.9	27.5	24.5	33.5	19.0	17.8	30.9	32.5	11.6	12.9	47.2	19.5	16.6	17.2	24.7	5.1	5.8	10.4	6.6	21.5	20.2	5.2	8.4	18.8	6.1	10.8	2.3	12.4	4.6	11.1	11.5	13.2	6.1	4.1	5.1	7.6	3.8	3.9	3.1	9.7	4.2	12.3	2.4	9.3	23.5	15.4	5.9	7.3	21.4	19.7	4.9	5.8	11.7	7.7	8.4	3.9	7.9	6.5	6.8	6.4	3.5	7.5	11.4	10.8	6.2	4.0	12.5	9.7	14.3	13.1	15.1	4.6	6.9	19.0	8.3	6.4	12.1	2.7	13.4	15.8	4.5	7.9	5.3	7.6	41.3	19.1	24.7	13.0	19.5	12.2	11.6	13.7	12.4	12.9	11.2	16.0	13.4	47.2	16.6	18.9	6.6	17.2	24.7	17.5	19.2	33.6	20.7	16.3	8.9	29.4	12.3	19.8	27.5	20.8	32.0	48.0	76.4	96.2	28.2	19.3	15.3	29.4	26.1	31.4	7.9	37.4	38.1	37.9	140.0	39.8	44.5	23.3	28.2	22.1	49.4	82.2	49.7	31.6	26.0	39.7	51.9	31.3	49.0	228.9	50.0	34.0	70.9	32.5	34.8	29.1	32.4	35.1	54.5	32.3	27.8	45.3	56.7	41.7	31.1	116.2	176.0	45.3	22.0	82.3
COG5	"GOLTC1, GTC90"	ENSG00000164597	"Component of oligomeric golgi complex 5"	Q9UP83	7	107201555-107564514	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020300, HPA041583"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA020300: AB_2081406, HPA041583: AB_2677564"	"unprognostic (3.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (9.72e-4)"	"unprognostic (2.41e-1)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.91e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (1.15e-1)"	17.2	15.8	15.2	13.7	14.9	16.5	13.9	16.1	17.7	24.8	12.1	15.0	18.3	8.8	28.4	14.0	16.4	10.9	20.3	25.7	13.3	10.3	12.7	8.9	12.9	9.5	14.7	12.5	16.7	18.9	40.3	28.4	14.4	13.4	25.6	14.1	10.5	34.0	20.6	16.5	15.8	12.5	23.8	17.5	10.8	13.1	12.6	15.3	14.0	26.3	11.5	17.3	13.9	21.4	9.8	8.6	10.1	12.9	7.0	12.3	8.9	16.2	7.5	6.8	2.6	2.0	1.8	6.7	12.0	14.3	6.4	10.2	4.8	7.5	2.3	4.6	11.8	14.7	8.4	2.8	2.1	9.3	11.3	2.1	1.8	3.1	8.0	1.5	4.6	10.7	6.1	1.1	12.5	14.0	12.2	18.4	4.6	5.2	8.9	12.3	8.0	4.8	0.0	0.9	16.0	8.1	2.1	3.0	4.2	5.5	7.8	1.5	10.1	4.1	12.4	13.1	8.5	1.2	3.0	20.9	3.9	6.6	19.9	7.0	2.9	6.7	5.0	10.5	6.4	19.0	9.9	10.8	10.1	9.6	12.5	12.3	9.8	12.0	10.3	8.6	8.2	10.2	10.1	5.1	7.0	12.9	5.5	9.5	8.9	15.2	14.9	16.1	17.7	13.3	10.3	14.7	12.5	13.4	15.3	3.0	13.3	7.0	10.2	10.9	20.8	22.6	5.1	12.0	12.5	14.0	31.4	8.8	1.7	9.2	12.8	11.7	13.0	0.0	9.5	6.7	12.2	18.0	3.5	4.9	10.2	11.1	9.9	7.4	11.0	17.5	10.9	12.3	11.8	10.8	14.9	7.8	8.4	10.5	11.7	5.4	17.5	25.8	6.2	14.0	13.2	11.7	8.8	13.8	12.5	12.3
GPR22		ENSG00000172209	"G protein-coupled receptor 22"	Q99680	7	107470018-107475659	"G-protein coupled receptors, Predicted membrane proteins"	"Cilium biogenesis/degradation"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 31.5;heart muscle: 18.7"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 15.6;Cardiomyocytes: 57.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	33	"SH-SY5Y: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.23e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.52e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.00e-1)"		"unprognostic (4.27e-3)"	"unprognostic (1.62e-1)"	"unprognostic (8.76e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.85e-4)"	"unprognostic (1.55e-1)"	"unprognostic (7.53e-3)"	"unprognostic (2.27e-3)"	"unprognostic (2.04e-1)"	0.6	2.7	10.9	0.6	4.4	0.7	0.6	15.5	31.5	6.3	0.6	0.0	0.0	0.6	4.1	0.6	0.6	0.6	0.6	18.7	19.4	2.0	1.0	0.6	0.6	0.6	1.8	13.0	0.6	0.6	0.6	0.3	0.6	6.0	0.6	0.6	0.0	0.6	0.8	0.6	0.6	0.6	1.0	0.7	0.6	0.6	0.6	1.1	0.0	0.6	0.0	0.6	0.6	1.7	1.0	0.2	0.3	0.3	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.2	0.3	0.9	0.4	0.5	0.0	1.0	0.4	1.0	0.3	0.2	0.2	0.2	0.4	0.0	10.9	4.4	15.5	31.5	19.4	2.0	1.8	13.0	6.0	1.1	0.0	0.0	0.0	0.0	0.2	15.6	57.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
DUS4L	"DUS4, PP35"	ENSG00000105865	"Dihydrouridine synthase 4 like"	O95620	7	107563484-107578464	"Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044301	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA044301: AB_10967460"	"unprognostic (7.95e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.29e-2)"	"unprognostic (9.21e-3)"	"unprognostic (7.74e-3)"	"unprognostic (6.72e-3)"	4.5	6.2	9.4	7.0	10.4	2.9	7.8	5.0	8.2	5.5	5.7	7.5	6.2	4.8	5.7	10.4	5.5	6.0	4.7	10.1	8.0	7.7	9.9	9.0	3.9	5.0	10.3	6.2	7.8	5.4	8.0	5.1	4.8	7.6	7.8	5.7	5.7	5.1	4.8	7.1	7.1	5.2	5.3	11.0	4.3	5.4	7.7	6.6	6.6	8.5	5.9	5.7	6.2	4.5	1.5	1.3	0.5	1.3	1.2	2.4	0.7	6.5	3.0	3.0	1.8	1.2	2.0	3.9	1.9	2.6	2.8	2.7	3.4	5.4	7.0	3.6	1.5	7.4	2.0	3.1	4.0	4.3	2.1	2.6	2.5	1.6	3.7	3.0	4.8	0.4	2.0	5.4	2.7	9.2	3.2	4.1	6.6	8.7	2.6	4.3	4.8	6.6	8.4	4.3	5.2	5.4	3.6	2.7	7.9	5.4	3.4	2.7	6.8	3.1	6.4	5.4	3.9	3.1	3.8	2.9	4.0	3.2	3.0	4.4	4.9	6.0	7.9	4.3	6.8	4.8	0.0	1.2	0.1	1.4	1.3	1.6	1.5	2.3	1.2	1.3	0.7	1.9	2.4	0.5	1.2	0.7	1.1	1.7	0.7	9.4	10.4	5.0	8.2	8.0	7.7	10.3	6.2	7.6	6.6	6.0	4.6	5.6	7.5	4.5	8.8	8.0	2.5	22.7	6.8	10.4	3.9	7.9	6.6	8.7	20.0	2.7	3.8	0.0	13.9	7.4	4.2	5.5	13.8	8.9	6.1	3.2	9.2	4.9	4.6	17.7	4.0	4.9	3.3	5.4	4.5	13.0	11.5	5.3	3.5	13.2	9.1	12.9	4.2	11.2	10.9	3.4	3.1	3.8	5.5	6.4
BCAP29	"BAP29, DKFZp686M2086"	ENSG00000075790	"B cell receptor associated protein 29"	Q9UHQ4	7	107579977-107629170	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Spermatocytes: 226.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029215, HPA049694"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA029215: AB_10602331, HPA049694: AB_2680854"	"unprognostic (3.96e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.42e-3)"	"unprognostic (4.71e-3)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (6.43e-2)"	"unprognostic (7.22e-2)"	"unprognostic (9.64e-2)"	"unprognostic (2.31e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.34e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.81e-1)"	25.6	16.0	17.6	13.7	21.3	11.0	24.0	15.9	33.8	30.5	18.9	10.3	13.6	10.4	27.4	12.3	23.3	13.5	14.7	34.0	18.9	17.0	16.7	24.4	17.3	10.6	20.3	28.7	14.6	12.3	20.8	14.8	23.6	25.7	18.5	19.3	10.0	12.1	17.0	22.9	13.6	13.6	24.0	28.1	12.8	14.6	40.0	13.7	6.3	51.4	13.8	9.8	20.5	20.8	6.6	6.3	20.0	12.4	5.1	6.5	4.3	18.9	5.0	7.9	4.1	17.0	20.2	6.4	21.4	18.6	10.5	11.6	5.5	20.3	3.7	15.2	16.0	18.5	9.5	4.8	10.1	14.6	12.5	5.2	9.1	7.8	5.3	16.8	10.4	12.6	13.0	7.4	13.4	11.0	24.7	28.4	6.8	15.3	10.7	20.7	12.9	6.6	8.8	4.7	6.9	7.8	6.0	10.7	11.7	15.8	9.9	3.4	11.0	20.7	17.9	15.8	10.5	6.8	10.2	30.3	31.0	14.3	27.2	29.6	8.2	21.1	8.8	23.2	9.6	22.6	20.0	6.4	13.0	5.4	7.4	5.5	6.6	4.5	5.7	6.3	5.2	2.7	5.1	2.2	5.1	12.4	6.1	6.5	4.3	17.6	21.3	15.9	33.8	18.9	17.0	20.3	28.7	25.7	13.7	62.5	45.7	19.1	44.3	34.2	31.4	99.3	15.3	32.1	34.2	22.7	9.8	28.2	13.3	40.3	198.1	89.9	22.6	46.7	64.6	44.0	48.3	97.8	56.6	39.4	46.1	7.9	21.5	62.6	29.8	66.5	56.7	40.5	35.4	39.7	32.4	30.9	57.9	31.6	83.8	17.0	22.5	77.6	55.3	226.6	29.8	33.9	59.2	24.5	45.9	62.9
SLC26A4	"DFNB4, PDS"	ENSG00000091137	"Solute carrier family 26 member 4"	O43511	7	107660635-107717809	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"thyroid gland: 79.2"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 11.4;Glandular cells: 8.7;Intestinal endocrine cells: 7.0;Melanocytes: 6.8"	"Cancer enriched"	"Detected in some"	8	"thyroid cancer: 37.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"naive B-cell: 3.1"	"Lineage enriched"	"Detected in single"	5	"B-cells: 3.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.5;hTERT-RPE1: 8.3;LHCN-M2: 4.6"	"Region enriched"	"Detected in some"	4	"hippocampal formation: 10.6"	"Low region specificity"	"Detected in all"			HPA042860	Approved					NA	NA					"HPA042860: AB_10796680"	"unprognostic (1.19e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.39e-1)"	0.1	0.0	0.8	0.2	0.5	0.0	0.2	0.0	2.9	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.2	3.3	0.0	0.2	0.0	0.1	0.6	0.1	0.1	0.1	0.1	0.0	0.0	1.8	0.0	1.4	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	79.2	0.0	0.1	0.8	0.1	3.1	0.1	0.1	0.2	0.1	0.5	0.3	0.7	0.3	0.5	0.0	0.7	1.5	0.4	0.3	0.2	0.3	0.1	0.0	0.1	0.1	2.5	0.3	0.0	0.2	0.5	0.2	0.1	3.5	0.9	0.0	0.3	0.2	0.4	0.4	1.1	0.0	0.9	0.4	0.0	8.3	0.1	0.8	0.0	0.4	4.6	0.7	0.0	0.4	0.0	0.0	0.8	0.2	1.3	0.0	0.0	0.1	2.5	0.1	0.0	0.0	1.7	0.2	0.0	0.4	0.7	0.7	0.5	0.2	2.8	0.7	0.7	0.3	0.8	0.4	1.7	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	3.1	0.0	0.1	0.1	0.1	0.2	0.1	0.5	0.3	0.8	0.5	0.0	1.4	0.5	0.2	0.1	0.6	0.0	0.0	3.0	11.4	0.0	0.6	1.4	5.6	0.7	0.0	1.4	4.5	0.0	2.0	0.2	0.0	0.1	2.6	0.7	0.0	0.0	0.0	0.1	1.1	8.7	4.7	0.0	0.2	1.6	7.0	0.6	0.3	2.0	0.9	1.4	6.8	1.0	0.0	0.4	0.1	0.0	1.1	0.0	1.1	0.0	0.9	1.7	0.3	1.3	0.0	1.0	0.0	1.2
CBLL1	"FLJ23109, HAKAI, RNF188"	ENSG00000105879	"Cbl proto-oncogene like 1"	Q75N03	7	107743697-107761667	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021773, HPA026699"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA021773: AB_1846103, HPA026699: AB_1846104"	"unprognostic (1.90e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.16e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.96e-3)"	"unprognostic (4.28e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.12e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.71e-2)"	15.8	12.0	11.7	13.6	20.0	38.8	16.8	18.7	19.4	15.3	17.2	19.2	11.6	10.8	22.9	9.7	14.4	14.2	10.2	11.5	11.9	10.7	11.6	12.5	12.9	16.5	12.6	14.3	18.2	15.5	14.5	17.2	13.5	16.5	18.7	13.0	14.7	12.8	19.6	32.6	16.6	14.4	16.2	15.1	15.8	14.7	21.1	13.3	29.0	15.8	11.8	19.3	17.6	12.7	17.9	16.7	32.2	15.7	23.4	40.3	20.1	13.7	15.7	12.2	15.5	11.2	9.8	8.3	10.4	10.8	11.6	11.6	10.6	14.0	19.9	15.0	11.6	19.7	9.8	16.8	12.5	16.0	14.2	10.6	16.2	11.6	8.9	13.0	23.9	15.9	10.1	11.7	15.7	17.2	8.8	12.0	14.1	25.5	17.0	11.1	23.5	32.6	16.2	17.5	11.6	10.7	15.2	13.2	20.6	8.8	12.7	13.0	20.3	15.5	22.7	11.3	14.9	7.7	12.2	11.7	18.2	13.1	17.2	15.8	27.6	30.0	32.3	11.2	14.9	15.3	32.2	14.2	23.3	19.0	14.7	28.0	17.9	30.1	21.8	16.7	17.4	20.9	19.6	21.9	23.4	15.7	9.0	40.3	20.1	11.7	20.0	18.7	19.4	11.9	10.7	12.6	14.3	16.5	13.3	17.9	8.3	18.6	13.2	20.9	11.5	14.9	7.6	5.3	10.3	3.5	3.9	9.0	6.6	8.7	7.0	12.0	7.7	0.0	9.4	7.7	8.2	13.2	12.7	9.4	9.1	9.5	16.1	12.9	21.5	3.6	8.6	10.8	18.6	7.2	7.2	6.8	9.1	14.4	11.0	9.2	13.7	19.4	9.9	22.4	13.0	17.3	8.6	19.8	8.4	16.3
SLC26A3	"CLD, DRA"	ENSG00000091138	"Solute carrier family 26 member 3"	P40879	7	107765467-107803225	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"gallbladder: 53.5;intestine: 110.1;lymphoid tissue: 42.8"	"Cell type enriched"	"Detected in some"	11	"Enterocytes: 543.6"	"Cancer enriched"	"Detected in many"	14	"colorectal cancer: 52.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;CACO-2: 1.9;NB-4: 1.5;RPMI-8226: 7.6"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA036055	Approved					NA	NA					"HPA036055: AB_10602401"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.05e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.85e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.58e-3)"	0.3	0.3	0.3	42.8	0.3	0.0	6.1	0.3	0.3	0.4	110.1	0.2	0.3	58.4	0.3	1.2	0.3	0.6	53.5	0.3	0.3	0.3	0.3	0.4	0.3	0.2	0.3	0.2	0.3	0.3	0.0	0.3	0.2	0.2	0.5	92.7	0.2	0.3	14.4	0.3	0.3	106.5	1.2	0.3	0.3	0.4	0.3	0.2	0.2	0.3	0.2	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	48.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	543.6	0.0	0.0	0.0	0.0	0.2	27.5	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	26.7	0.0	0.0	40.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	20.4	0.0
DLD	"DLDH, GCSL, LAD"	ENSG00000091140	"Dihydrolipoamide dehydrogenase"	P09622	7	107890970-107931730	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 284.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044849	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA		16000000	Mitochondria	Nucleoplasm	"HPA044849: AB_2679111"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.43e-2)"	"unprognostic (7.35e-2)"	"prognostic favorable (7.58e-9)"	"unprognostic (4.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.18e-1)"	25.7	37.9	14.5	12.7	25.4	12.0	15.2	16.6	27.2	13.2	28.0	10.6	12.2	20.9	13.6	9.6	25.6	11.6	12.7	69.1	16.4	14.4	40.7	37.9	11.0	13.0	16.7	20.1	15.1	14.8	24.6	22.4	15.4	29.3	14.7	26.8	12.8	19.4	14.4	71.5	13.8	29.5	23.7	10.6	17.4	23.0	10.6	10.7	18.7	17.0	31.8	16.9	20.1	11.7	13.5	30.4	45.8	37.8	22.9	19.4	20.2	40.1	32.6	18.1	31.1	26.0	23.0	20.5	23.1	19.5	26.9	20.9	38.0	22.6	39.3	39.9	24.5	44.0	26.7	36.3	32.6	40.7	26.2	21.6	27.6	43.2	27.1	20.0	45.4	28.5	26.2	23.7	28.6	15.6	17.1	32.3	33.0	68.9	29.3	29.2	45.1	37.1	32.9	21.5	48.5	23.7	26.8	29.0	53.3	36.8	60.0	22.5	23.8	37.8	64.0	34.0	37.6	24.4	38.9	20.4	29.8	24.4	57.9	35.1	22.2	42.3	26.4	28.0	48.5	30.7	36.5	22.3	45.8	17.5	28.2	18.5	13.5	17.7	17.3	30.4	12.3	18.7	19.4	14.0	22.9	37.8	10.5	16.8	20.2	14.5	25.4	16.6	27.2	16.4	14.4	16.7	20.1	29.3	10.7	26.8	16.5	23.1	30.6	27.8	45.9	284.8	61.1	37.5	18.2	75.0	21.6	94.8	192.3	59.5	3.8	30.0	47.9	46.7	49.3	49.9	26.3	23.6	26.5	77.8	61.0	20.6	29.4	27.6	36.8	5.6	21.6	34.1	35.4	65.9	39.3	31.3	37.7	56.1	39.6	134.4	33.4	25.8	43.4	41.2	52.4	28.2	90.6	27.7	64.6	28.5
LAMB1	CLM	ENSG00000091136	"Laminin subunit beta 1"	P07942	7	107923799-108003255	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 66.5;Leydig cells: 65.9;Peritubular cells: 133.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 81.8;ASC TERT1: 108.0;HSkMC: 105.6;TIME: 78.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004056, HPA004132, CAB004256"	Enhanced				"Secreted to extracellular matrix"	NA	NA		140000000			"CAB004256: AB_627867, HPA004056: AB_1079226, HPA004132: AB_1079225"	"unprognostic (2.39e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.01e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.45e-3)"	"unprognostic (8.26e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.44e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.46e-1)"	47.3	9.9	5.4	11.8	9.9	0.0	36.4	7.0	5.7	20.3	29.4	1.9	9.3	13.2	31.8	16.8	20.5	18.5	21.2	36.2	2.5	1.4	36.9	6.8	39.4	18.2	3.1	3.9	16.5	20.1	3.3	10.9	57.5	6.9	25.1	17.8	20.4	10.4	13.4	15.8	13.8	24.2	27.0	4.6	28.5	20.3	13.3	2.6	6.7	31.8	7.8	5.5	28.2	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	17.9	10.8	0.5	81.8	108.0	42.6	15.0	22.7	8.3	9.1	37.5	21.9	0.0	21.6	24.5	11.4	5.5	3.0	18.1	6.7	0.0	3.2	0.7	7.4	15.7	55.2	0.0	0.8	105.6	6.8	21.5	24.9	58.5	57.0	0.5	2.3	0.0	17.9	4.4	0.0	0.0	6.4	7.5	12.9	0.1	7.6	0.0	44.6	12.7	3.8	21.8	10.5	14.8	10.1	27.3	5.0	0.1	78.1	24.1	7.0	8.2	17.8	0.0	0.0	0.0	12.3	0.0	44.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	9.9	7.0	5.7	2.5	1.4	3.1	3.9	6.9	2.6	0.0	6.4	1.4	5.8	7.9	9.7	14.5	10.2	4.0	10.3	26.2	3.9	66.5	3.3	16.3	1.1	20.3	9.3	0.0	9.9	22.3	57.5	0.9	2.3	1.6	8.8	7.9	18.4	21.5	1.8	1.1	65.9	2.4	8.5	1.0	5.8	2.0	17.2	14.4	133.3	11.9	9.6	51.8	8.6	5.9	3.7	5.8	27.2	1.8	16.4	0.9
LAMB4		ENSG00000091128	"Laminin subunit beta 4"	A4D0S4	7	108023548-108130356	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"esophagus: 13.8;placenta: 26.2;skin 1: 31.1;tongue: 21.6"	"Cell type enhanced"	"Detected in some"	22	"Basal keratinocytes: 31.0;Early spermatids: 8.6;Late spermatids: 7.6;Suprabasal keratinocytes: 12.0"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"BEWO: 6.1;HMC-1: 3.6"					"Low region specificity"	"Detected in many"			"HPA020242, HPA024247"	Approved				"Secreted to extracellular matrix"	NA	NA					"HPA020242: AB_2670388, HPA024247: AB_2671496"	"unprognostic (7.41e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.79e-2)"	"unprognostic (6.29e-4)"	"unprognostic (8.90e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.03e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.23e-4)"	"unprognostic (4.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.2	13.8	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	31.1	0.2	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.1	21.6	2.0	0.1	0.1	0.6	0.5	1.6	0.3	1.0	0.4	0.2	0.0	0.9	0.3	0.1	0.6	0.5	6.1	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.8	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.4	0.1	0.0	3.6	1.0	0.2	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.3	0.4	0.0	0.7	0.0	0.0	0.2	0.4	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	1.6	0.3	0.1	0.4	0.1	0.2	0.2	0.2	0.2	0.1	0.6	0.3	0.2	1.6	1.0	0.2	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.9	5.0	0.0	8.6	0.1	0.0	0.0	0.2	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.2	2.2	0.3	12.0	1.1	0.0	0.0	0.0
NRCAM	"Bravo, KIAA0343"	ENSG00000091129	"Neuronal cell adhesion molecule"	Q92823	7	108147623-108456717	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 82.0"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 66.8;Cone photoreceptor cells: 96.2;Muller glia cells: 46.7"	"Cancer enriched"	"Detected in all"	7	"glioma: 57.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"naive CD8 T-cell: 5.5"	"Lineage enriched"	"Detected in single"	15	"T-cells: 5.5"	"Cell line enhanced"	"Detected in some"		"A549: 26.4;AF22: 25.7;EFO-21: 47.9;HMC-1: 51.2;SH-SY5Y: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012606	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		70000000	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA012606: AB_1854636"	"unprognostic (2.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.10e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.22e-2)"	"unprognostic (9.70e-3)"	"unprognostic (6.42e-2)"	"unprognostic (6.51e-3)"	"unprognostic (3.28e-2)"	2.5	28.7	24.5	2.3	23.7	1.2	1.6	16.6	82.0	5.0	1.6	10.5	9.5	1.5	2.6	26.6	1.5	3.7	6.3	1.1	19.1	15.9	5.8	1.3	2.7	1.6	11.8	21.2	2.1	21.5	1.2	14.6	6.4	21.7	1.6	1.6	0.7	2.4	12.1	1.0	1.6	1.5	1.6	10.8	4.2	2.3	2.2	9.9	0.0	4.0	0.0	2.9	1.5	0.8	0.1	0.0	0.3	0.0	0.0	5.5	0.6	0.0	26.4	25.7	0.0	3.1	0.6	0.5	0.1	0.1	0.2	0.4	10.6	0.0	0.0	47.9	0.2	0.4	0.1	0.6	0.4	0.2	0.0	3.4	0.0	0.2	0.2	0.0	0.2	51.2	4.3	0.0	0.0	0.1	0.0	16.5	0.0	0.0	0.2	0.4	9.9	0.1	0.0	3.5	15.7	0.0	0.0	7.5	8.6	5.9	0.0	5.0	31.5	0.3	0.0	0.5	0.9	0.0	0.0	17.5	1.1	0.2	0.0	4.3	0.0	0.1	0.2	0.2	0.0	14.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	5.5	0.0	0.0	0.0	0.0	0.0	0.6	24.5	23.7	16.6	34.7	19.1	15.9	11.8	21.2	21.7	9.9	0.0	0.0	0.0	0.0	0.3	66.8	0.5	2.5	0.0	0.0	5.2	96.2	2.1	3.3	1.3	25.4	0.9	0.0	0.0	10.2	0.2	0.9	0.7	22.0	0.0	0.7	12.7	0.0	2.5	1.5	4.7	0.9	0.0	3.3	1.0	0.0	46.7	5.7	0.0	0.4	2.1	7.9	0.0	0.9	1.0	1.1	0.1	3.7	0.0	0.0	0.0
PNPLA8	"IPLA2-2, IPLA2G, iPLA2gamma"	ENSG00000135241	"Patatin like phospholipase domain containing 8"	Q9NP80	7	108470422-108569666	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020083	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA020083: AB_1851849"	"unprognostic (4.48e-2)"	"unprognostic (3.37e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.61e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.86e-6)"	"unprognostic (3.16e-2)"	"unprognostic (3.64e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.24e-1)"	21.5	35.7	29.3	12.4	28.9	51.5	15.0	15.6	27.2	15.4	13.4	9.5	9.3	8.6	13.4	13.7	18.3	9.7	15.9	17.9	23.0	22.1	23.1	24.6	16.7	12.0	20.7	17.5	15.6	10.1	20.7	33.4	25.2	23.2	14.4	11.4	6.0	11.4	13.9	29.8	11.4	10.8	15.3	20.3	19.5	11.1	10.8	21.1	16.1	22.6	13.0	15.3	22.5	12.8	20.0	19.3	16.7	26.8	14.6	12.5	13.7	14.1	6.4	11.3	10.1	25.2	17.4	16.7	13.5	23.8	11.1	18.6	6.1	8.1	7.9	17.1	13.2	22.4	5.4	19.1	8.6	16.9	11.8	5.3	5.4	10.5	4.5	18.4	3.7	11.2	15.7	16.3	14.9	13.8	12.2	15.0	8.9	6.3	22.7	13.8	9.3	8.7	8.9	5.0	8.9	9.1	3.2	11.9	16.7	13.3	18.0	9.4	13.2	12.9	14.0	16.2	14.9	5.9	6.4	12.1	18.3	8.2	27.2	7.4	19.3	19.5	11.7	17.4	5.7	11.8	14.1	19.7	16.7	10.5	21.8	12.5	20.0	10.3	10.3	19.3	18.7	11.2	10.7	16.5	14.6	26.8	7.6	12.5	13.7	29.3	28.9	15.6	27.2	23.0	22.1	20.7	17.5	23.2	21.1	38.7	43.0	28.7	103.5	82.5	61.7	43.5	10.2	81.7	58.0	22.7	17.7	46.4	79.6	26.9	49.7	39.4	25.7	0.0	33.2	30.6	50.6	71.1	70.4	40.3	28.4	30.2	54.7	19.6	49.4	40.1	29.7	48.1	52.3	17.2	16.2	37.9	25.2	14.1	37.1	33.7	29.7	19.4	38.2	17.7	27.4	118.6	108.9	23.5	13.6	109.8
THAP5	DKFZp313O1132	ENSG00000177683	"THAP domain containing 5"	Q7Z6K1	7	108554543-108569750	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"Early spermatids: 374.3;Late spermatids: 414.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043170, HPA051488"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043170: AB_10964500, HPA051488: AB_2681504"	"unprognostic (2.53e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.20e-1)"	"prognostic favorable (8.99e-4)"	"unprognostic (6.00e-2)"	"unprognostic (3.39e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.79e-2)"	12.8	16.9	17.8	13.2	18.9	5.3	16.2	22.9	22.3	16.4	11.3	11.1	16.1	12.1	16.3	16.5	10.0	12.9	9.9	16.5	18.0	17.6	20.4	25.8	12.7	16.1	24.5	18.7	22.5	16.0	22.7	29.4	14.8	20.2	16.8	10.6	8.1	11.5	24.3	19.6	10.3	11.9	12.3	22.3	14.7	12.4	28.9	22.0	19.4	27.9	9.4	16.0	16.7	15.1	16.8	10.5	21.2	11.4	8.9	15.5	6.2	9.2	7.2	9.3	21.0	6.1	8.6	4.9	8.6	9.8	9.6	10.2	3.6	7.8	11.3	15.4	5.9	12.4	4.0	9.5	6.7	12.5	14.5	7.4	8.5	7.5	3.4	13.0	15.1	11.2	5.3	13.2	5.8	13.9	10.2	5.8	12.9	13.2	24.6	9.6	9.3	22.8	6.6	10.9	5.5	7.1	7.2	13.2	26.3	5.8	5.4	10.9	19.3	12.3	14.6	16.8	7.6	6.1	5.7	5.7	18.2	10.0	14.2	10.5	28.5	24.5	20.9	10.0	9.2	16.3	12.4	6.8	10.7	10.0	8.2	13.3	14.6	11.7	9.5	6.1	16.8	15.5	12.9	21.2	8.9	11.4	10.5	8.8	6.2	17.8	18.9	22.9	22.3	18.0	17.6	24.5	18.7	20.2	22.0	14.9	18.1	27.0	11.6	10.9	38.1	25.4	17.8	33.5	15.9	24.4	7.9	11.7	39.7	12.9	374.3	21.4	12.3	23.3	14.6	7.7	14.3	12.6	30.2	22.1	8.3	44.5	15.1	18.4	10.8	414.2	26.2	19.5	33.7	7.2	15.1	47.9	13.0	12.2	26.5	21.5	33.5	25.8	19.6	31.6	24.4	15.7	12.0	21.8	10.6	5.7
DNAJB9	MDG1	ENSG00000128590	"DnaJ heat shock protein family (Hsp40) member B9"	Q9UBS3	7	108569568-108574850	"Predicted intracellular proteins"	"Unfolded protein response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Melanocytes: 322.2;Syncytiotrophoblasts: 476.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 34.1;Karpas-707: 31.1;U-266/70: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040967, HPA041553"	Supported		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA040967: AB_10794430, HPA041553: AB_10794300"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.75e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.37e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.76e-2)"	13.7	28.9	11.6	9.7	14.1	16.7	14.6	8.6	15.4	18.2	11.1	10.0	33.7	11.1	12.6	31.4	8.7	12.8	10.8	24.2	11.6	18.7	29.2	54.3	16.1	13.3	14.0	11.4	14.6	47.9	6.9	31.0	51.2	15.7	14.2	9.6	10.1	32.2	29.5	29.4	7.6	10.8	10.7	14.7	10.8	11.9	18.5	10.6	5.4	37.4	7.2	14.2	18.1	13.5	10.0	30.1	25.8	7.7	9.9	24.0	11.4	2.5	2.9	4.0	4.6	11.2	8.1	8.9	9.4	11.4	5.2	6.3	2.9	4.9	3.4	10.5	2.9	16.4	3.1	4.5	2.3	5.4	3.6	2.4	1.8	2.1	9.0	34.1	2.7	3.6	5.7	18.0	3.0	16.9	11.8	5.4	2.0	2.6	31.1	8.1	3.7	2.5	3.1	4.0	3.0	1.6	1.6	4.1	17.7	4.3	1.6	2.8	5.9	3.5	15.8	17.3	11.8	2.9	3.7	6.2	5.5	2.6	6.8	3.3	54.8	17.5	3.9	4.8	3.5	5.0	25.8	7.7	3.5	14.1	5.8	24.0	10.0	15.4	14.1	5.7	8.1	8.9	10.2	2.1	9.9	6.2	30.1	8.9	11.4	11.6	14.1	8.6	15.4	11.6	18.7	14.0	11.4	15.7	10.6	3.0	24.5	55.9	74.7	164.9	35.2	49.9	33.1	12.0	26.1	50.6	7.9	92.1	41.4	36.7	250.3	25.6	26.9	46.7	40.0	74.4	81.3	107.9	93.2	138.2	37.2	19.1	63.8	27.0	30.2	167.7	35.4	38.7	322.2	17.2	22.8	79.9	42.7	35.1	43.5	139.7	27.0	38.8	75.0	129.5	59.0	138.6	476.2	51.1	13.6	74.9
IMMP2L	"IMMP2L-IT1, IMP2"	ENSG00000184903	"Inner mitochondrial membrane peptidase subunit 2"	Q96T52	7	110663051-111562517	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 135.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA026711	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA026711: AB_1851760"	"unprognostic (2.55e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (1.89e-5)"	"unprognostic (5.64e-3)"	"unprognostic (1.00e-1)"	"unprognostic (4.17e-1)"	"unprognostic (5.68e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.32e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.71e-1)"	12.4	12.4	7.9	7.3	10.8	2.9	11.8	5.4	9.1	12.4	11.1	5.7	10.6	5.2	23.8	10.4	8.0	11.5	5.8	8.6	7.1	6.0	23.8	17.7	7.4	4.4	5.7	6.1	14.4	10.0	13.4	15.7	8.0	6.3	13.8	5.8	31.6	11.6	15.8	18.6	7.5	10.9	14.4	5.6	5.3	9.8	9.0	5.6	8.2	16.7	8.3	9.5	11.0	9.2	18.1	11.7	5.8	8.4	24.3	15.1	5.1	7.9	4.7	2.8	11.8	7.6	7.8	5.0	5.5	5.5	3.7	3.9	2.3	9.2	13.0	15.0	4.7	6.8	4.5	3.0	10.9	6.1	8.1	3.1	4.4	18.9	6.4	11.7	8.2	0.5	13.5	14.6	1.5	10.2	16.7	4.8	12.2	14.2	10.1	2.7	5.5	10.8	9.2	2.8	15.1	7.4	2.3	23.7	6.8	13.3	3.4	3.4	10.5	2.4	11.2	30.2	8.5	4.5	4.8	3.0	5.6	5.9	5.6	6.5	5.8	1.5	7.9	6.2	3.9	29.5	5.8	5.1	1.6	6.4	6.4	11.4	16.3	10.8	7.2	9.4	18.1	15.1	10.5	0.2	24.3	8.4	11.7	6.4	5.1	7.9	10.8	5.4	9.1	7.1	6.0	5.7	6.1	6.3	5.6	17.9	10.4	9.1	30.1	29.2	10.8	17.3	10.2	12.0	18.2	45.4	7.9	18.7	135.9	25.4	7.3	16.5	7.1	0.0	7.2	20.5	12.8	27.2	3.5	21.5	10.0	7.9	18.6	7.4	5.9	4.0	45.8	4.9	20.3	14.4	6.8	10.4	12.7	5.9	32.9	52.2	15.8	12.9	24.0	17.5	9.1	23.2	13.6	4.3	10.0	16.1
LRRN3	"FIGLER5, FLJ11129, NLRR3"	ENSG00000173114	"Leucine rich repeat neuronal 3"	Q9H3W5	7	111091006-111125454	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 26.5;brain: 23.8"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 33.5;Leydig cells: 52.0;Peritubular cells: 15.2"	"Group enriched"	"Detected in many"	7	"glioma: 17.5;thyroid cancer: 4.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"naive CD4 T-cell: 20.3;naive CD8 T-cell: 18.4"	"Lineage enriched"	"Detected in single"	98	"T-cells: 20.3"	"Cell line enhanced"	"Detected in some"		"AF22: 14.7;BJ: 8.3;BJ hTERT+: 18.2;GAMG: 9.3;SH-SY5Y: 26.4;SuSa: 8.5;T-47d: 14.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043820, HPA046792"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043820: AB_2678687, HPA046792: AB_2679810"	"unprognostic (4.93e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.23e-2)"	7.8	26.5	12.7	1.6	21.2	1.1	2.1	20.0	23.8	3.6	1.4	1.9	0.8	1.0	1.0	3.1	1.9	1.3	1.6	9.0	10.4	10.7	0.9	2.7	8.7	3.6	7.7	13.0	7.9	1.5	0.7	4.9	6.7	9.0	4.7	1.6	0.8	1.9	6.4	4.0	0.8	2.1	1.0	2.9	2.0	0.9	16.4	6.3	8.8	22.3	0.0	4.4	1.6	1.3	0.2	0.0	0.1	0.0	0.0	20.3	4.0	0.0	0.0	14.7	1.8	6.8	2.9	0.0	8.3	18.2	0.8	0.7	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.9	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.2	0.1	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	26.4	0.0	0.0	0.0	8.5	14.4	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.6	1.2	0.0	0.0	20.3	18.4	0.1	0.0	0.0	0.0	0.2	4.0	12.7	21.2	20.0	23.8	10.4	10.7	7.7	13.0	9.0	6.3	0.0	7.0	0.0	0.0	0.0	33.5	12.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.3	9.6	0.0	1.1	0.0	0.7	3.2	1.7	1.3	0.0	3.4	52.0	0.0	1.7	0.0	0.0	10.8	0.0	0.0	15.2	0.0	3.9	0.0	1.2	0.9	0.5	0.1	0.3	3.2	0.0	0.1
DOCK4	"FLJ34238, KIAA0716"	ENSG00000128512	"Dedicator of cytokinesis 4"	Q8N1I0	7	111726110-112206411	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 44.7;Horizontal cells: 89.0;Ito cells: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 6.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.4"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 19.2;HUVEC TERT2: 36.4;TIME: 31.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071516			Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Nucleoli, Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA071516: AB_2686407"	"unprognostic (1.37e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.48e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.48e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	10.7	6.5	16.5	10.0	28.2	2.3	6.8	11.7	28.2	9.1	4.4	21.0	2.0	2.8	7.9	4.4	4.4	8.7	7.9	6.9	22.2	10.1	7.3	13.9	25.5	3.7	18.2	12.4	14.2	5.0	4.7	4.0	10.8	12.2	6.5	4.9	1.7	4.4	3.9	6.7	3.5	3.2	10.7	20.3	3.2	3.1	3.5	21.8	0.0	5.8	2.7	3.6	5.7	5.2	0.2	0.3	6.4	1.2	0.1	0.1	0.2	0.0	1.7	4.1	3.3	3.4	5.0	2.3	0.4	4.5	0.8	1.3	0.0	0.0	0.3	3.4	1.0	0.9	0.2	0.6	3.9	3.5	1.2	6.7	0.1	2.8	5.7	2.4	0.5	0.2	2.6	0.4	19.2	9.9	1.2	36.4	1.6	0.0	10.3	1.7	0.4	0.8	0.2	2.2	0.5	7.0	0.2	3.0	1.6	2.8	0.1	0.9	3.2	2.5	2.1	2.5	3.8	0.3	0.1	31.4	3.2	1.5	6.1	1.3	0.4	0.1	0.3	0.3	0.8	7.1	0.2	0.7	0.1	0.0	1.2	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	6.4	0.1	0.2	0.3	0.0	0.2	16.5	28.2	11.7	18.2	22.2	10.1	18.2	12.4	12.2	21.8	44.7	5.0	0.5	3.6	4.6	26.2	11.6	2.5	12.0	21.6	3.5	21.6	0.2	0.0	1.4	2.4	32.2	0.7	0.0	0.3	0.2	6.0	9.4	2.3	14.9	13.6	89.0	10.5	40.5	15.6	1.1	5.2	17.3	8.5	8.2	0.7	4.4	1.0	9.9	7.8	1.1	10.3	12.9	3.3	0.7	1.7	2.4	0.0	0.0	0.8	1.6
ZNF277	"NRIF4, ZNF277P"	ENSG00000198839	"Zinc finger protein 277"	Q9NRM2	7	112206588-112343096	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027307	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA027307: AB_1859164"	"unprognostic (2.04e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.60e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (9.47e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	15.2	14.8	11.2	12.9	16.2	10.9	20.1	9.3	13.8	13.6	13.9	8.4	8.8	13.7	14.7	8.8	18.4	12.6	14.3	14.4	11.8	9.1	22.7	30.0	19.2	14.3	11.3	11.9	15.4	23.5	13.5	16.4	8.1	11.6	17.1	14.2	5.5	14.9	12.9	12.7	17.7	13.4	15.9	16.1	13.7	14.6	10.2	14.1	23.9	22.4	11.1	15.6	26.6	13.6	13.3	10.4	9.5	14.3	12.4	17.2	9.1	5.9	6.2	8.3	10.3	13.7	38.1	6.4	5.8	12.8	4.9	10.4	5.7	9.3	13.3	11.6	6.2	11.1	5.0	5.2	10.1	11.6	7.0	8.0	5.4	6.1	12.6	13.4	10.3	7.9	21.9	18.1	9.4	12.4	19.8	16.9	14.7	9.5	14.2	9.2	9.6	14.4	20.1	4.9	7.9	6.4	8.0	9.8	13.8	14.4	6.8	6.3	12.7	7.1	13.7	14.1	13.3	5.5	11.0	10.4	6.8	4.1	17.7	5.5	10.4	8.4	13.2	5.8	10.2	7.6	7.1	11.6	9.5	11.2	14.3	15.9	13.3	15.2	17.2	10.4	11.2	16.3	13.5	9.3	12.4	11.6	10.1	17.0	9.1	11.2	16.2	9.3	13.8	11.8	9.1	11.3	11.9	11.6	14.1	35.7	18.2	13.7	16.1	18.3	10.0	11.8	22.9	10.7	18.2	5.2	2.0	10.4	23.2	20.2	37.5	16.5	11.8	0.0	27.0	13.8	12.7	16.7	7.0	17.3	19.2	30.2	17.7	10.4	39.5	4.4	15.8	26.3	11.8	36.9	21.0	5.8	24.3	21.0	23.7	25.9	11.4	19.4	13.3	20.6	7.8	21.2	11.6	28.4	22.1	18.1
IFRD1	"PC4, TIS7"	ENSG00000006652	"Interferon related developmental regulator 1"	O00458	7	112422968-112481017	"Predicted intracellular proteins, Predicted membrane proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 93.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"eosinophil: 25.6;neutrophil: 44.2"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 44.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024122, HPA072413"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"		"HPA024122: AB_1851452, HPA072413: "	"unprognostic (2.29e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.48e-2)"	"prognostic favorable (5.45e-4)"	"unprognostic (6.41e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.50e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.89e-1)"	"unprognostic (4.70e-2)"	19.5	18.0	16.7	12.9	19.6	83.1	24.0	14.3	15.7	10.7	18.3	15.6	11.7	18.7	15.7	12.5	12.7	11.4	12.7	16.0	15.2	13.3	11.9	14.1	19.2	7.9	30.9	13.2	16.9	93.0	12.5	23.1	18.7	16.9	14.7	11.7	11.2	14.3	11.0	37.6	12.3	19.0	23.9	28.2	11.7	17.7	17.9	22.0	7.5	16.5	13.5	7.4	14.7	37.5	3.8	2.9	44.2	3.2	3.4	3.7	2.6	15.0	10.1	15.7	14.8	26.9	17.5	14.6	14.9	14.3	19.3	17.4	16.7	12.7	7.3	28.5	7.7	38.4	9.0	10.9	12.6	26.4	12.4	15.5	8.2	18.8	16.0	30.8	11.1	6.5	13.3	27.0	20.4	23.4	15.5	8.0	12.6	25.0	16.5	7.8	13.6	14.1	18.7	35.8	14.0	17.8	12.3	6.3	13.6	5.8	4.2	25.3	13.1	17.0	14.5	48.1	29.7	5.6	12.0	6.9	32.9	7.0	25.6	44.9	14.8	17.5	20.0	8.9	30.9	37.6	5.7	3.2	25.6	3.6	2.8	2.8	3.8	3.5	3.4	2.9	3.0	3.4	3.3	44.2	3.4	2.8	2.1	3.7	2.6	16.7	19.6	14.3	15.7	15.2	13.3	30.9	13.2	16.9	22.0	29.8	31.8	25.5	140.2	175.3	48.0	49.5	22.9	13.4	33.0	17.4	84.4	63.5	14.9	41.7	32.2	54.5	231.2	23.3	49.6	52.8	71.4	123.0	75.8	18.7	104.1	20.6	132.5	47.9	76.5	7.5	33.9	78.9	97.8	73.1	82.8	22.6	50.8	210.5	38.5	11.0	72.9	38.8	197.8	13.7	11.5	110.2	126.9	55.4	87.9	126.0
LSMEM1	"C7orf53, FLJ39575"	ENSG00000181016	"Leucine rich single-pass membrane protein 1"	Q8N8F7	7	112480853-112491062	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"skeletal muscle: 51.3;tongue: 19.2"	"Group enriched"	"Detected in many"	6	"Early spermatids: 43.6;Late spermatids: 47.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"cerebellum: 3.6"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in many"		"HeLa: 12.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA013753, HPA047988"	Uncertain		Supported	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA013753: AB_1848926, HPA047988: AB_2680229"	"unprognostic (6.87e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.47e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.42e-2)"	1.1	0.7	0.6	0.6	0.6	0.8	0.9	3.6	0.7	0.6	0.6	0.6	0.6	1.3	0.6	1.7	0.7	0.4	0.6	2.1	0.7	0.8	1.4	3.5	1.8	0.6	0.7	0.6	0.6	2.8	0.3	0.9	0.6	0.6	0.9	0.8	0.6	1.9	0.6	51.3	0.8	0.8	0.6	0.6	1.9	0.8	1.1	0.6	0.6	0.9	19.2	1.5	0.6	0.6	0.0	0.1	2.7	0.1	0.0	0.2	2.2	0.8	1.3	0.7	2.8	2.9	3.2	0.1	1.3	0.9	0.6	0.5	2.2	1.9	1.2	1.9	0.3	1.9	0.7	0.8	1.0	1.2	0.6	0.8	0.8	12.5	2.3	1.3	1.2	0.7	2.2	3.8	0.8	0.8	2.7	0.8	1.1	0.9	2.8	0.4	1.1	1.0	3.7	0.6	1.1	0.9	0.4	0.2	0.6	2.4	1.5	2.7	1.4	2.3	1.1	1.5	3.4	0.4	0.5	0.5	2.8	1.0	0.8	1.1	0.9	1.7	1.1	0.8	0.8	0.9	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.0	2.2	0.6	0.6	3.6	0.7	0.7	0.8	0.7	0.6	0.6	0.6	0.0	3.2	0.8	2.4	4.8	2.2	7.7	5.1	1.4	2.3	1.8	2.0	1.2	0.0	0.6	43.6	2.9	7.1	0.0	0.8	0.7	2.8	7.4	0.0	1.0	3.2	0.0	2.9	1.8	2.7	47.7	0.9	1.3	1.7	2.8	4.0	0.3	1.0	4.3	0.4	0.1	3.4	0.0	6.6	0.5	0.6	4.1	1.6	0.7	3.2	2.2
TMEM168	"DKFZp564C012, FLJ13576"	ENSG00000146802	"Transmembrane protein 168"	Q9H0V1	7	112762382-112790592	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020389, HPA077143"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA020389: AB_1858101, HPA077143: "	"unprognostic (1.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.92e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.30e-3)"	"prognostic favorable (4.07e-6)"	"unprognostic (1.60e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.89e-3)"	"unprognostic (3.30e-2)"	14.4	14.9	9.0	11.4	14.6	5.6	15.4	6.9	15.7	15.7	21.2	17.9	17.6	13.2	17.4	18.3	19.1	15.0	12.1	18.9	11.8	8.2	18.8	11.8	13.5	21.3	12.6	7.8	17.5	9.9	28.2	12.7	26.3	15.5	16.6	24.3	18.4	19.6	14.5	11.0	25.5	18.4	19.7	15.7	16.4	14.3	13.9	12.4	17.8	17.5	12.6	17.4	14.7	16.9	15.4	17.9	16.5	16.9	13.7	22.4	10.0	9.2	7.9	7.4	6.7	12.8	26.2	10.5	10.4	9.8	3.9	3.4	10.0	9.9	9.9	7.0	10.2	8.9	10.1	7.5	9.0	10.2	15.5	7.7	8.4	9.8	5.7	8.6	9.5	11.0	12.7	23.5	4.5	6.7	3.7	11.4	8.0	11.5	9.1	14.1	14.9	8.2	6.0	6.0	9.8	6.1	5.5	3.7	14.4	9.8	17.8	5.6	11.0	13.6	18.6	7.9	9.5	10.4	8.5	16.2	18.9	9.6	8.7	13.3	15.6	13.2	11.2	12.2	8.4	23.7	16.5	16.9	12.5	14.2	13.7	16.9	12.4	15.3	13.8	17.9	15.4	22.4	15.5	9.4	13.7	13.5	12.2	13.7	10.0	9.0	14.6	6.9	15.7	11.8	8.2	12.6	7.8	15.5	12.4	11.9	18.2	6.4	16.7	27.6	30.5	13.7	10.2	2.7	22.7	31.4	25.5	25.1	0.0	5.4	1.5	13.4	13.1	0.0	7.8	7.0	13.4	17.7	11.5	11.1	7.7	15.9	19.8	18.4	8.9	1.5	17.0	9.4	23.6	1.8	33.2	19.0	4.6	7.0	13.8	7.1	28.6	6.5	8.5	16.2	12.1	22.7	11.9	11.4	26.4	11.9
BMT2	"C7orf60, DKFZp762M126, FLJ31818"	ENSG00000164603	"Base methyltransferase of 25S rRNA 2 homolog"	Q1RMZ1	7	112819147-112939916	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	13	"Collecting duct cells: 12.2;Extravillous trophoblasts: 24.3;Hofbauer cells: 7.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044405, HPA050733"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA044405: AB_10959783, HPA050733: AB_2681223"	"unprognostic (5.26e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.61e-5)"	"unprognostic (1.50e-3)"	"unprognostic (1.61e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.94e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.22e-2)"	"unprognostic (9.10e-2)"	9.4	7.8	15.5	8.6	14.5	8.1	11.0	27.6	17.1	11.8	11.2	5.2	11.0	5.0	13.9	8.3	13.7	8.7	9.5	22.9	13.0	12.2	10.3	4.5	8.1	9.8	9.0	7.5	11.4	7.9	11.5	18.0	12.0	10.9	11.1	8.3	6.3	9.3	15.9	7.9	9.3	6.9	13.7	11.0	11.9	6.4	14.2	9.7	13.7	10.0	5.1	10.3	14.6	11.0	3.9	5.7	12.7	5.9	5.4	7.3	2.6	4.2	3.7	9.3	8.3	12.5	14.5	2.8	4.5	20.6	8.2	12.0	2.2	3.4	1.4	5.8	8.3	9.0	2.1	4.9	6.7	13.5	4.5	5.0	7.5	2.7	2.7	5.7	2.8	7.3	10.9	5.3	6.4	5.7	10.2	6.6	2.7	2.3	2.8	9.8	3.2	6.8	8.2	2.0	3.0	3.8	3.4	12.2	4.4	6.2	5.8	3.7	9.5	8.6	3.5	4.9	9.4	1.7	2.7	4.6	10.5	2.6	6.7	3.5	3.7	3.5	2.7	11.4	4.3	6.1	8.0	5.5	9.1	4.9	5.7	6.0	3.9	4.9	5.7	5.7	3.9	6.8	5.7	12.7	5.4	5.9	3.3	7.3	2.6	15.5	14.5	27.6	17.1	13.0	12.2	9.0	7.5	10.9	9.7	6.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	6.7	3.4	12.2	0.0	5.8	0.0	2.4	0.0	0.0	0.0	0.0	2.1	24.3	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.8	0.0	0.0	3.2	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0
GPR85	SREB2	ENSG00000164604	"G protein-coupled receptor 85"	P60893	7	113078331-113087778	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"brain: 15.0;skeletal muscle: 30.4"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 34.4;Early spermatids: 106.1;Horizontal cells: 79.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"HEL: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.80e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.98e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.41e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.34e-5)"	"unprognostic (5.89e-3)"	"unprognostic (9.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-2)"	2.1	1.1	8.9	1.2	15.0	1.9	0.9	12.2	11.2	0.7	0.9	2.4	0.0	0.9	1.2	1.1	1.1	1.9	4.4	2.4	11.8	9.2	0.7	4.5	2.5	1.6	10.8	7.7	0.5	1.6	2.0	4.0	5.3	6.2	1.2	0.8	0.9	2.8	0.8	30.4	0.9	1.0	1.2	8.1	3.1	1.0	3.4	4.3	0.0	0.9	0.0	1.0	1.4	0.3	1.3	1.0	3.0	2.1	1.5	1.1	0.5	0.1	0.1	0.3	0.3	1.0	1.5	0.3	1.3	2.0	2.8	3.8	0.1	0.5	0.1	0.3	1.1	0.9	0.2	0.2	1.2	5.9	0.2	0.1	49.4	0.5	0.1	0.5	9.2	0.5	2.0	0.2	4.7	0.1	0.1	0.1	0.4	0.2	0.5	3.1	0.2	1.0	5.9	0.6	0.0	0.3	0.2	0.7	0.2	0.0	0.8	1.4	1.1	0.1	0.6	0.4	0.3	0.3	2.1	0.3	3.4	0.5	0.9	1.2	1.1	0.1	0.6	4.0	3.6	1.3	3.0	1.2	1.0	1.0	1.4	1.0	0.9	0.8	0.6	0.6	1.3	1.1	1.0	2.1	1.5	2.1	1.0	0.9	0.5	8.9	15.0	12.2	10.8	11.8	9.2	10.8	7.7	6.2	4.3	0.0	1.0	0.0	11.9	7.8	34.4	2.6	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	106.1	2.9	0.0	0.0	0.2	0.7	1.9	13.8	1.1	0.0	10.0	79.4	0.0	0.6	5.1	8.6	1.1	3.2	10.1	0.0	0.0	1.7	0.1	0.0	0.4	0.4	4.5	0.0	4.2	0.7	0.4	9.3	0.3	0.0	0.0	9.0
SMIM30	LINC00998	ENSG00000214194	"Small integral membrane protein 30"	A4D0T7	7	113116718-113118613	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 351.5;Hofbauer cells: 207.3;Proximal tubular cells: 287.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (1.25e-1)"	"unprognostic (1.73e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.44e-3)"	"unprognostic (3.89e-3)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (7.25e-2)"	"unprognostic (5.00e-3)"	"unprognostic (7.07e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (7.21e-4)"	"unprognostic (2.46e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.35e-1)"	16.1	19.7	19.0	7.8	19.8	2.8	14.2	11.8	12.6	11.6	12.6	9.2	7.7	9.3	9.3	22.1	21.2	9.2	13.9	58.3	16.8	13.7	30.4	16.4	13.6	9.8	16.8	8.5	12.6	12.0	20.2	21.7	18.6	11.6	11.8	10.7	11.2	16.5	9.5	38.1	5.8	19.2	13.9	19.3	25.3	11.2	11.6	12.3	9.8	27.7	13.9	8.8	15.6	8.8	13.1	23.4	7.5	11.1	12.5	14.3	9.8	11.1	5.6	13.6	11.8	24.7	39.3	0.0	13.5	22.4	14.5	22.8	5.8	19.6	13.3	16.9	16.8	25.5	7.1	13.3	29.8	35.6	8.8	26.5	30.4	8.3	9.6	16.5	40.7	0.1	29.5	28.8	22.3	11.5	26.9	22.7	14.3	40.0	12.6	47.0	5.7	17.3	44.6	14.0	16.9	15.5	11.1	32.7	36.3	27.9	14.7	20.5	15.0	10.2	20.5	31.3	24.7	13.9	27.3	13.0	23.7	12.0	26.7	20.0	18.8	23.1	47.8	31.0	37.5	33.1	1.3	10.2	7.5	11.1	11.1	12.2	13.1	12.7	11.5	16.1	11.3	12.2	12.1	0.4	12.5	8.8	23.4	14.3	9.8	19.0	19.8	11.8	12.6	16.8	13.7	16.8	8.5	11.6	12.3	47.6	55.1	0.0	0.0	0.0	0.0	0.0	0.0	60.2	60.3	120.4	0.0	70.2	351.5	92.2	0.0	0.0	0.0	0.0	61.5	59.6	0.0	0.0	30.2	0.0	207.3	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	77.5	0.0	0.0	75.7	0.0	0.0	287.3	0.0	0.0	0.0	0.0	0.0	0.0	34.8	0.0	0.0	0.0
PPP1R3A	"GM, PPP1R3"	ENSG00000154415	"Protein phosphatase 1 regulatory subunit 3A"	Q16821	7	113876777-114075920	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Glycogen metabolism"		"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"heart muscle: 24.1;skeletal muscle: 69.4;tongue: 75.4"	"Cell type enriched"	"Detected in some"	13	"Cardiomyocytes: 136.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	64	"THP-1: 18.1"	"Region enriched"	"Detected in single"	19	"thalamus: 1.2"	"Not detected"	"Not detected"			"HPA070440, HPA073138"	Enhanced					NA	NA					"HPA070440: , HPA073138: "						"unprognostic (8.96e-3)"												1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.7	0.0	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	1.4	0.0	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	75.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	136.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0
FOXP2	"CAGH44, SPCH1, TNRC10"	ENSG00000128573	"Forkhead box P2"	O15409	7	114086327-114693772	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 48.4;urinary bladder: 31.5"	"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 27.2;Muller glia cells: 42.1;Suprabasal keratinocytes: 22.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 15.0;RH-30: 27.6;THP-1: 8.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000382, HPA000383, HPA001679"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000382: AB_1078908, HPA000383: AB_1078909, HPA001679: AB_2666415"	"unprognostic (1.21e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.83e-3)"	"unprognostic (4.66e-1)"	"unprognostic (3.69e-4)"	"unprognostic (2.04e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.70e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.04e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.84e-1)"	"unprognostic (9.81e-2)"	"unprognostic (4.19e-2)"	1.7	1.5	0.9	9.4	2.9	0.0	2.0	0.6	2.8	9.4	20.4	0.7	3.6	2.7	18.1	2.1	12.4	3.5	7.7	1.2	0.7	2.9	1.5	2.9	1.4	0.6	2.0	1.0	11.1	4.5	0.0	0.9	0.7	1.8	13.3	5.7	1.4	2.8	1.5	4.6	3.3	4.2	48.4	0.9	0.6	4.6	0.9	0.9	0.6	5.3	3.2	1.2	31.5	5.4	9.4	16.5	11.1	7.2	6.3	10.3	16.3	0.2	2.2	15.0	0.0	3.5	4.7	0.9	2.4	2.6	0.5	0.3	1.0	0.2	0.2	0.6	0.8	0.1	0.3	0.6	0.0	0.1	0.1	5.1	5.6	3.4	4.6	0.0	0.3	0.3	1.2	0.6	0.0	0.0	0.9	0.6	0.0	1.2	2.1	0.5	1.1	1.2	0.8	0.8	0.2	0.7	0.4	27.6	5.3	0.3	6.0	3.9	1.6	0.0	0.9	0.7	1.0	0.7	8.2	1.1	1.0	0.4	1.4	0.4	5.4	0.4	0.6	1.1	0.5	0.4	7.5	5.2	11.1	6.2	7.2	6.3	9.4	7.0	6.8	6.8	7.3	7.2	8.1	5.6	6.3	5.9	16.5	10.3	16.3	0.9	2.9	0.6	2.7	0.7	2.9	2.0	1.0	1.8	0.9	0.0	5.1	0.0	1.7	27.2	0.0	1.4	7.6	12.0	7.9	3.5	2.0	0.1	0.0	0.0	8.1	2.2	4.3	0.0	4.8	0.0	7.2	3.1	0.0	10.6	0.2	12.7	4.1	9.8	1.9	4.5	4.9	0.7	3.3	0.0	11.9	42.1	2.0	16.1	0.7	2.2	1.0	0.0	1.0	0.1	0.2	22.3	0.2	0.0	12.1	2.4
MDFIC	"HIC, MDFIC1"	ENSG00000135272	"MyoD family inhibitor domain containing"	Q9P1T7	7	114922154-115019202	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Muller glia cells: 111.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA030716	Approved		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA030716: AB_10671364"	"unprognostic (1.24e-3)"	"unprognostic (4.15e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.02e-2)"	"unprognostic (6.38e-3)"	"unprognostic (3.68e-2)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (6.13e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.55e-1)"	39.4	21.1	4.6	29.3	4.6	5.1	62.4	2.5	4.0	18.4	15.5	5.1	13.9	3.7	22.8	8.8	18.2	7.7	9.7	15.9	4.4	4.7	8.3	8.6	17.5	48.0	4.7	4.1	11.2	5.9	15.2	6.6	11.2	13.6	11.9	5.8	11.2	14.4	19.4	13.7	8.1	9.4	16.7	13.7	28.3	6.6	4.0	3.4	17.8	16.1	11.2	24.1	18.0	25.4	3.6	8.1	1.1	2.5	2.7	6.9	1.2	0.0	4.8	6.4	0.0	13.7	19.0	2.7	24.4	29.4	5.6	7.1	0.1	14.5	3.4	0.3	16.0	9.0	2.8	2.0	4.2	9.7	12.0	5.7	0.0	6.0	0.0	7.0	7.4	5.0	15.8	4.1	12.7	4.0	14.4	3.7	3.3	0.0	23.6	19.0	0.0	0.0	0.6	5.2	0.3	5.5	0.0	18.9	7.3	5.7	5.9	0.2	0.0	10.6	10.0	11.0	9.2	3.1	6.7	10.4	20.9	5.9	38.6	11.7	9.6	0.0	0.0	14.6	0.0	17.8	0.2	1.5	1.1	3.0	1.9	4.6	3.6	6.9	6.4	2.4	3.2	4.0	3.4	0.1	2.7	2.5	8.1	5.6	1.2	4.6	4.6	2.5	4.0	4.4	4.7	4.7	4.1	13.6	3.4	14.9	25.0	24.0	5.8	8.4	0.5	23.2	10.2	20.1	17.0	14.0	0.0	6.9	8.3	2.0	1.3	27.3	0.0	0.0	2.5	4.5	13.4	6.6	2.3	13.9	22.0	0.0	0.0	48.5	50.6	0.9	4.0	28.8	35.4	5.4	2.1	111.3	6.0	2.0	2.5	4.1	3.4	6.5	8.3	0.0	0.5	12.0	3.1	40.1	4.2	6.4
TFEC	"bHLHe34, TCFEC, TFECL"	ENSG00000105967	"Transcription factor EC"	O14948	7	115935148-116159896	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 22.6"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 40.9;Kupffer cells: 42.8;Macrophages: 48.6;Proximal tubular cells: 52.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 8.7;myeloid DC: 7.7"	"Group enriched"	"Detected in many"	32	"B-cells: 4.9;dendritic cells: 7.7;monocytes: 8.7"	"Cell line enhanced"	"Detected in some"		"HEL: 12.3;HUVEC TERT2: 8.6;THP-1: 16.3;TIME: 9.6;U-937: 18.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB032260, HPA063577"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB032260: AB_2202845, HPA063577: AB_2685047"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.60e-2)"	11.2	3.5	5.8	15.4	9.2	12.3	7.6	0.8	4.6	1.8	3.7	1.4	0.6	3.4	1.6	6.1	2.4	2.6	4.2	2.5	6.0	2.1	22.6	2.8	15.7	17.0	13.0	2.2	1.6	1.8	0.4	1.8	3.9	8.8	1.9	3.6	0.8	3.1	0.7	1.2	1.3	11.6	2.6	15.2	16.4	2.3	1.7	9.4	1.6	2.1	1.1	10.0	3.8	1.7	4.9	7.7	0.2	8.7	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.8	0.0	1.3	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	16.3	9.6	1.7	0.1	1.0	0.0	4.3	0.0	0.0	0.0	18.5	0.9	0.0	8.7	0.0	0.0	3.7	0.0	4.9	0.0	0.0	7.7	2.1	0.0	0.0	0.2	0.0	0.5	3.9	0.0	1.7	5.8	9.2	0.8	4.6	6.0	2.1	13.0	2.2	8.8	9.4	0.0	2.1	5.0	0.0	0.5	0.0	0.7	2.5	0.0	0.0	3.5	0.0	0.1	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.2	0.3	0.0	2.3	0.0	40.9	0.0	0.0	0.0	42.8	2.7	0.0	48.6	0.0	8.2	0.0	0.0	0.1	0.0	0.0	52.2	0.0	0.0	0.0	0.2	0.4	0.4	0.7	0.0	0.0	0.0
TES	"DKFZP586B2022, TESS-2, TESTIN"	ENSG00000135269	"Testin LIM domain protein"	Q9UGI8	7	116210493-116258783	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 226.3;Early spermatids: 327.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 51.4;hTCEpi: 58.1;SK-BR-3: 58.3"					"Low region specificity"	"Detected in single"			"HPA015269, HPA018123"	Approved		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites,Cytosol"		NA	NA			"Focal adhesion sites, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA015269: AB_1857899, HPA018123: AB_1857900"	"unprognostic (9.81e-2)"	"unprognostic (5.53e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.01e-1)"	"unprognostic (6.08e-3)"	"unprognostic (1.84e-3)"	"unprognostic (4.81e-3)"	"unprognostic (8.81e-3)"	"unprognostic (6.19e-3)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.60e-2)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.86e-1)"	12.1	2.9	1.2	36.4	1.5	8.6	22.1	0.8	1.2	42.4	53.1	1.5	43.9	9.3	47.6	21.2	22.6	19.5	15.3	7.9	1.6	1.4	14.3	4.6	16.8	20.3	1.9	0.7	17.1	12.3	3.1	4.2	21.2	3.3	26.1	16.8	5.0	19.0	50.9	5.2	9.1	27.4	84.5	3.0	19.1	25.2	18.4	0.7	17.1	26.3	11.2	18.4	71.6	33.9	26.8	21.9	56.8	39.6	49.0	40.5	34.7	24.4	5.2	5.9	0.0	2.6	6.7	13.8	12.8	6.2	2.4	2.3	12.9	27.3	0.0	51.4	8.9	0.3	25.2	3.1	18.8	5.9	12.1	10.1	2.4	12.1	6.3	15.7	11.1	0.0	14.9	58.1	8.3	21.1	16.6	6.7	0.0	2.5	8.6	0.6	5.0	0.0	0.1	3.9	28.4	14.9	0.0	0.0	9.6	24.2	9.4	2.7	25.5	18.7	58.3	14.1	17.9	0.0	4.5	11.3	0.1	0.3	18.9	0.1	20.5	9.9	0.2	1.6	5.7	19.4	56.8	20.2	53.4	40.5	32.6	39.0	26.8	31.0	36.6	21.9	23.8	31.0	35.0	10.5	49.0	39.6	5.4	31.5	34.7	1.2	1.5	0.8	1.2	1.6	1.4	1.9	0.7	3.3	0.7	226.3	36.4	52.3	147.2	177.9	2.3	14.5	38.2	84.3	97.8	34.9	11.8	16.7	18.3	104.8	327.4	24.0	101.5	0.0	97.9	69.1	27.0	83.0	17.4	9.9	14.9	1.6	48.4	15.4	52.9	82.2	1.7	62.3	27.0	36.1	57.8	23.0	142.2	58.6	0.4	10.3	12.6	6.5	20.6	18.2	9.7	107.3	24.4	57.4	44.4	125.3
CAV2	CAV	ENSG00000105971	"Caveolin 2"	P51636	7	116287380-116508541	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 824.8;Basal keratinocytes: 429.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	82	"basophil: 31.8"	"Lineage enriched"	"Detected in single"	318	"granulocytes: 31.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 48.8;HBEC3-KT: 55.8;LHCN-M2: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013488, HPA044810"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"CAB013488: AB_2533493, HPA044810: AB_2679098"	"unprognostic (4.76e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.56e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.09e-3)"	"prognostic unfavorable (5.80e-5)"	"unprognostic (3.66e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.81e-1)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (6.32e-2)"	"unprognostic (3.44e-3)"	"unprognostic (7.84e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.34e-3)"	61.9	4.5	3.0	9.5	6.6	0.2	39.9	1.0	3.7	26.3	15.7	3.1	10.3	3.3	23.4	19.6	25.2	10.8	31.3	54.6	4.4	3.1	9.5	17.4	59.4	6.0	7.5	3.8	17.7	16.0	1.4	2.8	35.2	4.6	20.6	5.0	12.1	10.7	10.5	15.3	13.3	8.3	34.0	8.6	25.3	8.9	12.1	5.3	1.7	61.2	23.2	4.9	29.5	15.4	0.0	0.0	31.8	0.0	0.0	0.0	0.2	39.3	10.7	0.5	0.0	18.2	19.6	0.8	27.5	32.8	9.1	8.2	2.0	48.8	0.0	33.0	28.2	29.4	38.2	0.5	55.8	13.2	0.0	2.6	0.3	8.2	0.0	11.2	0.0	0.1	11.5	32.2	12.3	25.5	14.6	29.4	0.0	1.9	1.6	60.2	2.1	0.0	0.0	0.5	1.3	6.9	0.4	13.4	0.5	33.5	1.2	0.0	0.0	21.0	0.7	5.1	5.9	0.0	0.2	41.9	0.0	5.8	18.2	9.0	1.7	0.0	0.1	3.7	0.0	19.7	31.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	3.0	6.6	1.0	3.7	4.4	3.1	7.5	3.8	4.6	5.3	824.8	93.2	3.0	234.5	429.9	3.3	197.7	119.8	33.5	164.9	38.4	3.9	12.5	29.9	203.4	19.4	231.9	2.4	0.0	87.5	115.4	81.9	72.8	2.3	42.7	4.3	0.0	1.7	104.3	4.7	13.0	87.5	7.4	138.3	3.6	4.7	140.5	278.7	0.0	182.5	2.2	6.0	187.5	172.0	2.3	1.3	246.5	10.4	2.5	5.1	133.6
CAV1	CAV	ENSG00000105974	"Caveolin 1"	Q03135	7	116524785-116561184	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"Cancer-related genes, Congenital generalized lipodystrophy, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	15	"Alveolar cells type 1: 3305.3;Basal keratinocytes: 1221.7;Endothelial cells: 1019.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 10.6;memory B-cell: 6.0"	"Group enriched"	"Detected in many"	37	"B-cells: 6.0;granulocytes: 10.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 145.0;BJ hTERT+: 152.8;HBEC3-KT: 148.8;LHCN-M2: 155.1;U-138 MG: 123.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003791, HPA049326"	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB003791: AB_562068, HPA049326: AB_2680714"	"unprognostic (5.98e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.35e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.35e-3)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (7.17e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.79e-3)"	"unprognostic (7.92e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.65e-3)"	"unprognostic (2.72e-1)"	"unprognostic (7.40e-2)"	"unprognostic (6.14e-3)"	143.9	2.3	2.4	27.5	5.9	0.0	70.5	1.0	3.8	73.8	57.4	2.6	32.3	4.3	84.6	40.9	51.1	31.4	42.0	60.2	2.7	2.3	5.7	4.2	132.7	8.6	7.9	4.5	26.6	3.8	2.0	1.9	92.0	4.2	42.3	13.7	13.6	12.8	26.5	33.3	21.7	18.6	104.0	5.5	28.6	30.1	21.5	5.2	2.8	92.1	34.7	6.6	85.9	33.7	6.0	0.1	10.6	0.0	0.0	0.2	1.1	27.9	22.9	0.6	0.2	94.7	145.0	1.3	66.8	152.8	36.9	38.9	0.1	41.7	0.0	23.6	78.5	32.5	52.9	0.1	148.8	56.2	1.8	1.2	0.0	9.0	0.0	13.1	0.0	0.1	49.4	31.6	53.9	35.7	35.6	111.1	0.0	0.0	1.5	155.1	2.9	0.0	0.0	2.1	0.0	11.0	0.3	1.5	15.9	20.9	0.1	0.0	0.0	20.5	1.3	3.2	9.6	0.1	0.2	85.3	123.8	14.2	47.2	18.4	6.3	0.9	0.1	49.9	0.0	44.7	10.6	0.0	0.0	0.0	0.0	0.0	6.0	0.2	0.1	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.1	2.4	5.9	1.0	3.8	2.7	2.3	7.9	4.5	4.2	5.2	3305.3	101.8	0.8	331.2	1221.7	5.1	274.0	73.9	30.8	542.6	7.0	2.0	44.7	5.0	68.5	1.7	1019.9	0.4	23.3	0.6	374.1	329.7	54.2	12.8	3.4	12.7	0.0	1.7	373.8	14.3	5.0	349.2	22.2	416.7	6.4	0.1	209.8	27.0	0.0	531.4	0.0	4.5	549.7	544.6	1.9	4.9	534.0	97.8	6.4	0.4	74.0
MET	"DFNB97, HGFR, RCCP2"	ENSG00000105976	"MET proto-oncogene, receptor tyrosine kinase"	P08581	7	116672390-116798386	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 78.1;Club cells: 116.0;Urothelial cells: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 45.3;CAPAN-2: 49.5"	"Group enriched"	"Detected in many"	5	"amygdala: 3.5;basal ganglia: 9.9;cerebral cortex: 7.6;hippocampal formation: 8.0;olfactory region: 9.1"	"Low region specificity"	"Detected in many"			"CAB005282, CAB018577, HPA055607"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	179000000	70000000	"Plasma membrane, Cytosol"		"CAB005282: AB_631940, CAB018577: AB_649068, HPA055607: AB_2682860"	"unprognostic (1.60e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (1.68e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.21e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.20e-1)"	16.2	1.1	1.8	4.5	2.3	4.3	11.2	0.9	15.2	9.9	6.5	2.4	2.4	4.4	7.5	5.2	5.1	4.6	12.3	5.4	5.7	1.8	20.1	30.2	15.6	1.4	3.6	2.1	2.0	9.3	0.7	8.1	24.4	2.6	8.0	6.6	34.1	12.2	8.4	12.8	7.2	8.6	4.0	2.3	5.7	10.6	2.7	2.4	0.5	21.4	7.0	2.1	10.1	15.0	0.2	0.3	1.2	0.2	0.3	0.4	0.0	45.3	26.1	0.0	0.1	2.0	2.0	1.8	25.9	10.5	14.0	11.8	5.4	49.5	2.0	43.2	16.2	37.7	12.0	4.4	24.7	28.6	0.1	5.6	0.0	27.1	4.7	0.3	0.0	0.0	2.6	9.8	9.1	30.0	25.3	9.6	0.0	0.9	0.2	25.9	1.0	0.0	0.0	3.9	7.2	26.6	0.0	22.0	0.0	24.5	5.2	3.8	0.0	10.6	3.4	10.1	4.7	0.0	0.2	17.6	20.9	7.4	11.0	20.0	0.5	4.0	0.2	22.9	0.0	2.9	1.1	0.2	0.4	0.4	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	1.2	0.3	0.1	0.3	0.1	0.0	1.8	2.3	0.9	15.2	5.7	1.8	3.6	2.1	2.6	2.4	26.8	78.1	2.4	56.1	34.7	0.9	10.0	15.3	22.7	116.0	29.6	0.0	57.9	0.0	28.0	0.0	11.7	11.2	0.0	39.8	5.0	4.0	55.8	0.0	26.0	6.1	0.0	6.9	1.3	1.0	0.0	0.6	2.0	3.3	1.8	19.7	7.4	69.4	7.0	0.0	13.5	0.3	0.0	2.3	0.0	0.6	15.6	18.2	0.0	12.7	88.5
CAPZA2	"CAPPA2, CAPZ"	ENSG00000198898	"Capping actin protein of muscle Z-line alpha subunit 2"	P47755	7	116811070-116922049	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA007470, HPA007643"	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"		No	No		19000000	"Endoplasmic reticulum"	Cytosol	"HPA007470: AB_1845985, HPA007643: AB_2667886"	"unprognostic (1.37e-2)"	"unprognostic (2.25e-3)"	"unprognostic (4.16e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.63e-3)"	"prognostic unfavorable (9.34e-5)"	"unprognostic (1.90e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.65e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.91e-3)"	"unprognostic (6.58e-2)"	32.4	17.7	23.6	15.8	22.6	33.6	18.5	17.6	30.2	17.7	26.3	10.7	13.5	16.9	20.6	16.4	25.9	14.9	17.6	36.4	26.7	20.6	40.9	29.2	23.2	16.6	22.1	15.9	17.3	13.8	12.9	16.4	26.1	27.1	21.8	20.6	11.8	14.4	18.3	47.1	11.6	30.6	30.3	19.6	26.0	17.8	12.4	13.7	17.7	24.5	21.0	14.0	31.5	15.0	6.6	14.8	32.0	22.8	7.1	7.8	17.7	13.1	8.9	8.7	11.3	16.6	17.6	4.8	13.1	18.4	13.1	15.0	6.5	16.9	9.0	21.4	18.4	16.8	8.2	8.9	10.7	20.4	9.7	7.1	13.5	8.9	10.8	10.2	8.9	18.2	14.1	12.0	10.7	10.1	15.9	27.6	5.7	8.9	15.6	25.7	6.4	11.6	15.1	12.8	13.5	7.8	8.3	11.7	17.7	30.5	11.2	9.2	10.5	12.1	45.7	12.4	11.5	6.4	10.4	10.2	21.1	6.7	16.6	12.2	12.3	9.0	17.1	12.5	12.7	14.9	19.9	16.4	19.2	5.5	20.1	6.1	6.6	6.5	5.7	14.8	6.0	6.4	6.5	32.0	7.1	22.8	8.2	7.8	17.7	23.6	22.6	17.6	30.2	26.7	20.6	22.1	15.9	27.1	13.7	68.5	67.4	96.3	183.9	215.9	99.6	196.7	68.8	42.8	60.3	162.3	25.5	129.4	437.7	161.9	6.6	193.4	141.9	93.5	141.3	163.7	177.2	113.8	124.6	101.1	274.2	101.7	116.2	221.6	215.0	12.9	69.0	242.4	172.1	184.0	86.3	127.8	150.8	154.3	104.3	362.3	90.2	90.5	201.3	35.1	43.4	191.2	120.5	90.6	83.0	173.2
ST7	"ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, TSG7"	ENSG00000004866	"Suppression of tumorigenicity 7"	Q9NRC1	7	116953238-117230103	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 107.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038325, HPA038326"	Approved		Supported	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA038325: AB_10671740, HPA038326: AB_10672644"	"unprognostic (3.40e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.18e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-2)"	"prognostic favorable (3.39e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.40e-2)"	11.1	20.0	12.9	5.0	18.0	12.0	12.3	63.0	25.7	16.7	10.7	9.2	21.6	9.8	12.3	31.2	8.5	15.8	10.0	19.8	10.9	12.3	23.1	31.5	20.0	5.4	11.1	18.7	15.9	30.8	17.6	30.1	21.8	14.9	11.7	10.1	11.0	24.9	19.3	10.1	9.7	9.7	11.3	8.1	9.1	13.5	15.9	8.2	2.9	23.8	7.6	7.0	10.0	9.8	2.6	6.2	1.6	3.3	7.6	10.6	3.2	13.1	7.6	12.4	10.8	14.4	9.9	5.7	10.4	13.2	10.7	16.0	10.2	15.6	3.4	11.4	9.1	16.3	10.8	10.6	11.1	14.6	4.6	15.3	10.3	12.7	9.0	10.0	11.6	17.7	7.6	11.3	13.9	9.7	10.5	11.2	2.3	15.2	24.8	10.1	7.6	0.1	8.9	12.0	17.0	9.1	2.9	8.4	14.5	11.5	7.0	18.6	15.2	11.8	52.1	13.8	10.0	4.5	9.6	8.5	12.6	5.0	13.6	10.2	15.7	11.9	13.0	10.2	10.4	12.6	1.6	3.3	0.4	8.3	1.2	5.9	2.6	5.1	7.3	6.2	0.9	3.5	3.6	0.1	7.6	1.2	6.2	10.6	3.2	12.9	18.0	63.0	25.7	10.9	12.3	11.1	18.7	14.9	8.2	20.8	30.2	7.2	7.2	6.6	10.2	10.1	12.7	4.0	12.5	5.2	0.0	17.1	5.0	5.8	107.8	6.7	2.6	0.0	11.6	18.9	8.8	8.0	18.5	22.6	7.9	3.2	3.5	6.2	13.0	35.2	10.3	5.8	6.8	9.0	5.9	11.8	8.4	3.4	5.6	14.6	0.6	0.0	6.1	14.0	5.6	4.8	17.7	3.1	3.9	7.8
WNT2	"INT1L1, IRP"	ENSG00000105989	"Wnt family member 2"	P09544	7	117276631-117323289	"Cancer-related genes, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 10.4;lung: 10.9;placenta: 40.9"	"Cell type enhanced"	"Detected in some"	15	"Early spermatids: 24.8;Fibroblasts: 9.4;Hofbauer cells: 6.8;Ito cells: 11.1;Late spermatids: 7.0;Syncytiotrophoblasts: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-2197: 21.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 12.6"	"Low region specificity"	"Detected in all"			HPA020920			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA020920: AB_1858850"	"unprognostic (1.90e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.11e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.43e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.10e-1)"	1.8	0.0	0.2	0.1	1.1	0.0	1.4	0.3	2.3	3.0	0.2	0.4	0.4	0.0	10.4	2.7	0.4	1.0	0.2	0.7	0.9	0.9	0.3	0.8	10.9	0.0	0.1	0.5	0.8	0.1	0.0	0.2	40.9	0.5	7.6	0.0	0.9	0.1	0.5	0.0	1.1	0.2	1.2	0.2	1.5	0.1	0.7	0.0	0.0	0.2	0.0	0.1	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.4	2.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.3	2.3	0.9	0.9	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	2.3	0.0	0.0	3.8	0.0	0.0	24.8	0.4	0.0	0.0	0.0	2.9	9.4	0.2	0.0	0.0	6.8	0.0	0.0	11.1	1.0	7.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.3	1.6	0.1	2.4	7.6	0.0	0.0	0.1
ASZ1	"ALP1, ANKL1, C7orf7, CT1.19, GASZ, Orf3"	ENSG00000154438	"Ankyrin repeat, SAM and basic leucine zipper domain containing 1"	Q8WWH4	7	117363222-117428123	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"testis: 15.7"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 87.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"Daudi: 4.0;U-266/70: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020558	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA020558: AB_1845123"								"unprognostic (4.30e-1)"				"unprognostic (1.87e-1)"			"unprognostic (1.42e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	0.0	87.1	20.1	0.0	0.0	0.0	0.0	0.1
CFTR	"ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR"	ENSG00000001626	"Cystic fibrosis transmembrane conductance regulator"	P13569	7	117465784-117715971	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Isomerase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"pancreas: 103.0"	"Cell type enriched"	"Detected in many"	5	"Ductal cells: 325.5"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.9;pancreatic cancer: 28.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"CACO-2: 12.8;MOLT-4: 48.1;U-266/70: 26.3"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"olfactory region: 6.3"	"CAB001951, HPA021939, HPA079652"	Enhanced					NA	NA					"CAB001951: , HPA021939: AB_1846578, HPA079652: "	"unprognostic (6.38e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.44e-2)"	"unprognostic (8.74e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (9.44e-4)"	"unprognostic (3.20e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.64e-2)"	0.4	0.2	0.4	10.5	0.4	0.0	0.3	0.3	0.3	2.5	19.8	0.1	0.8	10.5	0.6	2.1	0.4	0.4	15.8	0.3	0.4	0.3	1.1	1.4	5.7	0.1	0.5	0.1	0.3	103.0	0.0	0.3	0.1	0.1	1.5	12.5	0.1	22.4	0.1	0.3	1.1	24.2	0.3	0.7	0.3	0.6	0.9	0.1	0.1	0.3	0.2	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.1	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.3	0.4	0.3	0.5	0.1	0.1	0.1	6.0	48.7	0.0	1.7	0.0	0.4	1.2	43.3	9.4	23.9	0.0	0.0	0.0	0.0	325.5	2.9	0.0	19.4	0.0	3.7	0.0	0.1	3.6	1.1	0.2	0.0	0.0	6.9	0.0	0.0	1.6	0.3	0.0	0.0	11.8	11.5	0.6	21.5	37.7	0.0	0.0	0.0	0.0	0.3	1.8	0.4	0.0	0.0	0.0	64.4	3.9
CTTNBP2	"C7orf8, CORTBP2, KIAA1758, Orf4"	ENSG00000077063	"Cortactin binding protein 2"	Q8WZ74	7	117710651-117874139	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 53.0;granulocytes: 134.2;Horizontal cells: 69.9;Muller glia cells: 122.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"non-classical monocyte: 9.6"	"Lineage enriched"	"Detected in single"	22	"monocytes: 9.6"	"Group enriched"	"Detected in some"	6	"HEL: 27.5;HMC-1: 36.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009151, HPA044654"	Enhanced		Approved	"Midbody ring,Cytosol"		Yes	No			"Midbody ring, Cytosol"		"CAB009151: AB_2088281, HPA044654: AB_2679037"	"unprognostic (6.28e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.28e-4)"	"unprognostic (3.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.71e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.45e-3)"	11.2	3.9	10.7	1.8	17.6	0.7	4.7	8.3	15.5	10.7	3.9	22.1	2.0	3.3	11.4	9.4	14.0	7.2	6.6	2.4	13.5	9.1	11.5	3.8	3.2	1.0	16.2	9.9	5.4	13.1	21.9	5.8	3.4	15.5	6.6	5.0	5.0	5.2	4.0	1.1	2.5	3.3	9.5	14.3	4.2	1.8	2.2	16.8	0.0	9.8	1.7	2.1	4.8	4.9	0.0	0.4	0.0	9.6	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.6	0.1	0.3	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	3.9	0.0	0.0	0.0	1.0	27.5	0.2	0.0	0.1	0.0	36.6	0.1	0.2	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	5.1	0.0	0.1	0.0	0.0	0.1	5.2	0.0	3.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	1.2	0.5	0.0	0.0	0.3	0.0	0.0	2.4	0.0	0.5	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	10.7	17.6	8.3	15.3	13.5	9.1	16.2	9.9	15.5	16.8	3.0	4.5	0.0	3.0	1.6	26.3	2.9	10.2	1.4	6.8	7.0	53.0	2.5	1.7	4.0	1.1	8.7	0.5	0.0	3.8	1.2	2.3	1.4	134.2	1.0	7.0	69.9	1.7	26.4	7.5	2.7	0.9	6.4	6.8	1.8	0.5	122.7	0.8	2.6	1.1	14.3	3.3	0.0	3.5	0.4	0.4	0.3	0.9	0.7	6.0	1.1
LSM8	YJR022W	ENSG00000128534	"LSM8 homolog, U6 small nuclear RNA associated"	O95777	7	118184032-118192824	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020116	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA020116: AB_1853385"	"unprognostic (1.02e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (3.33e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (7.46e-6)"	"unprognostic (4.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.80e-2)"	"unprognostic (3.00e-3)"	27.5	20.8	16.8	30.8	19.7	39.7	27.1	33.1	25.9	18.5	20.1	12.8	18.8	20.6	23.0	25.4	26.2	19.3	16.2	25.1	19.1	10.1	20.2	19.9	23.1	34.1	19.8	17.2	22.9	27.0	13.2	28.3	16.8	20.1	22.3	22.8	13.6	24.5	21.2	21.4	21.9	26.2	23.6	28.3	33.8	22.3	21.0	20.2	30.0	24.6	23.2	38.2	22.1	21.6	29.8	40.6	22.0	28.2	18.2	35.3	16.2	14.7	9.8	22.5	17.1	8.2	13.3	9.2	16.1	14.0	11.1	14.5	8.0	15.5	30.6	33.6	8.3	21.6	10.5	13.5	10.4	11.8	15.8	14.5	20.4	20.6	15.9	18.3	26.5	23.6	12.0	12.7	13.6	12.7	10.8	11.3	23.2	21.2	30.5	13.8	6.7	46.8	66.8	20.4	12.9	15.0	14.8	13.3	21.2	11.6	9.9	13.4	17.1	14.3	36.4	30.8	19.4	7.6	29.7	9.3	17.8	10.1	20.9	20.0	26.1	18.5	35.4	13.1	32.5	22.7	22.0	21.0	19.1	29.0	28.2	28.1	29.8	32.2	35.3	22.4	26.5	31.2	31.7	7.0	18.2	26.6	40.6	31.4	16.2	16.8	19.7	33.1	25.9	19.1	10.1	19.8	17.2	20.1	20.2	23.8	61.2	138.3	86.7	0.0	39.3	40.2	61.1	66.9	64.8	59.3	45.2	106.7	76.3	84.3	27.9	60.3	67.5	70.0	148.8	162.8	58.6	85.5	99.3	65.7	119.9	39.7	83.0	72.4	145.9	11.0	90.0	92.8	0.0	140.7	82.5	44.7	124.3	90.0	71.5	76.7	38.2	84.1	22.3	105.0	109.7	0.0	101.0	138.4	90.9	91.2
ANKRD7	TSA806	ENSG00000106013	"Ankyrin repeat domain 7"	Q92527	7	118214669-118496171	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	58	"testis: 184.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 2368.8;Spermatocytes: 2786.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.9"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 5.2;JURKAT: 5.8;SCLC-21H: 9.8;U-266/70: 12.7;WM-115: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043489, HPA052941"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043489: AB_10959304, HPA052941: "	"unprognostic (1.29e-1)"	"unprognostic (7.22e-4)"		"unprognostic (3.13e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.49e-2)"		"unprognostic (1.69e-1)"	"unprognostic (5.51e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.57e-4)"	"unprognostic (3.32e-2)"	0.1	0.1	0.5	0.0	0.8	0.0	0.1	0.1	1.0	0.1	0.1	0.0	0.0	0.1	0.1	1.3	0.1	0.1	0.0	0.1	0.4	0.1	0.2	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.9	0.0	1.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	184.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	3.1	0.4	1.0	0.0	0.0	0.8	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	5.2	1.6	0.0	3.1	0.0	0.1	0.3	0.1	1.4	1.0	0.0	0.0	0.0	1.9	0.0	0.0	2.3	0.4	0.7	0.0	0.4	0.0	5.8	0.0	2.2	1.4	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	2.4	0.0	0.0	1.9	0.0	0.0	1.2	0.4	0.0	1.1	0.3	0.0	12.7	0.6	0.5	1.8	0.0	4.0	0.0	0.0	1.0	0.4	0.0	0.3	3.1	0.2	0.6	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.4	0.0	0.1	0.5	0.8	0.1	1.0	0.4	0.1	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.4	2.5	0.0	0.0	0.0	0.0	0.1	5.0	0.1	2368.8	0.3	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.1	3.2	0.0	0.0	0.0	635.0	36.5	0.0	1.7	0.0	0.0	1.2	0.1	0.0	27.6	1.4	0.0	25.8	0.1	2786.2	17.7	0.1	0.0	0.0	0.0	0.0
KCND2	"KIAA1044, Kv4.2, RK5"	ENSG00000184408	"Potassium voltage-gated channel subfamily D member 2"	Q9NZV8	7	120273668-120750331	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 41.1"	"Cell type enhanced"	"Detected in some"	9	"Bipolar cells: 2.9;Cholangiocytes: 5.1;Ductal cells: 2.5;Leydig cells: 3.4;Spermatocytes: 4.2;Spermatogonia: 3.3"	"Cancer enhanced"	"Detected in many"		"glioma: 6.2"	"Region enhanced"	"Detected in all"		"cerebellum: 41.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.5;HSkMC: 4.1;NTERA-2: 3.2;RT4: 3.3;SCLC-21H: 16.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029068	Enhanced					NA	NA					"HPA029068: AB_10601436"	"unprognostic (4.22e-1)"	"unprognostic (2.79e-4)"	"unprognostic (3.79e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-3)"	"unprognostic (9.07e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.77e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.51e-4)"	"unprognostic (4.07e-5)"	"unprognostic (2.71e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.83e-3)"	2.9	1.0	3.9	1.0	6.7	0.3	1.9	41.1	20.6	2.4	0.7	1.5	0.0	0.7	5.6	0.5	0.5	1.7	7.0	0.5	3.7	5.4	0.3	0.4	0.6	0.5	4.2	3.6	5.9	0.6	2.5	6.6	0.8	12.1	0.5	0.6	0.0	0.7	1.7	0.5	0.3	0.5	3.7	3.7	0.3	0.5	2.9	4.5	0.0	0.8	1.1	0.3	2.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	6.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.7	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.0	3.3	16.6	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	6.7	41.1	5.3	3.7	5.4	4.2	3.6	12.1	4.5	0.0	0.0	0.0	0.0	0.0	2.9	1.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.3	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.4	3.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.5	0.0	0.4	4.2	3.3	0.1	0.0	0.0	0.0	0.1
TSPAN12	"NET-2, TM4SF12"	ENSG00000106025	"Tetraspanin 12"	O95859	7	120787320-120858402	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Angiogenesis		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 110.2;Collecting duct cells: 97.7;Distal tubular cells: 160.8;Proximal tubular cells: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 21.2;HUVEC TERT2: 23.7;RH-30: 21.7;RPTEC TERT1: 34.7;RT4: 26.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051570, HPA058244"	Uncertain		Approved	Vesicles,Microtubules		NA	NA			Microtubules	Vesicles	"HPA051570: , HPA058244: AB_2683652"	"unprognostic (2.40e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.97e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.43e-1)"	6.8	40.9	3.1	4.3	3.9	0.0	4.5	2.2	3.3	8.1	19.3	2.1	36.8	13.5	6.1	8.7	3.6	3.7	13.6	22.2	3.2	2.7	40.7	12.6	16.9	1.6	2.7	2.3	2.5	12.8	1.1	10.3	9.9	3.3	7.9	7.1	2.9	33.7	15.1	2.3	1.2	31.0	4.1	1.8	18.4	7.6	3.0	2.2	0.5	18.7	3.5	3.2	10.4	3.3	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	6.2	0.1	1.3	0.4	6.0	0.1	0.2	0.5	2.0	1.0	1.5	0.0	4.3	0.1	0.7	0.1	3.1	0.6	0.8	0.0	21.2	1.1	6.2	0.9	3.4	0.0	1.0	0.1	0.0	0.1	0.1	0.8	23.7	0.0	0.2	0.7	2.7	0.8	0.0	0.1	9.9	4.1	3.8	0.0	21.7	0.7	34.7	26.4	5.1	3.0	0.2	0.5	0.0	8.7	3.2	0.7	1.0	5.1	1.6	0.0	2.6	6.5	0.0	0.0	0.7	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.9	2.2	3.3	3.2	2.7	2.7	2.3	3.3	2.2	110.2	36.0	1.7	16.9	2.3	0.0	56.0	43.3	9.4	29.6	97.7	0.0	34.8	160.8	6.2	0.4	28.0	15.4	0.0	6.4	39.5	5.6	12.3	2.3	28.6	3.7	0.0	9.2	8.6	0.3	1.2	3.7	1.5	5.0	0.0	22.1	0.5	4.2	26.2	0.7	93.5	0.0	0.0	13.4	0.1	6.9	1.8	20.3	0.5	26.6	20.7
ING3	"Eaf4, FLJ20089, MEAF4, p47ING3"	ENSG00000071243	"Inhibitor of growth family member 3"	Q9NXR8	7	120950749-120977216	"Disease related genes, Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004762, HPA067388, HPA067575"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA004762: , HPA067388: AB_2685831, HPA067575: AB_2685863"	"unprognostic (1.35e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.26e-2)"	"unprognostic (7.09e-3)"	"unprognostic (4.07e-2)"	"unprognostic (5.18e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.86e-1)"	"unprognostic (6.90e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.64e-2)"	9.6	9.1	7.4	8.8	9.9	57.7	9.6	21.5	13.8	9.0	9.6	5.5	11.1	7.3	11.1	9.7	8.0	9.7	7.7	7.6	7.3	7.3	8.8	8.4	12.3	11.9	7.6	12.2	11.9	12.1	7.9	17.7	13.0	11.1	9.5	10.6	6.7	10.0	11.5	7.7	6.1	12.9	11.4	8.8	16.4	10.4	8.6	9.6	19.0	12.6	10.4	11.2	8.3	8.4	15.8	15.0	32.7	19.5	18.5	16.9	9.8	9.3	2.8	12.7	7.1	4.8	3.8	4.3	6.4	5.1	9.3	10.9	3.6	10.9	15.2	2.9	5.6	9.8	4.6	12.2	5.0	10.7	10.6	21.4	11.0	10.6	2.1	6.6	21.2	13.1	2.8	2.6	8.2	5.8	4.5	14.5	9.6	24.6	24.7	8.9	3.2	17.4	12.7	15.3	5.3	5.2	8.6	9.1	12.6	9.4	9.7	11.5	12.5	6.6	13.7	6.9	8.2	3.1	8.3	5.1	9.5	3.5	20.4	11.6	11.3	7.2	22.9	4.8	14.3	7.9	22.3	19.1	16.5	13.9	19.5	13.4	14.4	14.1	12.6	15.0	15.8	14.4	13.1	32.7	18.5	19.1	11.2	16.9	9.8	7.4	9.9	21.5	13.8	7.3	7.3	7.6	12.2	11.1	9.6	17.9	13.6	22.2	20.2	6.8	20.4	12.6	7.6	13.4	7.9	7.0	3.9	33.3	18.3	10.3	4.0	18.5	17.3	23.3	15.7	21.2	19.3	14.2	33.4	11.1	15.3	25.4	11.5	19.6	26.6	3.9	12.7	19.0	15.1	15.4	14.0	17.3	12.9	14.8	9.2	9.7	17.2	19.4	22.6	15.0	13.9	9.8	38.2	21.8	12.4	13.9
CPED1	"C7orf58, FLJ21986"	ENSG00000106034	"Cadherin like and PC-esterase domain containing 1"	A4D0V7	7	120988677-121297444	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Fibroblasts: 35.2;Ito cells: 30.7;Peritubular cells: 76.7;Smooth muscle cells: 39.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 7.6;intermediate monocyte: 7.8;myeloid DC: 17.2;non-classical monocyte: 4.8;plasmacytoid DC: 10.3"	"Group enriched"	"Detected in many"	9	"dendritic cells: 17.2;monocytes: 7.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 28.7;Hep G2: 16.5;K-562: 55.7;LHCN-M2: 19.7;U-138 MG: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA012058	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012058: AB_1845761"	"unprognostic (7.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.48e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.52e-3)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (6.28e-3)"	"unprognostic (5.05e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.54e-4)"	21.6	8.3	3.2	8.0	3.7	0.1	7.8	1.1	2.7	19.4	16.3	4.1	15.0	3.7	21.8	15.7	10.5	12.2	14.4	10.3	2.9	1.7	3.9	19.4	9.0	1.5	5.1	1.9	36.8	2.0	0.4	4.5	10.6	3.1	20.7	6.7	18.5	2.8	17.1	24.4	2.9	10.6	48.9	8.7	9.9	8.6	7.1	3.8	0.2	4.9	15.9	1.4	34.3	14.6	1.0	17.2	1.4	7.8	0.0	0.1	2.1	1.9	0.0	0.1	0.0	4.7	13.8	0.1	8.1	28.7	2.8	7.7	0.2	0.1	0.3	0.1	4.3	3.2	0.1	0.1	0.0	7.4	0.1	0.3	2.2	0.1	16.5	8.2	0.0	0.0	5.6	0.0	6.6	0.1	2.2	1.4	0.0	55.7	4.2	19.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	11.3	5.5	0.0	0.2	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.2	0.8	16.8	0.4	14.0	7.7	1.8	0.0	0.2	1.9	0.0	0.8	1.4	7.6	0.0	0.0	7.8	0.1	1.0	0.0	0.0	17.2	0.3	0.0	0.0	0.3	0.0	4.8	10.3	0.0	2.1	3.2	3.7	1.1	2.7	2.9	1.7	5.1	1.9	3.1	3.8	17.9	0.3	1.3	0.5	2.7	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	3.6	0.0	0.0	0.0	1.5	35.2	0.8	0.0	20.2	3.9	3.2	0.0	30.7	11.5	0.0	19.5	25.2	3.3	1.0	0.0	21.5	0.0	0.0	76.7	0.0	0.2	0.0	39.2	0.3	0.4	1.8	0.3	0.0	0.0	1.3
WNT16		ENSG00000002745	"Wnt family member 16"	Q9UBV4	7	121325367-121341104	"Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 13.1;cervix, uterine: 19.7;ductus deferens: 11.7;skin 1: 24.4"	"Group enriched"	"Detected in some"	49	"Basal keratinocytes: 9.0;Suprabasal keratinocytes: 10.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	125	"memory B-cell: 13.1;naive B-cell: 11.8"	"Lineage enriched"	"Detected in single"	132	"B-cells: 13.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.2;HEK 293: 10.0;hTEC/SVTERT24-B: 3.0;U-2197: 4.9;U-266/70: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (6.53e-2)"	"unprognostic (3.63e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.94e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.57e-10)"	"unprognostic (5.89e-3)"	"unprognostic (2.73e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.66e-1)"	0.3	0.5	0.8	0.7	1.0	0.2	2.0	0.9	2.2	19.7	1.0	0.2	11.7	0.2	2.1	7.9	0.3	0.4	0.3	0.2	0.8	0.4	0.2	0.4	0.4	1.3	0.8	0.9	0.1	0.2	0.1	0.6	0.8	1.6	1.0	0.3	0.0	0.5	4.0	0.3	24.4	0.7	0.3	2.3	1.2	0.3	0.6	0.8	0.0	0.2	0.0	0.6	0.5	5.5	13.1	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	1.8	0.0	0.1	0.0	0.1	0.2	0.3	4.2	0.3	0.0	0.9	0.2	1.0	0.0	0.0	0.1	0.0	10.0	0.0	0.4	0.1	0.0	0.0	0.0	1.9	0.0	3.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	4.9	0.5	3.0	0.1	0.0	0.6	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	1.0	0.9	2.2	0.8	0.4	0.8	0.9	1.6	0.8	0.0	0.0	0.0	0.0	9.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.0	0.0	0.0	0.0	0.0
FAM3C	"GS3876, ILEI"	ENSG00000196937	"Family with sequence similarity 3 member C"	Q92520	7	121348851-121396364	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Urothelial cells: 398.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 13.9;naive B-cell: 11.9"	"Lineage enriched"	"Detected in many"	6	"B-cells: 13.9"	"Cell line enhanced"	"Detected in all"		"CAPAN-2: 167.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043376, HPA050548"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted in other tissues"	NA	NA		59000000	"Golgi apparatus"		"HPA043376: AB_2678452, HPA050548: AB_2681169"	"unprognostic (9.44e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.38e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.06e-2)"	18.1	18.0	38.0	13.7	29.8	3.2	16.3	26.5	46.6	38.6	27.1	8.2	12.8	65.6	20.9	23.0	15.5	14.3	13.7	24.6	23.4	20.0	24.3	20.7	15.9	15.3	20.6	42.0	15.7	35.5	20.6	15.8	21.7	30.6	12.3	21.2	11.1	20.4	13.2	9.0	14.5	60.8	16.9	14.1	16.8	21.9	9.0	12.7	6.4	42.8	11.4	16.2	17.3	15.9	13.9	1.1	0.6	0.9	2.3	1.8	0.7	16.8	4.3	8.0	8.5	13.6	22.6	7.3	18.2	8.1	5.5	7.0	3.4	167.0	16.0	8.6	9.4	15.6	11.2	4.6	10.1	11.8	1.9	9.1	4.4	2.6	3.4	9.9	7.4	8.4	22.6	6.9	7.8	7.7	14.8	9.8	3.2	2.9	20.3	43.1	2.8	2.8	5.8	14.4	5.8	6.0	4.4	8.2	6.5	34.3	9.8	5.2	5.1	5.4	22.3	9.9	17.6	3.1	4.1	23.5	14.4	4.7	31.3	12.4	19.4	8.6	6.3	15.5	7.7	25.7	0.0	0.9	0.6	1.8	0.9	1.7	13.9	0.8	1.4	0.8	11.9	1.0	0.8	0.2	2.3	0.7	1.1	0.4	0.7	38.0	29.8	26.5	46.6	23.4	20.0	20.6	42.0	30.6	12.7	8.9	32.3	73.0	174.8	63.7	109.7	59.0	40.8	38.8	47.8	52.4	21.6	74.8	51.4	169.6	2.5	40.5	66.5	23.3	169.6	170.2	99.2	134.9	19.6	32.1	40.3	42.9	50.3	46.1	27.3	4.5	88.9	38.7	94.5	40.5	46.7	50.7	269.6	77.2	90.2	60.6	51.8	71.1	82.5	23.9	18.5	58.1	100.7	42.4	72.4	398.1
PTPRZ1	"phosphacan, PTP18, PTPRZ, PTPZ, RPTPB"	ENSG00000106278	"Protein tyrosine phosphatase, receptor type Z1"	P23471	7	121873089-122062036	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 118.1"	"Cell type enhanced"	"Detected in some"	17	"Club cells: 27.3;Horizontal cells: 62.0;Muller glia cells: 107.0"	"Cancer enriched"	"Detected in many"	14	"glioma: 175.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 94.3;NTERA-2: 26.3;WM-115: 41.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015103	Enhanced		Approved	Vesicles,Cytosol	"Secreted in brain"	NA	NA		950000	Cytosol	Vesicles	"HPA015103: AB_1855946"	"unprognostic (8.49e-4)"	"unprognostic (3.96e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.17e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.72e-6)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (9.36e-4)"	2.0	2.5	33.1	2.3	44.1	1.5	4.0	15.4	118.1	2.4	2.2	19.3	0.0	1.9	1.6	2.0	7.0	1.7	1.9	2.0	39.6	15.9	1.6	1.6	2.1	1.5	18.6	17.8	2.0	3.3	1.5	1.6	1.6	67.6	2.1	2.3	0.8	2.4	2.0	1.5	19.3	1.9	2.4	76.6	2.1	9.8	1.7	23.6	0.0	1.5	1.8	3.0	2.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	5.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	1.1	0.0	0.1	0.0	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	44.1	15.4	39.6	39.6	15.9	18.6	17.8	67.6	23.6	0.0	1.0	0.0	5.6	22.3	14.1	0.8	0.0	17.4	27.3	0.0	3.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.1	1.1	1.1	0.0	0.0	0.1	62.0	0.0	0.0	0.0	0.4	0.3	0.0	18.6	0.0	0.0	107.0	0.6	0.0	0.0	0.0	6.2	0.0	0.4	0.0	0.2	18.7	0.2	0.0	0.0	7.4
AASS	"LKRSDH, LORSDH"	ENSG00000008311	"Aminoadipate-semialdehyde synthase"	Q9UDR5	7	122075647-122144280	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 98.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Group enriched"	"Detected in many"	4	"B-cells: 1.0;granulocytes: 3.5;T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 25.6;NTERA-2: 25.0;SuSa: 21.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020637, HPA020728, HPA020734"	Enhanced		Enhanced	Vesicles,Mitochondria		Yes	No		17000	Mitochondria	Vesicles	"HPA020637: AB_1844415, HPA020728: AB_1844416, HPA020734: AB_1844417"	"unprognostic (4.84e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.91e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.00e-2)"	"prognostic favorable (9.81e-4)"	"unprognostic (4.48e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.76e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.67e-1)"	13.9	9.5	7.4	4.8	11.8	1.6	11.2	2.7	9.8	16.0	8.1	12.5	8.2	2.2	16.8	11.6	6.4	14.9	6.7	12.6	8.8	3.7	14.4	35.8	9.1	3.3	15.2	5.0	36.7	10.7	14.9	10.4	7.1	9.9	9.2	3.8	9.2	5.4	10.4	11.3	4.4	5.5	9.3	12.1	5.2	9.0	5.1	13.2	0.8	7.8	8.3	3.1	11.0	9.0	1.0	0.4	3.5	0.1	0.3	1.2	0.1	0.1	0.0	15.8	25.6	13.3	8.5	6.2	4.3	4.6	4.5	6.5	7.3	0.2	0.0	0.2	3.0	5.1	2.7	18.3	8.2	6.2	0.0	6.7	5.5	3.5	4.7	10.8	0.0	1.8	7.5	0.2	5.4	5.7	12.6	10.8	7.3	1.4	10.1	3.1	0.0	0.5	0.0	25.0	0.0	1.0	8.3	8.4	0.3	2.1	1.7	1.6	0.5	1.4	0.0	2.6	21.7	0.4	0.0	4.9	8.8	2.7	4.1	4.1	2.2	1.6	0.0	3.2	0.5	3.4	3.5	0.1	0.0	0.7	0.0	0.1	0.5	0.8	0.0	0.4	1.0	1.2	0.5	0.0	0.3	0.0	0.0	0.7	0.1	7.4	11.8	2.7	7.3	8.8	3.7	15.2	5.0	9.9	13.2	8.9	28.6	1.5	8.9	5.6	6.3	8.1	7.6	0.0	7.9	14.0	15.7	9.1	0.0	1.8	9.2	9.2	1.0	0.0	1.5	2.5	9.3	5.2	3.5	98.3	1.2	11.1	2.9	19.6	1.8	5.4	17.5	1.5	11.8	0.0	2.4	8.7	2.6	2.9	23.0	7.8	2.2	19.4	21.6	6.4	1.5	4.1	4.2	2.2	1.5	3.7
FEZF1	ZNF312B	ENSG00000128610	"FEZ family zinc finger 1"	A0PJY2	7	122301394-122310691	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 16.7;testis: 11.0"	"Cell type enriched"	"Detected in single"	5	"Spermatocytes: 2.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hypothalamus: 16.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"NTERA-2: 58.8;SCLC-21H: 25.7"	"Region enriched"	"Detected in single"	11	"hypothalamus: 13.7"	"Region enriched"	"Detected in some"	9	"hypothalamus: 6.9"	"HPA064639, HPA073693"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA064639: AB_2685308, HPA073693: AB_2686626"		"unprognostic (8.48e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.17e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.64e-3)"			"unprognostic (2.54e-1)"	"unprognostic (1.34e-1)"		"unprognostic (2.96e-2)"	"unprognostic (2.55e-1)"		"unprognostic (1.48e-2)"	0.6	0.2	6.4	0.2	4.9	0.2	0.2	0.0	2.0	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.3	1.0	16.7	0.2	0.2	0.2	0.2	2.0	0.0	0.3	0.2	0.2	3.1	0.2	0.0	0.3	0.2	1.4	0.6	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.3	11.0	3.5	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	58.8	1.4	1.0	0.0	0.0	0.0	0.0	0.1	25.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.8	0.1	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	4.9	0.0	2.0	1.0	16.7	2.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0
CADPS2	CAPS2	ENSG00000081803	"Calcium dependent secretion activator 2"	Q86UW7	7	122318425-122886759	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 105.4"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 31.6;Collecting duct cells: 38.4;Muller glia cells: 28.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 105.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 20.3;Karpas-707: 26.5;OE19: 29.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 325.7"	HPA056398			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA056398: AB_2683117"	"unprognostic (1.93e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.67e-3)"	"unprognostic (8.69e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.01e-7)"	"unprognostic (9.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.45e-2)"	5.1	11.2	5.1	1.9	7.1	0.0	9.5	105.4	21.1	16.5	5.3	1.4	13.3	6.1	16.3	16.4	5.7	5.7	8.0	4.6	6.8	8.8	20.3	6.2	9.0	1.3	14.0	9.3	5.2	13.2	15.4	17.7	2.7	7.0	10.4	5.4	4.7	23.0	11.5	2.6	2.4	4.7	11.2	4.1	3.3	9.8	1.9	1.4	0.4	9.4	2.4	1.6	4.4	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	2.4	2.5	0.1	0.2	6.3	1.4	6.4	0.0	5.9	0.0	0.0	2.9	0.2	0.0	0.2	0.8	0.6	0.0	5.2	2.0	0.0	11.4	8.2	0.0	0.1	2.6	1.1	1.0	0.8	5.7	20.3	0.0	0.0	26.5	0.1	13.9	0.0	0.0	5.9	29.0	10.0	0.0	0.0	10.5	0.3	6.6	10.3	0.0	0.2	11.5	0.5	1.6	4.4	0.0	5.8	2.2	1.5	0.0	4.1	7.9	0.3	0.0	8.7	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	7.1	105.4	21.1	6.8	8.8	14.0	9.3	7.0	1.4	8.9	31.6	0.0	7.7	1.9	0.0	10.1	5.1	8.1	17.0	38.4	0.0	0.2	14.9	4.7	5.5	19.6	4.5	0.0	9.4	0.3	3.8	16.7	1.1	10.2	0.3	3.2	4.6	16.0	2.7	5.3	8.9	1.1	3.3	0.0	11.6	28.4	6.6	2.9	9.6	6.9	1.3	0.0	5.1	0.5	2.5	1.3	0.2	0.0	7.6	7.4
RNF133		ENSG00000188050	"Ring finger protein 133"	Q8WVZ7	7	122697712-122699156	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	59	"testis: 28.3"	"Group enriched"	"Detected in some"	104	"Early spermatids: 461.8;Late spermatids: 540.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.1;MCF7: 1.5;NTERA-2: 1.2;PC-3: 1.1;U-266/70: 1.1"	"Not detected"	"Not detected"													NA	NA						"unprognostic (2.82e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.87e-3)"	"unprognostic (3.56e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.02e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.61e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.6	0.3	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.9	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	4.1	0.0	1.5	0.0	0.0	1.2	0.5	1.1	0.0	0.0	0.8	0.0	0.4	0.6	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.1	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	461.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	540.3	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	4.8	1.5	0.0	0.0	0.0	0.0	0.0
RNF148	MGC35222	ENSG00000235631	"Ring finger protein 148"	Q8N7C7	7	122701664-122702967	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	54	"testis: 31.0"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 297.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 7.4;MCF7: 2.8;OE19: 1.6;RPMI-8226: 1.8;SK-BR-3: 1.6"	"Not detected"	"Not detected"													NA	NA						"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.81e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.09e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.5	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	31.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.3	0.0	0.0	7.4	0.0	2.8	0.0	0.0	1.0	1.6	0.8	0.0	0.0	1.8	0.0	0.6	0.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	1.3	0.1	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	297.0	0.0	0.0	0.0	0.9	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.8	0.0	34.3	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	0.0	0.0	6.5	0.0	1.6	1.6	0.0	0.0	0.0	0.0	0.1
TAS2R16	T2R16	ENSG00000128519	"Taste 2 receptor member 16"	Q9NYV7	7	122994704-122995700	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC13A1	"NAS1, NaSi-1"	ENSG00000081800	"Solute carrier family 13 member 1"	Q9BZW2	7	123113531-123199986	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sulfate transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"kidney: 67.5"	"Cell type enriched"	"Detected in some"	17	"Proximal tubular cells: 400.4"	"Cancer enriched"	"Detected in single"	219	"renal cancer: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.0"	"Region enriched"	"Detected in single"	5	"cerebellum: 0.9"	"Low region specificity"	"Detected in all"			"HPA053615, HPA062714"	Enhanced					NA	NA					"HPA053615: AB_2682207, HPA062714: AB_2684846"											"unprognostic (1.86e-1)"		"prognostic favorable (8.95e-5)"	"unprognostic (1.71e-1)"	"unprognostic (3.76e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	67.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	1.0	0.9	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.8	0.1	0.6	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.0	0.0	0.0	23.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	400.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IQUB	FLJ35834	ENSG00000164675	"IQ motif and ubiquitin domain containing"	Q8NA54	7	123452400-123535077	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 20.8;testis: 35.5"	"Group enriched"	"Detected in many"	7	"Ciliated cells: 91.0;Early spermatids: 206.9;Late spermatids: 121.6;Spermatocytes: 83.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 1.9;RPTEC TERT1: 7.2;T-47d: 2.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049626			Approved	"Nuclear speckles,Intermediate filaments,Cytosol"		NA	NA			"Nuclear speckles, Intermediate filaments"	Cytosol	"HPA049626: AB_2732554"	"unprognostic (8.71e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.42e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.44e-6)"	"unprognostic (2.79e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.30e-2)"	0.6	1.0	1.3	0.3	2.9	0.3	0.9	3.0	3.5	1.2	0.5	1.8	3.2	0.4	1.4	6.9	1.8	5.7	1.6	0.6	2.6	1.2	8.5	0.4	3.2	0.3	0.7	1.2	2.7	0.7	2.7	20.8	0.5	6.4	0.9	0.4	0.3	0.7	4.3	0.6	0.5	0.5	0.6	1.0	0.4	0.6	35.5	2.8	0.0	5.6	0.0	0.3	0.7	0.6	0.8	0.0	0.0	0.3	0.5	0.7	0.0	0.3	0.0	1.3	0.6	0.6	0.6	0.1	0.0	0.1	0.0	0.3	0.0	0.8	0.8	0.0	0.4	0.3	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.7	0.3	0.2	0.3	0.7	0.0	0.2	1.9	0.2	0.8	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	7.2	1.6	1.1	0.4	0.0	0.0	0.1	1.1	2.5	0.0	0.0	0.5	0.3	0.5	0.2	0.5	0.1	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.7	0.3	0.4	0.2	0.2	0.2	0.0	0.8	0.7	0.2	0.0	0.5	0.1	0.0	0.3	0.0	1.3	2.9	3.0	3.5	2.6	1.2	0.7	1.2	6.4	2.8	6.0	0.3	0.0	0.5	0.5	2.7	1.0	0.0	91.0	15.9	17.4	3.9	0.3	1.7	0.9	206.9	0.4	0.0	0.0	0.4	0.2	0.5	0.6	1.1	0.0	0.1	3.2	1.7	0.6	0.0	121.6	2.3	0.1	0.0	0.0	0.0	2.5	0.1	0.0	2.8	4.3	8.8	6.5	0.9	83.1	7.1	0.1	0.6	0.0	0.0	0.3
NDUFA5	"B13, CI-13kB, CI-13KD-B, NUFM, UQOR13"	ENSG00000128609	"NADH:ubiquinone oxidoreductase subunit A5"	Q16718	7	123536997-123558255	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 621.7;Distal tubular cells: 906.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA043175	Supported					NA	NA		69000			"HPA043175: AB_10793992"	"prognostic favorable (8.47e-5)"	"unprognostic (4.00e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.20e-2)"	"prognostic favorable (3.99e-9)"	"unprognostic (3.39e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.73e-3)"	13.9	39.9	50.4	9.5	47.5	9.5	22.1	30.3	56.3	16.9	22.2	9.9	17.9	22.3	15.7	22.7	16.5	16.5	14.7	64.9	53.9	41.5	53.6	33.6	13.4	10.7	42.6	37.8	14.3	12.2	32.5	31.0	12.7	42.1	23.4	23.7	13.4	22.3	20.6	67.2	9.1	20.7	18.4	29.3	10.6	21.6	13.2	16.0	9.7	43.1	30.4	12.7	16.8	10.8	22.9	18.2	21.3	22.3	24.2	27.0	26.4	12.1	7.0	15.8	20.1	15.7	16.5	8.2	10.4	15.2	11.8	15.8	7.1	16.5	22.2	10.9	12.8	17.9	14.3	18.4	16.3	18.4	16.1	12.6	12.5	14.0	14.6	15.8	28.8	14.2	13.5	17.0	10.1	11.0	18.1	17.1	15.0	43.6	27.8	21.0	7.2	28.0	40.0	24.1	30.0	17.8	15.5	16.7	36.2	31.3	11.2	36.1	20.4	15.0	76.3	19.4	22.2	17.6	24.5	9.9	16.0	6.2	69.5	17.5	23.5	18.0	22.8	32.6	24.3	20.4	21.3	11.7	12.8	18.7	20.0	27.0	22.9	23.8	20.7	15.2	17.7	26.0	26.2	4.0	24.2	22.3	18.2	23.7	26.4	50.4	47.5	30.3	56.3	53.9	41.5	42.6	37.8	42.1	16.0	95.3	84.9	88.1	116.9	99.9	176.7	621.7	101.9	151.3	88.7	157.1	78.5	138.8	906.9	106.8	269.2	99.3	135.7	23.3	78.8	126.5	106.9	130.3	86.6	142.1	96.9	120.8	132.4	49.1	59.6	48.7	83.4	82.4	192.3	59.5	113.6	182.8	78.5	127.9	105.4	520.3	174.3	116.4	138.7	134.2	94.5	96.4	132.5	99.2	140.2	118.0
ASB15	FLJ43370	ENSG00000146809	"Ankyrin repeat and SOCS box containing 15"	Q8WXK1	7	123567010-123639481	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	10	"heart muscle: 20.1;skeletal muscle: 52.0;tongue: 28.1"	"Group enriched"	"Detected in some"	8	"Cardiomyocytes: 44.7;Early spermatids: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"A549: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.19e-1)"					"unprognostic (7.45e-2)"	"unprognostic (1.37e-1)"					"unprognostic (5.98e-1)"	"unprognostic (6.09e-6)"	"unprognostic (7.31e-2)"	"unprognostic (6.39e-2)"			0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	20.1	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	52.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	28.1	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	44.7	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	26.9	0.0	0.0	0.0	0.4	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.6	0.0	3.3	0.0	0.0	0.2	0.5	0.0	0.0	4.2	0.0	0.0	0.0	0.4	0.2	0.1	0.9	0.0	0.0	0.4
LMOD2		ENSG00000170807	"Leiomodin 2"	Q6P5Q4	7	123655807-123664290	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	44	"heart muscle: 117.3;skeletal muscle: 297.2;tongue: 100.1"	"Cell type enriched"	"Detected in some"	1164	"Cardiomyocytes: 1233.0"	"Group enriched"	"Detected in some"	20	"head and neck cancer: 3.5;prostate cancer: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HSkMC: 5.7;SuSa: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046370, HPA051039"	Enhanced		Uncertain	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane"	"Actin filaments, Cytosol"	"HPA046370: , HPA051039: AB_2681321"	"unprognostic (2.55e-1)"			"unprognostic (1.14e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.50e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.98e-2)"		"unprognostic (2.13e-2)"	"unprognostic (1.43e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.82e-3)"	3.3	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.2	3.8	0.0	0.0	117.3	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.5	0.0	0.0	2.6	0.0	297.2	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.4	100.1	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.3	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1233.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WASL	"N-WASP, NWASP, WASPB"	ENSG00000106299	"Wiskott-Aldrich syndrome like"	O00401	7	123681935-123749067	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 212.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 45.1;U-2197: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005399, HPA005750"	Supported		Approved	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"CAB005399: AB_2288632, HPA005750: AB_1854729"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.30e-5)"	"unprognostic (7.32e-2)"	"prognostic favorable (4.51e-8)"	"unprognostic (9.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (5.14e-1)"	17.9	19.3	25.6	11.6	29.5	3.8	20.7	21.0	39.3	23.7	31.2	17.0	8.9	27.4	21.0	14.6	22.5	14.8	21.7	15.4	35.2	22.5	33.3	34.5	15.3	5.5	18.8	23.0	27.8	21.9	36.7	16.9	25.4	28.6	19.9	28.8	18.0	16.9	19.5	21.6	14.4	30.2	18.2	16.6	12.1	22.0	17.3	15.0	10.0	26.7	12.0	9.7	23.7	21.1	4.6	4.5	4.9	6.2	6.2	4.3	1.5	10.9	8.1	8.9	7.6	14.1	14.6	11.6	7.6	12.8	5.6	7.3	6.6	13.9	1.1	6.1	11.5	12.1	8.3	16.5	8.4	8.8	1.9	6.6	0.9	6.7	7.1	15.3	1.4	0.9	11.7	15.8	8.3	14.3	12.8	9.7	1.1	4.8	2.1	13.4	6.6	1.8	1.9	16.7	11.7	7.4	1.1	7.2	2.4	11.9	45.1	11.0	16.2	10.5	31.6	20.5	14.5	6.1	1.4	11.0	15.2	4.3	42.8	7.4	2.4	0.8	2.4	13.1	1.2	12.1	4.9	4.1	1.8	4.3	4.1	3.6	4.6	2.8	2.6	3.5	3.2	3.6	3.8	1.8	6.2	6.2	4.5	1.4	1.5	25.6	29.5	21.0	39.3	35.2	22.5	18.8	23.0	28.6	15.0	80.4	46.6	7.8	37.8	53.7	27.6	63.7	61.1	45.5	51.2	50.6	19.6	36.7	44.7	43.5	16.7	34.6	105.1	0.0	46.9	46.1	45.8	67.4	3.5	49.7	11.1	25.4	65.3	56.4	14.8	6.2	44.5	13.4	28.7	14.4	96.1	57.1	59.0	118.1	60.8	80.1	28.9	19.4	43.2	15.5	19.8	59.7	68.0	7.5	56.6	212.0
HYAL4		ENSG00000106302	"Hyaluronoglucosaminidase 4"	Q2M3T9	7	123828983-123877478	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"placenta: 7.1;skeletal muscle: 8.3"	"Group enriched"	"Detected in some"	7	"Cytotrophoblasts: 4.0;Extravillous trophoblasts: 5.9;Spermatogonia: 2.8;Syncytiotrophoblasts: 1.8"	"Cancer enriched"	"Detected in single"	48	"testis cancer: 8.4"					"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.5;CAPAN-2: 7.2;RT4: 17.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029453	Uncertain					NA	NA					"HPA029453: AB_10601432"	"unprognostic (5.19e-5)"	"unprognostic (4.18e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.20e-1)"		"unprognostic (4.14e-2)"		"unprognostic (2.60e-1)"	"unprognostic (8.24e-2)"	"unprognostic (5.26e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (5.55e-3)"	0.1	0.3	0.0	0.0	0.0	0.7	0.2	0.0	0.5	0.0	0.1			0.0	0.1	0.4	0.4	0.2	0.0	0.4	0.0	0.0	0.6	0.1	0.4	0.0	0.0		0.1	0.6	0.0	0.1	7.1		0.2	0.0		1.2	0.0	8.3	1.4	0.2	0.0	0.1	1.0	0.2	3.4			0.4		1.5	1.0	0.1	1.3	0.6	3.3	0.6	1.0	0.9	0.1	0.3	0.6	0.1	0.4	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	7.2	0.3	0.4	0.0	0.7	1.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.2	0.1	0.0	17.0	0.2	0.1	0.0	1.0	0.0	1.4	0.4	0.2	2.4	0.1	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.5	0.4	0.6	0.5	0.5	0.4	0.5	0.5	0.2	1.3	0.7	0.9	3.3	1.0	0.6	0.6	0.3	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	5.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.8	0.0	1.8	0.0	0.0	0.1
SPAM1	"HYAL5, PH-20, SPAG15"	ENSG00000106304	"Sperm adhesion molecule 1"	P38567	7	123925237-123971414	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	38	"testis: 19.6"	"Group enriched"	"Detected in some"	58	"Early spermatids: 169.9;Late spermatids: 83.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.0;SuSa: 1.5"					"Not detected"	"Not detected"			HPA017984	Enhanced					NA	NA					"HPA017984: AB_1857413"															"unprognostic (2.44e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	169.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	83.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	1.1	0.0	2.2	0.0	0.0	0.0
TMEM229A		ENSG00000234224	"Transmembrane protein 229A"	B2RXF0	7	124030916-124033023	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.6;intestine: 16.4;testis: 10.6"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 3.3;Cytotrophoblasts: 1.9;Muller glia cells: 1.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	44	"SH-SY5Y: 55.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056391	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA056391: AB_2683114"					"unprognostic (2.52e-2)"			"unprognostic (3.04e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.21e-2)"		"unprognostic (4.74e-2)"	"unprognostic (2.31e-1)"		"unprognostic (4.31e-3)"	0.4	1.5	6.9	0.5	7.6	0.4	0.4	1.3	9.0	0.8	0.5	7.6	0.0	16.4	0.7	1.2	0.4	1.7	0.6	0.9	8.0	4.6	0.5	0.4	0.5	0.4	10.6	4.9	1.0	0.4	2.5	1.0	0.6	5.6	0.8	0.6	0.6	0.7	0.5	0.4	0.4	7.7	0.7	7.3	0.6	3.7	10.6	8.7	0.0	0.5	0.0	0.4	1.1	0.1	0.0	0.0	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.1	0.0	6.9	7.6	1.3	6.1	8.0	4.6	10.6	4.9	5.6	8.7	0.0	0.0	0.0	0.0	0.0	3.3	0.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1
SSU72P8		ENSG00000230268	"SSU72 pseudogene 8"		7	124476371-124476955	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	39	"testis: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 1.8;HeLa: 1.2;U-2 OS: 1.1"															NA	NA																				"unprognostic (2.29e-1)"			0.0	0.0		0.0		0.0	0.0		0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	5.6			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR37	"EDNRBL, hET(B)R-LP, PAELR"	ENSG00000170775	"G protein-coupled receptor 37"	O15354	7	124745997-124765627	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 62.4"	"Cell type enriched"	"Detected in many"	36	"Muller glia cells: 779.4"	"Cancer enhanced"	"Detected in many"		"glioma: 19.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 9.4;fHDF/TERT166: 22.0;hTCEpi: 9.8;SK-BR-3: 8.5;SuSa: 10.6;TIME: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042903, HPA068009"	Approved		Approved	"Nuclear membrane,Cytosol"		No	No		48000	"Nuclear membrane, Cytosol"		"HPA042903: AB_2678219, HPA068009: AB_2685940"	"unprognostic (2.47e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (6.19e-2)"	"prognostic favorable (7.26e-4)"	"unprognostic (6.54e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.71e-4)"	1.6	1.0	14.5	1.1	19.6	0.9	1.7	2.3	52.6	1.5	1.4	62.4	0.0	1.0	2.1	1.4	7.8	2.1	1.4	0.9	23.9	11.3	1.2	8.8	1.3	1.1	33.5	12.3	1.0	3.0	0.8	0.3	10.0	23.3	1.8	1.5	3.5	1.6	1.8	1.1	4.1	1.3	3.0	49.4	4.3	1.2	15.5	26.5	0.0	0.9	0.0	0.9	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	9.4	0.0	0.0	0.0	2.7	0.5	2.5	2.4	0.6	0.4	0.8	0.0	0.0	22.0	0.3	0.2	2.8	0.0	0.5	0.4	1.2	0.1	5.9	0.0	2.8	0.0	0.4	0.0	9.8	0.0	0.1	0.0	4.5	0.0	0.0	4.3	0.0	0.5	0.0	0.0	1.4	0.0	4.5	0.0	0.0	0.0	0.0	0.1	2.2	3.3	0.0	8.5	3.2	10.6	2.2	0.0	15.3	2.0	0.7	0.0	0.0	1.3	0.0	0.0	1.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	19.6	2.3	19.6	23.9	11.3	33.5	12.3	23.3	26.5	0.0	0.0	0.0	0.3	4.0	21.7	0.4	2.5	0.0	0.0	1.8	5.9	7.1	0.0	4.3	0.2	0.5	0.0	0.0	0.5	15.1	2.7	2.1	0.0	21.5	1.0	17.5	0.0	0.0	0.3	0.9	2.6	0.0	3.3	1.0	0.4	779.4	0.4	0.0	0.7	0.0	12.5	0.0	0.9	0.6	0.7	8.9	2.5	0.0	0.0	0.1
C7orf77		ENSG00000275356	"Chromosome 7 open reading frame 77"	A4D0Y5	7	124777292-124790689	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"liver: 2.1;lung: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HDLM-2: 9.6"															NA	NA										"unprognostic (9.32e-2)"		"unprognostic (1.05e-1)"											0.0	0.0		0.0		0.0	0.6		0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0	2.1	2.4	0.0			0.1	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.8	0.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
POT1	"DKFZp586D211, hPot1"	ENSG00000128513	"Protection of telomeres 1"	Q9NUX5	7	124822386-124929983	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 27.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA068538			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA068538: AB_2686001"	"unprognostic (1.39e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.38e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.48e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.75e-2)"	"unprognostic (4.77e-3)"	"unprognostic (7.42e-2)"	12.0	13.2	11.1	8.3	14.3	6.2	15.8	13.0	16.6	13.4	10.1	16.0	12.0	7.8	17.0	13.4	10.1	12.6	11.3	11.2	15.5	11.3	16.6	14.7	9.9	14.0	15.0	12.4	15.7	9.4	15.5	29.6	11.1	16.4	12.0	9.7	12.2	8.7	10.1	9.5	8.0	8.8	13.1	16.4	13.6	9.5	15.8	14.8	17.9	21.5	9.3	12.9	13.6	9.8	4.8	3.6	2.7	3.3	5.2	7.4	2.7	12.9	5.5	8.2	6.3	5.5	10.3	5.8	7.3	8.6	8.3	12.6	4.5	13.1	11.7	5.9	5.5	11.6	5.1	9.0	7.4	13.2	15.1	13.1	11.4	5.5	4.8	12.4	11.0	6.8	7.3	8.9	7.7	12.1	9.6	10.5	4.8	20.2	28.1	9.3	2.5	14.6	11.6	9.3	8.4	9.1	8.7	8.6	16.7	7.2	7.2	8.8	11.7	7.4	9.9	10.3	13.2	4.4	10.6	3.4	10.0	4.4	12.1	9.6	15.6	15.9	16.6	10.1	12.6	12.4	0.9	3.1	2.7	4.3	3.3	6.3	4.8	4.5	5.0	3.1	3.4	7.4	5.5	0.7	5.2	3.0	3.6	4.4	2.7	11.1	14.3	13.0	16.6	15.5	11.3	15.0	12.4	16.4	14.8	6.0	5.5	4.2	5.9	4.0	7.0	8.2	7.6	2.7	2.3	12.2	9.8	5.8	16.6	4.2	13.5	4.3	0.8	0.0	3.9	6.8	6.0	3.8	3.5	10.4	5.6	7.9	8.6	6.2	10.0	6.8	8.1	6.1	15.1	4.6	3.2	12.6	3.0	0.0	4.2	8.6	9.3	0.0	8.2	27.5	12.0	2.3	3.8	6.2	4.0	1.8
GRM8	"GLUR8, GPRC1H, mGlu8, MGLUR8"	ENSG00000179603	"Glutamate metabotropic receptor 8"	O00222	7	126438598-127253294	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.5;liver: 8.0"	"Group enriched"	"Detected in some"	22	"Early spermatids: 53.0;Late spermatids: 55.2"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 2.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 5.6;HEK 293: 2.9;NTERA-2: 7.2;RH-30: 4.3;SCLC-21H: 6.5;SH-SY5Y: 3.5;U-2 OS: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051481	Uncertain					NA	NA					"HPA051481: AB_2681499"	"unprognostic (4.57e-3)"	"unprognostic (5.10e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.79e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.12e-2)"	0.2	1.5	2.0	2.0	4.6	0.1	0.2	1.1	6.4	0.3	4.5	4.0	0.0	0.3	0.3	0.3	0.2	0.5	3.5	5.5	2.6	4.0	1.9	8.0	0.7	0.2	2.9	2.6	2.3	1.4	0.2	0.7	0.2	14.5	0.4	5.0	3.5	0.2	0.2	0.1	0.3	0.2	0.5	1.2	0.2	0.8	3.8	1.5	0.0	2.4	0.0	0.3	1.4	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.6	0.2	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	7.2	0.0	0.1	0.0	4.3	0.1	0.2	0.0	6.5	3.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.7	2.3	0.2	0.1	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.6	1.1	5.4	2.6	4.0	2.9	2.6	14.5	1.5	0.0	0.0	0.0	0.0	0.0	0.2	1.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.2	0.6	0.0	55.2	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.2	1.0	0.0	0.0	0.0	0.6	0.0
ZNF800		ENSG00000048405	"Zinc finger protein 800"	Q2TB10	7	127346790-127431924	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023090, HPA052194"	Approved		Supported	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	Cytosol	"HPA023090: AB_1859457, HPA052194: AB_2681757"	"unprognostic (2.93e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.43e-2)"	"unprognostic (8.99e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.96e-3)"	17.5	11.2	10.8	14.4	11.7	61.7	18.7	18.6	12.7	11.9	11.9	6.3	12.8	10.3	14.6	10.4	15.4	13.5	11.6	9.5	10.2	5.9	8.9	14.4	16.5	20.7	13.5	9.2	15.2	15.3	16.2	18.6	10.8	12.6	10.5	10.5	7.1	15.1	16.1	14.9	22.7	14.8	11.5	15.7	15.2	13.1	19.1	12.8	22.4	12.7	10.9	13.8	14.4	15.5	14.2	12.0	16.9	6.8	18.9	17.2	5.9	9.1	4.8	5.7	9.8	8.2	11.0	5.4	8.9	10.5	9.2	8.9	4.4	8.8	15.6	5.5	8.4	9.9	6.7	9.2	9.5	12.7	13.7	5.4	10.0	4.9	4.1	10.3	13.7	19.3	9.3	8.8	10.1	13.7	7.7	9.7	9.7	12.4	16.1	9.9	7.0	15.2	9.9	4.7	8.5	6.4	9.5	7.9	10.3	6.7	11.6	8.1	8.5	8.8	34.9	11.3	8.1	4.1	9.4	10.4	15.5	4.9	10.2	10.4	19.4	8.5	22.6	11.5	12.5	12.8	16.9	6.8	10.1	13.3	6.3	14.0	12.0	10.0	13.5	7.0	14.2	16.4	17.2	6.0	18.9	6.6	12.0	13.8	5.9	10.8	11.7	18.6	12.7	10.2	5.9	13.5	9.2	12.6	12.8	35.7	19.7	27.4	41.3	39.8	25.9	12.6	15.3	16.0	21.6	12.2	21.6	9.7	10.0	20.7	27.0	23.3	24.9	23.3	16.7	8.6	17.5	40.1	28.8	12.9	12.9	73.1	15.5	23.4	26.2	8.6	25.0	26.7	27.0	27.9	22.6	16.6	19.9	25.9	29.7	10.5	26.1	25.8	25.8	97.4	48.6	41.9	18.4	33.8	20.0	57.6
GCC1	"FLJ22035, GCC1P, GCC88, MGC20706"	ENSG00000179562	"GRIP and coiled-coil domain containing 1"	Q96CN9	7	127580618-127593611	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"Early spermatids: 108.4;Late spermatids: 98.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019369, HPA021323"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA019369: AB_1849552, HPA021323: AB_1849554"	"unprognostic (1.09e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.81e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.17e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.65e-2)"	"unprognostic (9.96e-2)"	11.5	14.1	13.4	11.0	13.7	17.7	14.2	13.9	12.8	11.6	10.2	12.8	8.6	9.6	13.2	10.3	14.1	10.7	12.2	9.0	10.2	7.9	9.8	17.8	10.4	12.3	19.8	7.6	13.6	12.7	14.8	14.5	13.6	13.0	11.5	9.6	8.4	13.8	11.0	12.5	14.5	12.9	8.4	12.1	15.5	12.7	20.7	17.9	15.7	11.8	9.5	14.4	10.3	29.2	8.4	7.9	15.6	9.1	10.2	11.6	8.8	8.4	11.4	5.0	10.8	11.3	7.8	7.0	7.4	8.6	7.4	9.4	9.5	5.8	7.8	4.5	6.8	16.8	9.3	7.3	8.1	8.0	10.8	6.6	5.7	6.2	4.9	16.8	9.8	9.5	7.3	22.3	7.9	15.7	7.0	7.0	7.8	9.3	8.9	8.3	8.4	9.5	8.5	10.5	9.3	8.9	6.8	5.4	8.8	6.4	6.5	8.0	11.6	7.9	37.8	14.7	9.5	6.4	7.1	9.0	11.0	3.5	9.5	8.4	24.5	10.7	5.0	10.9	10.1	11.2	5.8	8.1	15.0	9.1	8.2	11.6	8.4	8.2	8.9	7.9	8.0	6.8	6.7	15.6	10.2	9.1	4.6	7.6	8.8	13.4	13.7	13.9	12.8	10.2	7.9	19.8	7.6	13.0	17.9	11.9	7.7	0.9	5.0	9.4	3.7	3.7	5.1	0.0	3.4	3.5	3.9	5.4	5.0	4.5	108.4	5.6	6.6	0.0	5.5	3.9	4.3	5.3	1.1	6.8	4.5	11.1	6.9	4.9	7.9	98.5	4.9	5.4	11.8	5.4	7.5	4.4	5.5	5.5	3.5	3.3	5.3	6.5	6.1	5.6	4.5	9.2	8.7	5.7	4.5	5.1
ARF5		ENSG00000004059	"ADP ribosylation factor 5"	P84085	7	127588345-127591705	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		4600000				"unprognostic (6.72e-3)"	"unprognostic (2.34e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.04e-2)"	"unprognostic (5.81e-3)"	"unprognostic (9.41e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.75e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.95e-1)"	"unprognostic (2.46e-2)"	24.3	24.7	43.7	30.0	49.0	46.4	29.6	40.5	63.6	34.0	31.1	18.0	35.6	33.2	28.9	50.7	64.1	38.1	39.1	40.2	41.2	33.0	31.6	34.7	28.6	46.7	29.2	47.0	21.7	61.4	23.8	27.1	31.7	25.0	27.7	22.4	18.6	33.8	29.9	43.5	62.1	35.0	26.4	23.1	28.7	32.1	28.7	19.5	35.7	29.0	56.2	31.2	34.2	29.9	23.8	73.1	80.1	57.3	26.1	31.9	56.7	25.2	25.5	19.6	63.2	17.0	26.9	27.4	7.0	21.2	19.5	22.8	39.1	34.2	18.9	10.9	21.2	22.5	19.2	15.0	31.9	6.3	17.2	40.6	7.2	23.8	26.4	25.9	11.0	16.5	27.6	32.9	12.9	12.5	15.4	29.4	26.5	16.8	20.2	18.9	88.7	39.3	51.4	29.6	25.0	35.0	24.2	12.3	40.0	32.8	25.8	58.5	38.0	23.5	75.4	18.3	12.9	20.2	18.1	17.0	29.5	13.0	21.0	16.2	19.4	12.1	24.1	30.1	23.0	25.3	41.3	57.3	47.6	27.6	46.7	27.9	23.8	29.3	28.4	73.1	21.8	22.3	24.2	80.1	26.1	36.1	47.5	31.9	56.7	43.7	49.0	40.5	63.6	41.2	33.0	29.2	47.0	25.0	19.5	3.0	8.9	57.2	48.5	93.9	13.8	1.6	71.4	13.4	17.0	106.4	0.0	128.2	170.8	92.6	30.3	45.0	90.4	0.0	79.5	103.2	89.0	50.0	20.7	47.2	93.3	19.1	115.1	69.3	129.6	32.1	86.3	93.5	141.7	77.5	97.2	22.1	74.7	122.0	89.1	129.8	8.7	71.1	54.6	77.5	106.9	134.1	122.3	100.8	113.9	71.5
FSCN3		ENSG00000106328	"Fascin actin-bundling protein 3"	Q9NQT6	7	127591409-127602144	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"testis: 62.1"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 1905.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA075174	Enhanced					NA	NA					"HPA075174: "	"unprognostic (7.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.87e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.91e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.68e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.14e-5)"	"unprognostic (1.27e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.01e-1)"	"unprognostic (7.34e-2)"	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	62.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.3	0.0	0.0	0.3	0.0	0.0	1.1	0.3	0.8	0.0	0.0	1.4	0.1	0.4	0.3	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	2.5	0.6	0.0	0.0	0.0	0.5	0.3	0.6	0.0	0.7	0.7	0.7	1.4	0.0	0.0	0.5	0.7	0.2	0.0	0.5	0.2	0.3	0.0	1.5	0.0	0.3	0.0	0.6	0.0	0.1	0.1	0.5	0.0	0.8	0.3	0.7	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.4	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	317.1	0.3	0.0	0.0	0.2	0.2	0.2	0.3	1.1	0.0	0.1	0.0	0.0	0.0	0.0	1905.7	8.6	0.9	1.7	0.0	0.1	0.2	0.2	0.6	7.8	0.0	0.4	0.0	0.3	9.8	5.8	1.1	0.2	0.0	0.1	0.1
PAX4	MODY9	ENSG00000106331	"Paired box 4"	O43316	7	127610292-127618114	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"intestine: 3.9;testis: 3.6"	"Cell type enriched"	"Detected in some"	9	"Intestinal endocrine cells: 81.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	62	"SCLC-21H: 17.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA								"unprognostic (1.52e-1)"								"unprognostic (9.71e-2)"			"unprognostic (4.86e-3)"	"unprognostic (1.21e-1)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	3.4	0.1	0.1	3.8	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	3.9	0.1	0.1	0.1	0.1	0.0	2.1	0.1	0.1	0.1	0.0	3.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	81.6	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SND1	"p100, TDRD11"	ENSG00000197157	"Staphylococcal nuclease and tudor domain containing 1"	Q7KZF4	7	127652180-128092609	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cytotrophoblasts: 195.0;Syncytiotrophoblasts: 223.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002529, HPA002632, CAB019323"	Enhanced		Enhanced	Cytosol		NA	NA		1200000	Cytosol		"CAB019323: , HPA002529: AB_1857317, HPA002632: AB_1857316"	"unprognostic (2.06e-1)"	"unprognostic (8.27e-3)"	"unprognostic (2.21e-1)"	"prognostic favorable (1.95e-4)"	"unprognostic (5.10e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.26e-3)"	21.5	29.8	25.3	25.3	19.8	22.5	45.4	28.1	28.1	33.3	20.0	13.0	57.7	21.3	36.1	38.4	24.8	26.7	25.3	28.3	20.9	16.6	17.3	39.6	38.8	64.2	20.2	19.0	39.7	130.3	22.2	30.3	33.7	27.6	24.5	20.2	13.9	37.5	66.7	20.5	21.5	19.2	41.0	40.1	24.9	30.8	37.0	18.0	22.3	26.6	13.5	24.9	26.5	24.2	28.1	34.9	16.1	30.0	21.0	30.9	28.5	28.5	25.9	19.8	35.9	30.1	31.5	27.2	33.6	39.8	30.8	34.6	33.4	24.8	37.9	17.0	41.2	26.0	24.0	27.9	36.4	30.1	20.7	23.6	20.9	30.9	32.0	54.8	32.3	20.6	46.3	40.7	26.3	44.1	35.1	38.2	15.7	23.1	38.1	30.7	21.3	35.1	24.2	22.2	29.0	32.3	24.5	17.7	84.8	24.1	20.1	25.0	27.0	24.3	113.2	38.9	31.1	14.1	23.0	37.9	25.1	16.4	45.5	26.1	47.0	17.6	39.8	50.3	27.9	45.3	16.1	30.0	5.9	26.1	28.1	30.9	28.1	19.8	21.0	32.3	16.2	14.3	15.8	2.2	21.0	22.8	34.9	15.8	28.5	25.3	19.8	28.1	28.1	20.9	16.6	20.2	19.0	27.6	18.0	14.9	43.1	29.8	20.4	17.4	11.2	26.2	38.2	14.7	20.5	27.9	19.6	195.0	14.9	60.6	12.9	28.0	32.8	23.3	83.7	91.7	29.4	34.2	34.6	43.3	73.2	28.6	70.2	26.4	48.3	40.2	42.3	43.7	32.1	80.2	55.0	15.6	63.2	31.6	38.9	25.1	32.0	32.3	19.5	19.2	29.2	24.0	223.8	27.7	53.0	21.3
LRRC4	NAG14	ENSG00000128594	"Leucine rich repeat containing 4"	Q9HBW1	7	128027071-128032107	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.2"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 57.6;Club cells: 43.3;Horizontal cells: 52.4;Rod photoreceptor cells: 40.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 14.3"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 14.3"	"Group enriched"	"Detected in some"	6	"AF22: 10.7;NTERA-2: 23.8;REH: 21.9;SCLC-21H: 12.2;SH-SY5Y: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051100			Approved	"Golgi apparatus"		NA	NA		1100000	"Golgi apparatus"		"HPA051100: AB_2797241"	"unprognostic (7.98e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.85e-2)"	"prognostic favorable (8.19e-4)"	"unprognostic (2.33e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.63e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (6.98e-4)"	"unprognostic (4.79e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.84e-3)"	2.6	7.7	11.6	2.9	13.1	10.0	0.8	22.3	33.2	2.3	1.1	3.2	0.7	0.9	3.4	0.5	4.0	7.3	3.4	2.0	10.1	6.6	4.6	2.2	6.3	1.9	5.1	15.5	5.5	0.6	8.6	1.5	4.7	3.1	0.9	0.8	1.7	1.5	3.5	1.0	0.5	1.0	1.9	3.4	4.7	1.5	6.3	2.9	0.8	0.8	3.6	2.4	1.5	2.0	0.0	0.0	14.3	0.6	0.0	0.1	0.1	0.0	0.1	10.7	0.0	0.4	0.0	0.0	0.6	0.0	0.9	0.3	0.0	0.0	0.0	0.8	0.9	0.0	1.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.1	0.0	23.8	0.0	0.0	21.9	0.0	0.2	0.1	0.0	12.2	7.6	0.0	0.0	0.9	1.8	0.0	2.4	0.3	0.7	0.1	0.1	0.6	0.0	0.0	0.0	0.1	0.0	1.5	0.5	0.3	2.8	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.3	0.0	0.6	0.0	0.0	0.1	11.6	13.1	22.3	28.4	10.1	6.6	5.1	15.5	3.1	2.9	14.9	14.7	0.0	1.1	0.1	12.7	1.1	0.0	57.6	43.3	1.8	25.5	0.1	0.0	0.0	4.3	1.6	0.0	0.0	0.0	0.2	0.4	2.5	1.1	0.0	14.9	52.4	0.0	15.4	7.6	0.0	0.0	0.6	1.7	0.0	0.0	1.2	0.0	0.0	0.7	0.3	40.6	0.0	0.4	4.7	4.8	0.0	0.3	0.0	0.1	16.9
LEP	"OB, OBS"	ENSG00000174697	Leptin	P41159	7	128241284-128257628	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"adipose tissue: 85.2;breast: 63.7;placenta: 24.3"	"Cell type enriched"	"Detected in some"	28	"Syncytiotrophoblasts: 361.5"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 3.8"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.8"	"Group enriched"	"Detected in some"	11	"BEWO: 5.6;HSkMC: 2.3;SuSa: 7.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010490	Approved				"Secreted to blood"	NA	NA	17000000	26000000			"CAB010490: AB_2296951"	"unprognostic (8.19e-3)"	"unprognostic (5.33e-1)"	"unprognostic (1.60e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.99e-3)"	"unprognostic (1.83e-1)"		"unprognostic (6.56e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.84e-2)"	85.2	0.3	0.0	1.5	0.0	0.0	63.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.7	0.0	0.0	0.1	0.0	0.4	2.0	0.0	0.0	0.1	0.7	0.0	0.0	24.3	0.0	0.0	0.1	0.0	0.4	0.0	0.6	1.1	0.4	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	1.5	2.1	0.4	0.4	3.8	0.5	0.5	0.3	0.2	0.0	0.2	0.1	0.3	0.2	0.0	5.6	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.2	0.1	0.3	0.1	7.1	0.2	0.1	0.0	0.2	0.2	0.4	0.2	0.2	0.1	0.2	0.3	0.1	0.3	0.9	0.5	0.3	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.4	0.2	0.3	3.8	0.5	0.4	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.2	0.1	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	361.5	0.0	0.0	0.1
RBM28	FLJ10377	ENSG00000106344	"RNA binding motif protein 28"	Q9NW13	7	128297685-128343908	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019058, HPA026672, HPA031519"	Enhanced		Supported	Nucleoli		Yes	No			Nucleoli		"HPA019058: AB_1856118, HPA026672: AB_1856119, HPA031519: AB_2673920"	"unprognostic (2.34e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.72e-11)"	"unprognostic (6.83e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (7.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.45e-3)"	"unprognostic (7.15e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.04e-1)"	22.1	17.7	16.3	18.4	25.1	14.2	17.5	26.5	25.3	12.8	13.7	19.7	9.6	13.2	17.1	9.9	15.1	12.5	10.9	24.4	18.1	8.6	12.0	18.8	13.2	17.9	26.5	16.2	19.7	15.7	16.5	18.4	14.5	17.3	13.1	12.7	12.3	13.0	13.0	33.5	17.3	11.2	14.2	25.4	13.8	14.1	18.4	24.4	11.7	16.1	12.2	15.6	13.8	18.9	14.5	14.3	9.8	11.5	12.3	13.7	5.5	18.6	20.6	12.5	35.7	8.9	5.7	17.1	17.2	7.1	15.6	17.0	17.1	16.4	24.8	9.4	7.8	22.8	12.7	18.3	14.6	20.3	12.4	17.6	24.9	14.4	15.7	7.9	31.3	22.4	6.4	9.6	20.7	12.5	5.9	14.4	13.8	46.5	14.5	12.1	15.1	22.4	17.9	23.8	12.9	16.2	17.8	15.0	23.8	7.6	12.7	14.0	17.0	22.2	37.2	11.8	15.6	9.5	9.6	13.8	22.7	11.8	20.1	20.8	15.0	12.8	43.0	14.9	26.5	24.4	3.5	11.5	4.4	13.7	8.9	9.4	12.8	11.6	12.2	11.5	14.5	10.5	12.0	9.8	12.3	7.8	14.3	7.1	5.5	16.3	25.1	26.5	25.3	18.1	8.6	26.5	16.2	17.3	24.4	14.9	32.7	12.7	12.1	14.3	55.3	21.5	5.1	21.4	38.7	12.2	88.4	17.7	21.6	15.9	2.1	18.8	6.2	0.0	19.6	22.7	16.4	9.7	34.8	12.8	16.8	38.1	10.9	7.4	14.3	1.3	25.6	14.5	5.0	13.6	13.8	23.3	15.5	7.0	19.4	12.9	52.9	6.5	21.7	41.1	51.3	12.7	15.6	16.0	14.8	10.9
PRRT4		ENSG00000224940	"Proline rich transmembrane protein 4"	C9JH25	7	128350325-128361685	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"bone marrow: 49.0"	"Cell type enriched"	"Detected in some"	8	"Horizontal cells: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 72.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA046373, HPA052681"	Uncertain		Approved	"Nucleoplasm,Peroxisomes,Plasma membrane"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Peroxisomes, Plasma membrane"	"HPA046373: AB_2679642, HPA052681: AB_2681912"	"unprognostic (1.72e-1)"	"unprognostic (4.55e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.20e-4)"	"unprognostic (2.60e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.48e-4)"	"unprognostic (9.11e-2)"	"unprognostic (3.73e-4)"	"unprognostic (5.28e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.27e-2)"	12.1	1.9	2.0	5.9	11.3	49.0	6.8	6.5	3.1	1.6	2.7	0.6	0.0	0.6	0.7	0.5	1.9	1.0	1.1	2.4	1.7	6.2	0.5	0.7	0.8	0.6	1.6	2.4	1.0	0.6	0.8	0.0	0.6	2.9	0.8	0.7	3.4	1.9	1.3	4.2	1.5	0.8	1.0	2.8	1.3	1.6	0.7	1.5	0.7	0.7	1.7	1.0	2.0	3.2	0.0	0.4	0.4	0.4	0.0	1.5	0.4	0.0	0.0	0.1	0.1	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.3	0.7	14.1	0.3	0.0	0.0	3.9	0.2	0.3	0.0	0.0	0.1	72.0	0.1	0.0	0.1	0.5	0.0	1.9	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.2	0.5	0.0	0.0	1.5	0.7	0.4	0.0	0.0	0.4	0.0	0.4	2.0	11.3	6.5	3.1	1.7	6.2	1.6	2.4	2.9	1.5	0.0	0.0	0.0	0.0	0.6	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	9.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.4	0.3	0.2	0.0	0.0	0.0
IMPDH1	"LCA11, RP10, sWSS2608"	ENSG00000106348	"Inosine monophosphate dehydrogenase 1"	P20839	7	128392277-128410252	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	"DNA-binding, Oxidoreductase, RNA-binding"	"Disease mutation, FDA approved drug targets, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 172.4;Cone photoreceptor cells: 133.5;Horizontal cells: 114.4;Rod photoreceptor cells: 184.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 21.6;eosinophil: 20.2;intermediate monocyte: 26.2;myeloid DC: 15.1;neutrophil: 49.9;non-classical monocyte: 31.0"	"Group enriched"	"Detected in all"	5	"dendritic cells: 15.1;granulocytes: 49.9;monocytes: 31.0"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 89.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001400	Approved		Supported	"Cytosol,Rods & Rings"		NA	NA			Cytosol	"Rods & Rings"	"HPA001400: AB_1079139"	"unprognostic (2.84e-1)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (2.23e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (7.31e-5)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (1.24e-1)"	"unprognostic (7.45e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (1.78e-12)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (3.72e-5)"	26.0	7.4	7.5	20.7	8.5	24.5	37.1	7.7	10.2	11.3	10.9	3.6	12.4	5.2	8.5	6.5	14.6	9.1	7.6	12.6	7.6	5.0	7.5	3.5	14.8	31.2	5.1	5.8	10.7	20.3	5.2	12.0	7.2	9.9	12.1	6.3	19.5	20.6	11.4	3.5	11.9	8.8	12.3	6.4	25.1	20.6	7.1	5.6	3.9	5.5	11.2	9.7	14.2	9.9	4.1	15.1	49.9	31.0	2.8	6.4	11.7	25.5	22.0	3.3	24.5	13.9	10.1	9.4	17.5	11.1	15.0	9.8	16.0	8.2	16.3	6.0	26.0	15.6	19.6	18.5	24.6	7.5	5.9	20.7	10.7	16.3	11.3	12.7	14.1	5.1	12.0	11.8	15.2	15.2	7.1	17.7	9.9	10.6	12.3	5.0	17.5	9.9	38.0	18.6	20.3	25.8	11.9	6.1	33.7	6.6	8.2	13.2	13.3	11.3	89.8	15.8	2.1	10.2	27.4	16.2	25.3	9.2	13.2	12.4	9.2	8.5	20.9	12.9	31.3	15.3	2.3	21.6	20.2	5.9	26.2	6.4	4.1	4.7	5.1	15.1	2.4	2.8	3.4	49.9	2.8	31.0	1.5	5.2	11.7	7.5	8.5	7.7	10.2	7.6	5.0	5.1	5.8	9.9	5.6	0.0	12.8	13.7	7.5	7.8	172.4	4.5	0.0	6.7	6.8	5.2	133.5	2.2	5.0	6.6	0.5	14.0	1.7	0.0	15.6	18.1	11.6	17.1	20.7	0.4	41.4	114.4	9.2	12.9	59.2	1.3	4.4	34.4	15.1	56.9	8.9	17.6	11.7	0.0	6.3	1.3	184.8	0.0	13.3	3.1	18.8	6.5	1.9	14.9	11.9	8.5
HILPDA	"C7orf68, FLJ21076, HIG-2, HIG2"	ENSG00000135245	"Hypoxia inducible lipid droplet associated"	Q9Y5L2	7	128455849-128458418	"Predicted membrane proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.4;esophagus: 71.4"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 142.7;Syncytiotrophoblasts: 201.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 31.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 45.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010515	Approved		Supported	"Nucleoplasm,Lipid droplets"	"Intracellular and membrane"	NA	NA			"Lipid droplets"	Nucleoplasm	"HPA010515: AB_1850710"	"unprognostic (1.10e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (4.30e-11)"	"unprognostic (9.20e-3)"	"unprognostic (4.07e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.15e-2)"	"prognostic unfavorable (2.05e-7)"	"unprognostic (2.23e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.27e-1)"	24.5	5.2	25.3	5.5	34.2	14.1	16.2	8.6	53.9	15.7	14.4	6.4	2.8	4.7	9.1	6.3	71.4	7.9	7.2	16.7	25.1	8.5	10.4	10.3	13.2	4.9	22.4	3.1	22.9	5.0	3.0	4.2	25.7	46.5	7.0	6.2	2.8	7.7	6.1	5.2	14.4	4.4	6.9	66.4	3.0	6.4	10.1	21.1	1.7	5.6	6.9	6.0	60.5	18.6	9.2	5.9	31.7	3.6	6.9	3.3	2.0	11.2	23.8	13.0	14.2	17.8	6.6	24.4	4.1	5.2	8.7	9.7	5.9	10.3	7.7	3.3	6.2	8.9	7.2	7.3	8.8	11.1	4.2	6.7	4.7	5.0	5.3	4.0	7.4	6.5	10.9	7.6	6.8	4.6	8.9	7.1	12.2	6.8	3.2	8.6	13.9	22.2	13.5	16.1	8.3	10.5	16.8	6.1	11.9	4.8	16.8	12.5	11.5	6.4	45.2	8.0	12.2	36.8	7.2	5.2	11.2	5.5	8.4	5.1	3.1	2.3	9.8	21.1	11.5	9.6	9.2	3.5	31.7	2.3	3.6	3.3	7.8	2.9	2.8	3.4	9.2	3.0	2.9	1.4	6.9	2.7	5.9	1.9	2.0	25.3	34.2	8.6	53.9	25.1	8.5	22.4	3.1	46.5	21.1	8.9	5.6	5.8	11.4	57.1	6.2	3.1	5.1	33.5	47.8	1.8	17.7	95.4	0.0	16.4	0.3	26.9	2.9	0.0	7.6	142.7	49.5	20.7	17.4	3.2	23.2	25.4	12.6	7.4	4.3	1.7	28.1	20.8	35.4	20.8	7.7	14.1	55.4	5.5	23.0	8.4	22.5	6.5	49.5	5.9	16.3	45.5	201.6	5.1	15.3	8.0
METTL2B	"FLJ11350, METL, METTL2"	ENSG00000165055	"Methyltransferase like 2B"	Q6P1Q9	7	128476729-128506602	"Predicted intracellular proteins, Predicted membrane proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA						"unprognostic (2.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.81e-3)"	"unprognostic (9.91e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.36e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.46e-2)"	"unprognostic (8.38e-2)"	"unprognostic (5.67e-2)"	10.2	7.2	7.5	7.4	12.7	4.1	8.3	8.6	16.3	4.6	6.9	5.4	4.8	4.8	6.9	7.7	7.7	5.8	4.9	8.0	17.3	7.8	6.8	9.8	5.1	6.6	7.3	8.7	6.2	7.9	5.6	13.0	7.0	9.6	5.8	7.9	4.8	7.5	8.0	11.0	11.6	5.2	6.9	6.9	7.6	6.1	5.3	9.8	6.5	7.8	10.0	8.1	7.0	5.3	7.7	5.3	5.5	8.5	7.2	8.8	5.0	10.6	12.0	8.7	16.3	7.4	9.4	6.5	8.4	5.9	9.0	7.5	10.1	13.0	10.1	4.1	10.1	14.1	10.7	16.0	9.9	11.5	11.0	14.6	11.3	13.0	8.9	12.3	15.3	8.2	6.3	9.4	11.5	11.6	6.8	9.9	12.4	21.5	7.7	13.0	8.5	17.5	12.9	15.0	11.9	13.1	7.0	12.0	9.5	10.5	9.2	9.2	15.2	7.0	35.6	10.6	12.5	10.1	9.2	9.6	10.6	5.0	11.5	17.9	12.1	11.8	18.1	20.1	15.5	14.8	5.1	6.2	3.3	8.8	5.6	7.9	4.5	6.6	6.5	5.1	7.7	7.5	8.8	5.5	7.2	8.5	5.3	5.3	5.0	7.5	12.7	8.6	16.3	17.3	7.8	7.3	8.7	9.6	9.8	11.9	19.7	3.7	15.2	14.5	28.9	9.6	10.2	40.2	25.0	12.2	37.3	18.8	5.0	17.0	1.1	13.5	8.0	0.0	15.5	10.3	11.4	14.2	17.4	9.7	9.3	35.0	8.1	9.2	6.9	1.1	13.6	9.9	8.5	17.2	13.5	21.5	15.6	7.0	14.9	10.3	33.6	6.5	14.2	14.0	16.6	16.4	20.4	8.7	15.1	21.3
FAM71F2	FAM137B	ENSG00000205085	"Family with sequence similarity 71 member F2"	Q6NXP2	7	128672288-128687872	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	7	"testis: 28.1"	"Group enriched"	"Detected in many"	7	"Early spermatids: 138.1;Late spermatids: 512.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA020513, HPA024248"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020513: AB_1853077, HPA024248: AB_2671497"	"unprognostic (1.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.83e-2)"	"unprognostic (8.29e-3)"	"unprognostic (6.22e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.13e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.65e-4)"	"unprognostic (3.17e-2)"	"unprognostic (3.85e-4)"	"unprognostic (3.00e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.40e-4)"	"unprognostic (2.47e-2)"	1.4	1.1	0.7	0.7	1.2	1.3	0.7	1.8	1.1	0.7	0.7	0.7	0.7	0.4	0.7	1.6	0.7	0.5	0.8	0.9	0.7	0.7	0.9	0.7	0.7	0.7	0.7	0.7	0.9	0.7	0.2	2.5	0.7	0.7	0.9	0.5	0.7	1.6	0.7	1.6	1.3	0.7	1.0	0.7	1.2	1.0	28.1	0.7	0.7	0.9	0.7	0.7	0.7	0.7	1.4	1.3	4.2	0.8	1.2	0.9	0.2	0.8	1.3	1.5	2.9	2.6	2.0	0.7	1.7	0.4	0.4	1.0	0.3	1.4	0.9	0.8	2.8	1.0	2.0	0.2	0.7	0.7	0.9	1.3	0.5	2.7	0.2	0.7	0.7	1.9	1.7	0.7	3.0	0.5	2.0	0.4	0.9	0.4	1.4	1.2	1.3	0.4	1.4	0.9	0.3	1.9	1.1	0.3	0.4	1.0	3.5	1.2	0.8	0.7	0.8	2.2	1.9	1.1	0.4	4.3	1.9	0.7	3.9	1.6	2.9	2.5	0.9	1.0	1.2	1.3	3.9	0.8	0.6	0.5	0.4	0.5	0.8	0.6	0.5	0.3	1.4	0.6	0.6	4.2	1.2	0.5	1.3	0.9	0.2	0.7	1.2	1.8	1.1	0.7	0.7	0.7	0.7	0.7	0.7	3.0	2.1	0.0	1.4	0.0	12.1	1.1	0.0	0.0	0.0	3.5	49.1	0.4	0.0	1.3	138.1	0.7	0.3	0.0	0.6	0.7	0.8	1.6	2.3	0.6	0.8	0.0	1.2	1.8	2.2	512.3	3.7	0.2	0.0	1.0	1.3	2.9	1.0	1.5	2.8	0.0	17.9	0.0	0.9	10.2	2.7	0.1	2.1	0.0	1.4	0.8
FAM71F1	"FAM137A, NYD-SP18"	ENSG00000135248	"Family with sequence similarity 71 member F1"	Q96KD3	7	128709061-128731743	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	146	"testis: 64.8"	"Group enriched"	"Detected in some"	103	"Early spermatids: 1001.4;Late spermatids: 1429.0"	"Cancer enriched"	"Detected in single"	23	"testis cancer: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"NTERA-2: 19.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020636			Uncertain	Cytosol		No	NA			Cytosol		"HPA020636: AB_1854739"	"unprognostic (3.09e-2)"	"unprognostic (3.39e-3)"		"unprognostic (6.03e-2)"	"unprognostic (5.25e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-5)"	"unprognostic (1.48e-1)"	"unprognostic (2.18e-6)"	"unprognostic (6.97e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.19e-3)"	"unprognostic (1.99e-1)"	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	64.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.3	1.5	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1001.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1429.0	11.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.3	0.0	1.8	0.0	0.0	11.7	5.5	0.1	1.0	0.0	0.0	0.0
CALU		ENSG00000128595	Calumenin	O43852	7	128739292-128771807	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Extravillous trophoblasts: 431.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 156.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006018	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		15000000	"Endoplasmic reticulum"		"HPA006018: AB_1845934"	"unprognostic (7.22e-3)"	"unprognostic (1.16e-3)"	"unprognostic (3.16e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.52e-3)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.30e-11)"	"unprognostic (3.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.60e-5)"	33.6	20.7	10.2	30.8	13.6	6.2	27.6	7.8	13.0	33.6	35.0	13.9	34.0	8.4	57.0	29.4	29.7	27.3	24.0	60.0	10.5	9.0	23.6	38.3	31.4	17.0	14.0	9.8	28.5	21.5	18.6	19.7	104.6	14.4	29.9	21.1	18.7	26.9	40.2	26.5	12.5	16.6	78.1	17.4	26.6	25.6	14.3	10.8	8.1	25.5	16.7	13.4	57.0	27.6	14.0	19.5	13.4	22.9	13.7	18.5	16.4	16.4	13.9	32.5	10.4	90.8	88.3	17.9	113.8	99.3	41.9	55.3	18.0	25.6	8.2	20.7	156.9	48.5	9.6	16.8	22.3	63.2	5.0	11.7	9.0	20.8	19.9	41.6	12.8	16.8	59.4	16.5	57.7	22.5	57.4	37.9	8.0	15.3	11.9	81.1	9.4	9.4	7.5	21.9	15.6	14.0	7.7	23.5	12.8	17.4	9.2	3.4	19.5	36.7	33.9	45.9	62.4	7.2	10.1	50.8	116.1	15.0	96.8	50.3	19.2	23.7	15.2	120.9	16.2	118.3	11.2	21.7	13.4	18.5	22.9	17.0	14.0	12.7	13.8	18.6	10.0	11.3	13.4	2.8	13.7	18.2	19.5	13.6	16.4	10.2	13.6	7.8	13.0	10.5	9.0	14.0	9.8	14.4	10.8	20.8	32.6	29.2	53.7	72.2	27.3	197.2	22.9	49.5	37.5	24.4	17.7	103.1	14.9	67.6	7.8	81.7	12.2	0.0	52.9	431.1	239.3	93.2	58.8	48.7	119.8	27.0	18.9	138.7	55.3	4.7	92.9	49.6	114.7	20.8	39.1	30.4	58.9	7.0	111.7	16.5	11.7	58.2	119.2	21.2	38.7	67.1	203.2	20.3	23.0	60.8
OPN1SW	"BCP, BOP, CBT"	ENSG00000128617	"Opsin 1, short wave sensitive"	P03999	7	128772491-128775790	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 11.4;retina: 23.9"	"Cell type enriched"	"Detected in some"	12	"Cone photoreceptor cells: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 37.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA013562, HPA014083"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytokinetic bridge, Cytosol"	"HPA013562: AB_2668850, HPA014083: AB_2668938"	"unprognostic (2.88e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (8.50e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (2.26e-8)"	"prognostic unfavorable (5.98e-8)"	"unprognostic (2.53e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (9.33e-4)"	0.9	1.8	0.7	3.7	0.9	1.7	0.7	1.0	2.3	0.7	2.2	0.7	0.7	0.5	2.6	0.7	2.4	0.8	4.2	11.4	0.7	0.8	0.7	0.7	0.9	1.0	0.7	1.3	0.7	0.7	0.0	0.7	0.7	0.7	1.4	0.0	23.9	1.1	0.7	1.9	0.9	0.9	0.7	0.7	1.1	1.4	1.1	0.7	0.7	2.3	0.7	0.7	4.3	0.7	0.5	1.2	0.6	1.4	0.0	1.4	0.3	1.7	2.2	5.2	1.7	0.0	0.0	1.5	9.8	0.0	0.0	0.0	5.0	2.1	2.6	1.5	0.0	1.6	1.4	0.0	0.0	0.0	0.3	3.6	1.6	3.0	2.5	0.0	2.0	1.6	0.0	0.0	0.0	0.0	7.0	0.0	1.7	2.2	0.6	1.1	0.7	2.0	3.6	4.7	1.7	3.0	1.0	5.4	3.0	0.0	0.6	0.7	6.9	2.3	5.2	4.4	7.3	0.5	2.0	4.0	10.0	1.0	7.7	8.7	2.1	2.2	1.6	37.6	4.6	9.3	0.0	0.3	0.6	1.4	1.4	0.9	0.2	0.8	1.0	1.2	0.5	0.3	0.9	0.0	0.0	1.0	0.7	0.4	0.3	0.7	0.9	1.0	0.9	0.7	0.8	0.7	1.3	0.7	0.7	0.0	0.6	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	39.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
CCDC136	"DKFZP434G156, KIAA1793, NAG6"	ENSG00000128596	"Coiled-coil domain containing 136"	Q96JN2	7	128790757-128822132	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Fertilization, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 34.7;testis: 109.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 629.8;Late spermatids: 1449.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 18.6;U-937: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010646, HPA071015"	Enhanced	Approved	Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Golgi apparatus, Vesicles"	"Plasma membrane"	"HPA010646: , HPA071015: AB_2686334"	"unprognostic (2.07e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.29e-4)"	"unprognostic (4.65e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.43e-4)"	"unprognostic (2.58e-2)"	"unprognostic (8.44e-3)"	"unprognostic (4.35e-1)"	"unprognostic (1.18e-4)"	"unprognostic (5.27e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.93e-3)"	2.1	4.0	11.2	2.6	11.7	1.8	2.4	34.7	28.7	2.9	6.5	8.3	2.6	2.4	3.9	2.9	2.5	2.8	2.8	4.9	12.5	20.0	1.5	1.5	1.9	3.0	15.3	16.6	2.8	1.8	1.8	3.8	2.2	11.2	9.9	3.5	13.9	2.0	11.0	3.5	1.6	2.6	17.3	9.7	1.9	2.4	109.6	7.4	0.7	1.7	0.0	2.4	6.4	2.0	0.1	0.6	1.3	0.3	2.7	1.6	0.3	0.7	0.9	7.2	4.8	3.9	3.4	1.2	2.7	3.6	2.8	2.6	1.0	0.6	3.6	0.3	3.7	11.4	1.5	4.6	0.5	2.6	10.2	4.6	6.3	1.7	0.0	1.3	0.7	13.6	3.7	0.5	3.0	0.2	2.5	1.6	6.0	2.2	3.8	1.1	1.4	4.6	1.9	10.0	0.0	2.9	11.4	1.3	1.7	0.2	1.3	4.2	12.6	1.7	2.0	2.8	2.7	0.1	1.7	1.4	4.5	2.6	2.1	2.1	2.2	0.9	3.8	18.6	27.4	1.1	0.0	0.3	1.3	1.4	0.0	1.6	0.0	1.5	1.1	0.6	0.1	0.0	1.0	0.1	2.7	0.1	0.1	0.0	0.3	11.2	11.7	34.7	28.7	12.5	20.0	15.3	16.6	11.2	7.4	0.0	0.3	0.0	0.8	0.5	255.8	6.5	2.5	2.7	1.2	0.0	92.3	0.1	0.0	0.5	629.8	1.6	0.0	0.0	1.3	0.2	0.9	1.2	0.0	0.0	5.0	38.1	0.0	0.6	0.8	1449.2	16.7	0.9	0.0	1.0	0.0	22.8	0.8	0.0	7.1	0.0	16.0	6.5	2.8	193.1	9.4	0.4	0.3	2.2	0.0	0.4
FLNC	"ABP-280, ABPL, FLN2"	ENSG00000128591	"Filamin C"	Q14315	7	128830377-128859274	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 546.8"	"Cell type enriched"	"Detected in many"	40	"Cardiomyocytes: 1815.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 80.1;fHDF/TERT166: 36.4;hTEC/SVTERT24-B: 39.6;U-2 OS: 34.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA006135, HPA071007"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		54000000	"Plasma membrane, Cytosol"		"HPA006135: AB_1848602, HPA071007: "	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (2.17e-5)"	"unprognostic (1.03e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (5.68e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (3.73e-5)"	2.6	0.8	0.5	7.1	0.7	0.2	0.7	0.3	1.0	5.2	24.4	1.4	18.4	1.9	14.0	10.1	16.0	4.8	13.3	70.0	0.8	0.5	0.4	0.3	1.4	0.3	1.4	0.5	3.1	0.6	1.0	0.3	0.6	1.9	11.9	2.1	1.7	3.1	20.2	546.8	1.0	5.2	69.0	4.7	0.3	10.0	1.3	0.6	0.0	4.7	40.0	2.2	39.6	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	7.3	8.8	0.8	80.1	15.2	22.8	11.0	24.9	0.2	0.0	13.5	36.4	9.3	0.0	4.8	0.1	13.6	0.0	2.7	0.0	4.1	0.0	9.2	0.0	0.0	16.6	0.0	39.6	0.0	9.3	14.2	0.0	9.6	0.0	15.5	0.0	0.0	0.3	13.3	0.0	4.6	0.0	26.5	0.2	0.0	0.0	0.4	1.4	0.1	0.0	0.0	19.2	0.1	0.3	29.3	8.0	34.2	2.0	0.0	0.0	0.0	0.0	27.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.3	0.6	0.8	0.5	1.4	0.5	1.9	0.6	3.0	0.3	0.0	0.1	3.3	0.4	1815.4	0.0	0.0	3.4	1.8	0.0	0.3	0.0	0.6	0.2	6.2	0.0	0.0	0.2	0.7	11.9	1.4	0.0	0.0	0.8	0.0	0.0	1.8	0.0	0.0	4.9	0.8	5.0	0.0	0.0	0.1	1.8	0.0	9.9	1.0	0.1	0.0	45.3	0.2	0.4	4.0	1.6	0.0	0.0	0.4
KCP	"CRIM2, FLJ33365, NET67"	ENSG00000135253	"Kielin/chordin-like protein"		7	128862451-128910719	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	9	"ductus deferens: 30.0;kidney: 11.2;seminal vesicle: 28.3"	"Cell type enhanced"	"Detected in many"	14	"Collecting duct cells: 50.6;Early spermatids: 18.3;Late spermatids: 21.8"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.7;HMC-1: 7.7;U-87 MG: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"	NA	NA						"unprognostic (6.12e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.45e-3)"	"unprognostic (6.33e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.01e-3)"	"unprognostic (3.25e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.20e-3)"	"unprognostic (6.46e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.64e-3)"	2.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	30.0	0.9	0.1	1.7	0.4	0.6	2.1	0.3	0.0		11.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	1.3	0.0	0.1	0.1	28.3	0.0	0.0	2.1	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	13.7	0.2	2.1	0.0	0.3	1.0	0.0	0.0	0.0	1.9	0.1	1.0	0.0	1.2	0.2	0.0	7.7	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.1	0.6	0.1	0.0	1.8	0.5	0.0	0.0	0.0	0.0	0.4	0.1	0.8	0.9	0.4	0.0	0.0	0.1	0.2	0.0	0.3	0.3	0.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											11.9	4.3	0.8	1.1	0.0	2.5	0.8	0.0	0.0	6.8	50.6	2.0	0.2	0.0	0.2	18.3	0.3	5.9	0.0	0.2	1.0	1.1	0.3	2.3	0.2	1.0	3.2	2.4	2.5	2.2	21.8	1.1	2.3	0.0	0.0	3.1	0.2	2.5	1.9	0.4	2.9	1.0	0.0	0.0	5.1	2.4	0.0	1.1	1.9	6.4	3.6
ATP6V1F	"ATP6S14, VATF, Vma7"	ENSG00000128524	"ATPase H+ transporting V1 subunit F"	Q16864	7	128862826-128865844	"Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 1024.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009529, HPA048700, HPA062011"	Supported					NA	NA					"CAB009529: AB_2290237, HPA048700: AB_2680498, HPA062011: AB_2684656"	"unprognostic (1.70e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.46e-3)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (6.28e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.06e-1)"	"prognostic favorable (2.49e-5)"	"unprognostic (2.20e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.33e-2)"	42.2	44.3	72.8	35.3	66.6	62.7	30.4	49.2	82.8	31.5	26.8	29.2	30.3	26.0	22.6	22.8	62.7	35.7	36.0	38.3	63.0	63.9	65.6	26.0	38.9	42.3	60.7	56.9	27.0	37.2	21.1	33.3	49.6	43.5	27.8	20.3	30.1	44.8	31.3	53.1	44.0	25.3	25.0	43.3	36.8	29.5	41.9	29.8	32.5	31.5	39.2	35.0	39.1	31.3	47.7	73.5	67.4	101.2	32.3	43.9	105.3	44.0	51.0	22.9	48.4	46.0	36.6	13.1	22.5	30.0	37.3	40.6	37.5	26.7	41.8	23.9	25.7	56.3	24.4	33.4	37.2	14.0	45.2	54.4	32.0	33.3	36.5	53.3	32.6	61.0	42.8	51.0	43.0	25.0	28.9	35.4	38.7	75.9	44.7	41.2	58.2	54.4	71.4	30.4	27.9	41.9	24.4	16.6	67.7	46.5	35.0	43.4	29.9	31.8	119.8	52.9	24.9	27.6	41.7	37.4	46.4	10.0	61.9	34.4	50.8	45.4	52.9	91.7	46.0	39.3	44.8	101.2	67.4	37.8	66.4	36.2	47.7	38.4	36.3	73.5	47.0	37.2	37.4	29.7	32.3	44.0	41.6	43.9	105.3	72.8	66.6	49.2	82.8	63.0	63.9	60.7	56.9	43.5	29.8	26.8	64.5	166.3	164.2	211.0	100.0	143.6	150.3	76.3	53.4	314.0	35.3	152.3	893.6	205.5	442.7	189.8	97.4	0.0	194.5	171.0	184.8	188.9	270.0	99.0	1024.3	514.9	108.7	105.0	280.3	674.3	152.1	338.9	241.3	249.7	87.7	129.3	222.3	82.7	120.2	704.9	64.1	84.1	184.9	202.1	98.8	285.6	335.7	137.1	88.4	298.2
AC025594.2		ENSG00000272899			7	128866308-128872044	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	8	"testis: 45.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"T-reg: 1.0"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 9.8;HDLM-2: 6.9;HMC-1: 7.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.17e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (8.21e-4)"	"unprognostic (1.23e-1)"	"unprognostic (9.98e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.33e-3)"	1.1	0.0	0.4	0.2	0.2	0.0	0.2	0.2	3.6	0.2	0.2	0.2	0.2	2.4	0.2	0.5	0.2	0.0	1.6	0.8	0.2		2.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.6	1.0	5.3	0.3	0.2	0.2	0.0	45.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.0	0.1	0.0	0.1	0.0	1.0	0.0	1.4	0.5	0.5	4.9	1.4	0.7	0.2	0.4	0.6	0.6	0.4	0.4	9.8	1.7	0.6	0.2	1.3	1.5	0.5	0.2	0.4	6.9	1.0	2.5	0.3	0.1	0.8	0.3	7.9	0.6	0.4	0.3	0.4	1.0	0.2	0.9	1.2	3.6	0.5	0.6	0.5	2.3	0.2	0.4	0.5	1.0	1.7	1.4	0.2	0.4	2.6	1.1	0.4	2.5	0.5	1.8	0.7	1.1	0.2	2.6	0.6	4.6	0.4	5.3	6.1	1.2	3.3	2.6	0.8	0.0	0.0	0.0	0.2	0.1	0.7	0.0	0.1	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
IRF5		ENSG00000128604	"Interferon regulatory factor 5"	Q13568	7	128937612-128950035	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Immunity, Innate immunity, Transcription, Transcription regulation"	DNA-binding	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 40.1"	"Cell type enhanced"	"Detected in many"	17	"Hofbauer cells: 34.3;Kupffer cells: 30.3;Macrophages: 27.6;monocytes: 91.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	7	"B-cells: 8.9;dendritic cells: 20.6;monocytes: 24.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 46.0;RPMI-8226: 33.4;THP-1: 18.6;U-937: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA046700, HPA076024"	Enhanced					NA	NA					"HPA046700: AB_2679761, HPA076024: "	"unprognostic (4.01e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.57e-2)"	"unprognostic (5.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.66e-1)"	"unprognostic (4.89e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.20e-3)"	5.4	3.6	6.2	10.1	8.4	16.8	8.8	2.0	5.0	2.7	3.5	5.6	40.1	8.0	1.6	2.5	12.0	4.1	5.3	12.3	7.3	5.2	12.6	5.1	15.8	18.9	12.3	2.2	1.4	7.0	10.2	5.7	3.4	7.5	3.3	2.9	2.0	6.3	24.0	1.1	7.1	10.0	2.5	7.0	25.5	3.6	1.6	8.4	3.9	2.2	1.6	9.9	6.8	5.1	8.9	20.6	1.8	24.2	2.0	2.7	8.5	5.8	1.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.1	2.3	4.1	2.1	0.0	5.5	5.1	1.3	0.9	0.1	46.0	1.2	6.4	0.0	0.7	0.0	0.9	9.3	0.0	6.0	0.2	0.6	0.4	0.0	0.0	0.0	12.5	0.0	1.8	0.0	1.9	0.1	0.6	1.1	0.3	0.0	33.4	1.7	2.9	0.1	0.7	1.0	1.0	0.5	0.0	1.8	18.6	0.0	0.0	0.1	0.1	0.4	7.3	4.8	1.6	0.2	22.9	0.1	0.8	19.0	1.8	0.5	24.2	1.9	8.9	1.1	0.4	20.6	6.8	0.0	0.0	1.3	2.0	17.1	4.9	2.7	8.5	6.2	8.4	2.0	5.0	7.3	5.2	12.3	2.2	7.5	8.4	0.0	5.1	9.5	0.9	0.7	0.1	0.6	5.1	2.7	0.0	19.2	0.0	0.3	3.3	2.9	0.1	0.7	1.3	0.0	2.1	0.2	0.6	0.4	8.1	0.5	34.3	0.0	0.0	0.0	30.3	0.0	0.0	27.6	0.0	91.0	1.2	0.0	2.0	1.7	0.0	3.7	0.2	0.0	0.4	0.0	0.2	1.8	1.3	4.9	1.5	1.4
TNPO3	"IPO12, LGMD1F, MTR10A, TRN-SR, TRN-SR2"	ENSG00000064419	"Transportin 3"	Q9Y5L0	7	128954180-129055173	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039555, HPA041537"	Approved		Enhanced	Vesicles		NA	NA			Vesicles		"HPA039555: AB_10672000, HPA041537: AB_2677539"	"unprognostic (5.76e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (3.29e-5)"	"unprognostic (1.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.26e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.24e-2)"	17.8	24.0	22.6	23.8	20.5	28.9	16.2	29.6	21.4	15.2	18.4	15.8	30.1	15.5	19.7	17.9	26.3	16.1	12.9	16.1	16.6	17.7	19.1	21.6	15.4	20.5	17.7	15.5	20.7	19.8	21.7	19.2	13.9	18.4	16.7	19.7	15.6	19.0	20.4	41.4	19.2	17.8	18.9	16.2	17.2	21.9	36.3	15.1	29.5	22.3	15.9	26.4	22.6	18.1	16.6	15.9	20.9	21.7	14.4	17.4	10.5	20.3	23.1	18.0	30.3	17.5	15.1	15.3	18.4	16.1	17.2	20.4	18.8	18.9	25.6	8.6	19.6	32.7	15.1	36.3	17.7	24.8	21.2	16.1	18.8	19.2	14.7	16.7	34.3	16.1	14.1	18.1	21.0	18.8	15.1	21.4	21.2	42.6	18.4	21.9	15.1	29.6	25.4	51.4	22.5	21.4	21.2	16.7	20.8	17.4	19.2	22.4	17.7	19.6	9.2	20.6	27.2	10.4	21.4	16.0	21.9	10.9	25.7	25.0	23.7	18.4	35.5	31.6	35.3	37.9	20.6	13.6	20.9	17.4	17.2	15.5	16.6	14.2	15.4	15.9	15.5	14.1	16.1	15.9	14.4	21.7	7.7	14.5	10.5	22.6	20.5	29.6	21.4	16.6	17.7	17.7	15.5	18.4	15.1	14.9	14.7	29.0	13.4	6.1	22.0	17.3	17.8	12.0	13.6	17.4	21.6	21.1	6.6	20.5	30.3	15.5	17.6	23.3	21.6	30.1	13.4	15.7	10.4	23.2	24.5	35.0	11.1	15.4	23.5	19.0	15.5	20.1	8.5	44.1	20.5	14.0	25.4	17.5	16.6	15.2	20.6	12.9	12.7	72.0	30.2	7.2	29.3	15.3	22.6	23.5
AC011005.1		ENSG00000230626			7	129126518-129130793	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in single"	8	"testis: 7.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.7;MCF7: 2.3;RT4: 1.9"									HPA051993	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA051993: AB_2681685"	"unprognostic (2.03e-1)"	"unprognostic (7.97e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.36e-5)"	"unprognostic (3.43e-2)"	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.1		0.0	0.0		0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	7.8			0.0		0.0	0.0		0.6	0.4	0.9	0.3	0.7	0.6	0.1	0.2	0.6	0.3	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.7	1.7	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.5	0.0	2.3	0.4	0.1	0.2	0.1	0.5	0.2	0.0	0.0	0.0	1.9	0.3	0.1	0.0	0.0	0.8	0.1	0.0	0.7	0.0	0.2	0.0	0.9	0.3	0.2	0.1	0.3	0.4	0.0	0.0	0.5	0.3	0.9	0.3	0.3	0.5	0.4	0.3	0.6	0.4	0.6	0.4	0.4	0.8	0.7	0.2	0.0	0.5	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSPAN33	"MGC50844, Penumbra"	ENSG00000158457	"Tetraspanin 33"	Q86UF1	7	129144892-129169697	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 56.8"	"Cell type enhanced"	"Detected in many"	11	"Macrophages: 25.0;monocytes: 64.9;Peritubular cells: 30.8;Proximal tubular cells: 50.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 5.3;naive B-cell: 6.4"	"Group enriched"	"Detected in many"	5	"B-cells: 6.4;dendritic cells: 2.8;monocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.9;HEL: 32.6;U-266/70: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020357	Enhanced		Approved	Microtubules		NA	NA			Microtubules		"HPA020357: AB_1858410"	"unprognostic (3.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.66e-1)"	"prognostic favorable (8.88e-4)"	"unprognostic (1.67e-1)"	"prognostic favorable (8.74e-5)"	"unprognostic (2.50e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.16e-2)"	2.8	3.5	7.4	13.4	7.7	3.8	3.5	7.5	10.0	1.9	4.3	9.9	8.7	3.8	1.5	15.9	3.4	2.6	3.8	5.4	7.2	12.4	56.8	17.2	3.2	15.9	12.1	6.5	1.8	13.0	9.4	13.0	4.6	7.9	8.0	4.8	5.5	20.5	9.5	7.1	4.5	7.1	2.8	8.0	13.7	4.3	6.8	6.0	10.4	8.5	2.9	19.6	6.2	2.4	6.4	2.8	0.2	3.2	0.4	0.9	2.1	1.2	2.7	0.8	20.9	0.0	0.0	1.0	0.0	0.2	0.5	0.2	0.4	1.9	15.8	1.6	0.5	12.2	1.4	10.8	3.3	0.8	13.4	8.3	32.6	0.8	5.9	0.8	4.5	0.6	0.6	3.3	0.1	1.1	0.0	0.5	9.4	0.3	2.0	0.0	3.6	9.5	0.1	6.0	0.9	2.9	2.9	0.4	0.4	1.7	3.9	4.9	5.9	2.0	0.6	11.0	6.2	4.5	1.9	0.0	0.0	1.5	1.7	0.5	38.6	4.5	6.8	0.3	14.5	2.0	0.0	1.1	0.0	0.1	3.2	0.0	5.3	0.1	0.0	2.8	6.4	0.9	0.1	0.2	0.4	0.2	1.1	0.0	2.1	7.4	7.7	7.5	10.0	7.2	12.4	12.1	6.5	7.9	6.0	0.0	1.1	24.2	0.8	2.3	3.8	5.6	0.0	2.7	0.0	5.2	3.9	0.1	11.6	2.0	2.0	0.4	0.8	0.0	7.4	0.2	1.1	2.5	0.0	12.5	7.1	0.0	3.4	0.6	17.8	3.3	2.6	25.0	1.7	64.9	0.3	4.8	3.0	0.0	30.8	50.8	1.4	0.0	0.0	0.5	0.7	2.6	0.1	1.5	0.2	1.0
SMO	"FZD11, SMOH"	ENSG00000128602	"Smoothened, frizzled class receptor"	Q99835	7	129188872-129213545	"Cancer-related genes, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 10.4;Leydig cells: 19.2;Muller glia cells: 15.1;Peritubular cells: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 20.3;AN3-CA: 37.6;NTERA-2: 28.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011446	Approved					NA	NA					"CAB011446: "	"unprognostic (2.48e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.61e-2)"	4.0	4.1	4.2	3.8	4.8	0.5	7.4	5.3	4.6	18.2	5.8	5.1	9.2	2.5	20.9	18.7	10.3	11.4	10.0	5.2	8.4	3.7	10.6	13.7	2.4	2.0	4.3	4.5	23.0	7.1	14.4	13.5	2.6	9.0	18.4	2.2	17.2	9.4	12.8	3.5	16.6	3.5	9.8	7.0	2.0	4.2	7.9	3.4	5.3	9.2	6.8	4.6	6.3	17.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.0	20.3	37.6	0.5	0.1	6.4	2.2	2.9	4.5	2.6	6.1	0.1	0.0	6.2	4.5	10.2	12.4	12.2	0.7	1.7	0.0	9.9	3.9	0.0	9.8	2.5	0.1	0.0	7.4	5.0	1.4	0.0	9.0	2.6	11.2	0.6	0.0	1.4	0.0	10.3	0.0	28.8	0.0	2.3	15.0	8.7	0.0	2.3	0.0	0.6	13.6	0.0	0.0	5.3	8.1	4.9	2.6	0.0	0.3	6.5	7.8	4.3	0.4	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	4.8	5.3	4.6	8.4	3.7	4.3	4.5	9.0	3.4	0.0	0.0	0.0	2.3	1.6	0.6	1.2	2.5	0.0	4.5	10.4	0.0	0.3	1.7	3.2	0.3	0.4	0.0	0.0	1.0	0.3	4.4	2.8	0.0	5.1	3.3	0.0	0.0	1.3	1.3	0.9	19.2	0.4	0.0	1.0	0.0	15.1	1.9	0.0	20.5	3.7	0.3	6.5	2.1	0.0	0.4	2.5	0.5	0.0	0.0	0.4
AHCYL2	KIAA0828	ENSG00000158467	"Adenosylhomocysteinase like 2"	Q96HN2	7	129225023-129430211	"Enzymes, Predicted intracellular proteins"	"One-carbon metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 72.4"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 75.8;Enterocytes: 114.1;Muller glia cells: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	8	"HDLM-2: 73.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053128	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA053128: AB_2682050"	"unprognostic (1.57e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.71e-3)"	"unprognostic (7.44e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (8.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.79e-3)"	"prognostic favorable (1.08e-7)"	"unprognostic (4.70e-3)"	"unprognostic (2.46e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.62e-1)"	4.3	6.6	12.8	5.9	20.3	1.5	4.3	7.2	16.9	7.1	61.8	13.3	5.1	23.1	6.1	3.3	5.7	4.4	22.7	3.4	16.5	9.6	11.9	3.4	26.1	4.2	10.7	14.9	5.7	5.8	9.1	12.8	5.1	19.8	5.0	72.4	24.3	15.0	3.3	20.7	9.8	15.0	5.3	11.4	2.9	16.5	8.1	9.6	4.6	24.1	4.0	4.0	5.4	4.7	0.9	1.3	2.0	2.5	3.3	5.0	0.5	2.7	4.3	8.3	4.9	2.2	3.3	1.7	2.1	3.0	2.4	2.2	2.5	1.8	1.6	2.2	2.3	5.2	1.9	4.1	3.4	2.7	73.5	5.1	3.9	4.8	2.0	1.3	2.8	5.0	3.0	4.4	1.9	3.0	4.1	4.8	3.2	1.7	9.3	3.1	2.5	4.2	3.7	4.1	2.7	3.0	2.8	2.2	4.4	4.9	3.6	3.8	2.4	4.9	2.1	2.9	7.2	2.0	2.1	2.7	2.1	1.2	5.5	2.2	3.9	4.4	2.2	5.4	3.1	3.2	0.1	1.2	2.0	0.9	2.5	1.2	0.9	1.5	0.7	1.3	0.5	1.3	0.5	0.4	3.3	1.2	0.4	5.0	0.5	12.8	20.3	7.2	16.9	16.5	9.6	10.7	14.9	19.8	9.6	56.6	75.8	3.4	4.5	13.9	9.4	4.5	17.8	5.3	19.4	5.2	5.9	8.4	10.0	3.6	61.0	3.9	114.1	0.0	4.9	2.2	3.1	6.2	5.7	4.9	3.9	4.8	8.7	4.3	8.3	20.3	3.7	5.1	23.6	7.2	29.7	87.7	4.5	30.8	6.3	15.7	5.0	6.5	1.2	4.6	2.4	8.5	12.7	3.2	32.7	13.9
STRIP2	"FAM40B, FAR11B, KIAA1170"	ENSG00000128578	"Striatin interacting protein 2"	Q9ULQ0	7	129434433-129488399	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.6;retina: 55.6;skeletal muscle: 27.4"	"Cell type enhanced"	"Detected in many"	15	"Cardiomyocytes: 37.1;Muller glia cells: 70.1;Spermatocytes: 32.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 36.6"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 20.8;U-2197: 23.7;U-87 MG: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019657	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA019657: AB_1848399"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.80e-3)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (9.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.87e-6)"	"prognostic favorable (5.41e-4)"	"unprognostic (4.06e-2)"	"unprognostic (5.34e-2)"	"unprognostic (7.50e-2)"	0.7	2.4	1.9	2.0	36.6	3.7	0.8	7.0	10.0	0.4	0.8	3.0	0.0	0.8	0.8	1.6	1.1	0.4	1.2	10.3	1.5	2.1	5.6	0.6	1.0	2.7	2.2	2.9	0.7	1.3	0.4	4.7	1.3	7.6	1.6	1.4	55.6	1.7	0.5	27.4	1.5	1.0	0.8	1.2	1.5	1.0	13.5	9.4	0.2	0.8	2.1	2.1	0.9	0.3	0.6	0.7	2.5	0.6	0.4	0.9	0.4	7.7	3.4	3.1	4.9	1.2	1.1	13.6	3.2	4.1	5.4	5.3	1.8	4.4	3.3	0.4	1.3	17.7	8.8	3.3	2.9	8.3	19.0	2.8	2.5	5.6	1.9	0.8	1.6	13.3	1.3	1.0	9.2	5.8	9.0	9.3	3.0	10.8	2.1	20.8	0.4	4.1	4.0	3.0	1.7	7.0	2.7	5.8	0.7	2.0	2.9	0.7	0.7	7.4	0.6	1.6	2.5	0.9	3.9	3.3	3.1	3.1	23.7	9.2	1.9	1.2	3.9	21.1	4.1	4.4	2.5	0.6	0.6	0.9	0.4	0.3	0.3	0.6	0.3	0.2	0.6	0.5	0.4	2.0	0.4	0.5	0.7	0.9	0.4	1.9	36.6	7.0	4.8	1.5	2.1	2.2	2.9	7.6	9.4	3.0	0.6	0.0	0.2	0.2	11.0	37.1	0.0	1.4	0.0	0.0	2.0	0.4	0.0	0.8	4.7	0.5	0.0	0.0	3.3	3.4	1.0	0.1	7.0	0.0	0.7	1.6	0.0	0.6	0.0	7.9	0.6	1.3	1.7	13.6	0.0	70.1	3.8	0.0	0.7	9.6	3.5	0.0	0.5	32.7	9.6	0.1	0.2	0.0	0.4	0.6
SMKR1		ENSG00000240204	"Small lysine rich protein 1"	H3BMG3	7	129502479-129512932	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"testis: 65.7"	"Group enriched"	"Detected in many"	36	"Early spermatids: 1715.8;Late spermatids: 4654.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"B-cells: 2.9;NK-cells: 1.3;T-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"MCF7: 12.8;SCLC-21H: 22.5"					"Low region specificity"	"Detected in all"			HPA078358			Approved	Nucleoli		NA	NA			Nucleoli		"HPA078358: AB_2686883"	"unprognostic (5.08e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.13e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.02e-1)"	"unprognostic (9.24e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.72e-6)"	"unprognostic (1.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.40e-2)"	"unprognostic (3.67e-2)"	0.3	1.0	3.1	0.5	6.3	0.3	1.5	0.8	3.3	0.6	0.3	0.1	0.0	0.5	0.4	1.7	0.4	4.6	0.4	0.2	2.7	2.2	0.7	0.2	0.5	0.7	1.1	2.7	0.3	2.6	2.9	2.7	0.9	1.0	0.5	0.4	0.0	0.3	0.4	0.2	0.5	0.4	0.3	0.5	0.3	0.5	65.7	0.7	0.0	0.7	0.1	0.7	0.2	0.0	2.9	0.0	0.2	0.0	1.3	3.7	0.4	8.8	8.6	0.2	7.5	0.0	0.0	0.0	0.0	0.2	0.7	0.7	0.0	2.3	0.0	0.8	0.5	4.9	1.1	1.5	0.0	1.1	8.2	0.9	0.0	1.7	0.0	1.6	0.1	5.7	0.0	3.8	2.3	1.6	1.0	0.3	5.3	0.5	0.2	0.4	12.8	1.6	0.8	1.1	2.3	7.7	0.8	0.0	1.9	3.2	0.0	22.5	6.1	6.4	0.7	0.5	1.5	2.0	1.1	0.1	0.0	0.2	5.0	1.9	2.2	2.8	0.1	3.1	0.3	0.6	0.0	0.0	0.0	3.7	0.0	1.7	2.9	0.7	1.9	0.0	1.5	1.5	1.4	0.2	1.3	0.0	0.0	0.0	0.4	3.1	6.3	0.8	3.3	2.7	2.2	1.1	2.7	1.0	0.7	3.0	0.0	0.0	2.1	0.1	1.4	0.0	0.0	8.1	1.2	5.2	0.0	0.0	8.3	1.7	1715.8	0.1	0.0	0.0	5.3	0.2	0.6	1.0	0.0	0.0	0.1	0.0	8.6	0.6	0.0	4654.0	34.8	0.0	1.7	1.0	0.0	1.0	3.1	0.0	25.8	1.1	0.2	0.0	0.0	89.2	28.0	0.3	0.1	5.0	0.0	0.7
NRF1	"ALPHA-PAL, EWG"	ENSG00000106459	"Nuclear respiratory factor 1"	Q16656	7	129611714-129757082	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029329	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029329: AB_10601240"	"unprognostic (2.80e-2)"	"unprognostic (2.20e-3)"	"unprognostic (4.51e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.20e-3)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.99e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.20e-1)"	"unprognostic (2.06e-3)"	14.8	7.3	10.9	18.9	13.0	20.3	18.2	22.2	11.1	15.4	10.3	12.6	16.0	9.0	15.7	10.4	10.1	18.7	10.0	12.3	11.5	11.1	10.0	7.8	11.2	18.7	12.1	7.7	24.4	15.2	13.5	10.9	12.5	11.5	11.5	9.9	11.7	13.8	13.9	19.3	12.2	10.7	14.0	9.6	14.2	8.7	17.2	15.2	29.2	13.8	11.4	16.1	12.8	19.2	8.8	7.0	13.1	7.0	5.8	13.3	6.2	11.8	9.7	14.1	12.4	8.5	6.8	11.2	8.3	8.6	12.7	9.9	11.7	7.9	13.6	6.1	9.3	8.0	9.1	15.1	8.4	13.0	13.0	10.8	11.3	8.2	7.9	6.2	13.8	11.3	5.8	7.9	12.5	12.1	7.3	9.3	13.3	13.6	10.5	7.7	10.8	27.0	13.0	13.1	10.9	8.7	17.2	11.4	12.1	7.2	8.7	12.2	13.3	12.5	13.0	8.4	12.0	8.1	13.2	7.2	7.2	10.0	8.4	15.2	11.5	11.4	24.2	7.6	12.8	13.9	6.1	5.5	13.1	11.4	6.9	13.3	7.7	8.7	10.5	7.0	8.8	9.6	8.2	11.4	5.8	7.0	4.7	9.1	6.2	10.9	13.0	22.2	11.1	11.5	11.1	12.1	7.7	11.5	15.2	3.0	6.2	3.7	2.8	6.0	10.2	5.1	5.1	13.4	5.7	3.5	9.8	2.1	0.0	2.1	0.3	6.7	3.2	0.0	3.1	3.5	3.7	4.4	4.7	4.7	2.6	9.5	6.4	8.0	5.6	1.4	4.9	5.8	5.0	2.8	5.0	5.6	2.4	5.8	4.2	2.2	10.4	6.5	3.6	6.7	6.0	6.8	2.9	9.2	3.9	2.6
UBE2H	"GID3, UBC8, UBCH"	ENSG00000186591	"Ubiquitin conjugating enzyme E2 H"	P62256	7	129830732-129952949	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003302	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA003302: AB_1858526"	"unprognostic (1.15e-1)"	"unprognostic (5.85e-2)"	"unprognostic (5.67e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.19e-2)"	"prognostic unfavorable (2.33e-5)"	"unprognostic (1.13e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.23e-1)"	29.0	49.9	31.1	16.6	31.0	22.5	24.5	36.1	30.2	31.1	27.3	33.2	26.6	15.2	35.5	25.3	32.1	29.4	26.6	61.0	26.4	25.4	27.6	28.1	26.3	17.5	28.1	23.4	27.6	52.3	41.8	29.5	37.9	33.3	24.1	16.8	22.9	28.5	28.8	46.3	21.3	16.5	31.5	26.2	19.1	22.7	24.7	29.5	24.7	37.7	23.6	29.5	25.5	34.3	6.1	3.7	7.8	2.2	1.3	6.5	1.9	22.1	12.0	14.3	14.5	35.4	30.5	24.7	20.5	26.5	12.6	14.1	6.4	23.8	9.2	25.7	20.2	32.6	16.9	12.2	21.8	16.5	11.3	6.5	3.2	17.7	7.7	27.9	6.3	10.1	41.0	29.0	17.0	27.3	28.0	24.5	9.8	7.5	26.7	19.4	7.9	8.4	6.9	22.4	15.1	14.3	6.6	7.3	19.6	26.3	29.1	5.4	16.5	18.8	42.1	11.0	44.9	4.4	6.2	24.8	13.7	6.9	19.3	20.4	24.4	17.5	15.2	27.3	7.6	13.3	3.5	2.2	5.1	4.7	1.7	6.4	3.8	4.7	4.2	2.0	6.1	6.0	6.4	7.8	1.3	2.1	3.7	6.5	1.9	31.1	31.0	36.1	30.2	26.4	25.4	28.1	23.4	33.3	29.5	38.7	38.0	39.2	140.7	129.5	52.7	101.3	53.5	54.9	53.4	68.0	56.9	93.6	34.9	51.9	67.1	55.4	27.8	116.8	62.1	57.4	57.8	206.4	14.9	63.8	35.3	41.3	56.6	44.8	35.5	35.6	40.9	28.3	45.5	12.6	27.9	82.0	95.7	31.7	73.9	39.7	32.0	12.9	55.1	22.7	17.7	134.4	167.6	24.9	23.0	232.4
ZC3HC1	NIPA	ENSG00000091732	"Zinc finger C3HC-type containing 1"	Q86WB0	7	130018286-130051451	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019089, HPA024023"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA019089: AB_1858976, HPA024023: AB_1858977"	"unprognostic (7.14e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (1.89e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (1.02e-6)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.53e-1)"	11.0	13.8	8.1	10.0	10.3	4.9	14.2	9.5	12.6	9.5	9.2	9.9	5.9	6.0	14.5	11.0	7.9	9.4	7.5	16.3	8.2	8.9	13.2	14.8	6.9	13.6	7.3	8.4	10.7	10.6	10.5	9.6	10.0	10.5	9.0	8.4	9.6	10.5	8.4	33.0	7.1	7.8	12.9	5.5	13.7	9.0	24.6	6.6	15.4	8.3	11.9	11.5	8.5	9.6	23.1	20.2	17.4	17.7	17.4	23.8	15.8	7.0	12.0	14.9	16.8	8.5	7.8	10.3	9.2	11.0	17.4	18.1	14.1	12.1	16.3	6.7	11.7	23.8	6.5	19.5	13.9	17.2	10.6	16.7	11.3	10.9	13.7	13.7	13.0	11.6	9.4	10.5	18.1	11.8	9.9	19.0	14.0	33.9	5.7	17.6	12.4	15.3	25.1	30.4	12.4	13.7	14.5	11.5	14.2	17.6	4.8	9.6	17.2	13.3	19.3	14.7	22.3	8.4	13.8	8.7	11.9	5.8	10.4	15.4	11.1	16.7	21.2	18.8	16.7	20.2	17.4	16.2	14.5	17.0	17.7	19.5	23.1	18.2	18.2	20.2	20.6	23.8	18.8	1.3	17.4	16.3	11.9	18.5	15.8	8.1	10.3	9.5	12.6	8.2	8.9	7.3	8.4	10.5	6.6	6.0	2.9	5.1	4.3	1.3	5.8	12.1	7.6	10.7	3.4	7.0	0.0	16.1	14.9	10.7	2.6	6.5	2.1	0.0	8.4	13.7	4.8	2.2	4.6	8.5	7.8	6.4	3.5	11.6	3.2	4.3	8.1	4.1	1.7	15.4	4.1	7.2	7.8	7.0	6.0	17.0	5.6	0.0	5.1	31.6	18.8	1.5	6.2	5.7	4.2	1.4
KLHDC10	"KIAA0265, slim"	ENSG00000128607	"Kelch domain containing 10"	Q6PID8	7	130070510-130135720	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020119	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020119: AB_2249467"	"unprognostic (2.83e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.16e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.24e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.64e-2)"	11.7	18.6	15.5	9.1	21.1	7.2	14.8	27.1	24.1	13.4	12.6	16.9	13.6	11.0	13.4	14.4	13.0	15.5	9.7	14.9	14.2	24.8	21.3	22.8	11.8	7.9	17.0	18.6	15.2	15.3	37.4	25.1	13.6	23.4	13.4	13.0	15.0	10.7	17.1	23.2	13.1	11.7	11.9	14.1	11.0	11.9	35.3	10.2	9.8	18.3	8.9	11.6	9.6	12.3	3.3	1.9	1.8	2.5	0.6	3.4	0.6	11.3	10.6	7.3	40.0	9.7	10.8	3.4	10.8	8.3	8.2	8.6	5.7	8.6	9.6	7.7	9.9	13.8	8.9	11.7	6.9	10.4	7.8	7.0	5.6	11.9	6.7	7.7	10.3	6.9	6.7	11.9	12.7	8.0	10.3	11.5	6.7	27.2	6.1	9.2	9.5	8.9	10.0	1.2	8.3	6.9	7.3	13.8	6.9	11.3	7.8	11.9	9.5	17.4	31.1	8.8	9.4	7.6	7.7	13.0	10.6	4.6	14.1	12.9	8.0	10.4	8.9	22.2	10.0	14.3	0.0	1.8	1.8	2.4	2.5	2.0	1.7	1.7	2.8	1.9	3.3	1.5	2.8	1.6	0.6	1.9	1.6	3.4	0.6	15.5	21.1	27.1	24.1	14.2	24.8	17.0	18.6	23.4	10.2	17.9	13.2	6.0	6.4	20.6	19.5	19.4	33.1	16.0	20.5	33.2	37.3	10.1	3.3	15.5	51.3	15.6	11.8	23.3	20.5	7.9	20.1	11.2	5.8	37.5	10.8	33.4	19.1	32.5	22.9	12.4	14.1	11.7	16.9	13.6	15.5	18.1	18.9	3.5	23.0	23.2	21.6	0.0	10.3	29.7	4.5	25.5	9.4	7.5	18.2	11.5
TMEM209	"FLJ14803, NET31"	ENSG00000146842	"Transmembrane protein 209"	Q96SK2	7	130164715-130207770	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031678	Uncertain		Approved	"Nuclear membrane,Nuclear speckles,Vesicles"		NA	NA			"Nuclear membrane, Nuclear speckles, Vesicles"		"HPA031678: AB_10603135"	"unprognostic (3.03e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.50e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.34e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.24e-1)"	12.0	33.5	9.9	9.1	12.1	9.4	12.2	12.7	13.3	9.4	12.2	23.8	9.5	10.4	16.4	11.8	8.8	11.2	8.1	7.9	9.9	10.9	11.6	16.9	10.3	12.2	11.6	12.0	13.7	19.8	19.0	18.7	18.6	16.4	10.3	12.9	19.0	16.5	10.3	10.1	11.1	19.0	10.5	19.1	13.3	8.8	17.8	11.3	24.9	18.6	8.0	13.1	11.1	8.9	14.1	10.8	10.0	13.4	13.8	20.5	10.4	9.5	9.2	12.6	15.5	7.3	7.5	9.3	8.8	8.9	8.0	10.8	10.2	17.4	14.2	6.6	5.6	14.9	14.4	14.7	10.2	14.3	17.5	8.4	7.4	15.6	6.7	13.0	15.5	7.5	8.3	10.5	15.9	16.0	4.9	6.1	14.8	23.9	16.8	9.7	12.4	29.5	9.4	18.7	8.6	8.2	15.9	14.1	23.5	8.0	12.3	11.3	17.4	20.0	32.1	12.6	10.3	10.4	10.4	4.8	14.6	5.7	15.2	21.0	22.3	32.6	29.6	23.7	18.0	22.4	10.0	8.9	9.5	17.0	13.4	17.7	14.1	17.4	15.4	8.6	14.0	20.5	17.3	1.3	13.8	11.3	10.8	17.3	10.4	9.9	12.1	12.7	13.3	9.9	10.9	11.6	12.0	16.4	11.3	3.0	10.5	8.2	3.0	4.1	13.0	6.9	7.6	8.1	11.4	8.7	3.9	6.6	1.7	5.0	22.4	9.0	7.0	0.0	7.9	7.4	8.1	5.0	9.3	8.2	7.0	4.8	13.3	7.4	11.3	4.9	6.1	7.5	6.8	4.6	10.2	19.3	6.0	11.2	4.9	3.9	13.9	0.0	5.8	12.6	15.1	4.6	5.5	11.5	8.1	3.8
SSMEM1	"C7orf45, FLJ40316"	ENSG00000165120	"Serine rich single-pass membrane protein 1"	Q8WWF3	7	130207860-130216843	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	68	"testis: 31.7"	"Cell type enriched"	"Detected in some"	13	"Early spermatids: 346.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 1.7;U-87 MG: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA										"unprognostic (3.08e-1)"				"unprognostic (1.79e-1)"					"unprognostic (5.24e-1)"	"unprognostic (2.24e-1)"			0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.3	0.2	0.5	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.4	0.8	0.9	0.1	0.2	0.2	0.3	0.2	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	346.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.3	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	9.3	2.7	0.0	0.0	0.0	0.0	0.0
CPA2		ENSG00000158516	"Carboxypeptidase A2"	P48052	7	130266827-130289798	"Enzymes, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	529	"pancreas: 1357.9"	"Cell type enriched"	"Detected in some"	6	"Exocrine glandular cells: 4303.0"	"Cancer enriched"	"Detected in many"	60	"pancreatic cancer: 411.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.5;CACO-2: 7.5;RH-30: 6.2;SCLC-21H: 3.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA020342, HPA021317"	Enhanced		Approved	"Golgi apparatus"	"Secreted to digestive system"	NA	NA		1500000	"Golgi apparatus"		"HPA020342: AB_1846007, HPA021317: AB_1846008"	"unprognostic (1.12e-1)"	"unprognostic (3.97e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.76e-2)"		"unprognostic (4.65e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.84e-5)"	"unprognostic (7.52e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.12e-2)"	"unprognostic (8.48e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.4	1357.9	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.0	0.1	0.2	0.1	2.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	4.5	0.0	0.1	0.0	0.0	0.0	0.7	0.0	7.5	0.0	0.0	1.0	0.0	0.6	0.0	1.4	0.0	0.1	1.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.4	0.0	6.2	0.1	0.1	0.7	3.4	0.0	0.2	0.0	2.1	0.3	0.0	0.2	0.0	0.0	1.1	0.8	0.6	0.0	0.7	0.2	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.7	6.6	3.8	0.0	0.8	0.0	4303.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.3	0.0	0.0	24.4	0.0	2.8	764.8	8.6	0.0	0.0	0.3	0.0	0.0	0.3	1.5	0.1	0.2	0.0	0.2	0.1
CPA4	CPA3	ENSG00000128510	"Carboxypeptidase A4"	Q9UI42	7	130293134-130324180	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 18.0;skin 1: 41.0"	"Cell type enhanced"	"Detected in some"	18	"Basal keratinocytes: 15.8;Exocrine glandular cells: 45.1;Pancreatic endocrine cells: 12.8;Suprabasal keratinocytes: 27.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 10.0;head and neck cancer: 9.8"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 29.6;hTERT-RPE1: 55.9;LHCN-M2: 60.1;U-2 OS: 32.8;U-87 MG: 59.0"	"Low region specificity"	"Detected in single"							HPA021030			Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted in other tissues"	NA	Yes		480000	Nucleoplasm	"Centrosome, Cytosol"	"HPA021030: AB_1846010"	"unprognostic (7.60e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.36e-3)"	"unprognostic (3.23e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.49e-2)"	"unprognostic (6.21e-10)"	"unprognostic (2.39e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (1.31e-4)"	2.7	2.3	0.1	0.4	0.4	0.2	2.8	0.1	0.4	8.1	1.1	0.3	0.1	0.1	1.1	1.2	18.0	0.2	0.2	4.4	0.1	1.2	1.2	0.2	0.8	0.3	0.1	0.1	1.8	6.9	0.1	1.1	8.8	0.9	0.3	0.1	0.6	4.4	0.1	0.3	41.0	0.5	0.7	0.7	1.7	0.2	2.2	0.1	0.8	0.1	12.3	2.3	1.7	6.7	0.4	0.4	1.6	0.4	1.5	0.4	0.1	19.4	1.0	0.0	0.0	0.1	0.3	0.0	15.6	29.6	15.9	3.9	0.1	1.7	0.0	3.0	6.6	16.1	1.1	0.0	8.6	16.5	0.0	0.0	0.0	6.3	0.4	0.4	0.0	0.0	0.2	13.9	1.4	2.0	55.9	0.0	0.0	0.0	0.0	60.1	0.0	0.0	0.0	0.1	0.1	2.3	0.0	16.1	0.0	7.5	0.8	0.0	0.0	10.3	4.9	0.1	6.3	0.1	0.0	11.9	3.9	32.8	1.3	1.5	0.0	0.0	0.0	59.0	0.0	0.1	1.0	0.4	0.4	0.4	0.1	0.2	0.3	0.2	0.3	0.0	0.4	0.3	0.3	1.6	1.5	0.2	0.4	0.3	0.1	0.1	0.4	0.1	0.3	0.1	1.2	0.1	0.1	0.9	0.1	3.0	0.3	0.0	0.5	15.8	0.0	0.3	0.0	2.7	2.3	0.0	0.0	3.7	0.0	0.5	0.3	0.1	0.0	0.0	45.1	1.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	1.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	27.0	7.9	0.0	0.0	0.9
CPA5		ENSG00000158525	"Carboxypeptidase A5"	Q8WXQ8	7	130344816-130368730	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"blood: 25.2;testis: 30.4"	"Group enriched"	"Detected in some"	20	"Early spermatids: 46.3;Late spermatids: 106.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 8.0;naive CD8 T-cell: 20.3;T-reg: 25.2"	"Lineage enriched"	"Detected in single"	114	"T-cells: 25.2"	"Cell line enhanced"	"Detected in some"		"RH-30: 11.2;RT4: 5.1;U-266/84: 8.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020322			Approved	Nucleoplasm	"Secreted in male reproductive system"	NA	NA			Nucleoplasm		"HPA020322: AB_10960562"	"unprognostic (2.44e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.94e-2)"	"unprognostic (4.96e-2)"	"unprognostic (7.10e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (5.83e-4)"	"unprognostic (1.43e-1)"	"unprognostic (8.88e-13)"	"unprognostic (5.16e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.08e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	1.6	0.1	0.1	0.1	0.4	0.0	1.0	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.4	0.1	0.1	1.6	0.0	30.4	0.1	0.1	0.1	0.1	0.7	0.8	0.1	0.0	0.0	0.2	0.0	0.0	25.2	3.1	0.8	0.0	0.1	0.6	0.0	0.0	0.0	0.4	3.3	0.2	0.4	2.4	0.0	0.0	0.0	0.0	1.1	0.1	0.4	0.7	0.0	0.0	1.9	0.7	0.7	1.2	0.5	0.0	0.0	0.0	1.1	0.0	1.2	1.4	0.0	0.9	0.0	1.6	0.1	0.0	0.4	0.0	0.8	0.0	0.0	0.0	11.2	0.4	1.5	5.1	1.4	0.2	0.0	3.2	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	8.4	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	8.0	4.1	0.0	0.0	2.1	20.3	0.0	0.0	0.0	0.0	25.2	3.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	2.8	0.0	0.0	46.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	106.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.6	1.9	0.0	3.9	0.0	0.0	0.0
CPA1	CPA	ENSG00000091704	"Carboxypeptidase A1"	P15085	7	130380339-130388114	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	3231	"pancreas: 3541.6"	"Cell type enriched"	"Detected in some"	10	"Exocrine glandular cells: 8426.3"	"Cancer enriched"	"Detected in some"	639	"pancreatic cancer: 1377.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AN3-CA: 16.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021836, CAB025197, HPA052215"	Enhanced				"Secreted to digestive system"	NA	NA		17000000			"CAB025197: , HPA021836: AB_1846005, HPA052215: AB_2681764"	"unprognostic (8.41e-2)"			"unprognostic (9.24e-4)"	"unprognostic (5.22e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.76e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.34e-6)"	"unprognostic (4.99e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.37e-2)"	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.0	3541.6	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.6	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	2.3	0.0	0.3	0.0	1.9	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	3.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	5.0	13.2	1.2	0.0	0.0	0.0	8426.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.9	0.9	0.0	0.0	77.5	0.0	2.3	847.8	0.0	0.7	0.0	0.0	0.0	0.0	0.5	2.4	0.0	1.4	0.0	0.0	0.0
CEP41	"DKFZp762H1311, FLJ22445, JBTS15, TSGA14"	ENSG00000106477	"Centrosomal protein 41"	Q9BYV8	7	130393771-130442433	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"		"Autism, Autism spectrum disorder, Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 34.2;testis: 35.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 412.1;Late spermatids: 114.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA024090	Uncertain					NA	NA					"HPA024090: AB_10966276"	"unprognostic (3.87e-2)"	"unprognostic (5.96e-2)"	"prognostic favorable (4.54e-4)"	"unprognostic (1.17e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.26e-7)"	"unprognostic (1.80e-1)"	"unprognostic (2.89e-1)"	"unprognostic (8.45e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.76e-2)"	"unprognostic (7.72e-2)"	"unprognostic (3.35e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.57e-1)"	3.4	6.0	4.8	3.7	11.7	3.8	4.6	3.5	11.4	3.9	3.0	10.5	3.0	2.5	4.8	3.6	2.6	9.2	3.8	2.9	5.6	7.0	3.3	2.5	3.3	4.5	5.8	6.5	5.2	3.5	7.0	11.4	4.9	8.0	3.2	4.5	5.2	34.2	4.1	1.8	2.4	2.4	5.2	6.5	5.0	2.7	35.3	5.0	12.2	3.9	3.3	4.2	3.6	2.5	3.3	6.0	5.9	5.1	8.3	17.1	5.6	7.9	8.9	10.5	12.9	3.8	5.5	3.0	8.6	6.1	8.3	8.1	4.4	9.6	13.1	5.7	6.8	17.2	8.7	11.5	7.4	12.5	4.0	3.5	4.6	4.2	2.6	5.8	7.8	4.2	6.5	5.0	11.2	4.1	7.9	12.4	10.1	2.2	2.9	12.4	5.4	22.8	7.8	9.1	10.2	7.8	19.6	13.8	0.4	4.8	5.7	20.5	15.0	7.1	14.1	8.7	6.1	4.0	7.2	6.0	12.0	3.5	9.2	12.6	7.7	20.5	14.5	11.8	8.6	17.7	5.9	3.4	3.6	7.5	5.1	4.7	2.8	5.3	5.0	6.0	3.3	8.7	17.1	0.6	8.3	2.5	2.9	4.6	5.6	4.8	11.7	3.5	11.4	5.6	7.0	5.8	6.5	8.0	5.0	8.9	2.6	3.7	5.8	1.5	18.5	3.1	0.0	50.9	5.7	8.7	35.3	13.4	10.0	10.8	412.1	5.3	2.1	0.0	8.0	8.0	6.3	3.9	11.5	3.0	15.7	14.3	13.8	13.5	8.5	114.4	9.8	7.7	5.0	2.8	5.2	11.2	7.3	3.5	7.8	3.9	21.0	6.5	2.2	52.6	37.5	1.4	16.0	7.2	5.1	6.7
MEST	PEG1	ENSG00000106484	"Mesoderm specific transcript"	Q5EB52	7	130486171-130506465	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 63.8;placenta: 193.5"	"Group enriched"	"Detected in many"	8	"Cytotrophoblasts: 680.5;Syncytiotrophoblasts: 836.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 18.8"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"AN3-CA: 525.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005623			Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Golgi apparatus, Cytosol"		"HPA005623: AB_1079364"	"unprognostic (6.14e-2)"	"unprognostic (5.06e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.64e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.36e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.81e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (6.20e-5)"	"unprognostic (7.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.67e-2)"	44.9	26.0	7.8	4.7	12.9	3.4	63.8	2.6	22.7	2.4	7.5	3.4	1.1	7.9	7.3	4.6	2.6	5.2	6.6	3.7	7.9	8.0	6.7	13.7	18.8	4.1	3.3	9.0	7.8	13.0	2.5	15.4	193.5	15.5	4.1	6.1	8.4	7.0	2.5	2.2	2.1	7.2	5.3	3.2	22.4	3.0	10.1	3.3	2.0	4.3	2.5	1.9	4.5	3.7	3.1	6.7	8.6	2.0	2.7	18.8	5.3	3.2	1.7	8.5	525.5	0.1	0.0	0.0	3.5	1.6	3.7	1.7	10.1	4.9	1.6	1.2	0.1	3.2	0.4	0.1	0.0	1.4	0.0	0.0	2.8	2.7	1.6	14.5	0.1	0.0	0.2	0.1	2.7	0.0	18.9	1.4	0.0	3.1	0.0	7.1	4.5	0.3	3.5	5.3	4.8	0.8	0.0	94.6	1.0	4.0	3.0	30.0	0.0	3.1	10.2	0.0	9.0	0.3	2.4	1.4	1.2	0.0	11.7	0.2	0.1	0.3	0.0	4.5	0.0	0.4	8.6	1.9	6.2	0.7	2.0	1.7	3.1	2.0	1.4	6.7	2.8	7.6	18.8	1.1	2.7	1.2	0.3	0.1	5.3	7.8	12.9	2.6	22.7	7.9	8.0	3.3	9.0	15.5	3.3	6.0	3.8	2.4	36.0	3.9	9.1	0.6	17.8	4.0	5.7	15.7	3.9	680.5	10.0	19.8	53.5	3.4	10.9	0.0	35.4	99.2	31.1	18.0	0.0	15.8	79.5	1.6	28.4	35.6	7.7	27.3	78.6	1.9	1.7	1.0	19.5	40.4	28.9	28.1	12.7	9.2	19.9	19.4	5.2	33.9	38.5	0.5	836.0	0.0	33.2	16.5
COPG2	2-COP	ENSG00000158623	"Coatomer protein complex subunit gamma 2"	Q9UBF2	7	130506238-130668748	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045712	Approved					NA	NA		40000			"HPA045712: AB_2679428"	"unprognostic (9.48e-2)"	"unprognostic (3.31e-2)"	"unprognostic (7.98e-2)"	"unprognostic (9.40e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.23e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.23e-1)"	12.0	26.6	13.5	8.9	22.1	10.7	20.4	21.1	22.9	15.5	12.0	18.1	11.5	9.3	21.1	17.7	17.3	19.6	12.8	15.2	12.9	18.4	12.9	9.1	9.8	11.5	14.8	15.8	40.4	12.2	29.0	27.0	15.6	20.0	13.9	14.1	16.8	13.2	15.3	17.5	20.3	8.6	19.2	14.4	11.7	9.7	31.8	9.8	20.0	18.5	10.7	14.6	12.7	14.0	4.3	4.4	6.0	4.5	1.9	2.0	1.7	21.4	12.3	22.7	11.4	10.0	17.9	5.9	10.1	15.3	16.9	16.6	7.5	11.9	14.8	8.5	13.0	18.8	10.9	7.5	18.9	22.2	16.1	15.6	15.1	6.5	10.8	16.0	19.7	14.1	14.3	9.6	13.7	21.1	16.5	15.9	15.2	24.0	4.4	21.4	21.5	18.9	15.4	28.6	14.3	10.0	18.4	29.9	8.8	20.4	28.6	17.5	25.2	20.9	19.7	15.9	19.9	12.7	6.4	14.0	15.3	8.0	12.7	14.7	9.9	12.1	17.5	17.1	16.4	13.2	2.9	3.7	6.0	2.0	3.6	1.7	4.3	1.8	1.5	4.4	2.3	2.0	1.8	1.1	1.9	4.5	1.9	2.0	1.7	13.5	22.1	21.1	22.9	12.9	18.4	14.8	15.8	20.0	9.8	0.0	1.3	1.7	5.0	8.0	12.5	5.1	7.6	2.7	2.3	14.0	13.7	16.2	10.0	8.2	1.9	4.9	3.3	0.0	21.3	11.2	8.2	2.9	1.1	4.3	8.0	4.8	2.4	9.8	6.3	1.9	5.5	6.5	8.5	10.8	8.9	9.1	9.8	0.0	6.3	5.9	12.1	12.9	5.1	14.2	28.4	8.8	18.8	2.9	8.4	3.9
TSGA13		ENSG00000213265	"Testis specific 13"	Q96PP4	7	130668648-130687432	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 16.5"	"Group enriched"	"Detected in some"	9	"Early spermatids: 62.7;Late spermatids: 126.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.0;THP-1: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA022968	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Vesicles	"Plasma membrane, Cytosol"	"HPA022968: AB_2671013"					"unprognostic (1.49e-1)"					"unprognostic (1.13e-2)"		"unprognostic (1.86e-1)"		"unprognostic (1.34e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	1.2	0.6	0.8	0.5	0.3	0.1	0.5	0.0	0.0	0.9	0.7	0.2	0.4	0.0	0.2	1.0	0.0	0.6	0.2	0.1	0.0	0.1	0.1	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.0	0.1	0.0	1.3	0.0	0.1	0.0	0.0	0.4	0.9	0.1	0.3	0.4	0.1	0.2	1.1	0.6	0.2	0.5	0.2	0.3	0.2	0.2	0.1	0.2	0.6	0.5	0.4	1.2	0.8	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	4.6	0.5	0.1	1.4	1.4	0.0	0.0	10.7	3.4	0.0	7.9	0.1	0.0	0.0	62.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.8	126.7	0.6	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	1.1	0.0	0.1	1.2	0.6	0.4	0.6	0.0	0.0	0.0
KLF14	BTEB5	ENSG00000266265	"Kruppel like factor 14"		7	130731235-130734061	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"adipose tissue: 2.3;pancreas: 1.8;placenta: 2.9"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 1.4;Early spermatids: 3.2;Late spermatids: 3.0"	"Cancer enriched"	"Detected in single"	6	"melanoma: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;BJ hTERT+: 4.0;RH-30: 4.4;SK-MEL-30: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA044729	Uncertain					NA	NA					"HPA044729: AB_10960356"	"unprognostic (4.49e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.53e-1)"		"unprognostic (1.92e-1)"		"unprognostic (9.90e-3)"	"unprognostic (7.98e-2)"	"unprognostic (5.30e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.03e-3)"	"unprognostic (3.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-2)"	2.3	1.7		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.4	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.0			0.2	1.8	0.0		2.9		0.0	0.0		0.0	0.0	1.6	0.3	0.0	0.5		0.5	0.0	1.1			0.0		0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.1	0.0	3.0	0.8	4.0	1.3	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	4.4	0.0	0.0	0.0	0.8	0.0	0.4	0.0	1.7	0.0	0.5	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0
MKLN1	TWA2	ENSG00000128585	"Muskelin 1"	Q9UL63	7	131110096-131496636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 12.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 12.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022817, HPA041810"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Vesicles	"HPA022817: AB_1853974, HPA041810: AB_2677686"	"unprognostic (1.97e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.32e-1)"	22.7	21.1	22.1	15.7	27.6	12.8	34.4	27.5	25.8	18.8	15.0	11.7	26.6	14.2	19.3	19.8	11.8	19.6	11.6	16.7	21.9	14.4	23.0	22.8	19.3	18.7	26.6	17.5	23.2	12.6	20.9	28.8	18.2	25.0	26.4	12.2	10.0	18.1	28.9	28.6	15.4	13.5	20.8	30.3	13.1	14.4	16.9	24.0	14.7	18.0	9.9	12.0	17.8	21.5	2.3	1.6	12.4	1.6	0.9	2.3	0.5	8.3	9.7	8.4	8.5	20.9	18.8	5.1	8.1	18.9	9.3	11.9	4.4	7.2	8.7	5.5	10.1	18.3	5.8	8.8	7.7	15.2	8.4	4.3	3.7	7.5	5.1	10.0	6.1	5.4	11.3	5.5	12.5	6.3	10.0	8.4	5.4	13.6	6.3	11.4	3.1	7.2	6.6	9.6	6.8	5.1	4.5	10.0	6.0	10.3	4.9	4.4	9.4	15.9	15.9	7.3	9.2	3.1	7.7	8.6	7.3	4.1	13.1	6.6	15.4	5.7	14.9	25.0	7.4	10.6	1.2	1.0	1.7	1.6	1.1	1.2	1.2	1.5	1.3	1.0	2.3	2.3	1.9	12.4	0.9	1.6	1.6	0.9	0.5	22.1	27.6	27.5	25.8	21.9	14.4	26.6	17.5	25.0	24.0	47.6	36.6	23.7	26.7	39.2	45.2	21.2	38.2	10.7	22.7	43.6	66.8	14.7	6.6	17.8	2.6	48.1	26.9	0.0	20.5	13.9	40.1	45.0	33.5	67.6	18.7	50.9	35.6	60.2	36.9	3.6	63.0	28.4	33.7	24.4	27.8	54.4	22.4	31.9	79.2	25.0	67.1	84.1	41.9	34.6	26.5	40.1	12.4	26.1	25.0	33.3
PODXL	"Gp200, PC, PCLP"	ENSG00000128567	"Podocalyxin like"	O00592	7	131500262-131558217	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	15	"Cone photoreceptor cells: 82.5;Endothelial cells: 112.3;Rod photoreceptor cells: 186.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 34.6;NTERA-2: 46.7;SuSa: 47.0;TIME: 52.2;U-251 MG: 20.8"									"HPA002110, CAB016169, HPA045507, CAB062558, CAB068219, CAB068220"	Enhanced		Supported	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA		43000000	"Plasma membrane, Centriolar satellite"	Vesicles	"CAB016169: AB_628165, CAB062558: AB_2665627, CAB068219: AB_2665618, CAB068220: AB_2665619, HPA002110: AB_1855512, HPA045507: AB_2679356"	"unprognostic (1.26e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.28e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.16e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.52e-1)"	"unprognostic (9.20e-3)"	"unprognostic (3.40e-1)"	"prognostic favorable (2.89e-4)"	"unprognostic (2.56e-1)"	"unprognostic (8.78e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.03e-1)"	8.8	4.9	8.2	3.8	8.9	0.8	7.6	4.8	13.5	11.7	5.0	4.6	16.0	2.8	14.5	2.7	4.4	22.1	7.9	19.3	6.7	6.7	30.6	3.0	14.7	2.6	7.2	5.9	6.1	20.4	7.5	4.0	12.5	15.2	4.5	3.7	15.5	9.1	27.8	5.7	3.8	4.8	12.8	8.1	2.9	4.6	3.5	6.6	0.0	14.0	5.2	2.5	6.1	8.3	1.1	0.3	2.2	0.3	0.4	0.8	0.3	4.8	2.3	4.0	1.8	0.1	0.0	0.3	0.6	0.5	1.8	0.7	11.8	7.6	0.0	11.3	34.6	5.2	3.5	3.9	0.0	1.2	0.6	1.9	0.0	14.4	0.1	0.0	0.4	0.3	0.0	0.0	6.2	0.0	0.7	13.9	0.1	1.2	0.2	1.4	1.4	0.0	0.0	46.7	0.6	4.7	2.0	7.0	1.5	0.2	2.1	3.6	0.8	4.2	0.5	0.0	47.0	0.4	0.1	52.2	0.7	2.8	7.1	20.8	0.3	0.4	0.1	2.6	1.9	4.1	0.7	0.3	2.2	0.6	0.2	0.5	0.3	0.5	0.8	0.0	1.1	0.4	0.4	1.1	0.4	0.2	0.3	0.4	0.3	8.2	8.9	4.8	13.5	6.7	6.7	7.2	5.9	15.2	6.6	6.0	13.5	1.9	0.8	4.6	8.2	18.5	0.0	4.0	9.1	26.2	82.5	0.5	0.0	4.1	0.6	112.3	0.7	0.0	15.7	0.3	3.0	2.6	2.3	0.4	0.3	4.8	2.4	44.2	0.8	0.9	4.4	3.2	5.0	1.0	11.0	8.5	29.1	0.0	0.4	0.6	186.1	0.0	4.7	0.2	0.7	2.8	0.6	1.0	1.8	2.0
PLXNA4	"DKFZp434G0625PRO34003, FAYV2820, KIAA1550, PLXNA4A, PLXNA4B"	ENSG00000221866	"Plexin A4"	Q9HCM2	7	132123332-132648688	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.2;breast: 34.7"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 9.9;Cardiomyocytes: 9.5;Collecting duct cells: 12.2;Cone photoreceptor cells: 15.7;Early spermatids: 9.9;Leydig cells: 13.0;Muller glia cells: 10.0"	"Cancer enhanced"	"Detected in many"		"glioma: 3.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 6.1"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 6.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 15.0;HMC-1: 10.0;hTERT-RPE1: 12.9;RH-30: 10.7;TIME: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029919, HPA052141, HPA075592"	Approved		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"HPA029919: AB_10671093, HPA052141: AB_2681745, HPA075592: AB_2732297"	"unprognostic (2.05e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (1.61e-6)"	"unprognostic (5.76e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.99e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.69e-5)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.42e-3)"	23.2	5.1	8.7	3.5	9.0	1.1	34.7	3.9	15.1	16.2	2.0	1.0	0.8	1.5	2.3	1.0	7.7	3.0	4.2	6.9	9.7	7.2	2.0	1.3	1.8	2.5	4.0	6.6	6.2	1.0	1.0	1.6	6.7	6.6	1.4	2.1	0.7	1.2	2.4	1.7	4.1	1.4	5.1	1.5	2.4	2.8	2.4	1.8	0.0	3.3	0.0	1.3	2.1	9.4	0.0	6.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.1	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	10.0	0.1	0.0	0.0	0.0	12.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	10.7	1.1	0.0	0.0	0.2	5.6	0.0	0.0	0.0	0.1	0.0	0.0	32.6	3.3	0.1	0.7	0.2	0.0	0.0	0.0	3.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.1	0.0	6.1	0.0	0.0	8.7	9.0	3.9	15.1	9.7	7.2	4.0	6.6	6.6	1.8	0.0	0.0	0.0	0.1	0.6	9.9	9.5	0.0	0.0	0.0	12.2	15.7	0.0	0.0	0.0	9.9	0.7	0.0	0.0	0.0	0.1	5.4	0.2	1.1	0.0	0.1	0.0	1.2	1.8	0.0	5.9	13.0	0.0	6.8	0.0	0.0	10.0	0.4	0.0	6.7	0.3	1.4	0.0	1.4	0.2	0.1	1.1	0.0	0.0	0.0	0.5
CHCHD3	"FLJ20420, Mic19, MINOS3, PPP1R22"	ENSG00000106554	"Coiled-coil-helix-coiled-coil-helix domain containing 3"	Q9NX63	7	132784868-133082088	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 109.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042935	Enhanced		Supported	Mitochondria		NA	NA		110000	Mitochondria		"HPA042935: AB_10794538"	"unprognostic (1.53e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.00e-3)"	"unprognostic (5.69e-2)"	"unprognostic (4.75e-3)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.04e-1)"	"prognostic favorable (1.15e-4)"	"unprognostic (4.98e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.03e-2)"	15.2	15.8	9.9	13.4	11.6	15.4	13.7	10.1	14.2	10.5	17.3	9.8	7.9	19.9	13.2	9.7	10.5	9.7	10.4	42.6	9.5	8.9	23.2	17.9	11.7	10.6	10.4	8.0	11.6	9.8	13.9	17.0	10.7	10.9	10.5	18.3	11.5	10.6	11.1	109.1	9.0	20.5	13.9	9.7	12.2	13.9	6.4	10.8	19.7	14.6	30.1	13.2	12.9	13.6	19.0	28.2	15.4	29.9	21.2	19.9	15.3	23.4	24.1	24.5	33.8	17.7	16.3	14.5	23.0	21.9	26.3	29.2	28.3	26.1	19.5	9.2	14.6	58.5	16.5	28.3	19.8	37.2	25.5	26.8	20.1	24.9	16.4	35.2	45.1	15.0	14.7	13.7	36.0	37.7	13.2	18.3	25.8	42.8	17.9	24.3	30.9	65.6	39.6	40.2	37.9	27.9	32.7	35.9	27.9	25.6	19.5	31.3	39.1	19.1	15.1	43.5	17.5	12.6	27.1	15.1	25.2	10.8	39.4	41.2	17.3	22.1	49.2	39.7	38.7	35.3	14.9	21.8	15.4	16.1	29.9	15.3	19.0	14.7	15.5	28.2	11.7	13.0	14.5	3.1	21.2	24.1	24.6	19.9	15.3	9.9	11.6	10.1	14.2	9.5	8.9	10.4	8.0	10.9	10.8	23.8	19.2	25.3	26.1	31.0	23.1	116.2	40.8	29.4	28.4	14.0	21.6	64.7	106.1	46.3	76.6	29.3	40.2	0.0	53.2	67.5	37.3	25.3	33.5	19.2	67.5	14.3	34.4	16.0	24.0	74.9	29.1	38.1	35.4	59.5	46.7	22.9	42.8	21.0	33.2	67.4	23.8	32.3	50.9	12.7	24.7	35.3	57.2	35.5	71.7	35.4
EXOC4	"KIAA1699, MGC27170, SEC8, SEC8L1, Sec8p"	ENSG00000131558	"Exocyst complex component 4"	Q96A65	7	133253073-134066589	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Rod photoreceptor cells: 229.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031443, HPA031444"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA031443: AB_10602496, HPA031444: AB_2673886"	"unprognostic (1.70e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (6.19e-4)"	"unprognostic (9.78e-3)"	"prognostic favorable (6.85e-5)"	"unprognostic (5.91e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.35e-2)"	21.2	23.7	18.5	17.7	22.3	10.5	19.4	25.7	24.4	20.8	17.0	19.7	22.2	11.2	25.8	20.6	21.5	24.2	16.8	16.5	14.7	15.4	15.6	15.2	16.5	12.6	14.2	19.3	27.7	26.5	28.5	31.2	16.4	22.0	16.9	18.8	19.3	20.5	18.8	50.7	24.4	13.7	20.8	18.7	17.9	16.3	17.2	17.3	34.7	22.9	18.3	22.1	26.3	20.6	8.3	16.3	8.1	12.7	18.4	12.4	10.4	17.8	14.7	20.4	20.1	23.9	25.0	7.1	13.1	21.9	11.9	15.7	8.5	25.2	13.4	9.5	24.6	17.5	11.4	10.9	17.9	19.8	20.4	13.1	10.8	15.5	8.9	26.3	14.2	11.8	24.3	22.4	17.0	31.5	26.4	20.3	17.8	15.5	13.4	22.1	11.7	25.8	15.7	15.3	21.5	13.8	11.5	18.1	24.1	19.2	16.0	15.9	25.1	19.7	18.2	21.1	24.0	12.0	13.4	22.0	13.3	7.0	14.0	14.3	21.3	13.0	13.0	39.3	16.7	20.2	8.1	12.0	6.9	11.8	12.7	10.5	8.3	12.3	12.4	16.3	8.0	10.1	10.4	4.0	18.4	10.5	7.3	12.4	10.4	18.5	22.3	25.7	24.4	14.7	15.4	14.2	19.3	22.0	17.3	20.8	21.1	11.9	14.2	16.8	35.3	24.9	7.6	18.7	15.9	14.0	88.4	13.6	3.3	12.9	23.1	21.5	15.8	0.0	15.7	13.8	11.9	17.0	8.1	14.4	15.6	47.7	16.7	24.5	30.4	20.6	16.1	18.0	13.5	12.6	21.4	20.6	13.9	17.5	17.7	13.3	229.7	12.9	10.8	18.1	12.6	14.9	9.4	20.8	18.4	16.9
LRGUK	"CFAP246, FLJ32786"	ENSG00000155530	"Leucine rich repeats and guanylate kinase domain containing"	Q96M69	7	134127299-134264591	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.5;pituitary gland: 11.5;testis: 22.4"	"Group enriched"	"Detected in some"	7	"Ciliated cells: 26.8;Early spermatids: 14.4;Spermatocytes: 8.3"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"pons and medulla: 12.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 5.1;SH-SY5Y: 4.9;SK-MEL-30: 5.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029505, HPA029506"	Uncertain					NA	NA					"HPA029505: AB_10599606, HPA029506: AB_10601752"	"unprognostic (4.08e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.94e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.64e-2)"	"unprognostic (7.85e-4)"	"unprognostic (6.92e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.28e-2)"	"unprognostic (5.57e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.27e-3)"	"unprognostic (2.22e-3)"	"unprognostic (3.83e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.10e-2)"	0.7	0.6	2.3	0.6	6.4	1.3	1.2	0.5	1.4	1.2	0.5	4.1	0.3	0.5	1.5	4.0	0.4	9.1	0.7	0.4	2.4	1.2	1.2	0.9	3.4	0.4	0.3	0.6	2.4	1.9	0.4	11.5	0.4	12.5	1.6	0.7	2.2	1.3	0.5	0.2	1.2	0.5	0.5	1.6	1.3	0.6	22.4	0.9	0.0	2.2	0.0	0.6	0.5	0.4	0.5	0.3	0.0	0.4	0.0	0.0	0.0	0.3	0.4	0.7	1.1	0.1	0.3	0.3	0.0	0.1	0.5	0.4	0.0	1.0	0.2	0.3	0.1	1.0	0.3	0.4	0.1	0.8	0.5	0.5	0.1	0.3	0.2	0.1	0.2	0.6	0.3	0.7	0.9	0.0	0.1	0.2	0.7	0.2	0.8	0.8	0.2	0.3	0.6	5.1	0.2	1.2	0.7	0.1	0.0	0.8	0.4	1.6	4.9	1.5	0.0	5.1	0.7	0.2	1.1	0.0	0.3	0.6	0.3	0.6	1.2	1.7	1.5	1.4	0.2	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.3	6.4	0.5	1.4	2.4	1.2	0.3	0.6	12.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	26.8	2.3	0.0	0.0	0.0	0.0	0.2	14.4	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.3	0.0	1.7	0.0	0.0	1.4	0.0	0.0	0.4	0.0	1.8	0.0	0.0	8.3	0.7	0.4	0.2	0.0	0.0	0.1
SLC35B4	"FLJ14697, YEA4"	ENSG00000205060	"Solute carrier family 35 member B4"	Q969S0	7	134289332-134317051	"Predicted membrane proteins"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 50.1;Cytotrophoblasts: 73.7;Syncytiotrophoblasts: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049779	Approved					NA	NA					"HPA049779: AB_2680878"	"unprognostic (1.84e-1)"	"unprognostic (1.94e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.77e-3)"	"unprognostic (3.47e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.32e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.24e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.86e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.00e-1)"	7.8	10.1	9.6	7.4	16.8	2.7	5.3	22.4	21.6	6.8	5.4	10.8	4.8	4.5	9.4	10.1	5.0	6.8	6.1	4.0	10.1	12.4	15.9	11.6	5.1	6.3	9.4	9.6	10.3	4.0	6.4	6.7	17.5	12.7	8.4	5.7	9.9	3.8	10.0	3.5	4.9	5.9	10.8	8.6	6.5	5.2	6.9	8.6	6.8	5.4	2.0	7.2	6.4	4.3	3.2	6.5	1.3	4.6	4.0	5.7	2.9	3.8	12.8	11.3	16.8	11.0	9.3	5.8	9.7	8.1	8.6	7.3	4.9	3.6	12.9	3.3	10.4	11.3	4.1	16.6	8.6	14.4	8.1	12.4	8.7	7.5	6.5	8.1	12.2	7.9	8.1	3.7	10.3	8.8	6.5	8.3	9.0	8.4	4.8	12.9	3.4	10.8	9.0	23.3	3.9	11.6	7.9	9.9	6.3	4.8	4.7	4.0	23.2	8.6	2.9	10.6	9.8	1.6	7.0	9.2	11.3	3.7	6.7	9.5	15.9	21.8	15.0	20.1	11.6	12.9	1.3	3.4	0.7	3.8	4.6	5.7	3.1	3.5	4.7	6.5	3.2	3.4	5.0	0.4	4.0	3.5	4.5	3.7	2.9	9.6	16.8	22.4	21.6	10.1	12.4	9.4	9.6	12.7	8.6	8.9	4.8	6.4	4.8	1.9	50.1	5.3	7.6	8.1	9.1	1.8	43.2	73.7	10.0	7.7	1.5	8.7	3.1	0.0	4.6	21.6	9.3	4.4	1.1	14.4	18.3	39.7	4.1	4.9	8.6	2.9	10.3	8.6	5.0	3.6	3.8	16.4	6.9	3.1	11.7	13.6	20.5	6.5	4.2	10.8	21.7	2.9	69.6	7.1	3.1	3.4
AKR1B1	"ALDR1, AR"	ENSG00000085662	"Aldo-keto reductase family 1 member B"	P15121	7	134442350-134459284	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adrenal gland: 302.2;seminal vesicle: 109.3"	"Cell type enhanced"	"Detected in many"	13	"Collecting duct cells: 615.9;Cytotrophoblasts: 969.9;Extravillous trophoblasts: 1080.2;Syncytiotrophoblasts: 1691.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 122.4;BJ hTERT+: 224.5;RPTEC TERT1: 106.2;U-87 MG: 101.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026425, CAB027391, CAB047353, HPA052751"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		1700000	Cytosol	Nucleoplasm	"CAB027391: , CAB047353: , HPA026425: AB_10601563, HPA052751: AB_2681935"	"unprognostic (2.76e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (2.44e-5)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.00e-4)"	5.9	302.2	7.5	4.7	13.7	2.5	9.5	6.9	10.9	4.4	3.9	8.2	50.4	2.7	4.6	6.1	4.2	4.6	5.2	24.2	7.3	8.4	17.7	2.5	6.9	10.0	9.5	9.0	8.2	7.2	9.4	8.0	24.8	11.9	5.5	4.1	5.8	4.4	109.3	37.6	2.8	4.8	5.6	7.9	6.7	5.0	5.2	5.9	7.3	6.0	10.3	7.6	7.1	3.7	31.4	34.8	22.5	26.0	26.3	42.7	47.2	13.5	122.4	13.8	19.5	59.5	16.2	36.8	13.1	224.5	19.3	25.0	5.6	12.4	0.0	6.1	21.9	85.2	5.7	15.0	13.1	15.4	4.8	13.7	6.9	18.4	16.6	85.3	0.0	0.0	15.1	9.8	27.6	7.3	18.9	27.2	13.6	0.0	4.6	21.3	0.2	20.3	9.3	22.9	0.9	0.1	21.2	8.8	10.2	106.2	66.2	10.3	22.9	91.9	0.1	9.6	9.4	0.0	10.3	21.4	19.1	8.9	1.7	14.2	12.6	13.9	34.2	101.0	0.0	11.4	22.5	26.0	1.2	37.9	17.0	34.0	31.4	32.4	36.7	34.8	28.5	42.7	41.1	2.1	26.3	8.9	4.9	22.0	47.2	7.5	13.7	6.9	10.9	7.3	8.4	9.5	9.0	11.9	5.9	11.9	23.7	50.6	46.4	18.3	34.0	127.0	30.6	24.1	23.9	615.9	7.9	969.9	139.3	102.5	3.0	53.2	0.7	0.0	35.6	1080.2	76.5	15.6	52.0	1.3	331.4	68.3	29.7	89.6	135.4	11.5	73.4	69.6	28.7	93.8	13.6	46.3	62.2	5.8	72.9	43.7	20.2	58.2	30.9	20.7	70.9	10.2	1691.2	45.4	5.0	37.4
AKR1B10	"AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI"	ENSG00000198074	"Aldo-keto reductase family 1 member B10"	O60218	7	134527592-134541408	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 41.5;intestine: 99.7;stomach 1: 68.6"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 275.2;Enterocytes: 221.4;Pancreatic endocrine cells: 89.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 353.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	99	"A549: 217.4;Hep G2: 60.3;OE19: 227.4"									"HPA020280, CAB070163, HPA073633"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		68000000	Cytosol	"Plasma membrane"	"CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (1.29e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.91e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (4.80e-9)"	"unprognostic (2.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	0.6	0.8	0.6	2.2	0.6	0.0	0.6	0.6	0.6	13.1	11.5	0.6	0.6	99.7	0.6	0.9	41.5	0.0	28.9	0.6	0.6	0.0	4.0	6.3	2.0	0.6	0.6	0.6	0.6	0.6	0.0	2.5	0.6	0.6	2.0	7.3	1.3	6.1	0.6	0.6	1.0	54.1	7.1	0.6	0.6	68.6	0.8	0.6	0.9	0.7	28.6	3.6	16.3	22.9	0.4	0.1	1.8	0.2	0.4	0.2	0.1	0.0	217.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	60.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	227.4	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.2	1.8	0.4	0.1	0.1	0.1	0.1	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6	0.0	0.0	0.5	1.9	2.5	0.0	0.4	275.2	5.3	1.2	0.0	0.0	0.2	0.0	21.5	0.3	0.0	221.4	23.3	23.1	0.1	0.1	0.3	0.0	31.6	0.0	0.0	3.4	3.7	1.6	0.4	3.1	0.0	0.0	1.0	11.7	0.0	89.4	24.6	1.8	1.4	0.0	0.0	0.9	0.0	0.0	9.2	0.2	0.0	41.3	5.2
AKR1B15		ENSG00000227471	"Aldo-keto reductase family 1 member B15"	C9JRZ8	7	134549136-134579875	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 61.7;placenta: 31.8"	"Cell type enhanced"	"Detected in some"	27	"Early spermatids: 2.3;Late spermatids: 2.7;Syncytiotrophoblasts: 8.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"A549: 15.5;HDLM-2: 12.3;Hep G2: 10.8;SK-BR-3: 5.2;U-87 MG: 6.6"									"HPA020280, HPA073633"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (2.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (9.74e-3)"	"unprognostic (2.74e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (8.36e-4)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (5.04e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-7)"	"unprognostic (6.88e-2)"	"unprognostic (4.29e-1)"	"unprognostic (2.99e-3)"	"prognostic unfavorable (1.90e-5)"	2.7	0.1	0.1	0.1	0.1	0.0	61.7	0.1	0.2	1.6	0.6	0.2	0.1	5.6	0.1	1.5	3.8	0.0	2.2	0.1	0.1	0.0	0.1	0.8	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	31.8	0.2	0.8	0.2	0.5	2.9	0.1	11.6	1.9	1.7	0.8	0.4	0.1	5.0	0.6	0.1	0.3	0.4	16.1	1.8	1.5	3.0	0.1	0.0	1.8	0.1	0.4	0.0	0.3	0.0	15.5	0.2	0.0	0.6	0.5	1.0	0.0	0.4	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.7	0.1	0.0	0.1	0.0	12.3	0.1	0.1	0.2	10.8	0.0	0.2	0.5	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.2	0.2	3.2	0.3	0.0	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.6	5.2	0.0	0.1	0.1	0.3	0.0	0.1	0.7	0.4	0.0	0.2	0.2	0.2	6.6	0.2	0.2	1.8	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.7	0.0	0.0	0.1
BPGM		ENSG00000172331	"Bisphosphoglycerate mutase"	P07738	7	134646808-134679813	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Congenital erythrocytosis, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"placenta: 184.7"	"Group enriched"	"Detected in all"	5	"Distal tubular cells: 109.5;Erythroid cells: 303.7;Syncytiotrophoblasts: 308.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 38.0;RT4: 61.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016493, HPA028735"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA		69000000	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA016493: AB_1845414, HPA028735: AB_10600791"	"unprognostic (2.56e-1)"	"prognostic favorable (7.95e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.96e-1)"	"unprognostic (7.74e-2)"	"unprognostic (4.67e-3)"	"unprognostic (7.42e-2)"	"unprognostic (5.69e-2)"	"prognostic favorable (1.54e-8)"	"unprognostic (2.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.78e-2)"	6.1	7.3	13.6	4.5	11.1	37.7	6.9	11.7	11.6	7.1	6.9	9.1	6.1	4.3	5.4	10.2	14.6	4.7	6.9	7.3	12.5	14.2	19.1	8.1	8.0	5.2	13.9	7.8	5.7	5.4	16.5	14.4	184.7	12.4	7.5	5.4	6.7	10.6	10.3	17.7	5.5	6.0	6.6	15.9	8.6	6.8	7.4	8.8	8.5	7.5	22.2	13.3	24.9	9.5	11.6	10.2	28.2	12.8	9.8	14.5	12.8	4.5	5.5	7.4	9.9	8.5	5.0	7.4	13.7	16.6	5.3	8.0	2.2	6.1	5.5	4.1	7.6	10.6	3.7	7.8	7.5	9.4	38.0	6.8	3.2	5.1	2.5	5.8	6.0	4.2	4.9	6.9	10.0	5.5	8.2	19.3	7.0	9.2	7.0	12.6	2.2	9.8	8.4	7.6	9.3	5.3	7.5	5.3	4.0	12.1	61.1	6.3	10.7	6.3	7.7	6.8	8.2	5.1	3.9	14.7	8.5	2.0	11.4	11.1	11.5	13.2	6.9	14.7	5.8	14.5	28.2	9.8	27.6	14.5	12.8	10.4	11.6	9.5	12.7	10.2	10.5	13.2	13.4	18.0	9.8	12.5	6.7	12.0	12.8	13.6	11.1	11.7	11.6	12.5	14.2	13.9	7.8	12.4	8.8	8.9	26.7	14.4	18.4	34.7	20.3	20.5	15.3	29.4	14.8	26.2	2.0	35.3	109.5	38.4	2.2	11.9	5.1	303.7	15.9	28.0	17.1	21.1	24.3	4.3	13.3	19.1	12.6	8.0	7.3	5.1	9.5	11.3	21.9	19.8	3.8	18.6	36.1	3.5	11.3	47.1	11.6	6.5	24.7	27.9	22.5	11.5	308.5	21.5	4.5	13.7
CALD1	"CDM, H-CAD, L-CAD"	ENSG00000122786	"Caldesmon 1"	Q05682	7	134744252-134970728	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 224.5"	"Cell type enhanced"	"Detected in many"	8	"Leydig cells: 1615.7;Peritubular cells: 1885.2;Sertoli cells: 2257.2;Smooth muscle cells: 2337.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"neutrophil: 4.3"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 79.3;fHDF/TERT166: 128.9;U-138 MG: 82.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000006, HPA008066, HPA017330"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		Yes	No		110000000	"Plasma membrane, Actin filaments"		"CAB000006: AB_2065456, HPA008066: AB_1078378, HPA017330: AB_1845917"	"unprognostic (2.16e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.05e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (6.52e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-3)"	38.6	17.4	6.7	33.4	11.1	0.0	26.6	11.9	9.1	83.1	141.0	6.0	111.4	12.6	82.3	59.8	122.8	45.8	46.3	20.1	7.7	5.0	33.5	39.6	26.1	12.9	8.7	8.5	76.3	6.9	4.1	17.8	57.4	8.9	87.8	25.1	10.9	12.4	133.3	15.3	12.9	39.2	224.5	8.5	35.9	64.5	29.7	9.7	2.1	20.3	14.1	5.3	205.3	70.4	0.1	0.2	4.3	0.2	0.4	0.2	5.9	12.1	8.0	18.1	15.9	62.7	50.9	17.9	71.6	79.3	24.6	27.3	14.5	0.3	0.0	17.1	128.9	16.4	2.9	11.5	21.3	33.5	0.1	3.9	0.4	9.5	9.8	41.3	0.0	0.0	39.0	15.9	27.5	15.6	37.8	20.7	0.0	0.0	0.1	36.7	0.0	0.0	0.2	21.6	0.0	2.8	0.1	16.1	0.0	5.0	3.3	3.1	7.9	25.1	3.3	9.6	57.0	0.7	0.1	55.2	82.7	14.5	15.7	24.3	0.0	0.0	0.0	28.7	0.0	61.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.0	4.3	0.4	0.0	0.0	0.0	5.9	6.7	11.1	11.9	9.1	7.7	5.0	8.7	8.5	8.9	9.7	20.8	21.2	22.4	285.3	373.4	156.1	350.6	211.5	9.4	25.0	41.8	5.9	146.5	19.9	303.7	58.2	355.4	0.0	23.3	20.1	802.8	618.3	367.0	4.7	529.8	38.7	87.4	3.5	505.2	24.5	42.4	1615.7	35.2	318.9	11.8	0.9	180.9	118.9	0.0	1885.2	249.0	13.7	2257.2	2337.7	6.8	10.3	150.2	231.4	15.0	0.2	28.3
AGBL3	"CCP3, MGC32955"	ENSG00000146856	"ATP/GTP binding protein like 3"	Q8NEM8	7	134986508-135147963	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 40.4;Spermatocytes: 19.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020397, HPA024150"	Uncertain		Approved	Cytosol		NA	No			Cytosol		"HPA020397: AB_2242453, HPA024150: AB_1844639"	"unprognostic (8.84e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.39e-3)"	"unprognostic (3.32e-3)"	"unprognostic (4.18e-2)"	"unprognostic (7.15e-4)"	"unprognostic (5.00e-3)"	"unprognostic (6.10e-4)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (2.18e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.11e-3)"	3.2	2.7	4.2	4.1	8.4	3.8	4.6	8.7	4.5	4.3	2.4	4.4	4.5	1.6	5.5	15.4	2.2	3.6	3.1	2.4	5.0	3.4	5.3	2.6	3.6	4.0	2.7	4.5	6.8	4.5	0.6	9.2	1.9	3.3	3.8	3.0	3.1	4.9	4.3	4.2	4.7	3.7	3.3	2.9	6.5	4.4	18.7	3.7	2.7	5.4	0.8	2.8	3.3	2.5	2.2	1.7	0.5	0.2	2.2	5.0	1.7	2.6	1.4	3.6	0.8	1.0	1.4	2.2	0.7	0.0	0.5	0.8	4.7	3.0	4.3	1.3	0.0	1.4	2.8	1.3	0.5	0.0	3.4	8.8	3.6	5.3	4.6	0.0	1.6	0.0	0.2	0.0	2.1	0.0	0.0	1.6	4.7	2.6	2.5	0.6	2.5	0.9	1.5	3.1	0.4	0.3	2.5	0.2	1.2	2.6	0.5	2.1	2.4	0.5	0.0	0.3	0.1	1.9	3.5	0.0	0.4	0.9	0.5	1.6	5.3	1.6	1.9	1.8	4.3	4.4	0.0	0.2	0.4	2.4	0.0	1.8	2.1	1.2	2.5	0.5	2.2	2.0	5.0	0.5	2.2	0.1	1.7	1.7	1.7	4.2	8.4	8.7	4.5	5.0	3.4	2.7	4.5	3.3	3.7	3.0	1.1	1.3	1.0	1.1	4.9	1.6	5.1	5.3	2.3	8.7	2.0	0.2	6.6	3.1	40.4	3.8	0.3	0.0	2.5	0.3	1.4	1.5	1.1	1.6	0.4	3.2	2.9	5.5	1.6	8.5	3.1	0.3	5.0	11.8	0.3	2.7	1.6	0.0	2.1	5.1	2.9	0.0	2.3	19.5	3.6	0.3	0.1	1.0	0.0	0.8
C7orf49	"FLJ22450, FLJ27285, MGC5242, MRI, MRI-2"	ENSG00000122783	"Chromosome 7 open reading frame 49"	Q9BWK5	7	135092363-135170795	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 60.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020060	Approved					NA	NA					"HPA020060: AB_2290651"	"unprognostic (3.32e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.92e-3)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (8.89e-3)"	"unprognostic (2.92e-2)"	"unprognostic (3.21e-3)"	"unprognostic (8.39e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.69e-1)"	15.2	20.9	12.1	18.3	14.3	12.0	15.5	6.4	14.0	14.9	12.0	14.8	27.2	11.4	19.3	15.9	18.4	18.5	17.9	14.5	10.9	8.7	26.8	14.3	13.8	19.1	16.2	7.9	17.1	31.1	23.8	16.8	17.3	11.7	15.4	12.0	13.8	27.2	21.0	29.9	12.7	13.1	15.5	10.2	19.5	17.3	20.1	14.5	17.3	16.9	13.8	19.4	16.9	15.9	13.3	20.8	18.1	18.6	17.1	12.1	13.7	23.7	25.6	12.2	19.0	10.6	10.2	20.5	15.6	16.0	20.5	16.1	16.2	17.3	19.4	17.7	15.9	21.7	13.4	17.4	28.5	13.3	24.7	11.1	12.7	14.1	14.8	15.2	25.3	15.6	11.8	28.6	16.0	18.6	9.4	8.8	15.4	46.2	13.2	16.6	24.1	23.8	17.4	28.2	20.3	19.0	17.6	15.2	25.6	23.8	14.4	14.5	22.4	17.7	15.6	16.9	14.1	12.4	23.1	7.5	18.5	10.4	16.2	26.6	23.8	26.8	26.5	25.6	25.3	37.5	16.3	18.6	18.1	9.1	16.5	9.7	12.9	8.0	12.1	20.8	13.3	11.7	11.7	4.3	17.1	15.4	17.6	3.6	13.7	12.1	14.3	6.4	14.0	10.9	8.7	16.2	7.9	11.7	14.5	3.0	10.3	19.5	8.9	3.8	6.3	0.0	17.8	10.7	4.5	0.0	5.9	60.8	0.0	0.0	11.6	9.9	14.0	23.3	0.0	52.1	9.3	13.3	8.1	20.2	35.5	4.8	12.6	14.7	24.8	13.2	13.0	10.4	13.5	0.0	11.8	17.2	0.0	17.3	16.6	0.0	5.6	6.5	6.4	35.9	14.3	5.0	39.0	12.5	12.3	8.1
TMEM140	FLJ11000	ENSG00000146859	"Transmembrane protein 140"	Q9NV12	7	135148072-135166215	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"blood: 75.1"	"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 54.0;neutrophil: 75.1"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 75.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 36.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.52e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.37e-2)"	"unprognostic (9.72e-2)"	"unprognostic (7.65e-3)"	"unprognostic (3.41e-1)"	"unprognostic (7.59e-2)"	"unprognostic (5.20e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.05e-1)"	39.1	13.6	4.6	12.4	19.9	6.4	27.9	2.4	14.2	9.0	10.4	15.2	9.2	11.9	13.5	7.3	6.3	6.5	12.9	13.8	6.5	5.0	16.9	32.9	18.8	15.6	30.7	4.8	10.8	10.0	2.5	4.0	22.7	15.4	9.7	5.7	9.9	11.4	7.5	51.6	6.1	11.4	8.0	31.4	17.6	8.3	6.3	22.1	4.4	7.6	3.7	10.7	16.7	14.5	7.7	2.0	75.1	5.1	6.1	8.3	10.1	5.0	12.3	4.4	8.8	36.1	7.1	4.0	3.9	5.9	3.0	7.7	4.7	5.1	6.7	5.1	1.6	21.0	5.0	0.0	0.1	0.5	13.1	5.7	4.0	5.1	4.7	7.6	9.3	6.4	1.8	0.3	1.2	0.0	7.5	4.7	5.1	8.9	22.8	0.9	4.4	8.9	4.2	9.0	7.4	7.0	6.3	6.4	14.3	1.8	7.8	5.0	7.9	3.7	5.6	9.6	3.2	2.3	8.5	4.8	3.7	2.6	8.1	4.8	25.4	19.0	10.0	11.2	11.1	8.9	54.0	4.8	18.0	8.2	4.0	6.0	6.1	6.8	8.0	2.0	7.7	7.7	8.3	75.1	6.1	5.1	0.3	8.3	10.1	4.6	19.9	2.4	14.2	6.5	5.0	30.7	4.8	15.4	22.1	3.0	1.1	20.4	0.4	1.5	0.8	3.0	20.4	2.7	2.3	8.7	0.0	6.9	3.3	14.1	9.1	24.8	10.2	23.3	3.3	1.7	4.8	0.9	4.7	21.7	16.2	3.2	5.1	22.1	6.7	2.0	9.8	6.7	25.3	14.4	1.9	0.1	5.8	17.3	4.9	14.7	0.5	0.0	2.1	0.0	0.1	1.9	40.5	20.8	0.6	0.9
WDR91	"HSPC049, SORF-1"	ENSG00000105875	"WD repeat domain 91"	A4D1P6	7	135183839-135211534	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 25.1;THP-1: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024260	Uncertain					NA	NA					"HPA024260: AB_1844392"	"unprognostic (5.37e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (1.75e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.53e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	8.1	7.4	9.0	7.5	12.0	10.7	8.6	12.0	11.7	9.8	5.3	15.2	10.3	4.6	9.6	16.0	13.0	18.7	6.9	5.0	11.9	8.2	23.9	8.8	13.5	10.1	9.2	10.9	16.4	28.0	9.2	7.6	15.1	13.2	7.8	5.2	9.8	8.4	15.0	9.4	12.0	6.5	7.6	8.5	11.8	9.0	9.9	10.7	9.2	5.4	6.9	10.5	7.6	9.0	4.1	4.4	6.7	7.6	4.8	5.8	3.4	2.2	0.9	2.2	6.1	4.0	3.1	2.9	2.6	3.1	2.4	3.1	1.0	0.9	1.5	4.1	1.9	3.3	1.7	3.5	9.0	2.7	7.7	3.0	1.4	2.4	3.7	5.9	2.7	1.3	4.2	5.0	2.1	1.8	2.0	3.0	3.9	5.9	2.4	2.4	1.7	4.9	6.8	3.2	1.9	2.4	6.3	3.5	3.6	25.1	1.4	1.3	2.7	3.3	3.1	7.4	2.3	1.7	17.6	1.1	5.4	1.3	3.7	2.4	5.3	2.1	5.0	4.9	5.1	3.8	0.6	7.6	6.7	3.2	2.8	3.4	4.1	3.7	2.0	4.4	4.0	5.8	3.6	4.3	4.8	2.5	2.0	4.7	3.4	9.0	12.0	12.0	11.7	11.9	8.2	9.2	10.9	13.2	10.7	6.0	9.4	3.4	3.4	3.8	5.4	2.2	7.6	9.4	11.4	7.0	5.9	20.1	16.6	8.1	30.7	5.6	1.1	0.0	6.1	4.2	4.2	2.3	16.1	5.6	28.9	3.2	1.2	7.4	13.7	39.8	5.5	8.9	3.3	4.6	1.5	3.1	4.5	2.8	14.5	15.3	3.6	12.9	2.5	5.1	5.9	3.4	24.3	4.9	1.1	1.0
STRA8		ENSG00000146857	"Stimulated by retinoic acid 8"	Q7Z7C7	7	135231979-135258492	"Predicted intracellular proteins"	"Differentiation, DNA replication, Meiosis, Oogenesis, Spermatogenesis, Transcription, Transcription regulation"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 2.0;skin 1: 2.5;testis: 4.0"	"Cell type enhanced"	"Detected in some"	19	"Cytotrophoblasts: 1.4;Early spermatids: 1.1;Spermatogonia: 3.0"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.7;K-562: 1.2;SK-BR-3: 2.3;THP-1: 6.9;U-266/84: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA							"unprognostic (2.84e-1)"		"unprognostic (4.86e-2)"	"unprognostic (3.89e-2)"	"unprognostic (9.67e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.25e-1)"		"unprognostic (8.55e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.69e-1)"			0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.3	0.0	0.0			0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.1	2.0	0.0	0.0	0.0	0.3		0.0	0.0	0.0	0.0	1.2		0.0	0.0		0.1	0.0	0.0	2.5	0.3	0.0	0.1	0.0	0.0	4.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.5	2.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.5	3.0	0.0	0.7	0.0	0.0	0.0
CNOT4	"CLONE243, NOT4, NOT4H"	ENSG00000080802	"CCR4-NOT transcription complex subunit 4"	O95628	7	135361795-135510127	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005737	Approved					NA	NA					"HPA005737: AB_1078544"	"unprognostic (9.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (2.82e-2)"	"unprognostic (4.18e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.00e-2)"	"prognostic favorable (7.67e-6)"	"unprognostic (1.01e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.33e-2)"	19.4	14.3	19.8	12.0	23.3	11.1	13.8	31.6	24.6	18.7	15.0	21.9	7.0	11.3	21.1	15.2	15.8	16.7	13.8	18.7	19.2	18.0	16.0	16.0	13.6	14.4	18.5	15.1	24.7	14.1	22.6	28.6	16.1	21.1	15.3	13.4	16.4	16.8	15.6	35.0	15.6	12.3	17.1	22.6	13.7	12.3	25.8	18.5	18.5	21.1	12.3	18.1	16.2	15.7	12.0	10.0	21.5	12.7	16.7	15.5	9.1	13.6	12.9	13.3	17.7	22.1	17.6	9.6	15.4	16.8	13.1	16.4	11.1	14.1	13.7	13.4	13.9	18.6	13.0	16.7	11.6	18.8	15.4	12.9	11.3	11.2	9.9	12.3	12.6	13.5	13.5	14.9	16.8	10.5	15.1	13.4	9.8	19.6	10.9	19.2	17.1	17.3	20.5	17.4	12.6	11.0	11.3	13.1	14.8	15.5	12.6	14.1	16.5	17.9	20.2	11.2	12.9	12.4	14.3	18.1	16.0	9.5	14.8	16.6	16.8	15.8	19.5	16.1	14.9	21.2	21.5	11.5	14.9	14.1	11.5	15.5	11.0	12.0	11.7	10.0	12.0	13.1	12.1	10.7	16.7	12.7	8.0	10.1	9.1	19.8	23.3	31.6	24.6	19.2	18.0	18.5	15.1	21.1	18.5	20.8	41.3	39.1	72.1	60.1	49.7	39.2	25.5	29.4	34.2	34.9	100.1	25.2	59.7	27.4	14.2	43.4	27.3	0.0	18.1	19.0	52.1	62.8	60.2	23.3	22.5	52.4	39.0	36.2	21.4	15.3	60.4	32.6	40.5	50.5	23.7	70.1	25.3	25.9	65.0	41.4	66.1	19.4	57.9	120.0	69.4	66.1	37.3	43.1	24.7	86.4
NUP205	"C7orf14, KIAA0225"	ENSG00000155561	"Nucleoporin 205"	Q92621	7	135557919-135648757	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.64e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.66e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (1.90e-7)"	"unprognostic (2.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.27e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.35e-2)"	13.7	12.6	11.4	14.2	11.9	10.8	13.1	23.3	10.5	12.5	11.9	13.4	11.4	9.0	17.6	9.7	19.3	16.1	7.4	9.5	8.6	6.1	10.3	8.3	12.2	16.1	11.7	6.9	17.4	10.3	23.0	20.9	13.1	10.6	10.6	14.7	14.6	18.4	11.3	16.6	15.1	13.8	14.7	10.8	16.7	12.7	17.4	11.4	31.6	12.4	13.4	22.1	15.6	14.4	4.9	5.7	2.2	6.1	5.3	6.0	2.7	22.1	18.1	24.4	23.8	5.8	9.6	15.9	14.1	10.9	22.0	24.6	18.7	16.2	28.4	11.2	8.4	22.2	17.3	30.6	15.8	28.5	14.0	21.9	16.5	18.7	8.5	4.4	32.1	13.0	5.2	7.2	21.5	14.5	7.7	16.3	20.3	38.2	13.6	16.5	15.1	34.6	9.8	37.4	17.4	16.1	26.0	22.7	22.5	6.7	17.9	24.4	24.9	23.3	19.1	11.4	19.3	11.0	12.3	13.2	18.1	9.0	21.9	26.9	10.1	18.8	38.6	18.4	25.3	24.3	2.2	2.5	0.8	4.9	6.1	6.0	4.9	6.0	5.2	5.7	4.3	5.1	5.6	1.1	5.3	3.3	3.8	5.6	2.7	11.4	11.9	23.3	10.5	8.6	6.1	11.7	6.9	10.6	11.4	11.9	12.0	10.7	5.4	11.6	6.6	3.7	10.2	8.1	7.9	15.7	11.8	10.4	3.3	7.6	0.7	7.4	3.6	0.0	8.3	8.0	7.5	7.6	8.1	8.1	8.9	4.8	8.7	9.2	12.1	1.9	7.5	7.8	10.1	9.0	9.8	4.5	9.1	7.0	7.1	3.7	9.2	0.0	7.6	16.3	12.1	13.6	6.4	6.4	8.6	8.2
STMP1	"C7orf73, PL-5283"	ENSG00000243317	"Short transmembrane mitochondrial protein 1"	E0CX11	7	135662496-135693418	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 209.3;Extravillous trophoblasts: 217.6;monocytes: 256.1;Proximal tubular cells: 171.0;Syncytiotrophoblasts: 230.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 71.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 71.6"	"Low cell line specificity"	"Detected in all"											HPA065565			Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA065565: AB_2685512"	"unprognostic (3.94e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.12e-1)"	"unprognostic (4.43e-3)"	"prognostic favorable (2.95e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.21e-3)"	"unprognostic (4.90e-2)"	"unprognostic (9.99e-2)"	"unprognostic (9.62e-3)"	"unprognostic (6.81e-2)"	15.6	32.2	22.5	19.7	24.3	33.5	27.3	13.8	20.4	20.1	19.0	25.0	20.3	17.4	16.5	26.7	51.4	16.2	19.3	29.5	19.3	20.6	28.4	34.7	19.7	28.1	22.3	13.5	16.5	25.4	14.6	25.4	28.1	20.4	20.7	22.5	31.2	23.0	18.5	40.7	21.1	23.2	21.3	22.0	18.7	19.5	38.7	17.0	38.4	31.9	42.6	34.9	18.2	28.0	5.3	12.5	71.6	13.1	7.6	6.6	9.2	15.2	7.1	17.3	16.1	20.6	29.3	10.5	16.9	16.5	14.1	14.7	4.4	16.9	13.9	15.1	25.5	13.7	6.3	16.6	21.3	19.2	17.4	13.7	21.9	8.2	10.7	20.3	22.2	14.2	18.0	24.4	16.8	15.7	21.3	11.6	18.2	23.5	12.6	30.9	18.9	31.6	25.6	34.0	21.2	18.2	16.0	18.5	23.0	39.2	8.0	21.9	21.1	22.5	15.7	15.7	17.5	6.3	24.6	18.9	13.8	11.2	24.4	23.5	14.6	21.0	27.0	42.5	23.2	24.9	71.6	12.0	25.0	5.3	12.3	5.0	5.3	5.1	5.3	12.5	4.5	4.9	5.4	9.3	7.6	13.1	7.1	6.6	9.2	22.5	24.3	13.8	20.4	19.3	20.6	22.3	13.5	20.4	17.0	38.7	43.1	0.0	0.0	0.0	0.0	0.0	0.0	62.9	51.2	92.5	0.0	209.3	167.5	157.0	0.0	0.0	0.0	0.0	84.6	217.6	0.0	0.0	52.3	0.0	164.1	0.0	0.0	0.0	0.0	0.0	0.0	40.5	0.0	256.1	0.0	0.0	115.5	0.0	0.0	171.0	0.0	0.0	0.0	0.0	0.0	0.0	230.3	0.0	0.0	0.0
SLC13A4	"SUT-1, SUT1"	ENSG00000164707	"Solute carrier family 13 member 4"	Q9UKG4	7	135681237-135729258	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"brain: 85.4;placenta: 44.8;retina: 23.5"	"Cell type enriched"	"Detected in some"	7	"Syncytiotrophoblasts: 657.3"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	7	"pons and medulla: 85.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HDLM-2: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048582	Enhanced					NA	NA					"HPA048582: AB_2680450"	"unprognostic (2.40e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.78e-1)"	"unprognostic (7.69e-2)"	"unprognostic (3.96e-6)"	"unprognostic (3.33e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.30e-6)"	"unprognostic (1.53e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.73e-2)"	0.3	0.4	0.7	0.3	1.4	0.3	0.4	4.0	8.9	1.2	0.3	34.0	0.0	0.3	0.4	0.3	4.1	0.8	0.4	0.4	12.3	0.8	0.3	0.4	0.4	0.3	1.4	5.4	0.4	0.5	0.4	1.4	44.8	85.4	0.3	0.3	23.5	1.0	0.4	0.3	0.4	0.3	0.4	5.1	0.3	0.3	5.4	0.5	0.0	0.3	0.0	1.9	0.3	1.8	0.0	0.2	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	25.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	2.1	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	1.4	4.0	8.9	12.3	0.8	1.4	5.4	85.4	0.5	0.0	0.0	0.0	0.5	0.0	2.6	1.6	0.0	6.7	0.0	0.0	3.9	99.4	0.0	0.1	0.4	0.3	0.0	0.0	0.0	5.3	1.1	0.4	0.0	0.0	13.1	3.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.2	0.1	657.3	0.0	0.0	0.3
FAM180A	"HWKM1940, UNQ1940"	ENSG00000189320	"Family with sequence similarity 180 member A"	Q6UWF9	7	135728348-135748846	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.0"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 6.6;Cardiomyocytes: 5.2;Fibroblasts: 5.8;Ito cells: 8.0;Leydig cells: 2.6;Melanocytes: 6.8;Peritubular cells: 3.9;Smooth muscle cells: 2.8;Suprabasal keratinocytes: 4.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"basophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"U-2197: 74.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA021224	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA			Nucleoplasm		"HPA021224: AB_1851352"	"unprognostic (3.85e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.97e-3)"	"unprognostic (5.62e-2)"	"unprognostic (7.55e-2)"	"unprognostic (8.88e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.35e-4)"	"unprognostic (6.62e-4)"	9.3	2.6	0.1	1.7	0.5	0.0	5.6	0.1	1.0	7.8	5.7	0.3	0.5	0.7	9.4	2.0	5.1	3.0	21.2	14.7	0.1	0.1	8.7	23.0	4.6	0.0	0.1	0.0	8.1	1.1	0.0	0.3	1.4	0.5	6.1	1.8	1.9	2.2	0.1	3.5	5.5	3.2	8.1	0.4	0.9	1.6	3.9	0.1	0.0	4.6	4.8	0.9	6.6	8.3	0.6	0.2	2.0	0.3	0.4	0.5	0.1	0.0	0.0	0.0	0.0	8.1	8.4	0.0	4.2	16.1	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	10.3	1.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	16.7	0.0	74.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.0	0.1	0.1	0.3	0.1	0.2	0.2	0.3	0.2	0.0	0.6	0.4	0.5	0.8	0.4	0.3	0.2	0.2	0.1	0.1	0.5	0.1	1.0	0.1	0.1	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	6.6	0.0	5.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	2.6	0.0	6.8	0.0	0.0	0.0	0.1	0.0	3.9	0.0	0.0	0.0	2.8	0.0	0.0	4.3	0.6	0.0	0.0	0.0
MTPN	"GCDP, MYOTROPHIN, V-1"	ENSG00000105887	Myotrophin	P58546	7	135926761-135977353	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019735	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		48000000	"Plasma membrane, Cytosol"		"HPA019735: AB_1858710"	"unprognostic (5.97e-2)"	"unprognostic (2.53e-2)"	"unprognostic (8.52e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (2.06e-3)"	"unprognostic (3.30e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (4.50e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.00e-3)"	"unprognostic (4.86e-3)"	31.0	22.1	40.2	28.5	53.2	55.1	39.6	34.4	50.0	30.9	21.4	20.4	16.0	17.2	29.5	21.9	62.1	27.0	23.7	31.6	38.0	31.6	25.1	20.5	31.6	49.3	24.2	32.4	22.0	10.7	29.2	22.5	26.3	22.9	23.4	23.6	21.5	22.2	24.0	27.4	19.1	23.1	27.9	23.3	42.4	17.6	23.4	19.9	36.4	36.9	24.9	42.8	26.1	30.5	37.9	24.6	50.6	43.5	12.8	16.7	17.0	27.7	22.0	24.3	36.3	34.9	41.5	12.7	44.0	44.7	28.2	30.9	25.0	30.0	49.0	32.6	54.0	43.2	17.7	22.7	34.5	52.4	36.2	22.4	33.4	23.8	16.3	28.7	44.8	48.2	30.3	34.2	33.5	31.5	39.1	43.9	39.3	39.6	29.6	53.1	21.2	45.1	33.2	34.4	25.6	31.3	26.3	18.6	39.8	30.6	23.0	31.3	57.2	35.8	22.3	33.8	23.0	16.4	27.4	47.0	42.7	19.6	42.4	41.4	24.7	36.3	72.3	68.3	39.4	90.8	25.4	21.4	22.6	16.7	28.9	14.3	30.9	10.4	12.5	24.6	37.9	6.9	9.9	50.6	12.8	43.5	24.2	9.0	17.0	40.2	53.2	34.4	50.0	38.0	31.6	24.2	32.4	22.9	19.9	44.7	37.6	120.5	45.1	105.9	0.0	68.2	66.2	34.8	50.0	66.3	0.0	53.8	76.3	60.3	68.1	93.1	49.6	70.0	44.7	56.8	87.2	72.5	93.8	50.8	91.4	0.0	31.8	97.0	229.9	24.5	80.0	156.1	96.2	119.0	41.0	0.0	73.4	59.1	116.3	67.4	0.0	90.5	53.6	60.7	100.9	130.2	57.6	66.6	47.3	89.4
LUZP6	"MPD6, MTPNUT"	ENSG00000267697	"Leucine zipper protein 6"	Q538Z0	7	135927274-135927450	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"naive CD4 T-cell: 2.4;naive CD8 T-cell: 2.7;plasmacytoid DC: 2.9;T-reg: 4.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.9;T-cells: 4.4"	"Group enriched"	"Detected in some"	5	"MOLT-4: 9.8;OE19: 6.1;SK-MEL-30: 19.4"									HPA077907			Approved	"Lipid droplets"		NA	NA			"Lipid droplets"		"HPA077907: AB_2686869"																		1.2	1.2	2.3	1.2	3.5	1.2	1.2	1.2	1.8	3.6	1.2			1.2	1.2	1.2	4.9	2.9	1.2	1.2	2.1	0.8	1.2	1.3	1.2	1.2	1.9		1.2	1.2	1.2	2.0	1.2		1.2	1.2		1.2	1.2	7.2	1.2	1.2	1.2	0.5	3.4	1.2	1.2			1.2		1.2	1.2	1.2	0.5	2.9	0.1	0.0	0.6	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	9.8	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	2.4	2.7	0.0	0.6	0.0	2.9	4.4	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHRM2		ENSG00000181072	"Cholinergic receptor muscarinic 2"	P08172	7	136868669-137020255	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 25.5;heart muscle: 35.0;smooth muscle: 32.8"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 45.4"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.8"	"Region enhanced"	"Detected in many"		"pons and medulla: 15.7"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 44.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022338, HPA029795"	Approved					NA	NA					"CAB022338: , HPA029795: AB_10601357"			"unprognostic (3.51e-2)"	"unprognostic (3.73e-4)"	"unprognostic (5.77e-2)"			"unprognostic (1.78e-2)"		"unprognostic (1.97e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.69e-1)"		"unprognostic (1.43e-2)"	"unprognostic (1.80e-1)"		"unprognostic (1.35e-3)"	0.8	0.9	3.6	7.2	1.9	0.3	0.8	0.8	6.0	0.9	8.9	0.0	0.0	0.9	0.8	0.3	0.8	0.8	25.5	35.0	0.9	0.9	0.8	1.2	1.0	0.2	0.9	2.2	0.8	0.8	0.2	0.9	1.7	15.7	5.4	3.9	0.0	0.8	0.2	0.8	0.8	3.7	32.8	5.0	0.8	2.7	2.3	1.5	0.0	0.8	0.0	0.2	14.0	1.8	0.0	0.2	1.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	9.2	0.1	0.0	0.0	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.7	0.2	0.0	0.0	3.6	1.9	0.8	6.0	0.9	0.9	0.9	2.2	15.7	1.5	0.0	0.0	0.0	0.0	0.0	4.9	45.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0
PTN	"HBGF8, HBNF, NEGF1"	ENSG00000105894	Pleiotrophin	P21246	7	137227341-137343865	"Cancer-related genes, Predicted secreted proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 160.7"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 182.0;Extravillous trophoblasts: 368.5;Fibroblasts: 184.0;Horizontal cells: 497.4;Leydig cells: 159.9;Muller glia cells: 523.9;Peritubular cells: 174.3;Syncytiotrophoblasts: 161.7"	"Cancer enriched"	"Detected in all"	11	"glioma: 514.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"AF22: 190.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017685, HPA073913"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	167000	1800000	"Endoplasmic reticulum"		"CAB017685: AB_1128556, HPA073913: "	"unprognostic (1.51e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.81e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-2)"	7.8	6.6	55.5	2.0	43.3	0.9	27.7	38.6	58.5	30.7	7.2	26.9	9.9	2.5	25.2	18.7	25.0	7.2	18.2	29.4	42.3	29.7	12.7	3.4	6.5	2.6	31.6	27.0	7.2	3.4	160.7	52.5	11.8	31.4	38.5	7.7	19.0	12.0	18.1	1.5	3.6	4.0	17.7	23.4	12.4	5.4	16.8	23.3	1.3	5.1	8.7	5.3	7.7	18.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	190.8	2.3	0.0	0.1	15.6	4.9	14.6	2.7	3.8	0.0	0.0	0.0	0.0	6.4	1.7	0.1	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	1.8	0.0	2.7	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	14.7	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.9	13.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	4.2	3.7	0.2	10.6	0.0	0.0	0.0	13.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	43.3	38.6	42.0	42.3	29.7	31.6	27.0	31.4	23.3	0.0	0.0	0.0	1.3	20.6	19.5	14.2	0.0	2.7	4.5	1.8	5.9	182.0	8.3	1.2	11.9	8.4	0.0	0.0	0.0	368.5	184.0	17.1	0.0	0.0	18.1	497.4	0.0	8.6	0.3	8.3	159.9	1.4	42.2	0.0	0.0	523.9	0.2	0.0	174.3	5.1	27.0	58.2	33.4	1.8	1.5	12.2	161.7	0.0	0.0	2.0
DGKI	DGK-IOTA	ENSG00000157680	"Diacylglycerol kinase iota"	O75912	7	137381037-137847092	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.8;thyroid gland: 32.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 40.2;Horizontal cells: 42.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 4.0;GAMG: 4.5;hTEC/SVTERT24-B: 4.2;SCLC-21H: 6.8;U-2197: 18.8;U-87 MG: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.76e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.01e-2)"	"unprognostic (8.74e-2)"	"unprognostic (4.46e-2)"	"unprognostic (5.98e-5)"	"unprognostic (2.85e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.73e-3)"	1.5	1.3	5.0	1.1	19.8	0.7	1.1	11.4	12.7	0.8	0.9	2.6	0.0	0.9	1.4	0.9	0.9	0.9	1.9	5.0	4.6	3.3	1.7	0.7	0.8	0.8	2.8	9.0	0.8	0.7	0.8	6.0	0.8	6.6	1.0	0.9	10.8	1.0	1.1	0.7	0.9	0.9	2.7	2.5	0.8	0.8	1.9	5.8	0.0	32.1	0.0	0.8	1.1	0.3	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	1.0	0.9	0.0	4.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	1.3	4.5	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	1.0	0.0	0.1	0.2	0.0	4.2	0.1	0.8	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.8	2.9	0.0	0.0	0.5	0.3	0.0	0.0	0.3	1.6	0.6	18.8	0.9	0.1	0.0	0.0	7.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	5.0	19.8	11.4	12.7	4.6	3.3	2.8	9.0	6.6	5.8	0.0	0.0	0.0	0.2	1.0	40.2	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	42.9	0.0	0.0	0.0	1.7	0.9	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.4	0.3	3.0	0.0	1.0	0.2	0.2	0.5	0.0	0.0	0.0	0.0
CREB3L2	"BBF2H7, TCAG_1951439"	ENSG00000182158	"CAMP responsive element binding protein 3 like 2"	Q70SY1	7	137874979-138002067	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 81.6"	"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 120.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015068, HPA015534"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Nucleoplasm, Endoplasmic reticulum"		"HPA015068: AB_1847224, HPA015534: AB_2669210"	"unprognostic (8.50e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-3)"	"unprognostic (9.88e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.50e-1)"	"unprognostic (4.77e-1)"	"unprognostic (8.93e-2)"	"unprognostic (9.48e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.08e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.32e-2)"	14.9	19.8	4.7	17.1	9.8	10.8	15.7	1.9	6.0	25.4	16.7	11.4	18.7	11.6	28.2	25.5	12.8	16.2	16.2	20.4	5.6	4.3	17.0	11.7	14.6	15.2	11.8	3.7	25.9	16.0	38.4	28.8	81.6	9.8	15.9	9.5	24.9	26.5	23.3	5.0	6.9	17.5	17.7	6.2	12.1	14.1	9.8	9.1	7.0	35.8	10.9	18.1	21.3	15.7	4.6	12.4	7.4	5.6	6.5	11.8	3.2	4.0	6.3	12.0	0.2	20.5	20.4	9.0	20.4	33.0	14.3	14.5	8.6	3.7	0.8	5.5	22.1	7.8	2.2	7.0	14.9	28.0	5.9	3.5	25.7	8.6	20.5	13.6	7.7	36.9	8.4	9.5	18.0	21.1	14.7	18.8	2.1	13.2	12.0	16.7	7.3	2.4	9.5	4.3	5.6	4.5	5.4	6.5	6.8	11.2	4.2	3.1	7.2	6.6	17.1	9.1	7.3	2.5	5.8	20.0	19.2	2.9	23.1	7.4	14.2	4.9	5.3	23.0	21.8	42.5	7.4	5.6	5.9	8.2	2.9	10.6	4.0	6.0	8.6	5.8	4.6	2.2	3.8	2.1	6.5	1.5	12.4	11.8	3.2	4.7	9.8	1.9	6.0	5.6	4.3	11.8	3.7	9.8	9.1	6.0	20.4	20.6	8.1	10.9	7.2	14.1	20.4	10.7	18.2	22.7	9.8	50.6	11.6	9.3	48.0	20.2	32.0	0.0	15.3	76.5	40.4	27.0	48.5	24.5	49.4	14.3	15.1	30.1	33.2	14.1	57.2	25.1	25.3	10.0	17.0	6.7	15.1	17.3	96.9	9.1	12.4	38.8	42.4	1.1	4.3	6.1	120.8	27.3	14.9	17.2
AKR1D1	SRD5B1	ENSG00000122787	"Aldo-keto reductase family 1 member D1"	P51857	7	138002324-138117986	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease mutation, FDA approved drug targets, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"liver: 103.2"	"Group enriched"	"Detected in some"	41	"Early spermatids: 50.2;Hepatocytes: 96.2;Late spermatids: 85.4"	"Cancer enriched"	"Detected in single"	77	"liver cancer: 20.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	20	"Hep G2: 16.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA057002	Enhanced		Approved	Nucleoplasm,Cytosol		No	NA			Nucleoplasm	Cytosol	"HPA057002: AB_2683308"	"unprognostic (2.38e-1)"	"unprognostic (1.65e-2)"			"unprognostic (1.02e-2)"	"unprognostic (1.52e-2)"	"prognostic favorable (9.91e-5)"	"unprognostic (6.11e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.68e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	2.7	0.5	0.7	0.7	0.2	0.2	0.0	0.2	0.2	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.8	0.3	0.2	0.1	0.0	0.6	0.3	0.0	0.0	0.2	0.3	0.1	0.4	0.3	16.9	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.3	0.2	0.1	0.0	0.2	0.1	0.4	0.0	0.3	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.4	0.3	0.2	0.1	0.3	0.2	0.3	0.3	0.2	0.2	0.3	0.3	2.7	0.5	0.6	0.4	0.4	0.3	0.6	0.4	0.4	0.3	1.1	0.5	0.7	1.8	0.7	0.5	0.5	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	50.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	96.2	0.4	0.0	0.0	1.3	1.9	85.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.1
TRIM24	"hTIF1, RNF82, TIF1, Tif1a"	ENSG00000122779	"Tripartite motif containing 24"	O15164	7	138460334-138589993	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 43.3;HMC-1: 58.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043495, HPA061717"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA043495: AB_10962915, HPA061717: AB_2684592"	"unprognostic (2.40e-1)"	"unprognostic (9.52e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (9.94e-4)"	"prognostic favorable (6.57e-4)"	"unprognostic (4.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.54e-2)"	"unprognostic (6.34e-2)"	10.3	31.4	10.4	11.2	10.6	8.8	8.8	8.5	10.7	9.4	9.2	14.6	5.7	9.4	9.0	8.5	11.3	7.0	10.3	9.7	8.4	8.5	9.6	21.5	10.7	8.5	10.5	8.0	29.9	11.6	20.7	7.3	13.5	8.4	13.6	9.1	7.5	10.1	7.1	16.0	9.8	14.1	9.4	8.0	8.5	10.8	24.1	11.3	34.8	8.8	9.2	8.9	11.3	11.2	1.3	1.9	3.7	2.5	2.2	2.7	0.8	4.2	5.2	43.3	12.5	2.9	2.7	3.3	3.9	4.2	3.1	3.0	8.2	3.9	8.1	3.9	3.8	6.4	2.3	21.0	3.3	4.6	6.2	5.2	17.9	3.9	25.2	3.9	13.9	58.5	2.4	3.5	2.6	4.1	2.2	7.3	4.5	20.2	5.0	3.7	8.2	23.7	12.6	16.5	22.1	4.7	18.8	5.1	6.8	6.9	12.6	9.0	20.5	7.3	6.6	2.1	15.7	4.5	9.2	3.1	3.6	3.0	6.3	5.4	4.6	5.0	13.8	6.0	9.2	5.2	1.1	2.3	3.6	2.2	2.5	0.4	0.9	1.9	1.2	1.9	1.3	1.8	2.0	3.7	2.2	1.1	1.4	2.7	0.8	10.4	10.6	8.5	9.7	8.4	8.5	10.5	8.0	8.4	11.3	47.6	42.2	4.5	11.6	12.4	13.3	38.8	15.3	17.4	20.5	7.0	15.7	25.9	5.0	6.3	45.5	13.2	8.0	0.0	10.6	11.7	11.8	10.1	38.3	28.4	9.2	38.1	9.7	14.1	11.2	28.3	13.0	12.4	13.5	4.6	8.2	28.0	10.1	9.3	15.2	7.7	20.8	12.9	9.9	43.1	8.5	10.3	18.5	10.2	15.5	12.2
SVOPL	MGC46715	ENSG00000157703	"SVOP like"	Q8N434	7	138594285-138701352	"Predicted membrane proteins"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"parathyroid gland: 13.9;salivary gland: 6.5"	"Cell type enriched"	"Detected in some"	9	"granulocytes: 73.9"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	41	"eosinophil: 4.1"	"Lineage enriched"	"Detected in single"	41	"granulocytes: 4.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 8.3;NTERA-2: 2.3;RT4: 1.9;T-47d: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018035	Uncertain					NA	NA					"HPA018035: AB_2197028"	"unprognostic (6.70e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.59e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.46e-3)"	"unprognostic (5.03e-3)"	"unprognostic (2.22e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.51e-2)"	0.0	2.1	0.5	0.0	1.1	0.0	1.2	0.0	0.1	0.3	0.9			0.0	0.0	0.7	0.0	2.3	0.0	0.0	1.0	0.8	2.7	0.0	0.2	0.0	0.2		0.7	0.3	13.9	1.8	0.5		0.1	0.1		6.5	0.7	0.0	0.4	0.0	0.0	0.8	0.0	0.0	1.5			1.0		0.0	0.4	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	8.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.3	0.0	0.0	1.0	0.0	0.3	0.0	1.9	0.1	1.0	0.0	0.8	0.0	0.7	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	3.4	0.0	1.1	0.1	0.6	1.7	0.0	1.4	2.3	1.8	0.0	3.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.4	0.0	73.9	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.4	0.0	8.0	0.0	0.0	0.7	0.2	0.1	1.6	0.0	0.2	0.3
ATP6V0A4	"a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2"	ENSG00000105929	"ATPase H+ transporting V0 subunit a4"	Q9HBG4	7	138706294-138799560	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 40.6;salivary gland: 55.4"	"Cell type enhanced"	"Detected in some"	18	"Collecting duct cells: 15.7;Cytotrophoblasts: 11.7;Distal tubular cells: 26.6;Melanocytes: 6.8"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 25.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SK-BR-3: 35.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA018029, HPA064555"	Enhanced		Uncertain	Cytosol		NA	NA			Cytosol		"HPA018029: AB_1845190, HPA064555: AB_2685284"	"unprognostic (1.99e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.53e-2)"		"unprognostic (4.63e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.32e-6)"	"unprognostic (4.35e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.10e-2)"	0.1	0.0	0.5	0.0	0.3	0.0	2.2	0.1	0.4	1.7	0.0	0.3	3.1	0.0	0.3	0.5	2.7	0.0	0.0	0.0	0.4	0.3	40.6	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.6	0.2	1.0	0.2	0.5	0.0	0.3	55.4	1.2	0.0	6.5	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	1.8	7.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.4	0.4	1.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	3.1	1.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	3.0	0.1	0.0	0.0	0.0	35.9	1.2	2.0	0.1	0.0	0.1	0.4	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.1	0.4	0.4	0.3	0.3	0.0	0.2	0.1	0.0	0.6	0.0	0.8	0.0	0.0	0.3	0.0	1.4	1.2	15.7	2.0	11.7	26.6	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.3	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	4.2	0.0	0.0	1.1
TMEM213		ENSG00000214128	"Transmembrane protein 213"	A2RRL7	7	138797952-138838101	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"kidney: 48.1;salivary gland: 35.6"	"Cell type enhanced"	"Detected in some"	28	"Collecting duct cells: 50.6;Distal tubular cells: 122.7;Melanocytes: 25.3"	"Cancer enriched"	"Detected in some"	22	"renal cancer: 21.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 4.5"	"Not detected"	"Not detected"							HPA054059	Enhanced					NA	NA					"HPA054059: AB_2682361"	"unprognostic (2.79e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.84e-2)"		"unprognostic (1.17e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.14e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.91e-2)"	"prognostic favorable (5.54e-7)"	"unprognostic (4.33e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	0.1	0.0	0.1	0.0	0.1	0.4	2.1	0.0	0.1	1.2	0.0	0.0	4.3	0.3	0.1	0.2	0.1	0.0	0.4	0.0	0.1	0.1	48.1	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	35.6	2.9	0.0	3.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.3	0.1	0.0	1.1	0.8	4.1	0.7	4.6	1.2	0.2	0.4	0.4	0.7	1.6	0.3	0.3	1.4	0.6	0.2	0.1	0.3	1.1	1.7	0.9	0.6	0.1	0.6	0.9	0.0	0.0	0.3	0.6	1.2	1.4	1.0	0.7	0.1	1.0	0.9	0.5	0.2	0.1	0.4	0.5	0.5	0.8	1.2	1.9	0.3	0.2	0.4	0.9	0.3	0.2	0.3	0.6	0.9	0.7	4.5	1.7	1.3	1.1	0.5	1.1	0.2	1.0	1.2	0.3	0.1	1.8	0.9	1.4	0.8	1.7	0.5	1.2	0.8	0.4	0.9	4.1	0.7	0.7	0.9	0.6	1.2	0.7	0.5	0.6	0.3	1.1	0.6	0.6	3.4	4.6	0.6	0.8	0.4	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	3.0	6.9	0.0	0.7	0.0	0.3	0.4	0.0	5.3	3.4	50.6	0.0	0.0	122.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.4	1.1	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.3
KIAA1549		ENSG00000122778	KIAA1549	Q9HCM3	7	138831381-138981318	"Disease related genes, Predicted membrane proteins"			"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 27.5;seminal vesicle: 39.0"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.2;neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"PC-3: 20.4;SH-SY5Y: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019560	Uncertain		Approved	"Nuclear membrane,Intermediate filaments"		NA	NA			"Nuclear membrane"	"Intermediate filaments"	"HPA019560: AB_1852418"	"unprognostic (7.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.33e-2)"	"unprognostic (8.30e-2)"	"prognostic favorable (3.93e-7)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.28e-2)"	2.1	3.2	3.3	0.6	4.4	0.6	2.9	1.2	8.3	2.7	1.8	1.6	27.5	1.5	3.7	4.1	1.4	4.9	2.5	1.9	3.1	2.0	8.0	1.5	4.7	0.3	1.6	3.8	2.6	12.9	6.5	3.6	4.6	3.7	3.1	1.5	2.0	4.4	39.0	1.4	2.6	1.8	2.9	3.3	1.2	3.0	2.9	1.2	3.1	2.2	0.1	0.4	3.8	4.4	0.3	0.1	1.5	0.1	0.3	0.2	0.0	5.1	9.7	8.6	15.0	0.1	0.0	5.0	5.2	4.7	3.0	3.9	9.0	3.1	0.0	3.2	7.9	9.3	1.0	5.3	1.5	3.7	2.4	3.3	2.4	10.4	2.3	1.3	3.7	3.5	1.3	2.4	1.1	1.6	2.9	5.0	3.4	1.9	0.1	3.4	4.8	2.6	3.6	8.1	3.7	20.4	7.2	4.4	0.0	1.5	3.1	11.4	19.5	2.8	5.2	2.3	5.2	4.3	2.3	3.2	3.1	3.2	0.0	4.9	0.7	0.0	0.2	4.1	1.5	7.2	1.2	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	1.5	0.3	0.1	0.1	0.0	0.0	3.3	4.4	1.2	8.3	3.1	2.0	1.6	3.8	3.7	1.2	0.0	2.1	0.0	2.1	0.5	13.5	2.2	0.0	9.4	3.4	7.0	53.0	2.1	0.0	2.3	0.3	4.5	0.1	0.0	2.8	1.9	2.1	3.0	16.1	0.5	0.4	3.2	10.4	1.8	1.0	0.0	1.4	0.2	1.7	0.0	2.0	7.7	4.7	0.6	2.5	6.9	26.7	6.5	1.6	0.0	7.7	0.6	1.3	1.0	1.5	1.4
ZC3HAV1L	"C7orf39, MGC14289"	ENSG00000146858	"Zinc finger CCCH-type containing, antiviral 1 like"	Q96H79	7	139025706-139036029	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	11	"granulocytes: 4.6;Leydig cells: 1.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"basophil: 10.7"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 10.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA020386, HPA050741"	Uncertain		Enhanced	Cytosol		NA	NA			Cytosol		"HPA020386: AB_2257412, HPA050741: AB_2681224"	"unprognostic (1.12e-1)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.08e-3)"	8.2	6.1	2.9	3.1	4.7	1.5	9.4	1.1	3.0	14.7	6.6	2.0	5.0	4.2	10.3	9.7	8.6	7.4	5.6	4.7	2.0	2.4	6.2	1.9	5.3	3.0	1.6	1.7	20.2	9.9	4.4	12.2	14.1	2.0	12.0	4.4	8.4	5.9	10.1	3.0	11.6	4.4	8.8	1.8	6.0	4.5	4.4	2.1	10.5	17.4	5.6	6.2	9.0	9.1	1.0	0.3	10.7	0.3	0.3	0.4	0.3	9.1	7.5	5.5	18.5	4.7	7.2	0.2	4.5	2.0	3.4	4.7	12.4	5.3	0.2	6.6	4.9	0.0	6.6	7.7	1.8	10.4	5.4	0.1	11.7	7.3	4.2	3.7	0.1	4.3	5.5	3.0	5.1	2.4	0.2	5.7	5.8	5.0	0.3	6.9	0.0	12.3	7.0	1.0	1.2	4.8	13.0	18.8	0.1	3.1	5.0	3.7	16.9	11.2	1.6	6.9	1.2	6.9	4.8	8.0	6.2	5.5	2.1	0.0	0.3	0.0	0.2	3.5	0.1	5.7	10.7	0.3	1.3	0.2	0.1	0.3	0.6	0.4	0.4	0.2	1.0	0.3	0.4	0.8	0.3	0.1	0.3	0.3	0.3	2.9	4.7	1.1	3.0	2.0	2.4	1.6	1.7	2.0	2.1	0.0	0.0	0.0	0.7	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.9	0.0	0.0	0.0	1.5	0.8	0.5	4.6	0.0	0.7	0.0	0.0	0.0	0.8	0.0	1.7	0.0	0.0	0.0	0.0	0.8	0.2	0.0	1.4	0.3	0.0	0.0	1.4	0.0	0.6	0.9	0.6	0.0	0.0	0.4
ZC3HAV1	"FLB6421, FLJ13288, MGC48898, PARP13, ZAP, ZC3H2, ZC3HDC2"	ENSG00000105939	"Zinc finger CCCH-type containing, antiviral 1"	Q7Z2W4	7	139043520-139109719	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"T-cells: 124.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047818, HPA059096"	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			Cytosol	"Golgi apparatus"	"HPA047818: AB_10962642, HPA059096: AB_2683903"	"unprognostic (1.68e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.61e-2)"	"prognostic unfavorable (8.77e-7)"	"unprognostic (5.40e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.72e-1)"	"unprognostic (5.41e-2)"	"unprognostic (3.31e-3)"	"prognostic favorable (6.86e-4)"	"unprognostic (6.47e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.84e-2)"	14.3	14.8	6.8	19.8	6.6	52.6	13.8	1.6	5.6	11.2	11.5	6.7	10.8	6.9	10.0	10.9	14.2	9.5	10.4	7.0	5.4	7.2	11.2	13.1	17.2	44.4	7.5	4.0	10.6	11.0	9.8	11.4	8.5	8.6	11.2	10.2	9.3	16.9	11.5	3.8	9.5	14.8	10.8	9.0	22.6	9.6	7.8	6.9	43.9	18.2	8.8	26.1	10.8	29.0	16.3	7.0	28.8	11.9	15.6	27.9	11.8	11.4	14.2	2.0	11.8	18.8	18.1	8.6	13.0	10.0	22.8	23.5	10.2	15.0	10.1	12.3	20.8	19.7	13.1	15.9	15.5	13.0	17.9	5.9	20.1	14.4	12.6	10.8	23.3	18.7	18.4	9.9	25.9	5.8	8.5	16.9	15.3	17.0	11.4	9.7	10.9	19.2	27.2	8.0	8.8	8.7	22.8	7.1	9.8	15.6	14.5	3.7	7.5	20.1	14.2	17.3	4.8	8.3	14.6	21.3	4.9	7.1	13.3	10.7	8.7	9.1	23.8	10.9	21.8	11.5	28.8	8.2	11.9	19.4	10.6	24.6	14.3	27.9	23.5	6.4	16.3	27.3	26.4	22.1	15.6	11.9	7.0	24.2	11.8	6.8	6.6	1.6	5.6	5.4	7.2	7.5	4.0	8.6	6.9	23.8	44.5	82.7	23.7	25.4	2.1	4.4	30.6	28.1	20.5	50.6	3.9	10.5	8.3	17.4	2.2	46.7	36.0	23.3	18.3	17.5	51.6	34.7	31.2	29.9	30.5	0.0	51.0	46.1	44.1	1.2	17.3	62.3	37.1	37.9	31.3	15.0	19.2	26.4	25.1	31.0	0.7	12.9	57.9	0.7	0.7	19.4	1.9	124.6	27.3	23.0
TTC26	"dyf-13, DYF13, FLJ12571, IFT56"	ENSG00000105948	"Tetratricopeptide repeat domain 26"	A0AVF1	7	139133744-139191986	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Ciliated cells: 89.7;Spermatocytes: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036338, HPA036339"	Enhanced		Approved	"Nuclear speckles,Intermediate filaments,Cytosol"		NA	NA			"Nuclear speckles, Intermediate filaments, Cytosol"		"HPA036338: AB_10673351, HPA036339: AB_10673386"	"unprognostic (3.40e-2)"	"unprognostic (8.88e-2)"	"unprognostic (5.01e-2)"	"unprognostic (6.72e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.46e-7)"	"unprognostic (1.72e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.56e-1)"	3.5	6.5	6.9	2.5	8.1	3.3	5.6	6.9	8.3	6.1	3.1	4.4	7.4	1.3	6.6	7.6	3.1	20.9	4.5	3.5	5.7	5.1	8.3	1.9	5.1	2.8	2.7	4.8	8.8	3.2	13.0	20.1	3.8	8.4	5.6	2.8	5.4	3.6	5.5	2.3	3.2	2.2	4.6	2.7	2.6	3.1	17.4	3.9	3.8	7.3	2.8	3.1	3.7	3.9	3.6	2.5	5.3	1.5	1.6	2.3	0.9	11.2	8.5	7.5	8.9	9.4	10.9	3.7	5.5	5.7	9.0	9.2	5.4	8.1	2.4	9.2	4.2	14.7	5.6	8.3	6.4	13.1	7.0	7.2	3.0	6.8	4.6	4.7	8.6	2.1	6.2	5.8	13.4	6.1	5.6	6.6	5.9	6.7	1.6	7.1	10.5	14.7	10.1	7.5	3.3	7.5	5.1	8.9	4.0	7.7	3.3	11.0	7.9	13.4	5.7	7.7	2.3	6.9	4.7	4.6	8.4	7.3	7.6	10.0	3.6	4.6	1.8	14.6	4.3	9.8	1.2	0.5	1.2	2.1	0.5	1.1	3.6	1.5	1.4	1.1	2.4	2.3	1.7	5.3	1.6	1.5	2.5	1.0	0.9	6.9	8.1	6.9	8.3	5.7	5.1	2.7	4.8	8.4	3.9	0.0	2.6	2.7	1.7	1.0	6.9	1.7	7.6	89.7	19.4	5.2	11.8	1.0	0.0	4.8	15.8	2.1	0.0	0.0	2.3	2.8	3.1	1.1	5.7	1.7	1.8	0.0	1.2	4.3	0.6	12.2	3.7	2.2	3.3	2.8	0.9	4.5	1.6	2.9	4.9	4.6	16.0	0.0	2.1	40.9	5.7	1.5	0.3	1.7	0.6	0.5
UBN2	"FLJ25778, KIAA2030"	ENSG00000157741	"Ubinuclein 2"	Q6ZU65	7	139230356-139308236	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 109.8;Late spermatids: 132.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 9.0;NK-cell: 3.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 9.0;NK-cells: 3.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019743, HPA020122, HPA020124"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA019743: AB_1848851, HPA020122: AB_1848847, HPA020124: AB_2212202"	"unprognostic (1.96e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (4.49e-4)"	"unprognostic (1.24e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.30e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.54e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.05e-2)"	5.4	7.8	11.9	5.3	13.0	10.4	9.7	20.8	13.7	7.6	5.9	8.7	12.6	5.0	10.0	14.1	7.0	7.3	5.7	5.8	11.5	6.9	6.3	7.0	6.0	5.1	10.2	7.6	11.5	10.7	10.5	16.9	6.2	8.6	8.2	6.9	8.1	8.1	12.7	11.1	18.6	5.9	7.9	8.4	6.3	6.3	25.5	9.7	6.9	10.4	3.1	5.2	6.4	13.6	1.2	1.2	9.0	1.0	3.4	0.8	0.1	3.9	3.7	6.1	7.6	4.9	4.5	4.7	2.3	3.4	2.1	2.5	4.5	3.9	6.7	4.3	2.8	5.2	3.7	7.8	1.9	3.7	3.4	4.5	5.0	6.7	4.9	2.8	9.7	3.9	3.1	5.5	2.7	4.4	3.8	4.0	3.6	11.6	5.2	2.7	6.0	7.0	11.3	8.7	4.0	2.7	4.0	5.7	4.7	2.9	2.9	10.1	7.3	7.0	4.9	3.3	6.0	3.1	6.5	4.5	2.6	3.0	3.8	2.9	6.0	6.6	11.8	4.2	5.9	3.8	9.0	1.0	0.1	0.5	0.5	0.4	1.0	0.5	0.6	0.3	1.2	0.8	0.5	1.0	3.4	0.4	1.2	0.3	0.1	11.9	13.0	20.8	13.7	11.5	6.9	10.2	7.6	8.6	9.7	6.0	20.5	7.1	15.7	20.7	52.5	24.3	15.3	29.4	15.9	21.0	88.4	7.1	6.6	6.4	109.8	13.8	13.1	23.3	6.1	7.6	17.4	29.6	11.5	16.8	6.2	42.9	22.4	16.5	14.0	132.0	20.8	13.4	8.5	4.6	16.7	25.5	8.4	14.7	20.1	7.9	57.3	19.4	21.5	26.9	30.1	25.2	12.2	8.7	12.1	18.6
FMC1	"C7orf55, HSPC268"	ENSG00000164898	"Formation of mitochondrial complex V assembly factor 1 homolog"	Q96HJ9	7	139339457-139346319	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 68.3;Collecting duct cells: 80.3;Distal tubular cells: 169.1;Proximal tubular cells: 98.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045663, HPA050553"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA045663: AB_2679410, HPA050553: AB_2681173"	"unprognostic (3.71e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.80e-2)"	"unprognostic (8.90e-2)"	"unprognostic (9.00e-2)"	"unprognostic (4.39e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.19e-1)"	"prognostic favorable (5.63e-6)"	"unprognostic (1.04e-3)"	"unprognostic (2.39e-2)"	"prognostic favorable (2.05e-5)"	"unprognostic (1.50e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.02e-2)"	9.2	9.7	11.2	6.0	16.9	7.0	10.2	6.2	18.6	8.4	8.8	7.2	15.1	8.4	7.1	13.6	6.5	11.5	9.7	26.7	10.3	10.0	12.2	17.5	7.2	7.9	12.8	10.2	10.6	22.1	5.5	10.7	4.4	12.2	12.9	6.2	7.1	14.2	13.2	28.3	5.2	6.0	8.1	9.2	6.0	8.7	6.4	11.9	5.3	15.4	18.7	4.0	7.9	10.9	15.9	15.0	7.4	7.7	10.4	12.1	5.3	2.4	9.1	5.4	5.6	2.9	2.5	2.2	0.8	2.3	6.3	4.6	3.0	3.3	5.9	5.5	2.7	5.8	2.0	5.1	2.2	1.4	2.9	30.8	3.0	9.3	12.7	6.1	2.4	4.0	6.3	4.4	2.0	1.7	2.4	4.8	3.9	5.6	8.6	3.5	17.6	5.8	14.6	5.1	4.2	13.1	3.5	2.7	7.6	4.9	2.3	10.2	6.8	2.8	2.3	3.8	0.9	1.1	1.8	2.3	2.2	2.1	2.7	2.3	3.0	2.9	6.5	5.4	5.3	3.6	7.4	7.7	7.4	8.3	4.6	7.4	15.9	10.3	8.3	8.4	14.6	12.1	8.7	3.5	10.4	5.0	15.0	11.3	5.3	11.2	16.9	6.2	18.6	10.3	10.0	12.8	10.2	12.2	11.9	41.7	34.6	0.0	0.0	0.0	0.0	0.0	0.0	68.3	36.4	80.3	0.0	54.8	169.1	29.3	0.0	0.0	0.0	0.0	30.9	18.2	0.0	0.0	11.6	0.0	34.8	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	22.6	0.0	0.0	24.3	0.0	0.0	98.7	0.0	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.0	0.0
LUC7L2	"CGI-59, CGI-74, FLJ10657, H_NH0792N18.3, hLuc7B2, LUC7B2"	ENSG00000146963	"LUC7 like 2, pre-mRNA splicing factor"	Q9Y383	7	139340359-139423457	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051631	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051631: AB_2681558"	"unprognostic (1.07e-3)"	"unprognostic (2.71e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.54e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.48e-3)"	"unprognostic (3.54e-1)"	"unprognostic (2.20e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.28e-3)"	27.2	24.7	32.2	34.7	35.0	59.3	41.3	35.6	33.9	35.1	34.7	41.6	28.0	22.6	35.7	36.8	33.1	32.7	29.3	35.0	33.3	30.4	29.7	33.3	26.6	39.0	33.2	30.5	41.3	34.7	47.7	29.0	31.6	33.8	39.8	31.4	27.3	29.5	40.1	58.4	41.8	27.5	35.2	37.3	32.0	29.0	37.0	32.4	66.3	53.3	23.6	44.8	34.0	33.7	14.3	11.3	15.0	13.7	13.5	20.8	10.6	18.9	10.9	22.8	21.4	15.9	13.1	17.6	21.7	20.8	20.8	21.9	12.1	18.0	31.3	13.3	17.0	13.1	13.7	27.7	21.6	29.7	14.8	27.4	26.8	16.6	12.0	13.4	42.8	22.5	11.3	27.6	19.6	24.2	14.5	16.6	16.2	34.0	16.6	22.6	17.6	50.9	39.0	18.7	24.7	15.8	30.9	23.3	28.2	23.8	21.0	20.2	19.7	23.8	24.1	20.9	17.8	16.8	16.8	16.3	16.4	9.8	18.4	20.0	26.1	24.3	68.5	18.0	41.4	22.0	8.0	8.1	15.0	16.7	12.5	18.7	14.3	16.3	17.5	11.1	13.1	20.8	17.4	8.2	13.5	13.7	11.3	16.3	10.6	32.2	35.0	35.6	33.9	33.3	30.4	33.2	30.5	33.8	32.4	50.6	46.2	14.9	66.6	0.0	52.0	0.0	38.2	68.3	72.8	36.6	49.1	65.1	46.4	37.4	8.6	43.3	25.3	0.0	33.9	61.0	40.1	52.5	55.8	49.7	38.8	41.3	21.1	33.2	38.6	4.2	49.2	33.4	0.0	42.3	38.2	40.5	31.1	21.0	63.6	30.1	47.3	58.2	0.0	57.2	71.0	0.1	68.9	66.1	33.4	47.7
C7orf55-LUC7L2		ENSG00000269955	"C7orf55-LUC7L2 readthrough"		7	139341360-139422599	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	11	"Basal keratinocytes: 80.5;Melanocytes: 75.9;Smooth muscle cells: 39.2;Suprabasal keratinocytes: 78.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045663, HPA051631"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045663: AB_2679410, HPA051631: AB_2681558"	"unprognostic (2.54e-1)"	"unprognostic (5.27e-2)"			"unprognostic (3.21e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.68e-2)"		"unprognostic (4.48e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.42e-3)"		14.4	17.5	10.1	9.7	19.2	7.6	11.7	11.2	21.2	9.8	10.6	8.3	17.2	13.4	13.8	14.3	8.1	10.5	11.1	30.3	8.7	6.7	13.3	14.8	8.9	9.1	14.7	11.7	16.5	25.1	6.9	9.1	8.5	13.9	10.9	6.1	8.2	13.9	15.1	57.2	7.8	11.6	9.3	9.5	10.4	13.5	7.4	13.6	6.1	17.5	21.2	6.2	10.7	12.4	18.6	18.3	17.0	14.8	18.8	21.1	12.6	13.4	19.4	24.0	13.8	10.2	7.2	9.1	10.6	7.1	13.3	10.7	15.3	15.2	15.4	19.2	8.0	17.3	10.6	25.4	9.1	4.3	10.3	5.1	20.1	19.6	12.4	10.0	24.4	16.8	6.3	6.8	12.4	8.1	7.4	9.3	8.6	25.1	20.8	8.3	19.8	36.0	4.0	19.4	18.5	4.9	23.5	18.0	20.6	3.0	9.5	20.2	20.8	14.5	11.4	13.9	4.9	8.5	10.5	10.2	9.5	8.9	9.7	16.0	19.3	16.4	28.4	17.7	16.0	17.0	9.7	12.9	17.0	19.0	12.6	17.8	18.6	18.4	19.5	18.3	18.5	21.1	18.8	4.3	18.8	14.8	15.0	19.8	12.6	10.1	19.2	11.2	21.2	8.7	6.7	14.7	11.7	13.9	13.6	6.0	5.8	0.0	0.0	80.5	0.0	22.1	0.0	14.7	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	20.7	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	1.7	75.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.2	0.0	0.0	78.7	0.0	0.0	0.0	0.0
KLRG2	"CLEC15B, FLJ44186"	ENSG00000188883	"Killer cell lectin like receptor G2"	A4D1S0	7	139452690-139483712	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 9.7;thyroid gland: 22.1"	"Group enriched"	"Detected in some"	6	"Collecting duct cells: 7.0;Extravillous trophoblasts: 1.8;Syncytiotrophoblasts: 6.4"	"Cancer enriched"	"Detected in many"	11	"testis cancer: 42.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 11.2;HAP1: 11.8;NTERA-2: 6.2;SCLC-21H: 5.6;SK-BR-3: 23.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018199	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA018199: AB_2133260"	"unprognostic (2.50e-2)"	"unprognostic (3.05e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.38e-8)"	"unprognostic (2.41e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.13e-2)"	"prognostic favorable (8.61e-4)"	"unprognostic (2.14e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.34e-2)"	0.2	0.1	0.0	0.0	0.3	0.0	2.4	0.0	0.8	1.0	0.0	0.2	0.0	0.0	0.2	0.7	7.3	0.2	0.0	0.0	0.0	0.0	4.5	0.0	6.2	0.0	0.1	0.0	0.0	0.2	6.5	0.9	0.7	0.3	0.2	0.1	0.3	9.7	0.3	0.1	4.7	0.0	1.5	1.4	0.0	0.2	2.3	0.0	0.9	22.1	2.6	2.3	0.8	2.4	0.4	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	3.3	0.0	0.0	1.7	11.8	0.0	0.0	0.0	2.9	0.0	0.4	0.0	0.1	0.0	0.2	0.0	5.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.0	1.8	0.0	6.2	0.0	0.1	0.0	0.0	0.0	0.4	0.1	5.6	0.3	1.7	23.9	0.0	4.8	5.3	1.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.3	0.0	0.0	0.0	7.0	0.0	0.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	6.4	0.0	0.0	0.3
CLEC2L	FLJ32986	ENSG00000236279	"C-type lectin domain family 2 member L"	P0C7M8	7	139523856-139544984	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.8;parathyroid gland: 15.5"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 2.2;Extravillous trophoblasts: 2.6;Horizontal cells: 4.8;Muller glia cells: 1.7;Rod photoreceptor cells: 5.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 15.3;U-266/70: 3.7;U-266/84: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045050	Enhanced					NA	NA					"HPA045050: AB_10965839"	"unprognostic (1.18e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.20e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.29e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.31e-2)"	"unprognostic (7.94e-4)"	"unprognostic (3.57e-3)"	"unprognostic (4.03e-2)"	"unprognostic (8.42e-3)"	"unprognostic (3.02e-2)"	1.1	0.9	9.8	1.0	9.4	1.1	0.8	14.0	24.1	2.3	0.9	1.4	0.0	0.9	2.5	0.5	1.6	0.8	1.9	0.5	13.8	9.2	0.7	0.6	0.7	0.8	15.1	7.2	0.7	0.7	15.5	0.1	0.7	26.8	0.6	0.9	2.2	0.7	0.6	5.5	0.7	1.2	2.2	3.8	0.7	0.6	1.3	0.5	1.8	0.8	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.6	0.0	1.5	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	9.8	9.4	14.0	24.1	13.8	9.2	15.1	7.2	26.8	0.5	0.0	0.0	0.0	0.0	0.0	2.2	1.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.7	1.7	0.0	0.3	0.0	0.0	0.0
HIPK2		ENSG00000064393	"Homeodomain interacting protein kinase 2"	Q9H2X6	7	139561570-139777778	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Apoptosis, DNA damage, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.1"	"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 209.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 17.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 17.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007611	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA007611: AB_1850730"	"unprognostic (1.35e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.50e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.42e-3)"	"unprognostic (4.58e-2)"	"prognostic favorable (9.99e-4)"	"unprognostic (1.38e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.03e-2)"	19.6	9.8	58.8	7.4	53.6	14.4	12.6	8.5	39.8	5.5	7.4	54.5	5.2	8.2	4.7	5.2	10.2	9.9	5.5	30.5	60.0	39.9	28.2	17.5	8.6	5.3	66.1	16.4	6.6	12.3	17.2	7.6	10.8	26.4	10.7	5.8	9.4	11.5	7.1	21.6	3.2	6.2	4.8	56.2	7.3	15.4	2.6	38.6	1.7	10.4	2.8	4.9	6.8	7.4	0.6	0.5	17.8	2.9	0.2	1.4	0.5	4.1	18.5	8.6	5.2	21.0	15.1	1.0	2.3	2.3	2.6	2.7	1.3	2.3	0.0	5.3	4.3	16.0	0.2	3.9	6.0	6.5	42.6	1.6	19.0	3.0	6.5	11.8	5.2	5.2	22.9	3.9	11.8	17.8	6.1	6.4	3.6	11.0	5.2	19.8	3.1	6.5	3.7	2.2	2.3	12.7	7.8	4.7	0.5	11.7	0.7	5.2	4.8	5.2	0.1	2.6	1.6	2.9	2.1	21.5	9.1	4.3	10.5	11.3	25.8	15.3	3.7	18.6	2.8	4.9	17.8	1.1	2.7	0.2	0.9	0.3	0.6	0.5	0.1	0.5	0.3	1.4	0.4	1.5	0.2	2.9	0.2	0.0	0.5	58.8	53.6	8.5	25.2	60.0	39.9	66.1	16.4	26.4	38.6	14.9	31.1	34.2	22.5	8.2	100.5	179.2	58.6	29.4	29.6	61.1	143.3	6.0	29.9	26.8	2.4	43.9	23.1	0.0	58.5	1.5	18.6	91.5	42.8	127.8	14.7	209.7	64.5	159.0	115.1	3.1	12.0	28.9	42.2	32.5	35.2	61.0	53.9	17.5	17.7	62.8	59.6	45.3	63.6	0.9	1.7	8.3	8.0	30.2	23.3	40.0
TBXAS1	"CYP5, CYP5A1, THAS, TS, TXAS, TXS"	ENSG00000059377	"Thromboxane A synthase 1"	P24557	7	139777051-140020325	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 67.1;lymphoid tissue: 51.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 69.3;Hofbauer cells: 78.3;Kupffer cells: 159.9;Macrophages: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"basophil: 38.1;classical monocyte: 44.5;eosinophil: 45.2;intermediate monocyte: 67.1;myeloid DC: 18.7;neutrophil: 38.8;non-classical monocyte: 56.4"	"Group enriched"	"Detected in all"	20	"dendritic cells: 18.7;granulocytes: 45.2;monocytes: 67.1"	"Cell line enhanced"	"Detected in some"		"NB-4: 35.3;PC-3: 11.4;RPTEC TERT1: 10.1;U-937: 28.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA031257, HPA031258, HPA031259"	Enhanced					NA	NA		32000000			"HPA031257: AB_2673812, HPA031258: AB_2673813, HPA031259: AB_2673814"	"unprognostic (4.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.41e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.52e-1)"	"unprognostic (5.00e-3)"	"unprognostic (8.53e-2)"	"unprognostic (5.34e-2)"	13.5	7.7	6.6	17.6	8.9	13.8	5.4	1.5	5.6	3.7	6.3	13.9	0.8	6.5	3.2	4.1	3.4	5.0	13.9	3.7	7.6	5.7	6.1	8.1	20.3	43.9	12.6	2.0	2.5	3.1	1.4	3.5	9.0	9.0	5.2	8.6	4.4	8.2	2.6	1.6	1.9	9.3	7.9	19.3	51.7	7.1	2.0	12.7	7.5	2.4	2.2	6.1	9.3	2.5	1.3	18.7	45.2	67.1	1.5	2.2	25.1	0.1	3.0	0.1	0.0	0.6	1.9	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	4.6	0.4	8.3	0.0	0.0	0.8	2.8	7.4	1.0	0.0	0.0	0.4	0.5	1.1	0.0	0.2	1.0	0.3	0.0	1.0	35.3	0.1	8.3	11.4	1.3	0.0	0.5	10.1	0.0	0.1	0.5	0.1	0.0	0.3	0.0	0.0	6.7	0.9	0.3	0.1	0.7	0.5	2.4	0.4	0.1	0.2	28.7	0.9	38.1	44.5	45.2	1.1	67.1	1.7	1.3	2.2	0.6	18.7	0.5	0.3	0.2	38.8	1.5	56.4	3.3	2.0	25.1	6.6	8.9	1.5	5.6	7.6	5.7	12.6	2.0	9.0	12.7	3.0	16.2	6.0	0.9	0.3	1.0	0.8	7.6	1.4	2.3	1.8	5.9	0.4	8.3	4.3	0.4	2.9	0.1	0.0	8.4	0.6	0.8	7.4	69.3	4.0	78.3	3.2	1.7	18.4	159.9	0.4	0.3	116.3	3.3	16.2	2.0	3.2	3.9	7.0	0.0	4.6	3.8	19.4	0.9	0.4	0.4	0.5	0.5	14.9	2.7	1.0
PARP12	"FLJ22693, PARP-12, ZC3H1, ZC3HDC1"	ENSG00000059378	"Poly(ADP-ribose) polymerase family member 12"	Q9H0J9	7	140023744-140063721	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003584, HPA063872"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003584: AB_1079568, HPA063872: AB_2685139"	"unprognostic (1.46e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (2.30e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.86e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (4.12e-7)"	"unprognostic (3.31e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.01e-2)"	3.1	1.8	1.0	3.7	0.9	6.1	2.5	0.1	0.7	2.1	2.2			4.2	2.8	4.2	2.1	2.5	3.1	1.7	1.0	1.0	3.1	3.0	5.2	3.8	1.0		3.2	2.7	2.5	3.3	3.4		2.8	3.9		4.3	1.4	0.9	8.6	4.4	1.5	1.3	6.0	2.3	5.7			3.2		2.7	1.9	3.1	1.0	1.3	3.4	2.0	2.3	3.3	2.4	3.7	2.3	0.0	0.4	1.1	0.5	3.9	0.6	0.5	4.7	8.0	2.7	3.5	1.7	2.8	1.1	4.8	3.8	1.5	4.4	1.3	4.7	4.7	1.4	1.4	1.8	2.1	0.4	1.4	1.6	2.6	2.0	4.3	3.3	5.0	2.7	4.1	2.3	0.0	2.9	4.5	12.1	0.2	1.8	7.0	2.0	0.0	0.0	2.1	2.3	1.4	0.0	2.4	1.1	3.5	0.6	0.6	0.9	9.6	1.5	2.2	0.5	3.5	0.1	0.1	0.4	0.9	6.0	0.8	0.7	2.0	2.2	2.9	1.7	1.1	0.3	1.9	2.9	1.3	1.0	0.6	1.9	3.4	2.3	1.9	0.7	3.3	2.4											6.0	11.7	6.0	6.5	5.8	3.0	4.2	10.2	5.3	5.7	10.4	2.0	4.5	1.7	10.9	0.6	11.7	32.5	0.0	22.8	16.4	5.3	10.8	19.6	9.6	21.5	0.0	23.1	6.2	10.2	0.4	6.6	13.9	6.8	12.6	13.2	2.6	27.2	25.9	6.7	5.6	2.2	0.0	5.9	28.7	11.9	8.7	1.7	8.7	8.0	9.2
KDM7A	"JHDM1D, KIAA1718"	ENSG00000006459	"Lysine demethylase 7A"	Q6ZMT4	7	140084746-140177035	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012114	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA012114: AB_1852429"	"unprognostic (1.55e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.00e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.84e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.18e-1)"	20.1	3.2	6.6	15.2	4.7	18.7	10.4	8.7	6.1	13.2	12.0	4.7	4.6	10.3	8.9	5.8	13.0	5.8	6.0	8.0	5.7	3.5	4.9	8.5	9.7	10.1	4.8	2.8	5.0	6.4	7.0	6.7	15.5	6.7	6.9	12.2	3.7	11.4	4.5	24.6	15.0	16.3	9.3	6.0	6.7	11.9	9.4	5.9	10.8	6.4	10.3	15.2	13.1	9.1	2.8	3.0	6.1	2.3	1.8	1.6	0.8	0.9	0.4	2.9	3.1	2.7	2.3	5.9	1.3	1.9	0.5	0.6	0.3	0.4	2.0	2.0	1.3	1.6	1.1	4.1	2.5	0.9	11.3	2.5	0.1	0.4	5.3	2.7	1.9	2.1	2.7	5.6	1.6	8.8	1.4	2.8	5.4	6.4	8.9	0.5	0.8	3.5	3.1	4.7	6.5	1.6	4.0	0.2	4.0	1.0	1.2	5.2	6.3	3.0	7.0	3.0	4.9	9.6	0.7	4.9	0.6	1.1	1.9	0.8	3.1	0.4	6.6	1.6	5.2	1.1	1.6	2.3	0.9	1.1	1.3	0.9	1.5	1.6	1.5	3.0	2.8	1.5	1.0	6.1	1.8	0.5	1.2	1.3	0.8	6.6	4.7	8.7	6.1	5.7	3.5	4.8	2.8	6.7	5.9	14.9	27.5	13.2	37.9	44.3	12.4	12.1	10.2	26.8	25.0	15.7	25.5	7.1	1.7	6.4	4.1	20.3	28.2	23.3	8.2	2.5	15.4	28.1	8.1	16.9	9.7	6.4	50.6	24.5	36.3	3.4	7.2	33.7	3.3	3.6	38.6	3.7	10.2	26.8	3.9	2.6	9.5	6.5	17.6	24.7	10.0	40.7	31.7	13.1	21.9	43.9
SLC37A3	DKFZp761N0624	ENSG00000157800	"Solute carrier family 37 member 3"	Q8NCC5	7	140293693-140404433	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.39e-1)"	"prognostic unfavorable (9.54e-4)"	"unprognostic (1.44e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (4.78e-5)"	"unprognostic (1.97e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.50e-2)"	11.7	6.9	8.4	6.2	13.6	6.6	14.1	14.0	15.0	18.7	16.3	9.1	5.1	8.7	31.5	16.1	7.7	15.6	12.3	8.5	10.1	7.9	10.2	8.2	10.5	5.0	8.4	12.3	14.6	20.4	20.0	17.4	13.9	10.6	9.8	16.1	10.4	26.6	8.6	5.0	8.7	10.4	21.6	9.6	10.6	11.6	6.8	8.6	10.0	13.8	6.8	9.2	13.5	12.0	2.5	3.2	12.8	3.9	5.6	8.6	4.0	7.8	13.2	13.8	24.2	20.0	22.0	16.5	11.8	13.9	8.2	12.3	10.5	17.1	1.1	15.0	10.6	21.1	6.5	8.4	14.3	12.6	17.7	12.2	1.3	3.4	10.6	16.8	0.0	4.5	16.9	14.8	8.6	10.2	14.4	12.5	7.0	7.8	3.3	12.6	15.1	7.5	0.7	20.4	19.0	8.3	4.0	3.7	3.6	15.7	16.1	13.5	16.9	3.3	13.4	12.9	15.5	7.2	0.7	14.3	9.4	6.9	23.6	12.0	6.4	11.8	3.0	9.9	0.1	21.5	6.3	3.9	3.7	7.4	2.2	4.1	2.5	8.0	5.6	3.2	2.0	8.6	6.4	12.8	5.6	1.3	1.0	8.6	4.0	8.4	13.6	14.0	15.0	10.1	7.9	8.4	12.3	10.6	8.6	8.9	11.3	4.7	35.2	13.5	9.3	4.3	12.7	10.7	15.9	12.2	9.8	15.5	1.7	19.3	0.9	11.2	12.4	0.0	23.4	22.0	24.6	26.5	8.1	6.6	3.4	12.7	20.7	16.0	5.9	1.1	18.7	4.1	18.6	3.6	21.2	3.1	24.0	10.5	12.7	4.6	9.2	6.5	12.2	3.6	6.5	10.8	11.0	9.6	13.6	33.9
RAB19	RAB19B	ENSG00000146955	"RAB19, member RAS oncogene family"	A4D1S5	7	140404043-140426250	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 14.5"	"Cell type enriched"	"Detected in single"	12	"Intestinal endocrine cells: 1.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	4	"T-cells: 3.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.9;HDLM-2: 12.8;MCF7: 5.7;RPTEC TERT1: 4.2;RT4: 8.3;SK-BR-3: 6.5;T-47d: 7.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051077	Uncertain					NA	NA					"HPA051077: AB_2681336"	"unprognostic (3.40e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.53e-1)"	"prognostic favorable (2.36e-8)"	"unprognostic (1.73e-3)"	"unprognostic (6.42e-2)"	"unprognostic (3.44e-1)"	"unprognostic (6.09e-3)"	0.4	0.3	0.3	2.8	0.3	6.7	0.8	0.3	0.3	0.6	5.2	0.0	0.8	4.0	0.4	2.8	0.7	1.2	8.7	0.3	0.3	0.3	8.9	0.5	2.4	4.7	0.3	0.0	0.3	14.5	5.6	10.5	1.5	0.0	2.6	5.0	0.0	5.7	0.2	0.3	0.7	12.1	0.0	0.3	1.1	2.4	0.5	0.0	3.6	11.3	1.7	3.6	1.7	0.4	0.8	0.0	0.3	0.0	0.6	3.5	0.4	0.8	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.1	5.9	0.0	0.6	0.0	0.0	0.9	0.0	1.6	0.0	12.8	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	5.7	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.2	8.3	1.1	0.0	0.0	6.5	0.0	0.3	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.1	0.8	0.9	3.2	0.0	0.0	1.4	1.4	0.3	0.6	0.0	0.0	3.5	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MKRN1	RNF61	ENSG00000133606	"Makorin ring finger protein 1"	Q9UHC7	7	140453040-140479569	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000567			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA000567: AB_1079299"	"unprognostic (9.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.24e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.89e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-2)"	16.8	17.6	26.8	20.8	28.8	69.9	20.1	37.2	32.6	20.4	39.6	16.1	19.7	28.4	20.1	18.6	23.3	22.2	22.4	38.5	24.9	29.8	20.6	17.5	23.6	18.3	25.7	23.3	24.9	27.3	28.2	21.5	31.7	29.4	21.0	33.7	19.4	24.8	23.1	38.5	24.4	26.6	26.3	20.5	22.5	21.7	95.4	20.2	21.0	23.6	18.8	22.3	25.3	36.4	13.1	7.5	39.3	10.5	12.8	17.8	6.4	28.4	22.0	17.2	25.5	27.3	23.9	24.3	19.6	25.5	15.5	17.9	9.0	30.0	20.7	30.8	19.1	31.0	13.9	19.3	21.6	19.7	40.9	16.7	21.5	13.2	16.6	22.0	18.4	33.2	23.8	32.6	17.4	16.5	25.6	15.4	14.3	16.9	26.1	14.8	24.5	21.5	32.9	44.2	24.0	16.3	15.6	14.7	31.6	24.8	33.0	23.8	24.6	24.6	33.4	35.1	26.5	16.4	16.0	21.8	10.9	8.7	26.5	17.9	62.3	45.6	18.1	31.2	28.9	22.4	19.4	9.2	39.3	6.7	8.7	8.0	13.1	13.0	10.1	7.5	10.9	17.8	11.3	18.1	12.8	10.5	2.5	14.0	6.4	26.8	28.8	37.2	32.6	24.9	29.8	25.7	23.3	29.4	20.2	47.6	30.4	57.3	58.0	72.9	58.8	51.3	63.7	33.5	43.3	40.1	33.4	63.4	87.9	55.8	227.6	33.8	112.4	256.9	59.7	76.6	47.0	74.5	36.9	38.9	53.2	112.8	93.6	40.5	91.7	263.0	61.5	68.3	65.8	87.4	100.7	52.1	52.9	123.8	58.7	39.1	43.2	45.3	49.5	153.2	47.1	83.4	115.4	66.0	96.2	100.8
DENND2A	"FAM31D, KIAA1277"	ENSG00000146966	"DENN domain containing 2A"	Q9ULE3	7	140518420-140673993	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 50.5;Horizontal cells: 84.2;Mucus-secreting cells: 40.3;Paneth cells: 54.3;Undifferentiated cells: 40.9"	"Cancer enriched"	"Detected in all"	6	"glioma: 28.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 25.1;BJ hTERT+: 23.8;PC-3: 13.4;RPTEC TERT1: 31.3;U-2197: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.02e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (9.35e-4)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (3.05e-6)"	"unprognostic (1.03e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.38e-3)"	12.7	4.8	15.6	2.9	18.7	1.1	6.5	7.7	14.8	23.1	6.7	15.7	1.9	4.4	21.2	6.2	10.3	19.5	11.3	9.8	15.3	13.2	6.9	3.4	12.9	2.4	18.5	9.0	22.3	2.7	5.3	19.0	15.5	17.2	8.6	6.3	12.8	2.8	6.4	7.1	2.4	5.6	16.7	12.5	9.9	4.6	2.6	15.4	0.0	2.9	4.3	2.0	10.2	24.1	1.2	0.9	4.4	0.7	1.4	0.8	0.2	0.1	0.4	25.1	0.2	2.4	0.5	5.6	1.1	23.8	3.7	6.5	0.0	0.0	0.0	0.2	0.2	4.5	0.1	4.5	0.3	8.1	0.0	0.4	0.0	0.1	0.0	0.7	0.1	0.0	1.2	0.3	6.4	0.8	9.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	5.9	0.0	13.4	0.9	1.7	0.1	31.3	0.0	2.1	6.7	0.0	0.0	0.0	7.0	0.0	0.2	0.0	5.0	1.1	14.7	2.9	0.1	0.0	0.0	0.4	0.0	1.9	2.7	0.7	0.6	0.6	0.3	0.5	0.6	0.6	0.5	0.1	1.2	0.8	0.7	4.4	1.4	0.3	0.9	0.4	0.2	15.6	18.7	7.7	12.0	15.3	13.2	18.5	9.0	17.2	15.4	0.0	4.0	0.0	1.4	1.1	7.5	3.3	0.0	1.4	2.3	0.0	7.9	0.6	6.6	0.0	0.8	2.7	50.5	0.0	0.0	3.5	7.6	2.2	11.5	0.4	1.9	84.2	9.2	9.2	0.3	0.4	17.3	1.0	1.7	0.0	40.3	16.6	0.1	54.3	9.9	0.0	10.6	12.9	2.3	0.0	0.7	0.4	0.3	0.7	40.9	1.0
ADCK2	MGC20727	ENSG00000133597	"AarF domain containing kinase 2"	Q7Z695	7	140673153-140696261	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA036036	Approved		Uncertain	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA036036: AB_10672078"	"unprognostic (2.76e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.72e-2)"	"unprognostic (5.30e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.05e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.10e-3)"	"unprognostic (6.81e-3)"	"unprognostic (9.36e-3)"	"prognostic favorable (9.75e-5)"	"unprognostic (1.89e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.13e-1)"	12.3	10.6	15.3	11.3	16.6	8.8	13.4	15.4	27.0	12.3	15.1	26.3	13.2	8.8	10.3	11.4	18.0	20.0	10.3	10.2	16.6	18.2	12.3	12.5	12.8	15.6	19.5	13.1	14.5	22.8	21.4	12.7	19.9	18.2	14.4	13.2	10.7	16.8	14.0	12.5	25.8	13.0	10.9	24.0	13.6	13.0	7.6	13.3	20.6	25.1	9.9	16.2	13.4	18.9	8.2	12.0	3.2	5.0	5.1	7.3	2.2	16.0	11.6	2.7	12.7	10.0	11.4	16.5	8.3	10.2	8.7	5.8	10.5	11.4	21.6	12.6	5.8	20.4	13.3	13.9	9.5	2.6	15.9	14.2	4.5	4.5	5.1	13.9	3.0	11.3	9.5	29.1	5.0	6.9	9.0	7.5	15.4	7.9	10.6	3.1	20.0	22.5	7.5	4.0	12.8	12.6	17.8	0.1	10.4	4.7	16.1	10.8	7.6	11.4	16.7	11.4	5.5	14.8	6.1	7.9	10.9	3.8	18.1	16.0	7.4	11.2	15.8	16.1	12.1	12.9	0.0	3.7	3.2	5.4	5.0	4.9	8.2	4.8	5.3	5.7	4.2	7.3	4.7	0.1	5.1	3.0	12.0	6.0	2.2	15.3	16.6	15.4	27.0	16.6	18.2	19.5	13.1	18.2	13.3	8.9	5.1	8.2	18.5	11.0	11.4	5.8	5.1	2.7	1.2	8.7	0.0	25.4	5.0	5.3	16.9	9.0	8.5	0.0	6.4	18.4	7.1	15.5	11.5	8.6	27.9	11.1	16.1	6.7	7.9	12.5	3.1	11.8	3.3	7.2	13.8	11.6	5.9	14.4	12.7	4.8	4.8	0.0	6.9	5.9	3.1	12.2	28.3	7.7	11.3	16.1
NDUFB2	"AGGG, CI-AGGG"	ENSG00000090266	"NADH:ubiquinone oxidoreductase subunit B2"	O95178	7	140690777-140722790	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 153.5"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 3102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051377	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA051377: AB_2681460"	"unprognostic (1.17e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.30e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.35e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (7.60e-7)"	"unprognostic (2.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.55e-1)"	25.1	31.2	45.1	19.9	52.5	20.2	27.3	29.1	43.3	21.5	39.0	26.0	25.1	28.3	20.1	29.5	27.7	22.0	25.7	105.5	37.0	36.0	46.6	41.2	18.4	23.8	46.0	35.6	14.5	47.0	26.5	23.9	17.7	33.3	20.7	30.8	28.1	37.6	27.4	127.2	17.2	28.1	38.1	37.7	19.7	26.9	14.3	25.2	15.6	57.6	48.1	21.1	25.5	17.5	94.7	116.5	55.2	108.5	75.9	87.8	153.5	41.1	67.0	24.0	52.4	38.6	39.2	34.9	29.9	26.2	31.0	29.6	51.7	41.1	31.3	44.8	36.2	58.7	20.4	21.4	42.1	24.7	52.2	73.6	22.9	57.3	58.1	30.6	35.3	30.9	43.6	36.5	29.4	18.1	26.6	46.1	44.5	38.7	37.9	42.9	122.0	55.3	91.1	55.6	84.7	76.6	31.9	23.4	72.2	62.1	81.8	48.9	48.3	41.0	67.2	35.9	28.6	29.2	40.5	38.4	41.0	24.1	48.4	51.5	36.2	67.2	54.9	62.4	56.8	51.3	55.2	108.5	48.1	83.5	107.8	71.3	94.7	82.1	81.4	116.5	72.9	87.8	87.7	9.0	75.9	97.1	92.8	73.9	153.5	45.1	52.5	29.1	43.3	37.0	36.0	46.0	35.6	33.3	25.2	175.7	232.0	217.4	229.1	201.1	175.8	3102.3	435.7	235.5	197.9	638.6	92.3	489.8	1692.7	343.0	795.3	237.8	727.9	70.0	273.3	377.8	291.6	360.2	272.6	944.1	632.0	131.9	411.8	215.5	261.6	154.7	206.2	385.8	411.7	381.5	493.4	197.7	268.8	531.3	229.1	1640.6	200.8	194.1	278.2	77.7	190.5	245.3	430.7	214.4	506.9	369.0
BRAF	BRAF1	ENSG00000157764	"B-Raf proto-oncogene, serine/threonine kinase"	P15056	7	140719327-140924928	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cardiomyopathy, Deafness, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001328, CAB004552, HPA071048"	Approved		Approved	Vesicles,Cytosol		No	No			Vesicles	Cytosol	"CAB004552: AB_626760, HPA001328: AB_1078296, HPA071048: AB_2686336"	"unprognostic (2.98e-3)"	"unprognostic (5.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.01e-2)"	"unprognostic (5.46e-2)"	13.1	12.1	20.1	16.5	20.4	27.8	14.2	29.9	21.5	12.4	12.3	9.5	12.5	9.3	15.3	17.0	11.8	11.5	12.0	13.6	13.2	12.2	13.7	12.8	15.9	13.3	9.9	17.8	16.8	13.2	28.9	24.8	13.7	15.3	14.5	11.0	10.7	11.6	16.6	12.9	15.6	10.5	13.0	10.9	12.3	12.0	24.9	12.2	13.5	16.6	7.5	12.1	18.6	18.1	2.6	1.9	7.5	2.4	7.0	5.6	1.1	5.5	4.7	6.9	8.3	8.4	11.0	11.1	6.2	6.6	5.0	7.2	5.1	6.0	9.5	4.8	6.4	8.0	3.1	6.1	4.9	9.3	8.8	5.0	6.2	4.6	4.7	7.2	10.0	6.2	7.3	5.6	5.3	11.1	7.4	5.8	7.1	9.7	17.1	8.8	2.9	13.3	10.5	6.4	5.4	3.0	8.7	5.9	7.7	4.9	10.7	8.1	6.8	7.2	4.4	6.5	7.1	4.1	6.8	8.6	5.5	4.2	11.7	5.0	19.8	11.2	15.2	8.9	10.1	5.9	3.3	2.0	7.5	3.1	1.7	2.1	2.6	3.0	2.4	1.6	2.6	5.6	2.8	4.1	7.0	2.4	1.9	2.7	1.1	20.1	20.4	29.9	21.5	13.2	12.2	9.9	17.8	15.3	12.2	20.8	34.2	19.5	20.3	19.2	29.1	12.7	5.1	24.1	25.0	24.4	33.4	12.4	6.6	10.9	55.6	17.1	7.5	0.0	8.6	10.3	13.1	23.9	24.3	8.7	7.9	23.8	18.4	8.6	14.8	30.8	15.3	17.2	15.1	10.0	8.1	11.8	12.5	6.6	9.6	9.6	32.5	6.5	17.3	33.7	23.0	21.0	63.2	17.5	8.1	23.8
MRPS33	CGI-139	ENSG00000090263	"Mitochondrial ribosomal protein S33"	Q9Y291	7	141002610-141015228	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 335.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA030425	Uncertain					NA	NA					"HPA030425: AB_10602030"	"unprognostic (9.83e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.03e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.66e-2)"	"unprognostic (4.55e-3)"	"unprognostic (6.94e-3)"	"unprognostic (4.26e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.16e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.52e-2)"	14.2	26.8	22.4	12.9	32.9	8.9	25.1	12.9	27.4	13.5	27.0	13.0	19.1	21.0	11.1	35.2	18.6	15.2	13.8	33.9	26.4	21.8	30.3	34.5	11.0	16.2	28.4	22.8	15.6	42.4	25.9	29.7	10.1	25.7	15.8	30.2	9.3	20.6	18.1	64.5	13.2	18.2	16.3	26.2	12.2	16.2	15.7	25.3	11.7	22.1	25.8	17.4	14.5	11.4	29.9	32.6	12.5	23.0	26.2	37.5	20.9	22.5	32.4	18.5	19.5	23.6	32.4	20.2	20.4	20.3	19.6	22.2	19.4	31.0	31.2	30.3	19.6	42.5	14.9	20.5	30.1	27.1	27.7	24.5	19.5	6.3	37.6	28.8	27.9	11.8	30.6	31.0	30.2	27.1	22.2	16.0	31.9	32.0	25.1	38.0	35.8	31.1	44.0	38.6	40.5	37.3	8.1	14.5	53.7	34.1	29.1	33.6	26.6	27.5	27.7	40.1	20.6	23.6	26.3	12.2	17.2	11.6	41.2	21.8	38.6	43.1	36.4	38.0	28.9	28.0	3.8	17.1	12.5	18.2	23.0	22.7	29.9	32.1	22.6	27.7	21.8	37.5	31.4	1.6	26.2	19.5	32.6	26.1	20.9	22.4	32.9	12.9	27.4	26.4	21.8	28.4	22.8	25.7	25.3	35.7	32.9	60.3	61.8	37.8	23.9	335.0	81.5	69.6	40.9	108.2	29.5	119.5	300.1	88.2	77.1	40.5	103.8	23.3	118.9	107.8	52.4	53.8	47.3	175.3	98.0	54.0	86.3	34.4	47.9	25.4	53.5	46.7	72.6	110.0	139.9	26.2	91.7	66.6	40.0	239.7	25.8	19.4	41.5	74.8	43.2	40.0	97.7	45.4	197.3	65.6
TMEM178B	DKFZp547G036	ENSG00000261115	"Transmembrane protein 178B"	H3BS89	7	141074232-141480380	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;parathyroid gland: 20.6;pituitary gland: 18.5"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 23.0;Cardiomyocytes: 39.1;Horizontal cells: 28.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 7.1;HDLM-2: 6.4;NTERA-2: 6.0;RPTEC TERT1: 9.8;SCLC-21H: 7.7;WM-115: 10.4"									HPA048771	Uncertain		Approved	Nucleoli,Vesicles		NA	NA			Vesicles	Nucleoli	"HPA048771: AB_2680517"	"unprognostic (7.33e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.83e-2)"	"unprognostic (7.79e-4)"	"unprognostic (1.94e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.05e-1)"	"prognostic favorable (4.10e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.35e-3)"	"unprognostic (8.98e-2)"	0.9	1.7	5.2	0.7	7.4	0.1	0.7	3.2	13.4	0.5	0.8	1.0	2.3	0.1	1.1	0.6	1.8	0.3	0.7	11.6	4.8	5.8	2.9	0.6	0.4	1.5	4.9	1.0	0.2	2.6	20.6	18.5	0.1	1.8	2.8	0.4	0.5	4.4	0.8	4.5	0.2	1.2	1.3	2.4	0.8	0.5	0.8	0.4	1.0	9.5	0.1	3.3	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.6	0.3	1.8	0.1	2.8	0.8	1.0	0.0	0.0	2.2	2.4	0.2	0.5	0.0	7.1	0.0	2.3	6.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	5.1	0.1	0.0	0.0	6.0	0.0	0.0	0.4	1.1	3.0	9.8	2.8	7.7	4.7	0.1	0.3	1.0	1.5	1.0	0.0	0.0	0.1	1.2	3.2	0.0	0.1	0.0	0.0	0.5	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	7.4	3.2	9.6	4.8	5.8	4.9	1.0	1.8	0.4	0.0	0.0	0.0	0.4	0.5	23.0	39.1	0.0	0.0	0.0	1.8	2.0	0.0	1.7	0.0	0.8	0.1	0.0	0.0	0.3	0.0	0.2	3.1	0.0	0.0	0.1	28.6	0.0	0.0	0.0	1.3	0.0	0.0	1.7	0.0	0.0	3.8	1.2	0.0	0.7	2.8	1.6	0.0	0.8	0.5	0.7	0.1	0.2	0.0	0.0	1.6
AGK	"FLJ10842, MULK"	ENSG00000006530	"Acylglycerol kinase"	Q53H12	7	141551189-141655244	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Cardiomyopathy, Cataract, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 37.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020959, HPA053471"	Supported		Supported	Vesicles,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Vesicles	"HPA020959: AB_1854206, HPA053471: AB_2682164"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.47e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.24e-3)"	"unprognostic (7.90e-2)"	"unprognostic (9.29e-2)"	"unprognostic (9.65e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.18e-1)"	8.7	12.0	11.9	8.0	19.0	5.9	10.6	21.3	23.7	8.8	8.9	10.2	8.8	6.4	16.8	17.1	9.5	11.9	6.8	24.5	16.1	12.3	16.0	10.5	8.4	10.0	11.8	18.8	10.8	8.0	15.7	13.3	9.9	14.2	10.1	13.4	10.6	13.5	10.7	8.4	6.8	8.8	15.0	13.9	12.2	9.0	12.9	9.0	7.8	9.8	8.4	15.6	8.4	8.5	4.6	6.4	0.4	5.5	37.9	10.3	5.7	12.4	13.5	13.4	11.0	10.6	13.2	9.1	13.2	12.9	21.2	21.2	10.5	9.6	14.0	11.8	12.6	20.0	9.3	18.7	15.4	22.9	16.5	16.6	13.0	6.4	10.4	15.8	9.0	7.0	14.7	13.6	18.6	18.2	9.9	16.2	16.1	19.3	20.0	10.2	12.5	24.3	4.1	14.2	9.6	15.2	15.7	2.3	41.9	13.6	10.6	11.7	16.1	13.7	16.6	13.6	14.1	8.9	9.9	9.1	9.8	7.7	13.1	19.0	15.2	15.0	6.7	16.2	4.2	27.0	0.0	2.6	0.4	9.1	5.5	6.5	4.6	7.4	10.3	6.4	2.5	5.5	9.6	0.2	37.9	3.2	2.5	7.2	5.7	11.9	19.0	21.3	23.7	16.1	12.3	11.8	18.8	14.2	9.0	0.0	5.9	3.7	5.1	2.7	10.7	16.8	5.1	6.7	5.7	12.2	7.9	13.4	8.3	6.3	10.0	5.8	2.0	0.0	6.1	6.7	5.4	2.6	8.1	4.5	6.1	14.3	0.0	3.1	4.7	8.5	6.4	4.7	6.8	18.0	2.9	9.8	4.6	0.0	9.9	6.1	16.4	0.0	6.2	4.6	4.9	2.4	7.7	11.4	5.6	2.7
KIAA1147	LCHN	ENSG00000257093	KIAA1147	A4D1U4	7	141656728-141702153	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 84.4;Muller glia cells: 106.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 5.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029467, HPA061437"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA029467: AB_10602915, HPA061437: AB_2684517"	"unprognostic (1.27e-1)"	"unprognostic (5.68e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.44e-2)"	"prognostic favorable (6.24e-4)"	"unprognostic (6.49e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.27e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.75e-2)"	"prognostic favorable (8.01e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.78e-1)"	7.6	6.7	18.6	12.5	23.1	5.9	14.1	18.0	23.2	8.1	12.4	24.8	7.1	10.8	8.9	9.9	11.1	9.9	7.5	6.2	20.1	13.2	17.9	13.9	14.1	15.7	28.9	14.0	7.4	16.1	18.8	10.8	5.0	19.6	11.4	17.5	10.1	17.4	10.7	5.0	9.4	13.3	8.3	17.9	20.7	24.1	2.3	28.2	11.6	16.6	4.6	16.2	9.2	9.6	1.6	0.7	5.5	0.4	2.0	1.8	0.5	3.9	3.8	7.3	6.3	2.4	1.1	1.6	1.7	2.1	2.0	2.5	8.2	5.8	0.5	11.8	1.5	3.9	3.0	5.5	3.5	3.7	10.8	5.7	2.1	3.3	1.8	0.9	6.6	2.2	0.8	3.6	1.1	1.4	4.8	7.5	4.3	0.4	1.5	1.0	3.1	4.9	5.4	7.9	12.7	3.2	5.0	1.0	7.9	3.0	6.5	11.5	4.9	3.8	10.4	1.4	3.9	5.0	1.2	13.7	1.0	2.7	2.7	13.6	11.1	2.6	5.9	4.9	9.9	2.8	5.5	0.2	0.0	1.1	0.4	1.5	1.4	1.4	1.0	0.2	1.6	1.5	1.8	0.0	2.0	0.1	0.7	1.0	0.5	18.6	23.1	18.0	20.2	20.1	13.2	28.9	14.0	19.6	28.2	11.9	14.6	23.1	6.7	6.9	26.4	3.5	5.1	16.0	17.0	7.0	84.4	0.2	1.7	6.8	0.6	13.3	5.7	0.0	19.7	0.3	3.6	16.5	11.5	14.5	6.8	7.9	17.9	16.5	25.7	0.0	6.9	8.8	3.3	3.6	31.9	106.6	10.2	7.0	8.9	11.3	7.4	6.5	6.0	0.6	0.5	8.5	0.2	11.7	16.3	10.1
WEE2	FLJ16107	ENSG00000214102	"WEE1 homolog 2"	P0C1S8	7	141708353-141731271	"Enzymes, Predicted intracellular proteins"	Meiosis	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	21	"Distal tubular cells: 1.7;Proximal tubular cells: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"CACO-2: 8.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA027418, HPA054280"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA027418: AB_10603144, HPA054280: "	"unprognostic (6.35e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.88e-3)"	0.6	0.1	0.5	0.3	1.0	0.0	0.4	0.8	0.6	0.6	0.1			0.0	0.7	0.0	1.3	0.7	1.6	1.3	0.5	0.6	1.3	0.1	0.3	1.6	0.6		1.2	1.1	0.0	1.0	0.0		0.3	0.0		0.9	0.0	0.7	2.8	0.4	0.0	0.8	0.4	0.8	1.3			2.0		0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	1.4	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.2	0.4	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	1.4	0.1	0.1	0.0	0.3	1.0	0.3	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.3	0.5	1.6	1.2	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.0	0.2	0.1	1.7	1.1	0.5	0.0	0.4	0.7	0.0	0.0	0.0	0.4	0.0	0.1	0.2	0.4	0.6	0.0	0.1	0.1	0.6	0.0	0.5	0.0	0.0	0.2	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSBP1	"mtSSB, SSBP"	ENSG00000106028	"Single stranded DNA binding protein 1"	Q04837	7	141738321-141787922	"Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA002866	Supported		Supported	Mitochondria		NA	NA		250000	Mitochondria		"HPA002866: AB_1080092"	"unprognostic (2.95e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.62e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.86e-2)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (3.68e-2)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.40e-4)"	"unprognostic (9.23e-3)"	"unprognostic (4.02e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.25e-2)"	"unprognostic (9.58e-2)"	41.1	52.5	45.4	40.9	52.6	41.7	51.6	26.8	44.3	41.7	42.4	33.9	38.7	36.9	45.2	58.9	61.0	37.1	36.8	57.8	38.6	38.6	55.2	83.4	31.0	56.0	42.7	41.0	45.2	49.6	40.7	44.4	47.2	44.4	38.8	44.8	34.1	41.2	39.0	62.9	42.4	40.8	45.5	36.7	50.7	44.6	38.3	33.3	62.9	45.6	67.4	54.7	42.8	38.6	42.6	41.2	31.3	35.9	36.3	48.7	40.8	39.6	46.0	41.1	51.7	18.3	29.8	37.8	28.6	27.6	36.6	41.2	48.5	45.5	62.0	40.6	24.0	60.0	29.9	47.6	50.0	52.1	29.8	49.7	30.4	34.6	42.8	36.2	89.1	24.2	28.0	34.1	38.3	54.0	26.0	44.6	39.0	76.6	26.3	50.0	58.2	63.1	116.4	90.6	64.7	57.6	36.6	37.4	80.7	47.9	39.1	37.0	50.9	33.5	44.5	44.4	32.2	30.1	39.3	32.1	26.1	25.2	40.2	75.9	47.4	62.7	111.0	53.5	80.3	56.9	31.3	29.1	26.6	30.1	35.5	44.0	42.6	48.7	40.2	36.8	37.0	45.1	48.1	7.5	36.3	35.9	41.2	46.4	40.8	45.4	52.6	26.8	44.3	38.6	38.6	42.7	41.0	44.4	33.3	95.3	94.9	115.3	144.9	103.0	51.8	257.7	158.0	105.7	114.9	143.1	39.3	266.1	296.8	270.0	118.1	112.7	85.6	46.7	306.8	254.8	138.8	122.4	145.8	187.5	221.5	41.3	92.5	95.8	119.0	35.7	127.1	153.1	99.5	206.4	126.8	92.4	270.9	108.7	116.3	344.0	71.9	97.0	135.8	228.3	170.8	113.2	218.9	139.5	153.1	201.9
TAS2R3	T2R3	ENSG00000127362	"Taste 2 receptor member 3"	Q9NYW6	7	141764097-141765197	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	8	"T-reg: 1.3"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.9;HAP1: 1.7;HL-60: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (4.11e-2)"							"unprognostic (2.27e-1)"		"unprognostic (4.40e-2)"	"unprognostic (7.38e-2)"		"unprognostic (4.04e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.53e-1)"		0.1	0.0	0.1	0.0	0.5	0.0	1.9	2.5	0.6	0.6	0.3			0.0	0.6	1.7	0.3	0.9	0.1	0.1	0.1	0.1	0.4	0.0	0.2	1.0	0.0		2.6	0.5	0.7	0.2	0.4		0.2	0.3		0.5	0.0	0.2	1.9	0.5	0.0	0.0	0.3	0.3	0.1			0.5		0.5	0.3	0.5	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.4	0.7	0.2	0.0	2.9	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.8	0.0	0.3	0.0	0.3	0.6	3.3	0.0	0.4	0.8	0.5	0.3	0.3	0.2	0.4	1.5	0.2	0.2	0.0	0.0	0.2	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.4	0.9	0.3	0.0	0.7	0.0	0.1	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAS2R4	T2R4	ENSG00000127364	"Taste 2 receptor member 4"	Q9NYW5	7	141778442-141780819	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 6.9"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 12.5;Bipolar cells: 8.9;Club cells: 12.5;granulocytes: 10.5;Horizontal cells: 7.9"	"Low cancer specificity"	"Detected in single"							"Cell type enhanced"	"Detected in some"		"basophil: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HL-60: 3.9;NB-4: 4.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (6.15e-3)"	"unprognostic (5.80e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.00e-2)"	"unprognostic (3.86e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.76e-3)"	"unprognostic (6.15e-3)"	"unprognostic (1.04e-5)"	"unprognostic (5.58e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.18e-1)"	0.2	0.4	0.9	0.5	2.9	0.5	2.6	6.9	1.6	0.6	0.5			0.2	1.7	4.3	0.4	1.3	0.5	0.1	0.9	1.2	0.4	0.2	0.6	1.0	0.7		2.8	0.9	0.5	1.2	0.6		0.6	0.9		1.0	0.6	2.6	4.4	0.9	0.3	0.7	0.8	0.8	0.8			1.0		1.0	0.5	0.6	1.0	0.5	3.6	0.8	1.1	0.8	0.6	0.5	1.5	1.1	0.6	1.0	2.0	0.8	0.4	0.1	0.0	0.4	1.2	0.7	0.9	0.5	0.2	0.1	0.9	1.6	0.8	0.1	0.8	1.0	0.2	1.1	1.3	1.0	3.9	0.8	1.1	1.9	0.1	1.7	0.5	0.4	1.2	1.1	0.3	0.5	0.7	1.4	4.3	1.2	0.3	0.2	0.6	0.5	1.0	0.3	0.7	1.1	0.9	0.3	0.4	0.3	0.5	0.3	1.4	0.8	0.6	0.7	0.4	0.7	1.0	0.4	1.1	0.4	1.6	0.4	3.6	0.8	1.4	0.6	0.3	0.4	0.5	0.5	0.3	0.2	1.0	0.5	0.8	2.4	1.1	0.6	0.5	0.1	0.6											3.0	12.5	0.5	1.2	0.0	8.9	0.3	0.0	5.3	12.5	1.8	5.9	0.8	0.0	0.4	0.2	1.0	0.5	0.0	0.4	0.2	0.6	1.6	10.5	0.6	0.6	7.9	1.2	2.5	0.0	0.0	0.6	0.7	0.0	1.0	0.4	4.4	0.5	0.6	1.4	0.0	3.1	0.0	0.1	1.9	0.9	0.0	0.7	0.0	1.2	0.4
TAS2R5	T2R5	ENSG00000127366	"Taste 2 receptor member 5"	Q9NYW4	7	141790217-141791367	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 8.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 10.6"									HPA053742			Approved	"Nucleoplasm,Nucleoli,Cytoplasmic bodies"		NA	NA			"Nucleoplasm, Nucleoli"	"Cytoplasmic bodies"	"HPA053742: "	"unprognostic (5.48e-3)"	"unprognostic (3.90e-3)"	"unprognostic (6.07e-2)"	"unprognostic (8.00e-3)"	"unprognostic (7.56e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.13e-5)"	"unprognostic (1.13e-2)"	"unprognostic (8.29e-7)"	"unprognostic (1.29e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.39e-2)"	1.0	1.0	0.4	1.4	1.1	0.2	3.2	4.9	0.7	2.5	0.9			0.8	2.8	6.1	1.1	3.0	0.8	0.8	0.6	0.7	1.0	0.5	1.1	1.2	0.4		4.6	1.5	0.1	2.9	1.0		1.7	1.2		1.6	1.0	2.6	8.8	1.7	1.2	1.2	1.9	0.7	1.4			1.7		1.2	1.3	2.4	1.0	0.6	0.5	0.2	0.4	1.4	0.1	0.5	0.2	1.4	0.6	0.9	2.7	1.7	0.6	0.6	0.5	0.9	2.1	0.4	1.1	0.9	0.3	0.0	0.3	1.5	0.8	0.3	0.6	1.7	0.3	1.2	2.7	0.9	1.7	1.3	2.3	10.6	1.2	2.9	3.0	1.0	1.5	2.6	0.4	0.1	1.7	0.6	3.9	1.3	0.2	0.3	0.2	0.1	2.8	0.4	0.7	2.0	1.3	0.3	0.4	0.2	1.7	0.1	0.4	0.3	1.0	0.7	0.6	1.2	1.9	0.4	1.4	0.8	0.8	0.5	0.5	0.2	0.0	1.0	0.0	0.0	0.9	0.3	0.4	0.0	1.0	0.9	1.4	0.0	0.4	0.0	0.6	1.3	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS37		ENSG00000165076	"Serine protease 37"	A4D1T9	7	141836286-141841487	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	127	"testis: 39.1"	"Group enriched"	"Detected in some"	164	"Early spermatids: 641.3;Late spermatids: 239.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 2.3;U-937: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020541	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA020541: AB_1853004"	"unprognostic (4.70e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.69e-1)"		"unprognostic (2.41e-1)"			"unprognostic (3.21e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.30e-7)"	"unprognostic (1.42e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.72e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	39.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.3	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.2	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	641.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	239.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.7	1.0	0.0	0.0	0.0	0.0	0.0
MGAM	MGA	ENSG00000257335	Maltase-glucoamylase	O43451	7	141907813-142106747	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 155.5"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 50.7;Late spermatids: 90.5;Proximal tubular cells: 18.9"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 4.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 14.1"	"Lineage enriched"	"Detected in single"	104	"granulocytes: 14.1"	"Cell line enhanced"	"Detected in some"		"A549: 3.7;BJ hTERT+: 3.3;HL-60: 5.5;U-937: 8.7;WM-115: 2.1"	"Region enriched"	"Detected in single"	12	"olfactory region: 3.1"					HPA002270	Enhanced					NA	NA		68000			"HPA002270: AB_1079366"	"unprognostic (1.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.32e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.16e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.03e-1)"	0.9	0.2	0.3	0.8	0.2	6.9	0.3	0.2	0.2	0.2	59.4	0.1	7.6	25.2	0.2	36.0	0.2	1.0	0.1	0.3	0.2	0.2	8.7	0.4	2.1	0.1	0.3	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.6	0.0	0.1	0.2	3.2	0.2	0.1	155.5	0.1	0.3	8.3	0.7	4.3	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.0	0.0	14.1	0.1	0.0	0.0	0.0	0.0	3.7	0.2	0.1	0.0	0.0	0.5	0.1	3.3	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.3	1.0	0.4	0.1	0.3	0.0	0.1	0.0	8.7	2.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.1	0.1	0.0	4.5	0.0	0.0	0.0	0.0	1.1	0.0	2.7	2.3	12.2	0.0	0.0	1.7	0.0	50.7	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	90.5	0.6	1.8	0.0	0.0	0.4	0.5	0.2	0.0	0.4	18.9	0.0	0.0	0.0	1.6	1.2	0.0	0.0	0.0	0.2	0.2
OR9A4		ENSG00000258083	"Olfactory receptor family 9 subfamily A member 4"	Q8NGU2	7	141916399-141920625	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 1.9;epididymis: 1.0;testis: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"U-937: 5.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA																				"unprognostic (2.77e-1)"			0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	0.1	0.2	0.0			0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.6	0.0	0.0	0.4	0.1	0.0	1.0			0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLEC5A	"CLECSF5, MDL-1"	ENSG00000258227	"C-type lectin domain containing 5A"	Q9NY25	7	141927357-141947007	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.8"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 18.6;Macrophages: 57.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"classical monocyte: 11.5"	"Lineage enriched"	"Detected in many"	8	"monocytes: 11.5"	"Group enriched"	"Detected in some"	23	"HL-60: 15.2;U-937: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA054137			Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA054137: AB_2732582"	"unprognostic (6.89e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.33e-5)"	"unprognostic (4.57e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (6.58e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.64e-1)"	1.4	3.2	1.8	7.3	2.4	35.8	0.8	0.8	2.5	1.7	0.4	1.9	0.6	0.4	0.8	0.5	1.4	1.2	2.0	3.8	7.6	3.1	2.9	2.1	13.9	0.3	2.4	0.5	2.7	2.6	1.4	1.1	2.7	8.2	0.9	0.5	0.8	2.7	0.8	0.3	2.7	0.3	1.5	4.8	2.1	0.4	0.9	4.8	1.1	1.4	4.9	1.4	1.9	1.1	0.0	0.5	1.4	11.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.7	0.0	0.0	11.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	1.9	1.8	2.4	0.8	2.5	7.6	3.1	2.4	0.5	8.2	4.8	0.0	7.4	0.0	0.0	1.6	0.0	0.3	2.5	5.3	9.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	2.3	0.0	18.6	0.0	0.0	0.0	3.8	0.2	0.0	57.4	1.7	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	1.3	0.2	0.0	0.0	0.0
TAS2R38	"PTC, T2R61"	ENSG00000257138	"Taste 2 receptor member 38"	P59533	7	141972631-141973773	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"intestine: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.3;NB-4: 1.1;OE19: 1.6;SK-BR-3: 1.1;U-266/70: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA043862, HPA054366"	Uncertain					NA	NA					"HPA043862: AB_2678703, HPA054366: AB_2682464"			"unprognostic (5.18e-3)"			"unprognostic (6.87e-2)"		"unprognostic (1.22e-1)"		"unprognostic (3.58e-1)"	"unprognostic (1.25e-1)"			"unprognostic (8.36e-2)"	"unprognostic (5.86e-2)"		"unprognostic (8.05e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5			1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.5		0.1	1.9		0.1	0.0	0.0	0.0	2.2	0.2	0.0	0.2	0.2	0.4			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.5	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MGAM2		ENSG00000257743	"Maltase-glucoamylase 2 (putative)"	Q2M2H8	7	142111749-142222324	"Enzymes, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 61.2;pancreas: 15.6;salivary gland: 35.4"	"Group enriched"	"Detected in some"	10	"Early spermatids: 21.0;Late spermatids: 12.0"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 3.5;pancreatic cancer: 2.5;stomach cancer: 9.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"	"Group enriched"	"Detected in some"	8	"OE19: 5.5;RH-30: 4.0"					"Low region specificity"	"Detected in many"			HPA055697	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA055697: AB_2682890"	"unprognostic (1.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.50e-4)"	"unprognostic (7.11e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.71e-2)"	"unprognostic (9.33e-2)"	0.2	0.1	0.1	2.5	0.1	0.2	1.3	0.1	0.1	0.1	28.8	0.0	0.0	15.0	0.1	0.4	0.1	0.3	7.0	0.1	0.1	0.1	0.1	0.2	0.4	0.0	0.4	0.0	0.1	15.6	0.0	0.1	0.0	0.1	0.1	1.4	0.7	35.4	0.0	0.1	0.2	61.2	0.0	0.5	1.5	0.7	1.0	0.0	0.0	0.1	1.7	0.8	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.5	0.0	0.0	4.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS58	TRYX3	ENSG00000258223	"Serine protease 58"	Q8IYP2	7	142252143-142258058	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	85	"testis: 27.2"	"Group enriched"	"Detected in some"	128	"Early spermatids: 636.2;Late spermatids: 161.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	22	"RH-30: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	27.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	636.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	161.5	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.5	1.4	0.0	0.0	0.0	0.0	0.0
MTRNR2L6		ENSG00000270672	"MT-RNR2-like 6"	P0CJ73	7	142666272-142667718	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 81.7;skeletal muscle: 39.1"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 849.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 81.7"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 81.7"	"Cell line enhanced"	"Detected in many"		"HeLa: 50.0;Hep G2: 44.1"														"Secreted to blood"	NA	NA						"unprognostic (5.34e-2)"	"unprognostic (1.34e-3)"	"unprognostic (3.80e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.10e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.69e-1)"	"unprognostic (3.03e-2)"		"unprognostic (2.66e-2)"	"unprognostic (8.07e-3)"	3.4	8.2	1.4	0.8	2.3	0.1	1.1	1.2	5.5	1.1	3.9	1.5	0.8	1.1	1.1	0.8	1.7	1.1	0.8	17.9	6.1	1.4	7.3	4.7	1.1	5.9	2.2	3.9	1.1	2.2	0.0	1.1	0.8	4.5	1.1	2.3	0.8	2.5	0.8	39.1	1.5	2.6	0.8	3.5	1.1	2.2	1.7	1.8	0.8	1.5	0.8	0.8	1.8	1.1	8.4	4.2	81.7	8.2	4.7	3.9	9.5	5.6	9.6	3.3	22.6	3.8	2.0	5.5	6.0	0.5	0.6	1.0	3.1	10.3	4.9	8.2	1.1	0.5	19.9	0.1	1.1	0.5	3.1	3.7	6.8	50.0	44.1	1.2	1.4	7.3	3.4	1.4	0.5	1.6	12.7	0.5	6.1	5.8	7.3	1.8	3.1	2.8	15.2	1.2	3.1	1.1	4.5	2.8	3.7	3.9	8.3	2.2	8.2	1.6	3.8	11.5	4.9	5.3	9.6	6.9	6.5	6.6	7.8	2.0	2.9	1.3	3.1	3.9	8.7	1.6	20.0	8.2	21.6	2.4	4.9	2.4	8.4	2.9	2.9	4.1	7.7	3.2	3.9	81.7	4.7	4.4	4.2	3.1	9.5	1.4	2.3	1.2	2.9	6.1	1.4	2.2	3.9	4.5	1.8	35.7	50.8	1.4	7.4	5.7	0.0	849.8	0.0	75.0	127.4	31.4	0.0	0.5	38.1	0.0	0.3	1.5	0.0	23.3	0.0	0.6	7.1	3.3	51.1	1.9	0.5	0.0	0.0	0.6	0.6	0.6	2.3	14.5	3.3	0.0	0.0	0.0	0.0	0.0	0.4	4.9	0.0	0.0	4.7	0.3	2.0	3.9	0.2	1.0	0.0	3.7
PRSS1	TRY1	ENSG00000204983	"Serine protease 1"	P07477	7	142749468-142753076	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1708	"pancreas: 3057.4"	"Cell type enriched"	"Detected in some"	17	"Exocrine glandular cells: 49265.4"	"Cancer enriched"	"Detected in many"	224	"pancreatic cancer: 1920.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.7;OE19: 10.1;RPMI-8226: 5.4;U-2 OS: 3.2;U-266/84: 1.9"									"CAB025487, CAB025538, HPA062452, HPA063471"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		26000000000	Vesicles	"Endoplasmic reticulum"	"CAB025487: , CAB025538: , HPA062452: AB_2684768, HPA063471: AB_2685017"	"unprognostic (6.55e-5)"	"unprognostic (5.28e-1)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (6.41e-6)"				"unprognostic (8.26e-2)"		"prognostic favorable (7.05e-4)"	"unprognostic (1.35e-1)"			"unprognostic (3.93e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (3.12e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.6	3057.4	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.4	0.2	0.1	0.0	0.4	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.0	1.7	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	10.1	0.0	0.0	0.0	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	1.1	0.0	1.9	0.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.0	0.0	49265.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	208.2	0.0	0.5	2827.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1
PRSS2	TRY2	ENSG00000275896	"Serine protease 2"	P07478	7	142760398-142774564	"Enzymes, Plasma proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	708	"pancreas: 6267.9"	"Cell type enriched"	"Detected in some"	6	"Exocrine glandular cells: 92348.3"	"Cancer enriched"	"Detected in many"	72	"pancreatic cancer: 3463.4"					"Group enriched"	"Detected in some"	6	"basophil: 5.6;T-reg: 5.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 5.6;T-cells: 5.1"	"Cell line enhanced"	"Detected in some"		"OE19: 11.6;RPMI-8226: 37.4;U-2 OS: 8.1"									"HPA062452, HPA063471"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		27000000000	Vesicles	"Endoplasmic reticulum"	"HPA062452: AB_2684768, HPA063471: AB_2685017"	"prognostic favorable (2.32e-4)"	"unprognostic (3.80e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.30e-3)"		"unprognostic (1.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.36e-1)"		"unprognostic (4.62e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.18e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.6	6267.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	5.6	0.0	0.7	5.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	2.4	0.2	0.0	0.0	0.0	1.1	0.0	11.6	0.0	0.0	0.0	37.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.5	2.1	0.0	1.6	0.2	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.1	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	307.0	0.0	0.0	0.0	0.0	92348.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	608.7	0.0	0.0	14696.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EPHB6	HEP	ENSG00000106123	"EPH receptor B6"		7	142855061-142871094	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 30.1;lymphoid tissue: 26.7;skin 1: 32.1"	"Cell type enhanced"	"Detected in many"	16	"Muller glia cells: 270.3;Sertoli cells: 103.5;Suprabasal keratinocytes: 103.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"MOLT-4: 18.2;RT4: 34.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035784			Uncertain	"Nuclear speckles"	"Intracellular and membrane"	NA	NA			"Nuclear speckles"		"HPA035784: AB_2674781"	"unprognostic (1.90e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (7.08e-3)"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.10e-4)"	"unprognostic (2.53e-3)"	"unprognostic (3.15e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.16e-1)"	"prognostic favorable (4.68e-5)"	3.3	1.7	7.4	3.0	30.1	3.3	2.6	3.1	29.3	9.0	1.5	0.8	3.4	0.9	3.0	4.5	7.5	6.4	2.8	1.4	5.4	4.2	1.7	1.3	2.4	3.6	3.3	14.4	3.9	7.8	0.8	1.1	2.9	1.7	6.8	0.9	1.5	4.7	8.1	1.8	32.1	1.6	2.0	1.4	2.6	3.3	3.8	3.6	26.7	6.6	2.5	3.3	5.1	6.5	4.1	0.9	1.0	1.3	0.0	3.1	1.4	0.1	0.0	0.0	0.4	2.0	1.0	0.0	0.2	0.4	0.1	0.0	0.6	1.3	0.0	0.0	0.1	0.0	4.5	0.2	0.0	0.0	1.0	0.1	0.3	0.0	0.2	0.6	4.3	0.2	0.3	0.0	1.2	0.0	0.0	0.2	3.0	0.6	0.0	0.0	0.0	18.2	3.3	3.1	0.7	1.3	0.4	0.0	0.0	0.0	34.6	0.0	0.0	1.2	0.9	0.0	0.4	2.9	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	1.3	0.5	0.1	1.0	0.6	4.1	2.5	1.4	0.9	1.0	3.1	1.5	1.0	0.0	0.4	0.1	1.9	1.4	7.4	30.1	3.1	29.3	5.4	4.2	3.3	14.4	1.7	3.6	3.0	1.7	4.5	25.1	48.3	4.3	2.0	38.2	6.7	10.3	7.0	2.0	0.2	5.0	25.0	0.7	1.4	0.0	0.0	5.7	0.0	12.3	11.7	0.0	1.8	4.3	0.0	1.7	1.3	11.5	4.0	27.9	5.3	11.8	0.0	0.0	270.3	19.6	0.0	9.2	0.4	5.0	103.5	18.4	0.2	8.3	103.5	0.2	8.3	0.0	23.4
TRPV6	"CaT1, ECAC2"	ENSG00000165125	"Transient receptor potential cation channel subfamily V member 6"	Q9H1D0	7	142871203-142885762	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"pancreas: 26.1;placenta: 65.1;salivary gland: 34.2"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 25.5;Collecting duct cells: 26.2;Ductal cells: 63.7;Early spermatids: 26.4;Late spermatids: 28.8"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 16.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.7;HaCaT: 10.5;RT4: 18.7;SK-BR-3: 13.8;T-47d: 30.8"	"Low region specificity"	"Detected in some"							HPA062864	Approved					NA	NA					"HPA062864: AB_2684885"	"unprognostic (9.85e-2)"	"unprognostic (1.60e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.50e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.27e-2)"	"unprognostic (8.49e-2)"	"unprognostic (9.39e-3)"	"unprognostic (1.69e-1)"	"unprognostic (7.17e-3)"	"unprognostic (3.53e-2)"	0.3	0.0	0.3	0.3	0.3	0.0	2.1	0.3	0.3	0.4	1.2	0.3	0.3	4.1	0.3	0.4	1.7	0.1	4.1	0.3	0.3	0.2	2.5	0.6	0.8	0.3	0.8	0.3	0.3	26.1	0.0	0.4	65.1	0.4	12.6	0.0	0.4	34.2	0.7	0.3	3.7	1.0	0.5	2.0	0.3	2.4	0.7	0.3	0.3	0.7	0.6	1.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	1.1	0.0	0.0	13.8	0.3	0.6	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.2	0.8	0.3	0.4	0.3	3.0	0.0	0.0	0.9	0.5	0.4	1.6	25.5	1.4	2.3	26.2	0.0	13.3	0.0	63.7	26.4	0.0	0.0	0.0	2.8	0.6	0.4	14.3	0.0	0.0	1.4	3.2	0.0	0.0	0.0	28.8	0.9	0.0	0.0	3.6	0.0	0.8	13.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	1.6	5.0	0.0	0.0	3.1
TRPV5	"CaT2, ECAC1"	ENSG00000127412	"Transient receptor potential cation channel subfamily V member 5"	Q9NQA5	7	142908101-142933808	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"kidney: 26.0"	"Cell type enriched"	"Detected in single"	8	"Collecting duct cells: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in single"		"RT4: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA063175	Uncertain					NA	NA					"HPA063175: AB_2684954"	"unprognostic (7.44e-2)"	"unprognostic (3.93e-2)"		"unprognostic (1.22e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.98e-1)"		"unprognostic (3.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.95e-2)"	"unprognostic (7.73e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.58e-1)"	"unprognostic (7.76e-3)"	0.1	0.0	0.8	0.4	0.7	0.5	0.5	0.1	0.8	0.1	0.1	0.1	0.1	0.7	0.1	0.3	0.1	0.1	0.1	0.1	1.1	0.7	26.0	0.1	0.1	0.2	1.6	0.4	0.1	0.3	0.0	0.1	0.1	0.7	0.1	0.0	0.1	0.3	0.1	0.2	0.1	0.1	0.1	3.5	0.2	0.0	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.2	0.3	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.1	0.5	1.1	0.7	1.6	0.4	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LLCFC1	"C7orf34, CTM-1"	ENSG00000165131	"LLLL and CFNLAS motif containing 1"	Q96L11	7	142939343-142940868	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	21	"testis: 31.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.3"	"Group enriched"	"Detected in some"	5	"K-562: 3.2;RT4: 3.4;SiHa: 1.5"														"Intracellular and membrane"	NA	NA						"unprognostic (5.05e-2)"	"unprognostic (9.94e-2)"			"unprognostic (5.49e-3)"			"unprognostic (2.76e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.85e-3)"	"unprognostic (3.54e-1)"	"unprognostic (2.02e-1)"			0.1	0.0	0.1	0.1	0.1	1.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.8	0.5	0.0	31.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	3.2	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	3.4	0.0	0.1	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KEL	"CD238, ECE3"	ENSG00000197993	"Kell blood group, metallo-endopeptidase"	P23276	7	142941114-142962681	"Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 21.1;testis: 36.4"	"Cell type enriched"	"Detected in some"	14	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	7	"intermediate monocyte: 1.4"	"Lineage enriched"	"Detected in single"	14	"monocytes: 1.4"	"Group enriched"	"Detected in some"	12	"HEL: 15.3;K-562: 12.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064442			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA064442: "	"unprognostic (5.78e-3)"	"unprognostic (1.08e-5)"	"unprognostic (5.29e-3)"	"unprognostic (4.85e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.29e-3)"	"unprognostic (9.24e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.25e-3)"	0.2	0.0	0.9	2.5	1.1	21.1	0.2	0.2	0.4	0.4	0.2	0.3	0.2	0.0	0.2	0.2	0.6	0.1	0.2	0.2	1.4	0.7	0.4	0.2	1.4	5.0	2.0	0.2	0.2	0.2	0.0	0.2	1.1	0.3	0.2	0.0	0.3	2.5	0.2	0.2	0.0	0.5	0.2	4.4	3.8	0.0	36.4	0.3	0.4	0.2	0.2	3.7	0.2	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.4	0.1	0.0	0.0	0.5	0.3	0.3	0.0	0.0	0.1	0.0	0.1	0.0	1.2	0.0	0.1	0.2	0.0	0.5	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	1.1	0.2	0.4	1.4	0.7	2.0	0.2	0.3	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	2.3	3.5	0.0	0.0	1.7	0.2	1.9	0.0	0.0	46.7	0.0	0.2	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	1.0
OR9A2		ENSG00000179468	"Olfactory receptor family 9 subfamily A member 2"	Q8NGT5	7	143026158-143027195	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	4	"brain: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA																							0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.6	0.0	0.0			0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.6		0.0	0.0	0.0	0.0	0.2		0.0	0.0		0.0	0.0	0.3	0.0	0.0	0.0	2.6	0.0	0.0	0.6			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6V1	GPR138	ENSG00000225781	"Olfactory receptor family 6 subfamily V member 1"	Q8N148	7	143052320-143053347	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"blood: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	12	"memory B-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.2"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"									NA	NA															"unprognostic (3.24e-2)"								0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.8			0.0		0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PIP	"GCDFP-15, GCDFP15, GPIP4"	ENSG00000159763	"Prolactin induced protein"	P12273	7	143132077-143139746	"Plasma proteins, Predicted secreted proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"salivary gland: 1246.7;seminal vesicle: 651.3"	"Group enriched"	"Detected in some"	11	"Ciliated cells: 105.7;Melanocytes: 383.0"	"Cancer enriched"	"Detected in many"	70	"breast cancer: 672.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"memory B-cell: 1.5;naive B-cell: 2.6"	"Lineage enriched"	"Detected in single"	17	"B-cells: 2.6"	"Cell line enriched"	"Detected in single"	330	"T-47d: 126.4"									"CAB002661, HPA009177"	Enhanced				"Secreted in other tissues"	NA	NA		89000000			"CAB002661: , HPA009177: AB_1845459"	"unprognostic (2.80e-1)"	"unprognostic (2.15e-1)"		"unprognostic (1.08e-3)"		"unprognostic (3.01e-2)"		"unprognostic (5.93e-2)"		"unprognostic (2.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (5.96e-5)"	"unprognostic (3.14e-1)"		"unprognostic (3.49e-2)"	"unprognostic (5.55e-1)"	0.4	0.1	0.1	0.0	0.2	0.0	144.4	0.2	0.1	0.2	0.1	0.0	219.3	0.0	0.1	0.0	0.2	0.2	0.0	0.2	0.2	0.1	0.1	0.2	0.6	0.0	0.2	0.0	0.1	0.7	0.0	0.1	0.0	0.0	2.9	0.0	0.0	1246.7	651.3	0.2	7.7	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	49.3	1.1	1.8	0.1	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	126.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	1.3	0.0	1.1	9.6	0.0	0.0	0.0	105.7	6.8	1.8	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	2.1	0.0	0.6	21.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	383.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.5	0.0	0.0	0.0	1.8
TAS2R39		ENSG00000236398	"Taste 2 receptor member 39"	P59534	7	143183419-143184435	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA053456, HPA060680"	Uncertain					NA	NA					"HPA053456: AB_2682157, HPA060680: AB_2684341"																		0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.1	0.6	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4		0.5	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAS2R40	GPR60	ENSG00000221937	"Taste 2 receptor member 40"	P59535	7	143222037-143223079	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	8	"blood: 6.3;lymphoid tissue: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 6.3"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 6.3"	"Cell line enhanced"	"Detected in some"		"PC-3: 1.0;SK-BR-3: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.1	0.2	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0		0.0	0.0	0.0	0.0	0.2		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.9	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	6.3	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GSTK1	GST13	ENSG00000197448	"Glutathione S-transferase kappa 1"	Q9Y2Q3	7	143244093-143270854	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Late spermatids: 923.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA006311, HPA022904"	Supported		Supported	Peroxisomes		NA	NA		1300000	Peroxisomes		"HPA006311: AB_1849786, HPA022904: AB_1849787"	"prognostic favorable (4.41e-6)"	"unprognostic (2.40e-1)"	"unprognostic (6.53e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.99e-2)"	"unprognostic (7.27e-2)"	"prognostic favorable (2.10e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.13e-2)"	"unprognostic (2.15e-2)"	38.0	45.3	14.0	45.3	19.9	29.0	43.0	5.6	19.6	30.4	69.0	19.9	35.7	58.0	24.8	39.8	37.8	27.4	55.2	56.4	15.0	13.1	67.6	97.1	35.4	52.2	24.3	16.3	22.7	39.9	46.2	20.7	41.5	23.9	28.0	43.5	34.4	72.9	35.8	38.9	30.0	91.0	22.2	17.5	58.5	34.8	18.9	20.8	27.1	48.0	56.6	50.3	29.4	26.6	32.8	57.1	35.7	75.4	22.3	99.0	95.2	27.3	19.7	2.8	24.6	43.6	62.7	13.1	16.2	27.8	14.5	29.0	11.9	70.3	15.6	23.1	23.4	21.9	41.6	10.8	25.3	12.7	30.0	11.7	12.7	14.8	18.6	30.1	15.3	20.8	56.5	31.2	16.7	11.9	21.7	38.5	20.5	17.8	19.1	38.8	21.1	15.6	27.8	6.5	53.4	29.9	13.5	0.4	30.8	50.2	15.1	11.4	15.6	29.7	48.4	24.6	17.7	23.3	21.5	22.7	7.9	7.3	20.6	13.7	32.7	15.3	3.5	28.6	61.8	16.2	35.7	67.9	25.8	41.1	74.8	39.6	32.8	76.4	52.4	57.1	21.9	39.5	38.1	21.2	22.3	75.4	23.9	99.0	95.2	14.0	19.9	5.6	19.6	15.0	13.1	24.3	16.3	23.9	20.8	65.5	100.3	104.0	135.2	101.4	10.8	146.0	216.6	120.5	84.2	115.1	11.8	257.6	247.1	119.7	471.4	96.3	424.2	23.3	105.8	108.4	95.9	76.6	140.9	263.3	268.7	7.9	147.4	136.2	267.9	923.0	67.3	177.0	143.4	164.1	202.4	80.8	97.6	394.4	47.7	486.1	13.7	84.1	117.9	6.2	8.8	101.8	153.7	238.2	288.1	173.8
TMEM139	FLJ90586	ENSG00000178826	"Transmembrane protein 139"	Q8IV31	7	143279957-143288048	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.1;kidney: 22.6;placenta: 28.0"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 48.8;Ductal cells: 42.9;Enterocytes: 54.0;Proximal tubular cells: 67.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 9.7;CAPAN-2: 18.3;EFO-21: 12.9;RPTEC TERT1: 32.2;SK-BR-3: 11.3;T-47d: 31.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036982, HPA036983"	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane"	"Focal adhesion sites"	"HPA036982: AB_2675413, HPA036983: AB_10672275"	"unprognostic (2.58e-1)"	"unprognostic (4.38e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (2.89e-1)"	"prognostic favorable (3.05e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.08e-3)"	1.5	2.2	0.9	2.8	1.9	0.0	2.1	0.6	1.6	6.3	14.7	6.0	1.5	22.7	1.6	3.5	0.4	4.6	4.8	2.3	1.6	1.1	22.6	7.8	5.5	0.1	4.2	0.7	0.9	9.6	6.4	2.0	28.0	4.8	1.6	2.9	1.4	6.1	2.2	0.1	1.1	25.1	0.4	13.4	0.8	2.0	3.0	2.1	0.1	8.8	0.4	0.7	2.1	2.4	0.5	0.3	0.9	3.2	0.0	2.0	0.4	9.7	0.7	0.1	0.0	0.0	0.0	6.5	0.1	0.0	0.0	0.0	2.3	18.3	0.1	12.9	0.0	0.8	8.3	0.0	4.2	0.0	0.1	0.0	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.2	0.0	0.6	0.7	0.4	0.0	0.2	0.7	0.1	0.1	0.0	32.2	2.5	0.1	0.0	0.5	11.3	0.0	0.2	31.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.9	0.0	3.2	0.0	0.5	1.3	0.8	0.0	0.0	1.1	0.6	0.0	0.0	2.4	0.3	2.0	0.4	0.9	1.9	0.6	1.6	1.6	1.1	4.2	0.7	4.8	2.1	14.9	5.1	0.0	2.4	0.1	0.0	2.0	35.7	2.7	5.7	48.8	0.0	26.6	29.9	42.9	12.0	0.3	54.0	0.0	4.0	4.7	0.3	0.3	0.0	13.4	1.7	0.0	3.5	1.3	0.6	8.8	0.0	0.1	5.0	1.8	4.3	8.3	23.3	23.0	0.0	67.4	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.0	7.4	1.2
CASP2	"ICH1, MGC2181, NEDD2, PPP1R57"	ENSG00000106144	"Caspase 2"	P42575	7	143288215-143307696	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 45.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB012175, HPA050678"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB012175: , HPA050678: AB_2681214"	"unprognostic (6.96e-2)"	"prognostic favorable (7.38e-4)"	"unprognostic (2.74e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (1.74e-2)"	"unprognostic (1.34e-2)"	"prognostic favorable (2.89e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (5.01e-6)"	"unprognostic (2.66e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.64e-1)"	10.5	6.5	6.6	10.7	6.7	26.8	10.2	9.6	10.9	9.6	8.5	9.0	8.2	8.2	10.8	7.8	14.1	8.4	5.7	6.1	5.7	4.1	7.3	5.8	9.8	15.8	6.9	6.1	8.7	8.1	12.1	6.6	11.3	7.3	7.6	10.2	10.1	11.6	5.8	4.3	14.2	14.0	7.4	6.3	18.6	7.5	8.6	6.9	45.7	8.9	8.0	23.0	7.4	10.2	18.5	11.8	33.2	17.7	13.4	21.4	7.6	10.9	10.3	11.6	20.5	6.5	7.7	6.2	11.2	5.1	10.3	11.3	10.2	12.4	20.8	10.7	7.1	7.9	10.8	11.6	8.9	13.8	18.2	8.9	12.3	16.2	7.0	3.5	23.9	15.4	5.3	7.3	12.5	4.4	4.7	8.8	16.4	10.2	13.3	10.9	10.8	41.6	25.2	14.6	10.7	10.5	30.6	6.0	12.7	6.1	9.3	12.7	14.3	22.3	9.7	7.1	8.3	10.6	9.2	9.8	9.2	6.4	16.5	11.2	11.1	10.9	24.2	10.3	28.5	16.7	33.2	10.8	9.3	14.9	11.9	14.6	15.8	20.6	15.4	9.8	18.5	15.4	17.8	12.3	13.4	17.7	11.8	21.4	7.6	6.6	6.7	9.6	10.9	5.7	4.1	6.9	6.1	7.3	6.9	8.9	8.8	17.9	5.4	13.5	4.7	5.3	25.5	2.7	3.4	7.0	7.9	16.2	3.3	7.7	35.5	13.9	6.5	0.0	6.6	12.8	8.7	5.5	9.3	4.4	8.8	6.4	10.3	14.7	15.4	38.5	10.9	12.1	20.3	11.8	10.3	4.0	7.6	3.5	7.8	3.3	14.0	0.0	8.4	10.1	29.4	12.0	4.8	20.8	13.3	6.0
CLCN1	"ClC-1, CLC1"	ENSG00000188037	"Chloride voltage-gated channel 1"	P35523	7	143316126-143352083	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"skeletal muscle: 38.9;tongue: 21.1"	"Group enriched"	"Detected in some"	13	"Early spermatids: 20.5;Late spermatids: 67.5"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.4;intermediate monocyte: 2.6;myeloid DC: 1.8;non-classical monocyte: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.8;monocytes: 3.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.5;HSkMC: 5.5;NTERA-2: 1.2;PC-3: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (5.16e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.56e-4)"	"unprognostic (8.71e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.90e-3)"	"unprognostic (3.12e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.55e-3)"	"unprognostic (3.57e-2)"	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	38.9	0.0	0.8	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.7	21.1	0.9	0.1	0.0	0.0	1.8	0.5	3.8	0.0	0.2	0.9	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.2	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	2.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	3.8	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	67.5	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.0	0.0	0.0	2.1
FAM131B	KIAA0773	ENSG00000159784	"Family with sequence similarity 131 member B"	Q86XD5	7	143353400-143362770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 47.1"	"Cell type enhanced"	"Detected in some"	13	"Distal tubular cells: 1.7;Intestinal endocrine cells: 2.4;Late spermatids: 2.9"	"Cancer enriched"	"Detected in many"	11	"glioma: 14.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 10.3;hTERT-RPE1: 6.5;NTERA-2: 16.8;PC-3: 16.1;SCLC-21H: 16.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021371, HPA029992"			Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA021371: AB_1852341, HPA029992: "	"unprognostic (1.70e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.54e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.99e-5)"	"unprognostic (1.31e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.53e-2)"	1.5	2.1	10.0	2.0	12.4	0.9	1.2	37.2	47.1	2.7	2.0	15.1	0.0	1.7	4.4	1.0	1.7	1.6	1.4	1.1	9.1	6.8	1.1	0.9	1.5	1.3	14.6	12.3	1.0	0.9	6.4	0.4	0.9	13.8	1.0	2.2	0.0	0.9	1.0	7.7	0.8	2.1	5.6	18.6	1.1	1.4	1.2	11.3	0.0	0.9	0.0	1.1	1.2	0.5	0.0	0.2	0.0	0.5	0.1	2.1	0.2	0.0	0.1	5.0	0.0	4.1	5.2	0.0	0.2	1.2	0.8	0.2	10.3	0.0	0.0	0.0	0.3	0.0	0.2	2.0	0.4	0.7	2.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	5.7	0.0	0.0	0.0	6.5	0.9	0.1	0.0	0.0	0.7	0.0	0.0	0.3	16.8	0.0	16.1	0.0	0.0	0.0	0.0	0.0	16.4	0.5	0.2	1.2	0.0	1.1	0.0	0.0	0.7	0.3	1.6	0.1	0.0	0.0	0.0	0.0	0.1	3.3	0.1	0.0	0.3	0.0	2.1	0.5	0.8	0.0	0.1	0.0	0.2	0.0	0.0	0.8	0.0	0.1	0.2	0.0	0.0	0.2	10.0	12.4	37.2	25.0	9.1	6.8	14.6	12.3	13.8	11.3	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	2.4	0.6	0.3	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6
ZYX		ENSG00000159840	Zyxin	Q15942	7	143381080-143391111	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 188.3;monocytes: 174.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 47.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 16.5;granulocytes: 47.5;monocytes: 22.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004835, CAB009321, HPA073497, CAB075747"	Approved		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA		420000000	"Focal adhesion sites"	"Plasma membrane, Actin filaments"	"CAB009321: AB_2221290, CAB075747: AB_2665753, HPA004835: AB_1080771, HPA073497: AB_2686611"	"unprognostic (1.96e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.60e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (7.92e-5)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.72e-2)"	52.7	11.7	7.7	39.3	8.8	46.1	34.3	17.5	22.2	61.1	56.8	10.7	20.5	13.6	103.6	38.6	52.3	48.9	58.1	22.7	7.4	7.7	24.7	21.2	52.8	63.0	8.8	8.3	58.1	15.9	63.8	9.1	32.4	15.5	43.8	10.8	17.9	18.8	40.7	28.3	21.1	26.6	74.7	8.5	57.1	28.3	37.4	7.1	24.4	18.9	19.1	26.0	93.7	35.7	0.9	16.5	47.5	22.1	4.1	6.7	9.0	12.8	7.8	10.3	14.4	19.5	43.7	12.3	27.3	32.1	30.0	25.2	26.5	8.3	0.8	10.7	33.3	17.3	10.4	6.3	27.6	14.0	13.7	3.4	20.0	9.2	9.2	34.4	16.1	31.9	46.5	12.3	32.7	11.1	18.6	37.9	1.8	4.9	8.7	31.9	14.4	0.2	32.4	21.6	5.0	50.5	3.0	5.5	1.2	22.7	6.8	0.5	7.8	21.5	20.1	11.2	9.8	2.4	16.1	66.4	35.8	14.7	38.0	28.7	2.8	3.7	2.2	31.8	16.9	23.7	4.9	18.2	12.5	5.9	19.2	4.7	0.9	5.5	6.7	16.5	0.5	3.5	4.0	47.5	4.1	22.1	4.2	5.0	9.0	7.7	8.8	17.5	22.2	7.4	7.7	8.8	8.3	15.5	7.1	6.0	8.3	17.4	144.9	30.0	3.3	10.9	33.1	2.7	27.3	33.2	0.0	28.4	6.6	98.9	1.5	40.4	21.3	0.0	81.4	80.5	41.1	47.9	35.8	26.7	153.1	0.0	36.7	66.9	188.3	4.7	26.4	86.6	13.5	174.9	19.9	15.1	120.5	31.6	51.9	14.7	2.6	84.1	82.1	7.9	9.5	17.7	23.5	54.9	19.6	87.0
EPHA1	"EPH, EPHT, EPHT1"	ENSG00000146904	"EPH receptor A1"	P21709	7	143390289-143408892	"Cancer-related genes, Enzymes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 104.4"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 16.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.1"	"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 3.4;naive CD4 T-cell: 6.9;naive CD8 T-cell: 5.1"	"Lineage enriched"	"Detected in single"	9	"T-cells: 6.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 10.5;HaCaT: 9.8;HBEC3-KT: 8.0;MCF7: 8.7;NTERA-2: 32.7"	"Not detected"	"Not detected"							CAB026144	Uncertain					NA	NA		24000000			"CAB026144: "	"unprognostic (1.54e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.58e-3)"	"unprognostic (5.82e-3)"	"unprognostic (2.45e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.59e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.24e-3)"	"prognostic favorable (1.14e-6)"	"unprognostic (3.73e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	0.4	0.4	0.0	2.0	0.1	0.5	1.2	0.9	0.3	5.7	7.9	0.0	3.3	3.3	0.9	1.4	29.3	1.6	7.9	0.4	0.0	0.0	2.8	10.6	2.9	5.8	0.0	0.0	1.2	2.9	104.4	1.3	5.5	1.1	2.1	0.9	1.3	5.8	3.9	0.3	9.5	12.3	0.4	0.2	0.5	1.8	0.8	0.0	5.1	6.0	16.4	17.2	1.6	11.8	0.0	0.7	0.2	0.1	0.2	6.9	1.6	5.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	10.5	4.2	0.0	0.0	0.0	0.0	9.8	0.0	8.0	0.0	0.0	0.0	1.0	0.0	1.0	0.0	0.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	8.7	0.0	1.1	32.7	5.1	0.0	0.0	0.0	0.0	0.7	4.0	0.1	0.0	0.0	4.9	0.0	2.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	3.4	0.9	0.4	0.0	6.9	5.1	0.2	0.2	0.0	0.7	0.2	1.6	0.0	0.1	0.9	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.1	0.0	5.0	1.8	0.0	0.8	2.5	0.0	3.4	7.0	0.0	1.5	0.0	3.9	16.5	0.0	6.5	0.0	3.7	2.0	0.4	2.1	0.0	7.6	0.4	0.0	1.2	0.0	0.0	7.5	0.6	0.0	0.0	0.0	3.7	0.3	5.1	6.8	0.0	1.1	0.0	0.0	0.0	0.2	1.2	3.1	0.8	0.0	6.0	5.0
TAS2R60	T2R60	ENSG00000185899	"Taste 2 receptor member 60"	P59551	7	143443453-143444409	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.3;liver: 1.4;pancreas: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 2.4;U-937: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030416	Uncertain					NA	NA					"HPA030416: AB_10603344"						"unprognostic (1.78e-2)"								"unprognostic (7.98e-2)"				0.1	0.0	0.0	0.4	0.0	0.9	0.0	0.1	0.0	0.2	0.3			0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.2	0.0		0.0	1.3	0.5	0.0	0.3		0.0	0.1		0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.5	0.1	0.0			0.0		0.2	0.1	0.2	0.0	0.0	1.0	0.9	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	1.3	0.5	1.0	0.0	0.9	0.0	0.0	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAS2R41	T2R59	ENSG00000221855	"Taste 2 receptor member 41"	P59536	7	143477873-143478796	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057063	Uncertain					NA	NA					"HPA057063: AB_2683324"																		0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.1			0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1			0.0		0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTAGE15	CTAGE15P	ENSG00000271079	"CTAGE family member 15"	A4D2H0	7	143571801-143574387	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	15	"testis: 8.1"	"Cell type enhanced"	"Detected in single"	34	"Club cells: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000387, HPA000922"	Uncertain					NA	NA					"HPA000387: AB_1078582, HPA000922: AB_1078581"	"unprognostic (2.82e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.32e-1)"		"unprognostic (2.44e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.52e-2)"		"unprognostic (9.94e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.39e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0		0.1	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1			0.1		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TCAF2	"FAM115C, FAM139A, FLJ40722, GATD9"	ENSG00000170379	"TRPM8 channel associated factor 2"	A6NFQ2	7	143620952-143730409	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 12.2;Hepatocytes: 10.9;Syncytiotrophoblasts: 13.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 9.2;HUVEC TERT2: 9.8;TIME: 15.5;U-87 MG: 13.4"									"HPA038756, HPA038758"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"HPA038756: AB_10960427, HPA038758: AB_10960353"	"unprognostic (6.59e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.86e-3)"	"prognostic unfavorable (9.53e-5)"	"unprognostic (1.89e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.17e-6)"	"unprognostic (7.19e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.85e-2)"	3.1	2.7	1.5	5.8	2.7	5.8	8.4	2.0	4.0	5.2	1.8	0.6	2.0	1.8	6.1	2.1	13.1	2.2	3.5	3.5	2.3	1.9	3.1	6.4	7.1	12.4	1.6	1.2	4.2	3.2	2.1	3.8	8.1	2.8	5.5	1.6	1.7	5.7	9.2	2.1	6.7	3.5	5.0	4.7	4.0	3.1	2.2	2.0	7.3	2.3	7.6	7.0	8.0	12.1	2.6	1.0	7.0	0.4	3.5	6.5	1.3	4.8	0.3	0.3	0.3	1.0	1.0	1.9	1.5	2.6	0.7	1.9	0.2	0.5	0.3	2.1	1.2	0.6	0.9	0.1	2.5	2.2	9.2	0.5	0.8	0.7	0.3	1.1	0.3	0.6	2.6	1.1	0.3	0.9	2.0	9.8	0.7	2.7	4.8	4.1	0.9	0.7	0.9	0.4	4.7	2.4	0.4	2.0	2.2	0.0	1.9	0.3	0.2	0.5	3.5	0.3	0.9	1.8	0.3	15.5	1.4	1.0	5.2	0.4	7.7	2.4	0.2	13.4	0.5	2.8	7.0	0.4	0.4	4.0	0.4	4.2	2.6	6.5	4.1	0.3	2.5	5.8	4.6	1.6	3.5	0.3	1.0	6.2	1.3	1.5	2.7	2.0	4.0	2.3	1.9	1.6	1.2	2.8	2.0	0.0	2.6	0.0	1.1	0.0	0.2	0.4	0.0	0.0	3.4	0.0	0.0	12.2	0.0	0.4	0.9	2.1	0.0	0.0	0.3	4.3	0.5	2.7	2.3	10.9	1.8	0.0	0.0	0.6	1.6	0.4	1.7	0.7	0.0	0.0	0.1	1.7	1.3	0.0	0.7	0.3	0.0	0.0	0.6	3.2	0.2	0.0	13.2	2.9	0.0	1.0
TCAF2C		ENSG00000283528	"TRPM8 channel associated factor 2C"		7	143639230-143647646	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in some"	4	"blood: 2.2;parathyroid gland: 1.9;placenta: 1.3"	"Not detected"	"Not detected"											"Cell type enhanced"	"Detected in some"		"basophil: 2.2;T-reg: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 1.1;OE19: 1.5;U-266/70: 3.9;U-266/84: 1.8"									"HPA038756, HPA038758"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"HPA038756: AB_10960427, HPA038758: AB_10960353"																		0.0	0.0		0.2		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.4	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	1.9		1.3		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.1		0.0	0.1	0.0			0.0		0.0	0.0		0.6	0.0	2.2	0.0	0.0	1.8	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.9	1.8	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTAGE6	"CTAGE6P, MGC41943"	ENSG00000271321	"CTAGE family member 6"	Q86UF2	7	143755089-143757696	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	40	"testis: 15.0"	"Cell type enhanced"	"Detected in single"	27	"Early spermatids: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.1;HeLa: 1.6;U-266/70: 1.0"									"HPA000387, HPA000922"	Uncertain					NA	NA					"HPA000387: AB_1078582, HPA000922: AB_1078581"		"unprognostic (1.51e-2)"											"unprognostic (8.90e-12)"	"unprognostic (1.73e-2)"			"unprognostic (2.86e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	15.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.8	0.0	0.0	0.1	0.0	1.0	0.1	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0
TCAF1	"FAM115A, KIAA0738"	ENSG00000198420	"TRPM8 channel associated factor 1"	Q9Y4C2	7	143851375-143902198	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 187.1;Syncytiotrophoblasts: 436.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011732	Approved					NA	NA					"HPA011732: AB_2668526"	"unprognostic (1.57e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.73e-1)"	"unprognostic (7.00e-2)"	"unprognostic (5.70e-3)"	"unprognostic (3.07e-2)"	"unprognostic (4.93e-2)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.95e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.89e-1)"	15.9	31.2	17.6	7.2	46.8	2.5	12.9	23.6	29.4	17.5	10.9	12.4	4.1	7.1	19.6	9.5	9.1	13.8	11.5	13.6	18.4	23.3	9.1	16.7	11.0	5.4	14.5	17.7	25.0	11.2	18.3	27.0	46.2	25.0	22.1	12.1	8.8	8.6	12.4	10.2	9.9	9.0	18.1	11.3	6.4	12.4	5.4	16.5	9.7	15.9	5.6	5.3	8.8	8.4	2.9	4.4	1.4	4.4	6.8	8.3	3.4	14.8	9.2	29.7	30.7	19.5	19.0	18.2	17.5	20.8	14.0	18.8	19.3	10.7	0.0	8.3	20.3	18.1	9.7	11.3	11.5	15.5	8.2	8.4	8.1	5.2	17.1	13.4	0.0	5.5	19.6	10.4	16.5	6.1	22.3	17.4	10.4	13.4	1.4	27.1	22.3	13.1	5.0	9.1	16.5	5.8	8.2	20.0	1.9	11.1	12.0	8.5	50.9	18.0	11.2	8.2	22.1	16.9	1.2	15.7	14.8	9.6	13.9	10.4	4.6	5.8	0.1	27.3	2.4	20.3	0.6	2.2	1.4	8.3	2.8	5.7	2.8	4.9	5.3	4.4	2.9	4.4	5.5	0.8	6.8	4.4	2.4	3.3	3.4	17.6	46.8	23.6	26.1	18.4	23.3	14.5	17.7	25.0	16.5	41.7	36.2	1.4	13.2	0.0	45.0	38.9	28.1	14.7	27.3	3.5	23.6	187.1	0.0	30.7	1.7	31.5	14.4	0.0	30.7	32.2	41.1	26.7	7.0	68.4	28.6	28.6	18.7	28.8	6.2	0.7	49.2	9.9	0.0	10.8	36.9	28.5	48.8	14.0	53.0	6.8	24.7	12.9	15.0	14.4	11.1	0.0	436.2	7.5	30.3	16.4
OR2F2	OR7-1	ENSG00000221910	"Olfactory receptor family 2 subfamily F member 2"	O95006	7	143935166-143936279	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"testis: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.4		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2F1	"OLF3, OR14-60, OR2F3, OR2F3P, OR2F4, OR2F5, OR7-139, OR7-140"	ENSG00000213215	"Olfactory receptor family 2 subfamily F member 1 (gene/pseudogene)"	Q13607	7	143954844-143997312	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"testis: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 1.2"															NA	NA																							0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.9		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6B1	OR7-3	ENSG00000221813	"Olfactory receptor family 6 subfamily B member 1"	O95007	7	144000320-144008793	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"pancreas: 3.2;testis: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.6;RPMI-8226: 2.1;U-266/84: 1.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	20	"olfactory region: 0.1"	HPA053164	Uncertain					NA	NA					"HPA053164: AB_2682065"																		0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0			0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1		0.1	3.2	0.1	0.0	0.1		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.3			0.1		0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.5	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	5.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.5	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.5	0.1	0.5	0.1	0.0	0.1	0.3	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2A5	"OR2A26, OR2A8, OR7-138, OR7-141"	ENSG00000221836	"Olfactory receptor family 2 subfamily A member 5"	Q96R48	7	144048948-144058845	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.7"	"Not detected"	"Not detected"													NA	NA																							0.3	0.2	0.0	0.6	0.1	1.0	0.7	0.0	0.1	0.0	0.2			0.1	0.4	0.5	0.1	0.3	0.1	0.3	0.0	0.0	0.5	0.1	0.2	0.3	0.1		0.3	0.4	0.2	0.2	0.3		0.3	0.2		0.6	0.1	0.1	0.8	0.1	0.0	0.0	0.3	0.2	0.6			0.9		0.1	0.6	0.2	0.4	0.3	1.8	0.2	0.5	0.2	0.0	0.1	0.2	0.4	0.2	0.1	0.5	0.2	0.2	0.1	0.1	0.1	0.2	0.2	0.0	0.2	0.4	0.4	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.5	0.2	0.2	0.2	0.1	0.1	0.0	0.3	0.2	0.5	0.1	0.5	0.4	1.7	0.2	0.1	0.9	0.4	0.2	0.0	0.0	1.1	1.2	0.2	0.3	0.2	0.1	0.2	0.1	0.2	0.2	0.5	0.0	0.0	0.7	0.4	0.4	0.5	0.3	0.6	0.8	0.3	0.2	0.2	0.1	0.6	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.4	0.1	0.2	1.8	0.5	0.1	0.3	0.1	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2A25	"OR2A25P, OR2A27"	ENSG00000221933	"Olfactory receptor family 2 subfamily A member 25"	A4D2G3	7	144069811-144075870	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.4"	"Group enriched"	"Detected in some"	55	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 6.9;Club cells: 3.4;granulocytes: 5.8"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.1;THP-1: 1.5"	"Not detected"	"Not detected"							HPA058272	Uncertain					NA	NA					"HPA058272: AB_2683662"																		0.1	0.7	0.0	1.1	0.0	0.5	0.3	0.0	0.1	0.3	0.1			0.5	0.3	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.0		0.5	0.4	0.0	0.2	0.1		0.2	0.3		0.3	0.0	0.2	1.0	0.3	0.0	0.0	0.2	0.1	0.4			1.0		0.1	0.1	0.2	1.4	0.8	3.4	0.5	0.7	0.5	0.5	0.1	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.3	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.2	0.3	0.4	0.6	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.2	1.5	0.0	0.0	0.3	0.4	0.1	0.4	0.0	0.0	0.2	0.2	0.2	3.4	0.5	0.2	0.3	0.3	0.3	0.6	0.5	0.4	0.2	1.4	0.4	0.5	1.8	0.7	0.2	0.8	0.4	0.5											6.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2A12	OR2A12P	ENSG00000221858	"Olfactory receptor family 2 subfamily A member 12"	Q8NGT7	7	144086278-144098953	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"parathyroid gland: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA																							0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.2	0.1			0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0		0.5	0.3	1.0	0.0	0.1		0.1	0.2		0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.6			0.5		0.6	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2A2	"OR2A17P, OR2A2P, OST008"	ENSG00000221989	"Olfactory receptor family 2 subfamily A member 2"	Q6IF42	7	144109514-144110564	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0			0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0		0.4	0.2	0.0	0.0	0.0		0.1	0.0		0.4	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.1	0.3			0.6		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2A14	"OR2A14P, OR2A6, OST182"	ENSG00000221938	"Olfactory receptor family 2 subfamily A member 14"	Q96R47	7	144123176-144131188	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.0	0.6	0.1			0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.0		0.4	0.3	0.0	0.1	0.0		0.3	0.0		0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.6			0.7		0.1	0.2	0.3	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTAGE4	"cTAGE-4, FLJ43692"	ENSG00000225932	"CTAGE family member 4"	Q8IX94	7	144183466-144186053	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skin 1: 9.1"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 3.5;Ciliated cells: 4.0;Club cells: 2.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.3;T-reg: 2.0"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.0"	"Cell line enhanced"	"Detected in some"		"A-431: 13.8;hTCEpi: 12.2;RPTEC TERT1: 10.9;T-47d: 7.7;WM-115: 7.4"									"HPA000387, HPA000922"	Uncertain					NA	NA					"HPA000387: AB_1078582, HPA000922: AB_1078581"	"unprognostic (1.76e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.89e-1)"	"unprognostic (5.17e-2)"		"unprognostic (2.80e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.15e-1)"		"unprognostic (1.26e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.91e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.68e-1)"	1.3	0.9	0.2	0.0	0.7	0.0	3.8	0.1	0.2	0.7	1.2			3.7	1.4	2.5	1.3	1.1	1.9	1.4	0.2	0.4	1.3	1.6	2.0	0.0	0.7		1.9	4.1	0.0	2.1	0.8		1.3	3.5		2.0	0.3	0.3	9.1	1.0	0.0	0.4	1.3	2.4	4.9			7.5		0.0	0.8	1.3	0.4	0.0	0.0	0.0	0.0	2.0	0.0	13.8	0.1	0.0	0.0	0.0	0.0	5.8	0.4	0.2	0.0	0.2	1.3	4.4	0.0	0.0	0.5	0.3	0.4	0.0	2.5	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.3	12.2	0.4	3.8	0.6	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.5	3.9	0.0	0.0	0.0	0.0	10.9	3.6	0.0	0.0	5.0	5.1	0.4	2.3	7.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0											3.0	3.5	0.0	0.1	0.6	0.0	0.4	0.0	4.0	2.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1
ARHGEF35	"ARHGEF5L, CTAGE4, FLJ43692"	ENSG00000213214	"Rho guanine nucleotide exchange factor 35"	A5YM69	7	144186083-144195655	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Basal glandular cells: 73.7;Urothelial cells: 79.9"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"T-reg: 3.0"	"Group enriched"	"Detected in many"	5	"B-cells: 1.2;T-cells: 3.0"	"Cell line enhanced"	"Detected in many"		"A-431: 24.6;HBEC3-KT: 11.9;hTCEpi: 20.0;OE19: 21.0;RPTEC TERT1: 22.0;T-47d: 11.3;WM-115: 14.0"									"HPA044188, HPA045619, HPA045699"	Supported					NA	NA					"HPA044188: AB_2678850, HPA045619: AB_2679393, HPA045699: AB_2679423"	"unprognostic (1.23e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.41e-1)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.89e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (4.57e-4)"	"unprognostic (2.88e-1)"	"unprognostic (3.63e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.97e-2)"	1.1	0.3	0.0	0.4	0.1	0.0	6.0	0.0	0.0	2.1	5.0			6.0	0.4	1.9	9.9	3.1	0.7	0.8	0.0	0.0	4.8	3.2	2.0	0.0	0.0		0.7	4.7	7.9	1.7	1.4		3.0	7.1		6.6	1.7	0.0	10.6	4.9	0.1	0.0	0.5	5.4	0.1			8.4		0.8	2.0	3.6	1.2	0.4	0.0	0.0	0.0	3.0	0.2	24.6	0.5	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	7.3	8.7	0.0	0.0	1.2	1.1	3.4	0.0	11.9	0.0	0.0	0.0	0.0	1.5	0.0	2.0	0.0	0.0	1.9	20.0	0.1	5.4	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.4	21.0	1.7	0.0	0.0	0.0	22.0	7.2	0.0	0.0	1.0	6.7	0.6	0.6	11.3	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.8	0.0	0.1	0.3	0.8	0.3	0.0	1.2	0.2	0.2	0.0	0.0	0.0	0.4	3.0	0.2											8.9	7.8	0.8	73.7	41.3	0.8	0.4	22.9	13.4	33.0	59.3	15.7	40.7	14.9	40.7	2.4	1.9	38.7	0.0	26.0	58.3	4.7	31.7	0.0	17.4	4.6	0.0	18.4	1.3	1.8	0.5	4.4	2.5	15.1	0.0	23.1	5.7	33.2	34.9	2.8	17.0	5.5	0.0	1.9	0.7	1.7	41.0	50.1	0.5	22.5	79.9
OR2A42		ENSG00000212807	"Olfactory receptor family 2 subfamily A member 42"	Q8NGT9	7	144228244-144239605	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"thyroid gland: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 1.3;THP-1: 1.1;WM-115: 3.8"									HPA058272	Uncertain					NA	NA					"HPA058272: AB_2683662"													"unprognostic (1.41e-1)"			"unprognostic (3.14e-1)"		0.6	0.8	0.1	0.0	0.1	1.7	0.9	0.0	0.0	0.7	0.2			0.1	0.4	0.5	0.2	0.3	0.5	0.5	0.0	0.0	0.7	0.2	0.7	1.2	0.1		1.2	0.3	0.0	0.4	0.0		0.4	0.2		0.7	0.1	0.3	1.9	0.9	0.0	0.0	1.4	0.3	0.2			3.8		0.0	1.0	0.4	1.4	0.5	1.5	0.5	1.0	1.0	0.0	0.9	0.2	0.0	0.2	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.0	0.5	0.3	0.0	0.0	0.0	1.3	0.8	0.1	0.2	0.6	0.0	0.2	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.8	0.1	1.1	0.8	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	3.8	1.1	0.5	0.4	0.4	0.3	0.3	0.6	0.4	0.3	0.2	1.4	0.5	0.4	1.5	1.0	0.3	0.5	1.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2A7	HSDJ0798C17	ENSG00000243896	"Olfactory receptor family 2 subfamily A member 7"	Q96R45	7	144257663-144264792	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Ciliated cells: 1.4;Club cells: 1.2"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"basophil: 7.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 10.2;hTCEpi: 5.2;RT4: 4.1;SK-BR-3: 4.5"									HPA058272	Uncertain					NA	NA					"HPA058272: AB_2683662"	"unprognostic (6.48e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.05e-1)"	"unprognostic (4.13e-2)"	"unprognostic (5.75e-2)"	"unprognostic (7.28e-2)"	"unprognostic (3.33e-1)"	"unprognostic (9.08e-2)"	"unprognostic (3.58e-3)"	"unprognostic (5.52e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.22e-1)"	0.9	0.1	0.0	0.2	0.0	1.4	3.9	0.0	0.0	2.7	3.4			6.5	0.7	2.2	3.9	2.3	1.6	0.7	0.0	0.0	3.3	2.1	2.1	0.4	0.0		2.6	4.8	2.3	1.3	0.7		3.7	3.4		4.0	0.6	0.0	7.9	4.5	0.3	0.0	0.8	3.8	0.2			8.1		0.4	2.5	2.8	2.0	0.0	7.8	0.0	1.5	1.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.4	2.8	0.0	0.0	0.0	0.0	1.8	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	5.2	0.3	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.2	0.0	0.0	0.0	0.0	2.7	4.1	0.0	0.0	2.6	4.5	0.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	7.8	0.0	0.0	0.7	0.0	0.2	0.5	1.0	0.5	0.0	2.0	0.6	0.5	0.0	1.5	0.0	0.0	0.6	0.0											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTAGE8		ENSG00000244693	"CTAGE family member 8"	P0CG41	7	144266701-144269288	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 7.7"	"Cell type enhanced"	"Detected in some"	24	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 1.6;Ciliated cells: 1.4;Club cells: 3.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 8.5;CAPAN-2: 3.1;HaCaT: 2.9;HBEC3-KT: 2.9;OE19: 6.4;RT4: 4.1"									"HPA000387, HPA000922"	Uncertain					NA	NA					"HPA000387: AB_1078582, HPA000922: AB_1078581"	"unprognostic (4.80e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.93e-1)"			"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.33e-2)"	"unprognostic (8.73e-2)"	"unprognostic (6.23e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.84e-2)"	0.3	0.0	0.0	0.4	0.0	0.2	1.5	0.0	0.0	0.6	1.4			1.8	0.6	0.3	3.9	0.5	0.8	0.0	0.0	0.0	3.3	2.3	1.2	0.2	0.0		0.9	2.5	6.2	1.1	0.4		2.1	1.0		2.4	0.5	0.0	6.9	2.4	0.1	0.0	0.5	2.0	7.7			6.0		0.4	0.6	1.4	0.5	0.6	0.1	0.0	0.1	0.3	0.2	8.5	0.0	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.1	0.2	2.5	3.1	0.0	0.0	0.0	0.0	2.9	0.0	2.9	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.4	0.9	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.2	6.4	0.0	0.0	0.0	0.0	0.9	4.1	0.0	0.0	1.2	1.9	1.5	0.5	1.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.2	0.1	0.0	0.1	0.0	0.6	0.2	0.2											6.0	1.6	0.0	0.0	0.0	0.0	0.4	0.0	1.4	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
OR2A1		ENSG00000221970	"Olfactory receptor family 2 subfamily A member 1"	Q8NGT9	7	144312464-144322668	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"thyroid gland: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	4	"basophil: 1.1;T-reg: 1.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.1;T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 1.4;SK-MEL-30: 2.4;WM-115: 1.9"									HPA058272	Uncertain					NA	NA					"HPA058272: AB_2683662"	"unprognostic (3.98e-1)"							"unprognostic (6.53e-2)"					"unprognostic (1.13e-2)"		"unprognostic (9.14e-2)"	"unprognostic (2.22e-1)"		1.1	1.1	0.0	0.8	0.0	1.8	1.4	0.0	0.3	1.0	0.6			0.4	0.8	0.7	0.2	0.8	1.0	0.8	0.0	0.0	0.8	0.5	1.4	0.8	0.0		2.4	0.4	0.0	0.5	0.2		0.7	0.0		0.5	0.3	0.5	1.0	1.0	0.5	0.0	1.4	0.4	0.2			5.2		0.4	0.7	1.0	0.2	0.0	1.1	0.1	0.0	1.0	0.1	0.3	0.0	0.0	0.2	0.1	0.2	0.9	0.1	0.1	0.2	0.0	0.1	0.1	0.5	0.2	0.2	0.3	0.3	0.1	0.0	0.4	0.3	0.0	0.4	0.3	0.0	0.3	0.2	0.0	0.5	0.0	0.2	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.6	0.0	0.7	0.2	0.0	0.2	0.5	0.3	0.0	0.1	0.5	0.2	2.4	0.2	0.1	0.2	0.0	0.1	0.3	0.1	0.9	0.3	0.1	0.3	0.0	0.1	1.9	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ARHGEF5	"GEF5, P60, TIM, TIM1"	ENSG00000050327	"Rho guanine nucleotide exchange factor 5"	Q12774	7	144355288-144380632	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 44.1;Paneth cells: 42.1;Urothelial cells: 36.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"B-cells: 3.1;granulocytes: 1.1;T-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"A-431: 20.7;CAPAN-2: 14.1;hTCEpi: 15.6;WM-115: 15.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA020980, HPA029504, HPA044188, HPA045619, HPA045699"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA020980: AB_1845007, HPA029504: AB_10602231, HPA044188: AB_2678850, HPA045619: AB_2679393, HPA045699: AB_2679423"	"unprognostic (1.45e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.95e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (3.28e-7)"	"unprognostic (4.67e-2)"	"unprognostic (4.86e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.76e-2)"	2.3	1.0	1.2	5.2	1.8	0.9	7.6	1.2	1.2	4.6	7.7	1.2	7.4	8.5	3.4	7.8	16.6	2.5	8.4	1.3	1.2	0.4	9.0	6.7	4.8	3.2	1.2	1.2	3.0	8.8	7.7	4.3	14.3	2.6	6.6	4.6	4.0	17.7	9.4	1.2	21.1	16.7	2.2	1.7	2.4	6.5	1.4	1.2	1.5	11.6	10.0	4.5	3.4	6.9	3.1	0.2	1.1	0.1	0.0	4.2	0.4	20.7	2.0	0.0	0.0	0.0	0.0	7.1	2.2	1.5	1.0	1.3	7.0	14.1	0.0	6.8	0.9	1.7	9.7	0.8	9.6	1.0	0.0	2.9	0.0	3.2	1.1	2.3	0.0	0.0	3.6	15.6	0.7	7.2	3.2	0.2	0.0	0.0	0.0	0.9	8.6	0.0	0.0	4.5	9.3	3.8	0.8	0.0	0.2	11.5	7.1	0.0	0.0	8.8	8.6	3.7	2.6	5.3	1.3	0.2	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.0	15.3	0.0	0.0	0.0	0.8	0.1	1.3	1.8	2.7	2.1	0.1	3.1	2.7	0.7	1.1	0.0	0.0	0.2	4.2	0.4	1.2	1.8	1.2	1.2	1.2	0.4	1.2	1.2	2.6	1.2	6.0	15.0	0.8	31.5	16.5	0.0	1.1	7.6	18.7	12.5	21.0	3.9	9.2	5.0	12.2	1.3	0.8	44.1	0.0	14.5	11.9	2.3	16.5	0.0	5.9	1.5	0.0	9.2	1.3	0.0	0.4	1.4	0.0	5.0	0.0	15.4	3.4	19.5	42.1	1.4	3.4	2.4	0.0	1.6	0.4	0.9	14.6	11.9	0.5	15.6	36.6
NOBOX	"OG2, Og2x"	ENSG00000106410	"NOBOX oogenesis homeobox"	O60393	7	144397240-144410227	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Oogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"testis: 2.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"AN3-CA: 1.0"															NA	NA																				"unprognostic (7.88e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.5	0.2	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TPK1	"HTPK1, PP20"	ENSG00000196511	"Thiamin pyrophosphokinase 1"	Q9H3S4	7	144451941-144836395	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 70.4;Late spermatids: 75.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 27.3;CACO-2: 6.5;EFO-21: 8.3;TIME: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021545, HPA021849"	Approved		Approved	Vesicles		NA	NA		78000	Vesicles		"HPA021545: AB_1858209, HPA021849: AB_1858210"	"unprognostic (4.05e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.62e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.76e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.45e-3)"	"unprognostic (3.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.22e-3)"	12.2	7.4	5.1	9.6	4.7	3.6	7.6	4.0	7.2	4.3	8.4	4.2	2.4	18.2	5.1	5.0	3.3	3.9	5.4	6.4	5.6	6.6	6.0	6.2	8.8	23.3	4.9	3.1	4.4	3.3	3.6	4.6	7.0	4.4	3.7	8.5	8.9	7.1	4.1	3.0	2.9	13.9	5.1	6.0	15.1	4.0	5.9	2.0	5.1	4.9	4.1	14.2	5.5	3.3	5.4	9.6	3.4	7.4	4.0	5.5	3.8	0.2	0.2	0.3	27.3	0.2	0.2	2.2	0.1	0.1	0.0	0.0	6.5	1.1	0.4	8.3	0.4	0.5	0.0	0.5	0.3	0.2	1.6	0.4	0.1	0.1	0.1	0.7	2.0	0.6	0.5	0.5	0.3	0.4	0.7	5.2	1.0	0.5	1.2	0.1	0.8	0.6	3.0	0.7	0.8	2.3	0.2	0.6	0.9	4.2	2.4	0.2	0.0	0.4	0.0	0.5	0.5	0.3	3.9	6.2	0.3	0.7	0.5	0.3	0.6	1.5	0.6	0.9	5.2	0.2	0.3	7.3	0.2	3.9	5.3	4.0	5.0	4.4	3.5	9.6	5.4	5.2	4.2	3.4	4.0	7.4	2.3	5.5	3.8	5.1	4.7	4.0	7.2	5.6	6.6	4.9	3.1	4.4	2.0	8.9	3.2	15.9	2.3	2.1	3.2	4.5	10.2	2.7	0.0	3.5	7.9	35.1	16.6	4.2	70.4	7.7	15.5	0.0	5.7	11.9	5.3	2.4	7.0	3.9	14.8	1.6	1.2	6.7	13.9	75.1	4.6	16.2	8.5	7.2	4.3	2.4	6.9	7.4	1.1	6.9	4.5	0.0	3.4	7.9	11.8	1.5	26.8	6.4	6.3	3.6
CNTNAP2	"Caspr2, KIAA0868, NRXN4"	ENSG00000174469	"Contactin associated protein like 2"	Q9UHC6	7	146116002-148420998	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Autism, Autism spectrum disorder, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.8"	"Cell type enriched"	"Detected in many"	32	"Horizontal cells: 974.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	31	"memory B-cell: 1.8;naive B-cell: 6.1"	"Lineage enriched"	"Detected in single"	48	"B-cells: 6.1"	"Group enriched"	"Detected in some"	4	"AF22: 7.5;CACO-2: 6.3;NTERA-2: 11.2;SCLC-21H: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002739	Enhanced					NA	NA					"HPA002739: AB_1078545"	"unprognostic (2.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.05e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.00e-3)"	0.9	2.0	14.0	1.2	16.6	0.9	2.2	4.4	25.8	0.7	2.3	1.2	0.0	0.7	0.9	0.7	1.4	2.2	0.8	1.0	9.6	6.4	1.0	3.5	0.8	1.6	7.5	16.2	1.7	1.1	0.7	2.7	1.9	17.0	8.7	1.6	2.5	0.9	1.0	0.7	0.8	2.0	0.8	18.1	1.7	1.2	1.4	0.5	2.4	1.5	0.0	1.3	0.8	0.5	6.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	7.5	1.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	6.3	0.1	0.0	0.0	0.2	0.0	1.8	1.6	0.5	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	1.3	0.0	0.0	0.0	2.1	0.0	0.0	20.2	1.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	6.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	14.0	16.6	4.4	25.8	9.6	6.4	7.5	16.2	17.0	0.5	0.0	0.0	2.0	0.2	0.1	29.8	1.1	12.7	0.0	0.0	0.0	2.0	30.0	0.0	0.9	5.7	0.0	1.3	0.0	0.6	2.5	0.6	7.2	0.0	8.9	2.7	974.1	2.4	0.0	1.2	2.1	1.1	0.4	0.0	0.0	3.6	7.0	3.6	2.5	0.0	0.5	13.9	0.0	0.2	1.9	1.5	0.0	5.3	0.0	6.5	0.1
C7orf33		ENSG00000170279	"Chromosome 7 open reading frame 33"	Q8WU49	7	148590565-148615860	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"retina: 3.9;testis: 2.0"	"Cell type enhanced"	"Detected in some"	19	"Cone photoreceptor cells: 2.0;Early spermatids: 1.1;Extravillous trophoblasts: 4.0;Late spermatids: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	32	"SCLC-21H: 7.2"															NA	NA																				"unprognostic (4.09e-1)"			0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.9	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0
CUL1		ENSG00000055130	"Cullin 1"	Q13616	7	148697914-148801036	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"Early spermatids: 377.8;Late spermatids: 391.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002676, HPA064584"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		190000	Nucleoplasm	Nucleoli	"CAB002676: , HPA064584: AB_2685294"	"unprognostic (3.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.06e-3)"	"unprognostic (9.45e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.24e-3)"	26.0	20.9	21.2	20.4	22.4	22.3	27.5	27.5	26.2	23.9	25.8	19.5	22.5	16.7	30.2	23.7	22.7	21.2	18.7	25.7	21.1	21.8	16.9	35.2	20.5	26.5	21.7	16.7	25.0	17.9	24.9	30.7	32.0	21.0	23.9	18.8	22.7	19.6	25.0	58.9	20.5	21.2	37.7	26.3	21.9	22.4	65.6	23.7	16.9	24.5	24.6	24.5	26.1	28.8	16.8	24.1	13.4	17.1	22.1	20.8	16.1	30.8	24.0	23.6	36.5	18.6	20.9	30.0	25.5	30.2	25.8	24.7	25.5	21.6	42.4	20.5	25.2	41.8	20.9	33.7	23.8	30.5	27.7	28.6	25.0	17.0	24.8	21.8	28.4	23.8	17.1	23.4	18.9	19.2	23.4	28.1	21.4	38.6	32.7	28.1	29.5	24.6	32.5	44.2	26.3	23.0	29.9	20.8	40.8	21.2	22.6	34.0	24.9	29.8	35.5	20.1	29.0	11.6	22.6	21.6	18.5	6.4	37.4	29.3	30.7	21.3	42.0	37.6	31.7	27.2	13.4	15.2	12.0	16.1	17.1	18.6	16.8	16.7	18.6	24.1	14.4	20.8	16.7	2.1	22.1	14.5	5.5	15.9	16.1	21.2	22.4	27.5	26.2	21.1	21.8	21.7	16.7	21.0	23.7	32.8	29.7	24.2	26.3	24.7	29.4	23.2	10.2	42.8	42.1	8.7	27.5	57.0	14.9	24.9	377.8	21.8	9.5	23.3	22.9	69.2	23.6	16.6	22.0	37.5	26.1	20.6	15.0	19.0	15.2	391.5	20.1	22.4	27.0	64.1	19.5	32.1	23.7	14.4	28.7	9.3	42.8	32.3	27.8	53.2	33.0	22.2	61.2	20.8	16.5	17.9
EZH2	"ENX-1, EZH1, KMT6, KMT6A"	ENSG00000106462	"Enhancer of zeste 2 polycomb repressive complex 2 subunit"	Q15910	7	148807383-148884321	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.5;lymphoid tissue: 44.1"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 72.2;Spermatocytes: 126.7;Spermatogonia: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009589	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009589: "	"unprognostic (2.42e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.69e-3)"	"prognostic unfavorable (8.18e-12)"	"prognostic favorable (6.97e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.67e-2)"	2.0	1.7	1.8	10.6	1.6	25.5	1.4	4.9	2.7	2.6	4.8	1.1	0.1	3.8	1.7	2.8	11.0	0.9	3.0	0.9	0.8	0.6	1.7	3.3	2.3	12.6	1.3	0.3	2.2	3.8	0.6	1.7	3.4	1.4	1.4	5.1	1.8	3.2	1.6	3.7	6.4	4.8	1.5	1.2	5.8	2.7	19.6	1.3	44.1	0.9	5.5	12.4	2.6	3.5	1.5	4.7	1.3	3.9	8.5	10.3	1.7	17.0	8.0	27.3	18.2	0.8	1.4	14.9	13.3	5.4	11.0	11.1	12.0	19.7	30.2	6.5	5.0	10.0	10.5	14.0	4.6	14.0	43.2	14.0	12.9	9.9	9.3	2.2	28.6	10.6	1.2	2.6	8.2	4.4	3.3	6.4	29.3	27.3	20.1	9.8	19.3	55.6	23.9	21.7	15.0	10.8	34.4	15.3	18.7	5.1	8.2	26.1	16.6	16.7	12.7	4.4	7.3	9.3	12.3	3.9	11.7	5.4	23.3	23.8	18.0	19.6	30.4	10.7	19.6	22.9	0.5	2.2	1.3	1.7	1.5	1.3	1.5	3.4	2.9	4.7	0.8	1.9	1.2	0.2	8.5	3.9	1.0	10.3	1.7	1.8	1.6	4.9	2.7	0.8	0.6	1.3	0.3	1.4	1.3	0.0	7.9	6.7	5.7	23.6	4.8	6.5	2.5	14.7	7.9	7.0	33.4	13.6	3.3	9.1	72.2	7.1	6.7	23.3	7.4	29.5	10.8	4.4	21.8	1.3	10.4	14.3	8.6	4.3	8.9	19.2	2.8	10.9	13.5	19.0	10.2	2.0	10.1	9.3	0.7	1.0	21.1	6.5	9.9	126.7	62.4	25.3	25.5	18.7	18.6	4.0
PDIA4	"ERP70, ERP72"	ENSG00000155660	"Protein disulfide isomerase family A member 4"	P13667	7	149003062-149028641	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 164.3"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 542.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006139, HPA006140, CAB017368"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		12000000	"Endoplasmic reticulum"		"CAB017368: AB_10621725, HPA006139: AB_1848256, HPA006140: AB_1848257"	"unprognostic (1.98e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-3)"	"unprognostic (6.08e-3)"	"unprognostic (3.20e-2)"	"prognostic unfavorable (5.20e-9)"	"unprognostic (1.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.51e-1)"	17.6	13.0	7.7	25.6	11.9	7.4	27.4	5.1	7.9	25.5	20.9	12.1	28.8	18.2	19.4	46.3	15.2	20.8	28.1	16.9	7.3	8.0	27.7	164.3	19.1	29.1	11.6	6.2	19.4	76.3	7.0	19.1	24.7	12.0	18.0	21.9	7.8	36.4	26.5	5.8	10.1	21.3	17.8	13.9	27.9	23.7	11.5	11.3	19.2	89.8	11.9	24.3	17.4	22.6	26.6	63.3	16.2	21.2	21.5	35.9	34.5	32.4	30.9	33.6	93.9	30.7	21.9	48.7	45.7	30.6	26.2	42.8	25.6	87.8	23.4	102.6	37.5	72.2	21.3	22.6	43.3	23.1	16.6	13.3	11.2	8.9	56.1	41.2	25.5	31.7	21.5	19.4	28.7	23.1	34.2	53.2	12.0	18.3	63.8	23.0	35.5	24.3	29.1	50.1	66.4	18.0	16.0	26.1	56.6	30.6	25.5	10.7	28.2	41.5	29.9	15.9	41.9	17.0	19.7	29.0	20.7	11.7	50.1	32.1	48.6	21.8	16.4	48.3	30.2	70.3	16.2	20.1	12.1	34.3	21.2	35.9	26.6	22.6	26.7	19.4	15.1	21.5	22.7	2.7	21.5	21.0	63.3	16.6	34.5	7.7	11.9	5.1	7.9	7.3	8.0	11.6	6.2	12.0	11.3	26.8	33.4	29.0	71.4	30.8	3.3	20.4	96.8	65.6	44.3	40.1	3.9	152.3	13.3	102.2	2.7	35.1	89.5	46.7	79.9	277.0	90.5	103.6	57.6	542.5	131.4	0.0	59.1	95.8	80.7	3.2	54.7	53.4	82.7	48.7	104.5	19.3	96.2	87.1	40.3	54.4	6.1	32.3	34.2	53.4	71.9	25.0	192.7	54.6	97.0	59.2
ZNF786	DKFZp762I137	ENSG00000197362	"Zinc finger protein 786"	Q8N393	7	149069643-149090782	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 17.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021518, HPA053459"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Nuclear bodies"		NA	NA			"Nuclear speckles"	"Nucleoplasm, Nuclear bodies"	"HPA021518: AB_2670734, HPA053459: AB_2682159"	"unprognostic (3.13e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (5.62e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (2.01e-4)"	"unprognostic (3.97e-2)"	"unprognostic (1.39e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.47e-2)"	3.9	4.3	8.7	6.1	9.6	3.3	5.1	10.4	15.2	6.0	5.1	4.2	6.4	4.6	6.9	6.1	6.8	6.7	4.8	3.2	6.4	6.1	4.5	5.4	7.3	8.2	4.8	5.8	8.3	6.0	7.6	8.5	3.8	4.0	6.8	3.4	5.4	5.3	5.8	4.1	13.0	5.1	6.6	3.4	7.7	5.1	2.9	4.2	8.4	6.1	5.8	6.5	6.2	6.1	7.2	4.5	2.9	5.0	8.4	12.1	5.3	4.5	8.2	6.6	11.1	4.0	1.7	9.4	2.7	2.9	3.1	2.5	4.3	4.3	6.4	6.8	1.9	5.4	5.2	4.0	3.8	2.0	7.0	6.1	3.2	4.8	5.4	3.4	6.2	4.3	2.3	4.3	3.9	2.8	3.2	2.9	4.7	5.6	3.7	2.9	14.1	10.5	10.6	12.0	4.3	6.2	7.9	3.2	4.2	2.5	6.3	7.8	12.4	6.9	6.5	5.1	4.3	4.2	2.9	3.7	3.7	2.1	6.3	4.0	13.4	9.9	3.5	6.1	4.0	4.0	1.7	3.7	2.9	12.1	5.0	9.8	7.2	8.5	10.7	4.5	7.1	11.3	9.5	1.1	8.4	3.9	3.9	5.1	5.3	8.7	9.6	10.4	15.2	6.4	6.1	4.8	5.8	4.0	4.2	0.0	0.6	2.4	2.1	2.4	9.4	2.5	0.0	2.7	0.0	3.5	2.0	2.1	3.3	3.7	0.3	1.5	1.3	0.0	1.3	1.9	1.9	1.2	4.6	2.1	1.9	17.5	4.6	2.5	1.2	0.0	2.8	2.0	0.0	2.8	1.0	2.7	1.8	2.9	3.9	1.8	5.7	0.0	1.9	3.1	8.3	1.5	1.6	4.9	2.6	1.7
ZNF425		ENSG00000204947	"Zinc finger protein 425"	Q6IV72	7	149102784-149126346	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 5.0;Horizontal cells: 6.4;Peritubular cells: 4.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA020087	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020087: AB_2670358"	"unprognostic (4.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.40e-4)"	"unprognostic (9.97e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.21e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.25e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.19e-3)"	"unprognostic (1.58e-2)"	1.5	3.1	7.2	3.7	7.4	1.4	4.0	7.7	9.6	4.9	3.7	10.8	2.1	2.3	5.2	5.2	4.8	5.5	4.1	2.0	7.9	5.3	4.3	2.4	2.3	1.9	6.2	9.3	9.0	3.4	8.2	3.0	1.6	7.8	4.6	1.8	4.7	3.8	5.5	7.5	5.6	1.9	5.6	4.8	2.2	3.3	3.1	6.2	3.3	4.6	1.6	2.6	3.8	3.0	4.3	4.5	4.3	1.5	6.1	5.4	1.6	1.9	2.5	5.2	4.4	7.8	2.3	3.0	2.8	4.8	1.5	1.8	0.7	2.6	2.2	4.1	2.2	2.1	2.7	0.9	1.4	0.7	1.6	2.0	2.6	3.1	1.2	4.4	1.3	1.2	4.6	2.4	1.5	2.9	4.4	0.8	3.5	2.0	2.3	5.3	9.0	3.4	4.0	12.2	2.8	4.7	3.7	2.7	1.3	3.4	2.7	2.3	4.3	2.8	3.5	6.5	3.5	2.3	3.8	0.9	3.5	0.5	3.9	0.8	4.5	2.8	1.8	2.9	0.8	2.9	4.3	1.4	2.8	3.9	1.5	5.3	3.0	3.3	2.8	1.3	4.3	4.9	5.4	3.5	6.1	0.9	4.5	3.9	1.6	7.2	7.4	7.7	9.6	7.9	5.3	6.2	9.3	7.8	6.2	0.0	1.3	0.0	0.7	0.2	3.1	1.4	0.0	2.7	1.2	3.5	0.0	0.7	5.0	1.3	0.6	0.3	0.5	0.0	0.4	0.6	0.6	0.8	0.0	0.6	0.4	6.4	1.2	0.0	0.0	0.0	4.0	0.0	0.0	2.8	0.9	4.3	0.6	0.0	4.9	0.8	1.1	0.0	1.2	2.3	3.6	0.3	0.8	0.0	0.6	0.4
ZNF398	"KIAA1339, P51, P71, ZER6"	ENSG00000197024	"Zinc finger protein 398"	Q8TD17	7	149126416-149182802	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071533			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA071533: AB_2686412"	"unprognostic (4.11e-1)"	"unprognostic (8.56e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.94e-3)"	"unprognostic (2.27e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.97e-2)"	"unprognostic (9.27e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.89e-1)"	8.9	8.1	12.7	10.2	12.5	15.6	10.6	25.9	16.0	11.7	10.7	10.2	10.5	8.8	9.8	10.2	14.3	10.4	8.6	9.3	10.9	9.0	9.3	10.7	9.2	10.0	10.7	11.4	11.1	13.4	14.7	20.9	8.6	9.8	12.7	8.6	8.5	11.2	12.5	10.0	17.2	9.5	9.7	9.8	12.6	11.1	18.1	12.6	13.0	8.7	7.4	12.3	9.9	11.1	2.9	1.6	6.1	2.0	1.9	3.8	1.2	7.6	6.4	5.0	9.7	7.5	5.3	6.4	4.7	6.0	5.4	5.9	5.4	3.6	8.9	5.4	7.8	4.8	6.4	8.6	5.9	3.8	5.9	11.9	5.9	5.1	3.5	5.2	6.6	6.2	6.0	8.7	5.8	6.2	3.9	3.6	3.6	9.1	3.2	5.7	9.6	9.8	6.8	36.0	6.4	6.8	7.7	5.7	6.7	4.0	12.8	7.5	8.3	6.5	8.0	3.9	5.6	5.0	7.4	4.8	5.5	1.6	9.8	5.8	10.3	4.9	6.9	7.5	5.5	5.3	5.1	1.6	6.1	3.1	2.0	3.7	2.9	2.1	3.4	1.5	2.5	3.3	3.8	3.1	1.9	1.7	1.6	3.0	1.2	12.7	12.5	25.9	16.0	10.9	9.0	10.7	11.4	9.8	12.6	6.0	2.9	3.7	3.5	6.9	7.4	5.8	0.0	2.7	4.5	5.2	5.9	3.1	0.0	3.6	19.4	4.5	3.3	0.0	2.5	4.0	4.7	4.5	4.6	2.8	3.2	3.2	1.7	4.9	4.7	19.2	6.6	3.4	8.5	2.8	3.3	5.3	4.4	2.6	8.5	2.4	9.7	0.0	2.5	16.6	7.9	7.4	2.6	1.8	3.3	8.1
ZNF282	HUB1	ENSG00000170265	"Zinc finger protein 282"	Q9UDV7	7	149195485-149226248	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024374	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA024374: AB_1851322"	"unprognostic (1.79e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.23e-3)"	"unprognostic (3.11e-2)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.63e-3)"	"unprognostic (7.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.03e-2)"	13.6	11.7	12.6	12.7	11.5	17.5	13.1	20.7	18.1	19.1	16.1	16.6	16.8	17.7	17.9	14.1	17.9	17.2	18.1	12.5	10.2	8.4	12.4	14.4	12.3	11.2	10.8	11.8	18.5	26.6	12.2	12.3	24.9	10.8	21.4	7.8	13.3	17.8	15.8	20.7	19.5	14.5	15.1	8.9	15.2	14.6	6.4	12.9	14.2	14.1	16.3	12.7	17.0	13.8	3.9	2.4	3.5	1.8	1.8	3.4	1.0	11.6	11.5	6.8	16.3	6.0	7.1	10.0	10.6	7.8	9.4	9.4	10.5	12.8	11.7	16.1	6.6	8.3	12.9	8.0	10.1	3.6	17.6	28.2	9.8	7.5	8.9	8.9	12.3	11.1	8.1	13.8	9.0	9.9	7.1	9.7	7.9	18.8	9.2	5.0	13.7	25.9	18.3	22.0	6.7	14.5	16.9	6.6	16.3	5.1	11.2	15.5	14.8	11.8	14.2	9.7	3.8	9.1	12.0	12.1	13.5	3.0	16.1	15.4	13.3	7.9	8.7	11.2	10.7	11.5	0.0	1.8	3.5	2.1	1.5	2.3	0.9	2.7	2.1	1.0	3.9	1.4	1.8	1.8	1.8	1.7	2.4	3.4	1.0	12.6	11.5	20.7	18.1	10.2	8.4	10.8	11.8	10.8	12.9	3.0	5.0	1.9	2.4	6.4	10.9	4.0	7.6	0.0	2.3	1.8	3.9	9.2	0.0	4.4	25.4	4.5	8.3	0.0	3.7	4.7	4.7	4.3	5.7	7.5	5.3	14.3	12.6	6.2	4.5	21.6	5.8	2.5	1.7	3.6	10.2	5.4	5.3	9.5	5.3	3.2	7.0	12.9	3.8	1.1	1.2	5.6	4.2	1.5	9.3	3.3
ZNF212	C2H2-150	ENSG00000170260	"Zinc finger protein 212"	Q9UDV6	7	149239651-149255609	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA049807, HPA054178"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049807: AB_2680891, HPA054178: AB_2682406"	"unprognostic (1.07e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.77e-3)"	"unprognostic (3.66e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.79e-3)"	"unprognostic (5.55e-3)"	"unprognostic (8.75e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.32e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.59e-1)"	7.3	10.9	8.0	11.7	8.8	16.3	11.2	12.0	13.0	13.0	12.4	11.5	13.1	14.2	14.4	12.6	19.1	11.4	11.9	6.6	9.3	6.7	9.4	12.8	7.4	11.0	7.0	11.8	13.7	10.8	13.0	10.4	19.5	10.5	12.2	7.7	10.9	16.7	12.8	9.7	16.5	13.0	8.1	7.3	15.0	9.1	20.5	7.8	21.8	11.2	6.7	12.9	9.6	15.8	5.8	5.7	9.4	4.5	10.5	9.1	2.7	8.3	8.3	10.2	12.8	7.2	5.9	11.3	5.1	7.7	9.2	9.3	7.0	10.7	11.0	7.9	5.0	7.4	7.7	7.5	8.3	7.6	8.4	13.4	6.0	5.9	5.8	5.5	9.9	7.5	6.7	9.6	6.3	6.7	5.7	5.4	13.6	11.0	8.5	5.3	11.9	17.8	20.3	13.4	6.6	10.0	12.2	7.0	11.9	5.7	7.0	10.3	16.8	7.7	7.6	7.4	6.4	4.5	10.6	4.5	9.3	2.6	11.8	9.2	19.7	8.6	9.9	12.2	9.0	8.4	0.0	4.5	9.4	7.0	3.8	6.8	5.7	5.2	5.8	5.7	5.8	9.1	7.5	2.6	10.5	4.4	5.0	7.5	2.7	8.0	8.8	12.0	13.0	9.3	6.7	7.0	11.8	10.5	7.8	6.0	3.5	5.9	2.6	8.7	6.7	2.4	5.1	4.0	0.0	0.0	3.9	8.1	3.3	4.7	1.5	3.8	6.6	0.0	3.4	8.1	2.8	3.7	2.3	5.9	3.6	9.5	6.4	3.1	4.0	0.0	5.8	2.9	1.7	6.4	6.0	5.8	4.1	0.0	5.6	2.4	8.5	12.9	1.7	13.4	18.6	7.5	12.6	6.5	6.3	3.3
ZNF783	DKFZp667J212	ENSG00000204946	"Zinc finger family member 783"	Q6ZMS7	7	149262171-149297302	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA020375	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA020375: AB_1859453"	"unprognostic (3.17e-3)"	"unprognostic (2.54e-1)"	"unprognostic (8.40e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.08e-3)"	"unprognostic (4.28e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.29e-2)"	"prognostic unfavorable (2.24e-7)"	"unprognostic (2.49e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.61e-2)"	"prognostic favorable (4.11e-4)"	10.1	8.1	11.4	14.4	14.9	6.5	15.1	14.3	15.8	11.5	9.4	15.4	9.9	10.0	13.1	11.2	8.2	13.0	11.0	7.2	11.6	7.7	8.5	4.6	8.6	16.1	13.1	18.4	17.2	11.2	9.4	10.2	7.2	12.5	13.0	9.7	12.2	9.3	13.5	11.6	12.6	12.2	20.1	15.4	17.7	9.1	9.2	12.5	2.9	11.8	6.2	15.0	9.9	16.1	3.8	2.7	0.5	4.5	1.5	3.2	1.1	3.4	3.5	5.7	4.1	3.8	7.3	5.4	2.2	1.1	5.0	2.2	5.5	6.4	11.6	5.6	3.5	1.2	2.3	4.0	4.3	2.2	3.2	3.7	7.5	7.6	1.1	8.7	4.8	9.4	7.6	8.9	4.6	5.6	3.2	3.4	4.1	6.0	6.0	4.1	7.3	7.3	7.5	12.9	7.9	4.7	1.6	0.5	10.1	5.6	5.7	4.6	9.6	8.5	4.0	5.8	3.1	4.4	9.8	5.0	4.0	1.0	2.2	4.8	9.3	5.8	0.1	5.8	1.7	8.7	0.3	1.1	0.5	3.2	2.2	2.5	2.3	2.0	2.0	1.3	3.8	2.7	2.2	0.4	1.5	4.5	2.7	1.2	1.1	11.4	14.9	14.3	15.8	11.6	7.7	13.1	18.4	12.5	12.5	3.0	2.4	7.8	2.4	2.3	14.3	1.4	7.6	4.0	1.2	0.0	9.8	2.5	3.3	2.0	3.9	2.9	2.0	0.0	2.4	1.7	4.5	3.6	0.0	5.0	3.6	6.4	3.5	6.7	8.5	3.5	8.1	2.8	5.0	2.8	5.1	3.4	2.1	0.0	5.3	0.8	8.6	12.9	3.1	14.7	5.9	2.6	0.9	4.1	4.7	2.1
ZNF777	KIAA1285	ENSG00000196453	"Zinc finger protein 777"	Q9ULD5	7	149431363-149461123	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"placenta: 65.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003252	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003252: AB_1080755"	"unprognostic (7.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.78e-2)"	"unprognostic (6.64e-2)"	"unprognostic (5.87e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.15e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.00e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.23e-2)"	"unprognostic (5.72e-2)"	5.0	4.3	5.5	4.1	8.8	6.9	4.9	7.1	9.3	5.2	5.2	5.4	3.5	4.5	7.3	3.5	4.1	6.5	3.5	4.7	5.3	5.1	3.8	4.4	4.4	4.7	4.3	5.3	9.1	6.6	6.6	5.9	65.7	6.6	5.8	3.3	5.0	7.3	5.8	10.6	7.3	4.4	5.4	6.2	6.0	4.9	4.2	3.5	3.5	5.2	4.8	3.9	6.2	5.0	0.4	0.2	0.6	0.3	0.1	1.5	0.1	10.2	12.7	8.6	12.4	6.4	5.2	11.0	6.6	7.0	9.0	7.8	7.9	6.6	6.5	13.4	7.5	5.6	6.8	8.3	10.1	5.0	10.5	12.7	6.4	3.6	7.8	10.9	9.0	9.3	6.1	11.6	7.3	10.7	4.8	4.8	8.9	20.5	0.0	5.1	13.2	18.9	12.3	10.4	4.6	7.5	15.7	4.4	13.6	5.6	8.0	9.3	13.1	11.4	11.8	11.0	3.3	5.5	15.1	7.5	7.6	3.0	14.9	10.8	6.2	5.4	3.0	5.7	6.2	9.7	0.0	0.3	0.0	0.5	0.3	0.1	0.3	0.4	0.4	0.0	0.4	0.1	1.5	0.6	0.1	0.1	0.2	0.0	0.1	5.5	8.8	7.1	9.3	5.3	5.1	4.3	5.3	6.6	3.5	0.0	1.7	1.5	1.4	1.0	6.9	2.3	2.5	1.4	0.0	1.8	5.9	1.8	0.0	0.7	2.1	1.6	1.5	0.0	0.9	2.8	1.1	2.0	0.0	5.0	1.3	1.6	1.7	2.5	2.8	2.5	2.6	1.1	0.0	0.0	3.1	4.9	1.0	2.9	3.2	1.4	5.4	0.0	1.4	0.6	4.7	1.6	3.2	2.2	2.6	0.9
ZNF746	"FLJ31413, PARIS"	ENSG00000181220	"Zinc finger protein 746"	Q6NUN9	7	149472696-149497817	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 3.0;neutrophil: 10.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020272	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA020272: AB_2670398"	"unprognostic (2.66e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.85e-1)"	"prognostic unfavorable (2.32e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.33e-1)"	"prognostic favorable (4.22e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (7.47e-6)"	"unprognostic (2.21e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.06e-1)"	11.9	9.9	10.6	12.0	11.6	33.9	9.1	15.6	17.2	10.5	9.0	11.7	9.1	8.0	11.5	8.7	8.5	10.3	8.7	7.6	11.2	9.7	10.0	10.9	10.3	12.1	9.5	8.7	10.4	13.7	10.2	13.5	21.0	11.4	10.6	6.3	11.4	10.7	8.5	8.9	10.8	9.2	9.5	9.0	20.2	9.8	22.0	10.4	18.7	10.6	5.5	10.3	10.9	15.9	0.6	0.9	10.4	1.0	0.5	1.6	0.5	7.1	11.5	6.1	16.6	6.9	6.0	9.3	7.3	6.0	5.9	5.1	7.3	5.4	10.3	10.7	6.4	8.6	8.0	7.9	8.3	3.5	13.0	11.0	5.0	5.8	10.0	8.4	9.7	13.4	6.6	10.1	4.8	5.3	5.3	6.1	8.5	15.2	8.0	7.4	11.0	21.9	13.1	15.1	4.4	8.0	14.6	5.7	9.0	5.6	8.6	8.7	12.0	9.7	10.7	6.8	3.8	5.0	12.0	8.5	7.5	2.7	12.7	10.6	14.8	7.0	8.3	9.8	7.8	13.0	3.0	1.0	1.1	0.7	0.7	0.7	0.4	0.9	1.6	0.6	0.6	1.1	0.9	10.4	0.5	0.5	0.9	1.5	0.5	10.6	11.6	15.6	17.2	11.2	9.7	9.5	8.7	11.4	10.4	0.0	7.4	3.4	4.9	3.2	15.5	6.7	5.1	4.0	4.5	10.4	3.9	5.9	0.0	2.8	8.2	5.3	2.0	46.7	2.1	5.2	3.6	5.1	5.8	6.8	7.0	25.4	5.8	3.1	15.5	10.8	5.8	6.8	3.3	5.4	4.0	8.8	4.0	3.5	6.3	3.1	10.8	0.0	3.7	16.2	7.0	3.0	7.3	4.1	3.7	4.4
KRBA1	KIAA1862	ENSG00000133619	"KRAB-A domain containing 1"	A5PL33	7	149714781-149734575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 30.6"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 8.9;Muller glia cells: 11.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021237, HPA050448"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA021237: AB_2134145, HPA050448: AB_2681129"	"unprognostic (2.19e-2)"	"unprognostic (9.01e-2)"	"unprognostic (8.06e-2)"	"unprognostic (7.48e-3)"	"unprognostic (6.75e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.01e-5)"	"unprognostic (3.41e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (2.77e-4)"	"unprognostic (2.55e-1)"	"unprognostic (6.33e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.31e-2)"	3.8	4.6	5.6	6.2	8.1	4.7	5.6	8.7	12.8	5.2	5.2	7.6	11.0	2.2	7.8	4.9	5.5	5.2	5.8	30.6	6.7	5.2	5.3	2.2	4.5	5.7	6.3	9.0	7.9	7.0	9.7	16.9	3.1	7.1	6.0	1.9	9.4	17.2	9.5	7.4	6.4	3.6	8.5	5.1	6.4	5.0	5.7	6.5	2.5	4.3	5.5	4.8	5.0	5.3	4.1	3.7	1.3	3.7	0.3	4.2	1.7	6.2	3.9	7.8	16.2	3.5	3.5	6.8	3.3	4.2	5.4	6.2	0.4	1.7	1.9	7.1	4.2	11.0	6.2	5.8	11.2	2.7	8.7	11.0	3.5	5.0	3.6	4.4	0.0	9.8	7.7	5.3	3.7	2.0	6.4	4.9	10.5	14.1	2.0	2.7	2.4	9.0	5.3	9.3	2.9	3.8	9.5	3.1	1.0	4.1	5.0	6.2	10.4	5.1	14.9	3.5	3.7	2.6	5.4	5.0	6.6	2.9	0.0	4.6	9.6	3.1	8.4	3.9	6.0	6.8	0.0	1.8	0.4	3.8	1.7	2.6	1.8	1.9	2.2	2.6	4.1	3.4	2.9	1.3	0.3	3.7	3.7	4.2	1.7	5.6	8.1	8.7	12.8	6.7	5.2	6.3	9.0	7.1	6.5	0.0	2.7	1.5	2.1	1.5	6.3	8.9	0.0	0.0	0.0	3.5	3.9	0.9	0.0	4.5	0.5	0.9	0.0	0.0	2.3	1.9	2.3	2.2	0.0	0.8	4.2	7.9	0.0	0.6	3.0	0.9	3.7	1.1	0.0	1.0	0.0	11.2	1.2	0.0	3.2	1.5	4.4	6.5	1.7	0.7	3.6	1.6	1.0	1.0	0.0	1.5
ZNF467	"EZI, Zfp467"	ENSG00000181444	"Zinc finger protein 467"	Q7Z7K2	7	149764182-149773479	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 47.5;Distal tubular cells: 33.2;Kupffer cells: 44.2;Muller glia cells: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 27.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 27.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.1;EFO-21: 11.0;HMC-1: 12.8;MCF7: 10.6;SK-BR-3: 10.0;T-47d: 12.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042907	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042907: AB_10966965"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.40e-4)"	"unprognostic (5.99e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.14e-2)"	"prognostic favorable (4.56e-4)"	"unprognostic (2.12e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.25e-2)"	10.6	8.2	10.5	8.8	16.5	20.1	15.2	3.5	7.4	7.9	6.7	3.2	22.1	2.9	8.5	6.4	4.2	10.0	7.5	11.6	10.1	4.6	14.9	9.2	15.8	24.2	6.3	2.9	8.9	10.8	3.5	11.0	6.2	5.8	5.1	3.7	20.4	12.3	18.4	4.3	11.8	5.2	7.0	9.9	21.4	10.4	2.3	11.0	9.6	11.8	4.0	5.6	4.6	13.3	0.0	3.5	27.7	5.4	0.1	0.4	1.4	0.0	2.7	3.2	22.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.7	6.8	0.1	11.0	0.1	0.1	0.3	1.6	0.0	0.1	0.1	0.3	1.2	0.0	0.0	6.8	0.0	12.8	4.6	1.1	0.0	0.1	8.0	2.4	0.5	2.0	0.5	0.0	10.6	0.4	1.1	0.3	0.9	6.9	1.7	0.0	8.2	1.5	0.0	1.2	1.0	0.0	10.0	0.0	1.1	12.4	1.3	5.4	0.1	3.6	0.0	0.0	0.5	0.0	0.1	0.1	3.8	0.1	0.0	5.4	2.2	0.2	2.2	0.1	0.0	0.2	0.2	3.5	0.0	0.4	0.1	27.7	0.1	0.7	1.6	0.0	1.4	10.5	16.5	3.5	7.4	10.1	4.6	6.3	2.9	5.8	11.0	0.0	0.3	0.0	0.5	3.2	47.5	1.7	0.0	1.4	1.2	0.0	2.0	0.2	33.2	4.8	0.3	15.5	0.0	0.0	2.5	0.1	4.7	1.2	0.0	5.7	19.3	6.4	2.9	24.5	44.2	0.0	1.4	17.6	1.7	8.2	0.0	69.9	2.2	0.0	1.8	7.5	5.5	0.0	3.1	0.1	2.0	6.5	0.3	1.5	0.0	0.3
SSPO	"FLJ36112, KIAA0543, SCO-spondin"	ENSG00000197558	SCO-spondin		7	149776042-149833979	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 1.7;salivary gland: 1.7"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 24.9;Cone photoreceptor cells: 7.9;Horizontal cells: 15.9;Muller glia cells: 7.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.2;hTERT-RPE1: 1.4;RPMI-8226: 2.7"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in some"	13	"midbrain: 44.5"						"Secreted in brain"	NA	NA						"unprognostic (1.11e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.95e-4)"	"unprognostic (5.81e-3)"	"unprognostic (3.50e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.41e-3)"	"unprognostic (9.17e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.59e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.65e-10)"	"unprognostic (1.19e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.15e-3)"	"unprognostic (2.46e-2)"	0.6	0.0		0.3		0.2	0.1		1.7	0.0	0.0			0.0	0.0	0.0	0.0	0.3	0.1	0.0			0.2	0.0	0.0	0.0			0.1	0.3	0.0		0.0		0.2	0.0		1.7	0.1	0.1	0.3	0.0	0.0		0.4	0.2	0.2			0.2		0.0	0.0		0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.7	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.5	0.7	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	2.7	0.1	0.0	0.4	0.5	0.0	0.1	0.0	0.0	1.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.1	0.0	24.9	3.1	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	15.9	0.0	0.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.1
ZNF862		ENSG00000106479	"Zinc finger protein 862"	O60290	7	149838367-149867479	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 11.8;Horizontal cells: 9.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA024154	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA024154: AB_1859469"	"unprognostic (1.82e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.32e-3)"	"unprognostic (1.97e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.72e-3)"	"unprognostic (2.74e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.73e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.29e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.30e-2)"	"prognostic favorable (8.66e-4)"	7.1	9.7	12.7	11.2	15.5	7.5	11.8	22.6	13.6	11.1	10.0	16.7	18.8	6.6	12.1	18.1	9.0	13.7	12.2	8.0	13.1	8.7	11.3	9.4	9.6	12.8	17.1	12.1	15.1	14.7	22.6	17.7	5.8	12.2	11.5	10.7	12.3	16.9	14.5	8.6	24.1	10.8	10.0	12.6	13.2	9.4	7.4	19.8	18.7	18.2	6.7	13.2	9.9	9.1	3.1	3.0	1.6	4.3	1.6	6.9	2.0	2.9	3.2	7.2	11.3	8.3	9.1	0.2	6.1	6.0	2.1	3.3	0.3	7.8	1.4	8.0	6.9	2.8	2.0	2.0	2.9	1.5	4.4	3.1	1.3	2.2	0.0	7.3	2.1	1.3	10.0	10.8	2.0	3.2	9.0	4.9	8.3	1.5	5.6	3.4	7.5	2.5	5.5	2.4	5.6	3.2	4.5	0.9	8.0	5.8	1.8	2.8	9.6	5.3	3.9	5.3	3.6	3.0	2.6	8.7	5.2	0.2	11.7	2.2	8.7	4.7	1.3	8.8	5.7	5.9	0.0	2.4	1.6	6.9	4.3	1.9	3.1	2.6	3.6	3.0	1.3	3.1	2.7	0.2	1.6	1.3	3.0	1.8	2.0	12.7	15.5	22.6	13.6	13.1	8.7	17.1	12.1	12.2	19.8	0.0	1.0	0.0	0.6	0.7	5.1	3.2	2.5	2.7	3.4	7.0	11.8	0.9	1.7	1.5	1.1	1.7	1.0	0.0	1.2	0.2	1.0	1.5	4.6	2.1	0.9	9.5	1.7	1.3	1.2	1.0	1.4	2.1	0.0	1.0	2.6	2.8	1.2	2.3	2.1	0.7	5.8	0.0	1.0	0.9	2.3	1.1	2.2	2.6	1.3	0.8
ATP6V0E2	"ATP6V0E2L, C7orf32"	ENSG00000171130	"ATPase H+ transporting V0 subunit e2"	Q8NHE4	7	149872968-149880698	"Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 92.7"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 112.2;Horizontal cells: 108.1;Muller glia cells: 136.8;Proximal tubular cells: 94.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 51.0"															NA	NA						"unprognostic (8.72e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.42e-2)"	"unprognostic (5.84e-3)"	"unprognostic (3.57e-2)"	"prognostic favorable (5.80e-4)"	"unprognostic (1.21e-1)"	"prognostic favorable (8.26e-7)"	"unprognostic (1.96e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.48e-3)"	11.8	17.3	60.1	6.5	56.5	3.6	8.6	70.5	92.7	6.4	6.7	26.4	14.2	5.0	4.3	6.2	6.0	13.4	5.9	27.9	73.7	55.3	26.9	27.9	6.8	12.1	61.1	39.7	4.9	11.7	14.0	25.3	3.1	57.1	26.2	5.3	18.7	37.0	24.8	8.7	4.7	4.6	6.3	29.4	8.3	7.3	3.2	12.2	8.4	26.6	2.0	8.1	4.9	1.7	7.0	6.4	1.5	6.9	12.0	30.6	11.2	7.5	21.2	8.8	28.6	3.6	0.6	5.5	3.9	5.4	10.8	11.1	7.4	9.5	15.4	16.6	5.2	11.2	6.7	18.7	6.6	4.6	19.8	20.8	4.8	6.5	42.5	5.3	3.5	10.6	1.2	6.9	11.9	0.7	8.4	8.9	19.5	5.1	7.6	0.7	12.9	2.5	8.0	7.6	9.7	14.9	16.8	0.3	7.2	8.4	8.1	51.0	28.9	5.1	17.8	11.9	2.2	10.0	2.3	1.6	3.1	3.3	32.7	14.5	10.6	13.5	7.4	19.9	6.1	10.1	1.5	3.1	0.7	16.7	5.8	15.4	7.0	21.0	19.5	6.4	6.3	27.5	24.7	0.4	12.0	6.9	3.0	30.6	11.2	60.1	56.5	70.5	66.4	73.7	55.3	61.1	39.7	57.1	12.2	14.9	13.7	15.9	4.7	3.8	112.2	25.4	22.9	6.7	10.3	26.2	23.6	17.3	46.4	40.1	0.1	3.2	0.9	0.0	11.2	2.1	6.7	22.5	10.4	50.4	21.2	108.1	21.4	9.2	6.6	1.3	4.9	9.6	42.2	5.4	16.3	136.8	6.3	0.0	10.6	94.9	61.7	6.5	10.3	0.5	12.4	3.9	4.2	28.7	2.6	3.3
ACTR3C	ARP11	ENSG00000106526	"ARP3 actin related protein 3 homolog C"	Q9C0K3	7	150243916-150323725	"Predicted intracellular proteins"		Actin-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"parathyroid gland: 39.0"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 27.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 21.6;RT4: 18.2;SiHa: 12.2"															NA	NA						"unprognostic (3.41e-1)"	"unprognostic (4.79e-2)"	"unprognostic (9.62e-2)"	"unprognostic (8.25e-2)"	"unprognostic (6.07e-6)"	"unprognostic (2.83e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.69e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.73e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.14e-2)"	"unprognostic (5.53e-3)"	1.5	9.0	3.1	8.7	5.0	1.2	4.4	5.7	3.2	3.9	7.5	0.8	8.3	3.5	2.9	6.4	5.9	3.9	8.1	2.4	3.1	3.1	21.7	22.5	8.4	5.6	2.1	1.1	1.8	17.5	39.0	19.6	13.2	3.0	4.5	4.9	5.1	5.0	9.8	1.4	2.4	7.5	1.9	1.6	2.6	4.0	3.2	1.2	2.1	4.2	2.6	8.0	4.3	7.4	6.5	4.5	3.3	1.7	4.1	7.5	2.0	4.5	0.4	0.1	0.2	0.0	0.0	0.9	0.1	0.1	0.8	1.0	3.5	21.6	1.7	5.8	0.8	0.6	9.4	0.0	0.0	0.5	4.7	1.3	1.3	5.6	3.1	2.4	0.0	0.8	0.8	2.9	0.0	0.0	0.5	0.2	2.2	8.7	4.9	0.0	6.4	4.9	0.2	2.5	3.0	0.0	0.0	3.4	6.7	3.6	18.2	4.8	3.8	12.2	2.7	1.8	0.7	5.9	1.1	0.1	0.0	0.0	0.2	0.0	1.8	2.2	0.0	0.1	0.0	0.0	0.3	1.7	3.3	7.5	1.5	3.5	5.7	6.4	4.7	2.6	6.5	6.9	5.5	2.0	4.1	0.6	4.5	4.6	2.0	3.1	5.0	5.7	3.2	3.1	3.1	2.1	1.1	3.0	1.2	3.0	7.4	0.9	5.3	17.9	5.5	1.2	0.0	13.4	5.7	17.4	27.5	5.3	11.6	9.0	3.6	0.8	6.9	0.0	18.4	0.9	1.0	5.1	11.5	13.0	1.1	1.6	3.4	1.3	0.6	0.9	0.9	2.0	1.7	7.2	3.9	13.8	11.8	0.0	0.7	12.0	4.5	0.0	0.7	6.6	1.9	13.0	5.9	2.1	4.9	4.7
LRRC61	"FLJ31392, HSPC295, MGC3036"	ENSG00000127399	"Leucine rich repeat containing 61"	Q9BV99	7	150322639-150338150	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 41.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.1;Hep G2: 20.7;NTERA-2: 27.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019355	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA019355: AB_1853339"	"unprognostic (4.05e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.61e-3)"	"unprognostic (5.91e-3)"	"prognostic unfavorable (1.11e-5)"	"unprognostic (1.46e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (2.85e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.69e-3)"	2.8	14.7	6.7	9.0	9.3	2.3	4.1	7.5	7.3	6.7	6.0	3.5	4.5	5.8	7.0	4.0	6.4	20.8	8.0	3.3	5.4	13.1	10.8	18.3	4.8	9.1	5.0	3.4	18.5	12.7	12.2	10.9	7.3	5.1	6.4	2.9	10.6	6.2	6.7	3.0	5.4	7.9	3.8	3.0	10.1	6.6	6.6	3.9	41.0	16.4	3.0	11.8	4.2	9.0	9.5	15.1	11.6	2.4	6.5	10.5	4.2	7.8	0.2	0.2	0.0	0.0	0.0	3.7	0.0	0.0	1.0	3.2	14.8	7.8	2.4	3.3	0.1	0.0	7.1	0.0	0.0	0.5	31.1	10.1	2.8	9.5	20.7	5.7	0.0	1.5	0.6	3.2	0.0	0.0	0.2	0.0	16.2	9.8	4.6	0.0	14.2	14.3	1.2	27.3	5.3	0.0	0.0	0.0	6.4	2.3	5.1	14.1	13.8	13.2	2.9	5.4	2.3	2.2	1.7	0.0	0.0	0.0	0.0	0.0	5.1	1.6	0.0	0.0	0.0	0.0	2.3	2.4	6.7	9.5	1.0	7.6	8.0	6.8	7.3	2.6	9.5	6.7	7.7	11.6	6.5	1.0	15.1	10.5	4.2	6.7	9.3	7.5	7.3	5.4	13.1	5.0	3.4	5.1	3.9	6.0	1.0	6.5	4.0	1.0	7.7	2.1	10.2	20.1	4.5	15.7	0.0	22.6	16.6	22.1	4.7	2.1	9.6	0.0	24.7	21.2	2.4	4.0	1.1	18.3	5.5	12.7	18.6	1.3	1.3	12.9	9.5	1.8	3.3	24.4	7.6	13.0	27.0	13.9	5.3	27.2	4.7	0.0	0.8	20.4	22.8	2.4	22.5	8.7	9.5	2.6
ZBED6CL	C7orf29	ENSG00000188707	"ZBED6 C-terminal like"	Q96FA7	7	150329789-150332721	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"adrenal gland: 37.4;parathyroid gland: 11.3"	"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 7.9;Exocrine glandular cells: 11.0;Pancreatic endocrine cells: 19.3"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 40.8;K-562: 17.5"									"HPA019724, HPA055805"	Approved		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Nuclear membrane"	Vesicles	"HPA019724: AB_1845756, HPA055805: AB_2682929"	"prognostic favorable (9.48e-5)"	"unprognostic (6.77e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (3.35e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.78e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.44e-1)"	"prognostic favorable (2.44e-5)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (1.86e-2)"	"unprognostic (7.82e-2)"	"unprognostic (8.52e-3)"	"unprognostic (1.50e-3)"	0.4	37.4	0.4	2.6	0.4	1.7	0.8	0.3	0.2	1.1	1.4			1.6	2.0	0.2	1.2	1.9	0.4	0.4	0.3	0.6	1.8	5.6	1.5	3.9	0.3		3.1	3.2	11.3	2.5	0.0		1.5	1.5		1.1	0.9	0.1	2.2	2.1	0.6	0.1	2.3	1.7	0.3			1.8		3.7	1.3	0.8	3.6	1.0	2.8	1.0	2.8	3.5	2.4	4.5	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.4	6.3	4.7	2.6	2.3	0.0	0.0	1.8	0.0	0.0	0.3	40.8	3.3	3.1	6.7	10.7	1.3	0.0	4.8	0.9	2.4	0.0	0.0	0.1	0.2	9.1	17.5	6.8	0.0	2.0	7.7	1.9	3.0	1.8	0.0	0.0	0.3	5.7	2.1	9.0	8.6	5.0	6.9	1.9	0.3	1.4	0.6	2.1	0.1	0.0	0.0	0.0	0.0	5.5	1.5	0.0	0.0	0.0	0.0	0.0	1.0	1.0	2.7	0.7	3.2	2.2	2.4	3.4	0.7	3.6	3.5	2.9	2.8	2.8	0.2	1.0	2.2	2.4											0.0	1.0	0.0	0.3	0.2	1.0	0.6	5.1	0.0	2.3	1.8	7.9	1.3	5.0	2.1	0.0	0.0	0.9	0.0	11.0	0.7	0.6	0.3	1.1	2.6	0.5	0.0	4.6	0.0	1.6	0.0	2.6	0.0	0.0	3.6	2.0	1.4	19.3	0.0	1.1	0.7	0.5	0.0	0.2	0.5	0.9	0.1	1.6	0.0	2.3	0.5
RARRES2	"HP10433, TIG2"	ENSG00000106538	"Retinoic acid receptor responder 2"	Q99969	7	150338317-150341674	"Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Differentiation, Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 145.8;liver: 184.8;pancreas: 145.4"	"Cell type enhanced"	"Detected in all"	17	"Exocrine glandular cells: 588.4;Hepatocytes: 2447.4;Muller glia cells: 685.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 420.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"plasmacytoid DC: 8.2"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 8.2"	"Group enriched"	"Detected in some"	6	"AF22: 27.8;Hep G2: 40.2;HHSteC: 36.4;NTERA-2: 84.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	75000000	550000000				"unprognostic (1.96e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.83e-4)"	"unprognostic (2.94e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.17e-2)"	46.5	145.8	4.6	20.5	5.0	0.0	28.0	2.6	4.4	51.2	31.0	10.7	10.9	5.0	23.8	21.0	18.3	21.9	30.5	12.9	5.3	3.6	21.9	184.8	33.2	10.7	7.6	3.0	40.2	145.4	66.7	6.3	5.6	12.0	35.5	8.0	23.5	6.1	12.2	7.4	3.2	10.3	27.5	7.7	11.0	10.9	11.1	5.4	1.0	7.8	5.2	10.5	26.3	39.7	0.1	8.2	0.0	0.0	0.8	0.3	0.0	0.0	0.0	27.8	0.0	0.0	0.0	0.3	2.2	5.2	0.8	3.6	0.2	1.6	0.2	3.2	0.6	0.2	0.1	0.0	0.0	0.0	0.4	0.1	0.1	4.5	40.2	36.4	0.4	0.0	7.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.2	0.4	0.5	84.7	0.2	0.0	0.0	3.7	0.0	0.6	0.2	0.1	0.3	0.4	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.0	8.2	0.0	0.0	4.6	5.0	2.6	4.4	5.3	3.6	7.6	3.0	12.0	5.4	62.5	30.1	23.0	74.0	31.1	4.9	79.7	318.5	28.1	67.1	78.5	2.0	9.5	87.9	15.0	2.3	24.8	16.7	23.3	588.4	5.3	340.2	52.4	11.5	2447.4	10.5	9.5	93.8	86.5	50.8	10.2	420.5	12.9	42.2	1.8	172.4	685.2	332.8	31.7	183.2	228.5	19.9	12.9	165.1	3.3	5.4	25.2	12.2	17.8	286.2	21.6
REPIN1	"AP4, H_DJ0584D14.12, RIP60, Zfp464, ZNF464"	ENSG00000214022	"Replication initiator 1"	Q9BWE0	7	150368189-150374044	"Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 126.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 66.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036022	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036022: AB_10610417"	"unprognostic (2.73e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.50e-3)"	"unprognostic (5.42e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.52e-2)"	"unprognostic (6.88e-3)"	"unprognostic (6.68e-2)"	"unprognostic (6.59e-2)"	"prognostic favorable (1.12e-4)"	"unprognostic (3.40e-2)"	"prognostic favorable (5.56e-4)"	"prognostic favorable (1.61e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.02e-3)"	"prognostic favorable (6.41e-4)"	17.0	30.1	16.2	24.9	23.1	25.7	16.9	24.2	21.7	12.0	27.5	21.5	23.2	29.2	15.4	23.6	14.9	17.5	23.6	22.1	15.6	17.1	18.6	36.1	12.3	22.4	21.9	14.3	16.6	34.0	21.5	28.5	10.4	15.6	19.0	20.3	21.9	26.9	23.2	78.4	14.4	27.1	11.4	13.3	23.1	20.6	7.0	18.9	45.4	20.1	20.0	20.3	18.1	15.9	3.6	11.2	3.5	2.1	2.3	3.5	1.2	16.1	19.8	18.8	23.0	4.6	3.3	11.5	8.0	9.9	7.9	6.9	15.3	10.5	18.0	20.4	5.7	13.7	12.1	10.2	3.1	4.0	19.6	15.4	10.5	10.7	19.2	15.3	18.5	17.2	4.3	9.7	4.3	1.0	7.5	11.1	11.0	25.2	11.3	6.5	21.0	25.6	21.1	19.7	10.9	19.7	14.1	21.8	66.9	8.3	28.8	27.7	35.4	12.1	30.5	20.5	8.1	14.9	14.9	11.7	6.1	5.0	6.7	16.1	33.0	12.2	16.4	10.7	16.5	15.0	0.1	2.1	3.5	1.2	1.0	1.9	3.6	2.7	2.3	3.0	3.5	3.5	1.7	2.0	2.3	0.5	11.2	1.1	1.2	16.2	23.1	24.2	21.7	15.6	17.1	21.9	14.3	15.6	18.9	32.8	18.1	23.0	16.6	8.4	59.5	40.5	35.7	16.0	12.5	14.0	39.3	23.1	53.0	32.6	5.8	19.7	43.4	0.0	43.4	10.2	13.5	26.1	24.3	55.7	27.7	76.3	65.4	19.6	14.6	6.3	20.4	14.8	15.1	126.2	53.2	77.2	34.2	24.6	18.7	26.1	52.6	6.5	17.0	8.9	3.2	15.6	21.4	18.5	98.3	16.9
AC073111.3		ENSG00000284041			7	150368790-150396915	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 9.0;SH-SY5Y: 8.3"															NA	NA																							2.1	3.0	2.3	6.0	4.5	1.7	3.1	2.5	4.5	1.7	5.0	4.4	4.3	5.8	5.5	4.2	2.2	3.2	4.7	3.5	2.6		3.4	8.0	4.3	3.9	4.5	2.4	3.0	7.2	9.8	2.6	2.2	2.7	4.5	2.2	4.5	4.4	5.8	14.5	1.7	5.6	1.7	2.1	4.2	3.5	2.7	3.6	7.6	3.6	3.8	3.6	2.0	2.7	0.6	0.0	0.1	0.0	0.7	0.0	0.1	0.4	0.9	0.2	1.5	0.0	0.7	0.8	0.0	0.4	0.0	0.9	0.5	0.6	0.7	1.6	0.0	0.0	0.7	0.0	0.0	0.0	4.2	0.0	3.6	0.0	0.4	0.0	0.0	0.7	0.0	1.1	0.7	0.0	0.0	0.0	1.1	3.6	0.4	0.0	0.0	4.6	1.6	2.3	0.7	2.2	1.9	0.5	9.0	0.0	0.0	3.6	8.3	0.0	0.0	0.2	0.2	0.5	1.7	0.0	0.9	1.8	0.9	1.4	4.4	1.9	1.6	0.9	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZNF775	MGC33584	ENSG00000196456	"Zinc finger protein 775"	Q96BV0	7	150379335-150398631	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 18.8;Horizontal cells: 28.6;Muller glia cells: 26.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 14.5"															NA	NA						"unprognostic (9.67e-3)"	"unprognostic (6.96e-2)"	"unprognostic (1.06e-2)"	"unprognostic (8.47e-3)"	"unprognostic (4.74e-2)"	"prognostic favorable (3.48e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.65e-2)"	"prognostic favorable (1.35e-5)"	"unprognostic (1.49e-1)"	"prognostic favorable (2.84e-4)"	"unprognostic (1.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.28e-2)"	5.1	7.6	10.0	5.5	11.5	5.0	3.4	7.3	14.2	7.0	11.0	15.9	4.9	7.1	8.1	6.3	3.5	6.0	4.2	5.0	10.9	8.4	3.5	1.8	5.3	8.0	11.5	9.1	13.1	6.5	4.9	7.7	4.4	7.9	8.4	6.0	7.0	9.4	6.5	8.5	3.2	7.6	6.2	12.7	7.3	6.3	6.8	11.3	9.3	3.8	3.3	5.7	7.0	7.4	1.0	2.5	1.6	0.5	0.1	0.8	0.3	1.0	3.3	4.2	3.2	1.5	1.1	0.6	1.7	2.0	2.2	2.3	0.9	3.0	5.0	3.4	1.0	3.9	1.1	1.4	1.5	0.2	6.4	5.8	1.7	0.8	2.0	3.3	0.9	1.2	1.7	1.3	2.2	0.5	2.4	3.7	6.3	6.3	4.0	1.3	1.0	13.5	3.3	11.7	1.8	5.0	6.6	6.4	14.5	0.3	1.3	10.5	11.9	1.5	0.4	5.9	3.4	0.5	2.5	3.3	4.1	1.6	2.9	2.4	6.1	1.9	2.8	4.1	2.3	5.1	0.0	0.5	1.0	0.7	0.0	0.0	1.0	0.6	0.1	1.2	0.7	0.8	0.5	1.6	0.1	0.2	2.5	0.1	0.3	10.0	11.5	7.3	14.2	10.9	8.4	11.5	9.1	7.9	11.3	0.0	0.0	8.0	0.6	2.4	18.8	6.7	0.0	0.0	0.0	0.0	9.8	1.1	0.0	0.9	2.1	3.6	2.0	0.0	0.5	0.9	2.0	0.9	4.6	1.0	2.6	28.6	15.0	2.5	1.9	1.0	3.7	1.3	5.0	1.0	4.8	26.9	1.1	3.4	4.6	1.1	12.0	0.0	5.7	0.6	0.9	3.3	0.3	0.0	6.2	0.1
AC073111.5		ENSG00000284691			7	150400702-150412470	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"blood: 9.9"	"Cell type enhanced"	"Detected in some"	17	"Collecting duct cells: 7.0;Distal tubular cells: 11.6;monocytes: 19.0"									"Group enriched"	"Detected in many"	5	"gdT-cell: 4.5;MAIT T-cell: 3.3;memory B-cell: 5.3;memory CD4 T-cell: 5.9;memory CD8 T-cell: 3.9;naive B-cell: 7.2;naive CD4 T-cell: 6.7;naive CD8 T-cell: 4.5;plasmacytoid DC: 9.9;T-reg: 4.2"	"Group enriched"	"Detected in many"	7	"B-cells: 7.2;dendritic cells: 9.9;T-cells: 6.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 9.0;MOLT-4: 16.7;NTERA-2: 7.7;RPMI-8226: 14.3;U-266/70: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA																							3.2	3.3	4.5	4.5	3.4	2.1	0.3	2.9	5.3	0.5	2.8	1.3	1.6	6.1	2.4	1.0	0.9	1.5	0.8	0.5	1.8		1.3	0.2	1.7	7.7	0.9	2.3	2.7	4.5	0.6	1.2	0.9	1.8	1.9	0.8	1.0	4.6	1.5	3.5	3.5	4.1	2.7	0.0	7.4	4.5	0.4	1.5	6.3	1.2	0.3	5.0	1.0	1.1	7.2	9.9	0.8	0.7	1.0	6.7	2.7	0.0	2.3	1.1	0.4	0.3	0.5	1.0	0.9	0.3	0.0	0.1	0.4	1.6	3.6	5.2	0.1	0.3	0.4	0.0	0.2	0.0	9.0	0.6	0.8	0.1	1.7	0.4	1.5	0.6	0.1	0.2	0.0	0.0	0.2	0.1	3.5	2.0	1.9	0.0	0.5	16.7	3.2	7.7	0.4	0.7	4.5	0.4	14.3	0.0	0.7	1.2	1.9	0.3	0.2	0.6	0.5	0.2	1.4	1.2	0.3	0.1	0.0	0.1	20.4	1.5	1.8	0.6	0.7	0.6	0.0	0.3	0.8	4.5	0.7	3.3	5.3	5.9	3.9	0.8	7.2	6.7	4.5	0.0	1.0	0.0	9.9	4.2	2.7											0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	7.0	0.0	0.0	11.6	3.9	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	2.5	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GIMAP8	"DKFZp667I133, hIAN6, IAN9"	ENSG00000171115	"GTPase, IMAP family member 8"	Q8ND71	7	150450630-150479392	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 42.5;Ito cells: 81.6;Kupffer cells: 70.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"HUVEC TERT2: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA014474, HPA017765"	Supported					NA	NA					"HPA014474: AB_1849685, HPA017765: AB_1849683"	"unprognostic (7.86e-2)"	"unprognostic (7.87e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.11e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.07e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.07e-2)"	"unprognostic (6.26e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.04e-3)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (3.85e-1)"	"unprognostic (1.31e-1)"	17.9	4.5	2.6	13.4	4.8	0.2	23.4	1.3	3.8	8.3	5.4	3.1	3.0	4.3	11.3	9.8	5.3	7.1	8.9	16.6	3.8	2.8	6.7	7.5	31.9	34.6	4.0	1.5	4.3	4.3	3.6	2.9	10.3	3.1	7.9	4.8	5.3	4.9	3.6	8.4	4.3	8.4	8.6	4.7	32.8	4.4	3.9	3.1	3.5	10.9	6.2	8.7	7.3	10.2	0.2	5.6	2.1	25.9	6.4	8.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	36.6	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.0	5.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.2	18.7	0.0	7.0	25.9	8.0	0.2	6.9	6.3	5.6	0.0	7.9	6.3	2.1	6.4	22.6	0.3	3.2	10.1	2.6	4.8	1.3	3.8	3.8	2.8	4.0	1.5	3.1	3.1	3.0	7.7	0.0	0.4	2.7	0.0	4.0	7.6	2.7	0.0	1.8	0.0	0.0	0.0	0.0	0.1	42.5	0.0	0.0	0.0	0.0	0.9	0.1	3.5	0.6	5.7	0.0	0.0	81.6	70.3	0.0	0.3	8.9	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.2	1.5	0.1	12.8	0.0	0.4
GIMAP7	"IAN7, MGC27027"	ENSG00000179144	"GTPase, IMAP family member 7"	Q8NHV1	7	150514830-150521073	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 155.1"	"Group enriched"	"Detected in many"	7	"Endothelial cells: 154.6;Ito cells: 251.0;Kupffer cells: 150.3;T-cells: 350.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"monocytes: 41.1;NK-cells: 65.0;T-cells: 155.1"	"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 39.9;MOLT-4: 32.4"					"Low region specificity"	"Detected in some"			"HPA020266, HPA020268"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA020266: AB_1849680, HPA020268: AB_1849682"	"unprognostic (4.85e-3)"	"unprognostic (1.65e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.71e-1)"	"prognostic favorable (7.43e-4)"	"prognostic favorable (8.98e-5)"	"unprognostic (6.49e-3)"	"unprognostic (5.24e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.86e-2)"	32.2	7.3	6.2	30.1	9.8	1.9	19.7	4.3	8.0	19.9	9.5	2.1	5.3	7.6	13.4	11.9	12.2	10.2	9.4	14.6	9.3	6.4	20.1	10.5	22.8	54.7	10.0	3.3	7.0	4.7	3.3	4.9	12.5	7.2	13.5	8.8	6.2	10.7	4.6	17.0	4.6	20.5	12.4	8.1	51.5	7.7	6.7	8.2	18.7	16.7	11.3	34.9	13.4	11.0	0.4	18.0	3.4	41.1	65.0	155.1	131.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.9	4.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	41.1	0.5	79.6	36.9	77.6	0.4	118.6	95.4	18.0	0.3	155.1	108.0	3.4	65.0	38.6	1.0	64.7	131.0	6.2	9.8	4.3	8.0	9.3	6.4	10.0	3.3	7.2	8.2	0.0	19.9	6.5	0.2	2.2	0.0	8.9	7.6	1.4	1.2	1.8	0.0	0.1	0.0	0.0	1.3	154.6	0.0	0.0	0.6	0.0	2.3	0.2	12.8	2.6	14.9	0.0	0.0	251.0	150.3	0.7	2.3	34.3	1.7	12.6	0.0	0.3	0.7	0.2	0.4	1.6	0.2	0.0	1.4	0.0	0.5	2.9	0.3	350.3	0.0	0.0
GIMAP4	"FLJ11110, HIMAP4, IAN1, IMAP4"	ENSG00000133574	"GTPase, IMAP family member 4"	Q9NUV9	7	150567277-150573955	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 78.6"	"Group enriched"	"Detected in many"	6	"Endothelial cells: 177.9;Hofbauer cells: 83.4;Ito cells: 198.2;Kupffer cells: 164.1;Macrophages: 61.9;T-cells: 207.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	26	"HUVEC TERT2: 83.7"	"Not detected"	"Not detected"							"HPA019135, HPA019137, HPA027198"	Enhanced					NA	NA					"HPA019135: AB_1849670, HPA019137: AB_1849672, HPA027198: AB_10602599"	"unprognostic (5.03e-2)"	"unprognostic (3.30e-3)"	"unprognostic (4.08e-2)"	"prognostic favorable (7.63e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.73e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.29e-1)"	26.7	7.7	9.2	27.2	12.2	1.5	19.5	2.6	8.8	11.5	10.2	6.8	4.0	6.2	12.5	9.1	8.7	10.0	9.7	14.0	9.7	6.6	11.0	11.5	30.5	47.3	11.3	4.1	5.8	4.8	3.1	4.8	19.2	10.8	11.2	9.1	6.8	6.4	5.6	13.6	5.2	15.0	15.2	13.7	43.4	7.6	5.9	11.6	10.4	14.5	8.2	32.5	14.1	9.2	0.3	15.4	43.1	48.7	31.3	58.3	78.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	45.0	0.6	44.1	48.7	54.4	0.3	55.2	53.8	15.4	0.1	58.3	48.7	43.1	31.3	37.2	0.6	37.8	78.6	9.2	12.2	2.6	8.8	9.7	6.6	11.3	4.1	10.8	11.6	3.0	18.0	4.1	0.1	6.1	0.0	4.1	0.0	1.4	3.4	10.4	0.0	0.5	0.0	0.1	0.4	177.9	0.0	0.0	0.2	0.5	3.9	0.3	5.8	2.5	83.4	0.0	0.0	198.2	164.1	0.5	4.6	61.9	10.1	24.4	0.0	0.2	0.1	0.0	0.0	1.4	0.0	12.9	2.2	0.0	0.5	5.4	0.7	207.5	0.0	0.3
GIMAP6	"FLJ22690, IAN6"	ENSG00000133561	"GTPase, IMAP family member 6"	Q6P9H5	7	150625375-150632648	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Endothelial cells: 57.3;Erythroid cells: 23.3;Hofbauer cells: 24.5;Ito cells: 77.3;Kupffer cells: 57.9;T-cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"monocytes: 17.2;NK-cells: 46.4;T-cells: 31.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 7.7;HUVEC TERT2: 51.3;MOLT-4: 16.9;TIME: 14.6"									HPA026715	Uncertain					NA	NA					"HPA026715: AB_1849675"	"unprognostic (8.58e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.56e-3)"	"prognostic favorable (3.12e-4)"	"unprognostic (1.22e-1)"	"prognostic favorable (2.91e-4)"	"prognostic favorable (1.56e-4)"	"unprognostic (2.88e-2)"	"unprognostic (8.75e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.68e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (2.75e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.27e-1)"	32.5	6.7	4.8	15.5	5.5	0.8	21.2	2.0	4.5	12.1	8.6	5.2	3.3	6.4	11.9	7.6	6.3	10.4	9.4	17.6	5.2	4.7	10.7	7.1	19.6	41.9	6.8	3.8	5.6	4.7	3.3	3.4	15.9	5.6	10.0	6.0	8.1	6.1	5.6	10.7	5.3	14.0	12.8	7.0	42.0	6.8	4.7	5.5	19.9	12.2	8.1	16.1	9.3	10.6	0.1	5.1	2.6	17.2	46.4	31.1	32.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	2.5	0.0	0.0	0.0	0.1	7.7	0.0	0.0	0.0	0.0	0.0	51.3	0.2	0.0	1.9	0.0	0.0	16.9	2.1	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	14.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.2	0.0	2.6	13.1	0.4	27.5	17.2	31.1	0.1	25.9	29.2	5.1	0.0	27.3	25.7	1.8	46.4	12.6	0.1	23.3	32.0	4.8	5.5	2.0	4.5	5.2	4.7	6.8	3.8	5.6	5.5	0.0	0.6	2.4	0.0	3.4	0.0	5.6	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	57.3	0.0	23.3	0.2	0.2	1.4	0.0	2.3	1.1	24.5	0.0	0.0	77.3	57.9	1.5	1.1	8.6	1.7	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.9	0.2	0.0	2.8	0.3	48.4	0.0	0.1
GIMAP2	"DKFZp586D0824, HIMAP2, IAN12, IMAP2"	ENSG00000106560	"GTPase, IMAP family member 2"	Q9UG22	7	150685697-150693641	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.8;lymphoid tissue: 38.1"	"Cell type enhanced"	"Detected in many"	13	"Hofbauer cells: 34.8;Ito cells: 35.6;Kupffer cells: 100.1;T-cells: 62.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 28.0;JURKAT: 15.5;MOLT-4: 33.8;REH: 14.7;U-937: 14.1"					"Low region specificity"	"Detected in many"			HPA013589	Approved					NA	NA					"HPA013589: AB_1849666"	"prognostic favorable (3.50e-4)"	"unprognostic (4.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.56e-3)"	"unprognostic (6.60e-2)"	"unprognostic (6.64e-3)"	"unprognostic (4.60e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.91e-1)"	"unprognostic (5.52e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.08e-2)"	13.0	7.3	4.8	21.3	7.1	4.6	8.3	2.6	4.2	7.6	7.8	3.3	4.0	5.7	7.8	7.1	5.5	4.5	8.1	7.8	6.7	4.2	6.6	7.7	14.9	35.4	7.3	3.3	8.7	2.7	0.9	3.3	9.2	6.2	6.5	7.6	4.6	7.7	3.0	3.9	2.9	12.7	5.4	12.3	38.1	5.3	2.5	6.5	26.7	6.3	4.4	26.7	9.4	9.6	3.9	11.6	10.0	28.3	31.4	44.8	28.0	0.7	0.0	0.0	0.0	0.3	0.3	0.3	0.0	8.0	1.0	2.3	0.0	10.5	1.8	0.1	0.6	4.4	0.4	0.0	0.4	0.1	8.5	0.0	5.6	0.0	0.2	1.3	4.2	5.7	3.1	0.8	0.7	0.0	2.4	28.0	15.5	0.1	2.2	0.4	0.0	33.8	10.7	0.0	0.0	0.0	14.7	0.3	4.2	0.0	2.6	0.0	0.0	0.0	0.0	2.6	0.0	0.4	11.0	6.2	0.4	0.1	0.1	0.0	2.5	2.3	0.0	1.0	14.1	1.5	2.7	20.7	1.7	24.6	28.3	31.0	3.8	32.2	29.7	11.6	3.9	44.8	32.6	10.0	31.4	27.6	1.4	25.6	28.0	4.8	7.1	2.6	4.2	6.7	4.2	7.3	3.3	6.2	6.5	11.9	2.1	8.7	1.7	3.0	0.0	1.2	2.5	4.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	17.5	2.0	0.0	0.6	0.3	2.1	1.9	19.6	3.8	34.8	0.0	0.0	35.6	100.1	0.0	3.7	21.0	1.7	12.6	3.9	0.3	0.7	3.5	0.7	0.8	0.0	6.5	0.8	0.0	0.2	2.8	0.3	62.3	3.3	2.0
GIMAP1	"HIMAP1, IAN2, IMAP1, IMAP38"	ENSG00000213203	"GTPase, IMAP family member 1"	Q8WWP7	7	150716557-150724284	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 75.5;Hofbauer cells: 34.2;Ito cells: 91.4;Kupffer cells: 83.8;T-cells: 81.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 16.9;MOLT-4: 9.7;TIME: 4.3"	"Low region specificity"	"Detected in all"							"HPA044887, HPA053441"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044887: AB_10960351, HPA053441: AB_2682152"	"unprognostic (1.60e-2)"	"unprognostic (6.58e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.33e-3)"	"prognostic favorable (1.09e-4)"	"unprognostic (1.66e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.60e-3)"	"unprognostic (7.89e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (7.49e-2)"	"unprognostic (1.96e-1)"	18.9	3.6	3.5	11.5	4.9	1.3	10.3	1.2	4.1	8.5	4.1	2.8	3.6	4.2	12.4	5.5	6.2	5.5	5.9	7.4	3.8	2.9	5.3	4.6	11.2	23.8	4.1	2.1	2.6	3.7	1.8	2.2	8.3	4.4	6.3	3.0	5.2	3.6	2.8	6.4	3.6	8.2	4.9	4.6	28.9	3.8	2.9	3.8	6.7	7.9	5.4	12.0	4.9	11.5	0.2	5.1	1.0	11.5	14.6	27.4	11.4	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	16.9	2.2	0.0	0.0	0.0	0.0	9.7	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.9	11.5	0.0	17.2	10.4	20.3	0.1	18.8	21.4	5.1	0.2	27.4	22.2	1.0	14.6	10.4	0.3	11.8	11.4	3.5	4.9	1.2	4.1	3.8	2.9	4.1	2.1	4.4	3.8	3.0	1.0	6.5	0.5	4.8	0.2	4.8	2.5	0.0	1.2	0.0	0.0	0.3	0.0	0.1	0.1	75.5	0.0	0.0	0.3	0.2	1.8	0.5	8.1	1.6	34.2	0.0	0.0	91.4	83.8	0.8	1.4	15.8	8.5	2.8	0.0	0.2	0.1	0.0	0.0	0.5	0.9	0.0	3.8	0.2	0.2	2.8	0.3	81.2	0.0	0.5
GIMAP1-GIMAP5		ENSG00000281887	"GIMAP1-GIMAP5 readthrough"		7	150716668-150743646	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 37.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"monocytes: 15.5;NK-cells: 21.5;T-cells: 37.5"	"Group enriched"	"Detected in some"	8	"HUVEC TERT2: 8.4;JURKAT: 5.0;MOLT-4: 13.1;THP-1: 3.2;TIME: 6.2"									HPA053441			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA053441: AB_2682152"																		12.2	2.1	1.8	12.9	2.7	1.0	6.4	0.0	2.2	5.2	2.2	1.3	1.8	7.0	7.8	3.1	3.6	2.1	3.3	3.8	1.9		3.0	2.5	6.2	15.5	2.0	0.8	1.6	1.9	0.7	0.0	4.6	2.3	3.6	0.5	2.9	2.2	0.9	4.4	0.2	3.1	2.7	2.5	16.4	3.0	1.3	2.0	3.9	4.7	3.0	7.6	2.5	7.2	0.2	4.8	1.5	15.5	21.5	37.5	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	5.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	15.5	0.0	23.3	13.5	27.9	0.2	26.4	34.0	4.8	0.2	37.5	30.2	1.5	21.5	9.8	0.3	16.4	20.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GIMAP5	"HIMAP3, IAN4L1, IAN5"	ENSG00000196329	"GTPase, IMAP family member 5"	Q96F15	7	150722253-150750033	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 61.0;lymphoid tissue: 58.3"	"Cell type enhanced"	"Detected in some"	11	"Basal keratinocytes: 9.8;Endothelial cells: 18.8;Ito cells: 11.6;Suprabasal keratinocytes: 9.4;T-cells: 17.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"NK-cells: 17.3;T-cells: 61.0"	"Cell line enriched"	"Detected in some"	4	"MOLT-4: 24.9"															NA	NA						"unprognostic (6.77e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.61e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.34e-3)"	"unprognostic (2.21e-3)"	"unprognostic (6.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.96e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.13e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.47e-2)"	26.8	6.6	4.7	23.3	5.8	1.7	26.6	1.9	4.3	9.3	9.2	3.4	4.5	2.4	15.2	12.0	7.1	8.7	7.9	12.4	5.5	3.7	8.2	9.2	25.8	58.3	5.2	2.1	4.1	5.2	2.0	3.8	10.3	6.1	7.0	7.9	8.4	9.1	4.2	8.7	5.6	11.7	14.2	5.7	28.7	6.6	3.3	5.6	5.5	12.8	9.2	30.7	10.4	10.2	0.1	0.4	0.7	9.5	17.3	61.0	51.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	1.1	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.4	4.7	0.1	30.2	9.5	37.9	0.1	52.1	35.0	0.4	0.0	61.0	30.8	0.7	17.3	3.0	0.1	17.1	51.1	4.7	5.8	1.9	4.3	5.5	3.7	5.2	2.1	6.1	5.6	0.0	1.7	0.5	0.2	9.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.3	0.2	0.2	2.3	0.8	2.4	0.0	0.0	11.6	3.5	0.0	0.0	3.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.1	9.4	0.2	17.3	0.0	0.1
TMEM176B	"LR8, MS4B2"	ENSG00000106565	"Transmembrane protein 176B"	Q3YBM2	7	150791285-150801360	"Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 92.3;liver: 247.9"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 572.0;Hepatocytes: 1056.4;monocytes: 841.4;Paneth cells: 725.5;Proximal tubular cells: 817.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 537.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 92.3;intermediate monocyte: 68.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 92.3"	"Group enriched"	"Detected in some"	17	"HSkMC: 120.5;THP-1: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047509	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Plasma membrane"	"HPA047509: AB_2680072"	"unprognostic (5.21e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.72e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.11e-3)"	"unprognostic (5.56e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.05e-2)"	13.9	5.5	7.8	19.8	10.7	1.1	11.7	2.1	6.3	8.6	27.6	5.7	2.0	18.3	3.8	15.2	9.6	9.0	50.2	26.8	7.6	5.2	62.9	247.9	11.2	22.9	10.5	3.3	20.3	6.8	0.3	3.2	12.5	8.4	6.1	27.9	22.0	5.1	3.2	2.5	4.2	53.1	10.7	13.2	23.5	10.6	5.2	8.7	4.3	4.9	7.0	10.5	14.7	11.6	0.2	20.0	5.7	92.3	0.0	0.4	42.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	4.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	120.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	38.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	92.3	5.7	0.2	68.0	0.4	0.2	0.0	0.0	20.0	0.0	0.0	0.0	1.1	0.0	36.2	0.9	0.0	42.0	7.8	10.7	2.1	6.3	7.6	5.2	10.5	3.3	8.4	8.7	3.0	12.4	33.9	0.5	11.2	135.3	52.1	175.8	12.0	19.4	355.9	2.0	0.8	140.9	63.8	13.3	17.2	572.0	0.0	29.9	1.1	82.5	3.5	52.1	1056.4	94.1	6.4	123.0	27.0	68.8	9.8	40.3	84.1	15.1	841.4	193.4	69.9	82.8	725.5	3.2	817.7	17.3	0.0	22.6	3.2	3.4	13.7	2.3	14.6	213.0	1.0
TMEM176A	"HCA112, MS4B1"	ENSG00000002933	"Transmembrane protein 176A"	Q96HP8	7	150800403-150805120	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 76.8;liver: 234.5"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 542.2;Hepatocytes: 864.2;monocytes: 525.8;Paneth cells: 691.0;Proximal tubular cells: 954.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 210.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 38.4;intermediate monocyte: 27.1"	"Lineage enriched"	"Detected in many"	4	"monocytes: 38.4"	"Cell line enriched"	"Detected in some"	30	"HSkMC: 127.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA008770	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA008770: AB_2256120"	"unprognostic (4.70e-2)"	"unprognostic (7.71e-2)"	"unprognostic (5.71e-3)"	"unprognostic (6.09e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.91e-2)"	10.5	4.9	5.8	17.1	6.0	0.7	7.8	1.2	4.3	6.2	32.2	4.8	2.0	16.1	3.6	12.8	7.5	6.3	34.2	15.0	5.2	4.5	76.8	234.5	8.8	23.5	6.9	3.4	19.0	5.0	0.4	2.2	8.9	6.6	6.3	22.3	22.8	3.9	2.0	3.1	3.3	51.2	6.5	6.9	17.3	7.1	3.7	5.4	2.1	4.8	4.8	9.2	13.5	9.1	0.4	9.3	3.3	38.4	0.0	0.1	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	127.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.4	3.3	0.1	27.1	0.1	0.4	0.0	0.1	9.3	0.0	0.0	0.0	0.5	0.0	12.9	0.6	0.1	10.7	5.8	6.0	1.2	4.3	5.2	4.5	6.9	3.4	6.6	5.4	0.0	6.9	29.6	0.4	6.5	48.5	19.4	150.3	14.7	15.9	190.1	3.9	0.5	129.3	42.7	0.1	9.6	542.2	0.0	23.6	0.8	57.1	2.4	26.7	864.2	53.0	0.0	71.1	29.4	40.2	0.5	55.8	35.8	5.0	525.8	156.3	73.3	68.7	691.0	7.1	954.7	4.4	0.0	20.0	0.7	1.5	7.3	1.1	7.2	159.5	0.9
AOC1	"ABP1, DAO"	ENSG00000002726	"Amine oxidase, copper containing 1"	P19801	7	150824627-150861504	"Enzymes, Predicted secreted proteins"		"Heparin-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 108.6;placenta: 240.4"	"Cell type enhanced"	"Detected in many"	19	"Collecting duct cells: 258.2;Enterocytes: 648.3;Paneth cells: 375.2"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 61.3;endometrial cancer: 39.1;pancreatic cancer: 26.9;renal cancer: 69.4;stomach cancer: 43.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	10	"eosinophil: 20.3"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 20.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 16.4;HaCaT: 5.0;NB-4: 5.0;RPMI-8226: 6.0;THP-1: 21.4"					"Not detected"	"Not detected"			"HPA031032, HPA031033"	Approved				"Secreted in other tissues"	NA	NA		800000			"HPA031032: AB_10670150, HPA031033: AB_10669670"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (9.07e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.11e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (5.32e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.64e-1)"	0.3	0.3	0.3	6.7	0.3	0.0	0.3	0.3	0.3	0.9	68.3	0.2	1.2	30.2	0.3	3.9	1.7	0.3	4.4	0.3	0.3	0.3	37.9	1.5	0.3	0.6	0.3	0.1	0.3	0.6	0.0	0.3	240.4	0.1	1.3	15.5	0.1	0.4	0.2	0.3	0.8	108.6	0.2	0.3	0.4	2.7	1.8	0.1	0.7	0.3	0.1	1.0	0.4	0.4	0.0	1.0	20.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	2.5	16.4	0.0	2.2	0.0	1.4	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.1	5.0	0.2	1.5	0.0	0.0	0.0	6.0	0.2	0.1	1.8	2.1	0.0	0.7	0.0	0.3	0.6	21.4	0.5	0.2	0.1	0.5	0.0	0.2	0.1	0.1	0.1	0.8	0.0	0.1	0.1	20.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	1.2	258.2	0.0	1.1	13.3	0.0	5.7	0.0	648.3	0.0	3.0	3.0	0.2	0.9	5.7	0.0	2.8	0.0	41.6	0.0	0.0	8.4	0.0	1.3	0.0	115.4	108.6	0.0	2.2	375.2	0.0	73.1	0.0	0.0	0.1	2.8	0.7	0.1	2.9	0.0	80.4	0.3
KCNH2	"erg1, HERG, Kv11.1, LQT2"	ENSG00000055118	"Potassium voltage-gated channel subfamily H member 2"	Q12809	7	150944961-150978315	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Deafness, Disease mutation, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.9"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 199.1;Cardiomyocytes: 76.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.0"	"Group enriched"	"Detected in some"	7	"K-562: 59.8;NB-4: 29.8;SH-SY5Y: 25.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (6.06e-5)"	"unprognostic (9.79e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.52e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (6.08e-2)"	"unprognostic (2.26e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.83e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.02e-2)"	1.1	4.9	5.0	3.2	8.3	37.9	0.7	19.3	8.0	4.3	17.3	2.8	3.1	3.5	9.3	4.6	3.4	4.1	28.5	24.9	4.8	9.3	0.8	0.7	1.7	0.9	4.7	3.9	6.6	5.1	10.5	23.8	2.2	14.1	6.8	1.8	8.0	1.8	10.2	0.8	0.7	6.9	9.4	2.2	1.6	6.8	18.0	1.6	0.1	0.7	0.0	0.7	7.5	2.4	0.1	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.9	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.1	5.7	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	59.8	0.0	0.0	0.3	0.5	29.8	0.4	0.0	0.0	0.0	0.0	3.0	0.0	0.0	1.2	25.0	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.0	0.5	0.0	0.0	1.7	0.0	0.6	0.0	3.7	0.0	0.8	0.0	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	8.3	19.3	8.0	4.8	9.3	4.7	3.9	14.1	1.6	0.0	0.0	0.0	0.1	0.0	199.1	76.1	0.0	0.0	0.0	0.0	3.9	0.1	0.0	1.8	0.8	0.0	0.0	23.3	0.2	1.0	0.9	0.1	26.4	0.0	0.3	15.9	15.6	2.5	0.0	2.5	2.3	0.0	0.0	0.0	0.7	2.7	0.5	0.0	12.4	0.0	9.6	0.0	1.9	0.7	2.6	0.0	0.2	0.0	0.2	0.3
NOS3	"ECNOS, eNOS"	ENSG00000164867	"Nitric oxide synthase 3"	P29474	7	150990995-151014588	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.6"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 62.0;Endothelial cells: 23.5;Ito cells: 30.1;Late spermatids: 21.4"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basal ganglia: 32.4;cerebral cortex: 12.4;hippocampal formation: 18.8;pons and medulla: 35.3"	"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	5	"T-cells: 5.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.4;HUVEC TERT2: 22.1;K-562: 7.8;TIME: 40.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002168	Enhanced					NA	NA					"CAB002168: AB_564072"	"unprognostic (6.53e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.25e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.01e-1)"	11.4	4.5	3.1	7.5	32.4	1.9	25.6	1.8	12.4	4.6	3.2	1.7	1.0	4.0	8.3	2.5	4.7	5.0	6.6	35.2	18.8	3.4	5.5	5.4	14.0	10.3	4.7	1.7	4.5	4.1	2.7	4.8	11.5	35.3	5.2	2.5	5.2	3.0	3.2	6.0	4.9	4.0	5.4	25.9	70.6	3.6	4.5	1.6	0.0	5.9	2.1	2.4	5.1	7.3	1.1	0.5	0.7	0.4	0.5	5.3	1.2	0.2	0.0	0.6	2.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.1	1.0	0.2	1.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	1.0	0.1	3.0	0.3	0.2	5.1	0.0	0.1	0.0	0.0	0.0	22.1	2.5	7.8	1.8	0.0	0.0	0.1	0.2	0.8	0.3	0.0	1.4	0.0	0.8	0.0	0.1	0.2	0.2	0.1	0.7	0.0	0.2	0.1	0.7	40.2	0.1	0.4	0.2	0.0	1.2	4.1	1.0	0.0	3.6	0.0	0.3	0.3	0.2	2.5	0.4	1.5	0.8	3.9	2.2	0.5	1.1	5.3	2.1	0.7	0.5	0.4	0.5	4.4	1.2	3.1	32.4	1.8	12.4	18.8	3.4	4.7	1.7	35.3	1.6	8.9	2.1	0.0	0.0	0.8	0.0	2.0	0.0	1.4	1.2	0.0	0.0	0.2	0.0	0.5	62.0	23.5	0.0	0.0	0.0	0.1	3.1	0.2	5.7	0.0	0.3	0.0	0.0	30.1	0.6	21.4	0.9	0.4	0.0	0.0	0.0	0.0	1.0	0.0	1.1	0.1	0.3	0.0	1.0	3.7	2.5	0.5	3.0	0.0	0.0	0.2
ATG9B	"APG9L2, FLJ14885, NOS3AS, SONE"	ENSG00000181652	"Autophagy related 9B"	Q674R7	7	151012209-151024499	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"placenta: 67.1"	"Cell type enhanced"	"Detected in many"	21	"Early spermatids: 27.7;Late spermatids: 21.7;Syncytiotrophoblasts: 96.6"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in many"	4	"memory CD4 T-cell: 6.0;naive CD4 T-cell: 11.0;naive CD8 T-cell: 4.1;T-reg: 5.9"	"Lineage enriched"	"Detected in many"	7	"T-cells: 11.0"	"Group enriched"	"Detected in some"	5	"BEWO: 17.0;CAPAN-2: 5.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.59e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.05e-3)"	"unprognostic (2.79e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.38e-3)"	"unprognostic (6.76e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.08e-6)"	"unprognostic (2.82e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.63e-1)"	0.0	0.5	0.0	0.2	8.8	0.1	0.1	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.5	1.2	15.4	1.1	0.1	0.0	0.0		0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	6.1	67.1	0.3	0.0	0.0	0.0	0.4	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	8.8	10.5	0.0	0.1	1.6	0.8	0.2	0.1	0.4	11.0	1.9	0.7	0.0	0.9	0.2	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.1	5.5	0.4	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.7	1.1	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.8	0.2	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	2.0	0.5	0.7	0.0	1.5	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.2	1.3	0.0	1.2	1.1	6.0	1.6	0.0	1.6	11.0	4.1	0.0	0.4	0.1	0.8	5.9	1.9											0.0	0.0	3.2	0.2	0.0	1.7	1.1	0.0	16.0	0.0	0.0	0.0	6.6	0.0	0.3	27.7	1.0	0.0	0.0	0.2	2.3	0.0	0.3	14.9	0.0	1.7	0.0	0.0	3.7	0.0	21.7	0.6	0.2	0.0	0.0	0.0	0.5	2.4	0.0	0.7	0.0	0.4	0.0	0.2	16.9	10.4	0.3	96.6	2.2	0.0	1.1
ABCB8	"EST328128, M-ABC1, MABC1"	ENSG00000197150	"ATP binding cassette subfamily B member 8"	Q9NUT2	7	151028422-151047782	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045187	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA045187: AB_10964281"	"unprognostic (5.29e-2)"	"unprognostic (9.17e-3)"	"unprognostic (8.28e-2)"	"unprognostic (8.32e-2)"	"unprognostic (8.63e-3)"	"prognostic favorable (5.91e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (3.34e-4)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.88e-4)"	"unprognostic (7.52e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.23e-1)"	12.6	22.8	14.4	13.8	22.0	12.2	8.5	24.9	24.8	16.3	12.3	22.2	10.4	19.3	16.5	14.9	17.6	12.9	11.5	13.0	14.5	12.8	14.5	33.5	11.7	13.3	19.1	17.9	13.3	12.6	15.4	20.1	23.6	15.9	12.3	9.5	12.5	11.1	12.8	11.2	13.7	14.7	12.7	13.3	11.5	13.1	13.6	19.5	14.0	18.4	11.7	10.6	9.6	10.4	4.4	10.4	10.3	6.7	4.0	7.5	3.6	12.5	19.8	5.1	16.1	8.1	4.7	10.2	6.6	6.9	10.6	11.2	7.9	21.1	6.6	8.9	7.0	12.8	13.3	7.4	13.8	4.7	8.2	8.1	5.2	7.9	9.4	5.3	4.0	13.1	8.1	10.5	12.6	5.2	3.9	10.6	14.7	27.4	9.1	7.9	28.1	15.3	7.6	3.4	9.5	22.6	7.3	3.2	23.5	7.1	5.4	4.9	9.9	7.1	20.2	6.4	4.1	8.0	5.3	6.5	9.9	2.6	7.1	9.9	9.2	4.6	4.7	14.0	9.7	10.1	10.3	4.5	3.4	7.5	6.7	5.2	4.4	5.3	6.1	6.3	3.5	4.9	6.9	1.1	4.0	4.7	10.4	5.6	3.6	14.4	22.0	24.9	24.8	14.5	12.8	19.1	17.9	15.9	19.5	11.9	0.6	11.7	5.2	3.3	22.7	6.7	12.7	1.4	1.2	10.4	35.3	32.5	3.3	13.7	1.8	3.4	24.1	0.0	17.6	18.5	6.5	7.1	50.6	21.2	25.1	28.6	0.0	5.5	8.1	1.9	6.1	5.9	8.5	11.8	8.7	11.2	17.7	7.8	11.7	12.8	32.9	25.8	5.9	8.8	15.4	6.5	68.4	7.5	10.6	5.1
ASIC3	"ACCN3, DRASIC, TNaC1"	ENSG00000213199	"Acid sensing ion channel subunit 3"	Q9UHC3	7	151048292-151052756	"Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 27.1"	"Cell type enhanced"	"Detected in some"	18	"Cone photoreceptor cells: 11.8;Early spermatids: 11.6;Late spermatids: 43.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/70: 17.2;U-266/84: 9.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049155, HPA054805"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA049155: AB_2680657, HPA054805: AB_2732588"	"unprognostic (8.71e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.92e-4)"	"unprognostic (2.73e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.45e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.33e-12)"	"unprognostic (1.49e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.31e-3)"	2.6	2.4	6.8	0.9	27.1	1.5	1.3	20.1	15.4	3.6	2.3	0.9	0.5	2.9	4.9	3.5	0.6	2.4	1.9	2.4	6.5	5.3	1.5	1.3	2.7	1.9	4.2	9.9	3.0	1.4	1.4	7.1	1.8	6.2	1.9	1.8	0.7	1.7	1.4	9.0	3.5	2.7	2.4	6.0	2.1	2.8	10.2	2.2	0.5	1.1	0.5	1.9	0.9	1.2	0.0	0.0	0.0	0.8	0.0	0.7	0.0	1.3	3.6	1.7	2.4	3.3	0.0	7.4	0.4	0.0	0.3	0.4	0.7	1.6	0.9	0.4	0.2	1.6	2.3	0.9	0.0	0.7	7.8	4.2	1.6	2.7	0.0	0.0	0.1	3.9	0.5	0.5	0.2	0.0	2.6	0.1	0.9	3.8	6.4	0.5	6.0	0.3	0.4	1.7	0.1	2.8	2.9	1.6	0.5	0.3	1.3	2.2	8.6	0.6	0.4	4.1	4.6	1.7	0.4	0.1	1.5	2.2	4.0	1.0	17.2	9.1	0.1	2.1	5.7	1.4	0.0	0.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.8	27.1	20.1	15.4	6.5	5.3	4.2	9.9	6.2	2.2	0.0	0.3	0.0	0.0	0.6	8.6	1.6	0.0	0.0	0.0	0.0	11.8	0.1	0.0	0.2	11.6	0.3	0.3	0.0	0.3	0.1	0.5	0.2	9.2	0.6	0.6	6.4	0.0	0.0	0.6	43.6	1.4	0.3	0.0	1.0	0.0	1.9	0.3	0.0	1.8	0.3	5.0	0.0	0.0	9.2	5.1	0.6	0.6	0.0	0.2	0.1
CDK5	PSSALRE	ENSG00000164885	"Cyclin dependent kinase 5"	Q00535	7	151053812-151058530	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Lissencephaly, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 36.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008909, HPA064535"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"CAB008909: , HPA064535: AB_2685280"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.25e-3)"	"unprognostic (3.35e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-1)"	4.5	11.3	24.4	6.9	30.4	6.1	5.3	13.6	36.1	5.3	6.1	6.7	4.5	7.9	4.5	17.4	6.5	5.0	6.2	5.8	25.0	19.7	9.0	7.7	5.3	6.0	15.4	15.4	3.2	5.8	8.9	7.9	5.3	20.8	5.8	6.3	3.2	6.0	6.3	5.7	6.5	6.2	6.0	8.6	5.2	5.7	3.1	7.7	6.8	6.0	3.6	6.9	6.7	3.1	6.6	21.5	9.0	21.7	9.5	14.9	10.6	11.7	14.1	13.2	21.5	14.6	10.7	6.6	7.8	12.8	15.3	12.6	10.0	11.0	11.6	27.9	9.6	22.8	8.4	21.2	11.8	7.0	9.1	12.6	12.7	12.4	9.9	9.6	10.2	23.9	11.6	8.9	12.6	3.9	21.4	10.3	18.2	12.9	8.5	15.3	22.7	27.6	21.0	14.5	18.9	22.3	13.5	5.4	12.9	13.3	8.9	8.4	35.9	11.2	13.8	14.7	12.6	6.4	9.0	8.7	15.1	3.9	11.3	14.5	19.7	21.5	4.5	23.7	14.8	27.0	7.8	19.0	9.0	6.9	21.7	5.4	6.6	6.8	6.8	21.5	5.9	5.1	6.2	2.8	9.5	16.4	12.8	14.9	10.6	24.4	30.4	13.6	36.1	25.0	19.7	15.4	15.4	20.8	7.7	0.0	5.9	11.5	6.4	3.2	11.5	3.2	7.6	8.1	7.9	10.4	2.0	20.0	33.2	19.0	0.6	6.3	7.1	0.0	16.6	10.2	6.6	5.0	31.0	9.6	37.8	0.0	8.6	6.2	21.6	0.9	4.4	14.3	10.1	20.8	9.1	11.5	18.7	14.4	10.6	24.0	4.7	6.5	5.0	2.6	9.7	5.5	7.6	8.5	9.6	7.6
SLC4A2	"AE2, BND3L, EPB3L1, HKB3, NBND3"	ENSG00000164889	"Solute carrier family 4 member 2"	P04920	7	151057210-151076527	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.2;retina: 100.7"	"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 76.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"pons and medulla: 73.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA019339	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Nuclear speckles, Plasma membrane"	Cytosol	"HPA019339: AB_1844825"	"unprognostic (1.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (8.12e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (9.04e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (1.26e-4)"	"unprognostic (4.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.36e-2)"	9.9	13.5	4.7	10.4	7.4	6.7	10.5	3.0	8.6	12.4	18.6	29.0	6.0	12.1	16.2	6.3	7.7	10.8	14.1	11.9	10.1	3.8	35.5	94.2	12.3	7.2	10.4	4.8	12.6	34.1	30.6	5.3	31.4	73.3	10.5	4.0	100.7	11.9	8.3	8.7	9.5	26.0	10.7	10.4	10.1	27.1	6.5	8.5	8.8	9.7	7.0	5.9	11.7	10.6	2.5	5.6	2.1	4.2	0.5	2.7	1.9	15.9	52.8	10.4	21.4	10.4	6.1	23.8	19.4	10.5	15.9	13.8	30.0	25.6	9.6	42.6	9.2	23.4	15.7	10.6	9.4	2.9	27.6	15.8	12.6	25.7	15.2	17.0	6.5	40.6	8.9	8.3	18.0	4.6	17.1	8.8	13.6	38.9	8.1	12.3	30.6	18.6	11.2	24.7	21.5	19.6	14.7	5.7	11.2	13.0	12.1	8.6	31.2	17.7	33.5	16.5	8.2	13.8	12.8	19.0	21.4	10.9	21.0	28.5	8.8	11.8	5.4	32.7	16.3	42.9	0.0	4.2	2.1	2.7	3.9	1.9	2.5	2.1	1.8	2.4	1.0	2.4	2.4	1.0	0.5	2.5	5.6	1.0	1.9	4.7	7.4	3.0	8.6	10.1	3.8	10.4	4.8	73.3	8.5	8.9	10.9	6.7	4.5	9.8	7.9	3.6	17.8	1.4	2.3	19.2	23.6	28.5	14.9	31.0	0.6	9.8	17.3	0.0	30.9	9.0	16.2	5.0	48.3	31.4	23.1	14.3	26.5	14.7	15.1	1.3	12.7	9.9	25.3	9.0	11.1	22.3	39.3	14.0	18.7	18.9	8.8	12.9	15.5	3.2	7.7	6.0	76.5	8.3	18.9	3.1
FASTK	FAST	ENSG00000164896	"Fas activated serine/threonine kinase"	Q14296	7	151076593-151080866	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031621, CAB032539"	Approved		Supported	"Nuclear speckles,Mitochondria"		NA	NA			Mitochondria	"Nuclear speckles"	"CAB032539: AB_2101115, HPA031621: AB_10611966"	"unprognostic (7.67e-2)"	"unprognostic (6.41e-3)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (2.60e-1)"	"unprognostic (1.75e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.66e-2)"	"prognostic favorable (3.99e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.79e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.17e-2)"	13.8	16.8	18.8	15.7	19.0	6.4	10.2	19.0	26.4	18.0	20.6	13.4	20.3	21.2	12.4	14.6	20.3	16.7	16.8	35.7	17.6	12.9	17.7	25.6	9.5	10.4	12.0	15.0	14.4	20.7	20.2	21.8	18.5	12.0	16.8	10.6	14.0	21.7	17.9	89.5	14.4	25.8	11.3	9.2	14.9	14.8	10.6	10.9	11.2	16.8	28.1	16.9	17.4	11.8	15.4	26.0	19.7	22.3	13.1	19.0	14.5	15.9	18.6	5.9	14.2	22.1	10.0	9.9	12.8	17.4	10.9	13.1	12.8	13.7	3.8	17.5	17.3	20.1	10.3	5.7	15.3	2.9	10.9	10.2	4.6	4.6	10.8	28.1	3.2	10.5	13.0	22.5	12.6	9.3	8.9	12.8	9.5	6.8	8.0	12.6	31.9	7.8	9.2	9.9	19.8	21.8	5.2	7.1	11.8	14.8	10.9	7.1	7.4	16.9	26.2	17.0	5.3	14.1	12.7	10.4	13.9	3.0	13.0	11.3	21.4	13.0	2.4	27.7	7.2	15.9	10.5	22.3	19.7	16.4	21.7	17.1	13.7	17.3	16.9	19.4	15.4	19.0	16.3	4.8	13.1	20.8	26.0	18.7	14.5	18.8	19.0	19.0	26.4	17.6	12.9	12.0	15.0	12.0	10.9	0.0	6.5	32.8	35.2	21.9	39.2	16.5	28.1	2.7	12.5	24.4	23.6	42.5	72.9	43.5	7.1	22.2	63.6	0.0	41.8	23.0	34.8	27.1	39.1	31.6	38.4	35.0	43.1	22.7	26.6	11.6	33.6	25.5	89.4	34.3	42.5	51.0	35.5	39.6	32.2	50.2	48.9	12.9	27.8	47.1	68.2	22.1	50.6	38.4	50.8	26.7
TMUB1	"C7orf21, SB144"	ENSG00000164897	"Transmembrane and ubiquitin like domain containing 1"	Q9BVT8	7	151081080-151083546	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029429	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029429: AB_10601825"	"unprognostic (8.14e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.23e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.12e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	10.6	15.2	10.3	16.1	11.0	13.7	17.8	9.1	16.0	9.7	27.5	9.0	17.0	31.8	10.4	15.4	21.6	9.6	18.0	17.3	10.6	9.6	25.5	35.5	12.9	15.6	10.2	10.0	13.1	51.5	9.5	21.1	18.9	8.3	16.1	6.0	12.7	29.6	12.9	33.8	15.1	39.2	12.8	8.7	16.1	24.0	11.5	8.5	23.9	23.6	12.9	19.1	18.7	11.8	8.0	4.2	18.2	3.6	3.1	9.5	1.8	24.4	22.1	5.2	26.8	3.4	4.2	19.5	10.0	8.5	9.0	10.0	19.0	29.9	16.4	21.6	4.9	11.6	16.7	5.8	8.9	2.0	30.0	20.5	7.0	20.5	28.8	8.8	8.6	24.8	6.5	7.4	7.5	2.0	6.8	6.6	17.0	43.7	22.4	4.0	39.5	28.7	37.2	22.3	14.4	13.4	18.0	6.6	30.3	9.3	19.0	19.1	21.3	8.1	12.5	13.1	3.2	9.8	12.0	8.0	11.4	8.4	14.3	16.5	35.3	19.4	11.2	26.4	16.2	14.4	3.5	2.7	18.2	5.4	3.6	4.7	4.4	8.0	5.8	2.8	8.0	7.8	4.5	4.7	3.1	2.2	4.2	9.5	1.8	10.3	11.0	9.1	16.0	10.6	9.6	10.2	10.0	8.3	8.5	6.0	5.6	49.1	25.7	23.5	14.7	8.1	22.9	0.0	0.0	21.0	13.7	83.6	29.9	61.9	8.5	23.9	135.7	0.0	95.6	50.7	20.3	31.1	16.1	44.1	39.1	19.1	39.6	21.5	20.8	2.5	11.5	25.8	30.4	58.7	75.9	22.0	80.5	108.7	15.6	34.6	14.8	38.8	29.9	25.1	10.6	32.2	79.1	52.4	64.5	33.0
AGAP3	CENTG3	ENSG00000133612	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 3"	Q96P47	7	151085831-151144436	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 67.8"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012883	Approved					NA	NA					"HPA012883: AB_1846533"	"unprognostic (3.63e-2)"	"unprognostic (8.93e-2)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (4.35e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (6.21e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.15e-3)"	"prognostic unfavorable (8.58e-5)"	"unprognostic (1.34e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.55e-2)"	"unprognostic (9.50e-3)"	16.4	16.8	47.0	11.2	38.3	5.0	16.3	40.9	67.8	15.1	10.1	24.4	8.7	14.1	18.3	9.6	16.9	16.9	12.2	12.0	47.2	30.3	6.7	11.5	21.4	8.9	24.6	44.1	18.6	28.0	21.8	20.2	15.1	27.6	15.4	6.7	12.4	23.3	16.0	21.1	27.0	14.2	12.1	17.2	12.9	11.5	7.0	21.8	0.9	9.5	6.7	6.8	12.9	12.5	3.4	2.5	0.5	5.7	3.8	3.5	3.0	14.4	11.6	10.5	22.9	9.9	8.0	16.1	11.3	10.8	8.9	7.9	11.2	15.1	0.2	14.6	6.6	10.9	20.4	7.4	16.0	2.9	16.7	22.9	13.0	12.8	15.2	14.1	8.6	5.3	8.0	19.9	7.2	7.6	14.2	13.1	5.6	23.2	10.5	5.1	38.0	3.6	40.3	19.7	11.5	13.0	9.0	7.2	20.4	11.0	35.3	31.5	26.3	8.7	2.7	26.8	7.7	7.6	13.3	12.6	12.1	4.1	14.7	13.9	13.6	6.0	0.1	23.9	14.9	15.1	0.0	5.7	0.4	2.1	3.4	1.5	3.4	2.9	3.5	2.5	0.6	2.2	1.1	0.5	3.8	1.2	0.1	0.5	3.0	47.0	38.3	40.9	67.8	47.2	30.3	24.6	44.1	27.6	21.8	26.8	22.3	1.9	12.4	18.9	47.7	17.9	12.7	5.3	18.2	3.5	7.9	7.5	0.0	5.1	0.3	20.3	15.1	0.0	9.0	1.6	12.6	12.1	17.3	17.1	18.1	54.0	6.9	9.8	16.4	2.2	10.9	17.2	11.8	7.2	9.1	9.6	17.3	0.0	11.0	5.8	14.0	12.9	9.0	0.7	11.1	16.3	2.6	2.5	10.1	9.6
GBX1		ENSG00000164900	"Gastrulation brain homeobox 1"	Q14549	7	151148589-151174745	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 6.0;skeletal muscle: 16.6;testis: 9.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"cervical cancer: 1.0"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.9;HEK 293: 2.0;HMC-1: 5.7;PC-3: 1.1"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.4"	"Low region specificity"	"Detected in many"			HPA055783	Uncertain					NA	NA					"HPA055783: AB_2682919"		"unprognostic (4.24e-2)"			"unprognostic (3.87e-2)"			"unprognostic (3.58e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.95e-1)"				"unprognostic (1.87e-1)"	"unprognostic (1.91e-1)"		"unprognostic (3.14e-1)"	1.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.5	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	6.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.5	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
ASB10	GLC1F	ENSG00000146926	"Ankyrin repeat and SOCS box containing 10"	Q8WXI3	7	151175698-151187832	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	10	"heart muscle: 12.3;skeletal muscle: 44.0;tongue: 15.3"	"Cell type enriched"	"Detected in single"	122	"Cardiomyocytes: 12.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA079685	Enhanced					NA	NA					"HPA079685: "						"unprognostic (6.72e-3)"				"unprognostic (1.96e-1)"								0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.2	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	15.3	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IQCA1L	"IQCA1P1, TCAG_9762"	ENSG00000278685	"IQ motif containing with AAA domain 1 like"		7	151190873-151205496	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	14	"testis: 7.0"	"Group enriched"	"Detected in some"	58	"Early spermatids: 22.5;Late spermatids: 17.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"U-266/70: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA										"unprognostic (1.13e-1)"					"unprognostic (2.26e-2)"					"unprognostic (2.65e-1)"			0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.5	0.0	0.0	0.0		0.0	0.0	7.0			0.0		0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.1	0.0	3.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
ABCF2	"ABC28, EST133090, HUSSY-18, M-ABC1"	ENSG00000285292	"ATP binding cassette subfamily F member 2"	Q9UG63	7	151207837-151227166	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 41.5"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA020091, HPA021815, HPA030388"	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558"																		7.9	4.3	4.4	6.5	6.4	2.4	6.1	4.2	10.8	5.5	5.4	5.4	4.0	3.6	5.7	3.3	6.1	5.8	4.3	4.5	4.1		6.2	5.2	5.8	6.1	5.0	8.3	4.0	6.0	10.8	2.7	4.1	5.7	4.1	5.2	4.4	2.9	5.8	20.3	5.6	3.1	6.0	3.1	5.9	3.3	7.2	5.6	5.2	4.9	5.5	6.8	4.8	3.3	8.5	11.3	8.7	9.8	10.0	24.2	13.4	12.7	11.8	9.0	18.8	10.4	12.2	5.0	18.2	10.0	8.7	11.4	9.3	10.3	19.5	13.8	16.7	18.9	10.0	14.3	14.3	18.4	7.8	4.2	12.1	9.5	5.6	18.9	24.3	4.7	11.5	9.9	20.7	17.8	8.5	15.0	9.6	26.5	8.9	15.5	9.7	26.4	0.9	8.2	16.5	9.5	8.7	10.1	20.3	4.0	10.3	3.5	9.7	20.2	10.9	8.0	8.1	5.9	10.3	14.1	8.4	2.4	12.9	20.6	12.4	13.1	22.8	16.0	19.5	7.7	8.7	9.8	2.3	10.3	7.1	24.2	8.5	14.4	12.6	11.3	8.4	12.7	12.0	0.7	10.0	5.5	6.8	12.7	13.4											0.0	0.3	9.0	17.6	24.2	17.5	0.0	7.6	0.0	0.0	0.0	7.9	0.0	0.0	0.0	37.1	11.3	15.3	0.0	0.0	0.0	1.0	10.7	10.3	11.4	0.0	9.5	6.4	10.4	10.5	41.5	9.8	4.6	18.6	0.0	8.0	12.9	0.0	20.1	13.8	0.0	11.9	12.9	17.6	22.3	8.4	22.0	0.0	14.9	12.2	13.9
AC021097.2		ENSG00000285480			7	151207837-151210378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	5	"skin 1: 8.0"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-266/70: 9.2;U-266/84: 6.0"									HPA043013	Uncertain					NA	NA					"HPA043013: AB_2678269"																		1.0	0.2		0.2		0.5	1.2		0.0	0.2	0.0			0.0	1.5	0.0	0.6	0.0	1.1	0.0			0.0	0.0	1.0	1.6			0.8	0.0	0.0		0.0		0.0	0.0		0.0	0.1	0.9	8.0	0.0	0.5		1.2	0.0	0.1			0.0		0.2	0.0		0.5	0.1	0.8	0.4	0.0	0.5	0.0	0.0	0.8	0.0	0.6	2.0	2.3	0.0	0.7	0.3	0.3	0.0	1.9	1.2	1.4	0.7	0.5	0.0	0.0	0.0	0.5	0.0	1.0	3.6	0.4	0.4	0.0	1.0	0.5	1.9	2.6	0.4	0.0	3.4	0.6	0.8	0.8	0.3	3.0	0.0	0.5	0.2	0.2	0.2	0.1	1.2	0.8	0.0	1.1	0.0	0.0	0.4	0.0	0.4	0.0	1.5	0.0	0.0	2.3	1.0	0.0	0.4	1.2	0.2	9.2	6.0	0.3	0.7	2.9	0.2	0.0	0.3	0.0	0.2	0.4	0.1	0.5	0.1	0.0	0.1	0.2	0.1	0.5	0.8	0.0	0.0	0.0	0.3	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ABCF2	"ABC28, EST133090, HUSSY-18, M-ABC1"	ENSG00000033050	"ATP binding cassette subfamily F member 2"	Q9UG63	7	151212490-151227230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	228	"Cardiomyocytes: 20.9;Cytotrophoblasts: 24.9;Extravillous trophoblasts: 22.8;Hofbauer cells: 18.5;Syncytiotrophoblasts: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020091, CAB020682, HPA021815, HPA030388"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"CAB020682: , HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558"	"unprognostic (6.80e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (9.52e-6)"	"unprognostic (1.52e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.07e-2)"	"unprognostic (7.84e-3)"	18.3	15.4	14.9	15.9	18.8	9.7	12.6	19.0	29.6	10.9	14.2	16.3	12.9	9.5	14.9	17.7	16.1	13.7	13.6	22.2	14.5	17.4	14.2	10.6	12.4	16.1	16.4	23.3	13.6	17.7	25.1	14.9	15.2	17.1	13.9	17.7	13.7	12.5	16.8	46.6	17.4	10.7	21.7	12.7	15.5	13.9	20.7	16.7	15.8	14.8	16.5	22.4	14.5	11.2	13.0	14.2	6.8	15.0	15.7	22.4	14.5	17.9	29.2	10.2	36.4	20.9	17.5	13.9	21.8	18.8	28.4	24.2	24.8	12.6	29.5	18.9	24.4	23.9	14.2	32.1	26.7	27.7	14.7	26.7	12.3	14.5	15.0	24.6	29.0	19.6	23.1	22.6	31.6	18.6	12.3	23.9	17.7	35.1	12.4	25.3	45.6	32.2	34.6	24.7	21.9	31.7	20.7	16.4	27.2	19.5	13.1	17.8	17.3	20.8	21.9	14.6	11.3	9.3	15.0	21.4	18.2	7.3	21.7	32.9	24.1	25.7	21.8	25.1	29.2	34.3	6.8	12.1	4.0	15.9	14.3	22.4	12.7	16.2	15.9	14.2	13.0	15.3	15.8	1.7	15.7	15.0	10.2	16.9	14.5	14.9	18.8	19.0	29.6	14.5	17.4	16.4	23.3	17.1	16.7	0.0	0.0	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0
CHPF2	"ChSy-3, CSGlcA-T, KIAA1402"	ENSG00000033100	"Chondroitin polymerizing factor 2"	Q9P2E5	7	151232489-151238827	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020992	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"		"HPA020992: AB_1847267"	"unprognostic (8.31e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.79e-3)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (4.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.59e-3)"	13.5	29.3	13.4	19.0	12.9	22.6	19.1	13.1	20.2	15.3	14.4	11.4	20.7	14.9	19.5	16.9	13.3	14.9	17.6	18.8	13.7	12.5	14.9	20.7	17.4	23.4	11.4	17.4	14.4	23.7	16.7	41.5	18.6	11.8	18.5	10.8	12.2	25.4	19.8	7.9	14.2	17.1	17.3	9.4	28.1	20.1	12.9	11.1	16.2	17.5	7.4	13.7	18.9	12.8	2.7	9.5	9.9	5.6	2.6	5.7	3.7	9.0	7.4	5.0	14.5	17.4	17.3	7.5	19.1	29.8	10.4	12.7	4.9	15.4	2.7	33.8	30.3	14.2	11.4	2.2	13.6	4.5	10.4	6.8	2.9	8.1	6.8	16.3	5.8	24.2	26.4	7.7	9.8	3.5	21.6	16.3	4.6	2.7	8.0	16.5	14.9	5.4	22.9	6.6	3.8	8.6	5.1	2.9	9.1	10.1	7.2	5.4	9.6	10.2	10.1	4.8	3.9	3.9	9.6	22.2	11.6	1.9	15.3	16.1	14.8	2.1	4.0	42.1	7.8	15.6	1.2	5.6	7.9	5.7	5.1	5.4	2.7	3.1	5.1	6.3	2.7	2.2	2.3	9.9	2.6	5.0	9.5	3.4	3.7	13.4	12.9	13.1	20.2	13.7	12.5	11.4	17.4	11.8	11.1	8.9	10.2	11.5	4.8	4.0	9.5	1.6	12.7	4.0	4.5	10.4	3.9	9.1	1.7	10.3	0.5	4.7	10.2	23.3	14.5	12.1	9.7	9.5	5.8	8.3	11.2	23.8	8.1	13.5	11.6	0.7	15.8	8.5	6.8	7.2	10.1	4.3	14.8	15.9	14.2	3.3	6.9	19.4	6.2	3.4	1.7	3.9	8.6	12.1	8.1	8.9
SMARCD3	"BAF60C, CRACD3, Rsc6p"	ENSG00000082014	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3"	Q6STE5	7	151238764-151277896	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 75.2"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 59.6;Peritubular cells: 83.1;Sertoli cells: 64.7;Smooth muscle cells: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 8.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.6;granulocytes: 3.1;monocytes: 8.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063955, HPA065517"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063955: AB_2685159, HPA065517: AB_2685500"	"unprognostic (1.23e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (4.38e-3)"	"unprognostic (4.67e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.08e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.29e-1)"	9.7	16.0	34.2	4.0	40.3	4.9	9.8	25.4	36.8	12.9	5.6	7.8	7.9	2.9	8.6	11.4	6.7	14.5	10.7	38.5	22.2	24.7	4.9	2.0	8.3	4.0	18.7	18.8	19.2	7.5	6.8	14.7	4.6	13.3	10.8	3.6	7.6	6.6	18.1	75.2	5.7	3.4	10.0	14.1	4.3	4.8	9.0	11.6	0.0	7.4	9.5	2.5	10.1	4.8	0.2	2.6	3.1	8.8	0.0	0.8	2.1	0.3	2.8	9.4	33.3	15.0	6.7	0.7	6.1	6.2	3.6	2.1	2.1	1.9	3.6	2.2	9.6	1.4	0.6	7.5	0.6	1.4	1.1	4.6	0.0	1.9	0.6	12.9	0.1	6.1	15.9	0.8	1.2	0.1	15.7	0.7	9.3	7.2	1.2	19.0	3.8	0.6	4.7	2.9	0.9	1.2	0.2	14.8	0.1	3.2	0.0	5.4	11.0	5.8	1.0	4.4	1.5	0.8	9.3	1.1	2.3	3.7	7.1	2.0	7.9	0.0	3.0	6.6	8.2	10.3	0.6	8.8	0.0	0.2	1.9	0.1	0.2	0.8	0.0	2.6	0.0	0.5	0.8	3.1	0.0	0.4	0.0	0.7	2.1	34.2	40.3	25.4	27.9	22.2	24.7	18.7	18.8	13.3	11.6	6.0	20.8	0.0	31.9	9.5	12.7	59.6	17.8	6.7	5.7	10.4	3.9	0.4	26.6	14.9	1.8	4.7	0.0	0.0	2.1	0.2	19.3	7.3	2.3	0.4	3.4	11.1	3.4	2.5	17.1	8.9	46.9	6.4	6.8	1.0	0.0	23.4	4.3	0.0	83.1	1.7	4.6	64.7	51.5	1.7	9.5	4.1	0.9	0.9	0.0	8.1
NUB1	"BS4, NUB1L, NYREN18"	ENSG00000013374	"Negative regulator of ubiquitin like proteins 1"	Q9Y5A7	7	151341699-151378449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"monocytes: 930.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021220, HPA050722, HPA053648"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA021220: AB_2670630, HPA050722: AB_2681220, HPA053648: AB_2682217"	"unprognostic (7.04e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (8.70e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.83e-3)"	20.1	17.3	17.1	22.1	15.5	13.2	20.5	20.5	20.0	22.2	25.0	17.6	17.3	30.9	24.4	17.6	18.1	19.8	17.0	16.5	14.8	12.9	17.1	18.9	21.2	28.7	14.3	15.4	25.4	21.7	28.0	26.4	23.7	18.5	21.6	15.3	16.2	19.8	15.7	30.3	16.9	38.3	20.8	19.8	26.5	17.7	56.0	16.0	32.3	26.5	15.9	19.8	25.3	22.3	21.1	18.9	28.9	24.0	24.5	24.7	17.1	27.0	12.3	16.6	9.8	17.3	21.2	13.8	21.8	20.1	16.6	19.2	12.0	24.0	29.2	28.9	13.6	21.3	13.7	9.9	14.2	10.7	25.8	16.7	10.6	11.7	7.6	24.3	24.6	13.8	13.5	16.7	11.9	11.3	20.6	10.9	14.9	27.7	0.8	13.3	14.5	43.5	18.7	26.0	27.7	16.2	24.2	17.2	4.4	12.3	13.4	15.6	26.0	40.9	17.6	20.8	12.1	12.0	14.2	22.0	14.1	5.0	18.7	20.6	28.5	21.7	25.7	28.5	21.2	23.0	10.4	15.7	20.7	20.9	20.3	24.7	21.1	18.3	21.1	13.6	19.9	20.4	19.0	28.9	24.5	24.0	18.9	14.3	17.1	17.1	15.5	20.5	20.0	14.8	12.9	14.3	15.4	18.5	16.0	68.5	57.3	44.2	28.5	22.0	35.4	51.7	30.6	72.3	71.7	24.4	11.8	39.1	51.4	43.6	181.4	36.0	42.1	0.0	60.6	37.7	28.4	41.4	69.4	33.4	27.3	46.1	28.2	30.7	34.8	15.4	40.9	42.6	15.1	930.6	41.4	52.7	51.5	17.5	38.5	30.5	40.1	25.8	38.7	96.0	12.7	25.3	41.9	48.0	21.9	30.6
WDR86		ENSG00000187260	"WD repeat domain 86"	Q86TI4	7	151375909-151410727	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"thyroid gland: 33.8"	"Cell type enhanced"	"Detected in some"	15	"Ciliated cells: 2.7;Fibroblasts: 3.8;Muller glia cells: 9.1;Peritubular cells: 2.8"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 14.9"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HSkMC: 16.8;NTERA-2: 3.1;SCLC-21H: 7.1;SH-SY5Y: 5.1;SuSa: 4.8"	"Group enriched"	"Detected in many"	4	"basal ganglia: 1.5;cerebellum: 1.4;hippocampal formation: 4.4;pons and medulla: 3.6;thalamus: 2.7"	"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.93e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.13e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.32e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.84e-6)"	"unprognostic (7.22e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.04e-1)"	7.4	1.7	6.8	0.9	4.2	0.7	5.0	0.6	4.7	11.1	5.6	1.5	15.7	1.8	7.7	8.8	0.9	8.2	2.1	1.1	5.5	1.0	2.3	0.8	1.0	2.1	2.4	2.4	4.5	0.7	21.7	5.0	5.6	3.2	2.9	0.7	14.7	1.9	11.3	1.2	0.7	1.7	1.9	1.3	15.6	2.6	1.9	0.3	0.8	33.8	0.4	0.8	2.3	4.5	0.0	0.0	0.0	0.7	0.7	1.7	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	5.1	0.0	0.0	0.0	4.8	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.0	1.7	0.9	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	6.8	4.2	0.6	4.7	5.5	1.0	2.4	2.4	3.2	0.3	0.0	0.3	0.0	0.2	0.0	0.2	1.0	0.0	2.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	3.8	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.8	0.0	9.1	0.0	0.0	2.8	0.0	0.6	0.0	2.0	0.0	0.1	0.3	0.7	0.7	0.0	0.1
CRYGN		ENSG00000127377	"Crystallin gamma N"	Q8WXF5	7	151428835-151440813	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"seminal vesicle: 4.3;thyroid gland: 16.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	25	"thyroid cancer: 15.7"					"Group enriched"	"Detected in some"	31	"memory CD4 T-cell: 3.4;naive CD4 T-cell: 3.4;naive CD8 T-cell: 2.2"	"Lineage enriched"	"Detected in single"	35	"T-cells: 3.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;CAPAN-2: 2.7;MOLT-4: 2.0;SCLC-21H: 3.6"	"Region enriched"	"Detected in single"	4	"basal ganglia: 9.3"	"Not detected"	"Not detected"			HPA050788	Uncertain					NA	NA					"HPA050788: AB_2681239"	"unprognostic (1.69e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.55e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.94e-5)"	"unprognostic (2.49e-3)"	"unprognostic (1.55e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.48e-2)"	"unprognostic (8.93e-10)"	"unprognostic (2.55e-4)"	"unprognostic (2.71e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.36e-1)"	0.3	0.0	0.3	0.0	0.5	0.0	0.2	0.0	0.4	1.1	0.3			0.0	0.9	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0		0.4	0.0	2.6	0.8	0.3		0.3	0.0		0.1	4.3	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0			16.3		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.4	0.0	0.0	0.0	0.6	0.0	0.0	1.7	0.0	0.3	0.0	0.8	1.0	2.7	0.3	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.3	0.4	0.0	2.0	0.5	1.1	0.0	0.6	0.3	0.0	0.0	0.0	0.0	3.6	0.2	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	3.4	2.2	0.0	0.0	0.0	0.0	0.0	0.4											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0
RHEB	RHEB2	ENSG00000106615	"Ras homolog, mTORC1 binding"	Q15382	7	151466012-151520120	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							CAB019436	Uncertain					NA	NA		24000			"CAB019436: AB_2178777"	"unprognostic (2.22e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.25e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.08e-3)"	"prognostic unfavorable (9.08e-5)"	"unprognostic (9.37e-2)"	"unprognostic (4.76e-3)"	"unprognostic (9.76e-3)"	"unprognostic (1.85e-3)"	"unprognostic (3.67e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.15e-1)"	21.8	37.2	30.9	15.1	32.4	23.8	28.0	21.1	34.6	16.5	22.3	14.6	26.7	13.3	24.2	44.4	18.3	15.4	14.9	26.2	31.4	29.3	25.0	27.4	19.8	9.8	28.9	18.2	18.7	20.4	19.0	48.6	37.0	27.3	21.0	16.1	24.8	20.4	27.1	34.2	11.5	13.4	30.0	29.7	15.2	17.1	15.8	25.4	10.8	40.6	12.8	11.6	19.6	14.1	16.5	32.2	30.9	24.3	23.5	30.1	26.0	55.5	17.0	30.1	28.5	37.6	30.9	22.7	41.1	36.3	34.5	42.3	24.4	60.6	14.4	64.8	36.4	90.5	19.0	21.6	19.9	45.0	15.1	16.6	12.3	20.8	18.2	58.8	22.7	20.1	23.6	31.9	27.5	37.1	36.4	26.6	22.0	37.9	67.0	47.6	36.0	31.9	32.4	49.4	40.5	24.8	15.6	26.6	29.0	40.1	20.0	29.0	36.4	41.8	40.6	46.4	30.6	15.2	28.5	29.0	27.4	11.4	47.2	66.0	25.2	34.3	20.7	66.3	42.6	74.1	22.7	24.3	30.9	18.5	20.6	30.1	16.5	25.7	23.1	18.4	15.1	18.8	23.2	23.9	23.5	22.3	32.2	24.9	26.0	30.9	32.4	21.1	34.2	31.4	29.3	28.9	18.2	27.3	25.4	56.6	37.9	80.9	454.2	353.6	55.6	92.1	71.4	41.5	42.1	102.9	17.7	163.7	353.1	200.4	48.7	143.2	76.1	23.3	184.6	337.2	214.2	475.5	107.0	137.6	213.2	114.4	94.1	87.2	88.2	22.0	103.9	167.6	301.9	119.0	57.5	315.5	229.8	60.0	142.5	217.3	54.9	122.9	234.5	319.7	181.7	354.6	352.2	102.3	73.4	593.4
PRKAG2	"AAKG, AAKG2, CMH6, H91620p, WPWS"	ENSG00000106617	"Protein kinase AMP-activated non-catalytic subunit gamma 2"	Q9UGJ0	7	151556111-151877125	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"Cardiomyopathy, Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 77.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 58.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004246, CAB018641"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB018641: AB_2170355, HPA004246: AB_1078151"	"unprognostic (4.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.33e-3)"	"unprognostic (7.13e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.52e-1)"	12.8	5.5	15.3	8.7	28.8	6.3	9.7	31.1	19.2	8.8	11.5	7.5	9.4	16.7	10.4	10.9	10.8	8.6	12.0	77.2	15.1	13.5	15.4	18.5	8.6	7.7	12.3	14.3	6.8	6.2	6.7	5.1	20.0	18.3	17.5	13.5	7.8	11.9	14.8	21.5	6.9	17.8	32.8	8.5	12.8	13.8	9.7	9.5	2.3	12.6	5.2	7.1	22.4	12.4	7.9	7.8	18.4	6.0	3.1	6.1	3.5	15.5	4.5	3.0	3.6	13.9	11.8	5.4	7.1	6.4	7.7	7.6	2.9	19.9	0.0	11.8	9.5	58.6	5.0	1.9	8.3	12.5	3.7	2.1	4.1	0.5	0.3	20.7	3.1	4.0	5.7	17.8	7.7	8.2	12.8	13.2	4.7	1.4	1.9	23.3	5.8	1.6	2.2	3.1	6.8	13.2	1.5	2.2	3.2	14.7	3.7	13.7	2.1	4.2	7.8	3.1	8.3	2.5	4.1	17.6	1.8	1.5	0.9	4.5	1.4	1.6	0.0	21.9	9.6	17.3	18.4	6.0	10.5	5.1	5.4	3.7	7.9	4.5	4.5	4.3	3.8	4.2	6.1	13.6	3.1	5.4	7.8	2.4	3.5	15.3	28.8	31.1	19.2	15.1	13.5	12.3	14.3	18.3	9.5	6.0	17.5	17.5	32.5	9.4	15.4	84.3	7.6	14.7	13.6	43.6	7.9	2.9	54.7	13.4	39.3	19.4	29.8	0.0	19.9	19.0	16.6	41.6	21.9	55.7	17.5	3.2	12.6	19.6	50.9	26.6	6.9	39.9	15.1	42.3	27.6	18.6	19.6	17.5	7.4	14.7	4.4	12.9	29.1	3.5	19.8	9.5	42.3	26.1	25.4	38.3
GALNTL5	"GalNAc-T5L, GALNT15"	ENSG00000106648	"Polypeptide N-acetylgalactosaminyltransferase like 5"	Q7Z4T8	7	151956379-152019934	"Disease related genes, Predicted membrane proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"testis: 45.0"	"Group enriched"	"Detected in some"	89	"Early spermatids: 360.6;Late spermatids: 297.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA011140	Enhanced					NA	NA					"HPA011140: AB_1078944"					"unprognostic (2.33e-2)"									"unprognostic (2.09e-1)"	"unprognostic (1.55e-1)"			0.0	0.0	1.2	0.0	0.7	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	0.0	1.9	1.1	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	360.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	297.5	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.7	1.5	0.0	0.0	0.0	0.0	0.0
GALNT11	GalNAc-T11	ENSG00000178234	"Polypeptide N-acetylgalactosaminyltransferase 11"	Q8NCW6	7	152025674-152122347	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Notch signaling pathway"	"Glycosyltransferase, Transferase"	Heterotaxy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 82.0"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 116.5;Proximal tubular cells: 163.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039330	Uncertain					NA	NA					"HPA039330: AB_10795249"	"unprognostic (6.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (9.54e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.56e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.65e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (2.24e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.51e-2)"	10.7	9.4	11.1	5.1	18.7	3.8	10.4	20.8	21.8	9.1	7.5	11.4	7.1	5.1	9.6	9.2	9.8	8.3	9.3	9.2	11.4	9.3	82.0	7.1	9.6	4.9	7.0	13.4	10.6	29.7	19.3	10.5	15.9	34.1	12.0	6.5	21.7	7.8	9.8	8.8	8.3	6.9	9.5	6.5	8.5	7.6	7.3	4.4	4.6	12.5	5.6	6.4	9.4	8.1	6.3	8.3	8.2	12.5	15.7	19.3	8.7	10.6	9.6	14.2	15.8	32.9	32.5	14.6	8.5	9.8	7.2	6.8	7.7	11.3	0.0	22.3	13.8	20.1	5.0	6.7	12.1	8.9	8.8	10.0	2.1	8.7	6.7	10.8	9.6	11.4	28.6	15.6	6.0	5.0	12.6	13.0	7.5	10.7	0.1	18.0	9.2	8.2	8.7	11.6	16.8	7.7	0.0	6.2	0.3	23.7	16.5	12.6	16.8	14.2	6.9	11.5	15.8	10.3	8.3	11.7	9.7	3.4	12.2	9.3	3.2	4.0	0.1	20.2	9.4	33.0	5.8	8.3	8.2	19.3	9.4	19.0	6.3	10.7	17.7	8.3	3.8	9.2	14.0	4.4	15.7	12.5	2.5	7.9	8.7	11.1	18.7	20.8	21.8	11.4	9.3	7.0	13.4	34.1	4.4	11.9	18.5	17.9	21.5	9.3	116.5	24.0	10.2	20.1	11.4	33.2	25.5	66.9	51.4	15.4	3.0	20.7	7.7	0.0	16.2	11.7	25.1	24.5	13.9	13.5	21.9	71.5	21.9	25.8	16.5	2.9	18.4	11.5	16.9	15.4	9.0	30.9	11.9	7.0	33.9	163.9	35.9	0.0	21.7	17.7	13.8	10.3	30.3	22.0	8.5	15.4
KMT2C	"HALR, KIAA1506, MLL3"	ENSG00000055609	"Lysine methyltransferase 2C"	Q8NEZ4	7	152134922-152436005	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074736			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA074736: AB_2686709"	"unprognostic (7.75e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (8.01e-6)"	"unprognostic (1.78e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.64e-1)"	13.9	12.6	11.7	16.7	18.6	29.7	14.5	24.8	14.1	18.4	12.6	15.5	21.4	9.7	20.2	20.6	14.4	12.8	12.7	10.8	13.4	9.5	10.3	11.4	13.0	12.1	17.7	9.4	18.8	18.4	18.8	18.9	38.0	12.6	14.0	11.8	12.6	15.8	22.9	30.3	25.2	13.1	13.6	16.0	14.6	14.9	13.6	19.6	22.6	16.9	9.3	16.8	17.8	31.6	5.6	3.5	16.1	3.9	5.5	2.9	0.6	9.7	4.9	9.1	9.7	16.5	10.0	10.7	5.1	3.9	4.1	5.0	9.3	5.9	15.5	7.4	9.2	5.6	5.6	9.8	7.4	6.9	9.8	5.0	9.2	7.4	6.4	8.0	15.5	11.3	8.4	10.3	5.8	7.8	6.6	5.8	8.1	14.8	13.4	8.9	13.6	11.2	14.1	5.5	7.6	4.9	7.6	8.3	8.1	7.0	10.0	13.3	10.5	8.4	15.0	5.5	9.9	4.9	12.8	7.3	6.8	3.6	7.3	7.2	14.1	6.9	16.7	8.9	12.8	7.0	8.8	3.5	4.3	2.1	2.2	2.9	5.6	1.7	1.7	1.7	3.8	2.7	1.8	16.1	5.5	3.9	3.5	1.3	0.6	11.7	18.6	24.8	14.1	13.4	9.5	17.7	9.4	12.6	19.6	71.5	66.6	54.7	36.1	79.1	82.8	58.2	45.9	44.2	92.1	43.6	163.0	29.7	5.0	30.2	18.6	49.2	41.0	23.3	28.7	45.7	47.0	48.1	62.5	36.6	29.6	76.3	65.1	41.7	48.8	11.0	62.5	61.0	40.5	25.2	44.5	62.2	33.0	43.8	56.6	15.7	75.2	25.8	50.1	33.5	31.5	84.2	106.4	50.4	30.3	55.0
XRCC2	FANCU	ENSG00000196584	"X-ray repair cross complementing 2"	O43543	7	152644779-152676165	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Fanconi anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 12.7;testis: 11.7"	"Cell type enhanced"	"Detected in many"	9	"Extravillous trophoblasts: 19.4;Spermatocytes: 22.4;Spermatogonia: 24.3;Syncytiotrophoblasts: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065153			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA065153: AB_2685422"	"unprognostic (9.31e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (9.10e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.36e-5)"	"unprognostic (9.98e-3)"	"unprognostic (5.82e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.55e-15)"	"unprognostic (4.52e-3)"	"unprognostic (3.01e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.73e-2)"	1.3	1.3	3.4	4.5	2.0	5.4	2.4	4.4	2.6	1.6	1.5	2.5	0.6	1.1	1.9	2.2	2.6	1.3	0.6	2.5	3.3	1.1	1.1	1.3	1.4	3.0	1.9	1.9	2.0	1.2	0.4	1.3	7.2	2.7	1.5	2.9	0.6	1.5	1.3	1.1	1.6	1.9	1.3	1.8	1.8	1.5	11.7	2.2	12.7	1.2	1.1	3.6	1.3	1.6	1.8	1.0	3.1	1.1	1.1	1.6	0.6	7.5	4.5	6.7	7.3	0.8	0.7	7.7	5.4	2.0	4.7	4.7	5.7	6.6	10.7	4.2	2.1	7.4	5.5	5.4	4.4	8.7	5.1	5.6	7.7	6.1	3.1	0.3	11.5	3.8	0.5	0.4	7.7	2.0	1.0	1.6	6.4	15.9	9.2	2.7	5.2	10.6	2.7	8.8	4.5	4.1	8.5	9.0	6.0	1.4	5.0	6.4	6.1	6.1	2.7	1.1	4.5	2.2	2.5	3.2	6.3	2.8	5.9	10.0	3.3	6.5	9.4	3.3	6.2	8.2	2.0	0.9	1.5	1.6	0.6	1.1	1.3	1.3	1.1	0.3	1.8	1.6	0.8	3.1	1.1	1.1	1.0	1.5	0.6	3.4	2.0	4.4	2.6	3.3	1.1	1.9	1.9	2.7	2.2	0.0	1.4	1.5	0.9	1.1	4.8	0.6	0.0	0.0	2.3	1.8	0.0	7.1	0.0	0.6	6.1	0.6	0.0	0.0	0.2	19.4	1.9	0.5	0.0	0.0	2.1	0.0	0.0	1.8	1.2	3.6	0.9	0.4	0.0	1.0	1.4	2.0	0.3	0.0	1.1	0.1	2.0	0.0	0.5	22.4	24.3	1.3	10.5	0.5	1.5	0.8
ACTR3B	"ARP11, ARP3beta"	ENSG00000133627	"ARP3 actin related protein 3 homolog B"	Q9P1U1	7	152759749-152855378	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 38.1"	"Cell type enhanced"	"Detected in many"	5	"Melanocytes: 45.5;Peritubular cells: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047016, HPA051683"	Uncertain					NA	NA					"HPA047016: AB_2679903, HPA051683: AB_2681573"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.34e-3)"	"unprognostic (5.89e-2)"	"unprognostic (5.72e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.11e-3)"	"unprognostic (5.62e-2)"	"prognostic favorable (1.66e-4)"	"prognostic favorable (4.53e-4)"	"unprognostic (4.14e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.48e-2)"	3.3	8.2	16.4	3.8	38.1	3.9	7.5	12.7	37.3	4.6	4.0	6.2	7.8	4.4	5.2	8.8	3.3	8.6	3.2	5.1	21.9	11.2	7.1	7.0	3.5	4.5	8.1	14.1	6.8	8.7	11.7	10.9	3.9	7.9	4.4	4.5	5.3	13.6	5.4	6.6	4.4	3.6	3.7	5.1	3.3	5.0	14.8	5.8	2.6	5.7	1.8	4.8	4.2	2.7	2.7	1.9	0.4	0.8	2.5	4.7	2.7	11.9	5.8	10.9	13.6	3.3	4.2	9.1	6.3	4.0	2.6	2.6	7.0	7.1	10.2	4.9	4.1	4.9	4.4	10.0	3.0	3.2	3.7	5.3	4.1	4.0	6.5	3.5	5.6	1.7	2.1	3.7	1.5	3.9	1.8	3.3	4.2	21.3	0.2	5.6	12.5	8.2	11.0	23.6	11.8	6.5	6.7	4.2	8.0	4.3	6.7	21.6	18.2	8.0	6.3	5.3	4.2	6.5	4.5	1.9	2.6	0.6	3.4	5.4	9.1	9.9	7.0	5.3	8.1	5.5	0.0	0.8	0.0	2.1	0.5	2.7	1.7	2.2	4.3	1.9	2.7	4.7	2.7	0.4	2.5	0.3	1.0	3.0	2.7	16.4	38.1	12.7	23.9	21.9	11.2	8.1	14.1	7.9	5.8	6.0	0.6	7.6	4.5	2.4	18.0	3.6	2.5	6.7	3.4	3.5	21.6	7.4	26.6	4.8	25.5	3.5	1.3	0.0	4.9	6.3	3.4	5.7	4.6	7.4	2.7	14.3	10.4	2.5	1.8	29.5	39.7	2.7	45.5	1.8	3.6	31.9	4.4	3.5	50.9	5.1	19.9	6.5	4.7	24.4	23.4	1.4	10.4	1.8	3.7	3.4
DPP6	"DPL1, DPPX"	ENSG00000130226	"Dipeptidyl peptidase like 6"	P42658	7	153887097-154894285	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.7;endometrium 1: 24.5;thyroid gland: 24.1"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 13.3;Horizontal cells: 30.2;Late spermatids: 16.0;Melanocytes: 15.1;Muller glia cells: 18.7"	"Cancer enriched"	"Detected in some"	11	"glioma: 12.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	9	"NTERA-2: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050509	Enhanced	Supported				NA	NA					"HPA050509: AB_2681150"	"unprognostic (1.29e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.83e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.04e-3)"	"unprognostic (2.94e-3)"	"unprognostic (1.85e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.61e-3)"	"unprognostic (6.11e-2)"	1.6	7.2	15.4	1.4	32.5	1.3	1.5	26.6	45.7	2.3	6.8	8.7	0.0	1.6	24.5	3.1	1.5	4.6	1.3	1.4	26.6	15.2	3.6	1.2	2.2	1.3	14.0	22.7	1.3	4.0	1.2	4.9	1.3	18.8	1.5	2.4	0.4	1.3	8.1	4.6	3.7	2.0	15.8	7.2	4.2	3.5	7.9	10.0	0.0	24.1	0.0	1.2	1.3	0.4	0.6	0.6	1.9	0.9	0.9	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	11.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	1.2	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.9	0.4	0.7	0.4	0.6	0.7	0.6	0.6	0.4	0.4	0.6	0.7	0.7	1.6	0.9	0.9	0.6	0.5	0.3	15.4	32.5	26.6	32.4	26.6	15.2	14.0	22.7	18.8	10.0	0.0	0.0	0.0	0.4	3.0	9.3	5.9	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.1	13.3	0.0	0.0	0.0	3.6	0.0	0.3	0.1	0.0	0.0	0.2	30.2	9.9	0.0	0.0	16.0	1.1	0.0	15.1	0.0	0.2	18.7	0.5	0.0	3.5	0.3	6.0	0.0	0.3	0.9	1.7	1.4	0.0	0.0	0.0	0.1
PAXIP1	"CAGF28, CAGF29, PAXIP1L, PTIP, TNRC2"	ENSG00000157212	"PAX interacting protein 1"	Q6ZW49	7	154943687-155003084	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 32.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006694, HPA016950"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA006694: AB_1855011, HPA016950: AB_2669489"	"unprognostic (2.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-2)"	"unprognostic (7.39e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.98e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.30e-1)"	6.0	5.4	5.7	6.2	5.0	9.7	6.3	32.3	5.7	7.8	5.5	5.8	4.5	5.2	6.5	6.7	7.1	5.7	5.0	4.7	6.0	3.4	5.7	6.9	4.7	9.4	5.7	1.4	7.1	8.4	7.2	8.7	7.9	5.6	7.7	5.7	6.9	6.6	5.4	7.1	7.4	6.9	9.3	4.2	6.4	5.9	10.4	6.2	31.2	6.4	4.7	6.9	6.1	5.9	2.2	3.3	1.4	3.1	2.9	6.5	2.5	9.9	8.2	10.9	18.4	4.8	4.0	9.7	4.4	4.7	6.1	7.2	9.0	7.9	13.1	5.6	5.3	12.7	7.9	13.9	7.0	7.6	13.1	10.9	9.9	5.9	7.7	3.4	13.5	13.3	3.8	5.3	6.1	2.5	3.5	5.8	13.3	13.6	8.8	6.1	13.9	28.7	11.3	17.6	9.8	5.6	16.4	11.1	14.2	6.3	8.4	8.7	5.6	11.8	8.8	5.5	10.3	6.7	11.6	2.9	5.1	0.9	7.3	10.6	9.0	5.2	18.0	12.6	16.0	13.8	0.7	2.3	1.4	2.5	2.6	3.8	1.3	4.0	2.9	2.6	2.2	6.5	1.7	1.0	2.9	3.1	3.3	3.2	2.5	5.7	5.0	32.3	5.7	6.0	3.4	5.7	1.4	5.6	6.2	6.0	7.5	6.5	4.7	5.7	18.0	6.1	7.6	4.0	9.1	8.7	9.8	7.4	5.0	3.5	1.5	5.0	4.7	0.0	2.9	6.4	6.0	6.1	2.3	8.9	3.9	3.2	2.4	3.1	4.0	2.7	8.1	3.6	3.3	3.6	8.7	9.3	4.0	2.9	8.9	3.1	12.8	0.0	2.5	15.2	19.9	6.0	5.1	3.9	9.9	3.5
HTR5A	5-HT5A	ENSG00000157219	"5-hydroxytryptamine receptor 5A"	P47898	7	155070324-155085749	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"brain: 15.4"	"Group enriched"	"Detected in some"	14	"Early spermatids: 6.5;Late spermatids: 7.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB017467	Approved					NA	NA					"CAB017467: AB_2122566"					"unprognostic (1.62e-2)"										"unprognostic (1.15e-1)"			0.4	0.4	2.6	0.4	3.9	0.4	0.4	15.4	15.0	0.4	0.4	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	2.6	5.9	0.4	0.4	0.4	0.4	2.3	2.5	0.4	0.4	0.4	0.1	0.4	2.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.8	0.4	0.4	1.4	0.3	3.3	0.4	0.0	0.4	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.6	3.9	15.4	9.8	2.6	5.9	2.3	2.5	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
INSIG1	"CL-6, MGC1405"	ENSG00000186480	"Insulin induced gene 1"	O15503	7	155297776-155310235	"Plasma proteins, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 81.4;liver: 143.2"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 494.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 142.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"intermediate monocyte: 45.7;non-classical monocyte: 81.4"	"Lineage enriched"	"Detected in all"	6	"monocytes: 81.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 155.1;RPMI-8226: 72.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071524			Uncertain	Vesicles		NA	NA			Vesicles		"HPA071524: "	"unprognostic (8.11e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (9.62e-4)"	"unprognostic (4.97e-2)"	18.4	9.2	8.5	8.3	8.8	9.7	14.1	10.1	14.3	6.0	7.4	21.8	7.5	12.5	5.2	8.3	15.6	4.6	8.0	5.6	10.8	11.6	6.4	143.2	18.5	6.9	8.6	8.3	16.4	27.2	4.6	5.2	17.5	23.9	15.9	6.7	11.9	31.4	3.1	2.4	10.5	14.2	5.1	19.2	4.5	13.4	8.2	8.3	10.7	3.3	6.1	6.9	11.2	5.6	10.0	13.6	10.7	81.4	4.0	12.7	12.5	19.2	3.6	9.6	6.0	25.4	34.0	5.2	1.5	22.0	4.6	30.7	2.2	28.0	12.6	4.5	11.9	35.9	10.4	6.5	11.4	5.5	3.8	19.2	3.4	6.6	0.0	12.5	5.8	57.0	21.1	6.3	35.5	3.3	3.4	6.1	25.1	6.3	155.1	5.9	10.0	28.5	15.4	10.0	3.6	2.2	5.3	0.0	72.7	36.3	9.6	7.2	5.6	5.1	3.7	8.1	3.7	3.6	19.6	6.9	5.1	1.5	9.6	4.0	37.8	6.6	11.2	22.6	22.8	4.7	3.1	4.9	2.1	8.7	45.7	4.4	7.7	6.0	7.4	13.6	10.0	5.9	6.7	10.7	4.0	81.4	7.7	12.7	12.5	8.5	8.8	10.1	14.3	10.8	11.6	8.6	8.3	23.9	8.3	38.7	98.0	59.2	52.4	124.6	12.6	22.7	28.1	48.2	35.2	38.4	9.8	43.4	14.9	38.4	16.5	50.6	41.6	0.0	120.7	153.6	37.0	96.2	61.0	494.0	42.6	36.5	121.5	36.2	57.7	5.6	14.7	90.2	234.5	28.9	44.4	73.4	47.8	10.5	17.3	8.4	17.2	19.4	86.4	38.0	53.2	135.8	109.0	47.3	19.0	105.7
EN2		ENSG00000164778	"Engrailed homeobox 2"	P19622	7	155458129-155464831	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 26.5"	"Cell type enhanced"	"Detected in single"	16	"Spermatocytes: 1.2"	"Cancer enhanced"	"Detected in many"		"melanoma: 6.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 27.5;AN3-CA: 10.1;HAP1: 5.9;HEK 293: 16.7;SK-MEL-30: 8.1"	"Region enriched"	"Detected in some"	8	"cerebellum: 31.1"	"Region enriched"	"Detected in some"	6	"cerebellum: 71.6"	"HPA045646, HPA069809"			Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	No			Nucleoplasm	"Nucleoli fibrillar center"	"HPA045646: AB_2679404, HPA069809: AB_2686205"	"unprognostic (2.44e-3)"	"unprognostic (1.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.99e-3)"	"prognostic unfavorable (1.74e-6)"	"unprognostic (2.54e-1)"	"unprognostic (8.02e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.03e-13)"	"unprognostic (4.91e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.64e-3)"	0.3	0.2	0.1	0.0	0.1	0.0	0.1	26.5	0.1	0.0	0.0			0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.3		1.3	1.2	5.0	0.0	0.0		0.0	0.0		0.0	0.0	0.8	1.1	0.0	0.0	0.4	0.0	0.0	2.1			0.0		0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.5	27.5	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.9	0.0	5.9	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	3.5	0.0	0.0	0.0	0.0	1.3	0.0	2.1	0.0	0.1	0.2	0.0	0.0	2.0	0.0	8.1	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.5	0.1	0.0	0.0	0.0	0.0
CNPY1		ENSG00000146910	"Canopy FGF signaling regulator 1"	Q3B7I2	7	155474206-155555450	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	7	"brain: 21.1;pancreas: 8.5"	"Cell type enriched"	"Detected in single"	17	"Spermatogonia: 4.9"	"Cancer enriched"	"Detected in single"	10	"glioma: 1.6"	"Region enriched"	"Detected in some"	17	"cerebellum: 21.1"	"Cell type enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"AF22: 26.6"	"Region enriched"	"Detected in single"	29	"cerebellum: 215.6"					HPA047400	Uncertain					NA	NA					"HPA047400: AB_10960413"					"unprognostic (4.28e-3)"	"unprognostic (2.12e-1)"					"unprognostic (4.18e-2)"		"unprognostic (8.27e-12)"	"unprognostic (1.44e-1)"	"unprognostic (2.16e-1)"			0.1	0.0	0.2	0.1	0.3	0.7	0.1	21.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.3	0.9	0.1	0.2	8.5	0.0	0.2	0.1	1.2	0.1	0.1	0.5	0.2	0.1	0.1	1.2	0.5	0.1	0.5	0.1	0.2	2.1	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0.3	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.4	0.0	2.3	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.2	0.0	0.0	0.2	0.0	0.0	0.1	0.6	0.1	0.1	0.5	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.3	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.3	21.1	0.5	0.2	0.2	0.9	0.1	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.9	0.0	0.0	0.0	0.0	0.0
RBM33	"DKFZp434D1319, DKFZp686F102, MGC20460, PRR8"	ENSG00000184863	"RNA binding motif protein 33"	Q96EV2	7	155644451-155781485	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Horizontal cells: 125.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019232, HPA021497, HPA021768"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA019232: AB_1856121, HPA021497: AB_2176261, HPA021768: AB_1856123"	"unprognostic (1.35e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (9.63e-5)"	"unprognostic (3.48e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.85e-2)"	"unprognostic (3.89e-2)"	"unprognostic (8.90e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.46e-2)"	"prognostic favorable (4.29e-4)"	16.8	14.1	18.6	24.5	20.9	65.0	16.2	46.1	27.6	14.8	15.1	24.1	13.4	17.2	16.3	21.9	16.4	11.9	14.1	13.2	16.3	12.5	15.6	21.0	19.8	21.1	22.8	14.9	19.3	20.5	14.3	29.1	13.2	16.4	15.7	16.2	13.8	15.9	13.6	33.0	26.9	20.8	14.0	25.5	21.4	17.1	16.0	20.8	28.5	17.3	10.2	19.7	13.8	18.7	5.7	5.7	23.9	6.8	5.0	5.6	2.5	16.8	19.8	12.4	11.5	6.6	8.8	12.6	10.6	7.5	6.5	9.6	18.0	16.1	18.6	14.4	7.8	17.9	12.1	11.3	8.9	8.8	17.6	16.3	17.7	20.7	11.7	7.4	24.9	17.9	8.5	10.6	10.5	15.0	9.7	11.5	20.9	22.5	15.4	9.3	16.2	25.6	21.6	13.4	11.3	13.0	20.7	13.9	15.3	9.5	18.1	12.8	13.1	17.8	12.0	10.0	9.8	9.0	13.2	13.5	11.2	6.7	20.1	14.1	27.3	20.6	27.7	18.4	16.6	14.3	16.3	6.8	13.7	4.5	6.3	3.6	5.7	4.5	5.4	5.6	5.3	4.1	5.2	23.9	5.0	4.9	5.7	5.6	2.5	18.6	20.9	46.1	27.6	16.3	12.5	22.8	14.9	16.4	20.8	29.8	28.4	44.1	18.2	17.4	54.2	25.2	12.7	17.4	12.5	3.5	78.5	15.9	6.6	16.4	18.4	20.7	29.0	23.3	15.5	14.0	14.9	26.2	37.1	25.1	14.0	125.5	25.2	16.0	26.6	29.8	24.2	26.3	11.8	30.7	25.7	29.4	19.7	26.2	16.6	13.8	96.9	12.9	19.6	29.3	22.4	20.6	21.9	32.0	21.8	22.2
SHH	"HHG1, HLP3, HPE3, MCOPCB5, SMMCI, TPT, TPTPS"	ENSG00000164690	"Sonic hedgehog"	Q15465	7	155799986-155812273	"Disease related genes, Predicted intracellular proteins"		"Developmental protein, Hydrolase, Protease"	"Disease mutation, Holoprosencephaly, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.7;liver: 18.4"	"Cell type enhanced"	"Detected in some"	9	"Cholangiocytes: 12.7;Collecting duct cells: 8.7;Hepatocytes: 16.4;Urothelial cells: 7.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.2;GAMG: 28.0;OE19: 6.8;RT4: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"	NA	NA		3600000				"unprognostic (7.17e-2)"	"unprognostic (7.68e-3)"	"unprognostic (6.70e-2)"	"prognostic favorable (8.62e-5)"	"unprognostic (1.59e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.66e-2)"	0.3	11.9	1.1	1.0	2.4	0.2	0.2	0.6	2.5	6.1	1.7	0.4	4.7	1.9	0.9	9.5	0.3	0.3	27.7	0.2	0.9	3.0	3.8	18.4	2.9	0.1	1.9	0.9	0.2	0.4	0.1	0.4	0.1	5.7	6.0	1.5	0.0	0.2	2.7	0.2	0.4	1.8	5.2	1.7	0.2	13.6	0.3	0.6	0.0	0.2	0.0	0.1	14.1	3.1	0.2	0.8	1.5	0.4	0.4	0.4	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.6	0.0	6.2	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	6.8	2.8	0.0	0.0	0.0	1.4	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.4	0.1	0.2	0.4	0.2	0.2	0.2	0.1	0.2	0.2	0.3	1.5	0.4	0.4	0.8	0.2	0.3	1.1	2.4	0.6	2.5	0.9	3.0	1.9	0.9	5.7	0.6	3.0	5.6	0.0	5.8	0.0	0.4	0.6	12.7	0.0	2.3	8.7	0.0	0.0	0.0	1.3	2.9	0.0	2.5	0.0	0.7	0.1	0.0	0.7	0.0	16.4	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	6.7	0.0	7.4	0.0	0.4	5.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	7.8
RNF32	"FKSG33, HSD15, LMBR2"	ENSG00000105982	"Ring finger protein 32"	Q9H0A6	7	156640281-156677130	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"testis: 55.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 227.1;Late spermatids: 367.1;Spermatocytes: 116.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 11.3;HDLM-2: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019516, HPA073560"	Enhanced		Supported	"Nuclear bodies,Cytosol"		NA	NA			Cytosol	"Nuclear bodies"	"HPA019516: , HPA073560: AB_2686616"	"unprognostic (9.23e-2)"	"unprognostic (3.01e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (7.85e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-2)"	"unprognostic (5.73e-3)"	"unprognostic (1.71e-2)"	"unprognostic (8.72e-3)"	"unprognostic (6.08e-4)"	"unprognostic (4.64e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.15e-3)"	"unprognostic (1.25e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.44e-1)"	1.1	1.0	2.2	0.8	2.6	0.9	0.8	1.0	2.2	0.6	1.2	4.7	0.8	1.0	0.6	7.7	0.6	2.2	1.6	0.4	2.0	1.9	1.5	0.8	1.0	1.2	1.8	2.2	1.8	2.6	0.8	2.6	0.9	2.0	1.5	1.0	0.7	1.4	0.6	0.6	1.4	0.9	0.1	2.8	0.8	1.9	55.2	1.9	1.1	1.7	0.0	0.9	0.6	0.6	3.7	3.5	10.5	0.6	0.6	2.8	0.9	4.2	2.2	0.4	1.1	1.0	0.6	0.6	0.7	0.1	1.1	0.9	11.3	4.9	6.9	5.4	0.7	1.2	0.1	0.0	0.2	2.2	12.5	2.9	0.6	0.8	0.4	1.0	1.9	4.0	1.7	0.8	0.6	2.3	0.7	0.5	6.1	9.9	1.9	3.4	7.4	2.7	4.8	2.4	7.1	5.5	2.7	0.1	3.1	1.6	1.4	7.1	5.5	4.2	0.4	2.1	1.1	1.2	1.4	1.8	0.0	0.1	0.9	0.5	10.1	4.3	3.9	0.8	4.5	1.7	10.5	0.5	1.8	0.6	0.3	2.2	3.7	2.3	0.6	1.4	2.6	0.6	0.7	0.1	0.6	0.6	3.5	2.8	0.9	2.2	2.6	1.0	2.2	2.0	1.9	1.8	2.2	2.0	1.9	6.0	1.6	0.5	1.9	0.2	2.3	1.2	5.1	54.9	7.9	3.5	0.0	0.0	5.0	1.8	227.1	0.1	2.1	0.0	2.9	0.4	0.6	1.8	5.7	2.1	0.3	1.6	4.1	1.3	0.0	367.1	6.1	1.1	1.7	0.0	2.9	2.7	2.3	0.0	3.9	4.1	2.0	0.0	0.5	116.1	17.9	0.5	0.1	0.0	2.1	0.8
LMBR1	"ACHP, C7orf2, FLJ11665, ZRS"	ENSG00000105983	"Limb development membrane protein 1"	Q8WVP7	7	156668946-156893230	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016592	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA016592: AB_1852943"	"unprognostic (8.81e-3)"	"unprognostic (1.73e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.77e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.44e-6)"	"unprognostic (3.35e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.10e-2)"	15.8	30.5	15.2	12.4	23.7	7.1	12.9	20.4	25.5	16.3	10.1	13.4	12.8	9.1	19.0	19.4	12.1	16.9	12.8	12.9	15.9	17.4	17.5	15.9	11.5	11.3	17.8	11.5	18.9	12.0	38.2	22.7	11.6	24.4	14.1	12.2	11.3	10.6	13.1	14.8	11.2	10.9	15.1	14.4	9.4	12.7	20.3	13.2	14.7	20.9	8.7	12.8	13.9	12.3	2.3	3.6	4.2	2.0	0.9	4.1	1.5	12.5	11.0	12.5	15.4	10.1	12.2	8.5	7.3	9.2	6.6	7.3	7.9	20.5	12.3	14.0	9.4	12.4	10.1	13.1	13.6	14.0	8.8	13.3	9.1	6.1	9.5	7.0	11.2	6.3	9.2	12.3	9.6	12.6	10.5	14.2	10.5	17.4	11.3	13.4	11.8	11.2	9.0	14.5	13.3	9.9	6.1	8.9	15.0	10.4	12.5	13.3	24.8	9.6	13.1	7.0	8.4	9.2	6.2	19.9	11.9	4.6	40.9	9.2	13.7	10.7	12.2	20.2	14.3	7.3	4.2	2.0	2.7	1.7	1.0	4.1	1.3	3.6	2.6	3.6	2.3	4.0	2.5	1.5	0.9	1.7	2.2	2.2	1.5	15.2	23.7	20.4	25.5	15.9	17.4	17.8	11.5	24.4	13.2	3.0	7.2	6.4	11.5	9.3	11.2	15.4	12.7	5.3	4.5	12.2	2.0	12.6	5.0	9.4	6.0	20.0	8.4	0.0	8.9	4.8	11.6	16.2	5.7	18.1	8.5	7.9	7.9	8.6	8.6	8.0	9.8	6.1	6.8	4.6	9.7	6.5	10.3	7.0	8.1	9.4	10.6	0.0	6.0	9.6	27.4	11.2	19.3	5.7	11.0	13.3
NOM1	"C7orf3, PPP1R113, SGD1"	ENSG00000146909	"Nucleolar protein with MIF4G domain 1"	Q5C9Z4	7	156949723-156973182	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019866, HPA051624"	Approved		Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA019866: AB_2670300, HPA051624: AB_2681556"	"unprognostic (1.24e-1)"	"unprognostic (7.47e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.49e-1)"	12.3	10.9	10.8	16.9	14.2	15.3	11.1	13.0	15.9	9.7	11.4	9.9	11.1	8.9	12.8	9.0	12.9	11.4	8.1	8.3	11.2	6.4	8.4	12.2	9.9	13.4	11.9	11.7	13.9	14.5	11.1	8.4	10.3	11.4	9.6	10.0	9.3	10.5	12.5	21.0	15.5	10.5	12.0	10.0	12.1	10.6	13.9	11.9	9.9	9.9	9.8	12.4	11.4	17.0	5.0	2.8	2.5	2.8	2.6	3.4	0.9	9.1	7.9	5.8	8.7	5.9	6.2	8.0	9.2	4.5	7.5	6.1	8.5	7.8	16.1	9.3	7.4	7.6	7.5	10.5	11.1	9.2	7.3	9.2	13.5	6.6	7.9	4.8	23.5	8.3	4.4	5.5	6.7	8.7	4.3	6.3	9.1	20.3	8.7	6.7	12.0	14.8	19.7	14.1	8.2	8.6	10.6	8.9	12.4	4.8	11.0	7.2	8.8	8.4	6.7	6.3	6.9	3.2	12.7	10.1	8.1	2.6	15.0	11.8	11.2	8.0	14.9	10.4	17.0	7.6	2.5	2.8	1.5	2.1	1.9	1.2	3.8	2.7	2.9	2.8	5.0	3.4	1.8	1.3	2.6	2.1	2.8	1.0	0.9	10.8	14.2	13.0	15.9	11.2	6.4	11.9	11.7	11.4	11.9	8.9	16.5	13.4	26.4	34.9	15.8	9.2	12.7	17.4	18.2	5.2	19.6	12.5	3.3	16.5	7.2	14.4	6.4	0.0	11.8	17.3	12.0	18.5	19.8	13.1	12.8	11.1	7.5	6.7	10.5	1.8	16.1	18.2	23.6	14.4	10.4	9.8	12.4	10.5	12.4	4.9	30.5	0.0	14.6	28.2	35.7	37.1	6.1	12.8	14.6	26.9
MNX1	"HB9, HLXB9, HOXHB9, SCRA1"	ENSG00000130675	"Motor neuron and pancreas homeobox 1"	P50219	7	156994051-157010651	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pancreas: 43.3"	"Cell type enhanced"	"Detected in some"	15	"Intestinal endocrine cells: 24.1;Mucus-secreting cells: 18.0;Paneth cells: 9.0;Undifferentiated cells: 12.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.8;BEWO: 8.8;EFO-21: 11.3;HEK 293: 9.0;RPMI-8226: 24.7;SCLC-21H: 13.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071717			Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA071717: AB_2686437"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.07e-2)"	"unprognostic (5.06e-2)"	"unprognostic (8.62e-4)"	"unprognostic (1.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.23e-5)"	"unprognostic (1.67e-3)"	"unprognostic (5.80e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.08e-1)"	0.1	0.0	0.1	0.4	0.2	0.0	0.1	0.2	0.1	0.1	6.0	0.2	0.1	9.0	0.1	0.1	0.3	0.0	7.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	43.3	0.0	3.2	0.1	0.2	0.8	3.7	0.1	1.9	0.1	0.1	0.1	7.3	0.1	0.2	0.1	2.7	1.0	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	3.9	0.0	11.8	0.0	0.0	8.8	0.0	0.0	0.1	0.0	5.1	1.7	0.9	11.3	0.0	0.3	0.2	2.0	1.6	0.9	1.4	9.0	0.0	0.8	2.3	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	4.1	3.7	1.9	0.0	6.6	0.6	0.1	0.0	1.1	0.7	0.0	1.7	24.7	4.4	0.4	13.3	0.0	1.7	1.5	0.2	0.1	3.7	2.9	0.0	0.0	0.0	0.0	0.0	3.7	1.9	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.7	0.0	4.3	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	24.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	18.0	0.0	2.5	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	12.4	0.0
UBE3C	"KIAA0010, KIAA10"	ENSG00000009335	"Ubiquitin protein ligase E3C"	Q15386	7	157138913-157269372	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039915	Approved		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	NA			"Nucleoplasm, Mitochondria"	"Plasma membrane"	"HPA039915: AB_10795264"	"unprognostic (2.83e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.41e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.01e-3)"	"unprognostic (8.64e-2)"	"prognostic favorable (9.18e-6)"	"unprognostic (9.74e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.60e-2)"	24.7	21.0	14.0	17.9	23.1	12.4	19.8	25.5	29.9	21.3	23.4	17.2	15.3	17.4	28.8	16.8	26.8	18.8	24.8	31.8	14.4	13.8	21.2	30.5	16.7	16.7	14.5	15.1	20.7	22.1	29.6	20.3	21.3	22.3	19.0	21.0	20.2	31.7	21.5	51.2	21.2	23.9	25.7	16.1	20.5	21.8	35.9	11.1	20.3	15.6	24.5	24.4	23.1	19.1	2.5	4.0	2.1	4.6	3.7	6.6	2.9	22.8	18.2	11.7	23.3	21.0	22.1	12.9	25.3	21.9	21.4	21.7	16.3	19.1	12.4	22.5	27.9	27.9	14.5	18.1	23.3	25.4	22.5	16.6	12.6	12.7	11.7	20.9	18.8	18.5	19.5	21.6	23.7	19.7	16.3	24.9	10.4	18.3	13.8	30.2	20.0	18.4	11.9	18.5	20.5	21.9	10.6	13.1	25.4	22.1	25.2	18.7	19.3	24.9	21.5	18.5	13.6	11.1	13.2	22.3	27.0	5.8	66.1	31.3	13.9	13.9	12.5	31.0	28.1	30.8	0.5	3.5	2.1	4.8	4.6	6.6	2.5	5.2	5.2	4.0	2.5	4.9	5.9	1.3	3.7	4.5	3.6	5.2	2.9	14.0	23.1	25.5	29.9	14.4	13.8	14.5	15.1	22.3	11.1	20.8	19.5	9.7	13.9	24.5	31.4	31.5	28.1	16.0	9.1	24.4	62.8	12.2	8.3	17.0	8.4	19.9	22.1	0.0	15.2	14.4	14.7	19.9	9.2	39.2	13.9	30.2	23.5	24.5	21.2	8.5	14.4	15.0	5.0	12.6	20.6	10.9	22.5	10.5	24.1	16.5	42.8	0.0	17.6	20.4	27.4	29.1	12.6	13.8	22.4	27.3
DNAJB6	"LGMD1D, MRJ"	ENSG00000105993	"DnaJ heat shock protein family (Hsp40) member B6"	O75190	7	157335381-157417439	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Suprabasal keratinocytes: 839.6;Urothelial cells: 816.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004670, HPA024258, HPA058593"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004670: AB_425825, HPA024258: AB_1847795, HPA058593: AB_2683767"	"unprognostic (4.37e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.22e-2)"	"unprognostic (9.26e-3)"	"unprognostic (6.66e-3)"	"unprognostic (4.68e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.71e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.41e-2)"	"unprognostic (3.19e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.52e-1)"	24.0	23.1	38.0	17.9	35.0	51.3	40.5	42.2	41.3	17.1	25.5	21.7	19.1	14.5	23.3	38.8	33.2	20.9	17.3	37.0	31.7	32.2	24.5	16.7	19.4	16.4	37.6	32.2	22.8	18.8	17.2	20.2	24.4	37.7	19.5	17.2	15.3	20.1	25.6	96.9	34.2	15.6	31.7	33.9	17.2	16.8	38.3	35.2	12.2	17.9	23.5	21.9	23.4	51.9	32.7	30.4	74.3	48.1	35.5	42.1	55.0	37.8	23.0	28.0	28.3	28.4	25.8	25.9	42.6	34.9	39.7	43.6	31.3	38.3	14.6	80.3	31.5	36.1	24.3	19.0	29.8	61.6	29.2	26.0	26.1	13.9	22.1	26.2	19.3	22.0	22.6	28.9	30.0	14.3	39.9	29.5	15.7	42.3	14.6	50.8	25.7	48.2	38.1	56.0	26.8	30.7	26.0	20.2	20.3	32.7	23.2	16.9	44.7	33.3	26.1	31.1	60.4	19.0	27.4	36.7	25.1	19.1	59.7	36.6	28.0	39.9	17.1	35.7	44.5	31.7	70.6	41.5	48.8	36.2	41.6	36.1	32.7	33.2	37.2	30.4	28.1	42.1	39.3	74.3	35.5	48.1	27.6	38.9	55.0	38.0	35.0	42.2	41.3	31.7	32.2	37.6	32.2	37.7	35.2	44.7	57.9	61.6	535.0	672.2	87.1	103.2	40.8	135.1	83.0	92.5	76.6	239.3	164.2	120.8	82.9	125.4	92.1	46.7	61.0	198.1	160.4	315.0	212.0	42.7	149.9	89.0	185.4	94.5	124.0	94.1	139.8	162.9	268.2	444.6	63.2	102.0	105.0	73.7	190.2	165.4	87.6	97.0	208.1	297.0	373.7	839.6	425.0	152.3	79.1	816.5
PTPRN2	"IA-2beta, ICAAR, KIAA0387, phogrin"	ENSG00000155093	"Protein tyrosine phosphatase, receptor type N2"	Q92932	7	157539056-158587788	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Protein phosphatase, Receptor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6;pancreas: 51.3"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 84.3;Intestinal endocrine cells: 126.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 40.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 14.8"	"Cell line enhanced"	"Detected in some"		"AF22: 15.6;HDLM-2: 22.0;NB-4: 22.6;SCLC-21H: 12.5;SH-SY5Y: 12.7;THP-1: 11.1;U-87 MG: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006900, HPA007255, HPA026656"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA006900: AB_1079715, HPA007255: , HPA026656: AB_1855912"	"unprognostic (2.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (9.37e-5)"	"unprognostic (7.12e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.16e-2)"	2.1	10.5	20.1	1.7	33.9	1.0	1.1	6.2	40.6	1.7	4.6	2.9	0.0	5.1	2.0	2.9	1.5	6.9	4.7	1.9	18.2	21.3	2.0	1.2	3.1	2.1	11.3	22.3	5.8	51.3	0.5	20.0	1.5	10.3	10.2	3.7	1.5	3.4	2.6	0.8	0.7	4.2	1.6	5.3	7.7	24.2	2.2	5.2	0.0	5.6	0.3	1.7	2.8	0.6	3.4	1.3	14.8	1.1	1.5	3.5	1.1	0.0	0.2	15.6	1.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.6	0.2	3.7	0.0	0.4	0.0	0.0	22.0	0.2	0.0	0.0	2.5	0.6	0.0	0.0	1.1	0.2	0.0	0.1	0.1	0.0	1.1	0.0	0.1	0.0	0.2	6.5	22.6	3.1	5.5	0.8	0.0	0.7	0.1	0.0	0.0	12.5	12.7	0.0	0.0	0.0	0.0	0.0	11.1	3.3	5.1	1.9	0.0	0.4	0.1	0.0	0.0	15.4	9.2	3.7	8.7	1.1	1.6	0.9	0.1	0.3	2.3	1.5	1.1	1.3	3.4	1.4	0.9	14.8	1.5	0.0	0.2	3.5	1.1	20.1	33.9	6.2	40.6	18.2	21.3	11.3	22.3	10.3	5.2	3.0	11.7	10.4	12.5	2.1	31.6	2.2	7.6	84.3	13.6	38.4	9.8	0.4	29.9	15.8	35.1	23.3	4.5	0.0	11.7	0.4	3.9	21.1	18.5	0.8	34.3	11.1	126.1	41.1	11.0	13.1	11.5	6.0	11.8	3.6	39.6	40.1	6.1	5.8	18.4	3.5	6.3	25.8	5.1	41.6	11.7	1.3	0.6	10.0	7.2	22.5
NCAPG2	"CAP-G2, FLJ20311, hCAP-G2, LUZP5, MTB"	ENSG00000146918	"Non-SMC condensin II complex subunit G2"	Q86XI2	7	158631311-158704829	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 39.1"	"Cell type enhanced"	"Detected in many"	10	"Spermatocytes: 40.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026631, HPA049637"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"HPA026631: AB_1845983, HPA049637: "	"unprognostic (2.73e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (7.94e-4)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.91e-4)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (5.33e-3)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (4.06e-5)"	"unprognostic (2.58e-3)"	"unprognostic (1.28e-1)"	"unprognostic (8.21e-2)"	"unprognostic (7.37e-2)"	5.9	4.0	4.4	8.6	4.2	20.1	5.4	9.0	5.1	4.4	6.6	5.8	3.5	4.2	5.1	5.1	9.9	3.7	3.1	4.0	4.3	3.5	3.3	3.9	4.4	11.4	6.2	4.2	4.4	4.4	6.0	5.8	6.9	4.9	4.5	7.7	3.9	5.3	4.2	4.5	6.5	5.5	4.6	6.2	6.1	5.3	14.6	5.1	39.1	3.6	7.6	13.0	4.8	5.5	1.8	2.8	6.9	5.4	6.1	9.3	2.5	30.0	16.0	19.5	12.5	2.9	4.8	7.7	22.0	14.2	27.3	30.6	14.1	15.8	18.6	13.8	9.0	29.0	15.5	16.2	10.1	36.5	19.8	12.0	16.8	19.9	11.1	1.3	20.7	19.0	2.0	1.1	22.2	6.4	5.0	15.1	21.8	20.6	28.0	25.0	32.0	34.4	14.0	19.2	17.1	13.0	20.2	20.5	17.7	6.7	13.5	21.3	16.5	27.2	10.6	6.0	13.0	9.6	13.5	7.9	18.7	14.3	50.4	35.3	18.5	13.6	22.6	19.8	26.5	35.4	6.9	1.0	1.2	6.5	1.4	9.3	1.8	6.6	4.5	2.8	1.2	2.2	2.4	0.6	6.1	5.4	1.4	8.3	2.5	4.4	4.2	9.0	5.1	4.3	3.5	6.2	4.2	4.9	5.1	6.0	1.0	1.5	1.1	3.5	3.8	3.4	2.5	8.1	6.8	1.8	0.0	2.6	0.0	2.3	9.3	2.2	0.4	0.0	2.9	8.4	2.7	0.9	1.1	2.1	6.1	7.9	0.0	4.3	2.7	4.0	2.6	4.7	1.7	2.8	1.7	1.9	1.6	0.0	3.9	1.1	2.8	6.5	4.1	40.1	15.6	1.8	2.2	5.1	1.8	2.3
ESYT2	"CHR2SYT, FAM62B, KIAA1228"	ENSG00000117868	"Extended synaptotagmin 2"	A0FGR8	7	158730995-158830253	"Plasma proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002132	Approved		Uncertain	Cytosol		NA	NA		130000	Cytosol		"HPA002132: AB_1078807"	"unprognostic (2.30e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.72e-2)"	"unprognostic (5.43e-2)"	"unprognostic (9.01e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.13e-1)"	"unprognostic (7.54e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.58e-2)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (2.81e-5)"	33.3	25.6	15.3	16.2	23.5	19.6	27.3	21.7	26.3	26.7	27.9	17.8	21.6	15.8	31.2	31.0	32.5	28.3	31.1	28.4	16.1	17.5	20.6	16.7	26.1	18.0	15.6	16.7	41.6	23.2	29.7	22.0	35.2	20.6	21.1	22.6	23.4	26.7	31.4	34.5	24.5	22.5	37.8	14.9	13.2	19.4	13.3	12.1	29.0	30.5	24.3	23.2	30.5	27.6	1.4	3.6	2.0	2.3	6.6	8.5	2.9	29.6	17.8	5.7	6.0	19.2	22.3	19.0	14.0	14.3	11.2	12.6	9.9	39.0	9.1	16.2	25.1	23.1	14.8	8.2	14.7	10.8	9.4	8.4	7.5	14.2	10.5	19.6	26.9	17.2	16.1	18.3	12.6	16.9	22.5	13.2	24.8	16.1	30.8	18.2	24.9	27.9	19.5	9.1	20.0	17.2	23.8	11.0	11.2	19.0	12.7	16.7	9.2	44.6	36.1	20.3	13.9	13.1	29.5	20.4	12.4	6.5	54.7	17.8	21.1	5.4	8.9	30.7	28.0	36.5	2.0	1.9	1.5	8.5	2.3	4.7	1.4	7.1	6.0	3.6	1.0	6.7	7.9	1.2	6.6	1.5	2.4	5.8	2.9	15.3	23.5	21.7	26.3	16.1	17.5	15.6	16.7	20.6	12.1	35.7	32.5	9.0	10.9	41.0	15.1	25.8	22.9	36.1	33.0	45.4	15.7	24.1	3.3	13.5	11.2	41.4	27.1	23.3	17.1	22.4	41.1	18.3	11.6	17.4	18.3	12.7	20.3	25.2	23.8	3.0	32.5	22.6	49.0	10.8	29.5	15.2	24.1	5.8	51.2	8.2	10.6	32.3	52.8	10.9	10.0	45.2	34.1	25.9	22.5	21.4
WDR60	"FAP163, FLJ10300"	ENSG00000126870	"WD repeat domain 60"	Q8WVS4	7	158856578-158956747	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 401.8;Rod photoreceptor cells: 217.0;Spermatocytes: 279.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020607, HPA021316"	Approved		Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA020607: AB_1858817, HPA021316: AB_2215577"	"unprognostic (1.22e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.05e-1)"	"unprognostic (9.18e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.13e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.98e-1)"	14.5	9.5	19.0	7.7	18.0	6.0	11.2	18.0	22.8	12.1	13.7	9.8	8.6	10.9	11.4	15.3	8.2	17.3	8.7	17.4	15.9	8.7	10.3	4.9	10.4	6.1	9.0	16.7	12.2	7.3	19.9	24.5	8.3	13.7	8.4	7.7	8.0	9.5	9.1	33.5	7.9	11.7	9.2	12.4	8.7	9.4	44.3	14.2	7.0	13.1	4.9	4.5	12.4	9.0	12.9	24.1	18.6	5.0	5.5	8.0	1.3	10.3	10.4	7.4	17.6	5.8	5.6	3.3	6.5	5.9	5.4	5.9	5.0	9.5	4.1	10.3	4.0	6.6	4.9	3.4	7.0	6.1	4.4	6.8	5.5	6.4	2.2	5.8	6.2	12.8	4.6	5.3	4.2	1.8	12.9	4.4	3.0	16.3	2.3	6.3	6.1	10.3	5.7	6.4	3.9	6.8	9.3	7.4	5.0	9.2	5.3	14.8	10.5	13.3	8.1	7.6	6.7	5.9	3.9	5.4	6.8	2.4	22.1	4.8	6.2	6.6	8.9	18.6	6.1	10.1	18.6	5.0	2.5	8.0	3.1	7.2	10.2	6.2	6.6	3.0	12.9	6.0	6.2	3.1	5.5	3.2	24.1	2.8	1.3	19.0	18.0	18.0	22.8	15.9	8.7	9.0	16.7	13.7	14.2	23.8	36.3	9.3	15.4	17.3	71.4	70.2	10.2	198.1	54.6	45.4	155.1	14.0	24.9	22.0	401.8	45.0	49.0	0.0	12.1	9.5	23.7	13.6	11.6	11.3	7.0	82.6	30.5	17.2	11.8	138.6	55.3	12.9	21.9	9.0	28.1	49.5	14.2	22.8	55.9	18.1	217.0	51.8	38.1	279.9	49.8	13.7	9.6	14.6	23.0	9.7
VIPR2	"VPAC2, VPAC2R"	ENSG00000106018	"Vasoactive intestinal peptide receptor 2"	P41587	7	159028175-159144957	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Muller glia cells: 32.3;Rod photoreceptor cells: 44.5"	"Cancer enhanced"	"Detected in some"		"glioma: 2.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"plasmacytoid DC: 13.1"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 13.1"	"Cell line enhanced"	"Detected in some"		"HeLa: 4.2;HMC-1: 6.5;MOLT-4: 8.8;U-266/70: 29.8"	"Region enhanced"	"Detected in some"		"olfactory region: 33.2"	"Low region specificity"	"Detected in all"			HPA062707	Approved		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA062707: AB_2684842"	"unprognostic (3.65e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.04e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.89e-2)"	9.6	1.2	2.1	2.9	1.3	0.6	2.1	0.9	10.2	18.0	10.6	1.5	14.1	2.1	11.5	14.3	3.1	3.3	4.7	13.3	2.6	1.8	1.0	0.6	0.6	3.0	1.9	2.3	10.8	15.7	0.3	2.6	6.4	2.1	8.4	1.5	4.9	1.1	24.0	7.3	0.6	3.9	7.1	2.4	1.1	8.3	2.4	1.1	16.9	0.4	0.7	0.8	5.7	9.9	0.0	13.1	0.1	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.2	8.8	0.0	0.7	0.0	0.0	2.2	0.1	0.5	0.0	0.0	2.1	1.7	0.1	0.1	0.0	0.2	0.0	0.5	0.0	0.0	0.3	0.0	0.0	29.8	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.1	0.2	0.1	0.0	0.0	13.1	0.0	0.1	2.1	1.3	0.9	10.2	2.6	1.8	1.9	2.3	2.1	1.1	0.0	0.0	0.0	2.2	0.6	1.4	6.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	5.8	0.0	1.5	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	9.5	0.0	1.7	0.0	0.0	32.3	0.8	0.0	2.5	0.3	44.5	0.0	8.0	3.7	2.1	0.0	0.0	2.9	0.0	0.1
